<SEC-DOCUMENT>0001516513-22-000037.txt : 20220527
<SEC-HEADER>0001516513-22-000037.hdr.sgml : 20220527
<ACCEPTANCE-DATETIME>20220527163145
ACCESSION NUMBER:		0001516513-22-000037
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		111
CONFORMED PERIOD OF REPORT:	20220331
FILED AS OF DATE:		20220527
DATE AS OF CHANGE:		20220527

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Doximity, Inc.
		CENTRAL INDEX KEY:			0001516513
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER PROGRAMMING SERVICES [7371]
		IRS NUMBER:				272485512
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40508
		FILM NUMBER:		22978178

	BUSINESS ADDRESS:	
		STREET 1:		500 THIRD STREET
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94107
		BUSINESS PHONE:		(650) 549-4330

	MAIL ADDRESS:	
		STREET 1:		500 THIRD STREET
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94107
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>docs-20220331.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:7e9381b6-a1e4-41b8-8d47-38883b11be1e,g:11b17cc6-874f-42e4-b7f0-55cdc6f63454,d:6c4404140edb48938ba4e30b290c9ef9--><html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:docs="http://www.doximity.com/20220331" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>docs-20220331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODAzL2ZyYWc6MDM5NWU3OWJlZTRkNGY5ZmE3NzZhZTg2ZTlkZmJiOGMvdGFibGU6Y2M0ZjU3ZWNiYmNiNDAyNmJjMjZkMTdkNWRlNmRjNDgvdGFibGVyYW5nZTpjYzRmNTdlY2JiY2I0MDI2YmMyNmQxN2Q1ZGU2ZGM0OF8yLTEtMS0xLTEwNDY4Nw_068ef9e3-8ee8-4cc7-bedd-65399215c2b6">0001516513</ix:nonNumeric><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODAzL2ZyYWc6MDM5NWU3OWJlZTRkNGY5ZmE3NzZhZTg2ZTlkZmJiOGMvdGFibGU6Y2M0ZjU3ZWNiYmNiNDAyNmJjMjZkMTdkNWRlNmRjNDgvdGFibGVyYW5nZTpjYzRmNTdlY2JiY2I0MDI2YmMyNmQxN2Q1ZGU2ZGM0OF8zLTEtMS0xLTEwNDY4Nw_73e6d250-646b-431c-b9ed-6d12e81f86e9">2022</ix:nonNumeric><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODAzL2ZyYWc6MDM5NWU3OWJlZTRkNGY5ZmE3NzZhZTg2ZTlkZmJiOGMvdGFibGU6Y2M0ZjU3ZWNiYmNiNDAyNmJjMjZkMTdkNWRlNmRjNDgvdGFibGVyYW5nZTpjYzRmNTdlY2JiY2I0MDI2YmMyNmQxN2Q1ZGU2ZGM0OF80LTEtMS0xLTEwNDY4Nw_bad8dffc-696e-4d5c-85e9-43c5359eb11c">FY</ix:nonNumeric><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODAzL2ZyYWc6MDM5NWU3OWJlZTRkNGY5ZmE3NzZhZTg2ZTlkZmJiOGMvdGFibGU6Y2M0ZjU3ZWNiYmNiNDAyNmJjMjZkMTdkNWRlNmRjNDgvdGFibGVyYW5nZTpjYzRmNTdlY2JiY2I0MDI2YmMyNmQxN2Q1ZGU2ZGM0OF81LTEtMS0xLTEwNDY4Nw_a169f3f6-5d11-48e7-85b6-6baf38ded094">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="docs-20220331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifada4ef299464095aeb979c9bc3805d7_I20210930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i74d0f3bb04994da080b1e644b3d7dc0a_I20220520"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ia4b07bfbd2c7447999b3dc774b9c116e_I20220520"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fbc45340fb149a4a4218570cd8171e7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27e150c7cdf34baa99d770cedfcc88a0_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d3a91d95f5840f4be4445b0e6c7ad9f_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id85d3aef9cef4f97829dac4fc1a6b84f_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb57040c2a0e4f15b5f7abbbebc4adf5_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic86efb5739b64e849f20b652dd30ebcd_I20190331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30af202026344ba188b8654a2c38183c_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc604bd726fc487cb11cf5132d59f830_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf878bf045d24512bd9e3292775e7161_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a15f5b31d42419aa50ffb53e76f3705_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i414b68a2b4f24b3baf2fb76d57cbbea0_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i061b791ef37044a8a87103ab1684fc04_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibcefd2d03bd84fb9ae242a16f4ac44ee_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb3c1cc4265d4d458fbb645f03094085_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03b18f19eda34333b76bc6814b9d6346_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd16228ea691414ea7027a3ca0ceb2b0_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifc4d8e5790824c048cce3a6bf007c91d_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i489aff50eced4b4e8409601ad948730d_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1553167afc64f24beca75d407d45583_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07067e700dd84b60a562fa298de61bc9_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f5b7e290962451dbcf06e35be299e6a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iebb484f77246492db54ce7ef015c7dad_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39670721aeba48af82262e3df7572d7b_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i200ee5197c714141a7a48e99357f4b5e_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0bfa42b46ea49d485aa30692392a354_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd3cf31e65de4bbca6609f7743bb7da5_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i708549cf187748d19458fd6a1acc45a2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07f4d237a7d949c6a32f7dc1d04bf88e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00ffd06e9957435f8a032e13e5872afd_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9e2edf8663840efbaeced0815c8461f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e82783b746e45e0a6c7e59883f52e81_D20210601-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">docs:InitialPublicOfferingIncludingOverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bcd5d3197f043779574e3205ce6051a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">docs:InitialPublicOfferingIncludingOverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id77b48d8ffc446c1a18a4951dd7e173a_D20210601-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6d33d27d6278430c9585fcf4dd6fdf08_D20210601-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i62c961053180495bb8eed126ddb4d43b_D20210601-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="iaca56ad88a7f461f9aa0ca6977c6c5a1_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic768fc083be84a7890c4145464deef64_D20210608-20210608"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-08</xbrli:startDate><xbrli:endDate>2021-06-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c255afc92154f4c84be5e86a09930da_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">docs:CustomerAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i232cd9dacebb4bacabe5814953368da3_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">docs:CustomerAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05799a8437a248f4a953626f22ebc51e_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">docs:CustomerAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idce67be988654a3aba87d58e5fcbbae7_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">docs:CustomerAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c8278abf3274417845449b2b9d0ee93_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">docs:MarketingAgencyOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if63822cdcbe54d9aa0abc1f888beaab3_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">docs:MarketingAgencyOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i448a0e1cd7da4509b2f34555307a9792_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">docs:SubscriptionMarketingSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7859c8cbc9bd4e129a62d90e12bfc46d_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">docs:SubscriptionHiringSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2e71bd453e6a4a5c937ee4449f768fe2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">docs:DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i90363c012ca343ec80c6f828e4cfa8ee_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">docs:DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64c2cfc1b0024d94aff990227a41ebbc_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">docs:SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a0e1d9ff3f146f5a3c9a2720e716d4c_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">docs:FurnitureAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2deaa931c19f4b76a6b8cb6254e5036f_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">docs:FurnitureAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie20bbb49de3342faa35330af5ddaeedf_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">docs:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3585b880f7f444f1ae19972e18a16a3c_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="reporting_unit"><xbrli:measure>docs:reporting_unit</xbrli:measure></xbrli:unit><xbrli:context id="i75a13b9faa46498d802095eeb320936a_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">docs:SubscriptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00234c4f9e354fa79830f0c96b12428c_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">docs:SubscriptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id23527ddeed84383823da9485781ac68_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">docs:SubscriptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb9d4adeb75140e2a68cf494d5775877_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idaeaebe3ab244209926951f374b9e9c8_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51b462bd95564432b7a7495c9dff1958_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9ae84d280eb4f318ba2a0260ea07425_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9fdd40c78d445c3a42dd89ccb0a4447_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib54faec0bdf04bf2afd9946218f0ac8a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee115df4cfb64f938f087bc0a942628e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i72ae2b0209f24d0a8a959903f8cc0c7a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4492e8b1979a4c7ba9393c924e346c63_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e676ae804004183a75c60a053663a51_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae88e8a7906f4f01a07b94eb7dc2e2bf_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18044c22d5b544cdbb5fdd7bb2fe76d4_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i604823b3602e46ca831f8718dbb39615_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a05c1279cdf4518bd3081538e0be6be_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id244d9fec7044321a9fb14e83f5984f8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ccabfb89c594e59b08be568c57aa776_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48c4441bdd464dc0bb658f1e52a50fae_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87abe2fab1ba4ef68a9cb17800dc430a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e9550589bbf443f8841000a6dfbb584_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide076cccc18c49e3a68b3143aa7c33e6_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec88dd752efb47fab5bb0033f85e57f0_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib527f78664c7491ea47de8f8270b318c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacfd3978047743d09395e66d7259d2ff_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38b0eb18f6f9433eb026f897885f67f9_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibcd72d89f10e46c5b83365968fb5b465_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44d67e5169294894b512b0b90c0c74af_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f0c5fbad8e940fd82c45fb0835f9376_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26380d7634b346848bd64d717640dbd3_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2990b50678e04606a12ac8e532c0f906_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98b116561d274486a93f0e9b833bbc09_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13a7068cde934ebfaf0a93dc825b200e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i103e1316eb1546e9a33a93b9ee8e5d23_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i659c295d408e40e8921b445dd9705cba_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2b46ddbd30649f9964d6b0aef51743e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a78b23143e94b05b7011088f1bde0b1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f12428258e7416aa2c26ccc9570922a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i721efafc234b48ab8ea99bb7a86b14aa_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f8b0fb1f6524927bd336e7e7061c237_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id38c2d8b49424805aa289162c32d7b9e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i474320908a7b41cc92efce9528819f7b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i532a3e060f834264ba3c527d40875cdc_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f7356c1933c44718bcba9bf1f352ba2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i626d1eeffa1343138b59969cf31cd762_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d81508e21044c96b9ecd160987e38c8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i932aa3c5dd54406697aee512b3d1806e_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3721da26311a44e19ada2d73129c607c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6c70759748f44a39409b9430d98472c_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a3cd669c0874efaa60ccd3fd01baaa5_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i982c335e998347a28b119b85613cdb3a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib38daf1082dc430a9b64f0b7677f6c83_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38bda6505b4f4adf916f0a3922a00d63_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia91151d0fa9747bb8b8c5d38d7072ad2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18e4692c47ad48329cebc83bc3799e68_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb043afb1f564202b46d46afa0477aaf_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3bcc674299c845768df66da1b2f5bdb2_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafc2fd89312947f7a003de3d37d11718_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice4e787e809040d7940ae9963883e5f6_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iac3932efeb454191b80019d9cc3d5da8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9b4c1c4fcf94d5695baa53fb6a9f916_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86cda120cc8c4375b1f2178ee70c45d1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i578db33c6a934072bbe067902c563ae8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c4f245f500f4927ad1eb8d7f12714bc_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8476dc0fc3544b828b4aacf4934129b5_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie03e89c5126d41ec830e87d4165cf777_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56c340497cf441e683bdc17f8fc2ff7e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99d6758926cc4835972af44c8abfea6e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa762a9d99d64e26b88344760669498d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb407695229442378be2cc5e6794b4dc_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c3a8d602839469aa9abd46d6b23c3b7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45d51c39fc29442b936469cf96558a7a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i674cc6fab0fb438a93e5000f47d071fd_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c14c0c571b24e4a8f722913926177f6_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i838d198056aa4046821706ffe91ac209_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8285a266d2b84f64a873ce73025e5feb_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i022beaddadf04d3e99f5082fadd56106_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b1782e4152f4dd3a6b1f5b27d8f1bac_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9b9e40170a94d1597c47f1a840054a0_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ed0533ee5e34be3943e9fbebc78267c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9843e9aa5aa34d629a04be568ee0770f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55a153d9fcf6462a90947a8c0cc01fad_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92d19978f3d74e8393d55173e3261600_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58b67667851745b0921de5486a701250_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabb825f6081140068a661c6fce29a765_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e5dd024a0ab400e9341bcfe83899418_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i149cf0ff47ea404db23f4e4a1bc5fcdc_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6866262bbd66464e9d4917805ca3ad7e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b6266c5703b4348bebf658eb91fde7f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia44e2eb3c48e4364866cc26deb91d1a3_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5432548d20a44dd691468cebc30236b7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea566254ac80466eb792b98fee4468fc_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if27d9ddc7c024d20a99d07f62ff1a2e1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib3515ce776444aa4be7ca30f76d95991_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5c40b8b60cd40c8b22509a920df6d06_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i611917e8f7cf4a16937ba03415273dcd_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41a927ca494a4351bd716a0e60b21d1e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82b9f2d9387b45499ebeca44b8440fae_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34e4bf763fea49b5bdcf75dc219e7e92_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i349cf5c5812341ab8fa0686e31856780_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1cb90c50d62d4afbb1940f34e2a856de_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f039878467d46c288ef097207b6975b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b01aa2ae05c4047a50651aab2e681d7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i719069eb844247a9b2bd30c54120b216_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3163cbc1f2442c08773e69ca6f51425_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d93e12f702349bd99bf9d5330c3fb1b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92a4a2d0006947a8927335cfa305416f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id1df4b610f3946d98ae080e642659498_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5373de11d949417cbb36d85c87552143_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia35ead93812940d69566b0152cbba00b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i309ea865186047c0a5538f09e3c70ca9_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib27f206c94d44a2ea0ddaed560a54ac0_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e0ec08cc952440a92e76047bc39557f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5de02ef242964b299f7003623da7eef4_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fd4715dabf14628bd22641238042d34_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9f7e9e66c5b4bb09aa27555e1ad1902_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i83568bca22424ed2b2bcc387ae3fc3a2_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib1b26c7fd27543afab7eb6101e431209_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i973ce033b5444e8184b98b45f2f762bf_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">docs:FurnitureAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i408a5f0dc11f4858abf1563a67979081_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">docs:FurnitureAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1da69909cef146178323e0df47516982_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">docs:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief36ad090dfc4a189faf599f7900747f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">docs:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c6dd1041fd64455ab9d78b3daad3f68_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5edcc49f367e4d8c82a0bbeef2050a74_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5b202e466ea48b083f080fed8852b3f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28a7eabc1a4d486b92834db5677e9a27_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1f64c4a29d62477a8fad14379556ccb8_D20200401-20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:THMEDLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79a66d68c93b4bd0b2886189e06be17c_I20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:THMEDLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee7d28ec87cf452fb10c202c80f90fbe_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:THMEDLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57a0104cac79435c8a441386b54274b2_D20200401-20200401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:THMEDLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if7cf2424c4f2444491451d34b70a6297_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">docs:PortionOfCurativeTalentLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i700d59f0237c426e9f45e85c7868ccb3_D20201001-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">docs:PortionOfCurativeTalentLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3c81df0162042a5b0dc0d0c8592051a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96d0d9721f3845cf819e54f13b25b749_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2954aeea8a14482992a39c86bd074154_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InternetDomainNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41a71c7b00044b929b014c5f2a720f8c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InternetDomainNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="series"><xbrli:measure>docs:series</xbrli:measure></xbrli:unit><xbrli:context id="i90f5cd4e2e554cc583d589c82b6980d1_D20210601-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0d10847a28e64727936c5a6f5e2e80a5_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i123f862c0d9447efbbc8bdae111fa9a1_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d83f10d2f3d4f9f8308f66e84ed7f02_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="vote"><xbrli:measure>docs:vote</xbrli:measure></xbrli:unit><xbrli:unit id="board_of_director"><xbrli:measure>docs:board_of_director</xbrli:measure></xbrli:unit><xbrli:context id="i183a0b8f69a94170b9913a445fe4ab57_I20120831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:RedeemableConvertiblePreferredStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2012-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7bb2ecd4e0c946abb1d503513127046f_I20120831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:RedeemableConvertiblePreferredStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2012-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i903f14931847407cbb172b0f7bd884c6_I20120831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:RedeemableConvertiblePreferredStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2012-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i402085a78ad14a0f992a4f8b0ecdcd58_I20120831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:RedeemableConvertiblePreferredStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2012-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if157170dd5944a499d7ec585e0434c4d_I20120831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:RedeemableConvertiblePreferredStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2012-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib043fb4bcadb409c9fa4b0e1104a5b1d_I20210608"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7606a71ce4a84be3a6dde5784b7d32ae_I20210608"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib6f78b8e938a40e189a348c098b679d6_D20210608-20210608"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-08</xbrli:startDate><xbrli:endDate>2021-06-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffeb565b4545435983a69c61108b5344_D20210608-20210608"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-08</xbrli:startDate><xbrli:endDate>2021-06-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ee03b9d354947dba14b2c512b9bc336_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c6316b62a6d48928288e886e45e4dc6_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2075365cb96485192385bf947ef595a_I20170331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:ContractWithUSNewsWorldReportLPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f99466cf9f5440d9a1deb4533b63a0e_D20170301-20170331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:ContractWithUSNewsWorldReportLPMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-03-01</xbrli:startDate><xbrli:endDate>2017-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07bcfcbefba64208b4423f3a902e75e2_I20210614"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17b428b935264ffe87dec690a2b09118_D20210614-20210614"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-14</xbrli:startDate><xbrli:endDate>2021-06-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8bd91cc36430472099a03473544779d1_I20211008"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7358dd40974c4c15993593aef2ed49d4_I20211008"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie76d6e6102ef406399e4e136b24eca26_I20211008"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61bf36f882e84585b81cb908da335c25_I20211008"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39eec364f5b04f648b48c3dcc6d77519_I20211008"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8607743731e4071beb43262fa44f7cf_I20211008"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-10-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefca250a775b47afb7490aca201d7488_D20211008-20211008"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-08</xbrli:startDate><xbrli:endDate>2021-10-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16b887faed4f499cae154df41656fb5f_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id07380e73439483897907b5d88d89be6_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d4fd5c7f8d8423bb39a6ed8568b3356_D20100401-20100430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">docs:IndividualsWithVotingInterestLessThanThresholdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:EquityIncentivePlan2010Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2010-04-01</xbrli:startDate><xbrli:endDate>2010-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1341fe12e41432d9a0dd420afc78a66_D20100401-20100430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">docs:IndividualsWithVotingInterestAtThresholdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:EquityIncentivePlan2010Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2010-04-01</xbrli:startDate><xbrli:endDate>2010-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22d3b66c56b94252a2946d3a502fdae3_D20100401-20100430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:EquityIncentivePlan2010Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2010-04-01</xbrli:startDate><xbrli:endDate>2010-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ec1658b926c4ef39dfd202582dd44a8_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:StockOptionAndIncentivePlan2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab2ea80b2cbf4380ba57669907c19c02_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:EmployeeStockPurchasePlan2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5eaddeac25184da0affc7274c9201b26_D20170401-20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-04-01</xbrli:startDate><xbrli:endDate>2018-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4e53989ad534fe89ef01474dae63d8f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i725f9096e258495b86d6aa50c855aaa9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:EquityIncentivePlan2010Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56d735fe4eb34fe1922c7e4400822779_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:EquityIncentivePlan2010Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3541a109248a45dc94084818f280ac54_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:StockOptionAndIncentivePlan2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">docs:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67450ca940dd40f0a2d462baa0500656_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:StockOptionAndIncentivePlan2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">docs:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i062a7bd4fea64eff8312ec950069505b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:StockOptionAndIncentivePlan2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i474cc2747676411382999c3f91d30019_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:StockOptionAndIncentivePlan2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic7e987e8af04409dbdccaa86e531b3a0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:StockOptionAndIncentivePlan2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id01f8e0be0ee4f27ae203fcef745b3aa_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:StockOptionAndIncentivePlan2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie51ad27fff7e4a428edc6ea000fd35d2_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:EmployeeStockPurchasePlan2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i434b921a71c247e49c95cbfb98931fc2_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i846bae41a5fe4dd4a8ee4faa714617c2_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18e2b6fd4b074d7db710c23afcd10f34_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20ae6e1b9ad04e07b4597114eca5d5ee_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7493bbee46f24e8484095a81b057167c_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i226d0d1119d141748de5f3ec182d0ba9_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6e6975dac5d14fdeb07a8ecc86e9912d_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i31208a9ec3934804b4c4c3c9e4b9ae56_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63de954bcdf44beabda4a4cb41517cd6_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5570e6c29d854f898d1e5e342437be88_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i298cf9213fd94bf999a48f99a9e0d27c_D20180301-20180331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-03-01</xbrli:startDate><xbrli:endDate>2018-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c137a25b9864647b3377c74eb5c9329_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icd3eb1cf82ec45919e291170d616104d_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24ebf27ab6024144a01cc18be9301b97_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d1acfbd8dc54fa9b2bcb6aafeb4d7f5_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife196e39e85444efa18e6408b5528324_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i069e58edeaa64c12a8363d9a79919c2f_D20210624-20210624"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">docs:ShareBasedPaymentArrangementTrancheOneAndTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-24</xbrli:startDate><xbrli:endDate>2021-06-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d9b036a65e94e84b94ff795383a9281_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieda01ec82c8347f79e1ed7baa2764e9c_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d96c621dbad4b0893a45915a1e3eb41_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22cded30244a4dc4b48d2cc92c10c4be_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i610bf1430732450cbbf831aa9fbaf023_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic960f45dc6ee4214a384c76564f6f1a3_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i117af75205314c998fad1407c682e2d0_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">docs:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8075f5e61a6f4e0fa23f0b2d73e6bc0b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">docs:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54f0e6464d3d42999d152987a80350fc_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">docs:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e70174a995c49c9916aacfc83acfc7e_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">docs:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id49a07de8105430d9e5b763fa04c9419_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14587970434d4e5d831e458e0cf34e59_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i392e807a56904918a6a9e4076a92504d_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d4c019a802944bb81efba9687e2e06a_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc62a205668f49b9bf71eefe850ffc3f_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9164774a82a1435bb9edf034bfb5610d_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i381d7bd945a246b38630bd42ca02f556_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i643419a5871c4616afc52904e8243daa_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c63553114c049e0b99db51fd02c3a5a_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i847059421e7947a984ad34ce247eb9e4_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22d0ef822c3a4843b76143dba7a23603_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec4edfed98534025a3c42e669b77c905_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icce45add1e4a4c4ab8d74a95293ddd73_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieee0bbd772344ba3aa609a2395100a50_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0872333d3b584eeebd4ed5658baa1b13_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f8c647b40c747dba1ef8dc24e552b7a_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbdabf5291a64e328bdbbfff61aa8d5c_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">docs:OtherShareBasedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9e97d96aecb4d1d904052c4e11402f0_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">docs:OtherShareBasedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e38c40919b2480382413b360d2df583_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">docs:OtherShareBasedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80014f589fa24025aba4a9a6e7337c21_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37353189bac04c0c8499282980a6fbb4_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47d1b632be7e4cc090898a23568e0174_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2c5b92d76cd41efbbbb13447fd077b8_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i433b7b224b754032ae79af210bdf56c0_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19af305064d34ab0a9c791bd4989487e_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7166b08eefb94201a936dda4ab4a1b6f_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">docs:OtherShareBasedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d0cf67197d64b82a0f9be653ff65148_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">docs:OtherShareBasedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a29bfa4143c42cb8c0f174e1b701e1f_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">docs:OtherShareBasedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i366343ec548042d1a0b920b7da7cd459_D20210401-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0f97ef761814d6fa5b6219079762edc_D20200401-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f1b807dde644927a5cecfcdc7ea90b4_D20190401-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-04-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e814b9bfb97496daff7da69a24ec5cd_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic83e784502b44138b8906b62606b6cc0_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia779ca3233c64c28abdfc4d63196098d_D20211008-20211008"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-08</xbrli:startDate><xbrli:endDate>2021-10-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5427186226c84ccfa0800cadaa7de7c6_D20211008-20211008"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-08</xbrli:startDate><xbrli:endDate>2021-10-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i810401f3e11544ccb12389b06a087e25_D20211008-20211008"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-08</xbrli:startDate><xbrli:endDate>2021-10-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i481113436cc1402f934510336edc992b_D20220401-20220401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:AMiONMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1761c372f61844c2b98a7f045fe36118_I20220401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:AMiONMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief085275d125487ab483dab51f92a13d_D20220501-20220527"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-01</xbrli:startDate><xbrli:endDate>2022-05-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1d009a88cef49af96f5da8fc0da7d35_D20211201-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a3e9f0d2edd438b8e1b2bd756b26c00_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>docs:segment</xbrli:measure></xbrli:unit><xbrli:context id="i16625e145bd74701a4ae78f95675b6e5_D20220515-20220515"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-15</xbrli:startDate><xbrli:endDate>2022-05-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8a49fae532d49d9b87337bacae0b894_I20220512"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i809ae921d1e74261bd64ae9e74b5455c_D20220512-20220512"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001516513</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-12</xbrli:startDate><xbrli:endDate>2022-05-12</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i6c4404140edb48938ba4e30b290c9ef9_1"></div><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION </span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549 </span></div><div style="margin-bottom:12pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:36.403%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:25pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6MTc5OTIxNDk0NmQwNGRlMGI1YjFjNjFmNjdlOWJlNjMvdGFibGVyYW5nZToxNzk5MjE0OTQ2ZDA0ZGUwYjViMWM2MWY2N2U5YmU2M18wLTAtMS0xLTEwNDUxNy90ZXh0cmVnaW9uOjQ3ZTM0ZDIyNmNjNTQ1N2VhOTQ3MDg2NzNjYTJlZTU2XzI5MTM3MDU4MTM2MDkz_fb3931c9-08ec-46f9-84b6-f32f5f1267e5">10-K</ix:nonNumeric></span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:0.1%"></td><td style="width:2.627%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.073%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6NmI5ZDAwMGUxODJhNDY3YjkxZGEyYmNhNjZjYWQ5YzAvdGFibGVyYW5nZTo2YjlkMDAwZTE4MmE0NjdiOTFkYTJiY2E2NmNhZDljMF8wLTAtMS0xLTEwNDUxMw_1b63be17-7929-4e45-9170-a4c2396c6d60">&#9746;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">For the fiscal year ended <ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6NmI5ZDAwMGUxODJhNDY3YjkxZGEyYmNhNjZjYWQ5YzAvdGFibGVyYW5nZTo2YjlkMDAwZTE4MmE0NjdiOTFkYTJiY2E2NmNhZDljMF8xLTEtMS0xLTEwMDYyMi90ZXh0cmVnaW9uOjQzOWEyMzllZTlkYjQ5MjE4NmIxOGQ0Mjg5NGNhYzhjXzI5MTM3MDU4MTM2MTI0_0672e854-1bc5-4604-8a25-e56a3a5ea6b6"><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6NmI5ZDAwMGUxODJhNDY3YjkxZGEyYmNhNjZjYWQ5YzAvdGFibGVyYW5nZTo2YjlkMDAwZTE4MmE0NjdiOTFkYTJiY2E2NmNhZDljMF8xLTEtMS0xLTEwMDYyMi90ZXh0cmVnaW9uOjQzOWEyMzllZTlkYjQ5MjE4NmIxOGQ0Mjg5NGNhYzhjXzI5MTM3MDU4MTM2MTI0_fa3edf9b-816a-4495-a8ae-63831fd3f942">March&#160;31</ix:nonNumeric>, 2022</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">or</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6NmI5ZDAwMGUxODJhNDY3YjkxZGEyYmNhNjZjYWQ5YzAvdGFibGVyYW5nZTo2YjlkMDAwZTE4MmE0NjdiOTFkYTJiY2E2NmNhZDljMF8zLTAtMS0xLTEwNDUxNQ_b2322d51-2836-4990-b2bb-17dd18bd47a1">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">              </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">              </span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number <ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGV4dHJlZ2lvbjo3NDc0N2YwMzE5ZjY0OGI1OTFmZTZkYjJmMjJmYTkwM180NDUzMDIyMDk1MjczOQ_b78c31c8-8c66-41fc-a29d-7e55dd102477">001-40508</ix:nonNumeric></span></div><div style="margin-bottom:15pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.070%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:25pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6NzdkNjI0YTY3YzNhNGUzMDk4YmEwNWZhMTk2ZDc3ZDYvdGFibGVyYW5nZTo3N2Q2MjRhNjdjM2E0ZTMwOThiYTA1ZmExOTZkNzdkNl8wLTAtMS0xLTEwNDUyNQ_f21dd48b-8d96-4152-aca9-1fbd5b0cd94e">Doximity, Inc.</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Exact Name of Registrant as Specified in Its Charter) </span></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.391%"><tr><td style="width:1.0%"></td><td style="width:32.778%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.143%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.779%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6MzU4MmYxOTBiMjhlNGU0OGFiMWRhMDBjYTQ2MmE5MDkvdGFibGVyYW5nZTozNTgyZjE5MGIyOGU0ZTQ4YWIxZGEwMGNhNDYyYTkwOV8wLTAtMS0xLTEwNDUyNw_4a5fa676-ba9c-4d2f-8d44-b3cda87f0708">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6MzU4MmYxOTBiMjhlNGU0OGFiMWRhMDBjYTQ2MmE5MDkvdGFibGVyYW5nZTozNTgyZjE5MGIyOGU0ZTQ4YWIxZGEwMGNhNDYyYTkwOV8wLTItMS0xLTEwNDUyOQ_5341a5d4-60d3-42a7-aa39-e4c4844d5fd3">27-2485512</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(State or Other Jurisdiction of Incorporation or Organization)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(I.R.S. Employer Identification Number)</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6MzU4MmYxOTBiMjhlNGU0OGFiMWRhMDBjYTQ2MmE5MDkvdGFibGVyYW5nZTozNTgyZjE5MGIyOGU0ZTQ4YWIxZGEwMGNhNDYyYTkwOV8zLTAtMS0xLTEwMDcyMC90ZXh0cmVnaW9uOjRkMTlkZjYzYzZkNTRlNmI5OWY5NWRiMDZkNzljNTQ2XzMwNzg2MzI1NTc3ODc2_99e96b7c-f77e-447e-aceb-45b0ae88fe64">500 3rd St.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6MzU4MmYxOTBiMjhlNGU0OGFiMWRhMDBjYTQ2MmE5MDkvdGFibGVyYW5nZTozNTgyZjE5MGIyOGU0ZTQ4YWIxZGEwMGNhNDYyYTkwOV8zLTAtMS0xLTEwMDcyMC90ZXh0cmVnaW9uOjRkMTlkZjYzYzZkNTRlNmI5OWY5NWRiMDZkNzljNTQ2XzMwNzg2MzI1NTc3ODgw_ceceff67-6f6c-4345-9654-8d5d4e63747c">Suite 510</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6MzU4MmYxOTBiMjhlNGU0OGFiMWRhMDBjYTQ2MmE5MDkvdGFibGVyYW5nZTozNTgyZjE5MGIyOGU0ZTQ4YWIxZGEwMGNhNDYyYTkwOV8zLTAtMS0xLTEwMDcyMC90ZXh0cmVnaW9uOjRkMTlkZjYzYzZkNTRlNmI5OWY5NWRiMDZkNzljNTQ2XzMwNzg2MzI1NTc3ODg0_202a0b49-f50c-4475-9fc1-5a660b7db88d">San Francisco</ix:nonNumeric>, <ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6MzU4MmYxOTBiMjhlNGU0OGFiMWRhMDBjYTQ2MmE5MDkvdGFibGVyYW5nZTozNTgyZjE5MGIyOGU0ZTQ4YWIxZGEwMGNhNDYyYTkwOV8zLTAtMS0xLTEwMDcyMC90ZXh0cmVnaW9uOjRkMTlkZjYzYzZkNTRlNmI5OWY5NWRiMDZkNzljNTQ2XzMwNzg2MzI1NTc3ODg4_394fdb21-e035-4885-bb38-b0ae0e15a7e3">CA</ix:nonNumeric> <ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6MzU4MmYxOTBiMjhlNGU0OGFiMWRhMDBjYTQ2MmE5MDkvdGFibGVyYW5nZTozNTgyZjE5MGIyOGU0ZTQ4YWIxZGEwMGNhNDYyYTkwOV8zLTAtMS0xLTEwMDcyMC90ZXh0cmVnaW9uOjRkMTlkZjYzYzZkNTRlNmI5OWY5NWRiMDZkNzljNTQ2XzMwNzg2MzI1NTc3ODky_ad39dd10-7a40-4158-9e84-38d4bce6ad5b">94107</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices, including zip code)</span></div></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6MzU4MmYxOTBiMjhlNGU0OGFiMWRhMDBjYTQ2MmE5MDkvdGFibGVyYW5nZTozNTgyZjE5MGIyOGU0ZTQ4YWIxZGEwMGNhNDYyYTkwOV80LTAtMS0xLTEwMDcyMC90ZXh0cmVnaW9uOjEyYjQxZTkyM2MzNDRmZTliNjU5OGZjYzZiODhmNzBiXzI5MTM3MDU4MTM2MTgy_bad0d714-103b-4d57-a31e-e8e5564fb30c">(650)</ix:nonNumeric> <ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6MzU4MmYxOTBiMjhlNGU0OGFiMWRhMDBjYTQ2MmE5MDkvdGFibGVyYW5nZTozNTgyZjE5MGIyOGU0ZTQ4YWIxZGEwMGNhNDYyYTkwOV80LTAtMS0xLTEwMDcyMC90ZXh0cmVnaW9uOjEyYjQxZTkyM2MzNDRmZTliNjU5OGZjYzZiODhmNzBiXzI5MTM3MDU4MTM2MTc4_6300c65d-2b41-4e7d-810b-eec277f5e862">549-4330</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant's telephone number, including area code)</span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:31.839%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.839%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.390%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.842%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6ZWQ2NDc5ZmNkYzA3NGNkZjg5YjU1YTU2YTZhYzgxODQvdGFibGVyYW5nZTplZDY0NzlmY2RjMDc0Y2RmODliNTVhNTZhNmFjODE4NF8xLTAtMS0xLTEwMDc2Mg_e2cebb32-b22e-46d2-b2f2-cc21642d3cac">Class A common stock, $0.001 par value per share</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6ZWQ2NDc5ZmNkYzA3NGNkZjg5YjU1YTU2YTZhYzgxODQvdGFibGVyYW5nZTplZDY0NzlmY2RjMDc0Y2RmODliNTVhNTZhNmFjODE4NF8xLTItMS0xLTEwNDUzMQ_15caae5e-56c5-43e7-9c2a-a32a5d2d1647">DOCS</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6ZWQ2NDc5ZmNkYzA3NGNkZjg5YjU1YTU2YTZhYzgxODQvdGFibGVyYW5nZTplZDY0NzlmY2RjMDc0Y2RmODliNTVhNTZhNmFjODE4NF8xLTQtMS0xLTEwNDUzNA_5c941bc5-54b9-4b80-99ca-f6ed4c96db0c">The New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to section 12(g) of the Act: None </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. &#9744; Yes &#9746; <ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGV4dHJlZ2lvbjo3NDc0N2YwMzE5ZjY0OGI1OTFmZTZkYjJmMjJmYTkwM180NDUzMDIyMDk1Mjc0Mw_021688a2-7942-48d5-87d7-473f0c12fa9f">No</ix:nonNumeric> </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. &#9744; Yes &#9746; <ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGV4dHJlZ2lvbjo3NDc0N2YwMzE5ZjY0OGI1OTFmZTZkYjJmMjJmYTkwM180NDUzMDIyMDk1Mjc0Mg_cf8caaa0-e627-4c23-999a-287de5ca6731">No</ix:nonNumeric> </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGV4dHJlZ2lvbjo3NDc0N2YwMzE5ZjY0OGI1OTFmZTZkYjJmMjJmYTkwM180NDUzMDIyMDk1Mjc0NA_7a807dd2-011d-4c60-8813-67f6cad1fa8f">Yes</ix:nonNumeric> &#9746; No &#9744;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167; 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGV4dHJlZ2lvbjo3NDc0N2YwMzE5ZjY0OGI1OTFmZTZkYjJmMjJmYTkwM180NDUzMDIyMDk1Mjc0NQ_f61797cf-0253-4ec9-bd17-437900b881f6">Yes</ix:nonNumeric> &#9746; No &#9744; </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221;and "emerging growth company" in Rule 12b-2 of the Exchange Act. </span></div><div style="margin-bottom:9pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.993%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.995%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Large&#160;accelerated&#160;filer</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accelerated filer </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6N2IxMTQwNmVlMzBiNDFiY2JjMzFlMTZjMjhkMDVkMmIvdGFibGVyYW5nZTo3YjExNDA2ZWUzMGI0MWJjYmMzMWUxNmMyOGQwNWQyYl8xLTAtMS0xLTEwNDYzNg_8a1b54ea-8dec-434a-90af-20b8541ef9ac">Non-accelerated filer</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Smaller reporting company</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6N2IxMTQwNmVlMzBiNDFiY2JjMzFlMTZjMjhkMDVkMmIvdGFibGVyYW5nZTo3YjExNDA2ZWUzMGI0MWJjYmMzMWUxNmMyOGQwNWQyYl8xLTQtMS0xLTEwNDYzOA_c66d5482-df71-42af-a26d-9316e4c8b7f4">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Emerging growth company</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6N2IxMTQwNmVlMzBiNDFiY2JjMzFlMTZjMjhkMDVkMmIvdGFibGVyYW5nZTo3YjExNDA2ZWUzMGI0MWJjYmMzMWUxNmMyOGQwNWQyYl8yLTQtMS0xLTEwNDY0MA_4ea16bb0-bff1-40db-8757-96747a4d41d5">&#9746;</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="dei:EntityExTransitionPeriod" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGV4dHJlZ2lvbjo3NDc0N2YwMzE5ZjY0OGI1OTFmZTZkYjJmMjJmYTkwM182ODcxOTQ3Njc2MzgyMQ_0fc07673-5672-4d85-9908-4a4ca47ef1ff">&#9744;</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C.7262(b)) by the registered public accounting firm that prepared or issued its audit report. <ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGV4dHJlZ2lvbjo3NDc0N2YwMzE5ZjY0OGI1OTFmZTZkYjJmMjJmYTkwM180NDUzMDIyMDk1Mjc0Ng_ff4a504a-e01c-421e-9b4d-5bc263c76924">&#9744;</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).  <ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGV4dHJlZ2lvbjo3NDc0N2YwMzE5ZjY0OGI1OTFmZTZkYjJmMjJmYTkwM180NDUzMDIyMDk1Mjc0Nw_422aea21-98f4-4d52-9a19-f6555aa5a9d2">&#9744;</ix:nonNumeric></span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The aggregate market value of the voting and non-voting stock held by non-affiliates of the registrant as of September&#160;30, 2021, based on the closing price of $80.70 for a share of Class A common stock on the New York Stock Exchange, was approximately $<ix:nonFraction unitRef="usd" contextRef="ifada4ef299464095aeb979c9bc3805d7_I20210930" decimals="-8" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGV4dHJlZ2lvbjo3NDc0N2YwMzE5ZjY0OGI1OTFmZTZkYjJmMjJmYTkwM18zMDIzNjU2OTc4NjQ5Nw_33ae53be-5ff7-4ae4-be93-2f04ccccd45b">9.0</ix:nonFraction> billion. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The registrant had outstanding <ix:nonFraction unitRef="shares" contextRef="i74d0f3bb04994da080b1e644b3d7dc0a_I20220520" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGV4dHJlZ2lvbjo3NDc0N2YwMzE5ZjY0OGI1OTFmZTZkYjJmMjJmYTkwM180NDUzMDIyMDk1Mjc0MA_ffe6963e-33ae-4d79-a3bf-9f6a76aca2dd">110,086,201</ix:nonFraction> shares of Class A common stock and <ix:nonFraction unitRef="shares" contextRef="ia4b07bfbd2c7447999b3dc774b9c116e_I20220520" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGV4dHJlZ2lvbjo3NDc0N2YwMzE5ZjY0OGI1OTFmZTZkYjJmMjJmYTkwM18zMDc4NjMyNTU5OTY1Mw_b0fbc006-c075-4e9c-a771-bb0cd534364a">83,022,658</ix:nonFraction> shares of Class B common stock as of May&#160;20, 2022. </span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGV4dHJlZ2lvbjo3NDc0N2YwMzE5ZjY0OGI1OTFmZTZkYjJmMjJmYTkwM180NDUzMDIyMDk1Mjc0MQ_7482ebcf-fe51-4eb0-9e24-7f13d078bc5e" escape="true">Portions of the registrant&#8217;s Definitive Proxy Statement relating to the 2022 Annual Meeting of Stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. Such Definitive Proxy Statement will be filed with the Securities and Exchange Commission within 120 days after the end of the registrant&#8217;s fiscal year ended March&#160;31, 2022.</ix:nonNumeric> </span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i6c4404140edb48938ba4e30b290c9ef9_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:7.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.866%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.124%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PAGE</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center;text-indent:-9pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_864">Part I</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6c4404140edb48938ba4e30b290c9ef9_864">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_127">Item 1. </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_127">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6c4404140edb48938ba4e30b290c9ef9_127">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_43">Item 1A. </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_43">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6c4404140edb48938ba4e30b290c9ef9_43">14</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_881">Item 1B.</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_881">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6c4404140edb48938ba4e30b290c9ef9_881">43</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_891">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_891">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6c4404140edb48938ba4e30b290c9ef9_891">44</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_897">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_897">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6c4404140edb48938ba4e30b290c9ef9_897">44</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_903">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_903">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6c4404140edb48938ba4e30b290c9ef9_903">44</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_909">Part II</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6c4404140edb48938ba4e30b290c9ef9_909">45</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_915">Item 5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_915">Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6c4404140edb48938ba4e30b290c9ef9_915">45</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_922">Item 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_922">[Reserved]</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6c4404140edb48938ba4e30b290c9ef9_922">46</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_67">Item 7.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_67">Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6c4404140edb48938ba4e30b290c9ef9_67">47</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_929">Item 7A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_929">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6c4404140edb48938ba4e30b290c9ef9_929">57</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_163">Item 8.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_163">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6c4404140edb48938ba4e30b290c9ef9_163">58</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_936">Item 9.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_936">Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#i6c4404140edb48938ba4e30b290c9ef9_936">92</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_942">Item 9A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_942">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6c4404140edb48938ba4e30b290c9ef9_942">92</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_948">Item 9B.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_948">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6c4404140edb48938ba4e30b290c9ef9_948">92</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_954">Item 9C.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_954">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6c4404140edb48938ba4e30b290c9ef9_954">93</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_960">Part III</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6c4404140edb48938ba4e30b290c9ef9_960">94</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_966">Item 10.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_966">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6c4404140edb48938ba4e30b290c9ef9_966">94</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_133">Item 11.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_133">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6c4404140edb48938ba4e30b290c9ef9_133">94</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_975">Item 12.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_975">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6c4404140edb48938ba4e30b290c9ef9_975">94</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_136">Item 13.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_136">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6c4404140edb48938ba4e30b290c9ef9_136">94</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_983">Item 14.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_983">Principal Accounting Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6c4404140edb48938ba4e30b290c9ef9_983">94</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_989">Part IV</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6c4404140edb48938ba4e30b290c9ef9_989">95</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_253">Item 15.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_253">Exhibits, Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6c4404140edb48938ba4e30b290c9ef9_253">95</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_999">Item 16.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_999">Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6c4404140edb48938ba4e30b290c9ef9_999">96</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_259">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:none" href="#i6c4404140edb48938ba4e30b290c9ef9_259">97</a></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div></div></div><div id="i6c4404140edb48938ba4e30b290c9ef9_2389"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Annual Report on Form 10-K contains forward-looking statements within the meaning of the federal securities laws, which are statements that involve substantial risks and uncertainties. Forward-looking statements generally relate to future events or our future financial or operating performance. In some cases, you can identify forward-looking statements because they contain words such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;shall,&#8221; &#8220;should,&#8221; &#8220;expects,&#8221; &#8220;plans,&#8221; &#8220;anticipates,&#8221; &#8220;could,&#8221; &#8220;intends,&#8221; &#8220;target,&#8221; &#8220;projects,&#8221; &#8220;contemplates,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;predicts,&#8221; &#8220;potential,&#8221; or &#8220;continue&#8221; or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans, or intentions. Forward-looking statements contained in this Annual Report on From 10-K include, but are not limited to, statements about: </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding our revenue, expenses, and other operating results;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our future financial performance;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations and management of future growth;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to acquire new members and successfully retain existing members;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to acquire new customers and successfully retain existing customers;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to achieve or maintain our profitability;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">future investments in our business, our anticipated capital expenditures, and our estimates regarding our capital requirements;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the costs and success of our sales and marketing efforts, and our ability to promote our brand;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to effectively manage our growth, including our ability to identify, retain, and recruit personnel, and maintain our culture;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to comply with laws and regulations; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to successfully defend litigation brought against us; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to maintain, protect, and enhance our intellectual property rights and any costs associated therewith;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to maintain data privacy and data security;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to respond to rapid technological changes;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effects of the COVID-19 pandemic or other pandemic, epidemic, or infectious diseases;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding the impact of the COVID-19 pandemic and the end of the COVID-19 pandemic on our business;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to compete effectively with existing competitors and new market entrants; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the growth rates of the markets in which we compete;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the increased expenses associated with being a public company; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the sufficiency of our cash and cash equivalents and marketable securities to meet our liquidity needs;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to comply with modified or new laws and regulations applying to our business;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to successfully identify, acquire, and integrate companies and assets;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding the time during which we will be, and the risks related to our status as, an emerging growth company under the Jumpstart Our Business Startups Act, or JOBS Act;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments and projections relating to our competitors and our industry, including competing solutions;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">impact from future regulatory, judicial, and legislative changes or developments that may affect our customers&#8217; or our business; and</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the risks related to our Class A common stock and our dual class common stock structure.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We caution you that the foregoing list may not contain all of the forward-looking statements made in this Annual Report on Form 10-K. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should not rely upon forward-looking statements as predictions of future events. We have based the forward-looking statements contained in this Annual Report on Form 10-K primarily on our current expectations and projections about future events and trends that we believe may affect our business, results of operations, financial condition, and prospects. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties, and other factors described in the section titled &#8220;Risk Factors&#8221; and elsewhere in this Annual Report on Form 10-K. Moreover, we operate in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this Annual Report on  Form 10-K. The results, events, and circumstances reflected in the forward-looking statements may not be achieved or occur, and actual results, events, or circumstances could differ materially from those described in the forward-looking statements. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The forward-looking statements made in this Annual Report on Form 10-K relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements made in this Annual Report on Form 10-K to reflect events or circumstances after the date of this Annual Report on Form 10-K or to reflect new information or the occurrence of unanticipated events, except as required by law. We may not actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures, or investments we may make. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, statements that &#8220;we believe&#8221; and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this Annual Report on Form 10-K, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and you are cautioned not to unduly rely upon these statements. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i6c4404140edb48938ba4e30b290c9ef9_864"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div id="i6c4404140edb48938ba4e30b290c9ef9_127"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Business</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are the leading digital platform for U.S. medical professionals, as measured by the number of U.S. physician members, with over two million medical professional members as of March&#160;31, 2022. Our members include more than 80% of physicians across all 50 states and every medical specialty, as well as over 50% of U.S. nurse practitioners and physician assistants, and over 90% of graduating U.S. medical students. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our mission is to help every physician be more productive and provide better care for their patients. We are physicians-first, putting technology to work for doctors instead of the other way around. That guiding principle has enabled Doximity to become an essential and trusted professional platform for physicians. Doximity&#8217;s physician cloud puts modern software tools in the hands of physicians and other medical professionals. We provide our members with capabilities specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the core of our platform is the largest medical professional network in the nation, which creates proximity within our community of doctors and hundreds of thousands of other medical professionals. Our focus on clinician-centric product design and productivity has led to high levels of health professional adoption and endorsement. For example, we had over 350,000 unique active providers use our telehealth tools in the quarter ended March&#160;31, 2022. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business model is designed to both respect and support physicians while driving value for our customers through our Marketing, Hiring, and Telehealth Solutions (see defined below). Our revenue-generating customers, primarily pharmaceutical manufacturers and health systems, have access to a suite of commercial solutions that benefit from broad physician usage.  </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our &#8220;Marketing Solutions&#8221; enable our pharmaceutical and health system customers to get the right content, services, and peer connections to the right medical professionals through a variety of modules. Our Marketing Solutions deliver high engagement and high value and help those customers embrace the shift to digital marketing. We count the top pharmaceutical manufacturers and hospitals and health systems as our customers.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our &#8220;Hiring Solutions&#8221; provide digital recruiting capabilities to health systems and medical recruiting firms, enabling them  to identify, connect with, and hire from our network of both active and passive potential medical professional candidates, who might otherwise be missed through traditional recruiting channels. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our &#8220;Telehealth Solutions&#8221;, which are software tools that include voice and video Dialer, are designed to easily connect patients with care providers. Our Dialer tool has powered over 100 million virtual patient visits since launch. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ecosystem we have created in the medical community benefits from powerful network effects. Medical professional engagement with our platform increases as the breadth and utility of our tools expands, attracting even more members and driving broader and more effective communication and collaboration among healthcare professionals. This also drives greater value for our pharmaceutical and health system customers that seek to interact with specific groups of physicians. In turn, the insights that we gain from increased use of our platform enable us to invest in improving our tools and solutions to meet the changing needs of our members, customers, and the patients that they care for, ultimately creating a win-win-win for all constituents in our ecosystem. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our member interactions have enabled us to build a vast, interactive data set intelligently combining proprietary information and previously-siloed public information. When coupled with our customized algorithms and our team of analysts, engineers, and clinical experts, we believe this gives us unique, unparalleled insight into the specific needs of medical professionals in the United States that would be highly challenging and time consuming for any competitor to replicate.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Tools for Medical Professionals</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Doximity platform is free to join and use for U.S. medical professionals. Becoming a member of Doximity is as simple as navigating to our homepage or downloading our mobile app, and entering a first and last name and verifying real-name identity by National Prescriber Identifier, Social Security Number, Drug Enforcement Administration Registration Number, or medical email account confirmation. Our technology platform provides most medical professionals with a pre-populated profile using publicly and commercially available third-party data which members can further supplement, update, and refine.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Once verified, members gain access to our network, newsfeed, and&#8212;depending on their credentials&#8212;core features of our productivity tools, including telehealth.  </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Professional Network</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Profile.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Members have a personalized and validated professional profile on the Doximity network that acts as a digital curriculum vitae. Profile information includes education and training, hospital affiliations and practice contact  as well as information, certifications and licenses, specialization and clinical expertise, links to published research reports and press mentions, clinical trial participation, and any awards conferred. Our technology automatically searches for and updates new information on a daily basis. Members may also choose to share personal contact information (such as email or cell phone number) with other medical professionals on an individual, opt-in basis, each time they make a connection with another member.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Connectivity with colleagues.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our network makes it easy for professionals to connect and stay in touch with the broader medical community. We regularly suggest new connections to members, such as co-residents, co-fellows, co-authors, colleagues from the same hospital or practice, and medical school classmates, enabling referrals, sharing of medical knowledge, and career opportunities.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Search. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Members can use our powerful search technology to find other medical professionals by name, specialty, expertise, affiliation, or location. For example, a physician may have a patient with a chronic condition that requires specialist care at another health system or in another state. The physician can use our search tool to find the right expert for a right chronic condition at the closest health system, and potentially leverage mutual connections for a warm introduction. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Careers. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our platform provides numerous tools that empower physicians to manage their careers effectively from training through retirement. </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">For practicing physicians.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Members can browse permanent and locum tenens opportunities, set up job alerts to stay abreast of career opportunities matching their interests, and directly connect with our Hiring Solutions customers. Members also have access to detailed job market data, such as our Salary Map, which provides a first-of-its-kind county-level look at physician compensation trends across specialties and geographies.  </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">For students and residents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Members beginning their medical careers can discover and compare training programs across the country using Residency Navigator, a tool which provides a transparent look into U.S. medical residency programs, powered by peer nominations, ratings, and hand-written reviews, giving medical students the tools they need to navigate their future in medicine and to help choose the right program for their career goals. We do not accept fees or payments from hospitals or medical residency programs to impact their ranking or visibility on Residency Navigator. Residency Navigator serves as a relationship funnel for new members at the beginning of their medical careers. Over 90% of graduating U.S. medical students join Doximity to use tools including Residency Navigator before earning their medical degree.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Newsfeed</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our newsfeed serves as the personalized, curated home screen for each member when they sign on to the Doximity platform. We leverage artificial intelligence, or AI, including machine learning, or ML, to create a personalized and curated newsfeed for each of our members. Our platform provides access, free of charge to all of our members, to content from a variety of internal and third-party sources, including content created in-house and content linked to third-party sites (some of which may require a separate subscription).</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Medical articles.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our platform uses both algorithms and clinical editors to select content from a variety of sources based on a member&#8217;s profile and reading interests. Information used to select articles includes each member&#8217;s specialties, qualifications, connections, and content preferences, along with what is popular across our network at that time. We are able to aggregate connections to relevant content from a variety of different sources, such as medical journals and specialist websites that a member might otherwise have to search for separately.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Medical videos.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Information about recent clinical trials or research results are distributed in an easy-to-consume video format, optimized for desktop or mobile viewing. Videos are designed to be brief, relevant and eye-catching to disseminate knowledge without wasting a physician&#8217;s time.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Continuing Medical Education, or CME, credit. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our platform automatically tracks the articles that our members read, logging eligible CME credit for them as they go.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Peer and colleague updates.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Doximity members can stay abreast of and celebrate the professional updates and accomplishments of their peers and colleagues, from new jobs to awards, newly authored publications, and press mentions.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Clinical discussions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Members can comment on and react to posts directly in their newsfeed. For example, members might discuss the results of a new clinical study, or even ask questions to the author of that study. Members can also submit for publication Op-Med articles, which is long-form content written by clinicians for clinicians, covering topics such as front-line experiences and practice-changing viewpoints. Ultimately, dialogue and interactive elements drive engagement within the ecosystem and facilitate peer-to-peer education.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Sponsored content. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain articles and videos are marked as sponsored content and are designed to be highly relevant to our members. These can appear to our members and are created in concert with our pharmaceutical and health systems customers and may include information about medications, clinical trials, guidelines and resources, and trends in medical and patient care. They are developed in collaboration with our customer success team to ensure they meet the high quality standards of our community.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Productivity</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Members of our platform are able to access our productivity tools, a suite of Health Insurance Portability and Accountability Act, or HIPAA, compliant communication and digital workflow tools that are designed with their needs in mind to make their daily workflows more efficient. We put the following critical digital tools in one easy-to-use app and website. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Digital Fax and eSignature.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Allows physicians to send and receive HIPAA-compliant faxes through our mobile app or website. Members can electronically sign, edit, date, add attachments, and customize the cover page for their faxed documents, eliminating the need to print, manually sign, and re-scan documents. This streamlines patient care coordination and digital record keeping. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Secure Messaging. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Enables members to collaborate securely regarding patient consultations, and coordinate care across multiple care team members, specialists, systems, or locations. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Dialer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our members can connect with their patients through our Dialer telehealth feature through Dialer Free, which is available for free to all members, through Dialer Pro, a paid version with some enhanced capacities, or Dialer Enterprise, which may be purchased by a hospital enterprise.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Physicians can either initiate the visits in the Doximity app, or use the leading EHR app, Haiku by Epic, to find a patient&#8217;s information and start a visit with one tap, under an enterprise license. Dialer visits can be either voice or video based.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Voice visits allow physicians to pre-set their Caller ID to their office number, which maintains the privacy of their personal line while increasing the likelihood that the patient will answer so that they can efficiently connect on-the-go.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Video visits allow physicians to convert their smartphone and desktop to a telemedicine hub, without any extra download or sign in required for patients. Additional convenient features are accessible during a video call, such as the ability to easily add an interpreter or family member, or hand off the call to another member of the care team with one click, all in a HIPAA-compliant manner.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Solutions for Healthcare Customers</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer Marketing, Hiring, and Telehealth Solutions to pharmaceutical manufacturers, health systems, medical recruiting firms, and certain other healthcare companies on a predominantly subscription basis. In fiscal 2022, we had 265 customers which contributed at least $100,000 of subscription revenue. Our solutions focus on win-wins for our customers and our members, containing useful and relevant information for the physician's particular area of practice and their patients&#8217; needs, while being respectful of their time.</span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketing Solutions</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide a digital marketing platform for pharmaceutical manufacturers and health systems to serve our members with tailored content that is highly relevant to their clinical practices. Pharmaceutical manufacturers purchase programs on a brand-by-brand basis, and health systems execute programs on a service line by service line basis. Service lines in health systems refer to patient-centric clinical specialties, such as cardiology, oncology, neurology, and otolaryngology, among others. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our customers are able to specify a combination of audience attributes, such as specialty, credential, and location, and also choose modules. Modules are the core building blocks of the marketing plan and are additive to one another. We package them into programs to meet the needs of individual brands and service lines. Our modules can be categorized as Awareness, Interactivity, and Peer, as follows:</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Awareness:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> modules that generate awareness and build name recognition, such as text and video articles. The content of these modules may include updates on how certain drugs perform in clinical trials, the opening of new hospitals or departments within a health system, or other information that is relevant to our members.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Interactivity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: modules that enable digital activities such as conference attendance, connecting with a sales representative, booking an appointment, or ordering product samples.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Peer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: modules that enable our members to connect and build professional relationships with thought-leaders, department chairs, and other experts within the Doximity network.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We seek to develop new modules in response to customer feedback and market trends and to address specific needs of our customers. For example, an Interactivity module may appear adjacent to articles about scientific congresses or professional meetings. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our goal is to make sponsored content useful, relevant, and informative for our members. We have a customer success team that ensures both that our customers receive tangible, measurable, and repeatable benefits from their marketing spend, and that our members have access to sponsored content that is relevant and informative. The team works directly with our customers to deeply understand a customer&#8217;s goals, priorities, and messaging before helping with content and media formats. Our team can develop new content or fine-tune and reformat existing content for digital and feed-friendly marketing. We also provide ongoing support and reporting at the customer&#8217;s request.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have become a valued collaborator to our customers. We have a track record of expanding throughout the medication portfolios of pharmaceutical customers and into additional service lines throughout a health system while also upselling additional modules. </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hiring Solutions</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer our Hiring Solutions to both health systems and medical recruiting firms, which pay for subscriptions that provide them with the ability to search and connect with medical professionals on Doximity. Our AI and ML-supported platform enables customers to run highly targeted hiring campaigns across a range of medical specialties and sub-specialties, uncovering passive but eligible candidates for proactive outreach on any locum tenens or permanent position. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our modules for Hiring Solutions consist of the following:</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Job posts.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Individual listings on our platform for open jobs, either posted directly by a health system or by a recruiting firm. Our members can search and browse these listings. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Direct message.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Recruiters, physicians, and administrators can direct message members who might be a good fit for a given open position. These messages may or may not be for an opening that has been posted on our job posts.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Both job posts and direct messages are sold as a subscription that entitles the customer to a certain number of job listings or messages on a self-serve basis throughout the contract period. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have a tech-enabled, higher-touch Hiring Solution called Curative, combining Doximity&#8217;s data science and intelligence with the service of Curative&#8217;s customer-focused recruiters. Our account managers at Curative work with health systems to source both locum tenens and permanent staffing, leveraging our platform and providing a higher level of support on an ongoing basis than our self-service Hiring Solutions. Health systems enter into a contract with Curative on an hourly-fee or a  placement-fee basis.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Telehealth Solutions for Health Systems</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide Dialer Enterprise to health systems and hospitals seeking an accessible but powerful telehealth solution. The organic adoption of our direct-to-member offerings&#8212;Dialer Free and Dialer Pro&#8212; is an important factor driving our Enterprise offerings. Many users have already adopted Dialer into their regular workflow and this familiarity significantly streamlines implementation when health systems are deploying Dialer Enterprise while competitor solutions often require a full physician training.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dialer Enterprise enables unlimited access to Dialer for all users across a health system&#8217;s organization, and unlocks the same premium feature set as Dialer Pro with an added service layer for the organization that includes a dedicated customer success manager, premium user support, and monthly utilization reporting. Health system customers also have the opportunity to brand the user and patient experience as well as leverage their own security and HIPAA requirements to create consistent </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">protocols for use. Our health system team can also integrate Dialer into our customer's electronic medical record system so that their users can access Dialer from directly within their existing clinical workflows.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dialer Enterprise is sold as a subscription, with pricing based on the size of the health system. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Scheduling Capabilities for Health Systems</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022, we closed our acquisition of the AMiON shift scheduling service to further expand our physician cloud platform. Our AMiON shift scheduling tool helps health systems easily manage care coverage across their business units, by enabling administrators and staff to view work schedules, communicate with colleagues, swap and adjust shifts, and sync work shifts to personal calendars.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Strengths</span></div><div style="text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business exhibits a number of key strengths which we believe position us to drive sustained growth. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">We are the trusted and secure physician-first platform.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Since our founding, Doximity has been built to be physician-first, with trust at the core of what we do. We verify the identities and qualifications of our medical professionals through integration with third-party databases. In addition, our communications solutions are HIPAA compliant, providing medical professionals with a critical platform for protected communications.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">We have the largest digital network of medical professionals.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our members have the broadest available range of professional connections and networking opportunities through our platform, and we believe we have become the primary physician-to-physician connectivity medium. The scale and strength of our network has made us a strategic collaborator of choice for pharmaceutical manufacturers and health systems. We enable these organizations to engage with a valuable and otherwise difficult-to-reach audience, covering an increasing number of specialized medical professionals and enabling targeted outreach.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">We benefit from powerful network effects. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Both the medical professionals and customers that use our platform benefit immensely from access to our large and dynamic ecosystem, and we fuel the expansion of this network of medical professionals, pharmaceutical manufacturers, and health systems by adding new tools and solutions to our platform. As we expand our capabilities, Doximity becomes more attractive to new and existing members and customers, ultimately generating more data and insights that allow us to develop better tools and solutions, and build greater scale. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">We are deeply embedded in physician workflows</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our tools and third-party integrations are designed to solve workflow pain-points for physicians. Our tools provide physicians with the ability to deliver best-in-class healthcare, spend more time with patients, and ultimately improve patient care. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">We innately understand physician workflows are different from traditional technology workflows</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Through having product leaders who are physicians, designers, and engineers familiar with healthcare services, and an extended team of medical professionals in our advisory committees, we are able to build solutions that enable physicians and act as an extension of their practice. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">We are strategic to our customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide a unique, digital channel to connect with the most valuable professionals in healthcare. Pharmaceutical manufacturers and health systems gain access to a high value solution. Health systems and medical recruiting firms gain access to a comprehensive nationwide network and database of specialty and sub-specialty professionals. We align our goals with our customers and help them make the necessary leap to digital. </span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Growth Strategies</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Grow the Doximity Network.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> While we will continue to grow our number of physician members, we are under-penetrated among other types of medical professionals such as nurse practitioners, and have an opportunity to expand our offering to physical therapists, dentists, psychologists, and many other professions. As more medical professionals join our platform, we become a more valuable connectivity tool for members, and a more valuable marketing and hiring channel for pharmaceutical manufacturers and health systems. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Continuously improve and innovate on our platform.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Improving our existing capabilities, and innovating to add new tools and solutions, will make our platform more valuable to members, helping to attract new members and customers, while increasing the engagement of existing ones. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Expand within customers of our solutions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our existing customers represent a significant opportunity to grow our platform. Many of our large pharmaceutical customers initially run marketing programs for a certain number of brands but have a track record of increasing their spend with us both by adding modules and expanding across more of their portfolio of brands once they have seen the quantifiable benefits of our Marketing Solutions. Health systems have a similar track record of expanding their usage of our platform across different service lines. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Attract new customers.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have an opportunity to engage additional pharmaceutical manufacturers and health systems as we raise awareness of our offerings through our sales and marketing efforts and as we expand our offerings.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Further monetize our Telehealth Solutions. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our telehealth tools are used and trusted by hundreds of thousands of our members, and the rapid adoption by health systems of our commercial Telehealth Solution, Dialer Enterprise, reflects that professional trust. Our Dialer Enterprise solution is still in its early stages</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and we have significant whitespace ahead of us. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Grow our patient-facing tools.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Patients can search for the right doctor or hospital for their needs through our collaboration with the Doctor Finder tool of U.S. News &amp; World Report, which publicly displays summary physician profiles and hospital rankings powered by an integration with our Doximity network. We also collaborate with U.S. News &amp; World Report to offer a direct-to-patient scheduling tool for health systems. We see opportunities to expand our offerings to patients in the future. Consumers on the platform would also create a significant value opportunity for our customers.  </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Consider strategic acquisitions to expand our platform capabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In the past, we have selectively used mergers and acquisitions to accelerate our product roadmap to bring medical professionals and customers more complete solutions and increase demand for our products. For example, in the fiscal year ended March 31, 2021, or fiscal 2021, we acquired Curative Talent, a medical recruiting agency, in order to augment our Hiring Solutions with a tech-enabled, higher-touch service, and on April 1, 2022 we closed our acquisition of the AMiON shift scheduling service to further expand our physician cloud platform. We plan to continue evaluating similar opportunities and execute on them if we find the right fit for our members, customers, and our company.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Technology Platform</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our technology platform supports a vast network of member connections, with regularly updated profiles, secure communication and productivity tools, and vast amounts of searchable indexed data. Together, we believe these features of our physician cloud form a valuable competitive strength. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Platform Advantages</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Extensive and dynamic database of U.S. physician information:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the launch of our business, members have interacted with each other and our technology platform hundreds of millions of times. This has enabled us to build a vast, interactive data set intelligently combining proprietary information and previously siloed public information. Along with user-entered input, our proprietary algorithms constantly identify new information for our members from hundreds of third party sources that are isolated and siloed in the healthcare space. The up-to-date and scaled nature of our database is critical to the value proposition for both our members and our pharmaceutical manufacturer and health system customers. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Statistical and machine learning methodologies:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We utilize proprietary statistical and machine learning methodologies across our platform for a number of use cases to benefit our members. Some of the major components include:</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Aggregating and coupling disjointed datasets from numerous medical sources into a live database of physician information to perform descriptive, diagnostic, and prescriptive analysis. </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Medical news tailored to a member&#8217;s specific specialty, clinical areas of interest, and viewing history, ensuring that each member&#8217;s news feed is personalized to them and that the digital marketing content of our pharmaceutical and health system customers will be served to members that are more likely to find it relevant and interesting based on their profile and viewing history.</span></div><div style="margin-bottom:9pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Automatically matching top candidates with openings offered by recruiters and administrators based on job history, interests, and geography.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Extensive, interactive database of U.S. medical residency and employment data:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We collect and maintain a vast repository of residency and employment data from our members, which includes member reviews on their experience at hospitals and residency programs, detailed statistics on user experiences regarding program setting and training environment, and a salary map across different specialties and geographies across the country. We make this data available to all of our members in easily accessible portals which are automatically updated as our members provide additional data on the platform. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Proprietary productivity and telehealth tools:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our productivity and telehealth tools have been built to be physician-first with usability in mind at every step. Built on top of a modern software stack that ensures rapid scalability and enterprise-grade reliability, our tools allow doctors to communicate via messages, voice, and video&#8212;and their patients do not need to install an app to be connected. On top of this base service, we have designed a broad range of customized, physician-first telehealth features specific to our platform such as &#8216;call nudge&#8217; reminding a patient of a visit, &#8216;straight to voicemail&#8217; enabling physicians to choose not to disturb patients after-hours, and the flexibility to switch between voice and video at will, among others.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Design Principles:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our technology stack and product development teams are set up to enable rapid prototyping and development of new features via controlled rollouts. We focus on innovative, useful and unobtrusive features that are designed to optimize the healthcare professional&#8217;s workflow. And at all times, we follow the stringent security and privacy requirements of a physician&#8217;s data; our messaging tools are compliant with HIPAA and validated through external auditing procedures.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sales and Marketing</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We employ a direct sales organization composed of highly trained team members. The sales organization is segmented primarily by customer type. For example, there is one enterprise-focused team concentrating on pharmaceutical manufacturers and another concentrated on health systems. Our direct sales organization also reaches customers through indirect channels, such as third-party marketing agencies utilized by our pharmaceutical and health system customers. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The direct sales organization is supported by marketing and customer success specialists. We generate customer leads, accelerate sales opportunities, and build brand awareness through our marketing programs, both digitally and offline. These programs target decision makers to provide information about our company and solutions through digital advertising, field marketing events, integrated marketing programs (including direct email and online advertising), industry events, trade shows, and conferences. Our customer success team supports customer retention by working directly with customers to produce higher engagement with our solutions, which in turn expands their use of the platform in the future.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We buy a limited amount of digital search and display advertising on Google and Facebook to encourage potential members to sign up for our platform.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we have built a scaled and highly differentiated platform, we face competition across different aspects of our business. We have experienced, and expect to continue to experience, intense competition from a number of companies, and we expect such competition to increase as our industry evolves. Specifically, we compete for medical professionals as members, and for pharmaceutical and health system companies as customers for our Marketing, Hiring, and Telehealth Solutions. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Competing for members: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compete with large technology companies that have developed online networking and collaboration tools such as LinkedIn, Facebook, Google, and Twitter, in addition to smaller, emerging companies. However, we believe we are the only professional network solely dedicated to medical professionals, with a purpose-built platform to address their networking, collaboration, content, educational, and career management needs.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Competing for customers: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compete across several categories to access spend in the healthcare category. We specifically compete for access to marketing, hiring, and telehealth budgets. We believe that our platform and the network of medical professionals on Doximity allow us to provide our customers with solutions that result in attractive returns on their marketing and hiring budgets. </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:13.75pt">Marketing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: We compete with online and offline outlets that provide marketing and advertising services that enable pharmaceutical manufacturers and health systems to educate medical professionals about their brands. These outlets include health-related websites and mobile apps. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">Hiring:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We compete in the healthcare staffing industry with job boards, self-service recruiting tools, and medical recruiting firms in national, regional, and local markets. We compete with large healthcare staffing companies as well as smaller, more regionally focused companies. </span></div><div style="margin-bottom:9pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.46pt">Telehealth: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compete with other providers of telehealth services, such as Teladoc Health and Amwell, in addition to smaller, emerging companies that provide telehealth services on behalf of employers and insurance plans. In addition, with the COVID-19 pandemic, we have seen increased competition from broader video communication solutions, such as Zoom Video Communications. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The industries in which our products are offered are evolving rapidly and are becoming increasingly competitive. Larger and more established companies may focus on our market and could directly compete with us. Smaller companies, including application developers, could also launch new products and services that compete with us and that could gain market acceptance quickly. We also expect our existing competitors in the markets for Marketing and Hiring Solutions to continue to focus on these areas. Many of our competitors and potential competitors have significantly greater financial, technological, and other resources than we do and greater name recognition and more established distribution networks and relationships with healthcare providers than us. As a result, many of these companies may respond more quickly to new or emerging technologies and standards and changes in customer requirements. These companies may be able to invest more resources in research and development, strategic acquisitions, sales and marketing, patent prosecution, litigation, and financing capital equipment acquisitions for their customers.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our competitors may announce new products, services, or enhancements that better address changing industry standards or the needs of members and customers, such as mobile access. Any such increased competition could cause pricing pressure, loss of market share or decreased member engagement, any of which could adversely affect our business and operating results. Internet search engines could also change their methodologies in ways that adversely affect our ability to optimize our page rankings within their search results. If this occurs, our ability to successfully market our services to customers may be harmed and our business results may suffer.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our People, Culture, Values, and Human Capital Resources</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At Doximity, we organize our teams into small, nimble groups that operate autonomously and are empowered to make decisions quickly and who aim to stay close to our members and customers. We prioritize diversity and inclusion, and regularly track our progress against quantifiable goals. We have always been a geographically distributed team: over three-quarters of our employees were already working remotely prior to the COVID-19 pandemic. We supplement our workforce with contractors and consultants in the United States and internationally.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We champion the following core values: </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Get Stuff Done:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We are doers. We solve problems everyday by treating obstacles like an adventure. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Straight Talk:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We say what we think and every voice is heard and respected. Transparency makes us stronger.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Stretch Goals:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Innovation requires risk taking. We challenge assumptions and shoot for the stars.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Bring the Real You: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We bring our quirky, unique selves to work. Diverse personalities create a more interesting and creative environment.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and certain of our employees also volunteer time with a number of charity initiatives, including the Dox Foundation, which was formed by our Chief Executive Officer and his family. The Dox Foundation&#8217;s work includes helping clinicians reach underserved communities by funding flights for medical mission trips and providing grants to applicants. Applicants have traveled to Uganda, Cambodia, India, Myanmar, and the West Indies to provide services as diverse as cleft lip and palate surgery, orthopedic surgery education, and nursing education at a children&#8217;s hospital. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our human capital resources objectives include, as applicable, identifying, recruiting, retaining, incentivizing, and integrating our existing and additional employees. The principal purposes of our equity incentive plans are to attract, retain, and motivate selected employees, consultants, and directors through the granting of stock-based compensation awards and cash-based performance bonus awards. To our knowledge, none of our employees are represented by a labor union or covered by a collective bargaining agreement. We have not experienced any work stoppages, and we consider our relations with our employees to be good. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, we had a total of 887 full-time equivalent employees. More than 35% of our full-time equivalent  employees work in R&amp;D, including in product, engineering, and data. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Data Protection, Security, and Regulatory Compliance</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The data we collect and process is an integral part of our tools and solutions, allowing us to ensure our members are verified, the experience we provide is engaging and personalized, and the content we present is the most relevant. In addition, our business is subject to extensive, complex, and rapidly changing federal and state laws and regulations governing data collection, healthcare regulation, financial services laws, regulations and rules, such as the Payment Card Industry Data Security Standards, and related matters. Our respect for laws and regulations regarding the collection and processing of personal data underlies our strategy to improve our member experience and build trust in our network and platform. While we believe we comply in all material respects with applicable laws and regulations, these regulations can vary significantly from jurisdiction to jurisdiction, and interpretation and enforcement of existing laws and regulations may change periodically. Federal and state legislatures also may enact various legislative proposals that could materially impact certain aspects of our business. For additional information, see &#8220;Risk Factors&#8212;Risks Related to Our Business&#8212; We are subject to stringent and changing laws, regulations, self-regulatory schemes, contractual obligations, and standards related to privacy, data protection, and information security. The actual or perceived failure by us, our customers, partners, or vendors to comply with such obligations could harm our reputation, subject us to significant fines and liability, or otherwise adversely affect our business.&#8221;</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Data Collection and Protection</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We collect and may use personal information to help run our business (including for analytical purposes) and to communicate and otherwise reach our network members. In some instances, we may use third-party service providers to assist us in these efforts.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We endeavor to treat our members&#8217; data with respect and maintain member trust. We provide our members with options designed to allow them to control their data, such as allowing our members to decide which profile contact information is viewable publicly and which is accessible to new connections. Members can also request deletion of their data under applicable privacy laws and procedures. Our privacy and security teams are devoted to processing and fulfilling member requests regarding access to and deletion of their data. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Physician information that is posted to profiles is protected with anti-scraping technologies such as a Web Application Firewall, Runtime Application Self-Protection, Bot Protection, Rate-Limiting, and our network employs DDoS mitigation technology to protect against attacks. All data is encrypted in transit and at rest using TLS 1.2, and personal health information is encrypted at rest using AES-256 encryption. Along with a dedicated in-house security team and contracted security researchers, we maintain a comprehensive HackerOne program for proactive vulnerability inspection of our entire offering.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. state and federal health information privacy and security laws</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are numerous U.S. federal and state laws and regulations related to the privacy and security of personally identifiable information, including health information. In particular, HIPAA established privacy and security standards that limit the use and disclosure of protected health information, referred to as PHI, and require the implementation of administrative, physical, and technical safeguards to ensure the confidentiality, integrity, and availability of individually identifiable health information in electronic form. Our members as well as certain of our enterprise customers are regulated as covered entities under HIPAA. As a service provider who creates, receives, maintains, or transmits PHI on behalf of these covered entities for certain of our services, Doximity is a &#8220;business associate&#8221; as defined under HIPAA. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Violations of HIPAA may result in civil and criminal penalties and a single breach incident can result in violations of multiple standards. In the event of a breach, we must also comply with HIPAA&#8217;s breach notification rule and our covered entity enterprise customers may require we provide assistance in the breach notification process and may seek indemnification and other contractual remedies. State attorneys general also have the right to prosecute HIPAA violations committed against residents of their states, and individuals have used HIPAA standards as the basis for the duty of care in state civil suits, such as those for negligence or recklessness in misusing personal information. In addition, HIPAA mandates that HHS conduct periodic compliance audits of HIPAA covered entities and their business associates for compliance.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, many states in which we operate and in which our members and customers as well as their patients reside also have laws that protect the privacy and security of sensitive and personal information, including health information, information regarding mental health and substance use treatment, and other information related to the provision of healthcare services.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of these laws also prohibit unfair privacy and security practices and deceptive statements about privacy and security place specific requirements on certain types of activities, such as data security and texting. These laws may be similar to or even more protective than HIPAA and other federal privacy laws. For example, the laws of the State of California, in which we operate, are more restrictive than HIPAA, including the provisions of the California Consumer Privacy Act, or CCPA, which went into effect January 1, 2020. While any information we maintain in our role as a business associate may be exempt from the CCPA, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">other records and information we maintain on our members may be subject to the CCPA. Where state laws are more protective than HIPAA or require us to take action such as breach notification, we must comply with the state laws we are subject to, in addition to HIPAA. In certain cases, it may be necessary to modify our planned operations and procedures to comply with these more stringent state laws. Not only may some of these state laws impose fines and penalties upon violators, but also some, unlike HIPAA, may afford private rights of action to individuals who believe their personal information has been misused. In addition, state laws are changing rapidly, and there is discussion of a new federal privacy law or federal breach notification law, to which we may be subject. For additional information, see &#8220;Risk Factors&#8212;Risks Related to the Healthcare Industry.&#8221;</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Federal and State Telecommunications Laws</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are a number of federal and state laws and regulations potentially applicable to communications by phone, text message, or facsimile, including the TCPA, and those laws and regulations are continuously evolving. Our services that allow members and other platform users to leverage such telephonic communications may be subject to these laws and regulations.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Healthcare Laws and Regulations and Health Reform</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are many laws that govern the activities of healthcare professionals, some of which may be applied to us because of our relationships with them. Some of these requirements may apply to us even if we do not have a physical presence in the state, based solely on our agreements with providers licensed in the state. Many states limit the scope of business relationships between business entities and medical professionals. For example, while many states&#8217; fee-splitting laws only prohibit a physician from sharing medical fees with a referral source, some states have interpreted certain management agreements between business entities and physicians as unlawful fee-splitting. These laws generally prohibit us from exercising control over the medical judgments or decisions of physicians and non-physician healthcare providers and from engaging in certain financial arrangements, such as splitting professional fees with healthcare providers.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, certain federal and state anti-kickback and false claims laws may apply to us indirectly through our arrangements with healthcare professionals and entities. Statutes and regulations relating to the practice of medicine, anti-kickback, fraud, fee-splitting, and similar issues vary widely from state to state. Because these laws are often vague, their application is frequently dependent on court rulings and attorney general opinions. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, there have been several legislative and regulatory changes and proposed reforms of the healthcare system to contain costs, improve quality, and expand access to care. It is also possible that additional governmental action is taken in response to the COVID-19 pandemic.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Failure to comply with any of these laws or regulations could lead to adverse judicial or administrative action against us and/or our provider customers, civil or criminal penalties, receipt of cease and desist orders from state regulators, loss of provider licenses, the need to make changes to the terms of engagement of our provider customers that interfere with our business, and other materially adverse consequences. For additional information, see &#8220;Risk Factors&#8212;Risks Related to the Healthcare Industry.&#8221; </span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intellectual Property </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our intellectual property rights are valuable and important to our business. We rely on a combination of trademarks, copyrights, patents, trade secrets, license agreements, confidentiality procedures, non-disclosure agreements, employee disclosure and invention assignment agreements, as well as other legal and contractual rights, to establish and protect our proprietary rights. However, our contractual provisions may not always be effective at preventing unauthorized parties from obtaining our intellectual property and proprietary technologies. In addition, though we rely in part upon these legal and contractual protections, we believe that factors such as the skills and ingenuity of our employees and the functionality and frequent enhancements to our platform are larger contributors to our success in the market.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, we have four provisional patent applications in the United States. We continually review our development efforts to assess the existence and patentability of new intellectual property.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have an ongoing trademark and service mark registration program pursuant to which we register our brand names, product names, and logos in the United States to the extent we determine appropriate and cost-effective. As of March&#160;31, 2022, we have a total of seven registered or applied-for trademarks in the United States and two registered trademarks in non-U.S. jurisdictions. We also have registered domain names for websites that we use in our business, such as www.doximity.com and other variations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to pursue additional intellectual property protection to the extent we believe it would be beneficial and cost effective. Despite our efforts to protect our intellectual property rights, they may not be respected in the future or may be invalidated, circumvented, or challenged. In addition, if we were to expand internationally, the laws of certain foreign countries may not protect our intellectual property rights to the same extent as laws in the United States. We may be dependent on third-</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">party content, technology, and intellectual property in connection with our business. We expect that infringement claims may increase as the number of products and competitors in our market increase. In addition, to the extent that we gain greater visibility and market exposure as a public company, we face a higher risk of being the subject of intellectual property infringement claims from third parties. Any third-party intellectual property claims against us could significantly increase our expenses and could have a significant and negative impact on our business, results of operations, and financial condition.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Seasonality </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, we have experienced some seasonality based on the timing of marketing programs, subscription launches on our platform and budgetary timing of purchases of additional modules.  </span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate Information</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We were incorporated in the state of Delaware in April 2010 as 3MD Communications, Inc. and we subsequently changed the name to Doximity, Inc. in June 2010. Our principal executive offices are located at 500 3rd Street, Suite 510, San Francisco, California 94107, and our telephone number is (650) 549-4330. </span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Available Information </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We file electronically with the SEC our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, our Proxy Statement, current reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, or the Exchange Act. In addition, copies of these reports and other information may be obtained, free of charge, on our website at www.investors.doximity.com as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. The SEC also maintains an Internet website that contains reports, proxy statements and other information about issuers, like us, that file electronically with the SEC. The address of that website is www.sec.gov. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We webcast our earnings calls and certain events we participate in or host with members of the investment community on our investor relations website. Additionally, we provide notifications of news or announcements regarding our financial performance, including SEC filings, investor events, press and earnings releases, and blogs as part of our investor relations website. We have used, and intend to continue to use, our investor relations website as a means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD. Further corporate governance information, including our corporate governance guidelines, composition of our board and its committees, and Code of Conduct, are also available on our investor relations website under the heading &#8220;Governance Documents.&#8221; The contents of our websites are not intended to be incorporated by reference into this Annual Report on Form 10-K or in any other report or document we file with the SEC, and any references to our websites are intended to be inactive textual references only. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><div id="i6c4404140edb48938ba4e30b290c9ef9_43"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">A description of the risks and uncertainties associated with our business is set forth below. You should carefully consider the risks and uncertainties described below, together with all of the other information contained in this Annual Report on Form 10-K, including our consolidated financial statements and the related notes thereto, and the section titled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.&#8221; The risks and uncertainties described below may not be the only ones we face. Additional risks and uncertainties that we are unaware of, or that we currently believe are not material, may also become important factors that affect us. If any of the following risks occur, our business, results of operations, financial condition, and prospects could be harmed. In that event, the trading price of our Class A common stock could decline and you could lose a portion or all of your investment.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk Factors Summary</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The below is a summary of principal risks to our business and risks associated with ownership of our stock. It is only a summary. You should read the more detailed discussion of risks set forth below and elsewhere in this report for a more complete discussion of the risks listed below and other risks. Additional risks, beyond those summarized below, set forth in this section, or discussed elsewhere in this Annual Report on Form 10-K, may apply to our business, activities or operations as currently conducted or as we may conduct them in the future or in the markets in which we operate or may in the future operate. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we fail to effectively manage our growth, we may be unable to execute our business plan, adequately address competitive challenges or maintain our corporate culture, and our business, financial condition, and results of operations could be harmed;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have a limited operating history, which makes it difficult to evaluate our current business and future prospects and to predict our future operating results, and therefore increases the risk of investment;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we fail to retain existing members or add new members, our revenue, operating results, financial condition, and business may be significantly harmed;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we do not continue to attract new customers, or if existing customers do not renew their subscriptions, renew on less favorable terms, or fail to purchase additional solutions, it could have a material adverse effect on our business, financial condition, and results of operations;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our revenue is relatively concentrated within a small number of key customers, and the loss of one or more of such key customers could slow the growth rate of our revenue or cause our revenue to decline;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We expect to face increasing competition in the market for our solutions;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The COVID-19 pandemic and any other future pandemic, epidemic, or outbreak of an infectious disease may adversely affect our business, financial condition, and results of operations;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we are not able to maintain and enhance our reputation and brand recognition, our business, financial conditions, and results of operations will be harmed;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Making business decisions that prioritize the interests of our members  may adversely impact our financial results;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We depend on our talent to grow and operate our business, and if we are unable to hire, integrate, develop, motivate, and retain our personnel, we may not be able to grow effectively;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Failure to maintain, protect, or enforce our intellectual property rights could harm our business and results of operations; and</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The dual class structure of our common stock has the effect of concentrating voting control with our executive officers (including our Chief Executive Officer) and directors and their affiliates; this will limit or preclude your ability to influence corporate matters.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to adequately address these and other risks we face, our business, results of operations, financial condition and prospects may be harmed. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Business</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to effectively manage our growth, we may be unable to execute our business plan, adequately address competitive challenges or maintain our corporate culture, and our business, financial condition, and results of operations could be harmed.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since launching our platform in fiscal 2012, we have experienced rapid growth and we continue to rapidly and significantly expand our operations. While we have experienced significant revenue growth in prior periods, it is not indicative of our future revenue growth. We expect our revenue growth rate will decline. In the fiscal year ended March 31, 2022, or fiscal 2022, and fiscal 2021, our revenue grew by 66% and&#160;78%, respectively, as compared to the revenue from the prior fiscal years. In addition, our full-time equivalent employee headcount has grown from 713 as of March&#160;31, 2021 to 887 as of March&#160;31, 2022. This expansion increases the complexity of our business and places significant strain on our management, personnel, operations, systems, technical performance, financial resources, and internal financial control and reporting functions. We may not be able to manage growth effectively, which could damage our reputation, limit our growth, and negatively affect our operating results.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The growth and expansion of our business creates significant challenges for our management, operational, and financial resources. In the event of continued growth of our operations or in the number of our third-party relationships, our information technology systems and our internal controls and procedures may not be adequate to support our operations. To effectively manage our growth, we must continue to improve our operational, financial, and management processes and systems and to effectively expand, train, and manage our employee base. As our organization continues to grow and we are required to implement more complex organizational management structures, we may find it increasingly difficult to maintain the benefits of our corporate culture, including our ability to quickly develop and launch new and innovative solutions. This could negatively affect our business performance.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to invest heavily in growing our business, which may cause our sales and marketing, research and development, and other expenses to increase and our margins to decline. For example, our Telehealth Solutions have experienced significant growth amid a rapidly developing market, which may result in increased price competition and costs and may have an adverse impact on our margins if it continues to grow as a portion of our overall business. Our net income and adjusted EBITDA margin has grown in recent periods and as we continue to grow, may decrease.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our historical rate of growth may not be sustainable or indicative of our future rate of growth. We believe that our continued growth in revenue, as well as our ability to improve or maintain margins and profitability, will depend upon, among other factors, our ability to address the challenges, risks, and difficulties described elsewhere in this &#8220;Risk Factors&#8221; section and the extent to which our various offerings grow and contribute to our results of operations. We cannot provide assurance that we will be able to successfully manage any such challenges or risks to our future growth. In addition, our customer base may not continue to grow or may decline due to a variety of possible risks, including increased competition, changes in the regulatory landscape, and the maturation of our business. Any of these factors could cause our revenue growth to decline and may adversely affect our margins and profitability. Failure to continue our revenue growth or margin improvement could have a material adverse effect on our business, financial condition, and results of operations. You should not rely on our historical rate of revenue growth as an indication of our future performance.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have a limited operating history, which makes it difficult to evaluate our current business and future prospects and to predict our future operating results, and therefore increases the risk of investment.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Doximity, Inc. was incorporated in the state of Delaware in April 2010 as 3MD Communications, Inc. and we subsequently changed the name to Doximity, Inc. in June 2010. We began commercial offerings in fiscal 2012, and by fiscal 2014 we began serving our pharmaceutical and health system customers on some of our early stage solutions. As a result of our limited operating history and our rapid growth, our ability to forecast our future operating results, including revenue, cash flows, and profitability, is limited and subject to a number of uncertainties, including our ability to effectively plan for and model future growth. We have encountered and will encounter risks and challenges frequently experienced by growing companies with competitive offerings, such as the risks and uncertainties described in this Annual Report on Form 10-K. In addition, our business is affected by general economic and business conditions around the world, including the impact of the COVID-19 pandemic or any other similar pandemic or epidemic. If our assumptions regarding these risks and uncertainties are incorrect or change due to changes in our markets, or if we do not address these risks successfully, our operating and financial results may differ materially from our expectations and our business may suffer. These risks and challenges include our ability to:</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">maintain and increase our number of registered members for our platform;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">maintain and increase our number of customers for our solutions;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increase revenue from the solutions we provide; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">successfully compete with other companies that are currently in, or may in the future enter, the online professional network space, telehealth, or productivity tools;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">maintain and improve the infrastructure underlying our network, including Amazon Web Services and our apps and websites, including with respect to data protection and cybersecurity; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">maintain and further develop a scalable, high-performance technology infrastructure that can efficiently and reliably handle increased member usage, as well as the deployment of new features and tools; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">successfully update our network, including expanding our network and offerings, develop and update our apps, features, offerings, and services to benefit our members&#8217; experience;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">responsibly use the data that our members share with us to provide solutions that make our members more successful and productive and that are critical to the hiring and marketing needs of enterprises and professional organizations; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">comply with existing and new laws and regulations applicable to our business and our industry;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">process, store, and use personal data in compliance with governmental regulation and other legal obligations related to privacy; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">maintain and enhance the value of our reputation and brand;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continue to earn and preserve our members&#8217; trust with respect to their professional reputation and information; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">effectively manage our growth; and</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">hire, integrate, and retain talented people at all levels of our organization.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to retain existing members or add new members, our revenue, operating results, financial condition, and business may be significantly harmed.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The size of our member base and our members&#8217; level of engagement are critical to our success. Our financial performance has been and will continue to be significantly determined by our success in adding, retaining, and engaging members. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If medical professionals do not perceive our platform to be useful, reliable, and trustworthy, we may not be able to attract or retain members or otherwise maintain or increase the frequency and duration of their engagement. A decrease in member retention, growth, or engagement could render us less attractive to our pharmaceutical manufacturer and health system customers, which may have a material and adverse impact on our revenue, business, financial condition, and results of operations. Any number of factors could potentially negatively affect member retention, growth, and engagement, including if:</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we fail to introduce new and improved tools or if we introduce new tools for our members that are not favorably received;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">there are changes in member sentiment about the quality or usefulness of our tools or concerns related to privacy and sharing, safety, security, or other factors;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we are unable to manage and prioritize information to ensure members are presented with content that is interesting, useful, and relevant to them;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">there are adverse changes in our tools that are mandated by legislation, regulatory authorities, or litigation, including settlements or consent decrees;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">technical or other problems prevent us from delivering our tools in a rapid and reliable manner or otherwise affect the member experience; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we adopt policies or procedures related to areas such as sharing our member data that are perceived negatively by our members or the general public; and</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">new offerings from our competitors are introduced to the market.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to maintain and increase our member base and member engagement, our revenue, operating results, financial condition, business, and future growth potential may be adversely affected.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we do not continue to attract new customers, or if existing customers do not renew their subscriptions, renew on less favorable terms, or fail to purchase additional solutions, it could have a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to grow our business, we must continually attract new customers, sell additional solutions to existing customers and reduce the level of non-renewals in our business. Our ability to do so depends in large part on the success of our sales and marketing efforts. Most customers engage with us on particular marketing programs, either directly or through marketing agencies that act on their behalf. We do not typically enter into long-term contracts with our pharmaceutical manufacturer customers, who represent a significant portion of our revenue. When we do enter into long-term relationships with customers, they can generally terminate their relationship with us or move their marketing activity to a new agency with whom we do not currently do business. Even if we are successful in attracting new customers and their agencies, it may take several months or years for them to meaningfully increase the amount that they spend with us. Further, larger pharmaceutical customers with multiple brands typically have brand-level marketing budgets and marketing decision makers, and we may not be able to leverage our success into expanded business with other brands within the customer&#8217;s portfolio. Moreover, customers may place internal limits on the allocation of their marketing budgets to digital marketing, to particular programs, to a particular marketing vendor, or for other reasons. We may not accurately predict future trends with respect to rates of customer renewals, upgrades, and expansions. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customers of our Marketing Solutions may not continue to do business with us if their marketing content does not reach their intended audiences. Therefore, we must continue to demonstrate to our customers that using our Marketing Solutions offering is the most effective and cost-efficient way to maximize their results. Similarly, we must demonstrate that our Hiring Solutions are important recruiting tools for enterprises, professional organizations, and individuals and that our Hiring Solutions provide them with access to the target audience. Our Hiring Solutions customers will discontinue their purchases of our solutions if we fail to effectively connect them with the talent they seek. Finally, for our Telehealth Solutions, we may not be able to retain existing customers or attract new customers if we fail to provide high quality solutions, if customers are unable to realize the value of our solutions, or if we are not able to measure and demonstrate the value that our solutions provide.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our customer base may decline or fluctuate due to a number of factors, including the prices of our solutions, the prices of products and services offered by our competitors, reduced hiring by our customers or reductions in their talent or marketing spending levels due to macroeconomic or other factors, and the efficacy and cost-effectiveness of our solutions. Internet search engines could also change their methodologies in ways that adversely affect our ability to optimize our page rankings within their search results. If this occurs, our ability to successfully market our services may be harmed. If we are unable to retain and increase sales of our solutions to existing customers and their agencies or attract new ones for any of the reasons above or for other reasons, our business, financial condition, and results of operations could be adversely affected.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our revenue is relatively concentrated within a small number of key customers, and the loss of one or more of such key customers could slow the growth rate of our revenue or cause our revenue to decline.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the fiscal year ended March&#160;31, 2022, no customers accounted for 10% or more of total revenue. For the fiscal year ended March 31, 2021 and 2020, one of our customers accounted for 10% or more of total revenue. In addition, some of our customers purchase our services indirectly through marketing agencies, some of whom represent a number of customers.  The sudden loss of any of our largest customers, or the renegotiation of any of our largest customer contracts could have a significant impact on our revenue, the growth rate of our revenue, our reputation, and our ability to obtain new customers.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, we engage in active discussions and renegotiations with our customers, either directly or through marketing agencies, in respect of the solutions we provide and the terms of our customer agreements, including our fees. As our customers&#8217; businesses respond to market dynamics, financial pressures, and regulatory changes or delays impacting their businesses, and as our customers make strategic business decisions regarding how to market their offerings, our customers seek to, and we expect will continue to seek to, amend the terms of their arrangements with us. In the ordinary course, we renegotiate the terms of our agreements with our customers in connection with renewals or extensions of these agreements. These discussions and future discussions could result in reductions to the fees and changes to the scope contemplated by our original customer contracts and consequently could negatively impact our revenue, business, and prospects. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because we rely on a limited number of customers and agencies for a significant portion of our revenue, we depend on the creditworthiness of these entities. If the financial condition of these entities declines, our credit risk could increase. Should one or more of our significant customers or agencies declare bankruptcy, be declared insolvent, or otherwise be restricted by state or federal laws or regulation from continuing in some or all of their operations, this could adversely affect our ongoing revenue, the collectability of our accounts receivable, and affect our bad debt reserves and net income.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We expect to face increasing competition in the market for our solutions.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face significant competition across different aspects of our business, and we expect such competition to increase. Our industry and the markets we serve are evolving rapidly and becoming increasingly competitive. Larger and more established companies may focus on our markets and could directly compete with us. Smaller companies could also launch new products and services that compete with us and that could gain market acceptance quickly. We also expect our existing competitors in the markets for Marketing and Hiring Solutions to continue to focus on these areas. A number of these companies may have greater financial, technological, and other resources than we do and greater name recognition and more established distribution networks and relationships with healthcare providers than us, which may enable them to compete more effectively. Specifically, we compete for medical professionals as members against large technology companies that have developed online networking and collaboration tools like LinkedIn, Facebook, Google, and Twitter, in addition to smaller, emerging companies. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also compete to access marketing, hiring, and telehealth budgets of pharmaceutical and health system companies as customers for our Marketing, Hiring, and Telehealth Solutions. We compete for customers for our Marketing Solutions with online outlets such as health-related websites and mobile apps, like WebMD&#8217;s Medscape, as well as offline organizations that provide marketing and advertising services that enable pharmaceutical manufacturers and health systems to educate medical professionals. We compete for customers for our Hiring Solutions with large and regional staffing companies, job boards, self-service recruiting tools, and medical recruiting firms. We compete for customers for our Telehealth Solutions with other providers of telehealth offerings such as American Well and Teladoc Health, and other companies that offer telehealth capabilities such as Zoom Video Communications who may further focus on our market and could directly compete with us. We also compete for members, customers, and professional organizations in the market for online professional networks which continues to rapidly evolve. Our competitors may announce new products, services, or enhancements that better address changing industry standards or the needs of members and customers, such as mobile access. Any such increased competition could cause pricing pressure, loss of market share, or decreased member engagement, any of which could adversely affect our business and operating results. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The COVID-19 pandemic and any other future pandemic, epidemic, or outbreak of an infectious disease may adversely affect our business, financial condition, and results of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite vaccine efforts, the duration and severity of the COVID-19 pandemic is unknown, and the extent of the business disruption and financial impact depend on factors beyond our knowledge and control. The spread of COVID-19, including the Omicron variants and other variations of the variant, has caused us to modify our business practices, and we may take further actions as may be required by government authorities or that we determine are in the best interests of our employees, members, and partners. In addition, the COVID-19 pandemic and the determination of appropriate measures and business practices has diverted management&#8217;s time and attention. A larger percentage of our employees are now working from home, and if they are not able to effectively do so, or if our employees contract COVID-19 or another contagious disease, we may experience a decrease in productivity and operational efficiency, which would negatively impact our business, financial condition, and results of operations. Further, because an increased number of employees are working remotely in connection with the COVID-19 pandemic, we may experience an increased risk of security breaches, loss of data, and other disruptions as a result of accessing sensitive information from multiple remote locations. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With the COVID-19 pandemic, many of our Marketing Solutions customers have shifted their budgets away from in-person marketing to online solutions such as ours. The circumstances that have accelerated the growth of our business stemming from the effects of the COVID-19 pandemic may not continue in the future, and if these customers reallocate a significant portion of their budgets back to in-person marketing, this could cause our growth to decline in future periods. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Like many other businesses in the temporary and permanent staffing space, our Hiring Solutions have been negatively impacted by the COVID-19 pandemic, as doctors and other medical professionals change jobs and travel less frequently for temporary positions. If the hiring market slows or continues to decline, our ability to maintain or grow our business could be adversely affected.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COVID-19 pandemic-related market changes that have caused an increased demand in telehealth solutions and other increases in health systems spending may cause us to invest in additional solutions to meet these needs and may also cause an increase in competitive offerings. If we are not able to make a return on those investments, meet the market demands, or effectively compete in the marketplace, our business results may suffer. Also, the financial impact of COVID-19 or another pandemic, epidemic, or outbreak of an infectious disease may lead to an overall decrease in healthcare spending due to a potential economic downturn and overall uncertainty causing healthcare expenditures to be concentrated in emergency care, which may cause a material impact to our business. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While the potential economic impact brought by and the duration of any pandemic, epidemic, or outbreak of an infectious disease, including COVID-19, may be difficult to assess or predict, the widespread COVID-19 pandemic has resulted in, and may continue to result in, significant disruption of global financial markets, reducing our ability to access capital, which could in the future negatively affect our liquidity. The impact of any pandemic, epidemic, or outbreak of an infectious disease, including COVID-19, on the needs, expectations, and spending levels of our customers could impact our ability to maintain or grow our business and as a result our operating and financial results could be adversely affected.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The full extent to which the COVID-19 pandemic will impact our business, results of operations, and financial condition is still unknown and will depend on future developments, which are highly uncertain and cannot be predicted, including, but not limited to, the duration and spread of the COVID-19 pandemic, the impact and severity of new variants, the actions to contain the virus or treat its impact, and how quickly and to what extent normal economic and operating conditions can resume. Even after the COVID-19 pandemic has subsided, we may experience materially adverse impacts to our business as a result of its global economic impact, including any recession that has occurred or may occur in the future. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent the COVID-19 pandemic adversely affects our business, financial condition, and results of operations, it may also have the effect of heightening many of the other risks described in this &#8220;Risk Factors&#8221; section.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See the section titled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;Impact of COVID-19&#8221; for additional information.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are not able to maintain and enhance our reputation and brand recognition, our business, financial conditions, and results of operations will be harmed.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that maintaining and enhancing our reputation and brand recognition is critical to our relationships with existing customers and members and our ability to attract new customers and members. The promotion of our brand may require us to make substantial investments and we anticipate that, as our market becomes increasingly competitive, these marketing initiatives may become increasingly difficult and expensive. Our marketing activities may not be successful or yield increased revenue, and to the extent that these activities yield increased revenue, the increased revenue may not offset the expenses we incur, and our results of operations could be harmed. In addition, any factor that diminishes our reputation or that of our management, including failing to meet the expectations of our customers and members, could make it substantially more difficult for us to attract new customers. Similarly, because our customers often act as references for us with prospective new customers, any existing customer that questions the quality of our work or that of our employees could impair our ability to secure additional new customers. If we do not successfully maintain and enhance our reputation and brand recognition with our members and customers, our business may not grow and we could lose these relationships, which would harm our business, financial condition, and results of operations.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Making business decisions that prioritize the interests of our members  may adversely impact our financial results. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our &#8220;physicians first&#8221; philosophy may mean we make decisions based on the best interests of our members, which we believe is essential to our success in increasing our member growth rate and engagement, creating value for our members, and in serving the best interests of the Company and our stockholders. Therefore, in the past, we have forgone, and may in the future forgo, certain expansion or revenue opportunities that we do not believe are in the best interests of our members, even if our decision negatively impacts our operating results. In addition, our philosophy of putting our members first may cause disagreements, or negatively impact our relationships, with our existing or prospective customers. Our decisions may not result in the benefits that we expect, in which case our member engagement, business, and operating results could be harmed.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our members&#8217; profiles are out-of-date, inaccurate, or lack the information that members and customers want to see, we may not be able to realize the full potential of our network, which could adversely impact the growth of our business.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our members do not update their information or provide accurate and complete information when they join our platform, the value of our platform may be negatively impacted because our value proposition as a professional network and as a source of accurate and comprehensive data will be weakened. For example, incomplete or outdated member information would diminish the ability of our Marketing Solutions customers to reach their target audiences and our ability to provide our customers with valuable insights. Similarly, customers of our Hiring Solutions may not find members that meet their qualifications or may misidentify a candidate as having such qualifications, which could result in mismatches that erode customer confidence in our solutions. Therefore, we must provide features and tools that demonstrate the value of our network to our members and motivate them to contribute additional, timely, and accurate information to their profile and our network. In addition, we must ensure that methods by which we identify relevant audiences for our customers results in accurate targeting. If we fail to successfully undertake these activities, our business and operating results could be adversely affected.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The telehealth market is immature and volatile, and if it does not develop, or if it develops more slowly than we expect, if it encounters negative publicity, or if we are not successful in demonstrating and promoting the benefits of our solutions, the growth of our business will be harmed.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The telehealth market is relatively new and unproven, and it is uncertain whether it will achieve and sustain high levels of demand, consumer acceptance, and market adoption. The increased demand for telehealth solutions as a result of the COVID-19 pandemic may decline in the future. The success of our Telehealth Solutions will depend to a substantial extent on the willingness of our members to use, and to increase the frequency and extent of their utilization of, our network, as well as on our ability to demonstrate the value of telehealth to employers, health plans, government agencies, and other purchasers of healthcare for beneficiaries. If any of these events do not occur or do not occur quickly, it could have a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our corporate culture has contributed to our success, and if we cannot maintain our corporate culture as we grow, we could lose the innovation, teamwork, passion, and focus on execution that we believe contribute to our success, and our business may be harmed.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that a critical component to our success has been our corporate culture. We have invested substantial time and resources in building our team. As we continue to grow, we may find it difficult to maintain these important aspects of our corporate culture, especially given that the majority of our workforce has traditionally worked remotely and we have been unable to hold in-person employee gatherings as a result of the COVID-19 pandemic. We have experienced, and may continue to experience, rapid growth and organizational change, including growth and organizational change resulting from our acquisition of and subsequent integration with other businesses, which will continue to place significant demands on our management and our operational and financial infrastructure. As we continue to grow, we must effectively integrate, develop, and motivate a large number of new employees, and we must maintain the beneficial aspects of our corporate culture. We will require significant capital expenditures and the allocation of valuable management resources to grow and change in this way, without undermining our corporate culture. Any failure to preserve our culture could negatively affect our future success, including our ability to retain and recruit personnel and to effectively focus on and pursue our corporate objectives.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, to attract top talent, we have had to offer, and believe we will need to continue to offer, highly competitive compensation packages before we can validate the productivity of those employees. In addition, fluctuations in the price of our common stock may make it more difficult or costly to use equity compensation to motivate, incentivize, and retain our employees. We face significant competition for talent from other healthcare, technology, and high-growth companies, which include both large enterprises and privately-held companies. We may not be able to hire new employees quickly enough to meet our needs. If we fail to effectively manage our hiring needs and successfully integrate our new hires, our efficiency and ability to meet our forecasts and our employee morale, productivity, and retention could suffer, and our business, results of operations, and financial condition could be adversely affected.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The loss of one or more of any of the pharmaceutical brands that purchase our solutions could cause our revenue to decline.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell subscriptions for our marketing solutions across different brands within our pharmaceutical customers. The success of pharmaceutical brands and associated marketing spend can depend on patent life, competition, and other factors. For example, in the past we have lost marketing spend and associated revenue when a pharmaceutical brand marketed on our platform lost patent protection. The loss of the business of a significant brand could damage our relationship with that customer and its other brands, and our revenue, operating results, financial condition, business, and future growth potential may be adversely affected.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We calculate certain operational metrics using internal systems and tools and do not independently verify such metrics. Certain metrics are subject to inherent challenges in measurement, and real or perceived inaccuracies in such metrics may harm our reputation and negatively affect our business.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We present certain operational metrics herein, including size of our network of medical professionals and other metrics. We calculate these metrics using internal systems and tools that are not independently verified by any third party. These metrics may differ from estimates or similar metrics published by third parties or other companies due to differences in sources, methodologies, or the assumptions on which we rely. Our internal systems and tools have a number of limitations, and our methodologies for tracking these metrics may change over time, which could result in unexpected changes to our metrics, including the metrics we publicly disclose on an ongoing basis. If the internal systems and tools we use to track these metrics undercount or overcount performance or contain algorithmic or other technical errors, the data we present may not be accurate. While these numbers are based on what we believe to be reasonable estimates of our metrics for the applicable period of measurement, there are inherent challenges in measuring the size of our network and other metrics. For example, we face </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">challenges in accurately calculating the number of practicing doctors or other professionals in our network at a given time. In addition, limitations or errors with respect to how we measure data or with respect to the data that we measure may affect our understanding of certain details of our business, which would affect our long-term strategies. If our operating metrics or our estimates are not accurate representations of our business, or if investors do not perceive our operating metrics to be accurate, or if we discover material inaccuracies with respect to these figures, our reputation may be significantly harmed, and our operating and financial results could be adversely affected.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our estimates of market opportunity and forecasts of market growth may prove to be inaccurate, and even if the markets in which we compete achieve the forecasted growth, our business may not grow at similar rates, or at all.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market opportunity estimates and growth forecasts that we may issue from time to time are subject to significant uncertainty and are based on assumptions and estimates which may not prove to be accurate. Our estimates and forecasts relating to size and expected growth of our target market may prove to be inaccurate. Even if the markets in which we compete meet these size estimates and growth forecasts, our business may not grow at similar rates, or at all. Our growth is subject to many factors, including our success in implementing our business strategy, which is subject to many risks and uncertainties.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain of our operating results and financial metrics may be difficult to predict as a result of seasonality.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have experienced some seasonality in both revenue and net income based on the timing of marketing program subscription launches on our platform and budgetary timing of purchases of additional modules. We may be affected by seasonal trends in the future, particularly as our business matures. Additionally, this seasonality may be reflected to a much lesser extent, and sometimes may not be immediately apparent, in our revenue. To the extent we experience this seasonality, it may cause fluctuations in our operating results and financial metrics and make forecasting out future operating results and financial metrics more difficult.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our operating results have in the past and may in the future continue to fluctuate on a quarterly and annual basis and if we fail to meet the expectations of analysts or investors, our stock price and the value of your investment could decline substantially.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating results have in the past and may in the future continue to fluctuate significantly on a quarterly and annual basis and may fail to match our past performance, and if we fail to meet or exceed the expectations of securities analysts or investors, the trading price of our Class A common stock could decline. Moreover, our stock price may be based on expectations of our future performance that may be unrealistic or that may not be met. Some of the important factors that could cause our revenue and operating results to fluctuate from quarter to quarter include:</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to increase sales of our solutions to new customers and expand sales of additional solutions to our existing customers; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the extent to which existing customers renew their agreements with us and the timing and terms of those renewals;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the termination or renegotiation by our significant customers of their agreements with us;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the entrance of new competitors in our market whether by established companies or new companies; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in our pricing policies or those of our competitors; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost of investing in our technology infrastructure, which may be greater than we anticipate; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to maintain or increase our member base and member engagement; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disruptions or outages in our website availability, actual or perceived breaches of privacy, and compromises of our member data; and</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general industry and macroeconomic conditions including the impact of the COVID-19 pandemic on the global economy and the deterioration in labor markets, which would adversely impact sales of our Hiring Solutions, or economic growth that does not lead to job growth.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our estimates or judgments relating to our critical accounting policies prove to be incorrect, our results of operations could be adversely affected.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP and our key metrics require management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and amounts reported in our key metrics. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, as provided in Note 2 - Summary of Significant Accounting Policies  included in Part II, Item 8 of this Annual Report on Form 10-K. The results of these estimates form the basis for making judgments about the carrying values of assets, liabilities, and equity and the amount of revenue and expenses that are not readily apparent from other sources. Significant assumptions and estimates used in preparing our consolidated financial statements include those related to revenue recognition, the fair values of acquired intangible assets and goodwill, the useful lives of long-lived assets, the valuation of the Company&#8217;s common stock and stock-based awards, and deferred income taxes. Our results of operations may be adversely affected if our assumptions change or if actual circumstances differ from those in our assumptions, which could cause our results of operations to fall below the expectations of securities analysts and investors, resulting in a decline in the trading price of our Class A common stock.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to stringent and changing laws, regulations, self-regulatory schemes, contractual obligations, and standards related to privacy, data protection, and information security. The actual or perceived failure by us, our customers, partners, or vendors to comply with such obligations could harm our reputation, subject us to significant fines and liability, or otherwise adversely affect our business. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We collect, receive, store, process, generate, use, transfer, disclose, make accessible, protect, and share (collectively, Process, or Processing) sensitive, confidential, and proprietary information (collectively, Sensitive Information) in connection with providing our services.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are numerous domestic and foreign laws, regulations, self-regulatory schemes, and standards regarding privacy, data protection, and information security and Processing, or Data Protection Laws, the number and scope of which is changing, subject to differing applications and interpretations, and which may be inconsistent among jurisdictions or in conflict with each other. The regulatory framework for privacy, data protection, and information security issues worldwide is evolving and is likely to remain in flux for the foreseeable future. Various governmental and consumer agencies have also called for new regulations and changes in industry practices. Practices regarding privacy, data protection, and information security have recently come under increased public and regulatory scrutiny. The actual or perceived failure to address or comply with applicable Data Protection Laws by us or our customers, partners, or vendors could increase our compliance and operational costs, expose us to regulatory scrutiny, actions, fines, and penalties, result in reputational harm, lead to a loss of customers, reduce the use of our services, result in litigation and liability, have a material adverse effect on our business operations or financial results, or otherwise result in other material harm to our business.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a &#8220;Business Associate&#8221; as defined under the federal Health Insurance Portability and Accountability Act of 1996, as amended by the Health Information Technology for Economic and Clinical Health Act, or HITECH, and their implementing regulations, which we collectively refer to as HIPAA, and the U.S. Department of Health and Human Services Office of Civil Rights, or OCR, may impose significant penalties on a Business Associate for a failure to comply with an applicable requirement of HIPAA. Penalties may include civil monetary penalties, criminal monetary penalties and imprisonment. The U.S. Department of Justice, or the DOJ, is responsible for criminal prosecutions under HIPAA. State attorneys general also have the right to prosecute HIPAA violations committed against residents of their states. While HIPAA does not create a private right of action that would allow individuals to sue in civil court for HIPAA violations, its standards have been used as the basis for the duty of care in state civil suits, such as those for negligence or recklessness in misusing individuals&#8217; health information. Furthermore, in the event of a breach as defined by HIPAA, the Business Associate may have to comply with specific reporting requirements under HIPAA regulations. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The security measures that we and our third-party vendors and subcontractors have in place in an effort to ensure compliance with privacy and data protection laws may not protect our facilities and systems from security breaches, acts of vandalism or theft, computer viruses, misplaced or lost data, programming and human errors, or other similar events. Under the HITECH Act, as a Business Associate, we may also be liable for privacy and security breaches and failures of our subcontractors. Even though we provide for appropriate protections through our agreements with our subcontractors, we still have limited control over their actions and practices. A breach of privacy or security of individually identifiable health information by a subcontractor may result in an enforcement action, including criminal and civil liability, against us. We are not able to predict the extent of the impact such incidents may have on our business. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Enforcement actions against us could be costly and could interrupt regular operations, which may adversely affect our business. While we have not received any notices of violation of any Data Protection Law and believe we are in compliance with such laws, there can be no assurance that we will not receive such notices in the future. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Applicable Data Protection Laws may also include state medical privacy laws, including those related to mental health and substance use treatment, and the provision of healthcare services, as well as federal and state consumer protection laws. These laws may not be preempted by HIPAA, may be more protective than HIPAA, and may be subject to varying interpretations by </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the courts and government agencies, creating complex compliance issues for us and our customers and partners and potentially exposing us to additional expense, adverse publicity and liability, any of which could adversely affect our business. Federal and state consumer protection laws are increasingly being applied by the U.S. Federal Trade Commission, or FTC, and states&#8217; attorneys general to regulate the Processing of personal or personally identifiable information, through websites or otherwise, and to regulate the presentation of website content. The FTC in particular has approved consent decrees resolving complaints and their resulting investigations into the privacy and security practices of a number of online social media companies. These reviews can and have resulted in changes to our solutions and policies, and could result in additional changes in the future. If we are unable to comply with any such reviews or decrees that result in recommendations or binding changes, or if the recommended changes result in degradation of our solutions, our business could be harmed.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, U.S. states have begun to introduce more comprehensive Data Protection Laws. For example, the California Consumer Privacy Act, or CCPA, went into effect in January 2020 and established a new privacy framework for covered businesses such as ours that expands the scope of personal information and provides new privacy rights for California residents. These changes required us to modify our data processing practices and policies and incur compliance related costs and expenses. The CCPA also provides for civil penalties for violations, as well as a private right of action for data breaches, which may increase the likelihood and cost of data breach litigation. Additionally, a new privacy law, the California Privacy Rights Act, or CPRA, was approved by California voters in November 2020. The CPRA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">significantly modifies the CCPA by, among other things, creating a dedicated privacy regulatory agency, requiring businesses to implement data minimization and data integrity principles, and imposing additional requirements for contracts addressing the processing of personal information. Moreover, the CPRA calls for additional regulations to be implemented before the law becomes fully operative on January 1, 2023. These changes may result in further uncertainty with respect to privacy, data protection, and information security issues and will require us to incur additional costs and expenses in an effort to comply.    </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to Data Protection Laws, we are or may be subject to the terms of our internal and external policies, representations, publications, frameworks, self-regulatory standards, and industry certification commitments (collectively, Privacy Policies), and contractual obligations to third parties related to privacy, data protection, and information security (collectively, Data Protection Obligations), including the Payment Card Industry Data Security Standards (PCI-DSS), the rules imposed by credit card brands (e.g., VISA and Mastercard), and Security Organization Control 2 certification commitments. We strive to comply with applicable Data Protection Laws, Privacy Policies, and Data Protection Obligations, but we may at times fail to do so or may be perceived to have failed to do so, in which case we may be subject to and suffer a material harm to our business. For example, in the event we fail to comply with the PCI-DSS, we could be in breach of our obligations under customer and other contracts. Moreover, despite our efforts, we may not be successful in achieving compliance if our personnel, customers, partners, or vendors do not comply with applicable Data Protection Laws, Privacy Policies, and Data Protection Obligations. We may be subject to and suffer material harm to our business if our Privacy Policies are, in whole or part, found to be inaccurate, incomplete, deceptive, unfair, or misrepresentative of our actual practices. In addition, any such failure or perceived failure could result in public statements against us by consumer advocacy groups or others, which may cause us material reputational harm.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, our customers may expect us to comply with more stringent privacy, data protection, and information security requirements than those imposed by applicable Data Protection Laws, and we may be obligated contractually to comply with additional or different standards relating to our handling or protection of data on or by our offerings. For example, our mobile application is distributed through third-party platforms such as those operated by Apple and Google. These third parties may impose technical and privacy, data protection, and information security requirements on companies that distribute applications through their platforms. These requirements are subject to change and may adversely impact our ability to Process personal information. Complying with these requirements may cause us to incur additional expense, and the failure to comply with these requirements may cause us to lose access to the app store and users, and our business would be harmed. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New or amended Data Protection Laws, and changes in the interpretation of existing Data Protection Laws and our Data Protection Obligations, could impair our, or our customers&#8217;, our partners&#8217;, or our vendors&#8217; ability to Process personal information, which could have a material adverse effect on our business, financial condition, and results of operations. The enactment of the CCPA has prompted similar legislative developments in other states, which could create the potential for a patchwork of overlapping but different state laws. The federal government is also considering comprehensive privacy legislation. If we begin to conduct business in Europe, complying with the General Data Protection Regulation, or GDPR, would entail significant costs and increase our liability risks.  The GDPR imposes more stringent data protection requirements and would require us to undertake significant operational changes in order to comply, which could have a material adverse effect on our business, financial condition, and results of operations. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In view of applicable Data Protection Laws, Privacy Policies, and Data Protection Obligations imposing complex and burdensome obligations, and with substantial uncertainty in their interpretation and compliance, we have faced and may face </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">challenges in addressing and complying with them, and fundamentally changing our business activities, Privacy Policies, and practices, and may expend significant resources in an effort to do so, any of which could result in material harm to business, financial condition, results of operations, or other harm.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our security measures are compromised now or in the future, or the security, confidentiality, integrity, or availability of our information technology, software, services, communications, or data is compromised, limited, or fails, this could have a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our platform involves the storage and transmission of Sensitive Information. As a result, unauthorized access or security breaches as a result of third-party action (e.g., cyber-attacks), employee error, product defect, malfeasance, or other factors could result in the loss of information, inappropriate use of or access to information, service interruption, service degradation, outages, service level credits, litigation, indemnity obligations, damage to our reputation, and other liability. We believe our risk of cyber-attack may be elevated during this time due to an increase in cyber-attack attempts on U.S. businesses generally during the COVID-19 outbreak and the conflict in Ukraine. While we maintain and continue to improve our security measures, we may be unable to adequately anticipate security threats or to implement adequate preventative measures, in part, because the techniques used to obtain unauthorized access or sabotage systems change frequently and generally are not identified until they are launched against a target. Moreover, the detection, prevention, and remediation of known or unknown securities vulnerabilities, including those arising from third-parties, is becoming increasingly expensive and may cause us to incur significant costs in the future. We process significant amounts of Sensitive Information, including protected health information, personal information, data concerning our members, and in some cases, limited amounts of data concerning the patients they treat in connection with our members&#8217; utilization of our network and related services. While we have implemented security measures to protect such data, techniques used to gain unauthorized access to data and systems, disable or degrade service, or sabotage systems are constantly evolving, and we may be unable to anticipate such techniques or implement adequate preventative measures to avoid unauthorized access or other adverse impacts to such data or our systems. We may use third-party service providers and subprocessors to help us deliver services and engage in Processing on our behalf, including, without limitation, the processing of payment card information. If we, our service providers, partners, or other relevant third parties have experienced or in the future experience any security incidents that result in any data loss, deletion or destruction, unauthorized access to, loss of, unauthorized acquisition or disclosure of, or inadvertent exposure of, Sensitive Information, or compromise related to the security, confidentiality, integrity, or availability of our (or their) information technology, software, services, communications, or data (collectively, a Security Breach), it may result in material harm to our business, including, without limitation, regulatory investigations or enforcement actions, litigation, indemnity obligations, negative publicity, and financial loss.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our service is vulnerable to threat actors, software bugs, malicious code (such as computer viruses and internet worms), personnel theft or misuse, break-ins, phishing attacks, denial-of-service attacks (including credential stuffing), ransomware attacks, natural disasters, terrorism, war, telecommunication and electrical failures, server malfunction, software or hardware failures, loss of data or other computer assets, adware, or other similar issues or other attacks or similar disruptions, any of which could lead to system interruptions, delays, or shutdowns, causing loss of critical data or the unauthorized access of data. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be required to expend significant resources, fundamentally change our business activities and practices, or modify our services, software, operations, or information technology in an effort to protect against Security Breaches and to mitigate, detect, and remediate actual and potential vulnerabilities. Applicable Data Protection Laws, Privacy Policies, and Data Protection Obligations may require us to implement specific security measures or use industry-standard or reasonable measures to protect against Security Breaches. The recovery systems, security protocols, network protection mechanisms, and other security measures that we (and our third parties) have integrated into our platform, systems, networks, and physical facilities, which are designed to protect against, detect, and minimize Security Breaches, may not be adequate to prevent or detect service interruption, system failure, or data loss.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Applicable Data Protection Laws, Privacy Policies, or Data Protection Obligations may require us to notify affected individuals, regulators, customers, credit reporting agencies, and others in the event of a Security Breach. Patients about whom we obtain health information, as well as the providers who share this information with us, may have statutory or contractual rights that limit our ability to use and disclose the information. We may be required to expend significant capital and other resources to ensure ongoing compliance with applicable Data Protection Laws, Privacy Policies, and Data Protection Obligations. Claims that we have violated individuals&#8217; privacy rights or breached our Data Protection Obligations, even if we are not found liable, could be expensive and time-consuming to defend and could result in adverse publicity that could harm our business.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we maintain insurance for our business, the coverage under our policies may not apply to the liabilities or damages as a result of the events referenced above or be adequate to compensate us for all losses that may occur. There can also </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">be no assurance that the limitations of liability in our contracts would be enforceable or adequate or would otherwise protect us from liabilities or damages as a result of the events referenced above.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, varying parts of our workforce are currently working remotely on a part or full time basis. This could increase our cyber security risk, create data accessibility concerns, and make us more susceptible to communication disruptions. Any of the foregoing could have a material adverse effect on us.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on network and mobile infrastructure and our ability to maintain and scale our business and maintain competitiveness. Any significant interruptions or delays in service on our apps or websites or any undetected errors or design faults could adversely affect our business, financial condition, and results of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We depend on the use of information technologies and systems and our reputation and ability to acquire, retain, and serve our customers are dependent upon the reliable performance of our apps and websites and the underlying network infrastructure. As our operations grow, we must continuously improve and upgrade our systems and infrastructure while maintaining or improving the reliability and integrity of our infrastructure. Our future success also depends on our ability to adapt our systems and infrastructure to meet rapidly evolving consumer trends and demands while continuing to improve the performance, features, and reliability of our solutions in response to competitive services and offerings. We expect the use of alternative platforms such as tablets and wearables will continue to grow and the emergence of niche competitors who may be able to optimize offerings, services, or strategies for such platforms will require new investment in technology. New developments in other areas, such as cloud computing, have made it easier for competition to enter our markets due to lower up-front technology costs. In addition, we may not be able to maintain our existing systems or replace or introduce new technologies and systems as quickly as we would like or in a cost-effective manner. There is also no guarantee that we will possess the financial resources or personnel, for the research, design, and development of new applications or services, or that we will be able to utilize these resources successfully and avoid technological or market obsolescence. Further, there can be no assurance that technological advances by one or more of our competitors or future competitors will not result in our present or future applications and services becoming uncompetitive or obsolete. If we were unable to enhance our offerings and network capabilities to keep pace with rapid technological and regulatory change, or if new technologies emerge that are able to deliver competitive offerings at lower prices, more efficiently, more conveniently, or more securely than our offerings, our business, financial condition, and results of operations could be adversely affected.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success will also depend on the interoperability of our offerings with a range of third-party technologies, systems, networks, operating systems, and standards, including iOS and Android; the availability of our mobile apps in app stores and in &#8220;super-app&#8221; environments; and the creation, maintenance, and development of relationships with key participants in related industries, some of which may also be our competitors. In addition, if accessibility of various apps is limited by executive order or other government actions, the full functionality of devices may not be available to our customers. Moreover, third-party platforms, services, and offerings are constantly evolving, and we may not be able to modify our platform to assure its compatibility with those of third parties. If we lose such interoperability, we experience difficulties or increased costs in integrating our offerings into alternative devices or systems, or manufacturers or operating systems elect not to include our offerings, make changes that degrade the functionality of our offerings, or give preferential treatment to competitive products, the growth of our business, results of operations, and financial condition could be materially adversely affected. This risk may be exacerbated by the frequency with which consumers change or upgrade their devices. In the event consumers choose devices that do not already include or support our platform or do not install our mobile apps when they change or upgrade their devices, our customer engagement may be harmed.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may become subject to enforcement actions or litigation as a result of our or our members&#8217; failure to comply with laws and regulations relating to communications, even though noncompliance was inadvertent or unintentional.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain systems and procedures designed to ensure that our telephonic communications and telephonic communications made by members and others using our platform comply with applicable laws and regulations; however, some legal/regulatory frameworks provide for the imposition of fines or penalties for noncompliance even though the noncompliance was inadvertent or unintentional and even though there were systems and procedures designed to ensure compliance in place at the time.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, members use our platform to engage in telephone, text message, and facsimile communications with patients and other doctors and healthcare professionals. There are a number of federal and state laws and regulations potentially applicable to such communications, including the federal Telephone Consumer Protection Act, or TCPA, and those laws and regulations are continuously evolving. A determination by a court or regulatory agency that any of these laws and regulations are applicable to or operate to prohibit or limit telephone, text message, and facsimile communications made by members or others using our platform could invalidate all or some portions of our customer contracts, could require us to change or terminate some portions of our business, could require us to refund portions of our service fees, and could have an adverse </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">effect on our business. In addition, if a court or regulatory agency determines that communications made by members or others using our platform violate any of these laws or regulations and that we are responsible for the violation, we may be subject to substantial damages, substantial civil penalties, and adverse publicity that could have a material adverse effect on our business and financial condition. For violations of the TCPA, the law provides for a private right of action under which a plaintiff may recover statutory damages of $500 for each call, text message, or facsimile made in violation of the statute&#8217;s prohibitions. A court also may treble the amount of damages upon a finding of a &#8220;willful or knowing&#8221; violation of the statute. There is no statutory cap on maximum aggregate exposure. In addition, the Federal Communications Commission, or FCC, which implements and enforces the TCPA, a state attorney general or other federal and state regulators may seek civil penalties in an enforcement action for violations of the TCPA or other laws and regulations potentially applicable to telephone, text message, and facsimile communications made by members or others using our platform.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may incur liability as a result of information retrieved from or transmitted over the Internet or published using our platform and legislation regulating content on our platform may require us to change our solutions or business practices and may adversely affect our business and financial results.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because our platform allows for the exchange of news, information, and other content, we may face claims relating to the content that is published or made available on our platform. In particular, the nature of our business exposes us to claims related to defamation, dissemination of misinformation, discrimination, harassment, intellectual property rights, rights of publicity and privacy, personal injury torts, laws regulating hate speech or other types of content, and breach of contract, among others. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, the Communications Decency Act, or CDA, provides statutory protections to online service providers like us who distribute third-party content. However, in the United States, government authorities, elected officials, and political candidates have called for amendments to Section 230 of the CDA that would purport to limit or remove protections afforded interactive computer service providers and our current protections from liability for third-party content in the United States could decrease or change. We could incur significant costs investigating and defending such claims and, if we are found liable, significant damages. We could also face fines, orders restricting or blocking our services in particular geographies, or other government-imposed remedies as a result of content hosted on our platform.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Content-related legislation may require us to change our solutions or business practices, increase our compliance costs, or otherwise impact our operations or our ability to provide services in certain geographies. In addition, we could incur significant costs investigating and defending claims for violating such requirements and, if we are found liable, significant damages. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may experience fluctuations in our tax obligations and effective tax rate, which could materially and adversely affect our results of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to U.S. federal and state income taxes. Tax laws, regulations, and administrative practices in various jurisdictions may be subject to significant change, with or without advance notice, due to economic, political, and other conditions, and significant judgment is required in evaluating and estimating our provision and accruals for these taxes. There are many transactions that occur during the ordinary course of business for which the ultimate tax determination is uncertain. Our effective tax rates could be affected by numerous factors, such as changes in tax, accounting, and other laws, regulations, administrative practices, principles, and interpretations, the mix and level of earnings in a given taxing jurisdiction, or our ownership or capital structures.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to utilize our net operating loss carryforwards and certain other tax attributes may be limited.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, we accumulated $124.1 million and $97.1 million of federal and state net operating loss carryforwards, or NOLs to reduce future taxable income, portions of which will begin to expire in 2027. Under Section 382 and Section 383 of the Internal Revenue Code of 1986, as amended, or the Code, if a corporation undergoes an &#8220;ownership change,&#8221; the corporation&#8217;s ability to use its pre-change NOLs and other tax attributes, including R&amp;D tax credits, to offset its post-change income or taxes may be limited. In general, an &#8220;ownership change&#8221; will occur if there is a cumulative change in our ownership by &#8220;5 percent stockholders&#8221; that exceeds 50 percentage points over a rolling three-year period. Similar rules may apply under state tax laws. Based on an assessment of our historical ownership changes through March&#160;31, 2022, we do not anticipate a current limitation on the tax attributes. Our ability to use NOLs and other tax attributes to reduce future taxable income and liabilities may be subject to limitations as a result of ownership changes that may occur in the future.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under current law, U.S. federal net operating losses incurred in taxable years beginning after December 31, 2017 may be carried forward indefinitely. Such U.S. federal net operating losses generally may not be carried back to prior taxable years, except that net operating losses generated in 2018, 2019, and 2020 may be carried back to each of the five tax years preceding the tax years of such losses. Additionally, for tax years beginning after December 31, 2020, the deductibility of U.S. federal net operating losses incurred in taxable years beginning after December 31, 2017, is limited to 80% of taxable income. Our net </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">operating losses may also be impaired or restricted under state law. At the state level there may be periods during which the use of net operating losses is suspended or otherwise limited, which could increase or permanently accelerate state taxes owed. For example, California imposed limits on the usability of California state net operating losses to offset taxable income in tax years beginning after 2019 and before 2022.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We depend on our talent to grow and operate our business, and if we are unable to hire, integrate, develop, motivate, and retain our personnel, we may not be able to grow effectively.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to maintain our competitive position is largely dependent on the services of our senior management and other key personnel. In addition, our future success depends on our continuing ability to attract, develop, motivate, and retain highly qualified and skilled employees. The market for such positions is competitive, especially in the San Francisco Bay Area. Qualified individuals are in high demand and we may incur significant costs to attract them. In addition, the loss of any of our senior management or other key employees, in particular our Chief Executive Officer, or our inability to recruit and develop mid-level managers could materially and adversely affect our ability to execute our business plan and we may be unable to find adequate replacements. Competition for qualified employees is intense in our industry, and the loss of even a few qualified employees, or an inability to attract, retain, and motivate additional highly skilled employees required for the planned expansion of our business could harm our operating results and impair our ability to grow. To attract and retain key personnel, we use various measures, including an equity incentive program for key executive officers and other employees. These measures may not be enough to attract and retain the personnel we require to operate our business effectively. All of our employees are at-will employees, meaning that they may terminate their employment relationship with us at any time, and their knowledge of our business and industry would be extremely difficult to replace. If we fail to retain talented senior management and other key personnel, or if we do not succeed in attracting well-qualified employees or retaining and motivating existing employees, our business, financial condition, and results of operations may be materially adversely affected.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may become subject to litigation, which could have a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have been subject to litigation in the past, and may become subject to litigation in the future. Some of these claims may result in significant defense costs and potentially significant judgments against us, some of which we are not, or cannot be, insured against. We generally intend to defend ourselves vigorously; however, we cannot be certain of the ultimate outcomes of any claims that may arise in the future. Resolution of these types of matters against us may result in our having to pay significant fines, judgments, or settlements, which, if uninsured, or if the fines, judgments, and settlements exceed insured levels, could adversely impact our earnings and cash flows, thereby having a material adverse effect on our business, financial condition, results of operations, cash flow, and per share trading price of our Class A common stock. Certain litigation or the resolution of certain litigation may affect the availability or cost of some of our insurance coverage, which could adversely impact our results of operations and cash flows, expose us to increased risks that would be uninsured, and adversely impact our ability to attract directors and officers.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may require additional capital to support business growth, and this capital might not be available on acceptable terms, if at all.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to continue to make investments to support our business growth and may require additional funds to respond to business challenges, including the need to develop new features and tools or enhance our existing solutions, improve our operating infrastructure, or acquire complementary businesses and technologies. Accordingly, we have engaged and may continue to engage in equity or debt financings to secure additional funds. If we raise additional funds through future issuances of equity or convertible debt securities, our existing stockholders could suffer significant dilution, and any new equity securities we issue could have rights, preferences, and privileges superior to those of holders of our Class A common stock. Any debt financing we secure in the future could involve restrictive covenants relating to our capital raising activities and other financial and operational matters, which may make it more difficult for us to obtain additional capital and to pursue business opportunities, including potential acquisitions. We may not be able to obtain additional financing on terms favorable to us, if at all. If we are unable to obtain adequate financing or financing on terms satisfactory to us when we require it, our ability to continue to support our business growth and to respond to business challenges could be significantly impaired, and our business may be harmed.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may seek to grow our business through acquisitions of, or investments in, new or complementary businesses, technologies, tools, or solutions, or through strategic alliances, and the failure to manage these acquisitions, investments or alliances, or to integrate them with our existing business, could have a material adverse effect on us.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2021, we completed an acquisition of Curative Talent and on April 1, 2022 we completed the acquisition of the AMiON business, and we may in the future consider opportunities to acquire or make additional investments in new or </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">complementary businesses, technologies, offerings, tools, or solutions, or enter into strategic alliances, that may enhance our capabilities and platform in general, complement our current offerings, or expand the breadth of our markets. Our ability to successfully grow through these types of strategic transactions depends upon our ability to identify, negotiate, complete, and integrate suitable target businesses, technologies, tools, and solutions and to obtain any necessary financing, and is subject to numerous risks, including:</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure to identify acquisition, investment, or other strategic alliance opportunities that we deem suitable or available on favorable terms;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">problems integrating the acquired business, technologies, tools, or solutions, including issues maintaining uniform standards, procedures, controls, and policies; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">integrating personnel from the acquired company;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unanticipated costs associated with acquisitions, investments, or strategic alliances; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">adverse impacts on our overall margins; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">diversion of management&#8217;s attention from our existing business; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risks associated with entering new markets in which we may have limited or no experience; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potential loss of key employees of acquired businesses; and </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased legal and accounting compliance costs. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, a significant portion of the purchase price of companies we acquire may be allocated to acquired goodwill and other intangible assets. In the future, if our acquisitions do not yield expected returns, we may be required to take impairment charges to our results of operations based on our impairment assessment process, which could harm our results of operations. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may experience challenges with managing our growth related to our recent acquisition of AMiON or other future acquisitions. The operation and integration of the acquired technologies and business operations may require substantial financial costs and management attention. If we fail to manage such integration processes in a timely and effective manner, our business and financial results may suffer. If we are unable to identify suitable acquisitions or strategic relationships, or if we are unable to integrate any acquired businesses, technologies, tools, and solutions effectively, our business, financial condition, and results of operations could be materially and adversely affected. Also, while we employ several different methodologies to assess potential business opportunities, the new businesses may not meet or exceed our expectations.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may enter into collaborations, in-licensing arrangements, joint ventures, strategic alliances, or partnerships with third-parties that may not result in the development of commercially viable solutions or the generation of significant future revenue.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of our business, we may enter into collaborations, in-licensing arrangements, joint ventures, strategic alliances, or technology partnerships to develop proposed solutions and to pursue new markets, such as our agreement with U.S. News &amp; World Report to offer a direct-to-patient scheduling tool for health systems. Proposing, negotiating, and implementing collaborations, in-licensing arrangements, joint ventures, strategic alliances, or partnerships may be a lengthy and complex process. Other companies, including those with substantially greater financial, marketing, sales, technology, or other business resources, may compete with us for these opportunities or arrangements. We may not identify, secure, or complete any such transactions or arrangements in a timely manner, on a cost-effective basis, on acceptable terms, or at all. We have limited institutional knowledge and experience with respect to these business development activities, and we may also not realize the anticipated benefits of any such transaction or arrangement. In particular, these collaborations may not result in the development of solutions that achieve commercial success or result in significant revenue and could be terminated prior to developing any solutions.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we may not be in a position to exercise sole decision making authority regarding the transaction or arrangement, which could create the potential risk of creating impasses on decisions, and our collaborators may have economic or business interests or goals that are, or that may become, inconsistent with our business interests or goals. It is possible that conflicts may arise with our collaborators, such as conflicts concerning the achievement of performance milestones, or the interpretation of significant terms under any agreement, such as those related to financial obligations or the ownership or control of intellectual property developed during the collaboration. If any conflicts arise with our current or future collaborators, they may act in their self-interest, which may be adverse to our best interest, and they may breach their obligations to us. In addition, we have limited control over the amount and timing of resources that our current collaborators or any future </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">collaborators devote to our collaborators&#8217; or our future solutions. Disputes between us and our collaborators may result in litigation or arbitration which would increase our expenses and divert the attention of our management. Further, these transactions and arrangements are contractual in nature and may be terminated or dissolved under the terms of the applicable agreements and, in such event, we may not continue to have rights to the products relating to such transaction or arrangement or may need to purchase such rights at a premium.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be unable to successfully execute on our growth initiatives, business strategies, or operating plans.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are continually executing on growth initiatives, strategies, and operating plans designed to enhance our business and extend our solutions. The anticipated benefits from these efforts are based on several assumptions that may prove to be inaccurate. Moreover, we may not be able to successfully complete these growth initiatives, strategies, and operating plans and realize all of the benefits, including growth targets and cost savings, that we expect to achieve or it may be more costly to do so than we anticipate. A variety of risks could cause us not to realize some or all of the expected benefits. These risks include, among others, delays in the anticipated timing of activities related to such growth initiatives, strategies, and operating plans, increased difficulty and cost in implementing these efforts, including difficulties in complying with new regulatory requirements and the incurrence of other unexpected costs associated with operating our business. Moreover, our continued implementation of these programs may disrupt our operations and performance. As a result, we cannot assure you that we will realize these benefits. If for any reason the benefits we realize are less than our estimates, or the implementation of these growth initiatives, strategies, and operating plans adversely affect our operations or cost more or take longer to effectuate than we expect, or if our assumptions prove inaccurate, our business, financial condition, and results of operations may be materially adversely affected.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We employ third-party licensed software and software components for use in or with our solutions, and the inability to maintain these licenses or the presence of errors or security vulnerabilities in the software we license could limit the functionality of our solutions and result in increased costs or reduced service levels, which could adversely affect our business.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our network incorporates or utilizes certain third-party software and software components obtained under licenses from other companies. We anticipate that we will continue to rely on such third-party software and development tools from third parties in the future. Although we believe that there are commercially reasonable alternatives to the third-party software we currently license, this may not always be the case, or it may be difficult or costly to replace. Our use of additional or alternative third-party software would require us to enter into license agreements with third parties. In addition, if the third-party software we utilize has errors, security vulnerabilities, or otherwise malfunctions, the functionality of our solutions may be negatively impacted and our business may suffer. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on software-as-a-service, or SaaS, technologies from third parties.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on SaaS technologies from third parties in order to operate critical functions of our business, including financial management services, relationship management services, marketing services, and data storage services. For example, we rely on Amazon Web Services for a substantial portion of our computing and storage capacity, and rely on Google for storage capacity and collaboration tools. We are also highly dependent on our technology integration with products offered by certain third parties. Amazon Web Services provides us with computing and storage capacity pursuant to an agreement that continues until terminated by either party. Similarly, Google provides us with storage capacity and certain collaboration tools, and also may non-renew its agreement by providing 15 days notice prior to the end of the then-current term. Some of our other vendor agreements may be unilaterally terminated by the counterparty for convenience. If these services become unavailable due to contract cancellations, extended outages or interruptions, because they are no longer available on commercially reasonable terms or prices, or for any other reason, our expenses could increase, our ability to manage our finances could be interrupted, our processes for managing our offerings and supporting our consumers and partners could be impaired, and our ability to access or save data stored to the cloud may be impaired until equivalent services, if available, are identified, obtained, and implemented, all of which could harm our business, financial condition, and results of operations.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our growth depends in part on the success of our strategic relationships with third parties.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate that we will continue to depend on relationships with various third parties, including access to platforms and content providers and distributors to grow our business, authors who provide content (including learning and development material), and channel partners. Identifying, negotiating, and maintaining relationships with third parties require significant time and resources, as does integrating third-party content and technology. Our agreements with technology and content providers and similar third parties are typically non-exclusive and do not prohibit them from working with our competitors or from offering competing services. In some cases, in particular with respect to content providers, these relationships are undocumented, or, if there are agreements in place, they may be easily terminable. Our competitors may be effective in </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">providing incentives to these parties to favor their solutions or may prevent us from developing strategic relationships with these parties. These third parties may decide that working with us is not in their interest. In addition, these third parties may not perform as expected under our agreements with them, and we have had, and may in the future have, disagreements or disputes with these parties, which could negatively affect our brand and reputation. It is possible that these third parties may not be able to devote the resources we expect to the relationship or they may terminate their relationships with us. Further, as members increasingly access our services through mobile devices, we are becoming more dependent on the distribution of our mobile applications through third parties, and we may not be able to access their application program interfaces or be able to distribute our applications or provide ease of integration, and this may also impact our ability to monetize our mobile solutions. If we are unsuccessful in establishing or maintaining our relationships with third parties, our ability to compete in the marketplace or to grow our business could be impaired, and our operating results could suffer. Even if we are successful, these relationships may not result in improved operating results.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any restrictions on our use of, or ability to license, data, or our failure to license data and integrate third-party technologies, could have a material adverse effect on our business, financial condition, and results of operations. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We depend upon licenses from third parties for some of the technology and data used in our applications, and for some of the technology platforms upon which these applications are built and operate. We expect that we may need to obtain additional licenses from third parties in the future in connection with the development of our solutions and services. In addition, we obtain a portion of the data that we use from government entities, public records, and our partners for specific partner engagements. We believe that we have all rights necessary to use the data that is incorporated into our solutions and services. However, we cannot assure you that our licenses for information will allow us to use that information for all potential or contemplated applications and solutions. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the future, data providers could withdraw their data from us or restrict our usage for any reason, including if there is a competitive reason to do so, if legislation is passed restricting the use of the data, or if judicial interpretations are issued restricting use of the data that we currently use in our solutions and services. In addition, data providers could fail to adhere to our quality control standards in the future, causing us to incur additional expense to appropriately utilize the data. If a substantial number of data providers were to withdraw or restrict their data, or if they fail to adhere to our quality control standards, and if we are unable to identify and contract with suitable alternative data suppliers and integrate these data sources into our service offerings, our ability to provide solutions and services to our partners would be materially adversely impacted, which could have a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also integrate into our proprietary applications and use third-party software to maintain and enhance, among other things, content generation and delivery, and to support our technology infrastructure. Our use of third-party technologies exposes us to increased risks, including, but not limited to, risks associated with the integration of new technology into our solutions, the diversion of our resources from development of our own proprietary technology, and our inability to generate revenue from licensed technology sufficient to offset associated acquisition and maintenance costs. These technologies may not be available to us in the future on commercially reasonable terms or at all and could be difficult to replace once integrated into our own proprietary applications. Most of these licenses can be renewed only by mutual consent and may be terminated if we breach the terms of the license and fail to cure the breach within a specified period of time. Our inability to obtain, maintain, or comply with any of these licenses could delay development until equivalent technology can be identified, licensed, and integrated, which would harm our business, financial condition, and results of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Most of our third-party licenses are non-exclusive and our competitors may obtain the right to use any of the technology covered by these licenses to compete directly with us. If our data suppliers choose to discontinue support of the licensed technology in the future, we might not be able to modify or adapt our own solutions.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in accounting rules, assumptions, and/or judgments could materially and adversely affect us.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting rules and interpretations for certain aspects of our operations are highly complex and involve significant assumptions and judgment. These complexities could lead to a delay in the preparation and dissemination of our financial statements. Furthermore, changes in accounting rules and interpretations or in our accounting assumptions and/or judgments could significantly impact our financial statements. In some cases, we could be required to apply a new or revised standard retroactively, resulting in restating prior period financial statements. Any of these circumstances could have a material adverse effect on our business, prospects, liquidity, financial condition, and results of operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in tax laws or regulations that are applied adversely to us or our customers may have a material adverse effect on our business, cash flow, and financial condition or result of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to income taxes in the United States and our tax provision could also be impacted by changes in accounting principles and changes in U.S. federal and state tax laws applicable to corporations. For example, legislation enacted in 2017, informally titled the Tax Cuts and Jobs Act, or Tax Act, and the Coronavirus Aid, Relief, and Economic Security Act, or CARES Act, significantly changed how the U.S. Department of Treasury imposes income taxes on U.S. corporations. We made significant judgments and assumptions in the interpretation of these laws and in our calculations reflected in our financial statements. The U.S. Department of Treasury, the Internal Revenue Service, or the IRS, and other standard-setting bodies may issue additional guidance on how the provisions of the Tax Act and CARES Act will be applied or otherwise administered, and additional accounting guidance or interpretations may be issued in the future that is different from our current interpretation. As another example, the U.S. Supreme Court&#8217;s decision in South Dakota v. Wayfair, Inc., increasing states&#8217; ability to assert taxing jurisdiction on out-of-state retailers could result in certain additional jurisdictions asserting that sales and use and other taxes are applicable, which could result in tax assessments, penalties, and interest, and we may be required to collect such taxes in the future. After the U.S. Supreme Court's decision in South Dakota v. Wayfair, Inc., several U.S. states imposed an economic presence standard with respect to the imposition of taxes. These new rules often have uncertainty with respect to the level of activity necessary to cause a taxable presence for taxpayers within the state. Accordingly, additional jurisdictions may assert sales and use and other taxes, which could result in tax assessments, penalties, and interest, and we may be required to collect and remit/pay such taxes in the future. The U.S. Supreme Court&#8217;s decision in South Dakota v. Wayfair, Inc. increasing states&#8217; ability to assert taxing jurisdiction on out-of-state retailers could result in certain additional jurisdictions asserting that sales and use and other taxes are applicable, which could result in tax assessments, penalties, and interest, and we may be required to collect such taxes in the future.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to limit our liabilities by contract or through insurance may be ineffective or insufficient to cover our future liabilities.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We attempt to limit, by contract, our liability for damages arising from our negligence, errors, mistakes, or security breaches. Contractual limitations on liability, however, may not be enforceable or may otherwise not provide sufficient protection to us from liability for damages and we are not always able to negotiate meaningful limitations. We maintain liability insurance coverage, including coverage for cybersecurity and errors and omissions. It is possible, however, that claims could exceed the amount of our applicable insurance coverage, if any, or that this coverage may not continue to be available on acceptable terms or in sufficient amounts. Even if these claims do not result in liability to us, investigating and defending against them could be expensive and time-consuming and could divert management&#8217;s attention away from our operations. In addition, negative publicity caused by these events may delay market acceptance of our solutions and services, any of which could materially and adversely affect our reputation and our business.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business could be disrupted by catastrophic events such as power disruptions, data security breaches, and terrorism.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Natural disasters or other catastrophic events may cause damage or disruption to our operations, commerce, and the global economy, and thus could harm our business. In the event of a major earthquake, hurricane, fire, cyber-attack, war (including the recent conflict in Ukraine), terrorist attack, disease (including the COVID-19 pandemic), power loss, telecommunications failure, or other catastrophic events, we may be unable to continue our operations, in part or in whole, and may endure reputational harm, breaches of data security, and loss of critical data, all of which could harm our business, results of operations, and financial condition. Our insurance coverage may not compensate us for losses that may occur in the event of an earthquake or other significant natural disaster, such as fires, floods, severe weather, droughts, and travel-related health concerns including pandemics and epidemics. In addition, acts of terrorism, including malicious internet-based activity, could cause disruptions to the internet or the economy as a whole. Even with our disaster recovery arrangements, access to our platform could be interrupted. If our systems were to fail or be negatively impacted as a result of a natural disaster or other event, our ability to deliver our platform and solution to our customers and members would be impaired or we could lose critical data. If we are unable to develop adequate plans to ensure that our business functions continue to operate during and after a disaster, and successfully execute on those plans in the event of a disaster or emergency, our business, financial condition, and results of operations would be harmed.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have implemented a disaster recovery program that allows us to move website traffic to a backup data center in the event of a catastrophe. This allows us the ability to move traffic in the event of a problem, and the ability to recover in a short period of time. However, to the extent our disaster recovery program does not effectively support the movement of traffic in a timely or complete manner in the event of a catastrophe, our business and results of operations may be harmed.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not carry business interruption insurance sufficient to compensate us for the potentially significant losses, including the potential harm to our business, financial condition, and results of operations that may result from interruptions in access to our platform as a result of system failures.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we grow our business, the need for business continuity planning and disaster recovery plans will grow in significance. If we are unable to develop adequate plans to ensure that our business functions continue to operate during and after a disaster, and successfully execute on those plans in the event of a disaster or emergency, our business and reputation would be harmed.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our risk management policies and procedures may not be fully effective in mitigating our risk exposure in all market environments or against all types of risk.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in a rapidly changing industry. Accordingly, our risk management policies and procedures may not be fully effective to identify, monitor, and manage all the risks our business encounters. If our policies and procedures are not fully effective or we are not successful in identifying and mitigating all risks to which we are or may be exposed, we may suffer uninsured liability, harm to our reputation, or be subject to litigation or regulatory actions that could adversely affect our business, financial condition, or results of operations.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may incur significant additional costs and expenses, including costs and expenses associated with obligations relating to being a public company, which will require significant resources and management attention and may divert focus from our business operations, and we may generate losses in the future. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We incur significant expenses in developing our technology, marketing and providing the tools and solutions we offer, and acquiring customers. Our costs may increase due to our continued new product development and general administrative expenses, such as legal and accounting expenses related to becoming and being a public company. As a public company, we will incur significant legal, accounting, insurance, and other expenses. Compliance with these reporting requirements and other rules of the SEC and the rules of the New York Stock Exchange will increase our legal and financial compliance costs and make some activities more time-consuming and costly. Furthermore, the need to establish the corporate infrastructure demanded of a public company may divert management&#8217;s attention from implementing our growth strategy, which could prevent us from successfully implementing our strategic initiatives and improving our business, operating results, financial condition, and prospects. If we fail to manage these additional costs or increase our revenue, we may incur losses in the future.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are an &#8220;emerging growth company&#8221; and our compliance with the reduced reporting and disclosure requirements applicable to &#8220;emerging growth companies&#8221; may make our Class A common stock less attractive to investors.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are an &#8220;emerging growth company,&#8221; as defined in the JOBS Act, and we have elected to take advantage of certain exemptions and relief from various reporting requirements that are applicable to other public companies that are not &#8220;emerging growth companies.&#8221; These provisions include, but are not limited to: being permitted to have only two years of audited financial statements and only two years of related management&#8217;s discussion and analysis of financial condition and results of operations disclosures; being exempt from compliance with the auditor attestation requirements of Section 404(b) of the Sarbanes-Oxley Act of 2002, or the Sarbanes-Oxley Act; being subject to reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements; and not being required to hold nonbinding advisory votes on executive compensation or on any golden parachute payments not previously approved. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, while we are an &#8220;emerging growth company,&#8221; we will not be required to comply with any new financial accounting standard until such standard is generally applicable to private companies. As a result, our financial statements may not be comparable to companies that are not &#8220;emerging growth companies&#8221; or elect not to avail themselves of this provision. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may remain an &#8220;emerging growth company&#8221; until as late as March 31, 2027, the fiscal year-end following the fifth anniversary of the completion of our initial public offering, though we may cease to be an &#8220;emerging growth company&#8221; earlier under certain circumstances, including if (i) we have more than $1.07 billion in annual revenue in any fiscal year, (ii) we become a &#8220;large accelerated filer,&#8221; with at least $700 million of equity securities held by non-affiliates as of the end of the second quarter of that fiscal year, or (iii) we issue more than $1.0 billion of non-convertible debt over a three-year period. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exact implications of the JOBS Act are still subject to interpretations and guidance by the SEC and other regulatory agencies, and we cannot assure you that we will be able to take advantage of all of the benefits of the JOBS Act. In addition, investors may find our Class A common stock less attractive to the extent we rely on the exemptions and relief granted by the JOBS Act. If some investors find our Class A common stock less attractive as a result, there may be a less active trading market for our Class A common stock and our stock price may decline or become more volatile. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to implement and maintain effective internal controls over financial reporting, investors may lose confidence in the accuracy and completeness of our financial reports.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a public company, we are required to maintain internal controls over financial reporting and to report any material weaknesses in such internal controls. We will be required to furnish a report by management on, among other things, the effectiveness of our internal control over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act at the time of our second annual report on Form 10-K. However, our independent registered public accounting firm will not be required to attest to the effectiveness of our internal control over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act until the later of the year following our first annual report required to be filed with the SEC or the date we are no longer an &#8220;emerging growth company&#8221; as defined in the JOBS Act. Accordingly, you will not be able to depend on any attestation concerning our internal control over financial reporting from our independent registered public accounting firm for the foreseeable future.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The process of designing and implementing internal controls over financial reporting is time consuming, costly, and complicated. If during the evaluation and testing process, we identify one or more material weaknesses in our internal control over financial reporting or determine that existing material weaknesses have not been remediated, our management will be unable to assert that our internal control over financial reporting is effective. Even if our management concludes that our internal control over financial reporting is effective, our independent registered public accounting firm may conclude that there are material weaknesses with respect to our internal controls or the level at which our internal controls are documented, designed, implemented, or reviewed. If we are unable to assert that our internal control over financial reporting is effective, or when required in the future, if our independent registered public accounting firm is unable to express an opinion as to the effectiveness of our internal control over financial reporting, investors may lose confidence in the accuracy and completeness of our financial reports and the valuation of our common stock could be adversely affected.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Intellectual Property</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to halt the operations of entities that copy our intellectual property or that aggregate our data as well as data from other companies, including social networks, or copycat online services that may misappropriate our data. These activities could harm our brand and our business.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, third parties may try to access content or data from our networks through scraping, robots, or other means and use this content and data or combine this content and data with other content and data as part of their services. These activities could degrade our brand, negatively impact our website performance, and harm our business. We have employed contractual, technological, or legal measures in an attempt to halt unauthorized activities, but these measures may not be successful. In addition, if our members and customers do not comply with our terms of service, they also may be able to abuse our tools, solutions, and services and provide access to our solutions and content to unauthorized users. We may not be able to detect any or all of these types of activities in a timely manner and, even if we could, technological and legal measures may be insufficient to stop these actions. In some cases, particularly in the case of online services operating from outside of the United States, our available legal remedies may not be adequate to protect our business against such activities. Regardless of whether we can successfully enforce our rights against these parties, any measures that we may take could require us to expend significant financial or other resources.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Third parties may initiate legal proceedings alleging that we are infringing or otherwise violating their intellectual property rights, the outcome of which would be uncertain and could have a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our commercial success depends on our ability to develop and commercialize our services and use our proprietary technology without infringing the intellectual property or proprietary rights of third parties. From time to time, we may be subject to legal proceedings and claims in the ordinary course of business with respect to intellectual property. We are not currently subject to any material claims from third parties asserting infringement of their intellectual property rights. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intellectual property disputes can be costly to defend and may cause our business, operating results, and financial condition to suffer. Whether merited or not, we have in the past and may in the future face allegations that we, our partners, our licensees, or parties indemnified by us have infringed or otherwise violated the patents, trademarks, copyrights, or other intellectual property rights of third parties. Such claims may be made by competitors seeking to obtain a competitive advantage or by other parties. Some third parties may be able to sustain the costs of complex litigation more effectively than we can because they have substantially greater resources. Even if resolved in our favor, litigation or other legal proceedings relating to intellectual property claims may cause us to incur significant expenses and could distract our technical and management personnel from their normal responsibilities. In addition, there could be public announcements of the results of hearings, motions, or other interim proceedings or developments, and if securities analysts or investors perceive these results to be negative, it could have a </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">material adverse effect on the price of our Class A common stock. Moreover, any uncertainties resulting from the initiation and continuation of any legal proceedings could have a material adverse effect on our ability to raise the funds necessary to continue our operations. Assertions by third parties that we violate their intellectual property rights could therefore have a material adverse effect on our business, financial condition, and results of operations. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, in recent years, individuals and groups have begun purchasing intellectual property assets for the purpose of making claims of infringement and attempting to extract settlements from companies like ours. We may also face allegations that our employees have misappropriated the intellectual property or proprietary rights of their former employers or other third parties. It may be necessary for us to initiate litigation to defend ourselves in order to determine the scope, enforceability, and validity of third-party intellectual property or proprietary rights, or to establish our respective rights. In some cases, rather than licensing third party content, we rely on the doctrine of fair use as we incorporate excerpts of third party content in a curated content feed for our users, and we may face allegations that such use of third party content does not qualify to be treated as a fair use. Regardless of whether claims that we are infringing patents or other intellectual property rights have merit, such claims can be time-consuming, divert management&#8217;s attention and financial resources, and can be costly to evaluate and defend. Results of any such litigation are difficult to predict and may require us to stop commercializing or using our solutions or technology, obtain licenses, modify our services and technology while we develop non-infringing substitutes or incur substantial damages, settlement costs or face a temporary or permanent injunction prohibiting us from marketing or providing the affected solutions and services. If we require a third-party license, it may not be available on reasonable terms or at all, and we may have to pay substantial royalties, upfront fees, or grant cross-licenses to intellectual property rights for our solutions and services. We may also have to redesign our solutions or services so they do not infringe third-party intellectual property rights, which may not be possible or may require substantial monetary expenditures and time, during which our technology and solutions may not be available for commercialization or use. Even if we have an agreement to indemnify us against such costs, the indemnifying party may be unable to uphold its contractual obligations. If we cannot or do not obtain a third-party license to the infringed technology, license the technology on reasonable terms, or obtain similar technology from another source, our revenue and earnings could be adversely impacted.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, because patent applications can take years to issue and are often afforded confidentiality for some period of time there may currently be pending applications, unknown to us, that later result in issued patents that could cover one or more of our solutions.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to maintain, protect, or enforce our intellectual property rights could harm our business and results of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We pursue the registration of our domain names, trademarks, and service marks in the United States. We also strive to protect our intellectual property rights by relying on federal, state, and common law rights, as well as contractual restrictions. We typically enter into confidentiality and invention assignment agreements with our employees and contractors, and confidentiality agreements with parties with whom we conduct business in order to limit access to, and disclosure and use of, our proprietary information. However, we may not be successful in executing these agreements with every party who has access to our confidential information or contributes to the development of our technology or intellectual property rights. Those agreements that we do execute may be breached, and we may not have adequate remedies for any such breach. These contractual arrangements and the other steps we have taken to protect our intellectual property rights may not prevent the misappropriation or disclosure of our proprietary information nor deter independent development of similar technology or intellectual property by others. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective trade secret, patent, copyright, trademark, and domain name protection is expensive to obtain, develop, and maintain, both in terms of initial and ongoing registration or prosecution requirements and expenses and the costs of defending our rights. We have invested in and may, over time, increase our investment in protecting our intellectual property through patent filings that could be expensive and time-consuming. Our trademarks and other intellectual property rights may be challenged by others or invalidated through administrative process or litigation. We have not yet obtained any issued patents that provide protection for our technology or products, and we cannot guarantee that any of our pending patent applications will result in any issued patents. Moreover, any issued patents we obtain may not provide us with a competitive advantage and, as with any technology, competitors may be able to develop similar or superior technologies to our own, now or in the future. In addition, due to a recent U.S. Supreme Court case, it has become increasingly difficult to obtain and assert patents relating to software or business methods, as many such patents have been invalidated for being too abstract to constitute patent-eligible subject matter. We do not know whether this will affect our ability to obtain patents on our innovations, or successfully assert any patents we may pursue in litigation or pre-litigation campaigns. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Monitoring unauthorized use of the content on our apps and websites, and our other intellectual property and technology, is difficult and costly. Our efforts to protect our proprietary rights and intellectual property may not have been and may not be adequate to prevent their misappropriation or misuse. Third parties, including our competitors, could be infringing, misappropriating, or otherwise violating our intellectual property rights. We may not be successful in stopping unauthorized use </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of our content or other intellectual property or technology. Further, we may not have been and may not be able to detect unauthorized use of our technology or intellectual property, or to take appropriate steps to enforce our intellectual property rights. Any inability to meaningfully enforce our intellectual property rights could harm our ability to compete and could reduce demand for our solutions and services. Our competitors may also independently develop similar technology. Effective patent, trademark, copyright, and trade secret protection may not be available to us in every jurisdiction in which our solutions or technology are hosted or available. Further, legal standards relating to the validity, enforceability, and scope of protection of intellectual property rights are uncertain. The laws in the United States and elsewhere change rapidly, and any future changes could adversely affect us and our intellectual property. Our failure to meaningfully protect our intellectual property rights could result in competitors offering solutions that incorporate our most technologically advanced features, which could reduce demand for our solutions. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may find it necessary or appropriate to initiate claims or litigation to enforce our intellectual property rights, protect our trade secrets, or determine the validity and scope of intellectual property rights claimed by others. In any lawsuit we bring to enforce our intellectual property rights, a court may refuse to stop the other party from using the technology at issue on grounds that our intellectual property rights do not cover the use or technology in question. Further, in such proceedings, the defendant could counterclaim that our intellectual property is invalid or unenforceable and the court may agree, in which case we could lose valuable intellectual property rights. Litigation is inherently uncertain and any litigation of this nature, regardless of outcome or merit, could result in substantial costs and diversion of management and technical resources, any of which could adversely affect our business and results of operations. If we fail to maintain, protect, and enforce our intellectual property, our business and results of operations may be harmed. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The laws of some foreign countries do not protect intellectual property rights to the same extent as the laws of the United States. Many companies have encountered significant problems in protecting and defending intellectual property rights in certain foreign jurisdictions. The legal systems of some countries, particularly developing countries, do not favor the enforcement of intellectual property protection. This could make it difficult for us to stop the infringement or misappropriation of our intellectual property rights. Proceedings to enforce our intellectual property in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business. In addition, changes in the law and legal decisions by courts in the United States and foreign countries may affect our ability to obtain adequate protection for our technology and the enforcement of intellectual property.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our trademarks and trade names are not adequately protected, we may not be able to build name recognition in our markets of interest and our business may be adversely affected.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our brand is critical to the success of our business, and we utilize trademark registration and other means to protect it. Our business would be harmed if we were unable to protect our brand against infringement and its value was to decrease as a result.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The registered or unregistered trademarks or trade names that we own or license may be challenged, infringed, circumvented, declared generic, lapsed, or determined to be infringing on or dilutive of other marks. We may not be able to protect our rights in these trademarks and trade names, which we need in order to build name recognition with potential partners. In addition, third parties may in the future file for registration of trademarks similar or identical to our trademarks. If they succeed in registering or developing common law rights in such trademarks, and if we are not successful in challenging such third-party rights, we may not be able to use these trademarks to commercialize our technologies or solutions in certain relevant countries. If we are unable to establish name recognition based on our trademarks and trade names, we may not be able to compete effectively and our business may be adversely affected.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to protect the confidentiality of our trade secrets, our business and competitive position could be harmed.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely heavily on trade secrets and confidentiality agreements to protect our unpatented know-how, technology, and other proprietary information, including our technology platform, and to maintain our competitive position. With respect to our technology platform, we consider trade secrets and know-how to be one of our primary sources of intellectual property. However, trade secrets and know-how can be difficult to protect. We seek to protect these trade secrets and other proprietary technology in part by entering into non-disclosure and confidentiality agreements with parties who have access to them, such as our employees, corporate collaborators, outside contractors, consultants, advisors, and other third parties. We also enter into confidentiality and invention or patent assignment agreements with our employees and consultants. The confidentiality agreements are designed to protect our proprietary information and, in the case of agreements or clauses containing invention assignment, to grant us ownership of technologies that are developed through a relationship with employees or third parties. We cannot guarantee that we have entered into such agreements with each party that may have or have had access to our trade secrets or proprietary information, including our technology and processes. Despite these efforts, no assurance can be given that the confidentiality agreements we enter into will be effective in controlling access to such proprietary information and trade </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">secrets. The confidentiality agreements on which we rely to protect certain technologies may be breached, may not be adequate to protect our confidential information, trade secrets, and proprietary technologies and may not provide an adequate remedy in the event of unauthorized use or disclosure of our confidential information, trade secrets, or proprietary technology. Further, these agreements do not prevent our competitors or others from independently developing the same or similar technologies and processes, which may allow them to provide a service similar or superior to ours, which could harm our competitive position. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Enforcing a claim that a party illegally disclosed or misappropriated a trade secret is difficult, expensive, and time-consuming, and the outcome is unpredictable. In addition, some courts inside and outside the United States are less willing or unwilling to protect trade secrets. If any of our trade secrets were to be lawfully obtained or independently developed by a competitor or other third party, we would have no right to prevent them from using that technology or information to compete with us. If any of our trade secrets were to be disclosed to or independently developed by a competitor or other third party, it could harm our competitive position, business, financial condition, results of operations, and prospects.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our solutions utilize open source software, and any failure to comply with the terms of one or more of these open source licenses could adversely affect our business.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our solutions include software covered by open source licenses. The terms of various open source licenses have not been interpreted by U.S. courts, and there is a risk that such licenses could be construed in a manner that imposes unanticipated conditions or restrictions on our ability to market our solutions. By the terms of certain open source licenses, we could be required to release the source code of our proprietary software, and to make our proprietary software available under open source licenses, if we combine our proprietary software with open source software in a certain manner. In the event that portions of our proprietary software are determined to be subject to an open source license, we could be required to publicly release the affected portions of our source code, re-engineer all or a portion of our solutions, or otherwise be limited in the licensing of our solutions, each of which could reduce or eliminate the value of our solutions and services. In addition to risks related to license requirements, usage of open source software can lead to greater risks than use of third-party commercial software, as open source licensors generally do not provide non-infringement warranties or warranties related to the performance or suitability of the software. Many of the risks associated with usage of open source software cannot be eliminated and could adversely affect our business.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to comply with our obligations under license or technology agreements with third parties, we may be required to pay damages and we could lose license rights that are critical to our business.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We license certain intellectual property, including technologies and software from third parties, that is important to our business, and in the future we may enter into additional agreements that provide us with licenses to valuable intellectual property or technology. If we fail to comply with any of the obligations under our license agreements, we may be required to pay damages and the licensor may have the right to terminate the license. Termination by the licensor would cause us to lose valuable rights, and could prevent us from selling our solutions and services, or adversely impact our ability to commercialize future solutions and services. Our business would suffer if any current or future licenses terminate, if the licensors fail to abide by the terms of the license, if the licensors fail to enforce licensed patents against infringing third parties, if the licensed intellectual property are found to be invalid or unenforceable, or if we are unable to enter into necessary licenses on acceptable terms. In addition, our rights to certain technologies are licensed to us on a non-exclusive basis. The owners of these non-exclusively licensed technologies are therefore free to license them to third parties, including our competitors, on terms that may be superior to those offered to us, which could place us at a competitive disadvantage. Moreover, our licensors may own or control intellectual property that has not been licensed to us and, as a result, we may be subject to claims, regardless of their merit, that we are infringing or otherwise violating the licensor&#8217;s rights. In addition, the agreements under which we license intellectual property or technology from third parties are generally complex, and certain provisions in such agreements may be susceptible to multiple interpretations. The resolution of any contract interpretation disagreement that may arise could narrow what we believe to be the scope of our rights to the relevant intellectual property or technology, or increase what we believe to be our financial or other obligations under the relevant agreement. Any of the foregoing could harm our competitive position, business, financial condition, results of operations, and prospects.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we cannot license rights to use technologies on reasonable terms, we may not be able to commercialize new solutions or services in the future.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the future, we may identify additional third-party intellectual property we may need to license in order to engage in our business, including to develop or commercialize new solutions or services. However, such licenses may not be available on acceptable terms or at all. The licensing or acquisition of third-party intellectual property rights is a competitive area, and several more established companies may pursue strategies to license or acquire third-party intellectual property rights that we may consider attractive or necessary. These established companies may have a competitive advantage over us due to their size, capital resources, and greater development or commercialization capabilities. In addition, companies that perceive us to be a </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">competitor may be unwilling to assign or license rights to us. Even if such licenses are available, we may be required to pay the licensor substantial royalties based on sales of our solutions and services. Such royalties are a component of the cost of our solutions or services and may affect the margins on our solutions and services. In addition, such licenses may be non-exclusive, which could give our competitors access to the same intellectual property licensed to us. If we are unable to enter into the necessary licenses on acceptable terms or at all, if any necessary licenses are subsequently terminated, if our licensors fail to abide by the terms of the licenses, if our licensors fail to prevent infringement by third parties, or if the licensed intellectual property rights are found to be invalid or unenforceable, our business, financial condition, results of operations, and prospects could be affected. If licenses to third-party intellectual property rights are, or become required for us, to engage in our business, the rights may be non-exclusive, which could give our competitors access to the same technology or intellectual property rights licensed to us. Moreover, we could encounter delays and other obstacles in our attempt to develop alternatives. Defense of any lawsuit or failure to obtain any of these licenses on favorable terms could prevent us from commercializing solutions and services, which could harm our competitive position, business, financial condition, results of operations, and prospects.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on third-party platforms, such as the Apple App Store and Google Play App Store, to distribute our platform and offerings.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our apps are accessed and operate through third-party platforms or marketplaces, including the Apple App Store and Google Play App Store, which also serve as significant online distribution platforms for our apps. As a result, the expansion and prospects of our business and our apps depend on our continued relationships with these providers and any other emerging platform providers that are widely adopted by consumers. We are subject to the standard terms and conditions that these providers have for application developers, which govern the content, promotion, distribution, and operation of apps on their platforms or marketplaces, and which the providers can change unilaterally on short or no notice. Our business would be harmed if the providers discontinue or limit our access to their platforms or marketplaces; the platforms or marketplaces decline in popularity; the platforms modify their algorithms, communication channels available to developers, respective terms of service or other policies, including fees; the providers adopt changes or updates to their technology that impede integration with other software systems or otherwise require us to modify our technology or update our apps in order to ensure that consumers can continue to access and use our platform. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If alternative providers increase in popularity, we could be adversely impacted if we fail to create compatible versions of our apps in a timely manner, or if we fail to establish a relationship with such alternative providers. Likewise, if our current providers alter their operating platforms, we could be adversely impacted as our offerings may not be compatible with the altered platforms or may require significant and costly modifications in order to become compatible. If our providers do not perform their obligations in accordance with our platform agreements, we could be adversely impacted. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the past, some of these platforms or marketplaces have been unavailable for short periods of time. If this or a similar event were to occur on a short- or long-term basis, or if these platforms or marketplaces otherwise experience issues that impact the ability of consumers to download or access our apps and other information, it could have a material adverse effect on our brand and reputation, as well as our business, financial condition, and operating results.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to the Healthcare Industry</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The healthcare regulatory and political framework is uncertain and evolving.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthcare laws and regulations are rapidly evolving and may change significantly in the future, which could adversely affect our financial condition and results of operations. On March 9, 2020, the U.S. Department of Health and Human Services  or HHS, Office of the National Coordinator for Health Information Technology, or ONC, and CMS promulgated final rules aimed at supporting seamless and secure access, exchange, and use of electronic health information, or EHI, by increasing innovation and competition by giving patients and their healthcare providers secure access to health information and new tools, allowing for more choice in care and treatment. The final rules are intended to clarify and operationalize provisions of the 21st Century Cures Act, or CURES Act, regarding interoperability and &#8220;information blocking,&#8221; and create significant new requirements for healthcare industry participants. Information blocking is defined as activity that is likely to interfere with, prevent, or materially discourage access, exchange, or use of EHI, where a health information technology developer, health information network, or health information exchange knows or should know that such practice is likely to interfere with access to, exchange, or use of EHI. The new rules create significant new requirements for healthcare industry participants, and require certain electronic health record technology to incorporate standardized application programming interfaces, or APIs, to allow individuals to securely and easily access structured EHI using smartphone applications. The ONC will also implement provisions of the Cures Act requiring that patients can electronically access all of their EHI (structured and/or unstructured) at no cost. Finally, to further support access and exchange of EHI, the final ONC rule implements the information blocking provisions of the Cures Act and identified eight &#8220;reasonable and necessary activities&#8221; as exceptions to information blocking activities, as long as specific conditions are met. Pursuant to the final rule, health IT developers will be subject to requirements </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">such as prohibitions on participating in any action that constitutes information blocking, providing certification to the Secretary of HHS that they will not take actions that constitute information blocking, and other requirements regarding information blocking six months from when the final rule is published in the Federal Register. Certified API Developers must comply with new administrative requirements within six months of when the rule is published in the Federal Register and must provide all certified API technology within twenty-four months after publication of the rule in the Federal Register</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In light of the COVID-19 public health emergency, on October 29, 2020, HHS published an interim final rule delaying the effective date of compliance with the final information blocking and Conditions and Maintenance of Certification portions of the rule beyond the enforcement discretion period that was initially announced. Pursuant to the interim final rule, health IT developers will be subject to requirements such as prohibitions on participating in any action that constitutes information blocking, providing certification to the Secretary of HHS that they will not take actions that constitute information blocking, and other requirements regarding information blocking. Certified API Developers must provide all certified API technology by December 31, 2022. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The final CMS rule focuses on patients enrolled in Medicare Advantage plans, Medicaid and Children&#8217;s Health Insurance Program, or CHIP, fee-for-service programs, Medicaid managed care plans, CHIP managed care entities, and qualified health plans on the federally-facilitated exchanges, and enacts measures to enable patients to have both their clinical and administrative information travel with them. Payors must make patient data dating back to January 1, 2016 available through an API.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These rules constitute a significant departure from previous regulations regarding patient data. These rules may benefit us in that certain electronic health record, or EHR, vendors will no longer be permitted to interfere with our attempts at integration, but the rules may also make it easier for other similar companies to enter the market, creating increased competition and reducing our market share. It is unclear at this time what the costs of compliance with the final rules will be, and what additional risks there may be to our business.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the implementation of the Cures Act, certain regulatory changes that have occurred in response to the COVID-19 pandemic, have created opportunities for us. For example, many states have expanded Medicare and commercial reimbursement for telehealth, in many cases at parity with brick and mortar services and with $0 co-pay. However, if states do not maintain this reimbursement parity after the pandemic, this could lower usage of our network. In addition, OCR has announced that they will not impose penalties for noncompliance with the regulatory requirements under the HIPAA Rules for covered healthcare providers in connection with good faith provision of telehealth during the COVID-19 nationwide public health emergency. However, if this enforcement discretion is rescinded and if other changes are rolled back after the pandemic, such changes could negatively impact usage on our network.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consolidation in the healthcare industry could have a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many healthcare industry participants are consolidating to create larger and more integrated healthcare delivery systems with greater market power. We expect regulatory and economic conditions to result in additional consolidation in the healthcare industry in the future. As consolidation accelerates, the economies of scale of our customers&#8217; organizations may grow. If a customer experiences sizable growth following consolidation, it may determine that it no longer needs to rely on us and may reduce its demand for our solutions and services. In addition, as healthcare providers and life sciences companies consolidate to create larger and more integrated healthcare delivery systems with greater market power, these providers may try to use their market power to negotiate fee reductions for our solutions and services. Finally, consolidation may also result in the acquisition or future development by our healthcare provider and life sciences customers of solutions and services that compete with our solutions and services. Any of these potential results of consolidation could have a material adverse effect on our business, financial condition, and results of operations.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we or our customers fail to comply with federal and state healthcare laws, including those governing fee splitting, our business, and financial relationships, we or our customers may be subject to significant administrative, civil, and criminal penalties.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a participant in the healthcare industry, our operations and relationships, and those of our customers, are regulated by a number of federal, state, and local governmental entities. The impact of these regulations can adversely affect us even though we may not be directly regulated by certain specific healthcare laws and regulations. We must ensure that our solutions and services can be used by our customers in a manner that complies with those laws and regulations. Inability of our customers to do so could affect the marketability of our solutions and services or our compliance with our customer contracts, or even expose us to direct liability under the theory that we had assisted our customers in a violation of healthcare laws or regulations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, many states limit the scope of business relationships between business entities and medical professionals, particularly with respect to fee splitting. While many states&#8217; fee-splitting laws only prohibit a physician from sharing medical fees with a referral source, some states have interpreted certain management agreements between business entities and physicians as unlawful fee-splitting. Statutes and regulations relating to the practice of medicine, fee-splitting, and similar issues vary widely from state to state. Because these laws are often vague, their application is frequently dependent on court rulings and attorney general opinions. Some of these requirements may apply to us even if we do not have a physical presence in the state, based solely on our agreements with providers licensed in the state. However, regulatory authorities or other parties, including our providers, may assert that we are engaged in the corporate practice of medicine or that our contractual arrangements with our provider customers constitute unlawful fee splitting. These laws generally prohibit us from exercising control over the medical judgments or decisions of physicians and non-physician healthcare providers and from engaging in certain financial arrangements, such as splitting professional fees with healthcare providers. In this event, failure to comply could lead to adverse judicial or administrative action against us and/or our provider customers, civil or criminal penalties, receipt of cease and desist orders from state regulators, loss of provider licenses, the need to make changes to the terms of engagement of our provider customers that interfere with our business and other materially adverse consequences. Further, certain laws may apply to us indirectly through our relationships with healthcare professionals. For example, certain federal and state anti-kickback and false claims laws may apply to us indirectly through our arrangements with healthcare professionals and entities.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These laws and regulations may change rapidly, and it is frequently unclear how they apply to our business. Any failure of our solutions or services to comply with these laws and regulations could result in substantial administrative, civil, or criminal liability and could, among other things, adversely affect demand for our services, force us to expend significant capital, research and development, and other resources to address the failure, invalidate all or portions of some of our contracts with our customers, require us to change or terminate some portions of our business, require us to refund portions of our revenue, cause us to be disqualified from serving customers doing business with government payors, and give our customers the right to terminate our contracts with them, any one of which could have an adverse effect on our business. Even an unsuccessful challenge by regulatory authorities of our activities could result in adverse publicity and could require a costly response from us. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our solutions address heavily regulated functions within the life sciences industry, and failure to comply with applicable laws and regulations could lessen the demand for our solutions or subject us to significant claims and losses.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our customers use our solutions for business activities that are subject to a complex regime of laws and regulations, including requirements regarding processing of health data (as set forth in 45 CFR Part 164 of HIPAA), and other state, local, and federal laws and regulations. Our solutions are expected to be capable of use by our customers in compliance with such laws and regulations. Our efforts to provide solutions that comply with such laws and regulations are time-consuming and costly and include validation procedures that may delay the release of new versions of our solutions. As these laws and regulations change over time, we may find it difficult to adjust our solutions to comply with such changes.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we increase the number of solutions we offer, the complexity of adjusting our solutions to comply with legal and regulatory changes will increase. If we are unable to effectively manage this increase or if we are not able to provide solutions that can be used in compliance with applicable laws and regulations, customers may be unwilling to use our solutions and any such non-compliance could result in the termination of our customer agreements or claims arising from such agreements with our customers.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, any failure of our customers to comply with laws and regulations applicable to the functions for which our solutions are used could result in fines, penalties, or claims for substantial damages against our customers that may harm our business or reputation. If such failure were allegedly caused by our solutions or services, our customers may make a claim for damages against us, regardless of our responsibility for the failure. We may be subject to lawsuits that, even if unsuccessful, could divert our resources and our management&#8217;s attention and adversely affect our business and customer relationships, and our insurance coverage may not be sufficient to cover such claims against us.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evolving government regulations may require increased costs or adversely affect our results of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In a regulatory climate that is uncertain, our operations may be subject to direct and indirect adoption, expansion, or reinterpretation of various laws and regulations. There could be laws and regulations applicable to our business that we have not identified or that, if changed, may be costly to us, and we cannot predict all the ways in which implementation of such laws and regulations may affect us. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, we cannot predict the likelihood, nature, or extent of health reform initiatives that may arise from future legislation or administrative action, particularly as a result of the new Presidential administration. The introduction of new solutions may </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">require us to comply with additional, yet undetermined, laws and regulations. In addition, it is possible that additional governmental action is taken in response to the COVID-19 pandemic. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that we must modify our operations to comply with future laws, such modifications may undermine our existing and future offerings' attractiveness to customers, and our revenue may decline and our business, financial condition, and results of operations could be adversely affected.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Ownership of Our Class A Common Stock </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our stock price may be volatile or may decline regardless of our operating performance, resulting in substantial losses for investors of our Class A common stock.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market price of our Class A common stock may fluctuate significantly in response to numerous factors, many of which are beyond our control, including:</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">actual or anticipated fluctuations in our financial conditions and results of operations; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the financial projections we may provide to the public, any changes in these projections, or our failure to meet these projections; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure of securities analysts to initiate or maintain coverage of our company, changes in financial estimates or ratings by any securities analysts who follow our company, or our failure to meet these estimates or the expectations of investors; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announcements by us or our competitors of significant technical innovations, acquisitions, strategic partnerships, joint ventures, results of operations, or capital commitments; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in stock market valuations and operating performance of other healthcare and technology companies generally, or those in our industry in particular; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">price and volume fluctuations in the overall stock market, including as a result of trends in the economy as a whole; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in our board of directors or management; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sales of large blocks of our Class A common stock, including sales by certain affiliates of Jeff Tangney, Emergence Capital Partners II, L.P., or Emergence Capital Partners, InterWest X, L.P. or InterWest Partners, or our executive officers and directors; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">lawsuits threatened or filed against us; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">anticipated or actual changes in laws, regulations, or government policies applicable to our business; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in our capital structure, such as future issuances of debt or equity securities; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">short sales, hedging, and other derivative transactions involving our capital stock; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general economic conditions in the United States; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">&#8220;flash crashes,&#8221; &#8220;freeze flashes,&#8221; or other glitches that disrupt trading on the securities exchange on which we are listed;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other events or factors, including those resulting from war (including the recent conflict in Ukraine), pandemics (including the COVID-19 pandemic), incidents of terrorism, or responses to these events; and </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the other factors described in the sections of this Annual Report on Form 10-K titled &#8220;Risk Factors&#8221; and &#8220;Special Note Regarding Forward-Looking Statements.&#8221; </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The stock market has recently experienced extreme price and volume fluctuations. The market prices of securities of companies have experienced fluctuations that often have been unrelated or disproportionate to their results of operations. Market fluctuations could result in extreme volatility in the price of shares of our Class A common stock, which could cause a decline in the value of your investment. Price volatility may be greater if the public float and trading volume of shares of our Class A common stock is low. Furthermore, in the past, stockholders have sometimes instituted securities class action litigation against companies following periods of volatility in the market price of their securities. Any similar litigation against us could </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">result in substantial costs, divert management&#8217;s attention and resources, and harm our business, financial condition, and results of operations. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The dual class structure of our common stock has the effect of concentrating voting control with our executive officers (including our Chief Executive Officer) and directors and their affiliates&#894; this will limit or preclude your ability to influence corporate matters.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Class B common stock has ten votes per share, and our Class A common stock, has one vote per share. Stockholders who hold shares of Class B common stock, including our executive officers and directors and their affiliates, together hold approximately 88% of the voting power of our outstanding capital stock as of March&#160;31, 2022. Because of the ten-to-one voting ratio between our Class B common stock and Class A common stock, the holders of our Class B common stock collectively will continue to control a substantial majority of the combined voting power of our common stock and therefore, assuming no material sales of such shares, will be able to control all matters submitted to our stockholders for approval until ten-years from the date of the Final Prospectus, filed on Form 424(B)(4) June 25, 2021, including the election of directors, amendments of our organizational documents, and any merger, consolidation, sale of all or substantially all of our assets, or other major corporate transaction. This concentrated control will limit or preclude your ability to influence corporate matters for the foreseeable future. In addition, this may prevent or discourage unsolicited acquisition proposals or offers for our capital stock that you may feel are in your best interest as one of our stockholders. Future transfers by holders of Class B common stock will generally result in those shares converting to Class A common stock, subject to limited exceptions, such as certain transfers effected for estate planning purposes. The conversion of Class B common stock to Class A common stock will have the effect, over time, of increasing the relative voting power of those holders of Class B common stock who retain their shares in the long term. If, for example, our executive officers (including our Chief Executive Officer), employees, directors and their affiliates retain a significant portion of their holdings of Class B common stock for an extended period of time, they could, in the future, continue to control a majority of the combined voting power of our Class A common stock and Class B common stock.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future sales and issuances of our Class A common stock or rights to purchase Class A common stock, including pursuant to our equity incentive plans, could result in additional dilution of the percentage ownership of our stockholders and could cause the stock price of our Class A common stock to decline.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the future, we may sell Class A common stock, convertible securities, or other equity securities in one or more transactions at prices and in a manner we determine from time to time. We expect to issue securities to employees and directors pursuant to our equity incentive plans. If we sell common stock, convertible securities, or other equity securities in subsequent transactions, or common stock is issued pursuant to equity incentive plans, our investors may be materially diluted. New investors in such subsequent transactions could gain rights, preferences, and privileges senior to those of holders of our common stock, including our Class A common.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If a substantial number of shares become available for sale and are sold in a short period of time, the market price of our Class A common stock could decline.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our existing stockholders sell substantial amounts of our Class A common stock in the public market in a short period of time, the market price of our Class A common stock could decrease significantly. The perception in the public market that our existing stockholders might sell shares of Class A common stock could also depress our market price. Our executive officers and directors and certain of our stockholders are subject to the Rule 144 holding period requirements. After the holding periods have elapsed and, in the case of restricted stock, the shares have vested, additional shares will be eligible for sale in the public market. The market price of shares of our Class A common stock may drop significantly when the restrictions on resale by our existing stockholders lapse. A decline in the price of shares of our Class A common stock might impede our ability to raise capital through the issuance of additional shares of our Class A common stock or other equity securities.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, certain stockholders have rights, under our investors&#8217; rights agreement, to require us to register shares owned by them for public sale in the United States. We also have certain holders of outstanding options that, if fully exercised, would result in the issuance of shares of Class A common stock. All of the shares of Class A common stock issuable upon the exercise of stock options and the shares reserved for future issuance under our equity compensation plans have been registered for public resale under the Securities Act of 1933, as amended, or Securities Act. As a result, subject to the satisfaction of applicable exercise periods, the shares issued upon exercise of outstanding stock options will be available for immediate resale in the United States in the open market. Sales of our Class A common stock as restrictions end or pursuant to registration rights may make it more difficult for us to sell equity securities in the future at a time and at a price that we deem appropriate. These sales could also cause the trading price of our Class A common stock to fall and make it more difficult for you to sell shares of our Class A common stock.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, certain of our employees, executive officers, and directors have entered into, and may further enter into, Rule 10b5-1 trading plans providing for sales of shares of our Class A common stock from time to time. Under a Rule 10b5-1 trading plan, a broker executes trades pursuant to parameters established by the employee, director, or officer when entering into the plan, without further direction from the employee, officer, or director. Our employees, executive officers, and directors also may buy or sell additional shares outside of a Rule 10b5-1 trading plan when they are not in possession of material, nonpublic information, subject to the Rule 144 requirements referred to above.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If securities or industry analysts do not publish or cease publishing research or reports about our business, or they publish negative reports about our business, our share price and trading volume could decline.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading market for our Class A common stock depends in part on the research and reports that securities or industry analysts publish about us or our business, our market, and our competitors. We do not have any control over these analysts. If one or more of the analysts who cover us downgrade our shares or publish negative views on us or our shares, our share price would likely decline. If one or more of these analysts cease coverage of our company or fail to regularly publish reports on us, we could lose visibility in the financial markets, which could cause our share price or trading volume to decline.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Delaware law and provisions in our amended and restated certificate of incorporation and amended and restated bylaws could make a merger, tender offer, or proxy contest more difficult, limit attempts by our stockholders to replace or remove our current management and limit the market price of our Class A common stock.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain provisions in our amended and restated certificate of incorporation and amended and restated bylaws contain provisions that may make the acquisition of our company more difficult, including the following: </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">amendments to certain provisions of our amended and restated certificate of incorporation or amendments to our amended and restated bylaws generally require the approval of at least 66 2/3% of the voting power of our outstanding capital stock; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our dual class common stock structure, which provides certain affiliates of Jeff Tangney, Emergence Capital Partners, InterWest X, L.P. or InterWest Partners, individually or together, with the ability to significantly influence the outcome of matters requiring stockholder approval, even if they own significantly less than a majority of the shares of our outstanding Class A common stock and Class B common stock; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our staggered board of directors; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">at any time when the holders of our Class B common stock no longer beneficially own, in the aggregate, at least the majority of the voting power of our outstanding capital stock, our stockholders will only be able to take action at a meeting of stockholders and will not be able to take action by written consent for any matter; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our amended and restated certificate of incorporation does not provide for cumulative voting; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">vacancies on our board of directors are able to be filled only by our board of directors and not by stockholders, subject to the rights granted pursuant to the stockholders agreement; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a special meeting of our stockholders may only be called by the chairperson of our board of directors or our Chief Executive Officer, as applicable, or a majority of our board of directors; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">restrict the forum for certain litigation against us to Delaware or the federal courts, as applicable; </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our amended and restated certificate of incorporation authorizes undesignated preferred stock, the terms of which may be established and shares of which may be issued without further action by our stockholders; and </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">advance notice procedures apply for stockholders (other than the parties to our stockholders agreement) to nominate candidates for election as directors or to bring matters before an annual meeting of stockholders. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, Section 203 of the Delaware General Corporation Law may discourage, delay or prevent a change in control of our company. Section 203 imposes certain restrictions on mergers, business combinations and other transactions between us and holders of 15% or more of our common stock.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These provisions, alone or together, could discourage, delay or prevent a transaction involving a change in control of our company. These provisions could also discourage proxy contests and make it more difficult for stockholders to elect directors of their choosing and to cause us to take other corporate actions they desire, any of which, under certain circumstances, could </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">limit the opportunity for our stockholders to receive a premium for their shares of our Class A common stock, and could also affect the price that some investors are willing to pay for our Class A common stock.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our amended and restated bylaws designate specific state or federal courts located as the exclusive forum for certain litigation that may be initiated by our stockholders, which could limit stockholders&#8217; ability to obtain a favorable judicial forum for disputes with us.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our amended and restated bylaws provide that, unless we consent in writing to the selection of an alternative forum, to the fullest extent permitted by law, the Court of Chancery of the State of Delaware is the sole and exclusive forum for any state law claims for:</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any derivative action or proceeding brought on our behalf;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any action asserting a claim of breach of fiduciary duty owed by any of our directors, officers or other employees to us or our stockholders;</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any action asserting a claim arising pursuant to the Delaware General Corporation Law, our amended and restated certificate of incorporation or our amended and restated bylaws; or</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any action asserting a claim that is governed by the internal affairs doctrine, or Delaware Forum Provision.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Delaware Forum Provision does not apply to any causes of action arising under the Securities Act or the Exchange Act. Further, our amended and restated bylaws provide that, unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States will be the sole and exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act, or the Federal Forum Provision. In addition, our amended and restated bylaws provide that any person or entity purchasing or otherwise acquiring any interest in shares of our capital stock is deemed to have notice of and consented to the Delaware Forum Provision and the Federal Forum Provision; provided, however, that stockholders cannot and will not be deemed to have waived our compliance with the U.S. federal securities laws and the rules and regulations thereunder.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Delaware Forum Provision and the Federal Forum Provision in our amended and restated bylaws may impose additional litigation costs on stockholders in pursuing any such claims. Additionally, these forum selection clauses may limit our stockholders&#8217; ability to bring a claim in a judicial forum that they find favorable for disputes with us or our directors, officers or employees, which may discourage the filing of lawsuits against us and our directors, officers and employees, even though an action, if successful, might benefit our stockholders. In addition, while the Delaware Supreme Court ruled in March 2020 that federal forum selection provisions purporting to require claims under the Securities Act be brought in federal court are &#8220;facially valid&#8221; under Delaware law, there is uncertainty as to whether other courts will enforce our Federal Forum Provision. If the Federal Forum Provision is found to be unenforceable, we may incur additional costs associated with resolving such matters. The Federal Forum Provision may also impose additional litigation costs on stockholders who assert that the provision is not enforceable or invalid. The Court of Chancery of the State of Delaware and the federal district courts of the United States may also reach different judgments or results than would other courts, including courts where a stockholder considering an action may be located or would otherwise choose to bring the action, and such judgments may be more or less favorable to us than our stockholders.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We do not intend to pay dividends for the foreseeable future.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently intend to retain any future earnings to finance the operation and expansion of our business and we do not expect to declare or pay any dividends in the foreseeable future. In addition, Delaware law may impose requirements that may restrict our ability to pay dividends to holders of our common stock. As a result, stockholders must rely on sales of their Class A common stock after price appreciation as the only way to realize any future gains on their investment.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We could be subject to securities class action litigation.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the past, securities class action litigation has often been brought against a company following a decline in the market price of its securities. If we face such litigation, it could result in substantial costs and a diversion of management&#8217;s attention and resources, which could have a material adverse effect on our business, financial condition or results of operations. </span></div><div id="i6c4404140edb48938ba4e30b290c9ef9_881"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1B. Unresolved Staff Comments</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><div id="i6c4404140edb48938ba4e30b290c9ef9_891"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Properties</span></div><div style="margin-bottom:15pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our corporate headquarters is located in San Francisco, California and consists of approximately 9,197 square feet of space under a lease that expires on December&#160;31, 2023. We also lease additional facilities in Dallas, Texas. We lease all of our facilities and do not own any real property. We believe that our facilities are sufficient to meet our needs for the immediate future, and that, should it be needed, suitable additional space will be available to accommodate expansion of our operations.</span></div><div id="i6c4404140edb48938ba4e30b290c9ef9_897"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Legal Proceedings</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For discussion around our legal proceedings, please refer to Note 13&#8212;Commitments and Contingencies included in Part II, Item 8 of this Annual Report on Form 10-K. </span></div><div id="i6c4404140edb48938ba4e30b290c9ef9_903"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Mine Safety Disclosures</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="i6c4404140edb48938ba4e30b290c9ef9_909"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div id="i6c4404140edb48938ba4e30b290c9ef9_915"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5. Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market Information</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Class A common stock is listed on the New York Stock Exchange, or NYSE, under the symbol &#8220;DOCS&#8221; and began trading on June&#160;24, 2021. Prior to that date, there was no public trading market for our Class A common stock. There is no established public trading market for our Class B common stock. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Holders of Record</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of May&#160;20, 2022, there were 314 stockholders of record of our Class A common stock and 86 stockholders of record for our Class B common stock. Because many of our shares of Class A common stock are held by brokers and other institutions on behalf of stockholders, we are unable to estimate the total number of stockholders represented by these record holders. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividend Policy</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have never declared or paid any cash dividend on our capital stock. We currently intend to retain any future earnings and do not expect to pay any dividends in the foreseeable future. Any future determination to declare cash dividends will be made at the discretion of our board of directors, subject to applicable laws, and will depend on a number of factors, including our financial condition, results of operations, capital requirements, contractual restrictions, general business conditions, and other factors that our board of directors may deem relevant. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities Authorized for Issuance under Equity Compensation Plans</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to &#8220;Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters&#8221; included in Part III, Item 12 of this Annual Report on Form 10-K for more information regarding securities authorized for issuance.</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Sales of Unregistered Equity Securities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no unregistered sales of equity securities which have not been previously disclosed in a quarterly report on Form 10-Q and there have been no unregistered sales of equity securities since the filing of our last quarterly report on Form 10-Q filed with the SEC, February 9, 2022. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Proceeds</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June&#160;28, 2021, we closed our IPO of 22,505,750 shares of our Class A common stock sold by us, including 3,495,000 shares pursuant to the exercise of the underwriters&#8217; option to purchase additional shares of our Class A common stock, and 4,289,250 shares of Class A common stock sold by an existing stockholder, at an offering price of $26.00 per share, resulting in proceeds to us of $548.5 million after deducting underwriting discounts and commissions as well as deferred offering costs. All of the shares issued and sold in our IPO were registered under the Securities Act pursuant to a registration statement on Form S-1 (File No. 333-256584), which was declared effective by the SEC on June&#160;23, 2021. Morgan Stanley &amp; Co. LLC, Goldman Sachs &amp; Co. LLC, J.P. Morgan Securities LLC, Piper Sandler &amp; Co., William Blair &amp; Company, L.L.C., Canaccord Genuity LLC, Needham &amp; Company, LLC, Raymond James &amp; Associates, Inc., and SVB Leerink LLC acted as underwriters for the offering. We incurred offering expenses of approximately $5.5 million. No payments for such expenses were made to our directors or officers or their associates, holders of 10% or more of any class </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of our equity securities, or to our affiliates. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon completion of the sale of the shares of our Class A common stock referenced in the preceding sentences, the IPO terminated. There has been no material change in the planned use of proceeds from our IPO from those disclosed in the Final Prospectus. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Issuer Purchases of Equity Securities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Performance Graph</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This performance graph shall not be deemed &#8220;soliciting material&#8221; or to be &#8220;filed&#8221; with the SEC, for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities under that Section, and shall not be deemed to be incorporated by reference into any of our filings under the Securities Act. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The graph below shows the cumulative total return to our stockholders between June&#160;24, 2021 (the date that our Class A common stock commenced trading on the NYSE) through March&#160;31, 2022 in comparison to the S&amp;P 500 Index and the S&amp;P </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">500 Information Technology Index. The graph assumes (i) that $100 was invested in each of our Class A common stock, the S&amp;P 500 Index, and the S&amp;P 500 Information Technology Index at their respective closing prices on June 24, 2021 and (ii) reinvestment of gross dividends. The stock price performance shown in the graph represents past performance and should not be considered an indication of future stock price performance. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><img src="docs-20220331_g1.jpg" alt="docs-20220331_g1.jpg" style="height:380px;margin-bottom:5pt;vertical-align:text-bottom;width:613px"/></div><div id="i6c4404140edb48938ba4e30b290c9ef9_922"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. [Reserved]</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><div id="i6c4404140edb48938ba4e30b290c9ef9_67"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">You should read the following discussion and analysis of our financial condition and results of operations together with our consolidated financial statements and accompanying notes that are included elsewhere in this Annual Report on Form 10-K. This discussion contains forward-looking statements based upon current expectations that involve risks and uncertainties, as described under the heading &#8220;Special Note About Forward-Looking Statements&#8221; in this Annual Report on Form 10-K. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth under the section titled &#8220;Risk Factors&#8221; or in other parts of this Annual Report on Form 10-K. Our historical results are not necessarily indicative of the results that may be expected for any period in the future. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">A discussion regarding our financial condition and results of operations for the fiscal year ended March&#160;31, 2022 compared to the fiscal year ended March&#160;31, 2021 is presented below. A discussion regarding our financial condition and results of operations for the fiscal year ended March&#160;31, 2021 compared to the fiscal year ended March&#160;31, 2020 can be found in &#8220;Management's Discussion and Analysis of Financial Condition and Results of Operations&#8221; in our Final Prospectus dated June&#160;23, 2021, filed with the SEC pursuant to Rule 424(b) under the Securities Act on June&#160;25, 2021. </span></div><div id="i6c4404140edb48938ba4e30b290c9ef9_70"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are the leading digital platform for U.S. medical professionals, as measured by the number of U.S. physician members. Our members include more than&#160;80% of physicians across all 50 states and every medical specialty. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our mission is to help every physician be more productive and provide better care for their patients. We are physicians-first, putting technology to work for doctors instead of the other way around. That guiding principle has enabled Doximity to become an essential and trusted professional platform for physicians. Our cloud-based platform provides our members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers. Doximity membership is free for physicians. Our revenue-generating customers, primarily pharmaceutical manufacturers and healthcare systems, have access to a suite of commercial solutions that benefit from broad physician usage. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the core of our platform is the largest medical professional network in the nation, which creates proximity within our community of doctors and hundreds of thousands of other medical professionals. Verified members can search and connect with colleagues and specialists, which allows them to better coordinate patient care and streamline referrals. Our newsfeed addresses the ever increasing sub-specialization of medical expertise and volume of medical research by delivering news and information that is relevant to each physician's clinical practice. We also support physicians in their day-to-day practice of medicine with mobile-friendly and easy-to-use clinical workflow tools such as voice and video dialer, secure messaging, and digital faxing. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business model has delivered high revenue growth at scale, while increasing profitability. For the fiscal years ended March&#160;31, 2022, 2021 and 2020, we recognized revenue of $343.5 million, $206.9 million, and $116.4 million, respectively, representing year-over-year growth rates of 66% and 78%, respectively. Our net income was $154.8 million, $50.2 million, and $29.7 million for the fiscal years ended March&#160;31, 2022, 2021, and 2020, respectively. For the fiscal years ended March&#160;31, 2022, 2021 and 2020, we generated adjusted EBITDA of $150.3 million, $64.8 million, and $26.6 million, respectively. We have accomplished this while focusing on our core mission to help every physician be more productive and provide better care for their patients. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="i6c4404140edb48938ba4e30b290c9ef9_79"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact of COVID-19</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has had, and continues to have, a significant impact on the U.S. economy and the markets in which we operate. Doximity has been privileged to play an important role in supporting physicians, medical professionals, and health systems nationwide during this time. Our business has performed strongly, demonstrating the value and effectiveness of our platform to both our members and customers. While certain of the COVID-19 pandemic-related trends underlying our positive performance may not continue after the pandemic eases, we believe that certain key underlying trends have been accelerated and will persist long after the pandemic ends. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to closely monitor the impact of the COVID-19 pandemic on all aspects of our business. While the COVID-19 pandemic has not had a material adverse impact on our financial condition and results of operations to date, the extent to which the outbreak of the COVID-19 pandemic or any other pandemic, epidemic, or infectious diseases will impact our business, results of operations and financial condition in the future is still unknown and will depend on future developments, which are highly uncertain and cannot be predicted.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information, see &#8220;Risk Factors&#8212;Risks Related to Our Business&#8212;The COVID-19 pandemic and any other future pandemic, epidemic, or outbreak of an infectious disease may adversely affect our business, financial condition, and results of operations.&#8221; </span></div><div id="i6c4404140edb48938ba4e30b290c9ef9_85"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Business and Financial Metrics</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We monitor a number of key business and financial metrics to assess the health and success of our business, including: </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Customers with Trailing 12-Month Subscription Revenue Greater than $100,000.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The number of customers with trailing 12-month, or TTM, product revenue greater than $100,000 is calculated by counting the number of customers that contributed more than $100,000 in subscription revenue in the TTM period. The number of customers with TTM subscription-based revenue of at least $100,000 is a key indicator of the scale of our business. Our customer count is subject to adjustments for acquisitions, consolidations, spin-offs, and other market activity. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of customers with at least $100,000 of revenue has grown steadily in recent years as we have engaged new customers and expanded within existing ones. This cohort of customers accounted for approximately 88%&#160;of our revenue in fiscal 2022. </span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Number of customers with at least $100,000 of revenue </span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">265</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">200</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">141</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Revenue Retention Rate.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenue retention rate is calculated by taking the TTM subscription-based revenue from our customers that had revenue in the prior TTM period and dividing that by the total subscription-based revenue for the prior TTM period. Our net revenue retention rate compares our subscription revenue from the same set of customers across comparable periods and reflects customer renewals, expansion, contraction, and churn.  </span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net revenue retention rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">157&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">153&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">130&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="text-align:center"><span style="background-color:#ffff00;color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="i6c4404140edb48938ba4e30b290c9ef9_1136"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use adjusted EBITDA and free cash flow to measure our performance and identify trends, to formulate financial projections, and to make strategic decisions. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adjusted EBITDA</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We define adjusted EBITDA as net income before interest, income taxes, depreciation and amortization, and as further adjusted for acquisition and other related expenses, stock-based compensation expense, and other income, net. Net income margin represents net income as a percentage of revenue and adjusted EBITDA margin represents adjusted EBITDA as a percentage of revenue.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EBITDA is a key measure we use to assess our financial performance and is also used for internal planning and forecasting purposes. We believe adjusted EBITDA is helpful to investors, analysts, and other interested parties because it can assist in providing a more consistent and comparable overview of our operations across our historical financial periods. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EBITDA and adjusted EBITDA margin are non-GAAP measures and are presented for supplemental informational purposes only and should not be considered as alternatives or substitutes to the financial information presented in accordance with GAAP. These measures have certain limitations in that they do not include the impact of certain expenses that are reflected in our consolidated statement of operations that are necessary to run our business. Other companies, including other companies in our industry, may not use these measures or may calculate these measures differently than as presented in this Annual Report on Form 10-K, limiting their usefulness as comparative measures. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:145%">Adjusted EBITDA and adjusted EBITDA margin increased year-over-year primarily due to higher net income as a result of increased subscription revenue. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:145%">A reconciliation of net income to adjusted EBITDA and adjusted EBITDA margin is set forth below along with net income margin: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(unaudited)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands, except percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">154,783&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">50,210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">29,737&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Adjusted to exclude the following:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Acquisition and other related expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">496&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">31,442&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,252&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5,040&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,702&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">900&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Provision for (benefit from) income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(40,778)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,559&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6,223)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(469)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4,466)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1,351)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Adjusted EBITDA</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">150,272&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">64,753&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">26,574&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">343,548&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">206,897&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">116,388&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income margin</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">24&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Adjusted EBITDA margin</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">44&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Free Cash Flow</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Free cash flow is a key performance measure that our management uses to assess our overall performance. We consider free cash flow to be a liquidity measure that provides useful information to management and investors about the amount of cash generated by our business that can be used for strategic opportunities, including investing in our business, making strategic acquisitions, and strengthening our financial position.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate free cash flow as cash flow from operating activities less purchases of property and equipment and internal-use software development costs. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of our free cash flow to the most comparable GAAP measure, net cash provided by operating activities, for each of the periods indicated:</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net cash provided by operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">126,575&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">82,973&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">26,199&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1,912)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(245)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(285)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Internal-use software development costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3,785)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4,365)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3,959)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Free cash flow</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">120,878&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">78,363&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">21,955&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other cash flow components:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net cash used in investing activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(640,574)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(70,417)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(13,095)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net cash provided by financing activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">560,415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5,407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,719&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we believe free cash flow is a useful indicator of business performance, free cash flow is presented for supplemental informational purposes only and should not be considered a substitute for financial information presented in accordance with GAAP. Free cash flow has limitations as an analytical tool, and it should not be considered in isolation or as a substitute for analysis of other GAAP financial measures, such as cash provided by operating activities. Some of the limitations of free cash flow are that it may not properly reflect capital commitments to creators that need to be paid in the future or future contractual commitments that have not been realized in the current period. Our free cash flow may not be comparable to similarly titled measures of other companies because they may not calculate free cash flow in the same manner as we calculate the measure, limiting its usefulness as a comparative measure.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="i6c4404140edb48938ba4e30b290c9ef9_88"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Components of Results of Operations</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Marketing Solutions. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our customers purchase a subscription to Marketing Solutions, either directly or through marketing agencies, for the ability to share tailored content on the Doximity platform via a variety of modules for defined time </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">periods. We generally bill customers a portion of the contract upon contract execution and then bill throughout the remainder of the contract based on various time-based milestones. Generally, we bill in advance of revenue recognition and record unbilled revenue on the consolidated balance sheets within prepaid expenses and other current assets when revenue is recognized in advance of billings. Subscriptions to Marketing Solutions include the following contractual arrangements: </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Subscriptions for specific modules delivered on a monthly basis to a consistent number of targeted Doximity members during the subscription period. Pricing is based on the number and composition of the targeted Doximity members and on the specific modules purchased. </span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Integrated subscriptions for a fixed subscription fee that are not tied to a single module, allowing customers to utilize any combination of modules during the subscription period. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For these subscription-based contractual arrangements, we recognize revenue over time as control of the service is transferred to the customer. </span></div><div style="margin-bottom:4pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hiring Solutions. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide customers access to our platform which enables them to post job openings or deliver a fixed number of monthly messages to our network of medical professionals. We bill annually or quarterly ahead of the service period, or at the beginning of each month of service, and recognize revenue ratably over the contractual term. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our acquisition of Curative Talent, completed in fiscal 2021, we also generate revenue from temporary and permanent medical recruiting services which we charge on an hourly-fee and placement-fee basis, respectively. Revenue for temporary placement services is recognized net of third-party contractor fees. For the fiscal year ended March&#160;31, 2022, the revenue from temporary and permanent medical recruiting services was not significant to our total revenue.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Revenue</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue is primarily comprised of expenses related to cloud hosting, personnel-related expenses for our customer success team, costs for third-party platform access, software services and contractors, and other services used in connection with the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">delivery and support of our platform. Our cost of revenue also includes the amortization of internal-use software development costs and deferred contract costs, editorial and other content-related expenses, and allocated overhead. Cost of revenue is also driven by the growth of our member network and utilization of our telehealth tools. We intend to continue to invest additional resources in our cloud infrastructure and our customer support organizations to support the growth of our business and expect these expenses to increase on an absolute dollar basis.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross Profit and Gross Margin</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit is total revenue less total cost of revenue. Gross margin is gross profit expressed as a percentage of total revenue. Gross profit and gross margin has been and will continue to be affected by a number of factors, including the timing of our acquisition of new customers and </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sa</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">les of additional solutions to our existing customer</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the timing and extent of our investments in our operations, cloud hosting costs, growth in our customer success team, and the timing of amortization of internal-use software development costs. We expect our gross margin to remain relatively steady over the near term, although our quarterly gross margin is expected to fluctuate from period to period depending on the interplay of these and other factors. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating expenses consist of sales and marketing, research and development, and general and administrative expenses. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expense is primarily comprised of personnel-related expenses associated with our engineering and product teams who are responsible for building new products and improving existing products. Research and development expense also includes costs for third-party services and contractors, information technology and software-related costs, and allocated overhead. Other than internal-use software development costs that qualify for capitalization, research and development costs are expensed as incurred. We expect research and development expenses will increase on an absolute dollar basis as we continue to grow our platform and product offerings. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sales and Marketing</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales and marketing expense is primarily comprised of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">personnel-related expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, sales commissions, travel, and other event expenses. Sales and marketing expense also includes costs for third-party services and contractors, information technology and software-related costs, and allocated overhead. We capitalize the sales commissions that are considered to be </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">incremental and recoverable costs of obtaining a contract with a customer. These sales commissions are amortized over the period of benefit. We expect sales and marketing expense to increase and to be our largest expense on an absolute basis. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and Administrative</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expense is primarily comprised of </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">personnel-related expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> associated with our executive, finance, legal, human resources, information technology, and facilities employees. General and administrative expense includes fees for third-party legal and accounting services, recruitment fees, information technology and software-related costs, and allocated overhead. We expect that general and administrative expense will increase on an absolute dollar basis as we incur compliance costs associated with being a publicly-traded company, including legal, audit, and consulting fees. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income, Net</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consists primarily of administrative fees and penalties and interest income earned on our cash equivalents and marketable securities.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provision for (Benefit from) Income Taxes</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provision for (benefit from) income taxes consists primarily of income taxes in U.S federal, state, and local jurisdictions in which we conduct business. We continue to maintain a valuation allowance related to specific net deferred tax assets where it is not more likely than not that the deferred tax assets will be realized, which includes California research and development credits and capital loss carryforwards.</span></div><div id="i6c4404140edb48938ba4e30b290c9ef9_91"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth our consolidated results of operations data and such data as a percentage of revenue for the periods presented. </span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"></td><td style="width:62.159%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.751%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.392%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.751%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.392%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.755%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">343,548&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">206,897&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">116,388&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cost of revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">31,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">303,761&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">175,701&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101,488&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research and development</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">62,350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">43,873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sales and marketing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">92,129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">62,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39,448&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">General and administrative</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,746&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16,492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">190,225&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">122,398&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79,325&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113,536&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">53,303&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,351&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114,005&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">57,769&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,514&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Provision for (benefit from) income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(40,778)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,559&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,223)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154,783&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">50,210&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,737&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">_______________</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%;padding-left:9.84pt">Costs and expenses include stock-based compensation expenses as follows:</span></div><div style="margin-bottom:9pt;padding-left:9pt;padding-right:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cost of revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,979&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">173&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sales and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">847&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11,290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">31,442&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,252&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,353&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(percentage of revenue)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">85&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">87&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sales and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">55&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">59&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">68&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">33&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">33&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Provision for (benefit from) income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(12)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">45&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">24&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">26&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of the Years Ended March 31, 2022 and 2021</span></div><div style="margin-bottom:4pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands, except percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">343,548&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">206,897&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">136,651&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue for the fiscal year ended March&#160;31, 2022 increased $136.7 million as compared to the fiscal year ended 2021. The increase was primarily driven by a $127.0 million increase in subscription revenue. Of the increase in subscription revenue, $16.8 million was driven by the addition of new subscription customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$109.0 million was due to the expansion of existing customers. The expansion of existing customers was primarily driven by average revenue per existing Marketing Solutions customer increasing by 60% as a result of adding new brands and service lines, growing existing brands and service lines, and upselling additional modules. The remaining change in subscription revenue was generated from Dialer Pro subscriptions for individuals and small practices and other non-recurring items. Approximately 93% of our revenue for the fiscal year ended March&#160;31, 2022 was derived from subscription customers. The remaining increase in revenue was driven by an increase in medical recruiting services. </span></div><div style="margin-bottom:4pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of revenue, gross profit and gross margin</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands, except percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cost of revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">39,787&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">31,196&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,591&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">28&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Gross profit</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">303,761&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">175,701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">128,060&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Gross margin</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">85&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue for the fiscal year ended March&#160;31, 2022 increased $8.6 million as compared to the fiscal year ended 2021. The increase in cost of revenue was primarily driven by a $4.2 million increase in personnel-related costs as a result of headcount growth of 36%, $2.6 million increase in expense from the U.S. News warrant granted in October 2021, and a $1.8 million increase in stock-based compensation expense due to headcount growth and an increase in the weighted-average grant date fair values of our equity grants. In addition, there was a $1.2 million increase in consulting services and a $1.3 million increase in amortization of internal-use software development costs. These increases were partially offset by a $3.0 million decrease in third-party software as a result of renegotiating pricing terms with vendors combined with a lower volume of virtual visits as compared to the prior period, when our Dialer tool was available to all members for free. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross margin increased due to our revenue growth and continued efficiency as we scale.</span></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> We define new subscription customers as revenue generating subscription customers in the current fiscal period who did not contribute any revenue for the same period in the prior fiscal year.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-bottom:4pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and development </span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands, except percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research and development</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">62,350&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">43,873&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">18,477&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">42&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expense for the fiscal year ended March&#160;31, 2022 increased $18.5 million as compared to the fiscal year ended 2021. The increase in research and development expense was primarily driven by a $9.8 million increase in personnel-related costs as a result of headcount growth of approximately 26%. The increase was also driven by a $5.1 million increase in stock-based compensation primarily attributable to headcount growth and an increase in the weighted-average grant date fair values of our equity grants. The increase was also due to a $2.3 million increase in third-party software subscription and license costs as a result of headcount growth as well as a $1.1 million increase in employee events and travel-related expenses as we resumed certain in-person events. </span></div><div style="margin-bottom:4pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sales and marketing</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands, except percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sales and marketing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">92,129&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">62,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">30,096&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">49&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales and marketing expense for the fiscal year ended March&#160;31, 2022 increased $30.1 million as compared to the fiscal year ended 2021. The overall increase in sales and marketing expense was due to the growth in our business, specifically driven by a $10.7 million increase in personnel-related costs due to headcount growth of 23% as well as a $5.4 million increase in incentive compensation due to increased sales activity. The increase was also driven by a $6.1 million increase in stock-based compensation mainly due to headcount growth and an increase in the weighted-average grant date fair values of our equity grants. Additionally, there was a $2.5 million increase in deferred contract costs amortization due to higher sales volume, a $2.2 million increase for in-person trade shows and conferences, advertising and other marketing expenses, and a $1.4 million increase in employee events and travel-related expenses as we resumed certain in-person events. </span></div><div style="margin-bottom:4pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and administrative</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands, except percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">General and administrative</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">35,746&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16,492&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">19,254&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">117&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expense for the fiscal year ended March&#160;31, 2022 increased $19.3 million as compared to the fiscal year ended 2021. The increase in general and administrative expense was primarily driven by an $8.6 million increase in stock-based compensation, of which $5.3 million related to the increase in headcount and the weighted-average grant date fair values of our equity awards and $3.3 million was due to performance grants where the performance conditions were met or became probable of achievement during fiscal 2022. In addition, there was a $2.8 million increase in personnel-related costs due to headcount growth of approximately 48%, a $3.1 million increase in insurance expense, and a $3.1 million increase in accounting, legal, and other services as we incurred additional expenses as a result of becoming a public company.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other income, net</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands, except percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other income, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">469&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,466&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(3,997)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(89)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net for the fiscal year ended March&#160;31, 2022 decreased $4.0 million compared to the fiscal year ended 2021. The decrease was primarily driven by a $4.7 million non-recurring gain that was recognized in October 2020 upon the sale of a portion of the Curative Talent business, offset by a $0.6 million increase in interest income due to our increased investment in marketable securities. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provision for (benefit from) income taxes</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">%</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands, except percentages)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Provision for (benefit from) income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(40,778)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,559&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(48,337)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">NM</span></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the fiscal year ended March&#160;31, 2022, we had an income tax benefit of $40.8 million compared to a provision of $7.6 million for the fiscal year ended 2021. This change was primarily driven by excess tax benefit on stock option exercise and disqualifying disposition activities following our initial public offering in June 2021. </span></div><div style="margin-bottom:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">___________________</span></div><div style="margin-bottom:9pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">NM: Percentage not meaningful.</span></div><div id="i6c4404140edb48938ba4e30b290c9ef9_97"></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since inception, we have financed operations primarily through proceeds received from sales of equity securities and payments received from our customers. As of March&#160;31, 2022, our principal sources of liquidity were cash and cash equivalents and marketable securities of $798.1 million. Our marketable securities consist of U.S. government and agency securities, corporate notes and bonds, commercial paper, asset-backed securities, and sovereign bonds. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, we completed our IPO, in which we issued and sold 22,505,750 shares of our Class A common stock at $26.00 per share, including 3,495,000 shares issued upon the exercise of the underwriters&#8217; option to purchase additional shares. We received proceeds of $548.5 million after deducting underwriting discounts and commissions as well as deferred offering costs.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our existing cash and cash equivalents and marketable securities will be sufficient to support working capital and capital expenditure requirements for at least the next 12 months.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future capital requirements will depend on many factors, including our revenue growth rate, the timing and the amount of cash received from customers, the expansion of sales and marketing activities, and the timing and extent of spending to support research and development efforts. Further, we may in the future enter into arrangements to acquire or invest in businesses and technologies. We may be required to seek additional equity or debt financing. In the event that additional financing is required from outside sources, we may not be able to raise it on terms acceptable to us or at all. If we are unable to raise additional capital when desired, our business, financial condition, and results of operations could be adversely affected. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further details regarding our cash requirements from noncancelable operating lease obligations and other contractual commitments, see Note 13&#8212;Commitments and Contingencies included in Part II, Item 8 of this Annual Report on Form 10-K.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net cash provided by operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126,575&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82,973&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net cash used in investing activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(640,574)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(70,417)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net cash provided by financing activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">560,415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:4pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net cash provided by operating activities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash provided by operating activities was $126.6 million for the fiscal year ended March&#160;31, 2022. This consisted of net income of $154.8 million, adjusted for non-cash items of $12.1 million and a net decrease in operating assets and liabilities of $40.3 million. Non-cash items primarily consisted of stock-based compensation expense of $31.4 million, amortization of deferred contract costs of $9.8 million, depreciation and amortization expense of $5.0 million, amortization of the premium on marketable securities of $4.3 million, offset by a negative non-cash adjustment for deferred tax benefit of $41.2 million. The net decrease in operating assets and liabilities was driven by a $31.0 million increase in accounts receivable due to the growth of our business and the timing of collections, a $9.6 million increase in deferred contract costs due to increased sales activity, and a $9.1 million increase in prepaid expenses and other assets. These decreases were partially offset by an increase of $8.7 million in accounts payable, accrued expenses and other liabilities, which was primarily a result of increased accrued payroll, bonus, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and related expenses due to increased headcount and timing of payments and increased rebate liabilities due to higher sales combined with the timing of payments. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash provided by operating activities was $83.0 million for the fiscal year ended March&#160;31, 2021. This consisted of net income of $50.2 million, adjusted for non-cash items of $21.2 million and a net increase in operating assets and liabilities of $11.6 million. Non-cash items primarily consisted of stock-based compensation expense of $7.3 million, amortization of deferred contract costs of $6.9 million, deferred income tax expense of $5.0 million, and depreciation and amortization expense of $3.7 million, partially offset by a $4.7 million gain due to the sale of a portion of the Curative Talent business. The net increase in operating assets and liabilities was primarily driven by an increase of $38.6 million in deferred revenue due to the addition of new customers and expansion from existing customers combined with the timing of customer billings and an increase of $7.3 million in accounts payable, accrued expenses and other liabilities, which was primarily a result of increased accrued incentive compensation due to higher sales and timing of payments and increased accrued payroll, bonus, and related expenses due to increased headcount and timing of payments. These increases were partially offset by an increase of $20.5 million in accounts receivable due to the growth of our business and the timing of collections and an increase of $9.4 million in deferred contract costs due to increased sales activity. </span></div><div style="margin-bottom:4pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net cash used in investing activities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used in investing activities was $640.6 million for the fiscal year ended March&#160;31, 2022, which primarily consisted of purchases of marketable securities of $1.3 billion, partially offset by proceeds from the sale of marketable securities of $633.8 million, proceeds from the maturities of marketable securities of $47.9 million, and capitalization of internal-use software development costs of $3.8 million.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash used in investing activities was $70.4 million for the fiscal year ended March&#160;31, 2021, which primarily consisted of purchases of marketable securities of $78.9 million and cash paid for the acquisition of Curative Talent of $31.7 million, partially offset by proceeds from the maturities of marketable securities of $40.5 million. </span></div><div style="margin-bottom:4pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net cash provided by financing activities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash provided by financing activities was $560.4 million for the  fiscal year ended March&#160;31, 2022, which primarily consisted of $553.9 million of proceeds from the issuance of common stock upon our initial public offering after deducting underwriting fees and commissions, $12.6 million of net proceeds from the exercise of stock options, and $1.4 million of proceeds from the issuance of common stock in connection with the employee stock purchase plan. These proceeds were partially offset by $4.0 million in payments for deferred offering costs and $2.7 million in payments from the repurchase and retirement of common stock. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash provided by financing activities was $5.4 million for the fiscal year ended March&#160;31, 2021, which primarily consisted of $8.9 million of net proceeds from the exercise of stock options, partially offset by $1.5 million in payments for deferred offering costs and $2.0 million from the repurchase and retirement of common stock. </span></div><div id="i6c4404140edb48938ba4e30b290c9ef9_103"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off Balance Sheet Arrangements</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not have during the periods presented, and we do not currently have, any off-balance sheet financing arrangements or any relationships with unconsolidated entities or financial partnerships, including entities sometimes referred to as structured finance or special purpose entities, that were established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.</span><span style="background-color:#ffff00;color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="i6c4404140edb48938ba4e30b290c9ef9_106"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements and the related notes thereto included elsewhere in this Annual Report on Form 10-K are prepared in accordance with GAAP. The preparation of our financial statements also requires us to make estimates and assumptions that affect the amounts stated in the consolidated financial statements and accompanying notes. We base our estimates and judgments on historical experience and on various other assumptions that we believe are reasonable under the circumstances. Actual results could differ significantly from the estimates made by management. To the extent that there are differences between our estimates and actual results, our future financial statement presentation, financial condition, results of operations, and cash flows will be affected. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that of our significant accounting policies, which are described in Note 2&#8212;Summary of Significant Accounting Policies included in Part II, Item 8 of this Annual Report on Form 10-K, the following accounting policies involve a greater degree of judgment and complexity. Accordingly, we believe the below policies are the most critical to aid in fully understanding and evaluating our consolidated financial statements. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketing Solutions customers may purchase a subscription for a specific module to be used over a defined period of time. These customers may purchase more than one module with either the same or different subscription periods. Each module targets a consistent number of Doximity members per month for the duration of the subscription period. The Company treats each subscription to a specific module as a distinct performance obligation because each module is capable of being distinct as the customer can benefit from the subscription to each module on their own and each subscription can be sold standalone. The subscription to each module is treated as a series of distinct performance obligations because it is distinct and substantially the same, satisfied over time, and has the same measure of progress. The total transaction price is allocated to the individual module subscriptions, which represent separate performance obligations, based on the relative standalone selling price. We commence revenue recognition when the first content for the specific module is launched on the platform for the initial monthly period and revenue is recognized over time as each subsequent content period is delivered.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketing Solutions customers may also purchase integrated subscriptions for a fixed subscription fee that are not tied to a single module but allow customers to utilize any combination of modules during the subscription period subject to limits on the total number of modules launched in a given period of time, active at any given time, and members targeted. These represent stand-ready obligations in that the delivery of the underlying sponsored content is within the control of the customer and the extent of use in any given period does not diminish the remaining services. For these integrated campaign subscriptions, we record revenue ratably over the subscription period commencing with the beginning of the subscription term.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for stock-based compensation in accordance with the authoritative guidance on stock compensation. Under the fair value recognition provisions of this guidance, stock-based compensation is measured at the grant date based on the fair value of the award and is recognized as expense, net of estimated forfeitures, in the statement of operations over the requisite service period, which is generally the vesting period of the respective award. Forfeitures are estimated based upon our historical experience and we revise the estimates, if necessary, in subsequent periods if actual forfeitures differ from initial estimates. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Determining the grant-date fair value of stock options requires judgment. We estimate the fair value of restricted stock units, or RSUs, at our stock price on the grant date. We use the Black-Scholes option-pricing model to determine the fair value of stock options, warrants, purchase rights under the employee stock purchase plan, or ESPP. The determination of the grant-date fair value using the Black-Scholes model is affected by the fair value of our common stock and assumptions regarding a number of other complex and subjective variables. These assumptions include the expected term of the award, the expected stock price volatility over the expected term of the award, the risk-free interest rate for the expected term of the award, and expected dividends. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the IPO, when there was no public market for our common stock, significant judgment was involved in determining the fair value of our common stock and the expected stock price volatility. Our board of directors considered numerous objective and subjective factors to determine the fair value of our common stock at each meeting during which awards were approved. These factors included, but were not limited to (i) contemporaneous third-party valuations of common stock; (ii) the rights and preferences of our preferred stock relative to common stock; (iii) the lack of marketability of common stock; (iv) developments in the business; and (v) the likelihood of achieving a liquidity event, such as an IPO or sale of the Company, given prevailing market conditions. The expected volatility was determined using the historical volatilities of several publicly listed peer companies over a period equivalent to the expected term of the awards. We have not granted stock options to employees subsequent to the IPO.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Combinations</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We allocate the purchase price of acquired companies to tangible and intangible assets acquired and liabilities assumed based upon their estimated fair values at the acquisition date. The purchase price allocation process requires management to make significant estimates and assumptions with respect to the valuation of intangible assets. Examples of critical estimates in valuing certain of the intangible assets we have acquired or may acquire in the future include but are not limited to future expected cash flows, future revenue growth, margins, customer retention rates, technology life, royalty rates, expected use of acquired assets, and discount rates. These factors are also considered in determining the useful life of the acquired intangible assets. These estimates are based in part on historical experience, market conditions and information obtained from management of the acquired companies and are inherently uncertain. Goodwill represents the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recorded.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><div id="i6c4404140edb48938ba4e30b290c9ef9_109"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 2&#8212;Summary of Significant Accounting Policies included in Part II, Item 8 of this Annual Report on Form 10-K for recently adopted accounting pronouncements and recently issued accounting pronouncements not yet adopted. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="i6c4404140edb48938ba4e30b290c9ef9_112"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Jumpstart Our Business Startups Act of 2012</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are an emerging growth company, as defined in the JOBS Act. The JOBS Act provides that an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting standards. This provision allows an emerging growth company to delay the adoption of some accounting standards until those standards would otherwise apply to private companies. We have elected to use the extended transition period under the JOBS Act for the adoption of certain accounting standards until the earlier of the date we (i) are no longer an emerging growth company or (ii) affirmatively and irrevocably opt out of the extended transition period provided in the JOBS Act. As a result, our financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.</span></div><div style="text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="i6c4404140edb48938ba4e30b290c9ef9_929"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7A. Quantitative and Qualitative Disclosures about Market Risk</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of our operations are within the United States and we do not have any foreign currency exposure. We are exposed to market risks in the ordinary course of our business, including the effects of interest rate changes and inflation.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash and cash equivalents and marketable securities primarily consist of cash on hand and highly liquid investments in money market funds, corporate notes and bonds, asset-backed securities, commercial paper, U.S. government and agency securities, and sovereign bonds. As of March&#160;31, 2022 and 2021, we had cash and cash equivalents of $112.8 million and $66.4 million and marketable securities of $685.3 million and $76.1 million, respectively. We do not enter into investments for trading or speculative purposes. Our investments are exposed to market risk due to fluctuations in interest rates, which may affect our interest income and the fair value of our investments. Fixed rate securities may have their market value adversely affected due to a rise in interest rates, while floating rate securities may produce less income than expected if interest rates fall. Due in part to these factors, our future investment income may fall short of expectation due to changes in interest rates or we may suffer losses in principal if we are forced to sell securities that decline in market value due to changes in interest rates.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A hypothetical 100 basis point increase in interest rates would have resulted in a decrease of $10.6 million in the market value of our cash equivalents and marketable securities as of March&#160;31, 2022. A hypothetical 100 basis point increase in interest rates did not have a material impact on the market value of our cash equivalents and marketable securities as of March&#160;31, 2021. Fluctuations in the value of our investments caused by a change in interest rates are recorded in other comprehensive income and are realized only if we sell the underlying securities. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impact of Inflation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe that inflation has had a material effect on our business, results of operations, or financial condition. Nonetheless, if our costs were to become subject to significant inflationary pressures, we may not be able to fully offset such higher costs. Our inability or failure to do so could harm our business, financial condition, and results of operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><div id="i6c4404140edb48938ba4e30b290c9ef9_163"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 8. Financial Statements and Supplementary Data</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:89.104%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.696%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Page(s)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_166">Report of Independent Registered </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_166">Public Accounting Firm</a> (PCAOB ID <ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjMvZnJhZzo1ZmQ4M2U3NjNkNjM0OWM4YWE1ODlkODE4MmNiNjM1Yi90YWJsZTphZGEwZDc3ZDQwNTg0NmYzODdkZDI2ZWVkZmUxYjVhOC90YWJsZXJhbmdlOmFkYTBkNzdkNDA1ODQ2ZjM4N2RkMjZlZWRmZTFiNWE4XzEtMC0xLTEtMTI2OTExL3RleHRyZWdpb246ZTFkODljMzNkMzg3NDE1Y2I1NTY0MTlmMTFlNDQ1M2NfMjg1ODczMDIzMjI4OTU_29b52960-848d-4423-8a7b-c5bdd192711d">34</ix:nonNumeric>)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_166">59</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_169">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_169">60</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_172">Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_172">61</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_175">Consolidated Statements of Comprehensive Income</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_175">62</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_178">Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_178">63</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_181">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_181">65</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_184">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_184">67</a></span></div></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><div id="i6c4404140edb48938ba4e30b290c9ef9_166"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">To the Stockholders and the Board of Directors of Doximity, Inc.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of Doximity, Inc. and subsidiaries (the "Company") as of March 31, 2022 and 2021, the related consolidated statements of operations, comprehensive income, redeemable convertible preferred stock and stockholders&#8217; equity (deficit), and cash flows, for each of the three years in the period ended March 31, 2022, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of March 31, 2022 and 2021, and the results of its operations and its cash flows for each of the three years in the period ended March 31, 2022, in conformity with accounting principles generally accepted in the United States of America.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:43.128%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ <ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjYvZnJhZzo3NDI1ZWYwYmIyYjE0ZTMyYTc0MWRiOTliZDQxOTlkMy90YWJsZTozYjZjMDE1MDZhZjc0OThmYWRiYjVlM2I0MWQ1YTA3NS90YWJsZXJhbmdlOjNiNmMwMTUwNmFmNzQ5OGZhZGJiNWUzYjQxZDVhMDc1XzAtMC0xLTEtNTIzMDEvdGV4dHJlZ2lvbjowNzEwNTA4YmNmOGU0Y2JlODA3MGU5NWRmZDIyYzBjNV8zMTMzNjA4MTM5MTY2Ng_fc133adb-8b2f-4e24-afbf-490c7ec40bf6">Deloitte &amp; Touche LLP</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjYvZnJhZzo3NDI1ZWYwYmIyYjE0ZTMyYTc0MWRiOTliZDQxOTlkMy90YWJsZTozYjZjMDE1MDZhZjc0OThmYWRiYjVlM2I0MWQ1YTA3NS90YWJsZXJhbmdlOjNiNmMwMTUwNmFmNzQ5OGZhZGJiNWUzYjQxZDVhMDc1XzEtMC0xLTEtMTI3MDc3_186b0077-d14a-4182-bb77-3339549b6e7b">San Francisco, California</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 27, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company's auditor since 2015.</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><div id="i6c4404140edb48938ba4e30b290c9ef9_169"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share data)</span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:76.970%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.574%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzQtMy0xLTEtNDc5OTI_81fc70db-f37b-423b-995c-0106708b8fa1">112,809</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzQtNS0xLTEtNDc5OTI_13f6cc5c-8c57-4a67-9523-e80fcb5f7648">66,393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzUtMy0xLTEtNDc5OTI_a357864d-5245-4aa0-99cb-aab9ca429087">685,304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzUtNS0xLTEtNDc5OTI_82d4fc09-a53e-4862-8b7d-22bff58d3081">76,141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable, net of allowance for doubtful accounts of $<ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzYtMC0xLTEtOTI4NjUvdGV4dHJlZ2lvbjo5NzE4ZjBkYTUxNjQ0YWRhODNhZjkwNDE2ZjQzYTBkM18yOTEzNzA1ODEzNjE5Ng_289e6c0c-b261-4aa3-982e-c2d02b3edad9">359</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzYtMC0xLTEtOTI4NjUvdGV4dHJlZ2lvbjo5NzE4ZjBkYTUxNjQ0YWRhODNhZjkwNDE2ZjQzYTBkM18yOTEzNzA1ODEzNjIwNA_68ef3fd1-e6cf-4ea9-a4e6-7f5b7a6389d6">955</ix:nonFraction> as of March&#160;31, 2022 and 2021, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzYtMy0xLTEtNDc5OTI_cc885409-6883-4a21-a4bc-f37e199dfac3">81,073</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzYtNS0xLTEtNDc5OTI_edaa7b8a-c9a3-40fe-b3e7-ee85ed215d09">50,319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzctMy0xLTEtNDc5OTI_4e5529d1-5a9a-4141-af76-c2f9d3d9cbc1">19,439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzctNS0xLTEtNDc5OTI_3f842234-aab2-4d13-a665-56794c313166">10,692</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred contract costs, current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:CapitalizedContractCostNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzgtMy0xLTEtNDc5OTI_edef45a4-ff8b-4d2c-92ed-228b68ff3ced">5,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:CapitalizedContractCostNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzgtNS0xLTEtNDc5OTI_8a32a10e-e577-4d87-b4c5-b88584107822">5,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzktMy0xLTEtNDc5OTI_cbdb4940-9674-4bc4-a4d8-9100e9048283">904,137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzktNS0xLTEtNDc5OTI_cd52303c-cea7-4569-88fc-0d3c7af8df60">209,401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzEwLTMtMS0xLTQ3OTky_c6c5f901-00c3-42b6-bd6d-5580db4862a7">8,488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzEwLTUtMS0xLTQ3OTky_97ae8cb4-717e-4836-8e80-50a5c90d4d54">7,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred income tax assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzExLTMtMS0xLTQ3OTky_b4669728-42f3-41c8-9106-5c81eeecaa8f">48,558</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzExLTUtMS0xLTQ3OTky_cc1ecdd2-6a75-404a-9bd4-f0a15bfb7e09">2,112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzEyLTMtMS0xLTQ3OTky_2260587c-2670-4b80-a1fc-282598c58cdc">1,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzEyLTUtMS0xLTQ3OTky_e2911c6b-9cfd-44b4-8def-d3cdf8e588c4">1,339</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzEzLTMtMS0xLTQ3OTky_4b9f64f0-f778-47b5-9c28-a4e936627e74">7,909</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzEzLTUtMS0xLTQ3OTky_61d5e101-185f-40b2-a07b-0cc6db865f5d">9,596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzE0LTMtMS0xLTQ3OTky_a231f0d9-9cc1-41fa-b0a8-634fa4b351c6">18,915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzE0LTUtMS0xLTQ3OTky_59d3f758-138d-4aa4-9226-f13770f545cb">18,915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzE1LTMtMS0xLTQ3OTky_ef9953b6-b912-4e2f-a578-5d6ae3b0a845">2,263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzE1LTUtMS0xLTQ3OTky_3b4b1ec3-56c6-474c-a015-3dbe7a694e4a">2,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzE2LTMtMS0xLTQ3OTky_a388062f-09c8-4358-8335-7c3e52f66bfc">991,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzE2LTUtMS0xLTQ3OTky_cbb83793-fd4e-4229-8647-1d3bc9429e7a">251,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Liabilities, Redeemable Convertible Preferred Stock, and Stockholders&#8217; Equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzE5LTMtMS0xLTQ3OTky_f72e2be9-6878-4859-ac1a-a68df7122b3e">463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzE5LTUtMS0xLTQ3OTky_70fa0c70-5886-44b2-8b49-99412d83a9c3">1,515</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrued expenses and other current liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzIwLTMtMS0xLTQ3OTky_f1f1825b-74ee-43b8-82dd-8821210f3d13">25,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzIwLTUtMS0xLTQ3OTky_e564c948-1351-4ccc-b8cf-1033ad594e07">16,285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred revenue, current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzIxLTMtMS0xLTQ3OTky_9729c10c-b746-470f-9e9a-b0e384d828a1">84,907</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzIxLTUtMS0xLTQ3OTky_60160432-470c-4ce6-872a-3f76a122424c">83,272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease liabilities, current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzIyLTMtMS0xLTQ3OTky_e1503a00-2077-4801-8420-1fe058e6247e">642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzIyLTUtMS0xLTQ3OTky_4af03566-1ff4-4225-b4a6-5c318493dcb1">970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzI0LTMtMS0xLTQ3OTky_de18afa6-6164-4e53-b2e3-e67e2c0352fd">111,282</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzI0LTUtMS0xLTQ3OTky_03dfec13-bd23-48e2-80cc-93ea2db94895">102,042</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred revenue, non-current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzI1LTMtMS0xLTQ3OTky_d2d1b216-55b2-4d21-933c-1da2ddade1a7">78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzI1LTUtMS0xLTQ3OTky_15a68d2b-82a3-409c-ac1d-acecb4944f85">220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease liabilities, non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzI2LTMtMS0xLTQ3OTky_44d271df-1eae-4a6d-ab84-b213be49d985">447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzI2LTUtMS0xLTQ3OTky_14882aad-77bf-4de0-b355-55f457670346">284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other liabilities, non-current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzI3LTMtMS0xLTQ3OTky_4d119cf7-af2c-4b4d-925e-16a8ec3437ae">956</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzI3LTUtMS0xLTQ3OTky_9d0cb383-ef9f-4ac7-aa38-941af8f4fddd">972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzI4LTMtMS0xLTQ3OTky_32dbdd1d-d994-4250-8429-f2dd7c2fa0d3">112,763</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzI4LTUtMS0xLTQ3OTky_6d0fd023-53fc-4038-96e8-b110b241ae21">103,518</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commitments and contingencies (Note 13)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzI4LTEtMS0xLTEwMTY4NA_7ebeac49-ddb6-45ec-b048-d87231a900db"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzI4LTMtMS0xLTEwMTY4Ng_1f5ab4c1-1cc1-4bd4-a7ba-58a4606cd1d3"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Redeemable Convertible Preferred Stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Redeemable convertible preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="3" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM0LTAtMS0xLTQ4ODk5L3RleHRyZWdpb246YzZmNTRmMmVlMjk4NDBlNDljZDA4NmQxZjg3YmYwMmVfMjkxMzcwNTgxMzY5NzA_27f47052-3462-47da-befc-865f539ca4b0"><ix:nonFraction unitRef="usdPerShare" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="3" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM0LTAtMS0xLTQ4ODk5L3RleHRyZWdpb246YzZmNTRmMmVlMjk4NDBlNDljZDA4NmQxZjg3YmYwMmVfMjkxMzcwNTgxMzY5NzA_7c36d684-7bdb-4ba1-96e6-5e0ff1837ca0">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:TemporaryEquitySharesAuthorized" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM0LTAtMS0xLTQ4ODk5L3RleHRyZWdpb246YzZmNTRmMmVlMjk4NDBlNDljZDA4NmQxZjg3YmYwMmVfMjkxMzcwNTgxMzY5Nzk_1220a4f7-d6ff-44d3-b650-045d30154876">zero</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:TemporaryEquitySharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM0LTAtMS0xLTQ4ODk5L3RleHRyZWdpb246YzZmNTRmMmVlMjk4NDBlNDljZDA4NmQxZjg3YmYwMmVfMjkxMzcwNTgxMzY5ODQ_5926d6d4-203b-4c57-99b8-b4984d0197cf">76,350</ix:nonFraction> shares authorized as of March&#160;31, 2022 and 2021, respectively; <ix:nonFraction unitRef="shares" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM0LTAtMS0xLTQ4ODk5L3RleHRyZWdpb246YzZmNTRmMmVlMjk4NDBlNDljZDA4NmQxZjg3YmYwMmVfMjkxMzcwNTgxMzY5ODk_2fa88795-1a60-4180-a1d7-6a8bf12c44e2"><ix:nonFraction unitRef="shares" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM0LTAtMS0xLTQ4ODk5L3RleHRyZWdpb246YzZmNTRmMmVlMjk4NDBlNDljZDA4NmQxZjg3YmYwMmVfMjkxMzcwNTgxMzY5ODk_83b72113-b890-4c4a-b70e-51692e7dcd2a">zero</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM0LTAtMS0xLTQ4ODk5L3RleHRyZWdpb246YzZmNTRmMmVlMjk4NDBlNDljZDA4NmQxZjg3YmYwMmVfMjkxMzcwNTgxMzY5OTQ_7f83bad9-0587-488b-9ac0-8b3c7a2eb5df"><ix:nonFraction unitRef="shares" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM0LTAtMS0xLTQ4ODk5L3RleHRyZWdpb246YzZmNTRmMmVlMjk4NDBlNDljZDA4NmQxZjg3YmYwMmVfMjkxMzcwNTgxMzY5OTQ_b4092f78-50d1-4156-89e1-5674d99b184c">76,287</ix:nonFraction></ix:nonFraction> shares issued and outstanding as of March&#160;31, 2022 and 2021, respectively; liquidation preference of <ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:TemporaryEquityLiquidationPreference" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM0LTAtMS0xLTQ4ODk5L3RleHRyZWdpb246YzZmNTRmMmVlMjk4NDBlNDljZDA4NmQxZjg3YmYwMmVfMjkxMzcwNTgxMzY5OTk_5d7b541b-a68f-41eb-9f4c-cd40ee7bb4bd">zero</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:TemporaryEquityLiquidationPreference" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM0LTAtMS0xLTQ4ODk5L3RleHRyZWdpb246YzZmNTRmMmVlMjk4NDBlNDljZDA4NmQxZjg3YmYwMmVfMjkxMzcwNTgxMzcwMDQ_acadada5-1962-47a4-8a4f-f23d0c34db18">81,672</ix:nonFraction> as of March&#160;31, 2022 and 2021, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM0LTMtMS0xLTQ3OTky_f8ab565e-66b3-4d8a-96d5-efc5a63b46e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM0LTUtMS0xLTQ3OTky_3de414e3-ec94-4717-807b-778a2d142407">81,458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Stockholders&#8217; Equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="3" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzMyLTAtMS0xLTk3NjgyL3RleHRyZWdpb246NWZiODJhYWExMjAyNDJjMWFmM2I0MGE2NDA1ZmFmYjZfMjkxMzcwNTgxMzYyMjE_5b8a5791-e389-4667-937d-3509c479441a"><ix:nonFraction unitRef="usdPerShare" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="3" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzMyLTAtMS0xLTk3NjgyL3RleHRyZWdpb246NWZiODJhYWExMjAyNDJjMWFmM2I0MGE2NDA1ZmFmYjZfMjkxMzcwNTgxMzYyMjE_728c2842-373a-4d52-a54f-0b49bb6d2d2c">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzMyLTAtMS0xLTk3NjgyL3RleHRyZWdpb246NWZiODJhYWExMjAyNDJjMWFmM2I0MGE2NDA1ZmFmYjZfMjkxMzcwNTgxMzYyNTU_46544d1c-d0f2-4fb4-87cc-12a16097748e">100,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzMyLTAtMS0xLTk3NjgyL3RleHRyZWdpb246NWZiODJhYWExMjAyNDJjMWFmM2I0MGE2NDA1ZmFmYjZfMjkxMzcwNTgxMzYyNTk_849bc39e-b5e1-4848-b7b2-d7674b789b61">zero</ix:nonFraction> shares authorized as of March&#160;31, 2022 and 2021, respectively; <ix:nonFraction unitRef="shares" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzMyLTAtMS0xLTk3NjgyL3RleHRyZWdpb246NWZiODJhYWExMjAyNDJjMWFmM2I0MGE2NDA1ZmFmYjZfOTQ_086edaab-6544-4e8e-a0ae-8ba5f60f1e90"><ix:nonFraction unitRef="shares" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzMyLTAtMS0xLTk3NjgyL3RleHRyZWdpb246NWZiODJhYWExMjAyNDJjMWFmM2I0MGE2NDA1ZmFmYjZfOTQ_1c451f10-6570-44bf-a8a0-04e821fd8c68"><ix:nonFraction unitRef="shares" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzMyLTAtMS0xLTk3NjgyL3RleHRyZWdpb246NWZiODJhYWExMjAyNDJjMWFmM2I0MGE2NDA1ZmFmYjZfOTQ_3346a00c-502b-4a0e-93f2-83cf299467e3"><ix:nonFraction unitRef="shares" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzMyLTAtMS0xLTk3NjgyL3RleHRyZWdpb246NWZiODJhYWExMjAyNDJjMWFmM2I0MGE2NDA1ZmFmYjZfOTQ_b5ed4614-20d9-4d08-b5fb-a70b47d986ae">zero</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding as of March&#160;31, 2022 and 2021, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzMyLTEtMS0xLTEwMTY3Mg_222efae1-bdeb-4a3e-a978-a8d6b218d47c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzMyLTMtMS0xLTEwMTY4MA_776deadb-8ca3-482f-acdc-1c35c39307aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Class A and Class B common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="3" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM2LTAtMS0xLTQ5MDk0L3RleHRyZWdpb246YzkzMGM2OWNmYjIyNDM0ODlkMWU1MTU3MWYzODI4MzdfMjkxMzcwNTgxMzY1ODQ_07d4f461-b1d6-462d-9399-e12775f6d47f"><ix:nonFraction unitRef="usdPerShare" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="3" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM2LTAtMS0xLTQ5MDk0L3RleHRyZWdpb246YzkzMGM2OWNmYjIyNDM0ODlkMWU1MTU3MWYzODI4MzdfMjkxMzcwNTgxMzY1ODQ_2e483ca5-e445-48b7-9a84-0fef83e965ef">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM2LTAtMS0xLTQ5MDk0L3RleHRyZWdpb246YzkzMGM2OWNmYjIyNDM0ODlkMWU1MTU3MWYzODI4MzdfMjkxMzcwNTgxMzY2ODE_2ac44ee8-ab6e-4cc1-86f3-04ba751aa2c1">1,500,000</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM2LTAtMS0xLTQ5MDk0L3RleHRyZWdpb246YzkzMGM2OWNmYjIyNDM0ODlkMWU1MTU3MWYzODI4MzdfMjkxMzcwNTgxMzY2Njk_3ad369e3-3408-44dc-9e91-a0a1549e9eac">198,000</ix:nonFraction> shares authorized as of March&#160;31, 2022 and 2021, respectively; <ix:nonFraction unitRef="shares" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM2LTAtMS0xLTQ5MDk0L3RleHRyZWdpb246YzkzMGM2OWNmYjIyNDM0ODlkMWU1MTU3MWYzODI4MzdfMjkxMzcwNTgxMzY1OTc_276ea81b-c88b-49c4-9791-0f950a83d120"><ix:nonFraction unitRef="shares" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM2LTAtMS0xLTQ5MDk0L3RleHRyZWdpb246YzkzMGM2OWNmYjIyNDM0ODlkMWU1MTU3MWYzODI4MzdfMjkxMzcwNTgxMzY1OTc_83bda431-8992-4a67-babd-6054061240e3">192,398</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM2LTAtMS0xLTQ5MDk0L3RleHRyZWdpb246YzkzMGM2OWNmYjIyNDM0ODlkMWU1MTU3MWYzODI4MzdfMjkxMzcwNTgxMzY2MDE_91988f95-96d5-4bee-813b-09a8c9d46d34"><ix:nonFraction unitRef="shares" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM2LTAtMS0xLTQ5MDk0L3RleHRyZWdpb246YzkzMGM2OWNmYjIyNDM0ODlkMWU1MTU3MWYzODI4MzdfMjkxMzcwNTgxMzY2MDE_e201dc84-c88e-4a10-8c18-2324b17a30e3">82,910</ix:nonFraction></ix:nonFraction> shares issued and outstanding as of March&#160;31, 2022 and 2021, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM2LTMtMS0xLTQ3OTky_ecc4674b-033f-4abb-96b4-6d989adbb7ff">192</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM2LTUtMS0xLTQ3OTky_f2064d55-d03b-4bdf-b02b-764e9fef5db0">83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM3LTMtMS0xLTQ3OTky_4372c10b-780a-4cbe-a24a-27c087b0c509">702,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM3LTUtMS0xLTQ3OTky_cfa20e71-327d-4ce4-82c4-64e5b1379338">30,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM4LTMtMS0xLTQ3OTky_f24322b9-f04c-468b-bdca-20a34e286511">15,294</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM4LTUtMS0xLTQ3OTky_0fcf8dc9-a96f-453e-abd1-7dc202542843">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM5LTMtMS0xLTQ3OTky_2b3cf571-426b-4349-8e6f-04e77ea8955e">191,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM5LTUtMS0xLTQ3OTky_31ff8a74-179b-4852-b516-6fc67d7a6fe3">36,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total stockholders' equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzQwLTMtMS0xLTQ3OTky_64888a21-600c-43a2-8bba-f6f7cda6eede">878,594</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzQwLTUtMS0xLTQ3OTky_dbcaf141-8db9-4bb7-bdf7-b06f800674d9">66,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total liabilities, redeemable convertible preferred stock, and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzQxLTMtMS0xLTQ3OTky_814d660d-c1b2-4c19-b3c4-3a0061332fad">991,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzQxLTUtMS0xLTQ3OTky_f61ebbdd-6a7f-492c-bd51-0a1fe2c8ee2e">251,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><div id="i6c4404140edb48938ba4e30b290c9ef9_172"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except per share data)</span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzItMS0xLTEtNDgyODY_8e3cf32b-e178-46ed-ba6c-eefe3816f9eb">343,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzItMy0xLTEtNDgyODY_95b08759-6d95-4aa2-b889-482375077d14">206,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzItNS0xLTEtNDgyODY_504c6895-30ae-4a62-a70e-d2d267b2c1c2">116,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzMtMS0xLTEtNDgyODY_8039636a-5e9e-48f1-be55-9a844eb0ae07">39,787</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzMtMy0xLTEtNDgyODY_2569672a-5004-43b1-87b0-fd096b3a5c56">31,196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzMtNS0xLTEtNDgyODY_808dbd05-e7e2-4d9a-933a-5417df554bb9">14,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzQtMS0xLTEtNDgyODY_4ca14627-bd8f-48bf-919a-00e11b22ae7e">303,761</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzQtMy0xLTEtNDgyODY_2a68ee33-74f0-4cdf-8885-48923ae017da">175,701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzQtNS0xLTEtNDgyODY_b9503188-71e3-4fba-91b7-2667271d1403">101,488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzYtMS0xLTEtNDgyODY_c27abbaf-63d6-440d-958d-5472d5aabd7a">62,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzYtMy0xLTEtNDgyODY_478cb838-ee2a-4338-a14e-9429ab763bc8">43,873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzYtNS0xLTEtNDgyODY_748aa391-896b-4c2b-825a-998baf333b01">32,435</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sales and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzctMS0xLTEtNDgyODY_9f10e49c-c1b6-4517-a0d0-642f1a313a6a">92,129</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzctMy0xLTEtNDgyODY_c7879bc9-3263-459c-8ad3-44a88f1cef84">62,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzctNS0xLTEtNDgyODY_537c78b3-000d-4cde-8419-032dd00d564e">39,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzgtMS0xLTEtNDgyODY_58787f3f-7779-4248-b33c-03faf482fbe5">35,746</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzgtMy0xLTEtNDgyODY_8b5a6359-d0da-4318-b59d-052a047049fb">16,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzgtNS0xLTEtNDgyODY_117308db-fb76-4cc9-b87e-e4960cec90e4">7,442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzktMS0xLTEtNDgyODY_54099246-d091-4d2e-a1c3-728ae3014f3f">190,225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzktMy0xLTEtNDgyODY_6ca0c1e3-8b2b-4938-a80a-b64d4de80cd5">122,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzktNS0xLTEtNDgyODY_779e1a83-9521-4c36-bd38-222a19736df3">79,325</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzEwLTEtMS0xLTQ4Mjg2_32e11b79-ea8a-49d3-bd24-c1828e0bf969">113,536</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzEwLTMtMS0xLTQ4Mjg2_3c835c4b-7db3-4da8-bc8a-4ff6a4103027">53,303</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzEwLTUtMS0xLTQ4Mjg2_701d61b1-5995-4669-8d8f-14dcf6ed0aa2">22,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzEzLTEtMS0xLTQ4Mjg2_ed7de6ea-7643-47cd-994c-80e2a4fcdd28">469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzEzLTMtMS0xLTQ4Mjg2_338c33e4-08c1-4bfa-9259-9d79253d8973">4,466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzEzLTUtMS0xLTQ4Mjg2_1bee2fb9-1723-4de4-8272-73ba4e57fc36">1,351</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE0LTEtMS0xLTQ4Mjg2_3bfd87d6-5706-4f05-8bb1-53fb70f73bad">114,005</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE0LTMtMS0xLTQ4Mjg2_1b5c71b5-98af-4fbe-a301-a77aa959b8ea">57,769</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE0LTUtMS0xLTQ4Mjg2_b992c643-17e1-40dd-997c-b4b60fbb9c42">23,514</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Provision for (benefit from) income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE1LTEtMS0xLTQ4Mjg2_0228cb6d-44f7-48dc-a817-97d128df7669">40,778</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE1LTMtMS0xLTQ4Mjg2_7b5dff80-1d93-46fd-b531-21b81dae1914">7,559</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE1LTUtMS0xLTQ4Mjg2_009c0a36-65d3-4b51-9923-043d549cdf3c">6,223</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE2LTEtMS0xLTQ4Mjg2_d7eef550-8f30-4270-bede-5c19a5083b78">154,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE2LTMtMS0xLTQ4Mjg2_29c56e15-c251-46b8-bf8e-b65d93b3f006">50,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE2LTUtMS0xLTQ4Mjg2_956cd6a2-9587-43d9-a2bf-b493aba6bac3">29,737</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Undistributed earnings attributable to participating securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE3LTEtMS0xLTQ4Mjg2_10f48a89-c761-4381-9abc-dcb85e898922"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE3LTEtMS0xLTQ4Mjg2_224d14cc-7a6a-4b4c-926c-fe6ad2e7b41f">21,526</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE3LTMtMS0xLTQ4Mjg2_6e7a9abf-ab46-4fd0-950d-62a76b27e2b4"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE3LTMtMS0xLTQ4Mjg2_7a1926a8-bab0-43a5-8f36-9fb774fdd97c">28,654</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE3LTUtMS0xLTQ4Mjg2_52db5df5-79ed-4885-9f99-8a9f30006ac3"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE3LTUtMS0xLTQ4Mjg2_9542465f-fbe0-4d0c-a491-32601fa8b388">18,908</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income attributable to Class A and Class B common stockholders, basic and diluted</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE4LTEtMS0xLTQ4Mjg2_44f13d7b-4828-4724-b340-a14a5646d234"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE4LTEtMS0xLTQ4Mjg2_bcdf6ff6-5829-4f04-bf6e-5f135379249e">133,257</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE4LTMtMS0xLTQ4Mjg2_5bc43ea1-6d54-48a4-b8db-72d05b5c0ff8"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE4LTMtMS0xLTQ4Mjg2_c8979cf3-788f-436c-a102-d54aa214be7a">21,556</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE4LTUtMS0xLTQ4Mjg2_10b75117-d04e-441f-9d95-120b7f12e634"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE4LTUtMS0xLTQ4Mjg2_3f254eab-99b3-4502-977f-584d8b887b78">10,829</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income per share attributable to Class A and Class B common stockholders:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzIwLTEtMS0xLTQ4Mjg2_5597cb29-92b2-45a0-92b1-66731405a28d">0.82</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzIwLTMtMS0xLTQ4Mjg2_50c146fe-45b0-4aaa-8440-07c855147422">0.29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzIwLTUtMS0xLTQ4Mjg2_9fe0bcb9-0696-48dd-a5a0-ff0bb4ca015c">0.16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzIxLTEtMS0xLTQ4Mjg2_8ba40586-8a86-4906-bfaf-7e6a0a3f31a8">0.70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzIxLTMtMS0xLTQ4Mjg2_b6baba44-dad2-48e7-a401-2801da8115bf">0.23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzIxLTUtMS0xLTQ4Mjg2_ce6d1aa3-7d70-422c-8557-f99b01ad3100">0.13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzIzLTEtMS0xLTQ4Mjg2_3a29832c-c9c5-4b0d-b3cb-1ebac6813e2d">163,484</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzIzLTMtMS0xLTQ4Mjg2_70aaee8d-b4b1-4db2-824a-efc055b88cec">74,342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzIzLTUtMS0xLTQ4Mjg2_2ba89be2-4064-4624-92d5-59f8c07363a2">66,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzI0LTEtMS0xLTQ4Mjg2_2358bdac-4f9b-4237-af70-ecb01a9f749d">191,017</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzI0LTMtMS0xLTQ4Mjg2_1dcff520-28d6-422f-8ab0-e5cf63d00e87">95,134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzI0LTUtMS0xLTQ4Mjg2_5f3b3888-90c5-4736-a335-e370e36bb62d">81,710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><div id="i6c4404140edb48938ba4e30b290c9ef9_175"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzUvZnJhZzo1MGU5NTkwMTNlNGU0N2Q5ODNjODlhYWQ5ZjVhMDllNC90YWJsZTpkNmI3M2M1NzE4NDE0Mjk3OTg2ZjVlNjFmZWU5OGQyOC90YWJsZXJhbmdlOmQ2YjczYzU3MTg0MTQyOTc5ODZmNWU2MWZlZTk4ZDI4XzItMS0xLTEtNDgzMzM_5806dc1c-cef6-4f53-a919-9c1023393f20">154,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzUvZnJhZzo1MGU5NTkwMTNlNGU0N2Q5ODNjODlhYWQ5ZjVhMDllNC90YWJsZTpkNmI3M2M1NzE4NDE0Mjk3OTg2ZjVlNjFmZWU5OGQyOC90YWJsZXJhbmdlOmQ2YjczYzU3MTg0MTQyOTc5ODZmNWU2MWZlZTk4ZDI4XzItMy0xLTEtNDgzMzM_ea6e6a3e-86f7-4f00-b26e-5ebfda502a16">50,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzUvZnJhZzo1MGU5NTkwMTNlNGU0N2Q5ODNjODlhYWQ5ZjVhMDllNC90YWJsZTpkNmI3M2M1NzE4NDE0Mjk3OTg2ZjVlNjFmZWU5OGQyOC90YWJsZXJhbmdlOmQ2YjczYzU3MTg0MTQyOTc5ODZmNWU2MWZlZTk4ZDI4XzItNS0xLTEtNDgzMzM_f8d26a16-6285-478d-a194-22287fdfafdc">29,737</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other comprehensive loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Change in unrealized loss on available-for-sale-securities, net of tax of $<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzUvZnJhZzo1MGU5NTkwMTNlNGU0N2Q5ODNjODlhYWQ5ZjVhMDllNC90YWJsZTpkNmI3M2M1NzE4NDE0Mjk3OTg2ZjVlNjFmZWU5OGQyOC90YWJsZXJhbmdlOmQ2YjczYzU3MTg0MTQyOTc5ODZmNWU2MWZlZTk4ZDI4XzQtMC0xLTEtNDkyNzYvdGV4dHJlZ2lvbjowOWZiODEzMGZhNzc0M2ViYmQ1MWVkMjgyMGRjOGY2M18yOTEzNzA1ODEzNjI4Ng_b8341f6e-9610-4801-9176-598753e3ebe3">5,199</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzUvZnJhZzo1MGU5NTkwMTNlNGU0N2Q5ODNjODlhYWQ5ZjVhMDllNC90YWJsZTpkNmI3M2M1NzE4NDE0Mjk3OTg2ZjVlNjFmZWU5OGQyOC90YWJsZXJhbmdlOmQ2YjczYzU3MTg0MTQyOTc5ODZmNWU2MWZlZTk4ZDI4XzQtMC0xLTEtNDkyNzYvdGV4dHJlZ2lvbjowOWZiODEzMGZhNzc0M2ViYmQ1MWVkMjgyMGRjOGY2M18yOTEzNzA1ODEzNjI5MQ_88939e1c-f170-42c1-9eb8-d31d16f2d862">0</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzUvZnJhZzo1MGU5NTkwMTNlNGU0N2Q5ODNjODlhYWQ5ZjVhMDllNC90YWJsZTpkNmI3M2M1NzE4NDE0Mjk3OTg2ZjVlNjFmZWU5OGQyOC90YWJsZXJhbmdlOmQ2YjczYzU3MTg0MTQyOTc5ODZmNWU2MWZlZTk4ZDI4XzQtMC0xLTEtNDkyNzYvdGV4dHJlZ2lvbjowOWZiODEzMGZhNzc0M2ViYmQ1MWVkMjgyMGRjOGY2M18yOTEzNzA1ODEzNjI5Ng_abea02f4-9655-41c5-880c-022d5102ea0f">0</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzUvZnJhZzo1MGU5NTkwMTNlNGU0N2Q5ODNjODlhYWQ5ZjVhMDllNC90YWJsZTpkNmI3M2M1NzE4NDE0Mjk3OTg2ZjVlNjFmZWU5OGQyOC90YWJsZXJhbmdlOmQ2YjczYzU3MTg0MTQyOTc5ODZmNWU2MWZlZTk4ZDI4XzQtMS0xLTEtNDgzMzM_6f0ebebc-5c34-4d25-926f-5cc7503feb06">15,273</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzUvZnJhZzo1MGU5NTkwMTNlNGU0N2Q5ODNjODlhYWQ5ZjVhMDllNC90YWJsZTpkNmI3M2M1NzE4NDE0Mjk3OTg2ZjVlNjFmZWU5OGQyOC90YWJsZXJhbmdlOmQ2YjczYzU3MTg0MTQyOTc5ODZmNWU2MWZlZTk4ZDI4XzQtMy0xLTEtNDgzMzM_991548c8-d502-4a9d-b56c-915d539bcdb8">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzUvZnJhZzo1MGU5NTkwMTNlNGU0N2Q5ODNjODlhYWQ5ZjVhMDllNC90YWJsZTpkNmI3M2M1NzE4NDE0Mjk3OTg2ZjVlNjFmZWU5OGQyOC90YWJsZXJhbmdlOmQ2YjczYzU3MTg0MTQyOTc5ODZmNWU2MWZlZTk4ZDI4XzQtNS0xLTEtNDgzMzM_e3234d14-a922-4842-a7ed-1681510c7ca2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzUvZnJhZzo1MGU5NTkwMTNlNGU0N2Q5ODNjODlhYWQ5ZjVhMDllNC90YWJsZTpkNmI3M2M1NzE4NDE0Mjk3OTg2ZjVlNjFmZWU5OGQyOC90YWJsZXJhbmdlOmQ2YjczYzU3MTg0MTQyOTc5ODZmNWU2MWZlZTk4ZDI4XzUtMS0xLTEtNDgzMzM_2b87aaa9-b57b-44dd-8077-5df285d3d855">15,273</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzUvZnJhZzo1MGU5NTkwMTNlNGU0N2Q5ODNjODlhYWQ5ZjVhMDllNC90YWJsZTpkNmI3M2M1NzE4NDE0Mjk3OTg2ZjVlNjFmZWU5OGQyOC90YWJsZXJhbmdlOmQ2YjczYzU3MTg0MTQyOTc5ODZmNWU2MWZlZTk4ZDI4XzUtMy0xLTEtNDgzMzM_35e9ff67-9a21-40de-bf50-a1b184bf8dca">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzUvZnJhZzo1MGU5NTkwMTNlNGU0N2Q5ODNjODlhYWQ5ZjVhMDllNC90YWJsZTpkNmI3M2M1NzE4NDE0Mjk3OTg2ZjVlNjFmZWU5OGQyOC90YWJsZXJhbmdlOmQ2YjczYzU3MTg0MTQyOTc5ODZmNWU2MWZlZTk4ZDI4XzUtNS0xLTEtNDgzMzM_1b059926-7a84-42fe-b966-c27c333e60a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Comprehensive income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzUvZnJhZzo1MGU5NTkwMTNlNGU0N2Q5ODNjODlhYWQ5ZjVhMDllNC90YWJsZTpkNmI3M2M1NzE4NDE0Mjk3OTg2ZjVlNjFmZWU5OGQyOC90YWJsZXJhbmdlOmQ2YjczYzU3MTg0MTQyOTc5ODZmNWU2MWZlZTk4ZDI4XzYtMS0xLTEtNDgzMzM_5f30165c-ebea-457c-a95e-3400f77e9b09">139,510</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzUvZnJhZzo1MGU5NTkwMTNlNGU0N2Q5ODNjODlhYWQ5ZjVhMDllNC90YWJsZTpkNmI3M2M1NzE4NDE0Mjk3OTg2ZjVlNjFmZWU5OGQyOC90YWJsZXJhbmdlOmQ2YjczYzU3MTg0MTQyOTc5ODZmNWU2MWZlZTk4ZDI4XzYtMy0xLTEtNDgzMzM_4c043c6b-c18f-4ff2-8ca0-b4f99c7c0a85">50,189</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzUvZnJhZzo1MGU5NTkwMTNlNGU0N2Q5ODNjODlhYWQ5ZjVhMDllNC90YWJsZTpkNmI3M2M1NzE4NDE0Mjk3OTg2ZjVlNjFmZWU5OGQyOC90YWJsZXJhbmdlOmQ2YjczYzU3MTg0MTQyOTc5ODZmNWU2MWZlZTk4ZDI4XzYtNS0xLTEtNDgzMzM_32a5bfe6-b065-431e-af0b-b012bdba3a2e">29,737</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><div id="i6c4404140edb48938ba4e30b290c9ef9_178"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.172%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.800%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.800%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.800%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.800%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.315%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.327%"></td><td style="width:0.1%"></td></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Redeemable Convertible<br/>Preferred Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Additional Paid-In<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Retained Earnings (Accumulated Deficit)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stockholders' Equity (Deficit)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance as of March&#160;31, 2019 </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i27e150c7cdf34baa99d770cedfcc88a0_I20190331" decimals="-3" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzItMS0xLTEtNDg3NzU_a9758eff-16d8-4eb1-919f-9a0e5f4fe11f">76,249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i27e150c7cdf34baa99d770cedfcc88a0_I20190331" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzItMy0xLTEtNDg3NzU_996ef013-d17a-476b-9d55-4431ef16629b">81,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i1d3a91d95f5840f4be4445b0e6c7ad9f_I20190331" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzItNi0xLTEtNDg3NzU_26c078c1-3bbc-4583-9f8c-2c700b81a394">65,526</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1d3a91d95f5840f4be4445b0e6c7ad9f_I20190331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzItOC0xLTEtNDg3NzU_2475dc2b-69bc-4290-adf7-3e185f271780">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id85d3aef9cef4f97829dac4fc1a6b84f_I20190331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzItMTAtMS0xLTQ4Nzc1_4de5537c-5064-4fdb-a239-f7ded02b04f2">10,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifb57040c2a0e4f15b5f7abbbebc4adf5_I20190331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzItMTItMS0xLTQ4Nzc1_71fca18e-38ed-4c84-a59f-3da3b2a92c84">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ic86efb5739b64e849f20b652dd30ebcd_I20190331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzItMTQtMS0xLTQ4Nzc1_c2b16bb1-6a00-4120-929e-0a272ec43ad2">43,623</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i27e150c7cdf34baa99d770cedfcc88a0_I20190331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzItMTYtMS0xLTQ4Nzc1_8737cf2a-900e-426a-82d5-d7b0724eda10">32,935</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i30af202026344ba188b8654a2c38183c_D20190401-20200331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzMtMTAtMS0xLTQ4Nzc1_c8222f8b-b6b6-4c08-a54a-a51d27fb7eda">2,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzMtMTYtMS0xLTQ4Nzc1_88577753-4eb4-42c8-a6f6-2a5da86f4e18">2,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ibc604bd726fc487cb11cf5132d59f830_D20190401-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzQtNi0xLTEtNDg3NzU_d1d41fde-09d1-439d-84ed-b73981f5f477">3,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibc604bd726fc487cb11cf5132d59f830_D20190401-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzQtOC0xLTEtNDg3NzU_7662380f-d4ee-4d4a-b4f6-289a1bcb01d1">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i30af202026344ba188b8654a2c38183c_D20190401-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzQtMTAtMS0xLTQ4Nzc1_3494cc77-db1b-4a2f-8910-92bf31c0b587">1,691</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzQtMTYtMS0xLTQ4Nzc1_8a2e3d16-0789-42e3-9100-fd317fc20e95">1,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Common stock warrant expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i30af202026344ba188b8654a2c38183c_D20190401-20200331" decimals="-3" name="docs:APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzYtMTAtMS0xLTQ4Nzc1_3523638a-996f-4ae2-b4bb-41d747b62819">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="docs:APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzYtMTYtMS0xLTQ4Nzc1_acbf062f-d2d2-4dfc-8436-2160e0da4e45">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exercise of Series B redeemable convertible preferred stock warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="docs:TemporaryEquityExercisesOfWarrantsShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzktMS0xLTEtODgyMDQ_95452703-0466-4d95-95eb-23ac171a86c0">38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="docs:TemporaryEquityExercisesOfWarrantsAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzktMy0xLTEtODgyMDQ_fb5884f9-a33a-4055-be6f-acf6e81cd6f4">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i30af202026344ba188b8654a2c38183c_D20190401-20200331" decimals="-3" name="docs:AdjustmentsToAdditionalPaidInCapitalExerciseOfWarrants" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzktMTAtMS0xLTg4MjA0_517c5703-589f-4b39-ae6a-7332ad398e3f">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="docs:AdjustmentsToAdditionalPaidInCapitalExerciseOfWarrants" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzktMTYtMS0xLTg4MjA0_4921521b-b6db-44a5-b92f-29cb3d3f82fd">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibf878bf045d24512bd9e3292775e7161_D20190401-20200331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzgtMTQtMS0xLTQ4Nzc1_eb2592d2-ba0f-45b0-aa9a-100c4508373b">29,737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzgtMTYtMS0xLTQ4Nzc1_f0ce5488-6dc6-4aad-bc3f-07f99b07190f">29,737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance as of March&#160;31, 2020</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i7a15f5b31d42419aa50ffb53e76f3705_I20200331" decimals="-3" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzktMS0xLTEtNDg3NzU_6e1ba95d-851a-4280-b01b-a4ea93c1a824">76,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7a15f5b31d42419aa50ffb53e76f3705_I20200331" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzktMy0xLTEtNDg3NzU_7e8f830f-a75c-40a2-8401-ba6c75a8e3ac">81,458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i414b68a2b4f24b3baf2fb76d57cbbea0_I20200331" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzktNi0xLTEtNDg3NzU_6a7daadc-ed53-4d79-a442-3d9be3e5dad5">68,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i414b68a2b4f24b3baf2fb76d57cbbea0_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzktOC0xLTEtNDg3NzU_97876703-b240-4855-a63c-aad0f4bd1547">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i061b791ef37044a8a87103ab1684fc04_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzktMTAtMS0xLTQ4Nzc1_e98d37cc-2d16-44f5-85c9-badafdc27ed9">14,954</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibcefd2d03bd84fb9ae242a16f4ac44ee_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzktMTItMS0xLTQ4Nzc1_9386b74a-61b0-4be0-8c02-dee1d6047ac5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="idb3c1cc4265d4d458fbb645f03094085_I20200331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzktMTQtMS0xLTQ4Nzc1_6b07cde9-1034-48fd-92fc-14e890d9530e">13,886</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7a15f5b31d42419aa50ffb53e76f3705_I20200331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzktMTYtMS0xLTQ4Nzc1_1b004bf8-347d-42b9-8ee2-27bf7d070af0">1,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i03b18f19eda34333b76bc6814b9d6346_D20200401-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzEwLTEwLTEtMS00ODc3NQ_e34035cb-6e9c-4611-b179-eeda590adcee">7,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzEwLTE2LTEtMS00ODc3NQ_d232af38-d149-44cf-a8c0-e7bfda0742c9">7,398</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ibd16228ea691414ea7027a3ca0ceb2b0_D20200401-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzExLTYtMS0xLTQ4Nzc1_dfc3848d-c6cc-4b57-8a1e-c85d4122c3e9">13,890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibd16228ea691414ea7027a3ca0ceb2b0_D20200401-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzExLTgtMS0xLTQ4Nzc1_6ce0ac4c-12f7-4607-ba70-3757d237e6cd">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i03b18f19eda34333b76bc6814b9d6346_D20200401-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzExLTEwLTEtMS00ODc3NQ_dc9fb32a-f319-4390-943d-6ef5e0ee8acf">8,883</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzExLTE2LTEtMS00ODc3NQ_f9f7f0ca-95b1-43a2-9a39-b332cbd0b984">8,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Issuance of common stock in exchange for services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ibd16228ea691414ea7027a3ca0ceb2b0_D20200401-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzEyLTYtMS0xLTQ4Nzc1_7692e7f9-b1a9-48e2-8095-44790e2eab42">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i03b18f19eda34333b76bc6814b9d6346_D20200401-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzEyLTEwLTEtMS00ODc3NQ_2a279a94-11fc-4255-97e3-a34e31000276">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueIssuedForServices" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzEyLTE2LTEtMS00ODc3NQ_9c741c3e-ff91-443f-b040-3371e41a87eb">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Repurchase and retirement of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="ibd16228ea691414ea7027a3ca0ceb2b0_D20200401-20210331" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzEzLTYtMS0xLTQ4Nzc1_61525ee3-4bd4-4693-b696-8749237d34cd">258</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i03b18f19eda34333b76bc6814b9d6346_D20200401-20210331" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzEzLTEwLTEtMS00ODc3NQ_e5a8b7d6-dc91-41dd-8b09-67c0b49e2264">2,022</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzEzLTE2LTEtMS00ODc3NQ_31da205d-89a0-432e-a0f9-7785c7bfa666">2,022</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Common stock warrant expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i03b18f19eda34333b76bc6814b9d6346_D20200401-20210331" decimals="-3" name="docs:APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzE2LTEwLTEtMS04ODI2OA_2466005f-566d-4c72-8be5-6aa549e61fc3">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="docs:APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzE2LTE2LTEtMS04ODI2OA_df6bcfcc-f479-4494-b8f7-ba9c1b1d1e68">49</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc4d8e5790824c048cce3a6bf007c91d_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzE3LTEyLTEtMS04ODI2OA_ffc3ea6c-da79-4afa-bfd1-49f83c2ae399">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzE3LTE2LTEtMS04ODI2OA_7c3ea7b6-8d1e-4617-8013-2d2884295cc3">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Issuance of common stock in connection with an acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ibd16228ea691414ea7027a3ca0ceb2b0_D20200401-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzE4LTYtMS0xLTg4MjY4_cd01c7e8-cb1f-436c-b5d3-573df6cf129e">690</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibd16228ea691414ea7027a3ca0ceb2b0_D20200401-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzE4LTgtMS0xLTg4MjY4_615f1dec-18d5-4cc8-857e-6b7dbb5436c5">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i03b18f19eda34333b76bc6814b9d6346_D20200401-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzE4LTEwLTEtMS04ODI2OA_73919cb5-c616-410e-b355-bb7ac2e6a214">1,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzE4LTE2LTEtMS04ODI2OA_cfb66182-5231-42e2-a63a-962152c31136">1,062</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i489aff50eced4b4e8409601ad948730d_D20200401-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzE0LTE0LTEtMS00ODc3NQ_3e25cff4-0df7-41c5-945b-141d7a3ef6b1">50,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzE0LTE2LTEtMS00ODc3NQ_1d95e4a0-bec1-43f6-a4df-a7b6bd599716">50,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance as of March&#160;31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzE1LTEtMS0xLTQ4Nzc1_26f781d9-1ff0-49fe-a344-7087f54f3697">76,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzE1LTMtMS0xLTQ4Nzc1_fcb931ca-a9cc-4936-a77c-fc3a46b2b469">81,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ic1553167afc64f24beca75d407d45583_I20210331" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzE1LTYtMS0xLTQ4Nzc1_aa2339ec-4db9-4706-a46e-05c4ba90b6bf">82,910</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic1553167afc64f24beca75d407d45583_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzE1LTgtMS0xLTQ4Nzc1_6f4c7b3d-4b16-4a05-8563-f23ea5f5ad41">83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i07067e700dd84b60a562fa298de61bc9_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzE1LTEwLTEtMS00ODc3NQ_72f2a18f-59d8-4810-9d4e-5fe1ff402347">30,357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4f5b7e290962451dbcf06e35be299e6a_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzE1LTEyLTEtMS00ODc3NQ_6e21ac6c-a348-4c1b-9366-42fd4aeedb4b">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iebb484f77246492db54ce7ef015c7dad_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzE1LTE0LTEtMS00ODc3NQ_c99bf096-a040-490b-b867-6fe0d3af3bb2">36,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzE1LTE2LTEtMS00ODc3NQ_c21c0599-78be-4dc4-a5e9-9f8fcd106c3c">66,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (Continued)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div></div><div style="margin-top:15pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.376%"><tr><td style="width:1.0%"></td><td style="width:24.972%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.240%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.470%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.470%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.470%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.240%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.478%"></td><td style="width:0.1%"></td></tr><tr style="height:29pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Redeemable Convertible<br/>Preferred Stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Common Stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Additional Paid-In<br/>Capital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Retained Earnings (Accumulated Deficit)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" rowspan="2" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stockholders' Equity (Deficit)</span></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance as of March&#160;31, 2021 </span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzAtMS0xLTEtOTc5MzY_26f781d9-1ff0-49fe-a344-7087f54f3697">76,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzAtMy0xLTEtOTc5MzY_fcb931ca-a9cc-4936-a77c-fc3a46b2b469">81,458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ic1553167afc64f24beca75d407d45583_I20210331" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzAtNi0xLTEtOTc5MzY_aa2339ec-4db9-4706-a46e-05c4ba90b6bf">82,910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ic1553167afc64f24beca75d407d45583_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzAtOC0xLTEtOTc5MzY_6f4c7b3d-4b16-4a05-8563-f23ea5f5ad41">83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i07067e700dd84b60a562fa298de61bc9_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzAtMTAtMS0xLTk3OTM2_72f2a18f-59d8-4810-9d4e-5fe1ff402347">30,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4f5b7e290962451dbcf06e35be299e6a_I20210331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzAtMTItMS0xLTk3OTM2_6e21ac6c-a348-4c1b-9366-42fd4aeedb4b">21</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iebb484f77246492db54ce7ef015c7dad_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzAtMTQtMS0xLTk3OTM2_c99bf096-a040-490b-b867-6fe0d3af3bb2">36,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzAtMTYtMS0xLTk3OTM2_c21c0599-78be-4dc4-a5e9-9f8fcd106c3c">66,743</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39670721aeba48af82262e3df7572d7b_D20210401-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzAtMTAtMS0xLTk3OTA2_8cee6d1c-7235-4617-9b94-97cc609d540b">29,341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzAtMTYtMS0xLTk3OTA2_8b29bc19-dbcd-49ee-82ca-7fc50dcbe6b3">29,341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exercise of stock options </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i200ee5197c714141a7a48e99357f4b5e_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzEtNi0xLTEtOTc5MDY_9a5f1f4e-9f66-45fe-ba72-862fcaafe811">10,823</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i200ee5197c714141a7a48e99357f4b5e_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzEtOC0xLTEtOTc5MDY_56215e71-7db6-4c0e-b381-2ca46893c9b2">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39670721aeba48af82262e3df7572d7b_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzEtMTAtMS0xLTk3OTA2_ccc80d54-1409-40fc-a0ff-33ab1f60ffd8">12,601</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzEtMTYtMS0xLTk3OTA2_c6951aba-71f7-4cb7-9a56-aef2444807d7">12,612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Vesting of restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i200ee5197c714141a7a48e99357f4b5e_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzUtNi0xLTEtOTgwNzg_e1a95fba-1a5d-45e2-9e99-901525f9aaef">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Tax withholding on shares under stock-based compensation awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i39670721aeba48af82262e3df7572d7b_D20210401-20220331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzYtMTAtMS0xLTk4MDc4_6487503b-e3b0-48df-9c0b-b9d773ca747f">817</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzYtMTYtMS0xLTk4MDc4_c4b1c476-826a-4183-b2cc-d693664d7768">817</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Repurchase and retirement of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="i200ee5197c714141a7a48e99357f4b5e_D20210401-20220331" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzQtNi0xLTEtOTc5MDY_ad9b62f2-48b5-483c-993b-bf4f29cfb39a">181</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i39670721aeba48af82262e3df7572d7b_D20210401-20220331" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzQtMTAtMS0xLTk3OTA2_69f5f364-b536-4653-8e97-c88b8738126c">2,698</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:StockRepurchasedAndRetiredDuringPeriodValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzQtMTYtMS0xLTk3OTA2_486c1463-9798-4108-9137-717ad021622d">2,698</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Common stock warrant expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39670721aeba48af82262e3df7572d7b_D20210401-20220331" decimals="-3" name="docs:APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzUtMTAtMS0xLTk3OTA2_f3142c48-4731-4dc1-ad7f-48a3912d910f">2,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="docs:APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzUtMTYtMS0xLTk3OTA2_ddb14139-fdaf-41cf-acaf-b8bca99036d8">2,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ia0bfa42b46ea49d485aa30692392a354_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzYtMTItMS0xLTk3OTA2_721467db-07f4-413e-8c16-60b604b70670">15,273</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzYtMTYtMS0xLTk3OTA2_fa901e1c-f21c-41c0-a248-b62924ada149">15,273</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Conversion of redeemable convertible preferred stock upon initial public offering</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="docs:TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzctMS0xLTEtOTc5MDY_25e73c6d-f9f8-4a51-b0fb-32610a1f681d">76,287</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" sign="-" name="docs:TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzctMy0xLTEtOTc5MDY_b45db22e-9316-483d-a9d5-f66a08cdf3cc">81,458</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i200ee5197c714141a7a48e99357f4b5e_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzctNi0xLTEtOTc5MDY_b987e271-c7db-4247-aea8-66b64acd9e2b">76,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i200ee5197c714141a7a48e99357f4b5e_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzctOC0xLTEtOTc5MDY_f5aba060-36e1-4f0f-b518-9fa6eaa79b77">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39670721aeba48af82262e3df7572d7b_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzctMTAtMS0xLTk3OTA2_e95106ea-d69d-4371-8d36-a378a063ed88">81,382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzctMTYtMS0xLTk3OTA2_6dda6f36-7200-4078-8031-c16abdf16eaf">81,458</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Issuance of common stock upon initial public offering, net of underwriting discounts and commissions and deferred offering costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i200ee5197c714141a7a48e99357f4b5e_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzgtNi0xLTEtOTc5MDY_79673fea-9506-433d-b56d-d5febcfde4c5">22,506</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i200ee5197c714141a7a48e99357f4b5e_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzgtOC0xLTEtOTc5MDY_b720f398-6f49-4c36-bc3a-1c7f0c3845ca">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39670721aeba48af82262e3df7572d7b_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzgtMTAtMS0xLTk3OTA2_f231fae7-9dc2-492b-ae71-9adc9b3925ae">548,430</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzgtMTYtMS0xLTk3OTA2_36cb60c6-540d-41aa-bd2d-8f8cd78a3492">548,452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Issuance of common stock in connection with the employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i200ee5197c714141a7a48e99357f4b5e_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzEyLTYtMS0xLTEwMTMyOA_a15662b1-61b8-4a68-bd40-de0c3fbae7bc">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i39670721aeba48af82262e3df7572d7b_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzEyLTEwLTEtMS0xMDEzMjg_6afc00c9-7932-4558-a4c9-b7af4d606e0c">1,395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzEyLTE2LTEtMS0xMDEzMjg_d85ab406-5242-4a07-993b-7e1deede1b7a">1,395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icd3cf31e65de4bbca6609f7743bb7da5_D20210401-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzktMTQtMS0xLTk3OTA2_1796e283-91b2-42fa-91aa-1b17e2612fb4">154,783</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzktMTYtMS0xLTk3OTA2_3bbe3029-f4ff-44ff-b0bf-72f6151e67f7">154,783</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance as of March&#160;31, 2022</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzEwLTEtMS0xLTk3OTA2_d38fe96b-ce0b-4a2a-906f-74844eb31597">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzEwLTMtMS0xLTk3OTA2_88c5356c-c08e-46cc-8d6b-f727b327b973">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i708549cf187748d19458fd6a1acc45a2_I20220331" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzEwLTYtMS0xLTk3OTA2_f3593615-c36d-4966-958b-331426c46ecb">192,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i708549cf187748d19458fd6a1acc45a2_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzEwLTgtMS0xLTk3OTA2_70b09ec3-02d5-4215-839a-c49d34cdee0d">192</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i07f4d237a7d949c6a32f7dc1d04bf88e_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzEwLTEwLTEtMS05NzkwNg_d04b31e6-8d3b-4dde-85f0-0391636d3440">702,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i00ffd06e9957435f8a032e13e5872afd_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzEwLTEyLTEtMS05NzkwNg_078ee5b2-10d5-46cf-b596-dad0cad2166e">15,294</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id9e2edf8663840efbaeced0815c8461f_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzEwLTE0LTEtMS05NzkwNg_0916142d-b139-44db-a726-83159aaeb5b7">191,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzEwLTE2LTEtMS05NzkwNg_cfb88b5f-e4c2-419a-adff-54a4caa0c8eb">878,594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.  </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><div id="i6c4404140edb48938ba4e30b290c9ef9_181"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.698%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Cash flows from operating activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzMtOS0xLTEtNDg4NDc_658009bb-7424-481b-a2a0-13669c6d1888">154,783</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzMtMTMtMS0xLTQ4ODU0_dff753f2-0114-447d-ab06-9c606bea9fad">50,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzMtMTUtMS0xLTQ4ODYx_695b77f3-481a-4a21-bcf7-893c3622c8ac">29,737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Adjustments to reconcile net income to net cash provided by operating activities: </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzUtOS0xLTEtNDg4NDc_cf2c6fd7-4374-4c95-b499-4a71002602b7">5,040</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzUtMTMtMS0xLTQ4ODU0_3f69c350-681a-4556-bfe3-1f7b093ed2f5">3,702</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzUtMTUtMS0xLTQ4ODYx_4e652404-d96c-4b92-8f01-a09144c6bcce">900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzYtOS0xLTEtNDg4NDc_7345076e-35f0-40b0-a4ee-f9fbf79323bf">41,247</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzYtMTMtMS0xLTQ4ODU0_146b058a-62b8-4f95-bfb2-a5d3d6396426">4,987</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzYtMTUtMS0xLTQ4ODYx_2068cbbe-438a-4cf5-939e-85095330f9d5">7,099</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation, net of amounts capitalized</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzctOS0xLTEtNDg4NDc_e540e839-956f-493c-ae2b-063068df5fc0">31,442</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzctMTMtMS0xLTQ4ODU0_82643bb9-d665-40bb-a27c-e7101ddcb30b">7,252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzctMTUtMS0xLTQ4ODYx_7b676013-2254-43b8-9aac-c8917f14826d">2,353</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Non-cash lease expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzktOS0xLTEtNDg4NDc_6d00ce50-850e-4f35-b68e-8585b217d0a7">1,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzktMTMtMS0xLTQ4ODU0_09bd38e7-45e8-4c87-acbe-2802d5fd192c">2,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzktMTUtMS0xLTQ4ODYx_31f567b9-4ee8-483a-ad51-f6d3482a1ef5">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amortization of premium (accretion of discount) on marketable securities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzExLTktMS0xLTQ4ODQ3_f861445e-3296-4d34-8bb3-175cd29c149f">4,332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzExLTEzLTEtMS00ODg1NA_d24b4c57-185a-456a-a67e-4e4538f71f3f">197</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzExLTE1LTEtMS00ODg2MQ_52288e6b-30e3-4d84-9847-4d30909ab336">441</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Loss on sale of marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzExLTEtMS0xLTExNzA4OQ_914f2b60-d099-4baf-8fe0-c9c9686a5c48">1,231</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzExLTMtMS0xLTExNzA4OQ_8e18b169-0153-4c7c-8f44-c1183ba1fbd5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzExLTUtMS0xLTExNzA4OQ_e0744f52-2424-48dc-bffa-d3c04a05b7e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amortization of deferred contract costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:CapitalizedContractCostAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzE0LTktMS0xLTQ4ODQ3_e2d81584-ea43-40d6-a544-330d7a8e435c">9,755</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:CapitalizedContractCostAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzE0LTEzLTEtMS00ODg1NA_b8016bbc-977a-498a-bf16-df82a1004db3">6,883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:CapitalizedContractCostAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzE0LTE1LTEtMS00ODg2MQ_e0c0e279-a556-46b2-99e6-84bba300f19f">5,070</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Gain on sale of business</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzE0LTEtMS0xLTExNzIzMQ_38a89b4d-a467-4f79-9a33-bc6e7414457e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzE0LTMtMS0xLTExNzIzMQ_e91f8c06-687b-44ae-8289-48d72c0860e4">4,698</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:GainLossOnSaleOfBusiness" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzE0LTUtMS0xLTExNzIzMQ_c85aafdd-8147-4b48-b558-66b67ab07fc2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzE1LTEtMS0xLTk4MTI1_fa5fa3de-3d4a-4f25-83a0-9d5cf4a3e8ad">410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzE1LTMtMS0xLTk4MTI1_b1cc3baf-2161-4308-b7e2-abd36c47f434">403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzE1LTUtMS0xLTk4MTI1_4b892ce0-d15c-4ece-b649-45d513181b21">52</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Changes in operating assets and liabilities, net of effect of acquisition:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzE2LTktMS0xLTQ4ODQ3_86a84beb-52ee-4dc5-88fe-54f1799040e4">31,017</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzE2LTEzLTEtMS00ODg1NA_a064db5f-10bd-4730-b38d-da8fcd7d7a69">20,452</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzE2LTE1LTEtMS00ODg2MQ_dd90d47d-9c54-45a9-8dbc-641a51d3d5f2">12,036</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzE3LTktMS0xLTQ4ODQ3_eaae7092-f665-4b32-8f63-3f695a314225">9,089</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzE3LTEzLTEtMS00ODg1NA_d56dd921-224f-42fe-ba18-21f1b8040262">1,833</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzE3LTE1LTEtMS00ODg2MQ_ffcde728-d5b2-4b8c-87a1-9163b9c2a1f7">3,040</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred contract costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="docs:IncreaseDecreaseInCapitalizedContractCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzE5LTktMS0xLTQ4ODQ3_db8937b5-cea5-4a69-b9f3-612daf6f572e">9,609</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="docs:IncreaseDecreaseInCapitalizedContractCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzE5LTEzLTEtMS00ODg1NA_fe938286-3a19-48a9-a800-5a685622573f">9,384</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="docs:IncreaseDecreaseInCapitalizedContractCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzE5LTE1LTEtMS00ODg2MQ_fa4c1687-0ebe-4cd6-b217-cb58896f9cf2">5,674</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts payable, accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzIxLTktMS0xLTQ4ODQ3_78b14593-0c8d-4e59-ac6f-d1829d9ccdf0">8,664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzIxLTEzLTEtMS00ODg1NA_ad0a5b8e-3f1c-42c3-8f8b-d66bd2341d2f">7,285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzIxLTE1LTEtMS00ODg2MQ_396485a2-5630-4a16-b198-664b4654337d">5,056</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzIyLTktMS0xLTQ4ODQ3_a74148a0-0e53-4126-8453-c07b768bc650">1,828</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzIyLTEzLTEtMS00ODg1NA_99605252-9351-4a45-a06a-94b0c8ba95f5">38,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzIyLTE1LTEtMS00ODg2MQ_1541168a-1e35-411e-a98a-39bcf1bdfa25">13,318</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzIzLTktMS0xLTQ4ODQ3_b5ee5c78-46ec-406e-8aa7-e21da8c481eb">1,107</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzIzLTEzLTEtMS00ODg1NA_9162142a-7812-4289-99f2-6bd1260f3255">2,583</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzIzLTE1LTEtMS00ODg2MQ_66ab4522-b709-4e46-9ab6-0d9681f0a412">3,893</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzI1LTktMS0xLTQ4ODQ3_616601a9-d14b-484b-8e50-3600bc284efb">126,575</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzI1LTEzLTEtMS00ODg1NA_b789b658-6eeb-458f-9270-5791dcc3e70a">82,973</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzI1LTE1LTEtMS00ODg2MQ_8aab8ff2-3420-453c-a4d3-837457bc3373">26,199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Cash flows from investing activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzI3LTktMS0xLTQ4ODQ3_4c73d306-fd2b-47c8-88a5-aa13e0a1c765">1,912</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzI3LTEzLTEtMS00ODg1NA_f5b6e5e4-871a-4740-8cc4-afc2c463bed7">245</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzI3LTE1LTEtMS00ODg2MQ_2dcbcdde-54a1-4633-afa4-ce4420225bd8">285</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Internal-use software development costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:PaymentsToDevelopSoftware" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzI4LTktMS0xLTQ4ODQ3_df0a9982-d5bb-4f24-8cd9-4413f992b3a9">3,785</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:PaymentsToDevelopSoftware" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzI4LTEzLTEtMS00ODg1NA_20bdcb17-e1b7-4a38-b402-dda2a2b30f70">4,365</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:PaymentsToDevelopSoftware" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzI4LTE1LTEtMS00ODg2MQ_4b87357b-627d-4b6b-911f-71c5647bc713">3,959</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Purchases of marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzI5LTktMS0xLTQ4ODQ3_23227689-c7a2-4776-bae5-c4d0043cbcda">1,317,193</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzI5LTEzLTEtMS00ODg1NA_ea4250af-d0ce-4cb7-8a60-3371fb6558cd">78,880</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzI5LTE1LTEtMS00ODg2MQ_68eef138-983e-404b-8ef3-092e611e8bc3">79,107</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Maturities of marketable securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzMwLTktMS0xLTQ4ODQ3_7a2c34e2-46fd-493a-a092-2cf9b34b1980">47,919</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzMwLTEzLTEtMS00ODg1NA_0eeb0d2a-aa4b-47f2-a6f0-31a538f7a1d0">40,537</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzMwLTE1LTEtMS00ODg2MQ_8f07ecfd-408c-4f93-9dff-c2d0c1b269bf">70,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sales of marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzMwLTktMS0xLTg4NjMz_47114145-0ddc-4d62-9f75-8e9c7b8b505a">633,802</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzMwLTEzLTEtMS04ODY0Mw_94523a88-2c13-4b88-92c8-975ec2820489">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzMwLTE1LTEtMS04ODY1Mw_60d942ca-aa05-47b1-b9a1-39f8af6899e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash paid for acquisition, net of cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzMxLTktMS0xLTQ4ODQ3_01883374-8b15-4c1e-bbd4-50ca595505eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzMxLTEzLTEtMS00ODg1NA_88b2d431-33db-4682-aa03-e1b8b3f59596">31,682</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzMxLTE1LTEtMS00ODg2MQ_dda8865d-8bc9-45cb-8d58-44f2bb29b831">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Proceeds from sale of business</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzMyLTktMS0xLTQ4ODQ3_35cabac8-eed2-4ac3-be3c-5613880ebcad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzMyLTEzLTEtMS00ODg1NA_d389382f-4c68-4771-abdc-5f1503228ad8">4,230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzMyLTE1LTEtMS00ODg2MQ_bed84642-1d3e-46d0-8b82-ff7036c0f640">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzMzLTktMS0xLTQ4ODQ3_15be6637-661b-41c4-a825-63bc87334b6d">595</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzMzLTEzLTEtMS00ODg1NA_d2781204-809f-41d2-933b-214e524f4c5c">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzMzLTE1LTEtMS00ODg2MQ_78a63021-1ee5-4742-a9e9-f64b3bc06295">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM0LTktMS0xLTQ4ODQ3_9d34b737-814f-46bf-9919-4d465a780dce">640,574</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM0LTEzLTEtMS00ODg1NA_d64e39d4-62c7-43ef-ba33-d7c8f67477db">70,417</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM0LTE1LTEtMS00ODg2MQ_30b0d2a7-6f94-4942-b0c1-ead4390bc16e">13,095</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Cash flows from financing activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Proceeds from issuance of common stock upon initial public offering after deducting underwriting discounts and commissions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM1LTEtMS0xLTk4MjE2_0c9bdf42-4bc7-4e9d-ab02-856d36c71f48">553,905</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM1LTMtMS0xLTk4MjE2_0c791f66-15c0-4b34-92f6-c4045cbe6464">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM1LTUtMS0xLTk4MjE2_750c305e-9e46-4d83-98bb-072ca134ca63">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Proceeds from issuance of common stock upon exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM3LTktMS0xLTQ4ODQ3_b909f485-8073-40b9-bda5-9b50531bb66b">12,612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM3LTEzLTEtMS00ODg1NA_942d14a8-b83f-42c8-aac7-faad906d7b24">8,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM3LTE1LTEtMS00ODg2MQ_59026083-0753-4f85-9530-2345f8547d92">1,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Proceeds from issuance of common stock in connection with the employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:ProceedsFromStockPlans" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM2LTEtMS0xLTEwMDEwMQ_c452deaa-d902-4167-9e4c-5fac6cc81b82">1,395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:ProceedsFromStockPlans" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM2LTMtMS0xLTEwMDEwMQ_31d97cf1-a99b-4996-8ac1-08816d6374a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:ProceedsFromStockPlans" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM2LTUtMS0xLTEwMDEwMQ_a6127a8a-3899-454b-a2c1-55ff7d508694">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Taxes paid related to net share settlement of equity awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM2LTEtMS0xLTk4MjA4_783512bb-d41a-4539-ac24-92f034454139">817</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM2LTMtMS0xLTk4MjA4_47d853c0-d42d-4c7b-8686-37ff57d00a64">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM2LTUtMS0xLTk4MjA4_a6c9dfaf-63c2-4e00-ba62-97f2f5dbf144">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM4LTktMS0xLTQ4ODQ3_5354d93b-2954-4f8f-9b43-cebab229253c">2,698</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM4LTEzLTEtMS00ODg1NA_9e1803fa-8c53-4acb-8249-7850beeab714">2,022</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM4LTE1LTEtMS00ODg2MQ_7a80d0e1-c6fd-468c-b34f-cde096b9887a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Payments for deferred offering costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM5LTktMS0xLTQ4ODQ3_12b67684-4235-4870-9597-40e5ebf25a74">3,982</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM5LTEzLTEtMS00ODg1NA_7acf3867-c15a-48dc-884d-af5cfbc7fb23">1,468</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM5LTE1LTEtMS00ODg2MQ_f980626c-8ff4-42fd-9bdf-0e845d3fed59">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Proceeds from exercise of redeemable convertible preferred stock warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:ProceedsFromWarrantExercises" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzQwLTEtMS0xLTk4MTg0_2681a6c8-209b-4669-a366-81450015ec0b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:ProceedsFromWarrantExercises" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzQwLTMtMS0xLTk4MTg0_fa9b218c-b5d7-4763-81c4-964ad2ecf51a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:ProceedsFromWarrantExercises" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzQwLTUtMS0xLTk4MTg0_7b563e53-c288-402a-be8e-b160b9a703d0">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzQwLTktMS0xLTQ4ODQ3_a2c3033c-704b-4232-ace6-8737d7e45c49">560,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzQwLTEzLTEtMS00ODg1NA_3ed293bd-9076-40d8-8f11-a6d846aab05f">5,407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzQwLTE1LTEtMS00ODg2MQ_c7832808-f88d-4f3d-af75-1ee3a6ec329a">1,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzQxLTktMS0xLTQ4ODQ3_a3bf5d5c-6f53-4b2e-a1f7-f62fe69c6b48">46,416</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzQxLTEzLTEtMS00ODg1NA_3c1d1ff4-cff5-4cb6-a254-51757504fc71">17,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzQxLTE1LTEtMS00ODg2MQ_a3456da2-2cd7-480b-9b84-478ed787a172">14,823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash and cash equivalents, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzQyLTktMS0xLTQ4ODQ3_02a1082a-6c33-4536-b961-56c8da43b0eb">66,393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7a15f5b31d42419aa50ffb53e76f3705_I20200331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzQyLTEzLTEtMS00ODg1NA_c8a50f6a-db1b-4894-8e7e-39143707be77">48,430</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i27e150c7cdf34baa99d770cedfcc88a0_I20190331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzQyLTE1LTEtMS00ODg2MQ_b67c0af6-25b0-45b7-9eb9-c75138ff7db7">33,607</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Cash and cash equivalents, end of period</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzQzLTktMS0xLTQ4ODQ3_7d0ccba8-8d7e-499c-8f28-d78b539e662a">112,809</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzQzLTEzLTEtMS00ODg1NA_8326cf88-cc75-4530-ad49-699e780a9fb1">66,393</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7a15f5b31d42419aa50ffb53e76f3705_I20200331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzQzLTE1LTEtMS00ODg2MQ_0e919040-e46c-4827-a6db-e317e4e834cd">48,430</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="padding-left:18pt;padding-right:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS (Continued)</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.698%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Supplemental disclosures of cash flow information</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash paid for taxes</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:IncomeTaxesPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzEtMS0xLTEtOTgyMzU_8b628631-f6b2-441b-ad84-e0969c957468">206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzEtMy0xLTEtOTgyMzU_72e8af14-b125-446d-91ce-b07f7ed32a6e">5,972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzEtNS0xLTEtOTgyMzU_7334fd2a-803f-4997-af0c-bc6303f2acae">1,237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Non-cash financing and investing activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Conversion of redeemable convertible preferred stock to common stock</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:ConversionOfStockAmountConverted1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzMtMS0xLTEtOTgyNjc_db58cd1d-5eaf-4325-8d19-98fae36cbb83">81,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:ConversionOfStockAmountConverted1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzMtMy0xLTEtOTgyNjc_aba49d1b-56f6-463b-ae9f-2fc4a5ce886a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:ConversionOfStockAmountConverted1" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzMtNS0xLTEtOTgyNjc_bb1e08af-269a-48ac-8928-9722dd917103">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unpaid deferred offering costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="docs:StockIssuancesCostsIncurredButNotYetPaid" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzMtMS0xLTEtOTgyMzU_151780e3-db18-4c60-ba9a-6053dabc3877">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="docs:StockIssuancesCostsIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzMtMy0xLTEtOTgyMzU_29972f0a-cd37-40f9-bdf4-f2f2b5e4b6a9">782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="docs:StockIssuancesCostsIncurredButNotYetPaid" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzMtNS0xLTEtOTgyMzU_571f4d19-f6bb-4441-b1e8-3bca22e5d30f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Common stock issued in acquisition</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="docs:StockIssuedAcquisitions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzQtMS0xLTEtOTgyMzU_523351b6-96a6-48a7-9e2a-1ffeec5348f7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="docs:StockIssuedAcquisitions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzQtMy0xLTEtOTgyMzU_7a626fc4-083f-4932-9615-b861e0c611d7">1,062</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="docs:StockIssuedAcquisitions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzQtNS0xLTEtOTgyMzU_4d277c0a-b689-4e4a-98a1-fe26395cb8c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Capitalized stock-based compensation for internal-use software development costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzUtMS0xLTEtOTgyMzU_077016de-0608-4f0d-8f8d-01030a321dbf">497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzUtMy0xLTEtOTgyMzU_b58d2538-f196-41c1-97d6-b0d02670af9b">195</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzUtNS0xLTEtOTgyMzU_856e83cd-815f-4458-a0eb-68b5a23e7954">184</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Amounts held in escrow related to sale of business</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="docs:EscrowDepositsRelatedToSaleOfBusiness" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzYtMS0xLTEtOTgyMzU_9fc859fc-31ce-4b1f-91a2-4d1a85051deb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="docs:EscrowDepositsRelatedToSaleOfBusiness" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzYtMy0xLTEtOTgyMzU_c3d93bf9-07c5-475e-8b16-661201532de1">470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="docs:EscrowDepositsRelatedToSaleOfBusiness" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzYtNS0xLTEtOTgyMzU_693756ff-411c-4adc-a632-1886c44931c3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease right-of-use assets obtained in exchange for modified operating lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzgtMS0xLTEtOTgyMzU_176087e4-4543-4f69-8eb8-ce16bc7e8a48">1,151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzgtMy0xLTEtOTgyMzU_a747c52c-e400-46df-aabc-a7a4f46ccbcf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzgtNS0xLTEtOTgyMzU_99c38986-ee94-4483-810f-89019f2fdae0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><div id="i6c4404140edb48938ba4e30b290c9ef9_184"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><div style="text-align:center"><span><br/></span></div><div id="i6c4404140edb48938ba4e30b290c9ef9_187"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;<ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODcvZnJhZzoxMDA0YTgzMWIzMGM0YjU5YmYwMzVhYzY4ZjIzNzViMi90ZXh0cmVnaW9uOjEwMDRhODMxYjMwYzRiNTliZjAzNWFjNjhmMjM3NWIyXzY0MzIxNDMwMjQwNjY1_248194da-9f4e-496f-9dd4-9ae36d6227a3" continuedAt="i79e35a5ca78049b68f9d0ef7056945cc" escape="true">DESCRIPTION OF BUSINESS</ix:nonNumeric></span></div><ix:continuation id="i79e35a5ca78049b68f9d0ef7056945cc" continuedAt="ieab4ca47d52d4fb0b7f814fb6d2d885b"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Business</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Doximity,&#160;Inc. (the &#8220;Company&#8221;) was incorporated in the state of Delaware in April 2010 as 3MD Communications, Inc. and is headquartered in San Francisco, California. The Company subsequently changed its name to Doximity, Inc. in June 2010. The Company provides an online platform, which enables physicians and other healthcare professionals to collaborate with their colleagues, securely coordinate patient care, stay up to date with the latest medical news and research, and manage their careers. The Company&#8217;s customers primarily include pharmaceutical companies and health systems that connect with healthcare professionals through the Company&#8217;s digital Marketing and Hiring Solutions. Marketing Solutions provide customers with the ability to share tailored content on the network. Hiring Solutions enable customers to identify, connect with, and hire from the network of both active and passive potential physician candidates.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Initial Public Offering</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, the Company completed its initial public offering, or IPO, in which the Company issued and sold <ix:nonFraction unitRef="shares" contextRef="i2e82783b746e45e0a6c7e59883f52e81_D20210601-20210630" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODcvZnJhZzoxMDA0YTgzMWIzMGM0YjU5YmYwMzVhYzY4ZjIzNzViMi90ZXh0cmVnaW9uOjEwMDRhODMxYjMwYzRiNTliZjAzNWFjNjhmMjM3NWIyXzI5MTM3MDU4MTQ0NDQ4_eb8a6870-cd7f-423e-b3ff-5d7c600f18db">22,505,750</ix:nonFraction> shares of its Class A common stock at $<ix:nonFraction unitRef="usdPerShare" contextRef="i2bcd5d3197f043779574e3205ce6051a_I20210630" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODcvZnJhZzoxMDA0YTgzMWIzMGM0YjU5YmYwMzVhYzY4ZjIzNzViMi90ZXh0cmVnaW9uOjEwMDRhODMxYjMwYzRiNTliZjAzNWFjNjhmMjM3NWIyXzI5MTM3MDU4MTQ0NDU3_de7ff991-0509-4eca-b9b6-9a4a9b553d9d">26.00</ix:nonFraction> per share, including <ix:nonFraction unitRef="shares" contextRef="id77b48d8ffc446c1a18a4951dd7e173a_D20210601-20210630" decimals="INF" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODcvZnJhZzoxMDA0YTgzMWIzMGM0YjU5YmYwMzVhYzY4ZjIzNzViMi90ZXh0cmVnaW9uOjEwMDRhODMxYjMwYzRiNTliZjAzNWFjNjhmMjM3NWIyXzI5MTM3MDU4MTQ0NDcw_e80b1fd6-b3b6-4db6-8d10-3cebc1fc5846">3,495,000</ix:nonFraction> shares issued upon the exercise of the underwriters&#8217; option to purchase additional shares. The Company received proceeds of $<ix:nonFraction unitRef="usd" contextRef="i2e82783b746e45e0a6c7e59883f52e81_D20210601-20210630" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODcvZnJhZzoxMDA0YTgzMWIzMGM0YjU5YmYwMzVhYzY4ZjIzNzViMi90ZXh0cmVnaW9uOjEwMDRhODMxYjMwYzRiNTliZjAzNWFjNjhmMjM3NWIyXzI5MTM3MDU4MTQ0NDg3_a84f8937-c533-451c-bae8-6ec285f6104d">548.5</ix:nonFraction> million after deducting underwriting discounts and commissions as well as deferred offering costs. In connection with the IPO, all <ix:nonFraction unitRef="shares" contextRef="i6d33d27d6278430c9585fcf4dd6fdf08_D20210601-20210630" decimals="INF" name="us-gaap:ConversionOfStockSharesConverted1" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODcvZnJhZzoxMDA0YTgzMWIzMGM0YjU5YmYwMzVhYzY4ZjIzNzViMi90ZXh0cmVnaW9uOjEwMDRhODMxYjMwYzRiNTliZjAzNWFjNjhmMjM3NWIyXzI5MTM3MDU4MTQ0NTEx_c100b206-dc6d-4276-9e90-601ecada71fa">76,286,618</ix:nonFraction> shares of the Company&#8217;s outstanding redeemable convertible preferred stock automatically converted into an equivalent number of shares of Class B common stock on a <ix:nonFraction unitRef="number" contextRef="i62c961053180495bb8eed126ddb4d43b_D20210601-20210630" decimals="INF" name="docs:ConversionOfStockConversionRatio" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODcvZnJhZzoxMDA0YTgzMWIzMGM0YjU5YmYwMzVhYzY4ZjIzNzViMi90ZXh0cmVnaW9uOjEwMDRhODMxYjMwYzRiNTliZjAzNWFjNjhmMjM3NWIyXzI5MTM3MDU4MTQ0NTE3_7627e522-fa3d-4104-9503-be27b4d8ac55">one</ix:nonFraction>-to-one basis. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred offering costs, which consist of direct incremental legal, consulting, banking, and accounting fees relating to the Company&#8217;s planned initial public offering, were capitalized. Upon the consummation of the IPO, the $<ix:nonFraction unitRef="usd" contextRef="iaca56ad88a7f461f9aa0ca6977c6c5a1_I20210630" decimals="-5" name="us-gaap:DeferredOfferingCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODcvZnJhZzoxMDA0YTgzMWIzMGM0YjU5YmYwMzVhYzY4ZjIzNzViMi90ZXh0cmVnaW9uOjEwMDRhODMxYjMwYzRiNTliZjAzNWFjNjhmMjM3NWIyXzMwMjM2NTY5Nzc5NDI1_f813fd2e-9d1c-423c-ac9b-6d8298b8083d">5.5</ix:nonFraction> million of deferred offering costs were offset against proceeds. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Split</span></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ieab4ca47d52d4fb0b7f814fb6d2d885b">On June&#160;8, 2021, the Company&#8217;s board of directors and stockholders approved an amendment to the Company&#8217;s amended and restated certificate of incorporation effecting a <ix:nonFraction unitRef="number" contextRef="ic768fc083be84a7890c4145464deef64_D20210608-20210608" decimals="INF" name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODcvZnJhZzoxMDA0YTgzMWIzMGM0YjU5YmYwMzVhYzY4ZjIzNzViMi90ZXh0cmVnaW9uOjEwMDRhODMxYjMwYzRiNTliZjAzNWFjNjhmMjM3NWIyXzI5MTM3MDU4MTQ0NjM3_9b318ab8-808c-4f2e-a8ba-f37953e9f53a">2</ix:nonFraction>-for-1 forward split of the Company&#8217;s issued and outstanding stock, including outstanding stock-based instruments and redeemable convertible preferred stock. The par value of the common and redeemable convertible preferred stock was not adjusted as a result of the stock split. As such, the Company has reclassified amounts from additional paid-in capital to common stock. All issued and outstanding shares of common stock, stock-based instruments, redeemable convertible preferred stock, and per-share amounts included in the accompanying consolidated financial statements have been adjusted to reflect this stock split for all periods presented.</ix:continuation> </span></div><div id="i6c4404140edb48938ba4e30b290c9ef9_190"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;<ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0MzUx_941c7762-dc44-4417-be29-ae6a8738e34d" continuedAt="iae5bb8ac6d714b13ab6aabbff0d24ee7" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="iae5bb8ac6d714b13ab6aabbff0d24ee7" continuedAt="i8ef3a4288ab3439390d2bf677a5d241d"><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0MzUy_e5646834-2636-4d7d-a509-a3ad6fe8ca98" escape="true"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America, or U.S. GAAP.</span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0Mzc4_f02e34e7-43d9-40b5-b78c-622eacc1194f" escape="true">The accompanying consolidated financial statements include the accounts of the Company and its consolidated subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. Certain prior year amounts were reclassified, as applicable, to conform to the current year presentation.</ix:nonNumeric> </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:FiscalPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0MzUz_d3a8ae64-0c70-4502-81b6-b3fb9d3e9964" continuedAt="i472cb846346c4bb0ad27153f54c094f6" escape="true">Fiscal Year </ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><ix:continuation id="i472cb846346c4bb0ad27153f54c094f6" continuedAt="i093908c4a2d34b09aa49173efc6509b2"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s fiscal year ends on March 31</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i093908c4a2d34b09aa49173efc6509b2">. Unless otherwise noted, all references to a particular year shall mean the Company&#8217;s fiscal year.</ix:continuation> </span></div><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0MzU0_b157fe02-de0c-4119-82fd-0f59601e7bd2" continuedAt="i2ce87e3a4e67467aa4b804eee739b233" escape="true"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company&#8217;s consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts stated in the consolidated financial statements and accompanying notes. These judgments, estimates, and assumptions are used for, but not limited to, revenue recognition, the fair values of acquired intangible assets and goodwill, the useful lives of long-lived assets, the valuation of the Company&#8217;s common stock and stock-based awards, and deferred income taxes. The Company bases its estimates on historical experience and also on assumptions that management considers reasonable. The Company assesses these estimates on a regular basis; however, actual </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="i8ef3a4288ab3439390d2bf677a5d241d" continuedAt="i32a9a9649d9248beb575423b16346898"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2ce87e3a4e67467aa4b804eee739b233">results could differ from these estimates due to risks and uncertainties, including uncertainty in the current economic environment due to the potential long-term impact and duration of the ongoing COVID-19 pandemic.</ix:continuation></span></div><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0MzU1_ed88eb55-2d3e-49ca-be94-f0d245bd659b" escape="true"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities, and accounts receivable. The primary focus of the Company&#8217;s investment strategy is to preserve capital and meet liquidity requirements. The Company&#8217;s investment policy addresses the level of credit exposure by limiting the concentration in any one corporate issuer or sector and establishing a minimum allowable credit rating. To manage risk exposure, the Company invests cash equivalents and marketable securities in a variety of fixed income securities, including government and investment-grade debt securities and money market funds. The Company places its cash primarily in checking and money market accounts with reputable financial institutions. Deposits held with these financial institutions may exceed the amount of insurance provided on such deposits, if any.</span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concentrations of credit risk with respect to accounts receivable are primarily limited to certain customers to which the Company makes substantial sales. <ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0Mzc1_03bee1b0-92ec-421c-9c45-40af15d9029d" continuedAt="i8f7169c0de634a229ab2bb41d9bd3eb9" escape="true">The Company&#8217;s significant customers that represented 10% or more of revenue or accounts receivable, net for the periods presented were as follows:</ix:nonNumeric></span></div><ix:continuation id="i8f7169c0de634a229ab2bb41d9bd3eb9"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.162%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accounts Receivable, Net</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Customer A</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3c255afc92154f4c84be5e86a09930da_D20200401-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90YWJsZTpmZTA5N2ZjM2IyZmI0OTU5YmE1MjRlODE0NTY4YWU5MC90YWJsZXJhbmdlOmZlMDk3ZmMzYjJmYjQ5NTliYTUyNGU4MTQ1NjhhZTkwXzMtMy0xLTEtNTAyOTk_d90ef71c-9d12-417c-851e-462967abb567">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i232cd9dacebb4bacabe5814953368da3_D20190401-20200331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90YWJsZTpmZTA5N2ZjM2IyZmI0OTU5YmE1MjRlODE0NTY4YWU5MC90YWJsZXJhbmdlOmZlMDk3ZmMzYjJmYjQ5NTliYTUyNGU4MTQ1NjhhZTkwXzMtNS0xLTEtNTAyOTk_582e3098-696e-48df-a643-605255a8fa55">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i05799a8437a248f4a953626f22ebc51e_D20210401-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90YWJsZTpmZTA5N2ZjM2IyZmI0OTU5YmE1MjRlODE0NTY4YWU5MC90YWJsZXJhbmdlOmZlMDk3ZmMzYjJmYjQ5NTliYTUyNGU4MTQ1NjhhZTkwXzMtNy0xLTEtNTAyOTk_8536bbff-ec93-4df3-914c-339bf8d882b2">21</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="idce67be988654a3aba87d58e5fcbbae7_D20200401-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90YWJsZTpmZTA5N2ZjM2IyZmI0OTU5YmE1MjRlODE0NTY4YWU5MC90YWJsZXJhbmdlOmZlMDk3ZmMzYjJmYjQ5NTliYTUyNGU4MTQ1NjhhZTkwXzMtOS0xLTEtNTAyOTk_0ebe1e94-4d93-4fcd-8a7d-bddd7b1c92e4">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">_______________</span></div><div style="padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">* Less than 10%</span></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the purpose of assessing concentration of credit risk for significant customers, the Company defines a customer as an entity that purchases the Company&#8217;s services directly or indirectly through marketing agencies. The majority of marketing agencies have a pass-through arrangement for collection purposes, except one marketing agency which accounted for <ix:nonFraction unitRef="number" contextRef="i0c8278abf3274417845449b2b9d0ee93_D20210401-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzMwMjM2NTY5OTk5NzUy_a7eed2b4-d123-4a7d-aaf9-d3ee97cb17a0">17</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="if63822cdcbe54d9aa0abc1f888beaab3_D20200401-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzI4NTg3MzAyNTU4MTk1_dbd6b19b-5cac-4986-a19b-a2133ed15c4f">18</ix:nonFraction>% of accounts receivable, net as of March&#160;31, 2022 and 2021, respectively. </span></div><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:RevenueRecognitionPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0MzU2_4e346800-0a67-48d5-a9cf-8082ba67940e" continuedAt="i3e12c1b895694261b5574be90ccda3e1" escape="true"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenue is primarily derived from the sale of subscriptions for the following solutions:</span></div><div style="margin-bottom:9pt;padding-left:63pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">Marketing Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Hosting of customer-sponsored content on the Doximity platform and providing access to the Company&#8217;s professional database of healthcare professionals for referral or marketing purposes during the subscription period.</span></div><div style="margin-bottom:9pt;padding-left:63pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">Hiring Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Providing customers access to the Company&#8217;s professional tools where recruiters can access the Company&#8217;s database of healthcare professionals, allowing customers to send messages for talent sourcing and to share job postings during the subscription period. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines revenue recognition in accordance with ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, through the following five steps:</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt">Identify the contract with a customer</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers the terms and conditions of its contracts and the Company&#8217;s customary business practices in identifying its contracts under ASC 606. The Company determines it has a contract with a customer when the contract has been approved by both parties, it can identify each party&#8217;s rights regarding the services to be transferred and the payment terms for the services, it has determined the customer to have the ability and intent to pay, and the contract has commercial substance. At contract inception, the Company evaluates whether two or more contracts should be combined and accounted for as a single contract. The Company applies judgment in determining the customer&#8217;s ability and intent to pay, which is based on a variety of factors, including the customer&#8217;s payment history or, in the case of a new customer, credit and financial information pertaining to the customer.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual terms for Marketing Solutions contracts are generally <ix:nonNumeric contextRef="i448a0e1cd7da4509b2f34555307a9792_D20210401-20220331" name="docs:ContractWithCustomerTerm" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzI5MTM3MDU4MTk4MzAw_f72f352d-74f9-4246-8885-7f8872009a58">12</ix:nonNumeric> months or less. The contractual term for Hiring Solutions contracts is typically <ix:nonNumeric contextRef="i7859c8cbc9bd4e129a62d90e12bfc46d_D20210401-20220331" name="docs:ContractWithCustomerTerm" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzI5MTM3MDU4MTk4MzE1_f046b8ef-1eca-4433-9b94-39a6cd79414f">12</ix:nonNumeric> months. Customers are generally billed for a portion of the contract upon contract execution and then billed throughout the remainder of the contract based on various time-based milestones. Certain Marketing Solutions </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="i32a9a9649d9248beb575423b16346898" continuedAt="i291f9de2db2644f888d6f9f99b4ad8be"><ix:continuation id="i3e12c1b895694261b5574be90ccda3e1" continuedAt="ic38c9f64b8a24b248d2e83accb1c7da7"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">contracts are cancellable with a <ix:nonNumeric contextRef="i448a0e1cd7da4509b2f34555307a9792_D20210401-20220331" name="docs:ContractWithCustomerCancellationNoticePeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0Mzc2_fddaa341-27d7-49d3-9ca2-4975645a71d9">30-day</ix:nonNumeric> notice period. The Company is not required to refund any prepayment fees invoiced and customers are responsible for prorated amounts to cover services that were provided but payment was not made. Contracts related to Hiring Solutions are noncancellable and customers are billed in annual, quarterly, or monthly installments in advance of the service period.</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt">Identify the performance obligations in the contract</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance obligations promised in a contract are identified based on the services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the service either on its own or together with other resources that are readily available, and are distinct in the context of the contract, whereby the transfer of the services is separately identifiable from other promises in the contract.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketing Solutions customers may purchase a subscription for a specific module to be used over a defined period of time. These customers may purchase more than one module with either the same or different subscription periods. Modules are the core building blocks of the Company&#8217;s customers&#8217; marketing plan and can be broadly categorized as Awareness, Interactivity, and Peer. As an example, the Company&#8217;s Awareness modules may include:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A sponsored article, including a headline that appears in the targeted member&#8217;s newsfeed.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Short, animated videos that are presented in targeted members&#8217; newsfeeds.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Short-form content that is presented within the targeted members&#8217; newsfeeds.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each module targets a consistent number of Doximity members per month for the duration of the subscription period. The Company treats each subscription to a specific module as a distinct performance obligation because each module is capable of being distinct as the customer can benefit from the subscription to each module on their own and each subscription can be sold standalone. Furthermore, the subscriptions to individual modules are distinct in the context of the contract as (1) the Company is not integrating the services with other services promised in the contract into a bundle of services that represent a combined output, (2) the subscriptions to specific modules do not significantly modify or customize the subscription to another module, and (3) the specific modules are not highly interdependent or highly interrelated. The subscription to each module is treated as a series of distinct performance obligations because it is distinct and substantially the same, satisfied over time, and has the same measure of progress.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketing Solutions customers may also purchase integrated subscriptions for a fixed subscription fee that are not tied to a single module but allow customers to utilize any combination of modules during the subscription period subject to limits on the total number of modules launched in a given period of time, active at any given time, and members targeted. These represent stand-ready obligations in that the delivery of the underlying sponsored content is within the control of the customer and the extent of use in any given period does not diminish the remaining services. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some customers have negotiated to receive credits to purchase additional services at no extra cost if certain metrics have not been achieved. These credits are accounted for as material rights.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subscriptions to Hiring Solutions provide customers access to the platform to place targeted job postings and send a fixed number of monthly messages. Each subscription is treated as a series of distinct performance obligations that are satisfied over time. </span></div><div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt">Determine the transaction price </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price is determined based on the consideration the Company expects to be entitled to in exchange for transferring services to the customer. Variable consideration is included in the transaction price if, in the Company&#8217;s judgment, it is probable that a significant future reversal of cumulative revenue recognized under the contract will not occur.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may generate sales through the use of third-party media agencies that are authorized to enter into contracts on behalf of an end customer. The Company acts as the principal in these transactions since it maintains control prior to transferring the service to the customer and is primarily responsible for the fulfillment that occurs through the Company&#8217;s platform. The Company records revenue for the amount to which it is entitled from the third-party media agencies as the Company does not know and expects not to know the price charged by the third-party media agencies to its customers. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized net of any taxes collected from customers, which are subsequently remitted to governmental entities.</span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="i291f9de2db2644f888d6f9f99b4ad8be" continuedAt="iba8117ae3e25490aac8e7e6064792f29"><ix:continuation id="ic38c9f64b8a24b248d2e83accb1c7da7" continuedAt="i2b337179a4604db5b111b8fe4d917ea3"><div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt">Allocate the transaction price to performance obligations in the contract</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative stand-alone selling price, or SSP. The determination of a SSP for each distinct performance obligation requires judgment. The Company determines SSP for performance obligations based on overall pricing objectives, which take into consideration market conditions and customer-specific factors, including a review of internal discounting tables, the type of services being sold, and other factors. The estimate of standalone selling price is based on historical sales of standalone services. The Company estimates standalone selling price for arrangements where standalone sales do not provide sufficient evidence of standalone selling price. The Company believes the use of its estimation approach and allocation of the transaction price on a relative SSP basis to each performance obligation results in revenue recognition in a manner consistent with the underlying economics of the transaction and the allocation principle included in ASC 606.</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt">Recognize revenue when or as the Company satisfies a performance obligation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when or as control of the promised goods or service is transferred to the customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. Subscriptions represent a series of distinct goods or services because the performance obligations are satisfied over time as customers simultaneously receive and consume the benefits related to the services as the Company performs. In the case of module specific subscriptions, a consistent level of service is provided during each monthly period the sponsored content is available on the Company&#8217;s platform. The Company commences revenue recognition when the first content is launched on the platform for the initial monthly period and revenue is recognized over time as each subsequent content period is delivered. The Company&#8217;s obligation for its integrated subscriptions is to stand-ready throughout the subscription period; therefore, the Company considers an output method of time to measure progress towards satisfaction of its obligations with revenue commencing upon the beginning of the subscription period. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company treats Hiring Solutions subscriptions as a single performance obligation that represents a series of distinct performance obligations that is satisfied over time. Revenue recognition commences when the customer receives access to the services. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other revenue consists of fees earned from the temporary staffing and permanent placement of healthcare professionals. Revenue is recognized when control of these services is transferred to the Company&#8217;s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Balances </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Timing of revenue recognition may differ from the timing of invoicing to customers. A majority of customers are invoiced throughout the contract while others are billed upfront. Marketing Solutions customers are generally billed for a portion of the contract upon contract execution and then billed throughout the remainder of the contract based on various time-based milestones, starting when the tailored content is first shared on the Doximity platform. The Company&#8217;s contracts do not contain significant financing components. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records unbilled revenue when revenue is recognized in amounts for which it is contractually entitled but exceeds the amounts the Company has a right to bill as of the end of the period. The Company records unbilled revenue on the consolidated balance sheets within prepaid expenses and other current assets. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Deferred revenue consists of noncancelable customer billings or payments received in advance of revenue recognition. Deferred revenue balances are generally expected to be recognized within 12 months. Since the majority of the Company&#8217;s contracts have a duration of one year or less, the Company has elected not to disclose remaining performance obligations in accordance with the optional exemption in ASC 606. Remaining performance obligations for contracts with an original duration greater than one year are not material.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Contract Costs</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes sales commissions that are considered to be incremental and recoverable costs of obtaining a contract with a customer. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales compensation earned for the renewal of Marketing Solutions contracts are commensurate with commissions earned for a new or expansion Marketing Solutions contract, whereas commissions for the renewal of Hiring Solutions subscription contracts are earned at a lower rate than for new and expansion Hiring Solutions subscription contracts. </span></div></ix:continuation></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="iba8117ae3e25490aac8e7e6064792f29" continuedAt="id0eb99515f714c0ea07934d4da02053e"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2b337179a4604db5b111b8fe4d917ea3">Deferred compensation for Marketing Solutions contracts and Hiring Solutions renewal contracts is amortized over the weighted-average contractual term, ranging from <ix:nonNumeric contextRef="i2e71bd453e6a4a5c937ee4449f768fe2_I20220331" name="us-gaap:CapitalizedContractCostAmortizationPeriod" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzI4NTg3MzAyMzkzMjkx_3d40a24d-eed5-4bdc-afbe-7986fa45e616">7</ix:nonNumeric> months to <ix:nonNumeric contextRef="i90363c012ca343ec80c6f828e4cfa8ee_I20220331" name="us-gaap:CapitalizedContractCostAmortizationPeriod" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzI4NTg3MzAyMzkzMjk4_1d163828-8d01-4c87-abdd-2e8b992e7c83">13</ix:nonNumeric> months. Deferred compensation tied to new and expansion contracts for Hiring Solutions is amortized on a straight-line basis over the expected period of benefit of <ix:nonNumeric contextRef="i64c2cfc1b0024d94aff990227a41ebbc_I20220331" name="us-gaap:CapitalizedContractCostAmortizationPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzMxMzM2MDgxNDY1ODU0_05f1f8f4-9f13-4e07-b2fe-3d9df485e4e7">4</ix:nonNumeric> years, which is determined by the nature of the Company&#8217;s technology and services, the rate at which the Company continually enhances and updates its technology, and its historical customer retention. Deferred compensation is recorded as deferred contract costs on the consolidated balance sheets. Amortized costs are included in cost of revenues and sales and marketing expense in the consolidated statements of operations. Amounts expected to be recognized within one year of the balance sheet date are recorded as deferred contract costs, current, and the remaining portion is recorded as other assets on the consolidated balance sheets. Certain sales commissions that are not considered incremental costs are expensed in the same period as they are earned.</ix:continuation> </span></div><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0MzU4_5d4c7a11-a37e-40bc-b5b7-c7bdf4ed6b0f" escape="true"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale debt securities are recorded at fair value on the consolidated balance sheets. The carrying value of cash equivalents, accounts receivable, accounts payable, and accrued expenses and other current liabilities approximate their respective fair values due to their short maturities. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a three-tier hierarchy, which prioritizes the inputs used in measuring fair value as follows:</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Inputs that are unadjusted quoted prices in active markets for identical assets or liabilities at the measurement date.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Inputs (other than quoted prices included in Level&#160;1)&#160;that are either directly or indirectly observable for the asset or liability through correlation with market data at the measurement date and for the duration of the instrument&#8217;s anticipated life.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities and which reflect management&#8217;s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="docs:CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0MzU5_6bd4e3e9-1737-4947-8caf-055f72bcd7de" continuedAt="i1636d776bc3c4ae6b23a6f3c5e69017e" escape="true"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents and Marketable Securities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with maturities of three months or less at the time of acquisition to be cash equivalents. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s marketable securities portfolio includes only debt securities. Marketable debt securities that the Company may sell prior to maturity in response to changes in the Company's investment strategy, liquidity needs, or for other reasons are classified as available-for-sale. The Company's portfolio as of March&#160;31, 2022 and 2021 includes only available-for-sale securities. Available-for-sale securities are stated at fair value as of each balance sheet date. Unrealized gains and losses for available-for-sale securities are included in accumulated other comprehensive income, a component of stockholders&#8217; equity on the consolidated balance sheets. The Company&#8217;s marketable securities are available for use in current operations, even if the security matures beyond 12 months. The Company classifies its marketable securities as current assets on the consolidated balance sheets. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodically, the Company assesses the available-for-sale securities for impairment. An investment is impaired if the fair value of the investment is less than its amortized cost basis. The amortized cost of an investment will be written down to the fair value when the Company determines (i) it is more likely than not that management will be required to sell the impaired security before recovery of its amortized basis or (ii) management has the intention to sell the security. If neither of these conditions are met, the Company must determine whether the impairment is due to credit losses. A credit loss exists if the amortized cost basis of the security exceeds the present value of cash flows expected to be collected. All credit losses are recorded to other income, net and any remaining unrealized losses are recorded to other comprehensive loss. If the Company has the intent to sell an available-for-sale security in an unrealized loss position or it is more likely than not that it will be required to sell the security prior to recovery of its amortized cost basis, any previously recorded allowance is reversed and the entire difference between the amortized cost basis of the security and its fair value is recognized in other income, net in the consolidated statements of operations.</span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="id0eb99515f714c0ea07934d4da02053e" continuedAt="iee4fd23ae2e14c68bbbe702a18ca75f3"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1636d776bc3c4ae6b23a6f3c5e69017e">The Company determines any realized gains or losses on the sale of marketable securities on a specific identification method and records them to other income, net. Amortization of premiums and accretion of discounts are recorded to other income, net.</ix:continuation> </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0MzYw_2921dce7-3678-479a-8d4d-10e900637008" continuedAt="i6accec1e72b0444ca0eab6cc3ffcc095" escape="true">Accounts Receivable and Allowance for Doubtful Accounts</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6accec1e72b0444ca0eab6cc3ffcc095">Accounts receivable are recorded and carried at the original invoiced amount less an allowance for any potential uncollectible amounts. The Company estimates its allowance for doubtful accounts by evaluating the Company&#8217;s ability to collect outstanding receivable balances. The Company considers various factors, including the age of the balance, the creditworthiness of the customer, which is assessed based on ongoing credit evaluations and payment history, and the customer&#8217;s current financial condition.</ix:continuation> The Company had no material bad debt write offs for the years ending March&#160;31, 2022, 2021, and 2020.</span></div><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0MzYx_5097fecf-4f59-4a21-a637-871256094808" continuedAt="if7567c6c053c4e71ad4f1ef1d389aef2" escape="true"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost less accumulated depreciation. Depreciation and amortization expense is recorded on a straight-line basis over the estimated useful lives of the assets. <ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0Mzc0_86747943-1e3f-4495-973b-5c1f22129c36" continuedAt="ia3c928463aa04f72a7158a89bcfcc9ce" escape="true">The estimated useful life of each asset category is as follows:</ix:nonNumeric></span></div><div><ix:continuation id="ia3c928463aa04f72a7158a89bcfcc9ce" continuedAt="i38f55304026a4b19888789d79b452fa0"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.766%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furniture and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i8a0e1d9ff3f146f5a3c9a2720e716d4c_D20210401-20220331" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90YWJsZTplOWZmY2I3MzQ4NWE0MmNiODY5OWNmMzQ3NTY4NjI5MC90YWJsZXJhbmdlOmU5ZmZjYjczNDg1YTQyY2I4Njk5Y2YzNDc1Njg2MjkwXzAtMS0xLTEtNTAzMjAvdGV4dHJlZ2lvbjpkNTExODc1OGFkMmE0YTUwYTE2YmNiYzRkMTE0Y2MyNl8zMDIzNjU2OTc2Mzg2NQ_830c731e-27aa-4e03-848a-b72937002c2f">3</ix:nonNumeric>-<ix:nonNumeric contextRef="i2deaa931c19f4b76a6b8cb6254e5036f_D20210401-20220331" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90YWJsZTplOWZmY2I3MzQ4NWE0MmNiODY5OWNmMzQ3NTY4NjI5MC90YWJsZXJhbmdlOmU5ZmZjYjczNDg1YTQyY2I4Njk5Y2YzNDc1Njg2MjkwXzAtMS0xLTEtNTAzMjAvdGV4dHJlZ2lvbjpkNTExODc1OGFkMmE0YTUwYTE2YmNiYzRkMTE0Y2MyNl8zMDIzNjU2OTc2Mzg3Nw_b5160a1c-82eb-4b72-8900-4f28196d6141">5</ix:nonNumeric> years </span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Computers and software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ie20bbb49de3342faa35330af5ddaeedf_D20210401-20220331" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90YWJsZTplOWZmY2I3MzQ4NWE0MmNiODY5OWNmMzQ3NTY4NjI5MC90YWJsZXJhbmdlOmU5ZmZjYjczNDg1YTQyY2I4Njk5Y2YzNDc1Njg2MjkwXzEtMS0xLTEtNTAzMjA_df2a67b1-1b5f-4d84-a94b-353872a992c5">3</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internal-use software development costs</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i3585b880f7f444f1ae19972e18a16a3c_D20210401-20220331" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90YWJsZTplOWZmY2I3MzQ4NWE0MmNiODY5OWNmMzQ3NTY4NjI5MC90YWJsZXJhbmdlOmU5ZmZjYjczNDg1YTQyY2I4Njk5Y2YzNDc1Njg2MjkwXzMtMS0xLTEtNTAzMjA_4d7c19b1-990b-4565-b89b-985573e0e0ca">3</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shorter of useful life or remaining lease term</span></td></tr></table></ix:continuation></div></ix:nonNumeric><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if7567c6c053c4e71ad4f1ef1d389aef2">When assets are retired or otherwise disposed of, the cost and accumulated depreciation and amortization are written off, and any resulting gain or loss is recorded in the consolidated statement of operations in the period realized. Maintenance and repairs are expensed as incurred.</ix:continuation> </span></div><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:InternalUseSoftwarePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0MzYy_283aac72-aebd-479d-a999-d24710c8e24b" continuedAt="i843f6edf8fe743f1b78e0f6e53b38bde" escape="true"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Internal-Use Software Development Costs</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes certain costs to develop its website, mobile applications and internal-use software when preliminary planning efforts are successfully completed, management has committed project resourcing, and it is probable that the project will be completed. Costs incurred prior to meeting these criteria, as well as costs incurred for training, maintenance, and minor modifications or enhancements, are expensed as incurred. Capitalized costs include personnel and related expenses for employees and costs of third-party contractors who are directly associated with and who devote time to internal-use software projects. Capitalization of these costs ceases once the project is substantially complete and the software is ready for its intended use. </span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i843f6edf8fe743f1b78e0f6e53b38bde">Capitalized costs are included in property and equipment, net on the consolidated balance sheets and are amortized to cost of revenue over their estimated useful life.</ix:continuation> </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:BusinessCombinationsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0MzYz_62c14031-ef2d-403b-8679-4c3693e1ce29" continuedAt="i74ec804ce49c40a5bb75de6501ccc52a" escape="true">Business Combinations</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i74ec804ce49c40a5bb75de6501ccc52a">To determine whether a transaction is accounted for as an asset acquisition or business combination, the Company applies a screen test to evaluate if substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets. When the Company acquires a business, the purchase consideration is allocated to the tangible and intangible assets acquired and liabilities assumed at their estimated fair values on the acquisition date. The excess of the fair value of purchase consideration over the values of these identifiable assets and liabilities is recorded as goodwill. When determining the fair value of assets acquired and liabilities assumed, management makes significant estimates and assumptions, particularly with respect to the valuation of intangible assets. Acquisition costs, such as legal and consulting fees, are expensed as incurred.</ix:continuation> </span></div><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0MzY0_c2b64f42-dcc1-46ca-9104-cefc7304db3a" continuedAt="i1725aca1cd8f4894934a5e1b6cece995" escape="true"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill, Intangible Assets, and Long-Lived Assets</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of the purchase price over the fair value of the net tangible and intangible assets acquired in a business combination. Goodwill is not amortized, but is tested for impairment at least annually or more frequently if events or changes in circumstances indicate that the asset may be impaired. The Company has <ix:nonFraction unitRef="reporting_unit" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="0" name="us-gaap:NumberOfReportingUnits" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzM0NjM0NjE2NDk4NzE3_65ee2026-07bb-4968-aded-e3238524b5c8">one</ix:nonFraction> reporting unit and evaluates goodwill for impairment at the entity level. If the carrying value of the reporting unit exceeds its fair value, an impairment charge is </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="iee4fd23ae2e14c68bbbe702a18ca75f3" continuedAt="i4b91a3a9fbc5424f9c38c34c466888e0"><ix:continuation id="i1725aca1cd8f4894934a5e1b6cece995" continuedAt="ia14f3b60cb5b4517bf28f9e2ae49df10"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recognized for the excess of the carrying value of the reporting unit over its fair value, limited to the amount of goodwill allocated to the reporting unit. The Company performs its annual impairment test of goodwill in its fourth fiscal quarter and whenever events or circumstances indicate that the asset might be impaired. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The intangible assets are stated at cost less accumulated amortization and are amortized on a straight-line basis over their estimated remaining economic lives. Amortization expense related to intangible assets is included in sales and marketing expense. </span></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia14f3b60cb5b4517bf28f9e2ae49df10">Management evaluates the recoverability of the Company&#8217;s property and equipment and intangible assets when events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets held and used is measured by comparison of the carrying amount of an asset or an asset group to the estimated undiscounted future net cash flows expected to be generated by the asset or asset group. If the carrying value exceeds the estimated undiscounted future cash flows, an impairment loss is recognized for the amount by which the carrying amount exceeds the fair value for the asset or asset group.</ix:continuation> </span></div><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0MzY1_27dad849-dc78-4395-b028-d4615bd0ad80" continuedAt="id55a7b09d72840feb608665d526a8f17" escape="true"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures compensation expense for all stock-based awards based on the estimated fair value of the awards on the date of grant. Stock-based awards include stock options with service-based, performance-based and market-based vesting conditions, restricted stock units, or RSUs, performance-based restricted stock units, or PSUs, and warrants granted to employees, directors, and non-employees, as well as stock purchase rights granted to employees under the 2021 Employee Stock Purchase Plan, or ESPP. For awards that vest based on continued service, stock-based compensation, net of estimated forfeitures, is recognized on a straight-line basis over the requisite service period. For awards with performance-based vesting conditions, stock-based compensation expense, net of estimated forfeitures, is recognized using an accelerated attribution method from the time it is deemed probable that the vesting condition will be met through the time the service-based vesting condition has been achieved. The Company reassesses the probability of achieving the performance condition at each reporting date. For awards with market-based vesting conditions, stock-based compensation expense, net of estimated forfeitures, is recognized on an accelerated attribution basis over the requisite service period, even if the market condition is not satisfied. Forfeitures are estimated based upon the Company&#8217;s historical experience and the Company revises its estimates, if necessary, in subsequent periods if actual forfeitures differ from initial estimates. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each RSU and PSU is based on the fair value of the Company&#8217;s common stock on the date of grant. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The grant-date fair value of warrants, stock purchase rights granted to employees under the ESPP, and stock options with service-based or performance-based vesting conditions is estimated using the Black-Scholes pricing model. The grant-date fair value of stock options with market-based vesting conditions is estimated using the Monte Carlo simulation model. The determination of the grant-date fair value using an option-pricing model is affected by the fair value of the Company&#8217;s common stock and assumptions regarding a number of other complex and subjective variables. These assumptions include the expected term of the award, the expected stock price volatility over the expected term of the award, the risk-free interest rate for the expected term of the award, and expected dividends. The assumptions used in the Black-Scholes models are determined as follows: </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk-Free Interest Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The risk-free interest rate is based on the implied yield available on U.S. Treasury zero-coupon issues with an equivalent expected term of the options for each option group. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Prior to the IPO when there was no public market for the Company&#8217;s common stock, the expected volatility was determined using the historical volatilities of several publicly listed peer companies over a period equivalent to the expected term of the awards. The Company has not issued any stock options subsequent to the IPO. After the IPO, for the Company&#8217;s ESPP, the expected volatility was determined using the historical stock volatilities of the common stock of the Company over a period equivalent to the duration of the offering period. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Term</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The expected term represents the period that the Company&#8217;s stock-based awards are expected to be outstanding. For stock options granted to employees prior to the completion of the IPO, the Company estimated the expected term using the simplified method as the Company&#8217;s historical share option exercise experience did not provide a reasonable basis upon which to estimate the expected term. The simplified method uses the average of the vesting period and contractual term. For stock options granted to non-employees prior to the completion of the IPO, the Company used the contractual term as the expected term. The Company has not issued any stock options subsequent to the IPO. For stock purchase rights granted to employees under the ESPP, the expected term is equivalent to the offering period. </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="i4b91a3a9fbc5424f9c38c34c466888e0" continuedAt="iff44cebb728c415c9ef4fa6c1af1fad0"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><ix:continuation id="id55a7b09d72840feb608665d526a8f17" continuedAt="idb48d2d6fa1348ae9ef26ee6382d9a5e"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Dividend Yield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The Company has not historically issued dividends and does not currently expect to issue a dividend in the future. </span></ix:continuation></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:continuation id="idb48d2d6fa1348ae9ef26ee6382d9a5e" continuedAt="ic39f89573e09466d91ff0e7933172dba">Fair Value Per Share of the Company&#8217;s Common Stock</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic39f89573e09466d91ff0e7933172dba">&#8212;Because the Company&#8217;s common stock was not publicly traded until the completion of the IPO, the Company&#8217;s board of directors considered numerous objective and subjective factors to determine the fair value of the Company&#8217;s common stock at each meeting during which awards were approved. These factors included, but were not limited to (i) contemporaneous third-party valuations of common stock; (ii) the rights and preferences of the Company&#8217;s preferred stock relative to common stock; (iii) the lack of marketability of common stock; (iv) developments in the business; and (v) the likelihood of achieving a liquidity event, such as an IPO or sale of the Company, given prevailing market conditions.</ix:continuation> </span></div><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0MzY2_3a5c4d1e-018b-4ff4-a56e-648da650909a" continuedAt="icf6475da54784a8ebaa36e0cc86f036d" escape="true"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if a contract is or contains a lease at inception. All of the Company&#8217;s leases are operating leases. Operating lease right-of-use assets and lease liabilities are recognized at the lease commencement date based on the present value of the lease payments over the lease term, discounted using the Company&#8217;s incremental borrowing rate. As none of the Company&#8217;s leases provide an implicit rate, the incremental borrowing rate used is estimated based on what the Company would be required to pay for a collateralized loan over a similar term as the lease. The Company amortizes the present value of each right-of-use asset on a straight-line basis over its remaining lease term. Leases are included in operating lease right-of-use assets, operating lease liabilities, current, and operating lease liabilities, non-current on the consolidated balance sheets. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options to extend or terminate a lease are included in the lease term when it is reasonably certain that such options will be exercised. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our lease agreements may contain variable costs such as common area maintenance, insurance, property tax, and other operating costs. Variable lease costs are expensed as incurred in the consolidated statements of operations. The Company does not separate non-lease components from lease components for its facility asset portfolio. </span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="icf6475da54784a8ebaa36e0cc86f036d">The Company does not recognize right-of-use assets and lease liabilities for short-term leases, which have a lease term of 12 months or less. Lease cost for short-term leases is recognized on a straight-line basis over the lease term.</ix:continuation> </span></div><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0MzY3_b0791923-cbdd-453e-91f2-fd2d1736d1d6" continuedAt="id258a8ee13b243ff8ca0ba634cb33fe0" escape="true"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income Per Share Attributable to Common Stockholders</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net income per share attributable to common stockholders is presented in conformity with the two-class method required for participating securities. Holders of redeemable convertible preferred stock are each entitled to receive noncumulative dividends out of any funds legally available, when and if declared by the Company&#8217;s board of directors, payable prior and in preference to any dividends on any shares of common stock based on the proportion of common stock that would be held if all shares of redeemable convertible preferred stock were converted at the then-effective conversion rate.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redeemable convertible preferred stock is therefore considered a participating security and is included in the computation of earnings per share under the two-class method. Holders of redeemable convertible preferred stock do not have a contractual obligation to share in the Company&#8217;s losses. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the two-class method, net income attributable to common stockholders is determined by allocating undistributed earnings, calculated as net income, less (i) current period redeemable convertible preferred stock noncumulative dividends and (ii) earnings attributable to participating securities. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income per share attributable to common stockholders is computed by dividing the net income attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted net income per share attributable to common stockholders is computed by dividing net income attributable to common stockholders by the weighted-average number of common shares outstanding and the effect of potentially dilutive securities outstanding during the period. Potentially dilutive securities include stock options, RSUs, PSUs, ESPP, redeemable convertible preferred stock, redeemable convertible preferred stock warrants, and common stock warrants. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rights, including the liquidation and dividend rights, of the holders of Class A and Class B common stock are identical, except with respect to voting, converting, and transfer rights. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis to each class of common stock and the resulting basic and diluted </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="iff44cebb728c415c9ef4fa6c1af1fad0" continuedAt="i5faaaa1144ec4511b2a308eb270cb039"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id258a8ee13b243ff8ca0ba634cb33fe0">net loss per share attributable to common stockholders are, therefore, the same for both Class A and Class B common stock on both an individual and combined basis.</ix:continuation></span></div><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0MzY4_7c40aff8-7aaf-4854-b646-75c8c18c7984" continuedAt="i47f50750df0348f1a4d714f0f922deb5" escape="true"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. Deferred income tax assets and liabilities are measured using enacted tax rates for the year in which those temporary differences are expected to be recovered or settled. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the consolidated statements of operations in the period that includes the enactment date. A valuation allowance is recorded when it is more likely than not that some of the deferred tax assets will not be realized. </span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i47f50750df0348f1a4d714f0f922deb5">The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized. The Company&#8217;s policy is to classify interest and penalties associated with uncertain tax positions, if any, as a component of its provision for (benefit from) income taxes.</ix:continuation> </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:LegalCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0Mzgw_5bba7478-105d-445b-955e-1fc491249f86" continuedAt="i44d0d5bc3e0e43c9aee4a27c76a62bce" escape="true">Legal Contingencies</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i44d0d5bc3e0e43c9aee4a27c76a62bce">The Company may be subject to claims and other legal matters from time to time. The Company records a liability when it believes that it is both probable that a loss has been incurred and the amount can be reasonably estimated. When the Company believes that a loss is reasonably possible, it will disclose an estimate of the possible loss or range of loss. The Company expects to periodically evaluate developments in the legal matters that could affect the amount of liability that the Company accrues, if any, and adjust as appropriate. Until the final resolution of any such matter for which the Company may record a liability, there may be a loss exposure in excess of the liability recorded and such amount could be significant. Legal fees are expensed as incurred, other than amounts capitalized as deferred offering costs, as discussed above.</ix:continuation> </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:CostOfSalesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0Mzcw_fce8101b-8067-4fc9-9591-84a9f2435749" continuedAt="i2d9aae5d2c334b0294764417f466551a" escape="true">Cost of Revenue </ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><ix:continuation id="i2d9aae5d2c334b0294764417f466551a" continuedAt="i2c57ee9d9a66494097b78e6642ea8a74"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue consists primarily of expenses </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">related to cloud hosting, personnel-related expenses for the Company&#8217;s customer success team, costs for third-party platform access, software services and contractors, and other services used in connection with </span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2c57ee9d9a66494097b78e6642ea8a74">delivery and support of the Company&#8217;s platform. Cost of revenue also includes the amortization of  internal-use software development costs, editorial and other content-related expenses, and allocated overhead.</ix:continuation> </span></div><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0Mzcx_c10791c6-de36-4442-88cc-f5e4ec888d47" escape="true"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expense is primarily comprised of personnel-related</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> associated with the Company&#8217;s engineering and product teams who are responsible for building new products and improving existing products. Research and development expense also includes costs for third-party services and contractors, information technology and software-related costs, and allocated overhead. Other than internal-use software development costs that qualify for capitalization, research and development costs are expensed as incurred.</span></div></ix:nonNumeric><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:AdvertisingCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0Mzcy_a337e19b-ea6b-49fe-98a0-44b0afb33bab" continuedAt="ib9a9fe4cf04b42c1801bf0f38ce611ed" escape="true">Advertising Expenses </ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib9a9fe4cf04b42c1801bf0f38ce611ed">Advertising costs are expensed as incurred and are included in sales and marketing expense in the consolidated statements of operations.</ix:continuation> Advertising expense was $<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-5" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzI5Njg2ODE0MDY2NjM0_652a6bb9-6923-464f-bac6-754e173c167b">2.8</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-5" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzI5Njg2ODE0MDY2NjM5_c0483f0c-dd13-4998-8f16-eef27e724386">2.6</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-5" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzI5Njg2ODE0MDY2NjQ4_8456a9c9-84b3-4efe-bc99-a82a5d502b60">2.0</ix:nonFraction> million for the years ended March&#160;31, 2022, 2021, and 2020, respectively.</span></div><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0Mzcz_d7538eba-58e0-481e-a77d-54a96f1af52a" continuedAt="i2317fd7db6d94115a8b02e2acb6c730e" escape="true"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Pronouncements Recently Adopted</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2017, the FASB issued ASU 2017-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles&#8212;Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to simplify how entities assess goodwill for impairment by eliminating Step 2 from the goodwill impairment test. As amended, the goodwill impairment test consists of one step comparing the fair value of a reporting unit with its carrying amount. An entity should recognize a goodwill impairment charge for the amount by which the carrying amount exceeds the reporting unit&#8217;s fair value. This guidance is effective for the Company for its interim and annual period beginning April 1, 2023, and early adoption is permitted. The Company early adopted this new guidance effective April 1, 2021, using a prospective approach. The Company performed its annual impairment assessment in the fourth quarter of fiscal </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="i5faaaa1144ec4511b2a308eb270cb039" continuedAt="i084999562c6d4c859bb84e8895d730b2"><ix:continuation id="i2317fd7db6d94115a8b02e2acb6c730e" continuedAt="i24b79c793f40451daae55314b8cce797"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022 under this new guidance. The adoption of this guidance did not have a material impact on the consolidated financial statements. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that simplifies the accounting for income taxes by removing certain exceptions to the general principles in such areas as intraperiod tax allocation, year-to-date losses in interim periods, and deferred tax liabilities related to outside basis differences. Amendments also include simplifications in other areas such as franchise taxes, step-up in tax basis goodwill, separate entity financial statements, and interim recognition of enactment of tax laws or rate changes. This guidance is effective for the Company for its fiscal year beginning April 1, 2022 and interim periods within its fiscal year beginning April 1, 2023. The Company expects the impact on the consolidated financial statements from the adoption of this standard to be immaterial. </span></div></ix:continuation></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><ix:continuation id="i084999562c6d4c859bb84e8895d730b2" continuedAt="i2d5b3ba2e2bd4591bd20058834222847"><ix:continuation id="i24b79c793f40451daae55314b8cce797" continuedAt="i81c38207a5934c5d8a1599723d2297c5"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU 2021-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with Topic 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers,</span></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i2d5b3ba2e2bd4591bd20058834222847"><ix:continuation id="i81c38207a5934c5d8a1599723d2297c5"> as if it had originated the contracts. Under the current business combinations guidance, such assets and liabilities are recognized by the acquirer at fair value on the acquisition date, which has historically resulted in a reduction to unearned revenue on the balance sheet on acquisition date, and therefore, a reduction to revenues subsequently recognized than otherwise would have been recorded as an independent entity. Adoption of this guidance will result in higher unearned revenue on the balance sheet on acquisition date and higher revenues subsequently recognized. This guidance is effective for the Company for its fiscal year beginning April 1, 2023 and interim periods within that fiscal year, and early adoption is permitted. The Company expects to adopt this guidance in the first quarter of fiscal 2023 and expects the adoption to impact the accounting of business combinations subsequent to the adoption date.</ix:continuation></ix:continuation> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="i6c4404140edb48938ba4e30b290c9ef9_2438"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGV4dHJlZ2lvbjo0ZmQ4ODdmNzEzMWI0YTMwYjVhMGU0MjAxMDM5ZjZkM181ODI3NDExNjMwMTgxNQ_4f403247-8d0a-4ca2-bb7f-06c8d8d7a709" continuedAt="i14f93be14048448d8a153d30fd0e91d6" escape="true">Revenue Recognition </ix:nonNumeric></span></div><ix:continuation id="i14f93be14048448d8a153d30fd0e91d6" continuedAt="i3f852d10a51a482aa957119a60791231"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Disaggregation </span></div><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGV4dHJlZ2lvbjo0ZmQ4ODdmNzEzMWI0YTMwYjVhMGU0MjAxMDM5ZjZkM181ODI3NDExNjMwMTgxNg_ae202ce2-8971-4908-9d49-243a10381fa4" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue consisted of the following (in thousands): </span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.186%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.084%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Subscription</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i75a13b9faa46498d802095eeb320936a_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGFibGU6YmI3OWI2NGU3ZTg3NGI3YWE3ZDBmYzA4MGIzZjAzYjcvdGFibGVyYW5nZTpiYjc5YjY0ZTdlODc0YjdhYTdkMGZjMDgwYjNmMDNiN18yLTUtMS0xLTgzNDE4_0b769e1f-4843-4cd1-88a5-01ddb86b14d0">319,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i00234c4f9e354fa79830f0c96b12428c_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGFibGU6YmI3OWI2NGU3ZTg3NGI3YWE3ZDBmYzA4MGIzZjAzYjcvdGFibGVyYW5nZTpiYjc5YjY0ZTdlODc0YjdhYTdkMGZjMDgwYjNmMDNiN18yLTctMS0xLTgzNDE4_df3ab4bd-7fb9-4e94-b82f-33e12137a6a5">192,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id23527ddeed84383823da9485781ac68_D20190401-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGFibGU6YmI3OWI2NGU3ZTg3NGI3YWE3ZDBmYzA4MGIzZjAzYjcvdGFibGVyYW5nZTpiYjc5YjY0ZTdlODc0YjdhYTdkMGZjMDgwYjNmMDNiN18yLTUtMS0xLTg5NzE2_b2d8142a-cf2f-448c-8455-d48ed0094bbc">116,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifb9d4adeb75140e2a68cf494d5775877_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGFibGU6YmI3OWI2NGU3ZTg3NGI3YWE3ZDBmYzA4MGIzZjAzYjcvdGFibGVyYW5nZTpiYjc5YjY0ZTdlODc0YjdhYTdkMGZjMDgwYjNmMDNiN18zLTUtMS0xLTgzNDE4_5bebce8b-0304-4484-a780-7e2837d93d4e">24,250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="idaeaebe3ab244209926951f374b9e9c8_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGFibGU6YmI3OWI2NGU3ZTg3NGI3YWE3ZDBmYzA4MGIzZjAzYjcvdGFibGVyYW5nZTpiYjc5YjY0ZTdlODc0YjdhYTdkMGZjMDgwYjNmMDNiN18zLTctMS0xLTgzNDE4_b7092c6e-4ef7-4c74-a05d-68bf06f6b739">14,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i51b462bd95564432b7a7495c9dff1958_D20190401-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGFibGU6YmI3OWI2NGU3ZTg3NGI3YWE3ZDBmYzA4MGIzZjAzYjcvdGFibGVyYW5nZTpiYjc5YjY0ZTdlODc0YjdhYTdkMGZjMDgwYjNmMDNiN18zLTUtMS0xLTg5NzE2_1a2738ba-7b17-43bc-bdb2-0717eb2586a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGFibGU6YmI3OWI2NGU3ZTg3NGI3YWE3ZDBmYzA4MGIzZjAzYjcvdGFibGVyYW5nZTpiYjc5YjY0ZTdlODc0YjdhYTdkMGZjMDgwYjNmMDNiN180LTUtMS0xLTgzNDE4_dbf3b104-42fe-4797-8a64-695b145e4530">343,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGFibGU6YmI3OWI2NGU3ZTg3NGI3YWE3ZDBmYzA4MGIzZjAzYjcvdGFibGVyYW5nZTpiYjc5YjY0ZTdlODc0YjdhYTdkMGZjMDgwYjNmMDNiN180LTctMS0xLTgzNDE4_67c85d3c-7b67-41da-8f96-4cba0c8afff9">206,897</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGFibGU6YmI3OWI2NGU3ZTg3NGI3YWE3ZDBmYzA4MGIzZjAzYjcvdGFibGVyYW5nZTpiYjc5YjY0ZTdlODc0YjdhYTdkMGZjMDgwYjNmMDNiN180LTUtMS0xLTg5NzE2_30fbc5e9-cbf8-44a3-b2dd-4b18995511e7">116,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Balances </span></div><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGV4dHJlZ2lvbjo0ZmQ4ODdmNzEzMWI0YTMwYjVhMGU0MjAxMDM5ZjZkM181ODI3NDExNjMwMTgxNw_a51d28bd-02b4-4aac-ac61-1c8bfb555dc3" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the Company&#8217;s deferred revenue balances were as follows (in thousands): </span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGFibGU6YmMxNWE0MDZjMGM0NDkzODkyYTc5MGY0ZDRhMTA2ZmMvdGFibGVyYW5nZTpiYzE1YTQwNmMwYzQ0OTM4OTJhNzkwZjRkNGExMDZmY18yLTEtMS0xLTk1ODAy_536e7af4-b59d-4a83-afbb-a092bd748aae">83,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7a15f5b31d42419aa50ffb53e76f3705_I20200331" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGFibGU6YmMxNWE0MDZjMGM0NDkzODkyYTc5MGY0ZDRhMTA2ZmMvdGFibGVyYW5nZTpiYzE1YTQwNmMwYzQ0OTM4OTJhNzkwZjRkNGExMDZmY18yLTMtMS0xLTk1ODAy_07ac68cf-cc18-425d-a3e7-42ae10d5e7db">44,586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Additions, net, during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="docs:ContractWithCustomerLiabilityAdditionsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGFibGU6YmMxNWE0MDZjMGM0NDkzODkyYTc5MGY0ZDRhMTA2ZmMvdGFibGVyYW5nZTpiYzE1YTQwNmMwYzQ0OTM4OTJhNzkwZjRkNGExMDZmY18zLTEtMS0xLTk1ODAy_46afe89b-ac36-4104-95b7-107078cf445b">345,041</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="docs:ContractWithCustomerLiabilityAdditionsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGFibGU6YmMxNWE0MDZjMGM0NDkzODkyYTc5MGY0ZDRhMTA2ZmMvdGFibGVyYW5nZTpiYzE1YTQwNmMwYzQ0OTM4OTJhNzkwZjRkNGExMDZmY18zLTMtMS0xLTk1ODAy_8b74f3b4-f30e-4715-bcfc-225cb61dd31a">245,803</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue recognized from the beginning balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGFibGU6YmMxNWE0MDZjMGM0NDkzODkyYTc5MGY0ZDRhMTA2ZmMvdGFibGVyYW5nZTpiYzE1YTQwNmMwYzQ0OTM4OTJhNzkwZjRkNGExMDZmY180LTEtMS0xLTk1ODAy_d6ecf298-4aa7-44f8-bc45-20e139cd0ec7">82,534</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGFibGU6YmMxNWE0MDZjMGM0NDkzODkyYTc5MGY0ZDRhMTA2ZmMvdGFibGVyYW5nZTpiYzE1YTQwNmMwYzQ0OTM4OTJhNzkwZjRkNGExMDZmY180LTMtMS0xLTk1ODAy_4490210e-2d3d-4c96-982d-fab8fc55cf89">43,054</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue recognized from contracts invoiced during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="docs:ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGFibGU6YmMxNWE0MDZjMGM0NDkzODkyYTc5MGY0ZDRhMTA2ZmMvdGFibGVyYW5nZTpiYzE1YTQwNmMwYzQ0OTM4OTJhNzkwZjRkNGExMDZmY181LTEtMS0xLTk1ODAy_dab73e75-808f-4ad4-bf2d-289e979f577c">261,014</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="docs:ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGFibGU6YmMxNWE0MDZjMGM0NDkzODkyYTc5MGY0ZDRhMTA2ZmMvdGFibGVyYW5nZTpiYzE1YTQwNmMwYzQ0OTM4OTJhNzkwZjRkNGExMDZmY181LTMtMS0xLTk1ODAy_98ec0559-95f2-47f8-88dc-66f5bb15f56d">163,843</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGFibGU6YmMxNWE0MDZjMGM0NDkzODkyYTc5MGY0ZDRhMTA2ZmMvdGFibGVyYW5nZTpiYzE1YTQwNmMwYzQ0OTM4OTJhNzkwZjRkNGExMDZmY182LTEtMS0xLTk1ODAy_c0c3a88c-66aa-422d-8358-451a2d88fe04">84,985</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGFibGU6YmMxNWE0MDZjMGM0NDkzODkyYTc5MGY0ZDRhMTA2ZmMvdGFibGVyYW5nZTpiYzE1YTQwNmMwYzQ0OTM4OTJhNzkwZjRkNGExMDZmY182LTMtMS0xLTk1ODAy_f1580ff5-193c-4205-8404-3b44bea82480">83,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s unbilled revenue balances were $<ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-5" name="us-gaap:UnbilledReceivablesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGV4dHJlZ2lvbjo0ZmQ4ODdmNzEzMWI0YTMwYjVhMGU0MjAxMDM5ZjZkM18zMTMzNjA4MTQyMDY4Mg_07164fb3-f234-49df-aca3-be3ade40418a">1.4</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-5" name="us-gaap:UnbilledReceivablesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGV4dHJlZ2lvbjo0ZmQ4ODdmNzEzMWI0YTMwYjVhMGU0MjAxMDM5ZjZkM18zMTMzNjA4MTQyMDY4Nw_5fe11d5b-c5e5-4c79-8964-4921abaf1558">0.7</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i7a15f5b31d42419aa50ffb53e76f3705_I20200331" decimals="-5" name="us-gaap:UnbilledReceivablesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGV4dHJlZ2lvbjo0ZmQ4ODdmNzEzMWI0YTMwYjVhMGU0MjAxMDM5ZjZkM18zMTMzNjA4MTQyMDY5Ng_d368fcb9-012d-48be-81f4-97ea89d0cf22">0.2</ix:nonFraction> million as of March&#160;31, 2022, 2021 and 2020, respectively. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Contract Costs</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalized $<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-5" name="docs:CapitalizedContractCostAdditions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGV4dHJlZ2lvbjo0ZmQ4ODdmNzEzMWI0YTMwYjVhMGU0MjAxMDM5ZjZkM18yOTEzNzA1ODE2MDg4MQ_79d20d92-ed49-4ffe-9e27-8d78b871353f">9.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-5" name="docs:CapitalizedContractCostAdditions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGV4dHJlZ2lvbjo0ZmQ4ODdmNzEzMWI0YTMwYjVhMGU0MjAxMDM5ZjZkM18yOTEzNzA1ODE2MDg5MA_5cc9d17c-eb21-4463-ab06-78682758f47d">9.4</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-5" name="docs:CapitalizedContractCostAdditions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGV4dHJlZ2lvbjo0ZmQ4ODdmNzEzMWI0YTMwYjVhMGU0MjAxMDM5ZjZkM18yOTEzNzA1ODE2MDg5OA_3d00b814-1e46-4926-a40a-5bb0e072953f">5.7</ix:nonFraction> million of contract acquisition costs for the fiscal years ended March&#160;31, 2022, 2021, and 2020, respectively. Amortization of deferred contract costs was $<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-5" name="us-gaap:CapitalizedContractCostAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGV4dHJlZ2lvbjo0ZmQ4ODdmNzEzMWI0YTMwYjVhMGU0MjAxMDM5ZjZkM18yOTEzNzA1ODE2MDkxNw_f9e55e05-66c5-4ee0-81e0-982a862f2de1">9.8</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-5" name="us-gaap:CapitalizedContractCostAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGV4dHJlZ2lvbjo0ZmQ4ODdmNzEzMWI0YTMwYjVhMGU0MjAxMDM5ZjZkM18yOTEzNzA1ODE2MDkzOA_90c65624-a718-4871-bc97-b54720a491ea">6.9</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-5" name="us-gaap:CapitalizedContractCostAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGV4dHJlZ2lvbjo0ZmQ4ODdmNzEzMWI0YTMwYjVhMGU0MjAxMDM5ZjZkM18yOTEzNzA1ODE2MDk1OA_e6def14e-c019-4d54-8763-b0e023d3165b">5.1</ix:nonFraction> million for the fiscal years ended March&#160;31, 2022, 2021, and 2020, respectively. Deferred contract costs are </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3f852d10a51a482aa957119a60791231">periodically analyzed for impairment. There were <ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="INF" name="us-gaap:CapitalizedContractCostImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGV4dHJlZ2lvbjo0ZmQ4ODdmNzEzMWI0YTMwYjVhMGU0MjAxMDM5ZjZkM18yOTEzNzA1ODE2MTIwMA_13efe3cb-343a-4960-af59-b725a7f5258e"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="INF" name="us-gaap:CapitalizedContractCostImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGV4dHJlZ2lvbjo0ZmQ4ODdmNzEzMWI0YTMwYjVhMGU0MjAxMDM5ZjZkM18yOTEzNzA1ODE2MTIwMA_31e67ff3-cc99-4afe-bca2-d42fc2c02fca"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="INF" name="us-gaap:CapitalizedContractCostImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGV4dHJlZ2lvbjo0ZmQ4ODdmNzEzMWI0YTMwYjVhMGU0MjAxMDM5ZjZkM18yOTEzNzA1ODE2MTIwMA_f8f06aa8-0a59-4ec9-bbc8-2a24c6ac1835">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> impairment losses relating to deferred contract costs during the fiscal years ended March&#160;31, 2022, 2021, and 2020.</ix:continuation> </span></div><div id="i6c4404140edb48938ba4e30b290c9ef9_193"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;&#160;<ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90ZXh0cmVnaW9uOjBkZjE1MmE3YzBiNzRlNTBiNTQxYTNkZjMwNDM3OTczXzU2NjI0ODQ4ODQxMDM2_eda59157-447e-44a3-843e-f1bb9c5e6e06" continuedAt="ib584cb7a0f7b4163a3f79dd2804171dc" escape="true">Investments</ix:nonNumeric></span></div><ix:continuation id="ib584cb7a0f7b4163a3f79dd2804171dc" continuedAt="i33d778b9b8ac4403bfca5f362ac69a0c"><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90ZXh0cmVnaW9uOjBkZjE1MmE3YzBiNzRlNTBiNTQxYTNkZjMwNDM3OTczXzU2NjI0ODQ4ODQxMDM3_40b01fef-872b-4a72-8d9a-438ed5705688" continuedAt="i6b2cd657b2614762a62f5abcbc52e04f" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost, gross unrealized gains and losses, and fair value of investments are as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cost or<br/>Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9ae84d280eb4f318ba2a0260ea07425_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzMtMS0xLTEtODM1NTg_6f9d07cc-2363-44ef-8953-4c93abe28950">2,686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9ae84d280eb4f318ba2a0260ea07425_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzMtMy0xLTEtODM1NTg_3060ea69-6195-4949-884e-df229fcf041b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9ae84d280eb4f318ba2a0260ea07425_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzMtNS0xLTEtODM1NTg_c79666c0-9c00-4661-af0b-2974dba3cc70">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9ae84d280eb4f318ba2a0260ea07425_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzMtOS0xLTEtODM1NTg_b8da9ba8-20f7-4eda-a1c3-47d472000290">2,686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9fdd40c78d445c3a42dd89ccb0a4447_I20220331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzUtMS0xLTEtODM1NTg_f0d62736-a649-426b-8591-9302f9c42d9d">20,072</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if9fdd40c78d445c3a42dd89ccb0a4447_I20220331" decimals="-3" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzUtOS0xLTEtODM1NTg_2bfcef17-29d0-4b89-9e3f-49f9913c8f16">20,072</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib54faec0bdf04bf2afd9946218f0ac8a_I20220331" decimals="-3" name="docs:CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzctMS0xLTEtODM1NTg_50f6702a-949e-48c5-9379-d06cfd0e3205">22,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib54faec0bdf04bf2afd9946218f0ac8a_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzctOS0xLTEtODM1NTg_af9625c8-1301-4488-ac80-5d2b3340045a">22,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee115df4cfb64f938f087bc0a942628e_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzktMS0xLTEtODM1NTg_668f5fbf-3729-4c35-91ee-9d29a5445af7">7,791</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee115df4cfb64f938f087bc0a942628e_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzktMy0xLTEtODM1NTg_6443ac5e-fee5-4047-b992-07331b0846bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iee115df4cfb64f938f087bc0a942628e_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzktNS0xLTEtODM1NTg_9157ddf9-a9e4-439e-b748-48bc2317c790">51</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee115df4cfb64f938f087bc0a942628e_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzktOS0xLTEtODM1NTg_117af989-c3ff-4d09-bb9e-af816bcba136">7,740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72ae2b0209f24d0a8a959903f8cc0c7a_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzExLTEtMS0xLTgzNTU4_973efaea-43b8-4cff-8640-3b7df7762241">9,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72ae2b0209f24d0a8a959903f8cc0c7a_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzExLTMtMS0xLTgzNTU4_9532a9ac-da5e-431b-8454-dc6be514cba5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i72ae2b0209f24d0a8a959903f8cc0c7a_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzExLTUtMS0xLTgzNTU4_efd1de31-6888-4490-b49f-ab0881779305">53</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72ae2b0209f24d0a8a959903f8cc0c7a_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzExLTktMS0xLTgzNTU4_278bdb55-45fb-4747-8ff0-11e78ead8389">9,383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Corporate notes and bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4492e8b1979a4c7ba9393c924e346c63_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzEyLTEtMS0xLTgzNTU4_7b453b3b-e34f-4e0e-84a6-b073324370c4">129,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4492e8b1979a4c7ba9393c924e346c63_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzEyLTMtMS0xLTgzNTU4_b67f945c-9c57-494e-a9d8-9dd7f8079d54">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4492e8b1979a4c7ba9393c924e346c63_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzEyLTUtMS0xLTgzNTU4_a18555b0-b7f3-44a1-9a98-5e23b86d36be">1,796</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4492e8b1979a4c7ba9393c924e346c63_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzEyLTktMS0xLTgzNTU4_73ac729f-8902-4ec9-9e94-0415068d9523">128,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sovereign bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e676ae804004183a75c60a053663a51_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzEzLTEtMS0xLTgzNTU4_b1e217e1-9d8e-4fdd-9231-91a1b1dd2fe3">8,770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e676ae804004183a75c60a053663a51_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzEzLTMtMS0xLTgzNTU4_f0fd8e13-f6f4-4a05-96d3-1af08c1dd57a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2e676ae804004183a75c60a053663a51_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzEzLTUtMS0xLTgzNTU4_d02d4179-979e-4214-a11e-e80b627ca1b7">334</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e676ae804004183a75c60a053663a51_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzEzLTktMS0xLTgzNTU4_f4d45dfd-fd77-45ed-96d3-346a0f39a56e">8,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae88e8a7906f4f01a07b94eb7dc2e2bf_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzE0LTEtMS0xLTgzNTU4_e36db7e1-9b5e-4f2b-970e-f8e9fb8863f4">549,901</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae88e8a7906f4f01a07b94eb7dc2e2bf_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzE0LTMtMS0xLTgzNTU4_24020ef0-4e30-4123-8b19-d907173673f9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae88e8a7906f4f01a07b94eb7dc2e2bf_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzE0LTUtMS0xLTgzNTU4_7c852c09-900b-4373-a20a-05ff08c7cf0d">18,260</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae88e8a7906f4f01a07b94eb7dc2e2bf_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzE0LTktMS0xLTgzNTU4_d9b727ee-e10e-435e-926c-d65525825a4d">531,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i18044c22d5b544cdbb5fdd7bb2fe76d4_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzE2LTEtMS0xLTgzNTU4_5999fad2-65df-4efe-aa02-6adbcd08c09f">705,798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i18044c22d5b544cdbb5fdd7bb2fe76d4_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzE2LTMtMS0xLTgzNTU4_51337161-9156-48f2-b806-7be8037485bc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i18044c22d5b544cdbb5fdd7bb2fe76d4_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzE2LTUtMS0xLTgzNTU4_0916249a-b639-400e-a79e-f7f7f2b4a694">20,494</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i18044c22d5b544cdbb5fdd7bb2fe76d4_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzE2LTktMS0xLTgzNTU4_48dec902-2a9f-4751-8910-8d92f80c8a5a">685,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents and marketable securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="docs:CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzE3LTEtMS0xLTgzNTU4_5ca0fd68-7ed7-4e41-84cd-df75472157f9">728,556</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzE3LTMtMS0xLTgzNTU4_c2506196-3178-4986-b6ed-973f7e263fd6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzE3LTUtMS0xLTgzNTU4_7fe55c1f-e5dd-4cf2-aab8-4bfca4f9db4e">20,494</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsAndShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzE3LTktMS0xLTgzNTU4_ed15f827-86fb-47c3-87fa-c7b50e6d5059">708,062</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90ZXh0cmVnaW9uOjBkZjE1MmE3YzBiNzRlNTBiNTQxYTNkZjMwNDM3OTczXzU2NjI0ODQ4ODQxMDM5_028058d3-4cac-45ae-b380-d111f38e4f00" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the contractual maturities of the Company&#8217;s available-for-sale debt securities were as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:87.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.596%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Due within one year</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo4MzUwYjk4YWI3Zjk0YWEzYTlhMjY1MzE2MGRlNzhmZS90YWJsZXJhbmdlOjgzNTBiOThhYjdmOTRhYTNhOWEyNjUzMTYwZGU3OGZlXzEtMS0xLTEtODM1NTg_818b406d-01cb-4f5b-894b-c57dbc6c646a">157,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Due in one year to three years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="docs:DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo4MzUwYjk4YWI3Zjk0YWEzYTlhMjY1MzE2MGRlNzhmZS90YWJsZXJhbmdlOjgzNTBiOThhYjdmOTRhYTNhOWEyNjUzMTYwZGU3OGZlXzItMS0xLTEtODM1NTg_dcab6b27-4ee4-417e-be35-a5fcaa77a9d7">530,042</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo4MzUwYjk4YWI3Zjk0YWEzYTlhMjY1MzE2MGRlNzhmZS90YWJsZXJhbmdlOjgzNTBiOThhYjdmOTRhYTNhOWEyNjUzMTYwZGU3OGZlXzMtMS0xLTEtODM1NTg_65e8ae7a-bc35-41eb-88fe-f6b559019619">687,990</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:continuation id="i6b2cd657b2614762a62f5abcbc52e04f"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost, gross unrealized gains and losses, and fair value of investments were as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cost or<br/>Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i604823b3602e46ca831f8718dbb39615_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzMtMS0xLTEtODM1NTg_cd5a4ed5-2db0-422b-bebc-36955d557ac0">2,290</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i604823b3602e46ca831f8718dbb39615_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzMtMy0xLTEtODM1NTg_9f3b445d-24cc-4562-810b-ed4c2cb53d84">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i604823b3602e46ca831f8718dbb39615_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzMtNS0xLTEtODM1NTg_98430932-e5fe-43c6-82e4-f4693730cae4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i604823b3602e46ca831f8718dbb39615_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzMtOS0xLTEtODM1NTg_cdb975ff-3226-462f-a433-69d812f9c1a2">2,290</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Corporate notes and bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4a05c1279cdf4518bd3081538e0be6be_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzQtMS0xLTEtODM1NTg_8a4761fa-5823-4224-a8fc-9d13476283d8">3,517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4a05c1279cdf4518bd3081538e0be6be_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzQtMy0xLTEtODM1NTg_5461cd46-5179-40e0-a1c9-853408e5f52f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4a05c1279cdf4518bd3081538e0be6be_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzQtNS0xLTEtODM1NTg_9c4004b8-5a11-4e2f-9990-86d0bfed4f0d">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4a05c1279cdf4518bd3081538e0be6be_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzQtOS0xLTEtODM1NTg_ad87014b-4719-4a97-a3b6-6363a93df1f0">3,516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Money market funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id244d9fec7044321a9fb14e83f5984f8_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzUtMS0xLTEtODM1NTg_e9ad4223-7994-4b21-9e70-d54afcf3db1b">9,838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id244d9fec7044321a9fb14e83f5984f8_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzUtMy0xLTEtODM1NTg_8124bca1-e06a-4ba2-b67c-88390192dd51">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id244d9fec7044321a9fb14e83f5984f8_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzUtNS0xLTEtODM1NTg_b7b79048-56c5-4ca1-9716-42616b1e0733">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id244d9fec7044321a9fb14e83f5984f8_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzUtOS0xLTEtODM1NTg_a8cb212a-3396-4971-8e18-49e41caad058">9,838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0ccabfb89c594e59b08be568c57aa776_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzYtMS0xLTEtODM1NTg_7f6340bb-b08a-46be-b6e2-7b464d2948f9">1,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0ccabfb89c594e59b08be568c57aa776_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzYtMy0xLTEtODM1NTg_d34120c1-eb53-4c53-8d5a-867b3dbef657">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0ccabfb89c594e59b08be568c57aa776_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzYtNS0xLTEtODM1NTg_18fe21b0-623e-4be4-a97f-d464d15d4080">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0ccabfb89c594e59b08be568c57aa776_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzYtOS0xLTEtODM1NTg_749bfcf3-5e94-47fc-9207-a7f78aa8dbb9">1,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i48c4441bdd464dc0bb658f1e52a50fae_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzctMS0xLTEtODM1NTg_1537c87c-d22c-41c4-aa91-eadf853db432">16,946</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i48c4441bdd464dc0bb658f1e52a50fae_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzctMy0xLTEtODM1NTg_86616619-c87e-4bc5-b151-eecb569f5a1c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i48c4441bdd464dc0bb658f1e52a50fae_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzctNS0xLTEtODM1NTg_36ef0a39-2bb2-4b43-bc9f-0ad899c45934">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i48c4441bdd464dc0bb658f1e52a50fae_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzctOS0xLTEtODM1NTg_b9a49d33-1d5f-4fb6-9154-dee8ce51144d">16,945</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i87abe2fab1ba4ef68a9cb17800dc430a_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzktMS0xLTEtODM1NTg_7948821d-35a3-4014-98cb-8f9c5b7ef4f1">3,264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i87abe2fab1ba4ef68a9cb17800dc430a_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzktMy0xLTEtODM1NTg_aaa1414d-6a4a-49ca-83d5-ec330fe08a52">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i87abe2fab1ba4ef68a9cb17800dc430a_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzktNS0xLTEtODM1NTg_d5e6181f-f323-4b04-8c13-8b11c41fcf6c">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i87abe2fab1ba4ef68a9cb17800dc430a_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzktOS0xLTEtODM1NTg_897d16e6-a1df-4bb6-8b3e-8ab0590e9178">3,263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4e9550589bbf443f8841000a6dfbb584_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzEwLTEtMS0xLTgzNTU4_51faed7b-75d7-457e-b735-53ad989829be">4,867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4e9550589bbf443f8841000a6dfbb584_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzEwLTMtMS0xLTgzNTU4_10275072-a3bd-4766-babd-6155a75a8b63">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4e9550589bbf443f8841000a6dfbb584_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzEwLTUtMS0xLTgzNTU4_836f0a7e-16fc-4e52-b8e4-970f7f7ad8a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4e9550589bbf443f8841000a6dfbb584_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzEwLTktMS0xLTgzNTU4_6aa3efea-269f-4dd2-a674-b59732fee8bb">4,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ide076cccc18c49e3a68b3143aa7c33e6_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzExLTEtMS0xLTgzNTU4_f4d604a7-6f1e-4574-8953-e01deee3012d">16,411</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ide076cccc18c49e3a68b3143aa7c33e6_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzExLTMtMS0xLTgzNTU4_883d5430-39fd-4778-9a7b-fc50d1adb02b">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ide076cccc18c49e3a68b3143aa7c33e6_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzExLTUtMS0xLTgzNTU4_92a63452-7139-4e36-b102-c4e2fd26d8ce">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ide076cccc18c49e3a68b3143aa7c33e6_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzExLTktMS0xLTgzNTU4_359b88b0-60e7-4a0b-a524-2d46951a7e03">16,412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Corporate notes and bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88dd752efb47fab5bb0033f85e57f0_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzEyLTEtMS0xLTgzNTU4_0c9c1535-0575-4461-bb73-dce09184b0f3">46,662</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88dd752efb47fab5bb0033f85e57f0_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzEyLTMtMS0xLTgzNTU4_c9ff9f1f-41d1-4b8d-a05e-c49f8ff6be49">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="iec88dd752efb47fab5bb0033f85e57f0_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzEyLTUtMS0xLTgzNTU4_2ad78a11-4651-4d63-a5ad-9ba49300e84a">24</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec88dd752efb47fab5bb0033f85e57f0_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzEyLTktMS0xLTgzNTU4_50ea9d7d-f5eb-40c6-bd5e-3c6fa3de92db">46,641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sovereign bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib527f78664c7491ea47de8f8270b318c_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzEzLTEtMS0xLTgzNTU4_2ee1b482-c20c-4253-b298-09a36244dd50">1,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib527f78664c7491ea47de8f8270b318c_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzEzLTMtMS0xLTgzNTU4_4bea9656-145b-4ff7-a1ce-ebcebcaec99c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ib527f78664c7491ea47de8f8270b318c_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzEzLTUtMS0xLTgzNTU4_1078e545-f88f-4e62-9305-410d7fc0ce29">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib527f78664c7491ea47de8f8270b318c_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzEzLTktMS0xLTgzNTU4_ef890b6a-0b0a-4891-9a13-374d822abe39">1,099</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iacfd3978047743d09395e66d7259d2ff_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzE0LTEtMS0xLTgzNTU4_9efdd27f-8b12-4558-bd55-2094dc2b00f0">3,857</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iacfd3978047743d09395e66d7259d2ff_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzE0LTMtMS0xLTgzNTU4_c4e86d40-57c9-4252-a2b5-6453f9cec5f6">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iacfd3978047743d09395e66d7259d2ff_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzE0LTUtMS0xLTgzNTU4_b66f241c-1cce-42d7-acd1-b7e4bcacea84">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iacfd3978047743d09395e66d7259d2ff_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzE0LTktMS0xLTgzNTU4_433d6a04-3ff4-49cf-a4b5-aba4ea0fa24f">3,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i38b0eb18f6f9433eb026f897885f67f9_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzE1LTEtMS0xLTgzNTU4_3915518e-3f69-4d7b-9a42-fdfd6f51fc33">76,161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i38b0eb18f6f9433eb026f897885f67f9_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzE1LTMtMS0xLTgzNTU4_286de396-d03a-4bf3-b801-f8216f918e87">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i38b0eb18f6f9433eb026f897885f67f9_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzE1LTUtMS0xLTgzNTU4_2825410b-a5ef-4f66-9475-31137aafade6">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i38b0eb18f6f9433eb026f897885f67f9_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzE1LTktMS0xLTgzNTU4_1c25d3cc-5fe9-4270-a9e8-b292a3fdf34e">76,141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents and marketable securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzE2LTEtMS0xLTgzNTU4_557aee50-1973-4cf2-8072-e4912d2896fa">93,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzE2LTMtMS0xLTgzNTU4_c61bffd2-4d9f-48a6-ac8d-d69e579314b6">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzE2LTUtMS0xLTgzNTU4_45c20189-3b5d-4f1b-8221-dac78d0a270a">27</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzE2LTktMS0xLTgzNTU4_63217822-da30-4fd1-a707-4835f7159101">93,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022 and 2021, the Company has recognized accrued interest of $<ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90ZXh0cmVnaW9uOjBkZjE1MmE3YzBiNzRlNTBiNTQxYTNkZjMwNDM3OTczXzI5MTM3MDU4MTQ2MDc2_2cfeb562-56e7-4902-901a-ac37d5af7fff">2.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-5" name="us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90ZXh0cmVnaW9uOjBkZjE1MmE3YzBiNzRlNTBiNTQxYTNkZjMwNDM3OTczXzI5MTM3MDU4MTQ2MDk0_d6283ace-55c4-436c-867d-80bbffcaec70">0.3</ix:nonFraction> million, respectively, which is included in prepaid expenses and other current assets in the consolidated balance sheets. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="i33d778b9b8ac4403bfca5f362ac69a0c"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unrealized losses associated with the Company&#8217;s debt securities were $<ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90ZXh0cmVnaW9uOjBkZjE1MmE3YzBiNzRlNTBiNTQxYTNkZjMwNDM3OTczXzI5MTM3MDU4MTQ2MTM5_5bed2778-ebe9-498b-ad72-32c4d987d0c3">20.5</ix:nonFraction> million as of March&#160;31, 2022. As the Company does not intend to sell these securities and it is more likely than not that the Company will hold these securities until maturity or until the cost basis is recovered, the Company did <ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="0" name="docs:DebtSecuritiesAvailableForSaleImpairmentsLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90ZXh0cmVnaW9uOjBkZjE1MmE3YzBiNzRlNTBiNTQxYTNkZjMwNDM3OTczXzI5MTM3MDU4MTUyODkz_43e04676-17f4-44ec-87ca-24f822b07714">no</ix:nonFraction>t recognize any impairment on these securities as of March&#160;31, 2022. The Company did <ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleChangeInPresentValueExpenseReversal" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90ZXh0cmVnaW9uOjBkZjE1MmE3YzBiNzRlNTBiNTQxYTNkZjMwNDM3OTczXzI5MTM3MDU4MTQ2MTUw_2782a44d-dbdd-46d2-9110-544c09f3ff7d">no</ix:nonFraction>t recognize any credit losses related to the Company&#8217;s debt securities during the fiscal year ended March&#160;31, 2022. The fair value related to the debt securities with unrealized loss for which no credit losses were recognized was $<ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-5" name="docs:DebtSecuritiesAvailableForSaleWithNoCreditAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90ZXh0cmVnaW9uOjBkZjE1MmE3YzBiNzRlNTBiNTQxYTNkZjMwNDM3OTczXzI5MTM3MDU4MTQ2MjI4_eda81a9d-14e0-46c2-9125-c1b72d409ad9">684.7</ix:nonFraction> million as of March&#160;31, 2022. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unrealized losses associated with the Company&#8217;s debt securities were <ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90ZXh0cmVnaW9uOjBkZjE1MmE3YzBiNzRlNTBiNTQxYTNkZjMwNDM3OTczXzI5MTM3MDU4MTQ2MjY2_07131054-3bc0-4ddf-af25-44adb4f0af39">no</ix:nonFraction>t material as of March&#160;31, 2021. The Company did <ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="INF" name="us-gaap:DebtSecuritiesAvailableForSaleChangeInPresentValueExpenseReversal" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90ZXh0cmVnaW9uOjBkZjE1MmE3YzBiNzRlNTBiNTQxYTNkZjMwNDM3OTczXzI5MTM3MDU4MTQ2Mjg5_2e1c941e-bb24-4f90-b48b-435f366aa8ef">no</ix:nonFraction>t recognize any credit losses related to the Company&#8217;s debt securities during the fiscal year ended March&#160;31, 2021.</span></div></ix:continuation><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="i6c4404140edb48938ba4e30b290c9ef9_2461"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGV4dHJlZ2lvbjo0Njc1NGE1MTJmOGE0YWJlOTU2YTUzZDkyMzU3MjE2Nl81NjYyNDg0ODgzMzY4NA_f0d35a2e-1174-43c8-bf0e-fd01d405e200" continuedAt="iae13ab757b874f73be64841fdf3080f7" escape="true">Fair Value Measurements </ix:nonNumeric></span></div><ix:continuation id="iae13ab757b874f73be64841fdf3080f7"><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGV4dHJlZ2lvbjo0Njc1NGE1MTJmOGE0YWJlOTU2YTUzZDkyMzU3MjE2Nl81NjYyNDg0ODgzMzY4NQ_8f81ab72-629f-49e9-8cfb-03a189adaf5c" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the fair value hierarchy for the Company&#8217;s assets measured at fair value on a recurring basis (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 3</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibcd72d89f10e46c5b83365968fb5b465_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8zLTEtMS0xLTgzNjAx_9eb461c3-c2d8-4066-a3eb-43460cf79388">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i44d67e5169294894b512b0b90c0c74af_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8zLTMtMS0xLTgzNjAx_59472335-70db-4874-9639-4eca4f889fbd">2,686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4f0c5fbad8e940fd82c45fb0835f9376_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8zLTUtMS0xLTgzNjAx_df6d72b3-bb6c-4ecc-b60e-7f7c43d62dd8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i26380d7634b346848bd64d717640dbd3_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8zLTctMS0xLTgzNjAx_bc37f566-8688-430b-9732-42a3bedb0eaa">2,686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2990b50678e04606a12ac8e532c0f906_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF81LTEtMS0xLTgzNjAx_daaa0bc7-b2c3-4cab-bdf2-a39aa0bf4076">20,072</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i98b116561d274486a93f0e9b833bbc09_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF81LTMtMS0xLTgzNjAx_9af537f8-69ca-461b-b2d4-ff43a1c72df2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i13a7068cde934ebfaf0a93dc825b200e_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF81LTUtMS0xLTgzNjAx_c5c187e9-3f39-4960-9ede-cb3329ece324">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i103e1316eb1546e9a33a93b9ee8e5d23_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF81LTctMS0xLTgzNjAx_4f006121-b156-40a0-812b-39ec92b82f55">20,072</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i659c295d408e40e8921b445dd9705cba_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF83LTEtMS0xLTgzNjAx_e7fb3a8a-43e3-4f4a-9cc7-b98021b1f4ab">20,072</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if2b46ddbd30649f9964d6b0aef51743e_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF83LTMtMS0xLTgzNjAx_77c8eac7-a40f-494b-8f44-0ffcc59f5854">2,686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2a78b23143e94b05b7011088f1bde0b1_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF83LTUtMS0xLTgzNjAx_182ee517-41ad-43e3-a804-bee2b598bca8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3f12428258e7416aa2c26ccc9570922a_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF83LTctMS0xLTgzNjAx_536f3cee-6aed-4177-bcf1-9ca480a59504">22,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i721efafc234b48ab8ea99bb7a86b14aa_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF85LTEtMS0xLTgzNjAx_0fa94706-610c-44fc-888a-41f569489095">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6f8b0fb1f6524927bd336e7e7061c237_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF85LTMtMS0xLTgzNjAx_011ed065-9ac0-40b1-aa6d-29030958f695">7,740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id38c2d8b49424805aa289162c32d7b9e_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF85LTUtMS0xLTgzNjAx_042f288e-cb2b-498a-b149-3c0090c1a24c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i474320908a7b41cc92efce9528819f7b_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF85LTctMS0xLTgzNjAx_fe967102-cb82-4982-a5d7-fd14b37fd958">7,740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i532a3e060f834264ba3c527d40875cdc_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xMS0xLTEtMS04MzYwMQ_8b47f5f4-8081-44ae-a552-6cf3ac4f4890">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9f7356c1933c44718bcba9bf1f352ba2_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xMS0zLTEtMS04MzYwMQ_fc1bfc00-10ed-4a6d-b803-c6ab42973120">9,383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i626d1eeffa1343138b59969cf31cd762_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xMS01LTEtMS04MzYwMQ_d501fcfb-449a-4ef4-88db-5f18651c435a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4d81508e21044c96b9ecd160987e38c8_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xMS03LTEtMS04MzYwMQ_52f1f475-07b5-489f-b604-fc474bfc9d00">9,383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Corporate notes and bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i932aa3c5dd54406697aee512b3d1806e_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xMi0xLTEtMS04MzYwMQ_74414aa9-b794-41e4-839a-2167d2284954">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3721da26311a44e19ada2d73129c607c_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xMi0zLTEtMS04MzYwMQ_47db5b24-67c0-4fcf-be65-03c82b84d510">128,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib6c70759748f44a39409b9430d98472c_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xMi01LTEtMS04MzYwMQ_1613e848-471f-4a2e-8d06-44e5702d7d23">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4a3cd669c0874efaa60ccd3fd01baaa5_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xMi03LTEtMS04MzYwMQ_e1d4970d-1b22-4a01-917a-03d0f546dd62">128,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sovereign bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i982c335e998347a28b119b85613cdb3a_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xMy0xLTEtMS04MzYwMQ_6d55ebea-215a-4178-9300-f8a2bd77b9ed">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib38daf1082dc430a9b64f0b7677f6c83_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xMy0zLTEtMS04MzYwMQ_8470ff90-6977-45af-ada3-e1998aaaefe9">8,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i38bda6505b4f4adf916f0a3922a00d63_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xMy01LTEtMS04MzYwMQ_dc3e23ab-e294-4fe7-9390-733ea78ac935">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia91151d0fa9747bb8b8c5d38d7072ad2_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xMy03LTEtMS04MzYwMQ_e2c7abb8-c56c-4629-b729-6a06c0b8f963">8,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i18e4692c47ad48329cebc83bc3799e68_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xNC0xLTEtMS04MzYwMQ_cc6c6137-acad-4ed3-8e91-4314f3ab8fd1">530,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifb043afb1f564202b46d46afa0477aaf_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xNC0zLTEtMS04MzYwMQ_af13798a-e81e-44c2-80c5-ab18845f4c33">1,467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3bcc674299c845768df66da1b2f5bdb2_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xNC01LTEtMS04MzYwMQ_2f7ab420-c754-4366-8617-9166f1dddcc7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iafc2fd89312947f7a003de3d37d11718_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xNC03LTEtMS04MzYwMQ_b50748ed-ba65-4e57-a488-279d7c76f91c">531,641</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ice4e787e809040d7940ae9963883e5f6_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xNi0xLTEtMS04MzYwMQ_1ea924d1-42b7-42b5-b8f3-36d3058740ac">530,174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iac3932efeb454191b80019d9cc3d5da8_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xNi0zLTEtMS04MzYwMQ_b59f8efb-2886-4da4-9af4-aeca5b8f9f5d">155,130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib9b4c1c4fcf94d5695baa53fb6a9f916_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xNi01LTEtMS04MzYwMQ_43d73544-79f5-454d-b7a5-55cb9fec5993">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i86cda120cc8c4375b1f2178ee70c45d1_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xNi03LTEtMS04MzYwMQ_e2995454-046e-49f2-825b-f73420a5d14e">685,304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents and marketable securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i578db33c6a934072bbe067902c563ae8_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xNy0xLTEtMS04MzYwMQ_e1fbab55-2f0c-4d8b-a0fa-98db1b2bb007">550,246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4c4f245f500f4927ad1eb8d7f12714bc_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xNy0zLTEtMS04MzYwMQ_106a7e50-9438-4ceb-b892-9ac7003de66a">157,816</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8476dc0fc3544b828b4aacf4934129b5_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xNy01LTEtMS04MzYwMQ_6f86cc2d-e81b-4f07-b726-bc7060bb17d4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie03e89c5126d41ec830e87d4165cf777_I20220331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xNy03LTEtMS04MzYwMQ_f9eec43f-0cd1-4eb1-9db6-78607ccbe286">708,062</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.361%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 3</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i56c340497cf441e683bdc17f8fc2ff7e_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8zLTEtMS0xLTgzNjAx_e5fe7e1d-71d4-4d6c-a05e-8465e5d922a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i99d6758926cc4835972af44c8abfea6e_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8zLTMtMS0xLTgzNjAx_25acc87d-3267-413c-a7ad-59e1ce5d6ba9">2,290</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifa762a9d99d64e26b88344760669498d_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8zLTUtMS0xLTgzNjAx_92e10903-5b07-41a8-8b5a-055db6057bc1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ibb407695229442378be2cc5e6794b4dc_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8zLTctMS0xLTgzNjAx_f77c7ba5-d51f-49d9-a4dd-65299158eab1">2,290</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Corporate notes and bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8c3a8d602839469aa9abd46d6b23c3b7_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl80LTEtMS0xLTgzNjAx_8aac5308-af74-4e2d-859a-3804cbb19f77">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i45d51c39fc29442b936469cf96558a7a_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl80LTMtMS0xLTgzNjAx_b2152b2e-5ef1-4f68-a906-293df0f1a023">3,516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i674cc6fab0fb438a93e5000f47d071fd_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl80LTUtMS0xLTgzNjAx_92189bd3-63e0-4b12-b7f5-aec98cfbfca5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6c14c0c571b24e4a8f722913926177f6_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl80LTctMS0xLTgzNjAx_53210c01-a0d6-4a21-8869-284dda44c403">3,516</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Money market funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i838d198056aa4046821706ffe91ac209_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl81LTEtMS0xLTgzNjAx_89fda72d-bd46-4bd5-83b8-ee797d951c86">9,838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8285a266d2b84f64a873ce73025e5feb_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl81LTMtMS0xLTgzNjAx_dba43dc8-ee5f-449a-b08a-a52236e8a623">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i022beaddadf04d3e99f5082fadd56106_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl81LTUtMS0xLTgzNjAx_bb80ca8f-4848-485c-89c4-1ab11fbfeb5d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6b1782e4152f4dd3a6b1f5b27d8f1bac_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl81LTctMS0xLTgzNjAx_37b6fab9-c1d5-47af-ac8a-3023bb7a8b49">9,838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9b9e40170a94d1597c47f1a840054a0_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl82LTEtMS0xLTgzNjAx_9463da1f-72ab-4ded-a5c7-b62721344f35">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5ed0533ee5e34be3943e9fbebc78267c_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl82LTMtMS0xLTgzNjAx_212192a0-3a54-40ec-9b92-1c2c29cf8d03">1,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9843e9aa5aa34d629a04be568ee0770f_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl82LTUtMS0xLTgzNjAx_93686d43-6c9e-440e-90ba-df2d3c7f8314">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i55a153d9fcf6462a90947a8c0cc01fad_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl82LTctMS0xLTgzNjAx_a51f4ce7-b723-481c-94f6-3dbabc3bb4a0">1,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i92d19978f3d74e8393d55173e3261600_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl83LTEtMS0xLTgzNjAx_03e7c12e-5f52-4e45-bcc8-a40e92ae42d0">9,838</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i58b67667851745b0921de5486a701250_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl83LTMtMS0xLTgzNjAx_640e484f-4495-4aee-98ba-327db7fdcba1">7,107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iabb825f6081140068a661c6fce29a765_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl83LTUtMS0xLTgzNjAx_414544f2-74f3-4a3e-89e8-12b3d4d84e77">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9e5dd024a0ab400e9341bcfe83899418_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl83LTctMS0xLTgzNjAx_a14ac914-fbe6-437d-8ba7-30c09638f704">16,945</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i149cf0ff47ea404db23f4e4a1bc5fcdc_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl85LTEtMS0xLTgzNjAx_a37e33e6-d25a-4410-be9c-3a8039fb61f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i6866262bbd66464e9d4917805ca3ad7e_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl85LTMtMS0xLTgzNjAx_ec7e0ca7-7073-4e1d-a524-e680ccc5086f">3,263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2b6266c5703b4348bebf658eb91fde7f_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl85LTUtMS0xLTgzNjAx_fd062f38-5441-4c2e-9ab2-5b3b1e6ecbcb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia44e2eb3c48e4364866cc26deb91d1a3_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl85LTctMS0xLTgzNjAx_1d78d526-8746-47c2-bddd-47c645f765d3">3,263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5432548d20a44dd691468cebc30236b7_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xMC0xLTEtMS04MzYwMQ_5b1b620e-ea6f-4d79-82e3-0c2cf7956f05">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iea566254ac80466eb792b98fee4468fc_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xMC0zLTEtMS04MzYwMQ_707b854d-9542-4d21-af20-bffe1e87a67a">4,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="if27d9ddc7c024d20a99d07f62ff1a2e1_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xMC01LTEtMS04MzYwMQ_4fcea5b3-dcc6-4c8b-99b4-eb2f50f91823">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib3515ce776444aa4be7ca30f76d95991_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xMC03LTEtMS04MzYwMQ_cafa3260-33cd-425d-a665-14cda7da7bf7">4,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie5c40b8b60cd40c8b22509a920df6d06_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xMS0xLTEtMS04MzYwMQ_6bbeb87f-5979-4a33-9655-dfe3dc75403c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i611917e8f7cf4a16937ba03415273dcd_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xMS0zLTEtMS04MzYwMQ_1c2375b5-16ba-45fd-a756-9649638ae380">16,412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i41a927ca494a4351bd716a0e60b21d1e_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xMS01LTEtMS04MzYwMQ_6de2cd03-75c7-4cb2-83c7-052c3468ffa7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i82b9f2d9387b45499ebeca44b8440fae_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xMS03LTEtMS04MzYwMQ_46fe798d-48c6-455c-a918-07d1f91cc65f">16,412</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Corporate notes and bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i34e4bf763fea49b5bdcf75dc219e7e92_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xMi0xLTEtMS04MzYwMQ_d8ec070a-31a7-4052-8d69-1a0bba62fc81">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i349cf5c5812341ab8fa0686e31856780_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xMi0zLTEtMS04MzYwMQ_8a4eb224-5844-4e55-9c0a-ec3da2b02b77">46,641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1cb90c50d62d4afbb1940f34e2a856de_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xMi01LTEtMS04MzYwMQ_47c025f0-a9d7-4752-aabf-8a0eb633e1e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2f039878467d46c288ef097207b6975b_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xMi03LTEtMS04MzYwMQ_e33f8aa9-becc-449d-b254-99780fbbe512">46,641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sovereign bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i3b01aa2ae05c4047a50651aab2e681d7_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xMy0xLTEtMS04MzYwMQ_6c53ef29-e0f7-4784-8d7f-56ec71c99a7b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i719069eb844247a9b2bd30c54120b216_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xMy0zLTEtMS04MzYwMQ_2103d516-c65a-445b-b60b-133ba0cd5b95">1,099</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3163cbc1f2442c08773e69ca6f51425_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xMy01LTEtMS04MzYwMQ_542c5abd-7805-42df-9b89-2270eea40bfc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5d93e12f702349bd99bf9d5330c3fb1b_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xMy03LTEtMS04MzYwMQ_2cd58e1d-e6de-49cf-905c-ac17ede58cf2">1,099</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i92a4a2d0006947a8927335cfa305416f_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xNC0xLTEtMS04MzYwMQ_c7135df2-8c32-484f-9fb5-69dbf81077a3">3,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="id1df4b610f3946d98ae080e642659498_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xNC0zLTEtMS04MzYwMQ_21553759-166a-4e4d-89da-bc414d7c6eee">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5373de11d949417cbb36d85c87552143_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xNC01LTEtMS04MzYwMQ_ee3d23bc-e5f6-4a67-8d21-817c1517ef79">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia35ead93812940d69566b0152cbba00b_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xNC03LTEtMS04MzYwMQ_a6c9fde7-1d51-43af-afcd-9a2dca77bcf8">3,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i309ea865186047c0a5538f09e3c70ca9_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xNS0xLTEtMS04MzYwMQ_e55f8b7f-698c-409b-a785-f1e9036b9db9">3,858</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib27f206c94d44a2ea0ddaed560a54ac0_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xNS0zLTEtMS04MzYwMQ_743b5865-d242-4eca-af47-7728a2b663ac">72,283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8e0ec08cc952440a92e76047bc39557f_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xNS01LTEtMS04MzYwMQ_1a4ec0a1-2db8-437b-a99d-069da0e4d634">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5de02ef242964b299f7003623da7eef4_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xNS03LTEtMS04MzYwMQ_9450e859-f8d4-4cd1-b263-fb85807d02f3">76,141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents and marketable securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i8fd4715dabf14628bd22641238042d34_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xNi0xLTEtMS04MzYwMQ_58ad6ef8-2018-418b-8920-0d7f5af9e4fe">13,696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ia9f7e9e66c5b4bb09aa27555e1ad1902_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xNi0zLTEtMS04MzYwMQ_13190f31-8bd5-41e3-b4f1-4a639868a802">79,390</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i83568bca22424ed2b2bcc387ae3fc3a2_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xNi01LTEtMS04MzYwMQ_e2386a5b-3b3e-41f6-8070-44cd517ff143">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib1b26c7fd27543afab7eb6101e431209_I20210331" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xNi03LTEtMS04MzYwMQ_14c40437-5a9a-4de3-88f5-0971fe16886a">93,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal years ended March&#160;31, 2022 and 2021, the Company had no transfers between levels of the fair value hierarchy.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><div id="i6c4404140edb48938ba4e30b290c9ef9_196"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.&#160;&#160;<ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90ZXh0cmVnaW9uOjRkYWRhMDgyMTgwMTQyZTE4NTc2MjkyNDBiNjUyZWQ0XzU2NjI0ODQ4ODM1OTg4_5a474adf-ce82-4cd8-911d-6e816eeb9a3a" continuedAt="i9ef983add3e8468883d13f4e472eaa8e" escape="true">Property and Equipment, Net</ix:nonNumeric></span></div><ix:continuation id="i9ef983add3e8468883d13f4e472eaa8e"><ix:continuation id="i38f55304026a4b19888789d79b452fa0"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following (in&#160;thousands):</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.075%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Furniture and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i973ce033b5444e8184b98b45f2f762bf_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90YWJsZTo5NjVmNTk0MTczYmI0MWUyYTk2ZjZiYmZiYWM5NzgwZC90YWJsZXJhbmdlOjk2NWY1OTQxNzNiYjQxZTJhOTZmNmJiZmJhYzk3ODBkXzEtMS0xLTEtODM2ODU_5c621b18-bd89-40ce-9166-556fc2344e66">336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i408a5f0dc11f4858abf1563a67979081_I20210331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90YWJsZTo5NjVmNTk0MTczYmI0MWUyYTk2ZjZiYmZiYWM5NzgwZC90YWJsZXJhbmdlOjk2NWY1OTQxNzNiYjQxZTJhOTZmNmJiZmJhYzk3ODBkXzEtMy0xLTEtODM2ODU_2b5f9c2b-ee50-4411-a242-8dc5993f9ba8">299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Computers and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1da69909cef146178323e0df47516982_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90YWJsZTo5NjVmNTk0MTczYmI0MWUyYTk2ZjZiYmZiYWM5NzgwZC90YWJsZXJhbmdlOjk2NWY1OTQxNzNiYjQxZTJhOTZmNmJiZmJhYzk3ODBkXzItMS0xLTEtODM2ODU_00dbb913-dc82-46e5-a7e7-8d3cfd73dd5d">769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ief36ad090dfc4a189faf599f7900747f_I20210331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90YWJsZTo5NjVmNTk0MTczYmI0MWUyYTk2ZjZiYmZiYWM5NzgwZC90YWJsZXJhbmdlOjk2NWY1OTQxNzNiYjQxZTJhOTZmNmJiZmJhYzk3ODBkXzItMy0xLTEtODM2ODU_af2eaead-4531-4b3b-9eb5-df7247894694">704</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2c6dd1041fd64455ab9d78b3daad3f68_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90YWJsZTo5NjVmNTk0MTczYmI0MWUyYTk2ZjZiYmZiYWM5NzgwZC90YWJsZXJhbmdlOjk2NWY1OTQxNzNiYjQxZTJhOTZmNmJiZmJhYzk3ODBkXzMtMS0xLTEtODM2ODU_f4e512b2-bab1-4e39-a099-c09e12de861a">796</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5edcc49f367e4d8c82a0bbeef2050a74_I20210331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90YWJsZTo5NjVmNTk0MTczYmI0MWUyYTk2ZjZiYmZiYWM5NzgwZC90YWJsZXJhbmdlOjk2NWY1OTQxNzNiYjQxZTJhOTZmNmJiZmJhYzk3ODBkXzMtMy0xLTEtODM2ODU_57f0db7b-19b6-4cd6-8574-951504400220">549</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Internal-use software development costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ib5b202e466ea48b083f080fed8852b3f_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90YWJsZTo5NjVmNTk0MTczYmI0MWUyYTk2ZjZiYmZiYWM5NzgwZC90YWJsZXJhbmdlOjk2NWY1OTQxNzNiYjQxZTJhOTZmNmJiZmJhYzk3ODBkXzQtMS0xLTEtODM2ODU_7c345235-e909-4c84-a458-a4e041128e1f">15,057</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i28a7eabc1a4d486b92834db5677e9a27_I20210331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90YWJsZTo5NjVmNTk0MTczYmI0MWUyYTk2ZjZiYmZiYWM5NzgwZC90YWJsZXJhbmdlOjk2NWY1OTQxNzNiYjQxZTJhOTZmNmJiZmJhYzk3ODBkXzQtMy0xLTEtODM2ODU_a0c0549b-ba37-4fec-acf6-9c7491b79f1d">10,908</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total property and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90YWJsZTo5NjVmNTk0MTczYmI0MWUyYTk2ZjZiYmZiYWM5NzgwZC90YWJsZXJhbmdlOjk2NWY1OTQxNzNiYjQxZTJhOTZmNmJiZmJhYzk3ODBkXzUtMS0xLTEtODM2ODU_8baf2f6c-69f6-4760-995d-62564a36383f">16,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90YWJsZTo5NjVmNTk0MTczYmI0MWUyYTk2ZjZiYmZiYWM5NzgwZC90YWJsZXJhbmdlOjk2NWY1OTQxNzNiYjQxZTJhOTZmNmJiZmJhYzk3ODBkXzUtMy0xLTEtODM2ODU_e7edaab6-3e82-41be-aad2-27b5ff93fef1">12,460</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less: accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90YWJsZTo5NjVmNTk0MTczYmI0MWUyYTk2ZjZiYmZiYWM5NzgwZC90YWJsZXJhbmdlOjk2NWY1OTQxNzNiYjQxZTJhOTZmNmJiZmJhYzk3ODBkXzYtMS0xLTEtODM2ODU_f26dd5ef-2231-491d-933f-5e2261919499">8,470</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90YWJsZTo5NjVmNTk0MTczYmI0MWUyYTk2ZjZiYmZiYWM5NzgwZC90YWJsZXJhbmdlOjk2NWY1OTQxNzNiYjQxZTJhOTZmNmJiZmJhYzk3ODBkXzYtMy0xLTEtODM2ODU_8184729d-adfe-4941-99fa-c516dd92287d">4,862</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90YWJsZTo5NjVmNTk0MTczYmI0MWUyYTk2ZjZiYmZiYWM5NzgwZC90YWJsZXJhbmdlOjk2NWY1OTQxNzNiYjQxZTJhOTZmNmJiZmJhYzk3ODBkXzctMS0xLTEtODM2ODU_00802c34-ca56-45d6-b5e7-ec07209766d5">8,488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90YWJsZTo5NjVmNTk0MTczYmI0MWUyYTk2ZjZiYmZiYWM5NzgwZC90YWJsZXJhbmdlOjk2NWY1OTQxNzNiYjQxZTJhOTZmNmJiZmJhYzk3ODBkXzctMy0xLTEtODM2ODU_ddf1c5af-e84e-4baf-8ce6-f74681b2d030">7,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense on property and equipment for the fiscal years ended March&#160;31, 2022, 2021, and 2020 was $<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90ZXh0cmVnaW9uOjRkYWRhMDgyMTgwMTQyZTE4NTc2MjkyNDBiNjUyZWQ0XzI5MTM3MDU4MTM5NDQ2_26672ad9-ce70-401a-b80a-917edb52c9ea">4.0</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90ZXh0cmVnaW9uOjRkYWRhMDgyMTgwMTQyZTE4NTc2MjkyNDBiNjUyZWQ0XzI5MTM3MDU4MTM5NDU1_8b4358f2-683f-496c-aa64-dcd41eafc68b">2.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90ZXh0cmVnaW9uOjRkYWRhMDgyMTgwMTQyZTE4NTc2MjkyNDBiNjUyZWQ0XzI5MTM3MDU4MTM5NDc2_0292dddb-e8c9-4e9f-ac44-b5a830c3d161">0.9</ix:nonFraction> million, respectively. Included in these amounts was amortization expense for internal-use software development costs of $<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-5" name="us-gaap:CapitalizedComputerSoftwareAmortization1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90ZXh0cmVnaW9uOjRkYWRhMDgyMTgwMTQyZTE4NTc2MjkyNDBiNjUyZWQ0XzI5MTM3MDU4MTQxMTc3_eedee0cd-7bd2-4d94-aa0c-6c541356f336">3.5</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-5" name="us-gaap:CapitalizedComputerSoftwareAmortization1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90ZXh0cmVnaW9uOjRkYWRhMDgyMTgwMTQyZTE4NTc2MjkyNDBiNjUyZWQ0XzI5MTM3MDU4MTQxMTg1_61141241-358f-48c6-9170-eff42f142e0a">2.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-5" name="us-gaap:CapitalizedComputerSoftwareAmortization1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90ZXh0cmVnaW9uOjRkYWRhMDgyMTgwMTQyZTE4NTc2MjkyNDBiNjUyZWQ0XzI5MTM3MDU4MTQxMTky_849dd294-d417-4b0c-abc6-505570b8adcf">0.7</ix:nonFraction> million for the fiscal years ended March&#160;31, 2022, 2021, and 2020, respectively. The amortization of the internal-use software development costs is included in cost of revenue in the consolidated statements of operations. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended March&#160;31, 2022, 2021, and 2020, the Company capitalized $<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-5" name="us-gaap:CapitalizedComputerSoftwareAdditions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90ZXh0cmVnaW9uOjRkYWRhMDgyMTgwMTQyZTE4NTc2MjkyNDBiNjUyZWQ0XzI5MTM3MDU4MTQxMjEx_ed13d0ca-2098-4dea-a170-974db90707d7">4.3</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-5" name="us-gaap:CapitalizedComputerSoftwareAdditions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90ZXh0cmVnaW9uOjRkYWRhMDgyMTgwMTQyZTE4NTc2MjkyNDBiNjUyZWQ0XzI5MTM3MDU4MTQxMjI5_bba0734e-808c-4e9e-bff6-eeda10d32505">4.6</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-5" name="us-gaap:CapitalizedComputerSoftwareAdditions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90ZXh0cmVnaW9uOjRkYWRhMDgyMTgwMTQyZTE4NTc2MjkyNDBiNjUyZWQ0XzI5MTM3MDU4MTQxMjQ3_e0f8cd31-46b8-4e1e-87b2-a646d736ded6">4.1</ix:nonFraction> million, respectively, of internal-use software development costs, which are included in property and equipment, net on the consolidated balance sheets. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:TangibleAssetImpairmentCharges" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90ZXh0cmVnaW9uOjRkYWRhMDgyMTgwMTQyZTE4NTc2MjkyNDBiNjUyZWQ0XzMwNzg2MzI1NTgzMDQw_089f7229-a5b3-48eb-ae09-417ae9418f57"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:TangibleAssetImpairmentCharges" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90ZXh0cmVnaW9uOjRkYWRhMDgyMTgwMTQyZTE4NTc2MjkyNDBiNjUyZWQ0XzMwNzg2MzI1NTgzMDQw_30c2d3e8-c2c4-4421-8824-5440cae76738"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:TangibleAssetImpairmentCharges" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90ZXh0cmVnaW9uOjRkYWRhMDgyMTgwMTQyZTE4NTc2MjkyNDBiNjUyZWQ0XzMwNzg2MzI1NTgzMDQw_d2ddab0c-6b52-4eb0-b3f3-d4035f43c7c8">No</ix:nonFraction></ix:nonFraction></ix:nonFraction> impairment was recognized on property and equipment during the years ended March&#160;31, 2022, 2021, and 2020.</span></div></ix:continuation><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="i6c4404140edb48938ba4e30b290c9ef9_199"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;<ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="docs:AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTkvZnJhZzo1YmNhZmVjYzFlNmE0N2IzOGExODc1YzljMzA0ZmRjMy90ZXh0cmVnaW9uOjViY2FmZWNjMWU2YTQ3YjM4YTE4NzVjOWMzMDRmZGMzXzU2NjI0ODQ4ODMwODg1_809ac93b-74e1-4ae7-8d73-d9b7112a030d" continuedAt="if5cd9cb87e8a4c4abd0a4bcf45e54da3" escape="true">Accrued Expenses and Other Current Liabilities</ix:nonNumeric></span></div><ix:continuation id="if5cd9cb87e8a4c4abd0a4bcf45e54da3"><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="docs:ScheduleOfAccruedLiabilitiesCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTkvZnJhZzo1YmNhZmVjYzFlNmE0N2IzOGExODc1YzljMzA0ZmRjMy90ZXh0cmVnaW9uOjViY2FmZWNjMWU2YTQ3YjM4YTE4NzVjOWMzMDRmZGMzXzU2NjI0ODQ4ODMwODg2_c9327774-819b-42ad-9936-c9b865ff176f" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other current liabilities consisted of the following (in&#160;thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrued commissions</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:AccruedSalesCommissionCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTkvZnJhZzo1YmNhZmVjYzFlNmE0N2IzOGExODc1YzljMzA0ZmRjMy90YWJsZTo0NzcxOGI4OGQxZDQ0YWM1YmFkZWYxZjM3M2M3MTBlNi90YWJsZXJhbmdlOjQ3NzE4Yjg4ZDFkNDRhYzViYWRlZjFmMzczYzcxMGU2XzItMS0xLTEtOTA0Nzg_7754a74d-9f33-41fa-a443-68f4a044e51f">6,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:AccruedSalesCommissionCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTkvZnJhZzo1YmNhZmVjYzFlNmE0N2IzOGExODc1YzljMzA0ZmRjMy90YWJsZTo0NzcxOGI4OGQxZDQ0YWM1YmFkZWYxZjM3M2M3MTBlNi90YWJsZXJhbmdlOjQ3NzE4Yjg4ZDFkNDRhYzViYWRlZjFmMzczYzcxMGU2XzItMy0xLTEtOTA0Nzg_b8d8ec22-d38b-4cfa-a879-c1cc251a7dc5">5,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrued payroll, bonus, and related expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTkvZnJhZzo1YmNhZmVjYzFlNmE0N2IzOGExODc1YzljMzA0ZmRjMy90YWJsZTo0NzcxOGI4OGQxZDQ0YWM1YmFkZWYxZjM3M2M3MTBlNi90YWJsZXJhbmdlOjQ3NzE4Yjg4ZDFkNDRhYzViYWRlZjFmMzczYzcxMGU2XzMtMS0xLTEtNTA0ODc_1c0517a5-e811-4e2c-9600-fe95c4a2ff8f">8,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTkvZnJhZzo1YmNhZmVjYzFlNmE0N2IzOGExODc1YzljMzA0ZmRjMy90YWJsZTo0NzcxOGI4OGQxZDQ0YWM1YmFkZWYxZjM3M2M3MTBlNi90YWJsZXJhbmdlOjQ3NzE4Yjg4ZDFkNDRhYzViYWRlZjFmMzczYzcxMGU2XzMtMy0xLTEtNTA0ODc_21b9e01d-878f-4914-8e05-aaa635a9b0e7">5,006</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Employee contributions under employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="docs:AccruedEmployeeStockPurchasePlanCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTkvZnJhZzo1YmNhZmVjYzFlNmE0N2IzOGExODc1YzljMzA0ZmRjMy90YWJsZTo0NzcxOGI4OGQxZDQ0YWM1YmFkZWYxZjM3M2M3MTBlNi90YWJsZXJhbmdlOjQ3NzE4Yjg4ZDFkNDRhYzViYWRlZjFmMzczYzcxMGU2XzQtMS0xLTEtOTA0Nzg_67526023-349b-4eeb-a5d7-562ee3ddd72c">621</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="docs:AccruedEmployeeStockPurchasePlanCurrent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTkvZnJhZzo1YmNhZmVjYzFlNmE0N2IzOGExODc1YzljMzA0ZmRjMy90YWJsZTo0NzcxOGI4OGQxZDQ0YWM1YmFkZWYxZjM3M2M3MTBlNi90YWJsZXJhbmdlOjQ3NzE4Yjg4ZDFkNDRhYzViYWRlZjFmMzczYzcxMGU2XzQtMy0xLTEtOTA0Nzg_d8214fee-4e2e-4505-92ea-842f0e609fc5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Rebate liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="docs:RebateLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTkvZnJhZzo1YmNhZmVjYzFlNmE0N2IzOGExODc1YzljMzA0ZmRjMy90YWJsZTo0NzcxOGI4OGQxZDQ0YWM1YmFkZWYxZjM3M2M3MTBlNi90YWJsZXJhbmdlOjQ3NzE4Yjg4ZDFkNDRhYzViYWRlZjFmMzczYzcxMGU2XzUtMS0xLTEtOTA0Nzg_0039bf7d-17eb-483a-b1b2-aa44f25c7e6b">4,933</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="docs:RebateLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTkvZnJhZzo1YmNhZmVjYzFlNmE0N2IzOGExODc1YzljMzA0ZmRjMy90YWJsZTo0NzcxOGI4OGQxZDQ0YWM1YmFkZWYxZjM3M2M3MTBlNi90YWJsZXJhbmdlOjQ3NzE4Yjg4ZDFkNDRhYzViYWRlZjFmMzczYzcxMGU2XzUtMy0xLTEtOTA0Nzg_3d6d1606-96be-4aa4-a157-4bb99956de27">1,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sales and other tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:TaxesPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTkvZnJhZzo1YmNhZmVjYzFlNmE0N2IzOGExODc1YzljMzA0ZmRjMy90YWJsZTo0NzcxOGI4OGQxZDQ0YWM1YmFkZWYxZjM3M2M3MTBlNi90YWJsZXJhbmdlOjQ3NzE4Yjg4ZDFkNDRhYzViYWRlZjFmMzczYzcxMGU2XzQtMS0xLTEtNTA0ODc_5c04f397-a0e0-40ed-a495-76c1e89035be">785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:TaxesPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTkvZnJhZzo1YmNhZmVjYzFlNmE0N2IzOGExODc1YzljMzA0ZmRjMy90YWJsZTo0NzcxOGI4OGQxZDQ0YWM1YmFkZWYxZjM3M2M3MTBlNi90YWJsZXJhbmdlOjQ3NzE4Yjg4ZDFkNDRhYzViYWRlZjFmMzczYzcxMGU2XzQtMy0xLTEtNTA0ODc_1f7af170-b2c6-4b53-b1ef-077a24e8afdc">410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTkvZnJhZzo1YmNhZmVjYzFlNmE0N2IzOGExODc1YzljMzA0ZmRjMy90YWJsZTo0NzcxOGI4OGQxZDQ0YWM1YmFkZWYxZjM3M2M3MTBlNi90YWJsZXJhbmdlOjQ3NzE4Yjg4ZDFkNDRhYzViYWRlZjFmMzczYzcxMGU2XzUtMS0xLTEtNTA0ODc_b56d5cfb-69a3-4edd-84b3-0c6a4f0b1b30">4,263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTkvZnJhZzo1YmNhZmVjYzFlNmE0N2IzOGExODc1YzljMzA0ZmRjMy90YWJsZTo0NzcxOGI4OGQxZDQ0YWM1YmFkZWYxZjM3M2M3MTBlNi90YWJsZXJhbmdlOjQ3NzE4Yjg4ZDFkNDRhYzViYWRlZjFmMzczYzcxMGU2XzUtMy0xLTEtNTA0ODc_5a86b071-db44-4c08-a7b2-be250dbf0b9e">3,547</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total accrued expenses and other current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTkvZnJhZzo1YmNhZmVjYzFlNmE0N2IzOGExODc1YzljMzA0ZmRjMy90YWJsZTo0NzcxOGI4OGQxZDQ0YWM1YmFkZWYxZjM3M2M3MTBlNi90YWJsZXJhbmdlOjQ3NzE4Yjg4ZDFkNDRhYzViYWRlZjFmMzczYzcxMGU2XzYtMS0xLTEtNTA0ODc_197a177c-27ce-4bca-9df7-9f4392e75d23">25,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTkvZnJhZzo1YmNhZmVjYzFlNmE0N2IzOGExODc1YzljMzA0ZmRjMy90YWJsZTo0NzcxOGI4OGQxZDQ0YWM1YmFkZWYxZjM3M2M3MTBlNi90YWJsZXJhbmdlOjQ3NzE4Yjg4ZDFkNDRhYzViYWRlZjFmMzczYzcxMGU2XzYtMy0xLTEtNTA0ODc_60c95756-a6fb-4783-87dd-48d7764785d0">16,285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="i6c4404140edb48938ba4e30b290c9ef9_202"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;&#160;<ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="docs:BusinessCombinationGoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90ZXh0cmVnaW9uOjVmZmEwNzUyZGExODQ2ZjFhMTMwZDU5ZGY4YmY3ODA1XzQ0NTMwMjIwOTM0MzI3_44204574-ef28-4285-8d33-8b6a2092ae0a" continuedAt="i1c6e0f51661544478259e42a03e26d89" escape="true">Business Combinations, Intangible Assets, and Goodwill</ix:nonNumeric></span></div><ix:continuation id="i1c6e0f51661544478259e42a03e26d89" continuedAt="i4bbaae77b3c0418c8f2cde0b0ab13f8c"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Curative Talent Acquisition </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2020, the Company completed the acquisition of THMED, LLC (subsequently renamed Curative Talent, LLC, &#8220;Curative&#8221;), which was accounted for as a business combination. Curative provides temporary and permanent healthcare staffing services to hospitals, medical groups, and other healthcare facilities across the United States. The acquisition-date fair value of the consideration transferred was $<ix:nonFraction unitRef="usd" contextRef="i1f64c4a29d62477a8fad14379556ccb8_D20200401-20200401" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90ZXh0cmVnaW9uOjVmZmEwNzUyZGExODQ2ZjFhMTMwZDU5ZGY4YmY3ODA1XzI5MTM3MDU4MTQyMTQ2_cd67e320-348f-49e4-bcdd-873d493181d8">34.7</ix:nonFraction> million, consisting of $<ix:nonFraction unitRef="usd" contextRef="i1f64c4a29d62477a8fad14379556ccb8_D20200401-20200401" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90ZXh0cmVnaW9uOjVmZmEwNzUyZGExODQ2ZjFhMTMwZDU5ZGY4YmY3ODA1XzI5MTM3MDU4MTQyMTY1_ec1811ed-d0c3-4769-9b31-5f0d344a2633">33.6</ix:nonFraction> million in cash and <ix:nonFraction unitRef="shares" contextRef="i1f64c4a29d62477a8fad14379556ccb8_D20200401-20200401" decimals="INF" name="us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90ZXh0cmVnaW9uOjVmZmEwNzUyZGExODQ2ZjFhMTMwZDU5ZGY4YmY3ODA1XzI5MTM3MDU4MTQyMTc4_36f29736-066f-4b6a-ac73-b10b58aedb28">689,656</ix:nonFraction> shares of common stock valued at $<ix:nonFraction unitRef="usd" contextRef="i1f64c4a29d62477a8fad14379556ccb8_D20200401-20200401" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90ZXh0cmVnaW9uOjVmZmEwNzUyZGExODQ2ZjFhMTMwZDU5ZGY4YmY3ODA1XzI5MTM3MDU4MTQyMTkz_e8be0fa4-e53d-4864-83e5-6526397cc940">1.1</ix:nonFraction> million. The purchase consideration was allocated to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values as of the acquisition date, with the excess recorded to goodwill as shown below. <ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90ZXh0cmVnaW9uOjVmZmEwNzUyZGExODQ2ZjFhMTMwZDU5ZGY4YmY3ODA1XzQ0NTMwMjIwOTM0MzI4_b9017b92-c5fa-4341-ab2d-8c3feffc222e" continuedAt="i13c43103c32446d3b19bd4947420ee3c" escape="true">The purchase consideration allocation was as follows (in thousands):</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="i4bbaae77b3c0418c8f2cde0b0ab13f8c" continuedAt="ia90885ed349f498eb2f58d63586c11bd"><div style="margin-bottom:9pt;text-align:justify"><ix:continuation id="i13c43103c32446d3b19bd4947420ee3c"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Assets acquired: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79a66d68c93b4bd0b2886189e06be17c_I20200401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTo2ZTI3YzA5MzgzNmU0YzJjYmM3ZmMzMWMwMjI0MmE2OS90YWJsZXJhbmdlOjZlMjdjMDkzODM2ZTRjMmNiYzdmYzMxYzAyMjQyYTY5XzEtMS0xLTEtNTA1MDA_41fc7f7e-0dbf-428a-b35c-75226a9e1299">1,972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i79a66d68c93b4bd0b2886189e06be17c_I20200401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTo2ZTI3YzA5MzgzNmU0YzJjYmM3ZmMzMWMwMjI0MmE2OS90YWJsZXJhbmdlOjZlMjdjMDkzODM2ZTRjMmNiYzdmYzMxYzAyMjQyYTY5XzItMS0xLTEtNTA1MDA_79eaa4a0-422d-4dad-b7bd-70abb48ee8c4">4,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i79a66d68c93b4bd0b2886189e06be17c_I20200401" decimals="-3" name="docs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTo2ZTI3YzA5MzgzNmU0YzJjYmM3ZmMzMWMwMjI0MmE2OS90YWJsZXJhbmdlOjZlMjdjMDkzODM2ZTRjMmNiYzdmYzMxYzAyMjQyYTY5XzMtMS0xLTEtNTA1MDA_d01b84f9-4de0-4f8b-8ebe-63882e82fd6a">1,503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i79a66d68c93b4bd0b2886189e06be17c_I20200401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTo2ZTI3YzA5MzgzNmU0YzJjYmM3ZmMzMWMwMjI0MmE2OS90YWJsZXJhbmdlOjZlMjdjMDkzODM2ZTRjMmNiYzdmYzMxYzAyMjQyYTY5XzQtMS0xLTEtNTA1MDA_b72c4972-e9f2-453d-9a03-75bd3e4a0357">10,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total assets acquired</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i79a66d68c93b4bd0b2886189e06be17c_I20200401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTo2ZTI3YzA5MzgzNmU0YzJjYmM3ZmMzMWMwMjI0MmE2OS90YWJsZXJhbmdlOjZlMjdjMDkzODM2ZTRjMmNiYzdmYzMxYzAyMjQyYTY5XzUtMS0xLTEtNTA1MDA_74256f53-0749-48a9-a9b0-24fb78ba56a6">17,830</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Liabilities assumed:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts payable and accrued liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i79a66d68c93b4bd0b2886189e06be17c_I20200401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTo2ZTI3YzA5MzgzNmU0YzJjYmM3ZmMzMWMwMjI0MmE2OS90YWJsZXJhbmdlOjZlMjdjMDkzODM2ZTRjMmNiYzdmYzMxYzAyMjQyYTY5XzgtMS0xLTEtNTA1MDA_2a5dc538-6eb1-478f-b851-05d8667dca1b">2,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net assets acquired, excluding goodwill</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i79a66d68c93b4bd0b2886189e06be17c_I20200401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTo2ZTI3YzA5MzgzNmU0YzJjYmM3ZmMzMWMwMjI0MmE2OS90YWJsZXJhbmdlOjZlMjdjMDkzODM2ZTRjMmNiYzdmYzMxYzAyMjQyYTY5XzktMS0xLTEtNTA1MDA_639ea852-837f-418c-9602-d1cd24aa39b8">15,800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Goodwill</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i79a66d68c93b4bd0b2886189e06be17c_I20200401" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTo2ZTI3YzA5MzgzNmU0YzJjYmM3ZmMzMWMwMjI0MmE2OS90YWJsZXJhbmdlOjZlMjdjMDkzODM2ZTRjMmNiYzdmYzMxYzAyMjQyYTY5XzEwLTEtMS0xLTUwNTAw_e4259cca-c2ab-4614-9eb1-a867e917c329">18,915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total purchase consideration</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i79a66d68c93b4bd0b2886189e06be17c_I20200401" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTo2ZTI3YzA5MzgzNmU0YzJjYmM3ZmMzMWMwMjI0MmE2OS90YWJsZXJhbmdlOjZlMjdjMDkzODM2ZTRjMmNiYzdmYzMxYzAyMjQyYTY5XzExLTEtMS0xLTUwNTAw_b29c85d7-f207-43bd-ae80-842fe9335fa9">34,715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the future benefits as a result of the acquisition that will enhance the Company&#8217;s product available to both new and existing customers and increase the Company&#8217;s competitive position. Goodwill is deductible for income tax purposes. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s acquisition-related costs were $<ix:nonFraction unitRef="usd" contextRef="iee7d28ec87cf452fb10c202c80f90fbe_D20190401-20200331" decimals="-5" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90ZXh0cmVnaW9uOjVmZmEwNzUyZGExODQ2ZjFhMTMwZDU5ZGY4YmY3ODA1XzI5MTM3MDU4MTQyMjEx_a3ac7e54-42d5-4666-9cae-1a1fa33d1f9e">1.2</ix:nonFraction> million and were recorded as general and administrative expense in the Company&#8217;s consolidated statements of operations during the fiscal year ended March&#160;31, 2020.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets acquired are comprised of customer relationships with an estimated useful life of <ix:nonNumeric contextRef="i57a0104cac79435c8a441386b54274b2_D20200401-20200401" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90ZXh0cmVnaW9uOjVmZmEwNzUyZGExODQ2ZjFhMTMwZDU5ZGY4YmY3ODA1XzI5MTM3MDU4MTQyMjQx_7caacd51-a7da-4fba-a04b-1d8d4202edb9">10</ix:nonNumeric> years. The fair value assigned to the customer relationship was determined primarily using the multiple period excess earnings method cost approach, which estimates the direct cash flows expected to be generated from the existing customers acquired. The results of operations of this business combination have been included in the Company&#8217;s consolidated financial statements from the acquisition date. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the Company sold a portion of Curative Talent&#8217;s business for total consideration of $<ix:nonFraction unitRef="usd" contextRef="if7cf2424c4f2444491451d34b70a6297_I20201031" decimals="-5" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90ZXh0cmVnaW9uOjVmZmEwNzUyZGExODQ2ZjFhMTMwZDU5ZGY4YmY3ODA1XzQ3Mjc5MDAwMDAzNjg0_e6f296cc-9e51-4105-a5cf-c5d523e0d5c9">4.7</ix:nonFraction> million, of which $<ix:nonFraction unitRef="usd" contextRef="i700d59f0237c426e9f45e85c7868ccb3_D20201001-20201031" decimals="-5" name="us-gaap:ProceedsFromDivestitureOfBusinesses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90ZXh0cmVnaW9uOjVmZmEwNzUyZGExODQ2ZjFhMTMwZDU5ZGY4YmY3ODA1XzQ3Mjc5MDAwMDAzNzAy_b8c313b8-b04f-45a7-b4f8-c982565de360">4.2</ix:nonFraction> million has been received in cash and the remaining $<ix:nonFraction unitRef="usd" contextRef="if7cf2424c4f2444491451d34b70a6297_I20201031" decimals="-5" name="docs:DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90ZXh0cmVnaW9uOjVmZmEwNzUyZGExODQ2ZjFhMTMwZDU5ZGY4YmY3ODA1XzQ3Mjc5MDAwMDAzNzE5_c80b7c0b-fad4-4c84-83f9-103fffa26667">0.5</ix:nonFraction> million was held in escrow, subject to standard representations and warranties. The net assets of this business were not material. The Company recognized a gain on sale for the total consideration during the fiscal year ended March&#160;31, 2021 as a result of this sale. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90ZXh0cmVnaW9uOjVmZmEwNzUyZGExODQ2ZjFhMTMwZDU5ZGY4YmY3ODA1XzQ0NTMwMjIwOTM0MzI5_a31fbbbc-bb8e-4ee3-a2b9-80bbacd19111" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets, net consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3c81df0162042a5b0dc0d0c8592051a_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTpjNDgyOGMyMGMyOWE0ZmM2OWJkNDYyY2I4OGE2OTI2OC90YWJsZXJhbmdlOmM0ODI4YzIwYzI5YTRmYzY5YmQ0NjJjYjg4YTY5MjY4XzItMS0xLTEtNTA2MDE_ddf469bc-a22b-473a-b776-96289143cc3f">9,869</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i96d0d9721f3845cf819e54f13b25b749_I20210331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTpjNDgyOGMyMGMyOWE0ZmM2OWJkNDYyY2I4OGE2OTI2OC90YWJsZXJhbmdlOmM0ODI4YzIwYzI5YTRmYzY5YmQ0NjJjYjg4YTY5MjY4XzItMy0xLTEtNTA2MDE_2530cd39-a14d-4433-96c8-48ab7c45ee4e">10,280</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Domain names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i2954aeea8a14482992a39c86bd074154_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTpjNDgyOGMyMGMyOWE0ZmM2OWJkNDYyY2I4OGE2OTI2OC90YWJsZXJhbmdlOmM0ODI4YzIwYzI5YTRmYzY5YmQ0NjJjYjg4YTY5MjY4XzMtMS0xLTEtNTA2MDE_f1952db4-fd28-4861-b4e1-35b147bd58d7">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i41a71c7b00044b929b014c5f2a720f8c_I20210331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTpjNDgyOGMyMGMyOWE0ZmM2OWJkNDYyY2I4OGE2OTI2OC90YWJsZXJhbmdlOmM0ODI4YzIwYzI5YTRmYzY5YmQ0NjJjYjg4YTY5MjY4XzMtMy0xLTEtNTA2MDE_26257802-d721-4f4e-ab13-e0083511f641">436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total intangible assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTpjNDgyOGMyMGMyOWE0ZmM2OWJkNDYyY2I4OGE2OTI2OC90YWJsZXJhbmdlOmM0ODI4YzIwYzI5YTRmYzY5YmQ0NjJjYjg4YTY5MjY4XzQtMS0xLTEtNTA2MDE_81728e4d-bea0-4a5d-adec-5af059bb7170">9,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTpjNDgyOGMyMGMyOWE0ZmM2OWJkNDYyY2I4OGE2OTI2OC90YWJsZXJhbmdlOmM0ODI4YzIwYzI5YTRmYzY5YmQ0NjJjYjg4YTY5MjY4XzQtMy0xLTEtNTA2MDE_8241b9ff-65c5-45e6-b8df-0d150a5cc39d">10,716</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less: accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTpjNDgyOGMyMGMyOWE0ZmM2OWJkNDYyY2I4OGE2OTI2OC90YWJsZXJhbmdlOmM0ODI4YzIwYzI5YTRmYzY5YmQ0NjJjYjg4YTY5MjY4XzUtMS0xLTEtNTA2MDE_e6f1b8ac-1e95-478c-904d-6744999fefaf">1,971</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTpjNDgyOGMyMGMyOWE0ZmM2OWJkNDYyY2I4OGE2OTI2OC90YWJsZXJhbmdlOmM0ODI4YzIwYzI5YTRmYzY5YmQ0NjJjYjg4YTY5MjY4XzUtMy0xLTEtNTA2MDE_7a2bd33d-026d-401d-a2a9-2ca7fbdf535b">1,120</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total intangible assets, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTpjNDgyOGMyMGMyOWE0ZmM2OWJkNDYyY2I4OGE2OTI2OC90YWJsZXJhbmdlOmM0ODI4YzIwYzI5YTRmYzY5YmQ0NjJjYjg4YTY5MjY4XzYtMS0xLTEtNTA2MDE_2c0b96b0-e9b3-4922-b8cf-325289f4d2a3">7,909</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTpjNDgyOGMyMGMyOWE0ZmM2OWJkNDYyY2I4OGE2OTI2OC90YWJsZXJhbmdlOmM0ODI4YzIwYzI5YTRmYzY5YmQ0NjJjYjg4YTY5MjY4XzYtMy0xLTEtNTA2MDE_b4c3981c-2a5b-4dff-a8e3-6d97e29d7074">9,596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense for intangible assets was $<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90ZXh0cmVnaW9uOjVmZmEwNzUyZGExODQ2ZjFhMTMwZDU5ZGY4YmY3ODA1XzMwNzg2MzI1NTg0OTUx_7e427445-62d5-4f4b-b2d7-245931c39e06">1.0</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90ZXh0cmVnaW9uOjVmZmEwNzUyZGExODQ2ZjFhMTMwZDU5ZGY4YmY3ODA1XzMwNzg2MzI1NTg0OTYw_1291017e-989d-47ae-8464-8178bcae861a">1.1</ix:nonFraction> million and <ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90ZXh0cmVnaW9uOjVmZmEwNzUyZGExODQ2ZjFhMTMwZDU5ZGY4YmY3ODA1XzMwNzg2MzI1NTg0OTgw_85bf1272-cfac-47ae-a08c-296731a62a10">not</ix:nonFraction> material for the fiscal years ended March&#160;31, 2022, 2021, and 2020 respectively.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="ia90885ed349f498eb2f58d63586c11bd" continuedAt="idd150d2927204d7eadc8ceaf0925a096"><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90ZXh0cmVnaW9uOjVmZmEwNzUyZGExODQ2ZjFhMTMwZDU5ZGY4YmY3ODA1XzQ0NTMwMjIwOTM0MzMw_522af5b3-1288-4758-8804-c12cae78b575" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, future amortization expense is as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Years Ending March 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTpmNzM2YzU5ZmM2YTE0MzkwYTUzODRkM2U0NGViOWQxNi90YWJsZXJhbmdlOmY3MzZjNTlmYzZhMTQzOTBhNTM4NGQzZTQ0ZWI5ZDE2XzEtMi0xLTEtNTA2MDg_c141c3f6-7fd7-44a1-a4e9-b8d1c34d7483">990</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTpmNzM2YzU5ZmM2YTE0MzkwYTUzODRkM2U0NGViOWQxNi90YWJsZXJhbmdlOmY3MzZjNTlmYzZhMTQzOTBhNTM4NGQzZTQ0ZWI5ZDE2XzItMi0xLTEtNTA2MDg_673a7a87-fa2a-4e59-895a-f1e311d60f6b">990</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTpmNzM2YzU5ZmM2YTE0MzkwYTUzODRkM2U0NGViOWQxNi90YWJsZXJhbmdlOmY3MzZjNTlmYzZhMTQzOTBhNTM4NGQzZTQ0ZWI5ZDE2XzMtMi0xLTEtNTA2MDg_bff233b8-ba8b-4ae8-9b51-c9528f5fbc7c">990</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTpmNzM2YzU5ZmM2YTE0MzkwYTUzODRkM2U0NGViOWQxNi90YWJsZXJhbmdlOmY3MzZjNTlmYzZhMTQzOTBhNTM4NGQzZTQ0ZWI5ZDE2XzQtMi0xLTEtNTA2MDg_3ffdb1e6-1287-4333-837b-61a38c159acb">990</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTpmNzM2YzU5ZmM2YTE0MzkwYTUzODRkM2U0NGViOWQxNi90YWJsZXJhbmdlOmY3MzZjNTlmYzZhMTQzOTBhNTM4NGQzZTQ0ZWI5ZDE2XzUtMi0xLTEtNTA2MDg_77187afc-aab6-4400-b56c-c1f67fba65ec">988</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTpmNzM2YzU5ZmM2YTE0MzkwYTUzODRkM2U0NGViOWQxNi90YWJsZXJhbmdlOmY3MzZjNTlmYzZhMTQzOTBhNTM4NGQzZTQ0ZWI5ZDE2XzYtMi0xLTEtNTA2MDg_e2b85161-2094-4526-b2bf-be204f722895">2,961</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total future amortization expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTpmNzM2YzU5ZmM2YTE0MzkwYTUzODRkM2U0NGViOWQxNi90YWJsZXJhbmdlOmY3MzZjNTlmYzZhMTQzOTBhNTM4NGQzZTQ0ZWI5ZDE2XzctMi0xLTEtNTA2MDg_5aa80fb8-86cf-47d4-9a6c-757b6a2aac67">7,909</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill </span></div></ix:continuation><div style="margin-bottom:15pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="idd150d2927204d7eadc8ceaf0925a096">As of March&#160;31, 2022 and March&#160;31, 2021, goodwill was $<ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90ZXh0cmVnaW9uOjVmZmEwNzUyZGExODQ2ZjFhMTMwZDU5ZGY4YmY3ODA1XzMwNzg2MzI1NTg1Mjcy_025ba9b7-5891-4f3f-9bb2-9f9f0aa9661e"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90ZXh0cmVnaW9uOjVmZmEwNzUyZGExODQ2ZjFhMTMwZDU5ZGY4YmY3ODA1XzMwNzg2MzI1NTg1Mjcy_fc675553-6675-4a7c-ba2c-327c186933dd">18.9</ix:nonFraction></ix:nonFraction> million. <ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="INF" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90ZXh0cmVnaW9uOjVmZmEwNzUyZGExODQ2ZjFhMTMwZDU5ZGY4YmY3ODA1XzMwNzg2MzI1NTg1Mjgw_3d565ca6-8110-40c9-94db-39d3bbe3ca1f"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="INF" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90ZXh0cmVnaW9uOjVmZmEwNzUyZGExODQ2ZjFhMTMwZDU5ZGY4YmY3ODA1XzMwNzg2MzI1NTg1Mjgw_b5996931-62a0-4617-bd0d-f9194aa22821">No</ix:nonFraction></ix:nonFraction> goodwill impairment charges were recorded for each of the fiscal years ended March&#160;31, 2022 and 2021.</ix:continuation> </span></div><div id="i6c4404140edb48938ba4e30b290c9ef9_208"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.&#160;&#160;<ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="docs:TemporaryEquityTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzQ4Mzc4NTExNjQzMzYy_98e64fc6-0046-4ba7-b1c8-18c69c9d1075" continuedAt="i731c154c02ea4df8b173875e36972177" escape="true">Redeemable Convertible Preferred Stock</ix:nonNumeric></span></div><ix:continuation id="i731c154c02ea4df8b173875e36972177" continuedAt="ib1b0310bee14470585160e44b1833c17"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, there were <ix:nonFraction unitRef="series" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="INF" name="docs:TemporaryEquityPreferredStockOutstandingSeries" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI5MTM3MDU4MTU3MDY4_47f45af2-b9f0-49df-9c88-168ef653990e">three</ix:nonFraction> outstanding series of redeemable convertible preferred stock, each with a par value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="3" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI5MTM3MDU4MTU3MDc4_4db56928-285f-4cdc-ab1e-a44566f6dfd3">0.001</ix:nonFraction> per share. Upon completion of the IPO in June 2021, all shares of the Company&#8217;s redeemable convertible preferred stock outstanding, totaling <ix:nonFraction unitRef="shares" contextRef="i90f5cd4e2e554cc583d589c82b6980d1_D20210601-20210630" decimals="INF" name="us-gaap:ConversionOfStockSharesIssued1" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI4NTg3MzAyMzQyNjU3_7f63eec4-fb3c-4a02-8f53-85c69e99edf9">76,286,618</ix:nonFraction>, were automatically converted into an equivalent number of shares of Class B common stock on a <ix:nonFraction unitRef="number" contextRef="i62c961053180495bb8eed126ddb4d43b_D20210601-20210630" decimals="INF" name="docs:ConversionOfStockConversionRatio" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI4NTg3MzAyMzQyNzU2_e8840d34-e3b7-4bad-b7ce-6757cc2e5e60">one</ix:nonFraction>-to-one basis. The carrying value of redeemable convertible preferred stock of $<ix:nonFraction unitRef="usd" contextRef="i62c961053180495bb8eed126ddb4d43b_D20210601-20210630" decimals="-5" name="us-gaap:ReclassificationsOfTemporaryToPermanentEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI4NTg3MzAyMzQyODM4_8979a1ab-3d28-484d-8136-6bd07ef58cf3">81.5</ix:nonFraction> million was reclassified into stockholders&#8217; equity. As of March&#160;31, 2022, there were <ix:nonFraction unitRef="shares" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="INF" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI4NTg3MzAyMzQyOTA4_262814f0-d8e4-41dc-bf07-bcc3835dfe28"><ix:nonFraction unitRef="shares" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="INF" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI4NTg3MzAyMzQyOTA4_dc4e4079-cb5d-4134-bc1a-8dd7c8a62dbe">no</ix:nonFraction></ix:nonFraction> shares of redeemable convertible preferred stock issued or outstanding.</span></div><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:TemporaryEquityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzQ4Mzc4NTExNjQzMzY0_9b7b84f9-ad03-42a6-ae25-bfaae2fe854a" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the redeemable convertible preferred stock outstanding as of March&#160;31, 2021 and other related information is as follows (in thousands):</span></div><div style="margin-bottom:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Series</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares<br/>Authorized</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares<br/>Issued and<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Liquidation<br/>Preference</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i0d10847a28e64727936c5a6f5e2e80a5_I20210331" decimals="-3" name="us-gaap:TemporaryEquitySharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90YWJsZTpiODQ1YTk3YmVlNTM0ODA4OGUxNDMzOWY2OGYxNWUyZS90YWJsZXJhbmdlOmI4NDVhOTdiZWU1MzQ4MDg4ZTE0MzM5ZjY4ZjE1ZTJlXzItMS0xLTEtNTAxMTg_a5aad7bb-fa54-44de-9fd0-d0b12eca8383">27,636</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i0d10847a28e64727936c5a6f5e2e80a5_I20210331" decimals="-3" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90YWJsZTpiODQ1YTk3YmVlNTM0ODA4OGUxNDMzOWY2OGYxNWUyZS90YWJsZXJhbmdlOmI4NDVhOTdiZWU1MzQ4MDg4ZTE0MzM5ZjY4ZjE1ZTJlXzItMy0xLTEtNTAxMTg_b80c7954-e284-4801-94e6-115296451507"><ix:nonFraction unitRef="shares" contextRef="i0d10847a28e64727936c5a6f5e2e80a5_I20210331" decimals="-3" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90YWJsZTpiODQ1YTk3YmVlNTM0ODA4OGUxNDMzOWY2OGYxNWUyZS90YWJsZXJhbmdlOmI4NDVhOTdiZWU1MzQ4MDg4ZTE0MzM5ZjY4ZjE1ZTJlXzItMy0xLTEtNTAxMTg_c4574f83-2d53-4a48-8e85-97b1c3515128">27,636</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0d10847a28e64727936c5a6f5e2e80a5_I20210331" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90YWJsZTpiODQ1YTk3YmVlNTM0ODA4OGUxNDMzOWY2OGYxNWUyZS90YWJsZXJhbmdlOmI4NDVhOTdiZWU1MzQ4MDg4ZTE0MzM5ZjY4ZjE1ZTJlXzItNS0xLTEtNTAxMTg_977bf3d2-44e4-4b3e-a5b0-ea6414117c3a">10,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0d10847a28e64727936c5a6f5e2e80a5_I20210331" decimals="-3" name="us-gaap:TemporaryEquityLiquidationPreference" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90YWJsZTpiODQ1YTk3YmVlNTM0ODA4OGUxNDMzOWY2OGYxNWUyZS90YWJsZXJhbmdlOmI4NDVhOTdiZWU1MzQ4MDg4ZTE0MzM5ZjY4ZjE1ZTJlXzItNy0xLTEtNTAxMTg_d0f55ef0-1217-4d75-bc8a-64fb3b96e1fe">10,756</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i123f862c0d9447efbbc8bdae111fa9a1_I20210331" decimals="-3" name="us-gaap:TemporaryEquitySharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90YWJsZTpiODQ1YTk3YmVlNTM0ODA4OGUxNDMzOWY2OGYxNWUyZS90YWJsZXJhbmdlOmI4NDVhOTdiZWU1MzQ4MDg4ZTE0MzM5ZjY4ZjE1ZTJlXzMtMS0xLTEtNTAxMTg_eabab2bc-a6d8-400a-89e4-f6ab569fd22e">26,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i123f862c0d9447efbbc8bdae111fa9a1_I20210331" decimals="-3" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90YWJsZTpiODQ1YTk3YmVlNTM0ODA4OGUxNDMzOWY2OGYxNWUyZS90YWJsZXJhbmdlOmI4NDVhOTdiZWU1MzQ4MDg4ZTE0MzM5ZjY4ZjE1ZTJlXzMtMy0xLTEtNTAxMTg_1fc83bad-0761-48a0-9a39-4c00c4e3620f"><ix:nonFraction unitRef="shares" contextRef="i123f862c0d9447efbbc8bdae111fa9a1_I20210331" decimals="-3" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90YWJsZTpiODQ1YTk3YmVlNTM0ODA4OGUxNDMzOWY2OGYxNWUyZS90YWJsZXJhbmdlOmI4NDVhOTdiZWU1MzQ4MDg4ZTE0MzM5ZjY4ZjE1ZTJlXzMtMy0xLTEtNTAxMTg_5f2e21e9-cc56-4a09-92c2-115339624a34">26,314</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i123f862c0d9447efbbc8bdae111fa9a1_I20210331" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90YWJsZTpiODQ1YTk3YmVlNTM0ODA4OGUxNDMzOWY2OGYxNWUyZS90YWJsZXJhbmdlOmI4NDVhOTdiZWU1MzQ4MDg4ZTE0MzM5ZjY4ZjE1ZTJlXzMtNS0xLTEtNTAxMTg_3d74d53f-2ca9-45a7-beb1-f86921891fa8">17,014</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i123f862c0d9447efbbc8bdae111fa9a1_I20210331" decimals="-3" name="us-gaap:TemporaryEquityLiquidationPreference" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90YWJsZTpiODQ1YTk3YmVlNTM0ODA4OGUxNDMzOWY2OGYxNWUyZS90YWJsZXJhbmdlOmI4NDVhOTdiZWU1MzQ4MDg4ZTE0MzM5ZjY4ZjE1ZTJlXzMtNy0xLTEtNTAxMTg_b351c112-a60b-480d-8528-db8f7da0c166">17,075</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i1d83f10d2f3d4f9f8308f66e84ed7f02_I20210331" decimals="-3" name="us-gaap:TemporaryEquitySharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90YWJsZTpiODQ1YTk3YmVlNTM0ODA4OGUxNDMzOWY2OGYxNWUyZS90YWJsZXJhbmdlOmI4NDVhOTdiZWU1MzQ4MDg4ZTE0MzM5ZjY4ZjE1ZTJlXzQtMS0xLTEtNTAxMTg_7cfd72e4-9d85-459a-85e7-8954917b82bf">22,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i1d83f10d2f3d4f9f8308f66e84ed7f02_I20210331" decimals="-3" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90YWJsZTpiODQ1YTk3YmVlNTM0ODA4OGUxNDMzOWY2OGYxNWUyZS90YWJsZXJhbmdlOmI4NDVhOTdiZWU1MzQ4MDg4ZTE0MzM5ZjY4ZjE1ZTJlXzQtMy0xLTEtNTAxMTg_3190ed73-e6c9-49d4-bc3f-5d1efc32f6d8"><ix:nonFraction unitRef="shares" contextRef="i1d83f10d2f3d4f9f8308f66e84ed7f02_I20210331" decimals="-3" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90YWJsZTpiODQ1YTk3YmVlNTM0ODA4OGUxNDMzOWY2OGYxNWUyZS90YWJsZXJhbmdlOmI4NDVhOTdiZWU1MzQ4MDg4ZTE0MzM5ZjY4ZjE1ZTJlXzQtMy0xLTEtNTAxMTg_d2305e5b-a03c-4e17-b392-1e933cc3d0b9">22,337</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1d83f10d2f3d4f9f8308f66e84ed7f02_I20210331" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90YWJsZTpiODQ1YTk3YmVlNTM0ODA4OGUxNDMzOWY2OGYxNWUyZS90YWJsZXJhbmdlOmI4NDVhOTdiZWU1MzQ4MDg4ZTE0MzM5ZjY4ZjE1ZTJlXzQtNS0xLTEtNTAxMTg_12efc4c0-23df-4879-8b9e-c981c397d786">53,767</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i1d83f10d2f3d4f9f8308f66e84ed7f02_I20210331" decimals="-3" name="us-gaap:TemporaryEquityLiquidationPreference" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90YWJsZTpiODQ1YTk3YmVlNTM0ODA4OGUxNDMzOWY2OGYxNWUyZS90YWJsZXJhbmdlOmI4NDVhOTdiZWU1MzQ4MDg4ZTE0MzM5ZjY4ZjE1ZTJlXzQtNy0xLTEtNTAxMTg_0f6fa211-8270-4b93-8f75-777747f73025">53,841</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:TemporaryEquitySharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90YWJsZTpiODQ1YTk3YmVlNTM0ODA4OGUxNDMzOWY2OGYxNWUyZS90YWJsZXJhbmdlOmI4NDVhOTdiZWU1MzQ4MDg4ZTE0MzM5ZjY4ZjE1ZTJlXzUtMS0xLTEtNTAxMTg_a247a13b-8688-4fbb-b3e9-a9f7dd703740">76,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:TemporaryEquitySharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90YWJsZTpiODQ1YTk3YmVlNTM0ODA4OGUxNDMzOWY2OGYxNWUyZS90YWJsZXJhbmdlOmI4NDVhOTdiZWU1MzQ4MDg4ZTE0MzM5ZjY4ZjE1ZTJlXzUtMy0xLTEtNTAxMTg_c19245e3-68e3-4c5a-98ef-5ba2e48a1eff"><ix:nonFraction unitRef="shares" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90YWJsZTpiODQ1YTk3YmVlNTM0ODA4OGUxNDMzOWY2OGYxNWUyZS90YWJsZXJhbmdlOmI4NDVhOTdiZWU1MzQ4MDg4ZTE0MzM5ZjY4ZjE1ZTJlXzUtMy0xLTEtNTAxMTg_e288e7eb-67d4-4cb9-9700-e99a473a2766">76,287</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90YWJsZTpiODQ1YTk3YmVlNTM0ODA4OGUxNDMzOWY2OGYxNWUyZS90YWJsZXJhbmdlOmI4NDVhOTdiZWU1MzQ4MDg4ZTE0MzM5ZjY4ZjE1ZTJlXzUtNS0xLTEtNTAxMTg_6e8948a0-3105-476a-ace4-7ab2941a2084">81,458</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:TemporaryEquityLiquidationPreference" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90YWJsZTpiODQ1YTk3YmVlNTM0ODA4OGUxNDMzOWY2OGYxNWUyZS90YWJsZXJhbmdlOmI4NDVhOTdiZWU1MzQ4MDg4ZTE0MzM5ZjY4ZjE1ZTJlXzUtNy0xLTEtNTAxMTg_a65d224d-101b-4686-b57f-1f109c49d262">81,672</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rights, preferences, privileges, restrictions, and other matters relating to the redeemable convertible preferred stock are summarized as follows:</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidation Preference</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;In the event of any liquidation event, either voluntary or involuntary, the holders of Series&#160;A, Series&#160;B, and Series&#160;C redeemable convertible preferred stock were entitled to receive, in priority and preference to common stockholders&#8217; liquidation preference, $<ix:nonFraction unitRef="usdPerShare" contextRef="i0d10847a28e64727936c5a6f5e2e80a5_I20210331" decimals="INF" name="us-gaap:TemporaryEquityLiquidationPreferencePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI5MTM3MDU4MTU3MDg4_477d9a90-0b18-4cce-9ac3-103ff1a61b14">0.3892</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="i123f862c0d9447efbbc8bdae111fa9a1_I20210331" decimals="INF" name="us-gaap:TemporaryEquityLiquidationPreferencePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI5MTM3MDU4MTU3MTAx_2cd53224-eb05-4ad1-8a63-f0dd94b942db">0.6488925</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i1d83f10d2f3d4f9f8308f66e84ed7f02_I20210331" decimals="INF" name="us-gaap:TemporaryEquityLiquidationPreferencePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI5MTM3MDU4MTU3MTEx_22906d8a-786c-4482-adef-87bdb26e4d77">2.4104</ix:nonFraction> per share, respectively.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After paying the holders of the redeemable convertible preferred stock of their full respective preferential amounts, all of the remaining assets of the Company would be distributed on a pro rata basis among the holders of common stock. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Redemption</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The redeemable convertible preferred stock was classified as mezzanine equity on the consolidated balance sheets. The redeemable convertible preferred stock was not mandatorily redeemable; however, upon the event of a voluntary or involuntary liquidation, dissolution, change in control, or winding up of the Company, holders of the redeemable convertible preferred stock may have had the right to receive their liquidation preference under the terms of the preferred stockholder agreements. Accordingly, the preferred stockholders were entitled to redemption features that were not solely within the control of the Company.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The holders of Series&#160;A, Series&#160;B, and Series&#160;C redeemable convertible preferred stock were entitled to receive noncumulative dividends at the per annum rate of $<ix:nonFraction unitRef="usdPerShare" contextRef="i0d10847a28e64727936c5a6f5e2e80a5_I20210331" decimals="INF" name="docs:TemporaryEquityDividendRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI5MTM3MDU4MTU3MTIy_91931db0-d2d4-4638-b74f-1df2cfaa2b97">0.03115</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="i123f862c0d9447efbbc8bdae111fa9a1_I20210331" decimals="INF" name="docs:TemporaryEquityDividendRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI5MTM3MDU4MTU3MTMy_e03d997c-0c61-4cb7-9040-2d39b0ea101f">0.0519</ix:nonFraction>, and $<ix:nonFraction unitRef="usdPerShare" contextRef="i1d83f10d2f3d4f9f8308f66e84ed7f02_I20210331" decimals="INF" name="docs:TemporaryEquityDividendRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI5MTM3MDU4MTU3MTQz_be695c82-f1b8-4f94-aacd-b3bba7524fc6">0.19285</ix:nonFraction> per share, respectively, in preference and priority to any common stockholder, when and if declared by the board of directors. If, after such dividends above were paid or set apart for payment in any fiscal year, the board of directors declared additional dividends out of funds legally available, then such additional dividends would be set aside or paid among the holders of the redeemable convertible preferred stock and common stock on a pro-rata basis. No dividends on redeemable convertible preferred stock or common </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="ib1b0310bee14470585160e44b1833c17"><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">stock were declared by the board of directors from inception through the date the redeemable convertible preferred stock was converted into Class B common stock in June 2021.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Voting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The holders of redeemable convertible preferred stock had the same voting rights as the holders of common stock. The holders of common stock and redeemable convertible preferred stock voted together as a single class. Each holder of common stock was entitled to <ix:nonFraction unitRef="vote" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="0" name="docs:CommonStockVotingRightsNumberOfVotes" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzM0NjM0NjE2Mjk3NTQ1_bf6c7530-bb1a-41fd-a347-ed296b37bc19">one</ix:nonFraction> vote for each share of common stock held and each holder of redeemable convertible preferred stock was entitled to the number of votes equal to the number of shares of common stock into which such shares of redeemable convertible preferred stock could then be converted. So long as at least <ix:nonFraction unitRef="shares" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="INF" name="docs:TemporaryEquityElectionOfBoardMembersSharesOutstandingThreshold" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI5MTM3MDU4MTU3MTU2_15e96391-ba38-4a94-8f5e-2ce79a21ecb7">2,000,000</ix:nonFraction>&#160;shares of redeemable convertible preferred stock remained outstanding, the holders of redeemable convertible preferred stock were entitled to elect <ix:nonFraction unitRef="board_of_director" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="0" name="docs:TemporaryEquitySharesOutstandingThresholdSatisfiedNumberOfElectedBoardMembersPermitted" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzM0NjM0NjE2Mjk3NTU0_e1332e66-76c1-4ede-b377-2de8bb3be9a2">two</ix:nonFraction> members of the board of directors. The holders of a majority of the common stock were entitled to elect <ix:nonFraction unitRef="board_of_director" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="0" name="docs:CommonStockHoldingMajorityNumberOfElectedBoardMembersPermitted" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzM0NjM0NjE2Mjk3NTYz_5949d5a6-36c4-473b-8a06-88c8fac72c3e">two</ix:nonFraction> members of the board of directors. Any additional member of the board of directors was elected by the holders of a majority of the then outstanding redeemable convertible preferred stock and common stock, each voting as separate classes (and, with respected to redeemable convertible preferred stock, on an as-converted basis).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Conversion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Each share of redeemable convertible preferred stock was convertible to common stock at the option of the holder. Such conversion was determined by dividing the original issue price by the then effective conversion price (adjusted for any stock dividends, combinations, or splits with respect to such shares).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of redeemable convertible preferred stock would be automatically converted into shares of common stock at the conversion rate at the time in effect for such series of redeemable convertible preferred stock immediately upon the earlier of (i)&#160;the Company&#8217;s sale of its common stock in a firm commitment underwritten public offering pursuant to a registration statement under the Securities Act of 1933, as amended, with a price per share of at least $<ix:nonFraction unitRef="usdPerShare" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="2" name="docs:TemporaryEquityConvertibleStockPriceTrigger" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI5MTM3MDU4MTU3MTY0_8787f9f6-7de1-4504-b695-e0076f304a79">2.41</ix:nonFraction> (adjusted for any stock dividends, combinations, or splits with respect to such shares) and an aggregate offering price of at least $<ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-6" name="docs:TemporaryEquityConvertibleAggregateOfferingPriceTrigger" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI5MTM3MDU4MTU3MTc4_a10615b5-2751-4e0e-a0b6-55a8cc2c9bf1">50</ix:nonFraction> million or (ii)&#160;the date specified by written consent or agreement of the majority of the holders of redeemable convertible preferred stock, voting together as a single class on an as-converted basis.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Redeemable Convertible Preferred Stock Warrants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;In August 2012, the Company issued warrants to purchase <ix:nonFraction unitRef="shares" contextRef="i183a0b8f69a94170b9913a445fe4ab57_I20120831" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI5MTM3MDU4MTU3MTg5_85bf36be-00bb-4c0e-aa54-9015fdb47284">38,322</ix:nonFraction>&#160;shares of Series B redeemable convertible preferred stock at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i183a0b8f69a94170b9913a445fe4ab57_I20120831" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI5MTM3MDU4MTU3MTk5_ef6439e6-ae76-4c2e-8e97-80df234e9600">0.65</ix:nonFraction> per share. The warrants were issued to investors in connection with the Series&#160;B redeemable convertible preferred stock warrants financing. The fair value of the warrants at issuance was $<ix:nonFraction unitRef="usd" contextRef="i183a0b8f69a94170b9913a445fe4ab57_I20120831" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI5MTM3MDU4MTU3MjEx_6511f140-561b-49e2-a86f-0fc4a17a8819">14,000</ix:nonFraction> based on the Black-Scholes option-pricing model using the assumptions of dividend yield of <ix:nonFraction unitRef="number" contextRef="i7bb2ecd4e0c946abb1d503513127046f_I20120831" decimals="INF" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI5MTM3MDU4MTU3MjE3_6e630b40-64fe-40be-bd1a-dd630816e4a0">0</ix:nonFraction>%, volatility of <ix:nonFraction unitRef="number" contextRef="i903f14931847407cbb172b0f7bd884c6_I20120831" decimals="2" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI5MTM3MDU4MTU3MjIz_d6c0f79d-e685-4d07-a1e2-7fb1a596f1e9">55</ix:nonFraction>%, risk-free interest rate of <ix:nonFraction unitRef="number" contextRef="i402085a78ad14a0f992a4f8b0ecdcd58_I20120831" decimals="4" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI5MTM3MDU4MTU3MjM5_4a480d95-ce17-4d27-b9b0-f19728aaaac7">1.13</ix:nonFraction>%, and contractual life of <ix:nonNumeric contextRef="if157170dd5944a499d7ec585e0434c4d_I20120831" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI5MTM3MDU4MTU3MjUz_babdc801-4b6b-446d-92c3-5226185f2586">seven years</ix:nonNumeric>. The warrants were exercised during the fiscal year ended March&#160;31, 2020.</span></div></ix:continuation><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="i6c4404140edb48938ba4e30b290c9ef9_211"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.&#160;&#160;<ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzU3NzI0MzYwNDgyNTQ0_85dd479f-826b-4f95-a68f-51b47de43171" continuedAt="i231a143d8da843b4b967f5dfce302c32" escape="true">Equity</ix:nonNumeric></span></div><ix:continuation id="i231a143d8da843b4b967f5dfce302c32" continuedAt="ie39492275df24b53a61cb3af76bd18d3"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preferred Stock</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the IPO, the Company&#8217;s amended and restated certificate of incorporation became effective, which authorized the issuance of <ix:nonFraction unitRef="shares" contextRef="iaca56ad88a7f461f9aa0ca6977c6c5a1_I20210630" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwNzg2MzI1NTk0NjEw_0b5dacab-72c8-422c-bee1-76e1da0e55d4">100,000,000</ix:nonFraction> shares of undesignated preferred stock with a par value of $<ix:nonFraction unitRef="usdPerShare" contextRef="iaca56ad88a7f461f9aa0ca6977c6c5a1_I20210630" decimals="3" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwNzg2MzI1NTk0NjIw_d0eb45ff-d280-4e67-a220-7ed3d7f186bf">0.001</ix:nonFraction> per share with rights and preferences, including voting rights, designated from time to time by the board of directors. As of March&#160;31, 2022, there were <ix:nonFraction unitRef="shares" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwNzg2MzI1NTk0NjI1_02724223-6385-43f4-a6d5-8799beed1b5a"><ix:nonFraction unitRef="shares" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwNzg2MzI1NTk0NjI1_564fb8f5-f09c-4edd-a16f-877e0b5ca041">no</ix:nonFraction></ix:nonFraction> shares of preferred stock issued and outstanding.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock and Creation of Dual-Class Structure </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has two classes of common stock authorized: Class A common stock and Class B common stock, and are collectively referred to as common stock throughout the notes to the consolidated financial statements, unless otherwise noted. On June 8, 2021, the Company&#8217;s board of directors and stockholders approved an amendment to the Company&#8217;s amended and restated certificate of incorporation which authorized <ix:nonFraction unitRef="shares" contextRef="ib043fb4bcadb409c9fa4b0e1104a5b1d_I20210608" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMDA4_5145abc2-da17-4993-91b8-631ee5dfb58e">1,000,000,000</ix:nonFraction> shares of Class A common stock with par value of $<ix:nonFraction unitRef="usdPerShare" contextRef="ib043fb4bcadb409c9fa4b0e1104a5b1d_I20210608" decimals="3" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMDE3_5490dcde-99fe-495e-b90a-9b806e6d4fdd">0.001</ix:nonFraction> and <ix:nonFraction unitRef="vote" contextRef="ib043fb4bcadb409c9fa4b0e1104a5b1d_I20210608" decimals="INF" name="docs:CommonStockVotingRightsNumberOfVotes" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMDI0_1aa9a324-54be-43d2-94fb-763c20a1280d">one</ix:nonFraction> vote per share, and <ix:nonFraction unitRef="shares" contextRef="i7606a71ce4a84be3a6dde5784b7d32ae_I20210608" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMDQw_79c85797-5214-457d-ada3-c3a7ed72baa3">500,000,000</ix:nonFraction> shares of Class B common stock with par value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i7606a71ce4a84be3a6dde5784b7d32ae_I20210608" decimals="3" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMDQ5_80943b9b-566f-4806-a5c4-65fcc3aaadbc">0.001</ix:nonFraction> and <ix:nonFraction unitRef="vote" contextRef="i7606a71ce4a84be3a6dde5784b7d32ae_I20210608" decimals="INF" name="docs:CommonStockVotingRightsNumberOfVotes" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMDU2_ac65d519-ff62-4af2-97b7-0e0edeca53ba">ten</ix:nonFraction> votes per share. The holders of common stock are entitled to receive dividends, as may be declared by the board of directors. Each of the Company&#8217;s <ix:nonFraction unitRef="shares" contextRef="ib6f78b8e938a40e189a348c098b679d6_D20210608-20210608" decimals="INF" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMDcx_9e5c867d-0a43-42c0-ac9e-f9255d0cf71b">85,523,836</ix:nonFraction> shares of existing common stock outstanding was reclassified into Class B common stock. Each outstanding share of Class B common stock may be converted at any time at the option of the holder into <ix:nonFraction unitRef="number" contextRef="iffeb565b4545435983a69c61108b5344_D20210608-20210608" decimals="0" name="docs:ConversionOfStockConversionRatio" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTc0Mzk0_8c299f27-4dc2-4183-a904-d5b18c9f7239">one</ix:nonFraction> share of Class A common stock. As of March&#160;31, 2022, there were <ix:nonFraction unitRef="shares" contextRef="i3ee03b9d354947dba14b2c512b9bc336_I20220331" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMTA1_ff03c226-bdb2-4e8a-a84a-0a738f786db5">109,322,383</ix:nonFraction> shares of Class A common stock, and <ix:nonFraction unitRef="shares" contextRef="i4c6316b62a6d48928288e886e45e4dc6_I20220331" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMTE5_1fb29184-af94-4c46-a9d5-0a8769b14b1e">83,076,040</ix:nonFraction> shares of Class B common stock outstanding.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock Warrants</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="ie39492275df24b53a61cb3af76bd18d3" continuedAt="ifbea28f6bdca444281bf53074fbf39bb"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2017, the Company issued a warrant to purchase <ix:nonFraction unitRef="shares" contextRef="ie2075365cb96485192385bf947ef595a_I20170331" decimals="INF" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMTMw_035e596f-e190-4986-8f3f-8e9eff05cdee">250,000</ix:nonFraction> shares of common stock at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ie2075365cb96485192385bf947ef595a_I20170331" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMTM4_da0777f1-c1b6-457a-ae35-a246becf3967">0.72</ix:nonFraction> per share in connection with a contract signed between the Company and U.S. News &amp; World Report, L.P., or U.S. News. The warrant vested on a monthly basis over a <ix:nonNumeric contextRef="i3f99466cf9f5440d9a1deb4533b63a0e_D20170301-20170331" name="docs:WarrantsAndRightsOutstandingVestingPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMTQy_91a84e20-0e09-4d9e-832a-05a56a62239e">5</ix:nonNumeric>-year term starting on March 1, 2017 and expires <ix:nonNumeric contextRef="ie2075365cb96485192385bf947ef595a_I20170331" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzQ3Mjc5MDAwMDE3MDQ0_6b66e4c0-e2f4-4b37-9a19-faf8c596753a">10</ix:nonNumeric> years from the date of grant. The Company recognizes the fair value of the warrants as stock-based compensation expense and additional paid-in capital over the vesting term of the warrant. As of March&#160;31, 2022, the warrant was fully vested. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 14, 2021, the Company issued a warrant (the &#8220;U.S. News Warrant&#8221;) to U.S. News to purchase <ix:nonFraction unitRef="shares" contextRef="i07bcfcbefba64208b4423f3a902e75e2_I20210614" decimals="0" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMTU1_7f435ccf-06b3-4636-826b-9f3a82dc54f2">1,200,000</ix:nonFraction> shares of Class A common stock with an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i07bcfcbefba64208b4423f3a902e75e2_I20210614" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMTY0_f4ee4f5a-1284-4d9e-bee3-22aa89a9816f">12.56</ix:nonFraction> per share, contingent on the execution of a commercial agreement with the U.S. News (the &#8220;Commercial Agreement&#8221;) prior to September 10, 2021, which was then extended to October 10, 2021. The first tranche of the U.S. News Warrant will vest on May 1, 2022 and the remainder will vest on a monthly basis over approximately <ix:nonNumeric contextRef="i17b428b935264ffe87dec690a2b09118_D20210614-20210614" name="docs:WarrantsAndRightsOutstandingVestingPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5Njg2ODEzOTkxNTU1_c43af69c-e3d5-4aae-9977-61d3108eb875">6</ix:nonNumeric> years. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 8, 2021, the Company signed an amended agreement to revise and extend the existing partnership with the U.S. News. The U.S. News Warrant was concurrently amended to remove the contingency related to the execution of the Commercial Agreement and the number of shares of Class A common stock issuable upon exercise of the U.S. News Warrant was revised from <ix:nonFraction unitRef="shares" contextRef="i07bcfcbefba64208b4423f3a902e75e2_I20210614" decimals="0" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMTgw_7f435ccf-06b3-4636-826b-9f3a82dc54f2">1,200,000</ix:nonFraction> shares to <ix:nonFraction unitRef="shares" contextRef="i8bd91cc36430472099a03473544779d1_I20211008" decimals="0" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMTkw_1c84336b-92a5-42cb-8f27-cad49c16d8f2">516,000</ix:nonFraction> shares. Other terms of the U.S. News Warrant remained the same. The grant-date fair value of the U.S. News Warrant was $<ix:nonFraction unitRef="usd" contextRef="i8bd91cc36430472099a03473544779d1_I20211008" decimals="-5" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMjA2_38c43269-6bb8-4590-b174-a4c808cc7322">34.7</ix:nonFraction> million, which was determined using the Black-Scholes option-pricing model on the date of grant using the following assumptions: fair value of common stock of $<ix:nonFraction unitRef="number" contextRef="i7358dd40974c4c15993593aef2ed49d4_I20211008" decimals="2" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMjE5_20075c4a-3a49-43ff-8333-bcc97025bc86">76.50</ix:nonFraction>, volatility of <ix:nonFraction unitRef="number" contextRef="ie76d6e6102ef406399e4e136b24eca26_I20211008" decimals="3" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMjI3_c684bac4-170c-4ec2-9354-cbadff0c847f">46.9</ix:nonFraction>%, risk-free interest rate of <ix:nonFraction unitRef="number" contextRef="i61bf36f882e84585b81cb908da335c25_I20211008" decimals="4" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMjM1_b0237d52-4e60-41cc-817c-ca1c98ebfffe">1.61</ix:nonFraction>%, contractual term of <ix:nonNumeric contextRef="i39eec364f5b04f648b48c3dcc6d77519_I20211008" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMjQ2_647d02ee-9ee0-4d1e-b53e-15973fb5275a">10</ix:nonNumeric> years, and an expected dividend of <ix:nonFraction unitRef="number" contextRef="id8607743731e4071beb43262fa44f7cf_I20211008" decimals="0" name="us-gaap:WarrantsAndRightsOutstandingMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMjU0_2152e8b7-2157-46ae-9136-17ad5579df2a">0</ix:nonFraction>%. The fair value of the warrant will be recognized as expense in cost of revenue in the consolidated statements of operations on a straight-line basis over its vesting term of <ix:nonNumeric contextRef="iefca250a775b47afb7490aca201d7488_D20211008-20211008" name="docs:WarrantsAndRightsOutstandingVestingPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxMDU5_5a6b36a2-2a92-4394-87cc-5e7ecc5fcb85">6.48</ix:nonNumeric> years. The warrant expires <ix:nonNumeric contextRef="i8bd91cc36430472099a03473544779d1_I20211008" name="us-gaap:WarrantsAndRightsOutstandingTerm" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzQ3Mjc5MDAwMDE3MDU2_15fcface-3503-4c11-8a0f-736afb928fd1">10</ix:nonNumeric> years from the date of grant. During the fiscal year ended March&#160;31, 2022, $<ix:nonFraction unitRef="usd" contextRef="i16b887faed4f499cae154df41656fb5f_D20210401-20220331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxMTQ3_ef3592f4-e084-4b5c-8e86-3c5db85a17ad">2.6</ix:nonFraction> million was recognized as stock-based compensation expense relating to the U.S. News Warrant. As of March&#160;31, 2022, unamortized compensation expense, net of estimated forfeitures, related to the unvested warrants was $<ix:nonFraction unitRef="usd" contextRef="id07380e73439483897907b5d88d89be6_I20220331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxMTg4_eb804a93-1499-42bf-ac0f-6d7b1edc0e42">32.1</ix:nonFraction> million, which is expected to be recognized over the remaining vesting period of <ix:nonNumeric contextRef="i16b887faed4f499cae154df41656fb5f_D20210401-20220331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxMjA0_ca957746-5c49-4fed-add3-935b0961a8bf">6</ix:nonNumeric> years.  </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Incentive Plans</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2010, the Company&#8217;s board of directors and stockholders approved the adoption of the 2010 Equity Incentive Plan (the &#8220;2010 Plan&#8221;). The 2010 Plan provides for the granting of incentive stock options, nonstatutory stock options, restricted stock units, and restricted stock awards to employees, non-employee directors, and consultants of the Company. Options may be granted at a price per share not less than <ix:nonFraction unitRef="number" contextRef="i6d4fd5c7f8d8423bb39a6ed8568b3356_D20100401-20100430" decimals="INF" name="docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxMjEz_e2fb6d3e-4424-455b-b7db-10cc0b60cbe7">100</ix:nonFraction>% of the fair market value at date of grant. If the incentive stock option is granted to a <ix:nonFraction unitRef="number" contextRef="id1341fe12e41432d9a0dd420afc78a66_D20100401-20100430" decimals="INF" name="docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxMjE5_d531f919-f59e-4db4-8fdc-cf4ab2cb7de2">10</ix:nonFraction>% stockholder, then the purchase or exercise price per share shall not be less than <ix:nonFraction unitRef="number" contextRef="id1341fe12e41432d9a0dd420afc78a66_D20100401-20100430" decimals="INF" name="docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxMjI2_9dcc7b43-fb3c-4853-9894-4090a905692d">110</ix:nonFraction>% of the fair market value per share of common stock on the grant date. Options granted under the 2010 Plan continue to vest until the last day of employment and generally vest over <ix:nonNumeric contextRef="i22d3b66c56b94252a2946d3a502fdae3_D20100401-20100430" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxMjM5_39daaad1-0de4-4d68-af88-c96ddc8befe3">four years</ix:nonNumeric> and expire <ix:nonNumeric contextRef="i22d3b66c56b94252a2946d3a502fdae3_D20100401-20100430" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxMjUw_f8cab3db-2aa5-466c-a288-5f8524018942">10</ix:nonNumeric> years from the date of grant. Stock awards may also be granted for services performed by external consultants and vest according to an award-specific schedule as approved by the board of directors.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, the Company&#8217;s board of directors approved the adoption of the 2021 Stock Option and Incentive Plan (the &#8220;2021 Plan&#8221;), which became effective upon the Company&#8217;s initial public offering. The 2021 Plan provides for the granting of incentive stock options, nonstatutory stock options, restricted stock units, and restricted stock awards to employees, non-employee directors, and consultants of the Company. A total of <ix:nonFraction unitRef="shares" contextRef="i8ec1658b926c4ef39dfd202582dd44a8_I20210630" decimals="0" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5ODA0NTI5_1c0f0b23-bfae-4e53-afb8-d1601a88d184">22,500,000</ix:nonFraction> shares of Class A common stock was initially reserved for the 2021 Plan. The number of shares reserved and available for issuance for the 2021 Plan will automatically increase each April 1, beginning on April 1, 2022, by the lesser of <ix:nonFraction unitRef="number" contextRef="i8ec1658b926c4ef39dfd202582dd44a8_I20210630" decimals="2" name="docs:CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5ODA0NTM0_eb39c16d-acc4-45a2-8a34-f3f54ec28f91">5</ix:nonFraction>% of the outstanding number of shares of the Class A and Class B common stock on the immediately preceding March 31, or such lesser number of shares as determined by the Company&#8217;s compensation committee. Any shares of Class B common stock that would have otherwise been returned to the Company&#8217;s 2010 Plan as a result of forfeiture, expiration, cancellation, termination or net issuances of awards thereunder shall be returned to the share reserve under the 2021 Plan after being automatically converted from shares of Class B common stock to Class A common stock. The 2010 Plan and the 2021 Plan are collectively referred to as the &#8220;Plans&#8221; in the notes to the consolidated financial statements, unless otherwise noted.  </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s board of directors approved the adoption of the ESPP, which became effective upon the Company&#8217;s initial public offering. A total of <ix:nonFraction unitRef="shares" contextRef="iab2ea80b2cbf4380ba57669907c19c02_I20220331" decimals="0" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxMjgz_0ac3a8a4-c939-4f92-8b6a-84f2b018fafb">4,500,000</ix:nonFraction> shares of Class A common stock was initially reserved for the ESPP. The number of shares reserved and available for issuance for the ESPP will automatically increase each April 1, beginning on April 1, 2022 and continuing through April 1, 2031, by the lesser of <ix:nonFraction unitRef="shares" contextRef="iab2ea80b2cbf4380ba57669907c19c02_I20220331" decimals="0" name="docs:CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxMjg3_5a5f15c9-097b-4b07-b1ad-2e4474f7d618">6,750,000</ix:nonFraction> shares of Class A common stock, <ix:nonFraction unitRef="number" contextRef="iab2ea80b2cbf4380ba57669907c19c02_I20220331" decimals="2" name="docs:CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxMjkx_200c57fb-bd8d-4246-a0e8-ad57a30fb909">1</ix:nonFraction>% of the outstanding number of shares of the Class A and Class B common stock on the immediately preceding March 31, or such lesser number of shares as determined by the Company&#8217;s compensation committee.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="ifbea28f6bdca444281bf53074fbf39bb" continuedAt="ibc8f70bda36e45329b817e3b4493f752"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company grants stock options under the terms of the Plans and outside of the Plans, as approved by the board of directors. The Company granted <ix:nonFraction unitRef="shares" contextRef="i5eaddeac25184da0affc7274c9201b26_D20170401-20180331" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxMzAz_e6a64ee3-cf80-4a06-94b7-5e73b83c1d30">4,682,582</ix:nonFraction> options during the fiscal year ended March 31, 2018 outside of the Plans, of which <ix:nonFraction unitRef="shares" contextRef="if4e53989ad534fe89ef01474dae63d8f_I20220331" decimals="INF" name="docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxMzE1_0533fade-66b6-4ff9-ab92-239037d02f1b">2,011,252</ix:nonFraction> options were exercised as of March&#160;31, 2022. As of March&#160;31, 2022, <ix:nonFraction unitRef="shares" contextRef="if4e53989ad534fe89ef01474dae63d8f_I20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxMzI4_71ff9eb0-b65e-4bf2-9980-1646d4fa5a2d">2,671,330</ix:nonFraction> options issued outside of the Plans were outstanding. </span></div><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzU3NzI0MzYwNDgyNTQ1_7918c98a-a59e-4310-b0d4-6a479a76c4e1" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has shares of common stock reserved for issuance as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.229%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Redeemable convertible preferred stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTo0MmVkNTFjNzYzMzg0ZTcxYjZhMjViZWFlODViZmU5OS90YWJsZXJhbmdlOjQyZWQ1MWM3NjMzODRlNzFiNmEyNWJlYWU4NWJmZTk5XzEtMS0xLTEtODQ2MzM_93c5b53b-03b6-4190-ae18-eae9a410fecd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTo0MmVkNTFjNzYzMzg0ZTcxYjZhMjViZWFlODViZmU5OS90YWJsZXJhbmdlOjQyZWQ1MWM3NjMzODRlNzFiNmEyNWJlYWU4NWJmZTk5XzEtMy0xLTEtODQ2MzM_c6e57eb7-950c-4236-80ab-5e32abca3064">76,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Common stock warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTo0MmVkNTFjNzYzMzg0ZTcxYjZhMjViZWFlODViZmU5OS90YWJsZXJhbmdlOjQyZWQ1MWM3NjMzODRlNzFiNmEyNWJlYWU4NWJmZTk5XzItMS0xLTEtODQ2MzM_b214e24a-b20f-4ea1-86bb-dbc2162f3400">766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTo0MmVkNTFjNzYzMzg0ZTcxYjZhMjViZWFlODViZmU5OS90YWJsZXJhbmdlOjQyZWQ1MWM3NjMzODRlNzFiNmEyNWJlYWU4NWJmZTk5XzItMy0xLTEtODQ2MzM_b444b999-1e67-4393-ae0f-ddeed00fe0bb">250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2010 Plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Options outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i725f9096e258495b86d6aa50c855aaa9_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTo0MmVkNTFjNzYzMzg0ZTcxYjZhMjViZWFlODViZmU5OS90YWJsZXJhbmdlOjQyZWQ1MWM3NjMzODRlNzFiNmEyNWJlYWU4NWJmZTk5XzQtMS0xLTEtODQ2MzM_d4b6b95c-2497-4e41-bcd2-ca81f57ffb6f">24,312</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i56d735fe4eb34fe1922c7e4400822779_I20210331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTo0MmVkNTFjNzYzMzg0ZTcxYjZhMjViZWFlODViZmU5OS90YWJsZXJhbmdlOjQyZWQ1MWM3NjMzODRlNzFiNmEyNWJlYWU4NWJmZTk5XzQtMy0xLTEtODQ2MzM_49930b28-a476-4635-801d-c47df5144b5e">33,856</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Shares available for future grant</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i725f9096e258495b86d6aa50c855aaa9_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTo0MmVkNTFjNzYzMzg0ZTcxYjZhMjViZWFlODViZmU5OS90YWJsZXJhbmdlOjQyZWQ1MWM3NjMzODRlNzFiNmEyNWJlYWU4NWJmZTk5XzUtMS0xLTEtODQ2MzM_f7d34332-509d-4c3c-875b-3486d2abb4a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i56d735fe4eb34fe1922c7e4400822779_I20210331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTo0MmVkNTFjNzYzMzg0ZTcxYjZhMjViZWFlODViZmU5OS90YWJsZXJhbmdlOjQyZWQ1MWM3NjMzODRlNzFiNmEyNWJlYWU4NWJmZTk5XzUtMy0xLTEtODQ2MzM_9f319393-344b-4087-a50b-767b43f4e6fa">1,550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2021 Plan</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Performance-based restricted stock units outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3541a109248a45dc94084818f280ac54_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTo0MmVkNTFjNzYzMzg0ZTcxYjZhMjViZWFlODViZmU5OS90YWJsZXJhbmdlOjQyZWQ1MWM3NjMzODRlNzFiNmEyNWJlYWU4NWJmZTk5XzctMS0xLTEtODQ2MzM_2da84ff3-1a03-418b-8571-bbef262fd59d">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i67450ca940dd40f0a2d462baa0500656_I20210331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTo0MmVkNTFjNzYzMzg0ZTcxYjZhMjViZWFlODViZmU5OS90YWJsZXJhbmdlOjQyZWQ1MWM3NjMzODRlNzFiNmEyNWJlYWU4NWJmZTk5XzctMy0xLTEtODQ2MzM_208e7149-7373-4fe6-8c19-d6b96854d4bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Restricted stock units outstanding</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i062a7bd4fea64eff8312ec950069505b_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTo0MmVkNTFjNzYzMzg0ZTcxYjZhMjViZWFlODViZmU5OS90YWJsZXJhbmdlOjQyZWQ1MWM3NjMzODRlNzFiNmEyNWJlYWU4NWJmZTk5XzgtMS0xLTEtODQ2MzM_5626fd98-c53f-4ada-99ad-1a95b914f410">534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i474cc2747676411382999c3f91d30019_I20210331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTo0MmVkNTFjNzYzMzg0ZTcxYjZhMjViZWFlODViZmU5OS90YWJsZXJhbmdlOjQyZWQ1MWM3NjMzODRlNzFiNmEyNWJlYWU4NWJmZTk5XzgtMy0xLTEtODQ2MzM_626cf978-d9bf-44fd-8b64-b0bac5b3eda3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Shares available for future grant</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic7e987e8af04409dbdccaa86e531b3a0_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTo0MmVkNTFjNzYzMzg0ZTcxYjZhMjViZWFlODViZmU5OS90YWJsZXJhbmdlOjQyZWQ1MWM3NjMzODRlNzFiNmEyNWJlYWU4NWJmZTk5XzktMS0xLTEtODQ2MzM_1e2b056d-4bcf-4553-b4e4-27df3a4195c5">22,466</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="id01f8e0be0ee4f27ae203fcef745b3aa_I20210331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTo0MmVkNTFjNzYzMzg0ZTcxYjZhMjViZWFlODViZmU5OS90YWJsZXJhbmdlOjQyZWQ1MWM3NjMzODRlNzFiNmEyNWJlYWU4NWJmZTk5XzktMy0xLTEtODQ2MzM_15210048-aa1f-44da-8ffe-8a7ada5c6c42">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2021 ESPP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iab2ea80b2cbf4380ba57669907c19c02_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTo0MmVkNTFjNzYzMzg0ZTcxYjZhMjViZWFlODViZmU5OS90YWJsZXJhbmdlOjQyZWQ1MWM3NjMzODRlNzFiNmEyNWJlYWU4NWJmZTk5XzEwLTEtMS0xLTg0NjMz_1cb9ba78-7879-45c8-9ab6-66d0a416391f">4,471</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ie51ad27fff7e4a428edc6ea000fd35d2_I20210331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTo0MmVkNTFjNzYzMzg0ZTcxYjZhMjViZWFlODViZmU5OS90YWJsZXJhbmdlOjQyZWQ1MWM3NjMzODRlNzFiNmEyNWJlYWU4NWJmZTk5XzEwLTMtMS0xLTg0NjMz_4cfd80c2-c8f8-42a1-aafa-9c6e4af1cdec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Options outstanding outside the Plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if4e53989ad534fe89ef01474dae63d8f_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTo0MmVkNTFjNzYzMzg0ZTcxYjZhMjViZWFlODViZmU5OS90YWJsZXJhbmdlOjQyZWQ1MWM3NjMzODRlNzFiNmEyNWJlYWU4NWJmZTk5XzExLTEtMS0xLTg0NjMz_f2a91660-435a-4b27-82db-fff14722cbfa">2,671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i434b921a71c247e49c95cbfb98931fc2_I20210331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTo0MmVkNTFjNzYzMzg0ZTcxYjZhMjViZWFlODViZmU5OS90YWJsZXJhbmdlOjQyZWQ1MWM3NjMzODRlNzFiNmEyNWJlYWU4NWJmZTk5XzExLTMtMS0xLTg0NjMz_8c8a548a-3655-4d20-9fbd-57ed9577c1e8">2,720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTo0MmVkNTFjNzYzMzg0ZTcxYjZhMjViZWFlODViZmU5OS90YWJsZXJhbmdlOjQyZWQ1MWM3NjMzODRlNzFiNmEyNWJlYWU4NWJmZTk5XzEyLTEtMS0xLTg0NjMz_99f0ccc3-dd23-473b-9aae-ad9b2837f0dc">55,232</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTo0MmVkNTFjNzYzMzg0ZTcxYjZhMjViZWFlODViZmU5OS90YWJsZXJhbmdlOjQyZWQ1MWM3NjMzODRlNzFiNmEyNWJlYWU4NWJmZTk5XzEyLTMtMS0xLTg0NjMz_2e5714ad-7eea-40f1-8d1f-4a1ffe25a10f">114,663</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzU3NzI0MzYwNDgyNTQ2_823551e2-42c4-4d34-957e-979c67c60fde" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activities within the Plans as well as outside of the Plans were as follows for both service-based and performance-based options (in&#160;thousands, except per share information): </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.268%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.623%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted-Average <br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average Remaining Contractual Term <br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Balance, March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzEtMS0xLTEtODQ2MzM_737606e5-320f-4c4a-a196-15023ff36b30">36,576</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzEtMy0xLTEtODQ2MzM_290eb551-2513-4b3d-ab3d-71debbb52d60">2.80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzEtNS0xLTEtODQ2MzM_d60f42ac-c95f-423f-a7d6-d98336ae1da2">7.86</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzEtNy0xLTEtODQ2MzM_02cdd31b-747c-4aca-89df-0a968e27b099">357,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Options granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzItMS0xLTEtODQ2MzM_57b10008-44db-4dbc-8f5e-4d7cd4d73230">1,966</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzItMy0xLTEtODQ2MzM_98b97460-8ade-412a-9de3-0ef6eee14828">12.56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Options exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzMtMS0xLTEtODQ2MzM_bca8ea60-5e89-46c5-90f1-4d8b8eb8e29c">10,823</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzMtMy0xLTEtODQ2MzM_90a19274-d09d-4fed-a0e4-8d8795518585">1.17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Options forfeited or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzQtMS0xLTEtODQ2MzM_367905f3-2342-42b9-9ffa-1414276590ce">736</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzQtMy0xLTEtODQ2MzM_0cedb858-db39-4a60-92ed-9cae5e313a63">3.16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Balance, March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzUtMS0xLTEtODQ2MzM_92b5f96f-7471-4905-a977-15e8154fd5b9">26,983</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzUtMy0xLTEtODQ2MzM_7f4c5d7a-e2d7-448b-b41c-ce442ad72f59">4.15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzUtNS0xLTEtODQ2MzM_bf3a328a-a539-4391-91cf-9c7b79b28802">7.63</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzUtNy0xLTEtODQ2MzM_3881563e-738a-45f7-86d9-15abd88d97e5">1,293,545</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Vested and exercisable as of March 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzYtMS0xLTEtODQ2MzM_382b5032-c4a3-4b30-9036-6ed61868ab95">8,113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzYtMy0xLTEtODQ2MzM_a780835d-8c00-4c2f-82e9-48355857c4d9">1.77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzYtNS0xLTEtODQ2MzM_2fa1be5e-20eb-4491-9d0c-a40adb0c8b93">6.15</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzYtNy0xLTEtODQ2MzM_e2753e39-89ef-49c4-9171-aaf37aeb875a">408,238</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Vested and expected to vest as of March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzctMS0xLTEtODQ2MzM_fb9d0df7-5885-447e-a47a-d66f10cee721">25,021</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzctMy0xLTEtODQ2MzM_a9d9f45f-8ea1-42bb-b4a4-0cf37dad7dfb">4.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzctNS0xLTEtODQ2MzM_47e13394-464c-4e11-8481-59d1d0f8ad2b">7.55</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzctNy0xLTEtODQ2MzM_95d9fe6c-c542-4ebf-b63d-6f1d476bb0cb">1,202,634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate intrinsic value of options exercised during the fiscal years ended March&#160;31, 2022, 2021, and 2020 was $<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxNDU2_cabaf4c6-f160-45ea-a9aa-e443602f797f">521.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxNDc1_d358281d-2d9c-45e8-9fb2-ba7a783f086e">52.6</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTU1MTky_2795acb5-f1a8-4869-a834-ff6e7e87b69b">3.0</ix:nonFraction> million respectively.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant-date fair value of options granted for the fiscal years ended March&#160;31, 2022, 2021, and 2020 was $<ix:nonFraction unitRef="usdPerShare" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxNTYx_d970b343-5d9e-42a1-8cc1-c9327189a7ca">10.73</ix:nonFraction>, $<ix:nonFraction unitRef="usdPerShare" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxNTcw_3624bf37-2858-4d92-801e-580ef78e5f7e">3.18</ix:nonFraction>, and $<ix:nonFraction unitRef="usdPerShare" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTU1MjEz_6580dbed-65a1-4cb1-b513-bbc4afd87698">0.77</ix:nonFraction> respectively. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, unamortized compensation expense, net of estimated forfeitures, related to unvested stock options was $<ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxNjA4_e3087973-35ea-4022-b2ae-1628aabf6e75">55.2</ix:nonFraction> million, which is expected to be recognized over a weighted-average period of <ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxNjMx_7dc4c30f-e947-4f9d-8d42-e6e9f058e699">3.04</ix:nonNumeric> years. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="ibc8f70bda36e45329b817e3b4493f752" continuedAt="if13c0ffe072c4d08a626be3fa4b47d03"><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzU3NzI0MzYwNDgyNTQ3_fed109ce-7282-40c6-8d7f-c1ba23372d11" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each option on the date of grant is determined using the Black-Scholes option-pricing model with the assumptions set forth in the following table:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.940%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Fair value of common stock</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i846bae41a5fe4dd4a8ee4faa714617c2_D20210401-20220331" decimals="2" name="docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzItMS0xLTEtMTAwOTcxL3RleHRyZWdpb246YTQzNzc5YzEwMDZkNGE4OWJlNWU4N2NiNGZmMjk2MThfMjk2ODY4MTM5NDk5NTY_0ec3d123-45a9-494a-9262-eebd0a63db30">18.41</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="i18e2b6fd4b074d7db710c23afcd10f34_D20210401-20220331" decimals="2" name="docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzItMS0xLTEtMTAwOTcxL3RleHRyZWdpb246YTQzNzc5YzEwMDZkNGE4OWJlNWU4N2NiNGZmMjk2MThfMjk2ODY4MTM5NDk5NjI_bcb77023-a581-496e-9da3-4d5c93c4e578">21.41</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i20ae6e1b9ad04e07b4597114eca5d5ee_D20200401-20210331" decimals="2" name="docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzItNC0xLTEtMTAxMDA0L3RleHRyZWdpb246NjgwMDViZDkxMWE0NDAyOWJiNjczYTY1MTE3MWJmMjNfNDcyNzg5OTk5OTQzNzI_a9fe708d-b023-46ef-9d6a-3b49dd28172d">2.06</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="i7493bbee46f24e8484095a81b057167c_D20200401-20210331" decimals="2" name="docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzItNC0xLTEtMTAxMDA0L3RleHRyZWdpb246NjgwMDViZDkxMWE0NDAyOWJiNjczYTY1MTE3MWJmMjNfNDcyNzg5OTk5OTQzNzg_74c4de36-feac-43e2-b9bf-a46b5838ed06">10.51</ix:nonFraction></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i226d0d1119d141748de5f3ec182d0ba9_D20190401-20200331" decimals="2" name="docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzItOC0xLTEtMTAxMDI4L3RleHRyZWdpb246Nzk5YjQ0NDgyZDA0NDIzNDk2ZGZjZmUxNGUzZDk3OTRfNDcyNzg5OTk5OTQzNzI_19ce6c6d-aee6-49e1-bc54-33049e18b0fd">1.58</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="i6e6975dac5d14fdeb07a8ecc86e9912d_D20190401-20200331" decimals="2" name="docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzItOC0xLTEtMTAxMDI4L3RleHRyZWdpb246Nzk5YjQ0NDgyZDA0NDIzNDk2ZGZjZmUxNGUzZDk3OTRfNDcyNzg5OTk5OTQzNzg_a38a2aeb-c5b5-4efd-ae54-72a99e64fbbb">1.91</ix:nonFraction></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i31208a9ec3934804b4c4c3c9e4b9ae56_D20210401-20220331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzMtMS0xLTEtMTAxMDQwL3RleHRyZWdpb246OTAzMGViZTliYTFmNDczYzhiYTk0N2RmMjNiMTFkNWRfNDcyNzg5OTk5OTQzNzI_68d3051e-6a0f-47d3-9050-7bf76224286e">46.5</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i31208a9ec3934804b4c4c3c9e4b9ae56_D20210401-20220331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzMtMS0xLTEtMTAxMDQwL3RleHRyZWdpb246OTAzMGViZTliYTFmNDczYzhiYTk0N2RmMjNiMTFkNWRfNDcyNzg5OTk5OTQzNzg_10f06a04-565e-460b-b300-fc98a1d6853a">47.0</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i63de954bcdf44beabda4a4cb41517cd6_D20200401-20210331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzMtNC0xLTEtMTAxMDQ0L3RleHRyZWdpb246MTc2ZTYwMjYyNTkxNGM3OTk0MzZmNGExNDJmYTRiODVfNDcyNzg5OTk5OTQzNzI_3835b649-5880-4ff9-8149-775a9dc15789">38.1</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i63de954bcdf44beabda4a4cb41517cd6_D20200401-20210331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzMtNC0xLTEtMTAxMDQ0L3RleHRyZWdpb246MTc2ZTYwMjYyNTkxNGM3OTk0MzZmNGExNDJmYTRiODVfNDcyNzg5OTk5OTQzNzg_fbdc64e4-c06a-4739-a312-02c155a6d418">58.3</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i5570e6c29d854f898d1e5e342437be88_D20190401-20200331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzMtOC0xLTEtMTAxMDQ4L3RleHRyZWdpb246Njc2ZTUxYWMxZDc3NGJmNWE4YjYxZjVlMThhZWU3MWRfNDcyNzg5OTk5OTQzNzI_bbe982e8-f52e-4df7-b721-d69074bd0cd8">39.2</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i5570e6c29d854f898d1e5e342437be88_D20190401-20200331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzMtOC0xLTEtMTAxMDQ4L3RleHRyZWdpb246Njc2ZTUxYWMxZDc3NGJmNWE4YjYxZjVlMThhZWU3MWRfNDcyNzg5OTk5OTQzNzg_e36564ac-64fd-4007-906e-364813ed8d6e">46.5</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i31208a9ec3934804b4c4c3c9e4b9ae56_D20210401-20220331" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzQtMS0xLTEtMTAxMDU5L3RleHRyZWdpb246YzM5OTQ2ZWFiZTZkNDM5ODg4M2E4NmQxNDU3ZGE5ZDlfNDcyNzg5OTk5OTQzNzI_78e22093-c4ad-4f3e-959c-a6e940a62c0b">0.77</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i31208a9ec3934804b4c4c3c9e4b9ae56_D20210401-20220331" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzQtMS0xLTEtMTAxMDU5L3RleHRyZWdpb246YzM5OTQ2ZWFiZTZkNDM5ODg4M2E4NmQxNDU3ZGE5ZDlfNDcyNzg5OTk5OTQzNzg_fe666055-7891-4071-ac56-51d6d8456c95">1.02</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i63de954bcdf44beabda4a4cb41517cd6_D20200401-20210331" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzQtNC0xLTEtMTAxMDY0L3RleHRyZWdpb246NzZmOGViZTdmNDU2NDA0ZDlhOWU3YjU5NzNkNjE3Y2JfNDcyNzg5OTk5OTQzODQ_e80800da-efa9-4a04-9a4b-e20d1e0d8f6e">0.26</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i63de954bcdf44beabda4a4cb41517cd6_D20200401-20210331" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzQtNC0xLTEtMTAxMDY0L3RleHRyZWdpb246NzZmOGViZTdmNDU2NDA0ZDlhOWU3YjU5NzNkNjE3Y2JfNDcyNzg5OTk5OTQzOTA_11ceba5e-dcdb-4f54-a202-5161db848884">1.02</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i5570e6c29d854f898d1e5e342437be88_D20190401-20200331" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzQtNy0xLTEtMTAxMDY4L3RleHRyZWdpb246MDg0OTNlM2E5MWE3NDBhZDk3ODE3OTM3MmVjMWZlYzlfNDcyNzg5OTk5OTQzNzI_ec222a0f-1592-4f9c-bbbc-4b2e1a030fe3">0.68</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i5570e6c29d854f898d1e5e342437be88_D20190401-20200331" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzQtNy0xLTEtMTAxMDY4L3RleHRyZWdpb246MDg0OTNlM2E5MWE3NDBhZDk3ODE3OTM3MmVjMWZlYzlfNDcyNzg5OTk5OTQzNzg_a9a9ab08-a79d-4cdc-a9f8-0987037eb9a7">2.36</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i846bae41a5fe4dd4a8ee4faa714617c2_D20210401-20220331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzUtMS0xLTEtMTAxMDc2L3RleHRyZWdpb246MmZmY2E0N2IzMDQzNGU3Mzg2M2QxOGE5ZDdmZDA4MWNfNDcyNzg5OTk5OTQzNzI_97a275e9-9024-41ad-8df2-00b518a14c5c">5.00</ix:nonNumeric> - <ix:nonNumeric contextRef="i18e2b6fd4b074d7db710c23afcd10f34_D20210401-20220331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzUtMS0xLTEtMTAxMDc2L3RleHRyZWdpb246MmZmY2E0N2IzMDQzNGU3Mzg2M2QxOGE5ZDdmZDA4MWNfNDcyNzg5OTk5OTQzNzg_007b7ce0-22af-4162-98fb-5f21b4e07bf8">6.09</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i20ae6e1b9ad04e07b4597114eca5d5ee_D20200401-20210331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzUtNC0xLTEtMTAxMDgwL3RleHRyZWdpb246YmZhZTRiZTY2M2JjNDE3OWI3NzhhOTY3ZGMyYmE0YjZfNDcyNzg5OTk5OTQzNzI_f7f6e228-0179-4533-8e15-81cfabef4dad">5.00</ix:nonNumeric> - <ix:nonNumeric contextRef="i7493bbee46f24e8484095a81b057167c_D20200401-20210331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzUtNC0xLTEtMTAxMDgwL3RleHRyZWdpb246YmZhZTRiZTY2M2JjNDE3OWI3NzhhOTY3ZGMyYmE0YjZfNDcyNzg5OTk5OTQzNzg_2c8b57fd-d891-4ec9-bf42-fe2141b5d705">8.00</ix:nonNumeric></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i226d0d1119d141748de5f3ec182d0ba9_D20190401-20200331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzUtNy0xLTEtMTAxMDg0L3RleHRyZWdpb246Y2U3MGRhZTFlMjBhNDgwMzlhMWNkMjJhY2NmY2QwYTVfNDcyNzg5OTk5OTQzNzI_5e471bc7-d0db-494c-a82a-a8f7882d67f0">5.94</ix:nonNumeric> - <ix:nonNumeric contextRef="i6e6975dac5d14fdeb07a8ecc86e9912d_D20190401-20200331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzUtNy0xLTEtMTAxMDg0L3RleHRyZWdpb246Y2U3MGRhZTFlMjBhNDgwMzlhMWNkMjJhY2NmY2QwYTVfNDcyNzg5OTk5OTQzNzg_96da3002-79b3-4240-88bb-c98c211b0338">10.00</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Expected dividend</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i31208a9ec3934804b4c4c3c9e4b9ae56_D20210401-20220331" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzYtOS0xLTEtODQ2MzM_eea4abae-4397-489d-81b4-950a80fb8c79">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i63de954bcdf44beabda4a4cb41517cd6_D20200401-20210331" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzYtMTMtMS0xLTg0NjMz_a9023646-24eb-4e0a-ba37-eb83ce8844ab">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i5570e6c29d854f898d1e5e342437be88_D20190401-20200331" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzYtOS0xLTEtMTAwNTc0_c4bafdd6-e9ff-40a4-8468-585bf1d56952">&#8212;</ix:nonFraction>%</span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance-Based Options </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2018, the board of directors of the Company granted <ix:nonFraction unitRef="shares" contextRef="i298cf9213fd94bf999a48f99a9e0d27c_D20180301-20180331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxNjUw_feebcff1-3031-46bf-9729-9d816c1b962b">1,792,000</ix:nonFraction> options to the Chief Executive Officer with an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i298cf9213fd94bf999a48f99a9e0d27c_D20180301-20180331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxNjU4_c09bea09-b67b-43ab-992e-c3570b400161">0.97</ix:nonFraction> per share under the 2010 Plan (the &#8220;2018 CEO Grant&#8221;) with a liquidity-event performance-based vesting condition based on the occurrence of a qualifying liquidity event, including an IPO, as well as stock price target after the consummation of the IPO. In September 2020, the 2018 CEO Grant was modified to extend the stock price target achievement cutoff date. The fair value of the 2018 CEO Grant was determined using a Monte Carlo simulation approach on the modification date. The achievement of the qualifying event was not considered to be probable prior to the Company&#8217;s IPO. Upon the Company's IPO, the liquidity-event performance-based condition was met. During the fiscal year ended March&#160;31, 2022, $<ix:nonFraction unitRef="usd" contextRef="i7c137a25b9864647b3377c74eb5c9329_D20210401-20220331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxNzQ0_2fa5eae7-6702-44fb-a1c4-fd03766ba4d1">1.7</ix:nonFraction> million was recognized as stock-based compensation expense relating to the 2018 CEO Grant. As the grant consists of a single tranche, the Company will amortize the remaining unrecognized compensation expense of $<ix:nonFraction unitRef="usd" contextRef="icd3eb1cf82ec45919e291170d616104d_I20220331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxNzgw_e1776ec2-685e-4930-8cfc-af89c84e8de5">0.2</ix:nonFraction> million on a straight-line basis over the remaining term of <ix:nonNumeric contextRef="i7c137a25b9864647b3377c74eb5c9329_D20210401-20220331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTc0MzUx_9a6d1f8d-bb6f-42c5-ab7f-cd073a35e261">0.17</ix:nonNumeric> years.  </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the Company has <ix:nonFraction unitRef="shares" contextRef="i24ebf27ab6024144a01cc18be9301b97_I20220331" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxODI5_fa5f7621-a55c-4d50-b35f-35bb2d818fdf">480,000</ix:nonFraction> outstanding options with performance-based and service-based vesting conditions. The performance conditions are satisfied upon meeting certain financial performance and sales targets. During the fiscal year ended March&#160;31, 2022, $<ix:nonFraction unitRef="usd" contextRef="i4d1acfbd8dc54fa9b2bcb6aafeb4d7f5_D20210401-20220331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxODQ2_621e627c-d28c-472a-8552-a164b30fef17">1.7</ix:nonFraction> million was recognized as stock-based compensation expense related to performance-based options whose performance condition have either been met or achievement of which is considered probable. For the options for which the achievement of the performance vesting conditions is met or is considered probable, the remaining unrecognized compensation expense is $<ix:nonFraction unitRef="usd" contextRef="i24ebf27ab6024144a01cc18be9301b97_I20220331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxOTUz_08215846-bdae-4a75-8d1d-e36c1802f446">1.4</ix:nonFraction> million, which will be amortized using accelerated attribution method over the remainder of the vesting periods. The amount to be recognized may change based upon actual performance achieved and updates to estimates of future performance. During the fiscal year ended March&#160;31, 2021 and 2020, the stock-based compensation expense related to performance options was immaterial. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal year ended March&#160;31, 2022, the Company granted <ix:nonFraction unitRef="shares" contextRef="ife196e39e85444efa18e6408b5528324_D20210401-20220331" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgyMDE1_25c25a38-6cb8-4310-b6f6-1c930b2de46f">572,904</ix:nonFraction> RSUs under the 2021 Plan. The Company granted <ix:nonFraction unitRef="shares" contextRef="i069e58edeaa64c12a8363d9a79919c2f_D20210624-20210624" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgyMDI0_dae1164d-0840-4015-a175-f858534deaeb">28,250</ix:nonFraction> on June 24, 2021, <ix:nonFraction unitRef="number" contextRef="i8d9b036a65e94e84b94ff795383a9281_D20210401-20220331" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgyMDMw_ab97c267-d7c1-4e4e-8230-f4c325352d4c">50</ix:nonFraction>% of which vested on November&#160;15, 2021, with the remaining <ix:nonFraction unitRef="number" contextRef="ieda01ec82c8347f79e1ed7baa2764e9c_D20210401-20220331" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgyMDM2_8dda4857-f401-497b-9d34-44800f3d9f67">50</ix:nonFraction>% vested on February&#160;15, 2022. The remaining RSUs granted during the fiscal year ended March&#160;31, 2022 will generally vest over <ix:nonNumeric contextRef="i8d96c621dbad4b0893a45915a1e3eb41_D20210401-20220331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgyMTQ3_d0559a88-8394-424a-82cd-35b6e8a6ac9c">four years</ix:nonNumeric> based on continued service.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The RSUs are valued using the closing stock price of the Company&#8217;s common stock, which is traded on the NYSE, on the day of grant. </span></div><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzU3NzI0MzYwNDgyNTQ4_98f3dddd-549c-48de-9658-5813730f8cca" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes RSU activity during the fiscal year ended March&#160;31, 2022 (in&#160;thousands, except per share information):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.545%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted-<br/>Average<br/>Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unvested Balance, March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i22cded30244a4dc4b48d2cc92c10c4be_I20210331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozZmY1N2ZmMzg3YTk0MmM4YTkzMzI4YWE4ZTIwYmI4NC90YWJsZXJhbmdlOjNmZjU3ZmYzODdhOTQyYzhhOTMzMjhhYThlMjBiYjg0XzEtMS0xLTEtODQ2MzM_98417c9c-f816-421b-ada6-61dc50661bbb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i22cded30244a4dc4b48d2cc92c10c4be_I20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozZmY1N2ZmMzg3YTk0MmM4YTkzMzI4YWE4ZTIwYmI4NC90YWJsZXJhbmdlOjNmZjU3ZmYzODdhOTQyYzhhOTMzMjhhYThlMjBiYjg0XzEtMy0xLTEtODQ2MzM_594a98d3-a3ef-445b-876f-2ad426dfff4b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ife196e39e85444efa18e6408b5528324_D20210401-20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozZmY1N2ZmMzg3YTk0MmM4YTkzMzI4YWE4ZTIwYmI4NC90YWJsZXJhbmdlOjNmZjU3ZmYzODdhOTQyYzhhOTMzMjhhYThlMjBiYjg0XzItMS0xLTEtODQ2MzM_705adc43-78b1-4139-8114-d226bb665d78">573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="ife196e39e85444efa18e6408b5528324_D20210401-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozZmY1N2ZmMzg3YTk0MmM4YTkzMzI4YWE4ZTIwYmI4NC90YWJsZXJhbmdlOjNmZjU3ZmYzODdhOTQyYzhhOTMzMjhhYThlMjBiYjg0XzItMy0xLTEtODQ2MzM_3f0e29f1-5fb4-42d2-8d6c-7529f54fb047">67.60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="ife196e39e85444efa18e6408b5528324_D20210401-20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozZmY1N2ZmMzg3YTk0MmM4YTkzMzI4YWE4ZTIwYmI4NC90YWJsZXJhbmdlOjNmZjU3ZmYzODdhOTQyYzhhOTMzMjhhYThlMjBiYjg0XzMtMS0xLTEtODQ2MzM_047447b3-3181-4a12-afd0-ef45db1a17e0">38</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="ife196e39e85444efa18e6408b5528324_D20210401-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozZmY1N2ZmMzg3YTk0MmM4YTkzMzI4YWE4ZTIwYmI4NC90YWJsZXJhbmdlOjNmZjU3ZmYzODdhOTQyYzhhOTMzMjhhYThlMjBiYjg0XzMtMy0xLTEtODQ2MzM_43c7de69-a9fe-405c-aedf-6e777baf97d1">59.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="ife196e39e85444efa18e6408b5528324_D20210401-20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozZmY1N2ZmMzg3YTk0MmM4YTkzMzI4YWE4ZTIwYmI4NC90YWJsZXJhbmdlOjNmZjU3ZmYzODdhOTQyYzhhOTMzMjhhYThlMjBiYjg0XzQtMS0xLTEtODQ2MzM_3ed3d677-4e2e-4055-9343-b4330d531646">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="ife196e39e85444efa18e6408b5528324_D20210401-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozZmY1N2ZmMzg3YTk0MmM4YTkzMzI4YWE4ZTIwYmI4NC90YWJsZXJhbmdlOjNmZjU3ZmYzODdhOTQyYzhhOTMzMjhhYThlMjBiYjg0XzQtMy0xLTEtODQ2MzM_4a874d69-e5ce-4e96-a4d6-10e4883a36a8">54.59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unvested Balance, March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i610bf1430732450cbbf831aa9fbaf023_I20220331" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozZmY1N2ZmMzg3YTk0MmM4YTkzMzI4YWE4ZTIwYmI4NC90YWJsZXJhbmdlOjNmZjU3ZmYzODdhOTQyYzhhOTMzMjhhYThlMjBiYjg0XzUtMS0xLTEtODQ2MzM_566bac8c-2951-4625-ba3f-77b2caed9a73">534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i610bf1430732450cbbf831aa9fbaf023_I20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozZmY1N2ZmMzg3YTk0MmM4YTkzMzI4YWE4ZTIwYmI4NC90YWJsZXJhbmdlOjNmZjU3ZmYzODdhOTQyYzhhOTMzMjhhYThlMjBiYjg0XzUtMy0xLTEtODQ2MzM_deef3dcb-8140-4f68-a311-24e1cba64405">68.23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="if13c0ffe072c4d08a626be3fa4b47d03"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of RSUs vested during the fiscal year ended March&#160;31, 2022 was $<ix:nonFraction unitRef="usd" contextRef="ife196e39e85444efa18e6408b5528324_D20210401-20220331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzQ3Mjc5MDAwMDE4Mzky_87761866-e9bb-4903-93dd-444f328f802e">2.5</ix:nonFraction> million.  </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, total unrecognized stock-based compensation cost, net of estimated forfeitures, related to non-vested RSUs was $<ix:nonFraction unitRef="usd" contextRef="i610bf1430732450cbbf831aa9fbaf023_I20220331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgyMjY1_092aea50-180d-4259-9aed-0e259d451d3d">26.3</ix:nonFraction> million, and is expected to be recognized over a weighted-average period of approximately <ix:nonNumeric contextRef="ife196e39e85444efa18e6408b5528324_D20210401-20220331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgyMjgy_87f63750-6820-4153-b6c3-965d6d10f9fc">3.51</ix:nonNumeric> years. As of March&#160;31, 2021 and 2020, <ix:nonFraction unitRef="shares" contextRef="i22cded30244a4dc4b48d2cc92c10c4be_I20210331" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTc4MDU1_27a87c36-3e2f-4c7a-8535-881b0fbc40b3"><ix:nonFraction unitRef="shares" contextRef="ic960f45dc6ee4214a384c76564f6f1a3_I20200331" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTc4MDU1_c7f2ec8f-7b38-4554-beda-de3d40682922">no</ix:nonFraction></ix:nonFraction> RSUs were outstanding. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance-Based Restricted Stock Units</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal year ended March&#160;31, 2022, the Company granted <ix:nonFraction unitRef="shares" contextRef="i117af75205314c998fad1407c682e2d0_D20210401-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgyMzUx_1a9f4d52-abc9-4b70-8b00-9cb4b78c82db">15,239</ix:nonFraction> PSUs under the 2021 Plan, which had a weighted-average grant date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i117af75205314c998fad1407c682e2d0_D20210401-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgyMzYw_c5d2f6d5-e0f9-4b3c-b8e3-63e200c0b59e">80.00</ix:nonFraction>. The PSUs have performance-based vesting conditions that are satisfied upon meeting certain financial performance targets. During the fiscal year ended March&#160;31, 2022, <ix:nonFraction unitRef="shares" contextRef="i117af75205314c998fad1407c682e2d0_D20210401-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzM0MDg0ODYwNDg0ODYy_79fb438a-4e54-4b60-8ee2-3132352075df">3,170</ix:nonFraction> PSUs were forfeited. As of March&#160;31, 2022, <ix:nonFraction unitRef="shares" contextRef="i8075f5e61a6f4e0fa23f0b2d73e6bc0b_I20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgyNDU2_5cf3ba3c-59f9-4bda-81db-4ec45ec7aead">12,069</ix:nonFraction> PSUs were unvested. The performance conditions of these PSUs were met as of March&#160;31, 2022.  During the fiscal year ended March&#160;31, 2022, $<ix:nonFraction unitRef="usd" contextRef="i117af75205314c998fad1407c682e2d0_D20210401-20220331" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgyNTM4_7a9b0a47-07db-44fc-9b84-323a764655ba">0.6</ix:nonFraction> million  was recognized as stock-based compensation expense related to these PSUs. As of March&#160;31, 2022, the remaining unrecognized compensation expense was $<ix:nonFraction unitRef="usd" contextRef="i8075f5e61a6f4e0fa23f0b2d73e6bc0b_I20220331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgyNTU3_8e7d4f20-9108-489a-931d-c001aa7977dd">0.3</ix:nonFraction> million, which will be recognized on a straight-line basis over the remaining term of <ix:nonNumeric contextRef="i117af75205314c998fad1407c682e2d0_D20210401-20220331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgyNTcy_fd41a36c-baf6-4c12-bf12-f13871c71e7a">0.38</ix:nonNumeric> years, as the PSUs consist of a single tranche. As of March&#160;31, 2021 and 2020, <ix:nonFraction unitRef="shares" contextRef="i54f0e6464d3d42999d152987a80350fc_I20210331" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTc4MDY0_a8680b50-f54c-4867-885f-4e25050d9c29"><ix:nonFraction unitRef="shares" contextRef="i1e70174a995c49c9916aacfc83acfc7e_I20200331" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTc4MDY0_cbfe228d-2a34-425b-9654-53aed8cd62d7">no</ix:nonFraction></ix:nonFraction> PSUs were outstanding. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The PSUs are valued using the closing stock price of its common stock, which is traded on the NYSE, on the day of grant. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ESPP</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s first offering period under the ESPP began on November&#160;1, 2021 and ended on February&#160;15, 2022. Subsequent offering periods will begin on the first business day occurring on or after each February 16th and August 16th, and will end on the last business day occurring on or before the following August 15th and February 15th, respectively, unless and until otherwise determined by the administrator of the ESPP. The price at which Class A common stock is purchased under the ESPP is equal to <ix:nonFraction unitRef="number" contextRef="id49a07de8105430d9e5b763fa04c9419_D20210401-20220331" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgyNjMw_d9635b4e-dca4-47da-8175-4ccf7638fe22">85</ix:nonFraction>% of the fair market value of a share of the Company&#8217;s Class A common stock on the first or last day of the offering period, whichever is lower. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant-date fair value of ESPP stock purchase rights granted during the fiscal year ended March&#160;31, 2022 was $<ix:nonFraction unitRef="usdPerShare" contextRef="id49a07de8105430d9e5b763fa04c9419_D20210401-20220331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgyNjk2_786b0939-fa96-4bf6-a32f-811f2ace15ef">23.84</ix:nonFraction>. <ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzU3NzI0MzYwNDgyNTQ5_40cdb81b-7e92-4816-82b1-e271785eb908" continuedAt="ide28c888e71246f09205401f224e4a75" escape="true">The fair value of the ESPP stock purchase rights on the date of grant is determined using the Black-Scholes pricing model with the assumptions set forth in the following table:</ix:nonNumeric></span></div><div style="margin-bottom:9pt"><ix:continuation id="ide28c888e71246f09205401f224e4a75"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.854%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Fair value of common stock</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usdPerShare" contextRef="i14587970434d4e5d831e458e0cf34e59_D20210401-20220331" decimals="2" name="docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjNjgxYTIxZjhjNjA0MWYwOGU3ZDM5Y2IxMTBhY2ExMy90YWJsZXJhbmdlOmM2ODFhMjFmOGM2MDQxZjA4ZTdkMzljYjExMGFjYTEzXzItMS0xLTEtODQ2MzMvdGV4dHJlZ2lvbjpiNWVhNWVkZGY1ZjY0N2NhYmMyYWI5N2RjZmEwMWU4Y18yOTEzNzA1ODEzNjA5NQ_f982021d-2f46-4bca-80ae-52de0fc5c7a0">57.44</ix:nonFraction> - $<ix:nonFraction unitRef="usdPerShare" contextRef="i392e807a56904918a6a9e4076a92504d_D20210401-20220331" decimals="2" name="docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjNjgxYTIxZjhjNjA0MWYwOGU3ZDM5Y2IxMTBhY2ExMy90YWJsZXJhbmdlOmM2ODFhMjFmOGM2MDQxZjA4ZTdkMzljYjExMGFjYTEzXzItMS0xLTEtODQ2MzMvdGV4dHJlZ2lvbjpiNWVhNWVkZGY1ZjY0N2NhYmMyYWI5N2RjZmEwMWU4Y18yOTEzNzA1ODEzNjA5OQ_63acef34-f66a-4e01-bb4f-baa8bf79715e">73.73</ix:nonFraction></span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="id49a07de8105430d9e5b763fa04c9419_D20210401-20220331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjNjgxYTIxZjhjNjA0MWYwOGU3ZDM5Y2IxMTBhY2ExMy90YWJsZXJhbmdlOmM2ODFhMjFmOGM2MDQxZjA4ZTdkMzljYjExMGFjYTEzXzMtMS0xLTEtODQ2MzMvdGV4dHJlZ2lvbjozNDVhM2U0YWY0ODE0NWQ4YTdkMWI1MTk2MmYxNTYzY18yOTEzNzA1ODEzNjA5MQ_2e5cfa1b-03d4-4d3e-b346-3fc1a562c899">86.3</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="id49a07de8105430d9e5b763fa04c9419_D20210401-20220331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjNjgxYTIxZjhjNjA0MWYwOGU3ZDM5Y2IxMTBhY2ExMy90YWJsZXJhbmdlOmM2ODFhMjFmOGM2MDQxZjA4ZTdkMzljYjExMGFjYTEzXzMtMS0xLTEtODQ2MzMvdGV4dHJlZ2lvbjozNDVhM2U0YWY0ODE0NWQ4YTdkMWI1MTk2MmYxNTYzY18yOTEzNzA1ODEzNjA5NQ_dd2c58a3-01b1-4653-be80-60de1ffde424">103.6</ix:nonFraction>%</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="id49a07de8105430d9e5b763fa04c9419_D20210401-20220331" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjNjgxYTIxZjhjNjA0MWYwOGU3ZDM5Y2IxMTBhY2ExMy90YWJsZXJhbmdlOmM2ODFhMjFmOGM2MDQxZjA4ZTdkMzljYjExMGFjYTEzXzQtMS0xLTEtODQ2MzMvdGV4dHJlZ2lvbjpkMWJjOGM5ODQ0MjQ0YjE5ODAwNzk2Y2RlMjM2NGMyM18yOTEzNzA1ODEzNjA5MQ_e65fcfe6-5b59-46c4-a946-d054d9f4f65d">0.05</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="id49a07de8105430d9e5b763fa04c9419_D20210401-20220331" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjNjgxYTIxZjhjNjA0MWYwOGU3ZDM5Y2IxMTBhY2ExMy90YWJsZXJhbmdlOmM2ODFhMjFmOGM2MDQxZjA4ZTdkMzljYjExMGFjYTEzXzQtMS0xLTEtODQ2MzMvdGV4dHJlZ2lvbjpkMWJjOGM5ODQ0MjQ0YjE5ODAwNzk2Y2RlMjM2NGMyM18yOTEzNzA1ODEzNjA5NQ_3d85bc26-b65a-486b-8566-dbb7b54bd802">0.67</ix:nonFraction>%</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i14587970434d4e5d831e458e0cf34e59_D20210401-20220331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjNjgxYTIxZjhjNjA0MWYwOGU3ZDM5Y2IxMTBhY2ExMy90YWJsZXJhbmdlOmM2ODFhMjFmOGM2MDQxZjA4ZTdkMzljYjExMGFjYTEzXzUtMS0xLTEtODQ2MzMvdGV4dHJlZ2lvbjoyMjcxM2NhY2U0MmU0YTQ0YTUyN2MwZTdiNzk4OGVkOF8yOTEzNzA1ODEzNjA4NQ_50865424-2577-4a3a-bccd-93a79d048fe9">0.29</ix:nonNumeric> - <ix:nonNumeric contextRef="i392e807a56904918a6a9e4076a92504d_D20210401-20220331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjNjgxYTIxZjhjNjA0MWYwOGU3ZDM5Y2IxMTBhY2ExMy90YWJsZXJhbmdlOmM2ODFhMjFmOGM2MDQxZjA4ZTdkMzljYjExMGFjYTEzXzUtMS0xLTEtODQ2MzMvdGV4dHJlZ2lvbjoyMjcxM2NhY2U0MmU0YTQ0YTUyN2MwZTdiNzk4OGVkOF8yOTEzNzA1ODEzNjA4OQ_15fd8a3f-f07f-4a88-9876-ea035a50cccc">0.49</ix:nonNumeric></span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Expected dividend</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="id49a07de8105430d9e5b763fa04c9419_D20210401-20220331" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjNjgxYTIxZjhjNjA0MWYwOGU3ZDM5Y2IxMTBhY2ExMy90YWJsZXJhbmdlOmM2ODFhMjFmOGM2MDQxZjA4ZTdkMzljYjExMGFjYTEzXzYtMS0xLTEtODQ2MzM_97164f88-7efa-4f01-9f0b-425e33e69c91">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, unamortized compensation expense, net of estimated forfeitures, related to the ESPP was $<ix:nonFraction unitRef="usd" contextRef="i7d4c019a802944bb81efba9687e2e06a_I20220331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgyODIx_d885a67b-2e58-49e2-b2ac-40117df45ffc">0.9</ix:nonFraction> million, which will be recognized on a straight-line basis over a weighted-average period of <ix:nonNumeric contextRef="id49a07de8105430d9e5b763fa04c9419_D20210401-20220331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgyODMz_ca3f1e61-7754-4e2e-9089-bc1035d745e5">0.38</ix:nonNumeric> years. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the  fiscal year ended March&#160;31, 2022, <ix:nonFraction unitRef="shares" contextRef="id49a07de8105430d9e5b763fa04c9419_D20210401-20220331" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwNzg2MzI1NjAxODAy_f2d1cf83-8c76-4f25-a353-1a5e0246d05e">28,812</ix:nonFraction> shares of Class A common stock were purchased under the ESPP at a weighted average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="id49a07de8105430d9e5b763fa04c9419_D20210401-20220331" decimals="2" name="docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardPricesPerShareIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwNzg2MzI1NjAxODI0_acfb7e5e-667f-40f1-b61d-1130f1198a3b">48.40</ix:nonFraction> per share. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation Expense</span></div><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzU3NzI0MzYwNDgyNTUw_bb9fd056-feef-4f63-a75a-fadbf58c5867" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense recognized in the consolidated statement of operations for the fiscal years ended March&#160;31, 2022, 2021, and 2020 was as follows (in&#160;thousands): </span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cost of revenue</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ifc62a205668f49b9bf71eefe850ffc3f_D20210401-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjYzFhNzg4YTk5NzM0OTEyOGRhMWZhODg3NTExODBkYy90YWJsZXJhbmdlOmNjMWE3ODhhOTk3MzQ5MTI4ZGExZmE4ODc1MTE4MGRjXzItNS0xLTEtODQ2MzM_59fef0a9-6a4b-4cb1-a718-c4eae7201382">4,979</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9164774a82a1435bb9edf034bfb5610d_D20200401-20210331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjYzFhNzg4YTk5NzM0OTEyOGRhMWZhODg3NTExODBkYy90YWJsZXJhbmdlOmNjMWE3ODhhOTk3MzQ5MTI4ZGExZmE4ODc1MTE4MGRjXzItNy0xLTEtODQ2MzM_0552e010-b7ce-4ce9-bf0b-349e8b8ada60">600</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i381d7bd945a246b38630bd42ca02f556_D20190401-20200331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjYzFhNzg4YTk5NzM0OTEyOGRhMWZhODg3NTExODBkYy90YWJsZXJhbmdlOmNjMWE3ODhhOTk3MzQ5MTI4ZGExZmE4ODc1MTE4MGRjXzItNS0xLTEtOTE3Mjg_3b123746-c29b-4aea-a357-0495c99ac4fc">173</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i643419a5871c4616afc52904e8243daa_D20210401-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjYzFhNzg4YTk5NzM0OTEyOGRhMWZhODg3NTExODBkYy90YWJsZXJhbmdlOmNjMWE3ODhhOTk3MzQ5MTI4ZGExZmE4ODc1MTE4MGRjXzMtNS0xLTEtODQ2MzM_e9757dfd-b600-47e5-a331-ec600a882f52">7,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i9c63553114c049e0b99db51fd02c3a5a_D20200401-20210331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjYzFhNzg4YTk5NzM0OTEyOGRhMWZhODg3NTExODBkYy90YWJsZXJhbmdlOmNjMWE3ODhhOTk3MzQ5MTI4ZGExZmE4ODc1MTE4MGRjXzMtNy0xLTEtODQ2MzM_51f64dec-5c6d-45b3-84e4-f54ec35e022f">1,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i847059421e7947a984ad34ce247eb9e4_D20190401-20200331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjYzFhNzg4YTk5NzM0OTEyOGRhMWZhODg3NTExODBkYy90YWJsZXJhbmdlOmNjMWE3ODhhOTk3MzQ5MTI4ZGExZmE4ODc1MTE4MGRjXzMtNS0xLTEtOTE3Mjg_a9d21585-814e-4774-a8a7-808a036efe4d">710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sales and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i22d0ef822c3a4843b76143dba7a23603_D20210401-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjYzFhNzg4YTk5NzM0OTEyOGRhMWZhODg3NTExODBkYy90YWJsZXJhbmdlOmNjMWE3ODhhOTk3MzQ5MTI4ZGExZmE4ODc1MTE4MGRjXzQtNS0xLTEtODQ2MzM_b7ecd65f-8244-48ad-b509-5b8c8a76bed0">8,108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="iec4edfed98534025a3c42e669b77c905_D20200401-20210331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjYzFhNzg4YTk5NzM0OTEyOGRhMWZhODg3NTExODBkYy90YWJsZXJhbmdlOmNjMWE3ODhhOTk3MzQ5MTI4ZGExZmE4ODc1MTE4MGRjXzQtNy0xLTEtODQ2MzM_8a6a4fb9-d758-4fb8-9960-ca4df95d7682">1,998</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="icce45add1e4a4c4ab8d74a95293ddd73_D20190401-20200331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjYzFhNzg4YTk5NzM0OTEyOGRhMWZhODg3NTExODBkYy90YWJsZXJhbmdlOmNjMWE3ODhhOTk3MzQ5MTI4ZGExZmE4ODc1MTE4MGRjXzQtNS0xLTEtOTE3Mjg_4144cdf7-2000-4d46-bfbb-f910e7c660df">847</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ieee0bbd772344ba3aa609a2395100a50_D20210401-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjYzFhNzg4YTk5NzM0OTEyOGRhMWZhODg3NTExODBkYy90YWJsZXJhbmdlOmNjMWE3ODhhOTk3MzQ5MTI4ZGExZmE4ODc1MTE4MGRjXzUtNS0xLTEtODQ2MzM_b61bb82a-c52a-4e5d-9998-b75238dbf0c8">11,290</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i0872333d3b584eeebd4ed5658baa1b13_D20200401-20210331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjYzFhNzg4YTk5NzM0OTEyOGRhMWZhODg3NTExODBkYy90YWJsZXJhbmdlOmNjMWE3ODhhOTk3MzQ5MTI4ZGExZmE4ODc1MTE4MGRjXzUtNy0xLTEtODQ2MzM_bfeb3a11-bfaf-4214-9537-99f9c58df194">2,679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4f8c647b40c747dba1ef8dc24e552b7a_D20190401-20200331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjYzFhNzg4YTk5NzM0OTEyOGRhMWZhODg3NTExODBkYy90YWJsZXJhbmdlOmNjMWE3ODhhOTk3MzQ5MTI4ZGExZmE4ODc1MTE4MGRjXzUtNS0xLTEtOTE3Mjg_8ed8d5ce-2a7b-4cfa-a8d4-641ace16d7be">623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjYzFhNzg4YTk5NzM0OTEyOGRhMWZhODg3NTExODBkYy90YWJsZXJhbmdlOmNjMWE3ODhhOTk3MzQ5MTI4ZGExZmE4ODc1MTE4MGRjXzYtNS0xLTEtODQ2MzM_7a2db03c-a9f9-4d03-9a5e-ec77926ae69b">31,442</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjYzFhNzg4YTk5NzM0OTEyOGRhMWZhODg3NTExODBkYy90YWJsZXJhbmdlOmNjMWE3ODhhOTk3MzQ5MTI4ZGExZmE4ODc1MTE4MGRjXzYtNy0xLTEtODQ2MzM_20b784af-4159-4c50-a1f4-d45dd92d757a">7,252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjYzFhNzg4YTk5NzM0OTEyOGRhMWZhODg3NTExODBkYy90YWJsZXJhbmdlOmNjMWE3ODhhOTk3MzQ5MTI4ZGExZmE4ODc1MTE4MGRjXzYtNS0xLTEtOTE3Mjg_da848416-96c4-4fad-9c12-f810fe5d7658">2,353</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><div id="i6c4404140edb48938ba4e30b290c9ef9_223"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.&#160;&#160;<ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90ZXh0cmVnaW9uOmZmZWVkMjY1NTQxNzRiOGM5ODVjYzE0YTdhMDdkYzY5XzQ4Mzc4NTExNjIzNDgz_f5217449-2e41-4b57-bfd0-426d4e190963" continuedAt="i5b6f28fcb87c41aa977169c3482c8327" escape="true">Net Income Per Share Attributable to Common Stockholders</ix:nonNumeric></span></div><ix:continuation id="i5b6f28fcb87c41aa977169c3482c8327"><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90ZXh0cmVnaW9uOmZmZWVkMjY1NTQxNzRiOGM5ODVjYzE0YTdhMDdkYzY5XzQ4Mzc4NTExNjIzNDg0_a26b578e-a34c-4a81-b5c0-74e4b0620573" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the reconciliation of the numerator and denominator for calculating basic and diluted net income per share (in thousands, except per share data):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Numerator</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzMtNS0xLTEtODUwNDM_c7be9d79-ca7a-499b-9ac6-2bf915714e10">154,783</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzMtNy0xLTEtODUwNDM_159de6ff-557a-4a76-93a1-07e4276809a3">50,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzMtNS0xLTEtOTE4MDM_7432b139-af08-4443-8319-4c23cd41cdd1">29,737</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less: undistributed earnings attributable to participating securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzQtNS0xLTEtODUwNDM_18fa0c5f-81a0-4d04-aa93-64f1efe23a06"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzQtNS0xLTEtODUwNDM_f0624606-6225-4e1c-bf71-a1f8b9daeb31">21,526</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzQtNy0xLTEtODUwNDM_301ccc17-c8c0-47c6-a96c-8b3a42ede777"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzQtNy0xLTEtODUwNDM_661050f1-9352-495e-a856-0dfef1009dee">28,654</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzQtNS0xLTEtOTE4MDM_9e52501f-dba5-42bb-81d0-57b5ce3564be"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzQtNS0xLTEtOTE4MDM_aeb1cecb-6469-4f60-981a-ef96e233e75e">18,908</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income attributable to Class A and Class B common stockholders, basic and diluted</span></div></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzUtNS0xLTEtODUwNDM_42020a58-5ea4-4ee9-b545-026955fe6d11"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzUtNS0xLTEtODUwNDM_566017f4-0ef4-4c84-8881-91cd9135081d">133,257</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzUtNy0xLTEtODUwNDM_3a26ab3b-488d-41c1-a9d0-3f554c7d9f7a"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzUtNy0xLTEtODUwNDM_d0e5ded6-2d6c-4020-ba0c-1140bfc1531a">21,556</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzUtNS0xLTEtOTE4MDM_463a75ca-1a03-45f6-a910-3b664a44d951"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzUtNS0xLTEtOTE4MDM_6442bd45-608f-4b75-b175-92aed2d5491d">10,829</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Denominator</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, basic</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzctNS0xLTEtODUwNDM_ddd33b39-c089-4743-b10e-c21b0b9f4e98">163,484</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzctNy0xLTEtODUwNDM_4e876a0b-971c-4444-9d4f-027aef06bb41">74,342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzctNS0xLTEtOTE4MDM_cb9f40c7-52f4-4537-821f-3ea6a7655f6d">66,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dilutive effect of assumed exercise of options to purchase common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i31208a9ec3934804b4c4c3c9e4b9ae56_D20210401-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzgtNS0xLTEtODUwNDM_40e48f9c-50bc-453e-a160-7684f6a62110">27,290</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i63de954bcdf44beabda4a4cb41517cd6_D20200401-20210331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzgtNy0xLTEtODUwNDM_93bb21af-ce04-495f-9115-4f391c4ae467">20,612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i5570e6c29d854f898d1e5e342437be88_D20190401-20200331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzgtNS0xLTEtOTE4MDM_48903a5d-42c2-4853-a65f-6b02b18b7721">14,892</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dilutive effect of assumed exercise of common stock warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzEwLTUtMS0xLTg1MDQz_3e82eeb0-90e6-4b06-8ddb-36bfb44efb16">234</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzEwLTctMS0xLTg1MDQz_31ad2edd-fcda-47da-b9ce-95a11cab855d">180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzEwLTUtMS0xLTkxODAz_1a15157e-13d4-4198-b9a6-465ecb486e69">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dilutive effect of other share-based awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ifbdabf5291a64e328bdbbfff61aa8d5c_D20210401-20220331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzExLTUtMS0xLTg1MDQz_04817225-f905-4495-b881-319b661be175">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ia9e97d96aecb4d1d904052c4e11402f0_D20200401-20210331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzExLTctMS0xLTg1MDQz_7e13a450-e76c-4a5f-a54a-c39a00d80bdd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i9e38c40919b2480382413b360d2df583_D20190401-20200331" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzExLTUtMS0xLTkxODAz_16e04652-b465-4633-9754-c10b3699167d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, diluted</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzEzLTUtMS0xLTg1MDQz_0422ff7d-bce9-4bdc-857e-73c0efa5a4d9">191,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzEzLTctMS0xLTg1MDQz_fe9b75ac-06f7-44d8-b679-bd6fde2ac7ba">95,134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzEzLTUtMS0xLTkxODAz_3e4dd8f0-0c7f-44b6-b55d-5f3bd7d7a234">81,710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income per share attributable to Class A and Class B common stockholders, basic</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzE0LTUtMS0xLTg1MDQz_33aba4d7-0f78-46fa-809f-396e9767cf9b">0.82</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzE0LTctMS0xLTg1MDQz_c80a3c9c-b2c8-4b51-b559-e00629be40ba">0.29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzE0LTUtMS0xLTkxODAz_1d504e65-6998-40ed-b8a1-f8525884210f">0.16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income per share attributable to Class A and Class B common stockholders, diluted</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzE1LTUtMS0xLTg1MDQz_ff862ed4-5a25-4f6d-ba32-6a2035035b03">0.70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzE1LTctMS0xLTg1MDQz_33a15d60-c1f5-4a9a-ba8a-4c9df82a8538">0.23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzE1LTUtMS0xLTkxODAz_ad76e1bc-b079-4ef1-a1f2-0317d9248a73">0.13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90ZXh0cmVnaW9uOmZmZWVkMjY1NTQxNzRiOGM5ODVjYzE0YTdhMDdkYzY5XzQ4Mzc4NTExNjIzNDg1_e8e83558-720f-4045-bf0f-09cf5b542c40" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain potentially dilutive securities have been excluded from the calculation of diluted net income per share during the applicable periods because their inclusion would have been anti-dilutive (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Redeemable convertible preferred stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i80014f589fa24025aba4a9a6e7337c21_D20210401-20220331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2Zjk5YzhjMjkxYzM0ZGZiYTEwMzkzMjZhYTdjZTBlMC90YWJsZXJhbmdlOjZmOTljOGMyOTFjMzRkZmJhMTAzOTMyNmFhN2NlMGUwXzItNS0xLTEtODUwNDM_ebcccff4-af57-4e21-8bd4-a5e849ad03b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i37353189bac04c0c8499282980a6fbb4_D20200401-20210331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2Zjk5YzhjMjkxYzM0ZGZiYTEwMzkzMjZhYTdjZTBlMC90YWJsZXJhbmdlOjZmOTljOGMyOTFjMzRkZmJhMTAzOTMyNmFhN2NlMGUwXzItNy0xLTEtODUwNDM_64a2ea38-a17f-4624-9e2c-7bbdad3e40d1">76,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i47d1b632be7e4cc090898a23568e0174_D20190401-20200331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2Zjk5YzhjMjkxYzM0ZGZiYTEwMzkzMjZhYTdjZTBlMC90YWJsZXJhbmdlOjZmOTljOGMyOTFjMzRkZmJhMTAzOTMyNmFhN2NlMGUwXzItNS0xLTEtOTE4Mjg_b6bcb232-0a80-4cfe-8e7a-1aa6e1e76c02">76,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="if2c5b92d76cd41efbbbb13447fd077b8_D20210401-20220331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2Zjk5YzhjMjkxYzM0ZGZiYTEwMzkzMjZhYTdjZTBlMC90YWJsZXJhbmdlOjZmOTljOGMyOTFjMzRkZmJhMTAzOTMyNmFhN2NlMGUwXzQtNS0xLTEtODUwNDM_ddde8c34-4922-416d-bade-db7c97015194">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i433b7b224b754032ae79af210bdf56c0_D20200401-20210331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2Zjk5YzhjMjkxYzM0ZGZiYTEwMzkzMjZhYTdjZTBlMC90YWJsZXJhbmdlOjZmOTljOGMyOTFjMzRkZmJhMTAzOTMyNmFhN2NlMGUwXzQtNy0xLTEtODUwNDM_40a86d68-6b8e-409b-8465-69a546e18723">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i19af305064d34ab0a9c791bd4989487e_D20190401-20200331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2Zjk5YzhjMjkxYzM0ZGZiYTEwMzkzMjZhYTdjZTBlMC90YWJsZXJhbmdlOjZmOTljOGMyOTFjMzRkZmJhMTAzOTMyNmFhN2NlMGUwXzQtNS0xLTEtOTE4Mjg_523b5c9a-beb2-4e39-a3e3-5c1cc776a906">578</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other share-based awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i7166b08eefb94201a936dda4ab4a1b6f_D20210401-20220331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2Zjk5YzhjMjkxYzM0ZGZiYTEwMzkzMjZhYTdjZTBlMC90YWJsZXJhbmdlOjZmOTljOGMyOTFjMzRkZmJhMTAzOTMyNmFhN2NlMGUwXzUtNS0xLTEtODUwNDM_2c8858a8-2213-481e-a649-23279e5de363">217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i3d0cf67197d64b82a0f9be653ff65148_D20200401-20210331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2Zjk5YzhjMjkxYzM0ZGZiYTEwMzkzMjZhYTdjZTBlMC90YWJsZXJhbmdlOjZmOTljOGMyOTFjMzRkZmJhMTAzOTMyNmFhN2NlMGUwXzUtNy0xLTEtODUwNDM_baae685e-e824-4823-b921-139cffc56b59">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i3a29bfa4143c42cb8c0f174e1b701e1f_D20190401-20200331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2Zjk5YzhjMjkxYzM0ZGZiYTEwMzkzMjZhYTdjZTBlMC90YWJsZXJhbmdlOjZmOTljOGMyOTFjMzRkZmJhMTAzOTMyNmFhN2NlMGUwXzUtNS0xLTEtOTE4Mjg_f6e2fed8-e9a0-42e5-afec-ff2839ce6423">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Common stock warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i366343ec548042d1a0b920b7da7cd459_D20210401-20220331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2Zjk5YzhjMjkxYzM0ZGZiYTEwMzkzMjZhYTdjZTBlMC90YWJsZXJhbmdlOjZmOTljOGMyOTFjMzRkZmJhMTAzOTMyNmFhN2NlMGUwXzctNS0xLTEtODUwNDM_063c0647-92a5-4fdc-85e3-fb0e949f102b">247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="ie0f97ef761814d6fa5b6219079762edc_D20200401-20210331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2Zjk5YzhjMjkxYzM0ZGZiYTEwMzkzMjZhYTdjZTBlMC90YWJsZXJhbmdlOjZmOTljOGMyOTFjMzRkZmJhMTAzOTMyNmFhN2NlMGUwXzctNy0xLTEtODUwNDM_d51639c1-fc2f-4006-bb2c-f937fec0e74a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i1f1b807dde644927a5cecfcdc7ea90b4_D20190401-20200331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2Zjk5YzhjMjkxYzM0ZGZiYTEwMzkzMjZhYTdjZTBlMC90YWJsZXJhbmdlOjZmOTljOGMyOTFjMzRkZmJhMTAzOTMyNmFhN2NlMGUwXzctNS0xLTEtOTE4Mjg_e680f90b-7963-471a-b498-f8c07ddd2ce8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2Zjk5YzhjMjkxYzM0ZGZiYTEwMzkzMjZhYTdjZTBlMC90YWJsZXJhbmdlOjZmOTljOGMyOTFjMzRkZmJhMTAzOTMyNmFhN2NlMGUwXzgtNS0xLTEtODUwNDM_4ed072a8-4605-416e-88c4-bab6163d0316">464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2Zjk5YzhjMjkxYzM0ZGZiYTEwMzkzMjZhYTdjZTBlMC90YWJsZXJhbmdlOjZmOTljOGMyOTFjMzRkZmJhMTAzOTMyNmFhN2NlMGUwXzgtNy0xLTEtODUwNDM_5c09038e-d00c-4862-944e-737ff048f277">76,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2Zjk5YzhjMjkxYzM0ZGZiYTEwMzkzMjZhYTdjZTBlMC90YWJsZXJhbmdlOjZmOTljOGMyOTFjMzRkZmJhMTAzOTMyNmFhN2NlMGUwXzgtNS0xLTEtOTE4Mjg_042b6921-c446-4cbc-8e8f-a0de9cdad4a8">76,865</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i6c4404140edb48938ba4e30b290c9ef9_220"></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:-5.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.&#160;&#160;<ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90ZXh0cmVnaW9uOmU1MzdjYzA0NGE2YjQxMzRiMTM5ZTQwNmVkYzg5NGM0XzUxNjc3MDQ2NTEwOTgz_9e9e1a5a-2194-4602-90fb-ec7ae3e2f57f" continuedAt="i702d9582138a426e8bf3ed13c9677909" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="i702d9582138a426e8bf3ed13c9677909" continuedAt="ib282355cebd74d02abdeb1b46ce7dfaf"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company&#8217;s income before income taxes was generated in the United States for the fiscal year ended March 31, 2022, 2021, and 2020. </span></div><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90ZXh0cmVnaW9uOmU1MzdjYzA0NGE2YjQxMzRiMTM5ZTQwNmVkYzg5NGM0XzUxNjc3MDQ2NTEwOTg1_67ecb188-49e7-47e9-b5b8-a49560e01ded" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s provision for (benefit from) income taxes consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Current provision:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzMtMS0xLTEtNDkzNTY_ab1078d5-df8f-4ea5-a1ab-9c382c2efa0d">160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzMtMy0xLTEtNDkzNTY_3b5f5da2-b18b-49ff-b7c4-ba6871fdfd1b">1,302</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzMtNS0xLTEtNDkzNTY_aaa76110-b451-497d-bb35-aef1ca72b873">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzQtMS0xLTEtNDkzNTY_a99b1694-45ec-443e-a503-9254728e66b1">309</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzQtMy0xLTEtNDkzNTY_dbaf4578-589e-4353-890a-0406121686ca">1,270</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzQtNS0xLTEtNDkzNTY_e585777f-a2b6-4255-9e1d-11925c457cde">876</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzUtMS0xLTEtNDkzNTY_8ff4b103-ca30-4320-b10a-1c77b8118996">469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzUtMy0xLTEtNDkzNTY_1a4d9376-8dc9-4313-adbd-cd570b2e0057">2,572</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzUtNS0xLTEtNDkzNTY_ab6a326d-c1fb-4261-ae69-6d55fdbccb5e">876</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred provision (benefit):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzctMS0xLTEtNDkzNTY_d9cd6bb2-edb3-40f5-a76d-68e5f864b5e3">34,852</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzctMy0xLTEtNDkzNTY_3e385d08-e110-43d6-994b-a35ef3625c58">4,862</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzctNS0xLTEtNDkzNTY_2fb62aef-efe1-4e6b-85f8-c6d6f8287aad">6,458</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzgtMS0xLTEtNDkzNTY_51c25217-dd35-437f-9736-d6f2b667807c">6,395</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzgtMy0xLTEtNDkzNTY_61821e2f-3b0c-4df2-bfe0-07f6fc86bcf9">125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzgtNS0xLTEtNDkzNTY_1c597677-1912-408e-9a79-e144197282dc">641</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzktMS0xLTEtNDkzNTY_f179d5b4-b1f1-46c6-ae61-62abb349aa61">41,247</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzktMy0xLTEtNDkzNTY_c6cc8f5d-42be-44ce-bb84-8d18de762e89">4,987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" sign="-" name="us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzktNS0xLTEtNDkzNTY_f7fa65ac-4b2b-42b0-8e1f-a01c86c9da1e">7,099</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total provision for (benefit from) income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzEwLTEtMS0xLTQ5MzU2_de952962-d1dd-4d09-99cc-090140872326">40,778</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzEwLTMtMS0xLTQ5MzU2_6014d481-ac44-43d2-b8a8-1beabf7aa4d6">7,559</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzEwLTUtMS0xLTQ5MzU2_500d366f-69b2-4b07-ade1-00141845d8db">6,223</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="ib282355cebd74d02abdeb1b46ce7dfaf" continuedAt="i6c8e92a3e5e64b44bc8268e046f9a711"><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90ZXh0cmVnaW9uOmU1MzdjYzA0NGE2YjQxMzRiMTM5ZTQwNmVkYzg5NGM0XzUxNjc3MDQ2NTEwOTg2_9ed7b676-4df4-4101-a6b5-1a6c857f6ffb" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of the income tax expense at the federal statutory tax rate to the Company&#8217;s provision for (benefit from) income taxes (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income taxes at statutory rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzItMS0xLTEtNDkzNjI_aae9074f-c5fb-4d38-9510-0e1ff57db2ac">23,941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzItMy0xLTEtNDkzNjI_45f7b09a-80bf-494e-8031-253e68f07dd5">12,131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzItNS0xLTEtNDkzNjI_18ad6dff-8217-42e8-8726-df861ed82f84">4,938</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">State income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzMtMS0xLTEtNDkzNjI_671d9dbb-c4aa-4600-bbeb-35cc905cc217">5,503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzMtMy0xLTEtNDkzNjI_7feb32de-1e91-4da4-8595-817fee13903b">2,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzMtNS0xLTEtNDkzNjI_df48182e-2351-4ce2-8d18-191975851f8d">1,561</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research and development credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzQtMS0xLTEtNDkzNjI_6b39665b-5992-483d-bc64-124f66559ec3">8,332</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzQtMy0xLTEtNDkzNjI_143b478c-971b-4249-a944-655b933e058d">1,845</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzQtNS0xLTEtNDkzNjI_ee1a49b1-711d-4d48-b2ea-5dc552a3b092">1,842</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzUtMS0xLTEtNDkzNjI_f9a76bcb-be16-4912-b8c2-a9254089371f">71,780</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzUtMy0xLTEtNDkzNjI_9e6c5be1-23cd-4516-a690-923c533c15ec">5,796</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzUtNS0xLTEtNDkzNjI_ad8593c5-228d-4160-b7cc-a435f2eec40f">310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzYtMS0xLTEtNDkzNjI_103e5a5b-db07-46d6-b8ce-4e0bb245811b">1,878</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzYtMy0xLTEtNDkzNjI_43a76c9b-2dc0-46e3-80c1-2bcef0f9d1b1">171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzYtNS0xLTEtNDkzNjI_f5c8a3b4-bbe9-4d97-b268-7f96f3e5fb03">11,995</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Section 162(m) limitation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzctMS0xLTEtMTI3Njky_69e1e96e-ca7c-4daf-a4fa-a214a469344b">7,260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzctMy0xLTEtMTI3Njky_799e4414-5003-47aa-9f93-7a5a420f024f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzctNS0xLTEtMTI3Njky_b224bee0-a514-4c4b-a9e5-32cf710b685b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzctMS0xLTEtNDkzNjI_63f849c8-bcbb-4904-aedc-e92bb3a0191e">752</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzctMy0xLTEtNDkzNjI_10624aff-ef37-48bd-8dd3-74f43a2517f4">366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzctNS0xLTEtNDkzNjI_3c0f185f-8721-41f9-8550-ff2049b766c1">805</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total provision for (benefit from) income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzgtMS0xLTEtNDkzNjI_d16f6338-394a-4489-9458-603eb229071a">40,778</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzgtMy0xLTEtNDkzNjI_23bb35ad-41a7-46f8-9a33-239642d7b17c">7,559</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzgtNS0xLTEtNDkzNjI_5d38e0ce-038b-435e-a2a8-c6ec18d2986a">6,223</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90ZXh0cmVnaW9uOmU1MzdjYzA0NGE2YjQxMzRiMTM5ZTQwNmVkYzg5NGM0XzUxNjc3MDQ2NTEwOTg3_7401ef29-3dd9-4542-a22b-3d02dfc8e16e" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of deferred tax assets and liabilities were as follows (in&#160;thousands):</span></div><div style="margin-bottom:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.876%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.621%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accruals and deferred revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="docs:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzMtMy0xLTEtNDkzNzA_3df8baa5-e9c1-4a8b-9f8d-2058e883bf2d">1,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="docs:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzMtNS0xLTEtNDkzNzA_00929814-1933-4488-9ff8-7db5afaa1e48">1,257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzQtMy0xLTEtNDkzNzA_46b86b1a-2a63-46b2-9833-e42e6c1a9e02">32,215</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzQtNS0xLTEtNDkzNzA_5bf7bdff-0500-40c7-b0f4-0d89385da8de">486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research &amp; development credit carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzUtMy0xLTEtNDkzNzA_2d90aa57-8361-45bf-ba39-d52bfa20d5d4">12,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzUtNS0xLTEtNDkzNzA_e97b5bd9-0690-4145-81eb-9494126558ca">4,516</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="docs:DeferredTaxAssetsLeasingArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzYtMy0xLTEtNDkzNzA_6b38a4db-9975-4b51-8319-a6e50c13d9f4">276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="docs:DeferredTaxAssetsLeasingArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzYtNS0xLTEtNDkzNzA_122c5c7f-148d-4658-a90b-b8cac6b1c6c3">315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Acquisition and other related expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="docs:DeferredTaxAssetsAcquisitionAndOtherRelatedExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzctMy0xLTEtNDkzNzA_9778f05b-940f-4906-b793-f7284cde4df1">255</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="docs:DeferredTaxAssetsAcquisitionAndOtherRelatedExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzctNS0xLTEtNDkzNzA_afa0250e-4c61-44df-aab0-32ef05d96f0c">271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzgtMy0xLTEtNDkzNzA_1289b3f4-7739-4105-9e83-544e186b5164">3,847</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzgtNS0xLTEtNDkzNzA_a3a492c1-12da-4cab-9cd5-30c50d8891b7">431</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unrealized loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzktMS0xLTEtMTI3NzQ4_b051b17f-8639-42f2-85a4-7667d9aea153">5,199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzktMy0xLTEtMTI3NzQ4_af9ed5e5-b865-454b-b256-ec9ce7cbe5d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Gross deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzktMy0xLTEtNDkzNzA_8332deec-2996-4820-9812-427eda379f82">55,862</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzktNS0xLTEtNDkzNzA_1e956cc7-0869-4a7f-a567-d91f12c3d62d">7,276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzEwLTMtMS0xLTQ5Mzcw_6bfb5021-085f-459d-a8d8-53bd9ace264c">4,731</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzEwLTUtMS0xLTQ5Mzcw_b113b9a5-56c8-4622-b70c-9c1e52528188">2,896</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred tax assets, net of valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzExLTMtMS0xLTQ5Mzcw_28d37429-46a4-4f3f-834a-8c49d8b17021">51,131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzExLTUtMS0xLTQ5Mzcw_65b25590-2a9f-407b-a704-33ec5e589e30">4,380</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzEzLTMtMS0xLTQ5Mzcw_ea041e78-ac7e-40b2-8414-269422ff270a">1,899</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzEzLTUtMS0xLTQ5Mzcw_230b611a-ac48-4f36-b372-eeee5ec114b9">1,701</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzE0LTMtMS0xLTQ5Mzcw_1cb26665-cd0c-428d-82ed-23b2e62e4594">276</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzE0LTUtMS0xLTQ5Mzcw_cce7607b-1954-412c-9414-5f865c73b89c">336</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzE1LTMtMS0xLTQ5Mzcw_daf2bba5-b30c-46fa-8d52-436b4745ba1f">398</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzE1LTUtMS0xLTQ5Mzcw_20e8d94b-8b9b-441e-a39a-5bd6edd81270">231</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzE2LTMtMS0xLTQ5Mzcw_b7d31fd9-c1b5-44c7-9381-3cb3cda6f1bc">2,573</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzE2LTUtMS0xLTQ5Mzcw_05fc328f-6739-4772-bd6e-15789b7e5b69">2,268</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net deferred tax assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzE3LTMtMS0xLTQ5Mzcw_75ccd24a-f746-4f8a-b2eb-f142611c0ca9">48,558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzE3LTUtMS0xLTQ5Mzcw_9db1f9fb-8524-425c-a81d-4a7ea4cb5274">2,112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act, or CARES Act, was enacted and signed into law. The CARES Act did not have a material impact to the Company's consolidated financial statements. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a valuation allowance related to specific net deferred tax assets where it is not more likely than not that the deferred tax assets will be realized, which include California research and development credits and capital loss carryforwards. The Company concluded, based upon the preponderance of positive evidence (i.e., a strong earnings history exclusive of the loss that created the future deductible amount, a history of taxable income in recent periods, the taxable loss is a result of excess tax benefit on stock exercises as a result of a non-recurring event (IPO), and the current forecast of income before taxes for the United States going forward) over negative evidence and the anticipated ability to use the deferred tax assets, that it was more likely than not that the deferred tax assets could be realized. If there are unfavorable changes to actual operating results or to projections of future income, the Company may determine that it is more likely than not such deferred tax assets may not be realizable.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation allowance was $<ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90ZXh0cmVnaW9uOmU1MzdjYzA0NGE2YjQxMzRiMTM5ZTQwNmVkYzg5NGM0XzI5MTM3MDU4MTQwNjY1_a8c3717f-8210-4376-9b07-dcf085d0911e">4.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90ZXh0cmVnaW9uOmU1MzdjYzA0NGE2YjQxMzRiMTM5ZTQwNmVkYzg5NGM0XzI5MTM3MDU4MTQwNjg0_7ba7c158-828e-4246-a415-9d143e2c7678">2.9</ix:nonFraction> million as of March&#160;31, 2022 and 2021, respectively, relating to the California research and development tax credits and capital loss carryforwards. The valuation allowance increased by $<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90ZXh0cmVnaW9uOmU1MzdjYzA0NGE2YjQxMzRiMTM5ZTQwNmVkYzg5NGM0XzI5MTM3MDU4MTQ3NDAz_e93810b5-cc4d-4c5f-8fd7-5256d6d6d112">1.8</ix:nonFraction> million during the fiscal year ended March&#160;31, 2022, primarily due to the increase in California research and development credits generated during the year. The change in valuation allowance during the fiscal year ended March 31, 2021 was <ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90ZXh0cmVnaW9uOmU1MzdjYzA0NGE2YjQxMzRiMTM5ZTQwNmVkYzg5NGM0XzMwMjM2NTY5Nzc4Nzgz_28e666be-9c73-430a-9514-adabc739c5e3">no</ix:nonFraction>t material. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="i6c8e92a3e5e64b44bc8268e046f9a711"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the Company had net operating loss, or NOL, carryforwards for state tax purposes of $<ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90ZXh0cmVnaW9uOmU1MzdjYzA0NGE2YjQxMzRiMTM5ZTQwNmVkYzg5NGM0XzI5MTM3MDU4MTQwNzQ2_55a0cc20-ce32-4f71-a57b-69d019f5bacf">97.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90ZXh0cmVnaW9uOmU1MzdjYzA0NGE2YjQxMzRiMTM5ZTQwNmVkYzg5NGM0XzI5MTM3MDU4MTQwNzU3_26074e14-53cb-4478-a96f-99f345d8a45a">124.1</ix:nonFraction> million for federal tax purposes. If not utilized, $<ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-5" name="docs:OperatingLossCarryforwardsSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90ZXh0cmVnaW9uOmU1MzdjYzA0NGE2YjQxMzRiMTM5ZTQwNmVkYzg5NGM0XzI5MTM3MDU4MTUwOTI2_25927fbb-4b89-4397-98b2-99a86a41a3cd">83.6</ix:nonFraction> million of the state NOL carryforwards will expire at various dates beginning in the year 2027. The federal NOL carryforwards can be carried forward indefinitely. As of March&#160;31, 2022, the Company had research and development tax credit carryforwards for federal and state tax purposes of $<ix:nonFraction unitRef="usd" contextRef="i3e814b9bfb97496daff7da69a24ec5cd_I20220331" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90ZXh0cmVnaW9uOmU1MzdjYzA0NGE2YjQxMzRiMTM5ZTQwNmVkYzg5NGM0XzI5MTM3MDU4MTQwNzk4_aec53a2f-7e77-492e-98c7-698e2f9a7394">11.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic83e784502b44138b8906b62606b6cc0_I20220331" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90ZXh0cmVnaW9uOmU1MzdjYzA0NGE2YjQxMzRiMTM5ZTQwNmVkYzg5NGM0XzI5MTM3MDU4MTQwODE2_ad303f30-d087-4a72-a302-6382943c16a7">8.4</ix:nonFraction> million, respectively. The federal research and development tax credit carryforwards will expire at various dates beginning in the year 2040. If not utilized, $<ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-5" name="docs:TaxCreditCarryforwardsSubjectToExpiration" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90ZXh0cmVnaW9uOmU1MzdjYzA0NGE2YjQxMzRiMTM5ZTQwNmVkYzg5NGM0XzI5MTM3MDU4MTUwOTQ3_5e86558f-61b9-496c-80d5-935e4e3b4b95">0.2</ix:nonFraction> million of the state research and development tax credit carryforwards will expire at various dates beginning in the year 2032. Based on an assessment of the Company&#8217;s historical ownership changes through March&#160;31, 2022, the Company does not anticipate a current limitation on the tax attributes. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022 and 2021, the Company had unrecognized tax benefits, or UTBs, of $<ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90ZXh0cmVnaW9uOmU1MzdjYzA0NGE2YjQxMzRiMTM5ZTQwNmVkYzg5NGM0XzI5MTM3MDU4MTQwODg1_9a2277ce-2724-48f5-a69d-eee883618714">6.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90ZXh0cmVnaW9uOmU1MzdjYzA0NGE2YjQxMzRiMTM5ZTQwNmVkYzg5NGM0XzI5MTM3MDU4MTQwOTAy_5271eabd-a962-4160-a40d-cff0a0974ec6">3.2</ix:nonFraction> million, respectively. If realized, $<ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90ZXh0cmVnaW9uOmU1MzdjYzA0NGE2YjQxMzRiMTM5ZTQwNmVkYzg5NGM0XzI5MTM3MDU4MTQwOTIw_66904f23-c77c-42c7-b526-4a1970ed19a6">4.2</ix:nonFraction> million would impact the effective tax rate while the remainder would reduce deferred tax assets subject to a full valuation allowance. The Company does not expect any material changes to its UTBs within the next 12 months.</span></div><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90ZXh0cmVnaW9uOmU1MzdjYzA0NGE2YjQxMzRiMTM5ZTQwNmVkYzg5NGM0XzUxNjc3MDQ2NTEwOTg4_54d4dc9d-b993-45b4-b9e4-b95ec06852e3" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending balances for gross UTBs is as follows (in thousands):</span></div><div style="margin-bottom:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTpkMzcwMzU2MDQwZjg0MDNjOWUxYjY4NGY2NmM4YjllOC90YWJsZXJhbmdlOmQzNzAzNTYwNDBmODQwM2M5ZTFiNjg0ZjY2YzhiOWU4XzItMS0xLTEtNDk0NzY_7fcac7a6-3f69-4deb-b3af-bc92a4348be2">3,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7a15f5b31d42419aa50ffb53e76f3705_I20200331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTpkMzcwMzU2MDQwZjg0MDNjOWUxYjY4NGY2NmM4YjllOC90YWJsZXJhbmdlOmQzNzAzNTYwNDBmODQwM2M5ZTFiNjg0ZjY2YzhiOWU4XzItMy0xLTEtNDk0NzY_72d133fc-6428-46fb-8993-9eeee5c89171">2,475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i27e150c7cdf34baa99d770cedfcc88a0_I20190331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTpkMzcwMzU2MDQwZjg0MDNjOWUxYjY4NGY2NmM4YjllOC90YWJsZXJhbmdlOmQzNzAzNTYwNDBmODQwM2M5ZTFiNjg0ZjY2YzhiOWU4XzItNS0xLTEtNDk0NzY_d00cf2c6-12f1-42fb-b0de-b868f28af8b4">2,900</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Additions for tax positions related to the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTpkMzcwMzU2MDQwZjg0MDNjOWUxYjY4NGY2NmM4YjllOC90YWJsZXJhbmdlOmQzNzAzNTYwNDBmODQwM2M5ZTFiNjg0ZjY2YzhiOWU4XzMtMS0xLTEtNDk0NzY_240c9181-ab99-422f-aabc-34e197ec5bee">2,995</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTpkMzcwMzU2MDQwZjg0MDNjOWUxYjY4NGY2NmM4YjllOC90YWJsZXJhbmdlOmQzNzAzNTYwNDBmODQwM2M5ZTFiNjg0ZjY2YzhiOWU4XzMtMy0xLTEtNDk0NzY_1e8d96e6-6f4f-4e5d-aa4c-a2f90d4754b9">687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTpkMzcwMzU2MDQwZjg0MDNjOWUxYjY4NGY2NmM4YjllOC90YWJsZXJhbmdlOmQzNzAzNTYwNDBmODQwM2M5ZTFiNjg0ZjY2YzhiOWU4XzMtNS0xLTEtNDk0NzY_e59bf255-e0af-49f4-a6ef-e7d443e877eb">670</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Additions for tax positions related to prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTpkMzcwMzU2MDQwZjg0MDNjOWUxYjY4NGY2NmM4YjllOC90YWJsZXJhbmdlOmQzNzAzNTYwNDBmODQwM2M5ZTFiNjg0ZjY2YzhiOWU4XzQtMS0xLTEtMTI3ODQ2_781338b1-bd4e-4753-9e9e-cb722161d7c6">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTpkMzcwMzU2MDQwZjg0MDNjOWUxYjY4NGY2NmM4YjllOC90YWJsZXJhbmdlOmQzNzAzNTYwNDBmODQwM2M5ZTFiNjg0ZjY2YzhiOWU4XzQtMy0xLTEtMTI3ODQ2_ae40fcb7-31fe-4de5-99a3-8f2c1abbb8a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTpkMzcwMzU2MDQwZjg0MDNjOWUxYjY4NGY2NmM4YjllOC90YWJsZXJhbmdlOmQzNzAzNTYwNDBmODQwM2M5ZTFiNjg0ZjY2YzhiOWU4XzQtNS0xLTEtMTI3ODQ2_36bbf676-b67b-4c41-b3a3-9dc80a7ca408">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reductions for tax positions related to prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTpkMzcwMzU2MDQwZjg0MDNjOWUxYjY4NGY2NmM4YjllOC90YWJsZXJhbmdlOmQzNzAzNTYwNDBmODQwM2M5ZTFiNjg0ZjY2YzhiOWU4XzQtMS0xLTEtNDk0NzY_1b6138c4-dba1-4cc6-9056-31e063a74c78">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTpkMzcwMzU2MDQwZjg0MDNjOWUxYjY4NGY2NmM4YjllOC90YWJsZXJhbmdlOmQzNzAzNTYwNDBmODQwM2M5ZTFiNjg0ZjY2YzhiOWU4XzQtMy0xLTEtNDk0NzY_e49b4635-e176-4d48-990f-500e02bf712c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTpkMzcwMzU2MDQwZjg0MDNjOWUxYjY4NGY2NmM4YjllOC90YWJsZXJhbmdlOmQzNzAzNTYwNDBmODQwM2M5ZTFiNjg0ZjY2YzhiOWU4XzQtNS0xLTEtNDk0NzY_7cf6837d-391e-442b-89d7-70b1ca5b18f0">1,095</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reductions related to a lapse of statute</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTpkMzcwMzU2MDQwZjg0MDNjOWUxYjY4NGY2NmM4YjllOC90YWJsZXJhbmdlOmQzNzAzNTYwNDBmODQwM2M5ZTFiNjg0ZjY2YzhiOWU4XzYtMS0xLTEtMTI4MDM1_0c55cae3-4c26-4c69-a66a-cc81c81818fd">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTpkMzcwMzU2MDQwZjg0MDNjOWUxYjY4NGY2NmM4YjllOC90YWJsZXJhbmdlOmQzNzAzNTYwNDBmODQwM2M5ZTFiNjg0ZjY2YzhiOWU4XzYtMy0xLTEtMTI4MDM1_abcf7031-0dbd-4a4d-a434-638e8c7013a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTpkMzcwMzU2MDQwZjg0MDNjOWUxYjY4NGY2NmM4YjllOC90YWJsZXJhbmdlOmQzNzAzNTYwNDBmODQwM2M5ZTFiNjg0ZjY2YzhiOWU4XzYtNS0xLTEtMTI4MDM1_9a26c6fe-614f-429a-ada5-b1edc2429354">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTpkMzcwMzU2MDQwZjg0MDNjOWUxYjY4NGY2NmM4YjllOC90YWJsZXJhbmdlOmQzNzAzNTYwNDBmODQwM2M5ZTFiNjg0ZjY2YzhiOWU4XzUtMS0xLTEtNDk0NzY_58cfcde2-0f7e-48a4-bbb8-ff01f8f8cf4a">6,188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTpkMzcwMzU2MDQwZjg0MDNjOWUxYjY4NGY2NmM4YjllOC90YWJsZXJhbmdlOmQzNzAzNTYwNDBmODQwM2M5ZTFiNjg0ZjY2YzhiOWU4XzUtMy0xLTEtNDk0NzY_2cb6d205-e05f-4c80-baae-bb3661f0ca95">3,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i7a15f5b31d42419aa50ffb53e76f3705_I20200331" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTpkMzcwMzU2MDQwZjg0MDNjOWUxYjY4NGY2NmM4YjllOC90YWJsZXJhbmdlOmQzNzAzNTYwNDBmODQwM2M5ZTFiNjg0ZjY2YzhiOWU4XzUtNS0xLTEtNDk0NzY_13fe155f-c431-47fe-82b0-c2388551d83a">2,475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and penalties were not material during the years ended March&#160;31, 2022, 2021, and 2020.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in the U.S. federal and various state jurisdictions. With limited exceptions, all tax years for which the Company has filed a tax return remain subject to examination.</span></div></ix:continuation><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="i6c4404140edb48938ba4e30b290c9ef9_217"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.&#160;&#160;<ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTcvZnJhZzoyN2QxMGE5MDFmODY0OWMzOWU0MTRmYTlkMDNlYzZmYy90ZXh0cmVnaW9uOjI3ZDEwYTkwMWY4NjQ5YzM5ZTQxNGZhOWQwM2VjNmZjXzUxNjc3MDQ2NTE2MjEz_41573d22-c041-43a9-af0d-821e296dda5c" continuedAt="i0e6c9d382f8942a5aeff4df6cfc1925d" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="i0e6c9d382f8942a5aeff4df6cfc1925d" continuedAt="i531dd5d4f1fc4d10b1a4e7b8d638cee0"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Leases</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, the Company entered into an <ix:nonNumeric contextRef="iaca56ad88a7f461f9aa0ca6977c6c5a1_I20210630" name="us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTcvZnJhZzoyN2QxMGE5MDFmODY0OWMzOWU0MTRmYTlkMDNlYzZmYy90ZXh0cmVnaW9uOjI3ZDEwYTkwMWY4NjQ5YzM5ZTQxNGZhOWQwM2VjNmZjXzI5MTM3MDU4MTQ1NTYx_fd754633-8833-4923-b990-a55bd143f830">8</ix:nonNumeric>-year lease for office space in Irving, Texas. This lease will commence on or around June&#160;1, 2022, with total undiscounted lease payments of $<ix:nonFraction unitRef="usd" contextRef="iaca56ad88a7f461f9aa0ca6977c6c5a1_I20210630" decimals="-5" name="docs:LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTcvZnJhZzoyN2QxMGE5MDFmODY0OWMzOWU0MTRmYTlkMDNlYzZmYy90ZXh0cmVnaW9uOjI3ZDEwYTkwMWY4NjQ5YzM5ZTQxNGZhOWQwM2VjNmZjXzI5MTM3MDU4MTQ1NTk1_9a9d47ef-ee61-49d9-9ee2-acbabcc95599">17.9</ix:nonFraction> million. In accordance with ASC 842, Leases, the classification of the lease will be determined and the lease right-of-use assets and lease liabilities will be recognized on the lease commencement date based on the present value of lease payments over the lease term, discounted using the Company&#8217;s incremental borrowing rate. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Minimum Guarantees</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October&#160;8, 2021, the Company signed an amended agreement to revise and extend the existing partnership with the U.S. News for <ix:nonNumeric contextRef="ia779ca3233c64c28abdfc4d63196098d_D20211008-20211008" name="docs:PartnershipAgreementExtensionPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTcvZnJhZzoyN2QxMGE5MDFmODY0OWMzOWU0MTRmYTlkMDNlYzZmYy90ZXh0cmVnaW9uOjI3ZDEwYTkwMWY4NjQ5YzM5ZTQxNGZhOWQwM2VjNmZjXzI5MTM3MDU4MTQ1NjI5_95d06f67-cda5-4fb3-96ee-51e7df366634">six years</ix:nonNumeric>. This agreement can be terminated after <ix:nonNumeric contextRef="ia779ca3233c64c28abdfc4d63196098d_D20211008-20211008" name="docs:PartnershipsAgreementPeriodBeforeTerminationIsPermitted" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTcvZnJhZzoyN2QxMGE5MDFmODY0OWMzOWU0MTRmYTlkMDNlYzZmYy90ZXh0cmVnaW9uOjI3ZDEwYTkwMWY4NjQ5YzM5ZTQxNGZhOWQwM2VjNmZjXzI5MTM3MDU4MTQ1NjQ0_741bf983-45e7-4fbb-8ae6-8e0d69dc46a2">three years</ix:nonNumeric> by either party. Under this amended agreement, the Company pays the U.S. News a portion of the revenue generated with the end customers, with an annual minimum guarantee amount ranging from $<ix:nonFraction unitRef="usd" contextRef="i5427186226c84ccfa0800cadaa7de7c6_D20211008-20211008" decimals="-5" name="docs:PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTcvZnJhZzoyN2QxMGE5MDFmODY0OWMzOWU0MTRmYTlkMDNlYzZmYy90ZXh0cmVnaW9uOjI3ZDEwYTkwMWY4NjQ5YzM5ZTQxNGZhOWQwM2VjNmZjXzI5MTM3MDU4MTQ1Njc1_8eede031-91e7-4a44-8173-7f75433b99b2">2.5</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="i810401f3e11544ccb12389b06a087e25_D20211008-20211008" decimals="-5" name="docs:PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTcvZnJhZzoyN2QxMGE5MDFmODY0OWMzOWU0MTRmYTlkMDNlYzZmYy90ZXh0cmVnaW9uOjI3ZDEwYTkwMWY4NjQ5YzM5ZTQxNGZhOWQwM2VjNmZjXzI5MTM3MDU4MTQ1Njkz_93c09169-4739-4254-b9fc-731835676fba">6.2</ix:nonFraction> million. The total minimum guarantee amount for the initial noncancelable period of <ix:nonNumeric contextRef="ia779ca3233c64c28abdfc4d63196098d_D20211008-20211008" name="docs:PartnershipAgreementNoncancelablePeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTcvZnJhZzoyN2QxMGE5MDFmODY0OWMzOWU0MTRmYTlkMDNlYzZmYy90ZXh0cmVnaW9uOjI3ZDEwYTkwMWY4NjQ5YzM5ZTQxNGZhOWQwM2VjNmZjXzI5MTM3MDU4MTQ1NjU5_079d69cd-036b-4259-9edd-6cf82dcd9f4c">three years</ix:nonNumeric> is $<ix:nonFraction unitRef="usd" contextRef="ia779ca3233c64c28abdfc4d63196098d_D20211008-20211008" decimals="-5" name="docs:PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTcvZnJhZzoyN2QxMGE5MDFmODY0OWMzOWU0MTRmYTlkMDNlYzZmYy90ZXh0cmVnaW9uOjI3ZDEwYTkwMWY4NjQ5YzM5ZTQxNGZhOWQwM2VjNmZjXzI5MTM3MDU4MTQ1NzEx_54a9740d-56d2-4d23-880b-de10288893cf">9.1</ix:nonFraction> million. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">AMiON Acquisition</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;4, 2022, the Company entered into a definitive agreement to acquire the assets of the AMiON on-call scheduling and messaging application used by scheduling staff and physicians for cash consideration of $<ix:nonFraction unitRef="usd" contextRef="i481113436cc1402f934510336edc992b_D20220401-20220401" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTcvZnJhZzoyN2QxMGE5MDFmODY0OWMzOWU0MTRmYTlkMDNlYzZmYy90ZXh0cmVnaW9uOjI3ZDEwYTkwMWY4NjQ5YzM5ZTQxNGZhOWQwM2VjNmZjXzI5MTM3MDU4MTQ1ODgz_6b68292e-b51e-4b4f-a83f-cac7c5f285fe">53.5</ix:nonFraction> million paid at closing and earnout consideration of up to $<ix:nonFraction unitRef="usd" contextRef="i1761c372f61844c2b98a7f045fe36118_I20220401" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTcvZnJhZzoyN2QxMGE5MDFmODY0OWMzOWU0MTRmYTlkMDNlYzZmYy90ZXh0cmVnaW9uOjI3ZDEwYTkwMWY4NjQ5YzM5ZTQxNGZhOWQwM2VjNmZjXzI5MTM3MDU4MTQ1OTAy_abfd6b90-d54f-437f-a354-e9bf18618b12">24.0</ix:nonFraction> million, payable over the next <ix:nonNumeric contextRef="i481113436cc1402f934510336edc992b_D20220401-20220401" name="docs:BusinessCombinationContingentConsiderationLiabilityPayablePeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTcvZnJhZzoyN2QxMGE5MDFmODY0OWMzOWU0MTRmYTlkMDNlYzZmYy90ZXh0cmVnaW9uOjI3ZDEwYTkwMWY4NjQ5YzM5ZTQxNGZhOWQwM2VjNmZjXzI5MTM3MDU4MTQ1OTE0_e42c2aa9-32d0-4d2d-9fd6-319c2eaca353">four years</ix:nonNumeric>, subject to certain performance milestones. Under the definitive agreement, certain employees joining the Company as part of the acquisition are eligible for restricted stock unit awards, subject to future service-based vesting conditions. The acquisition closed and the cash consideration was paid on April 1, 2022. In May 2022, <ix:nonFraction unitRef="shares" contextRef="ief085275d125487ab483dab51f92a13d_D20220501-20220527" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTcvZnJhZzoyN2QxMGE5MDFmODY0OWMzOWU0MTRmYTlkMDNlYzZmYy90ZXh0cmVnaW9uOjI3ZDEwYTkwMWY4NjQ5YzM5ZTQxNGZhOWQwM2VjNmZjXzM0MDg0ODYwNDgwMjEw_877c9552-fd28-48a8-85b8-ce4980f2d10b">93,458</ix:nonFraction> restricted stock units with grant date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="ief085275d125487ab483dab51f92a13d_D20220501-20220527" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTcvZnJhZzoyN2QxMGE5MDFmODY0OWMzOWU0MTRmYTlkMDNlYzZmYy90ZXh0cmVnaW9uOjI3ZDEwYTkwMWY4NjQ5YzM5ZTQxNGZhOWQwM2VjNmZjXzM0MDg0ODYwNDgwMjE5_b15947cd-1beb-47bc-a93d-4bddb8df7d03">32.99</ix:nonFraction> per share were granted to the eligible employees joining the Company as part of the acquisition. The acquisition will be accounted for as a business combination in fiscal 2023.   </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="i531dd5d4f1fc4d10b1a4e7b8d638cee0"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Contractual Commitments </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company entered into a <ix:nonNumeric contextRef="ib1d009a88cef49af96f5da8fc0da7d35_D20211201-20211231" name="docs:HostingArrangementPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTcvZnJhZzoyN2QxMGE5MDFmODY0OWMzOWU0MTRmYTlkMDNlYzZmYy90ZXh0cmVnaW9uOjI3ZDEwYTkwMWY4NjQ5YzM5ZTQxNGZhOWQwM2VjNmZjXzI4NTg3MzAyMzMyMzYw_7147a8d9-e603-4aa8-a6d1-1d2942402fac">3</ix:nonNumeric>-year web hosting arrangement with an annual commitment of $<ix:nonFraction unitRef="usd" contextRef="i9a3e9f0d2edd438b8e1b2bd756b26c00_I20211231" decimals="-5" name="docs:HostingArrangementAnnualCommitment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTcvZnJhZzoyN2QxMGE5MDFmODY0OWMzOWU0MTRmYTlkMDNlYzZmYy90ZXh0cmVnaW9uOjI3ZDEwYTkwMWY4NjQ5YzM5ZTQxNGZhOWQwM2VjNmZjXzI4NTg3MzAyMzMyNDIy_226badd9-73a8-4680-bde9-32b990c992c0">5.2</ix:nonFraction> million, starting January&#160;1, 2022.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indemnification</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into indemnification provisions under agreements with other companies in the ordinary course of business, including, but not limited to, clients, business partners, landlords, and other parties involved in the performance of the Company&#8217;s services. Pursuant to these arrangements, the Company has agreed to indemnify, hold harmless, and reimburse the indemnified party for certain losses suffered or incurred by the indemnified party as a result of the Company&#8217;s activities. The terms of these indemnification agreements are generally perpetual. The maximum potential amount of future payments the Company could be required to make under these agreements is not determinable. The Company has never incurred costs to defend lawsuits or settle claims related to these indemnification agreements. The Company maintains commercial general liability insurance and product liability insurance that may offset certain of its potential liabilities under these indemnification provisions.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company has agreed to indemnify its officers and directors and certain key employees while they are serving in good faith in their respective capacities. To date, there have been no claims under these indemnification provisions.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Matters</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company has become involved in claims and other legal matters arising in the ordinary course of business. The Company investigates these claims as they arise. Although claims are inherently unpredictable, the Company is currently not aware of any matters that, if determined adversely to the Company, would individually or taken together have a material effect on its results of operations, financial position, or cash flows. <ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="INF" name="us-gaap:LossContingencyAccrualProvision" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTcvZnJhZzoyN2QxMGE5MDFmODY0OWMzOWU0MTRmYTlkMDNlYzZmYy90ZXh0cmVnaW9uOjI3ZDEwYTkwMWY4NjQ5YzM5ZTQxNGZhOWQwM2VjNmZjXzI5MTM3MDU4MTQ1NzYx_31e32331-92ca-4837-bbec-5a35248cf9bf"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="INF" name="us-gaap:LossContingencyAccrualProvision" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTcvZnJhZzoyN2QxMGE5MDFmODY0OWMzOWU0MTRmYTlkMDNlYzZmYy90ZXh0cmVnaW9uOjI3ZDEwYTkwMWY4NjQ5YzM5ZTQxNGZhOWQwM2VjNmZjXzI5MTM3MDU4MTQ1NzYx_4d47253a-8479-4acb-ba74-6ca1450f9a96"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="INF" name="us-gaap:LossContingencyAccrualProvision" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTcvZnJhZzoyN2QxMGE5MDFmODY0OWMzOWU0MTRmYTlkMDNlYzZmYy90ZXh0cmVnaW9uOjI3ZDEwYTkwMWY4NjQ5YzM5ZTQxNGZhOWQwM2VjNmZjXzI5MTM3MDU4MTQ1NzYx_594253c4-f456-47df-a3f0-e3bb0f8fa01b">No</ix:nonFraction></ix:nonFraction></ix:nonFraction> loss contingencies were recorded for the fiscal years ended March&#160;31, 2022, 2021, and 2020.</span></div></ix:continuation><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="i6c4404140edb48938ba4e30b290c9ef9_28587302325084"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.&#160;&#160;<ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RleHRyZWdpb246MWI1ZTNmY2Y0MWU1NGRlZWIzN2Q0YjdiMTI4ZjI2NDJfMjgwMzc1NDY1MTUyNzQ_8010cbe5-4671-40b4-9690-c10c7ac56fda" continuedAt="i9660e228b23f477c8460d58a5a297db7" escape="true">Leases</ix:nonNumeric></span></div><ix:continuation id="i9660e228b23f477c8460d58a5a297db7" continuedAt="i3bed2b220c2641d8afd87a63a9e82dbd"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has non-cancelable operating leases for the rental of office space, corporate housing, and laptops with various expiration dates through 2023. </span></div><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RleHRyZWdpb246MWI1ZTNmY2Y0MWU1NGRlZWIzN2Q0YjdiMTI4ZjI2NDJfMjgwMzc1NDY1MTUyNzU_8efc0917-ae47-4929-809d-4aa82e4df328" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjVhYWU5MTQ2YWQyMDQ0ODE5NWNlMmM3Yjc5YjAwNGM3L3RhYmxlcmFuZ2U6NWFhZTkxNDZhZDIwNDQ4MTk1Y2UyYzdiNzliMDA0YzdfMi0xLTEtMS0xMzUwMzE_85c7d4b4-9b7c-4755-a03c-b269d1896a7a">1,159</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjVhYWU5MTQ2YWQyMDQ0ODE5NWNlMmM3Yjc5YjAwNGM3L3RhYmxlcmFuZ2U6NWFhZTkxNDZhZDIwNDQ4MTk1Y2UyYzdiNzliMDA0YzdfMi0zLTEtMS0xMzUwMzE_0392b829-a32d-4229-8d8b-3a7f2a30866b">2,372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjVhYWU5MTQ2YWQyMDQ0ODE5NWNlMmM3Yjc5YjAwNGM3L3RhYmxlcmFuZ2U6NWFhZTkxNDZhZDIwNDQ4MTk1Y2UyYzdiNzliMDA0YzdfMi01LTEtMS0xMzUwMzE_2570ce6e-4a5d-4d20-8e48-a820c558fa85">2,010</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Variable lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjVhYWU5MTQ2YWQyMDQ0ODE5NWNlMmM3Yjc5YjAwNGM3L3RhYmxlcmFuZ2U6NWFhZTkxNDZhZDIwNDQ4MTk1Y2UyYzdiNzliMDA0YzdfMy0xLTEtMS0xMzUwMzE_aa94bbd7-90f1-4d99-be11-58012fd2c77f">114</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjVhYWU5MTQ2YWQyMDQ0ODE5NWNlMmM3Yjc5YjAwNGM3L3RhYmxlcmFuZ2U6NWFhZTkxNDZhZDIwNDQ4MTk1Y2UyYzdiNzliMDA0YzdfMy0zLTEtMS0xMzUwMzE_4b45ffe3-fbae-4a05-88e2-854bc9665239">143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:VariableLeaseCost" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjVhYWU5MTQ2YWQyMDQ0ODE5NWNlMmM3Yjc5YjAwNGM3L3RhYmxlcmFuZ2U6NWFhZTkxNDZhZDIwNDQ4MTk1Y2UyYzdiNzliMDA0YzdfMy01LTEtMS0xMzUwMzE_da7c018f-53fc-425e-8961-e1b76bb3b602">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjVhYWU5MTQ2YWQyMDQ0ODE5NWNlMmM3Yjc5YjAwNGM3L3RhYmxlcmFuZ2U6NWFhZTkxNDZhZDIwNDQ4MTk1Y2UyYzdiNzliMDA0YzdfNC0xLTEtMS0xMzUwMzE_6e810386-409b-49ae-95fe-61943ef6ce8d">1,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjVhYWU5MTQ2YWQyMDQ0ODE5NWNlMmM3Yjc5YjAwNGM3L3RhYmxlcmFuZ2U6NWFhZTkxNDZhZDIwNDQ4MTk1Y2UyYzdiNzliMDA0YzdfNC0zLTEtMS0xMzUwMzE_a35f8433-6447-438b-ade9-5ce9e18370b8">2,515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjVhYWU5MTQ2YWQyMDQ0ODE5NWNlMmM3Yjc5YjAwNGM3L3RhYmxlcmFuZ2U6NWFhZTkxNDZhZDIwNDQ4MTk1Y2UyYzdiNzliMDA0YzdfNC01LTEtMS0xMzUwMzE_814bcd16-51b0-477e-8d18-87911a1ff100">2,010</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash paid for amounts included in measurement of lease liabilities&#8212;Operating cash flows</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjU5OGE4Mjg3YmQwNTRhMmY5ZTg4YjM0MTI1NTY4OGY3L3RhYmxlcmFuZ2U6NTk4YTgyODdiZDA1NGEyZjllODhiMzQxMjU1Njg4ZjdfMi0xLTEtMS0xMzUwNDE_cf76f379-a907-4c3e-9d2d-2b0bde11ce8b">1,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjU5OGE4Mjg3YmQwNTRhMmY5ZTg4YjM0MTI1NTY4OGY3L3RhYmxlcmFuZ2U6NTk4YTgyODdiZDA1NGEyZjllODhiMzQxMjU1Njg4ZjdfMi0zLTEtMS0xMzUwNDE_cd320aa8-e18f-4cbc-81ee-c4603f8167b7">2,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjU5OGE4Mjg3YmQwNTRhMmY5ZTg4YjM0MTI1NTY4OGY3L3RhYmxlcmFuZ2U6NTk4YTgyODdiZDA1NGEyZjllODhiMzQxMjU1Njg4ZjdfMi01LTEtMS0xMzUwNDE_c5de2991-eb62-4577-ac25-4244088d0bf7">2,069</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.572%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted-average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjMyMjdjMjJmNTY4OTQ3NWRhMzEzY2RhZDM0MDBkYWUwL3RhYmxlcmFuZ2U6MzIyN2MyMmY1Njg5NDc1ZGEzMTNjZGFkMzQwMGRhZTBfMi0xLTEtMS0xMzUwNjk_e172b130-5145-4042-be1d-19d9bf786bcd">1.64</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjMyMjdjMjJmNTY4OTQ3NWRhMzEzY2RhZDM0MDBkYWUwL3RhYmxlcmFuZ2U6MzIyN2MyMmY1Njg5NDc1ZGEzMTNjZGFkMzQwMGRhZTBfMi0zLTEtMS0xMzUwNjk_7196a8d1-fd47-44e6-828b-9c3308ec143f">1.37</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7a15f5b31d42419aa50ffb53e76f3705_I20200331" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjMyMjdjMjJmNTY4OTQ3NWRhMzEzY2RhZDM0MDBkYWUwL3RhYmxlcmFuZ2U6MzIyN2MyMmY1Njg5NDc1ZGEzMTNjZGFkMzQwMGRhZTBfMi01LTEtMS0xMzUwNjk_1ae22653-7848-4817-8665-b9cc7b433243">1.15</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted-average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjMyMjdjMjJmNTY4OTQ3NWRhMzEzY2RhZDM0MDBkYWUwL3RhYmxlcmFuZ2U6MzIyN2MyMmY1Njg5NDc1ZGEzMTNjZGFkMzQwMGRhZTBfMy0xLTEtMS0xMzUwNjk_d9ad173f-313d-48d5-8a74-3d82580460ec">3.95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjMyMjdjMjJmNTY4OTQ3NWRhMzEzY2RhZDM0MDBkYWUwL3RhYmxlcmFuZ2U6MzIyN2MyMmY1Njg5NDc1ZGEzMTNjZGFkMzQwMGRhZTBfMy0zLTEtMS0xMzUwNjk_c8b542d3-e97f-4812-88b9-11fcc9340930">3.95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i7a15f5b31d42419aa50ffb53e76f3705_I20200331" decimals="4" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjMyMjdjMjJmNTY4OTQ3NWRhMzEzY2RhZDM0MDBkYWUwL3RhYmxlcmFuZ2U6MzIyN2MyMmY1Njg5NDc1ZGEzMTNjZGFkMzQwMGRhZTBfMy01LTEtMS0xMzUwNjk_31350735-751d-4559-b7a1-5853ff911a7a">1.75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="i3bed2b220c2641d8afd87a63a9e82dbd"><ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RleHRyZWdpb246MWI1ZTNmY2Y0MWU1NGRlZWIzN2Q0YjdiMTI4ZjI2NDJfMjgwMzc1NDY1MTUyNzk_23fa48cc-2192-4859-9e74-d94a061bedb4" escape="true"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of March 31, 2022 were as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.620%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjNkNTBhNzcwNjMwNTRhODM5ZTg3Y2FjZTU3YzRhNjViL3RhYmxlcmFuZ2U6M2Q1MGE3NzA2MzA1NGE4MzllODdjYWNlNTdjNGE2NWJfMS0xLTEtMS0xMzUxMjE_23aa36e0-0597-4629-a228-ed0bb1d1da36">673</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjNkNTBhNzcwNjMwNTRhODM5ZTg3Y2FjZTU3YzRhNjViL3RhYmxlcmFuZ2U6M2Q1MGE3NzA2MzA1NGE4MzllODdjYWNlNTdjNGE2NWJfMi0xLTEtMS0xMzUxMjE_8c989d97-6d4e-4540-8566-964e308dab73">455</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total future lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjNkNTBhNzcwNjMwNTRhODM5ZTg3Y2FjZTU3YzRhNjViL3RhYmxlcmFuZ2U6M2Q1MGE3NzA2MzA1NGE4MzllODdjYWNlNTdjNGE2NWJfNC0xLTEtMS0xMzUxMjE_602a3c13-7f54-4cdf-b77b-d80dd1f75b36">1,128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjNkNTBhNzcwNjMwNTRhODM5ZTg3Y2FjZTU3YzRhNjViL3RhYmxlcmFuZ2U6M2Q1MGE3NzA2MzA1NGE4MzllODdjYWNlNTdjNGE2NWJfNS0xLTEtMS0xMzUxMjE_6de31513-a1a3-43bd-ab1a-e521b190d8da">39</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Present value of lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjNkNTBhNzcwNjMwNTRhODM5ZTg3Y2FjZTU3YzRhNjViL3RhYmxlcmFuZ2U6M2Q1MGE3NzA2MzA1NGE4MzllODdjYWNlNTdjNGE2NWJfNi0xLTEtMS0xMzUxMjE_55c653ae-445f-4e81-8c73-65d2b5cc4686">1,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i6c4404140edb48938ba4e30b290c9ef9_229"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.&#160;&#160;<ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:CompensationAndEmployeeBenefitPlansTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjkvZnJhZzpiYzRkYzhhMmExMWU0NDBjOTEyOGMyOTAwMDJlMTYwYS90ZXh0cmVnaW9uOmJjNGRjOGEyYTExZTQ0MGM5MTI4YzI5MDAwMmUxNjBhXzUxNjc3MDQ2NTA2Nzgz_0299e4fb-48bc-4d39-b5eb-7007415f4aea" continuedAt="i3e2c352ef5f8442bb103b31dbb5e8031" escape="true">Employee Benefit Plan</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3e2c352ef5f8442bb103b31dbb5e8031">The Company sponsors a 401(k)&#160;savings plan. All U.S. employees are eligible to participate in the 401(k)&#160;plan after meeting certain eligibility requirements. Participants may elect to have a portion of their salary deferred and contributed to the 401(k)&#160;plan up to the limit allowed by applicable income tax regulations. The Company matched a portion of employee contributions to the 401(k) plan totaling $<ix:nonFraction unitRef="usd" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="-5" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjkvZnJhZzpiYzRkYzhhMmExMWU0NDBjOTEyOGMyOTAwMDJlMTYwYS90ZXh0cmVnaW9uOmJjNGRjOGEyYTExZTQ0MGM5MTI4YzI5MDAwMmUxNjBhXzI5MTM3MDU4MTM3MzA2_55852e91-4a5b-42bc-8a72-ea2e3595c7d9">2.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331" decimals="-5" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjkvZnJhZzpiYzRkYzhhMmExMWU0NDBjOTEyOGMyOTAwMDJlMTYwYS90ZXh0cmVnaW9uOmJjNGRjOGEyYTExZTQ0MGM5MTI4YzI5MDAwMmUxNjBhXzI5MTM3MDU4MTM3MzEx_540b8e9e-aae4-48fa-9143-d5bfff2b14e0">1.3</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331" decimals="-5" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjkvZnJhZzpiYzRkYzhhMmExMWU0NDBjOTEyOGMyOTAwMDJlMTYwYS90ZXh0cmVnaW9uOmJjNGRjOGEyYTExZTQ0MGM5MTI4YzI5MDAwMmUxNjBhXzI5MTM3MDU4MTM3MzM1_c032ecbb-54b7-4198-aa05-9ef951469e93">0.7</ix:nonFraction> million for the fiscal years ended March&#160;31, 2022, 2021 and 2020, respectively. Both employee contributions and the Company&#8217;s matching contributions are fully vested upon contribution.</ix:continuation> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="i6c4404140edb48938ba4e30b290c9ef9_226"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16. <ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjYvZnJhZzo4OTAxZmUyZjMyOGU0NzJlYWU2YzNkODY1MTFhYzExMC90ZXh0cmVnaW9uOjg5MDFmZTJmMzI4ZTQ3MmVhZTZjM2Q4NjUxMWFjMTEwXzUxNjc3MDQ2NTEwODcy_585a1729-e451-4b15-9bad-b3c871bc110f" continuedAt="ia446f57e09ea4e21a9e7244488470019" escape="true">Segment and Geographic Information</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia446f57e09ea4e21a9e7244488470019" continuedAt="i3f3fe8f3de294164b6ff1e6f2377fa7d">The Company considers operating segments to be components of the Company in which separate financial information is available and is evaluated regularly by the Company&#8217;s chief operating decision maker in deciding how to allocate resources and in assessing performance. The chief operating decision maker for the Company is the Chief Executive Officer. The chief operating decision maker reviews financial information on a consolidated basis to make decisions about how to allocate resources and how to measure the Company&#8217;s performance. As such, the Company has determined that it has <ix:nonFraction unitRef="segment" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjYvZnJhZzo4OTAxZmUyZjMyOGU0NzJlYWU2YzNkODY1MTFhYzExMC90ZXh0cmVnaW9uOjg5MDFmZTJmMzI4ZTQ3MmVhZTZjM2Q4NjUxMWFjMTEwXzI5MTM3MDU4MTQxMzQx_68f9b619-c362-4c3b-ba73-52dd583911e7"><ix:nonFraction unitRef="segment" contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjYvZnJhZzo4OTAxZmUyZjMyOGU0NzJlYWU2YzNkODY1MTFhYzExMC90ZXh0cmVnaW9uOjg5MDFmZTJmMzI4ZTQ3MmVhZTZjM2Q4NjUxMWFjMTEwXzI5MTM3MDU4MTQxMzQx_d812f442-db8a-45f6-a71c-bb3101d4fbb2">one</ix:nonFraction></ix:nonFraction> operating and reportable segment. </ix:continuation></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i3f3fe8f3de294164b6ff1e6f2377fa7d">Substantially all of the Company&#8217;s long-lived assets were based in the United States as of March&#160;31, 2022 and 2021. No country outside of the United States accounted for more than 10% of total revenue for the fiscal years ended March&#160;31, 2022, 2021, and 2020. Substantially all of the Company&#8217;s revenue was derived in the United States for the fiscal years ended March&#160;31, 2022, 2021, and 2020.</ix:continuation> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="i6c4404140edb48938ba4e30b290c9ef9_232"></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17.&#160;&#160;<ix:nonNumeric contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMzIvZnJhZzo0MzQzYjgxYWVkMzE0MmRjYWNiMWNhN2RhNTczNzEyOC90ZXh0cmVnaW9uOjQzNDNiODFhZWQzMTQyZGNhY2IxY2E3ZGE1NzM3MTI4XzUxNjc3MDQ2NTE2OTEy_2238a37d-2353-41ae-9efb-e5536914bff0" continuedAt="iabad4d4817ec45e680d64554d549eeee" escape="true">Subsequent Events</ix:nonNumeric></span></div><ix:continuation id="iabad4d4817ec45e680d64554d549eeee" continuedAt="iae7d6bc2dbf040429aa170e1e0c08317"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Grants</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, the Company&#8217;s compensation committee granted <ix:nonFraction unitRef="shares" contextRef="i16625e145bd74701a4ae78f95675b6e5_D20220515-20220515" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMzIvZnJhZzo0MzQzYjgxYWVkMzE0MmRjYWNiMWNhN2RhNTczNzEyOC90ZXh0cmVnaW9uOjQzNDNiODFhZWQzMTQyZGNhY2IxY2E3ZGE1NzM3MTI4XzI5MTM3MDU4MTU1NDkw_655ec91c-f569-43f9-b107-caa14f90503d">563,689</ix:nonFraction> RSUs with an effective date of May 15, 2022 and an estimated fair value of $<ix:nonFraction unitRef="usd" contextRef="i16625e145bd74701a4ae78f95675b6e5_D20220515-20220515" decimals="-5" name="docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMzIvZnJhZzo0MzQzYjgxYWVkMzE0MmRjYWNiMWNhN2RhNTczNzEyOC90ZXh0cmVnaW9uOjQzNDNiODFhZWQzMTQyZGNhY2IxY2E3ZGE1NzM3MTI4XzI5MTM3MDU4MTU1NTA4_dfa7cd1d-2cf1-42a0-8010-7b0d9064f19f">18.6</ix:nonFraction> million, including the RSUs granted to employees joining the Company as part of the AMiON acquisition. These RSUs will generally vest over <ix:nonNumeric contextRef="i16625e145bd74701a4ae78f95675b6e5_D20220515-20220515" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMzIvZnJhZzo0MzQzYjgxYWVkMzE0MmRjYWNiMWNhN2RhNTczNzEyOC90ZXh0cmVnaW9uOjQzNDNiODFhZWQzMTQyZGNhY2IxY2E3ZGE1NzM3MTI4XzI5MTM3MDU4MTU1NTI4_e08c3a3f-bca1-4ffc-b723-ab6374d4d795">four years</ix:nonNumeric> based on continued service. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Repurchase Program</span></div></ix:continuation><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iae7d6bc2dbf040429aa170e1e0c08317">On May 12 2022, the Company&#8217;s board of directors authorized a program to repurchase up to $<ix:nonFraction unitRef="usd" contextRef="id8a49fae532d49d9b87337bacae0b894_I20220512" decimals="-6" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMzIvZnJhZzo0MzQzYjgxYWVkMzE0MmRjYWNiMWNhN2RhNTczNzEyOC90ZXh0cmVnaW9uOjQzNDNiODFhZWQzMTQyZGNhY2IxY2E3ZGE1NzM3MTI4XzI5MTM3MDU4MTU3Nzg4_2f0921da-617e-4833-b608-8d5413a5cf7d">70</ix:nonFraction> million of the Company&#8217;s Class A common stock. The repurchases may be executed from time to time over the next <ix:nonNumeric contextRef="i809ae921d1e74261bd64ae9e74b5455c_D20220512-20220512" name="us-gaap:StockRepurchaseProgramPeriodInForce1" format="ixt-sec:durmonth" id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMzIvZnJhZzo0MzQzYjgxYWVkMzE0MmRjYWNiMWNhN2RhNTczNzEyOC90ZXh0cmVnaW9uOjQzNDNiODFhZWQzMTQyZGNhY2IxY2E3ZGE1NzM3MTI4XzI5MTM3MDU4MTU5Njk2_32607070-21b6-4b1d-92a3-f23a095ce318">12</ix:nonNumeric> months, subject to general business and market conditions and other investment opportunities, through open market purchases or privately negotiated transactions, including through Rule 10b5-1 plans. Immediately upon the repurchase of any shares of Class A common stock, such shares shall be retired by the Company and shall automatically return to the status of authorized but unissued shares of Class A common stock.</ix:continuation> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><div id="i6c4404140edb48938ba4e30b290c9ef9_936"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="i6c4404140edb48938ba4e30b290c9ef9_942"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9A. Controls and Procedures</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, have evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Annual Report on Form 10-K. The term &#8220;disclosure controls and procedures,&#8221; as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC&#8217;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company&#8217;s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. In designing and evaluating our disclosure controls and procedures, our management recognizes that disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable assurance that the objectives of the disclosure controls and procedures are met. Based on such evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of the end of the period covered by this Annual Report on Form 10-K, our disclosure controls and procedures were effective at the reasonable assurance level. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting identified in connection with the evaluation required by Rules 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the quarter ended March&#160;31, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inherent Limitations on Effectiveness of Controls</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Management&#8217;s Report on Internal Control over Financial Reporting</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Annual Report on Form 10-K does not include a report of management&#8217;s assessment regarding internal control over financial reporting or an attestation report of our independent registered public accounting firm due to a transition period established by the rules of the SEC for newly public companies. </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="i6c4404140edb48938ba4e30b290c9ef9_948"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9B. Other Information</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company will hold its 2022 Annual Meeting of Stockholders on July 27, 2022 at 1 p.m. Pacific Time. The 2022 Annual Meeting of Stockholders will be held virtually via a live audio-only webcast accessible at http://www.virtualshareholdermeeting.com/DOCS2022 for all stockholders of record at the close of business on June 1, 2022, the record date. </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><div id="i6c4404140edb48938ba4e30b290c9ef9_954"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><div id="i6c4404140edb48938ba4e30b290c9ef9_960"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div id="i6c4404140edb48938ba4e30b290c9ef9_966"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 10. Directors, Executive Officers and Corporate Governance</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item is incorporated by reference to the definitive Proxy Statement for the 2022 Annual Meeting of Stockholders, which will be filed with the SEC no later than 120 days after March&#160;31, 2022.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adopted a Code of Conduct, which applies to all employees, including our principal executive officers, our principal financial officer, and all other executive officers. The Code of Conduct is available on our investor relations website at investors.doximity.com/governance. We plan to post any future amendments or waivers of our Code of Conduct on our website. </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="i6c4404140edb48938ba4e30b290c9ef9_133"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 11. Executive Compensation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item is incorporated by reference to the definitive Proxy Statement for the 2022 Annual Meeting of Stockholders, which will be filed with the SEC no later than 120 days after March&#160;31, 2022.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="i6c4404140edb48938ba4e30b290c9ef9_975"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item is incorporated by reference to the definitive Proxy Statement for the 2022 Annual Meeting of Stockholders, which will be filed with the SEC no later than 120 days after March&#160;31, 2022.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="i6c4404140edb48938ba4e30b290c9ef9_136"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 13. Certain Relationships and Related Transactions, and Director Independence</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item is incorporated by reference to the definitive Proxy Statement for the 2022 Annual Meeting of Stockholders, which will be filed with the SEC no later than 120 days after March&#160;31, 2022.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="i6c4404140edb48938ba4e30b290c9ef9_983"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 14. Principal Accountant Fees and Services</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this item is incorporated by reference to the definitive Proxy Statement for the 2022 Annual Meeting of Stockholders, which will be filed with the SEC no later than 120 days after March&#160;31, 2022.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><div id="i6c4404140edb48938ba4e30b290c9ef9_989"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div id="i6c4404140edb48938ba4e30b290c9ef9_253"></div><div style="-sec-extract:summary;margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;15. Exhibits and Financial Statement Schedules</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.0%"></td><td style="width:0.293%"></td><td style="width:0.0%"></td><td style="width:1.0%"></td><td style="width:42.301%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.075%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Incorporated by Reference</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exhibit Title</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Form</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">File No.</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exhibit</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Filing Date</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1516513/000162828021012207/exhibit32-sx1a1.htm">Amended and Restated Certificate of Incorporation of the Registrant.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-1/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">333-256584</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 15, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001516513/000162828021012207/exhibit34-sx1a1.htm">Amended and Restated Bylaws of the Registrant.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-1/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">333-256584</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 15, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1516513/000162828021011269/exhibit41s-1.htm">Form of Class A common stock certificate of the Registrant.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">333-256584</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 28, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1516513/000162828021011269/exhibit42-sx1.htm">Amended and Restated Investors&#8217; Rights Agreement, dated April 10, 2014, by and among the Registrant and certain of its stockholders.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">333-256584</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 28, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit43-descriptionofsec.htm">Description of Securities.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1516513/000162828021011269/exhibit43-sx1.htm">Warrant to Purchase Shares of Common Stock issued to U.S. News &amp; World Report, L.P., dated March 10, 2017.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">333-256584</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 28, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1516513/000151651321000009/ex-422021usnewswarrantagre.htm">Warrant to Purchase Shares of Class A Common Stock issued to U.S. News &amp; World Report, </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1516513/000151651321000009/ex-422021usnewswarrantagre.htm">L.P., dated June 14, 2021.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-40508</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">August 12, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1516513/000151651321000028/usnwarrantextension.htm">Amendment to Warrant to Purchase Shares of Class A Common Stock issued to U.S. News &amp; World Report, L.P., dated September 2, 2021.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-40508</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November 10, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.7</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001516513/000151651321000028/usnewswarrantagreementamen.htm">Second Amendment to Warrant to Purchase Shares of Class A Common Stock issued to U.S. News &amp; World Report, L.P., dated October 8, 2021.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-Q</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">001-40508</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November 10, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1516513/000162828021012207/exhibit101-sx1a1.htm">Form of Indemnification Agreement between the Registrant and each of its directors and executive officers.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-1/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">333-256584</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 15, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.2#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1516513/000162828021012207/exhibit102-sx1a1.htm">2010 Equity Incentive Plan, as amended, and forms of agreements thereunder.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-1/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">333-256584</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 15, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.3#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit103-2021stockoption.htm">2021 Stock Option and Incentive Plan, and forms of agreements thereunder.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.4#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1516513/000162828021012207/exhibit104-sx1a1.htm">2021 Employee Stock Purchase Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-1/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">333-256584</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.4</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 15, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.5#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1516513/000162828021012207/exhibit105-sx1a1.htm">Senior Executive Cash Incentive Bonus Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-1/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">333-256584</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.5</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 15, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.6#</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1516513/000162828021012207/exhibit106-sx1a1.htm">Non-Employee Director Compensation Policy.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-1/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">333-256584</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.6</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 15, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit211-listofsubsidiar.htm">Subsidiaries of the Registrant.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit231-consentfy22.htm">Consent of Deloitte &amp; Touche LLP, independent registered public accounting firm.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6c4404140edb48938ba4e30b290c9ef9_2790">Power of Attorney (incorporated by reference to the Signature page of this Annual Report on Form 10-K).</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit31133122.htm">Certification of Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:11.656%"></td><td style="width:0.1%"></td><td style="width:0.0%"></td><td style="width:0.293%"></td><td style="width:0.0%"></td><td style="width:1.0%"></td><td style="width:42.301%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.363%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.457%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.075%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit31233122.htm">Certification of Chief Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit32133122.htm">Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furnished herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="exhibit32233122.htm">Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furnished herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Schema Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed herewith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">__________________</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">* &#160;The certifications attached as Exhibit 32.1 and 32.2 that accompany this Annual Report on Form 10-K are deemed furnished and not filed with the SEC and are not to be incorporated by reference into any filing of the Company under the Securities Act or the Exchange Act, whether made before or after the date of this Annual Report on Form 10-K, irrespective of any general incorporation language contained in such filing. </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">#   Indicates management contract or compensatory plan, contract or agreement.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:1pt;font-weight:400;line-height:120%"> </span></div><div id="i6c4404140edb48938ba4e30b290c9ef9_999"></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 16. Form 10-K Summary</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><div id="i6c4404140edb48938ba4e30b290c9ef9_259"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Annual Report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized, San Francisco, California, on May&#160;27, 2022.</span></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:59.615%"><tr><td style="width:1.0%"></td><td style="width:6.158%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:91.642%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOXIMITY, INC.</span></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Jeffrey Tangney</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jeffrey Tangney</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Executive Officer</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Principal Executive Officer)</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Anna Bryson</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anna Bryson</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Principal Financial Officer and Principal Accounting Officer)</span></div></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><div id="i6c4404140edb48938ba4e30b290c9ef9_2790"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">POWER OF ATTORNEY</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Anna Bryson and Jennifer Chaloemtiarana, and each of them, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his or her name, place, and stead, in any and all capacities, to sign any amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents full power and authority to do and perform each and every act and thing requisite or necessary to be done in connection therewith and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or their, his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this Annual Report on Form 10-K has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated. </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.508%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.579%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.331%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Signature</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Title</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Date</span></div></td></tr><tr style="height:9pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Jeffrey Tangney</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Executive Officer and Director</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Principal Executive Officer)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 27, 2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jeffrey Tangney</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Anna Bryson</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Financial Officer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(Principal Financial Officer and Principal Accounting Officer)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 27, 2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Anna Bryson</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Regina Benjamin</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 27, 2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regina Benjamin</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Tim Cabral</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 27, 2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tim Cabral</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Gilbert Kliman</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 27, 2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gilbert Kliman</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Kevin Spain</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 27, 2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kevin Spain</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Kira Wampler</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 27, 2022</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kira Wampler</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>2
<FILENAME>exhibit43-descriptionofsec.htm
<DESCRIPTION>EX-4.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i6aad3ec02419443998e560035edf44f7_33"></div><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 4.3</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DESCRIPTION OF SECURITIES</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of information concerning the capital stock of Doximity, Inc. (&#8220;us,&#8221; &#8220;our,&#8221; &#8220;we,&#8221; or the &#8220;Company&#8221;) and certain provisions of our amended and restated certificate of incorporation (&#8220;Certificate&#8221;) and amended and restated bylaws (&#8220;Bylaws&#8221;). This summary does not purport to be complete and is qualified in its entirety by the provisions of our Certificate and Bylaws, each previously filed with the Securities and Exchange Commission and incorporated by reference as an exhibit to the Annual Report on Form 10-K of which this Exhibit 4.3 is a part, as well as the applicable provisions of the Delaware General Corporate Law (the &#8220;DGCL&#8221;). We encourage you to read our Certificate, Bylaws, and the applicable portions of the DGCL carefully. </font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General</font></div><div style="margin-bottom:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Certificate provides for two classes of common stock&#58; Class A common stock and Class B common stock. In addition, our Certificate authorizes shares of undesignated preferred stock, the rights, preferences, and privileges of which may be designated from time to time by our board of directors.</font></div><div style="margin-bottom:6pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our authorized capital stock consists of the following, all with a par value of $0.001 per share, of which&#58;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">1,000,000,000 shares of Class A common stock&#59;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">500,000,000 shares of Class B common stock&#59; and</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">100,000,000 shares of undesignated preferred stock.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our board of directors is authorized, without stockholder approval except as required by the listing standards of the New York Stock Exchange, to issue additional shares of our capital stock.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Voting Rights</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of our Class A common stock are entitled to one vote for each share and holders of our Class B common stock are entitled to ten votes per share, on all matters submitted to a vote of stockholders. The holders of our Class A common stock and Class B common stock vote together as a single class on all matters submitted to a vote of our stockholders, unless otherwise required by the DGCL or our Certificate. The DGCL could require either holders of our Class A common stock or Class B common stock to vote separately as a single class in the following circumstances&#58;</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if we were to seek to amend our Certificate to increase or decrease the par value of a class of our capital stock, then that class would be required to vote separately to approve the proposed amendment&#59; and</font></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if we were to seek to amend our Certificate in a manner that alters or changes the powers, preferences or special rights of a class of our capital stock in a manner that affected its holders adversely, then that class would be required to vote separately to approve the proposed amendment.</font></div><div style="margin-bottom:12pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders do not have the ability to cumulate votes for the election of directors. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Certificate and Bylaws have established a classified board of directors that is divided into three classes with staggered three-year terms. Only the directors in one class will be subject to election by a plurality of the votes cast at each annual meeting of our stockholders, with the directors in the other classes continuing for the remainder of their respective three-year terms.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividend Rights</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to preferences that may apply to any shares of preferred stock outstanding at the time, the holders of our common stock are entitled to receive dividends out of funds legally available if our board of directors, in its discretion, determines to issue dividends and then only at the times and in the amounts that our board of directors may determine.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conversion</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each outstanding share of Class B common stock is convertible at any time at the option of the holder into one share of Class A common stock. In addition, each share of Class B common stock will convert automatically into one share of Class A common stock upon (i) any transfer, whether or not for value, except for certain permitted transfers described in our Certificate, including transfers to family members, trusts solely for the benefit of the stockholder or their family members, and partnerships, corporations and other entities exclusively owned by the stockholder or their family members or (ii), in the case of a stockholder who is a natural person, the death or incapacity of such stockholder. Once converted into Class A common stock, the Class B common stock will not be reissued. All outstanding shares of Class A common stock and Class B common stock will convert automatically into shares of a single class of common stock on the earlier of the date that is ten years from the date of this prospectus or the date the holders of at least 66 2&#47;3% of our Class B common stock elect to convert the Class B common stock to Class A common stock. The purpose of this provision is to ensure that following such conversion, each share of common stock will have one vote per share and the rights of the holders of all outstanding common stock will be identical. Once converted into a single class of common stock, the Class A common stock and Class B common stock may not be reissued. See the section titled &#8220;Risk Factors&#8212; Risks Related to Ownership of Our Class A Common Stock&#8221; in the Form 10-K of which this exhibit is a part, which is hereby incorporated by reference, for a description of the risks related to the dual class structure of our common stock.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">No Preemptive or Similar Rights</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Class A common stock and Class B common stock are not entitled to preemptive rights and are not subject to conversion, redemption, or sinking fund provisions.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Right to Receive Liquidation Distributions</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we become subject to a liquidation, dissolution, or winding-up, the assets legally available for distribution to our stockholders would be distributable ratably among the holders of our Class A common stock and Class B common stock and any participating preferred stock outstanding at that time, subject to prior satisfaction of all outstanding debt and liabilities and the preferential rights of and the payment of liquidation preferences, if any, on any outstanding shares of preferred stock.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fully Paid and Non-Assessable</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the outstanding shares of our Class A and Class B common stock are fully paid and non-assessable.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Preferred Stock</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our board of directors are authorized, subject to limitations prescribed by Delaware law, to issue preferred stock in one or more series, to establish from time to time the number of shares to be included in each series and to fix the designation, powers, preferences, and rights of the shares of each series and any of its qualifications, limitations or restrictions, in each case without further vote or action by our stockholders. Our board of directors can also increase or decrease the number of shares of any series of preferred stock, but not below the number of shares of that series then outstanding, without any further vote or action by our stockholders. Our board of directors may authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting power or other rights of the holders of our common stock. The issuance of preferred stock, while providing flexibility in connection with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring, or preventing a change in control of our company and might adversely affect the market price of our Class A common stock and the voting and other rights of the holders of our Class A common stock and Class B common stock. </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registration Rights</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are party to an investors&#8217; rights agreement which grants certain holders of our Class B common stock to rights with respect to the registration of their shares under the Securities Act. The registration rights set forth in the investors&#8217; rights agreement will expire five years following the listing of our Class A common stock on the NYSE or, with respect to any particular stockholder, when such stockholder is able to sell all of its shares pursuant to Rule 144 of the Securities Act. We will pay the registration expenses (other than underwriting discounts, selling commissions, and stock transfer taxes) of the holders of the shares registered pursuant to the registrations described below, including the reasonable fees of one counsel for the selling holders (not to exceed $50,000). In an underwritten offering, the underwriters have the right, subject to specified conditions, to limit the number of shares such holders may include.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Demand Registration Rights on Form S-1</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of a majority of our Class B common stock securities then outstanding may request that we register the offer and sale of their shares on a registration statement on Form S-1, so long as the request covers at least that number of shares (a) with an anticipated aggregate offering price of at least $25 million and (b) that constitute at least twenty percent of the shares entitled to demand registration rights then outstanding. We are obligated to effect only two such registrations. If in good faith our board of directors determine that it would be materially detrimental to our stockholders to effect such a demand registration, we have the right to defer such registration, not more than once in any 12-month period, for a period of not more than 90 days. Additionally, we will not be required to effect a demand registration if, within 30 days of the request for registration, we provide notice to such holders requesting registration that we intend to file a Company-initiated registration within 90 days thereof.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Demand Registration Rights on Form S-3</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of a majority of our Class B common stock securities then outstanding may request that we register the offer and sale of their shares on a registration statement on Form S-3 if we are eligible to file a registration statement on Form S-3 so long as the request covers at least that number of shares with an anticipated aggregate offering price of at least $500,000. These stockholders may make an unlimited number of requests for registration on Form S-3&#59; however, we will not be required to effect a registration on Form S-3 if we have effected two such registrations within the 12-month period preceding the date of the request. Additionally, if in good faith our board of directors determine that it would be materially detrimental to our stockholders to effect such a registration, we have the right to defer such registration, not more than once in any 12-month period, for a period of not more than 90 days. Additionally, we will not be required to effect a demand registration if, within 30 days of the request for registration, we provide notice to such holders requesting registration that we intend to file a Company-initiated registration within 90 days thereof.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Piggyback Registration Rights</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event we propose to register the offer and sale of our common stock under the Securities Act, in connection with the public offering of such common stock the holders of a majority of our Class B common stock securities then outstanding will be entitled to certain &#8220;piggyback&#8221; registration rights allowing the holders to include their shares in such registration, subject to certain marketing and other limitations. As a result, whenever we propose to file a registration statement under the Securities Act, other than with respect to a registration relating solely to employee benefit plans, a registration relating to the offer and sale of debt securities, a registration relating to a corporate reorganization or other transaction under Rule 145 of the Securities Act, or a registration on any registration form that does not permit secondary sales, the holders of these shares are entitled to notice of the registration and have the right, subject to certain limitations, to include their shares in the registration.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Anti-Takeover Provisions</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The DGCL, our Certificate, and our Bylaws may have the effect of delaying, deferring or discouraging another person from acquiring control of our company, as summarized below. These provisions are also designed, in part, to encourage persons seeking to acquire control of us to negotiate first with our board of directors. We believe that the benefits of increased protection of our potential ability to negotiate with an unfriendly or unsolicited acquirer outweigh the disadvantages of discouraging a proposal to acquire us because negotiation of these proposals could result in an improvement of their terms.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Delaware Law</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are governed by the provisions of Section 203 of the DGCL. In general, Section 203 prohibits a public Delaware corporation from engaging in a &#8220;business combination&#8221; with an &#8220;interested stockholder&#8221; for a period of three years after the date of the transaction in which the person became an interested stockholder, unless the business combination is approved in a prescribed manner. A &#8220;business combination&#8221; includes mergers, asset sales, or other transactions resulting in a financial benefit to the stockholder. An &#8220;interested stockholder&#8221; is a person who, together with affiliates and associates, owns, or within three years did own, 15% or more of the corporation&#8217;s outstanding voting stock. These provisions may have the effect of delaying, deferring or preventing a change in our control.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amended and Restated Certificate of Incorporation and Amended and Restated Bylaw Provisions</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Certificate and Bylaws include a number of provisions that could deter hostile takeovers or delay or prevent changes in control of our board of directors or management team, including the following&#58;</font></div><div style="margin-bottom:6pt"><font><br></font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dual Class Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As described above, our Certificate provides for a dual class common stock structure, which gives our founders, current investors, executives, and employees significant influence over all matters requiring stockholder approval, including the election of directors and significant corporate transactions, such as a merger or other sale of our company or our assets.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Board of Directors Vacancies</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our Certificate and Bylaws authorize only our board of directors to fill vacant directorships, including newly created seats. In addition, the number of directors constituting our board of directors will be permitted to be set only by a resolution adopted by a majority vote of our entire board of directors. These provisions would prevent a stockholder from increasing the size of our board of directors and then gaining control of our board of directors by filling the resulting vacancies with its own nominees. These provisions make it more difficult to change the composition of our board of directors and promote continuity of management.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Classified Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our Certificate and Bylaws provides that our board of directors is classified into three classes of directors. A third party may be discouraged from making a tender offer or otherwise attempting to obtain control of us as it is more difficult and time consuming for stockholders to replace a majority of the directors on a classified board of directors. </font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stockholder Action&#59; Special Meeting of Stockholders</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our Certificate provides that our stockholders may not take action by written consent, but may only take action at annual or special meetings of our stockholders. As a result, a holder controlling a majority of our capital stock would not be able to amend our Bylaws or remove directors without holding a meeting of our stockholders called in accordance with our Bylaws. Our Bylaws further provide that special meetings of our stockholders may be called only by a majority of our board of directors, the Chairperson of our board of directors, our President, or our Chief Executive Officer, thus prohibiting a stockholder from calling a special meeting. These provisions might delay the ability of our stockholders to force consideration of a proposal or for stockholders controlling a majority of our capital stock to take any action, including the removal of directors.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Advance Notice Requirements for Stockholder Proposals and Director Nominations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our Bylaws provide advance notice procedures for stockholders seeking to bring business before our annual meeting of stockholders or to nominate candidates for election as directors at our annual meeting of stockholders. Our Bylaws also specify certain requirements regarding the form and content of a stockholder&#8217;s notice. These provisions might preclude our stockholders from bringing matters before our annual meeting of stockholders or from making nominations for directors at our annual meeting of stockholders if the proper procedures are not followed. We expect that these provisions may also discourage or deter a potential acquirer from conducting a solicitation of proxies to elect the acquirer&#8217;s own slate of directors or otherwise attempting to obtain control of our company.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">No Cumulative Voting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The DGCL provides that stockholders are not entitled to cumulate votes in the election of directors unless a corporation&#8217;s certificate of incorporation provides otherwise. Our Certificate does not provide for cumulative voting.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Directors Removed Only for Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our Certificate provides that stockholders may remove directors only for cause.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amendment of Charter Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Any amendment of the above provisions in our Certificate requires approval by holders of at least two-thirds of our then outstanding common stock.</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Issuance of Undesignated Preferred Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our board of directors have the authority, without further action by the stockholders, to issue up to 100,000,000 shares of undesignated preferred stock with rights and preferences, including voting rights, designated from time to time by our board of directors. The existence of authorized but unissued shares of preferred stock would enable our board of directors to render more difficult or to discourage an attempt to obtain control of us by means of a merger, tender offer, proxy contest, or other means.</font></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exclusive Forum</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our Bylaws provide that, unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware shall be the sole and exclusive forum for any state law claims for (1) any derivative action or proceeding brought on our behalf, (2) any action asserting a claim of breach of a fiduciary duty owed by any of our directors, officers, and employees to us or our stockholders, (3) any action asserting a claim arising pursuant to the DGCL, our Certificate, or our Bylaws, or (4) any action asserting a claim that is governed by the internal affairs doctrine&#59; provided, however, that the Delaware Forum Provision shall not apply to any causes of action arising under the Securities Act or Exchange Act. In addition, our Bylaws provide that, unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States shall be the sole and exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act&#59; provided, however, that our stockholders cannot and will not be deemed to have waived our compliance with the U.S. federal securities laws and the rules and regulations thereunder. Any person or entity purchasing or otherwise acquiring any interest in our securities shall be deemed to have notice of and consented to this provision. These forum provisions may impose additional costs on stockholders, may limit our stockholders&#8217; ability to bring a claim in a forum they find favorable, and the designated courts may reach different judgments or results than other courts. In addition, there is uncertainty as to whether the Federal Forum Provision for Securities Act claims will be enforced, which may impose additional costs on us and our stockholders. </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>3
<FILENAME>exhibit103-2021stockoption.htm
<DESCRIPTION>EX-10.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i295ace35142e46ca9372ebbc2d03031e_1"></div><div style="min-height:69.12pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.04pt;padding-left:0.91pt;padding-right:0.91pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 10.3</font></div><div style="margin-top:0.04pt;padding-left:46pt;padding-right:46pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:100%">DOXIMITY, INC.</font></div><div style="margin-top:12.15pt;padding-left:91.37pt;padding-right:91.37pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:100%">2021 STOCK OPTION AND INCENTIVE PLAN</font></div><div style="margin-top:0.45pt"><font><br></font></div><div id="i295ace35142e46ca9372ebbc2d03031e_4"></div><div style="padding-left:50.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 1. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">GENERAL PURPOSE OF THE PLAN&#59; DEFINITIONS</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:13.35pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The name of the plan is the Doximity, Inc. 2021 Stock Option and Incentive Plan (the &#8220;Plan&#8221;). The purpose of the Plan is to encourage and enable the officers, employees, Non- Employee Directors and Consultants of Doximity, Inc. (the &#8220;Company&#8221;) and its Affiliates upon whose judgment, initiative and efforts the Company largely depends for the successful conduct of its business to acquire a proprietary interest in the Company. It is anticipated that providing such persons with a direct stake in the Company&#8217;s welfare will assure a closer identification of their interests with those of the Company and its stockholders, thereby stimulating their efforts on the Company&#8217;s behalf and strengthening their desire to remain with the Company.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:41.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The following terms shall be defined as set forth below&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Act&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">means the Securities Act of 1933, as amended, and the rules and regulations thereunder.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:5pt;padding-right:13.35pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Administrator&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">means either the Board or the compensation committee of the Board or a similar committee performing the functions of the compensation committee and which is comprised of not less than two Non-Employee Directors who are independent.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;padding-right:8.9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">Affiliate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, at the time of determination, any &#8220;parent&#8221; or &#8220;subsidiary&#8221; of the Company as such terms are defined in Rule 405 of the Act. The Board will have the authority to determine the time or times at which &#8220;parent&#8221; or &#8220;subsidiary&#8221; status is determined within the foregoing definition.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:5pt;padding-right:7.85pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Award&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Awards,&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">except where referring to a particular category of grant under the Plan, shall include Incentive Stock Options, Non-Qualified Stock Options, Stock Appreciation Rights, Restricted Stock Units, Restricted Stock Awards, Unrestricted Stock Awards, Cash- Based Awards, and Dividend Equivalent Rights.</font></div><div><font><br></font></div><div style="padding-left:5pt;padding-right:14.65pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Award Certificate&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">means a written or electronic document setting forth the terms and provisions applicable to an Award granted under the Plan. Each Award Certificate is subject to the terms and conditions of the Plan.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:41.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Board&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">means the Board of Directors of the Company.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Cash-Based Award&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">means an Award entitling the recipient to receive a cash- denominated payment.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:9.45pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Code&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">means the Internal Revenue Code of 1986, as amended, and any successor Code, and related rules, regulations and interpretations.</font></div><div style="margin-top:3.05pt;padding-left:5pt;padding-right:38.1pt;text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:0.05pt;padding-right:38.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Consultant&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">means a consultant or adviser who provides </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">bona fide </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">services to the Company or an Affiliate as an independent contractor and who qualifies as a consultant or advisor under Instruction A.1.(a)(1) of Form S-8 under the Act.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font><br></font></div></div><div style="padding-left:5pt;padding-right:13.35pt;text-indent:39pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Dividend Equivalent Right&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">means an Award entitling the grantee to receive credits based on cash dividends that would have been paid on the shares of Stock specified in the Dividend Equivalent Right (or other award to which it relates) if such shares had been issued to and held by the grantee.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:13.35pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:117%">&#8220;Effective Date&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">means the date on which the Plan becomes effective as set forth in Section 19.</font></div><div style="margin-top:11.6pt;padding-left:5pt;padding-right:13.35pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Exchange Act&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">means the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:7.85pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Fair Market Value&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">of the Stock on any given date means the fair market value of the Stock determined in good faith by the Administrator&#59; provided, however, that if the Stock is listed on the National Association of Securities Dealers Automated Quotation System (&#8220;NASDAQ&#8221;), NASDAQ Global Market, The New York Stock Exchange or another national securities exchange or traded on any established market, the determination shall be made by reference to market quotations. If there are no market quotations for such date, the determination shall be made by reference to the last date preceding such date for which there are market quotations&#59; provided further, however, that if the date for which Fair Market Value is determined is the Registration Date, the Fair Market Value shall be the &#8220;Price to the Public&#8221; (or equivalent) set forth on the cover page for the final prospectus relating to the Company&#8217;s initial public offering.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5pt;padding-right:13.35pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:117%">&#8220;Incentive Stock Option&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">means any Stock Option designated and qualified as an &#8220;incentive stock option&#8221; as defined in Section 422 of the Code.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Non-Employee Director&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">means a member of the Board who is not also an employee of the Company or any Subsidiary.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Non-Qualified Stock Option&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">means any Stock Option that is not an Incentive Stock Option.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Option&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Stock Option&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">means any option to purchase shares of Stock granted pursuant to Section 5.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.15pt;text-align:justify;text-indent:45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:117%">&#8220;Registration Date&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">means the date upon which the registration statement on Form S-1 that is filed by the Company with respect to its initial public offering is declared effective by the Securities and Exchange Commission.</font></div><div style="margin-top:11.45pt;padding-left:5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:119%">&#8220;Restricted Shares&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:119%">means the shares of Stock underlying a Restricted Stock Award that remain subject to a risk of forfeiture or the Company&#8217;s right of repurchase.</font></div><div style="margin-top:11.35pt;padding-left:5pt;padding-right:13.35pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Restricted Stock Award&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">means an Award of Restricted Shares subject to such restrictions and conditions as the Administrator may determine at the time of grant.</font></div><div style="padding-left:0.05pt;padding-right:13.35pt"><font><br></font></div><div style="margin-top:3.05pt;padding-left:5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Restricted Stock Units&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">means an Award of stock units subject to such restrictions and conditions as the Administrator may determine at the time of grant.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font><br></font></div></div><div style="padding-left:5pt;padding-right:7.85pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Sale Event&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">shall mean (i) the sale of all or substantially all of the assets of the Company on a consolidated basis to an unrelated person or entity, (ii) a merger, reorganization or consolidation pursuant to which the holders of the Company&#8217;s outstanding voting power and outstanding stock immediately prior to such transaction do not own a majority of the outstanding voting power and outstanding stock or other equity interests of the resulting or successor entity (or its ultimate parent, if applicable) immediately upon completion of such transaction, (iii) the sale of all of the Stock of the Company to an unrelated person, entity or group thereof acting in concert, or (iv) any other transaction in which the owners of the Company&#8217;s outstanding voting power immediately prior to such transaction do not own at least a majority of the outstanding voting power of the Company or any successor entity immediately upon completion of the transaction other than as a result of the acquisition of securities directly from the Company.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:5pt;padding-right:8.9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:117%">Sale Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">&#8221; means the value as determined by the Administrator of the consideration payable, or otherwise to be received by stockholders, per share of Stock pursuant to a Sale Event.</font></div><div style="margin-top:11.65pt;padding-left:5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:117%">&#8220;Section 409A&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">means Section 409A of the Code and the regulations and other guidance promulgated thereunder.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;padding-right:7.85pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Service Relationship&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">means any relationship as an employee, director or Consultant of the Company or any Affiliate (e.g., a Service Relationship shall be deemed to continue without interruption in the event an individual&#8217;s status changes from full-time employee to part-time employee or Consultant).</font></div><div><font><br></font></div><div style="padding-left:5pt;padding-right:8.9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Stock&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">means the Class A Common Stock, par value $0.001 per share, of the Company, subject to adjustments pursuant to Section 3.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Stock Appreciation Right&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">means an Award entitling the recipient to receive shares of Stock (or cash, to the extent explicitly provided for in the applicable Award Certificate) having a value equal to the excess of the Fair Market Value of the Stock on the date of exercise over the exercise price of the Stock Appreciation Right multiplied by the number of shares of Stock with respect to which the Stock Appreciation Right shall have been exercised.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:5pt;padding-right:8.9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:117%">&#8220;Subsidiary&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">means any corporation or other entity (other than the Company) in which the Company has at least a 50 percent interest, either directly or indirectly.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.95pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Ten Percent Owner&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">means an employee who owns or is deemed to own (by reason of the attribution rules of Section 424(d) of the Code) more than 10 percent of the combined voting power of all classes of stock of the Company or any parent or subsidiary corporation.</font></div><div style="margin-top:0.4pt;padding-left:0.05pt;padding-right:11.7pt;text-align:justify"><font><br></font></div><div style="padding-left:0.05pt;padding-right:11.7pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Unrestricted Stock Award&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">means an Award of shares of Stock free of any restrictions.</font></div><div style="padding-left:0.05pt;padding-right:11.7pt;text-align:justify"><font><br></font></div><div id="i295ace35142e46ca9372ebbc2d03031e_10"></div><div style="padding-left:122.05pt;padding-right:13.35pt;text-indent:-72.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:118%">SECTION 2. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:118%;text-decoration:underline">ADMINISTRATION OF PLAN&#59; ADMINISTRATOR AUTHORITY TO SELECT GRANTEES AND DETERMINE AWARDS</font></div><div style="padding-left:0.5pt"><font><br></font></div><div style="padding-left:77.05pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:22.7pt;text-decoration:underline">Administration of Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Plan shall be administered by the Administrator.</font></div><div style="padding-left:41.05pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:77.05pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:23.18pt;text-decoration:underline">Powers of Administrator</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Administrator shall have the power and authority to grant Awards consistent with the terms of the Plan, including the power and authority&#58;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font><br></font></div></div><div style="padding-left:113.05pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:24.74pt">to select the individuals to whom Awards may from time to time be granted&#59;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:8.4pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.36pt">to determine the time or times of grant, and the extent, if any, of Incentive Stock Options, Non-Qualified Stock Options, Stock Appreciation Rights, Restricted Stock Awards, Restricted Stock Units, Unrestricted Stock Awards, Cash-Based Awards, and Dividend Equivalent Rights, or any combination of the foregoing, granted to any one or more grantees&#59;</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:113.05pt;text-indent:-36.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.08pt">to determine the number of shares of Stock to be covered by any Award&#59;</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:8.4pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:13.69pt">to determine and modify from time to time the terms and conditions, including restrictions, not inconsistent with the terms of the Plan, of any Award, which terms and conditions may differ among individual Awards and grantees, and to approve the forms of Award Certificates&#59;</font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:8.4pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.02pt">to accelerate at any time the exercisability or vesting of all or any portion of any Award&#59;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:8.4pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:13.69pt">subject to the provisions of Section 5(c) or Section 6(d), to extend at any time the period in which Stock Options and Stock Appreciation Rights may be exercised&#59; and</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:5pt;padding-right:12.4pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(vii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:10.36pt">at any time to adopt, alter and repeal such rules, guidelines and practices for administration of the Plan and for its own acts and proceedings as it shall deem advisable&#59; to interpret the terms and provisions of the Plan and any Award (including related written instruments)&#59; to make all determinations it deems advisable for the administration of the Plan&#59; to decide all disputes arising in connection with the Plan&#59; and to otherwise supervise the administration of the Plan.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5pt;padding-right:8.9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">All decisions and interpretations of the Administrator shall be binding on all persons, including the Company and Plan grantees.</font></div><div style="margin-top:11.65pt;padding-left:5pt;padding-right:18.55pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.7pt;text-decoration:underline">Delegation of Authority to Grant Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Subject to applicable law, the Administrator, in its discretion, may delegate to a committee consisting of one or more officers of the Company, including the Chief Executive Officer of the Company, all or part of the Administrator&#8217;s authority and duties with respect to the granting of Awards to individuals who are (i) not subject to the reporting and other provisions of Section 16 of the Exchange Act and (ii) not members of the delegated committee. Any such delegation by the Administrator shall include a limitation as to the amount of Stock underlying Awards that may be granted during the period of the delegation and shall contain guidelines as to the determination of the exercise price and the vesting criteria. The Administrator may revoke or amend the terms of a delegation at any time but such action shall not invalidate any prior actions of the Administrator&#8217;s delegate or delegates that were consistent with the terms of the Plan.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:5pt;padding-right:45.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.02pt;text-decoration:underline">Award Certificate</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Awards under the Plan shall be evidenced by Award Certificates that set forth the terms, conditions and limitations for each Award which may include, without limitation, the term of an Award and the provisions applicable in the event employment or service terminates.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font><br></font></div></div><div style="padding-left:5pt;padding-right:9.4pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.7pt;text-decoration:underline">Indemnification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Neither the Board nor the Administrator, nor any member of either or any delegate thereof, shall be liable for any act, omission, interpretation, construction or determination made in good faith in connection with the Plan, and the members of the Board and the Administrator (and any delegate thereof) shall be entitled in all cases to indemnification and reimbursement by the Company in respect of any claim, loss, damage or expense (including, without limitation, reasonable attorneys&#8217; fees) arising or resulting therefrom to the fullest extent permitted by law and&#47;or under the Company&#8217;s articles or bylaws or any directors&#8217; and officers&#8217; liability insurance coverage which may be in effect from time to time and&#47;or any indemnification agreement between such individual and the Company.</font></div><div><font><br></font></div><div style="padding-left:5pt;padding-right:15.25pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.03pt;text-decoration:underline">Foreign Award Recipients</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding any provision of the Plan to the contrary, in order to comply with the laws in other countries in which the Company and its Subsidiaries operate or have employees or other individuals eligible for Awards, the Administrator, or its delegee, in its sole discretion, shall have the power and authority to&#58; (i) determine which Subsidiaries shall be covered by the Plan&#59; (ii) determine which individuals outside the United States are eligible to participate in the Plan&#59; (iii) modify the terms and conditions of any Award granted to individuals outside the United States to comply with applicable foreign laws&#59; (iv) establish subplans and modify exercise procedures and other terms and procedures, to the extent the Administrator determines such actions to be necessary or advisable (and such subplans and&#47;or modifications shall be attached to this Plan as appendices)&#59; provided, however, that no such subplans and&#47;or modifications shall increase the share limitations contained in Section 3(a) hereof&#59; and (v) take any action, before or after an Award is made, that the Administrator determines to be necessary or advisable to obtain approval or comply with any local governmental regulatory exemptions or approvals. Notwithstanding the foregoing, the Administrator may not take any actions hereunder, and no Awards shall be granted, that would violate the Exchange Act or any other applicable United States securities law, the Code, or any other applicable United States governing statute or law.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i295ace35142e46ca9372ebbc2d03031e_13"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font><br></font></div></div><div style="padding-left:122.05pt;padding-right:13.35pt;text-indent:-72.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:118%">SECTION 3. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:118%;text-decoration:underline">STOCK ISSUABLE UNDER THE PLAN&#59; MERGERS&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:118%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:118%;text-decoration:underline">SUBSTITUTION</font></div><div style="margin-top:11.65pt;padding-left:5pt;padding-right:7.45pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.7pt;text-decoration:underline">Stock Issuable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The maximum number of shares of Stock reserved and available for issuance under the Plan shall be 22,500,000 shares (the &#8220;Initial Limit&#8221;), subject to adjustment as provided in this Section 3, plus on April 1, 2022 and each April 1 thereafter, the number of shares of Stock reserved and available for issuance under the Plan shall be cumulatively increased by five percent (5%) of the number of shares of Class A and Class B common stock issued and outstanding on the immediately preceding March 31 or such lesser amount, including no increase, as determined by the Administrator (the &#8220;Annual Increase&#8221;). Subject to such overall limitation, the maximum aggregate number of shares of Stock that may be issued in the form of Incentive Stock Options shall not exceed the Initial Limit cumulatively increased on April 1, 2022 and on each April 1 thereafter by the lesser of the Annual Increase for such year or 22,500,000 shares of Stock, subject in all cases to adjustment as provided in Section 3(b). The shares of Stock underlying any awards under the Plan and underlying any awards under the Company&#8217;s 2010 Equity Incentive Plan, as amended, that are forfeited, canceled, held back upon exercise of an Option or settlement of an Award to cover the exercise price or tax withholding, reacquired by the Company prior to vesting, satisfied without the issuance of Stock or otherwise terminated (other than by exercise) shall be added back to the shares of Stock available for issuance under the Plan, and to the extent permitted under Section 422 of the Code and the regulations promulgated thereunder, the shares of Stock that may be issued as Incentive Stock Options (provided, that any such shares of Class B common stock of the Company shall first be converted to shares of Class A common stock of the Company). In the event the Company repurchases shares of Stock on the open market, such shares shall not be added to the shares of Stock available for issuance under the Plan. Subject to the foregoing limitations, shares of Stock may be issued up to such maximum number pursuant to any type or types of Award. The shares available for issuance under the Plan may be authorized but unissued shares of Stock or shares of Stock reacquired by the Company.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:8.15pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.02pt;text-decoration:underline">Changes in Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Subject to Section 3(c) hereof, if, as a result of any reorganization, recapitalization, reclassification, stock dividend, stock split, reverse stock split or other similar change in the Company&#8217;s capital stock, the outstanding shares of Stock are increased or decreased or are exchanged for a different number or kind of shares or other securities of the Company, or additional shares or new or different shares or other securities of the Company or other non-cash assets are distributed with respect to such shares of Stock or other securities, or, if, as a result of any merger or consolidation, sale of all or substantially all of the assets of the Company, the outstanding shares of Stock are converted into or exchanged for securities of the Company or any successor entity (or a parent or subsidiary thereof), the Administrator shall make an appropriate or proportionate adjustment in (i) the maximum number of shares reserved for issuance under the Plan, including the maximum number of shares that may be issued in the form of Incentive Stock Options, (ii) the number and kind of shares or other securities subject to any then outstanding Awards under the Plan, (iii) the repurchase price, if any, per share subject to each outstanding Restricted Stock Award, and (iv) the exercise price for each share subject to any then outstanding Stock Options and Stock Appreciation Rights under the Plan, without changing the aggregate exercise price (i.e., the exercise price multiplied by the number of shares subject to Stock Options and Stock Appreciation Rights) as to which such Stock Options and Stock Appreciation Rights remain exercisable. The Administrator shall also make equitable or proportionate adjustments in the number of shares subject to outstanding Awards and the exercise price and the terms of outstanding Awards to take into consideration cash dividends paid other than in the ordinary course or any other extraordinary corporate event. The adjustment by the Administrator shall be final, binding and conclusive. No fractional shares of Stock shall be issued under the Plan resulting from any such adjustment, but the Administrator in its discretion may make a cash payment in lieu of fractional shares.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font><br></font></div></div><div style="padding-left:5pt;padding-right:11.25pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.7pt;text-decoration:underline">Mergers and Other Transactions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. In the case of and subject to the consummation of a Sale Event, the parties thereto may cause the assumption or continuation of Awards theretofore granted by the successor entity, or the substitution of such Awards with new Awards of the successor entity or parent thereof, with appropriate adjustment as to the number and kind of shares and, if appropriate, the per share exercise prices, as such parties shall agree. To the extent the parties to such Sale Event do not provide for the assumption, continuation or substitution of Awards, upon the effective time of the Sale Event, the Plan and all outstanding Awards granted hereunder shall terminate. In such case, except as may be otherwise provided in the relevant Award Certificate, all Options and Stock Appreciation Rights with time-based vesting conditions or restrictions that are not vested and&#47;or exercisable immediately prior to the effective time of the Sale Event shall become fully vested and exercisable as of the effective time of the Sale Event, all other Awards with time-based vesting, conditions or restrictions shall become fully vested and nonforfeitable as of the effective time of the Sale Event, and all Awards with conditions and restrictions relating to the attainment of performance goals may become vested and nonforfeitable in connection with a Sale Event in the Administrator&#8217;s discretion or to the extent specified in the relevant Award Certificate. In the event of such termination, (i) the Company shall have the option (in its sole discretion) to make or provide for a payment, in cash or in kind, to the grantees holding Options and Stock Appreciation Rights, in exchange for the cancellation thereof, in an amount equal to the difference between (A) the Sale Price multiplied by the number of shares of Stock subject to outstanding Options and Stock Appreciation Rights (to the extent then exercisable at prices not in excess of the Sale Price) and (B) the aggregate exercise price of all such outstanding Options and Stock Appreciation Rights (provided that, in the case of an Option or Stock Appreciation Right with an exercise price equal to or greater than the Sale Price, such Option or Stock Appreciation Right shall be cancelled for no consideration)&#59; or (ii) each grantee shall be permitted, within a specified period of time prior to the consummation of the Sale Event as determined by the Administrator, to exercise all outstanding Options and Stock Appreciation Rights (to the extent then exercisable) held by such grantee. The Company shall also have the option (in its sole discretion) to make or provide for a payment, in cash or in kind, to the grantees holding other Awards in an amount equal to the Sale Price multiplied by the number of vested shares of Stock under such Awards.</font></div><div style="margin-top:11.65pt;padding-left:5pt;padding-right:12.85pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.02pt;text-decoration:underline">Maximum Awards to Non-Employee Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding anything to the contrary in this Plan, the value of all Awards awarded under this Plan and all other cash compensation paid by the Company to any Non-Employee Director in any calendar year shall not exceed $750,000&#59; provided, however, that such amount shall be $1,000,000 for the calendar year in which the applicable Non-Employee Director is initially elected or appointed to the Board. For the purpose of this limitation, the value of any Award shall be its grant date fair value, as determined in accordance with ASC 718 or successor provision but excluding the impact of estimated forfeitures related to service-based vesting provisions.</font></div><div style="margin-top:0.3pt"><font><br></font></div><div id="i295ace35142e46ca9372ebbc2d03031e_16"></div><div style="padding-left:50.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 4.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">ELIGIBILITY</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:7.85pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Grantees under the Plan will be such employees, Non-Employee Directors or Consultants of the Company and its Affiliates as are selected from time to time by the Administrator in its sole discretion.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div id="i295ace35142e46ca9372ebbc2d03031e_19"></div><div style="padding-left:50.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 5. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">STOCK OPTIONS</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:15.1pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.7pt;text-decoration:underline">Award of Stock Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Administrator may grant Stock Options under the Plan. Any Stock Option granted under the Plan shall be in such form as the Administrator may from time to time approve.</font></div><div><font><br></font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font><br></font></div></div><div style="padding-left:5pt;padding-right:30.9pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">Stock Options granted under the Plan may be either Incentive Stock Options or Non- Qualified Stock Options. Incentive Stock Options may be granted only to employees of the Company or any Subsidiary that is a &#8220;subsidiary corporation&#8221; within the meaning of Section 424(f) of the Code. To the extent that any Option does not qualify as an Incentive Stock Option, it shall be deemed a Non-Qualified Stock Option.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:7.85pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Stock Options granted pursuant to this Section 5 shall be subject to the following terms and conditions and shall contain such additional terms and conditions, not inconsistent with the terms of the Plan, as the Administrator shall deem desirable. If the Administrator so determines, Stock Options may be granted in lieu of cash compensation at the grantee&#8217;s election, subject to such terms and conditions as the Administrator may establish.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5pt;padding-right:11.4pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.02pt;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The exercise price per share for the Stock covered by a Stock Option granted pursuant to this Section 5 shall be determined by the Administrator at the time of grant but shall not be less than 100 percent of the Fair Market Value on the date of grant. In the case of an Incentive Stock Option that is granted to a Ten Percent Owner, the exercise price of such Incentive Stock Option shall be not less than 110 percent of the Fair Market Value on the grant date. Notwithstanding the foregoing, Stock Options may be granted with an exercise price per share that is less than 100 percent of the Fair Market Value on the date of grant (i) pursuant to a transaction described in, and in a manner consistent with, Section 424(a) of the Code, (ii) to individuals who are not subject to U.S. income tax on the date of grant or (iii) the Stock Option is otherwise compliant with Section 409A.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5pt;padding-right:10.95pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.7pt;text-decoration:underline">Option Term</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The term of each Stock Option shall be fixed by the Administrator, but no Stock Option shall be exercisable more than ten years after the date the Stock Option is granted. In the case of an Incentive Stock Option that is granted to a Ten Percent Owner, the term of such Stock Option shall be no more than five years from the date of grant.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:5pt;padding-right:10.45pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.02pt;text-decoration:underline">Exercisability&#59; Rights of a Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Stock Options shall become exercisable at such time or times, whether or not in installments, as shall be determined by the Administrator at or after the grant date. The Administrator may at any time accelerate the exercisability of all or any portion of any Stock Option. An optionee shall have the rights of a stockholder only as to shares acquired upon the exercise of a Stock Option and not as to unexercised Stock Options.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:5pt;padding-right:18.05pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.7pt;text-decoration:underline">Method of Exercise</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Stock Options may be exercised in whole or in part, by giving written or electronic notice of exercise to the Company, specifying the number of shares to be purchased. Payment of the purchase price may be made by one or more of the following methods except to the extent otherwise provided in the Award Certificate&#58;</font></div><div style="margin-top:11.45pt;padding-left:5pt;padding-right:12.7pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.69pt">In cash, by certified or bank check or other instrument acceptable to the Administrator&#59;</font></div><div style="margin-top:11.45pt;padding-left:5pt;padding-right:12.7pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.2pt">Through the delivery (or attestation to the ownership following such procedures as the Company may prescribe) of shares of Stock that are not then subject to restrictions under any Company plan. Such surrendered shares shall be valued at Fair Market Value on the exercise date&#59;</font></div><div style="margin-top:11.45pt;padding-left:5pt;padding-right:12.7pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:13.03pt">By the optionee electronically delivering to the Company a properly executed exercise notice together with irrevocable instructions to a broker to promptly deliver to the Company cash or a check payable and acceptable to the Company for the purchase price&#59; provided that in the event the optionee chooses to pay the purchase price as so provided, the optionee and the broker shall comply with such procedures and enter into such agreements of indemnity and other agreements as the Company shall prescribe as a condition of such payment procedure&#59; or</font></div><div style="margin-top:0.3pt"><font><br></font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font><br></font></div></div><div style="margin-top:4.5pt;padding-left:5pt;padding-right:15.9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:13.69pt">With respect to Stock Options that are not Incentive Stock Options, by a &#8220;net exercise&#8221; arrangement pursuant to which the Company will reduce the number of shares of Stock issuable upon exercise by the largest whole number of shares with a Fair Market Value that does not exceed the aggregate exercise price.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.4pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Payment instruments will be received subject to collection. The transfer to the optionee on the records of the Company or of the transfer agent of the shares of Stock to be purchased pursuant to the exercise of a Stock Option will be contingent upon receipt from the optionee (or a purchaser acting in his stead in accordance with the provisions of the Stock Option) by the Company of the full purchase price for such shares and the fulfillment of any other requirements contained in the Award Certificate or applicable provisions of laws (including the satisfaction of any withholding taxes that the Company is obligated to withhold with respect to the optionee). In the event an optionee chooses to pay the purchase price by previously-owned shares of Stock through the attestation method, the number of shares of Stock transferred to the optionee upon the exercise of the Stock Option shall be net of the number of attested shares. In the event that the Company establishes, for itself or using the services of a third party, an automated system for the exercise of Stock Options, such as a system using an internet website or interactive voice response, then the paperless exercise of Stock Options may be permitted through the use of such an automated system.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:5pt;padding-right:12.6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.03pt;text-decoration:underline">Annual Limit on Incentive Stock Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. To the extent required for &#8220;incentive stock option&#8221; treatment under Section 422 of the Code, the aggregate Fair Market Value (determined as of the time of grant) of the shares of Stock with respect to which Incentive Stock Options granted under this Plan and any other plan of the Company or its parent and subsidiary corporations become exercisable for the first time by an optionee during any calendar year shall not exceed $100,000. To the extent that any Stock Option exceeds this limit, it shall constitute a Non-Qualified Stock Option.</font></div><div style="padding-right:12.6pt;text-indent:54pt"><font><br></font></div><div id="i295ace35142e46ca9372ebbc2d03031e_22"></div><div style="padding-left:50.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 6. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">STOCK APPRECIATION RIGHTS</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:5pt;padding-right:15.1pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.7pt;text-decoration:underline">Award of Stock Appreciation Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Administrator may grant Stock Appreciation Rights under the Plan. A Stock Appreciation Right is an Award entitling the recipient to receive shares of Stock (or cash, to the extent explicitly provided for in the applicable Award Certificate) having a value equal to the excess of the Fair Market Value of a share of Stock on the date of exercise over the exercise price of the Stock Appreciation Right multiplied by the number of shares of Stock with respect to which the Stock Appreciation Right shall have been exercised.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.65pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.02pt;text-decoration:underline">Exercise Price of Stock Appreciation Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The exercise price of a Stock Appreciation Right shall not be less than 100 percent of the Fair Market Value of the Stock on the date of grant. Notwithstanding the foregoing, Stock Appreciation Rights may be granted with an exercise price per share that is less than 100 percent of the Fair Market Value on the date of grant (i) pursuant to a transaction described in, and in a manner consistent with, Section 424(a) of the Code, (ii) to individuals who are not subject to U.S. income tax on the date of grant, or (iii) if the Stock Appreciation Right is otherwise compliant with Section 409A.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:5pt;padding-right:5.15pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%;padding-left:17.7pt;text-decoration:underline">Grant and Exercise of Stock Appreciation Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">. Stock Appreciation Rights may be granted by the Administrator independently of any Stock Option granted pursuant to Section 5 of the Plan.</font></div><div style="margin-top:11.45pt;padding-left:5pt;padding-right:8.9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.02pt;text-decoration:underline">Terms and Conditions of Stock Appreciation Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Stock Appreciation Rights shall be subject to such terms and conditions as shall be determined on the date of grant by the Administrator. The term of a Stock Appreciation Right may not exceed ten years. The terms and conditions of each such Award shall be determined by the Administrator, and such terms and conditions may differ among individual Awards and grantees.</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i295ace35142e46ca9372ebbc2d03031e_25"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font><br></font></div></div><div style="padding-left:50.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 7. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">RESTRICTED STOCK AWARDS</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:32.45pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.7pt;text-decoration:underline">Nature of Restricted Stock Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Administrator may grant Restricted Stock Awards under the Plan. A Restricted Stock Award is any Award of Restricted Shares subject to such restrictions and conditions as the Administrator may determine at the time of grant. Conditions may be based on continuing employment (or other Service Relationship) and&#47;or achievement of pre-established performance goals and objectives.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div style="padding-left:5pt;padding-right:7.4pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.02pt;text-decoration:underline">Rights as a Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Upon the grant of the Restricted Stock Award and payment of any applicable purchase price, a grantee shall have the rights of a stockholder with respect to the voting of the Restricted Shares and receipt of dividends&#59; provided that if the lapse of restrictions with respect to the Restricted Stock Award is tied to the attainment of performance goals, any dividends paid by the Company during the performance period shall accrue and shall not be paid to the grantee until and to the extent the performance goals are met with respect to the Restricted Stock Award. Unless the Administrator shall otherwise determine, (i) uncertificated Restricted Shares shall be accompanied by a notation on the records of the Company or the transfer agent to the effect that they are subject to forfeiture until such Restricted Shares are vested as provided in Section 7(d) below, and (ii) certificated Restricted Shares shall remain in the possession of the Company until such Restricted Shares are vested as provided in Section 7(d) below, and the grantee shall be required, as a condition of the grant, to deliver to the Company such instruments of transfer as the Administrator may prescribe.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:7.9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.7pt;text-decoration:underline">Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Restricted Shares may not be sold, assigned, transferred, pledged or otherwise encumbered or disposed of except as specifically provided herein or in the Restricted Stock Award Certificate. Except as may otherwise be provided by the Administrator either in the Award Certificate or, subject to Section 16 below, in writing after the Award is issued, if a grantee&#8217;s employment (or other Service Relationship) with the Company and its Subsidiaries terminates for any reason, any Restricted Shares that have not vested at the time of termination shall automatically and without any requirement of notice to such grantee from or other action by or on behalf of, the Company be deemed to have been reacquired by the Company at its original purchase price (if any) from such grantee or such grantee&#8217;s legal representative simultaneously with such termination of employment (or other Service Relationship), and thereafter shall cease to represent any ownership of the Company by the grantee or rights of the grantee as a stockholder. Following such deemed reacquisition of Restricted Shares that are represented by physical certificates, a grantee shall surrender such certificates to the Company upon request without consideration.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.4pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.02pt;text-decoration:underline">Vesting of Restricted Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Administrator at the time of grant shall specify the date or dates and&#47;or the attainment of pre-established performance goals, objectives and other conditions on which the non-transferability of the Restricted Shares and the Company&#8217;s right of repurchase or forfeiture shall lapse. Subsequent to such date or dates and&#47;or the attainment of such pre-established performance goals, objectives and other conditions, the shares on which all restrictions have lapsed shall no longer be Restricted Shares and shall be deemed &#8220;vested.&#8221;</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i295ace35142e46ca9372ebbc2d03031e_28"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font><br></font></div></div><div style="padding-left:50.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 8. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">RESTRICTED STOCK UNITS</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:11.75pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.7pt;text-decoration:underline">Nature of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Administrator may grant Restricted Stock Units under the Plan. A Restricted Stock Unit is an Award of stock units that may be settled in shares of Stock (or cash, to the extent explicitly provided for in the Award Certificate) upon the satisfaction of such restrictions and conditions at the time of grant. Conditions may be based on continuing employment (or other Service Relationship) and&#47;or achievement of pre-established performance goals and objectives. The terms and conditions of each such Award shall be determined by the Administrator, and such terms and conditions may differ among individual Awards and grantees. Except in the case of Restricted Stock Units with a deferred settlement date that complies with Section 409A, at the end of the vesting period, the Restricted Stock Units, to the extent vested, shall be settled in the form of shares of Stock. Restricted Stock Units with deferred settlement dates are subject to Section 409A and shall contain such additional terms and conditions as the Administrator shall determine in its sole discretion in order to comply with the requirements of Section 409A.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:5pt;padding-right:7.65pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.02pt;text-decoration:underline">Election to Receive Restricted Stock Units in Lieu of Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Administrator may, in its sole discretion, permit a grantee to elect to receive a portion of future cash compensation otherwise due to such grantee in the form of an award of Restricted Stock Units. Any such election shall be made in writing and shall be delivered to the Company no later than the date specified by the Administrator and in accordance with Section 409A and such other rules and procedures established by the Administrator. Any such future cash compensation that the grantee elects to defer shall be converted to a fixed number of Restricted Stock Units based on the Fair Market Value of Stock on the date the compensation would otherwise have been paid to the grantee if such payment had not been deferred as provided herein. The Administrator shall have the sole right to determine whether and under what circumstances to permit such elections and to impose such limitations and other terms and conditions thereon as the Administrator deems appropriate. Any Restricted Stock Units that are elected to be received in lieu of cash compensation shall be fully vested, unless otherwise provided in the Award Certificate.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:5pt;padding-right:17pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.7pt;text-decoration:underline">Rights as a Stockholder</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. A grantee shall have the rights as a stockholder only as to shares of Stock acquired by the grantee upon settlement of Restricted Stock Units&#59; provided, however, that the grantee may be credited with Dividend Equivalent Rights with respect to the stock units underlying his or her Restricted Stock Units, subject to the provisions of Section 11 and such terms and conditions as the Administrator may determine.</font></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div style="margin-top:3.05pt;padding-left:5pt;padding-right:10.45pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.02pt;text-decoration:underline">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Except as may otherwise be provided by the Administrator either in the Award Certificate or, subject to Section 16 below, in writing after the Award is issued, a grantee&#8217;s right in all Restricted Stock Units that have not vested shall automatically terminate upon the grantee&#8217;s termination of employment (or cessation of Service Relationship) with the Company and its Subsidiaries for any reason.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div id="i295ace35142e46ca9372ebbc2d03031e_31"></div><div style="padding-left:50.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 9. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">UNRESTRICTED STOCK AWARDS</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:13.35pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Grant or Sale of Unrestricted Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Administrator may grant (or sell at par value or such higher purchase price determined by the Administrator) an Unrestricted Stock Award under the Plan. An Unrestricted Stock Award is an Award pursuant to which the grantee may receive shares of Stock free of any restrictions under the Plan. Unrestricted Stock Awards may be granted in respect of past services or other valid consideration, or in lieu of cash compensation due to such grantee.</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i295ace35142e46ca9372ebbc2d03031e_34"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font><br></font></div></div><div style="padding-left:50.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">CASH-BASED AWARDS</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:12.8pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">Grant of Cash-Based Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Administrator may grant Cash-Based Awards under the Plan. A Cash-Based Award is an Award that entitles the grantee to a payment in cash upon the attainment of specified performance goals. The Administrator shall determine the maximum duration of the Cash-Based Award, the amount of cash to which the Cash-Based Award pertains, the conditions upon which the Cash-Based Award shall become vested or payable, and such other provisions as the Administrator shall determine. Each Cash-Based Award shall specify a cash-denominated payment amount, formula or payment ranges as determined by the Administrator. Payment, if any, with respect to a Cash-Based Award shall be made in accordance with the terms of the Award and may be made in cash.</font></div><div><font><br></font></div><div id="i295ace35142e46ca9372ebbc2d03031e_37"></div><div style="padding-left:50.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 11.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">DIVIDEND EQUIVALENT RIGHTS</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.7pt;text-decoration:underline">Dividend Equivalent Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Administrator may grant Dividend Equivalent Rights under the Plan. A Dividend Equivalent Right is an Award entitling the grantee to receive credits based on cash dividends that would have been paid on the shares of Stock specified in the Dividend Equivalent Right (or other Award to which it relates) if such shares had been issued to the grantee. A Dividend Equivalent Right may be granted hereunder to any grantee as a component of an award of Restricted Stock Units or as a freestanding award. The terms and conditions of Dividend Equivalent Rights shall be specified in the Award Certificate. Dividend equivalents credited to the holder of a Dividend Equivalent Right may be paid currently or may be deemed to be reinvested in additional shares of Stock, which may thereafter accrue additional equivalents. Any such reinvestment shall be at Fair Market Value on the date of reinvestment or such other price as may then apply under a dividend reinvestment plan sponsored by the Company, if any. Dividend Equivalent Rights may be settled in cash or shares of Stock or a combination thereof, in a single installment or installments. A Dividend Equivalent Right granted as a component of an Award of Restricted Stock Units shall provide that such Dividend Equivalent Right shall be settled only upon settlement or payment of, or lapse of restrictions on, such other Award, and that such Dividend Equivalent Right shall expire or be forfeited or annulled under the same conditions as such other Award.</font></div><div style="margin-top:3.05pt;padding-right:10.45pt;text-indent:54pt"><font><br></font></div><div style="padding-left:5pt;padding-right:10.45pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:18.18pt;text-decoration:underline">Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Except as may otherwise be provided by the Administrator either in the Award Certificate or, subject to Section 16 below, in writing after the Award is issued, a grantee&#8217;s rights in all Dividend Equivalent Rights shall automatically terminate upon the grantee&#8217;s termination of employment (or cessation of Service Relationship) with the Company and its Subsidiaries for any reason.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div id="i295ace35142e46ca9372ebbc2d03031e_40"></div><div style="padding-left:50.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 12.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">TRANSFERABILITY OF AWARDS</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:18.15pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.7pt;text-decoration:underline">Transferability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Except as provided in Section 12(b) below, during a grantee&#8217;s lifetime, his or her Awards shall be exercisable only by the grantee, or by the grantee&#8217;s legal representative or guardian in the event of the grantee&#8217;s incapacity. No Awards shall be sold, assigned, transferred or otherwise encumbered or disposed of by a grantee other than by will or by the laws of descent and distribution or pursuant to a domestic relations order. No Awards shall be subject, in whole or in part, to attachment, execution, or levy of any kind, and any purported transfer in violation hereof shall be null and void.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font><br></font></div></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:9.65pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.02pt;text-decoration:underline">Administrator Action</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Notwithstanding Section 12(a), the Administrator, in its discretion, may provide either in the Award Certificate regarding a given Award or by subsequent written approval that the grantee (who is an employee or director) may transfer his or her Non-Qualified Stock Options to his or her immediate family members, to trusts for the benefit of such family members, or to partnerships in which such family members are the only partners, provided that the transferee agrees in writing with the Company to be bound by all of the terms and conditions of this Plan and the applicable Award. In no event may an Award be transferred by a grantee for value.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:15.85pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.7pt;text-decoration:underline">Family Member</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. For purposes of Section 12(b), &#8220;family member&#8221; shall mean a grantee&#8217;s child, stepchild, grandchild, parent, stepparent, grandparent, spouse, former spouse, sibling, niece, nephew, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in- law, or sister-in-law, including adoptive relationships, any person sharing the grantee&#8217;s household (other than a tenant of the grantee), a trust in which these persons (or the grantee) have more than 50 percent of the beneficial interest, a foundation in which these persons (or the grantee) control the management of assets, and any other entity in which these persons (or the grantee) own more than 50 percent of the voting interests.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:5pt;padding-right:8.9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.02pt;text-decoration:underline">Designation of Beneficiary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. To the extent permitted by the Company, each grantee to whom an Award has been made under the Plan may designate a beneficiary or beneficiaries to exercise any Award or receive any payment under any Award payable on or after the grantee&#8217;s death. Any such designation shall be on a form provided for that purpose by the Administrator and shall not be effective until received by the Administrator. If no beneficiary has been designated by a deceased grantee, or if the designated beneficiaries have predeceased the grantee, the beneficiary shall be the grantee&#8217;s estate.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div id="i295ace35142e46ca9372ebbc2d03031e_43"></div><div style="padding-left:50.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 13.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">TAX WITHHOLDING</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:5pt;padding-right:26.6pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%;padding-left:17.7pt;text-decoration:underline">Payment by Grantee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">. Each grantee shall, no later than the date as of which the value of an Award or of any Stock or other amounts received thereunder first becomes includable in the gross income of the grantee for federal income tax purposes, pay to the Company, or make arrangements satisfactory to the Administrator regarding payment of, any federal, state, or local taxes of any kind required by law to be withheld by the Company with respect to such income. The Company and its Subsidiaries shall, to the extent permitted by law, have the right to deduct any such taxes from any payment of any kind otherwise due to the grantee. The Company&#8217;s obligation to deliver evidence of book entry (or stock certificates) to any grantee is subject to and conditioned on tax withholding obligations being satisfied by the grantee.</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9.1pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.02pt;text-decoration:underline">Payment in Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Administrator may require the Company&#8217;s tax withholding obligation to be satisfied, in whole or in part, by the Company withholding from shares of Stock to be issued pursuant to any Award a number of shares with an aggregate Fair Market Value (as of the date the withholding is effected) that would satisfy the withholding amount due&#59; provided, however, that the amount withheld does not exceed the maximum statutory tax rate or such lesser amount as is necessary to avoid liability accounting treatment. For purposes of share withholding, the Fair Market Value of withheld shares shall be determined in the same manner as the value of Stock includible in income of the grantees. The Administrator may also require the Company&#8217;s tax withholding obligation to be satisfied, in whole or in part, by an arrangement whereby a certain number of shares of Stock issued pursuant to an Award are immediately sold and proceeds from such sale are remitted to the Company in an amount that would satisfy the withholding amount due.</font></div><div style="margin-top:0.4pt"><font><br></font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i295ace35142e46ca9372ebbc2d03031e_46"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font><br></font></div></div><div style="padding-left:50.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 14.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">SECTION 409A AWARDS</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:7.85pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Awards are intended to be exempt from Section 409A to the greatest extent possible and to otherwise comply with Section 409A. The Plan and all Awards shall be interpreted in accordance with such intent. To the extent that any Award is determined to constitute &#8220;nonqualified deferred compensation&#8221; within the meaning of Section 409A (a &#8220;409A Award&#8221;), the Award shall be subject to such additional rules and requirements as specified by the Administrator from time to time in order to comply with Section 409A. In this regard, if any amount under a 409A Award is payable upon a &#8220;separation from service&#8221; (within the meaning of Section 409A) to a grantee who is then considered a &#8220;specified employee&#8221; (within the meaning of Section 409A), then no such payment shall be made prior to the date that is the earlier of (i) six months and one day after the grantee&#8217;s separation from service, or (ii) the grantee&#8217;s death, but only to the extent such delay is necessary to prevent such payment from being subject to interest, penalties and&#47;or additional tax imposed pursuant to Section 409A. Further, the settlement of any 409A Award may not be accelerated except to the extent permitted by Section 409A. The Company makes no representation that any or all of the payments or benefits described in the Plan will be exempt from or comply with Section 409A of the Code and makes no undertaking to preclude Section 409A of the Code from applying to any such payment. The grantee shall be solely responsible for the payment of any taxes and penalties incurred under Section 409A.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div id="i295ace35142e46ca9372ebbc2d03031e_49"></div><div style="padding-left:81.55pt;text-indent:-76.6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 15. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">TERMINATION OF SERVICE RELATIONSHIP, TRANSFER, LEAVE OF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">ABSENCE, ETC.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:5pt;padding-right:8.95pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.7pt;text-decoration:underline">Termination of Service Relationship</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. If the grantee&#8217;s Service Relationship is with an Affiliate and such Affiliate ceases to be an Affiliate, the grantee shall be deemed to have terminated his or her Service Relationship for purposes of the Plan.</font></div><div><font><br></font></div><div style="margin-top:3.05pt;padding-left:5pt;padding-right:16.95pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.02pt">For purposes of the Plan, the following events shall not be deemed a termination of a Service Relationship&#58;</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:5pt;padding-right:7.6pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%;padding-left:19.69pt">a transfer to the employment of the Company from an Affiliate or from the Company to an Affiliate, or from one Affiliate to another&#59; or</font></div><div style="margin-top:11.65pt;padding-left:5pt;padding-right:9.7pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:16.36pt">an approved leave of absence for military service or sickness, or for any other purpose approved by the Company, if the employee&#8217;s right to re-employment is guaranteed either by a statute or by contract or under the policy pursuant to which the leave of absence was granted or if the Administrator otherwise so provides in writing.</font></div><div><font><br></font></div><div id="i295ace35142e46ca9372ebbc2d03031e_52"></div><div style="padding-left:50.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 16.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">AMENDMENTS AND TERMINATION</font></div><div style="padding-left:5pt;padding-right:7.85pt;text-indent:36pt"><font><br></font></div><div style="padding-left:5pt;padding-right:7.85pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Board may, at any time, amend or discontinue the Plan and the Administrator may, at any time, amend or cancel any outstanding Award for the purpose of satisfying changes in law or for any other lawful purpose, but no such action shall materially and adversely affect rights under any outstanding Award without the holder&#8217;s consent. Except as provided in Section 3(b) or 3(c), without prior stockholder approval, in no event may the Administrator exercise its discretion to reduce the exercise price of outstanding Stock Options or Stock Appreciation Rights or effect repricing through cancellation and re-grants or cancellation of Stock Options or Stock Appreciation Rights in exchange for cash or other Awards. To the extent required under the rules of any securities exchange or market system on which the Stock is listed, and to the extent determined by the Administrator to be required by the Code to ensure that Incentive Stock Options granted under the Plan are qualified under Section 422 of the Code, Plan amendments shall be subject to approval by Company stockholders. Nothing in this Section 16 shall limit the Administrator&#8217;s authority to take any action permitted pursuant to Section 3(b) or 3(c).</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i295ace35142e46ca9372ebbc2d03031e_55"></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font><br></font></div></div><div style="padding-left:50.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 17.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">STATUS OF PLAN</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:7.85pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">With respect to the portion of any Award that has not been exercised and any payments in cash, Stock or other consideration not received by a grantee, a grantee shall have no rights greater than those of a general creditor of the Company unless the Administrator shall otherwise expressly determine in connection with any Award or Awards. In its sole discretion, the Administrator may authorize the creation of trusts or other arrangements to meet the Company&#8217;s obligations to deliver Stock or make payments with respect to Awards hereunder, provided that the existence of such trusts or other arrangements is consistent with the foregoing sentence.</font></div><div style="margin-top:0.35pt"><font><br></font></div><div id="i295ace35142e46ca9372ebbc2d03031e_58"></div><div style="padding-left:50.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 18.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">GENERAL PROVISIONS</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:17.5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.7pt;text-decoration:underline">No Distribution</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. The Administrator may require each person acquiring Stock pursuant to an Award to represent to and agree with the Company in writing that such person is acquiring the shares without a view to distribution thereof.</font></div><div style="margin-top:0.05pt"><font><br></font></div><div style="padding-left:5pt;padding-right:13.85pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.02pt;text-decoration:underline">Issuance of Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. To the extent certificated, stock certificates to grantees under this Plan shall be deemed delivered for all purposes when the Company or a stock transfer agent of the Company shall have mailed such certificates in the United States mail, addressed to the grantee, at the grantee&#8217;s last known address on file with the Company. Uncertificated Stock shall be deemed delivered for all purposes when the Company or a Stock transfer agent of the Company shall have given to the grantee by electronic mail (with proof of receipt) or by United States mail, addressed to the grantee, at the grantee&#8217;s last known address on file with the Company, notice of issuance and recorded the issuance in its records (which may include electronic &#8220;book entry&#8221; records). Notwithstanding anything herein to the contrary, the Company shall not be required to issue or deliver any evidence of book entry or certificates evidencing shares of Stock pursuant to the exercise or settlement of any Award, unless and until the Administrator has determined, with advice of counsel (to the extent the Administrator deems such advice necessary or advisable), that the issuance and delivery is in compliance with all applicable laws, regulations of governmental authorities and, if applicable, the requirements of any exchange on which the shares of Stock are listed, quoted or traded. Any Stock issued pursuant to the Plan shall be subject to any stop-transfer orders and other restrictions as the Administrator deems necessary or advisable to comply with federal, state or foreign jurisdiction, securities or other laws, rules and quotation system on which the Stock is listed, quoted or traded. The Administrator may place legends on any Stock certificate or notations on any book entry to reference restrictions applicable to the Stock. In addition to the terms and conditions provided herein, the Administrator may require that an individual make such reasonable covenants, agreements, and representations as the Administrator, in its discretion, deems necessary or advisable in order to comply with any such laws, regulations, or requirements. The Administrator shall have the right to require any individual to comply with any timing or other restrictions with respect to the settlement or exercise of any Award, including a window-period limitation, as may be imposed in the discretion of the Administrator.</font></div><div style="margin-top:0.25pt"><font><br></font></div><div style="padding-left:5pt;padding-right:8.2pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.7pt;text-decoration:underline">No Fractional Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. No fractional shares of Stock shall be issued or delivered pursuant to the Plan or any Award, and the Administrator shall determine whether cash, other securities or other property shall be paid or transferred in lieu of any fractional shares, or whether such fractional shares or any rights thereto shall be canceled, terminated or otherwise eliminated.</font></div><div><font><br></font></div><div style="padding-left:5pt;padding-right:7.65pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.02pt;text-decoration:underline">Stockholder Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Until Stock is deemed delivered in accordance with Section 18(b), no right to vote or receive dividends or any other rights of a stockholder will exist with respect to shares of Stock to be issued in connection with an Award, notwithstanding the exercise of a Stock Option or any other action by the grantee with respect to an Award.</font></div><div><font><br></font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:69.12pt;width:100%"><div><font><br></font></div></div><div style="padding-left:5pt;padding-right:14.7pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:17.7pt;text-decoration:underline">Other Compensation Arrangements&#59; No Employment Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Nothing contained in this Plan shall prevent the Board from adopting other or additional compensation arrangements, including trusts, and such arrangements may be either generally applicable or applicable only in specific cases. The adoption of this Plan and the grant of Awards do not confer upon any employee any right to continued employment with the Company or any Subsidiary.</font></div><div style="margin-top:0.5pt"><font><br></font></div><div style="padding-left:5pt;padding-right:14.85pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:19.03pt;text-decoration:underline">Trading Policy Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">. Option exercises and other Awards under the Plan shall be subject to the Company&#8217;s insider trading policies and procedures, as in effect from time to time.</font></div><div><font><br></font></div><div style="margin-top:0.05pt;padding-left:5pt;padding-right:8.65pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">(g)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%;padding-left:17.02pt;text-decoration:underline">Clawback Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">. A grantee&#8217;s rights with respect to any Award hereunder shall in all events be subject to reduction, cancellation, forfeiture or recoupment to the extent necessary to comply with (i) any right that the Company may have under any Company clawback, forfeiture or recoupment policy as in effect from time to time or other agreement or arrangement with a grantee, or (ii) applicable law.</font></div><div style="margin-top:0.1pt"><font><br></font></div><div style="padding-left:5pt;padding-right:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">(h)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%;padding-left:17.02pt;text-decoration:underline">Termination of Grant</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">. Notwithstanding anything in the foregoing, the Administrator may, in its sole discretion, terminate an Award if the grantee has not electronically accepted the Award within six months of the Date of Grant.</font></div><div style="margin-top:0.55pt"><font><br></font></div><div id="i295ace35142e46ca9372ebbc2d03031e_61"></div><div style="padding-left:50.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 19.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">EFFECTIVE DATE OF PLAN</font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:5pt;padding-right:8.9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:117%">This Plan shall become effective upon the date immediately preceding the Registration Date subject to prior stockholder approval in accordance with applicable state law, the</font></div><div style="padding-left:5pt;padding-right:7.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Company&#8217;s bylaws and articles of incorporation, and applicable stock exchange rules. No grants of Stock Options and other Awards may be made hereunder after the tenth anniversary of the Effective Date and no grants of Incentive Stock Options may be made hereunder after the tenth anniversary of the date the Plan is approved by the Board.</font></div><div style="margin-top:0.2pt"><font><br></font></div><div id="i295ace35142e46ca9372ebbc2d03031e_64"></div><div style="padding-left:50.05pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">SECTION 20.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;text-decoration:underline">GOVERNING LAW</font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:5pt;padding-right:13.35pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Plan and all Awards and actions taken thereunder shall be governed by, and construed in accordance with, the General Corporation Law of the State of Delaware as to matters within the scope thereof, and as to all other matters shall be governed by and construed in accordance with the internal laws of the State of California, applied without regard to conflict of law principles.</font></div><div><font><br></font></div><div style="margin-top:0.15pt"><font><br></font></div><div style="padding-left:0.05pt;padding-right:127.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:217%">DATE APPROVED BY BOARD OF DIRECTORS&#58; June 7, 2021 </font></div><div style="padding-left:0.05pt;padding-right:127.85pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">DATE APPROVED BY STOCKHOLDERS&#58; June 7, 2021</font></div><div style="height:61.92pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>4
<FILENAME>exhibit211-listofsubsidiar.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ie69bb2b842c14a33839576ad47e2a835_1"></div><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Exhibit 21.1</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SUBSIDIARIES OF DOXIMITY</font></div><div style="margin-bottom:26pt;margin-top:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.581%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.583%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Name of Subsidiary</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Jurisdiction of Incorporation or Organization</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Curative Talent, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware, U.S.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Amion, LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Delaware, U.S.</font></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>5
<FILENAME>exhibit231-consentfy22.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i5d9c62376d744d83be20951f536ad7a8_1"></div><div style="min-height:54pt;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Exhibit 23.1</font></div><div style="margin-bottom:0.08pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div style="margin-bottom:26pt;margin-top:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">We consent to the incorporation by reference in Registration Statement Nos. 333-257332, 333-257333, and 333-258776 on Form S-8 of our report dated </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">May&#160;27, 2022</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, relating to the financial statements of Doximity, Inc. appearing in this Annual Report on Form 10-K for the year ended </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">March&#160;31, 2022</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#47;s&#47; Deloitte &#38; Touche LLP</font></div><div style="margin-bottom:9pt"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">San Francisco, California</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">May&#160;27, 2022</font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.08pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>6
<FILENAME>exhibit31133122.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i6754dd85965b436396315387dab58aa0_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a), AS ADOPTED</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Jeffrey Tangney, certify that&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Annual Report on Form 10-K of Doximity, Inc.&#59; </font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59; </font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59; </font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have&#58;</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58; </font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.046%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.732%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 27, 2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Jeffrey Tangney</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>7
<FILENAME>exhibit31233122.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i1ec073aafc52460f974c9a534a901f2f_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a), AS ADOPTED</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Anna Bryson, certify that&#58;</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Annual Report on Form 10-K of Doximity, Inc.&#59; </font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59; </font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59; </font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have&#58;</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58; </font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:10pt;padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.609%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 27, 2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Anna Bryson</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer and Principal Accounting Officer)</font></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>8
<FILENAME>exhibit32133122.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="iaa02c300c09d4bd8b1ced91247a4b0eb_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Jeffrey Tangney, Chief Executive Officer of Doximity, Inc. (the &#8220;Company&#8221;), do hereby certify, to the best of my knowledge and pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that&#58; </font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Annual Report on Form 10-K of the Company for the period ended March&#160;31, 2022 (the &#8220;Report&#8221;) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.046%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.732%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 27, 2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Jeffrey Tangney</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>9
<FILENAME>exhibit32233122.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="icb4f2d2a14054988b501321dc3b235c8_1"></div><div style="min-height:45pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="margin-top:10pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div style="margin-top:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Anna Bryson, Chief Financial Officer of Doximity, Inc. (the &#8220;Company&#8221;), do hereby certify, to the best of my knowledge and pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that&#58; </font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Annual Report on Form 10-K of the Company for the period ended March&#160;31, 2022 (the &#8220;Report&#8221;) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.847%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.609%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 27, 2022</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Anna Bryson</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer and Principal Accounting Officer)</font></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>docs-20220331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:7e9381b6-a1e4-41b8-8d47-38883b11be1e,g:11b17cc6-874f-42e4-b7f0-55cdc6f63454-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:docs="http://www.doximity.com/20220331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.doximity.com/20220331">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="docs-20220331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="docs-20220331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="docs-20220331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="docs-20220331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.doximity.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.doximity.com/role/AuditInformation">
        <link:definition>0002002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>1001003 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>1002004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>1003005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" roleURI="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME">
        <link:definition>1004006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical" roleURI="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical">
        <link:definition>1005007 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT" roleURI="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT">
        <link:definition>1006008 - Statement - CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1007009 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DESCRIPTIONOFBUSINESS" roleURI="http://www.doximity.com/role/DESCRIPTIONOFBUSINESS">
        <link:definition>2101101 - Disclosure - DESCRIPTION OF BUSINESS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DESCRIPTIONOFBUSINESSDetails" roleURI="http://www.doximity.com/role/DESCRIPTIONOFBUSINESSDetails">
        <link:definition>2402401 - Disclosure - DESCRIPTION OF BUSINESS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummarySignificantAccountingPolicies" roleURI="http://www.doximity.com/role/SummarySignificantAccountingPolicies">
        <link:definition>2103102 - Disclosure - Summary Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummarySignificantAccountingPoliciesPolicies" roleURI="http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies">
        <link:definition>2204201 - Disclosure - Summary Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummarySignificantAccountingPoliciesTables" roleURI="http://www.doximity.com/role/SummarySignificantAccountingPoliciesTables">
        <link:definition>2305301 - Disclosure - Summary Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>2406402 - Disclosure - Summary of Significant Accounting Policies- Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails" roleURI="http://www.doximity.com/role/SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails">
        <link:definition>2407403 - Disclosure - Summary of significant Accounting Policies- Significant Customers Representing 10% or more of Revenue or Accounts Receivable, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPropertyplantandequipmentDetails" roleURI="http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesPropertyplantandequipmentDetails">
        <link:definition>2408404 - Disclosure - Summary of Significant Accounting Policies- Property, plant and equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognition" roleURI="http://www.doximity.com/role/RevenueRecognition">
        <link:definition>2109103 - Disclosure - Revenue Recognition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionTables" roleURI="http://www.doximity.com/role/RevenueRecognitionTables">
        <link:definition>2310302 - Disclosure - Revenue Recognition (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionDisaggregationofRevenueDetails" roleURI="http://www.doximity.com/role/RevenueRecognitionDisaggregationofRevenueDetails">
        <link:definition>2411405 - Disclosure - Revenue Recognition - Disaggregation of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionDeferredRevenueContractBalanceDetails" roleURI="http://www.doximity.com/role/RevenueRecognitionDeferredRevenueContractBalanceDetails">
        <link:definition>2412406 - Disclosure - Revenue Recognition - Deferred Revenue Contract Balance (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionNarrativeDetails" roleURI="http://www.doximity.com/role/RevenueRecognitionNarrativeDetails">
        <link:definition>2413407 - Disclosure - Revenue Recognition - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Investments" roleURI="http://www.doximity.com/role/Investments">
        <link:definition>2114104 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsTables" roleURI="http://www.doximity.com/role/InvestmentsTables">
        <link:definition>2315303 - Disclosure - Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails" roleURI="http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails">
        <link:definition>2416408 - Disclosure - Investments - Cost, Gross Unrealized Gains and Losses, and Fair Value of Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails_1" roleURI="http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails_1">
        <link:definition>2416408 - Disclosure - Investments - Cost, Gross Unrealized Gains and Losses, and Fair Value of Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsContractualMaturitiesofAvailableForSaleDebtSecuritiesDetails" roleURI="http://www.doximity.com/role/InvestmentsContractualMaturitiesofAvailableForSaleDebtSecuritiesDetails">
        <link:definition>2417409 - Disclosure - Investments - Contractual Maturities of Available-For-Sale Debt Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsNarrativeDetails" roleURI="http://www.doximity.com/role/InvestmentsNarrativeDetails">
        <link:definition>2418410 - Disclosure - Investments - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.doximity.com/role/FairValueMeasurements">
        <link:definition>2119105 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.doximity.com/role/FairValueMeasurementsTables">
        <link:definition>2320304 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsDetails" roleURI="http://www.doximity.com/role/FairValueMeasurementsDetails">
        <link:definition>2421411 - Disclosure - Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNet" roleURI="http://www.doximity.com/role/PropertyandEquipmentNet">
        <link:definition>2122106 - Disclosure - Property and Equipment, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNetTables" roleURI="http://www.doximity.com/role/PropertyandEquipmentNetTables">
        <link:definition>2323305 - Disclosure - Property and Equipment, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails" roleURI="http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails">
        <link:definition>2424412 - Disclosure - Property and Equipment, Net - Total Property and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNetNarrativeDetails" roleURI="http://www.doximity.com/role/PropertyandEquipmentNetNarrativeDetails">
        <link:definition>2425413 - Disclosure - Property and Equipment, Net - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesandOtherCurrentLiabilities" roleURI="http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilities">
        <link:definition>2126107 - Disclosure - Accrued Expenses and Other Current Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesandOtherCurrentLiabilitiesTables" roleURI="http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables">
        <link:definition>2327306 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesandOtherCurrentLiabilitiesDetails" roleURI="http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails">
        <link:definition>2428414 - Disclosure - Accrued Expenses and Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsIntangibleAssetsandGoodwill" roleURI="http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwill">
        <link:definition>2129108 - Disclosure - Business Combinations, Intangible Assets, and Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsIntangibleAssetsandGoodwillTables" roleURI="http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillTables">
        <link:definition>2330307 - Disclosure - Business Combinations, Intangible Assets, and Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsIntangibleAssetsandGoodwillNarrativeDetails" roleURI="http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillNarrativeDetails">
        <link:definition>2431415 - Disclosure - Business Combinations, Intangible Assets, and Goodwill - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsIntangibleAssetsandGoodwillPurchaseConsiderationAllocationDetails" roleURI="http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillPurchaseConsiderationAllocationDetails">
        <link:definition>2432416 - Disclosure - Business Combinations, Intangible Assets, and Goodwill - Purchase Consideration Allocation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsIntangibleAssetsandGoodwillIntangibleAssetsNetDetails" roleURI="http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillIntangibleAssetsNetDetails">
        <link:definition>2433417 - Disclosure - Business Combinations, Intangible Assets, and Goodwill - Intangible Assets, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsIntangibleAssetsandGoodwillFutureAmortizationExpenseDetails" roleURI="http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillFutureAmortizationExpenseDetails">
        <link:definition>2434418 - Disclosure - Business Combinations, Intangible Assets, and Goodwill - Future Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableConvertiblePreferredStock" roleURI="http://www.doximity.com/role/RedeemableConvertiblePreferredStock">
        <link:definition>2135109 - Disclosure - Redeemable Convertible Preferred Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableConvertiblePreferredStockTables" roleURI="http://www.doximity.com/role/RedeemableConvertiblePreferredStockTables">
        <link:definition>2336308 - Disclosure - Redeemable Convertible Preferred Stock (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableConvertiblePreferredStockNarrativeDetails" roleURI="http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails">
        <link:definition>2437419 - Disclosure - Redeemable Convertible Preferred Stock - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockOutstandingDetails" roleURI="http://www.doximity.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockOutstandingDetails">
        <link:definition>2438420 - Disclosure - Redeemable Convertible Preferred Stock - Summary of Redeemable Convertible Preferred Stock Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Equity" roleURI="http://www.doximity.com/role/Equity">
        <link:definition>2139110 - Disclosure - Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityTables" roleURI="http://www.doximity.com/role/EquityTables">
        <link:definition>2340309 - Disclosure - Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityPreferredStockDetails" roleURI="http://www.doximity.com/role/EquityPreferredStockDetails">
        <link:definition>2441421 - Disclosure - Equity - Preferred Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityCommonStockandCreationofDualClassStructureDetails" roleURI="http://www.doximity.com/role/EquityCommonStockandCreationofDualClassStructureDetails">
        <link:definition>2442422 - Disclosure - Equity - Common Stock and Creation of Dual-Class Structure (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityCommonStockWarrantsDetails" roleURI="http://www.doximity.com/role/EquityCommonStockWarrantsDetails">
        <link:definition>2443423 - Disclosure - Equity - Common Stock Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityEquityIncentivePlansDetails" roleURI="http://www.doximity.com/role/EquityEquityIncentivePlansDetails">
        <link:definition>2444424 - Disclosure - Equity - Equity Incentive Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityCommonStockReservedforIssuanceDetails" roleURI="http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails">
        <link:definition>2445425 - Disclosure - Equity - Common Stock Reserved for Issuance (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityStockOptionActivityDetails" roleURI="http://www.doximity.com/role/EquityStockOptionActivityDetails">
        <link:definition>2446426 - Disclosure - Equity - Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityStockOptionsDetails" roleURI="http://www.doximity.com/role/EquityStockOptionsDetails">
        <link:definition>2447427 - Disclosure - Equity - Stock Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityStockOptionsValuationAssumptionsDetails" roleURI="http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails">
        <link:definition>2448428 - Disclosure - Equity - Stock Options Valuation Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityPerformanceBasedOptionsDetails" roleURI="http://www.doximity.com/role/EquityPerformanceBasedOptionsDetails">
        <link:definition>2449429 - Disclosure - Equity - Performance-Based Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityRestrictedStockUnitsDetails" roleURI="http://www.doximity.com/role/EquityRestrictedStockUnitsDetails">
        <link:definition>2450430 - Disclosure - Equity - Restricted Stock Units (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityRestrictedStockUnitActivityDetails" roleURI="http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails">
        <link:definition>2451431 - Disclosure - Equity - Restricted Stock Unit Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityPerformanceBasedRestrictedStockUnitsDetails" roleURI="http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsDetails">
        <link:definition>2452432 - Disclosure - Equity - Performance-Based Restricted Stock Units (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityEmployeeStockPurchasePlanDetails" roleURI="http://www.doximity.com/role/EquityEmployeeStockPurchasePlanDetails">
        <link:definition>2453433 - Disclosure - Equity - Employee Stock Purchase Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityEmployeeStockPurchasePlanValuationAssumptionsDetails" roleURI="http://www.doximity.com/role/EquityEmployeeStockPurchasePlanValuationAssumptionsDetails">
        <link:definition>2454434 - Disclosure - Equity - Employee Stock Purchase Plan Valuation Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EquityStockBasedCompensationExpenseDetails" roleURI="http://www.doximity.com/role/EquityStockBasedCompensationExpenseDetails">
        <link:definition>2455435 - Disclosure - Equity - Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareAttributabletoCommonStockholders" roleURI="http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholders">
        <link:definition>2156111 - Disclosure - Net Income Per Share Attributable to Common Stockholders</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareAttributabletoCommonStockholdersTables" roleURI="http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersTables">
        <link:definition>2357310 - Disclosure - Net Income Per Share Attributable to Common Stockholders (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails" roleURI="http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails">
        <link:definition>2458436 - Disclosure - Net Income Per Share Attributable to Common Stockholders- Schedule of Earnings Per Share, Basic and Diluted (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomePerShareAttributabletoCommonStockholdersAntidilutiveSecuritiesExcludedfromComputationofNetIncomePerShareDetails" roleURI="http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersAntidilutiveSecuritiesExcludedfromComputationofNetIncomePerShareDetails">
        <link:definition>2459437 - Disclosure - Net Income Per Share Attributable to Common Stockholders -Antidilutive Securities Excluded from Computation of Net Income Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.doximity.com/role/IncomeTaxes">
        <link:definition>2160112 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.doximity.com/role/IncomeTaxesTables">
        <link:definition>2361311 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails" roleURI="http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails">
        <link:definition>2462438 - Disclosure - Income Taxes - Schedule of Income Tax Expense Benefit (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" roleURI="http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails">
        <link:definition>2463439 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>2464440 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.doximity.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>2465441 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesSummaryofUnrecognizedTaxBenefitsDetails" roleURI="http://www.doximity.com/role/IncomeTaxesSummaryofUnrecognizedTaxBenefitsDetails">
        <link:definition>2466442 - Disclosure - Income Taxes - Summary of Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingencies" roleURI="http://www.doximity.com/role/CommitmentandContingencies">
        <link:definition>2167113 - Disclosure - Commitment and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingenciesDetails" roleURI="http://www.doximity.com/role/CommitmentandContingenciesDetails">
        <link:definition>2468443 - Disclosure - Commitment and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.doximity.com/role/Leases">
        <link:definition>2169114 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.doximity.com/role/LeasesTables">
        <link:definition>2370312 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesComponentsofLeaseExpenseDetails" roleURI="http://www.doximity.com/role/LeasesComponentsofLeaseExpenseDetails">
        <link:definition>2471444 - Disclosure - Leases - Components of Lease Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalCashFlowInformationDetails" roleURI="http://www.doximity.com/role/LeasesSupplementalCashFlowInformationDetails">
        <link:definition>2472445 - Disclosure - Leases - Supplemental Cash Flow Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalBalanceSheetInformationDetails" roleURI="http://www.doximity.com/role/LeasesSupplementalBalanceSheetInformationDetails">
        <link:definition>2473446 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofLeaseLiabilitiesDetails" roleURI="http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails">
        <link:definition>2474447 - Disclosure - Leases - Maturities of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturitiesofLeaseLiabilitiesDetails_1" roleURI="http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1">
        <link:definition>2474447 - Disclosure - Leases - Maturities of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlan" roleURI="http://www.doximity.com/role/EmployeeBenefitPlan">
        <link:definition>2175115 - Disclosure - Employee Benefit Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlanDetails" roleURI="http://www.doximity.com/role/EmployeeBenefitPlanDetails">
        <link:definition>2476448 - Disclosure - Employee Benefit Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicInformation" roleURI="http://www.doximity.com/role/SegmentandGeographicInformation">
        <link:definition>2177116 - Disclosure - Segment and Geographic Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentandGeographicInformationDetails" roleURI="http://www.doximity.com/role/SegmentandGeographicInformationDetails">
        <link:definition>2478449 - Disclosure - Segment and Geographic Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.doximity.com/role/SubsequentEvents">
        <link:definition>2179117 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://www.doximity.com/role/SubsequentEventsDetails">
        <link:definition>2480450 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="docs_USNewsWarrantMember" abstract="true" name="USNewsWarrantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding" abstract="false" name="CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="docs_SubscriptionMarketingSolutionsMember" abstract="true" name="SubscriptionMarketingSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_PartnershipAgreementExtensionPeriod" abstract="false" name="PartnershipAgreementExtensionPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="docs_IndividualsWithVotingInterestLessThanThresholdMember" abstract="true" name="IndividualsWithVotingInterestLessThanThresholdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_HostingArrangementAnnualCommitment" abstract="false" name="HostingArrangementAnnualCommitment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue" abstract="false" name="DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_EmployeeStockPurchasePlan2021Member" abstract="true" name="EmployeeStockPurchasePlan2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_ScheduleOfAccruedLiabilitiesCurrentTableTextBlock" abstract="false" name="ScheduleOfAccruedLiabilitiesCurrentTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="docs_TemporaryEquityPreferredStockOutstandingSeries" abstract="false" name="TemporaryEquityPreferredStockOutstandingSeries" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition" abstract="false" name="APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" abstract="false" name="LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_InitialPublicOfferingIncludingOverAllotmentOptionMember" abstract="true" name="InitialPublicOfferingIncludingOverAllotmentOptionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_TemporaryEquityExercisesOfWarrantsShares" abstract="false" name="TemporaryEquityExercisesOfWarrantsShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="docs_CommonStockHoldingMajorityNumberOfElectedBoardMembersPermitted" abstract="false" name="CommonStockHoldingMajorityNumberOfElectedBoardMembersPermitted" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted" abstract="false" name="PartnershipsAgreementPeriodBeforeTerminationIsPermitted" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="docs_PerformanceBasedRestrictedStockUnitsMember" abstract="true" name="PerformanceBasedRestrictedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow" abstract="false" name="DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance" abstract="false" name="ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock" abstract="false" name="CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="docs_HostingArrangementPeriod" abstract="false" name="HostingArrangementPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="docs_AMiONMember" abstract="true" name="AMiONMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_TemporaryEquityElectionOfBoardMembersSharesOutstandingThreshold" abstract="false" name="TemporaryEquityElectionOfBoardMembersSharesOutstandingThreshold" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="docs_StockIssuancesCostsIncurredButNotYetPaid" abstract="false" name="StockIssuancesCostsIncurredButNotYetPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost" abstract="false" name="CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughThree" abstract="false" name="DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughThree" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_IndividualsWithVotingInterestAtThresholdMember" abstract="true" name="IndividualsWithVotingInterestAtThresholdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_StockOptionAndIncentivePlan2021Member" abstract="true" name="StockOptionAndIncentivePlan2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_RebateLiabilitiesCurrent" abstract="false" name="RebateLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_ContractWithUSNewsWorldReportLPMember" abstract="true" name="ContractWithUSNewsWorldReportLPMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_TemporaryEquityConvertibleStockPriceTrigger" abstract="false" name="TemporaryEquityConvertibleStockPriceTrigger" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="docs_TemporaryEquityTextBlock" abstract="false" name="TemporaryEquityTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember" abstract="true" name="SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock" abstract="false" name="AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="docs_DebtSecuritiesAvailableForSaleWithNoCreditAllowance" abstract="false" name="DebtSecuritiesAvailableForSaleWithNoCreditAllowance" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_OperatingLossCarryforwardsSubjectToExpiration" abstract="false" name="OperatingLossCarryforwardsSubjectToExpiration" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_ContractWithCustomerLiabilityAdditionsNet" abstract="false" name="ContractWithCustomerLiabilityAdditionsNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod" abstract="false" name="BusinessCombinationContingentConsiderationLiabilityPayablePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="docs_ContractWithCustomerCancellationNoticePeriod" abstract="false" name="ContractWithCustomerCancellationNoticePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="docs_AccruedEmployeeStockPurchasePlanCurrent" abstract="false" name="AccruedEmployeeStockPurchasePlanCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_CommonStockVotingRightsNumberOfVotes" abstract="false" name="CommonStockVotingRightsNumberOfVotes" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="docs_StockIssuedAcquisitions" abstract="false" name="StockIssuedAcquisitions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense" abstract="false" name="DeferredTaxAssetsAcquisitionAndOtherRelatedExpense" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease" abstract="false" name="CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="docs_TemporaryEquityConvertibleAggregateOfferingPriceTrigger" abstract="false" name="TemporaryEquityConvertibleAggregateOfferingPriceTrigger" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_IncreaseDecreaseInCapitalizedContractCost" abstract="false" name="IncreaseDecreaseInCapitalizedContractCost" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_TemporaryEquityExercisesOfWarrantsAmount" abstract="false" name="TemporaryEquityExercisesOfWarrantsAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_TaxCreditCarryforwardsSubjectToExpiration" abstract="false" name="TaxCreditCarryforwardsSubjectToExpiration" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany" abstract="false" name="PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_MarketingAgencyOneMember" abstract="true" name="MarketingAgencyOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_CustomerAMember" abstract="true" name="CustomerAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_TemporaryEquityDividendRate" abstract="false" name="TemporaryEquityDividendRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="docs_DebtSecuritiesAvailableForSaleImpairmentsLoss" abstract="false" name="DebtSecuritiesAvailableForSaleImpairmentsLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="docs_AdjustmentsToAdditionalPaidInCapitalExerciseOfWarrants" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalExerciseOfWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_DeferredTaxAssetsLeasingArrangements" abstract="false" name="DeferredTaxAssetsLeasingArrangements" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_EquityIncentivePlan2010Member" abstract="true" name="EquityIncentivePlan2010Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_WarrantsAndRightsOutstandingVestingPeriod" abstract="false" name="WarrantsAndRightsOutstandingVestingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member" abstract="true" name="ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_ConversionOfStockConversionRatio" abstract="false" name="ConversionOfStockConversionRatio" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="docs_DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember" abstract="true" name="DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureTextBlock" abstract="false" name="BusinessCombinationGoodwillAndIntangibleAssetsDisclosureTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" abstract="false" name="TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_SubscriptionHiringSolutionsMember" abstract="true" name="SubscriptionHiringSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_SubscriptionMember" abstract="true" name="SubscriptionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_FurnitureAndEquipmentMember" abstract="true" name="FurnitureAndEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_CapitalizedContractCostAdditions" abstract="false" name="CapitalizedContractCostAdditions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_PortionOfCurativeTalentLLCMember" abstract="true" name="PortionOfCurativeTalentLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_RedeemableConvertiblePreferredStockWarrantsMember" abstract="true" name="RedeemableConvertiblePreferredStockWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="docs_ShareBasedPaymentArrangementTrancheOneAndTrancheTwoMember" abstract="true" name="ShareBasedPaymentArrangementTrancheOneAndTrancheTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPricesPerShareIssued" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardPricesPerShareIssued" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="docs_OtherShareBasedAwardsMember" abstract="true" name="OtherShareBasedAwardsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_ContractWithCustomerTerm" abstract="false" name="ContractWithCustomerTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="docs_TemporaryEquitySharesOutstandingThresholdSatisfiedNumberOfElectedBoardMembersPermitted" abstract="false" name="TemporaryEquitySharesOutstandingThresholdSatisfiedNumberOfElectedBoardMembersPermitted" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="docs_EscrowDepositsRelatedToSaleOfBusiness" abstract="false" name="EscrowDepositsRelatedToSaleOfBusiness" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" abstract="false" name="TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="docs_ComputerEquipmentAndSoftwareMember" abstract="true" name="ComputerEquipmentAndSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_THMEDLLCMember" abstract="true" name="THMEDLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="docs_PartnershipAgreementNoncancelablePeriod" abstract="false" name="PartnershipAgreementNoncancelablePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract" abstract="true" name="BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod" abstract="false" name="PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>11
<FILENAME>docs-20220331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:7e9381b6-a1e4-41b8-8d47-38883b11be1e,g:11b17cc6-874f-42e4-b7f0-55cdc6f63454-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="docs-20220331.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_6aec7eda-509c-4226-8c81-4008140801ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_57ab5d23-2fc5-4681-bfdc-b6d2f55b8647" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6aec7eda-509c-4226-8c81-4008140801ed" xlink:to="loc_us-gaap_Goodwill_57ab5d23-2fc5-4681-bfdc-b6d2f55b8647" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_092a95b6-d481-4782-9788-c47350b58516" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6aec7eda-509c-4226-8c81-4008140801ed" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_092a95b6-d481-4782-9788-c47350b58516" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_c55161a5-0079-413d-8ab7-141b4d4006d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6aec7eda-509c-4226-8c81-4008140801ed" xlink:to="loc_us-gaap_AssetsCurrent_c55161a5-0079-413d-8ab7-141b4d4006d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_ccc13eb1-e6d8-4c4a-a9a2-f75531c4fd36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6aec7eda-509c-4226-8c81-4008140801ed" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_ccc13eb1-e6d8-4c4a-a9a2-f75531c4fd36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_f195065a-7eea-473d-8251-5964811358ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6aec7eda-509c-4226-8c81-4008140801ed" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_f195065a-7eea-473d-8251-5964811358ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0c9de837-161e-4363-996f-29f37d1cc4db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6aec7eda-509c-4226-8c81-4008140801ed" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_0c9de837-161e-4363-996f-29f37d1cc4db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_169d7c3b-87cc-4c0a-a78b-9481b83fe982" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_6aec7eda-509c-4226-8c81-4008140801ed" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_169d7c3b-87cc-4c0a-a78b-9481b83fe982" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_19a09633-e741-4bf2-aadb-a17eafbf7ad2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_4134a9bf-d1b1-4db2-b8a1-1b1738d87ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_19a09633-e741-4bf2-aadb-a17eafbf7ad2" xlink:to="loc_us-gaap_Liabilities_4134a9bf-d1b1-4db2-b8a1-1b1738d87ed6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_172e9472-b28e-4662-8999-d471c103aa30" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_19a09633-e741-4bf2-aadb-a17eafbf7ad2" xlink:to="loc_us-gaap_CommitmentsAndContingencies_172e9472-b28e-4662-8999-d471c103aa30" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_b8153223-4aa9-4f12-976a-238f6fc47ebe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_19a09633-e741-4bf2-aadb-a17eafbf7ad2" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_b8153223-4aa9-4f12-976a-238f6fc47ebe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2bc21908-e017-4268-b3ef-cedd6d4dd2ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_19a09633-e741-4bf2-aadb-a17eafbf7ad2" xlink:to="loc_us-gaap_StockholdersEquity_2bc21908-e017-4268-b3ef-cedd6d4dd2ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8dcce6fa-05cf-4f41-8dbe-3fed3796499a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_308e7616-362c-4d0e-b104-472db393542b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8dcce6fa-05cf-4f41-8dbe-3fed3796499a" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_308e7616-362c-4d0e-b104-472db393542b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_4e8937ae-5e63-4f21-88cf-6d99830fdbc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8dcce6fa-05cf-4f41-8dbe-3fed3796499a" xlink:to="loc_us-gaap_CommonStockValue_4e8937ae-5e63-4f21-88cf-6d99830fdbc0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_44b653cf-9bad-47cd-b23f-8ce206238591" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8dcce6fa-05cf-4f41-8dbe-3fed3796499a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_44b653cf-9bad-47cd-b23f-8ce206238591" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_4bba9bc4-6210-4d18-ae09-ba670f341527" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8dcce6fa-05cf-4f41-8dbe-3fed3796499a" xlink:to="loc_us-gaap_AdditionalPaidInCapital_4bba9bc4-6210-4d18-ae09-ba670f341527" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_0279d358-1a7b-4f12-9e03-bc5cdd705ead" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8dcce6fa-05cf-4f41-8dbe-3fed3796499a" xlink:to="loc_us-gaap_PreferredStockValue_0279d358-1a7b-4f12-9e03-bc5cdd705ead" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_0c7793c1-14e8-4453-818e-5c59e472bb61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_54397cb3-0d76-40d2-83b4-cc7574166abc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0c7793c1-14e8-4453-818e-5c59e472bb61" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_54397cb3-0d76-40d2-83b4-cc7574166abc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_3c5ba4fd-09c3-4170-bb25-ba262e3e8b33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0c7793c1-14e8-4453-818e-5c59e472bb61" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_3c5ba4fd-09c3-4170-bb25-ba262e3e8b33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_d74efa76-d722-4c81-8964-4623f2f4f709" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0c7793c1-14e8-4453-818e-5c59e472bb61" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_d74efa76-d722-4c81-8964-4623f2f4f709" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_35a3d538-ed0a-454e-bacc-17e7708a524b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0c7793c1-14e8-4453-818e-5c59e472bb61" xlink:to="loc_us-gaap_AccountsPayableCurrent_35a3d538-ed0a-454e-bacc-17e7708a524b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_28528ade-0314-487c-8522-306315ac20a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f9673884-ab3f-41c4-9bc2-ec3dce621745" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_28528ade-0314-487c-8522-306315ac20a8" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f9673884-ab3f-41c4-9bc2-ec3dce621745" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_40e2e6a3-d984-42de-9975-c2f310b86a6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_28528ade-0314-487c-8522-306315ac20a8" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_40e2e6a3-d984-42de-9975-c2f310b86a6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1bd3f7fe-ba48-4062-9e44-1115b4154645" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_28528ade-0314-487c-8522-306315ac20a8" xlink:to="loc_us-gaap_LiabilitiesCurrent_1bd3f7fe-ba48-4062-9e44-1115b4154645" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_ea6e4652-903f-4114-8c62-f69acc93faf9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_28528ade-0314-487c-8522-306315ac20a8" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_ea6e4652-903f-4114-8c62-f69acc93faf9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_40607a0c-2f3a-4172-bbec-f2633aee1da3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_413778de-debf-4a16-93df-b6b7559a71db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_40607a0c-2f3a-4172-bbec-f2633aee1da3" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_413778de-debf-4a16-93df-b6b7559a71db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7c71aecf-44a9-48b9-8444-c601ff196ca5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_40607a0c-2f3a-4172-bbec-f2633aee1da3" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_7c71aecf-44a9-48b9-8444-c601ff196ca5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f5a8e953-58b8-43a5-a5a6-b2a5d98005d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_40607a0c-2f3a-4172-bbec-f2633aee1da3" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_f5a8e953-58b8-43a5-a5a6-b2a5d98005d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_6775906c-4df5-478d-9730-863adf342096" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_40607a0c-2f3a-4172-bbec-f2633aee1da3" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_6775906c-4df5-478d-9730-863adf342096" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNetCurrent_f25f4f85-55a5-4a0f-9486-53124b4acbae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostNetCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_40607a0c-2f3a-4172-bbec-f2633aee1da3" xlink:to="loc_us-gaap_CapitalizedContractCostNetCurrent_f25f4f85-55a5-4a0f-9486-53124b4acbae" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="docs-20220331.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_d4610e31-2bd4-40d3-8a26-0d970eacd671" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_860676f8-b077-43f0-b1b4-f18a2bf23280" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_d4610e31-2bd4-40d3-8a26-0d970eacd671" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_860676f8-b077-43f0-b1b4-f18a2bf23280" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_552eacba-cc4b-4bb5-9eae-7e692865d051" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_d4610e31-2bd4-40d3-8a26-0d970eacd671" xlink:to="loc_us-gaap_CostOfRevenue_552eacba-cc4b-4bb5-9eae-7e692865d051" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_7de12abf-ff37-45ca-8365-a458a4b146ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_c333a550-e7dd-4d00-a5ce-72b7b95b55cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_7de12abf-ff37-45ca-8365-a458a4b146ce" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_c333a550-e7dd-4d00-a5ce-72b7b95b55cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_2bc49855-915c-4e24-9dec-8f2c8dda1919" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_7de12abf-ff37-45ca-8365-a458a4b146ce" xlink:to="loc_us-gaap_OperatingIncomeLoss_2bc49855-915c-4e24-9dec-8f2c8dda1919" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_8932feb6-1294-4f90-afdb-fe449afbb65e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_877741c4-d5c3-4c87-83da-ce8b97fe7e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_8932feb6-1294-4f90-afdb-fe449afbb65e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_877741c4-d5c3-4c87-83da-ce8b97fe7e8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_8f74517f-5ff2-4f3e-ae7f-e81aaddbb339" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_8932feb6-1294-4f90-afdb-fe449afbb65e" xlink:to="loc_us-gaap_SellingAndMarketingExpense_8f74517f-5ff2-4f3e-ae7f-e81aaddbb339" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_1c72983f-8c99-4289-9b04-36f270cbe9b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_8932feb6-1294-4f90-afdb-fe449afbb65e" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_1c72983f-8c99-4289-9b04-36f270cbe9b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_3435c1b4-7c2b-41a7-b79c-e2af14c06583" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_272c45a2-5a2c-4485-a7f9-33794eb57f18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_3435c1b4-7c2b-41a7-b79c-e2af14c06583" xlink:to="loc_us-gaap_GrossProfit_272c45a2-5a2c-4485-a7f9-33794eb57f18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_9cbdc25a-1214-4f70-b742-96566a3026db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_3435c1b4-7c2b-41a7-b79c-e2af14c06583" xlink:to="loc_us-gaap_OperatingExpenses_9cbdc25a-1214-4f70-b742-96566a3026db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_70b8bef0-5d4a-4982-83b1-ad4ba4d20d48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7d0b6ead-85fa-40e0-ba7a-b7c2b26ffb82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_70b8bef0-5d4a-4982-83b1-ad4ba4d20d48" xlink:to="loc_us-gaap_NetIncomeLoss_7d0b6ead-85fa-40e0-ba7a-b7c2b26ffb82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_f0051064-c67a-4351-ba02-fe83f077e7bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_70b8bef0-5d4a-4982-83b1-ad4ba4d20d48" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_f0051064-c67a-4351-ba02-fe83f077e7bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_74be26fd-2389-42a3-ac35-8eb1e5e5eee9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_87ff0326-72e5-475e-8ec4-90930eb91dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_74be26fd-2389-42a3-ac35-8eb1e5e5eee9" xlink:to="loc_us-gaap_NetIncomeLoss_87ff0326-72e5-475e-8ec4-90930eb91dc7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_3028c0bc-9567-4165-991e-df2796308086" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_74be26fd-2389-42a3-ac35-8eb1e5e5eee9" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_3028c0bc-9567-4165-991e-df2796308086" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_103bd5cc-5694-44c2-ac4c-fa404791a605" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_adeea074-f72b-4fe3-8bc0-4c8e7db50f9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_103bd5cc-5694-44c2-ac4c-fa404791a605" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_adeea074-f72b-4fe3-8bc0-4c8e7db50f9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3b91aec4-7f0a-41d9-ae53-1739d30b02dd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_103bd5cc-5694-44c2-ac4c-fa404791a605" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3b91aec4-7f0a-41d9-ae53-1739d30b02dd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="docs-20220331.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_acc7dbb8-eabc-4032-a5b2-72a471f56b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_03bdc550-9986-4e65-a4e7-792374c675e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_acc7dbb8-eabc-4032-a5b2-72a471f56b3d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_03bdc550-9986-4e65-a4e7-792374c675e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_aeb9e910-e545-4589-9fb2-eb051398de42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_dcdab465-193f-4f7f-b15e-532cf85917bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_aeb9e910-e545-4589-9fb2-eb051398de42" xlink:to="loc_us-gaap_NetIncomeLoss_dcdab465-193f-4f7f-b15e-532cf85917bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2986a0a1-80c7-4e79-a8a4-283065b8a8da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_aeb9e910-e545-4589-9fb2-eb051398de42" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2986a0a1-80c7-4e79-a8a4-283065b8a8da" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="docs-20220331.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_156d547e-927f-4ddd-a33a-64cb5f9428d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_a39e724c-18c1-4794-b428-8389c16a4391" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_156d547e-927f-4ddd-a33a-64cb5f9428d1" xlink:to="loc_us-gaap_ProceedsFromStockPlans_a39e724c-18c1-4794-b428-8389c16a4391" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_cad4028c-381e-4580-a52d-fedd3d0737ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_156d547e-927f-4ddd-a33a-64cb5f9428d1" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_cad4028c-381e-4580-a52d-fedd3d0737ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_ed7c5ef6-58fa-492b-a907-0a76d4cabf81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_156d547e-927f-4ddd-a33a-64cb5f9428d1" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_ed7c5ef6-58fa-492b-a907-0a76d4cabf81" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_ee16fcff-f358-424c-bff5-f03fd68c21e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_156d547e-927f-4ddd-a33a-64cb5f9428d1" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_ee16fcff-f358-424c-bff5-f03fd68c21e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_345f531b-a0c3-4dce-9308-16977fb82393" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_156d547e-927f-4ddd-a33a-64cb5f9428d1" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_345f531b-a0c3-4dce-9308-16977fb82393" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_1158b782-e069-421b-b494-812c0af508aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_156d547e-927f-4ddd-a33a-64cb5f9428d1" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_1158b782-e069-421b-b494-812c0af508aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_36ed8748-8c9f-4be8-b0a8-7c6b2ce29858" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_156d547e-927f-4ddd-a33a-64cb5f9428d1" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_36ed8748-8c9f-4be8-b0a8-7c6b2ce29858" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e0a4a5ac-1e35-415f-9382-12f59bf27456" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_bb0857df-df95-4f31-ad8a-54b729fbb0bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e0a4a5ac-1e35-415f-9382-12f59bf27456" xlink:to="loc_us-gaap_NetIncomeLoss_bb0857df-df95-4f31-ad8a-54b729fbb0bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_9d19a62e-65cb-477d-8f40-10819fe533eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e0a4a5ac-1e35-415f-9382-12f59bf27456" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_9d19a62e-65cb-477d-8f40-10819fe533eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_08f1c6ea-c2d5-468a-a1ec-7642f0fb5b57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e0a4a5ac-1e35-415f-9382-12f59bf27456" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_08f1c6ea-c2d5-468a-a1ec-7642f0fb5b57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_IncreaseDecreaseInCapitalizedContractCost_7d13c7e0-629a-48a8-aab3-ecb554d19d4a" xlink:href="docs-20220331.xsd#docs_IncreaseDecreaseInCapitalizedContractCost"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e0a4a5ac-1e35-415f-9382-12f59bf27456" xlink:to="loc_docs_IncreaseDecreaseInCapitalizedContractCost_7d13c7e0-629a-48a8-aab3-ecb554d19d4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_89ff769e-b361-4a34-af61-1fb4b852d059" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e0a4a5ac-1e35-415f-9382-12f59bf27456" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_89ff769e-b361-4a34-af61-1fb4b852d059" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_3eeede53-30f1-46df-8a19-efc2ce08358f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e0a4a5ac-1e35-415f-9382-12f59bf27456" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_3eeede53-30f1-46df-8a19-efc2ce08358f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_79a2b8a6-4c91-4865-a504-6420ec56784a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e0a4a5ac-1e35-415f-9382-12f59bf27456" xlink:to="loc_us-gaap_ShareBasedCompensation_79a2b8a6-4c91-4865-a504-6420ec56784a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_cd88ed5a-3375-4a01-885b-39562ffac5be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e0a4a5ac-1e35-415f-9382-12f59bf27456" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_cd88ed5a-3375-4a01-885b-39562ffac5be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_a9d73a55-dc7e-4e19-93e0-43b30c8c273e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e0a4a5ac-1e35-415f-9382-12f59bf27456" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_a9d73a55-dc7e-4e19-93e0-43b30c8c273e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_f57aa411-7b50-4742-8601-f44c0f30f8c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e0a4a5ac-1e35-415f-9382-12f59bf27456" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_f57aa411-7b50-4742-8601-f44c0f30f8c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_62b6cfd4-580a-4834-8a23-7288c8b4e667" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e0a4a5ac-1e35-415f-9382-12f59bf27456" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_62b6cfd4-580a-4834-8a23-7288c8b4e667" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization_c27bc23e-8df1-449d-bac3-019567ad9060" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e0a4a5ac-1e35-415f-9382-12f59bf27456" xlink:to="loc_us-gaap_CapitalizedContractCostAmortization_c27bc23e-8df1-449d-bac3-019567ad9060" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_79043464-5edc-4553-a439-302c1ded6007" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e0a4a5ac-1e35-415f-9382-12f59bf27456" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_79043464-5edc-4553-a439-302c1ded6007" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_95fa1fb6-3fd0-4107-93e9-06287b6d4619" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e0a4a5ac-1e35-415f-9382-12f59bf27456" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_95fa1fb6-3fd0-4107-93e9-06287b6d4619" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_4b4e5596-13e3-4659-be90-96451f55ba89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e0a4a5ac-1e35-415f-9382-12f59bf27456" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_4b4e5596-13e3-4659-be90-96451f55ba89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_287004bd-3933-4750-a756-e56344c2f89c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss"/>
    <link:calculationArc order="16" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e0a4a5ac-1e35-415f-9382-12f59bf27456" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_287004bd-3933-4750-a756-e56344c2f89c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3eaa42a5-fc38-4002-8475-0cd0421f3241" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0cb30286-5638-4b77-ac76-3a132226e248" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3eaa42a5-fc38-4002-8475-0cd0421f3241" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0cb30286-5638-4b77-ac76-3a132226e248" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6f5d884b-58c5-43c3-b01e-937666145355" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3eaa42a5-fc38-4002-8475-0cd0421f3241" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6f5d884b-58c5-43c3-b01e-937666145355" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_298c798a-a80c-464f-905a-c051e6f51572" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3eaa42a5-fc38-4002-8475-0cd0421f3241" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_298c798a-a80c-464f-905a-c051e6f51572" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_aefe9d96-4852-4039-8919-cce49d877c10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_f63f116f-d209-4630-8a9d-831f65e8f29c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_aefe9d96-4852-4039-8919-cce49d877c10" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_f63f116f-d209-4630-8a9d-831f65e8f29c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_f98c5b6b-4726-4b57-9774-834413c2f4cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_aefe9d96-4852-4039-8919-cce49d877c10" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_f98c5b6b-4726-4b57-9774-834413c2f4cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopSoftware_869d8749-9339-4865-ab5a-61560d4dfbce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToDevelopSoftware"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_aefe9d96-4852-4039-8919-cce49d877c10" xlink:to="loc_us-gaap_PaymentsToDevelopSoftware_869d8749-9339-4865-ab5a-61560d4dfbce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_33fdce1f-1f51-4a2c-92d0-ef443ef00ad7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_aefe9d96-4852-4039-8919-cce49d877c10" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_33fdce1f-1f51-4a2c-92d0-ef443ef00ad7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_bc33b9ca-8e16-4bec-9a93-48164c81fe98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_aefe9d96-4852-4039-8919-cce49d877c10" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_bc33b9ca-8e16-4bec-9a93-48164c81fe98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_2e3c8437-6118-4ace-80a6-9e8d4dc3f9e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_aefe9d96-4852-4039-8919-cce49d877c10" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_2e3c8437-6118-4ace-80a6-9e8d4dc3f9e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_50a33623-c8df-472a-9e06-da5e49832595" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_aefe9d96-4852-4039-8919-cce49d877c10" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_50a33623-c8df-472a-9e06-da5e49832595" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_18d8af7b-9e9c-4683-b2c6-fb080319819b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_aefe9d96-4852-4039-8919-cce49d877c10" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_18d8af7b-9e9c-4683-b2c6-fb080319819b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost_8df34f28-911e-40f0-996d-ffb98d9c4e00" xlink:href="docs-20220331.xsd#docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_185278e0-9e51-4de0-8b56-8572c03b8569" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost_8df34f28-911e-40f0-996d-ffb98d9c4e00" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_185278e0-9e51-4de0-8b56-8572c03b8569" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_b20e8f65-d9ad-4d0e-b5f7-01b57df0650c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost_8df34f28-911e-40f0-996d-ffb98d9c4e00" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_b20e8f65-d9ad-4d0e-b5f7-01b57df0650c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_83866c7d-7a18-46b6-8e65-b02631c487e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_26c4dfc0-9980-4c43-a0b9-0d98216e70fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_83866c7d-7a18-46b6-8e65-b02631c487e3" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_26c4dfc0-9980-4c43-a0b9-0d98216e70fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_14bed21b-9958-4d13-9a5d-bab99485a2be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_83866c7d-7a18-46b6-8e65-b02631c487e3" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_14bed21b-9958-4d13-9a5d-bab99485a2be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_3b46bfed-203d-42be-9d32-ad2f36bc34a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_83866c7d-7a18-46b6-8e65-b02631c487e3" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_3b46bfed-203d-42be-9d32-ad2f36bc34a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_58e3cda6-b51c-41fa-9ff2-48111b69f07f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_5cf711fd-8a48-4fbe-9f79-f5a26ae371b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_58e3cda6-b51c-41fa-9ff2-48111b69f07f" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_5cf711fd-8a48-4fbe-9f79-f5a26ae371b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_73fb0011-88d1-4f64-b259-2bca1c496bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_58e3cda6-b51c-41fa-9ff2-48111b69f07f" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_73fb0011-88d1-4f64-b259-2bca1c496bf8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails_1" xlink:type="simple" xlink:href="docs-20220331.xsd#InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails_1"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost_9e7b7dd3-cb73-4115-9329-fed3c867eea6" xlink:href="docs-20220331.xsd#docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_c480dad3-0f10-4cf2-9e5d-cf86a9bf15d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost_9e7b7dd3-cb73-4115-9329-fed3c867eea6" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_c480dad3-0f10-4cf2-9e5d-cf86a9bf15d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_6fd554de-d256-4e97-90e3-c3bb274f2196" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost_9e7b7dd3-cb73-4115-9329-fed3c867eea6" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_6fd554de-d256-4e97-90e3-c3bb274f2196" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_ddf6536e-073c-4db6-8fe5-66649a6fbdcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost_9e7b7dd3-cb73-4115-9329-fed3c867eea6" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_ddf6536e-073c-4db6-8fe5-66649a6fbdcd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/InvestmentsContractualMaturitiesofAvailableForSaleDebtSecuritiesDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#InvestmentsContractualMaturitiesofAvailableForSaleDebtSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/InvestmentsContractualMaturitiesofAvailableForSaleDebtSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_637c5bb5-b9fc-4367-a783-49b729f1f259" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughThree_6979ba68-bb34-41f6-b727-5387ce3f4ccb" xlink:href="docs-20220331.xsd#docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_637c5bb5-b9fc-4367-a783-49b729f1f259" xlink:to="loc_docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughThree_6979ba68-bb34-41f6-b727-5387ce3f4ccb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_f1f26c0e-7d9b-4991-bed3-81a8bb0004f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_637c5bb5-b9fc-4367-a783-49b729f1f259" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_f1f26c0e-7d9b-4991-bed3-81a8bb0004f8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_66557bb6-c755-456c-a0e8-4ebd5c3541b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_ce4ff507-22da-43bd-a8ff-b4d1433843bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_66557bb6-c755-456c-a0e8-4ebd5c3541b3" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_ce4ff507-22da-43bd-a8ff-b4d1433843bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_b4f62022-3f98-4440-b177-972316bfc6e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_66557bb6-c755-456c-a0e8-4ebd5c3541b3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_b4f62022-3f98-4440-b177-972316bfc6e3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#AccruedExpensesandOtherCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_02928ac3-97de-4574-b545-515461b988be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrent_18ae6442-100f-4b9c-b6bf-3617a12acbab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_02928ac3-97de-4574-b545-515461b988be" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrent_18ae6442-100f-4b9c-b6bf-3617a12acbab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b86676a0-9122-4b8e-9dc2-c867d28ee687" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_02928ac3-97de-4574-b545-515461b988be" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_b86676a0-9122-4b8e-9dc2-c867d28ee687" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_RebateLiabilitiesCurrent_1c5e10b8-3e0c-46b3-8cd3-bc703cf72faa" xlink:href="docs-20220331.xsd#docs_RebateLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_02928ac3-97de-4574-b545-515461b988be" xlink:to="loc_docs_RebateLiabilitiesCurrent_1c5e10b8-3e0c-46b3-8cd3-bc703cf72faa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_83c6a560-72c9-46ce-9971-f209f92ddb01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_02928ac3-97de-4574-b545-515461b988be" xlink:to="loc_us-gaap_TaxesPayableCurrent_83c6a560-72c9-46ce-9971-f209f92ddb01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_AccruedEmployeeStockPurchasePlanCurrent_4a0e3f6a-12ea-430f-8175-b3d2029cb920" xlink:href="docs-20220331.xsd#docs_AccruedEmployeeStockPurchasePlanCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_02928ac3-97de-4574-b545-515461b988be" xlink:to="loc_docs_AccruedEmployeeStockPurchasePlanCurrent_4a0e3f6a-12ea-430f-8175-b3d2029cb920" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_c97aca5c-899f-446d-b405-7ecbd2726b71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_02928ac3-97de-4574-b545-515461b988be" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_c97aca5c-899f-446d-b405-7ecbd2726b71" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillPurchaseConsiderationAllocationDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#BusinessCombinationsIntangibleAssetsandGoodwillPurchaseConsiderationAllocationDetails"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillPurchaseConsiderationAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_b304f970-e510-4420-81b1-0a14370a354b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_e9b43684-ff6e-4f4a-b27f-3efd9ed0d15b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_b304f970-e510-4420-81b1-0a14370a354b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_e9b43684-ff6e-4f4a-b27f-3efd9ed0d15b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_c2fd229e-fa03-40aa-8100-517b0715de9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_b304f970-e510-4420-81b1-0a14370a354b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_c2fd229e-fa03-40aa-8100-517b0715de9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_085a3e2f-1a41-4084-93b7-feef514d992f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_cce6340b-b8e2-4f40-a4b8-b32020be8ced" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_085a3e2f-1a41-4084-93b7-feef514d992f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_cce6340b-b8e2-4f40-a4b8-b32020be8ced" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_846e426e-cf3d-4597-b2f1-e23f4f134efd" xlink:href="docs-20220331.xsd#docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_085a3e2f-1a41-4084-93b7-feef514d992f" xlink:to="loc_docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_846e426e-cf3d-4597-b2f1-e23f4f134efd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_722d4295-ff41-41ed-9c7d-a1c14f0743cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_085a3e2f-1a41-4084-93b7-feef514d992f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_722d4295-ff41-41ed-9c7d-a1c14f0743cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_60311c8b-70bc-4cf0-96f9-92720038db6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_085a3e2f-1a41-4084-93b7-feef514d992f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_60311c8b-70bc-4cf0-96f9-92720038db6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_a0f6a7d7-41db-4cfd-b52e-8fd256955205" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_bb136f8b-f879-4960-9a90-65568c5dd17a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_a0f6a7d7-41db-4cfd-b52e-8fd256955205" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_bb136f8b-f879-4960-9a90-65568c5dd17a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d3515d29-2fc7-40f6-b519-09b6de52a114" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_a0f6a7d7-41db-4cfd-b52e-8fd256955205" xlink:to="loc_us-gaap_Goodwill_d3515d29-2fc7-40f6-b519-09b6de52a114" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillIntangibleAssetsNetDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#BusinessCombinationsIntangibleAssetsandGoodwillIntangibleAssetsNetDetails"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillIntangibleAssetsNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9438a163-9a55-42e0-84da-6dff83eacbfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_0f660112-74e1-412d-aa5e-c7e56d1c84a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9438a163-9a55-42e0-84da-6dff83eacbfc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_0f660112-74e1-412d-aa5e-c7e56d1c84a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f5d9ef42-a007-4497-abf8-b722050d383c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9438a163-9a55-42e0-84da-6dff83eacbfc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_f5d9ef42-a007-4497-abf8-b722050d383c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillFutureAmortizationExpenseDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#BusinessCombinationsIntangibleAssetsandGoodwillFutureAmortizationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillFutureAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a5cfdd25-b57b-46d9-8d6a-c959d5d3696f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0c87464e-18c6-4ff5-ade3-db2f31baa67e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a5cfdd25-b57b-46d9-8d6a-c959d5d3696f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0c87464e-18c6-4ff5-ade3-db2f31baa67e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_a77a93e4-cae5-4b4f-9581-21cf5ed0fe7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a5cfdd25-b57b-46d9-8d6a-c959d5d3696f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_a77a93e4-cae5-4b4f-9581-21cf5ed0fe7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_b2c71094-a390-419c-9f0d-40b4e7cddc46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a5cfdd25-b57b-46d9-8d6a-c959d5d3696f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_b2c71094-a390-419c-9f0d-40b4e7cddc46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_ef2523cc-b4fb-4c69-970e-b945f76cb6b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a5cfdd25-b57b-46d9-8d6a-c959d5d3696f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_ef2523cc-b4fb-4c69-970e-b945f76cb6b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_68774706-b62c-4e57-9e41-e7710c201b49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a5cfdd25-b57b-46d9-8d6a-c959d5d3696f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_68774706-b62c-4e57-9e41-e7710c201b49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_81ddd16e-a47a-4719-9ef0-36e8bd8ca9f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_a5cfdd25-b57b-46d9-8d6a-c959d5d3696f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_81ddd16e-a47a-4719-9ef0-36e8bd8ca9f2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#EquityCommonStockReservedforIssuanceDetails"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_2aa0aedb-7031-4af6-88b6-f5ba88ff0e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_cfa9ac3f-45d8-4c61-b725-e6e586304b45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_2aa0aedb-7031-4af6-88b6-f5ba88ff0e5a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_cfa9ac3f-45d8-4c61-b725-e6e586304b45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_d716847f-21c3-48d3-a776-ef776120b811" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_2aa0aedb-7031-4af6-88b6-f5ba88ff0e5a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_d716847f-21c3-48d3-a776-ef776120b811" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4d46f323-9eb9-4e81-8f4c-7f3fb6ad9a47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_2aa0aedb-7031-4af6-88b6-f5ba88ff0e5a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_4d46f323-9eb9-4e81-8f4c-7f3fb6ad9a47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_d24fd667-6bc9-49b5-8549-dcd5fbdb81cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_2aa0aedb-7031-4af6-88b6-f5ba88ff0e5a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_d24fd667-6bc9-49b5-8549-dcd5fbdb81cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_92167c4b-5276-414b-82b8-4fda7ae03897" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_2aa0aedb-7031-4af6-88b6-f5ba88ff0e5a" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_92167c4b-5276-414b-82b8-4fda7ae03897" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_29d6688a-45d2-4756-a011-b8cabdafe958" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_fbfae6dd-faa4-4fdf-af54-56fe316c96c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_29d6688a-45d2-4756-a011-b8cabdafe958" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_fbfae6dd-faa4-4fdf-af54-56fe316c96c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_6d52d2bc-2e78-4102-90e7-cb7ceac53a68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_29d6688a-45d2-4756-a011-b8cabdafe958" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_6d52d2bc-2e78-4102-90e7-cb7ceac53a68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_20aa6e8d-5ee9-42df-b73d-7eff8fadf71b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_29d6688a-45d2-4756-a011-b8cabdafe958" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_20aa6e8d-5ee9-42df-b73d-7eff8fadf71b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_81dad262-0d81-4fd6-ac31-e212a9d01512" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_32e11188-59bf-4cbe-a7cd-1541ed649181" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_81dad262-0d81-4fd6-ac31-e212a9d01512" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_32e11188-59bf-4cbe-a7cd-1541ed649181" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_fdc5fe5b-3aef-4ad9-b077-00ef58274ca4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_81dad262-0d81-4fd6-ac31-e212a9d01512" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_fdc5fe5b-3aef-4ad9-b077-00ef58274ca4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit_631fb141-b2bd-48da-a435-408ea628bf15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_d42f908a-dfb1-48ad-bc6c-d1b12c86f717" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit_631fb141-b2bd-48da-a435-408ea628bf15" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_d42f908a-dfb1-48ad-bc6c-d1b12c86f717" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_b5bef70d-1074-4a42-acbb-eedc10eef141" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit_631fb141-b2bd-48da-a435-408ea628bf15" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_b5bef70d-1074-4a42-acbb-eedc10eef141" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_08d05f03-83e9-4152-9a87-8560725afcf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit_8d17e652-0abb-4f45-ba55-98d3491a7538" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_08d05f03-83e9-4152-9a87-8560725afcf7" xlink:to="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit_8d17e652-0abb-4f45-ba55-98d3491a7538" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_1bb5d275-765e-4cf7-896a-8abdc2d5888f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_08d05f03-83e9-4152-9a87-8560725afcf7" xlink:to="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_1bb5d275-765e-4cf7-896a-8abdc2d5888f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1deaeb35-d7cf-4062-aae0-d30571c74e05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_0370ce37-d256-4fb6-81fb-ece93e1241cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1deaeb35-d7cf-4062-aae0-d30571c74e05" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_0370ce37-d256-4fb6-81fb-ece93e1241cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_85c0fe72-9c2a-42d1-9c37-56d59f5bf59a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1deaeb35-d7cf-4062-aae0-d30571c74e05" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_85c0fe72-9c2a-42d1-9c37-56d59f5bf59a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_9ff6b0da-0e7f-4d90-b063-c0e87a7ad86d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1deaeb35-d7cf-4062-aae0-d30571c74e05" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_9ff6b0da-0e7f-4d90-b063-c0e87a7ad86d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_a92770f1-aeac-47a2-900e-b689459437d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1deaeb35-d7cf-4062-aae0-d30571c74e05" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_a92770f1-aeac-47a2-900e-b689459437d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_6e5f373d-ccbe-40ea-b545-959d3c394883" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1deaeb35-d7cf-4062-aae0-d30571c74e05" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_6e5f373d-ccbe-40ea-b545-959d3c394883" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_a862a287-8356-4798-b00f-f66c767be8ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1deaeb35-d7cf-4062-aae0-d30571c74e05" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_a862a287-8356-4798-b00f-f66c767be8ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_09bba96e-8feb-4adc-9ce8-549c9d6dc0a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_1deaeb35-d7cf-4062-aae0-d30571c74e05" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_09bba96e-8feb-4adc-9ce8-549c9d6dc0a9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_fbd6efcd-9e13-4f55-beb0-92f69fc6798c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_ff1b24ef-2470-4613-bd80-537f63443a46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_fbd6efcd-9e13-4f55-beb0-92f69fc6798c" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_ff1b24ef-2470-4613-bd80-537f63443a46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_15e3b34d-b2f0-4036-bd5c-e45f8fbfa257" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_fbd6efcd-9e13-4f55-beb0-92f69fc6798c" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_15e3b34d-b2f0-4036-bd5c-e45f8fbfa257" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_560d31ec-3ca9-4161-8bdd-65618ca1e78c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_4a656564-59dc-452d-b13f-eb4d38e08474" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_560d31ec-3ca9-4161-8bdd-65618ca1e78c" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_4a656564-59dc-452d-b13f-eb4d38e08474" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_0f8a179f-263b-436c-83a4-806e5a6ba873" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_560d31ec-3ca9-4161-8bdd-65618ca1e78c" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_0f8a179f-263b-436c-83a4-806e5a6ba873" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_2dbf8136-1e39-4a05-88b9-296b46dee386" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_560d31ec-3ca9-4161-8bdd-65618ca1e78c" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_2dbf8136-1e39-4a05-88b9-296b46dee386" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_23859f8e-7f69-4862-81a8-40c57ec94af3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DeferredTaxAssetsLeasingArrangements_b2bc0da4-d073-45ec-aeaa-d93c7241e2ea" xlink:href="docs-20220331.xsd#docs_DeferredTaxAssetsLeasingArrangements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_23859f8e-7f69-4862-81a8-40c57ec94af3" xlink:to="loc_docs_DeferredTaxAssetsLeasingArrangements_b2bc0da4-d073-45ec-aeaa-d93c7241e2ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_2512238a-4a95-4297-b57f-53ff95ed2466" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_23859f8e-7f69-4862-81a8-40c57ec94af3" xlink:to="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_2512238a-4a95-4297-b57f-53ff95ed2466" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_18ee07fc-8057-43b3-9d32-70134519d36d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_23859f8e-7f69-4862-81a8-40c57ec94af3" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_18ee07fc-8057-43b3-9d32-70134519d36d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_63c4201c-8ee3-497d-b254-803be3d0bd7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_23859f8e-7f69-4862-81a8-40c57ec94af3" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_63c4201c-8ee3-497d-b254-803be3d0bd7b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense_a9a77e1a-74bc-4066-ac0f-2210f86e7232" xlink:href="docs-20220331.xsd#docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_23859f8e-7f69-4862-81a8-40c57ec94af3" xlink:to="loc_docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense_a9a77e1a-74bc-4066-ac0f-2210f86e7232" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue_4088a39f-e2b5-41fc-b887-7ee6c3157e2a" xlink:href="docs-20220331.xsd#docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_23859f8e-7f69-4862-81a8-40c57ec94af3" xlink:to="loc_docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue_4088a39f-e2b5-41fc-b887-7ee6c3157e2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross_c4a75a69-69ba-4a2b-a746-d6970ccd3bdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_23859f8e-7f69-4862-81a8-40c57ec94af3" xlink:to="loc_us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross_c4a75a69-69ba-4a2b-a746-d6970ccd3bdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_ede0f4f6-725c-494c-a3df-0fb30337b04c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_6ec46390-d39f-4f99-a96e-6a67e3c3464a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_ede0f4f6-725c-494c-a3df-0fb30337b04c" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_6ec46390-d39f-4f99-a96e-6a67e3c3464a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_27a81726-878b-4219-9f28-5238af1c3aa7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_ede0f4f6-725c-494c-a3df-0fb30337b04c" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_27a81726-878b-4219-9f28-5238af1c3aa7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/LeasesComponentsofLeaseExpenseDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#LeasesComponentsofLeaseExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/LeasesComponentsofLeaseExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_b30fdb49-d06d-4418-bcfe-b95a40b2bcfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_e038bef7-b286-410e-a58c-c172562b053f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_b30fdb49-d06d-4418-bcfe-b95a40b2bcfe" xlink:to="loc_us-gaap_VariableLeaseCost_e038bef7-b286-410e-a58c-c172562b053f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_49d31140-a34d-4ea3-80d9-17f4a7ac7dbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_b30fdb49-d06d-4418-bcfe-b95a40b2bcfe" xlink:to="loc_us-gaap_OperatingLeaseCost_49d31140-a34d-4ea3-80d9-17f4a7ac7dbd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e0990587-07ca-4bfa-a537-f3c2395fac1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_dddf42a4-d704-4c8b-b4bf-a5ebf5ac5d89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e0990587-07ca-4bfa-a537-f3c2395fac1d" xlink:to="loc_us-gaap_OperatingLeaseLiability_dddf42a4-d704-4c8b-b4bf-a5ebf5ac5d89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_bb40d7f7-ed79-44c2-b232-c18853dfc2c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e0990587-07ca-4bfa-a537-f3c2395fac1d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_bb40d7f7-ed79-44c2-b232-c18853dfc2c9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="docs-20220331.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_000080f8-fb7b-4df1-8b47-f00376c9c06c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_13f85d70-48a5-4f15-8416-d64c9a6a3727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_000080f8-fb7b-4df1-8b47-f00376c9c06c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_13f85d70-48a5-4f15-8416-d64c9a6a3727" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f3626591-eeef-4c46-81a5-8f75589c5353" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_000080f8-fb7b-4df1-8b47-f00376c9c06c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f3626591-eeef-4c46-81a5-8f75589c5353" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>docs-20220331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:7e9381b6-a1e4-41b8-8d47-38883b11be1e,g:11b17cc6-874f-42e4-b7f0-55cdc6f63454-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.doximity.com/role/CoverPage" xlink:type="simple" xlink:href="docs-20220331.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/CoverPage" xlink:type="extended" id="i9e58d8e48b494ddb876a7ee9704aa0e5_CoverPage">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_80453bdd-e699-4ba7-8bae-29e94c05e015" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_DocumentType_80453bdd-e699-4ba7-8bae-29e94c05e015" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_2ae1e61e-75fe-48b2-86b4-6383a8b0416f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_DocumentAnnualReport_2ae1e61e-75fe-48b2-86b4-6383a8b0416f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_030bc5a3-00fc-4798-857f-9f1de49a315f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_DocumentPeriodEndDate_030bc5a3-00fc-4798-857f-9f1de49a315f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_74bf4ec5-b4b8-452f-96f9-e25164211620" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_CurrentFiscalYearEndDate_74bf4ec5-b4b8-452f-96f9-e25164211620" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_8afd9c4d-e11c-4831-a657-ada88c05eba2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_DocumentTransitionReport_8afd9c4d-e11c-4831-a657-ada88c05eba2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_7165288a-765f-4dac-a7d8-08388b164032" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntityFileNumber_7165288a-765f-4dac-a7d8-08388b164032" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_b54325c5-9387-40fb-bac5-525bd42e9819" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntityRegistrantName_b54325c5-9387-40fb-bac5-525bd42e9819" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_aecffa89-ccfd-4c31-98ed-3a1f85285f2f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntityIncorporationStateCountryCode_aecffa89-ccfd-4c31-98ed-3a1f85285f2f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_fe4ed4b7-e9cb-4782-9731-10bccbcb5525" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntityTaxIdentificationNumber_fe4ed4b7-e9cb-4782-9731-10bccbcb5525" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_f6da7226-1364-415f-b710-e4da7805af26" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntityAddressAddressLine1_f6da7226-1364-415f-b710-e4da7805af26" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_377b819e-4c84-4edc-93a3-93ebda2d06db" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntityAddressAddressLine2_377b819e-4c84-4edc-93a3-93ebda2d06db" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_ec174071-db9e-41d5-8073-601c8b58d795" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntityAddressCityOrTown_ec174071-db9e-41d5-8073-601c8b58d795" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_11a38e8a-1cb8-4afb-bda9-82ca9d330d36" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntityAddressStateOrProvince_11a38e8a-1cb8-4afb-bda9-82ca9d330d36" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_542f8de8-2dca-4a39-8d26-a29e6f64862a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntityAddressPostalZipCode_542f8de8-2dca-4a39-8d26-a29e6f64862a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_2f6820f9-f0f1-4fab-b2f6-84b906df0717" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_CityAreaCode_2f6820f9-f0f1-4fab-b2f6-84b906df0717" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_888419c2-acdc-4a5a-863c-0ef6ef314445" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_LocalPhoneNumber_888419c2-acdc-4a5a-863c-0ef6ef314445" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_c93cb4e2-4eb1-4990-92f2-804e4bd8c0e9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_Security12bTitle_c93cb4e2-4eb1-4990-92f2-804e4bd8c0e9" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_654b91ef-95aa-4ce5-b6f0-0cb5a2ac8d0d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_TradingSymbol_654b91ef-95aa-4ce5-b6f0-0cb5a2ac8d0d" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_e3d967af-238e-40c4-84bf-6a66d043ca39" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_SecurityExchangeName_e3d967af-238e-40c4-84bf-6a66d043ca39" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_05946c15-8f63-4a0a-bfb7-9461c8ac625f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_05946c15-8f63-4a0a-bfb7-9461c8ac625f" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_48c3c2bb-0e90-496c-a3f6-9bbec9239548" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntityVoluntaryFilers_48c3c2bb-0e90-496c-a3f6-9bbec9239548" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_2073c3b7-cc71-4790-b9e6-2f1eec00ceea" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntityCurrentReportingStatus_2073c3b7-cc71-4790-b9e6-2f1eec00ceea" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_c5b5b6e2-269f-4876-85c4-647c62da4024" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntityInteractiveDataCurrent_c5b5b6e2-269f-4876-85c4-647c62da4024" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_5ebae301-18b1-44e7-a180-271279d0304c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntityFilerCategory_5ebae301-18b1-44e7-a180-271279d0304c" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_1887f4a3-6ac4-41c3-b822-8901e915f4c4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntitySmallBusiness_1887f4a3-6ac4-41c3-b822-8901e915f4c4" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_1ee02166-2396-46d4-9c43-4bfb2965990b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntityEmergingGrowthCompany_1ee02166-2396-46d4-9c43-4bfb2965990b" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_6630b901-c972-41df-9aa8-7c4f5ae4e660" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntityExTransitionPeriod_6630b901-c972-41df-9aa8-7c4f5ae4e660" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_517affb1-740c-41a9-8b23-4476d78194e9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_IcfrAuditorAttestationFlag_517affb1-740c-41a9-8b23-4476d78194e9" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_756c7d02-a285-4cb9-924e-b94ebdebd943" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntityShellCompany_756c7d02-a285-4cb9-924e-b94ebdebd943" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_992270e1-67a9-40a0-a605-195063ed06c0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntityPublicFloat_992270e1-67a9-40a0-a605-195063ed06c0" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_b027cdbb-6ebc-446f-84e6-7336d9a37ffe" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_b027cdbb-6ebc-446f-84e6-7336d9a37ffe" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_242162b1-5ddf-4f51-9ffe-452b10be9d5b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_242162b1-5ddf-4f51-9ffe-452b10be9d5b" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_443c3ee4-4aed-44e9-ab01-33b26cdd27ad" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntityCentralIndexKey_443c3ee4-4aed-44e9-ab01-33b26cdd27ad" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_2e0977d3-98a2-49c2-ae6e-f53db3436a0f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_DocumentFiscalYearFocus_2e0977d3-98a2-49c2-ae6e-f53db3436a0f" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_3f2603c7-a2ee-4665-8ff7-1fb3c6bdfcc3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_DocumentFiscalPeriodFocus_3f2603c7-a2ee-4665-8ff7-1fb3c6bdfcc3" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_ba4cdc40-d2fb-450e-8a06-3cab6d68baca" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_AmendmentFlag_ba4cdc40-d2fb-450e-8a06-3cab6d68baca" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_812e8a0b-9b1d-4734-b6ab-78479b1e4b7e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_DocumentInformationTable_812e8a0b-9b1d-4734-b6ab-78479b1e4b7e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b527a334-31b0-4ba2-a389-4753ca7caa91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_812e8a0b-9b1d-4734-b6ab-78479b1e4b7e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b527a334-31b0-4ba2-a389-4753ca7caa91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b527a334-31b0-4ba2-a389-4753ca7caa91_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b527a334-31b0-4ba2-a389-4753ca7caa91" xlink:to="loc_us-gaap_ClassOfStockDomain_b527a334-31b0-4ba2-a389-4753ca7caa91_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_98e2d083-b7e1-4e4a-8bc2-8440fcbaa52f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b527a334-31b0-4ba2-a389-4753ca7caa91" xlink:to="loc_us-gaap_ClassOfStockDomain_98e2d083-b7e1-4e4a-8bc2-8440fcbaa52f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_86fccbbd-1fa3-43b1-b4d7-22748d0d977e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_98e2d083-b7e1-4e4a-8bc2-8440fcbaa52f" xlink:to="loc_us-gaap_CommonClassAMember_86fccbbd-1fa3-43b1-b4d7-22748d0d977e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_20d9b3df-bdb7-4b7b-a7a9-bafe27caa665" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_98e2d083-b7e1-4e4a-8bc2-8440fcbaa52f" xlink:to="loc_us-gaap_CommonClassBMember_20d9b3df-bdb7-4b7b-a7a9-bafe27caa665" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT" xlink:type="simple" xlink:href="docs-20220331.xsd#CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT" xlink:type="extended" id="i311a9104c2614c4d8e48a23e633a3536_CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ada02534-28d4-499b-96d1-99d8a16c0214" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_afb3f5d0-bc55-42e1-b823-67e1e6da7132" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ada02534-28d4-499b-96d1-99d8a16c0214" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_afb3f5d0-bc55-42e1-b823-67e1e6da7132" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_4f91d5a4-c075-4e2f-8322-362b99d645fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_afb3f5d0-bc55-42e1-b823-67e1e6da7132" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_4f91d5a4-c075-4e2f-8322-362b99d645fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_3c612ba9-06d1-42d1-ba96-c09700a894e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_afb3f5d0-bc55-42e1-b823-67e1e6da7132" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_3c612ba9-06d1-42d1-ba96-c09700a894e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TemporaryEquityExercisesOfWarrantsShares_aa8875a9-b718-4b4f-bf24-9d7e64fd8c58" xlink:href="docs-20220331.xsd#docs_TemporaryEquityExercisesOfWarrantsShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_afb3f5d0-bc55-42e1-b823-67e1e6da7132" xlink:to="loc_docs_TemporaryEquityExercisesOfWarrantsShares_aa8875a9-b718-4b4f-bf24-9d7e64fd8c58" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TemporaryEquityExercisesOfWarrantsAmount_aaa26dcb-5f39-4b31-80e6-825a869dfed7" xlink:href="docs-20220331.xsd#docs_TemporaryEquityExercisesOfWarrantsAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_afb3f5d0-bc55-42e1-b823-67e1e6da7132" xlink:to="loc_docs_TemporaryEquityExercisesOfWarrantsAmount_aaa26dcb-5f39-4b31-80e6-825a869dfed7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_2d2504aa-322f-4b71-ae22-0a622197aef7" xlink:href="docs-20220331.xsd#docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_afb3f5d0-bc55-42e1-b823-67e1e6da7132" xlink:to="loc_docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_2d2504aa-322f-4b71-ae22-0a622197aef7" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_d9bbae75-fd64-4ad0-b274-4497693f9e4e" xlink:href="docs-20220331.xsd#docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_afb3f5d0-bc55-42e1-b823-67e1e6da7132" xlink:to="loc_docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_d9bbae75-fd64-4ad0-b274-4497693f9e4e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_9c40eff6-9bdd-4bc4-af2d-43d0b9694c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_5ef5d036-8076-4654-bb2f-382b3bdc1694" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_ada02534-28d4-499b-96d1-99d8a16c0214" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_40042871-6c23-47c6-ac05-8cfa29c46b4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_SharesOutstanding_40042871-6c23-47c6-ac05-8cfa29c46b4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a049bdfd-eace-44eb-97e3-1e0410f35515" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_StockholdersEquity_a049bdfd-eace-44eb-97e3-1e0410f35515" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_726dcf67-a729-4eca-a5d0-76dfe412f0a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_726dcf67-a729-4eca-a5d0-76dfe412f0a7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_7fa9b0f0-c132-442b-9d54-2f6cf54fd65a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_7fa9b0f0-c132-442b-9d54-2f6cf54fd65a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_db66b4cd-e3b4-410d-9da2-b43a055fbd2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_db66b4cd-e3b4-410d-9da2-b43a055fbd2f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_ea6fe357-cf9d-4a38-8b3b-5358cf40b281" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_ea6fe357-cf9d-4a38-8b3b-5358cf40b281" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_5a31e77c-0b49-45d0-b40d-97db99316091" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_5a31e77c-0b49-45d0-b40d-97db99316091" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_51c1f61c-c2ef-4133-8b6b-8ffd41fe3c06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_51c1f61c-c2ef-4133-8b6b-8ffd41fe3c06" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_c95efba9-fbac-4008-b8cf-73cba3891e23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_c95efba9-fbac-4008-b8cf-73cba3891e23" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_5607a003-447e-4c81-9ef1-2e5850bf7b54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_5607a003-447e-4c81-9ef1-2e5850bf7b54" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_d99aa772-1156-4b51-bcee-6c8c4fc9b6a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_d99aa772-1156-4b51-bcee-6c8c4fc9b6a2" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition_a1b6d293-2273-48f5-a5a3-bdeb8f7b4cb1" xlink:href="docs-20220331.xsd#docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition_a1b6d293-2273-48f5-a5a3-bdeb8f7b4cb1" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_bd9d424a-aeee-4a3d-8edf-063a25526891" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_bd9d424a-aeee-4a3d-8edf-063a25526891" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_80c7ad12-a6d2-47b8-a02b-1e7987e468df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_80c7ad12-a6d2-47b8-a02b-1e7987e468df" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c284bac4-ae50-4267-a702-c9db7e14c001" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c284bac4-ae50-4267-a702-c9db7e14c001" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_321bf9dd-9c78-4163-b8e4-99d7e7e9b064" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_321bf9dd-9c78-4163-b8e4-99d7e7e9b064" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_62f91f87-19a7-4076-8eb5-d44cea26d5f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_62f91f87-19a7-4076-8eb5-d44cea26d5f1" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_38977c6e-9ae5-4737-b987-50b02f9fc2d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_38977c6e-9ae5-4737-b987-50b02f9fc2d0" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_cab418bb-9e2c-4d91-b3ec-56fb432e0d9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_cab418bb-9e2c-4d91-b3ec-56fb432e0d9a" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_AdjustmentsToAdditionalPaidInCapitalExerciseOfWarrants_ddd3a0da-2f6b-44cc-b39b-cb7215a027a3" xlink:href="docs-20220331.xsd#docs_AdjustmentsToAdditionalPaidInCapitalExerciseOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_docs_AdjustmentsToAdditionalPaidInCapitalExerciseOfWarrants_ddd3a0da-2f6b-44cc-b39b-cb7215a027a3" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_3084cfc2-a10f-4388-8020-424516d2823a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_3084cfc2-a10f-4388-8020-424516d2823a" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_2e788df6-da8e-4c61-ad54-b513144244b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_2e788df6-da8e-4c61-ad54-b513144244b3" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4c34526d-0664-42fe-88ce-4c0461a98066" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_NetIncomeLoss_4c34526d-0664-42fe-88ce-4c0461a98066" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_ebda478a-3b9c-48d4-83d7-0dfe096da270" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_71fee77a-d1d6-4875-9084-4fb8a2e6a347" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_6208d10f-dd69-46c0-a636-2511939bf90c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_ada02534-28d4-499b-96d1-99d8a16c0214" xlink:to="loc_us-gaap_StatementTable_6208d10f-dd69-46c0-a636-2511939bf90c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_39278237-2bd1-40df-b713-4dd104b12f64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_6208d10f-dd69-46c0-a636-2511939bf90c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_39278237-2bd1-40df-b713-4dd104b12f64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_39278237-2bd1-40df-b713-4dd104b12f64_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_39278237-2bd1-40df-b713-4dd104b12f64" xlink:to="loc_us-gaap_EquityComponentDomain_39278237-2bd1-40df-b713-4dd104b12f64_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_283e69ef-5fe4-4cb7-b511-7b90eb9efaeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_39278237-2bd1-40df-b713-4dd104b12f64" xlink:to="loc_us-gaap_EquityComponentDomain_283e69ef-5fe4-4cb7-b511-7b90eb9efaeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_f5aa8221-fcfa-4b4f-8486-e900e66a3820" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_283e69ef-5fe4-4cb7-b511-7b90eb9efaeb" xlink:to="loc_us-gaap_CommonStockMember_f5aa8221-fcfa-4b4f-8486-e900e66a3820" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_8d254179-f2f8-425e-9e2d-c4a26977eec1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_283e69ef-5fe4-4cb7-b511-7b90eb9efaeb" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_8d254179-f2f8-425e-9e2d-c4a26977eec1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d63adf2d-2730-4089-85f0-840490361a92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_283e69ef-5fe4-4cb7-b511-7b90eb9efaeb" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d63adf2d-2730-4089-85f0-840490361a92" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_14b2be97-aba7-4579-a4f6-b3638450fe26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_283e69ef-5fe4-4cb7-b511-7b90eb9efaeb" xlink:to="loc_us-gaap_RetainedEarningsMember_14b2be97-aba7-4579-a4f6-b3638450fe26" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/DESCRIPTIONOFBUSINESSDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#DESCRIPTIONOFBUSINESSDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/DESCRIPTIONOFBUSINESSDetails" xlink:type="extended" id="i72ca981be6c44fc49cc8b69d8c7a28a7_DESCRIPTIONOFBUSINESSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_a2c58f2d-2a1c-4a72-9a77-e50e0f2b2c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_325b459c-113e-4252-9797-b44eaa501e2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_a2c58f2d-2a1c-4a72-9a77-e50e0f2b2c2b" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_325b459c-113e-4252-9797-b44eaa501e2d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_71258312-a309-4ff5-b713-2a64ff14d52f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_a2c58f2d-2a1c-4a72-9a77-e50e0f2b2c2b" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_71258312-a309-4ff5-b713-2a64ff14d52f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_e2c61b38-7e59-49f8-ae2d-95664d18462c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_a2c58f2d-2a1c-4a72-9a77-e50e0f2b2c2b" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_e2c61b38-7e59-49f8-ae2d-95664d18462c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesConverted1_15331c39-3ff1-4c60-8abb-ece99f87eb63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_a2c58f2d-2a1c-4a72-9a77-e50e0f2b2c2b" xlink:to="loc_us-gaap_ConversionOfStockSharesConverted1_15331c39-3ff1-4c60-8abb-ece99f87eb63" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ConversionOfStockConversionRatio_1e95b34e-8d6c-4297-91c8-bf9124af37b4" xlink:href="docs-20220331.xsd#docs_ConversionOfStockConversionRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_a2c58f2d-2a1c-4a72-9a77-e50e0f2b2c2b" xlink:to="loc_docs_ConversionOfStockConversionRatio_1e95b34e-8d6c-4297-91c8-bf9124af37b4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOfferingCosts_e0a1e389-5d5e-4667-b5be-0bc526c13f1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredOfferingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_a2c58f2d-2a1c-4a72-9a77-e50e0f2b2c2b" xlink:to="loc_us-gaap_DeferredOfferingCosts_e0a1e389-5d5e-4667-b5be-0bc526c13f1c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_f0e1e958-5e31-42c9-93fc-505320ca5aa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_a2c58f2d-2a1c-4a72-9a77-e50e0f2b2c2b" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_f0e1e958-5e31-42c9-93fc-505320ca5aa8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_64ef34d0-003e-4268-b6d5-fe59735ebc28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_a2c58f2d-2a1c-4a72-9a77-e50e0f2b2c2b" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_64ef34d0-003e-4268-b6d5-fe59735ebc28" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_f07155c0-b018-4049-ae5c-b73fc589e703" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_64ef34d0-003e-4268-b6d5-fe59735ebc28" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_f07155c0-b018-4049-ae5c-b73fc589e703" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_f07155c0-b018-4049-ae5c-b73fc589e703_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_f07155c0-b018-4049-ae5c-b73fc589e703" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_f07155c0-b018-4049-ae5c-b73fc589e703_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_daeca82b-b388-4daf-9db6-cf38296873b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_f07155c0-b018-4049-ae5c-b73fc589e703" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_daeca82b-b388-4daf-9db6-cf38296873b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_InitialPublicOfferingIncludingOverAllotmentOptionMember_415e5e69-21ef-4097-95b0-6c4e224378d1" xlink:href="docs-20220331.xsd#docs_InitialPublicOfferingIncludingOverAllotmentOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_daeca82b-b388-4daf-9db6-cf38296873b3" xlink:to="loc_docs_InitialPublicOfferingIncludingOverAllotmentOptionMember_415e5e69-21ef-4097-95b0-6c4e224378d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_56380bb8-431a-4527-a8e0-bc279dcf1145" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_daeca82b-b388-4daf-9db6-cf38296873b3" xlink:to="loc_us-gaap_OverAllotmentOptionMember_56380bb8-431a-4527-a8e0-bc279dcf1145" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember_0362dd81-bf44-4c9b-8ebd-85973d7d666b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_daeca82b-b388-4daf-9db6-cf38296873b3" xlink:to="loc_us-gaap_RedeemableConvertiblePreferredStockMember_0362dd81-bf44-4c9b-8ebd-85973d7d666b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="iff876549366a4bc48872271a2aa5613e_SummaryofSignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_c30bc476-1e1a-4729-bedf-83e6175dba62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ContractWithCustomerTerm_cd122a71-32e9-495a-a509-e2dc99486ec9" xlink:href="docs-20220331.xsd#docs_ContractWithCustomerTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_c30bc476-1e1a-4729-bedf-83e6175dba62" xlink:to="loc_docs_ContractWithCustomerTerm_cd122a71-32e9-495a-a509-e2dc99486ec9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ContractWithCustomerCancellationNoticePeriod_900f3c80-b7bd-4476-a1c2-ac448e77fd76" xlink:href="docs-20220331.xsd#docs_ContractWithCustomerCancellationNoticePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_c30bc476-1e1a-4729-bedf-83e6175dba62" xlink:to="loc_docs_ContractWithCustomerCancellationNoticePeriod_900f3c80-b7bd-4476-a1c2-ac448e77fd76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_8a99bfae-f418-4507-a85c-68e2ce43c920" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostAmortizationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_c30bc476-1e1a-4729-bedf-83e6175dba62" xlink:to="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_8a99bfae-f418-4507-a85c-68e2ce43c920" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_0651d227-b41c-4965-9e9e-8ea6cb3a1cee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_c30bc476-1e1a-4729-bedf-83e6175dba62" xlink:to="loc_us-gaap_AdvertisingExpense_0651d227-b41c-4965-9e9e-8ea6cb3a1cee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_a13a61b3-f8fb-48d4-96b8-491e06008de4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_c30bc476-1e1a-4729-bedf-83e6175dba62" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_a13a61b3-f8fb-48d4-96b8-491e06008de4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_d3cfb39a-b268-48d5-adbc-28f423c96624" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_c30bc476-1e1a-4729-bedf-83e6175dba62" xlink:to="loc_us-gaap_NumberOfReportingUnits_d3cfb39a-b268-48d5-adbc-28f423c96624" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_444cd8fe-7f99-4c3e-8f9c-4dc9cf0cf080" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_c30bc476-1e1a-4729-bedf-83e6175dba62" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_444cd8fe-7f99-4c3e-8f9c-4dc9cf0cf080" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d02346cb-1220-492a-bd67-cb6688e4a8fb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_444cd8fe-7f99-4c3e-8f9c-4dc9cf0cf080" xlink:to="loc_srt_ProductOrServiceAxis_d02346cb-1220-492a-bd67-cb6688e4a8fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_d02346cb-1220-492a-bd67-cb6688e4a8fb_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_d02346cb-1220-492a-bd67-cb6688e4a8fb" xlink:to="loc_srt_ProductsAndServicesDomain_d02346cb-1220-492a-bd67-cb6688e4a8fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_16fbfa50-a4cd-45da-8938-a4862f3734e9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_d02346cb-1220-492a-bd67-cb6688e4a8fb" xlink:to="loc_srt_ProductsAndServicesDomain_16fbfa50-a4cd-45da-8938-a4862f3734e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_SubscriptionHiringSolutionsMember_de4c509d-b1af-4aed-9c66-4a609c0f3cc4" xlink:href="docs-20220331.xsd#docs_SubscriptionHiringSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_16fbfa50-a4cd-45da-8938-a4862f3734e9" xlink:to="loc_docs_SubscriptionHiringSolutionsMember_de4c509d-b1af-4aed-9c66-4a609c0f3cc4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_SubscriptionMarketingSolutionsMember_980b99a6-2ca3-4e8e-ab2e-aa2592c51b46" xlink:href="docs-20220331.xsd#docs_SubscriptionMarketingSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_16fbfa50-a4cd-45da-8938-a4862f3734e9" xlink:to="loc_docs_SubscriptionMarketingSolutionsMember_980b99a6-2ca3-4e8e-ab2e-aa2592c51b46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cc56251f-0391-48f7-9517-ca8f9553ec71" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_444cd8fe-7f99-4c3e-8f9c-4dc9cf0cf080" xlink:to="loc_srt_RangeAxis_cc56251f-0391-48f7-9517-ca8f9553ec71" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cc56251f-0391-48f7-9517-ca8f9553ec71_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_cc56251f-0391-48f7-9517-ca8f9553ec71" xlink:to="loc_srt_RangeMember_cc56251f-0391-48f7-9517-ca8f9553ec71_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b96369a4-05eb-4a7e-9bde-40d351a5ce85" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_cc56251f-0391-48f7-9517-ca8f9553ec71" xlink:to="loc_srt_RangeMember_b96369a4-05eb-4a7e-9bde-40d351a5ce85" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4737c056-53f1-45f3-baf3-7b76ed7778d3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b96369a4-05eb-4a7e-9bde-40d351a5ce85" xlink:to="loc_srt_MinimumMember_4737c056-53f1-45f3-baf3-7b76ed7778d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9c030249-b76c-446e-bf91-a9487b882054" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b96369a4-05eb-4a7e-9bde-40d351a5ce85" xlink:to="loc_srt_MaximumMember_9c030249-b76c-446e-bf91-a9487b882054" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAxis_fd27a41a-3f51-46b7-90b6-a059e83e0ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_444cd8fe-7f99-4c3e-8f9c-4dc9cf0cf080" xlink:to="loc_us-gaap_CapitalizedContractCostAxis_fd27a41a-3f51-46b7-90b6-a059e83e0ab2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostDomain_fd27a41a-3f51-46b7-90b6-a059e83e0ab2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CapitalizedContractCostAxis_fd27a41a-3f51-46b7-90b6-a059e83e0ab2" xlink:to="loc_us-gaap_CapitalizedContractCostDomain_fd27a41a-3f51-46b7-90b6-a059e83e0ab2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostDomain_42c4d3fd-dc79-4660-8abd-da0372878546" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CapitalizedContractCostAxis_fd27a41a-3f51-46b7-90b6-a059e83e0ab2" xlink:to="loc_us-gaap_CapitalizedContractCostDomain_42c4d3fd-dc79-4660-8abd-da0372878546" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember_3748d0d2-f7c4-4621-b765-fc705bad5212" xlink:href="docs-20220331.xsd#docs_DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_42c4d3fd-dc79-4660-8abd-da0372878546" xlink:to="loc_docs_DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember_3748d0d2-f7c4-4621-b765-fc705bad5212" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember_095be843-0805-460e-8d88-3f6c08d5c0e3" xlink:href="docs-20220331.xsd#docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_42c4d3fd-dc79-4660-8abd-da0372878546" xlink:to="loc_docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember_095be843-0805-460e-8d88-3f6c08d5c0e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_e28ae07e-10fa-4868-8d93-521e67262a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_444cd8fe-7f99-4c3e-8f9c-4dc9cf0cf080" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_e28ae07e-10fa-4868-8d93-521e67262a8c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_e28ae07e-10fa-4868-8d93-521e67262a8c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e28ae07e-10fa-4868-8d93-521e67262a8c" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_e28ae07e-10fa-4868-8d93-521e67262a8c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_06e884f3-328b-4807-9584-14ffc4f38656" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e28ae07e-10fa-4868-8d93-521e67262a8c" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_06e884f3-328b-4807-9584-14ffc4f38656" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditConcentrationRiskMember_ca5fe0b4-8e79-4906-ad9a-90030b7f2d34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_06e884f3-328b-4807-9584-14ffc4f38656" xlink:to="loc_us-gaap_CreditConcentrationRiskMember_ca5fe0b4-8e79-4906-ad9a-90030b7f2d34" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2e82f54b-7601-4dd7-917e-a03e8ea9dcee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_444cd8fe-7f99-4c3e-8f9c-4dc9cf0cf080" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2e82f54b-7601-4dd7-917e-a03e8ea9dcee" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2e82f54b-7601-4dd7-917e-a03e8ea9dcee_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2e82f54b-7601-4dd7-917e-a03e8ea9dcee" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_2e82f54b-7601-4dd7-917e-a03e8ea9dcee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e4896a45-6013-41c2-9a35-372adcd40d96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2e82f54b-7601-4dd7-917e-a03e8ea9dcee" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e4896a45-6013-41c2-9a35-372adcd40d96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_9d7f07fc-ddd7-4945-b2a3-d5f0dd1e0140" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e4896a45-6013-41c2-9a35-372adcd40d96" xlink:to="loc_us-gaap_AccountsReceivableMember_9d7f07fc-ddd7-4945-b2a3-d5f0dd1e0140" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_d3029028-2e19-4b5c-97e3-1ade1cb10ea0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_444cd8fe-7f99-4c3e-8f9c-4dc9cf0cf080" xlink:to="loc_srt_CounterpartyNameAxis_d3029028-2e19-4b5c-97e3-1ade1cb10ea0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d3029028-2e19-4b5c-97e3-1ade1cb10ea0_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_d3029028-2e19-4b5c-97e3-1ade1cb10ea0" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d3029028-2e19-4b5c-97e3-1ade1cb10ea0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d4cf24f2-1bda-4ff3-8d0c-29e0bb2801b7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_d3029028-2e19-4b5c-97e3-1ade1cb10ea0" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d4cf24f2-1bda-4ff3-8d0c-29e0bb2801b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_MarketingAgencyOneMember_382d9ad5-69b1-4c57-9df3-7faee9d670a2" xlink:href="docs-20220331.xsd#docs_MarketingAgencyOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d4cf24f2-1bda-4ff3-8d0c-29e0bb2801b7" xlink:to="loc_docs_MarketingAgencyOneMember_382d9ad5-69b1-4c57-9df3-7faee9d670a2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails" xlink:type="extended" id="ibcfb93ab6c8f4e33badd27036d0df989_SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_c06b2a07-5f01-4897-9128-9740e5312829" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_14cea938-bee4-4b76-b90a-cb6f22768208" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c06b2a07-5f01-4897-9128-9740e5312829" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_14cea938-bee4-4b76-b90a-cb6f22768208" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_b7a64aa1-fa51-4e6e-a1fb-86837f4a84bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c06b2a07-5f01-4897-9128-9740e5312829" xlink:to="loc_us-gaap_ConcentrationRiskTable_b7a64aa1-fa51-4e6e-a1fb-86837f4a84bc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_d70c2278-4fcf-4aae-b53d-f94cf1d6e948" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_b7a64aa1-fa51-4e6e-a1fb-86837f4a84bc" xlink:to="loc_srt_MajorCustomersAxis_d70c2278-4fcf-4aae-b53d-f94cf1d6e948" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_d70c2278-4fcf-4aae-b53d-f94cf1d6e948_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_d70c2278-4fcf-4aae-b53d-f94cf1d6e948" xlink:to="loc_srt_NameOfMajorCustomerDomain_d70c2278-4fcf-4aae-b53d-f94cf1d6e948_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_7efb9b13-9e45-4a33-99f7-51065329c816" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_d70c2278-4fcf-4aae-b53d-f94cf1d6e948" xlink:to="loc_srt_NameOfMajorCustomerDomain_7efb9b13-9e45-4a33-99f7-51065329c816" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CustomerAMember_b62936fe-d403-4088-8a2e-9f664d22f678" xlink:href="docs-20220331.xsd#docs_CustomerAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_7efb9b13-9e45-4a33-99f7-51065329c816" xlink:to="loc_docs_CustomerAMember_b62936fe-d403-4088-8a2e-9f664d22f678" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f061bb70-4568-4d5c-bfd4-9a12056a90ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_b7a64aa1-fa51-4e6e-a1fb-86837f4a84bc" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f061bb70-4568-4d5c-bfd4-9a12056a90ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f061bb70-4568-4d5c-bfd4-9a12056a90ce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f061bb70-4568-4d5c-bfd4-9a12056a90ce" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f061bb70-4568-4d5c-bfd4-9a12056a90ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_cc112867-1d4b-44cb-8265-57611a7e5b44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f061bb70-4568-4d5c-bfd4-9a12056a90ce" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_cc112867-1d4b-44cb-8265-57611a7e5b44" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_e8a9a9f7-05c9-474a-a4ac-46fa67d62a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_cc112867-1d4b-44cb-8265-57611a7e5b44" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_e8a9a9f7-05c9-474a-a4ac-46fa67d62a8d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_fdf63cdc-d89b-4555-b2fc-e9734bfdbf8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_cc112867-1d4b-44cb-8265-57611a7e5b44" xlink:to="loc_us-gaap_AccountsReceivableMember_fdf63cdc-d89b-4555-b2fc-e9734bfdbf8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_2b93d90f-78fc-46ec-a1ad-35e78bac97b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_b7a64aa1-fa51-4e6e-a1fb-86837f4a84bc" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_2b93d90f-78fc-46ec-a1ad-35e78bac97b3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_2b93d90f-78fc-46ec-a1ad-35e78bac97b3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_2b93d90f-78fc-46ec-a1ad-35e78bac97b3" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_2b93d90f-78fc-46ec-a1ad-35e78bac97b3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_23e3a467-ce38-47fc-972b-2b095769bfe7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_2b93d90f-78fc-46ec-a1ad-35e78bac97b3" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_23e3a467-ce38-47fc-972b-2b095769bfe7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_98db8589-4411-4194-a362-e50a78f949b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_23e3a467-ce38-47fc-972b-2b095769bfe7" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_98db8589-4411-4194-a362-e50a78f949b5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesPropertyplantandequipmentDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#SummaryofSignificantAccountingPoliciesPropertyplantandequipmentDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesPropertyplantandequipmentDetails" xlink:type="extended" id="ic5584a35d13c4c3eaddd4e8594e8a04c_SummaryofSignificantAccountingPoliciesPropertyplantandequipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_19cc8f94-85f5-4cd4-b638-e603b261e980" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_d8d55999-42f6-4bc2-9fa8-e64dd9b1bf2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_19cc8f94-85f5-4cd4-b638-e603b261e980" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_d8d55999-42f6-4bc2-9fa8-e64dd9b1bf2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a323ab45-4bb0-4a02-b3c9-ac5a63450935" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_19cc8f94-85f5-4cd4-b638-e603b261e980" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a323ab45-4bb0-4a02-b3c9-ac5a63450935" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5f7aa96e-b088-46a4-a5c7-28221951bff2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a323ab45-4bb0-4a02-b3c9-ac5a63450935" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5f7aa96e-b088-46a4-a5c7-28221951bff2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5f7aa96e-b088-46a4-a5c7-28221951bff2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5f7aa96e-b088-46a4-a5c7-28221951bff2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_5f7aa96e-b088-46a4-a5c7-28221951bff2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ba8aa2f1-6432-4e06-8133-17d29b7e2d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5f7aa96e-b088-46a4-a5c7-28221951bff2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ba8aa2f1-6432-4e06-8133-17d29b7e2d7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_FurnitureAndEquipmentMember_8f346926-3105-4055-b08b-98e301646bf4" xlink:href="docs-20220331.xsd#docs_FurnitureAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ba8aa2f1-6432-4e06-8133-17d29b7e2d7d" xlink:to="loc_docs_FurnitureAndEquipmentMember_8f346926-3105-4055-b08b-98e301646bf4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ComputerEquipmentAndSoftwareMember_ebc58052-171a-474b-9f8a-451395b57138" xlink:href="docs-20220331.xsd#docs_ComputerEquipmentAndSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ba8aa2f1-6432-4e06-8133-17d29b7e2d7d" xlink:to="loc_docs_ComputerEquipmentAndSoftwareMember_ebc58052-171a-474b-9f8a-451395b57138" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_64e6a4d7-656d-4131-8d55-57415ad1d45e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ba8aa2f1-6432-4e06-8133-17d29b7e2d7d" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_64e6a4d7-656d-4131-8d55-57415ad1d45e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7686e6ad-97c1-4bf7-a6c6-50149ee6a332" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a323ab45-4bb0-4a02-b3c9-ac5a63450935" xlink:to="loc_srt_RangeAxis_7686e6ad-97c1-4bf7-a6c6-50149ee6a332" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7686e6ad-97c1-4bf7-a6c6-50149ee6a332_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_7686e6ad-97c1-4bf7-a6c6-50149ee6a332" xlink:to="loc_srt_RangeMember_7686e6ad-97c1-4bf7-a6c6-50149ee6a332_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_091e9269-1598-42ed-b121-b08962b3144d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_7686e6ad-97c1-4bf7-a6c6-50149ee6a332" xlink:to="loc_srt_RangeMember_091e9269-1598-42ed-b121-b08962b3144d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_85d9d0b5-9f5e-4c72-a728-250cf6785bf6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_091e9269-1598-42ed-b121-b08962b3144d" xlink:to="loc_srt_MinimumMember_85d9d0b5-9f5e-4c72-a728-250cf6785bf6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_91bab560-4f67-4aae-8123-9180f2b61e9a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_091e9269-1598-42ed-b121-b08962b3144d" xlink:to="loc_srt_MaximumMember_91bab560-4f67-4aae-8123-9180f2b61e9a" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/RevenueRecognitionDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#RevenueRecognitionDisaggregationofRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/RevenueRecognitionDisaggregationofRevenueDetails" xlink:type="extended" id="ie805b8966cac4397afcea3e25408745e_RevenueRecognitionDisaggregationofRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_ed39127c-f707-4c44-84a5-59de69ff2fac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c037d0f7-671b-4be8-9d7b-b5dcdf295168" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ed39127c-f707-4c44-84a5-59de69ff2fac" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c037d0f7-671b-4be8-9d7b-b5dcdf295168" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_80fc2795-d0e4-4977-b205-643cf8ce57ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ed39127c-f707-4c44-84a5-59de69ff2fac" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_80fc2795-d0e4-4977-b205-643cf8ce57ca" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a7e6eaf5-b637-421a-9d71-a1c3344ea8b4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_80fc2795-d0e4-4977-b205-643cf8ce57ca" xlink:to="loc_srt_ProductOrServiceAxis_a7e6eaf5-b637-421a-9d71-a1c3344ea8b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a7e6eaf5-b637-421a-9d71-a1c3344ea8b4_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_a7e6eaf5-b637-421a-9d71-a1c3344ea8b4" xlink:to="loc_srt_ProductsAndServicesDomain_a7e6eaf5-b637-421a-9d71-a1c3344ea8b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_cfbcaee5-8137-463c-823c-96b4e4254908" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_a7e6eaf5-b637-421a-9d71-a1c3344ea8b4" xlink:to="loc_srt_ProductsAndServicesDomain_cfbcaee5-8137-463c-823c-96b4e4254908" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_SubscriptionMember_8fdf4499-2450-4c9b-abbc-629b35dd7de6" xlink:href="docs-20220331.xsd#docs_SubscriptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_cfbcaee5-8137-463c-823c-96b4e4254908" xlink:to="loc_docs_SubscriptionMember_8fdf4499-2450-4c9b-abbc-629b35dd7de6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceOtherMember_f5eab7bf-5d66-4f22-bb6b-f72181ee58ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_cfbcaee5-8137-463c-823c-96b4e4254908" xlink:to="loc_us-gaap_ServiceOtherMember_f5eab7bf-5d66-4f22-bb6b-f72181ee58ed" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails" xlink:type="extended" id="id47744f7c1834aa494abe91912c69796_InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_05d3b78b-9289-4805-a2c8-d59fe50b2202" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_2ff91c8c-14a8-4a1f-8c49-311947a3d530" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_05d3b78b-9289-4805-a2c8-d59fe50b2202" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_2ff91c8c-14a8-4a1f-8c49-311947a3d530" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_067a3bcb-f1dc-41bb-8fdd-51a63d23c18b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_05d3b78b-9289-4805-a2c8-d59fe50b2202" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_067a3bcb-f1dc-41bb-8fdd-51a63d23c18b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_b568efd0-85ce-4c03-adba-6b9f87aa468a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_05d3b78b-9289-4805-a2c8-d59fe50b2202" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_b568efd0-85ce-4c03-adba-6b9f87aa468a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_aed1a933-a6e6-471a-9ce5-06f4e617e507" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_05d3b78b-9289-4805-a2c8-d59fe50b2202" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_aed1a933-a6e6-471a-9ce5-06f4e617e507" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e86d6f02-184d-4546-bb0a-12d33a64c46b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_05d3b78b-9289-4805-a2c8-d59fe50b2202" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e86d6f02-184d-4546-bb0a-12d33a64c46b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_ffdb08ff-6047-4c4c-ab7c-276693d5a06b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_05d3b78b-9289-4805-a2c8-d59fe50b2202" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_ffdb08ff-6047-4c4c-ab7c-276693d5a06b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost_812aade4-039e-4d16-b7ef-4f69dc7629a1" xlink:href="docs-20220331.xsd#docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_05d3b78b-9289-4805-a2c8-d59fe50b2202" xlink:to="loc_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost_812aade4-039e-4d16-b7ef-4f69dc7629a1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_a7621a89-4418-43c0-81c1-213e1cff7c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_05d3b78b-9289-4805-a2c8-d59fe50b2202" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_a7621a89-4418-43c0-81c1-213e1cff7c8e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_77a59ce5-e66d-4a59-b03f-8c0d38ccda40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_05d3b78b-9289-4805-a2c8-d59fe50b2202" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_77a59ce5-e66d-4a59-b03f-8c0d38ccda40" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_65d72719-8586-48c2-bf12-a9ad62a9f632" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_77a59ce5-e66d-4a59-b03f-8c0d38ccda40" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_65d72719-8586-48c2-bf12-a9ad62a9f632" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_65d72719-8586-48c2-bf12-a9ad62a9f632_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_65d72719-8586-48c2-bf12-a9ad62a9f632" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_65d72719-8586-48c2-bf12-a9ad62a9f632_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c4078ea5-9be2-42e0-b7a8-eb4288ccf013" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_65d72719-8586-48c2-bf12-a9ad62a9f632" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c4078ea5-9be2-42e0-b7a8-eb4288ccf013" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_73cfa6b3-a64b-487d-b88c-5bc5a6d98f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c4078ea5-9be2-42e0-b7a8-eb4288ccf013" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_73cfa6b3-a64b-487d-b88c-5bc5a6d98f9e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesMember_ccf0631e-d700-4561-a092-4594d2f60fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableforsaleSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c4078ea5-9be2-42e0-b7a8-eb4288ccf013" xlink:to="loc_us-gaap_AvailableforsaleSecuritiesMember_ccf0631e-d700-4561-a092-4594d2f60fcc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_50bf3bb7-6116-4d03-a48d-450257ec5f24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_77a59ce5-e66d-4a59-b03f-8c0d38ccda40" xlink:to="loc_us-gaap_FinancialInstrumentAxis_50bf3bb7-6116-4d03-a48d-450257ec5f24" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_50bf3bb7-6116-4d03-a48d-450257ec5f24_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_50bf3bb7-6116-4d03-a48d-450257ec5f24" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_50bf3bb7-6116-4d03-a48d-450257ec5f24_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c584a828-f3d8-4798-a3c8-b1b855172d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_50bf3bb7-6116-4d03-a48d-450257ec5f24" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c584a828-f3d8-4798-a3c8-b1b855172d1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_46e56e05-e6b6-437f-9142-c974eb9547e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c584a828-f3d8-4798-a3c8-b1b855172d1c" xlink:to="loc_us-gaap_CommercialPaperMember_46e56e05-e6b6-437f-9142-c974eb9547e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_8c3063c9-82d8-4940-b404-243b0791cc60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c584a828-f3d8-4798-a3c8-b1b855172d1c" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_8c3063c9-82d8-4940-b404-243b0791cc60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_e14a564b-536d-4d96-8ba9-7dd689ef12e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c584a828-f3d8-4798-a3c8-b1b855172d1c" xlink:to="loc_us-gaap_MoneyMarketFundsMember_e14a564b-536d-4d96-8ba9-7dd689ef12e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_00343f2d-4620-4f83-9754-d796c90b65b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c584a828-f3d8-4798-a3c8-b1b855172d1c" xlink:to="loc_us-gaap_CertificatesOfDepositMember_00343f2d-4620-4f83-9754-d796c90b65b9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_e6721275-845f-4985-bc2b-3782688eb0c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c584a828-f3d8-4798-a3c8-b1b855172d1c" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_e6721275-845f-4985-bc2b-3782688eb0c6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_61fd08e7-d336-46c3-9f52-7e504604597a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c584a828-f3d8-4798-a3c8-b1b855172d1c" xlink:to="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_61fd08e7-d336-46c3-9f52-7e504604597a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SovereignDebtSecuritiesMember_ccec4588-026a-48ac-b550-58fcb8102cd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SovereignDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c584a828-f3d8-4798-a3c8-b1b855172d1c" xlink:to="loc_us-gaap_SovereignDebtSecuritiesMember_ccec4588-026a-48ac-b550-58fcb8102cd3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_35c67186-07b7-474b-afee-1223fd5d28ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c584a828-f3d8-4798-a3c8-b1b855172d1c" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_35c67186-07b7-474b-afee-1223fd5d28ec" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#FairValueMeasurementsDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/FairValueMeasurementsDetails" xlink:type="extended" id="i13c17b2e8e47480e959312f117cc5ad8_FairValueMeasurementsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_79b21350-e6b4-40d0-a3a7-64713ec5c4da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_8871d85c-a8b1-48c4-9338-2bab6b48ddaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_79b21350-e6b4-40d0-a3a7-64713ec5c4da" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_8871d85c-a8b1-48c4-9338-2bab6b48ddaa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ad976dab-f348-458e-8bd3-1b8238b5b95a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_79b21350-e6b4-40d0-a3a7-64713ec5c4da" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ad976dab-f348-458e-8bd3-1b8238b5b95a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d71e953c-19b2-49d8-8412-ee57dd8a570a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ad976dab-f348-458e-8bd3-1b8238b5b95a" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d71e953c-19b2-49d8-8412-ee57dd8a570a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d71e953c-19b2-49d8-8412-ee57dd8a570a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d71e953c-19b2-49d8-8412-ee57dd8a570a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_d71e953c-19b2-49d8-8412-ee57dd8a570a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_22f8f926-dd7b-416c-9f22-f440c9996549" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d71e953c-19b2-49d8-8412-ee57dd8a570a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_22f8f926-dd7b-416c-9f22-f440c9996549" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_eef6da11-25fa-4556-a84b-ed993dd4741e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_22f8f926-dd7b-416c-9f22-f440c9996549" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_eef6da11-25fa-4556-a84b-ed993dd4741e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_d66b7340-553b-4659-b67f-6704f7098657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_22f8f926-dd7b-416c-9f22-f440c9996549" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_d66b7340-553b-4659-b67f-6704f7098657" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_13d5c9c0-2384-4540-92bd-3448e70787b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_22f8f926-dd7b-416c-9f22-f440c9996549" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_13d5c9c0-2384-4540-92bd-3448e70787b4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_875eeea4-d751-41c1-914e-ab25c98add05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ad976dab-f348-458e-8bd3-1b8238b5b95a" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_875eeea4-d751-41c1-914e-ab25c98add05" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_875eeea4-d751-41c1-914e-ab25c98add05_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_875eeea4-d751-41c1-914e-ab25c98add05" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_875eeea4-d751-41c1-914e-ab25c98add05_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_aea618d6-9d27-4075-8329-2efc9057f745" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_875eeea4-d751-41c1-914e-ab25c98add05" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_aea618d6-9d27-4075-8329-2efc9057f745" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_d9cb1546-32fc-4171-9d1e-016055718722" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_aea618d6-9d27-4075-8329-2efc9057f745" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_d9cb1546-32fc-4171-9d1e-016055718722" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_cdd79656-de15-4479-89f3-98c4d1c943fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ad976dab-f348-458e-8bd3-1b8238b5b95a" xlink:to="loc_us-gaap_FinancialInstrumentAxis_cdd79656-de15-4479-89f3-98c4d1c943fe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cdd79656-de15-4479-89f3-98c4d1c943fe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_cdd79656-de15-4479-89f3-98c4d1c943fe" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cdd79656-de15-4479-89f3-98c4d1c943fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3e85f118-488f-4b5a-b15c-87dff02a92cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_cdd79656-de15-4479-89f3-98c4d1c943fe" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3e85f118-488f-4b5a-b15c-87dff02a92cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_fa16b664-72ae-4337-bd37-7b17b4114aae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3e85f118-488f-4b5a-b15c-87dff02a92cd" xlink:to="loc_us-gaap_MoneyMarketFundsMember_fa16b664-72ae-4337-bd37-7b17b4114aae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_f07b50a8-022a-494f-a45e-783a0920b52b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3e85f118-488f-4b5a-b15c-87dff02a92cd" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_f07b50a8-022a-494f-a45e-783a0920b52b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_9ae89235-daf5-490c-8256-463abdaaa9ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3e85f118-488f-4b5a-b15c-87dff02a92cd" xlink:to="loc_us-gaap_CertificatesOfDepositMember_9ae89235-daf5-490c-8256-463abdaaa9ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_6d4da371-2013-4ce5-ab76-e00100e300a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3e85f118-488f-4b5a-b15c-87dff02a92cd" xlink:to="loc_us-gaap_CommercialPaperMember_6d4da371-2013-4ce5-ab76-e00100e300a8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_564f4c7f-1076-4f81-be89-43e76dc7646a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3e85f118-488f-4b5a-b15c-87dff02a92cd" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_564f4c7f-1076-4f81-be89-43e76dc7646a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SovereignDebtSecuritiesMember_6f2d6753-aa91-403c-bd24-b2722f1123a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SovereignDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3e85f118-488f-4b5a-b15c-87dff02a92cd" xlink:to="loc_us-gaap_SovereignDebtSecuritiesMember_6f2d6753-aa91-403c-bd24-b2722f1123a8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_87aae8b1-79f1-4a0a-a741-d3782cefaf4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3e85f118-488f-4b5a-b15c-87dff02a92cd" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_87aae8b1-79f1-4a0a-a741-d3782cefaf4a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_6dd7f697-f852-408d-b3d5-d75d63ba13fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ad976dab-f348-458e-8bd3-1b8238b5b95a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_6dd7f697-f852-408d-b3d5-d75d63ba13fe" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_6dd7f697-f852-408d-b3d5-d75d63ba13fe_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6dd7f697-f852-408d-b3d5-d75d63ba13fe" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_6dd7f697-f852-408d-b3d5-d75d63ba13fe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3fdb574a-3829-4f44-9eaf-e37259bcb52e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6dd7f697-f852-408d-b3d5-d75d63ba13fe" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3fdb574a-3829-4f44-9eaf-e37259bcb52e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_ea78e097-d9a0-4315-8eb6-62788bb1b76e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3fdb574a-3829-4f44-9eaf-e37259bcb52e" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_ea78e097-d9a0-4315-8eb6-62788bb1b76e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesMember_274adda8-26fa-4f3f-afb4-f84a20e3bec2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableforsaleSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3fdb574a-3829-4f44-9eaf-e37259bcb52e" xlink:to="loc_us-gaap_AvailableforsaleSecuritiesMember_274adda8-26fa-4f3f-afb4-f84a20e3bec2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails" xlink:type="extended" id="i19191819b2154ad3aa016c55608019f7_PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_da37c820-ad1e-45da-bb04-a71cdcc6cd7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_58231a10-db52-41b7-9539-958879e0f232" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_da37c820-ad1e-45da-bb04-a71cdcc6cd7f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_58231a10-db52-41b7-9539-958879e0f232" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_77189d9e-d173-44e5-912a-72b2fb05a069" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_da37c820-ad1e-45da-bb04-a71cdcc6cd7f" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_77189d9e-d173-44e5-912a-72b2fb05a069" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_82c5f745-6c61-4d65-862b-5b1e19e82c3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_da37c820-ad1e-45da-bb04-a71cdcc6cd7f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_82c5f745-6c61-4d65-862b-5b1e19e82c3e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e8028cf8-d073-4529-9224-09be8bf7b431" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_da37c820-ad1e-45da-bb04-a71cdcc6cd7f" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e8028cf8-d073-4529-9224-09be8bf7b431" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c5789756-10d0-4386-bde1-ffe13270887e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e8028cf8-d073-4529-9224-09be8bf7b431" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c5789756-10d0-4386-bde1-ffe13270887e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c5789756-10d0-4386-bde1-ffe13270887e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c5789756-10d0-4386-bde1-ffe13270887e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_c5789756-10d0-4386-bde1-ffe13270887e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_476a4b29-a64b-45b9-8b1b-2ec59b45583a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c5789756-10d0-4386-bde1-ffe13270887e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_476a4b29-a64b-45b9-8b1b-2ec59b45583a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_FurnitureAndEquipmentMember_3d758f47-c22f-49d5-90ba-d2b99c8e79dd" xlink:href="docs-20220331.xsd#docs_FurnitureAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_476a4b29-a64b-45b9-8b1b-2ec59b45583a" xlink:to="loc_docs_FurnitureAndEquipmentMember_3d758f47-c22f-49d5-90ba-d2b99c8e79dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ComputerEquipmentAndSoftwareMember_f1574026-ba3e-471e-a770-5d960fd3dd29" xlink:href="docs-20220331.xsd#docs_ComputerEquipmentAndSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_476a4b29-a64b-45b9-8b1b-2ec59b45583a" xlink:to="loc_docs_ComputerEquipmentAndSoftwareMember_f1574026-ba3e-471e-a770-5d960fd3dd29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_589a48fe-8873-4341-8cd6-1ff0a85e28e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_476a4b29-a64b-45b9-8b1b-2ec59b45583a" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_589a48fe-8873-4341-8cd6-1ff0a85e28e1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_0a595b17-8dc6-4133-9658-62be639c8cee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_476a4b29-a64b-45b9-8b1b-2ec59b45583a" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_0a595b17-8dc6-4133-9658-62be639c8cee" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillNarrativeDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#BusinessCombinationsIntangibleAssetsandGoodwillNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillNarrativeDetails" xlink:type="extended" id="i54a294707eb7411287907558f779d412_BusinessCombinationsIntangibleAssetsandGoodwillNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_70a1b68e-100e-4d19-931b-1ae8091cf48d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_8bcf5844-f123-49ee-912d-df48e7391b15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_70a1b68e-100e-4d19-931b-1ae8091cf48d" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_8bcf5844-f123-49ee-912d-df48e7391b15" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_afc76617-6cd8-4531-a9d5-2622b27672e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_70a1b68e-100e-4d19-931b-1ae8091cf48d" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_afc76617-6cd8-4531-a9d5-2622b27672e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_4f1eb016-19fb-49f2-8a97-b60ce7beec68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_70a1b68e-100e-4d19-931b-1ae8091cf48d" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_4f1eb016-19fb-49f2-8a97-b60ce7beec68" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_4cbc068f-cb2a-4ae9-b16a-7783c29ad661" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_70a1b68e-100e-4d19-931b-1ae8091cf48d" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_4cbc068f-cb2a-4ae9-b16a-7783c29ad661" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_c450896e-b4be-4ea1-8319-39da9a6407a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_70a1b68e-100e-4d19-931b-1ae8091cf48d" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_c450896e-b4be-4ea1-8319-39da9a6407a4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_cd83638b-079f-4c30-8f86-7d871e2923ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_70a1b68e-100e-4d19-931b-1ae8091cf48d" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_cd83638b-079f-4c30-8f86-7d871e2923ea" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_bff151b4-6025-46ff-9616-d59d3e92abaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_70a1b68e-100e-4d19-931b-1ae8091cf48d" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_bff151b4-6025-46ff-9616-d59d3e92abaa" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_cabbbc2d-f850-4cd3-816e-4affb21b8e21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_70a1b68e-100e-4d19-931b-1ae8091cf48d" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_cabbbc2d-f850-4cd3-816e-4affb21b8e21" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow_e53b5e28-f370-4443-906e-97f77ee4f8f2" xlink:href="docs-20220331.xsd#docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_70a1b68e-100e-4d19-931b-1ae8091cf48d" xlink:to="loc_docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow_e53b5e28-f370-4443-906e-97f77ee4f8f2" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_f7b982d7-3758-4194-a488-dd92a0ad31e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_70a1b68e-100e-4d19-931b-1ae8091cf48d" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_f7b982d7-3758-4194-a488-dd92a0ad31e6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5dc55edd-8887-47d1-aa64-4ad37f43498d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_70a1b68e-100e-4d19-931b-1ae8091cf48d" xlink:to="loc_us-gaap_Goodwill_5dc55edd-8887-47d1-aa64-4ad37f43498d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_7b42a2ff-1b1c-46ad-996f-bbf683c0276e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_70a1b68e-100e-4d19-931b-1ae8091cf48d" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_7b42a2ff-1b1c-46ad-996f-bbf683c0276e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_819aef2f-c385-44d6-8c89-fa67372da668" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_70a1b68e-100e-4d19-931b-1ae8091cf48d" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_819aef2f-c385-44d6-8c89-fa67372da668" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_53030a01-1761-4eed-abd6-18400612ea4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_819aef2f-c385-44d6-8c89-fa67372da668" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_53030a01-1761-4eed-abd6-18400612ea4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_53030a01-1761-4eed-abd6-18400612ea4c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_53030a01-1761-4eed-abd6-18400612ea4c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_53030a01-1761-4eed-abd6-18400612ea4c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1f9de496-7746-4930-88be-f81685f58d01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_53030a01-1761-4eed-abd6-18400612ea4c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1f9de496-7746-4930-88be-f81685f58d01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_THMEDLLCMember_9f34617c-b5dd-4ba2-89e0-9dff564f1c2b" xlink:href="docs-20220331.xsd#docs_THMEDLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1f9de496-7746-4930-88be-f81685f58d01" xlink:to="loc_docs_THMEDLLCMember_9f34617c-b5dd-4ba2-89e0-9dff564f1c2b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_767dd736-704f-4fc5-9653-56bc811081dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_819aef2f-c385-44d6-8c89-fa67372da668" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_767dd736-704f-4fc5-9653-56bc811081dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_767dd736-704f-4fc5-9653-56bc811081dc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_767dd736-704f-4fc5-9653-56bc811081dc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_767dd736-704f-4fc5-9653-56bc811081dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_302426ea-453a-42d7-b3b4-77d1a4b54cf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_767dd736-704f-4fc5-9653-56bc811081dc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_302426ea-453a-42d7-b3b4-77d1a4b54cf1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_4cd761a0-4958-4837-8a89-9d00b08ef376" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_302426ea-453a-42d7-b3b4-77d1a4b54cf1" xlink:to="loc_us-gaap_CustomerRelationshipsMember_4cd761a0-4958-4837-8a89-9d00b08ef376" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_df16c2de-ac45-40d5-9523-97e615486365" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_819aef2f-c385-44d6-8c89-fa67372da668" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_df16c2de-ac45-40d5-9523-97e615486365" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_df16c2de-ac45-40d5-9523-97e615486365_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_df16c2de-ac45-40d5-9523-97e615486365" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_df16c2de-ac45-40d5-9523-97e615486365_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_76c19724-3591-455d-9e19-db10aa58e77a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_df16c2de-ac45-40d5-9523-97e615486365" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_76c19724-3591-455d-9e19-db10aa58e77a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_8e371380-8398-410f-9735-4ab82f092269" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_76c19724-3591-455d-9e19-db10aa58e77a" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_8e371380-8398-410f-9735-4ab82f092269" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c0f07ffb-05a4-458e-9c8a-b6da910ca4b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_819aef2f-c385-44d6-8c89-fa67372da668" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c0f07ffb-05a4-458e-9c8a-b6da910ca4b3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c0f07ffb-05a4-458e-9c8a-b6da910ca4b3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c0f07ffb-05a4-458e-9c8a-b6da910ca4b3" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_c0f07ffb-05a4-458e-9c8a-b6da910ca4b3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_26ee09b0-99d6-4366-894e-b2d6a2d59e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c0f07ffb-05a4-458e-9c8a-b6da910ca4b3" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_26ee09b0-99d6-4366-894e-b2d6a2d59e4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PortionOfCurativeTalentLLCMember_0476e3e9-59ba-4fef-b07b-5f73cdbc8a53" xlink:href="docs-20220331.xsd#docs_PortionOfCurativeTalentLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_26ee09b0-99d6-4366-894e-b2d6a2d59e4f" xlink:to="loc_docs_PortionOfCurativeTalentLLCMember_0476e3e9-59ba-4fef-b07b-5f73cdbc8a53" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillPurchaseConsiderationAllocationDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#BusinessCombinationsIntangibleAssetsandGoodwillPurchaseConsiderationAllocationDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillPurchaseConsiderationAllocationDetails" xlink:type="extended" id="i9a660c921234466e83b54aa391b128f3_BusinessCombinationsIntangibleAssetsandGoodwillPurchaseConsiderationAllocationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_29d07762-3cff-45af-b965-eebc86047527" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_69bd4a77-2f9d-445b-96e8-72f7d7c2d5c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29d07762-3cff-45af-b965-eebc86047527" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_69bd4a77-2f9d-445b-96e8-72f7d7c2d5c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_081b6a4d-741e-46f1-8ed5-3b5e90fa03c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_69bd4a77-2f9d-445b-96e8-72f7d7c2d5c6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_081b6a4d-741e-46f1-8ed5-3b5e90fa03c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_c94e0653-ad7d-40d1-979c-c13867ba1509" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_69bd4a77-2f9d-445b-96e8-72f7d7c2d5c6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_c94e0653-ad7d-40d1-979c-c13867ba1509" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_22ca8ae3-568f-4501-87c8-0f87e6f2eb1f" xlink:href="docs-20220331.xsd#docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_69bd4a77-2f9d-445b-96e8-72f7d7c2d5c6" xlink:to="loc_docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_22ca8ae3-568f-4501-87c8-0f87e6f2eb1f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_cd456a20-5afb-4964-a16f-cfe8b6407181" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_69bd4a77-2f9d-445b-96e8-72f7d7c2d5c6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_cd456a20-5afb-4964-a16f-cfe8b6407181" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_000a9d8a-4098-475a-8c8e-23e03e2c33fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_69bd4a77-2f9d-445b-96e8-72f7d7c2d5c6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_000a9d8a-4098-475a-8c8e-23e03e2c33fe" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_33703eb3-0816-4397-9872-0f34c8095e0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29d07762-3cff-45af-b965-eebc86047527" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_33703eb3-0816-4397-9872-0f34c8095e0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_f00f4aab-c2b9-4ec0-adf1-452c410d0e01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_33703eb3-0816-4397-9872-0f34c8095e0b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_f00f4aab-c2b9-4ec0-adf1-452c410d0e01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_cb5cae29-f501-4c67-ac6d-febc4e3f340a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29d07762-3cff-45af-b965-eebc86047527" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_cb5cae29-f501-4c67-ac6d-febc4e3f340a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_54713003-69ca-47f3-b9f4-1692782d1e81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29d07762-3cff-45af-b965-eebc86047527" xlink:to="loc_us-gaap_Goodwill_54713003-69ca-47f3-b9f4-1692782d1e81" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_adfd3acd-d9be-42e7-8b2e-30fe9d17afff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29d07762-3cff-45af-b965-eebc86047527" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_adfd3acd-d9be-42e7-8b2e-30fe9d17afff" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c8f93451-36fb-4658-89b0-fff6279550c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29d07762-3cff-45af-b965-eebc86047527" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c8f93451-36fb-4658-89b0-fff6279550c3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d3726428-20a6-428e-8060-a1667d57ca7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c8f93451-36fb-4658-89b0-fff6279550c3" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d3726428-20a6-428e-8060-a1667d57ca7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d3726428-20a6-428e-8060-a1667d57ca7c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d3726428-20a6-428e-8060-a1667d57ca7c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d3726428-20a6-428e-8060-a1667d57ca7c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_092f3eae-3faf-417c-a65b-f1ec9d00c0a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d3726428-20a6-428e-8060-a1667d57ca7c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_092f3eae-3faf-417c-a65b-f1ec9d00c0a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_THMEDLLCMember_6beef87e-54ad-4628-8b4c-059b9366fb30" xlink:href="docs-20220331.xsd#docs_THMEDLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_092f3eae-3faf-417c-a65b-f1ec9d00c0a0" xlink:to="loc_docs_THMEDLLCMember_6beef87e-54ad-4628-8b4c-059b9366fb30" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillIntangibleAssetsNetDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#BusinessCombinationsIntangibleAssetsandGoodwillIntangibleAssetsNetDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillIntangibleAssetsNetDetails" xlink:type="extended" id="i43c3c8a7663c4150a14e7108523e81d9_BusinessCombinationsIntangibleAssetsandGoodwillIntangibleAssetsNetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_18b84a43-9a50-468b-a3dc-692d03c44f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_b025b08f-931c-49d1-aa01-576312680a65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_18b84a43-9a50-468b-a3dc-692d03c44f7f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_b025b08f-931c-49d1-aa01-576312680a65" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2a89f301-b0e4-488c-94a2-d7cca74af8b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_18b84a43-9a50-468b-a3dc-692d03c44f7f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2a89f301-b0e4-488c-94a2-d7cca74af8b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2ba44ac9-fafc-43b2-9859-f92b91c8f921" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_18b84a43-9a50-468b-a3dc-692d03c44f7f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2ba44ac9-fafc-43b2-9859-f92b91c8f921" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ecb6c751-2a58-44b3-8c29-2e562b43f141" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_18b84a43-9a50-468b-a3dc-692d03c44f7f" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ecb6c751-2a58-44b3-8c29-2e562b43f141" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a589d09e-62a0-49c6-bfa4-ff83b868f95c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ecb6c751-2a58-44b3-8c29-2e562b43f141" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a589d09e-62a0-49c6-bfa4-ff83b868f95c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a589d09e-62a0-49c6-bfa4-ff83b868f95c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a589d09e-62a0-49c6-bfa4-ff83b868f95c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_a589d09e-62a0-49c6-bfa4-ff83b868f95c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_df0f22fe-f0ef-45b4-945f-ab7a04926978" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a589d09e-62a0-49c6-bfa4-ff83b868f95c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_df0f22fe-f0ef-45b4-945f-ab7a04926978" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_f1d80313-45bf-4d8e-818e-e18a25095408" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_df0f22fe-f0ef-45b4-945f-ab7a04926978" xlink:to="loc_us-gaap_CustomerRelationshipsMember_f1d80313-45bf-4d8e-818e-e18a25095408" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternetDomainNamesMember_892beaf4-5cb5-4414-bf2f-10543b287497" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternetDomainNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_df0f22fe-f0ef-45b4-945f-ab7a04926978" xlink:to="loc_us-gaap_InternetDomainNamesMember_892beaf4-5cb5-4414-bf2f-10543b287497" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#RedeemableConvertiblePreferredStockNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails" xlink:type="extended" id="i39e1fe03d18e4b61a3f830f0c774af05_RedeemableConvertiblePreferredStockNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TemporaryEquityPreferredStockOutstandingSeries_5cc7a4c6-448b-4e6b-ab36-f70cd33b3af9" xlink:href="docs-20220331.xsd#docs_TemporaryEquityPreferredStockOutstandingSeries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:to="loc_docs_TemporaryEquityPreferredStockOutstandingSeries_5cc7a4c6-448b-4e6b-ab36-f70cd33b3af9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_67218e7d-f95a-49cc-8da8-b9b39108bda5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:to="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_67218e7d-f95a-49cc-8da8-b9b39108bda5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesIssued1_e4b6f595-8a83-4857-933f-fd9c350e1e11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:to="loc_us-gaap_ConversionOfStockSharesIssued1_e4b6f595-8a83-4857-933f-fd9c350e1e11" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ConversionOfStockConversionRatio_18dfd48b-ae71-4607-8d4a-ddfba25987ba" xlink:href="docs-20220331.xsd#docs_ConversionOfStockConversionRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:to="loc_docs_ConversionOfStockConversionRatio_18dfd48b-ae71-4607-8d4a-ddfba25987ba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_710b52e5-1ad3-4149-9012-1b6216dd1f47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationsOfTemporaryToPermanentEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:to="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_710b52e5-1ad3-4149-9012-1b6216dd1f47" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_1f3f229f-6000-40e8-8ce2-33b6942370d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_1f3f229f-6000-40e8-8ce2-33b6942370d1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_856ac8e8-8a07-4437-95db-fc15e47a8778" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_856ac8e8-8a07-4437-95db-fc15e47a8778" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLiquidationPreferencePerShare_ab29b372-86f2-418f-8879-58a36af0cae0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreferencePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:to="loc_us-gaap_TemporaryEquityLiquidationPreferencePerShare_ab29b372-86f2-418f-8879-58a36af0cae0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TemporaryEquityDividendRate_771434e8-d180-4559-97cb-23da84ad2bed" xlink:href="docs-20220331.xsd#docs_TemporaryEquityDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:to="loc_docs_TemporaryEquityDividendRate_771434e8-d180-4559-97cb-23da84ad2bed" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CommonStockVotingRightsNumberOfVotes_3ed10bb0-3ef5-44ed-a29f-0692664faa3b" xlink:href="docs-20220331.xsd#docs_CommonStockVotingRightsNumberOfVotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:to="loc_docs_CommonStockVotingRightsNumberOfVotes_3ed10bb0-3ef5-44ed-a29f-0692664faa3b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TemporaryEquityElectionOfBoardMembersSharesOutstandingThreshold_1c610806-366b-430a-9c36-3a17e9ba7091" xlink:href="docs-20220331.xsd#docs_TemporaryEquityElectionOfBoardMembersSharesOutstandingThreshold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:to="loc_docs_TemporaryEquityElectionOfBoardMembersSharesOutstandingThreshold_1c610806-366b-430a-9c36-3a17e9ba7091" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TemporaryEquitySharesOutstandingThresholdSatisfiedNumberOfElectedBoardMembersPermitted_07730a0f-aa24-46cc-9548-602ec3d7ac35" xlink:href="docs-20220331.xsd#docs_TemporaryEquitySharesOutstandingThresholdSatisfiedNumberOfElectedBoardMembersPermitted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:to="loc_docs_TemporaryEquitySharesOutstandingThresholdSatisfiedNumberOfElectedBoardMembersPermitted_07730a0f-aa24-46cc-9548-602ec3d7ac35" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CommonStockHoldingMajorityNumberOfElectedBoardMembersPermitted_e721b095-f582-41c6-b3c5-039c52f55bd0" xlink:href="docs-20220331.xsd#docs_CommonStockHoldingMajorityNumberOfElectedBoardMembersPermitted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:to="loc_docs_CommonStockHoldingMajorityNumberOfElectedBoardMembersPermitted_e721b095-f582-41c6-b3c5-039c52f55bd0" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TemporaryEquityConvertibleStockPriceTrigger_8a9a32ec-f7f4-4866-9d35-ba74d19c91a5" xlink:href="docs-20220331.xsd#docs_TemporaryEquityConvertibleStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:to="loc_docs_TemporaryEquityConvertibleStockPriceTrigger_8a9a32ec-f7f4-4866-9d35-ba74d19c91a5" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TemporaryEquityConvertibleAggregateOfferingPriceTrigger_4e51e802-a285-478e-82cd-917ddd973863" xlink:href="docs-20220331.xsd#docs_TemporaryEquityConvertibleAggregateOfferingPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:to="loc_docs_TemporaryEquityConvertibleAggregateOfferingPriceTrigger_4e51e802-a285-478e-82cd-917ddd973863" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_765766c6-fa25-452f-ab93-41ede501b349" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_765766c6-fa25-452f-ab93-41ede501b349" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_8522b7c9-b9cc-49bd-83b5-ffcc37832e6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_8522b7c9-b9cc-49bd-83b5-ffcc37832e6a" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_80e7188c-6d24-4170-9e4f-cbb023b1b7ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_80e7188c-6d24-4170-9e4f-cbb023b1b7ec" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_f4293f09-f408-4664-89e2-f1140a50a7ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_f4293f09-f408-4664-89e2-f1140a50a7ef" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_e314db12-56b3-4e0a-96ef-ea54192c07f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_e314db12-56b3-4e0a-96ef-ea54192c07f4" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_081e475d-e4b0-499b-88f8-e03670743149" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_081e475d-e4b0-499b-88f8-e03670743149" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_72b100cc-0619-4721-94c6-12e534595ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_081e475d-e4b0-499b-88f8-e03670743149" xlink:to="loc_us-gaap_StatementClassOfStockAxis_72b100cc-0619-4721-94c6-12e534595ad5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_72b100cc-0619-4721-94c6-12e534595ad5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_72b100cc-0619-4721-94c6-12e534595ad5" xlink:to="loc_us-gaap_ClassOfStockDomain_72b100cc-0619-4721-94c6-12e534595ad5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_e5e8cc31-f7bb-4a2a-8e78-6d226927218e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_72b100cc-0619-4721-94c6-12e534595ad5" xlink:to="loc_us-gaap_ClassOfStockDomain_e5e8cc31-f7bb-4a2a-8e78-6d226927218e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_7ae7ac24-c9ab-4876-8315-1e84f919719f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e5e8cc31-f7bb-4a2a-8e78-6d226927218e" xlink:to="loc_us-gaap_CommonClassBMember_7ae7ac24-c9ab-4876-8315-1e84f919719f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_b5311e78-bf82-4bd4-a8d9-410d3562fdee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e5e8cc31-f7bb-4a2a-8e78-6d226927218e" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_b5311e78-bf82-4bd4-a8d9-410d3562fdee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_5c8b25a7-54b6-4db6-8628-c47d7c3bf6a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e5e8cc31-f7bb-4a2a-8e78-6d226927218e" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_5c8b25a7-54b6-4db6-8628-c47d7c3bf6a0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesCPreferredStockMember_dda7c909-d1e6-4d67-834f-d7fb1ef6fbc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e5e8cc31-f7bb-4a2a-8e78-6d226927218e" xlink:to="loc_us-gaap_SeriesCPreferredStockMember_dda7c909-d1e6-4d67-834f-d7fb1ef6fbc6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_617b7e7a-5e77-4d78-a777-cbad9fd44cab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_081e475d-e4b0-499b-88f8-e03670743149" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_617b7e7a-5e77-4d78-a777-cbad9fd44cab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_617b7e7a-5e77-4d78-a777-cbad9fd44cab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_617b7e7a-5e77-4d78-a777-cbad9fd44cab" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_617b7e7a-5e77-4d78-a777-cbad9fd44cab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_babc0699-6d6f-4c5f-81b5-59197eae9b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_617b7e7a-5e77-4d78-a777-cbad9fd44cab" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_babc0699-6d6f-4c5f-81b5-59197eae9b0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_RedeemableConvertiblePreferredStockWarrantsMember_35d33028-8ba9-4710-a072-febb63ca1575" xlink:href="docs-20220331.xsd#docs_RedeemableConvertiblePreferredStockWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_babc0699-6d6f-4c5f-81b5-59197eae9b0b" xlink:to="loc_docs_RedeemableConvertiblePreferredStockWarrantsMember_35d33028-8ba9-4710-a072-febb63ca1575" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_460afd0a-1acd-49b4-b0c5-0bdf4a5e8433" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_081e475d-e4b0-499b-88f8-e03670743149" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_460afd0a-1acd-49b4-b0c5-0bdf4a5e8433" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_460afd0a-1acd-49b4-b0c5-0bdf4a5e8433_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_460afd0a-1acd-49b4-b0c5-0bdf4a5e8433" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_460afd0a-1acd-49b4-b0c5-0bdf4a5e8433_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_6606437e-2512-421a-a529-62fd4866e477" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_460afd0a-1acd-49b4-b0c5-0bdf4a5e8433" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_6606437e-2512-421a-a529-62fd4866e477" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_693c97e7-70d7-4cae-bc22-31a6ea10c5db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6606437e-2512-421a-a529-62fd4866e477" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_693c97e7-70d7-4cae-bc22-31a6ea10c5db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_52d72bfe-51ff-4e33-b4b1-1bacfbb9c204" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6606437e-2512-421a-a529-62fd4866e477" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_52d72bfe-51ff-4e33-b4b1-1bacfbb9c204" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_347d3fc0-ca41-4a47-a586-2fe618db659e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6606437e-2512-421a-a529-62fd4866e477" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_347d3fc0-ca41-4a47-a586-2fe618db659e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_28b17a38-9894-4c5a-998b-48aae5ff3aac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6606437e-2512-421a-a529-62fd4866e477" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_28b17a38-9894-4c5a-998b-48aae5ff3aac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_249501dc-9d08-48c8-9323-6205de0487fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_081e475d-e4b0-499b-88f8-e03670743149" xlink:to="loc_us-gaap_ValuationTechniqueAxis_249501dc-9d08-48c8-9323-6205de0487fc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_249501dc-9d08-48c8-9323-6205de0487fc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationTechniqueAxis_249501dc-9d08-48c8-9323-6205de0487fc" xlink:to="loc_us-gaap_ValuationTechniqueDomain_249501dc-9d08-48c8-9323-6205de0487fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_2b4a2545-67d4-4188-b4cd-0540f3716716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationTechniqueAxis_249501dc-9d08-48c8-9323-6205de0487fc" xlink:to="loc_us-gaap_ValuationTechniqueDomain_2b4a2545-67d4-4188-b4cd-0540f3716716" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueOptionPricingModelMember_3cb18c62-2883-4463-9fe4-b981d1b45546" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationTechniqueDomain_2b4a2545-67d4-4188-b4cd-0540f3716716" xlink:to="loc_us-gaap_ValuationTechniqueOptionPricingModelMember_3cb18c62-2883-4463-9fe4-b981d1b45546" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockOutstandingDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockOutstandingDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockOutstandingDetails" xlink:type="extended" id="id1ee29ac246444e4a3702430fa5d47e2_RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockOutstandingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems_28a9e712-8028-4c9d-aced-f034b21b46e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_e5e79544-a54e-4b68-8097-2a4e43084fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_28a9e712-8028-4c9d-aced-f034b21b46e9" xlink:to="loc_us-gaap_TemporaryEquitySharesAuthorized_e5e79544-a54e-4b68-8097-2a4e43084fe7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_b3dd97ca-483c-4e09-aecb-1390da0b0805" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_28a9e712-8028-4c9d-aced-f034b21b46e9" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_b3dd97ca-483c-4e09-aecb-1390da0b0805" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_1067204e-774b-4ad5-8751-fdf2d657f93d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_28a9e712-8028-4c9d-aced-f034b21b46e9" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_1067204e-774b-4ad5-8751-fdf2d657f93d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_01c5a5fe-a6b8-4eac-86c5-6ab99f7aadf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_28a9e712-8028-4c9d-aced-f034b21b46e9" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_01c5a5fe-a6b8-4eac-86c5-6ab99f7aadf3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLiquidationPreference_c00f1476-e74e-437f-bcf3-39931ce39d4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_28a9e712-8028-4c9d-aced-f034b21b46e9" xlink:to="loc_us-gaap_TemporaryEquityLiquidationPreference_c00f1476-e74e-437f-bcf3-39931ce39d4d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_636abd99-a0da-4999-9a2e-e6ff782e469b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_TemporaryEquityLineItems_28a9e712-8028-4c9d-aced-f034b21b46e9" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_636abd99-a0da-4999-9a2e-e6ff782e469b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_6376f25c-9028-47a1-a536-f0dc4928101d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_636abd99-a0da-4999-9a2e-e6ff782e469b" xlink:to="loc_us-gaap_StatementClassOfStockAxis_6376f25c-9028-47a1-a536-f0dc4928101d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_6376f25c-9028-47a1-a536-f0dc4928101d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_6376f25c-9028-47a1-a536-f0dc4928101d" xlink:to="loc_us-gaap_ClassOfStockDomain_6376f25c-9028-47a1-a536-f0dc4928101d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_8dd98c06-21c8-41bd-8bc5-e50a048df32c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_6376f25c-9028-47a1-a536-f0dc4928101d" xlink:to="loc_us-gaap_ClassOfStockDomain_8dd98c06-21c8-41bd-8bc5-e50a048df32c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_7705aba8-681f-48fc-96a4-007eaaf2238f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_8dd98c06-21c8-41bd-8bc5-e50a048df32c" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_7705aba8-681f-48fc-96a4-007eaaf2238f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_59a22e4c-a5a0-4f26-bbcb-1f43a87c8cbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_8dd98c06-21c8-41bd-8bc5-e50a048df32c" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_59a22e4c-a5a0-4f26-bbcb-1f43a87c8cbe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesCPreferredStockMember_7ac92b0d-b79f-41f6-a162-5a2d1eab84f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_8dd98c06-21c8-41bd-8bc5-e50a048df32c" xlink:to="loc_us-gaap_SeriesCPreferredStockMember_7ac92b0d-b79f-41f6-a162-5a2d1eab84f0" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityCommonStockandCreationofDualClassStructureDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#EquityCommonStockandCreationofDualClassStructureDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/EquityCommonStockandCreationofDualClassStructureDetails" xlink:type="extended" id="ia932b434246c4539b919945c1dede137_EquityCommonStockandCreationofDualClassStructureDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_77a0e86a-e397-4597-bdaf-542b31bc7135" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_ea3c0fe8-d53c-4797-a1f2-68e95f751483" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_77a0e86a-e397-4597-bdaf-542b31bc7135" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_ea3c0fe8-d53c-4797-a1f2-68e95f751483" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_8df05da9-4007-4ff4-9c2e-8413ef30355a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_77a0e86a-e397-4597-bdaf-542b31bc7135" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_8df05da9-4007-4ff4-9c2e-8413ef30355a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CommonStockVotingRightsNumberOfVotes_506891f9-fc7d-48ef-a49f-47b3580d7ff5" xlink:href="docs-20220331.xsd#docs_CommonStockVotingRightsNumberOfVotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_77a0e86a-e397-4597-bdaf-542b31bc7135" xlink:to="loc_docs_CommonStockVotingRightsNumberOfVotes_506891f9-fc7d-48ef-a49f-47b3580d7ff5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_cfac3ba6-d8a7-4286-a47e-ef218ef573ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_77a0e86a-e397-4597-bdaf-542b31bc7135" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_cfac3ba6-d8a7-4286-a47e-ef218ef573ad" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ConversionOfStockConversionRatio_b72dec74-0384-4ea4-9317-b3da48025994" xlink:href="docs-20220331.xsd#docs_ConversionOfStockConversionRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_77a0e86a-e397-4597-bdaf-542b31bc7135" xlink:to="loc_docs_ConversionOfStockConversionRatio_b72dec74-0384-4ea4-9317-b3da48025994" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_73afc68b-c284-4cd9-84f7-cfa18145adca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_77a0e86a-e397-4597-bdaf-542b31bc7135" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_73afc68b-c284-4cd9-84f7-cfa18145adca" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fdd3e95e-8075-4f82-b62b-5a5cfe681b1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_77a0e86a-e397-4597-bdaf-542b31bc7135" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fdd3e95e-8075-4f82-b62b-5a5cfe681b1a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_65ddb7c0-53bc-4704-8f72-088d9648e103" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fdd3e95e-8075-4f82-b62b-5a5cfe681b1a" xlink:to="loc_us-gaap_StatementClassOfStockAxis_65ddb7c0-53bc-4704-8f72-088d9648e103" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_65ddb7c0-53bc-4704-8f72-088d9648e103_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_65ddb7c0-53bc-4704-8f72-088d9648e103" xlink:to="loc_us-gaap_ClassOfStockDomain_65ddb7c0-53bc-4704-8f72-088d9648e103_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_998f1f45-96f9-4be3-9f75-f8741b93f54c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_65ddb7c0-53bc-4704-8f72-088d9648e103" xlink:to="loc_us-gaap_ClassOfStockDomain_998f1f45-96f9-4be3-9f75-f8741b93f54c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_ea29876f-4509-40e5-a7b0-f8bb9ae38d66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_998f1f45-96f9-4be3-9f75-f8741b93f54c" xlink:to="loc_us-gaap_CommonClassAMember_ea29876f-4509-40e5-a7b0-f8bb9ae38d66" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_2d7a556b-798f-4eb9-880a-15c1978a8b41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_998f1f45-96f9-4be3-9f75-f8741b93f54c" xlink:to="loc_us-gaap_CommonClassBMember_2d7a556b-798f-4eb9-880a-15c1978a8b41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_9f73938f-2d12-4d89-9bd9-f63e921e57f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_998f1f45-96f9-4be3-9f75-f8741b93f54c" xlink:to="loc_us-gaap_CommonStockMember_9f73938f-2d12-4d89-9bd9-f63e921e57f6" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityCommonStockWarrantsDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#EquityCommonStockWarrantsDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/EquityCommonStockWarrantsDetails" xlink:type="extended" id="idc470b7c49094355b4c25e8eec080cdd_EquityCommonStockWarrantsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a29cb1fa-fac3-4bf0-bc04-3d4c2d088516" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_3a5cc31c-797a-40bc-bd19-c743fcbbed0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a29cb1fa-fac3-4bf0-bc04-3d4c2d088516" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_3a5cc31c-797a-40bc-bd19-c743fcbbed0b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_bc808c45-b29a-4b74-9fe6-3e9d47152f59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a29cb1fa-fac3-4bf0-bc04-3d4c2d088516" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_bc808c45-b29a-4b74-9fe6-3e9d47152f59" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_WarrantsAndRightsOutstandingVestingPeriod_6224b16d-4cd5-4f69-924a-d15f6df42d09" xlink:href="docs-20220331.xsd#docs_WarrantsAndRightsOutstandingVestingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a29cb1fa-fac3-4bf0-bc04-3d4c2d088516" xlink:to="loc_docs_WarrantsAndRightsOutstandingVestingPeriod_6224b16d-4cd5-4f69-924a-d15f6df42d09" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_850e99a1-79cc-4679-954b-3e26ac5b5862" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a29cb1fa-fac3-4bf0-bc04-3d4c2d088516" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_850e99a1-79cc-4679-954b-3e26ac5b5862" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_77e63576-09f0-4cf4-8e0e-649c330d9b20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a29cb1fa-fac3-4bf0-bc04-3d4c2d088516" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_77e63576-09f0-4cf4-8e0e-649c330d9b20" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_e543b577-8207-44db-beb0-6778c00f8a84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a29cb1fa-fac3-4bf0-bc04-3d4c2d088516" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_e543b577-8207-44db-beb0-6778c00f8a84" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_8b03de3f-9e3b-45cd-9378-6c4759181e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a29cb1fa-fac3-4bf0-bc04-3d4c2d088516" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_8b03de3f-9e3b-45cd-9378-6c4759181e7e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_ab6810c4-537f-4fe1-9fd3-49db9523d2a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a29cb1fa-fac3-4bf0-bc04-3d4c2d088516" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_ab6810c4-537f-4fe1-9fd3-49db9523d2a3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_082bde14-00f4-41e0-bf32-f8218d934fef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a29cb1fa-fac3-4bf0-bc04-3d4c2d088516" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_082bde14-00f4-41e0-bf32-f8218d934fef" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_aa98746c-0bcf-438d-a711-9aa0bad55368" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a29cb1fa-fac3-4bf0-bc04-3d4c2d088516" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_aa98746c-0bcf-438d-a711-9aa0bad55368" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1f27a717-8743-45ea-ae93-4b0c22f8572b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_aa98746c-0bcf-438d-a711-9aa0bad55368" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1f27a717-8743-45ea-ae93-4b0c22f8572b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_1f27a717-8743-45ea-ae93-4b0c22f8572b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1f27a717-8743-45ea-ae93-4b0c22f8572b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_1f27a717-8743-45ea-ae93-4b0c22f8572b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_07878863-e5dc-41b7-80a4-9167abb33eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1f27a717-8743-45ea-ae93-4b0c22f8572b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_07878863-e5dc-41b7-80a4-9167abb33eb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ContractWithUSNewsWorldReportLPMember_f903d9c0-31dd-4342-8292-891567fd2158" xlink:href="docs-20220331.xsd#docs_ContractWithUSNewsWorldReportLPMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_07878863-e5dc-41b7-80a4-9167abb33eb3" xlink:to="loc_docs_ContractWithUSNewsWorldReportLPMember_f903d9c0-31dd-4342-8292-891567fd2158" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_USNewsWarrantMember_ab1e2039-0dc2-4de2-8500-a619ce801284" xlink:href="docs-20220331.xsd#docs_USNewsWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_07878863-e5dc-41b7-80a4-9167abb33eb3" xlink:to="loc_docs_USNewsWarrantMember_ab1e2039-0dc2-4de2-8500-a619ce801284" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_1fe5c220-e267-4305-a01c-066e92739152" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_aa98746c-0bcf-438d-a711-9aa0bad55368" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_1fe5c220-e267-4305-a01c-066e92739152" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_1fe5c220-e267-4305-a01c-066e92739152_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_1fe5c220-e267-4305-a01c-066e92739152" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_1fe5c220-e267-4305-a01c-066e92739152_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_160530f8-5004-4464-a417-57891a9c221a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_1fe5c220-e267-4305-a01c-066e92739152" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_160530f8-5004-4464-a417-57891a9c221a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_8330b8a4-e70c-4aa2-9c29-29dc8baacd5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputSharePriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_160530f8-5004-4464-a417-57891a9c221a" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_8330b8a4-e70c-4aa2-9c29-29dc8baacd5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_92dc08de-be80-4914-9e35-0962108f27a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_160530f8-5004-4464-a417-57891a9c221a" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_92dc08de-be80-4914-9e35-0962108f27a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_b6aadd5a-7ed4-4ec2-b6f8-122a37856121" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_160530f8-5004-4464-a417-57891a9c221a" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_b6aadd5a-7ed4-4ec2-b6f8-122a37856121" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_ec9e4b54-09eb-4f04-b7e2-cc9d0e696f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_160530f8-5004-4464-a417-57891a9c221a" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_ec9e4b54-09eb-4f04-b7e2-cc9d0e696f9c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_33d7dd44-98cc-44a3-85a8-ed598baada27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_160530f8-5004-4464-a417-57891a9c221a" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_33d7dd44-98cc-44a3-85a8-ed598baada27" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityEquityIncentivePlansDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#EquityEquityIncentivePlansDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/EquityEquityIncentivePlansDetails" xlink:type="extended" id="ia67db66a7cd343dc9e1cb43a3edfa4d5_EquityEquityIncentivePlansDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb8db9b7-c10a-4c0e-8d0d-7d0f80c8e38c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock_308e82be-f53a-4d5b-9cbe-5ff8b6be07a2" xlink:href="docs-20220331.xsd#docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb8db9b7-c10a-4c0e-8d0d-7d0f80c8e38c" xlink:to="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock_308e82be-f53a-4d5b-9cbe-5ff8b6be07a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold_9572dfb5-128f-4044-bce0-64a2941e5c00" xlink:href="docs-20220331.xsd#docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb8db9b7-c10a-4c0e-8d0d-7d0f80c8e38c" xlink:to="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold_9572dfb5-128f-4044-bce0-64a2941e5c00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c8478fcd-fa9c-476c-9e54-0310ddfd14fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb8db9b7-c10a-4c0e-8d0d-7d0f80c8e38c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c8478fcd-fa9c-476c-9e54-0310ddfd14fd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_02b5e91f-d649-476c-bde2-45216e79e82a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb8db9b7-c10a-4c0e-8d0d-7d0f80c8e38c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_02b5e91f-d649-476c-bde2-45216e79e82a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_1f19ff00-52bb-429a-a05a-99dc079b46bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb8db9b7-c10a-4c0e-8d0d-7d0f80c8e38c" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_1f19ff00-52bb-429a-a05a-99dc079b46bb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding_7d194c0d-3e31-47f8-9c46-60079a70bf6f" xlink:href="docs-20220331.xsd#docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb8db9b7-c10a-4c0e-8d0d-7d0f80c8e38c" xlink:to="loc_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding_7d194c0d-3e31-47f8-9c46-60079a70bf6f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease_54fae8d0-e984-4bbe-8e1d-5c536e8f965c" xlink:href="docs-20220331.xsd#docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb8db9b7-c10a-4c0e-8d0d-7d0f80c8e38c" xlink:to="loc_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease_54fae8d0-e984-4bbe-8e1d-5c536e8f965c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4ee87f92-794c-4fa6-95df-fd589225ecbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb8db9b7-c10a-4c0e-8d0d-7d0f80c8e38c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4ee87f92-794c-4fa6-95df-fd589225ecbf" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised_e9554af4-d077-4340-9454-0a0f81a7ea47" xlink:href="docs-20220331.xsd#docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb8db9b7-c10a-4c0e-8d0d-7d0f80c8e38c" xlink:to="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised_e9554af4-d077-4340-9454-0a0f81a7ea47" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2706a48d-9d19-4110-840f-8659cf6261f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb8db9b7-c10a-4c0e-8d0d-7d0f80c8e38c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2706a48d-9d19-4110-840f-8659cf6261f6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c7abe67f-b1d0-43da-b30e-3de047e16ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb8db9b7-c10a-4c0e-8d0d-7d0f80c8e38c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c7abe67f-b1d0-43da-b30e-3de047e16ddc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_3df09b15-733b-428d-b55e-8c68f29e2eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c7abe67f-b1d0-43da-b30e-3de047e16ddc" xlink:to="loc_us-gaap_PlanNameAxis_3df09b15-733b-428d-b55e-8c68f29e2eeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_3df09b15-733b-428d-b55e-8c68f29e2eeb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_3df09b15-733b-428d-b55e-8c68f29e2eeb" xlink:to="loc_us-gaap_PlanNameDomain_3df09b15-733b-428d-b55e-8c68f29e2eeb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_a195f592-f7ad-4978-8d3b-c005d5e7785c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_3df09b15-733b-428d-b55e-8c68f29e2eeb" xlink:to="loc_us-gaap_PlanNameDomain_a195f592-f7ad-4978-8d3b-c005d5e7785c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_EquityIncentivePlan2010Member_d88441b5-06db-4db1-bc82-97051c26ed0d" xlink:href="docs-20220331.xsd#docs_EquityIncentivePlan2010Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_a195f592-f7ad-4978-8d3b-c005d5e7785c" xlink:to="loc_docs_EquityIncentivePlan2010Member_d88441b5-06db-4db1-bc82-97051c26ed0d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_StockOptionAndIncentivePlan2021Member_ef72d81c-2bf2-4f9e-8c24-4a7bab0efc46" xlink:href="docs-20220331.xsd#docs_StockOptionAndIncentivePlan2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_a195f592-f7ad-4978-8d3b-c005d5e7785c" xlink:to="loc_docs_StockOptionAndIncentivePlan2021Member_ef72d81c-2bf2-4f9e-8c24-4a7bab0efc46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_EmployeeStockPurchasePlan2021Member_adee5f3b-30aa-44b6-9d4b-0f92f15ba71c" xlink:href="docs-20220331.xsd#docs_EmployeeStockPurchasePlan2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_a195f592-f7ad-4978-8d3b-c005d5e7785c" xlink:to="loc_docs_EmployeeStockPurchasePlan2021Member_adee5f3b-30aa-44b6-9d4b-0f92f15ba71c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member_95748055-f886-46e5-ac51-380352cb9a56" xlink:href="docs-20220331.xsd#docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_a195f592-f7ad-4978-8d3b-c005d5e7785c" xlink:to="loc_docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member_95748055-f886-46e5-ac51-380352cb9a56" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_3a8954c9-6434-488c-8a48-6c3802b658a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c7abe67f-b1d0-43da-b30e-3de047e16ddc" xlink:to="loc_us-gaap_GranteeStatusAxis_3a8954c9-6434-488c-8a48-6c3802b658a5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_3a8954c9-6434-488c-8a48-6c3802b658a5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GranteeStatusAxis_3a8954c9-6434-488c-8a48-6c3802b658a5" xlink:to="loc_us-gaap_GranteeStatusDomain_3a8954c9-6434-488c-8a48-6c3802b658a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_51f10cdc-67c0-4016-ae83-1256f9f17d08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GranteeStatusAxis_3a8954c9-6434-488c-8a48-6c3802b658a5" xlink:to="loc_us-gaap_GranteeStatusDomain_51f10cdc-67c0-4016-ae83-1256f9f17d08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_IndividualsWithVotingInterestLessThanThresholdMember_348910bd-1d90-4160-a25f-d0d8d649647e" xlink:href="docs-20220331.xsd#docs_IndividualsWithVotingInterestLessThanThresholdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GranteeStatusDomain_51f10cdc-67c0-4016-ae83-1256f9f17d08" xlink:to="loc_docs_IndividualsWithVotingInterestLessThanThresholdMember_348910bd-1d90-4160-a25f-d0d8d649647e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_IndividualsWithVotingInterestAtThresholdMember_a547fc40-3cdb-4b2f-97a2-5069594a06cd" xlink:href="docs-20220331.xsd#docs_IndividualsWithVotingInterestAtThresholdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GranteeStatusDomain_51f10cdc-67c0-4016-ae83-1256f9f17d08" xlink:to="loc_docs_IndividualsWithVotingInterestAtThresholdMember_a547fc40-3cdb-4b2f-97a2-5069594a06cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_9d30f648-e1f0-4f90-938a-61a824c25ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c7abe67f-b1d0-43da-b30e-3de047e16ddc" xlink:to="loc_us-gaap_AwardTypeAxis_9d30f648-e1f0-4f90-938a-61a824c25ac5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9d30f648-e1f0-4f90-938a-61a824c25ac5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_9d30f648-e1f0-4f90-938a-61a824c25ac5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9d30f648-e1f0-4f90-938a-61a824c25ac5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_46607ce4-33e2-4ea9-9c47-0f70d2e363c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_9d30f648-e1f0-4f90-938a-61a824c25ac5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_46607ce4-33e2-4ea9-9c47-0f70d2e363c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_2b937d10-6f1b-49f3-829a-93ca5419ade6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_46607ce4-33e2-4ea9-9c47-0f70d2e363c2" xlink:to="loc_us-gaap_EmployeeStockOptionMember_2b937d10-6f1b-49f3-829a-93ca5419ade6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#EquityCommonStockReservedforIssuanceDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails" xlink:type="extended" id="i51cde5d622054ce6b89f447b2696d3cb_EquityCommonStockReservedforIssuanceDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_2ee14d53-e836-4733-8af4-365ea75fee4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_031e52ed-18f3-4cd3-afb6-bcbe6b33e2ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_2ee14d53-e836-4733-8af4-365ea75fee4b" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_031e52ed-18f3-4cd3-afb6-bcbe6b33e2ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_4ad54efb-0633-45a8-a5a9-413a0c51025c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_2ee14d53-e836-4733-8af4-365ea75fee4b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_4ad54efb-0633-45a8-a5a9-413a0c51025c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_26a36896-0a62-4efa-9cea-fc9ea068b985" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_2ee14d53-e836-4733-8af4-365ea75fee4b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_26a36896-0a62-4efa-9cea-fc9ea068b985" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_649cd79a-eabe-4202-b02c-1179815d912e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_2ee14d53-e836-4733-8af4-365ea75fee4b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_649cd79a-eabe-4202-b02c-1179815d912e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_70a415ec-85d8-47ec-9707-cb76496c4ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_2ee14d53-e836-4733-8af4-365ea75fee4b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_70a415ec-85d8-47ec-9707-cb76496c4ec0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_f8a06b29-da63-4d3b-ac81-b1a622e3169f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_2ee14d53-e836-4733-8af4-365ea75fee4b" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_f8a06b29-da63-4d3b-ac81-b1a622e3169f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7fb2a6ba-9a90-4e69-8015-646724d97415" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_2ee14d53-e836-4733-8af4-365ea75fee4b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7fb2a6ba-9a90-4e69-8015-646724d97415" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_44eecb64-6a59-49f9-93c7-f5fe91cf98f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7fb2a6ba-9a90-4e69-8015-646724d97415" xlink:to="loc_us-gaap_PlanNameAxis_44eecb64-6a59-49f9-93c7-f5fe91cf98f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_44eecb64-6a59-49f9-93c7-f5fe91cf98f6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_44eecb64-6a59-49f9-93c7-f5fe91cf98f6" xlink:to="loc_us-gaap_PlanNameDomain_44eecb64-6a59-49f9-93c7-f5fe91cf98f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_3ff30a02-6fed-4729-8a77-7c59b897db4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_44eecb64-6a59-49f9-93c7-f5fe91cf98f6" xlink:to="loc_us-gaap_PlanNameDomain_3ff30a02-6fed-4729-8a77-7c59b897db4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_EquityIncentivePlan2010Member_9114a589-591e-4bf6-98e0-810e72d0d27c" xlink:href="docs-20220331.xsd#docs_EquityIncentivePlan2010Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_3ff30a02-6fed-4729-8a77-7c59b897db4e" xlink:to="loc_docs_EquityIncentivePlan2010Member_9114a589-591e-4bf6-98e0-810e72d0d27c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_StockOptionAndIncentivePlan2021Member_c846bb07-6bdd-4402-9cbb-57b97911c607" xlink:href="docs-20220331.xsd#docs_StockOptionAndIncentivePlan2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_3ff30a02-6fed-4729-8a77-7c59b897db4e" xlink:to="loc_docs_StockOptionAndIncentivePlan2021Member_c846bb07-6bdd-4402-9cbb-57b97911c607" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_EmployeeStockPurchasePlan2021Member_a9103529-3cbf-4da6-9a8a-8e7b1b24060d" xlink:href="docs-20220331.xsd#docs_EmployeeStockPurchasePlan2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_3ff30a02-6fed-4729-8a77-7c59b897db4e" xlink:to="loc_docs_EmployeeStockPurchasePlan2021Member_a9103529-3cbf-4da6-9a8a-8e7b1b24060d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member_0020aa2f-1012-4b8f-bfa3-c2ede9d85b30" xlink:href="docs-20220331.xsd#docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_3ff30a02-6fed-4729-8a77-7c59b897db4e" xlink:to="loc_docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member_0020aa2f-1012-4b8f-bfa3-c2ede9d85b30" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_fb58399c-e254-4a2b-82d8-77cfe40224ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7fb2a6ba-9a90-4e69-8015-646724d97415" xlink:to="loc_us-gaap_AwardTypeAxis_fb58399c-e254-4a2b-82d8-77cfe40224ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fb58399c-e254-4a2b-82d8-77cfe40224ab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_fb58399c-e254-4a2b-82d8-77cfe40224ab" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fb58399c-e254-4a2b-82d8-77cfe40224ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_84254985-85be-464b-8916-6a8a7b480115" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_fb58399c-e254-4a2b-82d8-77cfe40224ab" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_84254985-85be-464b-8916-6a8a7b480115" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PerformanceBasedRestrictedStockUnitsMember_6eafa0f1-0e74-41d4-9d22-0f3420e93c5f" xlink:href="docs-20220331.xsd#docs_PerformanceBasedRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_84254985-85be-464b-8916-6a8a7b480115" xlink:to="loc_docs_PerformanceBasedRestrictedStockUnitsMember_6eafa0f1-0e74-41d4-9d22-0f3420e93c5f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_9c21e03c-fb24-4c00-953e-7ee2556251fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_84254985-85be-464b-8916-6a8a7b480115" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_9c21e03c-fb24-4c00-953e-7ee2556251fa" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#EquityStockOptionsValuationAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails" xlink:type="extended" id="i533e021067534562a78fe13b7307edb1_EquityStockOptionsValuationAssumptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9baa90a-915e-4539-ad39-bf4b1a933ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice_ab9cee5d-a92e-4261-ae8c-ff50fbedfdd1" xlink:href="docs-20220331.xsd#docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9baa90a-915e-4539-ad39-bf4b1a933ac2" xlink:to="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice_ab9cee5d-a92e-4261-ae8c-ff50fbedfdd1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_5b32aeab-a9ad-4056-a131-f96e189d7204" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9baa90a-915e-4539-ad39-bf4b1a933ac2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_5b32aeab-a9ad-4056-a131-f96e189d7204" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_2623dbda-bac7-41bc-94f4-a0af6bc01954" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9baa90a-915e-4539-ad39-bf4b1a933ac2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_2623dbda-bac7-41bc-94f4-a0af6bc01954" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_35484ffd-2ab0-4eba-acba-3a3a5bae4f16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9baa90a-915e-4539-ad39-bf4b1a933ac2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_35484ffd-2ab0-4eba-acba-3a3a5bae4f16" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_d803f9da-6c2c-4ebd-8f5e-9271d3e1bd7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9baa90a-915e-4539-ad39-bf4b1a933ac2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_d803f9da-6c2c-4ebd-8f5e-9271d3e1bd7b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ce3019db-77e3-4240-8d91-5f087f8c32d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9baa90a-915e-4539-ad39-bf4b1a933ac2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ce3019db-77e3-4240-8d91-5f087f8c32d8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_4327d7ba-97ff-4022-b07e-8a9118a9d96d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9baa90a-915e-4539-ad39-bf4b1a933ac2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_4327d7ba-97ff-4022-b07e-8a9118a9d96d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c44429be-75ee-4a3f-a0bb-8de2d5189b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9baa90a-915e-4539-ad39-bf4b1a933ac2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c44429be-75ee-4a3f-a0bb-8de2d5189b3a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_79c503e7-2276-43d7-86c8-1542ac3e4fd4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c44429be-75ee-4a3f-a0bb-8de2d5189b3a" xlink:to="loc_srt_RangeAxis_79c503e7-2276-43d7-86c8-1542ac3e4fd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_79c503e7-2276-43d7-86c8-1542ac3e4fd4_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_79c503e7-2276-43d7-86c8-1542ac3e4fd4" xlink:to="loc_srt_RangeMember_79c503e7-2276-43d7-86c8-1542ac3e4fd4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fb6b7fa6-2105-4cac-95f7-6a5bb47ed57a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_79c503e7-2276-43d7-86c8-1542ac3e4fd4" xlink:to="loc_srt_RangeMember_fb6b7fa6-2105-4cac-95f7-6a5bb47ed57a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c8c65446-c23e-41dd-87d1-81e556c98cc2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_fb6b7fa6-2105-4cac-95f7-6a5bb47ed57a" xlink:to="loc_srt_MinimumMember_c8c65446-c23e-41dd-87d1-81e556c98cc2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c1531511-d0d1-4172-9ce8-f14067e77f8f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_fb6b7fa6-2105-4cac-95f7-6a5bb47ed57a" xlink:to="loc_srt_MaximumMember_c1531511-d0d1-4172-9ce8-f14067e77f8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_5aa9a40f-f6c4-44f7-b0e2-4e08b054cb0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c44429be-75ee-4a3f-a0bb-8de2d5189b3a" xlink:to="loc_us-gaap_AwardTypeAxis_5aa9a40f-f6c4-44f7-b0e2-4e08b054cb0f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5aa9a40f-f6c4-44f7-b0e2-4e08b054cb0f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_5aa9a40f-f6c4-44f7-b0e2-4e08b054cb0f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5aa9a40f-f6c4-44f7-b0e2-4e08b054cb0f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_29f6cbbb-e343-4dfe-8232-337a90654e6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_5aa9a40f-f6c4-44f7-b0e2-4e08b054cb0f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_29f6cbbb-e343-4dfe-8232-337a90654e6b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_a6e2355d-7666-4e61-baff-0e0da813153c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_29f6cbbb-e343-4dfe-8232-337a90654e6b" xlink:to="loc_us-gaap_EmployeeStockOptionMember_a6e2355d-7666-4e61-baff-0e0da813153c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityPerformanceBasedOptionsDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#EquityPerformanceBasedOptionsDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/EquityPerformanceBasedOptionsDetails" xlink:type="extended" id="i5a63a9a7e0964b14a0fe3810d0dd05cf_EquityPerformanceBasedOptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a67aa495-bd37-48d6-af7d-b98a28de633a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_dcd2ea5a-f7b3-45e7-a7d8-25fff9202993" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a67aa495-bd37-48d6-af7d-b98a28de633a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_dcd2ea5a-f7b3-45e7-a7d8-25fff9202993" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_7257f9ca-6424-4f78-957e-15ada43017e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a67aa495-bd37-48d6-af7d-b98a28de633a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_7257f9ca-6424-4f78-957e-15ada43017e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_f2b7be13-fb30-4d79-9847-03c72e033da6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a67aa495-bd37-48d6-af7d-b98a28de633a" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_f2b7be13-fb30-4d79-9847-03c72e033da6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_7e883f2a-1c20-4548-bd8c-3782a6a04da7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a67aa495-bd37-48d6-af7d-b98a28de633a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_7e883f2a-1c20-4548-bd8c-3782a6a04da7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_ba78acec-404f-4343-951d-cef1d4b5613f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a67aa495-bd37-48d6-af7d-b98a28de633a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_ba78acec-404f-4343-951d-cef1d4b5613f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_db58c1f4-3803-4073-9f38-a2be94c7ca92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a67aa495-bd37-48d6-af7d-b98a28de633a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_db58c1f4-3803-4073-9f38-a2be94c7ca92" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_38676193-2ece-4da0-926e-e90cde7ee9b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a67aa495-bd37-48d6-af7d-b98a28de633a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_38676193-2ece-4da0-926e-e90cde7ee9b2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_e3fc641e-a051-422c-990a-26aaf4240ef1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_38676193-2ece-4da0-926e-e90cde7ee9b2" xlink:to="loc_srt_TitleOfIndividualAxis_e3fc641e-a051-422c-990a-26aaf4240ef1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e3fc641e-a051-422c-990a-26aaf4240ef1_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_e3fc641e-a051-422c-990a-26aaf4240ef1" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_e3fc641e-a051-422c-990a-26aaf4240ef1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_02b5927a-cf3b-435e-942d-f2f2c30feef2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_e3fc641e-a051-422c-990a-26aaf4240ef1" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_02b5927a-cf3b-435e-942d-f2f2c30feef2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_8e89722e-7b0a-4fbb-8a39-c16fb68dad7b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_02b5927a-cf3b-435e-942d-f2f2c30feef2" xlink:to="loc_srt_ChiefExecutiveOfficerMember_8e89722e-7b0a-4fbb-8a39-c16fb68dad7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_94e18d39-1195-45df-8875-8591b86d8467" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_38676193-2ece-4da0-926e-e90cde7ee9b2" xlink:to="loc_us-gaap_AwardTypeAxis_94e18d39-1195-45df-8875-8591b86d8467" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_94e18d39-1195-45df-8875-8591b86d8467_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_94e18d39-1195-45df-8875-8591b86d8467" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_94e18d39-1195-45df-8875-8591b86d8467_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_42bf53ae-8df8-4485-b531-2993402e4175" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_94e18d39-1195-45df-8875-8591b86d8467" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_42bf53ae-8df8-4485-b531-2993402e4175" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_d40eca49-3cb7-455b-ac17-5db90000bf97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_42bf53ae-8df8-4485-b531-2993402e4175" xlink:to="loc_us-gaap_PerformanceSharesMember_d40eca49-3cb7-455b-ac17-5db90000bf97" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityRestrictedStockUnitsDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#EquityRestrictedStockUnitsDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/EquityRestrictedStockUnitsDetails" xlink:type="extended" id="i89161d053d5847c6bce485c314f0dafd_EquityRestrictedStockUnitsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_03b2aae7-c5db-443f-ab4f-90ba0399bba7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_962b3f25-b870-4784-8b5c-1e7f3301a986" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_03b2aae7-c5db-443f-ab4f-90ba0399bba7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_962b3f25-b870-4784-8b5c-1e7f3301a986" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_be219fdb-f8f7-4481-8c71-e0bfb0440442" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_03b2aae7-c5db-443f-ab4f-90ba0399bba7" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_be219fdb-f8f7-4481-8c71-e0bfb0440442" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_468903cc-107d-46e2-a1fb-91a48e4562c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_03b2aae7-c5db-443f-ab4f-90ba0399bba7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_468903cc-107d-46e2-a1fb-91a48e4562c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_76c2ce86-c848-4e77-b18b-e476ef48ce70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_03b2aae7-c5db-443f-ab4f-90ba0399bba7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_76c2ce86-c848-4e77-b18b-e476ef48ce70" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_ffe6f88a-0d44-4d83-a893-5a52655d4ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_03b2aae7-c5db-443f-ab4f-90ba0399bba7" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_ffe6f88a-0d44-4d83-a893-5a52655d4ac5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_5f9ff335-1b98-45a6-9f10-6842dce7442e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_03b2aae7-c5db-443f-ab4f-90ba0399bba7" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_5f9ff335-1b98-45a6-9f10-6842dce7442e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_0ae35afc-aa9e-4107-a48b-acf4d7154b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_03b2aae7-c5db-443f-ab4f-90ba0399bba7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_0ae35afc-aa9e-4107-a48b-acf4d7154b8d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_669c589b-bed6-457b-b7f5-3990ff81b168" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_03b2aae7-c5db-443f-ab4f-90ba0399bba7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_669c589b-bed6-457b-b7f5-3990ff81b168" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6462d23b-47ac-407a-8f2b-4192386c83bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_669c589b-bed6-457b-b7f5-3990ff81b168" xlink:to="loc_us-gaap_AwardTypeAxis_6462d23b-47ac-407a-8f2b-4192386c83bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6462d23b-47ac-407a-8f2b-4192386c83bf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_6462d23b-47ac-407a-8f2b-4192386c83bf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6462d23b-47ac-407a-8f2b-4192386c83bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8fbc47ff-1c7a-4a91-9c5e-cdcb76efdee5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_6462d23b-47ac-407a-8f2b-4192386c83bf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8fbc47ff-1c7a-4a91-9c5e-cdcb76efdee5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_c18373c1-65fd-4ccc-8cdd-8fd1a1ac5062" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8fbc47ff-1c7a-4a91-9c5e-cdcb76efdee5" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_c18373c1-65fd-4ccc-8cdd-8fd1a1ac5062" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_d3c27c5e-3620-429f-bdd2-584308f50236" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_669c589b-bed6-457b-b7f5-3990ff81b168" xlink:to="loc_us-gaap_VestingAxis_d3c27c5e-3620-429f-bdd2-584308f50236" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_d3c27c5e-3620-429f-bdd2-584308f50236_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_d3c27c5e-3620-429f-bdd2-584308f50236" xlink:to="loc_us-gaap_VestingDomain_d3c27c5e-3620-429f-bdd2-584308f50236_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_744275fb-bd1a-475b-8b89-9260bc98532e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_d3c27c5e-3620-429f-bdd2-584308f50236" xlink:to="loc_us-gaap_VestingDomain_744275fb-bd1a-475b-8b89-9260bc98532e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ShareBasedPaymentArrangementTrancheOneAndTrancheTwoMember_1b02b4f0-d8f8-4672-87b4-e8d4c9a62fff" xlink:href="docs-20220331.xsd#docs_ShareBasedPaymentArrangementTrancheOneAndTrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_744275fb-bd1a-475b-8b89-9260bc98532e" xlink:to="loc_docs_ShareBasedPaymentArrangementTrancheOneAndTrancheTwoMember_1b02b4f0-d8f8-4672-87b4-e8d4c9a62fff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_509ac95c-bcb2-48f5-a367-3e704e5d6d6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_docs_ShareBasedPaymentArrangementTrancheOneAndTrancheTwoMember_1b02b4f0-d8f8-4672-87b4-e8d4c9a62fff" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_509ac95c-bcb2-48f5-a367-3e704e5d6d6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_b3f3c3c6-dbb8-482f-af4e-41bc5b227b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_docs_ShareBasedPaymentArrangementTrancheOneAndTrancheTwoMember_1b02b4f0-d8f8-4672-87b4-e8d4c9a62fff" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_b3f3c3c6-dbb8-482f-af4e-41bc5b227b3d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_08200897-96ee-4530-a4be-2696cabaa276" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_744275fb-bd1a-475b-8b89-9260bc98532e" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_08200897-96ee-4530-a4be-2696cabaa276" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#EquityRestrictedStockUnitActivityDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails" xlink:type="extended" id="i2004feb1c92240798c3fc4b28596f912_EquityRestrictedStockUnitActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_033e270c-8bef-4855-8035-211ec561b1e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7a02db76-82db-4e35-9657-c8715f71d8cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_033e270c-8bef-4855-8035-211ec561b1e9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7a02db76-82db-4e35-9657-c8715f71d8cb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1a991df1-0b7c-436e-85d9-2dcad12ae687" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7a02db76-82db-4e35-9657-c8715f71d8cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1a991df1-0b7c-436e-85d9-2dcad12ae687" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_76f7b470-3889-44df-9cd3-5b896a449d48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7a02db76-82db-4e35-9657-c8715f71d8cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_76f7b470-3889-44df-9cd3-5b896a449d48" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_777c8b63-8db3-494d-ac70-47156e826bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7a02db76-82db-4e35-9657-c8715f71d8cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_777c8b63-8db3-494d-ac70-47156e826bf2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_ca2b12e7-57b5-4e90-96d6-56d7c207163d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7a02db76-82db-4e35-9657-c8715f71d8cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_ca2b12e7-57b5-4e90-96d6-56d7c207163d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8195e647-2da8-447c-9118-e3ff866f808e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fd8257b4-c3b1-4198-80aa-75663c7d7132" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_033e270c-8bef-4855-8035-211ec561b1e9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fd8257b4-c3b1-4198-80aa-75663c7d7132" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_faa733fa-33a5-4e83-bd5f-b8f24b5ace1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fd8257b4-c3b1-4198-80aa-75663c7d7132" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_faa733fa-33a5-4e83-bd5f-b8f24b5ace1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_95230ba8-0169-42f0-992f-b4adb4125a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fd8257b4-c3b1-4198-80aa-75663c7d7132" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_95230ba8-0169-42f0-992f-b4adb4125a5a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_e908a41c-1845-4fd2-99fe-b140b4de5e32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fd8257b4-c3b1-4198-80aa-75663c7d7132" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_e908a41c-1845-4fd2-99fe-b140b4de5e32" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_35cefc14-a4f0-4733-a4b2-3920c3af866f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fd8257b4-c3b1-4198-80aa-75663c7d7132" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_35cefc14-a4f0-4733-a4b2-3920c3af866f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_bd6c4976-cef2-48f4-9fba-eba82677011a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b5093299-8c46-4285-9598-fca39ddc4ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_033e270c-8bef-4855-8035-211ec561b1e9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b5093299-8c46-4285-9598-fca39ddc4ce9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_78888d90-3a2a-4a3a-aab3-4febb5179736" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b5093299-8c46-4285-9598-fca39ddc4ce9" xlink:to="loc_us-gaap_AwardTypeAxis_78888d90-3a2a-4a3a-aab3-4febb5179736" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_78888d90-3a2a-4a3a-aab3-4febb5179736_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_78888d90-3a2a-4a3a-aab3-4febb5179736" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_78888d90-3a2a-4a3a-aab3-4febb5179736_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0b927418-7211-4ec6-bdcc-145cfe7d3c9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_78888d90-3a2a-4a3a-aab3-4febb5179736" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0b927418-7211-4ec6-bdcc-145cfe7d3c9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_d9737dc5-88cb-443f-9b70-39bc7cd610d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0b927418-7211-4ec6-bdcc-145cfe7d3c9a" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_d9737dc5-88cb-443f-9b70-39bc7cd610d9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#EquityPerformanceBasedRestrictedStockUnitsDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsDetails" xlink:type="extended" id="i468193ec91034018af08b61a24a14d32_EquityPerformanceBasedRestrictedStockUnitsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e8548bf-6429-4602-b0f0-c9ba459c66fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_54e2e510-0d95-40f7-a69f-70c3bea9d447" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e8548bf-6429-4602-b0f0-c9ba459c66fb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_54e2e510-0d95-40f7-a69f-70c3bea9d447" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a75e1f4a-d58e-4a32-b812-3331f53aa220" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e8548bf-6429-4602-b0f0-c9ba459c66fb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a75e1f4a-d58e-4a32-b812-3331f53aa220" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_36e25fd1-966d-48b4-9fea-4fde7fa65218" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e8548bf-6429-4602-b0f0-c9ba459c66fb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_36e25fd1-966d-48b4-9fea-4fde7fa65218" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_60cf496e-c804-4f7f-a234-54211cb293b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e8548bf-6429-4602-b0f0-c9ba459c66fb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_60cf496e-c804-4f7f-a234-54211cb293b7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_c2e9e74d-4208-4905-89f2-900b5aca59cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e8548bf-6429-4602-b0f0-c9ba459c66fb" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_c2e9e74d-4208-4905-89f2-900b5aca59cf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_9a2de25d-2404-44ce-b7e2-176a5d0e6afe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e8548bf-6429-4602-b0f0-c9ba459c66fb" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_9a2de25d-2404-44ce-b7e2-176a5d0e6afe" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_23b82dfc-aea5-4c05-92a0-f89fceae2d09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e8548bf-6429-4602-b0f0-c9ba459c66fb" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_23b82dfc-aea5-4c05-92a0-f89fceae2d09" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_e4928735-9b48-429b-9b44-8bb26fbd2194" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e8548bf-6429-4602-b0f0-c9ba459c66fb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_e4928735-9b48-429b-9b44-8bb26fbd2194" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_422f9e83-80a1-424e-861d-378789a96c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e8548bf-6429-4602-b0f0-c9ba459c66fb" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_422f9e83-80a1-424e-861d-378789a96c2f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_886a2ef3-207e-41be-a4dc-f091ea2119b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_422f9e83-80a1-424e-861d-378789a96c2f" xlink:to="loc_us-gaap_AwardTypeAxis_886a2ef3-207e-41be-a4dc-f091ea2119b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_886a2ef3-207e-41be-a4dc-f091ea2119b8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_886a2ef3-207e-41be-a4dc-f091ea2119b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_886a2ef3-207e-41be-a4dc-f091ea2119b8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6a8a1eeb-be73-46e1-af8d-e47dc588b4dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_886a2ef3-207e-41be-a4dc-f091ea2119b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6a8a1eeb-be73-46e1-af8d-e47dc588b4dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PerformanceBasedRestrictedStockUnitsMember_d4d5fc2d-07c6-42b0-ad11-01b1de651d4f" xlink:href="docs-20220331.xsd#docs_PerformanceBasedRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6a8a1eeb-be73-46e1-af8d-e47dc588b4dc" xlink:to="loc_docs_PerformanceBasedRestrictedStockUnitsMember_d4d5fc2d-07c6-42b0-ad11-01b1de651d4f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityEmployeeStockPurchasePlanDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#EquityEmployeeStockPurchasePlanDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/EquityEmployeeStockPurchasePlanDetails" xlink:type="extended" id="i07a0c6c3bb944dd4b150f386a560b29f_EquityEmployeeStockPurchasePlanDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e15f19e-715e-4711-be75-674e5f7de460" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_443c5179-246c-47b5-93e4-dbc7cdb9a405" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e15f19e-715e-4711-be75-674e5f7de460" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_443c5179-246c-47b5-93e4-dbc7cdb9a405" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a9c15026-c5e3-412a-8d26-6486b56922d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e15f19e-715e-4711-be75-674e5f7de460" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a9c15026-c5e3-412a-8d26-6486b56922d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_9965b0c1-7a9e-44a4-a822-1d720aac53ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e15f19e-715e-4711-be75-674e5f7de460" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_9965b0c1-7a9e-44a4-a822-1d720aac53ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_270e6cf8-51dc-474d-928f-da7aac48f479" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e15f19e-715e-4711-be75-674e5f7de460" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_270e6cf8-51dc-474d-928f-da7aac48f479" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_1cc4a8de-ce2d-4494-9d98-1b6ad0b9304a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e15f19e-715e-4711-be75-674e5f7de460" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_1cc4a8de-ce2d-4494-9d98-1b6ad0b9304a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPricesPerShareIssued_53009889-6c8a-4566-b8cc-206e6c82ad71" xlink:href="docs-20220331.xsd#docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPricesPerShareIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e15f19e-715e-4711-be75-674e5f7de460" xlink:to="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPricesPerShareIssued_53009889-6c8a-4566-b8cc-206e6c82ad71" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_35f0cf98-1add-4e83-a701-efe8c5493428" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e15f19e-715e-4711-be75-674e5f7de460" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_35f0cf98-1add-4e83-a701-efe8c5493428" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_aa3a8cb6-6988-4652-8ea0-8cb9c47bb61b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_35f0cf98-1add-4e83-a701-efe8c5493428" xlink:to="loc_us-gaap_AwardTypeAxis_aa3a8cb6-6988-4652-8ea0-8cb9c47bb61b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aa3a8cb6-6988-4652-8ea0-8cb9c47bb61b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_aa3a8cb6-6988-4652-8ea0-8cb9c47bb61b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_aa3a8cb6-6988-4652-8ea0-8cb9c47bb61b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f1f36668-133a-477b-9ab4-dfb093fbb49d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_aa3a8cb6-6988-4652-8ea0-8cb9c47bb61b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f1f36668-133a-477b-9ab4-dfb093fbb49d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_c57bc817-a5cd-4cbb-9bd9-99de95135158" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f1f36668-133a-477b-9ab4-dfb093fbb49d" xlink:to="loc_us-gaap_EmployeeStockMember_c57bc817-a5cd-4cbb-9bd9-99de95135158" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityEmployeeStockPurchasePlanValuationAssumptionsDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#EquityEmployeeStockPurchasePlanValuationAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/EquityEmployeeStockPurchasePlanValuationAssumptionsDetails" xlink:type="extended" id="i6300dfac3a424a1c8a9bb3092bb75c79_EquityEmployeeStockPurchasePlanValuationAssumptionsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d0d25c6-2088-4998-a5f3-18984e2c9bd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice_08cb8d54-000e-42c3-8bc4-2c372f628423" xlink:href="docs-20220331.xsd#docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d0d25c6-2088-4998-a5f3-18984e2c9bd6" xlink:to="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice_08cb8d54-000e-42c3-8bc4-2c372f628423" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_9bb8042f-5db2-4cf7-a0f4-d9e809f57a7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d0d25c6-2088-4998-a5f3-18984e2c9bd6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_9bb8042f-5db2-4cf7-a0f4-d9e809f57a7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_28767404-da8a-4c20-8df7-a5c1828aff47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d0d25c6-2088-4998-a5f3-18984e2c9bd6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_28767404-da8a-4c20-8df7-a5c1828aff47" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_8e880734-4f89-4095-8d82-01db4cc41780" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d0d25c6-2088-4998-a5f3-18984e2c9bd6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_8e880734-4f89-4095-8d82-01db4cc41780" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_79debebd-cb65-4ec3-8189-840febb44fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d0d25c6-2088-4998-a5f3-18984e2c9bd6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_79debebd-cb65-4ec3-8189-840febb44fc4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_8c8868f5-8db2-4b87-92da-5d68b31a99b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d0d25c6-2088-4998-a5f3-18984e2c9bd6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_8c8868f5-8db2-4b87-92da-5d68b31a99b5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_456b114c-37be-4c29-ac8a-c712aa3f2a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d0d25c6-2088-4998-a5f3-18984e2c9bd6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_456b114c-37be-4c29-ac8a-c712aa3f2a7d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4a89a456-a105-4c6b-8b56-57825297a4ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d0d25c6-2088-4998-a5f3-18984e2c9bd6" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4a89a456-a105-4c6b-8b56-57825297a4ad" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a1c16827-7b5a-4a90-b445-e32d519e3bfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4a89a456-a105-4c6b-8b56-57825297a4ad" xlink:to="loc_us-gaap_AwardTypeAxis_a1c16827-7b5a-4a90-b445-e32d519e3bfc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a1c16827-7b5a-4a90-b445-e32d519e3bfc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_a1c16827-7b5a-4a90-b445-e32d519e3bfc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a1c16827-7b5a-4a90-b445-e32d519e3bfc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_443730c1-e2b0-4c79-b0b3-ed078b6b6f28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_a1c16827-7b5a-4a90-b445-e32d519e3bfc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_443730c1-e2b0-4c79-b0b3-ed078b6b6f28" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_d2111c31-4556-477e-87b7-d0361f27c8e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_443730c1-e2b0-4c79-b0b3-ed078b6b6f28" xlink:to="loc_us-gaap_EmployeeStockMember_d2111c31-4556-477e-87b7-d0361f27c8e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6a1744d4-146a-401a-a25e-67573530c36b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4a89a456-a105-4c6b-8b56-57825297a4ad" xlink:to="loc_srt_RangeAxis_6a1744d4-146a-401a-a25e-67573530c36b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6a1744d4-146a-401a-a25e-67573530c36b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6a1744d4-146a-401a-a25e-67573530c36b" xlink:to="loc_srt_RangeMember_6a1744d4-146a-401a-a25e-67573530c36b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_595a470b-5ce5-4e24-a14f-a57d8648672f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6a1744d4-146a-401a-a25e-67573530c36b" xlink:to="loc_srt_RangeMember_595a470b-5ce5-4e24-a14f-a57d8648672f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0768d70b-2429-4943-bfd0-24e9dad811a8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_595a470b-5ce5-4e24-a14f-a57d8648672f" xlink:to="loc_srt_MinimumMember_0768d70b-2429-4943-bfd0-24e9dad811a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_149cc70c-88c3-45a3-a737-21187d7ba20b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_595a470b-5ce5-4e24-a14f-a57d8648672f" xlink:to="loc_srt_MaximumMember_149cc70c-88c3-45a3-a737-21187d7ba20b" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#EquityStockBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/EquityStockBasedCompensationExpenseDetails" xlink:type="extended" id="i0ce5f9640c2542b7b1613491e468d533_EquityStockBasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e5e6d811-2f69-4962-b605-d01ca5c5b191" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_3be9f700-5159-41e4-8369-950f65e6be33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e5e6d811-2f69-4962-b605-d01ca5c5b191" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_3be9f700-5159-41e4-8369-950f65e6be33" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4bfb7118-5129-4d5b-a85d-aac267f1160c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e5e6d811-2f69-4962-b605-d01ca5c5b191" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4bfb7118-5129-4d5b-a85d-aac267f1160c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_d806f436-b7a5-41fd-bf1d-13898a63d727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4bfb7118-5129-4d5b-a85d-aac267f1160c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_d806f436-b7a5-41fd-bf1d-13898a63d727" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d806f436-b7a5-41fd-bf1d-13898a63d727_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d806f436-b7a5-41fd-bf1d-13898a63d727" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d806f436-b7a5-41fd-bf1d-13898a63d727_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c657381e-8270-46cb-9186-3c32ac6ed090" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d806f436-b7a5-41fd-bf1d-13898a63d727" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c657381e-8270-46cb-9186-3c32ac6ed090" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_64403d54-3e60-4444-a9e9-26adb6deb8cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c657381e-8270-46cb-9186-3c32ac6ed090" xlink:to="loc_us-gaap_CostOfSalesMember_64403d54-3e60-4444-a9e9-26adb6deb8cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_22e38bc3-380a-42ec-ba85-a403afaa28b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c657381e-8270-46cb-9186-3c32ac6ed090" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_22e38bc3-380a-42ec-ba85-a403afaa28b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_aba03a1a-3a03-4a80-95e1-8a717304e2c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c657381e-8270-46cb-9186-3c32ac6ed090" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_aba03a1a-3a03-4a80-95e1-8a717304e2c5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_03bf7502-3c63-4c3d-9c2c-281ed17e3774" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c657381e-8270-46cb-9186-3c32ac6ed090" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_03bf7502-3c63-4c3d-9c2c-281ed17e3774" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails" xlink:type="extended" id="i86363586c1fb4308bc21f5823d62bc33_NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_d588bbca-1e4c-4dd5-b257-075642ed247a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract_301bf128-12af-4cd5-9675-721752a14f81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_d588bbca-1e4c-4dd5-b257-075642ed247a" xlink:to="loc_us-gaap_EarningsPerShareReconciliationAbstract_301bf128-12af-4cd5-9675-721752a14f81" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_14b56d72-2d63-404f-b217-2fda9eb6615c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_301bf128-12af-4cd5-9675-721752a14f81" xlink:to="loc_us-gaap_NetIncomeLoss_14b56d72-2d63-404f-b217-2fda9eb6615c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_e208b875-dc51-44f9-9176-618fca7290bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_301bf128-12af-4cd5-9675-721752a14f81" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_e208b875-dc51-44f9-9176-618fca7290bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_cf84f184-7ab1-44c1-a6a8-f8eef55219c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_301bf128-12af-4cd5-9675-721752a14f81" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_cf84f184-7ab1-44c1-a6a8-f8eef55219c4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_72f7596e-8dd2-41d1-a466-81387ea72c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_301bf128-12af-4cd5-9675-721752a14f81" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_72f7596e-8dd2-41d1-a466-81387ea72c8e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_aa011fa0-4f21-4353-9fd8-87286d148912" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_301bf128-12af-4cd5-9675-721752a14f81" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_aa011fa0-4f21-4353-9fd8-87286d148912" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_e57a0462-2c3a-4b3f-8844-2b0b571fcdf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_d588bbca-1e4c-4dd5-b257-075642ed247a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_e57a0462-2c3a-4b3f-8844-2b0b571fcdf1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_01e850e5-55ca-4dd5-bba4-4f9f8a67497a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_e57a0462-2c3a-4b3f-8844-2b0b571fcdf1" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_01e850e5-55ca-4dd5-bba4-4f9f8a67497a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_81152c0c-f0df-4a73-8358-a6ef7ec1c03b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_e57a0462-2c3a-4b3f-8844-2b0b571fcdf1" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_81152c0c-f0df-4a73-8358-a6ef7ec1c03b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_6f281100-4a70-424b-8dc4-c1fad18cdc33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_e57a0462-2c3a-4b3f-8844-2b0b571fcdf1" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_6f281100-4a70-424b-8dc4-c1fad18cdc33" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e73df9ac-b7fb-4a7d-bcba-eff0a3f21454" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_e57a0462-2c3a-4b3f-8844-2b0b571fcdf1" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e73df9ac-b7fb-4a7d-bcba-eff0a3f21454" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_3ecd161a-c8ab-472d-a121-e389986fa35d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_d588bbca-1e4c-4dd5-b257-075642ed247a" xlink:to="loc_us-gaap_EarningsPerShareBasic_3ecd161a-c8ab-472d-a121-e389986fa35d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_2b874605-faf0-4b47-b1ea-ab74e4f4a8e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_d588bbca-1e4c-4dd5-b257-075642ed247a" xlink:to="loc_us-gaap_EarningsPerShareDiluted_2b874605-faf0-4b47-b1ea-ab74e4f4a8e2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_6df59947-1720-4e98-b298-2629a53ad5d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_d588bbca-1e4c-4dd5-b257-075642ed247a" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_6df59947-1720-4e98-b298-2629a53ad5d6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_da1686d0-9248-40bf-9def-0b993ace4bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_6df59947-1720-4e98-b298-2629a53ad5d6" xlink:to="loc_us-gaap_AwardTypeAxis_da1686d0-9248-40bf-9def-0b993ace4bd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_da1686d0-9248-40bf-9def-0b993ace4bd2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_da1686d0-9248-40bf-9def-0b993ace4bd2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_da1686d0-9248-40bf-9def-0b993ace4bd2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_37f502dc-6be2-4467-8db3-e65997e4a56b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_da1686d0-9248-40bf-9def-0b993ace4bd2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_37f502dc-6be2-4467-8db3-e65997e4a56b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_d74b4345-0e8f-4a39-b18f-f3c6cb2666e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_37f502dc-6be2-4467-8db3-e65997e4a56b" xlink:to="loc_us-gaap_EmployeeStockOptionMember_d74b4345-0e8f-4a39-b18f-f3c6cb2666e4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_OtherShareBasedAwardsMember_4675de99-d1a9-4229-9da8-bba399bdd6b6" xlink:href="docs-20220331.xsd#docs_OtherShareBasedAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_37f502dc-6be2-4467-8db3-e65997e4a56b" xlink:to="loc_docs_OtherShareBasedAwardsMember_4675de99-d1a9-4229-9da8-bba399bdd6b6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersAntidilutiveSecuritiesExcludedfromComputationofNetIncomePerShareDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#NetIncomePerShareAttributabletoCommonStockholdersAntidilutiveSecuritiesExcludedfromComputationofNetIncomePerShareDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersAntidilutiveSecuritiesExcludedfromComputationofNetIncomePerShareDetails" xlink:type="extended" id="i2ce31161f4994cb8b1e3ad10ea1a9300_NetIncomePerShareAttributabletoCommonStockholdersAntidilutiveSecuritiesExcludedfromComputationofNetIncomePerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6daf2cdd-503c-441b-941f-7771c9285c7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f731cbec-fdde-4272-a2f6-73ed2f11b21a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6daf2cdd-503c-441b-941f-7771c9285c7e" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f731cbec-fdde-4272-a2f6-73ed2f11b21a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1eb34036-a5c5-4e5b-bce8-acbd569680fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6daf2cdd-503c-441b-941f-7771c9285c7e" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1eb34036-a5c5-4e5b-bce8-acbd569680fd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7c7adbd7-c453-481c-91e6-e9414858fbaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1eb34036-a5c5-4e5b-bce8-acbd569680fd" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7c7adbd7-c453-481c-91e6-e9414858fbaa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7c7adbd7-c453-481c-91e6-e9414858fbaa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7c7adbd7-c453-481c-91e6-e9414858fbaa" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7c7adbd7-c453-481c-91e6-e9414858fbaa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1c3e54e4-215e-4d0e-b51c-3ef267d471b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7c7adbd7-c453-481c-91e6-e9414858fbaa" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1c3e54e4-215e-4d0e-b51c-3ef267d471b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember_942c257f-3974-4488-9c64-b75505660205" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1c3e54e4-215e-4d0e-b51c-3ef267d471b5" xlink:to="loc_us-gaap_RedeemableConvertiblePreferredStockMember_942c257f-3974-4488-9c64-b75505660205" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_c35bac2d-7cbc-4913-91db-ade540326de0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1c3e54e4-215e-4d0e-b51c-3ef267d471b5" xlink:to="loc_us-gaap_EmployeeStockOptionMember_c35bac2d-7cbc-4913-91db-ade540326de0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_OtherShareBasedAwardsMember_f896a02b-2ae8-4e10-bdf6-e1c3a0afdda7" xlink:href="docs-20220331.xsd#docs_OtherShareBasedAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1c3e54e4-215e-4d0e-b51c-3ef267d471b5" xlink:to="loc_docs_OtherShareBasedAwardsMember_f896a02b-2ae8-4e10-bdf6-e1c3a0afdda7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_0cecc5cd-4604-4050-9d89-d08bff734f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1c3e54e4-215e-4d0e-b51c-3ef267d471b5" xlink:to="loc_us-gaap_WarrantMember_0cecc5cd-4604-4050-9d89-d08bff734f2c" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended" id="i32c7957b97f04a198cd5bc7e1e7809c1_IncomeTaxesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardLineItems_6b95938e-2c69-4884-b7e9-3833d009627b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_4866b12c-0c7c-4cb6-93c9-ff243ac58f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_6b95938e-2c69-4884-b7e9-3833d009627b" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_4866b12c-0c7c-4cb6-93c9-ff243ac58f5a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_523b279f-ff82-454b-ab0d-f0637cd587f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_6b95938e-2c69-4884-b7e9-3833d009627b" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_523b279f-ff82-454b-ab0d-f0637cd587f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_d6ada0f8-f413-4536-b8d0-7f51a5425e54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_6b95938e-2c69-4884-b7e9-3833d009627b" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_d6ada0f8-f413-4536-b8d0-7f51a5425e54" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_7725b08b-21b5-42e1-8c27-7ee5c7f1781a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_6b95938e-2c69-4884-b7e9-3833d009627b" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_7725b08b-21b5-42e1-8c27-7ee5c7f1781a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_OperatingLossCarryforwardsSubjectToExpiration_98110105-0a1f-4b6f-9169-5b5450bb2e3e" xlink:href="docs-20220331.xsd#docs_OperatingLossCarryforwardsSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_6b95938e-2c69-4884-b7e9-3833d009627b" xlink:to="loc_docs_OperatingLossCarryforwardsSubjectToExpiration_98110105-0a1f-4b6f-9169-5b5450bb2e3e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_bd081ef5-d5ae-41ac-82f9-7ff332d71028" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_6b95938e-2c69-4884-b7e9-3833d009627b" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_bd081ef5-d5ae-41ac-82f9-7ff332d71028" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TaxCreditCarryforwardsSubjectToExpiration_a694f7de-9e95-4632-bbb3-ed596fdb8354" xlink:href="docs-20220331.xsd#docs_TaxCreditCarryforwardsSubjectToExpiration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_6b95938e-2c69-4884-b7e9-3833d009627b" xlink:to="loc_docs_TaxCreditCarryforwardsSubjectToExpiration_a694f7de-9e95-4632-bbb3-ed596fdb8354" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_77e5b4ab-a5a7-434d-b5fb-3275f49fcba0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_6b95938e-2c69-4884-b7e9-3833d009627b" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_77e5b4ab-a5a7-434d-b5fb-3275f49fcba0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_7f646536-f2be-46b3-a721-4b5ee37f5d72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_6b95938e-2c69-4884-b7e9-3833d009627b" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_7f646536-f2be-46b3-a721-4b5ee37f5d72" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardTable_0982f740-f2df-4f34-8192-465e83b9a406" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_6b95938e-2c69-4884-b7e9-3833d009627b" xlink:to="loc_us-gaap_TaxCreditCarryforwardTable_0982f740-f2df-4f34-8192-465e83b9a406" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_fecbe9ee-5e30-4f91-b59b-9048bc2de11c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_0982f740-f2df-4f34-8192-465e83b9a406" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_fecbe9ee-5e30-4f91-b59b-9048bc2de11c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_fecbe9ee-5e30-4f91-b59b-9048bc2de11c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_fecbe9ee-5e30-4f91-b59b-9048bc2de11c" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_fecbe9ee-5e30-4f91-b59b-9048bc2de11c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_f8307fac-4ce5-4054-bb83-8471e9cca191" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_fecbe9ee-5e30-4f91-b59b-9048bc2de11c" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_f8307fac-4ce5-4054-bb83-8471e9cca191" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_aae2b530-b996-4498-8257-e26b20049614" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_f8307fac-4ce5-4054-bb83-8471e9cca191" xlink:to="loc_us-gaap_DomesticCountryMember_aae2b530-b996-4498-8257-e26b20049614" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_35dc2d8a-39d2-476a-8afd-841a660c359c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_f8307fac-4ce5-4054-bb83-8471e9cca191" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_35dc2d8a-39d2-476a-8afd-841a660c359c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/CommitmentandContingenciesDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#CommitmentandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/CommitmentandContingenciesDetails" xlink:type="extended" id="i04db126e9a0b4312a0f1e2e5bf6ba446_CommitmentandContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_24ffe594-e494-40eb-bfd8-c173d291a362" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_b16ecffa-8c24-4622-9d8e-4d38634a0c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_24ffe594-e494-40eb-bfd8-c173d291a362" xlink:to="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_b16ecffa-8c24-4622-9d8e-4d38634a0c5c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount_b485be5f-66f8-44fc-9087-61061c2d2104" xlink:href="docs-20220331.xsd#docs_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_24ffe594-e494-40eb-bfd8-c173d291a362" xlink:to="loc_docs_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount_b485be5f-66f8-44fc-9087-61061c2d2104" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PartnershipAgreementExtensionPeriod_f96f6cf9-9e49-4d1f-bfd1-9fedf45cefc7" xlink:href="docs-20220331.xsd#docs_PartnershipAgreementExtensionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_24ffe594-e494-40eb-bfd8-c173d291a362" xlink:to="loc_docs_PartnershipAgreementExtensionPeriod_f96f6cf9-9e49-4d1f-bfd1-9fedf45cefc7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted_4fed5271-df35-4172-9800-8072040fbbb8" xlink:href="docs-20220331.xsd#docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_24ffe594-e494-40eb-bfd8-c173d291a362" xlink:to="loc_docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted_4fed5271-df35-4172-9800-8072040fbbb8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany_ae06140c-0ca0-4f81-b804-15dbc334fc2c" xlink:href="docs-20220331.xsd#docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_24ffe594-e494-40eb-bfd8-c173d291a362" xlink:to="loc_docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany_ae06140c-0ca0-4f81-b804-15dbc334fc2c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PartnershipAgreementNoncancelablePeriod_973fe300-a3b7-422d-9b33-da831ca34405" xlink:href="docs-20220331.xsd#docs_PartnershipAgreementNoncancelablePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_24ffe594-e494-40eb-bfd8-c173d291a362" xlink:to="loc_docs_PartnershipAgreementNoncancelablePeriod_973fe300-a3b7-422d-9b33-da831ca34405" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod_0bf9bd41-8571-4c69-a7cc-b3b701bf7557" xlink:href="docs-20220331.xsd#docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_24ffe594-e494-40eb-bfd8-c173d291a362" xlink:to="loc_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod_0bf9bd41-8571-4c69-a7cc-b3b701bf7557" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_553c2d2b-0321-4e02-b7c5-7f25db55ed8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_24ffe594-e494-40eb-bfd8-c173d291a362" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_553c2d2b-0321-4e02-b7c5-7f25db55ed8d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_8bdd4b34-3b46-4898-b16b-234c369f2ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_24ffe594-e494-40eb-bfd8-c173d291a362" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_8bdd4b34-3b46-4898-b16b-234c369f2ed8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod_c511edee-03b5-4222-8da4-84fbde37d60d" xlink:href="docs-20220331.xsd#docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_24ffe594-e494-40eb-bfd8-c173d291a362" xlink:to="loc_docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod_c511edee-03b5-4222-8da4-84fbde37d60d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_dbdbe576-009a-4ede-98b6-7aa588b28b22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_24ffe594-e494-40eb-bfd8-c173d291a362" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_dbdbe576-009a-4ede-98b6-7aa588b28b22" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9a6b0a6c-8ffd-45f5-9600-1277b4b3561b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_24ffe594-e494-40eb-bfd8-c173d291a362" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9a6b0a6c-8ffd-45f5-9600-1277b4b3561b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_HostingArrangementPeriod_cc2868bb-31a0-444e-aab5-b073d05e922b" xlink:href="docs-20220331.xsd#docs_HostingArrangementPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_24ffe594-e494-40eb-bfd8-c173d291a362" xlink:to="loc_docs_HostingArrangementPeriod_cc2868bb-31a0-444e-aab5-b073d05e922b" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_HostingArrangementAnnualCommitment_a2a02de0-4dbd-4a1a-9dc9-1e4e4c900515" xlink:href="docs-20220331.xsd#docs_HostingArrangementAnnualCommitment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_24ffe594-e494-40eb-bfd8-c173d291a362" xlink:to="loc_docs_HostingArrangementAnnualCommitment_a2a02de0-4dbd-4a1a-9dc9-1e4e4c900515" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_e2e7f5bc-35d4-4a25-8f1c-036deac33b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_24ffe594-e494-40eb-bfd8-c173d291a362" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_e2e7f5bc-35d4-4a25-8f1c-036deac33b9c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_c8b9bd7c-4b5a-460a-8059-cb34397687ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_24ffe594-e494-40eb-bfd8-c173d291a362" xlink:to="loc_us-gaap_OtherCommitmentsTable_c8b9bd7c-4b5a-460a-8059-cb34397687ac" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fec4bae6-015a-4c6c-98d0-fce433a2c0d3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_c8b9bd7c-4b5a-460a-8059-cb34397687ac" xlink:to="loc_srt_RangeAxis_fec4bae6-015a-4c6c-98d0-fce433a2c0d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fec4bae6-015a-4c6c-98d0-fce433a2c0d3_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_fec4bae6-015a-4c6c-98d0-fce433a2c0d3" xlink:to="loc_srt_RangeMember_fec4bae6-015a-4c6c-98d0-fce433a2c0d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c971e48b-8d37-454f-859f-e85fb2333733" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_fec4bae6-015a-4c6c-98d0-fce433a2c0d3" xlink:to="loc_srt_RangeMember_c971e48b-8d37-454f-859f-e85fb2333733" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e7bd7862-9e68-48bd-ba60-3c32a0295438" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c971e48b-8d37-454f-859f-e85fb2333733" xlink:to="loc_srt_MinimumMember_e7bd7862-9e68-48bd-ba60-3c32a0295438" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b4e9cc4c-3ef2-4d8f-8348-93f7f2ea4095" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c971e48b-8d37-454f-859f-e85fb2333733" xlink:to="loc_srt_MaximumMember_b4e9cc4c-3ef2-4d8f-8348-93f7f2ea4095" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3fbb72a8-3189-4412-ada0-f640fcf977b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_c8b9bd7c-4b5a-460a-8059-cb34397687ac" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3fbb72a8-3189-4412-ada0-f640fcf977b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3fbb72a8-3189-4412-ada0-f640fcf977b1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3fbb72a8-3189-4412-ada0-f640fcf977b1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_3fbb72a8-3189-4412-ada0-f640fcf977b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cbf7b166-bdd9-4113-ac5f-ffe47cbca71c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3fbb72a8-3189-4412-ada0-f640fcf977b1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cbf7b166-bdd9-4113-ac5f-ffe47cbca71c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_AMiONMember_f6031649-6cf3-4505-8881-bda84d658297" xlink:href="docs-20220331.xsd#docs_AMiONMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cbf7b166-bdd9-4113-ac5f-ffe47cbca71c" xlink:to="loc_docs_AMiONMember_f6031649-6cf3-4505-8881-bda84d658297" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b9b2cc03-1c60-46da-be0b-c78fcb85ec8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_c8b9bd7c-4b5a-460a-8059-cb34397687ac" xlink:to="loc_us-gaap_AwardTypeAxis_b9b2cc03-1c60-46da-be0b-c78fcb85ec8b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b9b2cc03-1c60-46da-be0b-c78fcb85ec8b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_b9b2cc03-1c60-46da-be0b-c78fcb85ec8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b9b2cc03-1c60-46da-be0b-c78fcb85ec8b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5d636f59-4f64-4827-b21a-8d2f96228aac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_b9b2cc03-1c60-46da-be0b-c78fcb85ec8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5d636f59-4f64-4827-b21a-8d2f96228aac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_5feb3a6f-06ca-426d-a09e-01b694156c43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5d636f59-4f64-4827-b21a-8d2f96228aac" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_5feb3a6f-06ca-426d-a09e-01b694156c43" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_ab1aee87-3cbd-49f2-8d93-bf3259faf30b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OtherCommitmentsTable_c8b9bd7c-4b5a-460a-8059-cb34397687ac" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_ab1aee87-3cbd-49f2-8d93-bf3259faf30b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_ab1aee87-3cbd-49f2-8d93-bf3259faf30b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ab1aee87-3cbd-49f2-8d93-bf3259faf30b" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_ab1aee87-3cbd-49f2-8d93-bf3259faf30b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_4abb8c57-a2a7-4087-84b4-0af20ba44fff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ab1aee87-3cbd-49f2-8d93-bf3259faf30b" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_4abb8c57-a2a7-4087-84b4-0af20ba44fff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_fe00a069-8094-4d5a-91d0-86a388bcd51c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_4abb8c57-a2a7-4087-84b4-0af20ba44fff" xlink:to="loc_us-gaap_SubsequentEventMember_fe00a069-8094-4d5a-91d0-86a388bcd51c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.doximity.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://www.doximity.com/role/SubsequentEventsDetails" xlink:type="extended" id="i458de29f3eb3428285080fd51e91c953_SubsequentEventsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_f0c2e88d-d3e3-4428-ba48-2c1b08ad56fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_27b42190-01c1-4156-8df6-5fe4acdeb2d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_f0c2e88d-d3e3-4428-ba48-2c1b08ad56fa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_27b42190-01c1-4156-8df6-5fe4acdeb2d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue_8cb0b9c4-09b1-4e7c-8259-f95b15b2e682" xlink:href="docs-20220331.xsd#docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_f0c2e88d-d3e3-4428-ba48-2c1b08ad56fa" xlink:to="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue_8cb0b9c4-09b1-4e7c-8259-f95b15b2e682" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_4b48b262-29f2-467d-84bd-c991aaf428f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_f0c2e88d-d3e3-4428-ba48-2c1b08ad56fa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_4b48b262-29f2-467d-84bd-c991aaf428f0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_fd568094-9f08-4d16-bc5d-cd36a82954c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_f0c2e88d-d3e3-4428-ba48-2c1b08ad56fa" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_fd568094-9f08-4d16-bc5d-cd36a82954c6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_ac898380-e53f-4415-bf56-ab445f920cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_f0c2e88d-d3e3-4428-ba48-2c1b08ad56fa" xlink:to="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_ac898380-e53f-4415-bf56-ab445f920cb6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_3d786367-1efc-47cf-b2fd-456e93aef623" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_f0c2e88d-d3e3-4428-ba48-2c1b08ad56fa" xlink:to="loc_us-gaap_SubsequentEventTable_3d786367-1efc-47cf-b2fd-456e93aef623" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_9a90dd42-1d72-422d-9b1a-47b521a3ab76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_3d786367-1efc-47cf-b2fd-456e93aef623" xlink:to="loc_us-gaap_AwardTypeAxis_9a90dd42-1d72-422d-9b1a-47b521a3ab76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9a90dd42-1d72-422d-9b1a-47b521a3ab76_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_9a90dd42-1d72-422d-9b1a-47b521a3ab76" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9a90dd42-1d72-422d-9b1a-47b521a3ab76_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_071907ba-c71f-4fa0-8ce5-bd3c03d8805a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_9a90dd42-1d72-422d-9b1a-47b521a3ab76" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_071907ba-c71f-4fa0-8ce5-bd3c03d8805a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_d1d7398c-5fa2-4b38-b060-ab1d4ae2c699" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_071907ba-c71f-4fa0-8ce5-bd3c03d8805a" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_d1d7398c-5fa2-4b38-b060-ab1d4ae2c699" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_4c2b97e1-5730-4159-8c5d-5435015d5bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_3d786367-1efc-47cf-b2fd-456e93aef623" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_4c2b97e1-5730-4159-8c5d-5435015d5bc2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_4c2b97e1-5730-4159-8c5d-5435015d5bc2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_4c2b97e1-5730-4159-8c5d-5435015d5bc2" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_4c2b97e1-5730-4159-8c5d-5435015d5bc2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_21ebe150-1400-4981-8fb0-6f1bd800d822" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_4c2b97e1-5730-4159-8c5d-5435015d5bc2" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_21ebe150-1400-4981-8fb0-6f1bd800d822" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_361630cc-363c-4510-ace9-475ac1749b8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_21ebe150-1400-4981-8fb0-6f1bd800d822" xlink:to="loc_us-gaap_SubsequentEventMember_361630cc-363c-4510-ace9-475ac1749b8c" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>docs-20220331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:7e9381b6-a1e4-41b8-8d47-38883b11be1e,g:11b17cc6-874f-42e4-b7f0-55cdc6f63454-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ProceedsFromWarrantExercises_9b3397b4-a073-4185-8a19-8f377d11f168_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of redeemable convertible preferred stock warrants</link:label>
    <link:label id="lab_us-gaap_ProceedsFromWarrantExercises_label_en-US" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Warrant Exercises</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromWarrantExercises" xlink:to="lab_us-gaap_ProceedsFromWarrantExercises" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_f0f5a097-1539-48d8-a117-572ebca780b3_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_bcc0deea-dbfc-4a92-9236-80da4f0f2525_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosures of cash flow information</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_b1be120b-af14-4951-a0c1-a6923687b36b_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_6715d290-6441-46ae-9ecd-69683f56b2f0_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Per Share Attributable to Common Stockholders</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_USNewsWarrantMember_775485ea-5720-4500-acc5-356aa8077056_terseLabel_en-US" xlink:label="lab_docs_USNewsWarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U S News Warrant</link:label>
    <link:label id="lab_docs_USNewsWarrantMember_label_en-US" xlink:label="lab_docs_USNewsWarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U S News Warrant [Member]</link:label>
    <link:label id="lab_docs_USNewsWarrantMember_documentation_en-US" xlink:label="lab_docs_USNewsWarrantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U S News Warrant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_USNewsWarrantMember" xlink:href="docs-20220331.xsd#docs_USNewsWarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_USNewsWarrantMember" xlink:to="lab_docs_USNewsWarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_bb2377db-28b6-4d8a-b966-f8769b968867_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_da5c87c3-2b4f-4d9d-99aa-c5e3c9e37f12_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_5ebdd030-973a-4b0c-9781-2eef3f867cca_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_845eca14-8a5f-4c99-806d-a4e78a030182_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition_5c55b95d-896a-4f9e-a00e-bc13c8de9e21_terseLabel_en-US" xlink:label="lab_docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock warrant expense</link:label>
    <link:label id="lab_docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition_label_en-US" xlink:label="lab_docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Stock Warrant Issued for Services, Increase for Cost Recognition</link:label>
    <link:label id="lab_docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition_documentation_en-US" xlink:label="lab_docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Stock Warrant Issued for Services, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition" xlink:href="docs-20220331.xsd#docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition" xlink:to="lab_docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_29e19625-df73-4d65-826d-60fc7390f5f5_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_733c12d1-55f3-4ee7-9754-244057704f87_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_StockIssuancesCostsIncurredButNotYetPaid_2ffc6e23-204b-41bf-a70f-fc5c880ddd52_terseLabel_en-US" xlink:label="lab_docs_StockIssuancesCostsIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpaid deferred offering costs</link:label>
    <link:label id="lab_docs_StockIssuancesCostsIncurredButNotYetPaid_label_en-US" xlink:label="lab_docs_StockIssuancesCostsIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issuances Costs Incurred But Not Yet Paid</link:label>
    <link:label id="lab_docs_StockIssuancesCostsIncurredButNotYetPaid_documentation_en-US" xlink:label="lab_docs_StockIssuancesCostsIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issuances Costs Incurred But Not Yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_StockIssuancesCostsIncurredButNotYetPaid" xlink:href="docs-20220331.xsd#docs_StockIssuancesCostsIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_StockIssuancesCostsIncurredButNotYetPaid" xlink:to="lab_docs_StockIssuancesCostsIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_430e5613-e36a-4216-95da-06da3593165e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_6b904d6b-eecb-49c9-8b56-e7bda331bd1e_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_246d5d5d-858a-4493-ba92-ad5712147718_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_3f7bd562-84ae-4d97-a501-1a1d10d1aad5_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued payroll, bonus, and related expenses</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredOfferingCosts_dee044b5-6aeb-4f1e-83a8-05c8d37178ca_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredOfferingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized deferred offering costs</link:label>
    <link:label id="lab_us-gaap_DeferredOfferingCosts_label_en-US" xlink:label="lab_us-gaap_DeferredOfferingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Offering Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOfferingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredOfferingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredOfferingCosts" xlink:to="lab_us-gaap_DeferredOfferingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_2fadec1e-266f-44a4-8a5b-b431dc5100b4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_TemporaryEquityTextBlock_8b68ccf1-5fdc-4832-9a53-5e4845d0549d_terseLabel_en-US" xlink:label="lab_docs_TemporaryEquityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Convertible Preferred Stock</link:label>
    <link:label id="lab_docs_TemporaryEquityTextBlock_label_en-US" xlink:label="lab_docs_TemporaryEquityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity [Text Block]</link:label>
    <link:label id="lab_docs_TemporaryEquityTextBlock_documentation_en-US" xlink:label="lab_docs_TemporaryEquityTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TemporaryEquityTextBlock" xlink:href="docs-20220331.xsd#docs_TemporaryEquityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_TemporaryEquityTextBlock" xlink:to="lab_docs_TemporaryEquityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_650bb6bf-8877-4d4c-9c2a-296a42cf23d4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_bca93dd1-5334-4da2-bc0d-c134cb7e5e36_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition related costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_40c58f4c-cf16-46e1-8cd0-acde8ab889fc_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueOptionPricingModelMember_4247e1e4-8819-4c8b-a0b8-40d400aeedbd_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Technique, Option Pricing Model</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueOptionPricingModelMember_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Technique, Option Pricing Model [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:to="lab_us-gaap_ValuationTechniqueOptionPricingModelMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_001aba42-233f-44af-9441-012571555ba2_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_a7b72e35-6890-44ae-b2e2-07bf3869ca31_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of business consideration</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_9d00277b-f80f-4b0c-9c12-4bf8f0e11275_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_fcaf889c-6034-43e9-a5b8-52d4963210e1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_571dbb8c-884c-4cd7-91d8-c933875d7318_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Deferred Revenue Balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:to="lab_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised_fbde653b-e5b5-4c45-8a80-3bbbca887546_terseLabel_en-US" xlink:label="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (in shares)</link:label>
    <link:label id="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised_label_en-US" xlink:label="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercised</link:label>
    <link:label id="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised_documentation_en-US" xlink:label="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised" xlink:href="docs-20220331.xsd#docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised" xlink:to="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareReconciliationAbstract_e6a36bb8-15a7-49b1-804c-293b00946835_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract" xlink:to="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_8ebc3544-1197-422a-b7c8-5987404ff4ae_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining lease term (in years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_23a52cdf-34ab-48bb-b501-582d26162037_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable convertible preferred stock outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_93b2ece9-f35c-4fce-b290-13c6e2b8bd2b_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_33deedc4-eb3b-4542-b986-2cc0c478ee4b_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:to="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_fe4b187b-902c-4679-aa61-59d2cbe6ef39_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_3b59a7b4-975b-45d5-a30c-2d430cd456c0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_be5a8b9c-71ef-432a-9135-4dad498952bf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield (in percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_d80e529f-373b-410a-8f2d-ec5bb738ecd7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for future grant (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2702b686-c7dd-49d5-a851-2f80a316394a_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance_7291558c-511c-4271-af60-fb64374b553f_negatedTerseLabel_en-US" xlink:label="lab_docs_ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized from contracts invoiced during the period</link:label>
    <link:label id="lab_docs_ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance_label_en-US" xlink:label="lab_docs_ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized, Excluding Opening Balance</link:label>
    <link:label id="lab_docs_ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance_documentation_en-US" xlink:label="lab_docs_ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized, Excluding Opening Balance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance" xlink:href="docs-20220331.xsd#docs_ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance" xlink:to="lab_docs_ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_afddd158-a213-45af-af8c-d1710f79828a_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_155d58aa-0f49-40b9-8332-f92e5111aada_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_5054bf81-0818-4fae-a07d-ceddec0e5a03_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_9472df7b-db76-4eeb-b07e-ccfe169e8734_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized compensation expense, option</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_6fa52727-61e8-4ae7-a7dc-c129c405bfa8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options forfeited and expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_71192ef9-ca4e-4aca-9350-e7c45ee9385c_terseLabel_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of deposit</link:label>
    <link:label id="lab_us-gaap_CertificatesOfDepositMember_label_en-US" xlink:label="lab_us-gaap_CertificatesOfDepositMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Certificates of Deposit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CertificatesOfDepositMember" xlink:to="lab_us-gaap_CertificatesOfDepositMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_fddfe9b3-6750-453f-8ccd-a5b37159b427_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost, Gross Unrealized Gains and Losses, and Fair Value of Investments</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardLineItems_1657d076-1244-44fc-944d-496c3a433ae1_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Line Items]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardLineItems_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems" xlink:to="lab_us-gaap_TaxCreditCarryforwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_ContractWithCustomerLiabilityAdditionsNet_84796555-3ca5-4f0f-abf7-97dc0df2f3d3_terseLabel_en-US" xlink:label="lab_docs_ContractWithCustomerLiabilityAdditionsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions, net, during the period</link:label>
    <link:label id="lab_docs_ContractWithCustomerLiabilityAdditionsNet_label_en-US" xlink:label="lab_docs_ContractWithCustomerLiabilityAdditionsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Additions, Net</link:label>
    <link:label id="lab_docs_ContractWithCustomerLiabilityAdditionsNet_documentation_en-US" xlink:label="lab_docs_ContractWithCustomerLiabilityAdditionsNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Liability, Additions, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ContractWithCustomerLiabilityAdditionsNet" xlink:href="docs-20220331.xsd#docs_ContractWithCustomerLiabilityAdditionsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_ContractWithCustomerLiabilityAdditionsNet" xlink:to="lab_docs_ContractWithCustomerLiabilityAdditionsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditConcentrationRiskMember_12185e81-955f-438f-9545-8d152a08d97d_terseLabel_en-US" xlink:label="lab_us-gaap_CreditConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CreditConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CreditConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditConcentrationRiskMember" xlink:to="lab_us-gaap_CreditConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_a6f40313-5a3e-4af4-9b8c-bd352c0cbc82_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock_9fe6191a-7d2c-4a8e-8fed-c7685e5eb73a_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in Debt and Equity Instruments, Cash and Cash Equivalents, Unrealized and Realized Gains (Losses) [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock" xlink:to="lab_us-gaap_InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_f23a8d61-7fd2-4426-a485-448deacdf72e_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_4cfc85c2-21da-47ee-8edd-de3c89093141_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets acquired, useful life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_04a4c466-ead2-47c7-a681-9604fc12e385_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueDomain_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueDomain" xlink:to="lab_us-gaap_ValuationTechniqueDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_4ac9895c-6c71-4794-9fd0-cfe0a6aa051c_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions for tax positions related to prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_bf863c6d-aa1b-4225-9688-27cea8f5aee0_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable lease cost</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Goodwill And Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract_documentation_en-US" xlink:label="lab_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Goodwill And Intangible Assets Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="docs-20220331.xsd#docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_d4480456-1a8f-4f34-8d4e-c044a6539ec0_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_9c0c8e6f-6233-4cdb-8b55-3ba7dfb73522_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f9a50462-85ff-4712-b92f-9a123f327391_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share, amount (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_7a6466d8-10ca-4838-8166-dfb8111fa251_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized from the beginning balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_b713bf7c-eca0-4472-b9f3-b8dbd5a48cc6_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_28afef62-bb33-4d83-899d-5497330f2641_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_94a959df-5104-4130-ae4b-b82c095d5258_terseLabel_en-US" xlink:label="lab_docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_label_en-US" xlink:label="lab_docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Assets, Other</link:label>
    <link:label id="lab_docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_documentation_en-US" xlink:label="lab_docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" xlink:href="docs-20220331.xsd#docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" xlink:to="lab_docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_DebtSecuritiesAvailableForSaleWithNoCreditAllowance_7e6abd01-8d8b-4b25-b678-1508f094d859_terseLabel_en-US" xlink:label="lab_docs_DebtSecuritiesAvailableForSaleWithNoCreditAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of debt securities which no credit losses were recognized</link:label>
    <link:label id="lab_docs_DebtSecuritiesAvailableForSaleWithNoCreditAllowance_label_en-US" xlink:label="lab_docs_DebtSecuritiesAvailableForSaleWithNoCreditAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available For Sale, With No Credit Allowance</link:label>
    <link:label id="lab_docs_DebtSecuritiesAvailableForSaleWithNoCreditAllowance_documentation_en-US" xlink:label="lab_docs_DebtSecuritiesAvailableForSaleWithNoCreditAllowance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available For Sale, With No Credit Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DebtSecuritiesAvailableForSaleWithNoCreditAllowance" xlink:href="docs-20220331.xsd#docs_DebtSecuritiesAvailableForSaleWithNoCreditAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_DebtSecuritiesAvailableForSaleWithNoCreditAllowance" xlink:to="lab_docs_DebtSecuritiesAvailableForSaleWithNoCreditAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_262efccd-d5e7-40ed-8c22-5e99b7c3c0f9_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets, net of valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_f2283b0e-3af1-4ab6-a8c9-ad6f3bece447_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward split ratio</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note, Stock Split, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:to="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_fed562a8-b761-44c3-b9c9-f9fcae4fa2f1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_8846a513-d16a-442d-8411-7cb0149cdb64_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total fair value of vested equity instruments</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_e88b68da-f5c9-45fe-ba38-0c4a3c294335_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_EquityIncentivePlan2010Member_e599a77b-bf12-489f-990f-45fa7e470abf_terseLabel_en-US" xlink:label="lab_docs_EquityIncentivePlan2010Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2010 Plan</link:label>
    <link:label id="lab_docs_EquityIncentivePlan2010Member_label_en-US" xlink:label="lab_docs_EquityIncentivePlan2010Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Incentive Plan 2010 [Member]</link:label>
    <link:label id="lab_docs_EquityIncentivePlan2010Member_documentation_en-US" xlink:label="lab_docs_EquityIncentivePlan2010Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Incentive Plan 2010</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_EquityIncentivePlan2010Member" xlink:href="docs-20220331.xsd#docs_EquityIncentivePlan2010Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_EquityIncentivePlan2010Member" xlink:to="lab_docs_EquityIncentivePlan2010Member" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock_411f07d5-184e-46b8-9013-0825ba94686c_terseLabel_en-US" xlink:label="lab_docs_CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalent and Marketable Securities</link:label>
    <link:label id="lab_docs_CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock_label_en-US" xlink:label="lab_docs_CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalent And Marketable Securities [Policy Text Block]</link:label>
    <link:label id="lab_docs_CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock_documentation_en-US" xlink:label="lab_docs_CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalent And Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock" xlink:href="docs-20220331.xsd#docs_CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock" xlink:to="lab_docs_CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_067d792f-2d20-474d-86d7-6d5dd2c30843_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_78a903b6-1ff1-42c4-8666-190e969c037c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a75cce1c-b7b3-41a9-b810-2e376fa01db9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_77f3bb38-711f-470c-a321-5af6dea6cbe3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_ef99fd49-3d87-4b76-8e21-2781e8d00028_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_2d0269bb-cd8a-41c8-8011-57d8c984d8f6_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_6563d541-e55f-487e-9790-bb88b789bd0a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_fc72e1db-5156-40d5-a583-4ed3a6c2bf4c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and exercisable, at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_26265b9d-bef5-497d-ac37-ecc8f23c8445_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, vested and expected to vest at period end (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_7410a07c-e625-4cfd-b710-56140c7fd7ee_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill Intangible Assets and Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_dbfbd43d-c71c-466f-8f2e-b4caa37d70bd_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual Maturities of Available-For-Sale Debt Securities</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_1465de4f-589c-4363-9420-10170b9cd3f4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards, federal</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1a363f4e-be71-49ce-9b92-33b5a563fd04_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_1b40a935-7434-4e40-b32e-951426b8409a_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_c2f49ab2-6033-4194-bbaf-1366d76a98dd_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk, percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_d263b1a3-1d7b-4e5c-9061-af65e43bb17c_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.001 par value; 100,000 and zero shares authorized as of March&#160;31, 2022 and 2021, respectively; zero shares issued and outstanding as of March&#160;31, 2022 and 2021, respectively</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_a027f099-ad7d-4acf-97fe-4717947d1a4c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_af39c4ce-1b44-40d4-867d-0afc7b963986_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_38376568-3168-4179-bcd5-cabd2540d6e0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d3897869-2f2a-463d-8f28-c2d5e617a6ea_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_40d94de5-2995-44c1-a938-dc16cea095ba_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_7fbb0acc-bc8a-4206-a49b-99ea464ac4b5_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue_8d48f401-8e5e-4c90-bf4b-d1ff7b591c5b_terseLabel_en-US" xlink:label="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of granted equity instruments</link:label>
    <link:label id="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue_label_en-US" xlink:label="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Granted in Period, Fair Value</link:label>
    <link:label id="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue_documentation_en-US" xlink:label="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Granted in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" xlink:href="docs-20220331.xsd#docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" xlink:to="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_8201d131-2723-4427-960f-d36e2c602084_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_bdb7e3c5-1702-4d8a-bdb3-e6b6ca9a5195_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease term for lease not yet commenced</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:to="lab_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_923df32c-8767-4b62-9e8b-f4565e577b92_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Expenses</link:label>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Cost [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_54c06d4a-9332-43d9-8f33-3935f0094280_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_60928944-f0e6-41a1-9edf-665d39c7e96a_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_SubscriptionMarketingSolutionsMember_5eae2987-6a03-4b6f-872e-743b93383c2e_terseLabel_en-US" xlink:label="lab_docs_SubscriptionMarketingSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subscription, Marketing Solutions</link:label>
    <link:label id="lab_docs_SubscriptionMarketingSolutionsMember_label_en-US" xlink:label="lab_docs_SubscriptionMarketingSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subscription, Marketing Solutions [Member]</link:label>
    <link:label id="lab_docs_SubscriptionMarketingSolutionsMember_documentation_en-US" xlink:label="lab_docs_SubscriptionMarketingSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subscription, Marketing Solutions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_SubscriptionMarketingSolutionsMember" xlink:href="docs-20220331.xsd#docs_SubscriptionMarketingSolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_SubscriptionMarketingSolutionsMember" xlink:to="lab_docs_SubscriptionMarketingSolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_a334d64a-87e4-4663-ab0e-ca3d9568c9b3_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of redeemable convertible preferred stock upon initial public offering</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_70cf043b-718c-4925-a624-9b79df4eda2a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_797cedc8-c5ee-41fc-b2c4-b9bf44f9f8b9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase and retirement of common stock</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_115e86dd-fd9e-4d4c-a93e-6bef4524cddb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityTableTextBlock_0824eb68-3395-47bd-ac8a-40d549668932_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Redeemable Convertible Preferred Stock</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityTableTextBlock" xlink:to="lab_us-gaap_TemporaryEquityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_85b797f9-91e6-4e48-8b72-6165640f0201_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets obtained in exchange for modified operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_47bc335f-5fad-4bfb-9a16-076a7e315a36_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_HostingArrangementAnnualCommitment_40fb1134-418a-4d91-9a2b-93b7ca5107e8_terseLabel_en-US" xlink:label="lab_docs_HostingArrangementAnnualCommitment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hosting arrangement annual commitment</link:label>
    <link:label id="lab_docs_HostingArrangementAnnualCommitment_label_en-US" xlink:label="lab_docs_HostingArrangementAnnualCommitment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hosting Arrangement, Annual Commitment</link:label>
    <link:label id="lab_docs_HostingArrangementAnnualCommitment_documentation_en-US" xlink:label="lab_docs_HostingArrangementAnnualCommitment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hosting Arrangement, Annual Commitment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_HostingArrangementAnnualCommitment" xlink:href="docs-20220331.xsd#docs_HostingArrangementAnnualCommitment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_HostingArrangementAnnualCommitment" xlink:to="lab_docs_HostingArrangementAnnualCommitment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_cd7fd85d-3aa2-41e6-abc9-c0a541ba7111_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_4b41655a-b3ed-4a5b-aa07-14245abed6e8_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_988364e8-3075-4a44-9c7b-daa19a73c33e_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting percentage</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_b59b5008-5ddf-4831-a42e-8c330d17e5b9_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized stock-based compensation for internal-use software development costs</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Amount Capitalized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardTable_e9836bfa-2059-4ab8-8d7f-65693e562bc7_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Table]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardTable_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforward [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable" xlink:to="lab_us-gaap_TaxCreditCarryforwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_601d7929-706c-4edd-912a-e4260a37bda6_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_35d10416-e9fc-49f8-8519-731a30fd7de5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of business</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfBusiness_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfBusiness" xlink:to="lab_us-gaap_GainLossOnSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_a1c93d28-ebbe-459c-aa0a-8ce67a157515_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_1f124f37-7083-401f-b89b-d8a8afb41b9f_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share attributable to Class A and Class B common stockholders, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_a6e79858-5dd5-40a7-bc15-4ebd963d8bed_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_bcab824e-0138-447e-bd4c-10b8eee9c058_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_8a082cfe-8be9-4e28-a6e5-da69ba24c0ab_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_96d5d68a-b860-4ff7-bf94-8b4edcbc759d_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2b70ce64-0176-41a8-bb41-61c0e003d831_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_7ba51333-9e22-41b3-b68e-0961a4b7d6f5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_5a10884e-391e-4198-9619-83627665435f_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net assets acquired, excluding goodwill</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_e5051afa-9254-4df4-8d69-be121a7f27d9_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_PortionOfCurativeTalentLLCMember_df68175c-a198-408f-9cf7-3987ee90eaaf_terseLabel_en-US" xlink:label="lab_docs_PortionOfCurativeTalentLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion Of Curative Talent, LLC</link:label>
    <link:label id="lab_docs_PortionOfCurativeTalentLLCMember_label_en-US" xlink:label="lab_docs_PortionOfCurativeTalentLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion Of Curative Talent, LLC [Member]</link:label>
    <link:label id="lab_docs_PortionOfCurativeTalentLLCMember_documentation_en-US" xlink:label="lab_docs_PortionOfCurativeTalentLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Portion Of Curative Talent, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PortionOfCurativeTalentLLCMember" xlink:href="docs-20220331.xsd#docs_PortionOfCurativeTalentLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_PortionOfCurativeTalentLLCMember" xlink:to="lab_docs_PortionOfCurativeTalentLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c637a723-ebc1-4cec-956d-c437ce5b240c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_0752f5dc-20e8-4b69-a1aa-3983e7e6b27c_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_25632bfc-f088-44f4-8d49-e12e3862adda_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_StockIssuedAcquisitions_ad7c8857-67ee-42ee-b240-b73c7adff488_terseLabel_en-US" xlink:label="lab_docs_StockIssuedAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued in acquisition</link:label>
    <link:label id="lab_docs_StockIssuedAcquisitions_label_en-US" xlink:label="lab_docs_StockIssuedAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued, Acquisitions</link:label>
    <link:label id="lab_docs_StockIssuedAcquisitions_documentation_en-US" xlink:label="lab_docs_StockIssuedAcquisitions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_StockIssuedAcquisitions" xlink:href="docs-20220331.xsd#docs_StockIssuedAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_StockIssuedAcquisitions" xlink:to="lab_docs_StockIssuedAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_a2208459-4c5d-46a4-a16b-03006d54aa8a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax withholding on shares under stock-based compensation awards</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_ce94e94c-cda3-4402-97fa-e26d3b4373d4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for amounts included in measurement of lease liabilities&#8212;Operating cash flows</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_10276b50-daf2-4cac-9834-4d19ee4bad82_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_AdjustmentsToAdditionalPaidInCapitalExerciseOfWarrants_1eae22b5-3ea4-4d98-b249-d287469c243b_terseLabel_en-US" xlink:label="lab_docs_AdjustmentsToAdditionalPaidInCapitalExerciseOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of Series B redeemable convertible preferred stock warrants</link:label>
    <link:label id="lab_docs_AdjustmentsToAdditionalPaidInCapitalExerciseOfWarrants_label_en-US" xlink:label="lab_docs_AdjustmentsToAdditionalPaidInCapitalExerciseOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments To Additional Paid In Capital, Exercise Of Warrants</link:label>
    <link:label id="lab_docs_AdjustmentsToAdditionalPaidInCapitalExerciseOfWarrants_documentation_en-US" xlink:label="lab_docs_AdjustmentsToAdditionalPaidInCapitalExerciseOfWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments To Additional Paid In Capital, Exercise Of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_AdjustmentsToAdditionalPaidInCapitalExerciseOfWarrants" xlink:href="docs-20220331.xsd#docs_AdjustmentsToAdditionalPaidInCapitalExerciseOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_AdjustmentsToAdditionalPaidInCapitalExerciseOfWarrants" xlink:to="lab_docs_AdjustmentsToAdditionalPaidInCapitalExerciseOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_9e79a5e9-8e7f-400f-9e35-f3c99533d90d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_f1b9bdfb-8278-42db-ad2c-1a5cc085b5bc_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughThree_3a853883-2538-488b-9697-b92eea40e561_terseLabel_en-US" xlink:label="lab_docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due in one year to three years</link:label>
    <link:label id="lab_docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughThree_label_en-US" xlink:label="lab_docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Fair Value, Maturity, Allocated And Single Maturity Date, After Year One Through Three</link:label>
    <link:label id="lab_docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughThree_documentation_en-US" xlink:label="lab_docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughThree" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-For-Sale, Fair Value, Maturity, Allocated And Single Maturity Date, After Year One Through Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughThree" xlink:href="docs-20220331.xsd#docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughThree" xlink:to="lab_docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughThree" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureTextBlock_ed5b0106-ca9b-4ef8-b809-761be56a5148_terseLabel_en-US" xlink:label="lab_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations, Intangible Assets, and Goodwill</link:label>
    <link:label id="lab_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Goodwill And Intangible Assets Disclosure [Text Block]</link:label>
    <link:label id="lab_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureTextBlock_documentation_en-US" xlink:label="lab_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Goodwill And Intangible Assets Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="docs-20220331.xsd#docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_96a46078-f03e-4c51-9241-45dd39c4f10d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount_1d70207d-7530-43d1-8062-3e839b19906a_terseLabel_en-US" xlink:label="lab_docs_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total undiscounted lease payments for lease not yet commenced</link:label>
    <link:label id="lab_docs_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount_label_en-US" xlink:label="lab_docs_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Undiscounted Amount</link:label>
    <link:label id="lab_docs_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount_documentation_en-US" xlink:label="lab_docs_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Lease Not Yet Commenced, Undiscounted Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" xlink:href="docs-20220331.xsd#docs_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" xlink:to="lab_docs_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_748b2df1-3c75-41d7-8ad8-04613bfb1360_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare_30c9cb57-94a9-4b9d-97e4-97c2ef7a0e32_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable convertible preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="lab_us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_b580d65c-0146-4796-a58d-e24d8970f89d_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_07564386-6179-48d2-90cb-260449c8843a_terseLabel_en-US" xlink:label="lab_docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of redeemable convertible preferred stock upon initial public offering</link:label>
    <link:label id="lab_docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Value, Conversion Of Convertible Securities</link:label>
    <link:label id="lab_docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_documentation_en-US" xlink:label="lab_docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Value, Conversion Of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="docs-20220331.xsd#docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_60d075b7-48ed-4d3f-9d0a-5301abb1dccc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_ccbc84c5-cda7-49dc-909e-ae074d7078c3_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_7e3c8153-a187-40c4-8bab-073ec9a0e994_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_acceb5b8-0f67-401d-84b0-2493ae02f077_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_c79491ba-eacf-4976-818d-0c30f5ba02a3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_dc5363e4-0835-4e8d-a8df-432682c7c534_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income taxes, net of federal benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_cf761b4e-7ed1-4a78-85d1-cc98fe7bea43_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal-use software development costs</link:label>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareDevelopmentMember" xlink:to="lab_us-gaap_SoftwareDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_3e74c777-b638-4d4e-b0a9-d4a2a79ef518_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_cb8139a6-5da8-4727-ac6d-f9f349a6b406_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsMember" xlink:to="lab_us-gaap_CashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockSharesConverted1_e5d5d6c5-8e8c-4433-ac76-ce754818907d_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockSharesConverted1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of stock, shares converted (in shares)</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockSharesConverted1_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockSharesConverted1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Stock, Shares Converted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesConverted1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockSharesConverted1" xlink:to="lab_us-gaap_ConversionOfStockSharesConverted1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_b9b09f6c-1392-4b9e-91b3-4521fca1ecd4_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions for tax positions related to the current year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_91c2826e-58c9-4df2-95e2-f9218a8d0296_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities, redeemable convertible preferred stock, and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_546bdeec-ce1b-4825-9a4a-d164f37a84db_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="lab_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_b829bbbf-4ef3-4d76-b029-693c604667ee_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche One</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_1d5de644-8716-4605-bf89-7d1834ba499c_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue, current</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_0c3cb936-de41-492f-a76f-571019cc6834_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_eb21213f-fe7a-4757-9eb3-8678c56d017a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_06a67c63-0972-4498-a616-ce66f8260e8e_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_307b20e4-cf0b-4af5-980e-afe5e332226c_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bc4e263f-6dc6-4fda-85ef-445e8643cdd0_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Redeemable Convertible Preferred Stock, and Stockholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_2f9e9f24-01bf-4385-9b2e-b12be388e2e0_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_a965e1eb-3c22-473b-9928-00f8ac28621d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock upon initial public offering after deducting underwriting discounts and commissions</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance Initial Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember_55bfd240-4e10-4939-b6e7-2df685ab7046_terseLabel_en-US" xlink:label="lab_docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Commissions For Subscriptions Of New And Expansion Hiring Solutions Contracts</link:label>
    <link:label id="lab_docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember_label_en-US" xlink:label="lab_docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Commissions For Subscriptions Of New And Expansion Hiring Solutions Contracts [Member]</link:label>
    <link:label id="lab_docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember_documentation_en-US" xlink:label="lab_docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales Commissions For Subscriptions Of New And Expansion Hiring Solutions Contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember" xlink:href="docs-20220331.xsd#docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember" xlink:to="lab_docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_aae9e414-e6f2-4ef0-88e0-5208aba7f1c7_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income Per Share Attributable to Common Stockholders</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_6bb6bad1-6321-4bd1-897e-ab62f4cecc6c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_eb75cefa-b698-49d6-8ce1-58f7e95570ee_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_833eced3-6eda-47e5-ae8e-59c58ab36053_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_062332f8-5cea-41bf-8022-6a2460491697_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_c429dc89-df93-4931-9dd2-382a68caa24a_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_0c65ae92-321b-4471-917e-a948ce2124c5_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DESCRIPTION OF BUSINESS</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_b03e701b-4f5f-4dba-a520-6e3740dbef5f_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_037084e7-1a75-477b-9b03-f084d57f3c32_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_937b3acc-634b-4dc0-9c8c-bfe9aeec85cc_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_bc07e43d-fea8-4423-99cb-e413d5aec426_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited or expired (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_65031d11-3bf4-437e-baff-f541c170e681_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceOtherMember_1275ebfe-db57-4bf1-89b9-4f320acef9ef_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service, Other</link:label>
    <link:label id="lab_us-gaap_ServiceOtherMember_label_en-US" xlink:label="lab_us-gaap_ServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceOtherMember" xlink:to="lab_us-gaap_ServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_3866e149-3cf7-4d28-9d8d-e8ef33272316_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_91deb0ac-ac62-407e-8bcf-e6b9679585c1_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_48df6982-3180-44da-be37-11960e0c1e07_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_8e7993ae-c357-4ca2-9911-52409319e5f0_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_08848c7c-695f-45ad-8dd1-5eac9aca22c6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_80631cba-8a01-4991-88ec-4565b9aa223a_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_3a0a32e3-5270-4d13-babe-1cb8339a33fc_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:to="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_a240cc20-1ada-4142-b435-58032c51d477_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0d6f6d4f-400b-4682-beb9-130d57b7866e_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_4a2cbfb8-380b-46c2-8ba0-b8dad25292f8_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_CustomerAMember_4c473fff-1458-4c32-a992-59628264d476_terseLabel_en-US" xlink:label="lab_docs_CustomerAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer A</link:label>
    <link:label id="lab_docs_CustomerAMember_label_en-US" xlink:label="lab_docs_CustomerAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer A [Member]</link:label>
    <link:label id="lab_docs_CustomerAMember_documentation_en-US" xlink:label="lab_docs_CustomerAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer A</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CustomerAMember" xlink:href="docs-20220331.xsd#docs_CustomerAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_CustomerAMember" xlink:to="lab_docs_CustomerAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_InitialPublicOfferingIncludingOverAllotmentOptionMember_530e5d93-140a-4238-8bdd-f4d1dc835abb_terseLabel_en-US" xlink:label="lab_docs_InitialPublicOfferingIncludingOverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Public Offering Including Over Allotment Option</link:label>
    <link:label id="lab_docs_InitialPublicOfferingIncludingOverAllotmentOptionMember_label_en-US" xlink:label="lab_docs_InitialPublicOfferingIncludingOverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Public Offering Including Over Allotment Option [Member]</link:label>
    <link:label id="lab_docs_InitialPublicOfferingIncludingOverAllotmentOptionMember_documentation_en-US" xlink:label="lab_docs_InitialPublicOfferingIncludingOverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial Public Offering Including Over Allotment Option</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_InitialPublicOfferingIncludingOverAllotmentOptionMember" xlink:href="docs-20220331.xsd#docs_InitialPublicOfferingIncludingOverAllotmentOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_InitialPublicOfferingIncludingOverAllotmentOptionMember" xlink:to="lab_docs_InitialPublicOfferingIncludingOverAllotmentOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_b7ceaf3c-5a07-4ce7-9a20-66ed81c49002_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_4a9cdc5b-d7d7-4300-af9a-35e6229fdec6_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with an acquisition</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_22550b50-c413-4eef-986e-c214b1ae1ed9_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToDevelopSoftware_adf60630-27c5-469f-9131-d5cb58343748_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToDevelopSoftware" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal-use software development costs</link:label>
    <link:label id="lab_us-gaap_PaymentsToDevelopSoftware_label_en-US" xlink:label="lab_us-gaap_PaymentsToDevelopSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Develop Software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopSoftware" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToDevelopSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToDevelopSoftware" xlink:to="lab_us-gaap_PaymentsToDevelopSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_74b66d19-121d-446e-9c52-7380ac0c6217_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. government and agency securities</link:label>
    <link:label id="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">US Government Corporations and Agencies Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_e4e14912-5e8d-43f0-8598-b73227e2fcb8_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon initial public offering, net of underwriting discounts and commissions and deferred offering costs</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense_49332672-ae12-44aa-a8a0-371a6d74334f_terseLabel_en-US" xlink:label="lab_docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition and other related expense</link:label>
    <link:label id="lab_docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense_label_en-US" xlink:label="lab_docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Acquisition and Other Related Expense</link:label>
    <link:label id="lab_docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense_documentation_en-US" xlink:label="lab_docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Acquisition and Other Related Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense" xlink:href="docs-20220331.xsd#docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense" xlink:to="lab_docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_601afde6-3594-4748-9f70-fe04805bad99_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueRecognitionPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:to="lab_us-gaap_RevenueRecognitionPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_57d36c87-15c7-48aa-a919-145983b34865_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_81daec6f-77eb-4ac9-8a38-7bfde6b121bd_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member_80bc2c19-97ee-451e-a4e2-50f5f23e3ebf_terseLabel_en-US" xlink:label="lab_docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding outside the Plans</link:label>
    <link:label id="lab_docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member_label_en-US" xlink:label="lab_docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Approved By Board Of Directors, Excluding Equity Incentive Plan 2010 And Stock Option And Incentive Plan 2021 [Member]</link:label>
    <link:label id="lab_docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member_documentation_en-US" xlink:label="lab_docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Approved By Board Of Directors, Excluding Equity Incentive Plan 2010 And Stock Option And Incentive Plan 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member" xlink:href="docs-20220331.xsd#docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member" xlink:to="lab_docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_4e6dfada-ef86-4f27-9786-3c42c998c237_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for acquisition, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_ca3e4db8-2804-4097-8c0f-e06c537b132b_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_3f9078b9-539f-40af-b418-d69d6c49ba4c_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_1230ae36-40e5-4cdb-85cf-63f1d8a5721a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_e2d351a9-53b8-48e2-817c-0a0a6ac76087_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price, vested and exercisable at period end (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_3b6fe4ee-1231-47e8-8543-1da020060d33_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_030602af-ce18-4313-846b-02fc2b75cbb8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_AMiONMember_55ec6bb9-e981-4eb5-ac1a-465af29e4179_terseLabel_en-US" xlink:label="lab_docs_AMiONMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AMiON</link:label>
    <link:label id="lab_docs_AMiONMember_label_en-US" xlink:label="lab_docs_AMiONMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AMiON [Member]</link:label>
    <link:label id="lab_docs_AMiONMember_documentation_en-US" xlink:label="lab_docs_AMiONMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AMiON</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_AMiONMember" xlink:href="docs-20220331.xsd#docs_AMiONMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_AMiONMember" xlink:to="lab_docs_AMiONMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostDomain_f77590d8-ea1f-47da-9f7b-62c50e78eaf0_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost [Domain]</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostDomain_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostDomain" xlink:to="lab_us-gaap_CapitalizedContractCostDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_38ecf610-fdec-46c6-adc8-2e30865a8e8d_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average remaining contractual term, outstanding</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_e6224411-282b-4184-aa24-e1d0464e705e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for deferred offering costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_f8a76a89-3d8e-4dda-a84d-7a96aca530b0_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon initial public offering, net of underwriting discounts and commissions and deferred offering costs (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_d4febd96-4ebe-4e6b-aa9c-c43d4b9568f8_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortizationPeriod_8876f8a3-ab28-4a10-a44e-b57e3de6adb0_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization period</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortizationPeriod_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostAmortizationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:to="lab_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_StockOptionAndIncentivePlan2021Member_7af75df4-eb0d-452e-b2af-49bcfef820a5_terseLabel_en-US" xlink:label="lab_docs_StockOptionAndIncentivePlan2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Plan</link:label>
    <link:label id="lab_docs_StockOptionAndIncentivePlan2021Member_label_en-US" xlink:label="lab_docs_StockOptionAndIncentivePlan2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option and Incentive Plan 2021 [Member]</link:label>
    <link:label id="lab_docs_StockOptionAndIncentivePlan2021Member_documentation_en-US" xlink:label="lab_docs_StockOptionAndIncentivePlan2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option and Incentive Plan 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_StockOptionAndIncentivePlan2021Member" xlink:href="docs-20220331.xsd#docs_StockOptionAndIncentivePlan2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_StockOptionAndIncentivePlan2021Member" xlink:to="lab_docs_StockOptionAndIncentivePlan2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_fcc957a0-e02f-4f2a-9955-510b612f603f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_da243664-e364-46f5-b34b-e452381e487e_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternetDomainNamesMember_57039173-b6f5-4a21-95ad-d9b98a8792c1_terseLabel_en-US" xlink:label="lab_us-gaap_InternetDomainNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domain names</link:label>
    <link:label id="lab_us-gaap_InternetDomainNamesMember_label_en-US" xlink:label="lab_us-gaap_InternetDomainNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internet Domain Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternetDomainNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternetDomainNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternetDomainNamesMember" xlink:to="lab_us-gaap_InternetDomainNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_09ccec1f-cd6f-4e49-af61-e185b579a8af_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_1b26bdef-13ad-415e-8100-001a2049fd16_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class A and Class B common stock, $0.001 par value; 1,500,000 and 198,000 shares authorized as of March&#160;31, 2022 and 2021, respectively; 192,398 and 82,910 shares issued and outstanding as of March&#160;31, 2022 and 2021, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_af99e611-0cff-4f4e-8bf6-41381fa4361b_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_5541d01b-60f2-47cd-bb9c-ca1a652d8d27_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized compensation expense, weighted average period of recognition</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_22c29edb-6c9f-47d2-8232-2cc1da5d4256_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_857bfbb7-e395-421b-a506-f775a8ac78de_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_2c0ccb6f-455a-4cd4-887c-3ac7b04564e4_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_42c83616-a28d-4a98-99d8-42bfe465b5af_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_1b55e478-f526-4543-9169-50ea9be5f3e1_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_b60b830d-7d12-41a9-823b-dbd7b2d91c6b_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 13)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_5f73d623-87f1-4ee2-9768-443992d40d69_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_c5d29ce9-5ded-4cd2-8e22-b3fffb0a44c5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_18731380-1284-4ec9-aca4-8dafc1d5d2e5_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_63513e41-a061-451c-9d42-0b4c3617c0d2_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_9c44ec19-1021-4904-9b77-263c1a0aeedd_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAccrualProvision_e9f3de40-7629-4694-bf4f-7252ed4c42ff_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualProvision" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss contingency</link:label>
    <link:label id="lab_us-gaap_LossContingencyAccrualProvision_label_en-US" xlink:label="lab_us-gaap_LossContingencyAccrualProvision" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Accrual, Provision</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAccrualProvision" xlink:to="lab_us-gaap_LossContingencyAccrualProvision" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_TemporaryEquityExercisesOfWarrantsAmount_b9aefb66-f415-4aa7-bb78-dfa0c3f988ba_terseLabel_en-US" xlink:label="lab_docs_TemporaryEquityExercisesOfWarrantsAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of Series B redeemable convertible preferred stock warrants</link:label>
    <link:label id="lab_docs_TemporaryEquityExercisesOfWarrantsAmount_label_en-US" xlink:label="lab_docs_TemporaryEquityExercisesOfWarrantsAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Exercises of Warrants, Amount</link:label>
    <link:label id="lab_docs_TemporaryEquityExercisesOfWarrantsAmount_documentation_en-US" xlink:label="lab_docs_TemporaryEquityExercisesOfWarrantsAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Exercises of Warrants, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TemporaryEquityExercisesOfWarrantsAmount" xlink:href="docs-20220331.xsd#docs_TemporaryEquityExercisesOfWarrantsAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_TemporaryEquityExercisesOfWarrantsAmount" xlink:to="lab_docs_TemporaryEquityExercisesOfWarrantsAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_2b02aa04-0ec3-4d6f-8f1e-519d5e3e635c_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Benefit Plan</link:label>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_label_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation and Employee Benefit Plans [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:to="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_80949a25-ab74-4eab-9171-65d955c6037a_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_7492b779-cc0c-40d9-9647-94286127bb2f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsTable_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsTable" xlink:to="lab_us-gaap_OtherCommitmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_e268eb48-c2cf-4ff5-8aac-cd239ce64274_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Options Valuation Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_e8f38a91-2b7b-4202-9ad3-db1b90ce9bc0_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_793efffa-f087-418d-a6fd-3d0c097883b9_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_THMEDLLCMember_d34b534e-6450-497e-9ed2-aa3fc4d21267_terseLabel_en-US" xlink:label="lab_docs_THMEDLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">THMED, LLC</link:label>
    <link:label id="lab_docs_THMEDLLCMember_label_en-US" xlink:label="lab_docs_THMEDLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">THMED, LLC [Member]</link:label>
    <link:label id="lab_docs_THMEDLLCMember_documentation_en-US" xlink:label="lab_docs_THMEDLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">THMED, LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_THMEDLLCMember" xlink:href="docs-20220331.xsd#docs_THMEDLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_THMEDLLCMember" xlink:to="lab_docs_THMEDLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_80bbe27a-168d-4eba-9f4e-ce3c26f6029e_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_b8507e0a-68ce-4c55-bd5c-6774380d6dc0_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of share-based payment (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_ContractWithUSNewsWorldReportLPMember_9a17dc7e-d2a9-401b-b57f-8d35fdc43df4_terseLabel_en-US" xlink:label="lab_docs_ContractWithUSNewsWorldReportLPMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With U S News World Report L P</link:label>
    <link:label id="lab_docs_ContractWithUSNewsWorldReportLPMember_label_en-US" xlink:label="lab_docs_ContractWithUSNewsWorldReportLPMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With U S News World Report L P [Member]</link:label>
    <link:label id="lab_docs_ContractWithUSNewsWorldReportLPMember_documentation_en-US" xlink:label="lab_docs_ContractWithUSNewsWorldReportLPMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With U S News World Report L P</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ContractWithUSNewsWorldReportLPMember" xlink:href="docs-20220331.xsd#docs_ContractWithUSNewsWorldReportLPMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_ContractWithUSNewsWorldReportLPMember" xlink:to="lab_docs_ContractWithUSNewsWorldReportLPMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_b55fd065-9bc4-4419-b911-55fbb34d83cf_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityByClassOfStockTable_95ff3951-9626-4142-ac30-855b797963cc_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityByClassOfStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, by Class of Stock [Table]</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityByClassOfStockTable_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityByClassOfStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, by Class of Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="lab_us-gaap_TemporaryEquityByClassOfStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_cabe59c6-7572-48db-b36d-195b8eb51df8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_815dea66-427d-435d-8e23-5bbfc707fc8f_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_label_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_6cd34e80-f75b-4f0e-b226-3e7d3612ef75_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_cbca785e-d11e-4899-a0ae-33612e1e0b14_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate net proceeds from initial public offering</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnbilledReceivablesCurrent_7f2ccdc6-89b5-4955-a333-396e9718eb39_terseLabel_en-US" xlink:label="lab_us-gaap_UnbilledReceivablesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled revenue</link:label>
    <link:label id="lab_us-gaap_UnbilledReceivablesCurrent_label_en-US" xlink:label="lab_us-gaap_UnbilledReceivablesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unbilled Receivables, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledReceivablesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnbilledReceivablesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnbilledReceivablesCurrent" xlink:to="lab_us-gaap_UnbilledReceivablesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_TemporaryEquityDividendRate_a410a60c-aa73-4f95-9e51-78c180aa28a5_terseLabel_en-US" xlink:label="lab_docs_TemporaryEquityDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, dividend rate (in dollars per share)</link:label>
    <link:label id="lab_docs_TemporaryEquityDividendRate_label_en-US" xlink:label="lab_docs_TemporaryEquityDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Dividend Rate</link:label>
    <link:label id="lab_docs_TemporaryEquityDividendRate_documentation_en-US" xlink:label="lab_docs_TemporaryEquityDividendRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TemporaryEquityDividendRate" xlink:href="docs-20220331.xsd#docs_TemporaryEquityDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_TemporaryEquityDividendRate" xlink:to="lab_docs_TemporaryEquityDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_ed06713d-22cd-495a-bf36-35e7bf3be967_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_IndividualsWithVotingInterestAtThresholdMember_0481ecc4-cf56-45a7-bcbc-8bc96c462ef2_terseLabel_en-US" xlink:label="lab_docs_IndividualsWithVotingInterestAtThresholdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individuals With Voting Interest At Threshold</link:label>
    <link:label id="lab_docs_IndividualsWithVotingInterestAtThresholdMember_label_en-US" xlink:label="lab_docs_IndividualsWithVotingInterestAtThresholdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individuals With Voting Interest At Threshold [Member]</link:label>
    <link:label id="lab_docs_IndividualsWithVotingInterestAtThresholdMember_documentation_en-US" xlink:label="lab_docs_IndividualsWithVotingInterestAtThresholdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individuals With Voting Interest At Threshold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_IndividualsWithVotingInterestAtThresholdMember" xlink:href="docs-20220331.xsd#docs_IndividualsWithVotingInterestAtThresholdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_IndividualsWithVotingInterestAtThresholdMember" xlink:to="lab_docs_IndividualsWithVotingInterestAtThresholdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_d319f296-efd7-49f0-8ae5-79a50c3c7275_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_90ac6191-0e02-411c-8153-1c3f47cb2413_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable convertible preferred stock, $0.001 par value; zero and 76,350 shares authorized as of March&#160;31, 2022 and 2021, respectively; zero and 76,287 shares issued and outstanding as of March&#160;31, 2022 and 2021, respectively; liquidation preference of zero and $81,672 as of March&#160;31, 2022 and 2021, respectively</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_8fdbc402-766a-4ebf-9c2c-712eb0661609_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_d2c99172-656b-4399-a034-37aa09d3373c_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_a251905f-7bba-4ac1-91c1-ce532890e96f_verboseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Carrying Value</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Carrying Amount, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_e3c2ad01-ed13-4bdb-8234-cdf9450f8e27_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares issued</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_e0762613-7ade-4827-abbd-d6096255a0b5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_c95fb0fe-e9cd-481c-928a-25faf59b36ba_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Excluding Accrued Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_a9398cda-62fb-4124-a740-dc93b219e770_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_7590eb44-7c47-48e5-bd8d-11fb4a2b4064_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_796b240e-71c8-458a-a84c-8449ee810f51_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_fec5133a-e0f9-40c7-a087-39491b485172_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_13b99d24-ef2d-4d71-b563-3472152f8b9d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets acquired:</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAdditions_ff8982bd-1936-4771-adbb-36d08df151cb_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAdditions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized internal-use software development costs</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAdditions_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAdditions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Additions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAdditions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAdditions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareAdditions" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareAdditions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7280759c-005a-47e6-aab2-9bf7c18eb102_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current provision:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_0fb06e01-8912-48ca-badf-06235522c7a6_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityLiquidationPreferencePerShare_8969a414-5160-4911-9722-246dc64e7e6f_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityLiquidationPreferencePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, liquidation preference per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityLiquidationPreferencePerShare_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityLiquidationPreferencePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Liquidation Preference Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLiquidationPreferencePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreferencePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityLiquidationPreferencePerShare" xlink:to="lab_us-gaap_TemporaryEquityLiquidationPreferencePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_c3e12968-ed9e-48f0-b03a-1ca35726fac7_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_5a87cbf1-27ad-4823-b855-97cb3c650132_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_f8f786b6-5464-4188-9ebe-37b7dbd1bc39_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_428c4496-7485-4654-9ec7-d343a01e8fb7_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in exchange for services</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Issued for Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueIssuedForServices" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_c2d92357-6c46-446f-8dec-ce07cad12692_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_f468a256-9841-4fc9-a178-382c2f2fcf0a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_a6747315-dff1-458c-9bb4-5664ec5e9317_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment and Geographic Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_a3f9cc77-9e3e-4972-a59c-3adaa2190e30_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_38a84666-c8ee-4c8f-9072-7f7a7152c5ee_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employer discretionary contribution amount</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Discretionary Contribution Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8a16959b-5b3e-4d17-9d3e-8a2a59003446_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPricesPerShareIssued_dccfc08d-3fdb-4f2d-9469-c50ba69dc829_terseLabel_en-US" xlink:label="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPricesPerShareIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan price per share (in dollars per share)</link:label>
    <link:label id="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPricesPerShareIssued_label_en-US" xlink:label="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPricesPerShareIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Prices Per Share Issued</link:label>
    <link:label id="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPricesPerShareIssued_documentation_en-US" xlink:label="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPricesPerShareIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Prices Per Share Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPricesPerShareIssued" xlink:href="docs-20220331.xsd#docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPricesPerShareIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPricesPerShareIssued" xlink:to="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPricesPerShareIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramPeriodInForce1_9b2ade86-d048-497f-9394-417a2585a7e3_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock repurchase program, period in force</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramPeriodInForce1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Period in Force</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:to="lab_us-gaap_StockRepurchaseProgramPeriodInForce1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_b0193012-508f-4e43-ad73-17129c3fd0e1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="lab_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_8af3ced7-cb46-4bbe-9700-9bad6b84bcb1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_7cae4bb7-fda9-4ea2-8577-be2f1e14ffbd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_f116229f-b009-449d-95d0-d23a88f24bd1_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized losses related to debt securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_3877369a-fbbe-4a24-8a8f-1c05d647f5a5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_f4a65160-652a-47a6-af2a-da08fae28220_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on sale of marketable securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Realized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_ab926a8a-409c-4088-be8c-a894bab49bce_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_808769e8-8141-4ed7-8b22-7fbdda4de1da_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_2e87d32f-fac8-453a-a1c3-c9ffe183f9eb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation, net of amounts capitalized</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_989cf25c-2a54-49a7-affc-be5f24dbfdd4_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_e1aa78ee-0cbe-4d31-a010-dd2a1909a424_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_4aa05896-183d-47a6-8a37-7493703f680b_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost or Amortized Cost, money market funds</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_019aad54-c96d-4250-b556-d7f12917cf70_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_TemporaryEquityElectionOfBoardMembersSharesOutstandingThreshold_ebf6a8f7-69f6-4d57-b69f-d34f621eafbe_terseLabel_en-US" xlink:label="lab_docs_TemporaryEquityElectionOfBoardMembersSharesOutstandingThreshold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, election of board members, shares outstanding threshold (in shares)</link:label>
    <link:label id="lab_docs_TemporaryEquityElectionOfBoardMembersSharesOutstandingThreshold_label_en-US" xlink:label="lab_docs_TemporaryEquityElectionOfBoardMembersSharesOutstandingThreshold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Election Of Board Members, Shares Outstanding Threshold</link:label>
    <link:label id="lab_docs_TemporaryEquityElectionOfBoardMembersSharesOutstandingThreshold_documentation_en-US" xlink:label="lab_docs_TemporaryEquityElectionOfBoardMembersSharesOutstandingThreshold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Election Of Board Members, Shares Outstanding Threshold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TemporaryEquityElectionOfBoardMembersSharesOutstandingThreshold" xlink:href="docs-20220331.xsd#docs_TemporaryEquityElectionOfBoardMembersSharesOutstandingThreshold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_TemporaryEquityElectionOfBoardMembersSharesOutstandingThreshold" xlink:to="lab_docs_TemporaryEquityElectionOfBoardMembersSharesOutstandingThreshold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_89b7848a-725e-4f68-a441-20b9f1a20474_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_CapitalizedContractCostAdditions_28834eb7-265b-4ae1-b42c-4d53def58be8_terseLabel_en-US" xlink:label="lab_docs_CapitalizedContractCostAdditions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized contract acquisition costs</link:label>
    <link:label id="lab_docs_CapitalizedContractCostAdditions_label_en-US" xlink:label="lab_docs_CapitalizedContractCostAdditions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Additions</link:label>
    <link:label id="lab_docs_CapitalizedContractCostAdditions_documentation_en-US" xlink:label="lab_docs_CapitalizedContractCostAdditions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Additions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CapitalizedContractCostAdditions" xlink:href="docs-20220331.xsd#docs_CapitalizedContractCostAdditions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_CapitalizedContractCostAdditions" xlink:to="lab_docs_CapitalizedContractCostAdditions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_004b9545-fc19-4668-890e-4cfe4260c93d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleChangeInPresentValueExpenseReversal_4335795a-7e07-4a13-9aa2-be691368899a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleChangeInPresentValueExpenseReversal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities credit losses</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleChangeInPresentValueExpenseReversal_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleChangeInPresentValueExpenseReversal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Change in Present Value, Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleChangeInPresentValueExpenseReversal" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleChangeInPresentValueExpenseReversal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleChangeInPresentValueExpenseReversal" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleChangeInPresentValueExpenseReversal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss_9400b23e-d6f6-4bd1-a7b4-1c3e1546a339_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_2e91f276-7749-4cc1-8568-302770a39640_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_ec33372b-79e8-41d0-b6b7-1cb185568b6c_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock warrants (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_5c57986b-1b9a-49e5-9619-d6bb8e8c20b5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_TemporaryEquityPreferredStockOutstandingSeries_583238c3-cd7d-4f44-8b5c-838621ad4edf_terseLabel_en-US" xlink:label="lab_docs_TemporaryEquityPreferredStockOutstandingSeries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of outstanding series of redeemable convertible preferred stock</link:label>
    <link:label id="lab_docs_TemporaryEquityPreferredStockOutstandingSeries_label_en-US" xlink:label="lab_docs_TemporaryEquityPreferredStockOutstandingSeries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity Preferred Stock Outstanding Series</link:label>
    <link:label id="lab_docs_TemporaryEquityPreferredStockOutstandingSeries_documentation_en-US" xlink:label="lab_docs_TemporaryEquityPreferredStockOutstandingSeries" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity Preferred Stock Outstanding Series</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TemporaryEquityPreferredStockOutstandingSeries" xlink:href="docs-20220331.xsd#docs_TemporaryEquityPreferredStockOutstandingSeries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_TemporaryEquityPreferredStockOutstandingSeries" xlink:to="lab_docs_TemporaryEquityPreferredStockOutstandingSeries" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_TemporaryEquityConvertibleAggregateOfferingPriceTrigger_d88f4614-17b3-4ff5-96a9-403e94e615e1_terseLabel_en-US" xlink:label="lab_docs_TemporaryEquityConvertibleAggregateOfferingPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate offering price conversion trigger</link:label>
    <link:label id="lab_docs_TemporaryEquityConvertibleAggregateOfferingPriceTrigger_label_en-US" xlink:label="lab_docs_TemporaryEquityConvertibleAggregateOfferingPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Convertible, Aggregate Offering Price Trigger</link:label>
    <link:label id="lab_docs_TemporaryEquityConvertibleAggregateOfferingPriceTrigger_documentation_en-US" xlink:label="lab_docs_TemporaryEquityConvertibleAggregateOfferingPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Convertible, Aggregate Offering Price Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TemporaryEquityConvertibleAggregateOfferingPriceTrigger" xlink:href="docs-20220331.xsd#docs_TemporaryEquityConvertibleAggregateOfferingPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_TemporaryEquityConvertibleAggregateOfferingPriceTrigger" xlink:to="lab_docs_TemporaryEquityConvertibleAggregateOfferingPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue_248794bb-be91-4b73-a91f-64e9db6767b2_terseLabel_en-US" xlink:label="lab_docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accruals and deferred revenue</link:label>
    <link:label id="lab_docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue_label_en-US" xlink:label="lab_docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Revenue</link:label>
    <link:label id="lab_docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue_documentation_en-US" xlink:label="lab_docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue" xlink:href="docs-20220331.xsd#docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue" xlink:to="lab_docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_86ee643f-f7ff-48d7-aecb-7780acdc22ac_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_9107b1d1-51ce-470c-a49a-c4fb633c3f24_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase and retirement of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased and Retired During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_c0e07670-2c4b-4518-a5e3-ad3a32b09a9d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_5a8e1f60-3817-491c-8d28-69e3785ea987_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationTechniqueAxis_label_en-US" xlink:label="lab_us-gaap_ValuationTechniqueAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Approach and Technique [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationTechniqueAxis" xlink:to="lab_us-gaap_ValuationTechniqueAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_8bb87cc9-16f4-49ba-bf52-b11ea0e1d975_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_ComputerEquipmentAndSoftwareMember_55e3958e-3f56-4bfd-8597-96a9485b5ef6_terseLabel_en-US" xlink:label="lab_docs_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computers and software</link:label>
    <link:label id="lab_docs_ComputerEquipmentAndSoftwareMember_label_en-US" xlink:label="lab_docs_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment and Software [Member]</link:label>
    <link:label id="lab_docs_ComputerEquipmentAndSoftwareMember_documentation_en-US" xlink:label="lab_docs_ComputerEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computer Equipment and Software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ComputerEquipmentAndSoftwareMember" xlink:href="docs-20220331.xsd#docs_ComputerEquipmentAndSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_ComputerEquipmentAndSoftwareMember" xlink:to="lab_docs_ComputerEquipmentAndSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_2a394d08-29e6-4746-b4d0-e2f8c736cd9b_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_3b0cbc22-2eae-44e8-a76a-e6da7f7dd62c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_f842c158-eb78-4bbb-bd59-039e147c2465_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_d2d36936-581d-4743-8df0-36623a87f3c9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod_ed8d44c8-d089-4da8-b66e-6bffcb5a363e_terseLabel_en-US" xlink:label="lab_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partnership agreement, revenue guarantee during noncancelable period</link:label>
    <link:label id="lab_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod_label_en-US" xlink:label="lab_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partnership Agreement, Revenue Guarantee To Partnering Company During Noncancelable Period</link:label>
    <link:label id="lab_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod_documentation_en-US" xlink:label="lab_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partnership Agreement, Revenue Guarantee To Partnering Company During Noncancelable Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod" xlink:href="docs-20220331.xsd#docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod" xlink:to="lab_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_a2104f2b-a347-44c5-864e-fd7203d68306_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9bfb18de-8b03-4bfb-980b-9cdfa27e227c_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_85705074-792b-49a7-bb51-8e09378beb6d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value, outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_f6579919-b794-4d80-89b6-e69a7aa1fd81_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_88c84366-afbb-4679-a82b-01ad5e4dfbaf_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_97389589-6998-4d75-bad5-b73ce8cb0a52_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_3c871602-0789-408e-bf68-a443dddcdaef_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_4e44ff59-4fce-497b-8646-1decbfae859b_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_701f0f1c-60a9-4091-8faa-755ce58b4f10_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in exchange for services (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Issued for Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_1c9423d2-599d-4325-82a4-6a12ef95ccba_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_63b2a88a-dda7-4e5a-a115-eea94112cd84_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_45421d29-9f74-43c1-92ab-81fbe3cb333b_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_55aca2c1-4660-4cce-8e7a-3f2eb6d859b8_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable, accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_PartnershipAgreementNoncancelablePeriod_51e71558-e90f-4190-bf40-285b2a045da9_terseLabel_en-US" xlink:label="lab_docs_PartnershipAgreementNoncancelablePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partnership agreement, noncancelable period</link:label>
    <link:label id="lab_docs_PartnershipAgreementNoncancelablePeriod_label_en-US" xlink:label="lab_docs_PartnershipAgreementNoncancelablePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partnership Agreement Noncancelable Period</link:label>
    <link:label id="lab_docs_PartnershipAgreementNoncancelablePeriod_documentation_en-US" xlink:label="lab_docs_PartnershipAgreementNoncancelablePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partnership Agreement Noncancelable Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PartnershipAgreementNoncancelablePeriod" xlink:href="docs-20220331.xsd#docs_PartnershipAgreementNoncancelablePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_PartnershipAgreementNoncancelablePeriod" xlink:to="lab_docs_PartnershipAgreementNoncancelablePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_31f36339-e2b3-4177-9b4d-ef50fb85a91c_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value, vested and exercisable at period end</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputExpectedTermMember_a40b20ca-aef6-47bd-a300-5c8e2d625440_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedTermMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Expected Term</link:label>
    <link:label id="lab_us-gaap_MeasurementInputExpectedTermMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedTermMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Expected Term [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExpectedTermMember" xlink:to="lab_us-gaap_MeasurementInputExpectedTermMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_d0de566e-750d-49e3-a043-a268537e8398_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_e5633431-f9c1-4fc7-967e-8dc973bd03f8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_a0b5ef4d-7fa6-4084-aa01-3e980c331fdc_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_98eb1775-0ba2-46f6-b5cc-737e6c1ecd9a_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash financing and investing activities</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_df043daf-9a75-4ffe-8206-e656204d5f5a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_ce4596a0-2f0a-4a47-bda7-f41e6aa86370_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration of Credit Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_e820d793-e9a7-4789-b048-0c7ed954dd20_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_28529dd2-a52b-4f88-9352-78556ca91cec_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk free interest rate, minimum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_11cf3ae0-2d31-4a73-bf4f-ed7d20d016b3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, non-current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_bd65295d-61ef-4f09-9449-c1a7b1836892_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_8b6ce5aa-a0f0-4987-85b1-715a63f00b38_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred provision (benefit):</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_5af8fcaf-1b9b-4954-b795-b1450a021e3a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility, maximum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_ConversionOfStockConversionRatio_b97616ab-6df2-46e2-afea-35b475564726_terseLabel_en-US" xlink:label="lab_docs_ConversionOfStockConversionRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of stock conversion ratio</link:label>
    <link:label id="lab_docs_ConversionOfStockConversionRatio_label_en-US" xlink:label="lab_docs_ConversionOfStockConversionRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion Of Stock, Conversion Ratio</link:label>
    <link:label id="lab_docs_ConversionOfStockConversionRatio_documentation_en-US" xlink:label="lab_docs_ConversionOfStockConversionRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion Of Stock, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ConversionOfStockConversionRatio" xlink:href="docs-20220331.xsd#docs_ConversionOfStockConversionRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_ConversionOfStockConversionRatio" xlink:to="lab_docs_ConversionOfStockConversionRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_626637ae-3694-4530-be33-7bc3f73397e9_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total purchase consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_AccruedEmployeeStockPurchasePlanCurrent_3fe23064-f820-4b53-a01b-a2f7d797eb1e_terseLabel_en-US" xlink:label="lab_docs_AccruedEmployeeStockPurchasePlanCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee contributions under employee stock purchase plan</link:label>
    <link:label id="lab_docs_AccruedEmployeeStockPurchasePlanCurrent_label_en-US" xlink:label="lab_docs_AccruedEmployeeStockPurchasePlanCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Employee Stock Purchase Plan, Current</link:label>
    <link:label id="lab_docs_AccruedEmployeeStockPurchasePlanCurrent_documentation_en-US" xlink:label="lab_docs_AccruedEmployeeStockPurchasePlanCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Employee Stock Purchase Plan, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_AccruedEmployeeStockPurchasePlanCurrent" xlink:href="docs-20220331.xsd#docs_AccruedEmployeeStockPurchasePlanCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_AccruedEmployeeStockPurchasePlanCurrent" xlink:to="lab_docs_AccruedEmployeeStockPurchasePlanCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortization_a61fe897-0ce8-44da-94d2-12172a30214c_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred contract costs</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortization_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostAmortization" xlink:to="lab_us-gaap_CapitalizedContractCostAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_aa25b998-c0df-4415-b28e-491d054bf050_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_abb759eb-5ff1-469f-8c6c-c34baeeafa79_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration period from the date of grant</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_7a74155f-d47d-4770-9fb0-ad70dc66e3c8_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockAmountConverted1_a3e08fc5-440a-4b22-a690-48d509d8e37e_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockAmountConverted1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of redeemable convertible preferred stock to common stock</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockAmountConverted1_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockAmountConverted1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Stock, Amount Converted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockAmountConverted1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockAmountConverted1" xlink:to="lab_us-gaap_ConversionOfStockAmountConverted1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted_75f79d12-2115-423d-b4ab-2ff5f5458c07_terseLabel_en-US" xlink:label="lab_docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partnerships agreement, period before termination is permitted</link:label>
    <link:label id="lab_docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted_label_en-US" xlink:label="lab_docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partnerships Agreement Period Before Termination Is Permitted</link:label>
    <link:label id="lab_docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted_documentation_en-US" xlink:label="lab_docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partnerships Agreement Period Before Termination Is Permitted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted" xlink:href="docs-20220331.xsd#docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted" xlink:to="lab_docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_8fc14650-59ba-4f65-aff6-2fb716b41129_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Consideration Allocation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_0d1f1f99-7efe-4b44-a3d5-9a5b34b0a24a_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with the employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_89f203b7-bac5-4034-9f76-94e228313813_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_a25ea29a-e193-4efd-ab6a-fd692e609088_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_974cfeb0-e79c-45da-b2dc-5a1247d62893_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostImpairmentLoss_cabad992-e10a-4064-bc32-a31bdf83012d_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred contract costs, impairment losses</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostImpairmentLoss" xlink:to="lab_us-gaap_CapitalizedContractCostImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany_79b7e556-85f3-4397-9642-72c195a5e2bb_terseLabel_en-US" xlink:label="lab_docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partnership agreement, annual revenue guarantee to partnering company</link:label>
    <link:label id="lab_docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany_label_en-US" xlink:label="lab_docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partnership Agreement, Annual Revenue Guarantee To Partnering Company</link:label>
    <link:label id="lab_docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany_documentation_en-US" xlink:label="lab_docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partnership Agreement, Annual Revenue Guarantee To Partnering Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany" xlink:href="docs-20220331.xsd#docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany" xlink:to="lab_docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_c1a47dbc-b1ba-4cfa-93e1-82510e7d26bf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche Two</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_AuditInformationAbstract_label_en-US" xlink:label="lab_docs_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_docs_AuditInformationAbstract_documentation_en-US" xlink:label="lab_docs_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_AuditInformationAbstract" xlink:href="docs-20220331.xsd#docs_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_AuditInformationAbstract" xlink:to="lab_docs_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_30da1f21-93ea-4312-a7b2-9dc5620dff2b_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_c30b48ce-bda3-4ef7-9f53-82aae639e9f6_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_249b6e4a-b5f3-4c3d-a901-ea305d896c9d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_82d5461a-13a3-4a90-afdd-cfb07ef997a7_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock upon exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_7e9c4039-1d2c-4515-9c42-0cc1793b5572_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_618399d7-db4b-4f20-892d-0c03c761d733_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_e20a6e03-aa29-442a-a9c9-eb3e800123ae_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_e9e6d868-6bb2-4a3a-bd76-d10ba4483e23_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for (benefit from) income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_1e1563fb-cb74-4812-822b-8cba48ec4fbc_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for (benefit from) income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_8abaf45e-cd14-4d91-ad8e-da097a9886ee_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowance for doubtful accounts of $359 and $955 as of March&#160;31, 2022 and 2021, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_34c23580-9729-48d0-89b5-ff776b151548_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_0bfb6221-83ce-4bfe-8221-aff4c15cb237_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost or Amortized Cost</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_3b6d117b-c4b7-4a1b-a9b6-b3c14b9e7b08_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_d3471a16-7838-466c-a056-e5c0b03386e7_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_17506a0d-81b1-4e11-80f0-ebc6259bae1a_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_ae5bd969-a29e-4a12-b820-d2a13c5a96a2_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_c6670f40-92f4-41f2-b9aa-4b68c488911e_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_c4c55fec-0879-42c8-9a56-05c37aa081fd_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:to="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockSharesIssued1_7d1388ec-562a-4d45-84c4-dc0e630b332e_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockSharesIssued1_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockSharesIssued1" xlink:to="lab_us-gaap_ConversionOfStockSharesIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1effc595-93eb-4e21-a66c-99f70b6b532c_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_7a67966e-ac2c-4f1e-891c-68b31a144176_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_459e57cc-29a3-42ef-b107-6170f8fd59b2_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_73f872fc-f59a-437a-aae6-5f5b03c97bec_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_1de213f6-8347-4644-b889-3e34a9995d80_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_43976b54-7c48-495e-925d-178abf8d53f0_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_a844bcc0-9a25-43bb-859f-7c4c2c176f6a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_cd779c12-f0dd-4876-bb56-9b6f3842ae66_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease_9ed45608-4e9d-42e4-80f9-acd1a918a610_terseLabel_en-US" xlink:label="lab_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum annual increase of shares reserved for future issuance (in shares)</link:label>
    <link:label id="lab_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease_label_en-US" xlink:label="lab_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved For Future Issuance, Maximum Annual Increase</link:label>
    <link:label id="lab_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease_documentation_en-US" xlink:label="lab_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved For Future Issuance, Maximum Annual Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease" xlink:href="docs-20220331.xsd#docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease" xlink:to="lab_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_0bed08ef-fc9e-4fe9-91e5-1de1775202a0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in valuation allowance</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_b15de61f-4ed1-4af0-8133-d7e081d32edb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_980b6651-74e7-49dc-9af5-0077c6ac98c4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_d2a49b0b-92bf-4337-8b2d-3c97ac6f2537_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_bff21d7a-155b-4e8c-a880-8d8da61886d4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed earnings attributable to participating securities, basic</link:label>
    <link:label id="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_label_en-US" xlink:label="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed Earnings (Loss) Allocated to Participating Securities, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:to="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_d7a21b62-68d3-4735-ac43-339e5fc7c23e_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in valuation allowance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_CommonStockVotingRightsNumberOfVotes_258e3089-4194-420a-8b2b-53f17a0738db_terseLabel_en-US" xlink:label="lab_docs_CommonStockVotingRightsNumberOfVotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, number of votes per share</link:label>
    <link:label id="lab_docs_CommonStockVotingRightsNumberOfVotes_label_en-US" xlink:label="lab_docs_CommonStockVotingRightsNumberOfVotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Voting Rights, Number Of Votes</link:label>
    <link:label id="lab_docs_CommonStockVotingRightsNumberOfVotes_documentation_en-US" xlink:label="lab_docs_CommonStockVotingRightsNumberOfVotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Voting Rights, Number Of Votes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CommonStockVotingRightsNumberOfVotes" xlink:href="docs-20220331.xsd#docs_CommonStockVotingRightsNumberOfVotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_CommonStockVotingRightsNumberOfVotes" xlink:to="lab_docs_CommonStockVotingRightsNumberOfVotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_749e373d-29ed-42f4-84cf-4eae19f5b94a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized compensation expense, option</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_41f29b7e-6a2c-4281-b6cb-1121fa8cd61f_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_8f37c49a-4231-4c26-abbc-41e16742e0c3_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GranteeStatusAxis_31a9f46a-3eba-4907-83c3-697f13854fd0_terseLabel_en-US" xlink:label="lab_us-gaap_GranteeStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Axis]</link:label>
    <link:label id="lab_us-gaap_GranteeStatusAxis_label_en-US" xlink:label="lab_us-gaap_GranteeStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GranteeStatusAxis" xlink:to="lab_us-gaap_GranteeStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_b7f539f3-7124-42ea-82aa-633f7207e5df_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_f7ebb3d9-0b72-47f9-8a9f-c1b0e47d4eaa_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_c32a506e-ad8d-43cf-a330-711f762f563c_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_5134c6d2-af7a-4c86-ad08-44e3704cbce6_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unamortized compensation expense excluding option</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ChiefExecutiveOfficerMember_ae1bf12b-17e0-4386-8038-a83b092ac62f_terseLabel_en-US" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chief Executive Officer</link:label>
    <link:label id="lab_srt_ChiefExecutiveOfficerMember_label_en-US" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Chief Executive Officer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ChiefExecutiveOfficerMember" xlink:to="lab_srt_ChiefExecutiveOfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_bbc9c443-c8ec-41fe-b31d-82daa8ef6294_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average grant-date fair value of options granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_e9a776eb-3aad-4485-9374-f9a6012630f4_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_TaxCreditCarryforwardsSubjectToExpiration_042907ae-930d-4596-8b93-b85bd839cd23_terseLabel_en-US" xlink:label="lab_docs_TaxCreditCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State research and development tax credit carryforwards subject to expiration</link:label>
    <link:label id="lab_docs_TaxCreditCarryforwardsSubjectToExpiration_label_en-US" xlink:label="lab_docs_TaxCreditCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforwards, Subject to Expiration</link:label>
    <link:label id="lab_docs_TaxCreditCarryforwardsSubjectToExpiration_documentation_en-US" xlink:label="lab_docs_TaxCreditCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Credit Carryforwards, Subject to Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TaxCreditCarryforwardsSubjectToExpiration" xlink:href="docs-20220331.xsd#docs_TaxCreditCarryforwardsSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_TaxCreditCarryforwardsSubjectToExpiration" xlink:to="lab_docs_TaxCreditCarryforwardsSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_c6cac5c3-8b64-4c61-ab16-c543db2ba76a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Units outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_5b78b390-1bfb-4cb3-8359-2cb9ed5059f4_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of restricted stock units (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_aa2c9a90-04c1-4464-a999-6c602b22f2e7_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_f8ede67c-a023-4dc4-9539-92ef1b225412_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice_b8f2d2e2-8f87-4522-9a66-399aae6cd7aa_terseLabel_en-US" xlink:label="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of common stock (in dollars per share)</link:label>
    <link:label id="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice_label_en-US" xlink:label="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Share Price</link:label>
    <link:label id="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice_documentation_en-US" xlink:label="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" xlink:href="docs-20220331.xsd#docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" xlink:to="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_WarrantsAndRightsOutstandingVestingPeriod_3ea4ef45-8016-4c19-bb74-b184ce80dfe2_terseLabel_en-US" xlink:label="lab_docs_WarrantsAndRightsOutstandingVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants and rights outstanding, vesting period</link:label>
    <link:label id="lab_docs_WarrantsAndRightsOutstandingVestingPeriod_label_en-US" xlink:label="lab_docs_WarrantsAndRightsOutstandingVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants and Rights Outstanding, Vesting Period</link:label>
    <link:label id="lab_docs_WarrantsAndRightsOutstandingVestingPeriod_documentation_en-US" xlink:label="lab_docs_WarrantsAndRightsOutstandingVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants and Rights Outstanding, Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_WarrantsAndRightsOutstandingVestingPeriod" xlink:href="docs-20220331.xsd#docs_WarrantsAndRightsOutstandingVestingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_WarrantsAndRightsOutstandingVestingPeriod" xlink:to="lab_docs_WarrantsAndRightsOutstandingVestingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_d8d150d5-3b87-49d2-94d5-c75440520a85_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5674e3e3-547c-4d68-91a6-1c8164f3d68a_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_TemporaryEquitySharesOutstandingThresholdSatisfiedNumberOfElectedBoardMembersPermitted_98402a49-8516-4172-bda3-ae934a698bcb_terseLabel_en-US" xlink:label="lab_docs_TemporaryEquitySharesOutstandingThresholdSatisfiedNumberOfElectedBoardMembersPermitted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary equity, shares outstanding threshold met, number of board of director members entitled to elect</link:label>
    <link:label id="lab_docs_TemporaryEquitySharesOutstandingThresholdSatisfiedNumberOfElectedBoardMembersPermitted_label_en-US" xlink:label="lab_docs_TemporaryEquitySharesOutstandingThresholdSatisfiedNumberOfElectedBoardMembersPermitted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Outstanding Threshold Satisfied, Number of Elected Board Members Permitted</link:label>
    <link:label id="lab_docs_TemporaryEquitySharesOutstandingThresholdSatisfiedNumberOfElectedBoardMembersPermitted_documentation_en-US" xlink:label="lab_docs_TemporaryEquitySharesOutstandingThresholdSatisfiedNumberOfElectedBoardMembersPermitted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Outstanding Threshold Satisfied, Number of Elected Board Members Permitted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TemporaryEquitySharesOutstandingThresholdSatisfiedNumberOfElectedBoardMembersPermitted" xlink:href="docs-20220331.xsd#docs_TemporaryEquitySharesOutstandingThresholdSatisfiedNumberOfElectedBoardMembersPermitted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_TemporaryEquitySharesOutstandingThresholdSatisfiedNumberOfElectedBoardMembersPermitted" xlink:to="lab_docs_TemporaryEquitySharesOutstandingThresholdSatisfiedNumberOfElectedBoardMembersPermitted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_8331efb3-5402-4dda-8974-2a903878a5fb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of shares issued</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_3a66194b-a03f-491b-b316-9c314eb305c9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_b94a449d-0bc9-4def-915e-340857dbafd4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketable securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Excluding Accrued Interest, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost_83416bd3-9f26-43b6-b752-58b58fa45b2b_totalLabel_en-US" xlink:label="lab_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost or Amortized Cost, cash equivalents and marketable securities</link:label>
    <link:label id="lab_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost_label_en-US" xlink:label="lab_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents and Short Term Investments, Amortized Cost</link:label>
    <link:label id="lab_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost_documentation_en-US" xlink:label="lab_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents and Short Term Investments, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost" xlink:href="docs-20220331.xsd#docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost" xlink:to="lab_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_52103f33-42aa-4bbc-909c-8effda0189c9_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_973dbbb7-f230-4d67-b820-193d4ef60be3_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with an acquisition (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_ShareBasedPaymentArrangementTrancheOneAndTrancheTwoMember_bce3a641-edd6-4b25-b3a1-af52d9d58377_terseLabel_en-US" xlink:label="lab_docs_ShareBasedPaymentArrangementTrancheOneAndTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Payment Arrangement Tranche One And Tranche Two</link:label>
    <link:label id="lab_docs_ShareBasedPaymentArrangementTrancheOneAndTrancheTwoMember_label_en-US" xlink:label="lab_docs_ShareBasedPaymentArrangementTrancheOneAndTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Payment Arrangement Tranche One And Tranche Two [Member]</link:label>
    <link:label id="lab_docs_ShareBasedPaymentArrangementTrancheOneAndTrancheTwoMember_documentation_en-US" xlink:label="lab_docs_ShareBasedPaymentArrangementTrancheOneAndTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Payment Arrangement Tranche One And Tranche Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ShareBasedPaymentArrangementTrancheOneAndTrancheTwoMember" xlink:href="docs-20220331.xsd#docs_ShareBasedPaymentArrangementTrancheOneAndTrancheTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_ShareBasedPaymentArrangementTrancheOneAndTrancheTwoMember" xlink:to="lab_docs_ShareBasedPaymentArrangementTrancheOneAndTrancheTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GranteeStatusDomain_3e7228dc-e7a4-467a-8dfe-2391c2aa2bf8_terseLabel_en-US" xlink:label="lab_us-gaap_GranteeStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Domain]</link:label>
    <link:label id="lab_us-gaap_GranteeStatusDomain_label_en-US" xlink:label="lab_us-gaap_GranteeStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GranteeStatusDomain" xlink:to="lab_us-gaap_GranteeStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_463131da-7e25-4b19-aa7d-9f0256323a2c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_4842d9ad-cce4-4973-99d1-a89cdc73f07d_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesBPreferredStockMember_e9704437-9a33-4cca-a322-0acf0f07d765_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesBPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B</link:label>
    <link:label id="lab_us-gaap_SeriesBPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesBPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series B Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesBPreferredStockMember" xlink:to="lab_us-gaap_SeriesBPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalUseSoftwarePolicy_26441aac-2705-4ae3-8ef4-a462cd946315_terseLabel_en-US" xlink:label="lab_us-gaap_InternalUseSoftwarePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal-Use Software Development Costs</link:label>
    <link:label id="lab_us-gaap_InternalUseSoftwarePolicy_label_en-US" xlink:label="lab_us-gaap_InternalUseSoftwarePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal Use Software, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalUseSoftwarePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalUseSoftwarePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalUseSoftwarePolicy" xlink:to="lab_us-gaap_InternalUseSoftwarePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_28c0b55e-b234-4ca7-8817-35ea19abe3c4_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross_3c5bfc83-5c2c-46c5-bc0d-f7ec40e812b5_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized loss</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Debt Securities, Available-for-Sale, Unrealized Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross" xlink:to="lab_us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_RebateLiabilitiesCurrent_6f6d565b-5fc4-4b7d-8ed1-91f82cdedfc0_terseLabel_en-US" xlink:label="lab_docs_RebateLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rebate liabilities</link:label>
    <link:label id="lab_docs_RebateLiabilitiesCurrent_label_en-US" xlink:label="lab_docs_RebateLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rebate Liabilities, Current</link:label>
    <link:label id="lab_docs_RebateLiabilitiesCurrent_documentation_en-US" xlink:label="lab_docs_RebateLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rebate Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_RebateLiabilitiesCurrent" xlink:href="docs-20220331.xsd#docs_RebateLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_RebateLiabilitiesCurrent" xlink:to="lab_docs_RebateLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_b322292b-0555-4615-84fd-a437c197b23f_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Reserved for Issuance</link:label>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_2ce63cae-2391-44a2-af2c-c6f1c739c177_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price of common stock under an employee stock purchase plan as a percentage of market price</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_b28e9f29-dd54-4bf2-b736-fd2bb0dafa9a_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable and Allowance for Doubtful Accounts</link:label>
    <link:label id="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_label_en-US" xlink:label="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:to="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_7e0a40c4-0d23-4be9-9875-fb07dcf363e3_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_6404fd87-349d-49d3-a736-dba49aca3b3a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_7c30ed8d-a078-49f3-bf64-1fbd4477d5f1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development credits</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_68f0442d-39c1-4caf-9cb4-0da38d064b73_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_6f2e8f8b-f4f5-4e67-934f-09d27eb72c7d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_4604e409-b8cd-453a-9723-c03c4c24e579_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputExpectedDividendRateMember_bb2fd776-2f0b-4206-9239-55f85093fd51_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Expected Dividend Rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputExpectedDividendRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Expected Dividend Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:to="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_fbfeece6-8be2-43f9-8dc8-33be10766ba5_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_51b1c75c-f411-43f8-abb1-958e41b60809_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue, non-current</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_c216c1b5-7162-4e25-8b6e-5450735b8b6b_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_ScheduleOfAccruedLiabilitiesCurrentTableTextBlock_4cb60b4d-f348-41fc-9c50-994a566079b4_terseLabel_en-US" xlink:label="lab_docs_ScheduleOfAccruedLiabilitiesCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of accrued expenses and other liabilities, current</link:label>
    <link:label id="lab_docs_ScheduleOfAccruedLiabilitiesCurrentTableTextBlock_label_en-US" xlink:label="lab_docs_ScheduleOfAccruedLiabilitiesCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Accrued Liabilities, Current [Table Text Block]</link:label>
    <link:label id="lab_docs_ScheduleOfAccruedLiabilitiesCurrentTableTextBlock_documentation_en-US" xlink:label="lab_docs_ScheduleOfAccruedLiabilitiesCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ScheduleOfAccruedLiabilitiesCurrentTableTextBlock" xlink:href="docs-20220331.xsd#docs_ScheduleOfAccruedLiabilitiesCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_ScheduleOfAccruedLiabilitiesCurrentTableTextBlock" xlink:to="lab_docs_ScheduleOfAccruedLiabilitiesCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_c67f0d74-5f15-410d-b206-5b5bb705861b_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityAbstract_8171ac68-3a1a-48d0-a6bb-ffaa4c2d7a3b_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Convertible Preferred Stock</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityAbstract_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityAbstract" xlink:to="lab_us-gaap_TemporaryEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_1d7f2ddc-c580-4dc9-8fad-b8e2dd249740_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_PartnershipAgreementExtensionPeriod_89af3585-f460-438d-ab77-8ef35f80182e_terseLabel_en-US" xlink:label="lab_docs_PartnershipAgreementExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partnership agreement, extension period</link:label>
    <link:label id="lab_docs_PartnershipAgreementExtensionPeriod_label_en-US" xlink:label="lab_docs_PartnershipAgreementExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partnership Agreement Extension Period</link:label>
    <link:label id="lab_docs_PartnershipAgreementExtensionPeriod_documentation_en-US" xlink:label="lab_docs_PartnershipAgreementExtensionPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Partnership Agreement Extension Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PartnershipAgreementExtensionPeriod" xlink:href="docs-20220331.xsd#docs_PartnershipAgreementExtensionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_PartnershipAgreementExtensionPeriod" xlink:to="lab_docs_PartnershipAgreementExtensionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_6f8ecfe0-4df2-467b-9a49-353ae4014d76_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c696b9a9-0bca-4ae6-b4f6-b0bc4f48fbc1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_abd77278-10aa-4d87-83f2-5eb82b6a1553_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_d53cacdc-4ec9-4247-9e5b-40ade085ba47_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_e2b12faf-7f26-4197-9e63-7a30766819f6_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_8f4ef76d-5f39-44aa-95a2-a9dca8e34223_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_b3ecf01e-2974-41f7-a18d-52da7c84e53d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_b3a06cf3-6ccb-4db6-a077-c49a1fe5580d_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_40a5836e-82f8-43fc-8b57-9c8e75ab916d_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_6b6e363f-7f4a-4a01-a708-fdd5357eef5a_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_11581d16-bddd-46d9-b400-fcc19b02c441_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_f917b562-75f7-41e3-a3cc-06432340a90b_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_22d1dd52-ef7b-4ad6-b63a-e2bc96727d90_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_e44e8ee6-c0f7-487b-a6b0-c864e71601f4_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_DeferredTaxAssetsLeasingArrangements_f96baf19-4fb6-4e3b-900b-f9593a2ebf8a_terseLabel_en-US" xlink:label="lab_docs_DeferredTaxAssetsLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_docs_DeferredTaxAssetsLeasingArrangements_label_en-US" xlink:label="lab_docs_DeferredTaxAssetsLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Leasing Arrangements</link:label>
    <link:label id="lab_docs_DeferredTaxAssetsLeasingArrangements_documentation_en-US" xlink:label="lab_docs_DeferredTaxAssetsLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DeferredTaxAssetsLeasingArrangements" xlink:href="docs-20220331.xsd#docs_DeferredTaxAssetsLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_DeferredTaxAssetsLeasingArrangements" xlink:to="lab_docs_DeferredTaxAssetsLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent_9c9735f9-5756-4294-b01c-aa67736e9727_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unrealized loss on available-for-sale-securities, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Available-for-sale Securities, Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_c4c46a61-d9a9-46c1-8927-d01f6daa6aa2_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Class A and Class B common stockholders, diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputSharePriceMember_9bb887b0-63e0-45ed-93ec-4aaf9f47768b_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputSharePriceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Share Price</link:label>
    <link:label id="lab_us-gaap_MeasurementInputSharePriceMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputSharePriceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Share Price [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputSharePriceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputSharePriceMember" xlink:to="lab_us-gaap_MeasurementInputSharePriceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_1fc9f31c-ff28-4df0-98f3-8dba6f001fc4_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_35b78654-f0fb-487a-9544-135ffe0f0e38_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Class A and Class B common stockholders, basic</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_a704582d-7640-461f-9dee-24e0c992bdd4_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_36ca5347-275f-491a-a26c-1350dd0cc637_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Unit Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow_e8467323-862d-4173-b8db-fa5bd6b84ca2_terseLabel_en-US" xlink:label="lab_docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of business consideration, held in escrow</link:label>
    <link:label id="lab_docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow_label_en-US" xlink:label="lab_docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Held In Escrow</link:label>
    <link:label id="lab_docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow_documentation_en-US" xlink:label="lab_docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration, Held In Escrow</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow" xlink:href="docs-20220331.xsd#docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow" xlink:to="lab_docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_cd0fda06-38d5-418d-b4b0-6012c1bd9185_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_db3dee0b-b219-401e-bbce-d4485a746ec7_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit_90d7dd65-7094-4bb7-b3e6-27e61058e91e_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal, State and Local, Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_e240db85-7f4f-42e4-99a3-c41baab11b34_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_748250c6-7e52-4f70-87bd-f7f9a465ce44_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, contingent consideration, liability</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9b57fefb-1625-451d-9fb5-1898f04ef2e5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_3589f9fc-a09a-46ab-ac61-35e4ce381fcc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_28ffffb6-6745-46c5-bbef-1212d51db5e8_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_abb5a070-7f14-4031-a22c-6af7fcc06893_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableConvertiblePreferredStockMember_c5767d4a-e246-4503-941b-b5305a104fda_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable convertible preferred stock</link:label>
    <link:label id="lab_us-gaap_RedeemableConvertiblePreferredStockMember_label_en-US" xlink:label="lab_us-gaap_RedeemableConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Convertible Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableConvertiblePreferredStockMember" xlink:to="lab_us-gaap_RedeemableConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_b3f2b930-3571-46b8-9717-16086e00fc13_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of Lease Expense and Supplemental Cash Flow/Balance Sheet Information Related to Leases</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_2e9e29d8-140b-4291-b0d9-7b0ec8646ae5_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_EmployeeStockPurchasePlan2021Member_c2f1397b-c535-4b41-85f8-1be04783d608_terseLabel_en-US" xlink:label="lab_docs_EmployeeStockPurchasePlan2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 ESPP</link:label>
    <link:label id="lab_docs_EmployeeStockPurchasePlan2021Member_label_en-US" xlink:label="lab_docs_EmployeeStockPurchasePlan2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan 2021 [Member]</link:label>
    <link:label id="lab_docs_EmployeeStockPurchasePlan2021Member_documentation_en-US" xlink:label="lab_docs_EmployeeStockPurchasePlan2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_EmployeeStockPurchasePlan2021Member" xlink:href="docs-20220331.xsd#docs_EmployeeStockPurchasePlan2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_EmployeeStockPurchasePlan2021Member" xlink:to="lab_docs_EmployeeStockPurchasePlan2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostAxis_78e401d5-5f6e-427a-bf29-307489d5ef5a_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost [Axis]</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostAxis_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostAxis" xlink:to="lab_us-gaap_CapitalizedContractCostAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_386d44b5-37c4-4bfd-b869-684e604a43ce_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commercial Paper, Not Included with Cash and Cash Equivalents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1e4fe7c3-654f-478f-8761-83fec0888dcd_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_a62baa9b-e1ee-4286-99d1-3764dbf4332f_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_172bc369-183b-4cb8-9aa6-ad4738fc46b9_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_73c352e4-e0ac-490f-8b13-a6e3ed1aacd6_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share attributable to Class A and Class B common stockholders, diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_c51b35ee-e694-4a16-b247-4805316a010f_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_4327fca9-0317-49ce-b94d-8cd24a76b061_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Initial public offering price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_c906ddda-a436-4484-bad8-505c3dd03e49_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Amortization Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_f0c631af-c939-4ad6-a5bc-117d33f2c394_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense_61e8ebb1-02f4-4c17-948f-9140a6db8bf9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Section 162(m) limitation</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_5cbb5ad3-0269-4a19-ba52-68ea345bdba8_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets acquired</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_f8345f8c-68bf-4453-a43b-b6e253948fd9_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_c2a191a5-5cd2-4fbc-af73-fc5bad845ee0_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesAuthorized_aeecd73d-c3e4-4494-94f5-b78f8969d65b_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable convertible preferred stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesAuthorized_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesAuthorized" xlink:to="lab_us-gaap_TemporaryEquitySharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_b0d46ff6-6a86-4fb8-9463-a39dfcefdcaf_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_b58a6024-e913-4d25-9485-b28aa88ad734_periodStartLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_11097427-5a06-463a-9b15-d7f895cfbda2_periodEndLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_1565622c-1b9b-4a02-9048-d3d779631996_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_43d290bd-dc95-4836-8434-45966c85d34b_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_fc8c270d-8d41-480c-9e6a-1dd2345cc423_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_CommonStockHoldingMajorityNumberOfElectedBoardMembersPermitted_1108e1fb-0cbc-4ad7-923e-039d22eca09f_terseLabel_en-US" xlink:label="lab_docs_CommonStockHoldingMajorityNumberOfElectedBoardMembersPermitted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, holding majority, number of board of director members entitled to elect</link:label>
    <link:label id="lab_docs_CommonStockHoldingMajorityNumberOfElectedBoardMembersPermitted_label_en-US" xlink:label="lab_docs_CommonStockHoldingMajorityNumberOfElectedBoardMembersPermitted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Holding Majority, Number of Elected Board Members Permitted</link:label>
    <link:label id="lab_docs_CommonStockHoldingMajorityNumberOfElectedBoardMembersPermitted_documentation_en-US" xlink:label="lab_docs_CommonStockHoldingMajorityNumberOfElectedBoardMembersPermitted" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Holding Majority, Number of Elected Board Members Permitted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CommonStockHoldingMajorityNumberOfElectedBoardMembersPermitted" xlink:href="docs-20220331.xsd#docs_CommonStockHoldingMajorityNumberOfElectedBoardMembersPermitted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_CommonStockHoldingMajorityNumberOfElectedBoardMembersPermitted" xlink:to="lab_docs_CommonStockHoldingMajorityNumberOfElectedBoardMembersPermitted" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_EscrowDepositsRelatedToSaleOfBusiness_d19a88a1-c64b-45bf-bba8-f05220a4b3ab_terseLabel_en-US" xlink:label="lab_docs_EscrowDepositsRelatedToSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts held in escrow related to sale of business</link:label>
    <link:label id="lab_docs_EscrowDepositsRelatedToSaleOfBusiness_label_en-US" xlink:label="lab_docs_EscrowDepositsRelatedToSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Escrow Deposits Related To Sale Of Business</link:label>
    <link:label id="lab_docs_EscrowDepositsRelatedToSaleOfBusiness_documentation_en-US" xlink:label="lab_docs_EscrowDepositsRelatedToSaleOfBusiness" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Escrow Deposits Related To Sale Of Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_EscrowDepositsRelatedToSaleOfBusiness" xlink:href="docs-20220331.xsd#docs_EscrowDepositsRelatedToSaleOfBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_EscrowDepositsRelatedToSaleOfBusiness" xlink:to="lab_docs_EscrowDepositsRelatedToSaleOfBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1d3b88d2-a27d-4cc8-8fac-649424542599_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of redeemable convertible preferred stock upon initial public offering (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_00b08a6a-0772-4f41-9565-94367abcb641_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock_d155d480-8cc7-4c47-814b-45fcead41fe1_terseLabel_en-US" xlink:label="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant exercise price, percentage of estimated fair value of common stock on date of grant (not less than)</link:label>
    <link:label id="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock_label_en-US" xlink:label="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercise Price, Percentage Of Fair Value Of Common Stock</link:label>
    <link:label id="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock_documentation_en-US" xlink:label="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercise Price, Percentage Of Fair Value Of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock" xlink:href="docs-20220331.xsd#docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock" xlink:to="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_SubscriptionMember_f6912ca3-de86-4197-ae4f-3a791a0c51fb_terseLabel_en-US" xlink:label="lab_docs_SubscriptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subscription</link:label>
    <link:label id="lab_docs_SubscriptionMember_label_en-US" xlink:label="lab_docs_SubscriptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subscription [Member]</link:label>
    <link:label id="lab_docs_SubscriptionMember_documentation_en-US" xlink:label="lab_docs_SubscriptionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subscription</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_SubscriptionMember" xlink:href="docs-20220331.xsd#docs_SubscriptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_SubscriptionMember" xlink:to="lab_docs_SubscriptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_ad57d4fb-67fe-4559-b4f2-6df9900eb383_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate notes and bonds</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_TemporaryEquityExercisesOfWarrantsShares_0d9beb4f-ed46-4a44-bdd0-1e9d03abdfc1_verboseLabel_en-US" xlink:label="lab_docs_TemporaryEquityExercisesOfWarrantsShares" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of Series B redeemable convertible preferred stock warrants (in shares)</link:label>
    <link:label id="lab_docs_TemporaryEquityExercisesOfWarrantsShares_label_en-US" xlink:label="lab_docs_TemporaryEquityExercisesOfWarrantsShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Exercises of Warrants, Shares</link:label>
    <link:label id="lab_docs_TemporaryEquityExercisesOfWarrantsShares_documentation_en-US" xlink:label="lab_docs_TemporaryEquityExercisesOfWarrantsShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Exercises of Warrants, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TemporaryEquityExercisesOfWarrantsShares" xlink:href="docs-20220331.xsd#docs_TemporaryEquityExercisesOfWarrantsShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_TemporaryEquityExercisesOfWarrantsShares" xlink:to="lab_docs_TemporaryEquityExercisesOfWarrantsShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_d0c617b1-39e6-433f-91ae-237ee3c5bcfd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_bd84a0e7-8b15-4d83-bf04-8ca49dc23f4f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold_521e9b95-e518-42b5-9737-df534e878e88_terseLabel_en-US" xlink:label="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Voting interests threshold</link:label>
    <link:label id="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold_label_en-US" xlink:label="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Percentage Of Voting Interests Threshold</link:label>
    <link:label id="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold_documentation_en-US" xlink:label="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Percentage Of Voting Interests Threshold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold" xlink:href="docs-20220331.xsd#docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold" xlink:to="lab_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_7a8b39b8-de25-4b82-9db2-b50fca79e94e_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_da9edd92-48da-429b-8e66-89b26c72a07f_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_aaf4196a-51c6-469f-85dd-1b9e73fa39a9_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_458c8981-2414-4c01-b1fc-d06d9cca2cc0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_30aa9784-29b8-4280-8e90-0643983244a7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_SubscriptionHiringSolutionsMember_a4c12c60-ef15-4e8a-973c-56a299ae613c_terseLabel_en-US" xlink:label="lab_docs_SubscriptionHiringSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subscription, Hiring Solutions</link:label>
    <link:label id="lab_docs_SubscriptionHiringSolutionsMember_label_en-US" xlink:label="lab_docs_SubscriptionHiringSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subscription, Hiring Solutions [Member]</link:label>
    <link:label id="lab_docs_SubscriptionHiringSolutionsMember_documentation_en-US" xlink:label="lab_docs_SubscriptionHiringSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subscription, Hiring Solutions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_SubscriptionHiringSolutionsMember" xlink:href="docs-20220331.xsd#docs_SubscriptionHiringSolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_SubscriptionHiringSolutionsMember" xlink:to="lab_docs_SubscriptionHiringSolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableforsaleSecuritiesMember_71c9af7d-2b2b-4d27-a8b8-2d53b3c67022_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableforsaleSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale securities</link:label>
    <link:label id="lab_us-gaap_AvailableforsaleSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AvailableforsaleSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Available-for-sale Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableforsaleSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableforsaleSecuritiesMember" xlink:to="lab_us-gaap_AvailableforsaleSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_d2344893-2536-404b-bede-a23d2fc0409f_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsPolicy_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsPolicy" xlink:to="lab_us-gaap_BusinessCombinationsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_7047d2f9-1ac9-4723-aca0-8271a5b9a7b6_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_08752eae-c8ec-4479-a51d-9f31744bcdbe_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of assumed exercise of common stock warrants (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_f7f8ebf1-3be8-4478-9493-f81dc82e9e51_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_9ba2c253-0001-489a-9a86-bdd3c1775019_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="lab_us-gaap_TemporaryEquityDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_4a73b0e8-f5a9-4a89-b16d-4b09ffb28fe2_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_OperatingLossCarryforwardsSubjectToExpiration_d2429909-4432-4427-9fea-12e729e90761_terseLabel_en-US" xlink:label="lab_docs_OperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State net operating loss carryforwards subject to expiration</link:label>
    <link:label id="lab_docs_OperatingLossCarryforwardsSubjectToExpiration_label_en-US" xlink:label="lab_docs_OperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Subject To Expiration</link:label>
    <link:label id="lab_docs_OperatingLossCarryforwardsSubjectToExpiration_documentation_en-US" xlink:label="lab_docs_OperatingLossCarryforwardsSubjectToExpiration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Subject To Expiration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_OperatingLossCarryforwardsSubjectToExpiration" xlink:href="docs-20220331.xsd#docs_OperatingLossCarryforwardsSubjectToExpiration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_OperatingLossCarryforwardsSubjectToExpiration" xlink:to="lab_docs_OperatingLossCarryforwardsSubjectToExpiration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract_16d3bca8-3914-4817-8225-9a71cd2b34bd_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_a03a5e50-55a9-4155-b083-7a302cd80ea9_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonClassBMember_19900455-48fb-4c12-b877-c3675dcc76d1_terseLabel_en-US" xlink:label="lab_us-gaap_CommonClassBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class B</link:label>
    <link:label id="lab_us-gaap_CommonClassBMember_label_en-US" xlink:label="lab_us-gaap_CommonClassBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class B [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassBMember" xlink:to="lab_us-gaap_CommonClassBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_c5a5675a-7beb-4810-8c08-0b9d2b8fd74f_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reporting units</link:label>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_label_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reporting Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportingUnits" xlink:to="lab_us-gaap_NumberOfReportingUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_8d1de32d-ee11-4d6c-b1fc-b3820258628d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of business</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_cb75a4fe-d5d3-4ffa-b7db-63b47fcbfcfc_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_472d8c9d-9987-433f-ae20-164c4ea8ba7b_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_43f86d32-cd6b-41fb-bd68-6614f9de7c04_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_d2a7e720-5778-42a3-8c81-b9e46da5a07c_terseLabel_en-US" xlink:label="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Abstract]</link:label>
    <link:label id="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in Contract with Customer, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInContractWithCustomerLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:to="lab_us-gaap_ChangeInContractWithCustomerLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e470d3ff-248a-43ad-8040-7697834c17a7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_af547a08-aea4-486d-81d0-eb94a981f264_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TangibleAssetImpairmentCharges_b1c8109c-ba74-4c60-8a3f-61cf54ade0cb_terseLabel_en-US" xlink:label="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_us-gaap_TangibleAssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tangible Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TangibleAssetImpairmentCharges" xlink:to="lab_us-gaap_TangibleAssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_cf4e96af-a9ab-4bcd-aabc-4fcf95ad0a2a_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_933318ff-45e0-45be-89e7-fa5c04b097f1_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_0d0f5c16-4b41-4d72-8540-2f08f46c38fd_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credit carryforwards, research</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Research</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_PerformanceBasedRestrictedStockUnitsMember_6d07e20e-9a8a-43a6-a717-4470b3666c27_terseLabel_en-US" xlink:label="lab_docs_PerformanceBasedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-Based Restricted Stock Units</link:label>
    <link:label id="lab_docs_PerformanceBasedRestrictedStockUnitsMember_label_en-US" xlink:label="lab_docs_PerformanceBasedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-Based Restricted Stock Units [Member]</link:label>
    <link:label id="lab_docs_PerformanceBasedRestrictedStockUnitsMember_documentation_en-US" xlink:label="lab_docs_PerformanceBasedRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance-Based Restricted Stock Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PerformanceBasedRestrictedStockUnitsMember" xlink:href="docs-20220331.xsd#docs_PerformanceBasedRestrictedStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_PerformanceBasedRestrictedStockUnitsMember" xlink:to="lab_docs_PerformanceBasedRestrictedStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_797ffc54-dee3-4ddd-863f-282ae1e94df6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_e121fa86-1bc3-4959-8fc6-197dd1573cc2_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_30882d21-a338-46da-869c-10d88f42cbbf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions for tax positions related to prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_251bb5e9-4ff2-465e-99ad-d5169af955ef_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTable_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_5bc79537-37ea-4501-b5bc-f1cb1d683967_terseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications of temporary to permanent equity</link:label>
    <link:label id="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_label_en-US" xlink:label="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications of Temporary to Permanent Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationsOfTemporaryToPermanentEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:to="lab_us-gaap_ReclassificationsOfTemporaryToPermanentEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_2bdda5cf-43b6-402d-829f-175b422336c1_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesIssued_905cd01b-f605-44df-b84b-a5398bb054ef_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable convertible preferred stock issued (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesIssued_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesIssued" xlink:to="lab_us-gaap_TemporaryEquitySharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_aebaa16b-7eeb-467a-b32f-c11f7bbb1cd5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed earnings attributable to participating securities, diluted</link:label>
    <link:label id="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_label_en-US" xlink:label="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:to="lab_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_c3944f36-f1d0-4484-9772-19b8fe455e0c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_a21a52ac-786c-4d11-af24-34af83a1d5b8_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_8d9788bf-c846-4226-990d-490c146c4f65_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_455d251b-2b2a-4f64-8740-4ad0673e2f73_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_d6afb120-baaa-4cb2-b0cc-ef14e087a75d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity</link:label>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity and Share-based Payments [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_f853db2b-772e-48e6-8dbd-3f3ecadfbaaa_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities, non-current</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_DebtSecuritiesAvailableForSaleImpairmentsLoss_272439f9-376d-4472-84c7-3c224441c754_terseLabel_en-US" xlink:label="lab_docs_DebtSecuritiesAvailableForSaleImpairmentsLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt securities impairments loss</link:label>
    <link:label id="lab_docs_DebtSecuritiesAvailableForSaleImpairmentsLoss_label_en-US" xlink:label="lab_docs_DebtSecuritiesAvailableForSaleImpairmentsLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Impairments Loss</link:label>
    <link:label id="lab_docs_DebtSecuritiesAvailableForSaleImpairmentsLoss_documentation_en-US" xlink:label="lab_docs_DebtSecuritiesAvailableForSaleImpairmentsLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale, Impairments Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DebtSecuritiesAvailableForSaleImpairmentsLoss" xlink:href="docs-20220331.xsd#docs_DebtSecuritiesAvailableForSaleImpairmentsLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_DebtSecuritiesAvailableForSaleImpairmentsLoss" xlink:to="lab_docs_DebtSecuritiesAvailableForSaleImpairmentsLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityLiquidationPreference_331d64e4-b975-4bc4-ab46-4ce1aa8a8971_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityLiquidationPreference" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liquidation Preference</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityLiquidationPreference_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityLiquidationPreference" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Liquidation Preference</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLiquidationPreference" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityLiquidationPreference" xlink:to="lab_us-gaap_TemporaryEquityLiquidationPreference" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_9a468a85-b3b3-41dc-860d-788c2f92fdeb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiscalPeriod_d2c5b373-2fd7-42b0-a47a-18562cd32118_terseLabel_en-US" xlink:label="lab_us-gaap_FiscalPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Year</link:label>
    <link:label id="lab_us-gaap_FiscalPeriod_label_en-US" xlink:label="lab_us-gaap_FiscalPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal Period, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiscalPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiscalPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiscalPeriod" xlink:to="lab_us-gaap_FiscalPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_496a8301-0e8c-4f3f-9703-e73cc0573355_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_d5871f22-431a-4ea7-8ba2-f4512f522a73_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per share attributable to Class A and Class B common stockholders:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_RedeemableConvertiblePreferredStockWarrantsMember_23ad2d15-c706-46c3-8ec1-9d6077f7dba1_terseLabel_en-US" xlink:label="lab_docs_RedeemableConvertiblePreferredStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable convertible preferred stock warrants</link:label>
    <link:label id="lab_docs_RedeemableConvertiblePreferredStockWarrantsMember_label_en-US" xlink:label="lab_docs_RedeemableConvertiblePreferredStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Convertible Preferred Stock Warrants [Member]</link:label>
    <link:label id="lab_docs_RedeemableConvertiblePreferredStockWarrantsMember_documentation_en-US" xlink:label="lab_docs_RedeemableConvertiblePreferredStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Convertible Preferred Stock Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_RedeemableConvertiblePreferredStockWarrantsMember" xlink:href="docs-20220331.xsd#docs_RedeemableConvertiblePreferredStockWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_RedeemableConvertiblePreferredStockWarrantsMember" xlink:to="lab_docs_RedeemableConvertiblePreferredStockWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_054c55a0-446e-4671-b230-1a848139948b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_d025e6e9-78b9-4733-8c72-9ca14c8e1e2f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_b0a62829-62c9-4c2b-9555-16f1e3bc9781_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price called by warrants (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_1bd6208f-1647-4fbd-a38f-8369f5206251_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and expected to vest, at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_786a7fc5-ed57-4ed9-89d8-169af8c79b44_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche Three</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Tranche Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_8d6f8e6f-7607-47fd-8ab9-b4aacc9942ce_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_f513b76e-7473-4026-b42b-7713c6a912f0_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:label id="lab_us-gaap_OtherCommitmentsLineItems_label_en-US" xlink:label="lab_us-gaap_OtherCommitmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Commitments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCommitmentsLineItems" xlink:to="lab_us-gaap_OtherCommitmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_c5741e9d-c7cb-4e6d-8a71-f893aa987b46_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock warrants</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_028d50f2-70d9-432d-bb4a-58a5efb72a76_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_5a896512-92c8-4c95-90f4-3702db28089b_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesCPreferredStockMember_7f665b09-acac-47c2-872d-e56b8f0985b4_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesCPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series C</link:label>
    <link:label id="lab_us-gaap_SeriesCPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesCPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series C Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesCPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesCPreferredStockMember" xlink:to="lab_us-gaap_SeriesCPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_f068814b-616f-42c0-8be7-57b984ef29d9_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal, State and Local, Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingTerm_b2daf2ac-f802-4ae8-ba79-44d25836943e_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants and rights outstanding, term</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingTerm_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants and Rights Outstanding, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:to="lab_us-gaap_WarrantsAndRightsOutstandingTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_6e4a5c63-1d8d-4bdc-b136-ae42345c93cf_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_40c18a2d-3448-4b9e-ab5f-76e3b3e4b3aa_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Service [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:to="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_a29b5977-fbbf-40cd-a540-ba958ebaf0a3_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average remaining contractual term, vested and exercisable at period end</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_ebeb4950-9537-4afe-9b1e-65465fda5640_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicLineItems_b4188f45-6c27-4a51-bf2a-cd950525b35f_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicLineItems_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems" xlink:to="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember_3c15cb49-741d-4806-97ae-dd3fb1458c94_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Risk Free Interest Rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_202e1b48-8de5-4c8d-98d4-c9090a73892a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_2716a4e9-1fca-41cd-a4c0-38f7cafe3a42_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility, minimum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalCostsPolicyTextBlock_2a35a614-983a-4407-a1d7-7fc3d6321497_terseLabel_en-US" xlink:label="lab_us-gaap_LegalCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Contingencies</link:label>
    <link:label id="lab_us-gaap_LegalCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LegalCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalCostsPolicyTextBlock" xlink:to="lab_us-gaap_LegalCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_IndividualsWithVotingInterestLessThanThresholdMember_0ce951c8-24ca-4000-b663-28254ae4d468_terseLabel_en-US" xlink:label="lab_docs_IndividualsWithVotingInterestLessThanThresholdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individuals With Voting Interest Less Than Threshold</link:label>
    <link:label id="lab_docs_IndividualsWithVotingInterestLessThanThresholdMember_label_en-US" xlink:label="lab_docs_IndividualsWithVotingInterestLessThanThresholdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individuals With Voting Interest Less Than Threshold [Member]</link:label>
    <link:label id="lab_docs_IndividualsWithVotingInterestLessThanThresholdMember_documentation_en-US" xlink:label="lab_docs_IndividualsWithVotingInterestLessThanThresholdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Individuals With Voting Interest Less Than Threshold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_IndividualsWithVotingInterestLessThanThresholdMember" xlink:href="docs-20220331.xsd#docs_IndividualsWithVotingInterestLessThanThresholdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_IndividualsWithVotingInterestLessThanThresholdMember" xlink:to="lab_docs_IndividualsWithVotingInterestLessThanThresholdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesAPreferredStockMember_21427ef8-74fd-4107-8602-72f9f180cda0_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesAPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A</link:label>
    <link:label id="lab_us-gaap_SeriesAPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesAPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series A Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesAPreferredStockMember" xlink:to="lab_us-gaap_SeriesAPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_ContractWithCustomerCancellationNoticePeriod_a33c80a7-9a46-4841-83af-622a23943fb8_terseLabel_en-US" xlink:label="lab_docs_ContractWithCustomerCancellationNoticePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with customer, cancellation period</link:label>
    <link:label id="lab_docs_ContractWithCustomerCancellationNoticePeriod_label_en-US" xlink:label="lab_docs_ContractWithCustomerCancellationNoticePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Cancellation, Notice Period</link:label>
    <link:label id="lab_docs_ContractWithCustomerCancellationNoticePeriod_documentation_en-US" xlink:label="lab_docs_ContractWithCustomerCancellationNoticePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Cancellation, Notice Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ContractWithCustomerCancellationNoticePeriod" xlink:href="docs-20220331.xsd#docs_ContractWithCustomerCancellationNoticePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_ContractWithCustomerCancellationNoticePeriod" xlink:to="lab_docs_ContractWithCustomerCancellationNoticePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_MarketingAgencyOneMember_25b65aeb-44dc-4f1e-84f0-e4731687c9f8_terseLabel_en-US" xlink:label="lab_docs_MarketingAgencyOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing Agency One</link:label>
    <link:label id="lab_docs_MarketingAgencyOneMember_label_en-US" xlink:label="lab_docs_MarketingAgencyOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing Agency One [Member]</link:label>
    <link:label id="lab_docs_MarketingAgencyOneMember_documentation_en-US" xlink:label="lab_docs_MarketingAgencyOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Marketing Agency One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_MarketingAgencyOneMember" xlink:href="docs-20220331.xsd#docs_MarketingAgencyOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_MarketingAgencyOneMember" xlink:to="lab_docs_MarketingAgencyOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_OtherShareBasedAwardsMember_780cbc75-471a-46f4-ba87-f87723090b5c_terseLabel_en-US" xlink:label="lab_docs_OtherShareBasedAwardsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other share-based awards</link:label>
    <link:label id="lab_docs_OtherShareBasedAwardsMember_label_en-US" xlink:label="lab_docs_OtherShareBasedAwardsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Share-Based Awards [Member]</link:label>
    <link:label id="lab_docs_OtherShareBasedAwardsMember_documentation_en-US" xlink:label="lab_docs_OtherShareBasedAwardsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Share-Based Awards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_OtherShareBasedAwardsMember" xlink:href="docs-20220331.xsd#docs_OtherShareBasedAwardsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_OtherShareBasedAwardsMember" xlink:to="lab_docs_OtherShareBasedAwardsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_2aff13c5-2cee-4fe8-9d46-1cff45bf1341_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of premium (accretion of discount) on marketable securities, net</link:label>
    <link:label id="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_label_en-US" xlink:label="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accretion (Amortization) of Discounts and Premiums, Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="lab_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_HostingArrangementPeriod_0f7112ea-cb8f-4c78-bdc9-64bcc63abf1c_terseLabel_en-US" xlink:label="lab_docs_HostingArrangementPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hosting arrangement period</link:label>
    <link:label id="lab_docs_HostingArrangementPeriod_label_en-US" xlink:label="lab_docs_HostingArrangementPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hosting Arrangement, Period</link:label>
    <link:label id="lab_docs_HostingArrangementPeriod_documentation_en-US" xlink:label="lab_docs_HostingArrangementPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hosting Arrangement, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_HostingArrangementPeriod" xlink:href="docs-20220331.xsd#docs_HostingArrangementPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_HostingArrangementPeriod" xlink:to="lab_docs_HostingArrangementPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_e8642895-e457-42ab-96bf-f41e75698f36_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_5a0d430c-9711-43b5-8499-4766611e9967_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_d01cf040-987c-4d75-b49a-c8f54b459b64_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:to="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonClassAMember_06693f7a-79dd-4ae8-af7e-84c46ec7cc3c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class A</link:label>
    <link:label id="lab_us-gaap_CommonClassAMember_label_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class A [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassAMember" xlink:to="lab_us-gaap_CommonClassAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c87fc0d2-61ea-4e3d-ab5e-2af5913ba195_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_474ee808-42e9-4ba4-8c90-ab86e274d392_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SovereignDebtSecuritiesMember_c674bc9d-0870-464a-acf2-651e2a082d5d_terseLabel_en-US" xlink:label="lab_us-gaap_SovereignDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sovereign bonds</link:label>
    <link:label id="lab_us-gaap_SovereignDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_SovereignDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sovereign Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SovereignDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SovereignDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SovereignDebtSecuritiesMember" xlink:to="lab_us-gaap_SovereignDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_d8e95351-172f-45c6-9c30-9069faaf5329_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares issued and sold in initial public offering</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_2f578858-c445-413c-af1f-6c70d6c5a674_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_cce1b3df-aed5-4c66-80e1-cdccef1af257_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk free interest rate, maximum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_b847db2b-5354-4397-a937-7aa01fe99a35_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and other tax liabilities</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrent" xlink:to="lab_us-gaap_TaxesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_a09ab902-4209-4134-af42-0df84536cbee_terseLabel_en-US" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Customers Representing 10% or more of Revenue or Accounts Receivable, Net</link:label>
    <link:label id="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_label_en-US" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedules of Concentration of Risk, by Risk Factor [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:to="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_8f6330bc-53ff-4362-b545-0ad5b8342319_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_ff8adb02-2816-4c08-a0e1-961a6855b1f0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, gross</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_6f3f7b44-88ab-455d-930a-e20bf4a94f5f_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares reserved for future issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_bcc318e7-31b0-4184-8dd1-4e72585ba1df_totalLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_TemporaryEquityConvertibleStockPriceTrigger_95c445b6-f327-44a1-9836-c609cc8830bd_terseLabel_en-US" xlink:label="lab_docs_TemporaryEquityConvertibleStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion price (in dollars per share)</link:label>
    <link:label id="lab_docs_TemporaryEquityConvertibleStockPriceTrigger_label_en-US" xlink:label="lab_docs_TemporaryEquityConvertibleStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Convertible, Stock Price Trigger</link:label>
    <link:label id="lab_docs_TemporaryEquityConvertibleStockPriceTrigger_documentation_en-US" xlink:label="lab_docs_TemporaryEquityConvertibleStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Convertible, Stock Price Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TemporaryEquityConvertibleStockPriceTrigger" xlink:href="docs-20220331.xsd#docs_TemporaryEquityConvertibleStockPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_TemporaryEquityConvertibleStockPriceTrigger" xlink:to="lab_docs_TemporaryEquityConvertibleStockPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_dd0a737f-d00d-4446-af68-fe0b0689c7b6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_7e6677ca-9912-4fe2-b280-564fbb2bde58_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAmortization1_1019393a-d40e-4318-aaec-60372c637dcf_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of internal-use software development costs</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAmortization1_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Computer Software, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PostemploymentBenefitsAbstract_label_en-US" xlink:label="lab_us-gaap_PostemploymentBenefitsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Postemployment Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract" xlink:to="lab_us-gaap_PostemploymentBenefitsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_c434d4a1-b007-49a4-b74a-90db21a88955_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_48158b5e-070c-4264-a8f2-ad68b900cabb_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, money market funds</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_dbcd9a7e-e1ef-45cc-8271-9c92a6bf097f_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_IncreaseDecreaseInCapitalizedContractCost_7f281e8d-bdbb-42ef-8da3-e88af4dbaee1_negatedTerseLabel_en-US" xlink:label="lab_docs_IncreaseDecreaseInCapitalizedContractCost" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred contract costs</link:label>
    <link:label id="lab_docs_IncreaseDecreaseInCapitalizedContractCost_label_en-US" xlink:label="lab_docs_IncreaseDecreaseInCapitalizedContractCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Capitalized Contract Cost</link:label>
    <link:label id="lab_docs_IncreaseDecreaseInCapitalizedContractCost_documentation_en-US" xlink:label="lab_docs_IncreaseDecreaseInCapitalizedContractCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Capitalized Contract Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_IncreaseDecreaseInCapitalizedContractCost" xlink:href="docs-20220331.xsd#docs_IncreaseDecreaseInCapitalizedContractCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_IncreaseDecreaseInCapitalizedContractCost" xlink:to="lab_docs_IncreaseDecreaseInCapitalizedContractCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_33a3fdd7-655f-4fbf-81d7-127eab34299d_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_c9c865f1-d856-428b-ac9d-5640bd7964ae_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_FurnitureAndEquipmentMember_577e909a-cb0f-4def-8240-79c6c2a7d139_terseLabel_en-US" xlink:label="lab_docs_FurnitureAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and equipment</link:label>
    <link:label id="lab_docs_FurnitureAndEquipmentMember_label_en-US" xlink:label="lab_docs_FurnitureAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Equipment [Member]</link:label>
    <link:label id="lab_docs_FurnitureAndEquipmentMember_documentation_en-US" xlink:label="lab_docs_FurnitureAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_FurnitureAndEquipmentMember" xlink:href="docs-20220331.xsd#docs_FurnitureAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_FurnitureAndEquipmentMember" xlink:to="lab_docs_FurnitureAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_35185354-3329-4bd5-be97-90eaf138e3e2_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_84f60c4d-e261-463a-a946-2e82f286b3a4_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstanding_494676f7-ae93-4b90-8fe8-e549a6c3ddef_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants and rights outstanding</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstanding_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants and Rights Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstanding" xlink:to="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock_91f1f195-daa1-4f9c-8708-30819f74c94c_terseLabel_en-US" xlink:label="lab_docs_AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Expenses and Other Current Liabilities</link:label>
    <link:label id="lab_docs_AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock_label_en-US" xlink:label="lab_docs_AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable And Accrued Liabilities, Current Disclosure [Text Block]</link:label>
    <link:label id="lab_docs_AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock_documentation_en-US" xlink:label="lab_docs_AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable And Accrued Liabilities, Current Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock" xlink:href="docs-20220331.xsd#docs_AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock" xlink:to="lab_docs_AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_d22bac90-4bad-4fea-889c-7da807660cda_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_e8641b73-c685-4092-bdee-7a6a587509f9_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_label_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary or Equity Method Investee [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:to="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_a02b9880-8462-4cb4-a40e-513919d86943_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities assumed:</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_f256f1ec-a9fa-41de-ae20-3d65de28ff43_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OverAllotmentOptionMember_5515b95f-48aa-4976-8749-2eac5c2bc02c_terseLabel_en-US" xlink:label="lab_us-gaap_OverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Over-Allotment Option</link:label>
    <link:label id="lab_us-gaap_OverAllotmentOptionMember_label_en-US" xlink:label="lab_us-gaap_OverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Over-Allotment Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OverAllotmentOptionMember" xlink:to="lab_us-gaap_OverAllotmentOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_429608ec-3971-4595-9e26-0defcdff59b9_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, cash equivalents and marketable securities</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, and Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:to="lab_us-gaap_CashCashEquivalentsAndShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_a5104e3d-dd2d-4e10-907c-7b8411f51ed3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_ba741f13-e9d3-45ea-92d6-46ac8e231f9e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions related to a lapse of statute</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_5b2fb5d9-f67d-45cc-9ff6-a6ce91581786_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_3080d689-8542-4deb-ad04-f030bbf4aa99_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_3ae9b7b0-0bff-4133-892e-cd0a6e881690_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_ContractWithCustomerTerm_dc055ad8-f984-490f-a721-acf9481f1c6a_terseLabel_en-US" xlink:label="lab_docs_ContractWithCustomerTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contractual terms</link:label>
    <link:label id="lab_docs_ContractWithCustomerTerm_label_en-US" xlink:label="lab_docs_ContractWithCustomerTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Term</link:label>
    <link:label id="lab_docs_ContractWithCustomerTerm_documentation_en-US" xlink:label="lab_docs_ContractWithCustomerTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract With Customer, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ContractWithCustomerTerm" xlink:href="docs-20220331.xsd#docs_ContractWithCustomerTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_ContractWithCustomerTerm" xlink:to="lab_docs_ContractWithCustomerTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_43869642-1143-4877-960b-42c2b45c18a8_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_cf37573f-710d-41c3-9b18-7f74e9d3f818_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_c2f5ed66-a0b9-49f8-af74-1ac981c6e14a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_8cf99675-11db-427a-96ba-97f69c1a9dc5_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_945c422d-96d1-4989-a452-639514c407cf_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_c03ccdeb-1384-42ff-b488-c6f5b6c38b39_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities, net of effect of acquisition:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_4c805d3f-6afc-4aa0-8163-edbb2fd66b2a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_b909828f-f964-475f-ae57-fbc4244e7b4b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with the employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_14d4ccb6-2e4f-400c-b1e1-8d7f86374ce7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in unrealized loss on available-for-sale-securities, net of tax of $5,199, $0, and $0, respectively</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5bc88b65-fd6c-46f1-b6b9-18dbc74c5eba_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_4c6b944f-d386-4c88-9cac-94bb1725caf4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research &amp; development credit carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, in Process Research and Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_8fee083f-972e-4a7b-bdcc-0532e4588757_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_4568df3a-0136-4158-bc90-79a6c637340d_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_163f13d3-45b1-446e-96aa-d8629f2f6508_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_bef05081-6758-41ac-9eb1-feb35940e871_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_40779ed3-55e8-40a8-8bfa-ce572fc74c29_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding_7695dc1e-9e28-4da9-81e8-4ad080ed5c05_terseLabel_en-US" xlink:label="lab_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum annual increase of shares reserved for future issuance as a percentage of common stock outstanding</link:label>
    <link:label id="lab_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding_label_en-US" xlink:label="lab_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved For Future Issuance, Maximum Annual Increase As A Percentage Of Common Stock Outstanding</link:label>
    <link:label id="lab_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding_documentation_en-US" xlink:label="lab_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved For Future Issuance, Maximum Annual Increase As A Percentage Of Common Stock Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding" xlink:href="docs-20220331.xsd#docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding" xlink:to="lab_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_1583a0c1-d378-4721-8cd7-a1ab2b7187c3_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_e276c206-fe7a-4264-82c8-eaa8bc8698f0_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_b6c94f1a-c5c1-469d-aa1b-a4545db5a091_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Taxes paid related to net share settlement of equity awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_53f13fbd-cf41-4eea-8bc9-dbb8fb40b731_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_478838f2-ea98-463b-93a8-9caa581f3d68_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to acquire businesses</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityLineItems_ff0f08be-b1de-4f44-893f-71366cb89a2b_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity [Line Items]</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityLineItems_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityLineItems" xlink:to="lab_us-gaap_TemporaryEquityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_f7b1a680-b727-45c2-b0e7-1f72daa2de60_negatedTerseLabel_en-US" xlink:label="lab_docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Conversion of redeemable convertible preferred stock upon initial public offering (in shares)</link:label>
    <link:label id="lab_docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Shares, Conversion Of Convertible Securities</link:label>
    <link:label id="lab_docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_documentation_en-US" xlink:label="lab_docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Shares, Conversion Of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="docs-20220331.xsd#docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_a23d265c-5d6c-4997-9842-105db7ed1152_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_130f2a18-3d29-4614-936a-85d5c1134ff8_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_66446616-fc35-4a68-8241-74e170d546a4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value, vested and expected to vest at period end</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_f1539743-c4c0-41e4-bab2-a046a7e74965_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedSalesCommissionCurrent_06207e01-f9cb-4c32-a587-e16af2d9913d_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedSalesCommissionCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued commissions</link:label>
    <link:label id="lab_us-gaap_AccruedSalesCommissionCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedSalesCommissionCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Sales Commission, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedSalesCommissionCurrent" xlink:to="lab_us-gaap_AccruedSalesCommissionCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_0a58b0fd-ac27-43cb-9f50-bb1cc210ec60_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock in connection with the employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockPlans_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockPlans" xlink:to="lab_us-gaap_ProceedsFromStockPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_365b1032-1f41-4bfa-ab24-eaf088a8f443_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod_aeff4fec-7c32-43ad-b396-d98614a4aa0b_terseLabel_en-US" xlink:label="lab_docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination contingent consideration liability payable period</link:label>
    <link:label id="lab_docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod_label_en-US" xlink:label="lab_docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability Payable Period</link:label>
    <link:label id="lab_docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod_documentation_en-US" xlink:label="lab_docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability Payable Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod" xlink:href="docs-20220331.xsd#docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod" xlink:to="lab_docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_1672de30-d14e-4cd5-b4b0-ad824831c805_terseLabel_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed securities</link:label>
    <link:label id="lab_us-gaap_AssetBackedSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_AssetBackedSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset-backed Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetBackedSecuritiesMember" xlink:to="lab_us-gaap_AssetBackedSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingExpense_2ca987e6-b5db-4a66-a1f7-5f7fc1a12d77_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising expense</link:label>
    <link:label id="lab_us-gaap_AdvertisingExpense_label_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingExpense" xlink:to="lab_us-gaap_AdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_6acee3d4-edc6-4049-ac37-8be3a2b1abd5_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Pronouncements Recently Adopted/ Accounting Pronouncements Not Yet Adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_27005fd1-7b43-427a-be2c-9682fe4012ee_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_a72cf450-016a-4c11-be55-05502827dc2c_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_284909cb-f485-4181-8905-ca9a4bb2267c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes at statutory rate</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_62921108-385c-4df6-94cf-8b8d3ca2e739_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_114b3cab-b6d0-46ac-ae99-6ef72f4b1d03_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_fb51e140-091a-4bcf-ac4f-4b8cacadf73e_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputPriceVolatilityMember_07b21fa3-c742-42d7-af17-a8fa09fa3d4c_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Price Volatility</link:label>
    <link:label id="lab_us-gaap_MeasurementInputPriceVolatilityMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Price Volatility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_fbe97c90-d491-46e3-b868-1018ade3f449_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_13d714e8-073a-4f7e-8210-0c6b9ff8767d_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant, measurement input</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants and Rights Outstanding, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:to="lab_us-gaap_WarrantsAndRightsOutstandingMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_c6e88a1f-9a6f-4f2b-9b17-121b5ed58e73_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards, state</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards, State and Local</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_13087d23-eb53-49d0-84b8-5b5519946c59_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_de129534-cd44-4c28-8fec-6fc661b4f57d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_afe5e2c4-1524-4217-a34b-2510c0ccf219_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due within one year</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_d14d9997-966c-4113-8fe2-4e2e427a0af1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_f1c79b8a-fc9c-418f-a5f3-0bb0e987f329_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_docs_DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember_ce681249-bf14-4e0b-962b-d14b100a042a_terseLabel_en-US" xlink:label="lab_docs_DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Commissions For Marketing Solutions Contracts And For Hiring Solutions Renewal Contracts</link:label>
    <link:label id="lab_docs_DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember_label_en-US" xlink:label="lab_docs_DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Commissions For Marketing Solutions Contracts And For Hiring Solutions Renewal Contracts [Member]</link:label>
    <link:label id="lab_docs_DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember_documentation_en-US" xlink:label="lab_docs_DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Commissions For Marketing Solutions Contracts And For Hiring Solutions Renewal Contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember" xlink:href="docs-20220331.xsd#docs_DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_docs_DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember" xlink:to="lab_docs_DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostNetCurrent_d534c6ec-de26-4a27-b921-1cdb6d397379_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred contract costs, current</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostNetCurrent_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized Contract Cost, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostNetCurrent" xlink:to="lab_us-gaap_CapitalizedContractCostNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6fbf8459-c158-410c-b128-816d0e4c622c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_bc675968-eef7-4a64-868a-29f08959fbda_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan Valuation Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_21d635ff-b084-485a-a9bc-1a5008499aa8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_64fc1685-b704-4820-a528-63133ca6720b_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average remaining contractual term, vested and expected to vest at period end</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>docs-20220331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:7e9381b6-a1e4-41b8-8d47-38883b11be1e,g:11b17cc6-874f-42e4-b7f0-55cdc6f63454-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.doximity.com/role/CoverPage" xlink:type="simple" xlink:href="docs-20220331.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_4f04886e-f363-4fd3-9887-0af7fed3bd8c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_812e8a0b-9b1d-4734-b6ab-78479b1e4b7e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_4f04886e-f363-4fd3-9887-0af7fed3bd8c" xlink:to="loc_dei_DocumentInformationTable_812e8a0b-9b1d-4734-b6ab-78479b1e4b7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b527a334-31b0-4ba2-a389-4753ca7caa91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_812e8a0b-9b1d-4734-b6ab-78479b1e4b7e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b527a334-31b0-4ba2-a389-4753ca7caa91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_98e2d083-b7e1-4e4a-8bc2-8440fcbaa52f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b527a334-31b0-4ba2-a389-4753ca7caa91" xlink:to="loc_us-gaap_ClassOfStockDomain_98e2d083-b7e1-4e4a-8bc2-8440fcbaa52f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_86fccbbd-1fa3-43b1-b4d7-22748d0d977e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_98e2d083-b7e1-4e4a-8bc2-8440fcbaa52f" xlink:to="loc_us-gaap_CommonClassAMember_86fccbbd-1fa3-43b1-b4d7-22748d0d977e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_20d9b3df-bdb7-4b7b-a7a9-bafe27caa665" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_98e2d083-b7e1-4e4a-8bc2-8440fcbaa52f" xlink:to="loc_us-gaap_CommonClassBMember_20d9b3df-bdb7-4b7b-a7a9-bafe27caa665" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_812e8a0b-9b1d-4734-b6ab-78479b1e4b7e" xlink:to="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_80453bdd-e699-4ba7-8bae-29e94c05e015" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_DocumentType_80453bdd-e699-4ba7-8bae-29e94c05e015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_2ae1e61e-75fe-48b2-86b4-6383a8b0416f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_DocumentAnnualReport_2ae1e61e-75fe-48b2-86b4-6383a8b0416f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_030bc5a3-00fc-4798-857f-9f1de49a315f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_DocumentPeriodEndDate_030bc5a3-00fc-4798-857f-9f1de49a315f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_74bf4ec5-b4b8-452f-96f9-e25164211620" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_CurrentFiscalYearEndDate_74bf4ec5-b4b8-452f-96f9-e25164211620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_8afd9c4d-e11c-4831-a657-ada88c05eba2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_DocumentTransitionReport_8afd9c4d-e11c-4831-a657-ada88c05eba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_7165288a-765f-4dac-a7d8-08388b164032" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntityFileNumber_7165288a-765f-4dac-a7d8-08388b164032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_b54325c5-9387-40fb-bac5-525bd42e9819" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntityRegistrantName_b54325c5-9387-40fb-bac5-525bd42e9819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_aecffa89-ccfd-4c31-98ed-3a1f85285f2f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntityIncorporationStateCountryCode_aecffa89-ccfd-4c31-98ed-3a1f85285f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_fe4ed4b7-e9cb-4782-9731-10bccbcb5525" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntityTaxIdentificationNumber_fe4ed4b7-e9cb-4782-9731-10bccbcb5525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_f6da7226-1364-415f-b710-e4da7805af26" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntityAddressAddressLine1_f6da7226-1364-415f-b710-e4da7805af26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_377b819e-4c84-4edc-93a3-93ebda2d06db" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntityAddressAddressLine2_377b819e-4c84-4edc-93a3-93ebda2d06db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_ec174071-db9e-41d5-8073-601c8b58d795" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntityAddressCityOrTown_ec174071-db9e-41d5-8073-601c8b58d795" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_11a38e8a-1cb8-4afb-bda9-82ca9d330d36" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntityAddressStateOrProvince_11a38e8a-1cb8-4afb-bda9-82ca9d330d36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_542f8de8-2dca-4a39-8d26-a29e6f64862a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntityAddressPostalZipCode_542f8de8-2dca-4a39-8d26-a29e6f64862a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_2f6820f9-f0f1-4fab-b2f6-84b906df0717" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_CityAreaCode_2f6820f9-f0f1-4fab-b2f6-84b906df0717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_888419c2-acdc-4a5a-863c-0ef6ef314445" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_LocalPhoneNumber_888419c2-acdc-4a5a-863c-0ef6ef314445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_c93cb4e2-4eb1-4990-92f2-804e4bd8c0e9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_Security12bTitle_c93cb4e2-4eb1-4990-92f2-804e4bd8c0e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_654b91ef-95aa-4ce5-b6f0-0cb5a2ac8d0d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_TradingSymbol_654b91ef-95aa-4ce5-b6f0-0cb5a2ac8d0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_e3d967af-238e-40c4-84bf-6a66d043ca39" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_SecurityExchangeName_e3d967af-238e-40c4-84bf-6a66d043ca39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_05946c15-8f63-4a0a-bfb7-9461c8ac625f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_05946c15-8f63-4a0a-bfb7-9461c8ac625f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_48c3c2bb-0e90-496c-a3f6-9bbec9239548" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntityVoluntaryFilers_48c3c2bb-0e90-496c-a3f6-9bbec9239548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_2073c3b7-cc71-4790-b9e6-2f1eec00ceea" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntityCurrentReportingStatus_2073c3b7-cc71-4790-b9e6-2f1eec00ceea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_c5b5b6e2-269f-4876-85c4-647c62da4024" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntityInteractiveDataCurrent_c5b5b6e2-269f-4876-85c4-647c62da4024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_5ebae301-18b1-44e7-a180-271279d0304c" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntityFilerCategory_5ebae301-18b1-44e7-a180-271279d0304c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_1887f4a3-6ac4-41c3-b822-8901e915f4c4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntitySmallBusiness_1887f4a3-6ac4-41c3-b822-8901e915f4c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_1ee02166-2396-46d4-9c43-4bfb2965990b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntityEmergingGrowthCompany_1ee02166-2396-46d4-9c43-4bfb2965990b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_6630b901-c972-41df-9aa8-7c4f5ae4e660" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntityExTransitionPeriod_6630b901-c972-41df-9aa8-7c4f5ae4e660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_517affb1-740c-41a9-8b23-4476d78194e9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_IcfrAuditorAttestationFlag_517affb1-740c-41a9-8b23-4476d78194e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_756c7d02-a285-4cb9-924e-b94ebdebd943" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntityShellCompany_756c7d02-a285-4cb9-924e-b94ebdebd943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_992270e1-67a9-40a0-a605-195063ed06c0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntityPublicFloat_992270e1-67a9-40a0-a605-195063ed06c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_b027cdbb-6ebc-446f-84e6-7336d9a37ffe" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_b027cdbb-6ebc-446f-84e6-7336d9a37ffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_242162b1-5ddf-4f51-9ffe-452b10be9d5b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_242162b1-5ddf-4f51-9ffe-452b10be9d5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_443c3ee4-4aed-44e9-ab01-33b26cdd27ad" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_EntityCentralIndexKey_443c3ee4-4aed-44e9-ab01-33b26cdd27ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_2e0977d3-98a2-49c2-ae6e-f53db3436a0f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_DocumentFiscalYearFocus_2e0977d3-98a2-49c2-ae6e-f53db3436a0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_3f2603c7-a2ee-4665-8ff7-1fb3c6bdfcc3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_DocumentFiscalPeriodFocus_3f2603c7-a2ee-4665-8ff7-1fb3c6bdfcc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_ba4cdc40-d2fb-450e-8a06-3cab6d68baca" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_28be4a80-f7f5-4476-83be-d0af03e44705" xlink:to="loc_dei_AmendmentFlag_ba4cdc40-d2fb-450e-8a06-3cab6d68baca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/AuditInformation" xlink:type="simple" xlink:href="docs-20220331.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_docs_AuditInformationAbstract_8f6a2aee-ded2-49ed-9464-7945ef5620a4" xlink:href="docs-20220331.xsd#docs_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_75e1007c-d573-453b-a3b9-85659b89fc64" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_docs_AuditInformationAbstract_8f6a2aee-ded2-49ed-9464-7945ef5620a4" xlink:to="loc_dei_AuditorName_75e1007c-d573-453b-a3b9-85659b89fc64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_a0b28796-f515-4e8a-8f5b-a7d3a0f8c016" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_docs_AuditInformationAbstract_8f6a2aee-ded2-49ed-9464-7945ef5620a4" xlink:to="loc_dei_AuditorLocation_a0b28796-f515-4e8a-8f5b-a7d3a0f8c016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_552a92e8-62c3-4826-8cdc-f1b05e86633e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_docs_AuditInformationAbstract_8f6a2aee-ded2-49ed-9464-7945ef5620a4" xlink:to="loc_dei_AuditorFirmId_552a92e8-62c3-4826-8cdc-f1b05e86633e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="docs-20220331.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_63332d84-8f11-4de0-9e2b-b3d205087018" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_e22a3627-7f7c-432a-b869-7706e91b3e1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_63332d84-8f11-4de0-9e2b-b3d205087018" xlink:to="loc_us-gaap_AssetsAbstract_e22a3627-7f7c-432a-b869-7706e91b3e1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_48a3b24f-36cd-4a3b-ad48-7e277a53d263" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e22a3627-7f7c-432a-b869-7706e91b3e1c" xlink:to="loc_us-gaap_AssetsCurrentAbstract_48a3b24f-36cd-4a3b-ad48-7e277a53d263" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3cca59e7-e7bc-4854-a369-5c050a2454df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_48a3b24f-36cd-4a3b-ad48-7e277a53d263" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3cca59e7-e7bc-4854-a369-5c050a2454df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_1440512b-f323-45e1-90ac-d1c6f97f94fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_48a3b24f-36cd-4a3b-ad48-7e277a53d263" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent_1440512b-f323-45e1-90ac-d1c6f97f94fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_ec4aea2e-87a8-4abc-8e67-f251d09f2f8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_48a3b24f-36cd-4a3b-ad48-7e277a53d263" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_ec4aea2e-87a8-4abc-8e67-f251d09f2f8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9a5b05e2-d66c-4ff5-a9f5-26cfbf8b90b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_48a3b24f-36cd-4a3b-ad48-7e277a53d263" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_9a5b05e2-d66c-4ff5-a9f5-26cfbf8b90b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNetCurrent_e12e99e9-9713-446e-9c7c-fbdb8e210280" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostNetCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_48a3b24f-36cd-4a3b-ad48-7e277a53d263" xlink:to="loc_us-gaap_CapitalizedContractCostNetCurrent_e12e99e9-9713-446e-9c7c-fbdb8e210280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_0c569341-2190-4096-b9d9-11e0f017f856" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_48a3b24f-36cd-4a3b-ad48-7e277a53d263" xlink:to="loc_us-gaap_AssetsCurrent_0c569341-2190-4096-b9d9-11e0f017f856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a206ece4-b68e-4f6e-8f25-69c2cfadce29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e22a3627-7f7c-432a-b869-7706e91b3e1c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a206ece4-b68e-4f6e-8f25-69c2cfadce29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_58bc2c87-7846-4876-bea2-902072d1ee88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e22a3627-7f7c-432a-b869-7706e91b3e1c" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_58bc2c87-7846-4876-bea2-902072d1ee88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_356ab00e-32e8-4aaf-8427-3a7109cbf82d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e22a3627-7f7c-432a-b869-7706e91b3e1c" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_356ab00e-32e8-4aaf-8427-3a7109cbf82d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_71f9e8b8-2cdf-4670-9969-7d24828a4013" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e22a3627-7f7c-432a-b869-7706e91b3e1c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_71f9e8b8-2cdf-4670-9969-7d24828a4013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4fc78b4a-13af-4a21-bfd3-0e7f302394ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e22a3627-7f7c-432a-b869-7706e91b3e1c" xlink:to="loc_us-gaap_Goodwill_4fc78b4a-13af-4a21-bfd3-0e7f302394ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_4a0ad9fe-a229-46e3-8a88-25624ec0925c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e22a3627-7f7c-432a-b869-7706e91b3e1c" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_4a0ad9fe-a229-46e3-8a88-25624ec0925c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_60e82b2f-34f3-434c-b5f2-7111620a247b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_e22a3627-7f7c-432a-b869-7706e91b3e1c" xlink:to="loc_us-gaap_Assets_60e82b2f-34f3-434c-b5f2-7111620a247b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3dab0ddd-f3ac-4756-93a1-27ec93818181" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_63332d84-8f11-4de0-9e2b-b3d205087018" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3dab0ddd-f3ac-4756-93a1-27ec93818181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_2c9c517b-18af-49e3-b071-0c1c6b947811" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3dab0ddd-f3ac-4756-93a1-27ec93818181" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_2c9c517b-18af-49e3-b071-0c1c6b947811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_1f7d8ed0-92ad-487f-b661-aae1729b84d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2c9c517b-18af-49e3-b071-0c1c6b947811" xlink:to="loc_us-gaap_AccountsPayableCurrent_1f7d8ed0-92ad-487f-b661-aae1729b84d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_00c3734e-e347-450d-a79a-6a1efcdf1f77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2c9c517b-18af-49e3-b071-0c1c6b947811" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_00c3734e-e347-450d-a79a-6a1efcdf1f77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_43650ff3-6363-481f-a7b6-e2707fc50590" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2c9c517b-18af-49e3-b071-0c1c6b947811" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_43650ff3-6363-481f-a7b6-e2707fc50590" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_d24eb490-25a0-44e6-b826-d42218f4a14b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2c9c517b-18af-49e3-b071-0c1c6b947811" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_d24eb490-25a0-44e6-b826-d42218f4a14b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_41aabee2-2419-4ce2-9620-4199c1b41cc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2c9c517b-18af-49e3-b071-0c1c6b947811" xlink:to="loc_us-gaap_LiabilitiesCurrent_41aabee2-2419-4ce2-9620-4199c1b41cc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_42213041-86bd-42f3-9909-c34dc2853f88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3dab0ddd-f3ac-4756-93a1-27ec93818181" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_42213041-86bd-42f3-9909-c34dc2853f88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1aeefa22-120b-4d72-bc0c-cb9c2e9c49c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3dab0ddd-f3ac-4756-93a1-27ec93818181" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1aeefa22-120b-4d72-bc0c-cb9c2e9c49c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_336a0ebf-a7b7-475c-a998-73fb71d749a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3dab0ddd-f3ac-4756-93a1-27ec93818181" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_336a0ebf-a7b7-475c-a998-73fb71d749a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_194058fd-dcfe-4380-bae7-418298233eea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3dab0ddd-f3ac-4756-93a1-27ec93818181" xlink:to="loc_us-gaap_Liabilities_194058fd-dcfe-4380-bae7-418298233eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_ca3f20bf-fa39-444d-b0ca-ce96f2dd4631" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3dab0ddd-f3ac-4756-93a1-27ec93818181" xlink:to="loc_us-gaap_CommitmentsAndContingencies_ca3f20bf-fa39-444d-b0ca-ce96f2dd4631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityAbstract_70cbb9f5-e51d-4f88-bad4-7a8f5d33baa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3dab0ddd-f3ac-4756-93a1-27ec93818181" xlink:to="loc_us-gaap_TemporaryEquityAbstract_70cbb9f5-e51d-4f88-bad4-7a8f5d33baa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_fe960852-eca3-4b60-a04a-01081090768c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityAbstract_70cbb9f5-e51d-4f88-bad4-7a8f5d33baa1" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_fe960852-eca3-4b60-a04a-01081090768c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_43664f86-499b-4b8b-95e4-6f66e7f5c0ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3dab0ddd-f3ac-4756-93a1-27ec93818181" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_43664f86-499b-4b8b-95e4-6f66e7f5c0ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_019b2df5-c865-4a5c-bf96-2747aefffaf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_43664f86-499b-4b8b-95e4-6f66e7f5c0ad" xlink:to="loc_us-gaap_PreferredStockValue_019b2df5-c865-4a5c-bf96-2747aefffaf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_16c4900e-9348-432d-90b7-d016df76f10c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_43664f86-499b-4b8b-95e4-6f66e7f5c0ad" xlink:to="loc_us-gaap_CommonStockValue_16c4900e-9348-432d-90b7-d016df76f10c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_b8ed6fc4-dba8-42d9-be6e-809b33c6d19e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_43664f86-499b-4b8b-95e4-6f66e7f5c0ad" xlink:to="loc_us-gaap_AdditionalPaidInCapital_b8ed6fc4-dba8-42d9-be6e-809b33c6d19e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_67384a9a-41fc-49ed-bcf2-6c26926f226b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_43664f86-499b-4b8b-95e4-6f66e7f5c0ad" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_67384a9a-41fc-49ed-bcf2-6c26926f226b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_865af87f-dd71-4ad1-8870-46ecd01d81c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_43664f86-499b-4b8b-95e4-6f66e7f5c0ad" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_865af87f-dd71-4ad1-8870-46ecd01d81c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c1897e9f-576b-44d1-b225-e17f189e9740" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_43664f86-499b-4b8b-95e4-6f66e7f5c0ad" xlink:to="loc_us-gaap_StockholdersEquity_c1897e9f-576b-44d1-b225-e17f189e9740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_7a4f0fcb-bafb-4f42-a22a-1b44aec03780" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_3dab0ddd-f3ac-4756-93a1-27ec93818181" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_7a4f0fcb-bafb-4f42-a22a-1b44aec03780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="docs-20220331.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_026a9dd5-d439-4382-aa07-11545ea7bf69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_b1a4a7f5-f060-4fa5-b342-df55f990664d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_026a9dd5-d439-4382-aa07-11545ea7bf69" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_b1a4a7f5-f060-4fa5-b342-df55f990664d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_40a3da4b-95ae-484b-9fee-787870886ad2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_026a9dd5-d439-4382-aa07-11545ea7bf69" xlink:to="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_40a3da4b-95ae-484b-9fee-787870886ad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_4f4daaa9-af24-4013-9363-84cfdde25b10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_026a9dd5-d439-4382-aa07-11545ea7bf69" xlink:to="loc_us-gaap_TemporaryEquitySharesAuthorized_4f4daaa9-af24-4013-9363-84cfdde25b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_e2194412-ea4a-4686-a045-21eb14590591" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_026a9dd5-d439-4382-aa07-11545ea7bf69" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_e2194412-ea4a-4686-a045-21eb14590591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_aaa9fb43-323d-43f3-85df-c821bbe959fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_026a9dd5-d439-4382-aa07-11545ea7bf69" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_aaa9fb43-323d-43f3-85df-c821bbe959fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLiquidationPreference_fdcff259-62db-4dd6-9f7f-26b2ee814cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_026a9dd5-d439-4382-aa07-11545ea7bf69" xlink:to="loc_us-gaap_TemporaryEquityLiquidationPreference_fdcff259-62db-4dd6-9f7f-26b2ee814cf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_9fe98911-f107-4ad2-a50b-42a7b1f97e19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_026a9dd5-d439-4382-aa07-11545ea7bf69" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_9fe98911-f107-4ad2-a50b-42a7b1f97e19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_3ff78ac1-89d4-4893-8a80-ca468edde99c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_026a9dd5-d439-4382-aa07-11545ea7bf69" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_3ff78ac1-89d4-4893-8a80-ca468edde99c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_f785041c-1f28-4e8a-b9b3-5dbaef643945" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_026a9dd5-d439-4382-aa07-11545ea7bf69" xlink:to="loc_us-gaap_PreferredStockSharesIssued_f785041c-1f28-4e8a-b9b3-5dbaef643945" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_1ea442e9-312e-49e2-bfb5-55fe687ec2da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_026a9dd5-d439-4382-aa07-11545ea7bf69" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_1ea442e9-312e-49e2-bfb5-55fe687ec2da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_9fb643c7-6ac6-4b4c-8bcd-1535f51dd2cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_026a9dd5-d439-4382-aa07-11545ea7bf69" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_9fb643c7-6ac6-4b4c-8bcd-1535f51dd2cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_44e9b24f-a699-4868-84fb-62b9e5dd3cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_026a9dd5-d439-4382-aa07-11545ea7bf69" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_44e9b24f-a699-4868-84fb-62b9e5dd3cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_4f46a9c5-1f50-47ce-9a6f-77b201038a94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_026a9dd5-d439-4382-aa07-11545ea7bf69" xlink:to="loc_us-gaap_CommonStockSharesIssued_4f46a9c5-1f50-47ce-9a6f-77b201038a94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_85bfeb35-f4c7-44d5-9a24-4ebdc32b8e0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_026a9dd5-d439-4382-aa07-11545ea7bf69" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_85bfeb35-f4c7-44d5-9a24-4ebdc32b8e0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="docs-20220331.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_ef97606e-d4fd-4608-9acc-a52ad6e73b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c0c2ceed-db6c-430a-a732-face8a81a970" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ef97606e-d4fd-4608-9acc-a52ad6e73b2c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c0c2ceed-db6c-430a-a732-face8a81a970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_b6479ead-a60b-46e2-8278-44366f38c778" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ef97606e-d4fd-4608-9acc-a52ad6e73b2c" xlink:to="loc_us-gaap_CostOfRevenue_b6479ead-a60b-46e2-8278-44366f38c778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_ca59a3ab-a070-4534-8a7a-ffabb60dacba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ef97606e-d4fd-4608-9acc-a52ad6e73b2c" xlink:to="loc_us-gaap_GrossProfit_ca59a3ab-a070-4534-8a7a-ffabb60dacba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_04dfe46d-1393-4cd0-9936-493db3a8d341" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ef97606e-d4fd-4608-9acc-a52ad6e73b2c" xlink:to="loc_us-gaap_OperatingExpensesAbstract_04dfe46d-1393-4cd0-9936-493db3a8d341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_8ca75478-1563-4c6a-8e54-26e9128cbaa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_04dfe46d-1393-4cd0-9936-493db3a8d341" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_8ca75478-1563-4c6a-8e54-26e9128cbaa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_6b2ede72-8e82-41c9-a6da-e36c648d54e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_04dfe46d-1393-4cd0-9936-493db3a8d341" xlink:to="loc_us-gaap_SellingAndMarketingExpense_6b2ede72-8e82-41c9-a6da-e36c648d54e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_75f7fbf9-7b3a-49c5-a030-66bbabd75f79" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_04dfe46d-1393-4cd0-9936-493db3a8d341" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_75f7fbf9-7b3a-49c5-a030-66bbabd75f79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_6faa0bcf-a1a1-4f61-be55-db1a0a13f18f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_04dfe46d-1393-4cd0-9936-493db3a8d341" xlink:to="loc_us-gaap_OperatingExpenses_6faa0bcf-a1a1-4f61-be55-db1a0a13f18f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c87b7c4b-30d3-4308-9995-5b41143113c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ef97606e-d4fd-4608-9acc-a52ad6e73b2c" xlink:to="loc_us-gaap_OperatingIncomeLoss_c87b7c4b-30d3-4308-9995-5b41143113c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_5e60dabb-0145-4d2c-9a85-0809f4a7f415" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ef97606e-d4fd-4608-9acc-a52ad6e73b2c" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_5e60dabb-0145-4d2c-9a85-0809f4a7f415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_31adfe6a-1e44-443b-865a-38596d627dec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ef97606e-d4fd-4608-9acc-a52ad6e73b2c" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_31adfe6a-1e44-443b-865a-38596d627dec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f565bbc3-5376-4cea-8378-901240eb8f91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ef97606e-d4fd-4608-9acc-a52ad6e73b2c" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f565bbc3-5376-4cea-8378-901240eb8f91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0d67eda7-481e-4841-a073-6731177df631" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ef97606e-d4fd-4608-9acc-a52ad6e73b2c" xlink:to="loc_us-gaap_NetIncomeLoss_0d67eda7-481e-4841-a073-6731177df631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_b05db960-96c9-48a9-a555-03db4f601114" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ef97606e-d4fd-4608-9acc-a52ad6e73b2c" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_b05db960-96c9-48a9-a555-03db4f601114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_2500cb3f-6d3c-42b8-af0f-810a6f720401" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ef97606e-d4fd-4608-9acc-a52ad6e73b2c" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_2500cb3f-6d3c-42b8-af0f-810a6f720401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_5d0b5f63-9e8f-4e0e-abf8-b823bd7fec34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ef97606e-d4fd-4608-9acc-a52ad6e73b2c" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_5d0b5f63-9e8f-4e0e-abf8-b823bd7fec34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_8b89fab2-5519-4785-be67-a05d1f987822" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ef97606e-d4fd-4608-9acc-a52ad6e73b2c" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_8b89fab2-5519-4785-be67-a05d1f987822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b333d905-9742-4be7-adfb-fadef555fc35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ef97606e-d4fd-4608-9acc-a52ad6e73b2c" xlink:to="loc_us-gaap_EarningsPerShareAbstract_b333d905-9742-4be7-adfb-fadef555fc35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_06a2dad7-7138-4c27-8d9b-3e29e99278dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b333d905-9742-4be7-adfb-fadef555fc35" xlink:to="loc_us-gaap_EarningsPerShareBasic_06a2dad7-7138-4c27-8d9b-3e29e99278dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_9149e9fa-deb7-407d-b037-b808f00f981d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b333d905-9742-4be7-adfb-fadef555fc35" xlink:to="loc_us-gaap_EarningsPerShareDiluted_9149e9fa-deb7-407d-b037-b808f00f981d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_fddca843-ede8-4679-a7f2-1f63deeb5a95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ef97606e-d4fd-4608-9acc-a52ad6e73b2c" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_fddca843-ede8-4679-a7f2-1f63deeb5a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_38474d25-e1d4-44be-90ba-c0c077922614" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_fddca843-ede8-4679-a7f2-1f63deeb5a95" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_38474d25-e1d4-44be-90ba-c0c077922614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b9d72bdb-8c26-4955-829a-fea840fdb406" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_fddca843-ede8-4679-a7f2-1f63deeb5a95" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b9d72bdb-8c26-4955-829a-fea840fdb406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="simple" xlink:href="docs-20220331.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_29f15cde-a555-4b3f-858c-c2e79dab2a17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_10e4f722-b1b7-46ef-8860-7b0fd943abdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_29f15cde-a555-4b3f-858c-c2e79dab2a17" xlink:to="loc_us-gaap_NetIncomeLoss_10e4f722-b1b7-46ef-8860-7b0fd943abdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_9a837827-9a42-460e-8c9c-6eb3aa7ba69b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_29f15cde-a555-4b3f-858c-c2e79dab2a17" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_9a837827-9a42-460e-8c9c-6eb3aa7ba69b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_fe58b215-1042-4390-9850-5bb9ea4dd29b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_9a837827-9a42-460e-8c9c-6eb3aa7ba69b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_fe58b215-1042-4390-9850-5bb9ea4dd29b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_692cdc04-bc55-4502-acff-77369e792ba6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_9a837827-9a42-460e-8c9c-6eb3aa7ba69b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_692cdc04-bc55-4502-acff-77369e792ba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_87815547-d0fc-4063-a639-47100105604f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_29f15cde-a555-4b3f-858c-c2e79dab2a17" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_87815547-d0fc-4063-a639-47100105604f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical" xlink:type="simple" xlink:href="docs-20220331.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f87c4283-69ee-43c2-8bd4-fd6cb3d58639" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent_d6855177-ee20-4d66-a361-5de08ad86ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f87c4283-69ee-43c2-8bd4-fd6cb3d58639" xlink:to="loc_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent_d6855177-ee20-4d66-a361-5de08ad86ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT" xlink:type="simple" xlink:href="docs-20220331.xsd#CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_7aaa4a45-38ce-4d62-8918-7892acf8c023" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_6208d10f-dd69-46c0-a636-2511939bf90c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_7aaa4a45-38ce-4d62-8918-7892acf8c023" xlink:to="loc_us-gaap_StatementTable_6208d10f-dd69-46c0-a636-2511939bf90c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_39278237-2bd1-40df-b713-4dd104b12f64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6208d10f-dd69-46c0-a636-2511939bf90c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_39278237-2bd1-40df-b713-4dd104b12f64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_283e69ef-5fe4-4cb7-b511-7b90eb9efaeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_39278237-2bd1-40df-b713-4dd104b12f64" xlink:to="loc_us-gaap_EquityComponentDomain_283e69ef-5fe4-4cb7-b511-7b90eb9efaeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_f5aa8221-fcfa-4b4f-8486-e900e66a3820" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_283e69ef-5fe4-4cb7-b511-7b90eb9efaeb" xlink:to="loc_us-gaap_CommonStockMember_f5aa8221-fcfa-4b4f-8486-e900e66a3820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_8d254179-f2f8-425e-9e2d-c4a26977eec1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_283e69ef-5fe4-4cb7-b511-7b90eb9efaeb" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_8d254179-f2f8-425e-9e2d-c4a26977eec1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d63adf2d-2730-4089-85f0-840490361a92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_283e69ef-5fe4-4cb7-b511-7b90eb9efaeb" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_d63adf2d-2730-4089-85f0-840490361a92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_14b2be97-aba7-4579-a4f6-b3638450fe26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_283e69ef-5fe4-4cb7-b511-7b90eb9efaeb" xlink:to="loc_us-gaap_RetainedEarningsMember_14b2be97-aba7-4579-a4f6-b3638450fe26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_ada02534-28d4-499b-96d1-99d8a16c0214" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_6208d10f-dd69-46c0-a636-2511939bf90c" xlink:to="loc_us-gaap_StatementLineItems_ada02534-28d4-499b-96d1-99d8a16c0214" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_afb3f5d0-bc55-42e1-b823-67e1e6da7132" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ada02534-28d4-499b-96d1-99d8a16c0214" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_afb3f5d0-bc55-42e1-b823-67e1e6da7132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_4f91d5a4-c075-4e2f-8322-362b99d645fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_afb3f5d0-bc55-42e1-b823-67e1e6da7132" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_4f91d5a4-c075-4e2f-8322-362b99d645fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_3c612ba9-06d1-42d1-ba96-c09700a894e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_afb3f5d0-bc55-42e1-b823-67e1e6da7132" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_3c612ba9-06d1-42d1-ba96-c09700a894e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TemporaryEquityExercisesOfWarrantsShares_aa8875a9-b718-4b4f-bf24-9d7e64fd8c58" xlink:href="docs-20220331.xsd#docs_TemporaryEquityExercisesOfWarrantsShares"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_afb3f5d0-bc55-42e1-b823-67e1e6da7132" xlink:to="loc_docs_TemporaryEquityExercisesOfWarrantsShares_aa8875a9-b718-4b4f-bf24-9d7e64fd8c58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TemporaryEquityExercisesOfWarrantsAmount_aaa26dcb-5f39-4b31-80e6-825a869dfed7" xlink:href="docs-20220331.xsd#docs_TemporaryEquityExercisesOfWarrantsAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_afb3f5d0-bc55-42e1-b823-67e1e6da7132" xlink:to="loc_docs_TemporaryEquityExercisesOfWarrantsAmount_aaa26dcb-5f39-4b31-80e6-825a869dfed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_2d2504aa-322f-4b71-ae22-0a622197aef7" xlink:href="docs-20220331.xsd#docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_afb3f5d0-bc55-42e1-b823-67e1e6da7132" xlink:to="loc_docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_2d2504aa-322f-4b71-ae22-0a622197aef7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_d9bbae75-fd64-4ad0-b274-4497693f9e4e" xlink:href="docs-20220331.xsd#docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_afb3f5d0-bc55-42e1-b823-67e1e6da7132" xlink:to="loc_docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_d9bbae75-fd64-4ad0-b274-4497693f9e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_9c40eff6-9bdd-4bc4-af2d-43d0b9694c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_afb3f5d0-bc55-42e1-b823-67e1e6da7132" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_9c40eff6-9bdd-4bc4-af2d-43d0b9694c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_5ef5d036-8076-4654-bb2f-382b3bdc1694" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_afb3f5d0-bc55-42e1-b823-67e1e6da7132" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_5ef5d036-8076-4654-bb2f-382b3bdc1694" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_ada02534-28d4-499b-96d1-99d8a16c0214" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_40042871-6c23-47c6-ac05-8cfa29c46b4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_SharesOutstanding_40042871-6c23-47c6-ac05-8cfa29c46b4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a049bdfd-eace-44eb-97e3-1e0410f35515" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_StockholdersEquity_a049bdfd-eace-44eb-97e3-1e0410f35515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_726dcf67-a729-4eca-a5d0-76dfe412f0a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_726dcf67-a729-4eca-a5d0-76dfe412f0a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_7fa9b0f0-c132-442b-9d54-2f6cf54fd65a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_7fa9b0f0-c132-442b-9d54-2f6cf54fd65a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_db66b4cd-e3b4-410d-9da2-b43a055fbd2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_db66b4cd-e3b4-410d-9da2-b43a055fbd2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_ea6fe357-cf9d-4a38-8b3b-5358cf40b281" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_ea6fe357-cf9d-4a38-8b3b-5358cf40b281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_5a31e77c-0b49-45d0-b40d-97db99316091" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_5a31e77c-0b49-45d0-b40d-97db99316091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_51c1f61c-c2ef-4133-8b6b-8ffd41fe3c06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueIssuedForServices"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueIssuedForServices_51c1f61c-c2ef-4133-8b6b-8ffd41fe3c06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_c95efba9-fbac-4008-b8cf-73cba3891e23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_c95efba9-fbac-4008-b8cf-73cba3891e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_5607a003-447e-4c81-9ef1-2e5850bf7b54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodShares"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares_5607a003-447e-4c81-9ef1-2e5850bf7b54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_d99aa772-1156-4b51-bcee-6c8c4fc9b6a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchasedAndRetiredDuringPeriodValue"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue_d99aa772-1156-4b51-bcee-6c8c4fc9b6a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition_a1b6d293-2273-48f5-a5a3-bdeb8f7b4cb1" xlink:href="docs-20220331.xsd#docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition_a1b6d293-2273-48f5-a5a3-bdeb8f7b4cb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_bd9d424a-aeee-4a3d-8edf-063a25526891" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_bd9d424a-aeee-4a3d-8edf-063a25526891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_80c7ad12-a6d2-47b8-a02b-1e7987e468df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_80c7ad12-a6d2-47b8-a02b-1e7987e468df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c284bac4-ae50-4267-a702-c9db7e14c001" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_c284bac4-ae50-4267-a702-c9db7e14c001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_321bf9dd-9c78-4163-b8e4-99d7e7e9b064" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_321bf9dd-9c78-4163-b8e4-99d7e7e9b064" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_62f91f87-19a7-4076-8eb5-d44cea26d5f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_62f91f87-19a7-4076-8eb5-d44cea26d5f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_38977c6e-9ae5-4737-b987-50b02f9fc2d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesAcquisitions"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesAcquisitions_38977c6e-9ae5-4737-b987-50b02f9fc2d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_cab418bb-9e2c-4d91-b3ec-56fb432e0d9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueAcquisitions"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueAcquisitions_cab418bb-9e2c-4d91-b3ec-56fb432e0d9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_AdjustmentsToAdditionalPaidInCapitalExerciseOfWarrants_ddd3a0da-2f6b-44cc-b39b-cb7215a027a3" xlink:href="docs-20220331.xsd#docs_AdjustmentsToAdditionalPaidInCapitalExerciseOfWarrants"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_docs_AdjustmentsToAdditionalPaidInCapitalExerciseOfWarrants_ddd3a0da-2f6b-44cc-b39b-cb7215a027a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_3084cfc2-a10f-4388-8020-424516d2823a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_3084cfc2-a10f-4388-8020-424516d2823a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_2e788df6-da8e-4c61-ad54-b513144244b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_2e788df6-da8e-4c61-ad54-b513144244b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4c34526d-0664-42fe-88ce-4c0461a98066" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_NetIncomeLoss_4c34526d-0664-42fe-88ce-4c0461a98066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_ebda478a-3b9c-48d4-83d7-0dfe096da270" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_SharesOutstanding_ebda478a-3b9c-48d4-83d7-0dfe096da270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_71fee77a-d1d6-4875-9084-4fb8a2e6a347" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_2f16b19c-0d42-4ddb-bca8-603438c9a341" xlink:to="loc_us-gaap_StockholdersEquity_71fee77a-d1d6-4875-9084-4fb8a2e6a347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="docs-20220331.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_bb5bb0a6-58e7-4748-a74f-f3b07b608dd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_390722c1-29fd-4c51-9fa9-e36922c984f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_bb5bb0a6-58e7-4748-a74f-f3b07b608dd2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_390722c1-29fd-4c51-9fa9-e36922c984f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9e597e42-adb8-4593-ba82-79a4e57a0fe6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_390722c1-29fd-4c51-9fa9-e36922c984f9" xlink:to="loc_us-gaap_NetIncomeLoss_9e597e42-adb8-4593-ba82-79a4e57a0fe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_59a31412-2a7a-4fb1-8602-bf076f0b43c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_390722c1-29fd-4c51-9fa9-e36922c984f9" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_59a31412-2a7a-4fb1-8602-bf076f0b43c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_2f24cb4d-b55c-44fc-b3e3-119d7b00bb2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_59a31412-2a7a-4fb1-8602-bf076f0b43c9" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_2f24cb4d-b55c-44fc-b3e3-119d7b00bb2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e0d03d0e-56be-4e1c-9a8b-ee83ef34d545" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_59a31412-2a7a-4fb1-8602-bf076f0b43c9" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e0d03d0e-56be-4e1c-9a8b-ee83ef34d545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_71c8926a-6db5-4f10-a893-5b24961d9e72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_59a31412-2a7a-4fb1-8602-bf076f0b43c9" xlink:to="loc_us-gaap_ShareBasedCompensation_71c8926a-6db5-4f10-a893-5b24961d9e72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_351225a8-60b0-4e8b-b3d0-345a7337c14b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_59a31412-2a7a-4fb1-8602-bf076f0b43c9" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_351225a8-60b0-4e8b-b3d0-345a7337c14b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_da9d2003-f0f1-448c-b248-dfc91811befd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_59a31412-2a7a-4fb1-8602-bf076f0b43c9" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_da9d2003-f0f1-448c-b248-dfc91811befd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_7b81a663-0870-4955-b80b-423f5f5adae9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_59a31412-2a7a-4fb1-8602-bf076f0b43c9" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss_7b81a663-0870-4955-b80b-423f5f5adae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization_7fa02fdd-5999-4f24-9da2-4363e618eb62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_59a31412-2a7a-4fb1-8602-bf076f0b43c9" xlink:to="loc_us-gaap_CapitalizedContractCostAmortization_7fa02fdd-5999-4f24-9da2-4363e618eb62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfBusiness_d2eccb21-ee4a-40be-bc5e-6eee4708c0d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnSaleOfBusiness"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_59a31412-2a7a-4fb1-8602-bf076f0b43c9" xlink:to="loc_us-gaap_GainLossOnSaleOfBusiness_d2eccb21-ee4a-40be-bc5e-6eee4708c0d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_c72a1001-1874-4931-a9c4-4a7d51140f62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_59a31412-2a7a-4fb1-8602-bf076f0b43c9" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_c72a1001-1874-4931-a9c4-4a7d51140f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4f04da30-9c1a-49ef-a031-7f917d66a063" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_59a31412-2a7a-4fb1-8602-bf076f0b43c9" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4f04da30-9c1a-49ef-a031-7f917d66a063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_fbed0b6c-5047-4bd8-b97c-656ac4c8b595" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4f04da30-9c1a-49ef-a031-7f917d66a063" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_fbed0b6c-5047-4bd8-b97c-656ac4c8b595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_7d08ac4a-b8af-4a73-8ba0-dd8ae39653c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4f04da30-9c1a-49ef-a031-7f917d66a063" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_7d08ac4a-b8af-4a73-8ba0-dd8ae39653c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_IncreaseDecreaseInCapitalizedContractCost_d96a996d-05a8-4641-830e-6ca8393052f9" xlink:href="docs-20220331.xsd#docs_IncreaseDecreaseInCapitalizedContractCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4f04da30-9c1a-49ef-a031-7f917d66a063" xlink:to="loc_docs_IncreaseDecreaseInCapitalizedContractCost_d96a996d-05a8-4641-830e-6ca8393052f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_d8584b43-1ae6-4520-a6af-7f0ee8c15089" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4f04da30-9c1a-49ef-a031-7f917d66a063" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_d8584b43-1ae6-4520-a6af-7f0ee8c15089" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_88acae04-8312-4d7a-8cda-bb19f4c22015" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4f04da30-9c1a-49ef-a031-7f917d66a063" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_88acae04-8312-4d7a-8cda-bb19f4c22015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_fc75cf7a-24c9-4217-8677-31d82f344e36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_4f04da30-9c1a-49ef-a031-7f917d66a063" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_fc75cf7a-24c9-4217-8677-31d82f344e36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_814895ee-5bb7-4878-b88c-b7514bc0ed87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_390722c1-29fd-4c51-9fa9-e36922c984f9" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_814895ee-5bb7-4878-b88c-b7514bc0ed87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0bb280b4-6f24-4335-8886-a8acd0f5976e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_bb5bb0a6-58e7-4748-a74f-f3b07b608dd2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0bb280b4-6f24-4335-8886-a8acd0f5976e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2c8247cc-8b85-4b4e-8c4a-ec5413fc614f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0bb280b4-6f24-4335-8886-a8acd0f5976e" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2c8247cc-8b85-4b4e-8c4a-ec5413fc614f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopSoftware_23fa2b13-0ba8-4135-b655-49d3a0f5e034" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToDevelopSoftware"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0bb280b4-6f24-4335-8886-a8acd0f5976e" xlink:to="loc_us-gaap_PaymentsToDevelopSoftware_23fa2b13-0ba8-4135-b655-49d3a0f5e034" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_e384ea88-b404-4c00-9d20-bd38fd074736" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0bb280b4-6f24-4335-8886-a8acd0f5976e" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_e384ea88-b404-4c00-9d20-bd38fd074736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_7bcc5c4d-1afe-49dc-b2bb-3d8f0133128c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0bb280b4-6f24-4335-8886-a8acd0f5976e" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_7bcc5c4d-1afe-49dc-b2bb-3d8f0133128c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_e693cdb9-e33c-4c13-b488-fd801294e180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0bb280b4-6f24-4335-8886-a8acd0f5976e" xlink:to="loc_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_e693cdb9-e33c-4c13-b488-fd801294e180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_d3cafe95-8717-442e-8925-52e8eede04e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0bb280b4-6f24-4335-8886-a8acd0f5976e" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_d3cafe95-8717-442e-8925-52e8eede04e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_cd62f7b4-7494-4792-bf95-85aa17b4ba71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0bb280b4-6f24-4335-8886-a8acd0f5976e" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_cd62f7b4-7494-4792-bf95-85aa17b4ba71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_bbed680d-1a59-4bbc-946a-70e78a465cef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0bb280b4-6f24-4335-8886-a8acd0f5976e" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_bbed680d-1a59-4bbc-946a-70e78a465cef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_45555079-64f0-4864-8512-a9772ebbbd14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_0bb280b4-6f24-4335-8886-a8acd0f5976e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_45555079-64f0-4864-8512-a9772ebbbd14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0bc83295-fde5-4fa4-ae67-94f866094c11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_bb5bb0a6-58e7-4748-a74f-f3b07b608dd2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0bc83295-fde5-4fa4-ae67-94f866094c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_ca757029-dc6e-4d1a-bd39-aeab1e01815d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0bc83295-fde5-4fa4-ae67-94f866094c11" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_ca757029-dc6e-4d1a-bd39-aeab1e01815d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_11acd385-188d-4649-9ba2-6e859109b5f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0bc83295-fde5-4fa4-ae67-94f866094c11" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_11acd385-188d-4649-9ba2-6e859109b5f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_236029c8-69c9-46c8-b33f-b2f77a4eca16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0bc83295-fde5-4fa4-ae67-94f866094c11" xlink:to="loc_us-gaap_ProceedsFromStockPlans_236029c8-69c9-46c8-b33f-b2f77a4eca16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_cad74bf0-98c0-44dc-8353-f62095f9ba4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0bc83295-fde5-4fa4-ae67-94f866094c11" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_cad74bf0-98c0-44dc-8353-f62095f9ba4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_46fc11ec-ed5a-44e9-a714-6cb2798fdfba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0bc83295-fde5-4fa4-ae67-94f866094c11" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_46fc11ec-ed5a-44e9-a714-6cb2798fdfba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_ea94f860-89de-4bcc-9f6f-86f107ecbec9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0bc83295-fde5-4fa4-ae67-94f866094c11" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_ea94f860-89de-4bcc-9f6f-86f107ecbec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_941943fe-6847-4cb7-ba7c-ffcf3d9c033e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0bc83295-fde5-4fa4-ae67-94f866094c11" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_941943fe-6847-4cb7-ba7c-ffcf3d9c033e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_aa429c86-e147-405e-9516-d0a49ea74bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_0bc83295-fde5-4fa4-ae67-94f866094c11" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_aa429c86-e147-405e-9516-d0a49ea74bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b234b48f-201d-4ad9-8f7a-908938232bfd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_bb5bb0a6-58e7-4748-a74f-f3b07b608dd2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b234b48f-201d-4ad9-8f7a-908938232bfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_452e9ccf-7003-41a6-b77d-edc6d00acb92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_bb5bb0a6-58e7-4748-a74f-f3b07b608dd2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_452e9ccf-7003-41a6-b77d-edc6d00acb92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b1128001-a493-49b0-abd5-e6644fdd47ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_bb5bb0a6-58e7-4748-a74f-f3b07b608dd2" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b1128001-a493-49b0-abd5-e6644fdd47ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_f282cd91-5b1b-4d79-b811-13017b000db4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_bb5bb0a6-58e7-4748-a74f-f3b07b608dd2" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_f282cd91-5b1b-4d79-b811-13017b000db4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_38a60659-9710-4c76-8a32-739264b48b3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_f282cd91-5b1b-4d79-b811-13017b000db4" xlink:to="loc_us-gaap_IncomeTaxesPaid_38a60659-9710-4c76-8a32-739264b48b3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_97ec9e56-c3c6-4ea0-9209-b6973c6a977c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_bb5bb0a6-58e7-4748-a74f-f3b07b608dd2" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_97ec9e56-c3c6-4ea0-9209-b6973c6a977c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockAmountConverted1_5f39b84f-3500-4e37-acba-8b765a1198d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_97ec9e56-c3c6-4ea0-9209-b6973c6a977c" xlink:to="loc_us-gaap_ConversionOfStockAmountConverted1_5f39b84f-3500-4e37-acba-8b765a1198d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_StockIssuancesCostsIncurredButNotYetPaid_2e021831-548a-4395-aa93-a6030959a5a1" xlink:href="docs-20220331.xsd#docs_StockIssuancesCostsIncurredButNotYetPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_97ec9e56-c3c6-4ea0-9209-b6973c6a977c" xlink:to="loc_docs_StockIssuancesCostsIncurredButNotYetPaid_2e021831-548a-4395-aa93-a6030959a5a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_StockIssuedAcquisitions_9527db6c-1ab2-48dd-aced-145f97ac5d15" xlink:href="docs-20220331.xsd#docs_StockIssuedAcquisitions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_97ec9e56-c3c6-4ea0-9209-b6973c6a977c" xlink:to="loc_docs_StockIssuedAcquisitions_9527db6c-1ab2-48dd-aced-145f97ac5d15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_fa22f5a6-87b6-4794-b011-2fc2363faba3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_97ec9e56-c3c6-4ea0-9209-b6973c6a977c" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_fa22f5a6-87b6-4794-b011-2fc2363faba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_EscrowDepositsRelatedToSaleOfBusiness_09c4990f-4b8e-4a8d-a5d5-e16a1a5fc7cb" xlink:href="docs-20220331.xsd#docs_EscrowDepositsRelatedToSaleOfBusiness"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_97ec9e56-c3c6-4ea0-9209-b6973c6a977c" xlink:to="loc_docs_EscrowDepositsRelatedToSaleOfBusiness_09c4990f-4b8e-4a8d-a5d5-e16a1a5fc7cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_90195ec3-5de8-4229-97eb-4a913b5846cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_97ec9e56-c3c6-4ea0-9209-b6973c6a977c" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_90195ec3-5de8-4229-97eb-4a913b5846cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/DESCRIPTIONOFBUSINESS" xlink:type="simple" xlink:href="docs-20220331.xsd#DESCRIPTIONOFBUSINESS"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/DESCRIPTIONOFBUSINESS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8a61fa39-e4a6-46a6-9beb-cdab032fda8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_63884789-ddaa-439f-a257-3db6f5db0592" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8a61fa39-e4a6-46a6-9beb-cdab032fda8c" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_63884789-ddaa-439f-a257-3db6f5db0592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/DESCRIPTIONOFBUSINESSDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#DESCRIPTIONOFBUSINESSDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/DESCRIPTIONOFBUSINESSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0e7cdab6-1faf-48dc-b363-32591cdd654e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_64ef34d0-003e-4268-b6d5-fe59735ebc28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0e7cdab6-1faf-48dc-b363-32591cdd654e" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_64ef34d0-003e-4268-b6d5-fe59735ebc28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_f07155c0-b018-4049-ae5c-b73fc589e703" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_64ef34d0-003e-4268-b6d5-fe59735ebc28" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_f07155c0-b018-4049-ae5c-b73fc589e703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_daeca82b-b388-4daf-9db6-cf38296873b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_f07155c0-b018-4049-ae5c-b73fc589e703" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_daeca82b-b388-4daf-9db6-cf38296873b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_InitialPublicOfferingIncludingOverAllotmentOptionMember_415e5e69-21ef-4097-95b0-6c4e224378d1" xlink:href="docs-20220331.xsd#docs_InitialPublicOfferingIncludingOverAllotmentOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_daeca82b-b388-4daf-9db6-cf38296873b3" xlink:to="loc_docs_InitialPublicOfferingIncludingOverAllotmentOptionMember_415e5e69-21ef-4097-95b0-6c4e224378d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_56380bb8-431a-4527-a8e0-bc279dcf1145" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_daeca82b-b388-4daf-9db6-cf38296873b3" xlink:to="loc_us-gaap_OverAllotmentOptionMember_56380bb8-431a-4527-a8e0-bc279dcf1145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember_0362dd81-bf44-4c9b-8ebd-85973d7d666b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_daeca82b-b388-4daf-9db6-cf38296873b3" xlink:to="loc_us-gaap_RedeemableConvertiblePreferredStockMember_0362dd81-bf44-4c9b-8ebd-85973d7d666b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_a2c58f2d-2a1c-4a72-9a77-e50e0f2b2c2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_64ef34d0-003e-4268-b6d5-fe59735ebc28" xlink:to="loc_us-gaap_SubsidiarySaleOfStockLineItems_a2c58f2d-2a1c-4a72-9a77-e50e0f2b2c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_325b459c-113e-4252-9797-b44eaa501e2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_a2c58f2d-2a1c-4a72-9a77-e50e0f2b2c2b" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_325b459c-113e-4252-9797-b44eaa501e2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_71258312-a309-4ff5-b713-2a64ff14d52f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_a2c58f2d-2a1c-4a72-9a77-e50e0f2b2c2b" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_71258312-a309-4ff5-b713-2a64ff14d52f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_e2c61b38-7e59-49f8-ae2d-95664d18462c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_a2c58f2d-2a1c-4a72-9a77-e50e0f2b2c2b" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_e2c61b38-7e59-49f8-ae2d-95664d18462c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesConverted1_15331c39-3ff1-4c60-8abb-ece99f87eb63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesConverted1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_a2c58f2d-2a1c-4a72-9a77-e50e0f2b2c2b" xlink:to="loc_us-gaap_ConversionOfStockSharesConverted1_15331c39-3ff1-4c60-8abb-ece99f87eb63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ConversionOfStockConversionRatio_1e95b34e-8d6c-4297-91c8-bf9124af37b4" xlink:href="docs-20220331.xsd#docs_ConversionOfStockConversionRatio"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_a2c58f2d-2a1c-4a72-9a77-e50e0f2b2c2b" xlink:to="loc_docs_ConversionOfStockConversionRatio_1e95b34e-8d6c-4297-91c8-bf9124af37b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredOfferingCosts_e0a1e389-5d5e-4667-b5be-0bc526c13f1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredOfferingCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_a2c58f2d-2a1c-4a72-9a77-e50e0f2b2c2b" xlink:to="loc_us-gaap_DeferredOfferingCosts_e0a1e389-5d5e-4667-b5be-0bc526c13f1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_f0e1e958-5e31-42c9-93fc-505320ca5aa8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_a2c58f2d-2a1c-4a72-9a77-e50e0f2b2c2b" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_f0e1e958-5e31-42c9-93fc-505320ca5aa8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/SummarySignificantAccountingPolicies" xlink:type="simple" xlink:href="docs-20220331.xsd#SummarySignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/SummarySignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7b5b5f3f-27a6-4d7a-acb2-aa8f6496ac35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_84f93abf-fd24-4ca6-8e75-b4592856c81a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7b5b5f3f-27a6-4d7a-acb2-aa8f6496ac35" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_84f93abf-fd24-4ca6-8e75-b4592856c81a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="docs-20220331.xsd#SummarySignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ed81a371-e787-4c39-86e0-48671364b044" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_0aee7732-5747-45a1-b678-274e47896cc3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ed81a371-e787-4c39-86e0-48671364b044" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_0aee7732-5747-45a1-b678-274e47896cc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_5f7f510b-5df5-45eb-831b-12a4c644f06c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ed81a371-e787-4c39-86e0-48671364b044" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_5f7f510b-5df5-45eb-831b-12a4c644f06c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiscalPeriod_4e89c799-213f-4ccf-8c54-3d4e81bab8c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiscalPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ed81a371-e787-4c39-86e0-48671364b044" xlink:to="loc_us-gaap_FiscalPeriod_4e89c799-213f-4ccf-8c54-3d4e81bab8c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_75243e5a-be8c-446e-bffe-8bfbf29b8ffc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ed81a371-e787-4c39-86e0-48671364b044" xlink:to="loc_us-gaap_UseOfEstimates_75243e5a-be8c-446e-bffe-8bfbf29b8ffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_4f2a11e3-d683-4830-8aa5-71731879bfc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ed81a371-e787-4c39-86e0-48671364b044" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_4f2a11e3-d683-4830-8aa5-71731879bfc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRecognitionPolicyTextBlock_263119fa-6b1d-4678-850c-abd15828af99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRecognitionPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ed81a371-e787-4c39-86e0-48671364b044" xlink:to="loc_us-gaap_RevenueRecognitionPolicyTextBlock_263119fa-6b1d-4678-850c-abd15828af99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_94904891-2a53-409d-a646-7e4ce96d6973" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ed81a371-e787-4c39-86e0-48671364b044" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_94904891-2a53-409d-a646-7e4ce96d6973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock_e1f48447-a203-4984-a9df-dee90ef815a2" xlink:href="docs-20220331.xsd#docs_CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ed81a371-e787-4c39-86e0-48671364b044" xlink:to="loc_docs_CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock_e1f48447-a203-4984-a9df-dee90ef815a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_d3b144b2-12ef-4884-8093-24782882f097" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ed81a371-e787-4c39-86e0-48671364b044" xlink:to="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_d3b144b2-12ef-4884-8093-24782882f097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_6046c509-693d-41ee-b211-62eea84180fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ed81a371-e787-4c39-86e0-48671364b044" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_6046c509-693d-41ee-b211-62eea84180fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalUseSoftwarePolicy_f3da407e-9fb8-416f-9b96-8d4c4675f1f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternalUseSoftwarePolicy"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ed81a371-e787-4c39-86e0-48671364b044" xlink:to="loc_us-gaap_InternalUseSoftwarePolicy_f3da407e-9fb8-416f-9b96-8d4c4675f1f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsPolicy_9e888e72-de4f-419a-a7d0-851aae4989e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationsPolicy"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ed81a371-e787-4c39-86e0-48671364b044" xlink:to="loc_us-gaap_BusinessCombinationsPolicy_9e888e72-de4f-419a-a7d0-851aae4989e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_cbb45cf2-f0ba-4371-982a-d1c558e31d55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ed81a371-e787-4c39-86e0-48671364b044" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_cbb45cf2-f0ba-4371-982a-d1c558e31d55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_f6a968e2-8e83-42d6-9eb1-6a2241f43912" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ed81a371-e787-4c39-86e0-48671364b044" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_f6a968e2-8e83-42d6-9eb1-6a2241f43912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_ea57763c-fc7f-45f1-b2bd-5103b9ae47b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ed81a371-e787-4c39-86e0-48671364b044" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_ea57763c-fc7f-45f1-b2bd-5103b9ae47b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_ac24a462-1fff-4a19-ba16-572ec3ef51d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ed81a371-e787-4c39-86e0-48671364b044" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_ac24a462-1fff-4a19-ba16-572ec3ef51d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_f953bf69-1b6b-4f32-b92d-54841925048b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ed81a371-e787-4c39-86e0-48671364b044" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_f953bf69-1b6b-4f32-b92d-54841925048b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalCostsPolicyTextBlock_76e7a33a-1a93-4b24-a74e-c2c23b7c58b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LegalCostsPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ed81a371-e787-4c39-86e0-48671364b044" xlink:to="loc_us-gaap_LegalCostsPolicyTextBlock_76e7a33a-1a93-4b24-a74e-c2c23b7c58b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock_565073e6-3d93-4070-8785-db0ecc277465" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ed81a371-e787-4c39-86e0-48671364b044" xlink:to="loc_us-gaap_CostOfSalesPolicyTextBlock_565073e6-3d93-4070-8785-db0ecc277465" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_75c29a9f-a745-4d10-85ae-15c49ee4d57b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ed81a371-e787-4c39-86e0-48671364b044" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_75c29a9f-a745-4d10-85ae-15c49ee4d57b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_70ababab-4f12-4748-9ddd-d5493a711228" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ed81a371-e787-4c39-86e0-48671364b044" xlink:to="loc_us-gaap_AdvertisingCostsPolicyTextBlock_70ababab-4f12-4748-9ddd-d5493a711228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_c66584ed-d425-4af0-b5ab-bb60a318e279" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ed81a371-e787-4c39-86e0-48671364b044" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_c66584ed-d425-4af0-b5ab-bb60a318e279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/SummarySignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="docs-20220331.xsd#SummarySignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/SummarySignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_21e05fac-f3d7-4d72-9519-2cb9ee887c44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_582cad3e-df98-4faf-9cea-0961493bed10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21e05fac-f3d7-4d72-9519-2cb9ee887c44" xlink:to="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_582cad3e-df98-4faf-9cea-0961493bed10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_35d96ff4-283e-47bc-82d9-bfbf4612caa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_21e05fac-f3d7-4d72-9519-2cb9ee887c44" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_35d96ff4-283e-47bc-82d9-bfbf4612caa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ccce56ce-7fd9-472e-81e7-10293f920f53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_444cd8fe-7f99-4c3e-8f9c-4dc9cf0cf080" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ccce56ce-7fd9-472e-81e7-10293f920f53" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_444cd8fe-7f99-4c3e-8f9c-4dc9cf0cf080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_d02346cb-1220-492a-bd67-cb6688e4a8fb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_444cd8fe-7f99-4c3e-8f9c-4dc9cf0cf080" xlink:to="loc_srt_ProductOrServiceAxis_d02346cb-1220-492a-bd67-cb6688e4a8fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_16fbfa50-a4cd-45da-8938-a4862f3734e9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_d02346cb-1220-492a-bd67-cb6688e4a8fb" xlink:to="loc_srt_ProductsAndServicesDomain_16fbfa50-a4cd-45da-8938-a4862f3734e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_SubscriptionHiringSolutionsMember_de4c509d-b1af-4aed-9c66-4a609c0f3cc4" xlink:href="docs-20220331.xsd#docs_SubscriptionHiringSolutionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_16fbfa50-a4cd-45da-8938-a4862f3734e9" xlink:to="loc_docs_SubscriptionHiringSolutionsMember_de4c509d-b1af-4aed-9c66-4a609c0f3cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_SubscriptionMarketingSolutionsMember_980b99a6-2ca3-4e8e-ab2e-aa2592c51b46" xlink:href="docs-20220331.xsd#docs_SubscriptionMarketingSolutionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_16fbfa50-a4cd-45da-8938-a4862f3734e9" xlink:to="loc_docs_SubscriptionMarketingSolutionsMember_980b99a6-2ca3-4e8e-ab2e-aa2592c51b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cc56251f-0391-48f7-9517-ca8f9553ec71" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_444cd8fe-7f99-4c3e-8f9c-4dc9cf0cf080" xlink:to="loc_srt_RangeAxis_cc56251f-0391-48f7-9517-ca8f9553ec71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b96369a4-05eb-4a7e-9bde-40d351a5ce85" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_cc56251f-0391-48f7-9517-ca8f9553ec71" xlink:to="loc_srt_RangeMember_b96369a4-05eb-4a7e-9bde-40d351a5ce85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_4737c056-53f1-45f3-baf3-7b76ed7778d3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b96369a4-05eb-4a7e-9bde-40d351a5ce85" xlink:to="loc_srt_MinimumMember_4737c056-53f1-45f3-baf3-7b76ed7778d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_9c030249-b76c-446e-bf91-a9487b882054" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b96369a4-05eb-4a7e-9bde-40d351a5ce85" xlink:to="loc_srt_MaximumMember_9c030249-b76c-446e-bf91-a9487b882054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAxis_fd27a41a-3f51-46b7-90b6-a059e83e0ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_444cd8fe-7f99-4c3e-8f9c-4dc9cf0cf080" xlink:to="loc_us-gaap_CapitalizedContractCostAxis_fd27a41a-3f51-46b7-90b6-a059e83e0ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostDomain_42c4d3fd-dc79-4660-8abd-da0372878546" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostAxis_fd27a41a-3f51-46b7-90b6-a059e83e0ab2" xlink:to="loc_us-gaap_CapitalizedContractCostDomain_42c4d3fd-dc79-4660-8abd-da0372878546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember_3748d0d2-f7c4-4621-b765-fc705bad5212" xlink:href="docs-20220331.xsd#docs_DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_42c4d3fd-dc79-4660-8abd-da0372878546" xlink:to="loc_docs_DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember_3748d0d2-f7c4-4621-b765-fc705bad5212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember_095be843-0805-460e-8d88-3f6c08d5c0e3" xlink:href="docs-20220331.xsd#docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CapitalizedContractCostDomain_42c4d3fd-dc79-4660-8abd-da0372878546" xlink:to="loc_docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember_095be843-0805-460e-8d88-3f6c08d5c0e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_e28ae07e-10fa-4868-8d93-521e67262a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_444cd8fe-7f99-4c3e-8f9c-4dc9cf0cf080" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_e28ae07e-10fa-4868-8d93-521e67262a8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_06e884f3-328b-4807-9584-14ffc4f38656" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e28ae07e-10fa-4868-8d93-521e67262a8c" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_06e884f3-328b-4807-9584-14ffc4f38656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditConcentrationRiskMember_ca5fe0b4-8e79-4906-ad9a-90030b7f2d34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_06e884f3-328b-4807-9584-14ffc4f38656" xlink:to="loc_us-gaap_CreditConcentrationRiskMember_ca5fe0b4-8e79-4906-ad9a-90030b7f2d34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2e82f54b-7601-4dd7-917e-a03e8ea9dcee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_444cd8fe-7f99-4c3e-8f9c-4dc9cf0cf080" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2e82f54b-7601-4dd7-917e-a03e8ea9dcee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e4896a45-6013-41c2-9a35-372adcd40d96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_2e82f54b-7601-4dd7-917e-a03e8ea9dcee" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e4896a45-6013-41c2-9a35-372adcd40d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_9d7f07fc-ddd7-4945-b2a3-d5f0dd1e0140" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e4896a45-6013-41c2-9a35-372adcd40d96" xlink:to="loc_us-gaap_AccountsReceivableMember_9d7f07fc-ddd7-4945-b2a3-d5f0dd1e0140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_d3029028-2e19-4b5c-97e3-1ade1cb10ea0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_444cd8fe-7f99-4c3e-8f9c-4dc9cf0cf080" xlink:to="loc_srt_CounterpartyNameAxis_d3029028-2e19-4b5c-97e3-1ade1cb10ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d4cf24f2-1bda-4ff3-8d0c-29e0bb2801b7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_d3029028-2e19-4b5c-97e3-1ade1cb10ea0" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d4cf24f2-1bda-4ff3-8d0c-29e0bb2801b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_MarketingAgencyOneMember_382d9ad5-69b1-4c57-9df3-7faee9d670a2" xlink:href="docs-20220331.xsd#docs_MarketingAgencyOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d4cf24f2-1bda-4ff3-8d0c-29e0bb2801b7" xlink:to="loc_docs_MarketingAgencyOneMember_382d9ad5-69b1-4c57-9df3-7faee9d670a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_c30bc476-1e1a-4729-bedf-83e6175dba62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_444cd8fe-7f99-4c3e-8f9c-4dc9cf0cf080" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_c30bc476-1e1a-4729-bedf-83e6175dba62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ContractWithCustomerTerm_cd122a71-32e9-495a-a509-e2dc99486ec9" xlink:href="docs-20220331.xsd#docs_ContractWithCustomerTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_c30bc476-1e1a-4729-bedf-83e6175dba62" xlink:to="loc_docs_ContractWithCustomerTerm_cd122a71-32e9-495a-a509-e2dc99486ec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ContractWithCustomerCancellationNoticePeriod_900f3c80-b7bd-4476-a1c2-ac448e77fd76" xlink:href="docs-20220331.xsd#docs_ContractWithCustomerCancellationNoticePeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_c30bc476-1e1a-4729-bedf-83e6175dba62" xlink:to="loc_docs_ContractWithCustomerCancellationNoticePeriod_900f3c80-b7bd-4476-a1c2-ac448e77fd76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_8a99bfae-f418-4507-a85c-68e2ce43c920" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostAmortizationPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_c30bc476-1e1a-4729-bedf-83e6175dba62" xlink:to="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_8a99bfae-f418-4507-a85c-68e2ce43c920" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_0651d227-b41c-4965-9e9e-8ea6cb3a1cee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_c30bc476-1e1a-4729-bedf-83e6175dba62" xlink:to="loc_us-gaap_AdvertisingExpense_0651d227-b41c-4965-9e9e-8ea6cb3a1cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_a13a61b3-f8fb-48d4-96b8-491e06008de4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_c30bc476-1e1a-4729-bedf-83e6175dba62" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_a13a61b3-f8fb-48d4-96b8-491e06008de4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_d3cfb39a-b268-48d5-adbc-28f423c96624" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_c30bc476-1e1a-4729-bedf-83e6175dba62" xlink:to="loc_us-gaap_NumberOfReportingUnits_d3cfb39a-b268-48d5-adbc-28f423c96624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_42b8d6ae-953b-4c70-881f-d7c380fbbe22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_b7a64aa1-fa51-4e6e-a1fb-86837f4a84bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_42b8d6ae-953b-4c70-881f-d7c380fbbe22" xlink:to="loc_us-gaap_ConcentrationRiskTable_b7a64aa1-fa51-4e6e-a1fb-86837f4a84bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_d70c2278-4fcf-4aae-b53d-f94cf1d6e948" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_b7a64aa1-fa51-4e6e-a1fb-86837f4a84bc" xlink:to="loc_srt_MajorCustomersAxis_d70c2278-4fcf-4aae-b53d-f94cf1d6e948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_7efb9b13-9e45-4a33-99f7-51065329c816" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_d70c2278-4fcf-4aae-b53d-f94cf1d6e948" xlink:to="loc_srt_NameOfMajorCustomerDomain_7efb9b13-9e45-4a33-99f7-51065329c816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CustomerAMember_b62936fe-d403-4088-8a2e-9f664d22f678" xlink:href="docs-20220331.xsd#docs_CustomerAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_7efb9b13-9e45-4a33-99f7-51065329c816" xlink:to="loc_docs_CustomerAMember_b62936fe-d403-4088-8a2e-9f664d22f678" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f061bb70-4568-4d5c-bfd4-9a12056a90ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_b7a64aa1-fa51-4e6e-a1fb-86837f4a84bc" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f061bb70-4568-4d5c-bfd4-9a12056a90ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_cc112867-1d4b-44cb-8265-57611a7e5b44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f061bb70-4568-4d5c-bfd4-9a12056a90ce" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_cc112867-1d4b-44cb-8265-57611a7e5b44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_e8a9a9f7-05c9-474a-a4ac-46fa67d62a8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_cc112867-1d4b-44cb-8265-57611a7e5b44" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_e8a9a9f7-05c9-474a-a4ac-46fa67d62a8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_fdf63cdc-d89b-4555-b2fc-e9734bfdbf8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_cc112867-1d4b-44cb-8265-57611a7e5b44" xlink:to="loc_us-gaap_AccountsReceivableMember_fdf63cdc-d89b-4555-b2fc-e9734bfdbf8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_2b93d90f-78fc-46ec-a1ad-35e78bac97b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_b7a64aa1-fa51-4e6e-a1fb-86837f4a84bc" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_2b93d90f-78fc-46ec-a1ad-35e78bac97b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_23e3a467-ce38-47fc-972b-2b095769bfe7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_2b93d90f-78fc-46ec-a1ad-35e78bac97b3" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_23e3a467-ce38-47fc-972b-2b095769bfe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_98db8589-4411-4194-a362-e50a78f949b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_23e3a467-ce38-47fc-972b-2b095769bfe7" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_98db8589-4411-4194-a362-e50a78f949b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_c06b2a07-5f01-4897-9128-9740e5312829" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_b7a64aa1-fa51-4e6e-a1fb-86837f4a84bc" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_c06b2a07-5f01-4897-9128-9740e5312829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_14cea938-bee4-4b76-b90a-cb6f22768208" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_c06b2a07-5f01-4897-9128-9740e5312829" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_14cea938-bee4-4b76-b90a-cb6f22768208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesPropertyplantandequipmentDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#SummaryofSignificantAccountingPoliciesPropertyplantandequipmentDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesPropertyplantandequipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_e45a482e-06c1-4f21-a779-8e65db7d83d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a323ab45-4bb0-4a02-b3c9-ac5a63450935" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_e45a482e-06c1-4f21-a779-8e65db7d83d4" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a323ab45-4bb0-4a02-b3c9-ac5a63450935" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5f7aa96e-b088-46a4-a5c7-28221951bff2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a323ab45-4bb0-4a02-b3c9-ac5a63450935" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5f7aa96e-b088-46a4-a5c7-28221951bff2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ba8aa2f1-6432-4e06-8133-17d29b7e2d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_5f7aa96e-b088-46a4-a5c7-28221951bff2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ba8aa2f1-6432-4e06-8133-17d29b7e2d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_FurnitureAndEquipmentMember_8f346926-3105-4055-b08b-98e301646bf4" xlink:href="docs-20220331.xsd#docs_FurnitureAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ba8aa2f1-6432-4e06-8133-17d29b7e2d7d" xlink:to="loc_docs_FurnitureAndEquipmentMember_8f346926-3105-4055-b08b-98e301646bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ComputerEquipmentAndSoftwareMember_ebc58052-171a-474b-9f8a-451395b57138" xlink:href="docs-20220331.xsd#docs_ComputerEquipmentAndSoftwareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ba8aa2f1-6432-4e06-8133-17d29b7e2d7d" xlink:to="loc_docs_ComputerEquipmentAndSoftwareMember_ebc58052-171a-474b-9f8a-451395b57138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_64e6a4d7-656d-4131-8d55-57415ad1d45e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ba8aa2f1-6432-4e06-8133-17d29b7e2d7d" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_64e6a4d7-656d-4131-8d55-57415ad1d45e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7686e6ad-97c1-4bf7-a6c6-50149ee6a332" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a323ab45-4bb0-4a02-b3c9-ac5a63450935" xlink:to="loc_srt_RangeAxis_7686e6ad-97c1-4bf7-a6c6-50149ee6a332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_091e9269-1598-42ed-b121-b08962b3144d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_7686e6ad-97c1-4bf7-a6c6-50149ee6a332" xlink:to="loc_srt_RangeMember_091e9269-1598-42ed-b121-b08962b3144d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_85d9d0b5-9f5e-4c72-a728-250cf6785bf6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_091e9269-1598-42ed-b121-b08962b3144d" xlink:to="loc_srt_MinimumMember_85d9d0b5-9f5e-4c72-a728-250cf6785bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_91bab560-4f67-4aae-8123-9180f2b61e9a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_091e9269-1598-42ed-b121-b08962b3144d" xlink:to="loc_srt_MaximumMember_91bab560-4f67-4aae-8123-9180f2b61e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_19cc8f94-85f5-4cd4-b638-e603b261e980" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_a323ab45-4bb0-4a02-b3c9-ac5a63450935" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_19cc8f94-85f5-4cd4-b638-e603b261e980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_d8d55999-42f6-4bc2-9fa8-e64dd9b1bf2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_19cc8f94-85f5-4cd4-b638-e603b261e980" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_d8d55999-42f6-4bc2-9fa8-e64dd9b1bf2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/RevenueRecognition" xlink:type="simple" xlink:href="docs-20220331.xsd#RevenueRecognition"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/RevenueRecognition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d263f48d-e83e-4ed4-b61b-6f72d4d063a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_0a6dcc4b-d32d-4406-ac08-ac753ce5e498" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d263f48d-e83e-4ed4-b61b-6f72d4d063a9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_0a6dcc4b-d32d-4406-ac08-ac753ce5e498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/RevenueRecognitionTables" xlink:type="simple" xlink:href="docs-20220331.xsd#RevenueRecognitionTables"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/RevenueRecognitionTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4e5a3903-2733-41ab-8990-8b27d3c477d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_8ac25003-0f10-4e0e-8ba6-e17e7b1f1e25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4e5a3903-2733-41ab-8990-8b27d3c477d1" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_8ac25003-0f10-4e0e-8ba6-e17e7b1f1e25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_9000a840-3154-4ac6-b6c1-08cb73c9c6b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4e5a3903-2733-41ab-8990-8b27d3c477d1" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_9000a840-3154-4ac6-b6c1-08cb73c9c6b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/RevenueRecognitionDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#RevenueRecognitionDisaggregationofRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/RevenueRecognitionDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_0185db3b-35d0-4a49-9f5d-838a84e962ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_80fc2795-d0e4-4977-b205-643cf8ce57ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_0185db3b-35d0-4a49-9f5d-838a84e962ad" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_80fc2795-d0e4-4977-b205-643cf8ce57ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a7e6eaf5-b637-421a-9d71-a1c3344ea8b4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_80fc2795-d0e4-4977-b205-643cf8ce57ca" xlink:to="loc_srt_ProductOrServiceAxis_a7e6eaf5-b637-421a-9d71-a1c3344ea8b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_cfbcaee5-8137-463c-823c-96b4e4254908" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_a7e6eaf5-b637-421a-9d71-a1c3344ea8b4" xlink:to="loc_srt_ProductsAndServicesDomain_cfbcaee5-8137-463c-823c-96b4e4254908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_SubscriptionMember_8fdf4499-2450-4c9b-abbc-629b35dd7de6" xlink:href="docs-20220331.xsd#docs_SubscriptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_cfbcaee5-8137-463c-823c-96b4e4254908" xlink:to="loc_docs_SubscriptionMember_8fdf4499-2450-4c9b-abbc-629b35dd7de6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceOtherMember_f5eab7bf-5d66-4f22-bb6b-f72181ee58ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ServiceOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_cfbcaee5-8137-463c-823c-96b4e4254908" xlink:to="loc_us-gaap_ServiceOtherMember_f5eab7bf-5d66-4f22-bb6b-f72181ee58ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_ed39127c-f707-4c44-84a5-59de69ff2fac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_80fc2795-d0e4-4977-b205-643cf8ce57ca" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_ed39127c-f707-4c44-84a5-59de69ff2fac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c037d0f7-671b-4be8-9d7b-b5dcdf295168" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ed39127c-f707-4c44-84a5-59de69ff2fac" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_c037d0f7-671b-4be8-9d7b-b5dcdf295168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/RevenueRecognitionDeferredRevenueContractBalanceDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#RevenueRecognitionDeferredRevenueContractBalanceDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/RevenueRecognitionDeferredRevenueContractBalanceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_82b404a5-6fde-444d-85a9-ac677337457b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_416ad875-921a-4a46-81d4-903528687390" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInContractWithCustomerLiabilityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_82b404a5-6fde-444d-85a9-ac677337457b" xlink:to="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_416ad875-921a-4a46-81d4-903528687390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_ca0c0416-81d5-41ff-9835-f5a02a6a2d19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_416ad875-921a-4a46-81d4-903528687390" xlink:to="loc_us-gaap_ContractWithCustomerLiability_ca0c0416-81d5-41ff-9835-f5a02a6a2d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ContractWithCustomerLiabilityAdditionsNet_1eda822e-3940-472c-801c-ccf18b96860e" xlink:href="docs-20220331.xsd#docs_ContractWithCustomerLiabilityAdditionsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_416ad875-921a-4a46-81d4-903528687390" xlink:to="loc_docs_ContractWithCustomerLiabilityAdditionsNet_1eda822e-3940-472c-801c-ccf18b96860e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_630b02e1-04c7-4341-87b2-48fdb53a5540" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_416ad875-921a-4a46-81d4-903528687390" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_630b02e1-04c7-4341-87b2-48fdb53a5540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance_5d9de236-8799-4661-977e-f244c5148e9a" xlink:href="docs-20220331.xsd#docs_ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_416ad875-921a-4a46-81d4-903528687390" xlink:to="loc_docs_ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance_5d9de236-8799-4661-977e-f244c5148e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_25a50811-adb0-4ac0-94bb-348f258bba5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ChangeInContractWithCustomerLiabilityAbstract_416ad875-921a-4a46-81d4-903528687390" xlink:to="loc_us-gaap_ContractWithCustomerLiability_25a50811-adb0-4ac0-94bb-348f258bba5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/RevenueRecognitionNarrativeDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#RevenueRecognitionNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/RevenueRecognitionNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1c5a1d9e-09a9-408c-a99c-395e1d47afda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledReceivablesCurrent_152bc01f-f485-492d-b8b6-4002b4bb5ffa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnbilledReceivablesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1c5a1d9e-09a9-408c-a99c-395e1d47afda" xlink:to="loc_us-gaap_UnbilledReceivablesCurrent_152bc01f-f485-492d-b8b6-4002b4bb5ffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CapitalizedContractCostAdditions_f75d7fb8-76db-4815-bd1e-2f87785ee8e8" xlink:href="docs-20220331.xsd#docs_CapitalizedContractCostAdditions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1c5a1d9e-09a9-408c-a99c-395e1d47afda" xlink:to="loc_docs_CapitalizedContractCostAdditions_f75d7fb8-76db-4815-bd1e-2f87785ee8e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization_fae3a4e6-3281-45ec-878a-88e80715d73d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1c5a1d9e-09a9-408c-a99c-395e1d47afda" xlink:to="loc_us-gaap_CapitalizedContractCostAmortization_fae3a4e6-3281-45ec-878a-88e80715d73d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostImpairmentLoss_ceb2978f-a602-4949-b70c-1b167aca1271" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedContractCostImpairmentLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1c5a1d9e-09a9-408c-a99c-395e1d47afda" xlink:to="loc_us-gaap_CapitalizedContractCostImpairmentLoss_ceb2978f-a602-4949-b70c-1b167aca1271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/Investments" xlink:type="simple" xlink:href="docs-20220331.xsd#Investments"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/Investments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_eda4498a-461e-4f60-950a-3bee334c439e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock_356e19b1-a533-438a-9a1d-3f26872e1dae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_eda4498a-461e-4f60-950a-3bee334c439e" xlink:to="loc_us-gaap_InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock_356e19b1-a533-438a-9a1d-3f26872e1dae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/InvestmentsTables" xlink:type="simple" xlink:href="docs-20220331.xsd#InvestmentsTables"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/InvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_11b45a45-2131-4f9e-bc1f-0838a6471edc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_ff5ecf62-d5c1-4b7d-b5a7-a25c030ffa6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_11b45a45-2131-4f9e-bc1f-0838a6471edc" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_ff5ecf62-d5c1-4b7d-b5a7-a25c030ffa6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_a38c673a-d2a7-43dd-9a8b-3cece61f1f0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_11b45a45-2131-4f9e-bc1f-0838a6471edc" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_a38c673a-d2a7-43dd-9a8b-3cece61f1f0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_855d1591-6469-4efe-bde7-0c0a1610a63c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_77a59ce5-e66d-4a59-b03f-8c0d38ccda40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_855d1591-6469-4efe-bde7-0c0a1610a63c" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_77a59ce5-e66d-4a59-b03f-8c0d38ccda40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_65d72719-8586-48c2-bf12-a9ad62a9f632" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_77a59ce5-e66d-4a59-b03f-8c0d38ccda40" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_65d72719-8586-48c2-bf12-a9ad62a9f632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c4078ea5-9be2-42e0-b7a8-eb4288ccf013" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_65d72719-8586-48c2-bf12-a9ad62a9f632" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c4078ea5-9be2-42e0-b7a8-eb4288ccf013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_73cfa6b3-a64b-487d-b88c-5bc5a6d98f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c4078ea5-9be2-42e0-b7a8-eb4288ccf013" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_73cfa6b3-a64b-487d-b88c-5bc5a6d98f9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesMember_ccf0631e-d700-4561-a092-4594d2f60fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableforsaleSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c4078ea5-9be2-42e0-b7a8-eb4288ccf013" xlink:to="loc_us-gaap_AvailableforsaleSecuritiesMember_ccf0631e-d700-4561-a092-4594d2f60fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_50bf3bb7-6116-4d03-a48d-450257ec5f24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_77a59ce5-e66d-4a59-b03f-8c0d38ccda40" xlink:to="loc_us-gaap_FinancialInstrumentAxis_50bf3bb7-6116-4d03-a48d-450257ec5f24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c584a828-f3d8-4798-a3c8-b1b855172d1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_50bf3bb7-6116-4d03-a48d-450257ec5f24" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c584a828-f3d8-4798-a3c8-b1b855172d1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_46e56e05-e6b6-437f-9142-c974eb9547e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c584a828-f3d8-4798-a3c8-b1b855172d1c" xlink:to="loc_us-gaap_CommercialPaperMember_46e56e05-e6b6-437f-9142-c974eb9547e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_8c3063c9-82d8-4940-b404-243b0791cc60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c584a828-f3d8-4798-a3c8-b1b855172d1c" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_8c3063c9-82d8-4940-b404-243b0791cc60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_e14a564b-536d-4d96-8ba9-7dd689ef12e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c584a828-f3d8-4798-a3c8-b1b855172d1c" xlink:to="loc_us-gaap_MoneyMarketFundsMember_e14a564b-536d-4d96-8ba9-7dd689ef12e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_00343f2d-4620-4f83-9754-d796c90b65b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c584a828-f3d8-4798-a3c8-b1b855172d1c" xlink:to="loc_us-gaap_CertificatesOfDepositMember_00343f2d-4620-4f83-9754-d796c90b65b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_e6721275-845f-4985-bc2b-3782688eb0c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c584a828-f3d8-4798-a3c8-b1b855172d1c" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_e6721275-845f-4985-bc2b-3782688eb0c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_61fd08e7-d336-46c3-9f52-7e504604597a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c584a828-f3d8-4798-a3c8-b1b855172d1c" xlink:to="loc_us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember_61fd08e7-d336-46c3-9f52-7e504604597a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SovereignDebtSecuritiesMember_ccec4588-026a-48ac-b550-58fcb8102cd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SovereignDebtSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c584a828-f3d8-4798-a3c8-b1b855172d1c" xlink:to="loc_us-gaap_SovereignDebtSecuritiesMember_ccec4588-026a-48ac-b550-58fcb8102cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_35c67186-07b7-474b-afee-1223fd5d28ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c584a828-f3d8-4798-a3c8-b1b855172d1c" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_35c67186-07b7-474b-afee-1223fd5d28ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_05d3b78b-9289-4805-a2c8-d59fe50b2202" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTable_77a59ce5-e66d-4a59-b03f-8c0d38ccda40" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_05d3b78b-9289-4805-a2c8-d59fe50b2202" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_2ff91c8c-14a8-4a1f-8c49-311947a3d530" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_05d3b78b-9289-4805-a2c8-d59fe50b2202" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss_2ff91c8c-14a8-4a1f-8c49-311947a3d530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_067a3bcb-f1dc-41bb-8fdd-51a63d23c18b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_05d3b78b-9289-4805-a2c8-d59fe50b2202" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_067a3bcb-f1dc-41bb-8fdd-51a63d23c18b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_b568efd0-85ce-4c03-adba-6b9f87aa468a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_05d3b78b-9289-4805-a2c8-d59fe50b2202" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_b568efd0-85ce-4c03-adba-6b9f87aa468a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_aed1a933-a6e6-471a-9ce5-06f4e617e507" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_05d3b78b-9289-4805-a2c8-d59fe50b2202" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_aed1a933-a6e6-471a-9ce5-06f4e617e507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e86d6f02-184d-4546-bb0a-12d33a64c46b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_05d3b78b-9289-4805-a2c8-d59fe50b2202" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_e86d6f02-184d-4546-bb0a-12d33a64c46b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_ffdb08ff-6047-4c4c-ab7c-276693d5a06b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_05d3b78b-9289-4805-a2c8-d59fe50b2202" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_ffdb08ff-6047-4c4c-ab7c-276693d5a06b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost_812aade4-039e-4d16-b7ef-4f69dc7629a1" xlink:href="docs-20220331.xsd#docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_05d3b78b-9289-4805-a2c8-d59fe50b2202" xlink:to="loc_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost_812aade4-039e-4d16-b7ef-4f69dc7629a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_a7621a89-4418-43c0-81c1-213e1cff7c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_05d3b78b-9289-4805-a2c8-d59fe50b2202" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_a7621a89-4418-43c0-81c1-213e1cff7c8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails_1" xlink:type="simple" xlink:href="docs-20220331.xsd#InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails_1"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.doximity.com/role/InvestmentsContractualMaturitiesofAvailableForSaleDebtSecuritiesDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#InvestmentsContractualMaturitiesofAvailableForSaleDebtSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/InvestmentsContractualMaturitiesofAvailableForSaleDebtSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_70c31831-857b-42f6-a61d-d0ea8802cfa1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_374cf7b5-dd7d-4a19-8337-903701409e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_70c31831-857b-42f6-a61d-d0ea8802cfa1" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_374cf7b5-dd7d-4a19-8337-903701409e5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughThree_c9ed1053-762a-4f30-9f06-ccbcba0e3707" xlink:href="docs-20220331.xsd#docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughThree"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_70c31831-857b-42f6-a61d-d0ea8802cfa1" xlink:to="loc_docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughThree_c9ed1053-762a-4f30-9f06-ccbcba0e3707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_8bb00cfe-28ed-483e-a706-77171b5c08b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_70c31831-857b-42f6-a61d-d0ea8802cfa1" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_8bb00cfe-28ed-483e-a706-77171b5c08b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/InvestmentsNarrativeDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#InvestmentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/InvestmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_ed9b1bd8-b64b-4526-b0e4-612a6ac951e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss_294f84c6-a46e-49eb-a779-7a28192bf50f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_ed9b1bd8-b64b-4526-b0e4-612a6ac951e7" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss_294f84c6-a46e-49eb-a779-7a28192bf50f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_5bad52b8-4796-4861-b477-9bb38e550dd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_ed9b1bd8-b64b-4526-b0e4-612a6ac951e7" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_5bad52b8-4796-4861-b477-9bb38e550dd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DebtSecuritiesAvailableForSaleImpairmentsLoss_4b2f67db-8fb4-440e-aab5-e01e3e325991" xlink:href="docs-20220331.xsd#docs_DebtSecuritiesAvailableForSaleImpairmentsLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_ed9b1bd8-b64b-4526-b0e4-612a6ac951e7" xlink:to="loc_docs_DebtSecuritiesAvailableForSaleImpairmentsLoss_4b2f67db-8fb4-440e-aab5-e01e3e325991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleChangeInPresentValueExpenseReversal_04791300-5b3b-4529-b394-1c0601105714" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleChangeInPresentValueExpenseReversal"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_ed9b1bd8-b64b-4526-b0e4-612a6ac951e7" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleChangeInPresentValueExpenseReversal_04791300-5b3b-4529-b394-1c0601105714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DebtSecuritiesAvailableForSaleWithNoCreditAllowance_3d7d7f57-5219-447a-b027-7becdb8e382b" xlink:href="docs-20220331.xsd#docs_DebtSecuritiesAvailableForSaleWithNoCreditAllowance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_ed9b1bd8-b64b-4526-b0e4-612a6ac951e7" xlink:to="loc_docs_DebtSecuritiesAvailableForSaleWithNoCreditAllowance_3d7d7f57-5219-447a-b027-7becdb8e382b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="docs-20220331.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_9d32fbba-0136-4402-9f4a-489d51b966d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_b87b5703-04d1-498f-9150-5a5e675c56bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9d32fbba-0136-4402-9f4a-489d51b966d5" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_b87b5703-04d1-498f-9150-5a5e675c56bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="docs-20220331.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_40e20c0f-431c-4ce2-9caf-7ef1e0244468" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_65462c77-2bc7-4aad-8790-ad35de615176" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_40e20c0f-431c-4ce2-9caf-7ef1e0244468" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_65462c77-2bc7-4aad-8790-ad35de615176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/FairValueMeasurementsDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#FairValueMeasurementsDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/FairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_eb7124c7-db16-4c9e-9f93-8a9aaee5e152" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ad976dab-f348-458e-8bd3-1b8238b5b95a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_eb7124c7-db16-4c9e-9f93-8a9aaee5e152" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ad976dab-f348-458e-8bd3-1b8238b5b95a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d71e953c-19b2-49d8-8412-ee57dd8a570a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ad976dab-f348-458e-8bd3-1b8238b5b95a" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d71e953c-19b2-49d8-8412-ee57dd8a570a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_22f8f926-dd7b-416c-9f22-f440c9996549" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_d71e953c-19b2-49d8-8412-ee57dd8a570a" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_22f8f926-dd7b-416c-9f22-f440c9996549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_eef6da11-25fa-4556-a84b-ed993dd4741e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_22f8f926-dd7b-416c-9f22-f440c9996549" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_eef6da11-25fa-4556-a84b-ed993dd4741e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_d66b7340-553b-4659-b67f-6704f7098657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_22f8f926-dd7b-416c-9f22-f440c9996549" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_d66b7340-553b-4659-b67f-6704f7098657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_13d5c9c0-2384-4540-92bd-3448e70787b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_22f8f926-dd7b-416c-9f22-f440c9996549" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_13d5c9c0-2384-4540-92bd-3448e70787b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_875eeea4-d751-41c1-914e-ab25c98add05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ad976dab-f348-458e-8bd3-1b8238b5b95a" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_875eeea4-d751-41c1-914e-ab25c98add05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_aea618d6-9d27-4075-8329-2efc9057f745" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_875eeea4-d751-41c1-914e-ab25c98add05" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_aea618d6-9d27-4075-8329-2efc9057f745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_d9cb1546-32fc-4171-9d1e-016055718722" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_aea618d6-9d27-4075-8329-2efc9057f745" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_d9cb1546-32fc-4171-9d1e-016055718722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_cdd79656-de15-4479-89f3-98c4d1c943fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ad976dab-f348-458e-8bd3-1b8238b5b95a" xlink:to="loc_us-gaap_FinancialInstrumentAxis_cdd79656-de15-4479-89f3-98c4d1c943fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3e85f118-488f-4b5a-b15c-87dff02a92cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_cdd79656-de15-4479-89f3-98c4d1c943fe" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3e85f118-488f-4b5a-b15c-87dff02a92cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_fa16b664-72ae-4337-bd37-7b17b4114aae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3e85f118-488f-4b5a-b15c-87dff02a92cd" xlink:to="loc_us-gaap_MoneyMarketFundsMember_fa16b664-72ae-4337-bd37-7b17b4114aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetBackedSecuritiesMember_f07b50a8-022a-494f-a45e-783a0920b52b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetBackedSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3e85f118-488f-4b5a-b15c-87dff02a92cd" xlink:to="loc_us-gaap_AssetBackedSecuritiesMember_f07b50a8-022a-494f-a45e-783a0920b52b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CertificatesOfDepositMember_9ae89235-daf5-490c-8256-463abdaaa9ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CertificatesOfDepositMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3e85f118-488f-4b5a-b15c-87dff02a92cd" xlink:to="loc_us-gaap_CertificatesOfDepositMember_9ae89235-daf5-490c-8256-463abdaaa9ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_6d4da371-2013-4ce5-ab76-e00100e300a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3e85f118-488f-4b5a-b15c-87dff02a92cd" xlink:to="loc_us-gaap_CommercialPaperMember_6d4da371-2013-4ce5-ab76-e00100e300a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_564f4c7f-1076-4f81-be89-43e76dc7646a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3e85f118-488f-4b5a-b15c-87dff02a92cd" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_564f4c7f-1076-4f81-be89-43e76dc7646a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SovereignDebtSecuritiesMember_6f2d6753-aa91-403c-bd24-b2722f1123a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SovereignDebtSecuritiesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3e85f118-488f-4b5a-b15c-87dff02a92cd" xlink:to="loc_us-gaap_SovereignDebtSecuritiesMember_6f2d6753-aa91-403c-bd24-b2722f1123a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_87aae8b1-79f1-4a0a-a741-d3782cefaf4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_3e85f118-488f-4b5a-b15c-87dff02a92cd" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_87aae8b1-79f1-4a0a-a741-d3782cefaf4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_6dd7f697-f852-408d-b3d5-d75d63ba13fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ad976dab-f348-458e-8bd3-1b8238b5b95a" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_6dd7f697-f852-408d-b3d5-d75d63ba13fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_3fdb574a-3829-4f44-9eaf-e37259bcb52e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_6dd7f697-f852-408d-b3d5-d75d63ba13fe" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_3fdb574a-3829-4f44-9eaf-e37259bcb52e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsMember_ea78e097-d9a0-4315-8eb6-62788bb1b76e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3fdb574a-3829-4f44-9eaf-e37259bcb52e" xlink:to="loc_us-gaap_CashAndCashEquivalentsMember_ea78e097-d9a0-4315-8eb6-62788bb1b76e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableforsaleSecuritiesMember_274adda8-26fa-4f3f-afb4-f84a20e3bec2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableforsaleSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_3fdb574a-3829-4f44-9eaf-e37259bcb52e" xlink:to="loc_us-gaap_AvailableforsaleSecuritiesMember_274adda8-26fa-4f3f-afb4-f84a20e3bec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_79b21350-e6b4-40d0-a3a7-64713ec5c4da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_ad976dab-f348-458e-8bd3-1b8238b5b95a" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_79b21350-e6b4-40d0-a3a7-64713ec5c4da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_8871d85c-a8b1-48c4-9338-2bab6b48ddaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_79b21350-e6b4-40d0-a3a7-64713ec5c4da" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest_8871d85c-a8b1-48c4-9338-2bab6b48ddaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/PropertyandEquipmentNet" xlink:type="simple" xlink:href="docs-20220331.xsd#PropertyandEquipmentNet"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/PropertyandEquipmentNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_804ff0fa-4d93-4128-9064-6ac4b3062679" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_97c4fae5-9b9c-4acd-be09-040f016aca6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_804ff0fa-4d93-4128-9064-6ac4b3062679" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_97c4fae5-9b9c-4acd-be09-040f016aca6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/PropertyandEquipmentNetTables" xlink:type="simple" xlink:href="docs-20220331.xsd#PropertyandEquipmentNetTables"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/PropertyandEquipmentNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_8b1446cb-97fd-4312-a3d2-dde5a82aebbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_49028cf7-4728-4db4-a3b5-375e5cec7469" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_8b1446cb-97fd-4312-a3d2-dde5a82aebbe" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_49028cf7-4728-4db4-a3b5-375e5cec7469" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0044ddb6-8a92-4303-9905-3aa9285a5df0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e8028cf8-d073-4529-9224-09be8bf7b431" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_0044ddb6-8a92-4303-9905-3aa9285a5df0" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e8028cf8-d073-4529-9224-09be8bf7b431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c5789756-10d0-4386-bde1-ffe13270887e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e8028cf8-d073-4529-9224-09be8bf7b431" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c5789756-10d0-4386-bde1-ffe13270887e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_476a4b29-a64b-45b9-8b1b-2ec59b45583a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_c5789756-10d0-4386-bde1-ffe13270887e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_476a4b29-a64b-45b9-8b1b-2ec59b45583a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_FurnitureAndEquipmentMember_3d758f47-c22f-49d5-90ba-d2b99c8e79dd" xlink:href="docs-20220331.xsd#docs_FurnitureAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_476a4b29-a64b-45b9-8b1b-2ec59b45583a" xlink:to="loc_docs_FurnitureAndEquipmentMember_3d758f47-c22f-49d5-90ba-d2b99c8e79dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ComputerEquipmentAndSoftwareMember_f1574026-ba3e-471e-a770-5d960fd3dd29" xlink:href="docs-20220331.xsd#docs_ComputerEquipmentAndSoftwareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_476a4b29-a64b-45b9-8b1b-2ec59b45583a" xlink:to="loc_docs_ComputerEquipmentAndSoftwareMember_f1574026-ba3e-471e-a770-5d960fd3dd29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_589a48fe-8873-4341-8cd6-1ff0a85e28e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_476a4b29-a64b-45b9-8b1b-2ec59b45583a" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_589a48fe-8873-4341-8cd6-1ff0a85e28e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_0a595b17-8dc6-4133-9658-62be639c8cee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_476a4b29-a64b-45b9-8b1b-2ec59b45583a" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_0a595b17-8dc6-4133-9658-62be639c8cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_da37c820-ad1e-45da-bb04-a71cdcc6cd7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_e8028cf8-d073-4529-9224-09be8bf7b431" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_da37c820-ad1e-45da-bb04-a71cdcc6cd7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_58231a10-db52-41b7-9539-958879e0f232" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_da37c820-ad1e-45da-bb04-a71cdcc6cd7f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_58231a10-db52-41b7-9539-958879e0f232" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_77189d9e-d173-44e5-912a-72b2fb05a069" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_da37c820-ad1e-45da-bb04-a71cdcc6cd7f" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_77189d9e-d173-44e5-912a-72b2fb05a069" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_82c5f745-6c61-4d65-862b-5b1e19e82c3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_da37c820-ad1e-45da-bb04-a71cdcc6cd7f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_82c5f745-6c61-4d65-862b-5b1e19e82c3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/PropertyandEquipmentNetNarrativeDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#PropertyandEquipmentNetNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/PropertyandEquipmentNetNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_3fe6bd4d-ee15-4bd1-872d-38ea9364404a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_7c6e1b8b-8b7f-463b-bffd-b3ca013c187e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_3fe6bd4d-ee15-4bd1-872d-38ea9364404a" xlink:to="loc_us-gaap_Depreciation_7c6e1b8b-8b7f-463b-bffd-b3ca013c187e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_7de0810d-68de-4dab-9bad-975159c4ed7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_3fe6bd4d-ee15-4bd1-872d-38ea9364404a" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_7de0810d-68de-4dab-9bad-975159c4ed7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAdditions_260bc978-4b70-40f0-9697-cb479a50682a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalizedComputerSoftwareAdditions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_3fe6bd4d-ee15-4bd1-872d-38ea9364404a" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAdditions_260bc978-4b70-40f0-9697-cb479a50682a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TangibleAssetImpairmentCharges_3d60bc85-7eeb-41b1-bc3f-f17edab86e66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TangibleAssetImpairmentCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_3fe6bd4d-ee15-4bd1-872d-38ea9364404a" xlink:to="loc_us-gaap_TangibleAssetImpairmentCharges_3d60bc85-7eeb-41b1-bc3f-f17edab86e66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilities" xlink:type="simple" xlink:href="docs-20220331.xsd#AccruedExpensesandOtherCurrentLiabilities"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_94b433f2-d953-4ca2-9de3-ccc83d5ace5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock_4e9b7eb5-bffd-4b17-b265-ffcdecf0ab74" xlink:href="docs-20220331.xsd#docs_AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_94b433f2-d953-4ca2-9de3-ccc83d5ace5d" xlink:to="loc_docs_AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock_4e9b7eb5-bffd-4b17-b265-ffcdecf0ab74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables" xlink:type="simple" xlink:href="docs-20220331.xsd#AccruedExpensesandOtherCurrentLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_fa7166e4-e9aa-4baf-8bce-fad03dd38a48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ScheduleOfAccruedLiabilitiesCurrentTableTextBlock_dede2fad-4928-417d-b181-42cbd4fb129a" xlink:href="docs-20220331.xsd#docs_ScheduleOfAccruedLiabilitiesCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_fa7166e4-e9aa-4baf-8bce-fad03dd38a48" xlink:to="loc_docs_ScheduleOfAccruedLiabilitiesCurrentTableTextBlock_dede2fad-4928-417d-b181-42cbd4fb129a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#AccruedExpensesandOtherCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_b399f8af-73ab-41bc-a417-d867e6f5d49a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrent_13012ced-035a-4662-abab-ea3b727b0f5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_b399f8af-73ab-41bc-a417-d867e6f5d49a" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrent_13012ced-035a-4662-abab-ea3b727b0f5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_76665795-01e7-40ee-b60e-1b96944acc83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_b399f8af-73ab-41bc-a417-d867e6f5d49a" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_76665795-01e7-40ee-b60e-1b96944acc83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_AccruedEmployeeStockPurchasePlanCurrent_6b12c36b-ab64-4c1f-a902-272e80fb5b4c" xlink:href="docs-20220331.xsd#docs_AccruedEmployeeStockPurchasePlanCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_b399f8af-73ab-41bc-a417-d867e6f5d49a" xlink:to="loc_docs_AccruedEmployeeStockPurchasePlanCurrent_6b12c36b-ab64-4c1f-a902-272e80fb5b4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_RebateLiabilitiesCurrent_2b67bdd4-93cb-4c36-9bd6-d7d25d834c23" xlink:href="docs-20220331.xsd#docs_RebateLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_b399f8af-73ab-41bc-a417-d867e6f5d49a" xlink:to="loc_docs_RebateLiabilitiesCurrent_2b67bdd4-93cb-4c36-9bd6-d7d25d834c23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_19300201-a05e-479d-a6f3-12b035e4c772" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_b399f8af-73ab-41bc-a417-d867e6f5d49a" xlink:to="loc_us-gaap_TaxesPayableCurrent_19300201-a05e-479d-a6f3-12b035e4c772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_79fa27f2-6030-4e85-b010-11423826f240" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_b399f8af-73ab-41bc-a417-d867e6f5d49a" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_79fa27f2-6030-4e85-b010-11423826f240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_b7e253d7-a575-434b-aa63-f909597bd7ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_b399f8af-73ab-41bc-a417-d867e6f5d49a" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_b7e253d7-a575-434b-aa63-f909597bd7ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwill" xlink:type="simple" xlink:href="docs-20220331.xsd#BusinessCombinationsIntangibleAssetsandGoodwill"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwill" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract_06542bf6-19c4-4f34-b497-2f77c8967910" xlink:href="docs-20220331.xsd#docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureTextBlock_73dbe720-0759-40d2-87b2-202921a80ad7" xlink:href="docs-20220331.xsd#docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract_06542bf6-19c4-4f34-b497-2f77c8967910" xlink:to="loc_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureTextBlock_73dbe720-0759-40d2-87b2-202921a80ad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillTables" xlink:type="simple" xlink:href="docs-20220331.xsd#BusinessCombinationsIntangibleAssetsandGoodwillTables"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract_c81f7c26-ef97-4802-9668-7de0f3e33ef5" xlink:href="docs-20220331.xsd#docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_d86441e4-97d2-4851-aa76-2724bec45e17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract_c81f7c26-ef97-4802-9668-7de0f3e33ef5" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_d86441e4-97d2-4851-aa76-2724bec45e17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_c0df21df-e1ac-4194-85cf-544ee4bfcc98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract_c81f7c26-ef97-4802-9668-7de0f3e33ef5" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_c0df21df-e1ac-4194-85cf-544ee4bfcc98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_7ad4a1c5-f70f-4cee-8311-e3969d9f451d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract_c81f7c26-ef97-4802-9668-7de0f3e33ef5" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_7ad4a1c5-f70f-4cee-8311-e3969d9f451d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillNarrativeDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#BusinessCombinationsIntangibleAssetsandGoodwillNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract_7716d7a4-a336-4d3e-ad52-a9c33560bd5a" xlink:href="docs-20220331.xsd#docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_819aef2f-c385-44d6-8c89-fa67372da668" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract_7716d7a4-a336-4d3e-ad52-a9c33560bd5a" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_819aef2f-c385-44d6-8c89-fa67372da668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_53030a01-1761-4eed-abd6-18400612ea4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_819aef2f-c385-44d6-8c89-fa67372da668" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_53030a01-1761-4eed-abd6-18400612ea4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1f9de496-7746-4930-88be-f81685f58d01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_53030a01-1761-4eed-abd6-18400612ea4c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1f9de496-7746-4930-88be-f81685f58d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_THMEDLLCMember_9f34617c-b5dd-4ba2-89e0-9dff564f1c2b" xlink:href="docs-20220331.xsd#docs_THMEDLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1f9de496-7746-4930-88be-f81685f58d01" xlink:to="loc_docs_THMEDLLCMember_9f34617c-b5dd-4ba2-89e0-9dff564f1c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_767dd736-704f-4fc5-9653-56bc811081dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_819aef2f-c385-44d6-8c89-fa67372da668" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_767dd736-704f-4fc5-9653-56bc811081dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_302426ea-453a-42d7-b3b4-77d1a4b54cf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_767dd736-704f-4fc5-9653-56bc811081dc" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_302426ea-453a-42d7-b3b4-77d1a4b54cf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_4cd761a0-4958-4837-8a89-9d00b08ef376" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_302426ea-453a-42d7-b3b4-77d1a4b54cf1" xlink:to="loc_us-gaap_CustomerRelationshipsMember_4cd761a0-4958-4837-8a89-9d00b08ef376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_df16c2de-ac45-40d5-9523-97e615486365" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_819aef2f-c385-44d6-8c89-fa67372da668" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_df16c2de-ac45-40d5-9523-97e615486365" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_76c19724-3591-455d-9e19-db10aa58e77a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_df16c2de-ac45-40d5-9523-97e615486365" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_76c19724-3591-455d-9e19-db10aa58e77a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_8e371380-8398-410f-9735-4ab82f092269" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_76c19724-3591-455d-9e19-db10aa58e77a" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_8e371380-8398-410f-9735-4ab82f092269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c0f07ffb-05a4-458e-9c8a-b6da910ca4b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_819aef2f-c385-44d6-8c89-fa67372da668" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c0f07ffb-05a4-458e-9c8a-b6da910ca4b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_26ee09b0-99d6-4366-894e-b2d6a2d59e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_c0f07ffb-05a4-458e-9c8a-b6da910ca4b3" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_26ee09b0-99d6-4366-894e-b2d6a2d59e4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PortionOfCurativeTalentLLCMember_0476e3e9-59ba-4fef-b07b-5f73cdbc8a53" xlink:href="docs-20220331.xsd#docs_PortionOfCurativeTalentLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_26ee09b0-99d6-4366-894e-b2d6a2d59e4f" xlink:to="loc_docs_PortionOfCurativeTalentLLCMember_0476e3e9-59ba-4fef-b07b-5f73cdbc8a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_70a1b68e-100e-4d19-931b-1ae8091cf48d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_819aef2f-c385-44d6-8c89-fa67372da668" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_70a1b68e-100e-4d19-931b-1ae8091cf48d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_8bcf5844-f123-49ee-912d-df48e7391b15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_70a1b68e-100e-4d19-931b-1ae8091cf48d" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_8bcf5844-f123-49ee-912d-df48e7391b15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_afc76617-6cd8-4531-a9d5-2622b27672e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_70a1b68e-100e-4d19-931b-1ae8091cf48d" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_afc76617-6cd8-4531-a9d5-2622b27672e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_4f1eb016-19fb-49f2-8a97-b60ce7beec68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_70a1b68e-100e-4d19-931b-1ae8091cf48d" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_4f1eb016-19fb-49f2-8a97-b60ce7beec68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_4cbc068f-cb2a-4ae9-b16a-7783c29ad661" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_70a1b68e-100e-4d19-931b-1ae8091cf48d" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_4cbc068f-cb2a-4ae9-b16a-7783c29ad661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_c450896e-b4be-4ea1-8319-39da9a6407a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_70a1b68e-100e-4d19-931b-1ae8091cf48d" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_c450896e-b4be-4ea1-8319-39da9a6407a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_cd83638b-079f-4c30-8f86-7d871e2923ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_70a1b68e-100e-4d19-931b-1ae8091cf48d" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_cd83638b-079f-4c30-8f86-7d871e2923ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_bff151b4-6025-46ff-9616-d59d3e92abaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_70a1b68e-100e-4d19-931b-1ae8091cf48d" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_bff151b4-6025-46ff-9616-d59d3e92abaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_cabbbc2d-f850-4cd3-816e-4affb21b8e21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_70a1b68e-100e-4d19-931b-1ae8091cf48d" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_cabbbc2d-f850-4cd3-816e-4affb21b8e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow_e53b5e28-f370-4443-906e-97f77ee4f8f2" xlink:href="docs-20220331.xsd#docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_70a1b68e-100e-4d19-931b-1ae8091cf48d" xlink:to="loc_docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow_e53b5e28-f370-4443-906e-97f77ee4f8f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_f7b982d7-3758-4194-a488-dd92a0ad31e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_70a1b68e-100e-4d19-931b-1ae8091cf48d" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_f7b982d7-3758-4194-a488-dd92a0ad31e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_5dc55edd-8887-47d1-aa64-4ad37f43498d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_70a1b68e-100e-4d19-931b-1ae8091cf48d" xlink:to="loc_us-gaap_Goodwill_5dc55edd-8887-47d1-aa64-4ad37f43498d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_7b42a2ff-1b1c-46ad-996f-bbf683c0276e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_70a1b68e-100e-4d19-931b-1ae8091cf48d" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_7b42a2ff-1b1c-46ad-996f-bbf683c0276e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillPurchaseConsiderationAllocationDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#BusinessCombinationsIntangibleAssetsandGoodwillPurchaseConsiderationAllocationDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillPurchaseConsiderationAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract_57c7c4e7-10db-4e9e-b645-ee9d2da09fc0" xlink:href="docs-20220331.xsd#docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c8f93451-36fb-4658-89b0-fff6279550c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract_57c7c4e7-10db-4e9e-b645-ee9d2da09fc0" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c8f93451-36fb-4658-89b0-fff6279550c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d3726428-20a6-428e-8060-a1667d57ca7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c8f93451-36fb-4658-89b0-fff6279550c3" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d3726428-20a6-428e-8060-a1667d57ca7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_092f3eae-3faf-417c-a65b-f1ec9d00c0a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d3726428-20a6-428e-8060-a1667d57ca7c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_092f3eae-3faf-417c-a65b-f1ec9d00c0a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_THMEDLLCMember_6beef87e-54ad-4628-8b4c-059b9366fb30" xlink:href="docs-20220331.xsd#docs_THMEDLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_092f3eae-3faf-417c-a65b-f1ec9d00c0a0" xlink:to="loc_docs_THMEDLLCMember_6beef87e-54ad-4628-8b4c-059b9366fb30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_29d07762-3cff-45af-b965-eebc86047527" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_c8f93451-36fb-4658-89b0-fff6279550c3" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_29d07762-3cff-45af-b965-eebc86047527" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_69bd4a77-2f9d-445b-96e8-72f7d7c2d5c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29d07762-3cff-45af-b965-eebc86047527" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_69bd4a77-2f9d-445b-96e8-72f7d7c2d5c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_081b6a4d-741e-46f1-8ed5-3b5e90fa03c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_69bd4a77-2f9d-445b-96e8-72f7d7c2d5c6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_081b6a4d-741e-46f1-8ed5-3b5e90fa03c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_c94e0653-ad7d-40d1-979c-c13867ba1509" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_69bd4a77-2f9d-445b-96e8-72f7d7c2d5c6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_c94e0653-ad7d-40d1-979c-c13867ba1509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_22ca8ae3-568f-4501-87c8-0f87e6f2eb1f" xlink:href="docs-20220331.xsd#docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_69bd4a77-2f9d-445b-96e8-72f7d7c2d5c6" xlink:to="loc_docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther_22ca8ae3-568f-4501-87c8-0f87e6f2eb1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_cd456a20-5afb-4964-a16f-cfe8b6407181" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_69bd4a77-2f9d-445b-96e8-72f7d7c2d5c6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles_cd456a20-5afb-4964-a16f-cfe8b6407181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_000a9d8a-4098-475a-8c8e-23e03e2c33fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract_69bd4a77-2f9d-445b-96e8-72f7d7c2d5c6" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets_000a9d8a-4098-475a-8c8e-23e03e2c33fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_33703eb3-0816-4397-9872-0f34c8095e0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29d07762-3cff-45af-b965-eebc86047527" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_33703eb3-0816-4397-9872-0f34c8095e0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_f00f4aab-c2b9-4ec0-adf1-452c410d0e01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract_33703eb3-0816-4397-9872-0f34c8095e0b" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_f00f4aab-c2b9-4ec0-adf1-452c410d0e01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_cb5cae29-f501-4c67-ac6d-febc4e3f340a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29d07762-3cff-45af-b965-eebc86047527" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_cb5cae29-f501-4c67-ac6d-febc4e3f340a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_54713003-69ca-47f3-b9f4-1692782d1e81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29d07762-3cff-45af-b965-eebc86047527" xlink:to="loc_us-gaap_Goodwill_54713003-69ca-47f3-b9f4-1692782d1e81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_adfd3acd-d9be-42e7-8b2e-30fe9d17afff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_29d07762-3cff-45af-b965-eebc86047527" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_adfd3acd-d9be-42e7-8b2e-30fe9d17afff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillIntangibleAssetsNetDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#BusinessCombinationsIntangibleAssetsandGoodwillIntangibleAssetsNetDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillIntangibleAssetsNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_cdba329d-49a9-4d45-af0a-f77bdf9f5be7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ecb6c751-2a58-44b3-8c29-2e562b43f141" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_cdba329d-49a9-4d45-af0a-f77bdf9f5be7" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ecb6c751-2a58-44b3-8c29-2e562b43f141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a589d09e-62a0-49c6-bfa4-ff83b868f95c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ecb6c751-2a58-44b3-8c29-2e562b43f141" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a589d09e-62a0-49c6-bfa4-ff83b868f95c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_df0f22fe-f0ef-45b4-945f-ab7a04926978" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_a589d09e-62a0-49c6-bfa4-ff83b868f95c" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_df0f22fe-f0ef-45b4-945f-ab7a04926978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_f1d80313-45bf-4d8e-818e-e18a25095408" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_df0f22fe-f0ef-45b4-945f-ab7a04926978" xlink:to="loc_us-gaap_CustomerRelationshipsMember_f1d80313-45bf-4d8e-818e-e18a25095408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternetDomainNamesMember_892beaf4-5cb5-4414-bf2f-10543b287497" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InternetDomainNamesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_df0f22fe-f0ef-45b4-945f-ab7a04926978" xlink:to="loc_us-gaap_InternetDomainNamesMember_892beaf4-5cb5-4414-bf2f-10543b287497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_18b84a43-9a50-468b-a3dc-692d03c44f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_ecb6c751-2a58-44b3-8c29-2e562b43f141" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_18b84a43-9a50-468b-a3dc-692d03c44f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_b025b08f-931c-49d1-aa01-576312680a65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_18b84a43-9a50-468b-a3dc-692d03c44f7f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_b025b08f-931c-49d1-aa01-576312680a65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2a89f301-b0e4-488c-94a2-d7cca74af8b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_18b84a43-9a50-468b-a3dc-692d03c44f7f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_2a89f301-b0e4-488c-94a2-d7cca74af8b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2ba44ac9-fafc-43b2-9859-f92b91c8f921" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_18b84a43-9a50-468b-a3dc-692d03c44f7f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_2ba44ac9-fafc-43b2-9859-f92b91c8f921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillFutureAmortizationExpenseDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#BusinessCombinationsIntangibleAssetsandGoodwillFutureAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillFutureAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract_44060705-b9b3-471b-8706-85bfc93c51d7" xlink:href="docs-20220331.xsd#docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_112651e5-c792-46c4-a330-103cde839070" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract_44060705-b9b3-471b-8706-85bfc93c51d7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_112651e5-c792-46c4-a330-103cde839070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_95885bf3-5ffa-4629-aed0-eddce9ab2012" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract_44060705-b9b3-471b-8706-85bfc93c51d7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_95885bf3-5ffa-4629-aed0-eddce9ab2012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_f073ba2c-1aba-445b-9dc2-e76f9e6720ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract_44060705-b9b3-471b-8706-85bfc93c51d7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_f073ba2c-1aba-445b-9dc2-e76f9e6720ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_68e7e8fe-a549-45bf-b216-18acab5c35b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract_44060705-b9b3-471b-8706-85bfc93c51d7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_68e7e8fe-a549-45bf-b216-18acab5c35b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_e46bf089-ff28-4a39-8e95-aa47422be3e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract_44060705-b9b3-471b-8706-85bfc93c51d7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_e46bf089-ff28-4a39-8e95-aa47422be3e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_6e4b0e9a-5d74-4a29-9a3e-14642016908a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract_44060705-b9b3-471b-8706-85bfc93c51d7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_6e4b0e9a-5d74-4a29-9a3e-14642016908a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_27c056c2-b4de-44f8-8b2b-b4659d453d86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract_44060705-b9b3-471b-8706-85bfc93c51d7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_27c056c2-b4de-44f8-8b2b-b4659d453d86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/RedeemableConvertiblePreferredStock" xlink:type="simple" xlink:href="docs-20220331.xsd#RedeemableConvertiblePreferredStock"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/RedeemableConvertiblePreferredStock" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_8c5b26bb-ca79-4f5c-94bb-28fe01408bca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TemporaryEquityTextBlock_fdfd12a7-7cdf-4d07-8379-58ad5654c19d" xlink:href="docs-20220331.xsd#docs_TemporaryEquityTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_8c5b26bb-ca79-4f5c-94bb-28fe01408bca" xlink:to="loc_docs_TemporaryEquityTextBlock_fdfd12a7-7cdf-4d07-8379-58ad5654c19d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/RedeemableConvertiblePreferredStockTables" xlink:type="simple" xlink:href="docs-20220331.xsd#RedeemableConvertiblePreferredStockTables"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/RedeemableConvertiblePreferredStockTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_1220d65a-ee80-46b7-b615-e06de86544d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityTableTextBlock_397346f5-22aa-494b-996b-d601db036a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_1220d65a-ee80-46b7-b615-e06de86544d8" xlink:to="loc_us-gaap_TemporaryEquityTableTextBlock_397346f5-22aa-494b-996b-d601db036a9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#RedeemableConvertiblePreferredStockNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_169dc1ce-5a84-4244-a7e6-70ab145fac2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_081e475d-e4b0-499b-88f8-e03670743149" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_169dc1ce-5a84-4244-a7e6-70ab145fac2e" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_081e475d-e4b0-499b-88f8-e03670743149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_72b100cc-0619-4721-94c6-12e534595ad5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_081e475d-e4b0-499b-88f8-e03670743149" xlink:to="loc_us-gaap_StatementClassOfStockAxis_72b100cc-0619-4721-94c6-12e534595ad5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_e5e8cc31-f7bb-4a2a-8e78-6d226927218e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_72b100cc-0619-4721-94c6-12e534595ad5" xlink:to="loc_us-gaap_ClassOfStockDomain_e5e8cc31-f7bb-4a2a-8e78-6d226927218e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_7ae7ac24-c9ab-4876-8315-1e84f919719f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e5e8cc31-f7bb-4a2a-8e78-6d226927218e" xlink:to="loc_us-gaap_CommonClassBMember_7ae7ac24-c9ab-4876-8315-1e84f919719f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_b5311e78-bf82-4bd4-a8d9-410d3562fdee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e5e8cc31-f7bb-4a2a-8e78-6d226927218e" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_b5311e78-bf82-4bd4-a8d9-410d3562fdee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_5c8b25a7-54b6-4db6-8628-c47d7c3bf6a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e5e8cc31-f7bb-4a2a-8e78-6d226927218e" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_5c8b25a7-54b6-4db6-8628-c47d7c3bf6a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesCPreferredStockMember_dda7c909-d1e6-4d67-834f-d7fb1ef6fbc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e5e8cc31-f7bb-4a2a-8e78-6d226927218e" xlink:to="loc_us-gaap_SeriesCPreferredStockMember_dda7c909-d1e6-4d67-834f-d7fb1ef6fbc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_617b7e7a-5e77-4d78-a777-cbad9fd44cab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_081e475d-e4b0-499b-88f8-e03670743149" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_617b7e7a-5e77-4d78-a777-cbad9fd44cab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_babc0699-6d6f-4c5f-81b5-59197eae9b0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_617b7e7a-5e77-4d78-a777-cbad9fd44cab" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_babc0699-6d6f-4c5f-81b5-59197eae9b0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_RedeemableConvertiblePreferredStockWarrantsMember_35d33028-8ba9-4710-a072-febb63ca1575" xlink:href="docs-20220331.xsd#docs_RedeemableConvertiblePreferredStockWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_babc0699-6d6f-4c5f-81b5-59197eae9b0b" xlink:to="loc_docs_RedeemableConvertiblePreferredStockWarrantsMember_35d33028-8ba9-4710-a072-febb63ca1575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_460afd0a-1acd-49b4-b0c5-0bdf4a5e8433" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_081e475d-e4b0-499b-88f8-e03670743149" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_460afd0a-1acd-49b4-b0c5-0bdf4a5e8433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_6606437e-2512-421a-a529-62fd4866e477" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_460afd0a-1acd-49b4-b0c5-0bdf4a5e8433" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_6606437e-2512-421a-a529-62fd4866e477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_693c97e7-70d7-4cae-bc22-31a6ea10c5db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6606437e-2512-421a-a529-62fd4866e477" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_693c97e7-70d7-4cae-bc22-31a6ea10c5db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_52d72bfe-51ff-4e33-b4b1-1bacfbb9c204" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6606437e-2512-421a-a529-62fd4866e477" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_52d72bfe-51ff-4e33-b4b1-1bacfbb9c204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_347d3fc0-ca41-4a47-a586-2fe618db659e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6606437e-2512-421a-a529-62fd4866e477" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_347d3fc0-ca41-4a47-a586-2fe618db659e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_28b17a38-9894-4c5a-998b-48aae5ff3aac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_6606437e-2512-421a-a529-62fd4866e477" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_28b17a38-9894-4c5a-998b-48aae5ff3aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueAxis_249501dc-9d08-48c8-9323-6205de0487fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_081e475d-e4b0-499b-88f8-e03670743149" xlink:to="loc_us-gaap_ValuationTechniqueAxis_249501dc-9d08-48c8-9323-6205de0487fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueDomain_2b4a2545-67d4-4188-b4cd-0540f3716716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueAxis_249501dc-9d08-48c8-9323-6205de0487fc" xlink:to="loc_us-gaap_ValuationTechniqueDomain_2b4a2545-67d4-4188-b4cd-0540f3716716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationTechniqueOptionPricingModelMember_3cb18c62-2883-4463-9fe4-b981d1b45546" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationTechniqueOptionPricingModelMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationTechniqueDomain_2b4a2545-67d4-4188-b4cd-0540f3716716" xlink:to="loc_us-gaap_ValuationTechniqueOptionPricingModelMember_3cb18c62-2883-4463-9fe4-b981d1b45546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_081e475d-e4b0-499b-88f8-e03670743149" xlink:to="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TemporaryEquityPreferredStockOutstandingSeries_5cc7a4c6-448b-4e6b-ab36-f70cd33b3af9" xlink:href="docs-20220331.xsd#docs_TemporaryEquityPreferredStockOutstandingSeries"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:to="loc_docs_TemporaryEquityPreferredStockOutstandingSeries_5cc7a4c6-448b-4e6b-ab36-f70cd33b3af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_67218e7d-f95a-49cc-8da8-b9b39108bda5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:to="loc_us-gaap_TemporaryEquityParOrStatedValuePerShare_67218e7d-f95a-49cc-8da8-b9b39108bda5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockSharesIssued1_e4b6f595-8a83-4857-933f-fd9c350e1e11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConversionOfStockSharesIssued1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:to="loc_us-gaap_ConversionOfStockSharesIssued1_e4b6f595-8a83-4857-933f-fd9c350e1e11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ConversionOfStockConversionRatio_18dfd48b-ae71-4607-8d4a-ddfba25987ba" xlink:href="docs-20220331.xsd#docs_ConversionOfStockConversionRatio"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:to="loc_docs_ConversionOfStockConversionRatio_18dfd48b-ae71-4607-8d4a-ddfba25987ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_710b52e5-1ad3-4149-9012-1b6216dd1f47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReclassificationsOfTemporaryToPermanentEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:to="loc_us-gaap_ReclassificationsOfTemporaryToPermanentEquity_710b52e5-1ad3-4149-9012-1b6216dd1f47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_1f3f229f-6000-40e8-8ce2-33b6942370d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_1f3f229f-6000-40e8-8ce2-33b6942370d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_856ac8e8-8a07-4437-95db-fc15e47a8778" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_856ac8e8-8a07-4437-95db-fc15e47a8778" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLiquidationPreferencePerShare_ab29b372-86f2-418f-8879-58a36af0cae0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreferencePerShare"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:to="loc_us-gaap_TemporaryEquityLiquidationPreferencePerShare_ab29b372-86f2-418f-8879-58a36af0cae0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TemporaryEquityDividendRate_771434e8-d180-4559-97cb-23da84ad2bed" xlink:href="docs-20220331.xsd#docs_TemporaryEquityDividendRate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:to="loc_docs_TemporaryEquityDividendRate_771434e8-d180-4559-97cb-23da84ad2bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CommonStockVotingRightsNumberOfVotes_3ed10bb0-3ef5-44ed-a29f-0692664faa3b" xlink:href="docs-20220331.xsd#docs_CommonStockVotingRightsNumberOfVotes"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:to="loc_docs_CommonStockVotingRightsNumberOfVotes_3ed10bb0-3ef5-44ed-a29f-0692664faa3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TemporaryEquityElectionOfBoardMembersSharesOutstandingThreshold_1c610806-366b-430a-9c36-3a17e9ba7091" xlink:href="docs-20220331.xsd#docs_TemporaryEquityElectionOfBoardMembersSharesOutstandingThreshold"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:to="loc_docs_TemporaryEquityElectionOfBoardMembersSharesOutstandingThreshold_1c610806-366b-430a-9c36-3a17e9ba7091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TemporaryEquitySharesOutstandingThresholdSatisfiedNumberOfElectedBoardMembersPermitted_07730a0f-aa24-46cc-9548-602ec3d7ac35" xlink:href="docs-20220331.xsd#docs_TemporaryEquitySharesOutstandingThresholdSatisfiedNumberOfElectedBoardMembersPermitted"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:to="loc_docs_TemporaryEquitySharesOutstandingThresholdSatisfiedNumberOfElectedBoardMembersPermitted_07730a0f-aa24-46cc-9548-602ec3d7ac35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CommonStockHoldingMajorityNumberOfElectedBoardMembersPermitted_e721b095-f582-41c6-b3c5-039c52f55bd0" xlink:href="docs-20220331.xsd#docs_CommonStockHoldingMajorityNumberOfElectedBoardMembersPermitted"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:to="loc_docs_CommonStockHoldingMajorityNumberOfElectedBoardMembersPermitted_e721b095-f582-41c6-b3c5-039c52f55bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TemporaryEquityConvertibleStockPriceTrigger_8a9a32ec-f7f4-4866-9d35-ba74d19c91a5" xlink:href="docs-20220331.xsd#docs_TemporaryEquityConvertibleStockPriceTrigger"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:to="loc_docs_TemporaryEquityConvertibleStockPriceTrigger_8a9a32ec-f7f4-4866-9d35-ba74d19c91a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TemporaryEquityConvertibleAggregateOfferingPriceTrigger_4e51e802-a285-478e-82cd-917ddd973863" xlink:href="docs-20220331.xsd#docs_TemporaryEquityConvertibleAggregateOfferingPriceTrigger"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:to="loc_docs_TemporaryEquityConvertibleAggregateOfferingPriceTrigger_4e51e802-a285-478e-82cd-917ddd973863" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_765766c6-fa25-452f-ab93-41ede501b349" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_765766c6-fa25-452f-ab93-41ede501b349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_8522b7c9-b9cc-49bd-83b5-ffcc37832e6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_8522b7c9-b9cc-49bd-83b5-ffcc37832e6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_80e7188c-6d24-4170-9e4f-cbb023b1b7ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_80e7188c-6d24-4170-9e4f-cbb023b1b7ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_f4293f09-f408-4664-89e2-f1140a50a7ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_f4293f09-f408-4664-89e2-f1140a50a7ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_e314db12-56b3-4e0a-96ef-ea54192c07f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_8c269239-0c70-438a-9502-3d152e5a0fdb" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_e314db12-56b3-4e0a-96ef-ea54192c07f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockOutstandingDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockOutstandingDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_106102b6-fb4e-4a73-8ce5-0c30237a15b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_636abd99-a0da-4999-9a2e-e6ff782e469b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_106102b6-fb4e-4a73-8ce5-0c30237a15b3" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_636abd99-a0da-4999-9a2e-e6ff782e469b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_6376f25c-9028-47a1-a536-f0dc4928101d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_636abd99-a0da-4999-9a2e-e6ff782e469b" xlink:to="loc_us-gaap_StatementClassOfStockAxis_6376f25c-9028-47a1-a536-f0dc4928101d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_8dd98c06-21c8-41bd-8bc5-e50a048df32c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_6376f25c-9028-47a1-a536-f0dc4928101d" xlink:to="loc_us-gaap_ClassOfStockDomain_8dd98c06-21c8-41bd-8bc5-e50a048df32c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesAPreferredStockMember_7705aba8-681f-48fc-96a4-007eaaf2238f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesAPreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_8dd98c06-21c8-41bd-8bc5-e50a048df32c" xlink:to="loc_us-gaap_SeriesAPreferredStockMember_7705aba8-681f-48fc-96a4-007eaaf2238f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesBPreferredStockMember_59a22e4c-a5a0-4f26-bbcb-1f43a87c8cbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesBPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_8dd98c06-21c8-41bd-8bc5-e50a048df32c" xlink:to="loc_us-gaap_SeriesBPreferredStockMember_59a22e4c-a5a0-4f26-bbcb-1f43a87c8cbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesCPreferredStockMember_7ac92b0d-b79f-41f6-a162-5a2d1eab84f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesCPreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_8dd98c06-21c8-41bd-8bc5-e50a048df32c" xlink:to="loc_us-gaap_SeriesCPreferredStockMember_7ac92b0d-b79f-41f6-a162-5a2d1eab84f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems_28a9e712-8028-4c9d-aced-f034b21b46e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_636abd99-a0da-4999-9a2e-e6ff782e469b" xlink:to="loc_us-gaap_TemporaryEquityLineItems_28a9e712-8028-4c9d-aced-f034b21b46e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesAuthorized_e5e79544-a54e-4b68-8097-2a4e43084fe7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_28a9e712-8028-4c9d-aced-f034b21b46e9" xlink:to="loc_us-gaap_TemporaryEquitySharesAuthorized_e5e79544-a54e-4b68-8097-2a4e43084fe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesIssued_b3dd97ca-483c-4e09-aecb-1390da0b0805" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_28a9e712-8028-4c9d-aced-f034b21b46e9" xlink:to="loc_us-gaap_TemporaryEquitySharesIssued_b3dd97ca-483c-4e09-aecb-1390da0b0805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_1067204e-774b-4ad5-8751-fdf2d657f93d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_28a9e712-8028-4c9d-aced-f034b21b46e9" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_1067204e-774b-4ad5-8751-fdf2d657f93d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_01c5a5fe-a6b8-4eac-86c5-6ab99f7aadf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_28a9e712-8028-4c9d-aced-f034b21b46e9" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_01c5a5fe-a6b8-4eac-86c5-6ab99f7aadf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLiquidationPreference_c00f1476-e74e-437f-bcf3-39931ce39d4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_28a9e712-8028-4c9d-aced-f034b21b46e9" xlink:to="loc_us-gaap_TemporaryEquityLiquidationPreference_c00f1476-e74e-437f-bcf3-39931ce39d4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/Equity" xlink:type="simple" xlink:href="docs-20220331.xsd#Equity"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/Equity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_96e9a2f5-f1cf-4750-b6fb-f3e581fa4e25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_2548791d-b72b-4a3d-8028-6dc7a1a57a6d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_96e9a2f5-f1cf-4750-b6fb-f3e581fa4e25" xlink:to="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_2548791d-b72b-4a3d-8028-6dc7a1a57a6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityTables" xlink:type="simple" xlink:href="docs-20220331.xsd#EquityTables"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/EquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_713947fe-7d29-4340-851e-cc2e18da4d0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_6e46b250-19b4-4eb0-867a-85abd003d6cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_713947fe-7d29-4340-851e-cc2e18da4d0f" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_6e46b250-19b4-4eb0-867a-85abd003d6cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_3169293a-30c9-4bf1-b154-bdb2c71607e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_713947fe-7d29-4340-851e-cc2e18da4d0f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_3169293a-30c9-4bf1-b154-bdb2c71607e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_be353217-85bf-4bc5-8ff7-09d8b12de43e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_713947fe-7d29-4340-851e-cc2e18da4d0f" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_be353217-85bf-4bc5-8ff7-09d8b12de43e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_4013bd12-ae69-4651-af4b-3e8106a8dcf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_713947fe-7d29-4340-851e-cc2e18da4d0f" xlink:to="loc_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock_4013bd12-ae69-4651-af4b-3e8106a8dcf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_d8601130-9832-4aaa-b482-6e1270ea8ad2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_713947fe-7d29-4340-851e-cc2e18da4d0f" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_d8601130-9832-4aaa-b482-6e1270ea8ad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_8ef20774-72c3-41bc-837f-c3f7e838045b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_713947fe-7d29-4340-851e-cc2e18da4d0f" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_8ef20774-72c3-41bc-837f-c3f7e838045b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityPreferredStockDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#EquityPreferredStockDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/EquityPreferredStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_08950629-d44e-46af-9db8-d5f2d41f473a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_d023482a-9e91-4e16-94dc-be9db9c078d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_08950629-d44e-46af-9db8-d5f2d41f473a" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_d023482a-9e91-4e16-94dc-be9db9c078d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_d15ba787-3256-4e7b-99bc-a940db581ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_08950629-d44e-46af-9db8-d5f2d41f473a" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_d15ba787-3256-4e7b-99bc-a940db581ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_b98b7c5c-945c-4ee4-980a-16dd5c7055fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_08950629-d44e-46af-9db8-d5f2d41f473a" xlink:to="loc_us-gaap_PreferredStockSharesIssued_b98b7c5c-945c-4ee4-980a-16dd5c7055fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_74c9296c-251d-444b-8735-a7a5f35c152c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_08950629-d44e-46af-9db8-d5f2d41f473a" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_74c9296c-251d-444b-8735-a7a5f35c152c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityCommonStockandCreationofDualClassStructureDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#EquityCommonStockandCreationofDualClassStructureDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/EquityCommonStockandCreationofDualClassStructureDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_26fd8cf1-3fcf-4ad3-8120-6895f2415b69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fdd3e95e-8075-4f82-b62b-5a5cfe681b1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_26fd8cf1-3fcf-4ad3-8120-6895f2415b69" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fdd3e95e-8075-4f82-b62b-5a5cfe681b1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_65ddb7c0-53bc-4704-8f72-088d9648e103" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fdd3e95e-8075-4f82-b62b-5a5cfe681b1a" xlink:to="loc_us-gaap_StatementClassOfStockAxis_65ddb7c0-53bc-4704-8f72-088d9648e103" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_998f1f45-96f9-4be3-9f75-f8741b93f54c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_65ddb7c0-53bc-4704-8f72-088d9648e103" xlink:to="loc_us-gaap_ClassOfStockDomain_998f1f45-96f9-4be3-9f75-f8741b93f54c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_ea29876f-4509-40e5-a7b0-f8bb9ae38d66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_998f1f45-96f9-4be3-9f75-f8741b93f54c" xlink:to="loc_us-gaap_CommonClassAMember_ea29876f-4509-40e5-a7b0-f8bb9ae38d66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_2d7a556b-798f-4eb9-880a-15c1978a8b41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_998f1f45-96f9-4be3-9f75-f8741b93f54c" xlink:to="loc_us-gaap_CommonClassBMember_2d7a556b-798f-4eb9-880a-15c1978a8b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_9f73938f-2d12-4d89-9bd9-f63e921e57f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_998f1f45-96f9-4be3-9f75-f8741b93f54c" xlink:to="loc_us-gaap_CommonStockMember_9f73938f-2d12-4d89-9bd9-f63e921e57f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_77a0e86a-e397-4597-bdaf-542b31bc7135" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_fdd3e95e-8075-4f82-b62b-5a5cfe681b1a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_77a0e86a-e397-4597-bdaf-542b31bc7135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_ea3c0fe8-d53c-4797-a1f2-68e95f751483" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_77a0e86a-e397-4597-bdaf-542b31bc7135" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_ea3c0fe8-d53c-4797-a1f2-68e95f751483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_8df05da9-4007-4ff4-9c2e-8413ef30355a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_77a0e86a-e397-4597-bdaf-542b31bc7135" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_8df05da9-4007-4ff4-9c2e-8413ef30355a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CommonStockVotingRightsNumberOfVotes_506891f9-fc7d-48ef-a49f-47b3580d7ff5" xlink:href="docs-20220331.xsd#docs_CommonStockVotingRightsNumberOfVotes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_77a0e86a-e397-4597-bdaf-542b31bc7135" xlink:to="loc_docs_CommonStockVotingRightsNumberOfVotes_506891f9-fc7d-48ef-a49f-47b3580d7ff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_cfac3ba6-d8a7-4286-a47e-ef218ef573ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_77a0e86a-e397-4597-bdaf-542b31bc7135" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_cfac3ba6-d8a7-4286-a47e-ef218ef573ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ConversionOfStockConversionRatio_b72dec74-0384-4ea4-9317-b3da48025994" xlink:href="docs-20220331.xsd#docs_ConversionOfStockConversionRatio"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_77a0e86a-e397-4597-bdaf-542b31bc7135" xlink:to="loc_docs_ConversionOfStockConversionRatio_b72dec74-0384-4ea4-9317-b3da48025994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_73afc68b-c284-4cd9-84f7-cfa18145adca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_77a0e86a-e397-4597-bdaf-542b31bc7135" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_73afc68b-c284-4cd9-84f7-cfa18145adca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityCommonStockWarrantsDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#EquityCommonStockWarrantsDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/EquityCommonStockWarrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_c5bf966f-8ba1-48e8-b7ec-852026cb8d59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_aa98746c-0bcf-438d-a711-9aa0bad55368" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_c5bf966f-8ba1-48e8-b7ec-852026cb8d59" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_aa98746c-0bcf-438d-a711-9aa0bad55368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_1f27a717-8743-45ea-ae93-4b0c22f8572b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_aa98746c-0bcf-438d-a711-9aa0bad55368" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_1f27a717-8743-45ea-ae93-4b0c22f8572b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_07878863-e5dc-41b7-80a4-9167abb33eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_1f27a717-8743-45ea-ae93-4b0c22f8572b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_07878863-e5dc-41b7-80a4-9167abb33eb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ContractWithUSNewsWorldReportLPMember_f903d9c0-31dd-4342-8292-891567fd2158" xlink:href="docs-20220331.xsd#docs_ContractWithUSNewsWorldReportLPMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_07878863-e5dc-41b7-80a4-9167abb33eb3" xlink:to="loc_docs_ContractWithUSNewsWorldReportLPMember_f903d9c0-31dd-4342-8292-891567fd2158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_USNewsWarrantMember_ab1e2039-0dc2-4de2-8500-a619ce801284" xlink:href="docs-20220331.xsd#docs_USNewsWarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_07878863-e5dc-41b7-80a4-9167abb33eb3" xlink:to="loc_docs_USNewsWarrantMember_ab1e2039-0dc2-4de2-8500-a619ce801284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_1fe5c220-e267-4305-a01c-066e92739152" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_aa98746c-0bcf-438d-a711-9aa0bad55368" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_1fe5c220-e267-4305-a01c-066e92739152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_160530f8-5004-4464-a417-57891a9c221a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_1fe5c220-e267-4305-a01c-066e92739152" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_160530f8-5004-4464-a417-57891a9c221a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_8330b8a4-e70c-4aa2-9c29-29dc8baacd5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputSharePriceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_160530f8-5004-4464-a417-57891a9c221a" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_8330b8a4-e70c-4aa2-9c29-29dc8baacd5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_92dc08de-be80-4914-9e35-0962108f27a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_160530f8-5004-4464-a417-57891a9c221a" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_92dc08de-be80-4914-9e35-0962108f27a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_b6aadd5a-7ed4-4ec2-b6f8-122a37856121" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_160530f8-5004-4464-a417-57891a9c221a" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_b6aadd5a-7ed4-4ec2-b6f8-122a37856121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_ec9e4b54-09eb-4f04-b7e2-cc9d0e696f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_160530f8-5004-4464-a417-57891a9c221a" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_ec9e4b54-09eb-4f04-b7e2-cc9d0e696f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_33d7dd44-98cc-44a3-85a8-ed598baada27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_160530f8-5004-4464-a417-57891a9c221a" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_33d7dd44-98cc-44a3-85a8-ed598baada27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a29cb1fa-fac3-4bf0-bc04-3d4c2d088516" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_aa98746c-0bcf-438d-a711-9aa0bad55368" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a29cb1fa-fac3-4bf0-bc04-3d4c2d088516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_3a5cc31c-797a-40bc-bd19-c743fcbbed0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a29cb1fa-fac3-4bf0-bc04-3d4c2d088516" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_3a5cc31c-797a-40bc-bd19-c743fcbbed0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_bc808c45-b29a-4b74-9fe6-3e9d47152f59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a29cb1fa-fac3-4bf0-bc04-3d4c2d088516" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_bc808c45-b29a-4b74-9fe6-3e9d47152f59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_WarrantsAndRightsOutstandingVestingPeriod_6224b16d-4cd5-4f69-924a-d15f6df42d09" xlink:href="docs-20220331.xsd#docs_WarrantsAndRightsOutstandingVestingPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a29cb1fa-fac3-4bf0-bc04-3d4c2d088516" xlink:to="loc_docs_WarrantsAndRightsOutstandingVestingPeriod_6224b16d-4cd5-4f69-924a-d15f6df42d09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingTerm_850e99a1-79cc-4679-954b-3e26ac5b5862" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingTerm"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a29cb1fa-fac3-4bf0-bc04-3d4c2d088516" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingTerm_850e99a1-79cc-4679-954b-3e26ac5b5862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_77e63576-09f0-4cf4-8e0e-649c330d9b20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a29cb1fa-fac3-4bf0-bc04-3d4c2d088516" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_77e63576-09f0-4cf4-8e0e-649c330d9b20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_e543b577-8207-44db-beb0-6778c00f8a84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantsAndRightsOutstandingMeasurementInput"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a29cb1fa-fac3-4bf0-bc04-3d4c2d088516" xlink:to="loc_us-gaap_WarrantsAndRightsOutstandingMeasurementInput_e543b577-8207-44db-beb0-6778c00f8a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_8b03de3f-9e3b-45cd-9378-6c4759181e7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a29cb1fa-fac3-4bf0-bc04-3d4c2d088516" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_8b03de3f-9e3b-45cd-9378-6c4759181e7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_ab6810c4-537f-4fe1-9fd3-49db9523d2a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a29cb1fa-fac3-4bf0-bc04-3d4c2d088516" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_ab6810c4-537f-4fe1-9fd3-49db9523d2a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_082bde14-00f4-41e0-bf32-f8218d934fef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a29cb1fa-fac3-4bf0-bc04-3d4c2d088516" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_082bde14-00f4-41e0-bf32-f8218d934fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityEquityIncentivePlansDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#EquityEquityIncentivePlansDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/EquityEquityIncentivePlansDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_6fe6cd48-ac17-4117-a7cb-c10e16281d50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c7abe67f-b1d0-43da-b30e-3de047e16ddc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_6fe6cd48-ac17-4117-a7cb-c10e16281d50" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c7abe67f-b1d0-43da-b30e-3de047e16ddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_3df09b15-733b-428d-b55e-8c68f29e2eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c7abe67f-b1d0-43da-b30e-3de047e16ddc" xlink:to="loc_us-gaap_PlanNameAxis_3df09b15-733b-428d-b55e-8c68f29e2eeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_a195f592-f7ad-4978-8d3b-c005d5e7785c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_3df09b15-733b-428d-b55e-8c68f29e2eeb" xlink:to="loc_us-gaap_PlanNameDomain_a195f592-f7ad-4978-8d3b-c005d5e7785c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_EquityIncentivePlan2010Member_d88441b5-06db-4db1-bc82-97051c26ed0d" xlink:href="docs-20220331.xsd#docs_EquityIncentivePlan2010Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_a195f592-f7ad-4978-8d3b-c005d5e7785c" xlink:to="loc_docs_EquityIncentivePlan2010Member_d88441b5-06db-4db1-bc82-97051c26ed0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_StockOptionAndIncentivePlan2021Member_ef72d81c-2bf2-4f9e-8c24-4a7bab0efc46" xlink:href="docs-20220331.xsd#docs_StockOptionAndIncentivePlan2021Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_a195f592-f7ad-4978-8d3b-c005d5e7785c" xlink:to="loc_docs_StockOptionAndIncentivePlan2021Member_ef72d81c-2bf2-4f9e-8c24-4a7bab0efc46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_EmployeeStockPurchasePlan2021Member_adee5f3b-30aa-44b6-9d4b-0f92f15ba71c" xlink:href="docs-20220331.xsd#docs_EmployeeStockPurchasePlan2021Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_a195f592-f7ad-4978-8d3b-c005d5e7785c" xlink:to="loc_docs_EmployeeStockPurchasePlan2021Member_adee5f3b-30aa-44b6-9d4b-0f92f15ba71c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member_95748055-f886-46e5-ac51-380352cb9a56" xlink:href="docs-20220331.xsd#docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_a195f592-f7ad-4978-8d3b-c005d5e7785c" xlink:to="loc_docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member_95748055-f886-46e5-ac51-380352cb9a56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_3a8954c9-6434-488c-8a48-6c3802b658a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c7abe67f-b1d0-43da-b30e-3de047e16ddc" xlink:to="loc_us-gaap_GranteeStatusAxis_3a8954c9-6434-488c-8a48-6c3802b658a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_51f10cdc-67c0-4016-ae83-1256f9f17d08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GranteeStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusAxis_3a8954c9-6434-488c-8a48-6c3802b658a5" xlink:to="loc_us-gaap_GranteeStatusDomain_51f10cdc-67c0-4016-ae83-1256f9f17d08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_IndividualsWithVotingInterestLessThanThresholdMember_348910bd-1d90-4160-a25f-d0d8d649647e" xlink:href="docs-20220331.xsd#docs_IndividualsWithVotingInterestLessThanThresholdMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusDomain_51f10cdc-67c0-4016-ae83-1256f9f17d08" xlink:to="loc_docs_IndividualsWithVotingInterestLessThanThresholdMember_348910bd-1d90-4160-a25f-d0d8d649647e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_IndividualsWithVotingInterestAtThresholdMember_a547fc40-3cdb-4b2f-97a2-5069594a06cd" xlink:href="docs-20220331.xsd#docs_IndividualsWithVotingInterestAtThresholdMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusDomain_51f10cdc-67c0-4016-ae83-1256f9f17d08" xlink:to="loc_docs_IndividualsWithVotingInterestAtThresholdMember_a547fc40-3cdb-4b2f-97a2-5069594a06cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_9d30f648-e1f0-4f90-938a-61a824c25ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c7abe67f-b1d0-43da-b30e-3de047e16ddc" xlink:to="loc_us-gaap_AwardTypeAxis_9d30f648-e1f0-4f90-938a-61a824c25ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_46607ce4-33e2-4ea9-9c47-0f70d2e363c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_9d30f648-e1f0-4f90-938a-61a824c25ac5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_46607ce4-33e2-4ea9-9c47-0f70d2e363c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_2b937d10-6f1b-49f3-829a-93ca5419ade6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_46607ce4-33e2-4ea9-9c47-0f70d2e363c2" xlink:to="loc_us-gaap_EmployeeStockOptionMember_2b937d10-6f1b-49f3-829a-93ca5419ade6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb8db9b7-c10a-4c0e-8d0d-7d0f80c8e38c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c7abe67f-b1d0-43da-b30e-3de047e16ddc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb8db9b7-c10a-4c0e-8d0d-7d0f80c8e38c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock_308e82be-f53a-4d5b-9cbe-5ff8b6be07a2" xlink:href="docs-20220331.xsd#docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb8db9b7-c10a-4c0e-8d0d-7d0f80c8e38c" xlink:to="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock_308e82be-f53a-4d5b-9cbe-5ff8b6be07a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold_9572dfb5-128f-4044-bce0-64a2941e5c00" xlink:href="docs-20220331.xsd#docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb8db9b7-c10a-4c0e-8d0d-7d0f80c8e38c" xlink:to="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold_9572dfb5-128f-4044-bce0-64a2941e5c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c8478fcd-fa9c-476c-9e54-0310ddfd14fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb8db9b7-c10a-4c0e-8d0d-7d0f80c8e38c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_c8478fcd-fa9c-476c-9e54-0310ddfd14fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_02b5e91f-d649-476c-bde2-45216e79e82a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb8db9b7-c10a-4c0e-8d0d-7d0f80c8e38c" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_02b5e91f-d649-476c-bde2-45216e79e82a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_1f19ff00-52bb-429a-a05a-99dc079b46bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb8db9b7-c10a-4c0e-8d0d-7d0f80c8e38c" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_1f19ff00-52bb-429a-a05a-99dc079b46bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding_7d194c0d-3e31-47f8-9c46-60079a70bf6f" xlink:href="docs-20220331.xsd#docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb8db9b7-c10a-4c0e-8d0d-7d0f80c8e38c" xlink:to="loc_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding_7d194c0d-3e31-47f8-9c46-60079a70bf6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease_54fae8d0-e984-4bbe-8e1d-5c536e8f965c" xlink:href="docs-20220331.xsd#docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb8db9b7-c10a-4c0e-8d0d-7d0f80c8e38c" xlink:to="loc_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease_54fae8d0-e984-4bbe-8e1d-5c536e8f965c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4ee87f92-794c-4fa6-95df-fd589225ecbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb8db9b7-c10a-4c0e-8d0d-7d0f80c8e38c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4ee87f92-794c-4fa6-95df-fd589225ecbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised_e9554af4-d077-4340-9454-0a0f81a7ea47" xlink:href="docs-20220331.xsd#docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb8db9b7-c10a-4c0e-8d0d-7d0f80c8e38c" xlink:to="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised_e9554af4-d077-4340-9454-0a0f81a7ea47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2706a48d-9d19-4110-840f-8659cf6261f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bb8db9b7-c10a-4c0e-8d0d-7d0f80c8e38c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2706a48d-9d19-4110-840f-8659cf6261f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#EquityCommonStockReservedforIssuanceDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_0e2a99f5-8f45-45fe-9b89-73e1523dbc49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7fb2a6ba-9a90-4e69-8015-646724d97415" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_0e2a99f5-8f45-45fe-9b89-73e1523dbc49" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7fb2a6ba-9a90-4e69-8015-646724d97415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_44eecb64-6a59-49f9-93c7-f5fe91cf98f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7fb2a6ba-9a90-4e69-8015-646724d97415" xlink:to="loc_us-gaap_PlanNameAxis_44eecb64-6a59-49f9-93c7-f5fe91cf98f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_3ff30a02-6fed-4729-8a77-7c59b897db4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_44eecb64-6a59-49f9-93c7-f5fe91cf98f6" xlink:to="loc_us-gaap_PlanNameDomain_3ff30a02-6fed-4729-8a77-7c59b897db4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_EquityIncentivePlan2010Member_9114a589-591e-4bf6-98e0-810e72d0d27c" xlink:href="docs-20220331.xsd#docs_EquityIncentivePlan2010Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_3ff30a02-6fed-4729-8a77-7c59b897db4e" xlink:to="loc_docs_EquityIncentivePlan2010Member_9114a589-591e-4bf6-98e0-810e72d0d27c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_StockOptionAndIncentivePlan2021Member_c846bb07-6bdd-4402-9cbb-57b97911c607" xlink:href="docs-20220331.xsd#docs_StockOptionAndIncentivePlan2021Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_3ff30a02-6fed-4729-8a77-7c59b897db4e" xlink:to="loc_docs_StockOptionAndIncentivePlan2021Member_c846bb07-6bdd-4402-9cbb-57b97911c607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_EmployeeStockPurchasePlan2021Member_a9103529-3cbf-4da6-9a8a-8e7b1b24060d" xlink:href="docs-20220331.xsd#docs_EmployeeStockPurchasePlan2021Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_3ff30a02-6fed-4729-8a77-7c59b897db4e" xlink:to="loc_docs_EmployeeStockPurchasePlan2021Member_a9103529-3cbf-4da6-9a8a-8e7b1b24060d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member_0020aa2f-1012-4b8f-bfa3-c2ede9d85b30" xlink:href="docs-20220331.xsd#docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_3ff30a02-6fed-4729-8a77-7c59b897db4e" xlink:to="loc_docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member_0020aa2f-1012-4b8f-bfa3-c2ede9d85b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_fb58399c-e254-4a2b-82d8-77cfe40224ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7fb2a6ba-9a90-4e69-8015-646724d97415" xlink:to="loc_us-gaap_AwardTypeAxis_fb58399c-e254-4a2b-82d8-77cfe40224ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_84254985-85be-464b-8916-6a8a7b480115" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_fb58399c-e254-4a2b-82d8-77cfe40224ab" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_84254985-85be-464b-8916-6a8a7b480115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PerformanceBasedRestrictedStockUnitsMember_6eafa0f1-0e74-41d4-9d22-0f3420e93c5f" xlink:href="docs-20220331.xsd#docs_PerformanceBasedRestrictedStockUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_84254985-85be-464b-8916-6a8a7b480115" xlink:to="loc_docs_PerformanceBasedRestrictedStockUnitsMember_6eafa0f1-0e74-41d4-9d22-0f3420e93c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_9c21e03c-fb24-4c00-953e-7ee2556251fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_84254985-85be-464b-8916-6a8a7b480115" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_9c21e03c-fb24-4c00-953e-7ee2556251fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_2ee14d53-e836-4733-8af4-365ea75fee4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7fb2a6ba-9a90-4e69-8015-646724d97415" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_2ee14d53-e836-4733-8af4-365ea75fee4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_031e52ed-18f3-4cd3-afb6-bcbe6b33e2ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_2ee14d53-e836-4733-8af4-365ea75fee4b" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_031e52ed-18f3-4cd3-afb6-bcbe6b33e2ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_4ad54efb-0633-45a8-a5a9-413a0c51025c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_2ee14d53-e836-4733-8af4-365ea75fee4b" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_4ad54efb-0633-45a8-a5a9-413a0c51025c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_26a36896-0a62-4efa-9cea-fc9ea068b985" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_2ee14d53-e836-4733-8af4-365ea75fee4b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_26a36896-0a62-4efa-9cea-fc9ea068b985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_649cd79a-eabe-4202-b02c-1179815d912e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_2ee14d53-e836-4733-8af4-365ea75fee4b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_649cd79a-eabe-4202-b02c-1179815d912e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_70a415ec-85d8-47ec-9707-cb76496c4ec0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_2ee14d53-e836-4733-8af4-365ea75fee4b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_70a415ec-85d8-47ec-9707-cb76496c4ec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_f8a06b29-da63-4d3b-ac81-b1a622e3169f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems_2ee14d53-e836-4733-8af4-365ea75fee4b" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_f8a06b29-da63-4d3b-ac81-b1a622e3169f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityStockOptionActivityDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#EquityStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/EquityStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_85018866-e8de-419c-a51a-f6bb4a361b60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_64458fd5-09e8-4e11-be65-530795c9747a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_85018866-e8de-419c-a51a-f6bb4a361b60" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_64458fd5-09e8-4e11-be65-530795c9747a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_bfd0d7ff-1bee-455b-8f86-71e17fb44ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_64458fd5-09e8-4e11-be65-530795c9747a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_bfd0d7ff-1bee-455b-8f86-71e17fb44ab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4b7eed38-e86a-4d57-990a-b7091ea8cec9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_64458fd5-09e8-4e11-be65-530795c9747a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_4b7eed38-e86a-4d57-990a-b7091ea8cec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_f5abf538-c915-496a-b773-8668fab71f55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_64458fd5-09e8-4e11-be65-530795c9747a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_f5abf538-c915-496a-b773-8668fab71f55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_0095e11c-1c08-493f-ac84-8af83d1365b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_64458fd5-09e8-4e11-be65-530795c9747a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_0095e11c-1c08-493f-ac84-8af83d1365b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d3834bb6-00bb-451f-b917-97afcdb1b378" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_64458fd5-09e8-4e11-be65-530795c9747a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d3834bb6-00bb-451f-b917-97afcdb1b378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_96faead2-097d-4472-bfcd-7b9660079a67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_85018866-e8de-419c-a51a-f6bb4a361b60" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_96faead2-097d-4472-bfcd-7b9660079a67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_dcb63162-4fcf-44af-92f4-55c9aafa50eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_85018866-e8de-419c-a51a-f6bb4a361b60" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_dcb63162-4fcf-44af-92f4-55c9aafa50eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_153fd19c-8ba7-4b16-9800-7a8d195a6d68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_85018866-e8de-419c-a51a-f6bb4a361b60" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_153fd19c-8ba7-4b16-9800-7a8d195a6d68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_8ab74f1a-b256-4eb0-9477-11fdfb51ce11" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_153fd19c-8ba7-4b16-9800-7a8d195a6d68" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_8ab74f1a-b256-4eb0-9477-11fdfb51ce11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_bb497b2a-6604-48c3-acb4-86b9e079a7a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_153fd19c-8ba7-4b16-9800-7a8d195a6d68" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_bb497b2a-6604-48c3-acb4-86b9e079a7a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d884f00f-a920-4dd1-b406-72927fdae7a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_153fd19c-8ba7-4b16-9800-7a8d195a6d68" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d884f00f-a920-4dd1-b406-72927fdae7a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_eea98d0c-ce4b-463c-b9d3-583856e03fd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_153fd19c-8ba7-4b16-9800-7a8d195a6d68" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_eea98d0c-ce4b-463c-b9d3-583856e03fd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_724b6814-f525-496e-a930-07883d0c914e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_153fd19c-8ba7-4b16-9800-7a8d195a6d68" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_724b6814-f525-496e-a930-07883d0c914e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_69fc658f-ac78-4b94-b61b-d720df4eeeb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_85018866-e8de-419c-a51a-f6bb4a361b60" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_69fc658f-ac78-4b94-b61b-d720df4eeeb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_9ee062e9-09b1-49c8-b7a3-b7da330deb58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_85018866-e8de-419c-a51a-f6bb4a361b60" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_9ee062e9-09b1-49c8-b7a3-b7da330deb58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_bec4513a-99ea-403e-ac40-3bcf859d6d78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_85018866-e8de-419c-a51a-f6bb4a361b60" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_bec4513a-99ea-403e-ac40-3bcf859d6d78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_6acff810-b81e-4dc0-9e19-fa60570d0f19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_bec4513a-99ea-403e-ac40-3bcf859d6d78" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_6acff810-b81e-4dc0-9e19-fa60570d0f19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_6b372afd-fefd-4b59-b578-94cadd47b44c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_bec4513a-99ea-403e-ac40-3bcf859d6d78" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_6b372afd-fefd-4b59-b578-94cadd47b44c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_c2464f46-3276-4539-9de2-e7f1e940a057" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_bec4513a-99ea-403e-ac40-3bcf859d6d78" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_c2464f46-3276-4539-9de2-e7f1e940a057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_9ac7dfc1-4f39-4cb2-8089-db1baff3309b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_bec4513a-99ea-403e-ac40-3bcf859d6d78" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_9ac7dfc1-4f39-4cb2-8089-db1baff3309b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_320bff80-4200-436c-b018-ac2eefaedad6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_bec4513a-99ea-403e-ac40-3bcf859d6d78" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_320bff80-4200-436c-b018-ac2eefaedad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_8e01b344-5204-4bfa-9587-3a721601b7c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_bec4513a-99ea-403e-ac40-3bcf859d6d78" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_8e01b344-5204-4bfa-9587-3a721601b7c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityStockOptionsDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#EquityStockOptionsDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/EquityStockOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_8d005504-2094-4ec4-aa6c-e695060330e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_845feb3b-162f-4b99-93f1-baa2f677fffc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_8d005504-2094-4ec4-aa6c-e695060330e1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_845feb3b-162f-4b99-93f1-baa2f677fffc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_fd967453-720e-4be7-bff8-04eb0c30ba3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_8d005504-2094-4ec4-aa6c-e695060330e1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_fd967453-720e-4be7-bff8-04eb0c30ba3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_4ccb7765-6b15-4028-aefe-51f15c05550a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_8d005504-2094-4ec4-aa6c-e695060330e1" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_4ccb7765-6b15-4028-aefe-51f15c05550a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_b4d81946-21ef-449d-99fb-df9b06a0b3a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_8d005504-2094-4ec4-aa6c-e695060330e1" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_b4d81946-21ef-449d-99fb-df9b06a0b3a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#EquityStockOptionsValuationAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_45753e73-a67f-4ce8-9d60-ee3021dd037c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c44429be-75ee-4a3f-a0bb-8de2d5189b3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_45753e73-a67f-4ce8-9d60-ee3021dd037c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c44429be-75ee-4a3f-a0bb-8de2d5189b3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_79c503e7-2276-43d7-86c8-1542ac3e4fd4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c44429be-75ee-4a3f-a0bb-8de2d5189b3a" xlink:to="loc_srt_RangeAxis_79c503e7-2276-43d7-86c8-1542ac3e4fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fb6b7fa6-2105-4cac-95f7-6a5bb47ed57a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_79c503e7-2276-43d7-86c8-1542ac3e4fd4" xlink:to="loc_srt_RangeMember_fb6b7fa6-2105-4cac-95f7-6a5bb47ed57a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c8c65446-c23e-41dd-87d1-81e556c98cc2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_fb6b7fa6-2105-4cac-95f7-6a5bb47ed57a" xlink:to="loc_srt_MinimumMember_c8c65446-c23e-41dd-87d1-81e556c98cc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_c1531511-d0d1-4172-9ce8-f14067e77f8f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_fb6b7fa6-2105-4cac-95f7-6a5bb47ed57a" xlink:to="loc_srt_MaximumMember_c1531511-d0d1-4172-9ce8-f14067e77f8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_5aa9a40f-f6c4-44f7-b0e2-4e08b054cb0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c44429be-75ee-4a3f-a0bb-8de2d5189b3a" xlink:to="loc_us-gaap_AwardTypeAxis_5aa9a40f-f6c4-44f7-b0e2-4e08b054cb0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_29f6cbbb-e343-4dfe-8232-337a90654e6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_5aa9a40f-f6c4-44f7-b0e2-4e08b054cb0f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_29f6cbbb-e343-4dfe-8232-337a90654e6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_a6e2355d-7666-4e61-baff-0e0da813153c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_29f6cbbb-e343-4dfe-8232-337a90654e6b" xlink:to="loc_us-gaap_EmployeeStockOptionMember_a6e2355d-7666-4e61-baff-0e0da813153c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9baa90a-915e-4539-ad39-bf4b1a933ac2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c44429be-75ee-4a3f-a0bb-8de2d5189b3a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9baa90a-915e-4539-ad39-bf4b1a933ac2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice_ab9cee5d-a92e-4261-ae8c-ff50fbedfdd1" xlink:href="docs-20220331.xsd#docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9baa90a-915e-4539-ad39-bf4b1a933ac2" xlink:to="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice_ab9cee5d-a92e-4261-ae8c-ff50fbedfdd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_5b32aeab-a9ad-4056-a131-f96e189d7204" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9baa90a-915e-4539-ad39-bf4b1a933ac2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_5b32aeab-a9ad-4056-a131-f96e189d7204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_2623dbda-bac7-41bc-94f4-a0af6bc01954" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9baa90a-915e-4539-ad39-bf4b1a933ac2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_2623dbda-bac7-41bc-94f4-a0af6bc01954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_35484ffd-2ab0-4eba-acba-3a3a5bae4f16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9baa90a-915e-4539-ad39-bf4b1a933ac2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_35484ffd-2ab0-4eba-acba-3a3a5bae4f16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_d803f9da-6c2c-4ebd-8f5e-9271d3e1bd7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9baa90a-915e-4539-ad39-bf4b1a933ac2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_d803f9da-6c2c-4ebd-8f5e-9271d3e1bd7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ce3019db-77e3-4240-8d91-5f087f8c32d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9baa90a-915e-4539-ad39-bf4b1a933ac2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ce3019db-77e3-4240-8d91-5f087f8c32d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_4327d7ba-97ff-4022-b07e-8a9118a9d96d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9baa90a-915e-4539-ad39-bf4b1a933ac2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_4327d7ba-97ff-4022-b07e-8a9118a9d96d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityPerformanceBasedOptionsDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#EquityPerformanceBasedOptionsDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/EquityPerformanceBasedOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_dc05c852-f359-47aa-afa5-25b2ffd17cd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_38676193-2ece-4da0-926e-e90cde7ee9b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_dc05c852-f359-47aa-afa5-25b2ffd17cd1" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_38676193-2ece-4da0-926e-e90cde7ee9b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_e3fc641e-a051-422c-990a-26aaf4240ef1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_38676193-2ece-4da0-926e-e90cde7ee9b2" xlink:to="loc_srt_TitleOfIndividualAxis_e3fc641e-a051-422c-990a-26aaf4240ef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_02b5927a-cf3b-435e-942d-f2f2c30feef2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_e3fc641e-a051-422c-990a-26aaf4240ef1" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_02b5927a-cf3b-435e-942d-f2f2c30feef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_8e89722e-7b0a-4fbb-8a39-c16fb68dad7b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_02b5927a-cf3b-435e-942d-f2f2c30feef2" xlink:to="loc_srt_ChiefExecutiveOfficerMember_8e89722e-7b0a-4fbb-8a39-c16fb68dad7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_94e18d39-1195-45df-8875-8591b86d8467" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_38676193-2ece-4da0-926e-e90cde7ee9b2" xlink:to="loc_us-gaap_AwardTypeAxis_94e18d39-1195-45df-8875-8591b86d8467" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_42bf53ae-8df8-4485-b531-2993402e4175" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_94e18d39-1195-45df-8875-8591b86d8467" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_42bf53ae-8df8-4485-b531-2993402e4175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_d40eca49-3cb7-455b-ac17-5db90000bf97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_42bf53ae-8df8-4485-b531-2993402e4175" xlink:to="loc_us-gaap_PerformanceSharesMember_d40eca49-3cb7-455b-ac17-5db90000bf97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a67aa495-bd37-48d6-af7d-b98a28de633a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_38676193-2ece-4da0-926e-e90cde7ee9b2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a67aa495-bd37-48d6-af7d-b98a28de633a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_dcd2ea5a-f7b3-45e7-a7d8-25fff9202993" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a67aa495-bd37-48d6-af7d-b98a28de633a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_dcd2ea5a-f7b3-45e7-a7d8-25fff9202993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_7257f9ca-6424-4f78-957e-15ada43017e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a67aa495-bd37-48d6-af7d-b98a28de633a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_7257f9ca-6424-4f78-957e-15ada43017e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_f2b7be13-fb30-4d79-9847-03c72e033da6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a67aa495-bd37-48d6-af7d-b98a28de633a" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_f2b7be13-fb30-4d79-9847-03c72e033da6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_7e883f2a-1c20-4548-bd8c-3782a6a04da7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a67aa495-bd37-48d6-af7d-b98a28de633a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_7e883f2a-1c20-4548-bd8c-3782a6a04da7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_ba78acec-404f-4343-951d-cef1d4b5613f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a67aa495-bd37-48d6-af7d-b98a28de633a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_ba78acec-404f-4343-951d-cef1d4b5613f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_db58c1f4-3803-4073-9f38-a2be94c7ca92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a67aa495-bd37-48d6-af7d-b98a28de633a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_db58c1f4-3803-4073-9f38-a2be94c7ca92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityRestrictedStockUnitsDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#EquityRestrictedStockUnitsDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/EquityRestrictedStockUnitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_669c589b-bed6-457b-b7f5-3990ff81b168" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6462d23b-47ac-407a-8f2b-4192386c83bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_669c589b-bed6-457b-b7f5-3990ff81b168" xlink:to="loc_us-gaap_AwardTypeAxis_6462d23b-47ac-407a-8f2b-4192386c83bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8fbc47ff-1c7a-4a91-9c5e-cdcb76efdee5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_6462d23b-47ac-407a-8f2b-4192386c83bf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8fbc47ff-1c7a-4a91-9c5e-cdcb76efdee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_c18373c1-65fd-4ccc-8cdd-8fd1a1ac5062" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8fbc47ff-1c7a-4a91-9c5e-cdcb76efdee5" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_c18373c1-65fd-4ccc-8cdd-8fd1a1ac5062" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_d3c27c5e-3620-429f-bdd2-584308f50236" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_669c589b-bed6-457b-b7f5-3990ff81b168" xlink:to="loc_us-gaap_VestingAxis_d3c27c5e-3620-429f-bdd2-584308f50236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_744275fb-bd1a-475b-8b89-9260bc98532e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_d3c27c5e-3620-429f-bdd2-584308f50236" xlink:to="loc_us-gaap_VestingDomain_744275fb-bd1a-475b-8b89-9260bc98532e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ShareBasedPaymentArrangementTrancheOneAndTrancheTwoMember_1b02b4f0-d8f8-4672-87b4-e8d4c9a62fff" xlink:href="docs-20220331.xsd#docs_ShareBasedPaymentArrangementTrancheOneAndTrancheTwoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_744275fb-bd1a-475b-8b89-9260bc98532e" xlink:to="loc_docs_ShareBasedPaymentArrangementTrancheOneAndTrancheTwoMember_1b02b4f0-d8f8-4672-87b4-e8d4c9a62fff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_509ac95c-bcb2-48f5-a367-3e704e5d6d6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_docs_ShareBasedPaymentArrangementTrancheOneAndTrancheTwoMember_1b02b4f0-d8f8-4672-87b4-e8d4c9a62fff" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheOneMember_509ac95c-bcb2-48f5-a367-3e704e5d6d6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_b3f3c3c6-dbb8-482f-af4e-41bc5b227b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_docs_ShareBasedPaymentArrangementTrancheOneAndTrancheTwoMember_1b02b4f0-d8f8-4672-87b4-e8d4c9a62fff" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_b3f3c3c6-dbb8-482f-af4e-41bc5b227b3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_08200897-96ee-4530-a4be-2696cabaa276" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_744275fb-bd1a-475b-8b89-9260bc98532e" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_08200897-96ee-4530-a4be-2696cabaa276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_03b2aae7-c5db-443f-ab4f-90ba0399bba7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_669c589b-bed6-457b-b7f5-3990ff81b168" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_03b2aae7-c5db-443f-ab4f-90ba0399bba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_962b3f25-b870-4784-8b5c-1e7f3301a986" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_03b2aae7-c5db-443f-ab4f-90ba0399bba7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_962b3f25-b870-4784-8b5c-1e7f3301a986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_be219fdb-f8f7-4481-8c71-e0bfb0440442" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_03b2aae7-c5db-443f-ab4f-90ba0399bba7" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_be219fdb-f8f7-4481-8c71-e0bfb0440442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_468903cc-107d-46e2-a1fb-91a48e4562c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_03b2aae7-c5db-443f-ab4f-90ba0399bba7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_468903cc-107d-46e2-a1fb-91a48e4562c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_76c2ce86-c848-4e77-b18b-e476ef48ce70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_03b2aae7-c5db-443f-ab4f-90ba0399bba7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_76c2ce86-c848-4e77-b18b-e476ef48ce70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_ffe6f88a-0d44-4d83-a893-5a52655d4ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_03b2aae7-c5db-443f-ab4f-90ba0399bba7" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_ffe6f88a-0d44-4d83-a893-5a52655d4ac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_5f9ff335-1b98-45a6-9f10-6842dce7442e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_03b2aae7-c5db-443f-ab4f-90ba0399bba7" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_5f9ff335-1b98-45a6-9f10-6842dce7442e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_0ae35afc-aa9e-4107-a48b-acf4d7154b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_03b2aae7-c5db-443f-ab4f-90ba0399bba7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_0ae35afc-aa9e-4107-a48b-acf4d7154b8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#EquityRestrictedStockUnitActivityDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_fce11ae2-0324-4062-94ae-bcce45c98c47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b5093299-8c46-4285-9598-fca39ddc4ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_fce11ae2-0324-4062-94ae-bcce45c98c47" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b5093299-8c46-4285-9598-fca39ddc4ce9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_78888d90-3a2a-4a3a-aab3-4febb5179736" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b5093299-8c46-4285-9598-fca39ddc4ce9" xlink:to="loc_us-gaap_AwardTypeAxis_78888d90-3a2a-4a3a-aab3-4febb5179736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0b927418-7211-4ec6-bdcc-145cfe7d3c9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_78888d90-3a2a-4a3a-aab3-4febb5179736" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0b927418-7211-4ec6-bdcc-145cfe7d3c9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_d9737dc5-88cb-443f-9b70-39bc7cd610d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0b927418-7211-4ec6-bdcc-145cfe7d3c9a" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_d9737dc5-88cb-443f-9b70-39bc7cd610d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_033e270c-8bef-4855-8035-211ec561b1e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b5093299-8c46-4285-9598-fca39ddc4ce9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_033e270c-8bef-4855-8035-211ec561b1e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7a02db76-82db-4e35-9657-c8715f71d8cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_033e270c-8bef-4855-8035-211ec561b1e9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7a02db76-82db-4e35-9657-c8715f71d8cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1a991df1-0b7c-436e-85d9-2dcad12ae687" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7a02db76-82db-4e35-9657-c8715f71d8cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1a991df1-0b7c-436e-85d9-2dcad12ae687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_76f7b470-3889-44df-9cd3-5b896a449d48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7a02db76-82db-4e35-9657-c8715f71d8cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_76f7b470-3889-44df-9cd3-5b896a449d48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_777c8b63-8db3-494d-ac70-47156e826bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7a02db76-82db-4e35-9657-c8715f71d8cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_777c8b63-8db3-494d-ac70-47156e826bf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_ca2b12e7-57b5-4e90-96d6-56d7c207163d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7a02db76-82db-4e35-9657-c8715f71d8cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_ca2b12e7-57b5-4e90-96d6-56d7c207163d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8195e647-2da8-447c-9118-e3ff866f808e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_7a02db76-82db-4e35-9657-c8715f71d8cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8195e647-2da8-447c-9118-e3ff866f808e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fd8257b4-c3b1-4198-80aa-75663c7d7132" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_033e270c-8bef-4855-8035-211ec561b1e9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fd8257b4-c3b1-4198-80aa-75663c7d7132" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_faa733fa-33a5-4e83-bd5f-b8f24b5ace1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fd8257b4-c3b1-4198-80aa-75663c7d7132" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_faa733fa-33a5-4e83-bd5f-b8f24b5ace1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_95230ba8-0169-42f0-992f-b4adb4125a5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fd8257b4-c3b1-4198-80aa-75663c7d7132" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_95230ba8-0169-42f0-992f-b4adb4125a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_e908a41c-1845-4fd2-99fe-b140b4de5e32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fd8257b4-c3b1-4198-80aa-75663c7d7132" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_e908a41c-1845-4fd2-99fe-b140b4de5e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_35cefc14-a4f0-4733-a4b2-3920c3af866f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fd8257b4-c3b1-4198-80aa-75663c7d7132" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_35cefc14-a4f0-4733-a4b2-3920c3af866f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_bd6c4976-cef2-48f4-9fba-eba82677011a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fd8257b4-c3b1-4198-80aa-75663c7d7132" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_bd6c4976-cef2-48f4-9fba-eba82677011a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#EquityPerformanceBasedRestrictedStockUnitsDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_438abb50-568a-40c1-a2c2-21aa6a627dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_422f9e83-80a1-424e-861d-378789a96c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_438abb50-568a-40c1-a2c2-21aa6a627dd9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_422f9e83-80a1-424e-861d-378789a96c2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_886a2ef3-207e-41be-a4dc-f091ea2119b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_422f9e83-80a1-424e-861d-378789a96c2f" xlink:to="loc_us-gaap_AwardTypeAxis_886a2ef3-207e-41be-a4dc-f091ea2119b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6a8a1eeb-be73-46e1-af8d-e47dc588b4dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_886a2ef3-207e-41be-a4dc-f091ea2119b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6a8a1eeb-be73-46e1-af8d-e47dc588b4dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PerformanceBasedRestrictedStockUnitsMember_d4d5fc2d-07c6-42b0-ad11-01b1de651d4f" xlink:href="docs-20220331.xsd#docs_PerformanceBasedRestrictedStockUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6a8a1eeb-be73-46e1-af8d-e47dc588b4dc" xlink:to="loc_docs_PerformanceBasedRestrictedStockUnitsMember_d4d5fc2d-07c6-42b0-ad11-01b1de651d4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e8548bf-6429-4602-b0f0-c9ba459c66fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_422f9e83-80a1-424e-861d-378789a96c2f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e8548bf-6429-4602-b0f0-c9ba459c66fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_54e2e510-0d95-40f7-a69f-70c3bea9d447" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e8548bf-6429-4602-b0f0-c9ba459c66fb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_54e2e510-0d95-40f7-a69f-70c3bea9d447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a75e1f4a-d58e-4a32-b812-3331f53aa220" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e8548bf-6429-4602-b0f0-c9ba459c66fb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a75e1f4a-d58e-4a32-b812-3331f53aa220" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_36e25fd1-966d-48b4-9fea-4fde7fa65218" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e8548bf-6429-4602-b0f0-c9ba459c66fb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_36e25fd1-966d-48b4-9fea-4fde7fa65218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_60cf496e-c804-4f7f-a234-54211cb293b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e8548bf-6429-4602-b0f0-c9ba459c66fb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_60cf496e-c804-4f7f-a234-54211cb293b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_c2e9e74d-4208-4905-89f2-900b5aca59cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e8548bf-6429-4602-b0f0-c9ba459c66fb" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_c2e9e74d-4208-4905-89f2-900b5aca59cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_9a2de25d-2404-44ce-b7e2-176a5d0e6afe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e8548bf-6429-4602-b0f0-c9ba459c66fb" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_9a2de25d-2404-44ce-b7e2-176a5d0e6afe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_23b82dfc-aea5-4c05-92a0-f89fceae2d09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e8548bf-6429-4602-b0f0-c9ba459c66fb" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_23b82dfc-aea5-4c05-92a0-f89fceae2d09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_e4928735-9b48-429b-9b44-8bb26fbd2194" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3e8548bf-6429-4602-b0f0-c9ba459c66fb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_e4928735-9b48-429b-9b44-8bb26fbd2194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityEmployeeStockPurchasePlanDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#EquityEmployeeStockPurchasePlanDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/EquityEmployeeStockPurchasePlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_7ff852c2-b66b-466f-9bd2-78d27d6cb403" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_35f0cf98-1add-4e83-a701-efe8c5493428" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_7ff852c2-b66b-466f-9bd2-78d27d6cb403" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_35f0cf98-1add-4e83-a701-efe8c5493428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_aa3a8cb6-6988-4652-8ea0-8cb9c47bb61b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_35f0cf98-1add-4e83-a701-efe8c5493428" xlink:to="loc_us-gaap_AwardTypeAxis_aa3a8cb6-6988-4652-8ea0-8cb9c47bb61b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f1f36668-133a-477b-9ab4-dfb093fbb49d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_aa3a8cb6-6988-4652-8ea0-8cb9c47bb61b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f1f36668-133a-477b-9ab4-dfb093fbb49d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_c57bc817-a5cd-4cbb-9bd9-99de95135158" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f1f36668-133a-477b-9ab4-dfb093fbb49d" xlink:to="loc_us-gaap_EmployeeStockMember_c57bc817-a5cd-4cbb-9bd9-99de95135158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e15f19e-715e-4711-be75-674e5f7de460" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_35f0cf98-1add-4e83-a701-efe8c5493428" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e15f19e-715e-4711-be75-674e5f7de460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_443c5179-246c-47b5-93e4-dbc7cdb9a405" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e15f19e-715e-4711-be75-674e5f7de460" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent_443c5179-246c-47b5-93e4-dbc7cdb9a405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a9c15026-c5e3-412a-8d26-6486b56922d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e15f19e-715e-4711-be75-674e5f7de460" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a9c15026-c5e3-412a-8d26-6486b56922d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_9965b0c1-7a9e-44a4-a822-1d720aac53ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e15f19e-715e-4711-be75-674e5f7de460" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_9965b0c1-7a9e-44a4-a822-1d720aac53ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_270e6cf8-51dc-474d-928f-da7aac48f479" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e15f19e-715e-4711-be75-674e5f7de460" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_270e6cf8-51dc-474d-928f-da7aac48f479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_1cc4a8de-ce2d-4494-9d98-1b6ad0b9304a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e15f19e-715e-4711-be75-674e5f7de460" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod_1cc4a8de-ce2d-4494-9d98-1b6ad0b9304a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPricesPerShareIssued_53009889-6c8a-4566-b8cc-206e6c82ad71" xlink:href="docs-20220331.xsd#docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPricesPerShareIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0e15f19e-715e-4711-be75-674e5f7de460" xlink:to="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPricesPerShareIssued_53009889-6c8a-4566-b8cc-206e6c82ad71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityEmployeeStockPurchasePlanValuationAssumptionsDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#EquityEmployeeStockPurchasePlanValuationAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/EquityEmployeeStockPurchasePlanValuationAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_dadd427b-1cf1-4168-9e0a-82f7db4dbd94" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4a89a456-a105-4c6b-8b56-57825297a4ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_dadd427b-1cf1-4168-9e0a-82f7db4dbd94" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4a89a456-a105-4c6b-8b56-57825297a4ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a1c16827-7b5a-4a90-b445-e32d519e3bfc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4a89a456-a105-4c6b-8b56-57825297a4ad" xlink:to="loc_us-gaap_AwardTypeAxis_a1c16827-7b5a-4a90-b445-e32d519e3bfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_443730c1-e2b0-4c79-b0b3-ed078b6b6f28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_a1c16827-7b5a-4a90-b445-e32d519e3bfc" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_443730c1-e2b0-4c79-b0b3-ed078b6b6f28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_d2111c31-4556-477e-87b7-d0361f27c8e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_443730c1-e2b0-4c79-b0b3-ed078b6b6f28" xlink:to="loc_us-gaap_EmployeeStockMember_d2111c31-4556-477e-87b7-d0361f27c8e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6a1744d4-146a-401a-a25e-67573530c36b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4a89a456-a105-4c6b-8b56-57825297a4ad" xlink:to="loc_srt_RangeAxis_6a1744d4-146a-401a-a25e-67573530c36b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_595a470b-5ce5-4e24-a14f-a57d8648672f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6a1744d4-146a-401a-a25e-67573530c36b" xlink:to="loc_srt_RangeMember_595a470b-5ce5-4e24-a14f-a57d8648672f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0768d70b-2429-4943-bfd0-24e9dad811a8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_595a470b-5ce5-4e24-a14f-a57d8648672f" xlink:to="loc_srt_MinimumMember_0768d70b-2429-4943-bfd0-24e9dad811a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_149cc70c-88c3-45a3-a737-21187d7ba20b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_595a470b-5ce5-4e24-a14f-a57d8648672f" xlink:to="loc_srt_MaximumMember_149cc70c-88c3-45a3-a737-21187d7ba20b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d0d25c6-2088-4998-a5f3-18984e2c9bd6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4a89a456-a105-4c6b-8b56-57825297a4ad" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d0d25c6-2088-4998-a5f3-18984e2c9bd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice_08cb8d54-000e-42c3-8bc4-2c372f628423" xlink:href="docs-20220331.xsd#docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d0d25c6-2088-4998-a5f3-18984e2c9bd6" xlink:to="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice_08cb8d54-000e-42c3-8bc4-2c372f628423" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_9bb8042f-5db2-4cf7-a0f4-d9e809f57a7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d0d25c6-2088-4998-a5f3-18984e2c9bd6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_9bb8042f-5db2-4cf7-a0f4-d9e809f57a7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_28767404-da8a-4c20-8df7-a5c1828aff47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d0d25c6-2088-4998-a5f3-18984e2c9bd6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_28767404-da8a-4c20-8df7-a5c1828aff47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_8e880734-4f89-4095-8d82-01db4cc41780" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d0d25c6-2088-4998-a5f3-18984e2c9bd6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_8e880734-4f89-4095-8d82-01db4cc41780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_79debebd-cb65-4ec3-8189-840febb44fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d0d25c6-2088-4998-a5f3-18984e2c9bd6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_79debebd-cb65-4ec3-8189-840febb44fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_8c8868f5-8db2-4b87-92da-5d68b31a99b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d0d25c6-2088-4998-a5f3-18984e2c9bd6" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_8c8868f5-8db2-4b87-92da-5d68b31a99b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_456b114c-37be-4c29-ac8a-c712aa3f2a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9d0d25c6-2088-4998-a5f3-18984e2c9bd6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_456b114c-37be-4c29-ac8a-c712aa3f2a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EquityStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#EquityStockBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/EquityStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_b23c6d5a-48f8-4c6a-9c48-91171c79998b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4bfb7118-5129-4d5b-a85d-aac267f1160c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_b23c6d5a-48f8-4c6a-9c48-91171c79998b" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4bfb7118-5129-4d5b-a85d-aac267f1160c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_d806f436-b7a5-41fd-bf1d-13898a63d727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4bfb7118-5129-4d5b-a85d-aac267f1160c" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_d806f436-b7a5-41fd-bf1d-13898a63d727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c657381e-8270-46cb-9186-3c32ac6ed090" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d806f436-b7a5-41fd-bf1d-13898a63d727" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c657381e-8270-46cb-9186-3c32ac6ed090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_64403d54-3e60-4444-a9e9-26adb6deb8cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c657381e-8270-46cb-9186-3c32ac6ed090" xlink:to="loc_us-gaap_CostOfSalesMember_64403d54-3e60-4444-a9e9-26adb6deb8cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_22e38bc3-380a-42ec-ba85-a403afaa28b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c657381e-8270-46cb-9186-3c32ac6ed090" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_22e38bc3-380a-42ec-ba85-a403afaa28b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_aba03a1a-3a03-4a80-95e1-8a717304e2c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c657381e-8270-46cb-9186-3c32ac6ed090" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_aba03a1a-3a03-4a80-95e1-8a717304e2c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_03bf7502-3c63-4c3d-9c2c-281ed17e3774" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_c657381e-8270-46cb-9186-3c32ac6ed090" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_03bf7502-3c63-4c3d-9c2c-281ed17e3774" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e5e6d811-2f69-4962-b605-d01ca5c5b191" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4bfb7118-5129-4d5b-a85d-aac267f1160c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e5e6d811-2f69-4962-b605-d01ca5c5b191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_3be9f700-5159-41e4-8369-950f65e6be33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e5e6d811-2f69-4962-b605-d01ca5c5b191" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_3be9f700-5159-41e4-8369-950f65e6be33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholders" xlink:type="simple" xlink:href="docs-20220331.xsd#NetIncomePerShareAttributabletoCommonStockholders"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholders" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_0d93e351-a2f4-4965-b9ef-923dc1d046de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_a63ed9ae-a2ca-4e4e-b5bc-cff03a6d82e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_0d93e351-a2f4-4965-b9ef-923dc1d046de" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_a63ed9ae-a2ca-4e4e-b5bc-cff03a6d82e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersTables" xlink:type="simple" xlink:href="docs-20220331.xsd#NetIncomePerShareAttributabletoCommonStockholdersTables"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_1ea4fbbd-6089-428e-9ef1-4462e88fdd36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_d73834cc-5079-43ac-b44e-b860dc7d565d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1ea4fbbd-6089-428e-9ef1-4462e88fdd36" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_d73834cc-5079-43ac-b44e-b860dc7d565d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_157cd0a7-1338-479d-8a5e-cb8ed5f5ffdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_1ea4fbbd-6089-428e-9ef1-4462e88fdd36" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_157cd0a7-1338-479d-8a5e-cb8ed5f5ffdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_ce683c7d-0938-4766-9325-a6dfeffbb0ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_6df59947-1720-4e98-b298-2629a53ad5d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ce683c7d-0938-4766-9325-a6dfeffbb0ff" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_6df59947-1720-4e98-b298-2629a53ad5d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_da1686d0-9248-40bf-9def-0b993ace4bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_6df59947-1720-4e98-b298-2629a53ad5d6" xlink:to="loc_us-gaap_AwardTypeAxis_da1686d0-9248-40bf-9def-0b993ace4bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_37f502dc-6be2-4467-8db3-e65997e4a56b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_da1686d0-9248-40bf-9def-0b993ace4bd2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_37f502dc-6be2-4467-8db3-e65997e4a56b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_d74b4345-0e8f-4a39-b18f-f3c6cb2666e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_37f502dc-6be2-4467-8db3-e65997e4a56b" xlink:to="loc_us-gaap_EmployeeStockOptionMember_d74b4345-0e8f-4a39-b18f-f3c6cb2666e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_OtherShareBasedAwardsMember_4675de99-d1a9-4229-9da8-bba399bdd6b6" xlink:href="docs-20220331.xsd#docs_OtherShareBasedAwardsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_37f502dc-6be2-4467-8db3-e65997e4a56b" xlink:to="loc_docs_OtherShareBasedAwardsMember_4675de99-d1a9-4229-9da8-bba399bdd6b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_d588bbca-1e4c-4dd5-b257-075642ed247a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_6df59947-1720-4e98-b298-2629a53ad5d6" xlink:to="loc_us-gaap_EarningsPerShareBasicLineItems_d588bbca-1e4c-4dd5-b257-075642ed247a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract_301bf128-12af-4cd5-9675-721752a14f81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_d588bbca-1e4c-4dd5-b257-075642ed247a" xlink:to="loc_us-gaap_EarningsPerShareReconciliationAbstract_301bf128-12af-4cd5-9675-721752a14f81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_14b56d72-2d63-404f-b217-2fda9eb6615c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_301bf128-12af-4cd5-9675-721752a14f81" xlink:to="loc_us-gaap_NetIncomeLoss_14b56d72-2d63-404f-b217-2fda9eb6615c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_e208b875-dc51-44f9-9176-618fca7290bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_301bf128-12af-4cd5-9675-721752a14f81" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic_e208b875-dc51-44f9-9176-618fca7290bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_cf84f184-7ab1-44c1-a6a8-f8eef55219c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_301bf128-12af-4cd5-9675-721752a14f81" xlink:to="loc_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted_cf84f184-7ab1-44c1-a6a8-f8eef55219c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_72f7596e-8dd2-41d1-a466-81387ea72c8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_301bf128-12af-4cd5-9675-721752a14f81" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_72f7596e-8dd2-41d1-a466-81387ea72c8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_aa011fa0-4f21-4353-9fd8-87286d148912" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_301bf128-12af-4cd5-9675-721752a14f81" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_aa011fa0-4f21-4353-9fd8-87286d148912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_e57a0462-2c3a-4b3f-8844-2b0b571fcdf1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_d588bbca-1e4c-4dd5-b257-075642ed247a" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_e57a0462-2c3a-4b3f-8844-2b0b571fcdf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_01e850e5-55ca-4dd5-bba4-4f9f8a67497a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_e57a0462-2c3a-4b3f-8844-2b0b571fcdf1" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_01e850e5-55ca-4dd5-bba4-4f9f8a67497a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_81152c0c-f0df-4a73-8358-a6ef7ec1c03b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_e57a0462-2c3a-4b3f-8844-2b0b571fcdf1" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_81152c0c-f0df-4a73-8358-a6ef7ec1c03b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_6f281100-4a70-424b-8dc4-c1fad18cdc33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_e57a0462-2c3a-4b3f-8844-2b0b571fcdf1" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_6f281100-4a70-424b-8dc4-c1fad18cdc33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e73df9ac-b7fb-4a7d-bcba-eff0a3f21454" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_e57a0462-2c3a-4b3f-8844-2b0b571fcdf1" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e73df9ac-b7fb-4a7d-bcba-eff0a3f21454" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_3ecd161a-c8ab-472d-a121-e389986fa35d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_d588bbca-1e4c-4dd5-b257-075642ed247a" xlink:to="loc_us-gaap_EarningsPerShareBasic_3ecd161a-c8ab-472d-a121-e389986fa35d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_2b874605-faf0-4b47-b1ea-ab74e4f4a8e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_d588bbca-1e4c-4dd5-b257-075642ed247a" xlink:to="loc_us-gaap_EarningsPerShareDiluted_2b874605-faf0-4b47-b1ea-ab74e4f4a8e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersAntidilutiveSecuritiesExcludedfromComputationofNetIncomePerShareDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#NetIncomePerShareAttributabletoCommonStockholdersAntidilutiveSecuritiesExcludedfromComputationofNetIncomePerShareDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersAntidilutiveSecuritiesExcludedfromComputationofNetIncomePerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_c991d174-e136-44ea-8ac2-9cc82eb20b96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1eb34036-a5c5-4e5b-bce8-acbd569680fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c991d174-e136-44ea-8ac2-9cc82eb20b96" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1eb34036-a5c5-4e5b-bce8-acbd569680fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7c7adbd7-c453-481c-91e6-e9414858fbaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1eb34036-a5c5-4e5b-bce8-acbd569680fd" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7c7adbd7-c453-481c-91e6-e9414858fbaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1c3e54e4-215e-4d0e-b51c-3ef267d471b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7c7adbd7-c453-481c-91e6-e9414858fbaa" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1c3e54e4-215e-4d0e-b51c-3ef267d471b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableConvertiblePreferredStockMember_942c257f-3974-4488-9c64-b75505660205" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemableConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1c3e54e4-215e-4d0e-b51c-3ef267d471b5" xlink:to="loc_us-gaap_RedeemableConvertiblePreferredStockMember_942c257f-3974-4488-9c64-b75505660205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_c35bac2d-7cbc-4913-91db-ade540326de0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1c3e54e4-215e-4d0e-b51c-3ef267d471b5" xlink:to="loc_us-gaap_EmployeeStockOptionMember_c35bac2d-7cbc-4913-91db-ade540326de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_OtherShareBasedAwardsMember_f896a02b-2ae8-4e10-bdf6-e1c3a0afdda7" xlink:href="docs-20220331.xsd#docs_OtherShareBasedAwardsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1c3e54e4-215e-4d0e-b51c-3ef267d471b5" xlink:to="loc_docs_OtherShareBasedAwardsMember_f896a02b-2ae8-4e10-bdf6-e1c3a0afdda7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_0cecc5cd-4604-4050-9d89-d08bff734f2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1c3e54e4-215e-4d0e-b51c-3ef267d471b5" xlink:to="loc_us-gaap_WarrantMember_0cecc5cd-4604-4050-9d89-d08bff734f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6daf2cdd-503c-441b-941f-7771c9285c7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_1eb34036-a5c5-4e5b-bce8-acbd569680fd" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6daf2cdd-503c-441b-941f-7771c9285c7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f731cbec-fdde-4272-a2f6-73ed2f11b21a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_6daf2cdd-503c-441b-941f-7771c9285c7e" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f731cbec-fdde-4272-a2f6-73ed2f11b21a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/IncomeTaxes" xlink:type="simple" xlink:href="docs-20220331.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f79c57b3-a175-4d19-b4ad-074bda1501ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_720f9960-3932-47fc-8054-4d4546e3668b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f79c57b3-a175-4d19-b4ad-074bda1501ea" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_720f9960-3932-47fc-8054-4d4546e3668b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="docs-20220331.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9f22eb28-e504-42a9-b8f0-49aacda447a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_f8b081ef-d1da-4d86-bef3-267c639313b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9f22eb28-e504-42a9-b8f0-49aacda447a3" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_f8b081ef-d1da-4d86-bef3-267c639313b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_94790f4f-4867-4315-8bae-4bc211bea119" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9f22eb28-e504-42a9-b8f0-49aacda447a3" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_94790f4f-4867-4315-8bae-4bc211bea119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_a51145f9-49c9-4307-8dc3-3c0480654bee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9f22eb28-e504-42a9-b8f0-49aacda447a3" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_a51145f9-49c9-4307-8dc3-3c0480654bee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_32fbc56a-5857-4044-b11b-84054a78cc84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9f22eb28-e504-42a9-b8f0-49aacda447a3" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_32fbc56a-5857-4044-b11b-84054a78cc84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_7fb4ed9e-5857-4fbe-9f08-52bf10b55d44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7e4688c1-7dc0-4786-af6c-e0ef0797b3f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7fb4ed9e-5857-4fbe-9f08-52bf10b55d44" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7e4688c1-7dc0-4786-af6c-e0ef0797b3f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_2bd211f9-5794-410c-afcc-67a3a83aea74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7e4688c1-7dc0-4786-af6c-e0ef0797b3f3" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_2bd211f9-5794-410c-afcc-67a3a83aea74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_fcb58dee-e9fe-4eae-a722-e01a1ad63d96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7e4688c1-7dc0-4786-af6c-e0ef0797b3f3" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_fcb58dee-e9fe-4eae-a722-e01a1ad63d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit_716a70a3-15de-4ff1-848a-6d0e9bbb294e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_7e4688c1-7dc0-4786-af6c-e0ef0797b3f3" xlink:to="loc_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit_716a70a3-15de-4ff1-848a-6d0e9bbb294e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_05259c93-589a-4ae5-b59b-5127a8d8632f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7fb4ed9e-5857-4fbe-9f08-52bf10b55d44" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_05259c93-589a-4ae5-b59b-5127a8d8632f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_48cf5ede-2a61-416a-8f64-c7734272ba3f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_05259c93-589a-4ae5-b59b-5127a8d8632f" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_48cf5ede-2a61-416a-8f64-c7734272ba3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_f98a0812-0d72-4fbb-9ce0-6291046c195f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_05259c93-589a-4ae5-b59b-5127a8d8632f" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_f98a0812-0d72-4fbb-9ce0-6291046c195f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_2dccaf82-7e9d-4c6f-98b7-95977cd37773" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_05259c93-589a-4ae5-b59b-5127a8d8632f" xlink:to="loc_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit_2dccaf82-7e9d-4c6f-98b7-95977cd37773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ae2b15bc-b592-476b-881a-75c7248e1367" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_7fb4ed9e-5857-4fbe-9f08-52bf10b55d44" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ae2b15bc-b592-476b-881a-75c7248e1367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_a509522e-84b0-4e25-a19d-79fab1274726" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_9583b10e-64bf-48bf-b3c6-cdae57c893dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a509522e-84b0-4e25-a19d-79fab1274726" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_9583b10e-64bf-48bf-b3c6-cdae57c893dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_cd208822-45c7-4730-bc82-5e27501d4ec3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a509522e-84b0-4e25-a19d-79fab1274726" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_cd208822-45c7-4730-bc82-5e27501d4ec3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_7ffac6e8-2cf4-401c-a76a-f38ac5225534" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a509522e-84b0-4e25-a19d-79fab1274726" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_7ffac6e8-2cf4-401c-a76a-f38ac5225534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_616735a5-92e1-4451-a198-3d5c2fc98155" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a509522e-84b0-4e25-a19d-79fab1274726" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount_616735a5-92e1-4451-a198-3d5c2fc98155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_7c855947-3cc2-4728-8e3a-cff452ab149f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a509522e-84b0-4e25-a19d-79fab1274726" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_7c855947-3cc2-4728-8e3a-cff452ab149f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_81ef8211-9703-4943-ad30-e35509648e0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a509522e-84b0-4e25-a19d-79fab1274726" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpense_81ef8211-9703-4943-ad30-e35509648e0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_2e4d8cfb-4a8b-4fd9-9f12-e9bde60ab9a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a509522e-84b0-4e25-a19d-79fab1274726" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_2e4d8cfb-4a8b-4fd9-9f12-e9bde60ab9a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_65fb2fed-b240-40d7-a46a-cc7ddd561293" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_a509522e-84b0-4e25-a19d-79fab1274726" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_65fb2fed-b240-40d7-a46a-cc7ddd561293" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0d207199-7335-4496-a9ad-375d8f8e3b52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract_f7f3d93a-7f4d-4493-b384-ce7ea788faa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0d207199-7335-4496-a9ad-375d8f8e3b52" xlink:to="loc_us-gaap_DeferredTaxAssetsNetAbstract_f7f3d93a-7f4d-4493-b384-ce7ea788faa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue_e8310684-286b-4287-88a1-60b841c6f318" xlink:href="docs-20220331.xsd#docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_f7f3d93a-7f4d-4493-b384-ce7ea788faa2" xlink:to="loc_docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue_e8310684-286b-4287-88a1-60b841c6f318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_8429fe1e-5eaf-4798-940e-2a5161011a5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_f7f3d93a-7f4d-4493-b384-ce7ea788faa2" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_8429fe1e-5eaf-4798-940e-2a5161011a5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_a74c95d8-c72e-4db1-8499-7ed19a7dee03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_f7f3d93a-7f4d-4493-b384-ce7ea788faa2" xlink:to="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_a74c95d8-c72e-4db1-8499-7ed19a7dee03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DeferredTaxAssetsLeasingArrangements_7275afb0-35d6-4780-be58-dbd24a1ca230" xlink:href="docs-20220331.xsd#docs_DeferredTaxAssetsLeasingArrangements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_f7f3d93a-7f4d-4493-b384-ce7ea788faa2" xlink:to="loc_docs_DeferredTaxAssetsLeasingArrangements_7275afb0-35d6-4780-be58-dbd24a1ca230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense_d772c610-56ac-4ae8-b927-2894eff4bb1d" xlink:href="docs-20220331.xsd#docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_f7f3d93a-7f4d-4493-b384-ce7ea788faa2" xlink:to="loc_docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense_d772c610-56ac-4ae8-b927-2894eff4bb1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_bbfcf759-9220-44a5-9e00-ff4e8bd2af97" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_f7f3d93a-7f4d-4493-b384-ce7ea788faa2" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_bbfcf759-9220-44a5-9e00-ff4e8bd2af97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross_edb57fec-2ba9-4676-bdc9-38dd8f19f7db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_f7f3d93a-7f4d-4493-b384-ce7ea788faa2" xlink:to="loc_us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross_edb57fec-2ba9-4676-bdc9-38dd8f19f7db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_0cc0609b-2267-4733-944b-02c0d0f0169b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_f7f3d93a-7f4d-4493-b384-ce7ea788faa2" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_0cc0609b-2267-4733-944b-02c0d0f0169b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_2fc0714e-0b94-407b-abd0-71851a91ad50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_f7f3d93a-7f4d-4493-b384-ce7ea788faa2" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_2fc0714e-0b94-407b-abd0-71851a91ad50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_b440f1db-3646-423a-ba72-0b61758da8f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_f7f3d93a-7f4d-4493-b384-ce7ea788faa2" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_b440f1db-3646-423a-ba72-0b61758da8f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_1de4026b-9516-422c-b95d-75903c79f0d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNetAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0d207199-7335-4496-a9ad-375d8f8e3b52" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_1de4026b-9516-422c-b95d-75903c79f0d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_a405793e-2a21-42eb-85ef-9c546bf714e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_1de4026b-9516-422c-b95d-75903c79f0d0" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_a405793e-2a21-42eb-85ef-9c546bf714e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_8f5ce6a0-5587-4bf8-a93f-c0fa09038483" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_1de4026b-9516-422c-b95d-75903c79f0d0" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_8f5ce6a0-5587-4bf8-a93f-c0fa09038483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_99621bad-6446-4167-bc86-81727715474c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_1de4026b-9516-422c-b95d-75903c79f0d0" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_99621bad-6446-4167-bc86-81727715474c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_5e707a7d-d09c-4460-a451-4026e94a587b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesNetAbstract_1de4026b-9516-422c-b95d-75903c79f0d0" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_5e707a7d-d09c-4460-a451-4026e94a587b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_7c72f498-8c9a-4563-b341-7f63e2787f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0d207199-7335-4496-a9ad-375d8f8e3b52" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_7c72f498-8c9a-4563-b341-7f63e2787f3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_669b9249-f5e2-4436-8222-52badd137ca5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardTable_0982f740-f2df-4f34-8192-465e83b9a406" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_669b9249-f5e2-4436-8222-52badd137ca5" xlink:to="loc_us-gaap_TaxCreditCarryforwardTable_0982f740-f2df-4f34-8192-465e83b9a406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_fecbe9ee-5e30-4f91-b59b-9048bc2de11c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_0982f740-f2df-4f34-8192-465e83b9a406" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_fecbe9ee-5e30-4f91-b59b-9048bc2de11c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_f8307fac-4ce5-4054-bb83-8471e9cca191" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_fecbe9ee-5e30-4f91-b59b-9048bc2de11c" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_f8307fac-4ce5-4054-bb83-8471e9cca191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_aae2b530-b996-4498-8257-e26b20049614" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_f8307fac-4ce5-4054-bb83-8471e9cca191" xlink:to="loc_us-gaap_DomesticCountryMember_aae2b530-b996-4498-8257-e26b20049614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_35dc2d8a-39d2-476a-8afd-841a660c359c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_f8307fac-4ce5-4054-bb83-8471e9cca191" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_35dc2d8a-39d2-476a-8afd-841a660c359c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardLineItems_6b95938e-2c69-4884-b7e9-3833d009627b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardTable_0982f740-f2df-4f34-8192-465e83b9a406" xlink:to="loc_us-gaap_TaxCreditCarryforwardLineItems_6b95938e-2c69-4884-b7e9-3833d009627b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_4866b12c-0c7c-4cb6-93c9-ff243ac58f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_6b95938e-2c69-4884-b7e9-3833d009627b" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_4866b12c-0c7c-4cb6-93c9-ff243ac58f5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_523b279f-ff82-454b-ab0d-f0637cd587f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_6b95938e-2c69-4884-b7e9-3833d009627b" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_523b279f-ff82-454b-ab0d-f0637cd587f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_d6ada0f8-f413-4536-b8d0-7f51a5425e54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_6b95938e-2c69-4884-b7e9-3833d009627b" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_d6ada0f8-f413-4536-b8d0-7f51a5425e54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_7725b08b-21b5-42e1-8c27-7ee5c7f1781a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_6b95938e-2c69-4884-b7e9-3833d009627b" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_7725b08b-21b5-42e1-8c27-7ee5c7f1781a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_OperatingLossCarryforwardsSubjectToExpiration_98110105-0a1f-4b6f-9169-5b5450bb2e3e" xlink:href="docs-20220331.xsd#docs_OperatingLossCarryforwardsSubjectToExpiration"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_6b95938e-2c69-4884-b7e9-3833d009627b" xlink:to="loc_docs_OperatingLossCarryforwardsSubjectToExpiration_98110105-0a1f-4b6f-9169-5b5450bb2e3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_bd081ef5-d5ae-41ac-82f9-7ff332d71028" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_6b95938e-2c69-4884-b7e9-3833d009627b" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_bd081ef5-d5ae-41ac-82f9-7ff332d71028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_TaxCreditCarryforwardsSubjectToExpiration_a694f7de-9e95-4632-bbb3-ed596fdb8354" xlink:href="docs-20220331.xsd#docs_TaxCreditCarryforwardsSubjectToExpiration"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_6b95938e-2c69-4884-b7e9-3833d009627b" xlink:to="loc_docs_TaxCreditCarryforwardsSubjectToExpiration_a694f7de-9e95-4632-bbb3-ed596fdb8354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_77e5b4ab-a5a7-434d-b5fb-3275f49fcba0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_6b95938e-2c69-4884-b7e9-3833d009627b" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_77e5b4ab-a5a7-434d-b5fb-3275f49fcba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_7f646536-f2be-46b3-a721-4b5ee37f5d72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardLineItems_6b95938e-2c69-4884-b7e9-3833d009627b" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_7f646536-f2be-46b3-a721-4b5ee37f5d72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/IncomeTaxesSummaryofUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#IncomeTaxesSummaryofUnrecognizedTaxBenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/IncomeTaxesSummaryofUnrecognizedTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_99fcf606-d5e8-43da-865d-a8e59602c960" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_64c66b61-1b3a-4118-aed5-9573d5afc63f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_99fcf606-d5e8-43da-865d-a8e59602c960" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_64c66b61-1b3a-4118-aed5-9573d5afc63f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_77309ffd-c146-4b21-bf9f-01afc99f6ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_64c66b61-1b3a-4118-aed5-9573d5afc63f" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_77309ffd-c146-4b21-bf9f-01afc99f6ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_f2151bf9-86e3-47a3-be64-c2cc7285b681" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_64c66b61-1b3a-4118-aed5-9573d5afc63f" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_f2151bf9-86e3-47a3-be64-c2cc7285b681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_84b82e4c-656c-4c3f-81ed-25491a5533e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_64c66b61-1b3a-4118-aed5-9573d5afc63f" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_84b82e4c-656c-4c3f-81ed-25491a5533e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_d6a31a4c-d753-48cd-b5dd-7661ba5ebaa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_64c66b61-1b3a-4118-aed5-9573d5afc63f" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_d6a31a4c-d753-48cd-b5dd-7661ba5ebaa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_bcfe9b75-a22f-47a2-a237-b4d1dd705533" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_64c66b61-1b3a-4118-aed5-9573d5afc63f" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations_bcfe9b75-a22f-47a2-a237-b4d1dd705533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_768af83b-10c0-42b7-a400-e556199678d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_64c66b61-1b3a-4118-aed5-9573d5afc63f" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_768af83b-10c0-42b7-a400-e556199678d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/CommitmentandContingencies" xlink:type="simple" xlink:href="docs-20220331.xsd#CommitmentandContingencies"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/CommitmentandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0a3f3aba-2dc0-4def-9610-9962693735bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_ccf483d3-c1a5-42d1-b826-ac676430ae13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0a3f3aba-2dc0-4def-9610-9962693735bd" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_ccf483d3-c1a5-42d1-b826-ac676430ae13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/CommitmentandContingenciesDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#CommitmentandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/CommitmentandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9950ce73-9ca7-41ae-8153-7c24fbda1292" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsTable_c8b9bd7c-4b5a-460a-8059-cb34397687ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9950ce73-9ca7-41ae-8153-7c24fbda1292" xlink:to="loc_us-gaap_OtherCommitmentsTable_c8b9bd7c-4b5a-460a-8059-cb34397687ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_fec4bae6-015a-4c6c-98d0-fce433a2c0d3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_c8b9bd7c-4b5a-460a-8059-cb34397687ac" xlink:to="loc_srt_RangeAxis_fec4bae6-015a-4c6c-98d0-fce433a2c0d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c971e48b-8d37-454f-859f-e85fb2333733" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_fec4bae6-015a-4c6c-98d0-fce433a2c0d3" xlink:to="loc_srt_RangeMember_c971e48b-8d37-454f-859f-e85fb2333733" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e7bd7862-9e68-48bd-ba60-3c32a0295438" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c971e48b-8d37-454f-859f-e85fb2333733" xlink:to="loc_srt_MinimumMember_e7bd7862-9e68-48bd-ba60-3c32a0295438" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b4e9cc4c-3ef2-4d8f-8348-93f7f2ea4095" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c971e48b-8d37-454f-859f-e85fb2333733" xlink:to="loc_srt_MaximumMember_b4e9cc4c-3ef2-4d8f-8348-93f7f2ea4095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_3fbb72a8-3189-4412-ada0-f640fcf977b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_c8b9bd7c-4b5a-460a-8059-cb34397687ac" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_3fbb72a8-3189-4412-ada0-f640fcf977b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cbf7b166-bdd9-4113-ac5f-ffe47cbca71c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_3fbb72a8-3189-4412-ada0-f640fcf977b1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cbf7b166-bdd9-4113-ac5f-ffe47cbca71c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_AMiONMember_f6031649-6cf3-4505-8881-bda84d658297" xlink:href="docs-20220331.xsd#docs_AMiONMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_cbf7b166-bdd9-4113-ac5f-ffe47cbca71c" xlink:to="loc_docs_AMiONMember_f6031649-6cf3-4505-8881-bda84d658297" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b9b2cc03-1c60-46da-be0b-c78fcb85ec8b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_c8b9bd7c-4b5a-460a-8059-cb34397687ac" xlink:to="loc_us-gaap_AwardTypeAxis_b9b2cc03-1c60-46da-be0b-c78fcb85ec8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5d636f59-4f64-4827-b21a-8d2f96228aac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_b9b2cc03-1c60-46da-be0b-c78fcb85ec8b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5d636f59-4f64-4827-b21a-8d2f96228aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_5feb3a6f-06ca-426d-a09e-01b694156c43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5d636f59-4f64-4827-b21a-8d2f96228aac" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_5feb3a6f-06ca-426d-a09e-01b694156c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_ab1aee87-3cbd-49f2-8d93-bf3259faf30b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_c8b9bd7c-4b5a-460a-8059-cb34397687ac" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_ab1aee87-3cbd-49f2-8d93-bf3259faf30b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_4abb8c57-a2a7-4087-84b4-0af20ba44fff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_ab1aee87-3cbd-49f2-8d93-bf3259faf30b" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_4abb8c57-a2a7-4087-84b4-0af20ba44fff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_fe00a069-8094-4d5a-91d0-86a388bcd51c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_4abb8c57-a2a7-4087-84b4-0af20ba44fff" xlink:to="loc_us-gaap_SubsequentEventMember_fe00a069-8094-4d5a-91d0-86a388bcd51c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCommitmentsLineItems_24ffe594-e494-40eb-bfd8-c173d291a362" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCommitmentsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsTable_c8b9bd7c-4b5a-460a-8059-cb34397687ac" xlink:to="loc_us-gaap_OtherCommitmentsLineItems_24ffe594-e494-40eb-bfd8-c173d291a362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_b16ecffa-8c24-4622-9d8e-4d38634a0c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_24ffe594-e494-40eb-bfd8-c173d291a362" xlink:to="loc_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1_b16ecffa-8c24-4622-9d8e-4d38634a0c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount_b485be5f-66f8-44fc-9087-61061c2d2104" xlink:href="docs-20220331.xsd#docs_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_24ffe594-e494-40eb-bfd8-c173d291a362" xlink:to="loc_docs_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount_b485be5f-66f8-44fc-9087-61061c2d2104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PartnershipAgreementExtensionPeriod_f96f6cf9-9e49-4d1f-bfd1-9fedf45cefc7" xlink:href="docs-20220331.xsd#docs_PartnershipAgreementExtensionPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_24ffe594-e494-40eb-bfd8-c173d291a362" xlink:to="loc_docs_PartnershipAgreementExtensionPeriod_f96f6cf9-9e49-4d1f-bfd1-9fedf45cefc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted_4fed5271-df35-4172-9800-8072040fbbb8" xlink:href="docs-20220331.xsd#docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_24ffe594-e494-40eb-bfd8-c173d291a362" xlink:to="loc_docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted_4fed5271-df35-4172-9800-8072040fbbb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany_ae06140c-0ca0-4f81-b804-15dbc334fc2c" xlink:href="docs-20220331.xsd#docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_24ffe594-e494-40eb-bfd8-c173d291a362" xlink:to="loc_docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany_ae06140c-0ca0-4f81-b804-15dbc334fc2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PartnershipAgreementNoncancelablePeriod_973fe300-a3b7-422d-9b33-da831ca34405" xlink:href="docs-20220331.xsd#docs_PartnershipAgreementNoncancelablePeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_24ffe594-e494-40eb-bfd8-c173d291a362" xlink:to="loc_docs_PartnershipAgreementNoncancelablePeriod_973fe300-a3b7-422d-9b33-da831ca34405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod_0bf9bd41-8571-4c69-a7cc-b3b701bf7557" xlink:href="docs-20220331.xsd#docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_24ffe594-e494-40eb-bfd8-c173d291a362" xlink:to="loc_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod_0bf9bd41-8571-4c69-a7cc-b3b701bf7557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_553c2d2b-0321-4e02-b7c5-7f25db55ed8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_24ffe594-e494-40eb-bfd8-c173d291a362" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_553c2d2b-0321-4e02-b7c5-7f25db55ed8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_8bdd4b34-3b46-4898-b16b-234c369f2ed8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_24ffe594-e494-40eb-bfd8-c173d291a362" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_8bdd4b34-3b46-4898-b16b-234c369f2ed8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod_c511edee-03b5-4222-8da4-84fbde37d60d" xlink:href="docs-20220331.xsd#docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_24ffe594-e494-40eb-bfd8-c173d291a362" xlink:to="loc_docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod_c511edee-03b5-4222-8da4-84fbde37d60d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_dbdbe576-009a-4ede-98b6-7aa588b28b22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_24ffe594-e494-40eb-bfd8-c173d291a362" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_dbdbe576-009a-4ede-98b6-7aa588b28b22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9a6b0a6c-8ffd-45f5-9600-1277b4b3561b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_24ffe594-e494-40eb-bfd8-c173d291a362" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9a6b0a6c-8ffd-45f5-9600-1277b4b3561b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_HostingArrangementPeriod_cc2868bb-31a0-444e-aab5-b073d05e922b" xlink:href="docs-20220331.xsd#docs_HostingArrangementPeriod"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_24ffe594-e494-40eb-bfd8-c173d291a362" xlink:to="loc_docs_HostingArrangementPeriod_cc2868bb-31a0-444e-aab5-b073d05e922b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_HostingArrangementAnnualCommitment_a2a02de0-4dbd-4a1a-9dc9-1e4e4c900515" xlink:href="docs-20220331.xsd#docs_HostingArrangementAnnualCommitment"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_24ffe594-e494-40eb-bfd8-c173d291a362" xlink:to="loc_docs_HostingArrangementAnnualCommitment_a2a02de0-4dbd-4a1a-9dc9-1e4e4c900515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAccrualProvision_e2e7f5bc-35d4-4a25-8f1c-036deac33b9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAccrualProvision"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherCommitmentsLineItems_24ffe594-e494-40eb-bfd8-c173d291a362" xlink:to="loc_us-gaap_LossContingencyAccrualProvision_e2e7f5bc-35d4-4a25-8f1c-036deac33b9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/Leases" xlink:type="simple" xlink:href="docs-20220331.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_695ad869-ecb2-4d5f-a47a-a5238ee66e84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_9174c751-c483-4e3c-88c6-c46b37bb60cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_695ad869-ecb2-4d5f-a47a-a5238ee66e84" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_9174c751-c483-4e3c-88c6-c46b37bb60cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/LeasesTables" xlink:type="simple" xlink:href="docs-20220331.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_811a3e0d-b51f-4a68-8b89-06ee6d32b8cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_7fca7b4f-4e73-4ad4-a5ad-d34940864d6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_811a3e0d-b51f-4a68-8b89-06ee6d32b8cb" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_7fca7b4f-4e73-4ad4-a5ad-d34940864d6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_1406b889-9b48-4e47-b720-b1fb9e0e7a68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_811a3e0d-b51f-4a68-8b89-06ee6d32b8cb" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_1406b889-9b48-4e47-b720-b1fb9e0e7a68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/LeasesComponentsofLeaseExpenseDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#LeasesComponentsofLeaseExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/LeasesComponentsofLeaseExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_c9ece172-7528-4668-9cc1-2e824fd87d44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_59ef1bc8-da5a-4cb2-8bfa-6b16af5a9831" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c9ece172-7528-4668-9cc1-2e824fd87d44" xlink:to="loc_us-gaap_OperatingLeaseCost_59ef1bc8-da5a-4cb2-8bfa-6b16af5a9831" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_de8c4750-bc47-4a4d-8915-217f0c8bebab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c9ece172-7528-4668-9cc1-2e824fd87d44" xlink:to="loc_us-gaap_VariableLeaseCost_de8c4750-bc47-4a4d-8915-217f0c8bebab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_97f24ff6-266b-4049-90c8-2fff74b682b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c9ece172-7528-4668-9cc1-2e824fd87d44" xlink:to="loc_us-gaap_LeaseCost_97f24ff6-266b-4049-90c8-2fff74b682b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#LeasesSupplementalCashFlowInformationDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/LeasesSupplementalCashFlowInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_79c567c5-cda5-429f-bb54-b8bb96a784a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_f1e76288-b863-4af0-b995-db17c323b3cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_79c567c5-cda5-429f-bb54-b8bb96a784a3" xlink:to="loc_us-gaap_OperatingLeasePayments_f1e76288-b863-4af0-b995-db17c323b3cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_903520b6-13a2-42af-8f2e-7ecbcd87e0fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_68f06769-965a-4be4-a54b-576548c4f3c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_903520b6-13a2-42af-8f2e-7ecbcd87e0fd" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_68f06769-965a-4be4-a54b-576548c4f3c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_36565403-7c48-41d2-a420-76d771868b08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_903520b6-13a2-42af-8f2e-7ecbcd87e0fd" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_36565403-7c48-41d2-a420-76d771868b08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_909b62b7-73e1-43ed-a3db-3d8f0d62221f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_56808e29-985d-4537-ac83-bc26215d7747" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_909b62b7-73e1-43ed-a3db-3d8f0d62221f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_56808e29-985d-4537-ac83-bc26215d7747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_ea6f0201-11ee-43c9-b255-22efa6a78d04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_909b62b7-73e1-43ed-a3db-3d8f0d62221f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_ea6f0201-11ee-43c9-b255-22efa6a78d04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_b26966c5-8fe2-4037-abbd-df6c38329c2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_909b62b7-73e1-43ed-a3db-3d8f0d62221f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_b26966c5-8fe2-4037-abbd-df6c38329c2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_213bd559-f891-408d-8019-1fcce06d8ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_909b62b7-73e1-43ed-a3db-3d8f0d62221f" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_213bd559-f891-408d-8019-1fcce06d8ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_e4a5b8e9-b3d4-40fa-8398-2990972b903b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_909b62b7-73e1-43ed-a3db-3d8f0d62221f" xlink:to="loc_us-gaap_OperatingLeaseLiability_e4a5b8e9-b3d4-40fa-8398-2990972b903b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="docs-20220331.xsd#LeasesMaturitiesofLeaseLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.doximity.com/role/EmployeeBenefitPlan" xlink:type="simple" xlink:href="docs-20220331.xsd#EmployeeBenefitPlan"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/EmployeeBenefitPlan" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract_013b40cb-58a0-4144-8837-2d65c561e32b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_8f1aea79-23fc-4964-ac20-8730243fd11c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_013b40cb-58a0-4144-8837-2d65c561e32b" xlink:to="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_8f1aea79-23fc-4964-ac20-8730243fd11c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/EmployeeBenefitPlanDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#EmployeeBenefitPlanDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/EmployeeBenefitPlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PostemploymentBenefitsAbstract_7ceb881e-8a30-4bc8-8aeb-07e6efa1d9be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PostemploymentBenefitsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_23ffd6af-680a-4c11-a115-1d9e0aaaf5b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PostemploymentBenefitsAbstract_7ceb881e-8a30-4bc8-8aeb-07e6efa1d9be" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_23ffd6af-680a-4c11-a115-1d9e0aaaf5b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/SegmentandGeographicInformation" xlink:type="simple" xlink:href="docs-20220331.xsd#SegmentandGeographicInformation"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/SegmentandGeographicInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_12785787-b614-4353-a710-a3b292f4a26b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_ba630ceb-9627-4e08-8a2e-cd46a145909e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_12785787-b614-4353-a710-a3b292f4a26b" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_ba630ceb-9627-4e08-8a2e-cd46a145909e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/SegmentandGeographicInformationDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#SegmentandGeographicInformationDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/SegmentandGeographicInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_b3ab19c6-4d07-4317-a341-8ea2378bf114" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_d3fb0850-768f-461c-b539-4698ea231539" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b3ab19c6-4d07-4317-a341-8ea2378bf114" xlink:to="loc_us-gaap_NumberOfOperatingSegments_d3fb0850-768f-461c-b539-4698ea231539" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_5c593617-b99e-4b41-8b3a-3465fb37047f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b3ab19c6-4d07-4317-a341-8ea2378bf114" xlink:to="loc_us-gaap_NumberOfReportableSegments_5c593617-b99e-4b41-8b3a-3465fb37047f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/SubsequentEvents" xlink:type="simple" xlink:href="docs-20220331.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_5492c71d-cdbe-4cdd-92db-0dfdebf2f558" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_37316fd6-59ef-4186-85cc-dfe540da00be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_5492c71d-cdbe-4cdd-92db-0dfdebf2f558" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_37316fd6-59ef-4186-85cc-dfe540da00be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.doximity.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="docs-20220331.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://www.doximity.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_b8c3d136-2508-4058-8578-551e6a2c0c07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_3d786367-1efc-47cf-b2fd-456e93aef623" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_b8c3d136-2508-4058-8578-551e6a2c0c07" xlink:to="loc_us-gaap_SubsequentEventTable_3d786367-1efc-47cf-b2fd-456e93aef623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_9a90dd42-1d72-422d-9b1a-47b521a3ab76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_3d786367-1efc-47cf-b2fd-456e93aef623" xlink:to="loc_us-gaap_AwardTypeAxis_9a90dd42-1d72-422d-9b1a-47b521a3ab76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_071907ba-c71f-4fa0-8ce5-bd3c03d8805a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_9a90dd42-1d72-422d-9b1a-47b521a3ab76" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_071907ba-c71f-4fa0-8ce5-bd3c03d8805a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_d1d7398c-5fa2-4b38-b060-ab1d4ae2c699" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_071907ba-c71f-4fa0-8ce5-bd3c03d8805a" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_d1d7398c-5fa2-4b38-b060-ab1d4ae2c699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_4c2b97e1-5730-4159-8c5d-5435015d5bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_3d786367-1efc-47cf-b2fd-456e93aef623" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_4c2b97e1-5730-4159-8c5d-5435015d5bc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_21ebe150-1400-4981-8fb0-6f1bd800d822" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_4c2b97e1-5730-4159-8c5d-5435015d5bc2" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_21ebe150-1400-4981-8fb0-6f1bd800d822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_361630cc-363c-4510-ace9-475ac1749b8c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_21ebe150-1400-4981-8fb0-6f1bd800d822" xlink:to="loc_us-gaap_SubsequentEventMember_361630cc-363c-4510-ace9-475ac1749b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_f0c2e88d-d3e3-4428-ba48-2c1b08ad56fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_3d786367-1efc-47cf-b2fd-456e93aef623" xlink:to="loc_us-gaap_SubsequentEventLineItems_f0c2e88d-d3e3-4428-ba48-2c1b08ad56fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_27b42190-01c1-4156-8df6-5fe4acdeb2d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_f0c2e88d-d3e3-4428-ba48-2c1b08ad56fa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_27b42190-01c1-4156-8df6-5fe4acdeb2d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue_8cb0b9c4-09b1-4e7c-8259-f95b15b2e682" xlink:href="docs-20220331.xsd#docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_f0c2e88d-d3e3-4428-ba48-2c1b08ad56fa" xlink:to="loc_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue_8cb0b9c4-09b1-4e7c-8259-f95b15b2e682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_4b48b262-29f2-467d-84bd-c991aaf428f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_f0c2e88d-d3e3-4428-ba48-2c1b08ad56fa" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_4b48b262-29f2-467d-84bd-c991aaf428f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_fd568094-9f08-4d16-bc5d-cd36a82954c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_f0c2e88d-d3e3-4428-ba48-2c1b08ad56fa" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_fd568094-9f08-4d16-bc5d-cd36a82954c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_ac898380-e53f-4415-bf56-ab445f920cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockRepurchaseProgramPeriodInForce1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_f0c2e88d-d3e3-4428-ba48-2c1b08ad56fa" xlink:to="loc_us-gaap_StockRepurchaseProgramPeriodInForce1_ac898380-e53f-4415-bf56-ab445f920cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>docs-20220331_g1.jpg
<TEXT>
begin 644 docs-20220331_g1.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?GW>YH-SL!'O\_H ,%>*YWQA_P %F/V4=#\3:EX?\#>$OB%X\MM'N6@U37?
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'BGP;I]CH.M_VE;/]JN([?3$=/)60S)AK>89=%!V<$Y&?J^B@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI'W!24 +8X!.!F@#$\4_
M$WX;^!KJ&Q\;?$'0]'GN1FWAU75H;=Y1G&5$C MSQQ6U#-#<0I<6\JR1R*&1
MT;(8'D$$=17R;\ O^"7?PU71?$7CO]N3PUX<^)?Q%\5:S=7FM^(+PS7$%O;L
MQ$,%L)@A@1(P/NJ"N=H;:JX\0_9A^/\ XA_9V_8;_::\3?"3Q)=ZCX%^'_B[
M4=/^#VJ7LYN%@21A$BQ.^?,ACDE@D7L=['^(T ?H3+\2/AW;^*E\"S^/=%36
MWQLT=]4A%TV1D8BW;SQSTK:KXB^'?_!*S]G+QC^PSI__  DO@M;OXD:_X2CU
MR[^($]Q(VK)K<\ N1.+@MNVI,P&S.&5?F!))/G'C/]KCXK_'[_@EG\%/#5MX
MPO+/Q5\8/'-AX!U[6X)=MR81=36\\^\?QRK#%O\ 43N.] 'Z%>'_ (D?#OQ;
MJMQH7A7Q[HNIWUGG[79Z?JD,TL&#@[T1B5YXY'6MJOA']OG]B#X$_LF_LM']
MI3]D[P%:^"_&_P *;BQU'1]:TIW66]B%Q%#/#=MNS<*\;L6WY)VXSM9@?M;X
M>>+[7XA> -#\?6,)C@US1[74(8R<E$FB60#/? :@#8HHHH ***R)/$>JI(R+
MX3O& 8@,&7!]Z ->BL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_
M^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\
MZ%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\
MH4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI
M: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_O
MI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V
M**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$E
MU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (27
M5_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+
MW_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4
M+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^
MEH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:
M/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_
M (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?
M_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU
M?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]
M_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W
M_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -B
MBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^
M$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_
M^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\
MZ%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\
MH4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI
M: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_O
MI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V
M**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$E
MU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (27
M5_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+
MW_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4
M+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^
MEH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:
M/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_
M (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?
M_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU
M?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]
M_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W
M_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -B
MBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^
M$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\ Z%"]_P"^EH V**Q_
M^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\ H4+W_OI:/^$EU?\
MZ%"]_P"^EH V**Q_^$EU?_H4+W_OI:/^$EU?_H4+W_OI: -BBL?_ (275_\
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MX>^+/"]CJ&A7]D;2\TFZME:WE@*[?+*$8VXZ#M@8Z4 ?-O\ P5Y^)/AK3?\
M@GOXITW3M5M[V]\;)8:5X5M;242-JDUQ<PLH@VD^9^Z#R?+G(7W%?07P9\'W
M?P]^#_A3P#?D&?0_#5CI\Q4Y!>&W2,_JIKR;X3?\$POV*?@M\0+#XE^"?A)(
MVJ:/*9-!_M;7;R^@TMB<[K>*XE=(V!P0V"RD @@\U[]0 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%5-<U[0_#&D7'B#Q+
MK-IIUA9Q&6[OKZX6&&!!U9W<A5 ]2<4ZZUG2+'3#K=[JMM#9",.;N6=5B"G&
M&WDXP<CG/>@"S16!_P +6^%W_12= _\ !Q!_\56C:^)O#=[H[^(;/Q!8S:?&
MK-)?17:-"H7[Q+@[0!WYXH O45@?\+6^%W_12= _\'$'_P 56^"",@Y!Z&@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** /SF_X+'>'/VTOB!\ OB/XP\8:]
MI/@_X4^#KNR&C>'],G,]_P"+'DOK:W6>[=3MA@4RF1(NNY%W*2%=?M^^^%?@
M'XW?L]VGPK^*/AY=5T#6?#]G%J6GO/)$)D"1N!NB97'S*IX(Z5XM_P %I/\
ME&?\2_\ <TC_ -/%E7T5\./^2>:#_P!@6U_]$K0!^>?_  4)_8/_ &%/@OX8
M\-_!?]G[]F'3I_BI\4-7&C^#$F\0:DZ6"_+]HU"16N2"D*L#\P(RP8AE1A7>
M_MQ_"SP9^P3_ ,$>]8^ /P]U%S]IAL]&%_=R[3>W5W=QM=S-DX0.GGG:.%7
MZ"MW]G: ?M(?\%6_B[\=-8'GZ;\(=)M/!GA2.3E8KJ4.]Y*OHZLL\9/=9P.W
M'J_[?'Q._9C^&/PV\.77[6OPMD\3>%=3\:65E&\FF0W5KI=XXD\N[N1+(GEQ
M*OF9<!C@D;3NP0#Y#^%GP^_X-^_%WB?1OA)'H-K<:S>I%:66KZK-KUE::M<
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M_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\
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M8_Z#4'_?5'_"8^&/^@U!_P!]5<_L[3_^?&'_ +]"C^SM/_Y\8?\ OT* *?\
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M_?57/[.T_P#Y\8?^_0H_L[3_ /GQA_[]"@"G_P )CX8_Z#4'_?5'_"8^&/\
MH-0?]]5<_L[3_P#GQA_[]"C^SM/_ .?&'_OT* *?_"8^&/\ H-0?]]4?\)CX
M8_Z#4'_?57/[.T__ )\8?^_0H_L[3_\ GQA_[]"@"G_PF/AC_H-0?]]4?\)C
MX8_Z#4'_ 'U5S^SM/_Y\8?\ OT*/[.T__GQA_P"_0H I_P#"8^&/^@U!_P!]
M4?\ "8^&/^@U!_WU5S^SM/\ ^?&'_OT*/[.T_P#Y\8?^_0H I_\ "8^&/^@U
M!_WU1_PF/AC_ *#4'_?57/[.T_\ Y\8?^_0H_L[3_P#GQA_[]"@"G_PF/AC_
M *#4'_?5'_"8^&/^@U!_WU5S^SM/_P"?&'_OT*/[.T__ )\8?^_0H I_\)CX
M8_Z#4'_?5'_"8^&/^@U!_P!]5<_L[3_^?&'_ +]"C^SM/_Y\8?\ OT* *?\
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MRMY=I Q'0#<\K \ &-NU?=OQ%\>>'/A;X#UCXC^+KSR-,T/39KV^D[B.-"Q
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% %37->T/PQI%QX@\2ZS::=86<1EN[Z^N%AA@0=6=W(50/4G%68)X;F%+FVF
M62.10T<B,"K*1D$$=0:_.C_@L=X<_;2^('P"^(_C#QAKVD^#_A3X.N[(:-X?
MTR<SW_BQY+ZVMUGNW4[88%,ID2+KN1=RDA77[8\3_$"'X3?LK7_Q2N'4)X;\
M 2:F2W3]Q9&7'O\ =H Z.3XI?#&*1HI?B-H*LI(96U>$$'T/S5L:?J.GZO91
MZEI5_#=6\JYBGMY0Z./4,"0:_(+]DBQ_X(JV'P"\'P?M7V/]J^.=0@>7Q1KY
M37#:V]S//))'#++;,(5=8GC4[<X*DL0<U]7_ +?MUX;^%/['7PQ_9;_9/UA=
M$T#XI>-](\):/?Z)J+S"'2KUWDD>&=G=G#Y5=VXY25AG!H ^NO#_ ,2/AWXM
MU6XT+PKX]T74[ZSS]KL]/U2&:6#!P=Z(Q*\\<CK6U7PC^WS^Q!\"?V3?V6C^
MTI^R=X"M?!?C?X4W%CJ.CZUI3NLM[$+B*&>&[;=FX5XW8MOR3MQG:S _:WP\
M\7VOQ"\ :'X^L83'!KFCVNH0QDY*)-$L@&>^ U &Q1110 445G/XN\-1N8Y-
M8A#*<,">AH T:*S?^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\ OJ@#2HK-_P"$Q\,?
M]!J#_OJC_A,?#'_0:@_[ZH TJ*S?^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\ OJ@#
M2HK-_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZH TJ*S?^$Q\,?\ 0:@_[ZH_X3'P
MQ_T&H/\ OJ@#2HK-_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZH TJ*S?^$Q\,?\
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MCX8_Z#4'_?5'_"8^&/\ H-0?]]4 :5%9O_"8^&/^@U!_WU1_PF/AC_H-0?\
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M;)_)Z]O*\O'MBO>*^&?^">7_  4P\'7FCZ7^S!^T+IEOX/\ $.@V\6E:3=O
M;>UNA"HC2"1#C[/. H&#A7(XVDA3]J?\)CX8_P"@U!_WU7\%\>93FF5\4XJ6
M-I>S]K4G4C;6+C.3DG&2T:UZ;;-)Z'^@GA_F^4YKPIA(X&M[3V5.%.5])1E"
M*BU.+U3TZ[[IM:FE16;_ ,)CX8_Z#4'_ 'U1_P )CX8_Z#4'_?5?''VAI45F
M_P#"8^&/^@U!_P!]4?\ "8^&/^@U!_WU0!I45F_\)CX8_P"@U!_WU1_PF/AC
M_H-0?]]4 :5%9O\ PF/AC_H-0?\ ?5'_  F/AC_H-0?]]4 :5%9O_"8^&/\
MH-0?]]4?\)CX8_Z#4'_?5 &E16;_ ,)CX8_Z#4'_ 'U1_P )CX8_Z#4'_?5
M&E16;_PF/AC_ *#4'_?5'_"8^&/^@U!_WU0!I45F_P#"8^&/^@U!_P!]4?\
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M_H-0?]]4 :5%9O\ PF/AC_H-0?\ ?5'_  F/AC_H-0?]]4 :5%9O_"8^&/\
MH-0?]]4?\)CX8_Z#4'_?5 &E16;_ ,)CX8_Z#4'_ 'U1_P )CX8_Z#4'_?5
M&E16;_PF/AC_ *#4'_?5'_"8^&/^@U!_WU0!I45F_P#"8^&/^@U!_P!]4?\
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M_H-0?]]4 :5%9O\ PF/AC_H-0?\ ?5'_  F/AC_H-0?]]4 :5%9O_"8^&/\
MH-0?]]4?\)CX8_Z#4'_?5 &E16;_ ,)CX8_Z#4'_ 'U1_P )CX8_Z#4'_?5
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M;7;R^@TMB<[K>*XE=(V!P0V"RD @@\U[]0 4444 %0G3[ G)LH23U)C%344
M0_V=I_\ SXP_]^A1_9VG_P#/C#_WZ%344 0_V=I__/C#_P!^A1_9VG_\^,/_
M 'Z%344 0_V=I_\ SXP_]^A1_9VG_P#/C#_WZ%344 0_V=I__/C#_P!^A1_9
MVG_\^,/_ 'Z%344 0_V=I_\ SXP_]^A1_9VG_P#/C#_WZ%344 0_V=I__/C#
M_P!^A1_9VG_\^,/_ 'Z%344 0_V=I_\ SXP_]^A1_9VG_P#/C#_WZ%344 0_
MV=I__/C#_P!^A1_9VG_\^,/_ 'Z%344 0_V=I_\ SXP_]^A1_9VG_P#/C#_W
MZ%344 0_V=I__/C#_P!^A1_9VG_\^,/_ 'Z%344 0_V=I_\ SXP_]^A1_9VG
M_P#/C#_WZ%344 0_V=I__/C#_P!^A1_9VG_\^,/_ 'Z%344 0_V=I_\ SXP_
M]^A1_9VG_P#/C#_WZ%344 >0_MM?'?1?V7_V;?$7Q26"V74UM_L?A^)XE/FW
M\P*Q<$?,%YD([K&U> ?\$7OV<'\+_"75?VD/&MD9M7\;7+1Z;+=+ND6PB<[G
MRW.99@S'/411MWKSO_@I!XKUW]LS]MGP=^Q#\/+]S8:->JNL3P_,J74BB2XE
M(Z,(+8?@QD6OT0\(>%-!\">%--\%>%K!;73=(L(K.PMDZ10QH$1?P4"OU;,O
M^,1\/*.7K3$9@U5J=U0C_"B_\;][[TS\DRS_ (S'Q'KYB]<-ER=&GV=>2_>R
M7^!>Y]S1;_L[3_\ GQA_[]"C^SM/_P"?&'_OT*FHK\I/ULA_L[3_ /GQA_[]
M"C^SM/\ ^?&'_OT*FHH A_L[3_\ GQA_[]"C^SM/_P"?&'_OT*FHH A_L[3_
M /GQA_[]"C^SM/\ ^?&'_OT*FHH A_L[3_\ GQA_[]"C^SM/_P"?&'_OT*FH
MH A_L[3_ /GQA_[]"C^SM/\ ^?&'_OT*FHH A_L[3_\ GQA_[]"C^SM/_P"?
M&'_OT*FHH A_L[3_ /GQA_[]"C^SM/\ ^?&'_OT*FHH A_L[3_\ GQA_[]"C
M^SM/_P"?&'_OT*FHH A_L[3_ /GQA_[]"C^SM/\ ^?&'_OT*FHH ^;/VY?\
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M_L[3_P#GQA_[]"IJ* (?[.T__GQA_P"_0H_L[3_^?&'_ +]"IJ* (?[.T_\
MY\8?^_0H_L[3_P#GQA_[]"IJ* (?[.T__GQA_P"_0H_L[3_^?&'_ +]"IJ*
M(?[.T_\ Y\8?^_0H_L[3_P#GQA_[]"IJ* (?[.T__GQA_P"_0H_L[3_^?&'_
M +]"IJ* (?[.T_\ Y\8?^_0H_L[3_P#GQA_[]"IJ* (?[.T__GQA_P"_0H_L
M[3_^?&'_ +]"IJ* (?[.T_\ Y\8?^_0H_L[3_P#GQA_[]"IJ* (?[.T__GQA
M_P"_0H_L[3_^?&'_ +]"IJ* (?[.T_\ Y\8?^_0H_L[3_P#GQA_[]"IJ* (?
M[.T__GQA_P"_0H_L[3_^?&'_ +]"IJ* (?[.T_\ Y\8?^_0H_L[3_P#GQA_[
M]"IJ* (?[.T__GQA_P"_0H_L[3_^?&'_ +]"IJ* (?[.T_\ Y\8?^_0H_L[3
M_P#GQA_[]"IJ* (?[.T__GQA_P"_0H_L[3_^?&'_ +]"IJ* (?[.T_\ Y\8?
M^_0H_L[3_P#GQA_[]"IJ* (?[.T__GQA_P"_0H_L[3_^?&'_ +]"IJ* (?[.
MT_\ Y\8?^_0H_L[3_P#GQA_[]"IJ* (?[.T__GQA_P"_0H_L[3_^?&'_ +]"
MIJ* (?[.T_\ Y\8?^_0H_L[3_P#GQA_[]"IJ* (?[.T__GQA_P"_0H_L[3_^
M?&'_ +]"IJ* (?[.T_\ Y\8?^_0H_L[3_P#GQA_[]"IJ* (?[.T__GQA_P"_
M0H_L[3_^?&'_ +]"IJ* (?[.T_\ Y\8?^_0H_L[3_P#GQA_[]"IJ* (?[.T_
M_GQA_P"_0H_L[3_^?&'_ +]"IJ* (?[.T_\ Y\8?^_0H_L[3_P#GQA_[]"IJ
M* (?[.T__GQA_P"_0I\5M;0$F"W1">I1 ,T^B@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M)M?LV?\ #-/[+>BZ'J]AY.OZ\/[7\0[EPZ33*-D)[CRX@B$=-P<CK7ZMD/\
MQB7 >)SF6F(QMZ%'NJ:_C37_ *0GNI)=S\DX@_XR_P 0,+DD=</@K8BOV=1_
MP8/T^-IZ.+?8]\HHHK\I/UL**** "BBB@ HHHH **** "BBB@ HHHH ****
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M2H?6:2E6Y).,:KYY)<T4TFURW;MK>[UU>]X'^*?Q*^&FN)XE^'WCW5]%OXY
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M8_Z#4'_?5'_"8^&/^@U!_P!]5<_L[3_^?&'_ +]"C^SM/_Y\8?\ OT* *?\
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M8^&/^@U!_P!]5<_L[3_^?&'_ +]"C^SM/_Y\8?\ OT* *?\ PF/AC_H-0?\
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M'_OT* *?_"8^&/\ H-0?]]4?\)CX8_Z#4'_?57/[.T__ )\8?^_0H_L[3_\
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M_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\
MA,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/
M_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0
M!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP
M_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:
M?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_
M9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H
M4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP
M_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9
MVG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[ZH_X3'PQ_T&H/^^JN
M?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[ZH_X3'PQ_P!!J#_O
MJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!J#_OJC_A,?#'_0:@
M_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A,?#'_0:@_P"^J/\
MA,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[Z
MH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[
MZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!
MJ#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A
M,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MU\^%D^H'Q=^R+^TGXA\'ZE!)YUG8>(XA>PQR#[HCN(/*F@ _O$2M7G/]A_\
M!R/_ ,$Z.=,U"[^,'A:Q_@23_A)HY%7H K[-210.R[5 X[5^S5%?7X7QDXGJ
M4%ALZIT<PHK[.(IQE)+RFK23\VY,\^IP[@5+GPSE2EW@VE\UM\M#\H?@E_P<
M_>%=.U;_ (0G]L[]EC7O"FJ6TGE7]]X8D\X1R=_,L[KRI80.X\R1O;M7W/\
MLZ_\%-OV$/VJ?(M/@U^TMX;N]1N,"/0]3NCI^H,Q_A6VNA')(0>,H&'H3D5W
MGQN_9?\ V=/VDM)_L7X]?!+PSXLA$92)];T>*>6 ?],I2/,B/)Y1E//6OAC]
MHK_@V3_8J^)?GZI\!O&GB7X;W\F3%:I/_:NG(?\ KE<,)_RG ]JZ/K/@SQ)_
M&HU\LJOK!^WHKS<7:I\HZ(CDXCP?PRC7CY^Y+[]OO/TBHK\9?^&!/^"_G_!/
M0_:?V5?VA)?B#X9LN8=&L=;6Z1(1V.G:H-B$],6Y=L=#GIM> O\ @X^_:6^
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M.*_B3B^;I=QDX.5O[W+S:::Z!1117QY]F%%%% !1110 4444 %%%% !1110
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MI-MMN[;>[;>K;[GW-"A1PU&-*C%1A%)))622V22T278****R-0HHHH ****
M"BBB@ HHJ*_O['2K&;4]3O8K:VMHFEN+B>0(D2*"6=F/"J "23P *:3;L@):
M*_-G]J;_ (.8_P!DWX,>+KOP5\"?AOJ_Q/FL96BN-7MM133=,D<$@B&9XY9)
M@"/OB((PP59@<T?LL_\ !S'^R;\9_%UIX*^.WPWU?X837TJQ6^KW.HIJ6F1N
M2 !-,D<4D()/WS$4 R690,U^C?\ $(_$C^R_[0_LVI[.U_L\]O\ KWS>T_\
M)3Q_]8,F]O[+VRO\[??:WXGZ345%87]CJMC#J>F7L5S;7,2RV]Q!('25&&5=
M6'#*0001P0:EK\Y::=F>QN%%%%( HHHH **** "BBB@ HHHH **** "BBB@
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M^-=5EOIOAAK%O#I%Q.Y9X],O$D>& DDDB.2"X"]@A11P@K])J_GX_P""=_\
MP1-_:C_:<_9RM_VKO@O^TM!\/=?N-5G@T739EN[626V18REPUW;/YD.]BVU1
M$V457#$, /=#X=_X.;OV*^=.UNZ^*>AVGWL75IXA\_'M,$U \>F/SK^%^/\
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M% !1110 4444 %%17M[9Z;:2ZAJ-W%!!!&7FGFD"I&H&2S$\  =S7RM^T?\
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M?)NP!A=^!E6 P-P!X !'0CPW_AC3X^?;OLG_  C-KY>['VK^TX?+^N-V['_
M:^T:* /(/V>/V5].^$=T/%GB>^BU#7#&5A,*GR;0$8;9D99B,C<0."0!U)]<
MN;6VO8&MKRWCEC<8>.5 RL/<'K3Z* .*\2?LZ?!/Q7N;5/AUIZ.W66RC-LV?
M7,17)^N:\_\ $G[!?PZU#=)X9\4ZIIKGHLP2XC7Z#"M^;5[K10!\U?\ #,O[
M3/P]^?X;_%C[1!']RV34)8-WI^[?,?YFC_A;O[:'PY^7Q?X .JPI]^9M,$H
M]=]J0H^IS7TK10!\^:!^WSH@D^R^-?AW?6;J<2/8W"R\_P"XX0CZ9-=[X;_:
MO^!/B7:B>-4L96ZQ:E \./JQ&S_QZNTU_P '>$O%4?D^)O#&GZ@N, 7MFDN/
MIN!Q7 ^)/V/?@5XAW/#X;GTV1NLFFWCI^2ON0?\ ?- 'HNCZ_H7B&W^V:!K=
MI?1?\];.Y65?S4D5;KYUU?\ 8.GTZY_M#X?_ !0N+65/]4MY;D,/^VL; C_O
MFJG_  A/[<?PWYT3Q2^MP1]0+Z.Z!'IBY ?_ +YYH ^E:R?'O@;PK\3O ^L?
M#CQSH\6H:+K^F3Z?JUC,/DN+::-HY(S[%6(_&O %_:[^.7@1A#\4?A -BG!E
M-M-9EO?<P=3^ Q71Z?\ MX_#2ZTV:6^\.:K:WB0,T4!1'CD< X3>&R,GC)4
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M4AU%&41W:%8I?F\O?&R*H+@QY;]VHK[._P"'SW_!;#XZ8B_9Z_X)WBTM)_\
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M_&G)[0Q5.5*WK55X?<@_M/.,-_O&$;7>#4O_ "7<_9.DDD2)&EE<*J@EF8X
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M^H&2?0L1VKI/!?P7^%GP\N?MO@_P59VEP 0+DAI)5!Z@/(68?@:ZB@ HHHH
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MU(GX;;=2IKS3]D3_ (*YZ-XAU9/@Y^V)I0\(>*;6;[*VMSV[6]I-*#M*W,;
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MYA_VTC88_P"^:J?\*H_;7\ <^%_B =5C3[D:ZJ)ACTVW0 'T%?0?_"8^&/\
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MWU7FFQI45F_\)CX8_P"@U!_WU1_PF/AC_H-0?]]4 :5%9O\ PF/AC_H-0?\
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M#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\
M\^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C
M#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U%
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ME:0=PAO?+8[+.$'I;1G/F/U=BPR69ROZ6VUM;V=O':6D"111($BBC4*J*!@
M <  <8K]6SC&87PZRF>1Y=-2Q]56Q-6/_+M/_ES3?_I;7YV4/R/)L%BO$K-X
M9]F4''+Z+OAJ,O\ EXU_R_J+M_)%_E=S9_9VG_\ /C#_ -^A1_9VG_\ /C#_
M -^A4U%?D!^RD/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_
M -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\ \^,/_?H5-10!
M#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C#_WZ%']G:?\
M\^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U% $/\ 9VG_ //C
M#_WZ%']G:?\ \^,/_?H5-10!#_9VG_\ /C#_ -^A1_9VG_\ /C#_ -^A4U%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110!_/-XT_MO_ (3'5O\ A)=_]H_VG/\ VAYN=WG^
M8WF9SSG=GK697Z ?\%-_^"9'Q#G^(6J?M$?L[^%YM:L-9F:[\0^'M/CW75K=
M-S)/#&.94D/S%5RZNS$ J?E^$O\ A"O&7]M_\(U_PB6I_P!I>9L_L_[!)Y^[
M.-OE[=V<\8Q7^A_"G%>3<3Y-3Q>$J1^%<T;J\';6,ENK/9[-:K0_S?XMX1SO
MA7.JF#QE*7Q/EE9VFKZ2B]G?JMT]'J5]!U6[T+7++6]/N3#/9W<<\$RDYC=&
M#!N.>" :_>/X/_M2_L\_'R!9/A'\7=%UF9EW?88KKR[M1ZM;R;95'U45\ ?\
M$]_^"3?B3QMK"_%+]K+P5/I_AU+=QIWA6^=X+K4'9<"294*R01KDD*2KLP'
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M4DU^Q+V7A7E5W9YO7CZ_5J<E_P"G9+_P%>7Q_B[=;Q9S:RNLGP\O3ZU4B_\
MTU%_^!/S^#6\+>%O#O@CPW8^$/".C6^G:9IMJEO86-K&%C@B4855'H!5^BBO
MQV<YU)N<W=O5M[M]V?M$(0IP4(*R6B2T22Z(****DH**** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ JAXH\*>&/&^@W/A;QEX=L=6TV\CV76GZC:I
M-#,OHR."#^(J_150G.G-3@[-:IK=,F<(5(.$U=/1IZIKS/!_^'8_["?]M_\
M"0?\,[Z9Y_F;_+^WW?D9SG_4^=Y>/;;CVKVGPOX4\,>"-!MO"W@WP[8Z3IMG
M'LM=/TZU2&&%?140 #\!5^BO1Q^=9SFD(PQN)J55'93G*27IS-V/-R_(\ERF
M<IX'"TZ3ENX0C%OUY4K_ #"BBBO,/4"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'H:OX)TQ42>2/4EN(K2.218DS:7JGRR7=!^YW8)!SC./U KS/]L?X.:A\?\
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MIXVGP O;JT75FX></=U_\#YPHHHK\;/VL**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@#YO\ VLO^"8/[/7[5.MR^.;D7?ACQ/./])UK153;=D# ,\+#;(1_>
M!1S@ L0 !XQX'_X(.?#/2]<2]^(/Q[UC6;!'#&QTW18[%G /W6D:6;@]#A0?
M0BOO>BOM\N\2..,JR]8+"XZ<::5DK1DTNT923E%+HDU;H?"YEX9\"9MF+QV*
MP,)56[MWE%-]Y1C)1DWU;3OU.>^%OPJ^'OP5\$67PZ^%_A:VT?1[!-MO9VRG
MJ>KLQ)9W)Y+L2Q/4FNAHHKXVM6K8FM*K5DY2DVVV[MM[MMZMON?:T*%'#48T
MJ,5&$4DDE9)+9)+1)=@HHHK(U"BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHJ'4=2T[1[*34M6OX+6VB&9;BYE"(@SC)9B .: )J*P/^%K?"[_H
MI.@?^#B#_P"*K1M?$WAN]T=_$-GX@L9M/C5FDOHKM&A4+]XEP=H [\\4 7J*
MP/\ A:WPN_Z*3H'_ (.(/_BJWP01D'(/0T %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MG_\ /C#_ -^A0!3_ .$Q\,?]!J#_ +ZH_P"$Q\,?]!J#_OJKG]G:?_SXP_\
M?H4?V=I__/C#_P!^A0!3_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZJY_9VG_ //C
M#_WZ%']G:?\ \^,/_?H4 4_^$Q\,?]!J#_OJC_A,?#'_ $&H/^^JN?V=I_\
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M_P!^A0!3_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZJY_9VG_ //C#_WZ%']G:?\
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MZ% %/_A,?#'_ $&H/^^J/^$Q\,?]!J#_ +ZJY_9VG_\ /C#_ -^A1_9VG_\
M/C#_ -^A0!3_ .$Q\,?]!J#_ +ZH_P"$Q\,?]!J#_OJKG]G:?_SXP_\ ?H4?
MV=I__/C#_P!^A0!3_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZJY_9VG_ //C#_WZ
M%']G:?\ \^,/_?H4 4_^$Q\,?]!J#_OJC_A,?#'_ $&H/^^JN?V=I_\ SXP_
M]^A1_9VG_P#/C#_WZ% %/_A,?#'_ $&H/^^J/^$Q\,?]!J#_ +ZJY_9VG_\
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MG_\ /C#_ -^A0!3_ .$Q\,?]!J#_ +ZH_P"$Q\,?]!J#_OJKG]G:?_SXP_\
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M/PU^V=\*+SXP^#O#-UI>EQ^)+W3;!+V8-+<10, L[*%'EEPP/E_-MZ;C7K-
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M_"7PL^,>L?#KQ3I:PZ-X7^&LWC'Q5XE:\.-/A%P88;<0K&3))*([AA\P/[H
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M>VT/0OC%\1OV4/%GA?X3>);^"WTKXB7^JV<GDQ7#A+:ZN[*-S+:V\A9<2$D
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M_AGP;X=^/47@W3-#UK^U-2L;GPFFK0:O-'L-NLT;SQ(T<9$A,;AT<NN1\@R
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M_9MS^VD/VOO^$SZ?"\^#O^$>_L[_ *B(O?M7G^9[;/+\O_:W_P - 'J%%%%
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M_8G[7NO_ +5?_"9^;_;G@FT\/?V#_9VWR/(N&F\_S_,.[=NV[-@QC.X]*L_
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M=6C4QAE'R Y XQ0!])4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M2>RMT6[>BU-?_AHC_@MM_P!$+'_A,P__ !ROT$\'W.MWGA+2[OQ-!Y6I2Z=
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M),AS7*UF6%Q,)4&K\_,K)?WK_"UU4K-;-(_(ZV#Q5"O[&I!J7:WY=_D>L_\
M!,'X@?MT_#7]H2_\1_\ !/[P3<:_XQ/A>XAU*PBTQ;M/[.:: R.Z,RK@2B#!
M)X8CUK]=?^";W[0G_!:GXC_M-6OAG]N7X'#0? 3:-=R7&H#PU#:XNE4>2OF)
M(Q&3GC'-=E_P18_X)7W'_!._X3ZEXL^*D]I=_$KQE'#_ &X;.020Z3:IEH[&
M.3^-MS%I77Y68*!N$:NWVW7\5>+/BED&?9UB\-@<OP]:'+[..)E%NIHK.4)7
M2M%M\CL[VOLS])R'(\7A<-3G5JSB[W<$_=]&O/J%?(7Q!_9:_8F_X*,?$;Q%
M\5OA5\1_$OAKXA>"=:D\/^(/%?@NXGTN^AO+<!?*F6:,>:% V"50"0FT2$(
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MC)!(W*RD9[]*^B_V<O@#X"_9>^"V@_ OX:03+I&@6ABBEN6#37$C.TDLTA
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M .&7]0^)-]_PGO\ ;G_"POB/J/BO9_9?V;[!]J*G[-GS9/-VX_UGR9_NBF?
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MV4 KF.5U)SSG)R:^P_"%Y<:AX2TN_O)2\L^G022N>K,T:DG\S7GG[:W[,_\
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M.TU:)XM*N&FA*.EHF#:^:K[SD?/\I' 4#TKQS^PG\7/"/QM\2_'7]C+]I?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
G%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497067356712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br> $ in Billions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>May 20, 2022</div></th>
<th class="th"><div>Sep. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--03-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40508<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Doximity, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">27-2485512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">500 3rd St.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Francisco<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(650)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">549-4330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A common stock, $0.001 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">DOCS<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">Portions of the registrant&#8217;s Definitive Proxy Statement relating to the 2022 Annual Meeting of Stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. Such Definitive Proxy Statement will be filed with the Securities and Exchange Commission within 120 days after the end of the registrant&#8217;s fiscal year ended March&#160;31, 2022.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001516513<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110,086,201<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83,022,658<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497067358296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Deloitte & Touche LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">San Francisco, California<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">34<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Audit Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497065292488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents, at Carrying Value</a></td>
<td class="nump">$ 112,809<span></span>
</td>
<td class="nump">$ 66,393<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent', window );">Marketable securities</a></td>
<td class="nump">685,304<span></span>
</td>
<td class="nump">76,141<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance for doubtful accounts of $359 and $955 as of March&#160;31, 2022 and 2021, respectively</a></td>
<td class="nump">81,073<span></span>
</td>
<td class="nump">50,319<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">19,439<span></span>
</td>
<td class="nump">10,692<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostNetCurrent', window );">Deferred contract costs, current</a></td>
<td class="nump">5,512<span></span>
</td>
<td class="nump">5,856<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">904,137<span></span>
</td>
<td class="nump">209,401<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">8,488<span></span>
</td>
<td class="nump">7,598<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred income tax assets</a></td>
<td class="nump">48,558<span></span>
</td>
<td class="nump">2,112<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">1,087<span></span>
</td>
<td class="nump">1,339<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">7,909<span></span>
</td>
<td class="nump">9,596<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">18,915<span></span>
</td>
<td class="nump">18,915<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">2,263<span></span>
</td>
<td class="nump">2,758<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">991,357<span></span>
</td>
<td class="nump">251,719<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">463<span></span>
</td>
<td class="nump">1,515<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">25,270<span></span>
</td>
<td class="nump">16,285<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue, current</a></td>
<td class="nump">84,907<span></span>
</td>
<td class="nump">83,272<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current</a></td>
<td class="nump">642<span></span>
</td>
<td class="nump">970<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">111,282<span></span>
</td>
<td class="nump">102,042<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue, non-current</a></td>
<td class="nump">78<span></span>
</td>
<td class="nump">220<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, non-current</a></td>
<td class="nump">447<span></span>
</td>
<td class="nump">284<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities, non-current</a></td>
<td class="nump">956<span></span>
</td>
<td class="nump">972<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">112,763<span></span>
</td>
<td class="nump">103,518<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 13)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityAbstract', window );"><strong>Redeemable Convertible Preferred Stock</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Redeemable convertible preferred stock, $0.001 par value; zero and 76,350 shares authorized as of March&#160;31, 2022 and 2021, respectively; zero and 76,287 shares issued and outstanding as of March&#160;31, 2022 and 2021, respectively; liquidation preference of zero and $81,672 as of March&#160;31, 2022 and 2021, respectively</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">81,458<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders&#8217; Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.001 par value; 100,000 and zero shares authorized as of March&#160;31, 2022 and 2021, respectively; zero shares issued and outstanding as of March&#160;31, 2022 and 2021, respectively</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Class A and Class B common stock, $0.001 par value; 1,500,000 and 198,000 shares authorized as of March&#160;31, 2022 and 2021, respectively; 192,398 and 82,910 shares issued and outstanding as of March&#160;31, 2022 and 2021, respectively</a></td>
<td class="nump">192<span></span>
</td>
<td class="nump">83<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">702,589<span></span>
</td>
<td class="nump">30,357<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(15,294)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">191,107<span></span>
</td>
<td class="nump">36,324<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">878,594<span></span>
</td>
<td class="nump">66,743<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, redeemable convertible preferred stock, and stockholders&#8217; equity</a></td>
<td class="nump">$ 991,357<span></span>
</td>
<td class="nump">$ 251,719<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer; classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123353750&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497067237224">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Accounts receivable, allowance for doubtful accounts</a></td>
<td class="nump">$ 359<span></span>
</td>
<td class="nump">$ 955<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Redeemable convertible preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Redeemable convertible preferred stock, authorized (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">76,350,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Redeemable convertible preferred stock issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">76,287,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Redeemable convertible preferred stock outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">76,287,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Liquidation Preference</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 81,672<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized (in shares)</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="nump">1,500,000,000<span></span>
</td>
<td class="nump">198,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued (in shares)</a></td>
<td class="nump">192,398,000<span></span>
</td>
<td class="nump">82,910,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding (in shares)</a></td>
<td class="nump">192,398,000<span></span>
</td>
<td class="nump">82,910,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497063787688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 343,548<span></span>
</td>
<td class="nump">$ 206,897<span></span>
</td>
<td class="nump">$ 116,388<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="nump">39,787<span></span>
</td>
<td class="nump">31,196<span></span>
</td>
<td class="nump">14,900<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">303,761<span></span>
</td>
<td class="nump">175,701<span></span>
</td>
<td class="nump">101,488<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">62,350<span></span>
</td>
<td class="nump">43,873<span></span>
</td>
<td class="nump">32,435<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">92,129<span></span>
</td>
<td class="nump">62,033<span></span>
</td>
<td class="nump">39,448<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">35,746<span></span>
</td>
<td class="nump">16,492<span></span>
</td>
<td class="nump">7,442<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">190,225<span></span>
</td>
<td class="nump">122,398<span></span>
</td>
<td class="nump">79,325<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">113,536<span></span>
</td>
<td class="nump">53,303<span></span>
</td>
<td class="nump">22,163<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">469<span></span>
</td>
<td class="nump">4,466<span></span>
</td>
<td class="nump">1,351<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">114,005<span></span>
</td>
<td class="nump">57,769<span></span>
</td>
<td class="nump">23,514<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for (benefit from) income taxes</a></td>
<td class="num">(40,778)<span></span>
</td>
<td class="nump">7,559<span></span>
</td>
<td class="num">(6,223)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">154,783<span></span>
</td>
<td class="nump">50,210<span></span>
</td>
<td class="nump">29,737<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic', window );">Undistributed earnings attributable to participating securities, basic</a></td>
<td class="num">(21,526)<span></span>
</td>
<td class="num">(28,654)<span></span>
</td>
<td class="num">(18,908)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted', window );">Undistributed earnings attributable to participating securities, diluted</a></td>
<td class="num">(21,526)<span></span>
</td>
<td class="num">(28,654)<span></span>
</td>
<td class="num">(18,908)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income attributable to Class A and Class B common stockholders, basic</a></td>
<td class="nump">133,257<span></span>
</td>
<td class="nump">21,556<span></span>
</td>
<td class="nump">10,829<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net income attributable to Class A and Class B common stockholders, diluted</a></td>
<td class="nump">$ 133,257<span></span>
</td>
<td class="nump">$ 21,556<span></span>
</td>
<td class="nump">$ 10,829<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per share attributable to Class A and Class B common stockholders:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 0.82<span></span>
</td>
<td class="nump">$ 0.29<span></span>
</td>
<td class="nump">$ 0.16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 0.70<span></span>
</td>
<td class="nump">$ 0.23<span></span>
</td>
<td class="nump">$ 0.13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">163,484<span></span>
</td>
<td class="nump">74,342<span></span>
</td>
<td class="nump">66,758<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">191,017<span></span>
</td>
<td class="nump">95,134<span></span>
</td>
<td class="nump">81,710<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 65<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2793-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 66<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2814-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2740-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 65<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2793-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 66<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2814-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497065201128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 154,783<span></span>
</td>
<td class="nump">$ 50,210<span></span>
</td>
<td class="nump">$ 29,737<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other comprehensive loss</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent', window );">Change in unrealized loss on available-for-sale-securities, net of tax of $5,199, $0, and $0, respectively</a></td>
<td class="num">(15,273)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive loss</a></td>
<td class="num">(15,273)<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">$ 139,510<span></span>
</td>
<td class="nump">$ 50,189<span></span>
</td>
<td class="nump">$ 29,737<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497071188232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent', window );">Change in unrealized loss on available-for-sale-securities, tax</a></td>
<td class="nump">$ 5,199<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497066278376">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Loss</div></th>
<th class="th"><div>Retained Earnings (Accumulated Deficit)</div></th>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2019</a></td>
<td class="nump">76,249,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance at Mar. 31, 2019</a></td>
<td class="nump">$ 81,433<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_TemporaryEquityExercisesOfWarrantsShares', window );">Exercise of Series B redeemable convertible preferred stock warrants (in shares)</a></td>
<td class="nump">38,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_TemporaryEquityExercisesOfWarrantsAmount', window );">Exercise of Series B redeemable convertible preferred stock warrants</a></td>
<td class="nump">$ 25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2020</a></td>
<td class="nump">76,287,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance at Mar. 31, 2020</a></td>
<td class="nump">$ 81,458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,526,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2019</a></td>
<td class="num">(32,935)<span></span>
</td>
<td class="nump">$ 65<span></span>
</td>
<td class="nump">$ 10,623<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (43,623)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">2,537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,040,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">1,694<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">1,691<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition', window );">Common stock warrant expense</a></td>
<td class="nump">57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_AdjustmentsToAdditionalPaidInCapitalExerciseOfWarrants', window );">Exercise of Series B redeemable convertible preferred stock warrants</a></td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">29,737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,737<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,566,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2020</a></td>
<td class="nump">$ 1,136<span></span>
</td>
<td class="nump">$ 68<span></span>
</td>
<td class="nump">14,954<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(13,886)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2021</a></td>
<td class="nump">76,287,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance at Mar. 31, 2021</a></td>
<td class="nump">$ 81,458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">7,398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,890,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">8,897<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">8,883<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Issuance of common stock in exchange for services (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices', window );">Issuance of common stock in exchange for services</a></td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase and retirement of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(258,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase and retirement of common stock</a></td>
<td class="num">(2,022)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,022)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition', window );">Common stock warrant expense</a></td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss</a></td>
<td class="num">(21)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions', window );">Issuance of common stock in connection with an acquisition (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">690,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions', window );">Issuance of common stock in connection with an acquisition</a></td>
<td class="nump">1,062<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">1,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">50,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,210<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82,910,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2021</a></td>
<td class="nump">$ 66,743<span></span>
</td>
<td class="nump">$ 83<span></span>
</td>
<td class="nump">30,357<span></span>
</td>
<td class="num">(21)<span></span>
</td>
<td class="nump">36,324<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of redeemable convertible preferred stock upon initial public offering (in shares)</a></td>
<td class="num">(76,287,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of redeemable convertible preferred stock upon initial public offering</a></td>
<td class="num">$ (81,458)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2022</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance at Mar. 31, 2022</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">$ 29,341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,341<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="nump">10,823,000<span></span>
</td>
<td class="nump">10,823,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">$ 12,612<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">12,601<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Vesting of restricted stock units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Tax withholding on shares under stock-based compensation awards</a></td>
<td class="num">(817)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(817)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares', window );">Repurchase and retirement of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(181,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue', window );">Repurchase and retirement of common stock</a></td>
<td class="num">(2,698)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,698)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition', window );">Common stock warrant expense</a></td>
<td class="nump">2,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive loss</a></td>
<td class="num">(15,273)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15,273)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of redeemable convertible preferred stock upon initial public offering (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,287,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of redeemable convertible preferred stock upon initial public offering</a></td>
<td class="nump">81,458<span></span>
</td>
<td class="nump">$ 76<span></span>
</td>
<td class="nump">81,382<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock upon initial public offering, net of underwriting discounts and commissions and deferred offering costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,506,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock upon initial public offering, net of underwriting discounts and commissions and deferred offering costs</a></td>
<td class="nump">548,452<span></span>
</td>
<td class="nump">$ 22<span></span>
</td>
<td class="nump">548,430<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock in connection with the employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock in connection with the employee stock purchase plan</a></td>
<td class="nump">1,395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,395<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">154,783<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">154,783<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">192,398,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2022</a></td>
<td class="nump">$ 878,594<span></span>
</td>
<td class="nump">$ 192<span></span>
</td>
<td class="nump">$ 702,589<span></span>
</td>
<td class="num">$ (15,294)<span></span>
</td>
<td class="nump">$ 191,107<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>APIC, Share-based Payment Arrangement, Stock Warrant Issued for Services, Increase for Cost Recognition</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_AdjustmentsToAdditionalPaidInCapitalExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments To Additional Paid In Capital, Exercise Of Warrants</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_AdjustmentsToAdditionalPaidInCapitalExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_TemporaryEquityExercisesOfWarrantsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Exercises of Warrants, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_TemporaryEquityExercisesOfWarrantsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_TemporaryEquityExercisesOfWarrantsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Exercises of Warrants, Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_TemporaryEquityExercisesOfWarrantsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Stock Issued During Period, Shares, Conversion Of Convertible Securities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Stock Issued During Period, Value, Conversion Of Convertible Securities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued during the period pursuant to acquisitions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued pursuant to acquisitions during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased and retired during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedAndRetiredDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedAndRetiredDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497065125368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 154,783<span></span>
</td>
<td class="nump">$ 50,210<span></span>
</td>
<td class="nump">$ 29,737<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">5,040<span></span>
</td>
<td class="nump">3,702<span></span>
</td>
<td class="nump">900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(41,247)<span></span>
</td>
<td class="nump">4,987<span></span>
</td>
<td class="num">(7,099)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation, net of amounts capitalized</a></td>
<td class="nump">31,442<span></span>
</td>
<td class="nump">7,252<span></span>
</td>
<td class="nump">2,353<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Non-cash lease expense</a></td>
<td class="nump">1,159<span></span>
</td>
<td class="nump">2,433<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Amortization of premium (accretion of discount) on marketable securities, net</a></td>
<td class="nump">4,332<span></span>
</td>
<td class="nump">197<span></span>
</td>
<td class="num">(441)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss', window );">Loss on sale of marketable securities</a></td>
<td class="nump">1,231<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortization', window );">Amortization of deferred contract costs</a></td>
<td class="nump">9,755<span></span>
</td>
<td class="nump">6,883<span></span>
</td>
<td class="nump">5,070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfBusiness', window );">Gain on sale of business</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,698)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other</a></td>
<td class="nump">410<span></span>
</td>
<td class="nump">403<span></span>
</td>
<td class="num">(52)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities, net of effect of acquisition:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(31,017)<span></span>
</td>
<td class="num">(20,452)<span></span>
</td>
<td class="num">(12,036)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(9,089)<span></span>
</td>
<td class="num">(1,833)<span></span>
</td>
<td class="num">(3,040)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_IncreaseDecreaseInCapitalizedContractCost', window );">Deferred contract costs</a></td>
<td class="num">(9,609)<span></span>
</td>
<td class="num">(9,384)<span></span>
</td>
<td class="num">(5,674)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable, accrued expenses and other liabilities</a></td>
<td class="nump">8,664<span></span>
</td>
<td class="nump">7,285<span></span>
</td>
<td class="nump">5,056<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Deferred revenue</a></td>
<td class="nump">1,828<span></span>
</td>
<td class="nump">38,571<span></span>
</td>
<td class="nump">13,318<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="num">(1,107)<span></span>
</td>
<td class="num">(2,583)<span></span>
</td>
<td class="num">(3,893)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">126,575<span></span>
</td>
<td class="nump">82,973<span></span>
</td>
<td class="nump">26,199<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(1,912)<span></span>
</td>
<td class="num">(245)<span></span>
</td>
<td class="num">(285)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToDevelopSoftware', window );">Internal-use software development costs</a></td>
<td class="num">(3,785)<span></span>
</td>
<td class="num">(4,365)<span></span>
</td>
<td class="num">(3,959)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchases of marketable securities</a></td>
<td class="num">(1,317,193)<span></span>
</td>
<td class="num">(78,880)<span></span>
</td>
<td class="num">(79,107)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities', window );">Maturities of marketable securities</a></td>
<td class="nump">47,919<span></span>
</td>
<td class="nump">40,537<span></span>
</td>
<td class="nump">70,256<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt', window );">Sales of marketable securities</a></td>
<td class="nump">633,802<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Cash paid for acquisition, net of cash acquired</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(31,682)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from sale of business</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,230<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other</a></td>
<td class="nump">595<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(640,574)<span></span>
</td>
<td class="num">(70,417)<span></span>
</td>
<td class="num">(13,095)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from issuance of common stock upon initial public offering after deducting underwriting discounts and commissions</a></td>
<td class="nump">553,905<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from issuance of common stock upon exercise of stock options</a></td>
<td class="nump">12,612<span></span>
</td>
<td class="nump">8,897<span></span>
</td>
<td class="nump">1,694<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockPlans', window );">Proceeds from issuance of common stock in connection with the employee stock purchase plan</a></td>
<td class="nump">1,395<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Taxes paid related to net share settlement of equity awards</a></td>
<td class="num">(817)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="num">(2,698)<span></span>
</td>
<td class="num">(2,022)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments for deferred offering costs</a></td>
<td class="num">(3,982)<span></span>
</td>
<td class="num">(1,468)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from exercise of redeemable convertible preferred stock warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">560,415<span></span>
</td>
<td class="nump">5,407<span></span>
</td>
<td class="nump">1,719<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash and cash equivalents</a></td>
<td class="nump">46,416<span></span>
</td>
<td class="nump">17,963<span></span>
</td>
<td class="nump">14,823<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, beginning of period</a></td>
<td class="nump">66,393<span></span>
</td>
<td class="nump">48,430<span></span>
</td>
<td class="nump">33,607<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, end of period</a></td>
<td class="nump">112,809<span></span>
</td>
<td class="nump">66,393<span></span>
</td>
<td class="nump">48,430<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of cash flow information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid for taxes</a></td>
<td class="nump">206<span></span>
</td>
<td class="nump">5,972<span></span>
</td>
<td class="nump">1,237<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Non-cash financing and investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountConverted1', window );">Conversion of redeemable convertible preferred stock to common stock</a></td>
<td class="nump">81,458<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_StockIssuancesCostsIncurredButNotYetPaid', window );">Unpaid deferred offering costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">782<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_StockIssuedAcquisitions', window );">Common stock issued in acquisition</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,062<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount', window );">Capitalized stock-based compensation for internal-use software development costs</a></td>
<td class="nump">497<span></span>
</td>
<td class="nump">195<span></span>
</td>
<td class="nump">184<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_EscrowDepositsRelatedToSaleOfBusiness', window );">Amounts held in escrow related to sale of business</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">470<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating lease right-of-use assets obtained in exchange for modified operating lease liabilities</a></td>
<td class="nump">$ 1,151<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_EscrowDepositsRelatedToSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Escrow Deposits Related To Sale Of Business</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_EscrowDepositsRelatedToSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_IncreaseDecreaseInCapitalizedContractCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Capitalized Contract Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_IncreaseDecreaseInCapitalizedContractCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_StockIssuancesCostsIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issuances Costs Incurred But Not Yet Paid</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_StockIssuancesCostsIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_StockIssuedAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued, Acquisitions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_StockIssuedAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123353750&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27357-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost capitalized for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4582445-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123371682&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToDevelopSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the development or modification of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToDevelopSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3151-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3151-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the stock plan during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497069743240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">DESCRIPTION OF BUSINESS</a></td>
<td class="text">DESCRIPTION OF BUSINESS<div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Description of Business</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Doximity,&#160;Inc. (the &#8220;Company&#8221;) was incorporated in the state of Delaware in April 2010 as 3MD Communications, Inc. and is headquartered in San Francisco, California. The Company subsequently changed its name to Doximity, Inc. in June 2010. The Company provides an online platform, which enables physicians and other healthcare professionals to collaborate with their colleagues, securely coordinate patient care, stay up to date with the latest medical news and research, and manage their careers. The Company&#8217;s customers primarily include pharmaceutical companies and health systems that connect with healthcare professionals through the Company&#8217;s digital Marketing and Hiring Solutions. Marketing Solutions provide customers with the ability to share tailored content on the network. Hiring Solutions enable customers to identify, connect with, and hire from the network of both active and passive potential physician candidates.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Initial Public Offering</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, the Company completed its initial public offering, or IPO, in which the Company issued and sold 22,505,750 shares of its Class A common stock at $26.00 per share, including 3,495,000 shares issued upon the exercise of the underwriters&#8217; option to purchase additional shares. The Company received proceeds of $548.5 million after deducting underwriting discounts and commissions as well as deferred offering costs. In connection with the IPO, all 76,286,618 shares of the Company&#8217;s outstanding redeemable convertible preferred stock automatically converted into an equivalent number of shares of Class B common stock on a one-to-one basis. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred offering costs, which consist of direct incremental legal, consulting, banking, and accounting fees relating to the Company&#8217;s planned initial public offering, were capitalized. Upon the consummation of the IPO, the $5.5 million of deferred offering costs were offset against proceeds. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Split</span></div>On June&#160;8, 2021, the Company&#8217;s board of directors and stockholders approved an amendment to the Company&#8217;s amended and restated certificate of incorporation effecting a 2-for-1 forward split of the Company&#8217;s issued and outstanding stock, including outstanding stock-based instruments and redeemable convertible preferred stock. The par value of the common and redeemable convertible preferred stock was not adjusted as a result of the stock split. As such, the Company has reclassified amounts from additional paid-in capital to common stock. All issued and outstanding shares of common stock, stock-based instruments, redeemable convertible preferred stock, and per-share amounts included in the accompanying consolidated financial statements have been adjusted to reflect this stock split for all periods presented.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497151306392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Summary Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America, or U.S. GAAP.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements include the accounts of the Company and its consolidated subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. Certain prior year amounts were reclassified, as applicable, to conform to the current year presentation. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal Year </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s fiscal year ends on March 31</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Unless otherwise noted, all references to a particular year shall mean the Company&#8217;s fiscal year. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company&#8217;s consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts stated in the consolidated financial statements and accompanying notes. These judgments, estimates, and assumptions are used for, but not limited to, revenue recognition, the fair values of acquired intangible assets and goodwill, the useful lives of long-lived assets, the valuation of the Company&#8217;s common stock and stock-based awards, and deferred income taxes. The Company bases its estimates on historical experience and also on assumptions that management considers reasonable. The Company assesses these estimates on a regular basis; however, actual </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">results could differ from these estimates due to risks and uncertainties, including uncertainty in the current economic environment due to the potential long-term impact and duration of the ongoing COVID-19 pandemic.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities, and accounts receivable. The primary focus of the Company&#8217;s investment strategy is to preserve capital and meet liquidity requirements. The Company&#8217;s investment policy addresses the level of credit exposure by limiting the concentration in any one corporate issuer or sector and establishing a minimum allowable credit rating. To manage risk exposure, the Company invests cash equivalents and marketable securities in a variety of fixed income securities, including government and investment-grade debt securities and money market funds. The Company places its cash primarily in checking and money market accounts with reputable financial institutions. Deposits held with these financial institutions may exceed the amount of insurance provided on such deposits, if any.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Concentrations of credit risk with respect to accounts receivable are primarily limited to certain customers to which the Company makes substantial sales. The Company&#8217;s significant customers that represented 10% or more of revenue or accounts receivable, net for the periods presented were as follows:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.162%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Revenue</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accounts Receivable, Net</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Customer A</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">_______________</span></div><div style="padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">* Less than 10%</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the purpose of assessing concentration of credit risk for significant customers, the Company defines a customer as an entity that purchases the Company&#8217;s services directly or indirectly through marketing agencies. The majority of marketing agencies have a pass-through arrangement for collection purposes, except one marketing agency which accounted for 17% and 18% of accounts receivable, net as of March&#160;31, 2022 and 2021, respectively. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenue is primarily derived from the sale of subscriptions for the following solutions:</span></div><div style="margin-bottom:9pt;padding-left:63pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">Marketing Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Hosting of customer-sponsored content on the Doximity platform and providing access to the Company&#8217;s professional database of healthcare professionals for referral or marketing purposes during the subscription period.</span></div><div style="margin-bottom:9pt;padding-left:63pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">Hiring Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Providing customers access to the Company&#8217;s professional tools where recruiters can access the Company&#8217;s database of healthcare professionals, allowing customers to send messages for talent sourcing and to share job postings during the subscription period. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines revenue recognition in accordance with ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, through the following five steps:</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt">Identify the contract with a customer</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers the terms and conditions of its contracts and the Company&#8217;s customary business practices in identifying its contracts under ASC 606. The Company determines it has a contract with a customer when the contract has been approved by both parties, it can identify each party&#8217;s rights regarding the services to be transferred and the payment terms for the services, it has determined the customer to have the ability and intent to pay, and the contract has commercial substance. At contract inception, the Company evaluates whether two or more contracts should be combined and accounted for as a single contract. The Company applies judgment in determining the customer&#8217;s ability and intent to pay, which is based on a variety of factors, including the customer&#8217;s payment history or, in the case of a new customer, credit and financial information pertaining to the customer.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual terms for Marketing Solutions contracts are generally 12 months or less. The contractual term for Hiring Solutions contracts is typically 12 months. Customers are generally billed for a portion of the contract upon contract execution and then billed throughout the remainder of the contract based on various time-based milestones. Certain Marketing Solutions </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">contracts are cancellable with a 30-day notice period. The Company is not required to refund any prepayment fees invoiced and customers are responsible for prorated amounts to cover services that were provided but payment was not made. Contracts related to Hiring Solutions are noncancellable and customers are billed in annual, quarterly, or monthly installments in advance of the service period.</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt">Identify the performance obligations in the contract</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance obligations promised in a contract are identified based on the services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the service either on its own or together with other resources that are readily available, and are distinct in the context of the contract, whereby the transfer of the services is separately identifiable from other promises in the contract.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketing Solutions customers may purchase a subscription for a specific module to be used over a defined period of time. These customers may purchase more than one module with either the same or different subscription periods. Modules are the core building blocks of the Company&#8217;s customers&#8217; marketing plan and can be broadly categorized as Awareness, Interactivity, and Peer. As an example, the Company&#8217;s Awareness modules may include:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A sponsored article, including a headline that appears in the targeted member&#8217;s newsfeed.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Short, animated videos that are presented in targeted members&#8217; newsfeeds.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Short-form content that is presented within the targeted members&#8217; newsfeeds.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each module targets a consistent number of Doximity members per month for the duration of the subscription period. The Company treats each subscription to a specific module as a distinct performance obligation because each module is capable of being distinct as the customer can benefit from the subscription to each module on their own and each subscription can be sold standalone. Furthermore, the subscriptions to individual modules are distinct in the context of the contract as (1) the Company is not integrating the services with other services promised in the contract into a bundle of services that represent a combined output, (2) the subscriptions to specific modules do not significantly modify or customize the subscription to another module, and (3) the specific modules are not highly interdependent or highly interrelated. The subscription to each module is treated as a series of distinct performance obligations because it is distinct and substantially the same, satisfied over time, and has the same measure of progress.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketing Solutions customers may also purchase integrated subscriptions for a fixed subscription fee that are not tied to a single module but allow customers to utilize any combination of modules during the subscription period subject to limits on the total number of modules launched in a given period of time, active at any given time, and members targeted. These represent stand-ready obligations in that the delivery of the underlying sponsored content is within the control of the customer and the extent of use in any given period does not diminish the remaining services. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some customers have negotiated to receive credits to purchase additional services at no extra cost if certain metrics have not been achieved. These credits are accounted for as material rights.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subscriptions to Hiring Solutions provide customers access to the platform to place targeted job postings and send a fixed number of monthly messages. Each subscription is treated as a series of distinct performance obligations that are satisfied over time. </span></div><div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt">Determine the transaction price </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price is determined based on the consideration the Company expects to be entitled to in exchange for transferring services to the customer. Variable consideration is included in the transaction price if, in the Company&#8217;s judgment, it is probable that a significant future reversal of cumulative revenue recognized under the contract will not occur.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may generate sales through the use of third-party media agencies that are authorized to enter into contracts on behalf of an end customer. The Company acts as the principal in these transactions since it maintains control prior to transferring the service to the customer and is primarily responsible for the fulfillment that occurs through the Company&#8217;s platform. The Company records revenue for the amount to which it is entitled from the third-party media agencies as the Company does not know and expects not to know the price charged by the third-party media agencies to its customers. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized net of any taxes collected from customers, which are subsequently remitted to governmental entities.</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt">Allocate the transaction price to performance obligations in the contract</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative stand-alone selling price, or SSP. The determination of a SSP for each distinct performance obligation requires judgment. The Company determines SSP for performance obligations based on overall pricing objectives, which take into consideration market conditions and customer-specific factors, including a review of internal discounting tables, the type of services being sold, and other factors. The estimate of standalone selling price is based on historical sales of standalone services. The Company estimates standalone selling price for arrangements where standalone sales do not provide sufficient evidence of standalone selling price. The Company believes the use of its estimation approach and allocation of the transaction price on a relative SSP basis to each performance obligation results in revenue recognition in a manner consistent with the underlying economics of the transaction and the allocation principle included in ASC 606.</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt">Recognize revenue when or as the Company satisfies a performance obligation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when or as control of the promised goods or service is transferred to the customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. Subscriptions represent a series of distinct goods or services because the performance obligations are satisfied over time as customers simultaneously receive and consume the benefits related to the services as the Company performs. In the case of module specific subscriptions, a consistent level of service is provided during each monthly period the sponsored content is available on the Company&#8217;s platform. The Company commences revenue recognition when the first content is launched on the platform for the initial monthly period and revenue is recognized over time as each subsequent content period is delivered. The Company&#8217;s obligation for its integrated subscriptions is to stand-ready throughout the subscription period; therefore, the Company considers an output method of time to measure progress towards satisfaction of its obligations with revenue commencing upon the beginning of the subscription period. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company treats Hiring Solutions subscriptions as a single performance obligation that represents a series of distinct performance obligations that is satisfied over time. Revenue recognition commences when the customer receives access to the services. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other revenue consists of fees earned from the temporary staffing and permanent placement of healthcare professionals. Revenue is recognized when control of these services is transferred to the Company&#8217;s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Balances </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Timing of revenue recognition may differ from the timing of invoicing to customers. A majority of customers are invoiced throughout the contract while others are billed upfront. Marketing Solutions customers are generally billed for a portion of the contract upon contract execution and then billed throughout the remainder of the contract based on various time-based milestones, starting when the tailored content is first shared on the Doximity platform. The Company&#8217;s contracts do not contain significant financing components. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records unbilled revenue when revenue is recognized in amounts for which it is contractually entitled but exceeds the amounts the Company has a right to bill as of the end of the period. The Company records unbilled revenue on the consolidated balance sheets within prepaid expenses and other current assets. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Deferred revenue consists of noncancelable customer billings or payments received in advance of revenue recognition. Deferred revenue balances are generally expected to be recognized within 12 months. Since the majority of the Company&#8217;s contracts have a duration of one year or less, the Company has elected not to disclose remaining performance obligations in accordance with the optional exemption in ASC 606. Remaining performance obligations for contracts with an original duration greater than one year are not material.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Contract Costs</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes sales commissions that are considered to be incremental and recoverable costs of obtaining a contract with a customer. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales compensation earned for the renewal of Marketing Solutions contracts are commensurate with commissions earned for a new or expansion Marketing Solutions contract, whereas commissions for the renewal of Hiring Solutions subscription contracts are earned at a lower rate than for new and expansion Hiring Solutions subscription contracts. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred compensation for Marketing Solutions contracts and Hiring Solutions renewal contracts is amortized over the weighted-average contractual term, ranging from 7 months to 13 months. Deferred compensation tied to new and expansion contracts for Hiring Solutions is amortized on a straight-line basis over the expected period of benefit of 4 years, which is determined by the nature of the Company&#8217;s technology and services, the rate at which the Company continually enhances and updates its technology, and its historical customer retention. Deferred compensation is recorded as deferred contract costs on the consolidated balance sheets. Amortized costs are included in cost of revenues and sales and marketing expense in the consolidated statements of operations. Amounts expected to be recognized within one year of the balance sheet date are recorded as deferred contract costs, current, and the remaining portion is recorded as other assets on the consolidated balance sheets. Certain sales commissions that are not considered incremental costs are expensed in the same period as they are earned. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale debt securities are recorded at fair value on the consolidated balance sheets. The carrying value of cash equivalents, accounts receivable, accounts payable, and accrued expenses and other current liabilities approximate their respective fair values due to their short maturities. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a three-tier hierarchy, which prioritizes the inputs used in measuring fair value as follows:</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Inputs that are unadjusted quoted prices in active markets for identical assets or liabilities at the measurement date.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Inputs (other than quoted prices included in Level&#160;1)&#160;that are either directly or indirectly observable for the asset or liability through correlation with market data at the measurement date and for the duration of the instrument&#8217;s anticipated life.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities and which reflect management&#8217;s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents and Marketable Securities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with maturities of three months or less at the time of acquisition to be cash equivalents. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s marketable securities portfolio includes only debt securities. Marketable debt securities that the Company may sell prior to maturity in response to changes in the Company's investment strategy, liquidity needs, or for other reasons are classified as available-for-sale. The Company's portfolio as of March&#160;31, 2022 and 2021 includes only available-for-sale securities. Available-for-sale securities are stated at fair value as of each balance sheet date. Unrealized gains and losses for available-for-sale securities are included in accumulated other comprehensive income, a component of stockholders&#8217; equity on the consolidated balance sheets. The Company&#8217;s marketable securities are available for use in current operations, even if the security matures beyond 12 months. The Company classifies its marketable securities as current assets on the consolidated balance sheets. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodically, the Company assesses the available-for-sale securities for impairment. An investment is impaired if the fair value of the investment is less than its amortized cost basis. The amortized cost of an investment will be written down to the fair value when the Company determines (i) it is more likely than not that management will be required to sell the impaired security before recovery of its amortized basis or (ii) management has the intention to sell the security. If neither of these conditions are met, the Company must determine whether the impairment is due to credit losses. A credit loss exists if the amortized cost basis of the security exceeds the present value of cash flows expected to be collected. All credit losses are recorded to other income, net and any remaining unrealized losses are recorded to other comprehensive loss. If the Company has the intent to sell an available-for-sale security in an unrealized loss position or it is more likely than not that it will be required to sell the security prior to recovery of its amortized cost basis, any previously recorded allowance is reversed and the entire difference between the amortized cost basis of the security and its fair value is recognized in other income, net in the consolidated statements of operations.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines any realized gains or losses on the sale of marketable securities on a specific identification method and records them to other income, net. Amortization of premiums and accretion of discounts are recorded to other income, net. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable and Allowance for Doubtful Accounts</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are recorded and carried at the original invoiced amount less an allowance for any potential uncollectible amounts. The Company estimates its allowance for doubtful accounts by evaluating the Company&#8217;s ability to collect outstanding receivable balances. The Company considers various factors, including the age of the balance, the creditworthiness of the customer, which is assessed based on ongoing credit evaluations and payment history, and the customer&#8217;s current financial condition. The Company had no material bad debt write offs for the years ending March&#160;31, 2022, 2021, and 2020.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost less accumulated depreciation. Depreciation and amortization expense is recorded on a straight-line basis over the estimated useful lives of the assets. The estimated useful life of each asset category is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.766%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furniture and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3-5 years </span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Computers and software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internal-use software development costs</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shorter of useful life or remaining lease term</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When assets are retired or otherwise disposed of, the cost and accumulated depreciation and amortization are written off, and any resulting gain or loss is recorded in the consolidated statement of operations in the period realized. Maintenance and repairs are expensed as incurred. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Internal-Use Software Development Costs</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes certain costs to develop its website, mobile applications and internal-use software when preliminary planning efforts are successfully completed, management has committed project resourcing, and it is probable that the project will be completed. Costs incurred prior to meeting these criteria, as well as costs incurred for training, maintenance, and minor modifications or enhancements, are expensed as incurred. Capitalized costs include personnel and related expenses for employees and costs of third-party contractors who are directly associated with and who devote time to internal-use software projects. Capitalization of these costs ceases once the project is substantially complete and the software is ready for its intended use. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitalized costs are included in property and equipment, net on the consolidated balance sheets and are amortized to cost of revenue over their estimated useful life. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Combinations</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To determine whether a transaction is accounted for as an asset acquisition or business combination, the Company applies a screen test to evaluate if substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets. When the Company acquires a business, the purchase consideration is allocated to the tangible and intangible assets acquired and liabilities assumed at their estimated fair values on the acquisition date. The excess of the fair value of purchase consideration over the values of these identifiable assets and liabilities is recorded as goodwill. When determining the fair value of assets acquired and liabilities assumed, management makes significant estimates and assumptions, particularly with respect to the valuation of intangible assets. Acquisition costs, such as legal and consulting fees, are expensed as incurred. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill, Intangible Assets, and Long-Lived Assets</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of the purchase price over the fair value of the net tangible and intangible assets acquired in a business combination. Goodwill is not amortized, but is tested for impairment at least annually or more frequently if events or changes in circumstances indicate that the asset may be impaired. The Company has one reporting unit and evaluates goodwill for impairment at the entity level. If the carrying value of the reporting unit exceeds its fair value, an impairment charge is </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recognized for the excess of the carrying value of the reporting unit over its fair value, limited to the amount of goodwill allocated to the reporting unit. The Company performs its annual impairment test of goodwill in its fourth fiscal quarter and whenever events or circumstances indicate that the asset might be impaired. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The intangible assets are stated at cost less accumulated amortization and are amortized on a straight-line basis over their estimated remaining economic lives. Amortization expense related to intangible assets is included in sales and marketing expense. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management evaluates the recoverability of the Company&#8217;s property and equipment and intangible assets when events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets held and used is measured by comparison of the carrying amount of an asset or an asset group to the estimated undiscounted future net cash flows expected to be generated by the asset or asset group. If the carrying value exceeds the estimated undiscounted future cash flows, an impairment loss is recognized for the amount by which the carrying amount exceeds the fair value for the asset or asset group. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures compensation expense for all stock-based awards based on the estimated fair value of the awards on the date of grant. Stock-based awards include stock options with service-based, performance-based and market-based vesting conditions, restricted stock units, or RSUs, performance-based restricted stock units, or PSUs, and warrants granted to employees, directors, and non-employees, as well as stock purchase rights granted to employees under the 2021 Employee Stock Purchase Plan, or ESPP. For awards that vest based on continued service, stock-based compensation, net of estimated forfeitures, is recognized on a straight-line basis over the requisite service period. For awards with performance-based vesting conditions, stock-based compensation expense, net of estimated forfeitures, is recognized using an accelerated attribution method from the time it is deemed probable that the vesting condition will be met through the time the service-based vesting condition has been achieved. The Company reassesses the probability of achieving the performance condition at each reporting date. For awards with market-based vesting conditions, stock-based compensation expense, net of estimated forfeitures, is recognized on an accelerated attribution basis over the requisite service period, even if the market condition is not satisfied. Forfeitures are estimated based upon the Company&#8217;s historical experience and the Company revises its estimates, if necessary, in subsequent periods if actual forfeitures differ from initial estimates. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each RSU and PSU is based on the fair value of the Company&#8217;s common stock on the date of grant. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The grant-date fair value of warrants, stock purchase rights granted to employees under the ESPP, and stock options with service-based or performance-based vesting conditions is estimated using the Black-Scholes pricing model. The grant-date fair value of stock options with market-based vesting conditions is estimated using the Monte Carlo simulation model. The determination of the grant-date fair value using an option-pricing model is affected by the fair value of the Company&#8217;s common stock and assumptions regarding a number of other complex and subjective variables. These assumptions include the expected term of the award, the expected stock price volatility over the expected term of the award, the risk-free interest rate for the expected term of the award, and expected dividends. The assumptions used in the Black-Scholes models are determined as follows: </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk-Free Interest Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The risk-free interest rate is based on the implied yield available on U.S. Treasury zero-coupon issues with an equivalent expected term of the options for each option group. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Prior to the IPO when there was no public market for the Company&#8217;s common stock, the expected volatility was determined using the historical volatilities of several publicly listed peer companies over a period equivalent to the expected term of the awards. The Company has not issued any stock options subsequent to the IPO. After the IPO, for the Company&#8217;s ESPP, the expected volatility was determined using the historical stock volatilities of the common stock of the Company over a period equivalent to the duration of the offering period. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Term</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The expected term represents the period that the Company&#8217;s stock-based awards are expected to be outstanding. For stock options granted to employees prior to the completion of the IPO, the Company estimated the expected term using the simplified method as the Company&#8217;s historical share option exercise experience did not provide a reasonable basis upon which to estimate the expected term. The simplified method uses the average of the vesting period and contractual term. For stock options granted to non-employees prior to the completion of the IPO, the Company used the contractual term as the expected term. The Company has not issued any stock options subsequent to the IPO. For stock purchase rights granted to employees under the ESPP, the expected term is equivalent to the offering period. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Dividend Yield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The Company has not historically issued dividends and does not currently expect to issue a dividend in the future. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Per Share of the Company&#8217;s Common Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Because the Company&#8217;s common stock was not publicly traded until the completion of the IPO, the Company&#8217;s board of directors considered numerous objective and subjective factors to determine the fair value of the Company&#8217;s common stock at each meeting during which awards were approved. These factors included, but were not limited to (i) contemporaneous third-party valuations of common stock; (ii) the rights and preferences of the Company&#8217;s preferred stock relative to common stock; (iii) the lack of marketability of common stock; (iv) developments in the business; and (v) the likelihood of achieving a liquidity event, such as an IPO or sale of the Company, given prevailing market conditions. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if a contract is or contains a lease at inception. All of the Company&#8217;s leases are operating leases. Operating lease right-of-use assets and lease liabilities are recognized at the lease commencement date based on the present value of the lease payments over the lease term, discounted using the Company&#8217;s incremental borrowing rate. As none of the Company&#8217;s leases provide an implicit rate, the incremental borrowing rate used is estimated based on what the Company would be required to pay for a collateralized loan over a similar term as the lease. The Company amortizes the present value of each right-of-use asset on a straight-line basis over its remaining lease term. Leases are included in operating lease right-of-use assets, operating lease liabilities, current, and operating lease liabilities, non-current on the consolidated balance sheets. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options to extend or terminate a lease are included in the lease term when it is reasonably certain that such options will be exercised. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our lease agreements may contain variable costs such as common area maintenance, insurance, property tax, and other operating costs. Variable lease costs are expensed as incurred in the consolidated statements of operations. The Company does not separate non-lease components from lease components for its facility asset portfolio. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not recognize right-of-use assets and lease liabilities for short-term leases, which have a lease term of 12 months or less. Lease cost for short-term leases is recognized on a straight-line basis over the lease term. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income Per Share Attributable to Common Stockholders</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net income per share attributable to common stockholders is presented in conformity with the two-class method required for participating securities. Holders of redeemable convertible preferred stock are each entitled to receive noncumulative dividends out of any funds legally available, when and if declared by the Company&#8217;s board of directors, payable prior and in preference to any dividends on any shares of common stock based on the proportion of common stock that would be held if all shares of redeemable convertible preferred stock were converted at the then-effective conversion rate.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redeemable convertible preferred stock is therefore considered a participating security and is included in the computation of earnings per share under the two-class method. Holders of redeemable convertible preferred stock do not have a contractual obligation to share in the Company&#8217;s losses. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the two-class method, net income attributable to common stockholders is determined by allocating undistributed earnings, calculated as net income, less (i) current period redeemable convertible preferred stock noncumulative dividends and (ii) earnings attributable to participating securities. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income per share attributable to common stockholders is computed by dividing the net income attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted net income per share attributable to common stockholders is computed by dividing net income attributable to common stockholders by the weighted-average number of common shares outstanding and the effect of potentially dilutive securities outstanding during the period. Potentially dilutive securities include stock options, RSUs, PSUs, ESPP, redeemable convertible preferred stock, redeemable convertible preferred stock warrants, and common stock warrants. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rights, including the liquidation and dividend rights, of the holders of Class A and Class B common stock are identical, except with respect to voting, converting, and transfer rights. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis to each class of common stock and the resulting basic and diluted </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">net loss per share attributable to common stockholders are, therefore, the same for both Class A and Class B common stock on both an individual and combined basis.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. Deferred income tax assets and liabilities are measured using enacted tax rates for the year in which those temporary differences are expected to be recovered or settled. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the consolidated statements of operations in the period that includes the enactment date. A valuation allowance is recorded when it is more likely than not that some of the deferred tax assets will not be realized. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized. The Company&#8217;s policy is to classify interest and penalties associated with uncertain tax positions, if any, as a component of its provision for (benefit from) income taxes. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Contingencies</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may be subject to claims and other legal matters from time to time. The Company records a liability when it believes that it is both probable that a loss has been incurred and the amount can be reasonably estimated. When the Company believes that a loss is reasonably possible, it will disclose an estimate of the possible loss or range of loss. The Company expects to periodically evaluate developments in the legal matters that could affect the amount of liability that the Company accrues, if any, and adjust as appropriate. Until the final resolution of any such matter for which the Company may record a liability, there may be a loss exposure in excess of the liability recorded and such amount could be significant. Legal fees are expensed as incurred, other than amounts capitalized as deferred offering costs, as discussed above. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Revenue </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue consists primarily of expenses </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">related to cloud hosting, personnel-related expenses for the Company&#8217;s customer success team, costs for third-party platform access, software services and contractors, and other services used in connection with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">delivery and support of the Company&#8217;s platform. Cost of revenue also includes the amortization of  internal-use software development costs, editorial and other content-related expenses, and allocated overhead. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expense is primarily comprised of personnel-related</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> associated with the Company&#8217;s engineering and product teams who are responsible for building new products and improving existing products. Research and development expense also includes costs for third-party services and contractors, information technology and software-related costs, and allocated overhead. Other than internal-use software development costs that qualify for capitalization, research and development costs are expensed as incurred.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advertising Expenses </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advertising costs are expensed as incurred and are included in sales and marketing expense in the consolidated statements of operations. Advertising expense was $2.8 million, $2.6 million, and $2.0 million for the years ended March&#160;31, 2022, 2021, and 2020, respectively.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Pronouncements Recently Adopted</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2017, the FASB issued ASU 2017-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles&#8212;Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to simplify how entities assess goodwill for impairment by eliminating Step 2 from the goodwill impairment test. As amended, the goodwill impairment test consists of one step comparing the fair value of a reporting unit with its carrying amount. An entity should recognize a goodwill impairment charge for the amount by which the carrying amount exceeds the reporting unit&#8217;s fair value. This guidance is effective for the Company for its interim and annual period beginning April 1, 2023, and early adoption is permitted. The Company early adopted this new guidance effective April 1, 2021, using a prospective approach. The Company performed its annual impairment assessment in the fourth quarter of fiscal </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022 under this new guidance. The adoption of this guidance did not have a material impact on the consolidated financial statements. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that simplifies the accounting for income taxes by removing certain exceptions to the general principles in such areas as intraperiod tax allocation, year-to-date losses in interim periods, and deferred tax liabilities related to outside basis differences. Amendments also include simplifications in other areas such as franchise taxes, step-up in tax basis goodwill, separate entity financial statements, and interim recognition of enactment of tax laws or rate changes. This guidance is effective for the Company for its fiscal year beginning April 1, 2022 and interim periods within its fiscal year beginning April 1, 2023. The Company expects the impact on the consolidated financial statements from the adoption of this standard to be immaterial. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU 2021-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with Topic 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers,</span> as if it had originated the contracts. Under the current business combinations guidance, such assets and liabilities are recognized by the acquirer at fair value on the acquisition date, which has historically resulted in a reduction to unearned revenue on the balance sheet on acquisition date, and therefore, a reduction to revenues subsequently recognized than otherwise would have been recorded as an independent entity. Adoption of this guidance will result in higher unearned revenue on the balance sheet on acquisition date and higher revenues subsequently recognized. This guidance is effective for the Company for its fiscal year beginning April 1, 2023 and interim periods within that fiscal year, and early adoption is permitted. The Company expects to adopt this guidance in the first quarter of fiscal 2023 and expects the adoption to impact the accounting of business combinations subsequent to the adoption date.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497069447384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue Recognition</a></td>
<td class="text">Revenue Recognition <div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Disaggregation </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue consisted of the following (in thousands): </span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.186%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Subscription</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">319,298&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">192,256&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">116,388&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">24,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">14,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">343,548&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">206,897&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">116,388&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Balances </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the Company&#8217;s deferred revenue balances were as follows (in thousands): </span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">83,492&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">44,586&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Additions, net, during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">345,041&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">245,803&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue recognized from the beginning balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(82,534)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(43,054)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue recognized from contracts invoiced during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(261,014)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(163,843)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">84,985&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">83,492&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s unbilled revenue balances were $1.4 million, $0.7 million, and $0.2 million as of March&#160;31, 2022, 2021 and 2020, respectively. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Contract Costs</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalized $9.6 million, $9.4 million, and $5.7 million of contract acquisition costs for the fiscal years ended March&#160;31, 2022, 2021, and 2020, respectively. Amortization of deferred contract costs was $9.8 million, $6.9 million, and $5.1 million for the fiscal years ended March&#160;31, 2022, 2021, and 2020, respectively. Deferred contract costs are </span></div>periodically analyzed for impairment. There were no impairment losses relating to deferred contract costs during the fiscal years ended March&#160;31, 2022, 2021, and 2020.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497066113848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock', window );">Investments</a></td>
<td class="text">Investments<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost, gross unrealized gains and losses, and fair value of investments are as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cost or<br/>Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22,758&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22,758&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,791&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,383&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Corporate notes and bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,796)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128,104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sovereign bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,770&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(334)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">549,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,260)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">531,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">705,798&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(20,494)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">685,304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents and marketable securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">728,556&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(20,494)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">708,062&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the contractual maturities of the Company&#8217;s available-for-sale debt securities were as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Due within one year</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">157,948&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Due in one year to three years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">530,042&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">687,990&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost, gross unrealized gains and losses, and fair value of investments were as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cost or<br/>Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Corporate notes and bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,517&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,516&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Money market funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16,946&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16,945&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16,411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Corporate notes and bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">46,662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">46,641&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sovereign bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,857&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,858&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">76,161&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(26)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">76,141&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents and marketable securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">93,107&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(27)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">93,086&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022 and 2021, the Company has recognized accrued interest of $2.1 million and $0.3 million, respectively, which is included in prepaid expenses and other current assets in the consolidated balance sheets. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unrealized losses associated with the Company&#8217;s debt securities were $20.5 million as of March&#160;31, 2022. As the Company does not intend to sell these securities and it is more likely than not that the Company will hold these securities until maturity or until the cost basis is recovered, the Company did not recognize any impairment on these securities as of March&#160;31, 2022. The Company did not recognize any credit losses related to the Company&#8217;s debt securities during the fiscal year ended March&#160;31, 2022. The fair value related to the debt securities with unrealized loss for which no credit losses were recognized was $684.7 million as of March&#160;31, 2022. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unrealized losses associated with the Company&#8217;s debt securities were not material as of March&#160;31, 2021. The Company did not recognize any credit losses related to the Company&#8217;s debt securities during the fiscal year ended March&#160;31, 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for cash, cash equivalents, investments in debt and equity instruments (including cost and equity investees and related income statement amounts), equity and cost method investments, investments in joint ventures and any other investment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497069329864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements <div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the fair value hierarchy for the Company&#8217;s assets measured at fair value on a recurring basis (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 3</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20,072&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,686&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22,758&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,383&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,383&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Corporate notes and bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">128,104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">128,104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sovereign bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">530,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">531,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">530,174&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">155,130&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">685,304&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents and marketable securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">550,246&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">157,816&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">708,062&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 3</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Corporate notes and bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,516&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,516&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Money market funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,838&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,107&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16,945&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Corporate notes and bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">46,641&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">46,641&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sovereign bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,858&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,858&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,858&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">72,283&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">76,141&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents and marketable securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">13,696&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">79,390&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">93,086&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal years ended March&#160;31, 2022 and 2021, the Company had no transfers between levels of the fair value hierarchy.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497066167128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment, Net</a></td>
<td class="text">Property and Equipment, Net<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following (in&#160;thousands):</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Furniture and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">336&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">299&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Computers and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">769&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">796&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Internal-use software development costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10,908&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total property and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16,958&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12,460&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less: accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(8,470)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4,862)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,488&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,598&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense on property and equipment for the fiscal years ended March&#160;31, 2022, 2021, and 2020 was $4.0 million, $2.6 million and $0.9 million, respectively. Included in these amounts was amortization expense for internal-use software development costs of $3.5 million, $2.2 million and $0.7 million for the fiscal years ended March&#160;31, 2022, 2021, and 2020, respectively. The amortization of the internal-use software development costs is included in cost of revenue in the consolidated statements of operations. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended March&#160;31, 2022, 2021, and 2020, the Company capitalized $4.3 million, $4.6 million, and $4.1 million, respectively, of internal-use software development costs, which are included in property and equipment, net on the consolidated balance sheets. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No impairment was recognized on property and equipment during the years ended March&#160;31, 2022, 2021, and 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497069469784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses and Other Current Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock', window );">Accrued Expenses and Other Current Liabilities</a></td>
<td class="text">Accrued Expenses and Other Current Liabilities<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other current liabilities consisted of the following (in&#160;thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrued commissions</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6,653&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5,864&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrued payroll, bonus, and related expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Employee contributions under employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">621&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Rebate liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,933&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sales and other tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total accrued expenses and other current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">25,270&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16,285&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts Payable And Accrued Liabilities, Current Disclosure</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497069772824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations, Intangible Assets, and Goodwill<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Business Combination, Goodwill And Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Business Combinations, Intangible Assets, and Goodwill</a></td>
<td class="text">Business Combinations, Intangible Assets, and Goodwill<div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Curative Talent Acquisition </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2020, the Company completed the acquisition of THMED, LLC (subsequently renamed Curative Talent, LLC, &#8220;Curative&#8221;), which was accounted for as a business combination. Curative provides temporary and permanent healthcare staffing services to hospitals, medical groups, and other healthcare facilities across the United States. The acquisition-date fair value of the consideration transferred was $34.7 million, consisting of $33.6 million in cash and 689,656 shares of common stock valued at $1.1 million. The purchase consideration was allocated to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values as of the acquisition date, with the excess recorded to goodwill as shown below. The purchase consideration allocation was as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Assets acquired: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10,280&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total assets acquired</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">17,830&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Liabilities assumed:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts payable and accrued liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net assets acquired, excluding goodwill</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15,800&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Goodwill</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">18,915&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total purchase consideration</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">34,715&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the future benefits as a result of the acquisition that will enhance the Company&#8217;s product available to both new and existing customers and increase the Company&#8217;s competitive position. Goodwill is deductible for income tax purposes. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s acquisition-related costs were $1.2 million and were recorded as general and administrative expense in the Company&#8217;s consolidated statements of operations during the fiscal year ended March&#160;31, 2020.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets acquired are comprised of customer relationships with an estimated useful life of 10 years. The fair value assigned to the customer relationship was determined primarily using the multiple period excess earnings method cost approach, which estimates the direct cash flows expected to be generated from the existing customers acquired. The results of operations of this business combination have been included in the Company&#8217;s consolidated financial statements from the acquisition date. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the Company sold a portion of Curative Talent&#8217;s business for total consideration of $4.7 million, of which $4.2 million has been received in cash and the remaining $0.5 million was held in escrow, subject to standard representations and warranties. The net assets of this business were not material. The Company recognized a gain on sale for the total consideration during the fiscal year ended March&#160;31, 2021 as a result of this sale. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets, net consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,869&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10,280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Domain names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total intangible assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,880&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10,716&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less: accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1,971)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1,120)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total intangible assets, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,909&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,596&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense for intangible assets was $1.0 million, $1.1 million and not material for the fiscal years ended March&#160;31, 2022, 2021, and 2020 respectively.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, future amortization expense is as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Years Ending March 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">990&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">990&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">990&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">988&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,961&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total future amortization expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,909&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill </span></div>As of March&#160;31, 2022 and March&#160;31, 2021, goodwill was $18.9 million. No goodwill impairment charges were recorded for each of the fiscal years ended March&#160;31, 2022 and 2021.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Goodwill And Intangible Assets Disclosure</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Goodwill And Intangible Assets Disclosure</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497069777304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Convertible Preferred Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityDisclosureAbstract', window );"><strong>Temporary Equity Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_TemporaryEquityTextBlock', window );">Redeemable Convertible Preferred Stock</a></td>
<td class="text">Redeemable Convertible Preferred Stock<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, there were three outstanding series of redeemable convertible preferred stock, each with a par value of $0.001 per share. Upon completion of the IPO in June 2021, all shares of the Company&#8217;s redeemable convertible preferred stock outstanding, totaling 76,286,618, were automatically converted into an equivalent number of shares of Class B common stock on a one-to-one basis. The carrying value of redeemable convertible preferred stock of $81.5 million was reclassified into stockholders&#8217; equity. As of March&#160;31, 2022, there were no shares of redeemable convertible preferred stock issued or outstanding.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the redeemable convertible preferred stock outstanding as of March&#160;31, 2021 and other related information is as follows (in thousands):</span></div><div style="margin-bottom:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Series</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares<br/>Authorized</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares<br/>Issued and<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Liquidation<br/>Preference</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">27,636&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">27,636&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10,677&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10,756&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">26,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">26,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">17,014&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">17,075&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22,337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">53,767&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">53,841&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">76,350&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">76,287&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">81,458&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">81,672&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rights, preferences, privileges, restrictions, and other matters relating to the redeemable convertible preferred stock are summarized as follows:</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidation Preference</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;In the event of any liquidation event, either voluntary or involuntary, the holders of Series&#160;A, Series&#160;B, and Series&#160;C redeemable convertible preferred stock were entitled to receive, in priority and preference to common stockholders&#8217; liquidation preference, $0.3892, $0.6488925 and $2.4104 per share, respectively.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After paying the holders of the redeemable convertible preferred stock of their full respective preferential amounts, all of the remaining assets of the Company would be distributed on a pro rata basis among the holders of common stock. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Redemption</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The redeemable convertible preferred stock was classified as mezzanine equity on the consolidated balance sheets. The redeemable convertible preferred stock was not mandatorily redeemable; however, upon the event of a voluntary or involuntary liquidation, dissolution, change in control, or winding up of the Company, holders of the redeemable convertible preferred stock may have had the right to receive their liquidation preference under the terms of the preferred stockholder agreements. Accordingly, the preferred stockholders were entitled to redemption features that were not solely within the control of the Company.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The holders of Series&#160;A, Series&#160;B, and Series&#160;C redeemable convertible preferred stock were entitled to receive noncumulative dividends at the per annum rate of $0.03115, $0.0519, and $0.19285 per share, respectively, in preference and priority to any common stockholder, when and if declared by the board of directors. If, after such dividends above were paid or set apart for payment in any fiscal year, the board of directors declared additional dividends out of funds legally available, then such additional dividends would be set aside or paid among the holders of the redeemable convertible preferred stock and common stock on a pro-rata basis. No dividends on redeemable convertible preferred stock or common </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">stock were declared by the board of directors from inception through the date the redeemable convertible preferred stock was converted into Class B common stock in June 2021.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Voting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The holders of redeemable convertible preferred stock had the same voting rights as the holders of common stock. The holders of common stock and redeemable convertible preferred stock voted together as a single class. Each holder of common stock was entitled to one vote for each share of common stock held and each holder of redeemable convertible preferred stock was entitled to the number of votes equal to the number of shares of common stock into which such shares of redeemable convertible preferred stock could then be converted. So long as at least 2,000,000&#160;shares of redeemable convertible preferred stock remained outstanding, the holders of redeemable convertible preferred stock were entitled to elect two members of the board of directors. The holders of a majority of the common stock were entitled to elect two members of the board of directors. Any additional member of the board of directors was elected by the holders of a majority of the then outstanding redeemable convertible preferred stock and common stock, each voting as separate classes (and, with respected to redeemable convertible preferred stock, on an as-converted basis).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Conversion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Each share of redeemable convertible preferred stock was convertible to common stock at the option of the holder. Such conversion was determined by dividing the original issue price by the then effective conversion price (adjusted for any stock dividends, combinations, or splits with respect to such shares).</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of redeemable convertible preferred stock would be automatically converted into shares of common stock at the conversion rate at the time in effect for such series of redeemable convertible preferred stock immediately upon the earlier of (i)&#160;the Company&#8217;s sale of its common stock in a firm commitment underwritten public offering pursuant to a registration statement under the Securities Act of 1933, as amended, with a price per share of at least $2.41 (adjusted for any stock dividends, combinations, or splits with respect to such shares) and an aggregate offering price of at least $50 million or (ii)&#160;the date specified by written consent or agreement of the majority of the holders of redeemable convertible preferred stock, voting together as a single class on an as-converted basis.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Redeemable Convertible Preferred Stock Warrants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;In August 2012, the Company issued warrants to purchase 38,322&#160;shares of Series B redeemable convertible preferred stock at an exercise price of $0.65 per share. The warrants were issued to investors in connection with the Series&#160;B redeemable convertible preferred stock warrants financing. The fair value of the warrants at issuance was $14,000 based on the Black-Scholes option-pricing model using the assumptions of dividend yield of 0%, volatility of 55%, risk-free interest rate of 1.13%, and contractual life of seven years. The warrants were exercised during the fiscal year ended March&#160;31, 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_TemporaryEquityTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_TemporaryEquityTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497066136328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock', window );">Equity</a></td>
<td class="text">Equity<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preferred Stock</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the IPO, the Company&#8217;s amended and restated certificate of incorporation became effective, which authorized the issuance of 100,000,000 shares of undesignated preferred stock with a par value of $0.001 per share with rights and preferences, including voting rights, designated from time to time by the board of directors. As of March&#160;31, 2022, there were no shares of preferred stock issued and outstanding.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock and Creation of Dual-Class Structure </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has two classes of common stock authorized: Class A common stock and Class B common stock, and are collectively referred to as common stock throughout the notes to the consolidated financial statements, unless otherwise noted. On June 8, 2021, the Company&#8217;s board of directors and stockholders approved an amendment to the Company&#8217;s amended and restated certificate of incorporation which authorized 1,000,000,000 shares of Class A common stock with par value of $0.001 and one vote per share, and 500,000,000 shares of Class B common stock with par value of $0.001 and ten votes per share. The holders of common stock are entitled to receive dividends, as may be declared by the board of directors. Each of the Company&#8217;s 85,523,836 shares of existing common stock outstanding was reclassified into Class B common stock. Each outstanding share of Class B common stock may be converted at any time at the option of the holder into one share of Class A common stock. As of March&#160;31, 2022, there were 109,322,383 shares of Class A common stock, and 83,076,040 shares of Class B common stock outstanding.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock Warrants</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2017, the Company issued a warrant to purchase 250,000 shares of common stock at an exercise price of $0.72 per share in connection with a contract signed between the Company and U.S. News &amp; World Report, L.P., or U.S. News. The warrant vested on a monthly basis over a 5-year term starting on March 1, 2017 and expires 10 years from the date of grant. The Company recognizes the fair value of the warrants as stock-based compensation expense and additional paid-in capital over the vesting term of the warrant. As of March&#160;31, 2022, the warrant was fully vested. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 14, 2021, the Company issued a warrant (the &#8220;U.S. News Warrant&#8221;) to U.S. News to purchase 1,200,000 shares of Class A common stock with an exercise price of $12.56 per share, contingent on the execution of a commercial agreement with the U.S. News (the &#8220;Commercial Agreement&#8221;) prior to September 10, 2021, which was then extended to October 10, 2021. The first tranche of the U.S. News Warrant will vest on May 1, 2022 and the remainder will vest on a monthly basis over approximately 6 years. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 8, 2021, the Company signed an amended agreement to revise and extend the existing partnership with the U.S. News. The U.S. News Warrant was concurrently amended to remove the contingency related to the execution of the Commercial Agreement and the number of shares of Class A common stock issuable upon exercise of the U.S. News Warrant was revised from 1,200,000 shares to 516,000 shares. Other terms of the U.S. News Warrant remained the same. The grant-date fair value of the U.S. News Warrant was $34.7 million, which was determined using the Black-Scholes option-pricing model on the date of grant using the following assumptions: fair value of common stock of $76.50, volatility of 46.9%, risk-free interest rate of 1.61%, contractual term of 10 years, and an expected dividend of 0%. The fair value of the warrant will be recognized as expense in cost of revenue in the consolidated statements of operations on a straight-line basis over its vesting term of 6.48 years. The warrant expires 10 years from the date of grant. During the fiscal year ended March&#160;31, 2022, $2.6 million was recognized as stock-based compensation expense relating to the U.S. News Warrant. As of March&#160;31, 2022, unamortized compensation expense, net of estimated forfeitures, related to the unvested warrants was $32.1 million, which is expected to be recognized over the remaining vesting period of 6 years.  </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Incentive Plans</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2010, the Company&#8217;s board of directors and stockholders approved the adoption of the 2010 Equity Incentive Plan (the &#8220;2010 Plan&#8221;). The 2010 Plan provides for the granting of incentive stock options, nonstatutory stock options, restricted stock units, and restricted stock awards to employees, non-employee directors, and consultants of the Company. Options may be granted at a price per share not less than 100% of the fair market value at date of grant. If the incentive stock option is granted to a 10% stockholder, then the purchase or exercise price per share shall not be less than 110% of the fair market value per share of common stock on the grant date. Options granted under the 2010 Plan continue to vest until the last day of employment and generally vest over four years and expire 10 years from the date of grant. Stock awards may also be granted for services performed by external consultants and vest according to an award-specific schedule as approved by the board of directors.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, the Company&#8217;s board of directors approved the adoption of the 2021 Stock Option and Incentive Plan (the &#8220;2021 Plan&#8221;), which became effective upon the Company&#8217;s initial public offering. The 2021 Plan provides for the granting of incentive stock options, nonstatutory stock options, restricted stock units, and restricted stock awards to employees, non-employee directors, and consultants of the Company. A total of 22,500,000 shares of Class A common stock was initially reserved for the 2021 Plan. The number of shares reserved and available for issuance for the 2021 Plan will automatically increase each April 1, beginning on April 1, 2022, by the lesser of 5% of the outstanding number of shares of the Class A and Class B common stock on the immediately preceding March 31, or such lesser number of shares as determined by the Company&#8217;s compensation committee. Any shares of Class B common stock that would have otherwise been returned to the Company&#8217;s 2010 Plan as a result of forfeiture, expiration, cancellation, termination or net issuances of awards thereunder shall be returned to the share reserve under the 2021 Plan after being automatically converted from shares of Class B common stock to Class A common stock. The 2010 Plan and the 2021 Plan are collectively referred to as the &#8220;Plans&#8221; in the notes to the consolidated financial statements, unless otherwise noted.  </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s board of directors approved the adoption of the ESPP, which became effective upon the Company&#8217;s initial public offering. A total of 4,500,000 shares of Class A common stock was initially reserved for the ESPP. The number of shares reserved and available for issuance for the ESPP will automatically increase each April 1, beginning on April 1, 2022 and continuing through April 1, 2031, by the lesser of 6,750,000 shares of Class A common stock, 1% of the outstanding number of shares of the Class A and Class B common stock on the immediately preceding March 31, or such lesser number of shares as determined by the Company&#8217;s compensation committee.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company grants stock options under the terms of the Plans and outside of the Plans, as approved by the board of directors. The Company granted 4,682,582 options during the fiscal year ended March 31, 2018 outside of the Plans, of which 2,011,252 options were exercised as of March&#160;31, 2022. As of March&#160;31, 2022, 2,671,330 options issued outside of the Plans were outstanding. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has shares of common stock reserved for issuance as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.229%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Redeemable convertible preferred stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">76,287&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Common stock warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">766&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2010 Plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Options outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">33,856&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Shares available for future grant</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2021 Plan</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Performance-based restricted stock units outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Restricted stock units outstanding</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">534&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Shares available for future grant</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,466&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2021 ESPP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,471&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Options outstanding outside the Plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,671&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,720&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,232&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114,663&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activities within the Plans as well as outside of the Plans were as follows for both service-based and performance-based options (in&#160;thousands, except per share information): </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted-Average <br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average Remaining Contractual Term <br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Balance, March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">36,576&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.80&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.86</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">357,366&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Options granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Options exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(10,823)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Options forfeited or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(736)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Balance, March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">26,983&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.63</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,293,545&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Vested and exercisable as of March 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,113&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.15</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">408,238&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Vested and expected to vest as of March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">25,021&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.55</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,202,634&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate intrinsic value of options exercised during the fiscal years ended March&#160;31, 2022, 2021, and 2020 was $521.6 million, $52.6 million, and $3.0 million respectively.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant-date fair value of options granted for the fiscal years ended March&#160;31, 2022, 2021, and 2020 was $10.73, $3.18, and $0.77 respectively. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, unamortized compensation expense, net of estimated forfeitures, related to unvested stock options was $55.2 million, which is expected to be recognized over a weighted-average period of 3.04 years. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each option on the date of grant is determined using the Black-Scholes option-pricing model with the assumptions set forth in the following table:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Fair value of common stock</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$18.41 - $21.41</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$2.06 - $10.51</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$1.58 - $1.91</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">46.5% - 47.0%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">38.1% - 58.3%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">39.2% - 46.5%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.77% - 1.02%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.26% - 1.02%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.68% - 2.36%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.00 - 6.09</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.00 - 8.00</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.94 - 10.00</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Expected dividend</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;%</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance-Based Options </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2018, the board of directors of the Company granted 1,792,000 options to the Chief Executive Officer with an exercise price of $0.97 per share under the 2010 Plan (the &#8220;2018 CEO Grant&#8221;) with a liquidity-event performance-based vesting condition based on the occurrence of a qualifying liquidity event, including an IPO, as well as stock price target after the consummation of the IPO. In September 2020, the 2018 CEO Grant was modified to extend the stock price target achievement cutoff date. The fair value of the 2018 CEO Grant was determined using a Monte Carlo simulation approach on the modification date. The achievement of the qualifying event was not considered to be probable prior to the Company&#8217;s IPO. Upon the Company's IPO, the liquidity-event performance-based condition was met. During the fiscal year ended March&#160;31, 2022, $1.7 million was recognized as stock-based compensation expense relating to the 2018 CEO Grant. As the grant consists of a single tranche, the Company will amortize the remaining unrecognized compensation expense of $0.2 million on a straight-line basis over the remaining term of 0.17 years.  </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the Company has 480,000 outstanding options with performance-based and service-based vesting conditions. The performance conditions are satisfied upon meeting certain financial performance and sales targets. During the fiscal year ended March&#160;31, 2022, $1.7 million was recognized as stock-based compensation expense related to performance-based options whose performance condition have either been met or achievement of which is considered probable. For the options for which the achievement of the performance vesting conditions is met or is considered probable, the remaining unrecognized compensation expense is $1.4 million, which will be amortized using accelerated attribution method over the remainder of the vesting periods. The amount to be recognized may change based upon actual performance achieved and updates to estimates of future performance. During the fiscal year ended March&#160;31, 2021 and 2020, the stock-based compensation expense related to performance options was immaterial. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Units</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal year ended March&#160;31, 2022, the Company granted 572,904 RSUs under the 2021 Plan. The Company granted 28,250 on June 24, 2021, 50% of which vested on November&#160;15, 2021, with the remaining 50% vested on February&#160;15, 2022. The remaining RSUs granted during the fiscal year ended March&#160;31, 2022 will generally vest over four years based on continued service.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The RSUs are valued using the closing stock price of the Company&#8217;s common stock, which is traded on the NYSE, on the day of grant. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes RSU activity during the fiscal year ended March&#160;31, 2022 (in&#160;thousands, except per share information):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted-<br/>Average<br/>Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unvested Balance, March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">67.60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">59.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">54.59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unvested Balance, March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">534&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">68.23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total fair value of RSUs vested during the fiscal year ended March&#160;31, 2022 was $2.5 million.  </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, total unrecognized stock-based compensation cost, net of estimated forfeitures, related to non-vested RSUs was $26.3 million, and is expected to be recognized over a weighted-average period of approximately 3.51 years. As of March&#160;31, 2021 and 2020, no RSUs were outstanding. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance-Based Restricted Stock Units</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal year ended March&#160;31, 2022, the Company granted 15,239 PSUs under the 2021 Plan, which had a weighted-average grant date fair value of $80.00. The PSUs have performance-based vesting conditions that are satisfied upon meeting certain financial performance targets. During the fiscal year ended March&#160;31, 2022, 3,170 PSUs were forfeited. As of March&#160;31, 2022, 12,069 PSUs were unvested. The performance conditions of these PSUs were met as of March&#160;31, 2022.  During the fiscal year ended March&#160;31, 2022, $0.6 million  was recognized as stock-based compensation expense related to these PSUs. As of March&#160;31, 2022, the remaining unrecognized compensation expense was $0.3 million, which will be recognized on a straight-line basis over the remaining term of 0.38 years, as the PSUs consist of a single tranche. As of March&#160;31, 2021 and 2020, no PSUs were outstanding. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The PSUs are valued using the closing stock price of its common stock, which is traded on the NYSE, on the day of grant. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ESPP</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s first offering period under the ESPP began on November&#160;1, 2021 and ended on February&#160;15, 2022. Subsequent offering periods will begin on the first business day occurring on or after each February 16th and August 16th, and will end on the last business day occurring on or before the following August 15th and February 15th, respectively, unless and until otherwise determined by the administrator of the ESPP. The price at which Class A common stock is purchased under the ESPP is equal to 85% of the fair market value of a share of the Company&#8217;s Class A common stock on the first or last day of the offering period, whichever is lower. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted-average grant-date fair value of ESPP stock purchase rights granted during the fiscal year ended March&#160;31, 2022 was $23.84. The fair value of the ESPP stock purchase rights on the date of grant is determined using the Black-Scholes pricing model with the assumptions set forth in the following table:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.854%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Fair value of common stock</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$57.44 - $73.73</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">86.3% - 103.6%</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.05% - 0.67%</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.29 - 0.49</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Expected dividend</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, unamortized compensation expense, net of estimated forfeitures, related to the ESPP was $0.9 million, which will be recognized on a straight-line basis over a weighted-average period of 0.38 years. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the  fiscal year ended March&#160;31, 2022, 28,812 shares of Class A common stock were purchased under the ESPP at a weighted average price of $48.40 per share. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation Expense</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense recognized in the consolidated statement of operations for the fiscal years ended March&#160;31, 2022, 2021, and 2020 was as follows (in&#160;thousands): </span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.991%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cost of revenue</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,979&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">600&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">173&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sales and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">847&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11,290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">31,442&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,252&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,353&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497066165688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share Attributable to Common Stockholders<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Income Per Share Attributable to Common Stockholders</a></td>
<td class="text">Net Income Per Share Attributable to Common Stockholders<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the reconciliation of the numerator and denominator for calculating basic and diluted net income per share (in thousands, except per share data):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.991%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Numerator</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">154,783&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">50,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">29,737&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less: undistributed earnings attributable to participating securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(21,526)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(28,654)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(18,908)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income attributable to Class A and Class B common stockholders, basic and diluted</span></div></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">133,257&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">21,556&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10,829&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Denominator</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, basic</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">163,484&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">74,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">66,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dilutive effect of assumed exercise of options to purchase common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">27,290&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20,612&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">14,892&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dilutive effect of assumed exercise of common stock warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dilutive effect of other share-based awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, diluted</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">191,017&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">95,134&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">81,710&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income per share attributable to Class A and Class B common stockholders, basic</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.82&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income per share attributable to Class A and Class B common stockholders, diluted</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.70&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.23&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.13&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain potentially dilutive securities have been excluded from the calculation of diluted net income per share during the applicable periods because their inclusion would have been anti-dilutive (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.991%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Redeemable convertible preferred stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">76,287&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">76,287&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other share-based awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Common stock warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">464&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">76,287&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">76,865&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497069766424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company&#8217;s income before income taxes was generated in the United States for the fiscal year ended March 31, 2022, 2021, and 2020. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s provision for (benefit from) income taxes consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Current provision:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">876&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">469&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,572&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">876&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred provision (benefit):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(34,852)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,862&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6,458)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6,395)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(641)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(41,247)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,987&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7,099)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total provision for (benefit from) income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(40,778)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,559&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6,223)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of the income tax expense at the federal statutory tax rate to the Company&#8217;s provision for (benefit from) income taxes (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income taxes at statutory rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">23,941&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12,131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">State income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,561&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research and development credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(8,332)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1,845)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1,842)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(71,780)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5,796)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,878&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(11,995)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Section 162(m) limitation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">752&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">805&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total provision for (benefit from) income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(40,778)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,559&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6,223)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of deferred tax assets and liabilities were as follows (in&#160;thousands):</span></div><div style="margin-bottom:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accruals and deferred revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,760&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">32,215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research &amp; development credit carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">315&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Acquisition and other related expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,847&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">431&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unrealized loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5,199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Gross deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">55,862&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,276&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4,731)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2,896)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred tax assets, net of valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">51,131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,380&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1,899)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1,701)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(276)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(336)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(398)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(231)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2,573)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2,268)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net deferred tax assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">48,558&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,112&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act, or CARES Act, was enacted and signed into law. The CARES Act did not have a material impact to the Company's consolidated financial statements. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company maintains a valuation allowance related to specific net deferred tax assets where it is not more likely than not that the deferred tax assets will be realized, which include California research and development credits and capital loss carryforwards. The Company concluded, based upon the preponderance of positive evidence (i.e., a strong earnings history exclusive of the loss that created the future deductible amount, a history of taxable income in recent periods, the taxable loss is a result of excess tax benefit on stock exercises as a result of a non-recurring event (IPO), and the current forecast of income before taxes for the United States going forward) over negative evidence and the anticipated ability to use the deferred tax assets, that it was more likely than not that the deferred tax assets could be realized. If there are unfavorable changes to actual operating results or to projections of future income, the Company may determine that it is more likely than not such deferred tax assets may not be realizable.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation allowance was $4.7 million and $2.9 million as of March&#160;31, 2022 and 2021, respectively, relating to the California research and development tax credits and capital loss carryforwards. The valuation allowance increased by $1.8 million during the fiscal year ended March&#160;31, 2022, primarily due to the increase in California research and development credits generated during the year. The change in valuation allowance during the fiscal year ended March 31, 2021 was not material. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the Company had net operating loss, or NOL, carryforwards for state tax purposes of $97.1 million and $124.1 million for federal tax purposes. If not utilized, $83.6 million of the state NOL carryforwards will expire at various dates beginning in the year 2027. The federal NOL carryforwards can be carried forward indefinitely. As of March&#160;31, 2022, the Company had research and development tax credit carryforwards for federal and state tax purposes of $11.4 million and $8.4 million, respectively. The federal research and development tax credit carryforwards will expire at various dates beginning in the year 2040. If not utilized, $0.2 million of the state research and development tax credit carryforwards will expire at various dates beginning in the year 2032. Based on an assessment of the Company&#8217;s historical ownership changes through March&#160;31, 2022, the Company does not anticipate a current limitation on the tax attributes. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022 and 2021, the Company had unrecognized tax benefits, or UTBs, of $6.2 million and $3.2 million, respectively. If realized, $4.2 million would impact the effective tax rate while the remainder would reduce deferred tax assets subject to a full valuation allowance. The Company does not expect any material changes to its UTBs within the next 12 months.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending balances for gross UTBs is as follows (in thousands):</span></div><div style="margin-bottom:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,162&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,475&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,900&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Additions for tax positions related to the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,995&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Additions for tax positions related to prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reductions for tax positions related to prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1,095)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reductions related to a lapse of statute</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,188&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,162&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,475&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and penalties were not material during the years ended March&#160;31, 2022, 2021, and 2020.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company files income tax returns in the U.S. federal and various state jurisdictions. With limited exceptions, all tax years for which the Company has filed a tax return remain subject to examination.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497066124696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Leases</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, the Company entered into an 8-year lease for office space in Irving, Texas. This lease will commence on or around June&#160;1, 2022, with total undiscounted lease payments of $17.9 million. In accordance with ASC 842, Leases, the classification of the lease will be determined and the lease right-of-use assets and lease liabilities will be recognized on the lease commencement date based on the present value of lease payments over the lease term, discounted using the Company&#8217;s incremental borrowing rate. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Minimum Guarantees</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October&#160;8, 2021, the Company signed an amended agreement to revise and extend the existing partnership with the U.S. News for six years. This agreement can be terminated after three years by either party. Under this amended agreement, the Company pays the U.S. News a portion of the revenue generated with the end customers, with an annual minimum guarantee amount ranging from $2.5 million to $6.2 million. The total minimum guarantee amount for the initial noncancelable period of three years is $9.1 million. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">AMiON Acquisition</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;4, 2022, the Company entered into a definitive agreement to acquire the assets of the AMiON on-call scheduling and messaging application used by scheduling staff and physicians for cash consideration of $53.5 million paid at closing and earnout consideration of up to $24.0 million, payable over the next four years, subject to certain performance milestones. Under the definitive agreement, certain employees joining the Company as part of the acquisition are eligible for restricted stock unit awards, subject to future service-based vesting conditions. The acquisition closed and the cash consideration was paid on April 1, 2022. In May 2022, 93,458 restricted stock units with grant date fair value of $32.99 per share were granted to the eligible employees joining the Company as part of the acquisition. The acquisition will be accounted for as a business combination in fiscal 2023.   </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Contractual Commitments </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, the Company entered into a 3-year web hosting arrangement with an annual commitment of $5.2 million, starting January&#160;1, 2022.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indemnification</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into indemnification provisions under agreements with other companies in the ordinary course of business, including, but not limited to, clients, business partners, landlords, and other parties involved in the performance of the Company&#8217;s services. Pursuant to these arrangements, the Company has agreed to indemnify, hold harmless, and reimburse the indemnified party for certain losses suffered or incurred by the indemnified party as a result of the Company&#8217;s activities. The terms of these indemnification agreements are generally perpetual. The maximum potential amount of future payments the Company could be required to make under these agreements is not determinable. The Company has never incurred costs to defend lawsuits or settle claims related to these indemnification agreements. The Company maintains commercial general liability insurance and product liability insurance that may offset certain of its potential liabilities under these indemnification provisions.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company has agreed to indemnify its officers and directors and certain key employees while they are serving in good faith in their respective capacities. To date, there have been no claims under these indemnification provisions.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Matters</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company has become involved in claims and other legal matters arising in the ordinary course of business. The Company investigates these claims as they arise. Although claims are inherently unpredictable, the Company is currently not aware of any matters that, if determined adversely to the Company, would individually or taken together have a material effect on its results of operations, financial position, or cash flows. No loss contingencies were recorded for the fiscal years ended March&#160;31, 2022, 2021, and 2020.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497069351704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has non-cancelable operating leases for the rental of office space, corporate housing, and laptops with various expiration dates through 2023. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,159&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,372&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,010&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Variable lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,273&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,515&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,010&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash paid for amounts included in measurement of lease liabilities&#8212;Operating cash flows</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,107&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,569&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,069&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted-average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.64</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.37</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.15</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted-average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of March 31, 2022 were as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">673&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">455&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total future lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,128&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Present value of lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,089&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497066155896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitsAbstract', window );"><strong>Postemployment Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock', window );">Employee Benefit Plan</a></td>
<td class="text">Employee Benefit PlanThe Company sponsors a 401(k)&#160;savings plan. All U.S. employees are eligible to participate in the 401(k)&#160;plan after meeting certain eligibility requirements. Participants may elect to have a portion of their salary deferred and contributed to the 401(k)&#160;plan up to the limit allowed by applicable income tax regulations. The Company matched a portion of employee contributions to the 401(k) plan totaling $2.1 million, $1.3 million, and $0.7 million for the fiscal years ended March&#160;31, 2022, 2021 and 2020, respectively. Both employee contributions and the Company&#8217;s matching contributions are fully vested upon contribution.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 712<br> -URI http://asc.fasb.org/topic&amp;trid=2197446<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 710<br> -URI http://asc.fasb.org/topic&amp;trid=2127225<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndEmployeeBenefitPlansTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497066099528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment and Geographic Information</a></td>
<td class="text">Segment and Geographic InformationThe Company considers operating segments to be components of the Company in which separate financial information is available and is evaluated regularly by the Company&#8217;s chief operating decision maker in deciding how to allocate resources and in assessing performance. The chief operating decision maker for the Company is the Chief Executive Officer. The chief operating decision maker reviews financial information on a consolidated basis to make decisions about how to allocate resources and how to measure the Company&#8217;s performance. As such, the Company has determined that it has one operating and reportable segment. Substantially all of the Company&#8217;s long-lived assets were based in the United States as of March&#160;31, 2022 and 2021. No country outside of the United States accounted for more than 10% of total revenue for the fiscal years ended March&#160;31, 2022, 2021, and 2020. Substantially all of the Company&#8217;s revenue was derived in the United States for the fiscal years ended March&#160;31, 2022, 2021, and 2020.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497069479640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text">Subsequent Events<div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Grants</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, the Company&#8217;s compensation committee granted 563,689 RSUs with an effective date of May 15, 2022 and an estimated fair value of $18.6 million, including the RSUs granted to employees joining the Company as part of the AMiON acquisition. These RSUs will generally vest over four years based on continued service. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Repurchase Program</span></div>On May 12 2022, the Company&#8217;s board of directors authorized a program to repurchase up to $70 million of the Company&#8217;s Class A common stock. The repurchases may be executed from time to time over the next 12 months, subject to general business and market conditions and other investment opportunities, through open market purchases or privately negotiated transactions, including through Rule 10b5-1 plans. Immediately upon the repurchase of any shares of Class A common stock, such shares shall be retired by the Company and shall automatically return to the status of authorized but unissued shares of Class A common stock.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497065171112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America, or U.S. GAAP.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text">The accompanying consolidated financial statements include the accounts of the Company and its consolidated subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. Certain prior year amounts were reclassified, as applicable, to conform to the current year presentation.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiscalPeriod', window );">Fiscal Year</a></td>
<td class="text">Fiscal Year <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s fiscal year ends on March 31</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">st</span>. Unless otherwise noted, all references to a particular year shall mean the Company&#8217;s fiscal year.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the Company&#8217;s consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts stated in the consolidated financial statements and accompanying notes. These judgments, estimates, and assumptions are used for, but not limited to, revenue recognition, the fair values of acquired intangible assets and goodwill, the useful lives of long-lived assets, the valuation of the Company&#8217;s common stock and stock-based awards, and deferred income taxes. The Company bases its estimates on historical experience and also on assumptions that management considers reasonable. The Company assesses these estimates on a regular basis; however, actual </span></div>results could differ from these estimates due to risks and uncertainties, including uncertainty in the current economic environment due to the potential long-term impact and duration of the ongoing COVID-19 pandemic.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities, and accounts receivable. The primary focus of the Company&#8217;s investment strategy is to preserve capital and meet liquidity requirements. The Company&#8217;s investment policy addresses the level of credit exposure by limiting the concentration in any one corporate issuer or sector and establishing a minimum allowable credit rating. To manage risk exposure, the Company invests cash equivalents and marketable securities in a variety of fixed income securities, including government and investment-grade debt securities and money market funds. The Company places its cash primarily in checking and money market accounts with reputable financial institutions. Deposits held with these financial institutions may exceed the amount of insurance provided on such deposits, if any.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRecognitionPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenue is primarily derived from the sale of subscriptions for the following solutions:</span></div><div style="margin-bottom:9pt;padding-left:63pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">Marketing Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Hosting of customer-sponsored content on the Doximity platform and providing access to the Company&#8217;s professional database of healthcare professionals for referral or marketing purposes during the subscription period.</span></div><div style="margin-bottom:9pt;padding-left:63pt;text-align:justify;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt">Hiring Solutions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Providing customers access to the Company&#8217;s professional tools where recruiters can access the Company&#8217;s database of healthcare professionals, allowing customers to send messages for talent sourcing and to share job postings during the subscription period. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines revenue recognition in accordance with ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, through the following five steps:</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt">Identify the contract with a customer</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers the terms and conditions of its contracts and the Company&#8217;s customary business practices in identifying its contracts under ASC 606. The Company determines it has a contract with a customer when the contract has been approved by both parties, it can identify each party&#8217;s rights regarding the services to be transferred and the payment terms for the services, it has determined the customer to have the ability and intent to pay, and the contract has commercial substance. At contract inception, the Company evaluates whether two or more contracts should be combined and accounted for as a single contract. The Company applies judgment in determining the customer&#8217;s ability and intent to pay, which is based on a variety of factors, including the customer&#8217;s payment history or, in the case of a new customer, credit and financial information pertaining to the customer.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual terms for Marketing Solutions contracts are generally 12 months or less. The contractual term for Hiring Solutions contracts is typically 12 months. Customers are generally billed for a portion of the contract upon contract execution and then billed throughout the remainder of the contract based on various time-based milestones. Certain Marketing Solutions </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">contracts are cancellable with a 30-day notice period. The Company is not required to refund any prepayment fees invoiced and customers are responsible for prorated amounts to cover services that were provided but payment was not made. Contracts related to Hiring Solutions are noncancellable and customers are billed in annual, quarterly, or monthly installments in advance of the service period.</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt">Identify the performance obligations in the contract</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance obligations promised in a contract are identified based on the services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the service either on its own or together with other resources that are readily available, and are distinct in the context of the contract, whereby the transfer of the services is separately identifiable from other promises in the contract.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketing Solutions customers may purchase a subscription for a specific module to be used over a defined period of time. These customers may purchase more than one module with either the same or different subscription periods. Modules are the core building blocks of the Company&#8217;s customers&#8217; marketing plan and can be broadly categorized as Awareness, Interactivity, and Peer. As an example, the Company&#8217;s Awareness modules may include:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A sponsored article, including a headline that appears in the targeted member&#8217;s newsfeed.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Short, animated videos that are presented in targeted members&#8217; newsfeeds.</span></div><div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Short-form content that is presented within the targeted members&#8217; newsfeeds.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each module targets a consistent number of Doximity members per month for the duration of the subscription period. The Company treats each subscription to a specific module as a distinct performance obligation because each module is capable of being distinct as the customer can benefit from the subscription to each module on their own and each subscription can be sold standalone. Furthermore, the subscriptions to individual modules are distinct in the context of the contract as (1) the Company is not integrating the services with other services promised in the contract into a bundle of services that represent a combined output, (2) the subscriptions to specific modules do not significantly modify or customize the subscription to another module, and (3) the specific modules are not highly interdependent or highly interrelated. The subscription to each module is treated as a series of distinct performance obligations because it is distinct and substantially the same, satisfied over time, and has the same measure of progress.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketing Solutions customers may also purchase integrated subscriptions for a fixed subscription fee that are not tied to a single module but allow customers to utilize any combination of modules during the subscription period subject to limits on the total number of modules launched in a given period of time, active at any given time, and members targeted. These represent stand-ready obligations in that the delivery of the underlying sponsored content is within the control of the customer and the extent of use in any given period does not diminish the remaining services. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some customers have negotiated to receive credits to purchase additional services at no extra cost if certain metrics have not been achieved. These credits are accounted for as material rights.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subscriptions to Hiring Solutions provide customers access to the platform to place targeted job postings and send a fixed number of monthly messages. Each subscription is treated as a series of distinct performance obligations that are satisfied over time. </span></div><div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt">Determine the transaction price </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transaction price is determined based on the consideration the Company expects to be entitled to in exchange for transferring services to the customer. Variable consideration is included in the transaction price if, in the Company&#8217;s judgment, it is probable that a significant future reversal of cumulative revenue recognized under the contract will not occur.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may generate sales through the use of third-party media agencies that are authorized to enter into contracts on behalf of an end customer. The Company acts as the principal in these transactions since it maintains control prior to transferring the service to the customer and is primarily responsible for the fulfillment that occurs through the Company&#8217;s platform. The Company records revenue for the amount to which it is entitled from the third-party media agencies as the Company does not know and expects not to know the price charged by the third-party media agencies to its customers. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized net of any taxes collected from customers, which are subsequently remitted to governmental entities.</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt">Allocate the transaction price to performance obligations in the contract</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative stand-alone selling price, or SSP. The determination of a SSP for each distinct performance obligation requires judgment. The Company determines SSP for performance obligations based on overall pricing objectives, which take into consideration market conditions and customer-specific factors, including a review of internal discounting tables, the type of services being sold, and other factors. The estimate of standalone selling price is based on historical sales of standalone services. The Company estimates standalone selling price for arrangements where standalone sales do not provide sufficient evidence of standalone selling price. The Company believes the use of its estimation approach and allocation of the transaction price on a relative SSP basis to each performance obligation results in revenue recognition in a manner consistent with the underlying economics of the transaction and the allocation principle included in ASC 606.</span></div><div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt">Recognize revenue when or as the Company satisfies a performance obligation</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized when or as control of the promised goods or service is transferred to the customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. Subscriptions represent a series of distinct goods or services because the performance obligations are satisfied over time as customers simultaneously receive and consume the benefits related to the services as the Company performs. In the case of module specific subscriptions, a consistent level of service is provided during each monthly period the sponsored content is available on the Company&#8217;s platform. The Company commences revenue recognition when the first content is launched on the platform for the initial monthly period and revenue is recognized over time as each subsequent content period is delivered. The Company&#8217;s obligation for its integrated subscriptions is to stand-ready throughout the subscription period; therefore, the Company considers an output method of time to measure progress towards satisfaction of its obligations with revenue commencing upon the beginning of the subscription period. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company treats Hiring Solutions subscriptions as a single performance obligation that represents a series of distinct performance obligations that is satisfied over time. Revenue recognition commences when the customer receives access to the services. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other revenue consists of fees earned from the temporary staffing and permanent placement of healthcare professionals. Revenue is recognized when control of these services is transferred to the Company&#8217;s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Balances </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Timing of revenue recognition may differ from the timing of invoicing to customers. A majority of customers are invoiced throughout the contract while others are billed upfront. Marketing Solutions customers are generally billed for a portion of the contract upon contract execution and then billed throughout the remainder of the contract based on various time-based milestones, starting when the tailored content is first shared on the Doximity platform. The Company&#8217;s contracts do not contain significant financing components. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records unbilled revenue when revenue is recognized in amounts for which it is contractually entitled but exceeds the amounts the Company has a right to bill as of the end of the period. The Company records unbilled revenue on the consolidated balance sheets within prepaid expenses and other current assets. </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Deferred revenue consists of noncancelable customer billings or payments received in advance of revenue recognition. Deferred revenue balances are generally expected to be recognized within 12 months. Since the majority of the Company&#8217;s contracts have a duration of one year or less, the Company has elected not to disclose remaining performance obligations in accordance with the optional exemption in ASC 606. Remaining performance obligations for contracts with an original duration greater than one year are not material.</span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Contract Costs</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes sales commissions that are considered to be incremental and recoverable costs of obtaining a contract with a customer. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales compensation earned for the renewal of Marketing Solutions contracts are commensurate with commissions earned for a new or expansion Marketing Solutions contract, whereas commissions for the renewal of Hiring Solutions subscription contracts are earned at a lower rate than for new and expansion Hiring Solutions subscription contracts. </span></div>Deferred compensation for Marketing Solutions contracts and Hiring Solutions renewal contracts is amortized over the weighted-average contractual term, ranging from 7 months to 13 months. Deferred compensation tied to new and expansion contracts for Hiring Solutions is amortized on a straight-line basis over the expected period of benefit of 4 years, which is determined by the nature of the Company&#8217;s technology and services, the rate at which the Company continually enhances and updates its technology, and its historical customer retention. Deferred compensation is recorded as deferred contract costs on the consolidated balance sheets. Amortized costs are included in cost of revenues and sales and marketing expense in the consolidated statements of operations. Amounts expected to be recognized within one year of the balance sheet date are recorded as deferred contract costs, current, and the remaining portion is recorded as other assets on the consolidated balance sheets. Certain sales commissions that are not considered incremental costs are expensed in the same period as they are earned.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Financial Instruments</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available-for-sale debt securities are recorded at fair value on the consolidated balance sheets. The carrying value of cash equivalents, accounts receivable, accounts payable, and accrued expenses and other current liabilities approximate their respective fair values due to their short maturities. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a three-tier hierarchy, which prioritizes the inputs used in measuring fair value as follows:</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Inputs that are unadjusted quoted prices in active markets for identical assets or liabilities at the measurement date.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Inputs (other than quoted prices included in Level&#160;1)&#160;that are either directly or indirectly observable for the asset or liability through correlation with market data at the measurement date and for the duration of the instrument&#8217;s anticipated life.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Level&#160;3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities and which reflect management&#8217;s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock', window );">Cash and Cash Equivalent and Marketable Securities</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents and Marketable Securities</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers all highly liquid investments with maturities of three months or less at the time of acquisition to be cash equivalents. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s marketable securities portfolio includes only debt securities. Marketable debt securities that the Company may sell prior to maturity in response to changes in the Company's investment strategy, liquidity needs, or for other reasons are classified as available-for-sale. The Company's portfolio as of March&#160;31, 2022 and 2021 includes only available-for-sale securities. Available-for-sale securities are stated at fair value as of each balance sheet date. Unrealized gains and losses for available-for-sale securities are included in accumulated other comprehensive income, a component of stockholders&#8217; equity on the consolidated balance sheets. The Company&#8217;s marketable securities are available for use in current operations, even if the security matures beyond 12 months. The Company classifies its marketable securities as current assets on the consolidated balance sheets. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodically, the Company assesses the available-for-sale securities for impairment. An investment is impaired if the fair value of the investment is less than its amortized cost basis. The amortized cost of an investment will be written down to the fair value when the Company determines (i) it is more likely than not that management will be required to sell the impaired security before recovery of its amortized basis or (ii) management has the intention to sell the security. If neither of these conditions are met, the Company must determine whether the impairment is due to credit losses. A credit loss exists if the amortized cost basis of the security exceeds the present value of cash flows expected to be collected. All credit losses are recorded to other income, net and any remaining unrealized losses are recorded to other comprehensive loss. If the Company has the intent to sell an available-for-sale security in an unrealized loss position or it is more likely than not that it will be required to sell the security prior to recovery of its amortized cost basis, any previously recorded allowance is reversed and the entire difference between the amortized cost basis of the security and its fair value is recognized in other income, net in the consolidated statements of operations.</span></div>The Company determines any realized gains or losses on the sale of marketable securities on a specific identification method and records them to other income, net. Amortization of premiums and accretion of discounts are recorded to other income, net.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy', window );">Accounts Receivable and Allowance for Doubtful Accounts</a></td>
<td class="text">Accounts Receivable and Allowance for Doubtful AccountsAccounts receivable are recorded and carried at the original invoiced amount less an allowance for any potential uncollectible amounts. The Company estimates its allowance for doubtful accounts by evaluating the Company&#8217;s ability to collect outstanding receivable balances. The Company considers various factors, including the age of the balance, the creditworthiness of the customer, which is assessed based on ongoing credit evaluations and payment history, and the customer&#8217;s current financial condition.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost less accumulated depreciation. Depreciation and amortization expense is recorded on a straight-line basis over the estimated useful lives of the assets. The estimated useful life of each asset category is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.766%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furniture and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3-5 years </span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Computers and software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internal-use software development costs</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shorter of useful life or remaining lease term</span></td></tr></table></div>When assets are retired or otherwise disposed of, the cost and accumulated depreciation and amortization are written off, and any resulting gain or loss is recorded in the consolidated statement of operations in the period realized. Maintenance and repairs are expensed as incurred.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InternalUseSoftwarePolicy', window );">Internal-Use Software Development Costs</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Internal-Use Software Development Costs</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company capitalizes certain costs to develop its website, mobile applications and internal-use software when preliminary planning efforts are successfully completed, management has committed project resourcing, and it is probable that the project will be completed. Costs incurred prior to meeting these criteria, as well as costs incurred for training, maintenance, and minor modifications or enhancements, are expensed as incurred. Capitalized costs include personnel and related expenses for employees and costs of third-party contractors who are directly associated with and who devote time to internal-use software projects. Capitalization of these costs ceases once the project is substantially complete and the software is ready for its intended use. </span></div>Capitalized costs are included in property and equipment, net on the consolidated balance sheets and are amortized to cost of revenue over their estimated useful life.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsPolicy', window );">Business Combinations</a></td>
<td class="text">Business CombinationsTo determine whether a transaction is accounted for as an asset acquisition or business combination, the Company applies a screen test to evaluate if substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets. When the Company acquires a business, the purchase consideration is allocated to the tangible and intangible assets acquired and liabilities assumed at their estimated fair values on the acquisition date. The excess of the fair value of purchase consideration over the values of these identifiable assets and liabilities is recorded as goodwill. When determining the fair value of assets acquired and liabilities assumed, management makes significant estimates and assumptions, particularly with respect to the valuation of intangible assets. Acquisition costs, such as legal and consulting fees, are expensed as incurred.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill Intangible Assets and Long-Lived Assets</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill, Intangible Assets, and Long-Lived Assets</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of the purchase price over the fair value of the net tangible and intangible assets acquired in a business combination. Goodwill is not amortized, but is tested for impairment at least annually or more frequently if events or changes in circumstances indicate that the asset may be impaired. The Company has one reporting unit and evaluates goodwill for impairment at the entity level. If the carrying value of the reporting unit exceeds its fair value, an impairment charge is </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recognized for the excess of the carrying value of the reporting unit over its fair value, limited to the amount of goodwill allocated to the reporting unit. The Company performs its annual impairment test of goodwill in its fourth fiscal quarter and whenever events or circumstances indicate that the asset might be impaired. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The intangible assets are stated at cost less accumulated amortization and are amortized on a straight-line basis over their estimated remaining economic lives. Amortization expense related to intangible assets is included in sales and marketing expense. </span></div>Management evaluates the recoverability of the Company&#8217;s property and equipment and intangible assets when events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets held and used is measured by comparison of the carrying amount of an asset or an asset group to the estimated undiscounted future net cash flows expected to be generated by the asset or asset group. If the carrying value exceeds the estimated undiscounted future cash flows, an impairment loss is recognized for the amount by which the carrying amount exceeds the fair value for the asset or asset group.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock-Based Compensation</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures compensation expense for all stock-based awards based on the estimated fair value of the awards on the date of grant. Stock-based awards include stock options with service-based, performance-based and market-based vesting conditions, restricted stock units, or RSUs, performance-based restricted stock units, or PSUs, and warrants granted to employees, directors, and non-employees, as well as stock purchase rights granted to employees under the 2021 Employee Stock Purchase Plan, or ESPP. For awards that vest based on continued service, stock-based compensation, net of estimated forfeitures, is recognized on a straight-line basis over the requisite service period. For awards with performance-based vesting conditions, stock-based compensation expense, net of estimated forfeitures, is recognized using an accelerated attribution method from the time it is deemed probable that the vesting condition will be met through the time the service-based vesting condition has been achieved. The Company reassesses the probability of achieving the performance condition at each reporting date. For awards with market-based vesting conditions, stock-based compensation expense, net of estimated forfeitures, is recognized on an accelerated attribution basis over the requisite service period, even if the market condition is not satisfied. Forfeitures are estimated based upon the Company&#8217;s historical experience and the Company revises its estimates, if necessary, in subsequent periods if actual forfeitures differ from initial estimates. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each RSU and PSU is based on the fair value of the Company&#8217;s common stock on the date of grant. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The grant-date fair value of warrants, stock purchase rights granted to employees under the ESPP, and stock options with service-based or performance-based vesting conditions is estimated using the Black-Scholes pricing model. The grant-date fair value of stock options with market-based vesting conditions is estimated using the Monte Carlo simulation model. The determination of the grant-date fair value using an option-pricing model is affected by the fair value of the Company&#8217;s common stock and assumptions regarding a number of other complex and subjective variables. These assumptions include the expected term of the award, the expected stock price volatility over the expected term of the award, the risk-free interest rate for the expected term of the award, and expected dividends. The assumptions used in the Black-Scholes models are determined as follows: </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk-Free Interest Rate</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The risk-free interest rate is based on the implied yield available on U.S. Treasury zero-coupon issues with an equivalent expected term of the options for each option group. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;Prior to the IPO when there was no public market for the Company&#8217;s common stock, the expected volatility was determined using the historical volatilities of several publicly listed peer companies over a period equivalent to the expected term of the awards. The Company has not issued any stock options subsequent to the IPO. After the IPO, for the Company&#8217;s ESPP, the expected volatility was determined using the historical stock volatilities of the common stock of the Company over a period equivalent to the duration of the offering period. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Term</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The expected term represents the period that the Company&#8217;s stock-based awards are expected to be outstanding. For stock options granted to employees prior to the completion of the IPO, the Company estimated the expected term using the simplified method as the Company&#8217;s historical share option exercise experience did not provide a reasonable basis upon which to estimate the expected term. The simplified method uses the average of the vesting period and contractual term. For stock options granted to non-employees prior to the completion of the IPO, the Company used the contractual term as the expected term. The Company has not issued any stock options subsequent to the IPO. For stock purchase rights granted to employees under the ESPP, the expected term is equivalent to the offering period. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expected Dividend Yield</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;The Company has not historically issued dividends and does not currently expect to issue a dividend in the future. </span>Fair Value Per Share of the Company&#8217;s Common Stock&#8212;Because the Company&#8217;s common stock was not publicly traded until the completion of the IPO, the Company&#8217;s board of directors considered numerous objective and subjective factors to determine the fair value of the Company&#8217;s common stock at each meeting during which awards were approved. These factors included, but were not limited to (i) contemporaneous third-party valuations of common stock; (ii) the rights and preferences of the Company&#8217;s preferred stock relative to common stock; (iii) the lack of marketability of common stock; (iv) developments in the business; and (v) the likelihood of achieving a liquidity event, such as an IPO or sale of the Company, given prevailing market conditions.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if a contract is or contains a lease at inception. All of the Company&#8217;s leases are operating leases. Operating lease right-of-use assets and lease liabilities are recognized at the lease commencement date based on the present value of the lease payments over the lease term, discounted using the Company&#8217;s incremental borrowing rate. As none of the Company&#8217;s leases provide an implicit rate, the incremental borrowing rate used is estimated based on what the Company would be required to pay for a collateralized loan over a similar term as the lease. The Company amortizes the present value of each right-of-use asset on a straight-line basis over its remaining lease term. Leases are included in operating lease right-of-use assets, operating lease liabilities, current, and operating lease liabilities, non-current on the consolidated balance sheets. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options to extend or terminate a lease are included in the lease term when it is reasonably certain that such options will be exercised. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our lease agreements may contain variable costs such as common area maintenance, insurance, property tax, and other operating costs. Variable lease costs are expensed as incurred in the consolidated statements of operations. The Company does not separate non-lease components from lease components for its facility asset portfolio. </span></div>The Company does not recognize right-of-use assets and lease liabilities for short-term leases, which have a lease term of 12 months or less. Lease cost for short-term leases is recognized on a straight-line basis over the lease term.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Income Per Share Attributable to Common Stockholders</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income Per Share Attributable to Common Stockholders</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net income per share attributable to common stockholders is presented in conformity with the two-class method required for participating securities. Holders of redeemable convertible preferred stock are each entitled to receive noncumulative dividends out of any funds legally available, when and if declared by the Company&#8217;s board of directors, payable prior and in preference to any dividends on any shares of common stock based on the proportion of common stock that would be held if all shares of redeemable convertible preferred stock were converted at the then-effective conversion rate.</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Redeemable convertible preferred stock is therefore considered a participating security and is included in the computation of earnings per share under the two-class method. Holders of redeemable convertible preferred stock do not have a contractual obligation to share in the Company&#8217;s losses. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the two-class method, net income attributable to common stockholders is determined by allocating undistributed earnings, calculated as net income, less (i) current period redeemable convertible preferred stock noncumulative dividends and (ii) earnings attributable to participating securities. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income per share attributable to common stockholders is computed by dividing the net income attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted net income per share attributable to common stockholders is computed by dividing net income attributable to common stockholders by the weighted-average number of common shares outstanding and the effect of potentially dilutive securities outstanding during the period. Potentially dilutive securities include stock options, RSUs, PSUs, ESPP, redeemable convertible preferred stock, redeemable convertible preferred stock warrants, and common stock warrants. </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rights, including the liquidation and dividend rights, of the holders of Class A and Class B common stock are identical, except with respect to voting, converting, and transfer rights. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis to each class of common stock and the resulting basic and diluted </span></div>net loss per share attributable to common stockholders are, therefore, the same for both Class A and Class B common stock on both an individual and combined basis.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. Deferred income tax assets and liabilities are measured using enacted tax rates for the year in which those temporary differences are expected to be recovered or settled. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the consolidated statements of operations in the period that includes the enactment date. A valuation allowance is recorded when it is more likely than not that some of the deferred tax assets will not be realized. </span></div>The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized. The Company&#8217;s policy is to classify interest and penalties associated with uncertain tax positions, if any, as a component of its provision for (benefit from) income taxes.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LegalCostsPolicyTextBlock', window );">Legal Contingencies</a></td>
<td class="text">Legal ContingenciesThe Company may be subject to claims and other legal matters from time to time. The Company records a liability when it believes that it is both probable that a loss has been incurred and the amount can be reasonably estimated. When the Company believes that a loss is reasonably possible, it will disclose an estimate of the possible loss or range of loss. The Company expects to periodically evaluate developments in the legal matters that could affect the amount of liability that the Company accrues, if any, and adjust as appropriate. Until the final resolution of any such matter for which the Company may record a liability, there may be a loss exposure in excess of the liability recorded and such amount could be significant. Legal fees are expensed as incurred, other than amounts capitalized as deferred offering costs, as discussed above.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Cost of Revenue</a></td>
<td class="text">Cost of Revenue <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue consists primarily of expenses </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">related to cloud hosting, personnel-related expenses for the Company&#8217;s customer success team, costs for third-party platform access, software services and contractors, and other services used in connection with </span>delivery and support of the Company&#8217;s platform. Cost of revenue also includes the amortization of  internal-use software development costs, editorial and other content-related expenses, and allocated overhead.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development </span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expense is primarily comprised of personnel-related</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> associated with the Company&#8217;s engineering and product teams who are responsible for building new products and improving existing products. Research and development expense also includes costs for third-party services and contractors, information technology and software-related costs, and allocated overhead. Other than internal-use software development costs that qualify for capitalization, research and development costs are expensed as incurred.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Expenses</a></td>
<td class="text">Advertising Expenses Advertising costs are expensed as incurred and are included in sales and marketing expense in the consolidated statements of operations.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Accounting Pronouncements Recently Adopted/ Accounting Pronouncements Not Yet Adopted</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Pronouncements Recently Adopted</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2017, the FASB issued ASU 2017-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles&#8212;Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to simplify how entities assess goodwill for impairment by eliminating Step 2 from the goodwill impairment test. As amended, the goodwill impairment test consists of one step comparing the fair value of a reporting unit with its carrying amount. An entity should recognize a goodwill impairment charge for the amount by which the carrying amount exceeds the reporting unit&#8217;s fair value. This guidance is effective for the Company for its interim and annual period beginning April 1, 2023, and early adoption is permitted. The Company early adopted this new guidance effective April 1, 2021, using a prospective approach. The Company performed its annual impairment assessment in the fourth quarter of fiscal </span></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2022 under this new guidance. The adoption of this guidance did not have a material impact on the consolidated financial statements. </span></div><div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that simplifies the accounting for income taxes by removing certain exceptions to the general principles in such areas as intraperiod tax allocation, year-to-date losses in interim periods, and deferred tax liabilities related to outside basis differences. Amendments also include simplifications in other areas such as franchise taxes, step-up in tax basis goodwill, separate entity financial statements, and interim recognition of enactment of tax laws or rate changes. This guidance is effective for the Company for its fiscal year beginning April 1, 2022 and interim periods within its fiscal year beginning April 1, 2023. The Company expects the impact on the consolidated financial statements from the adoption of this standard to be immaterial. </span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued ASU 2021-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with Topic 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers,</span> as if it had originated the contracts. Under the current business combinations guidance, such assets and liabilities are recognized by the acquirer at fair value on the acquisition date, which has historically resulted in a reduction to unearned revenue on the balance sheet on acquisition date, and therefore, a reduction to revenues subsequently recognized than otherwise would have been recorded as an independent entity. Adoption of this guidance will result in higher unearned revenue on the balance sheet on acquisition date and higher revenues subsequently recognized. This guidance is effective for the Company for its fiscal year beginning April 1, 2023 and interim periods within that fiscal year, and early adoption is permitted. The Company expects to adopt this guidance in the first quarter of fiscal 2023 and expects the adoption to impact the accounting of business combinations subsequent to the adoption date.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash, Cash Equivalent And Marketable Securities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -Subparagraph (a)-(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6909625&amp;loc=d3e227-128457<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123345438&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 705<br> -URI http://asc.fasb.org/topic&amp;trid=2122478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13279-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiscalPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=d3e5291-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiscalPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InternalUseSoftwarePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 40<br> -Section 30<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=118172244&amp;loc=d3e17916-109280<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 50<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=16397303&amp;loc=d3e19379-109286<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InternalUseSoftwarePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for legal costs incurred to protect or defend the entity's assets and rights, or to obtain assets, including monetary damages, or to obtain rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=27011672&amp;loc=d3e149975-122751<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5144-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRecognitionPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRecognitionPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497069438264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock', window );">Significant Customers Representing 10% or more of Revenue or Accounts Receivable, Net</a></td>
<td class="text">The Company&#8217;s significant customers that represented 10% or more of revenue or accounts receivable, net for the periods presented were as follows:<div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.162%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Revenue</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accounts Receivable, Net</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Customer A</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">_______________</span></div><div style="padding-left:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">* Less than 10%</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text">The estimated useful life of each asset category is as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.766%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furniture and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3-5 years </span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Computers and software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internal-use software development costs</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shorter of useful life or remaining lease term</span></td></tr></table><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following (in&#160;thousands):</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Furniture and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">336&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">299&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Computers and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">769&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">796&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Internal-use software development costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10,908&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total property and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16,958&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12,460&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less: accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(8,470)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4,862)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,488&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,598&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6327-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6442-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497065588056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue consisted of the following (in thousands): </span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.186%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.084%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Subscription</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">319,298&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">192,256&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">116,388&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">24,250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">14,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">343,548&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">206,897&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">116,388&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock', window );">Changes in Deferred Revenue Balance</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the Company&#8217;s deferred revenue balances were as follows (in thousands): </span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">83,492&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">44,586&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Additions, net, during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">345,041&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">245,803&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue recognized from the beginning balance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(82,534)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(43,054)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Revenue recognized from contracts invoiced during the period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(261,014)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(163,843)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">84,985&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">83,492&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130551-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497069746312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Cost, Gross Unrealized Gains and Losses, and Fair Value of Investments</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost, gross unrealized gains and losses, and fair value of investments are as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cost or<br/>Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22,758&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22,758&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,791&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,383&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Corporate notes and bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129,900&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,796)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">128,104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sovereign bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,770&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(334)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">549,901&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,260)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">531,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">705,798&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(20,494)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">685,304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents and marketable securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">728,556&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(20,494)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">708,062&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The cost, gross unrealized gains and losses, and fair value of investments were as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Cost or<br/>Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Corporate notes and bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,517&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,516&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Money market funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16,946&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16,945&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,264&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16,411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Corporate notes and bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">46,662&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">46,641&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sovereign bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,857&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,858&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">76,161&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(26)</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">76,141&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents and marketable securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">93,107&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(27)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">93,086&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Contractual Maturities of Available-For-Sale Debt Securities</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, the contractual maturities of the Company&#8217;s available-for-sale debt securities were as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:87.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.596%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Due within one year</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">157,948&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Due in one year to three years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">530,042&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">687,990&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497069460264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Fair Value, Assets Measured on Recurring Basis</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present the fair value hierarchy for the Company&#8217;s assets measured at fair value on a recurring basis (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 3</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,686&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Money market funds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20,072&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,686&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22,758&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,383&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,383&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Corporate notes and bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">128,104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">128,104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sovereign bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">530,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">531,641&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">530,174&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">155,130&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">685,304&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents and marketable securities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">550,246&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">157,816&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">708,062&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.361%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 2</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 3</span></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash equivalents:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Corporate notes and bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,516&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,516&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Money market funds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,838&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,838&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,107&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16,945&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Marketable securities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Asset-backed securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16,412&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Corporate notes and bonds</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">46,641&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">46,641&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sovereign bonds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,099&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">U.S. government and agency securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,858&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,858&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total marketable securities</span></td><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,858&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">72,283&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">76,141&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total cash equivalents and marketable securities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">13,696&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">79,390&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">93,086&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497066153016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text">The estimated useful life of each asset category is as follows:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.766%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furniture and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3-5 years </span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Computers and software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internal-use software development costs</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shorter of useful life or remaining lease term</span></td></tr></table><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following (in&#160;thousands):</span></div><div style="margin-bottom:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.075%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Furniture and equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">336&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">299&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Computers and software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">769&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">704&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">796&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">549&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Internal-use software development costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15,057&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10,908&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total property and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16,958&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12,460&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less: accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(8,470)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4,862)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,488&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,598&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497069446536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses and Other Current Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_ScheduleOfAccruedLiabilitiesCurrentTableTextBlock', window );">Schedule of accrued expenses and other liabilities, current</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other current liabilities consisted of the following (in&#160;thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrued commissions</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6,653&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5,864&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrued payroll, bonus, and related expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,015&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5,006&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Employee contributions under employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">621&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Rebate liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,933&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,458&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sales and other tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total accrued expenses and other current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">25,270&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16,285&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_ScheduleOfAccruedLiabilitiesCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Accrued Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_ScheduleOfAccruedLiabilitiesCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497069492616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations, Intangible Assets, and Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Business Combination, Goodwill And Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Purchase Consideration Allocation</a></td>
<td class="text">The purchase consideration allocation was as follows (in thousands):<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Assets acquired: </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,972&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10,280&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total assets acquired</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">17,830&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Liabilities assumed:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts payable and accrued liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,030&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net assets acquired, excluding goodwill</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15,800&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Goodwill</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">18,915&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total purchase consideration</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">34,715&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Intangible Assets, Net</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets, net consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Customer relationships</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,869&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10,280&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Domain names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total intangible assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,880&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10,716&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less: accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1,971)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1,120)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total intangible assets, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,909&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9,596&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Future Amortization Expense</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2022, future amortization expense is as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Years Ending March 31,</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">990&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">990&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">990&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">990&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">988&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,961&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total future amortization expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,909&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Goodwill And Intangible Assets Disclosure</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497066116328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Convertible Preferred Stock (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityDisclosureAbstract', window );"><strong>Temporary Equity Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityTableTextBlock', window );">Summary of Redeemable Convertible Preferred Stock</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of the redeemable convertible preferred stock outstanding as of March&#160;31, 2021 and other related information is as follows (in thousands):</span></div><div style="margin-bottom:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Series</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares<br/>Authorized</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares<br/>Issued and<br/>Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Carrying<br/>Value</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Liquidation<br/>Preference</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">27,636&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">27,636&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10,677&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10,756&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">26,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">26,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">17,014&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">17,075&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">C</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22,400&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22,337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">53,767&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">53,841&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">76,350&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">76,287&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">81,458&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">81,672&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497069539704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Common Stock Reserved for Issuance</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has shares of common stock reserved for issuance as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.229%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">March 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Redeemable convertible preferred stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">76,287&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Common stock warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">766&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2010 Plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Options outstanding</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">33,856&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Shares available for future grant</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2021 Plan</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Performance-based restricted stock units outstanding</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Restricted stock units outstanding</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">534&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Shares available for future grant</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,466&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2021 ESPP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,471&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Options outstanding outside the Plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,671&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,720&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55,232&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">114,663&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Stock Option Activity</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock option activities within the Plans as well as outside of the Plans were as follows for both service-based and performance-based options (in&#160;thousands, except per share information): </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.623%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted-Average <br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Average Remaining Contractual Term <br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Balance, March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">36,576&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2.80&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.86</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">357,366&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Options granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Options exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(10,823)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Options forfeited or expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(736)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Balance, March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">26,983&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.63</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,293,545&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Vested and exercisable as of March 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,113&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.15</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">408,238&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Vested and expected to vest as of March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">25,021&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.55</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,202,634&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Stock Options Valuation Assumptions</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each option on the date of grant is determined using the Black-Scholes option-pricing model with the assumptions set forth in the following table:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Fair value of common stock</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$18.41 - $21.41</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$2.06 - $10.51</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$1.58 - $1.91</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">46.5% - 47.0%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">38.1% - 58.3%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">39.2% - 46.5%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.77% - 1.02%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.26% - 1.02%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.68% - 2.36%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.00 - 6.09</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.00 - 8.00</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5.94 - 10.00</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Expected dividend</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock', window );">Restricted Stock Unit Activity</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes RSU activity during the fiscal year ended March&#160;31, 2022 (in&#160;thousands, except per share information):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.545%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Number of Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted-<br/>Average<br/>Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unvested Balance, March 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">67.60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(38)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">59.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">54.59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unvested Balance, March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">534&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">68.23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock', window );">Employee Stock Purchase Plan Valuation Assumptions</a></td>
<td class="text">The fair value of the ESPP stock purchase rights on the date of grant is determined using the Black-Scholes pricing model with the assumptions set forth in the following table:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.946%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.854%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Fair value of common stock</span></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$57.44 - $73.73</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">86.3% - 103.6%</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.05% - 0.67%</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Expected term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.29 - 0.49</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Expected dividend</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Stock-Based Compensation Expense</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stock-based compensation expense recognized in the consolidated statement of operations for the fiscal years ended March&#160;31, 2022, 2021, and 2020 was as follows (in&#160;thousands): </span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.991%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cost of revenue</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,979&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">600&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">173&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Sales and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8,108&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,998&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">847&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11,290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,679&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total stock-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">31,442&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,252&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,353&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock units.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497071021896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share Attributable to Common Stockholders (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the reconciliation of the numerator and denominator for calculating basic and diluted net income per share (in thousands, except per share data):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.991%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Numerator</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">154,783&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">50,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">29,737&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less: undistributed earnings attributable to participating securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(21,526)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(28,654)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(18,908)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income attributable to Class A and Class B common stockholders, basic and diluted</span></div></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">133,257&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">21,556&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10,829&#160;</span></td><td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Denominator</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div></td><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, basic</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">163,484&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">74,342&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">66,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dilutive effect of assumed exercise of options to purchase common stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">27,290&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20,612&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">14,892&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dilutive effect of assumed exercise of common stock warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">60&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Dilutive effect of other share-based awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, diluted</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">191,017&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">95,134&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">81,710&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income per share attributable to Class A and Class B common stockholders, basic</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.82&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.29&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income per share attributable to Class A and Class B common stockholders, diluted</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.70&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.23&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.13&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain potentially dilutive securities have been excluded from the calculation of diluted net income per share during the applicable periods because their inclusion would have been anti-dilutive (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.991%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Redeemable convertible preferred stock</span></td><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">76,287&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">76,287&#160;</span></td><td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">578&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other share-based awards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">217&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Common stock warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">464&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">76,287&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">76,865&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497071080328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense (Benefit)</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s provision for (benefit from) income taxes consisted of the following (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Current provision:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,302&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,270&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">876&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">469&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,572&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">876&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred provision (benefit):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(34,852)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,862&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6,458)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6,395)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">125&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(641)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(41,247)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,987&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(7,099)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total provision for (benefit from) income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(40,778)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,559&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6,223)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a reconciliation of the income tax expense at the federal statutory tax rate to the Company&#8217;s provision for (benefit from) income taxes (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Income taxes at statutory rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">23,941&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12,131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,938&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">State income taxes, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,561&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research and development credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(8,332)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1,845)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1,842)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(71,780)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(5,796)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,878&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(11,995)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Section 162(m) limitation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">752&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">805&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total provision for (benefit from) income taxes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(40,778)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,559&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(6,223)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Components of deferred tax assets and liabilities were as follows (in&#160;thousands):</span></div><div style="margin-bottom:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.876%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.621%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accruals and deferred revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,760&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net operating loss carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">32,215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">486&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Research &amp; development credit carryforwards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,516&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">315&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Acquisition and other related expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">271&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,847&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">431&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Unrealized loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5,199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Gross deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">55,862&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7,276&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(4,731)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2,896)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred tax assets, net of valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">51,131&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4,380&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1,899)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1,701)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(276)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(336)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(398)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(231)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2,573)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(2,268)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net deferred tax assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">48,558&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,112&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of Unrecognized Tax Benefits Roll Forward</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending balances for gross UTBs is as follows (in thousands):</span></div><div style="margin-bottom:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Beginning balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,162&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,475&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,900&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Additions for tax positions related to the current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,995&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">687&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Additions for tax positions related to prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reductions for tax positions related to prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(1,095)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Reductions related to a lapse of statute</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,188&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3,162&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,475&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI http://asc.fasb.org/extlink&amp;oid=124434304&amp;loc=d3e36027-109320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497071027464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Components of Lease Expense and Supplemental Cash Flow/Balance Sheet Information Related to Leases</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense were as follows (in thousands):</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease cost</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,159&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,372&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,010&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Variable lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">114&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,273&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,515&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,010&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental cash flow information related to leases was as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash paid for amounts included in measurement of lease liabilities&#8212;Operating cash flows</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,107&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,569&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2,069&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supplemental balance sheet information related to leases was as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.572%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Year Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted-average remaining lease term (in years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.64</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.37</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.15</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Weighted-average discount rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1.75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Maturities of Lease Liabilities</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of March 31, 2022 were as follows (in thousands):</span></div><div style="margin-bottom:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.620%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Operating Leases</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">673&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">455&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Total future lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,128&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Less: imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(39)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Present value of lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1,089&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497067118328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 08, 2021</div></th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_ConversionOfStockConversionRatio', window );">Conversion of stock conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Capitalized deferred offering costs | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Forward split ratio</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=docs_InitialPublicOfferingIncludingOverAllotmentOptionMember', window );">Initial Public Offering Including Over Allotment Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued and sold in initial public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,505,750<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Initial public offering price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Aggregate net proceeds from initial public offering | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 548.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued and sold in initial public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,495,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_RedeemableConvertiblePreferredStockMember', window );">Redeemable convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesConverted1', window );">Conversion of stock, shares converted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,286,618<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_ConversionOfStockConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Conversion Of Stock, Conversion Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_ConversionOfStockConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.A)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040515&amp;loc=d3e105025-122735<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB TOPIC 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=docs_InitialPublicOfferingIncludingOverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=docs_InitialPublicOfferingIncludingOverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_RedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_RedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497066982344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies- Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>reporting_unit</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising expense | $</a></td>
<td class="nump">$ 2.8<span></span>
</td>
<td class="nump">$ 2.6<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportingUnits', window );">Number of reporting units | reporting_unit</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CreditConcentrationRiskMember', window );">Credit Concentration Risk | Accounts Receivable | Marketing Agency One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAxis=docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember', window );">Sales Commissions For Subscriptions Of New And Expansion Hiring Solutions Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortizationPeriod', window );">Amortization period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Deferred Commissions For Marketing Solutions Contracts And For Hiring Solutions Renewal Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortizationPeriod', window );">Amortization period</a></td>
<td class="text">7 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Deferred Commissions For Marketing Solutions Contracts And For Hiring Solutions Renewal Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortizationPeriod', window );">Amortization period</a></td>
<td class="text">13 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=docs_SubscriptionHiringSolutionsMember', window );">Subscription, Hiring Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_ContractWithCustomerTerm', window );">Contractual terms</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=docs_SubscriptionMarketingSolutionsMember', window );">Subscription, Marketing Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_ContractWithCustomerTerm', window );">Contractual terms</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_ContractWithCustomerCancellationNoticePeriod', window );">Contract with customer, cancellation period</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_ContractWithCustomerCancellationNoticePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Cancellation, Notice Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_ContractWithCustomerCancellationNoticePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_ContractWithCustomerTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_ContractWithCustomerTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAmortizationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization period of cost capitalized in obtaining or fulfilling contract with customer, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123353750&amp;loc=SL49131251-203054<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAmortizationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportingUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportingUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CreditConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CreditConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=docs_MarketingAgencyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=docs_MarketingAgencyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAxis=docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAxis=docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAxis=docs_DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAxis=docs_DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=docs_SubscriptionHiringSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=docs_SubscriptionHiringSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=docs_SubscriptionMarketingSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=docs_SubscriptionMarketingSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497069559112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of significant Accounting Policies- Significant Customers Representing 10% or more of Revenue or Accounts Receivable, Net (Details) - Customer A - Customer Concentration Risk<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=docs_CustomerAMember', window );">Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=docs_CustomerAMember', window );">Accounts Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=docs_CustomerAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=docs_CustomerAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497066232984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies- Property, plant and equipment (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2022</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=docs_FurnitureAndEquipmentMember', window );">Furniture and equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=docs_FurnitureAndEquipmentMember', window );">Furniture and equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=docs_ComputerEquipmentAndSoftwareMember', window );">Computers and software</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember', window );">Internal-use software development costs</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=docs_FurnitureAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=docs_FurnitureAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=docs_ComputerEquipmentAndSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=docs_ComputerEquipmentAndSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497065318712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Disaggregation of Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 343,548<span></span>
</td>
<td class="nump">$ 206,897<span></span>
</td>
<td class="nump">$ 116,388<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=docs_SubscriptionMember', window );">Subscription</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">319,298<span></span>
</td>
<td class="nump">192,256<span></span>
</td>
<td class="nump">116,388<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceOtherMember', window );">Service, Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 24,250<span></span>
</td>
<td class="nump">$ 14,641<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=docs_SubscriptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=docs_SubscriptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497069552664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Deferred Revenue Contract Balance (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInContractWithCustomerLiabilityAbstract', window );"><strong>Change in Contract with Customer, Liability [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Beginning balance</a></td>
<td class="nump">$ 83,492<span></span>
</td>
<td class="nump">$ 44,586<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_ContractWithCustomerLiabilityAdditionsNet', window );">Additions, net, during the period</a></td>
<td class="nump">345,041<span></span>
</td>
<td class="nump">245,803<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized from the beginning balance</a></td>
<td class="num">(82,534)<span></span>
</td>
<td class="num">(43,054)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance', window );">Revenue recognized from contracts invoiced during the period</a></td>
<td class="num">(261,014)<span></span>
</td>
<td class="num">(163,843)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Ending balance</a></td>
<td class="nump">$ 84,985<span></span>
</td>
<td class="nump">$ 83,492<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_ContractWithCustomerLiabilityAdditionsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract With Customer, Liability, Additions, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_ContractWithCustomerLiabilityAdditionsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract with Customer, Liability, Revenue Recognized, Excluding Opening Balance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInContractWithCustomerLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInContractWithCustomerLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497069551832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnbilledReceivablesCurrent', window );">Unbilled revenue</a></td>
<td class="nump">$ 1,400,000<span></span>
</td>
<td class="nump">$ 700,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_CapitalizedContractCostAdditions', window );">Capitalized contract acquisition costs</a></td>
<td class="nump">9,600,000<span></span>
</td>
<td class="nump">9,400,000<span></span>
</td>
<td class="nump">5,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortization', window );">Amortization of deferred contract costs</a></td>
<td class="nump">9,755,000<span></span>
</td>
<td class="nump">6,883,000<span></span>
</td>
<td class="nump">5,070,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostImpairmentLoss', window );">Deferred contract costs, impairment losses</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_CapitalizedContractCostAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Capitalized Contract Cost, Additions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_CapitalizedContractCostAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123353750&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss for asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123353750&amp;loc=SL49131252-203054<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnbilledReceivablesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount received for services rendered and products shipped, but not yet billed, for non-contractual agreements due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnbilledReceivablesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497061054232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Cost, Gross Unrealized Gains and Losses, and Fair Value of Investments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Cost or Amortized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 93,107<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(20,494)<span></span>
</td>
<td class="num">(27)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">687,990<span></span>
</td>
<td class="nump">93,086<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cost or Amortized Cost, money market funds</a></td>
<td class="nump">112,809<span></span>
</td>
<td class="nump">66,393<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost', window );">Cost or Amortized Cost, cash equivalents and marketable securities</a></td>
<td class="nump">728,556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Fair Value, cash equivalents and marketable securities</a></td>
<td class="nump">708,062<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cost or Amortized Cost, money market funds</a></td>
<td class="nump">20,072<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Fair Value, money market funds</a></td>
<td class="nump">20,072<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Cost or Amortized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,946<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,945<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost', window );">Cost or Amortized Cost, cash equivalents and marketable securities</a></td>
<td class="nump">22,758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsAndShortTermInvestments', window );">Fair Value, cash equivalents and marketable securities</a></td>
<td class="nump">22,758<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Cost or Amortized Cost</a></td>
<td class="nump">2,686<span></span>
</td>
<td class="nump">2,290<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">2,686<span></span>
</td>
<td class="nump">2,290<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents | Corporate notes and bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Cost or Amortized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,517<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,516<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents | Money market funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Cost or Amortized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,838<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,838<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Cost or Amortized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,301<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,301<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Available-for-sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Cost or Amortized Cost</a></td>
<td class="nump">705,798<span></span>
</td>
<td class="nump">76,161<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(20,494)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">685,304<span></span>
</td>
<td class="nump">76,141<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Available-for-sale securities | Corporate notes and bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Cost or Amortized Cost</a></td>
<td class="nump">129,900<span></span>
</td>
<td class="nump">46,662<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(1,796)<span></span>
</td>
<td class="num">(24)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">128,104<span></span>
</td>
<td class="nump">46,641<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Available-for-sale securities | Certificates of deposit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Cost or Amortized Cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,867<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,868<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Available-for-sale securities | Asset-backed securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Cost or Amortized Cost</a></td>
<td class="nump">7,791<span></span>
</td>
<td class="nump">3,264<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(51)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">7,740<span></span>
</td>
<td class="nump">3,263<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Available-for-sale securities | Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Cost or Amortized Cost</a></td>
<td class="nump">9,436<span></span>
</td>
<td class="nump">16,411<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(53)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">9,383<span></span>
</td>
<td class="nump">16,412<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Available-for-sale securities | Sovereign bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Cost or Amortized Cost</a></td>
<td class="nump">8,770<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(334)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">8,436<span></span>
</td>
<td class="nump">1,099<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Available-for-sale securities | U.S. government and agency securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Debt Securities, Available-for-sale [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss', window );">Cost or Amortized Cost</a></td>
<td class="nump">549,901<span></span>
</td>
<td class="nump">3,857<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(18,260)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">$ 531,641<span></span>
</td>
<td class="nump">$ 3,858<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash and Cash Equivalents and Short Term Investments, Amortized Cost</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsAndShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsAndShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost excluding accrued interest, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AvailableforsaleSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AvailableforsaleSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_SovereignDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_SovereignDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497071100856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Contractual Maturities of Available-For-Sale Debt Securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Due within one year</a></td>
<td class="nump">$ 157,948<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughThree', window );">Due in one year to three years</a></td>
<td class="nump">530,042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">$ 687,990<span></span>
</td>
<td class="nump">$ 93,086<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale, Fair Value, Maturity, Allocated And Single Maturity Date, After Year One Through Three</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123599081&amp;loc=SL120269850-112803<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27198-111563<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497070845112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss', window );">Accrued interest</a></td>
<td class="nump">$ 2,100,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Unrealized losses related to debt securities</a></td>
<td class="nump">20,494,000<span></span>
</td>
<td class="nump">27,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_DebtSecuritiesAvailableForSaleImpairmentsLoss', window );">Debt securities impairments loss</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleChangeInPresentValueExpenseReversal', window );">Debt securities credit losses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_DebtSecuritiesAvailableForSaleWithNoCreditAllowance', window );">Fair value of debt securities which no credit losses were recognized</a></td>
<td class="nump">$ 684,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_DebtSecuritiesAvailableForSaleImpairmentsLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-for-sale, Impairments Loss</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_DebtSecuritiesAvailableForSaleImpairmentsLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_DebtSecuritiesAvailableForSaleWithNoCreditAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available For Sale, With No Credit Allowance</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_DebtSecuritiesAvailableForSaleWithNoCreditAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of accrued interest on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL120267853-210455<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=SL121698322-111563<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL120267856-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleChangeInPresentValueExpenseReversal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), from change in present value of expected cash flows.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82922868-210454<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922897-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleChangeInPresentValueExpenseReversal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497058948008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">$ 687,990<span></span>
</td>
<td class="nump">$ 93,086<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,945<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AvailableforsaleSecuritiesMember', window );">Available-for-sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">685,304<span></span>
</td>
<td class="nump">76,141<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember', window );">Money market funds | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,838<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember', window );">Asset-backed securities | Available-for-sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">7,740<span></span>
</td>
<td class="nump">3,263<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,301<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember', window );">Certificates of deposit | Available-for-sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,868<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">2,686<span></span>
</td>
<td class="nump">2,290<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate notes and bonds | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,516<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate notes and bonds | Available-for-sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">128,104<span></span>
</td>
<td class="nump">46,641<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_SovereignDebtSecuritiesMember', window );">Sovereign bonds | Available-for-sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">8,436<span></span>
</td>
<td class="nump">1,099<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember', window );">U.S. government and agency securities | Available-for-sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">531,641<span></span>
</td>
<td class="nump">3,858<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">708,062<span></span>
</td>
<td class="nump">93,086<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">22,758<span></span>
</td>
<td class="nump">16,945<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Available-for-sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">685,304<span></span>
</td>
<td class="nump">76,141<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Money market funds | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">20,072<span></span>
</td>
<td class="nump">9,838<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Asset-backed securities | Available-for-sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">7,740<span></span>
</td>
<td class="nump">3,263<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Certificates of deposit | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,301<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Certificates of deposit | Available-for-sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,868<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Commercial paper | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">2,686<span></span>
</td>
<td class="nump">2,290<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Commercial paper | Available-for-sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">9,383<span></span>
</td>
<td class="nump">16,412<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Corporate notes and bonds | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,516<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Corporate notes and bonds | Available-for-sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">128,104<span></span>
</td>
<td class="nump">46,641<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Sovereign bonds | Available-for-sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">8,436<span></span>
</td>
<td class="nump">1,099<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | U.S. government and agency securities | Available-for-sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">531,641<span></span>
</td>
<td class="nump">3,858<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">550,246<span></span>
</td>
<td class="nump">13,696<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Fair Value, Recurring | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">20,072<span></span>
</td>
<td class="nump">9,838<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Fair Value, Recurring | Available-for-sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">530,174<span></span>
</td>
<td class="nump">3,858<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Fair Value, Recurring | Money market funds | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">20,072<span></span>
</td>
<td class="nump">9,838<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Fair Value, Recurring | Asset-backed securities | Available-for-sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Fair Value, Recurring | Certificates of deposit | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Fair Value, Recurring | Certificates of deposit | Available-for-sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Fair Value, Recurring | Commercial paper | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Fair Value, Recurring | Commercial paper | Available-for-sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Fair Value, Recurring | Corporate notes and bonds | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Fair Value, Recurring | Corporate notes and bonds | Available-for-sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Fair Value, Recurring | Sovereign bonds | Available-for-sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Fair Value, Recurring | U.S. government and agency securities | Available-for-sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">530,174<span></span>
</td>
<td class="nump">3,858<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">157,816<span></span>
</td>
<td class="nump">79,390<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Recurring | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">2,686<span></span>
</td>
<td class="nump">7,107<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Recurring | Available-for-sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">155,130<span></span>
</td>
<td class="nump">72,283<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Recurring | Money market funds | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Recurring | Asset-backed securities | Available-for-sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">7,740<span></span>
</td>
<td class="nump">3,263<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Recurring | Certificates of deposit | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,301<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Recurring | Certificates of deposit | Available-for-sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,868<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Recurring | Commercial paper | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">2,686<span></span>
</td>
<td class="nump">2,290<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Recurring | Commercial paper | Available-for-sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">9,383<span></span>
</td>
<td class="nump">16,412<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Recurring | Corporate notes and bonds | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,516<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Recurring | Corporate notes and bonds | Available-for-sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">128,104<span></span>
</td>
<td class="nump">46,641<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Recurring | Sovereign bonds | Available-for-sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">8,436<span></span>
</td>
<td class="nump">1,099<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level 2 | Fair Value, Recurring | U.S. government and agency securities | Available-for-sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">1,467<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Fair Value, Recurring | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Fair Value, Recurring | Available-for-sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Fair Value, Recurring | Money market funds | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Fair Value, Recurring | Asset-backed securities | Available-for-sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Fair Value, Recurring | Certificates of deposit | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Fair Value, Recurring | Certificates of deposit | Available-for-sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Fair Value, Recurring | Commercial paper | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Fair Value, Recurring | Commercial paper | Available-for-sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Fair Value, Recurring | Corporate notes and bonds | Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Fair Value, Recurring | Corporate notes and bonds | Available-for-sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Fair Value, Recurring | Sovereign bonds | Available-for-sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Fair Value, Recurring | U.S. government and agency securities | Available-for-sale securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest', window );">Fair Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_CashAndCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AvailableforsaleSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AvailableforsaleSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_AssetBackedSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_SovereignDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_SovereignDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497058920536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment, Net - Total Property and Equipment, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 16,958<span></span>
</td>
<td class="nump">$ 12,460<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation and amortization</a></td>
<td class="num">(8,470)<span></span>
</td>
<td class="num">(4,862)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">8,488<span></span>
</td>
<td class="nump">7,598<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=docs_FurnitureAndEquipmentMember', window );">Furniture and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">336<span></span>
</td>
<td class="nump">299<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=docs_ComputerEquipmentAndSoftwareMember', window );">Computers and software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">769<span></span>
</td>
<td class="nump">704<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">796<span></span>
</td>
<td class="nump">549<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember', window );">Internal-use software development costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 15,057<span></span>
</td>
<td class="nump">$ 10,908<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=docs_FurnitureAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=docs_FurnitureAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=docs_ComputerEquipmentAndSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=docs_ComputerEquipmentAndSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497070862664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation and amortization expense</a></td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="nump">$ 2,600<span></span>
</td>
<td class="nump">$ 900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareAmortization1', window );">Amortization of internal-use software development costs</a></td>
<td class="nump">3,500<span></span>
</td>
<td class="nump">2,200<span></span>
</td>
<td class="nump">700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareAdditions', window );">Capitalized internal-use software development costs</a></td>
<td class="nump">4,300<span></span>
</td>
<td class="nump">4,600<span></span>
</td>
<td class="nump">4,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TangibleAssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additions made to capitalized computer software costs during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareAmortization1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for amortization of capitalized computer software costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128487-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareAmortization1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TangibleAssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TangibleAssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497069714008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses and Other Current Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedSalesCommissionCurrent', window );">Accrued commissions</a></td>
<td class="nump">$ 6,653<span></span>
</td>
<td class="nump">$ 5,864<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued payroll, bonus, and related expenses</a></td>
<td class="nump">8,015<span></span>
</td>
<td class="nump">5,006<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_AccruedEmployeeStockPurchasePlanCurrent', window );">Employee contributions under employee stock purchase plan</a></td>
<td class="nump">621<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_RebateLiabilitiesCurrent', window );">Rebate liabilities</a></td>
<td class="nump">4,933<span></span>
</td>
<td class="nump">1,458<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Sales and other tax liabilities</a></td>
<td class="nump">785<span></span>
</td>
<td class="nump">410<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">4,263<span></span>
</td>
<td class="nump">3,547<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">$ 25,270<span></span>
</td>
<td class="nump">$ 16,285<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_AccruedEmployeeStockPurchasePlanCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Employee Stock Purchase Plan, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_AccruedEmployeeStockPurchasePlanCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_RebateLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rebate Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_RebateLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalesCommissionCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalesCommissionCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497064725128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations, Intangible Assets, and Goodwill - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 01, 2020</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 4,230,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="nump">1,100,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,915,000<span></span>
</td>
<td class="nump">18,915,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Disposed of by Sale, Not Discontinued Operations | Portion Of Curative Talent, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Sale of business consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from sale of business</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow', window );">Sale of business consideration, held in escrow</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=docs_THMEDLLCMember', window );">THMED, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="nump">$ 34,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to acquire businesses</a></td>
<td class="nump">$ 33,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Number of shares issued</a></td>
<td class="nump">689,656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Value of shares issued</a></td>
<td class="nump">$ 1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,200,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 18,915,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=docs_THMEDLLCMember', window );">THMED, LLC | Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets acquired, useful life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disposal Group, Including Discontinued Operation, Consideration, Held In Escrow</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=docs_PortionOfCurativeTalentLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=docs_PortionOfCurativeTalentLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=docs_THMEDLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=docs_THMEDLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497066920456">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Combinations, Intangible Assets, and Goodwill - Purchase Consideration Allocation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Apr. 01, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Liabilities assumed:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 18,915<span></span>
</td>
<td class="nump">$ 18,915<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=docs_THMEDLLCMember', window );">THMED, LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract', window );"><strong>Assets acquired:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,972<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,075<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,503<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,280<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets', window );">Total assets acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,830<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract', window );"><strong>Liabilities assumed:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,030<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet', window );">Net assets acquired, excluding goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,915<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total purchase consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34,715<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Assets, Other</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable intangible assets recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=docs_THMEDLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=docs_THMEDLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497061488872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Combinations, Intangible Assets, and Goodwill - Intangible Assets, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible assets, gross</a></td>
<td class="nump">$ 9,880<span></span>
</td>
<td class="nump">$ 10,716<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">(1,971)<span></span>
</td>
<td class="num">(1,120)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">7,909<span></span>
</td>
<td class="nump">9,596<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible assets, gross</a></td>
<td class="nump">9,869<span></span>
</td>
<td class="nump">10,280<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InternetDomainNamesMember', window );">Domain names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible assets, gross</a></td>
<td class="nump">$ 11<span></span>
</td>
<td class="nump">$ 436<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InternetDomainNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InternetDomainNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497061629640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Combinations, Intangible Assets, and Goodwill - Future Amortization Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Business Combination, Goodwill And Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2024</a></td>
<td class="nump">990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2025</a></td>
<td class="nump">990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2026</a></td>
<td class="nump">990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2027</a></td>
<td class="nump">988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">2,961<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">$ 7,909<span></span>
</td>
<td class="nump">$ 9,596<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Goodwill And Intangible Assets Disclosure</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497059556568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Convertible Preferred Stock - Narrative (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 08, 2021 </div>
<div>vote</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>vote </div>
<div>board_of_director </div>
<div>series </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2019 </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 31, 2012 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_TemporaryEquityPreferredStockOutstandingSeries', window );">Number of outstanding series of redeemable convertible preferred stock | series</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Redeemable convertible preferred stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_ConversionOfStockConversionRatio', window );">Conversion of stock conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationsOfTemporaryToPermanentEquity', window );">Reclassifications of temporary to permanent equity | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 81,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Redeemable convertible preferred stock issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">76,287,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Redeemable convertible preferred stock outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">76,287,000<span></span>
</td>
<td class="nump">76,287,000<span></span>
</td>
<td class="nump">76,249,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_CommonStockVotingRightsNumberOfVotes', window );">Common stock, number of votes per share | vote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_TemporaryEquityElectionOfBoardMembersSharesOutstandingThreshold', window );">Temporary equity, election of board members, shares outstanding threshold (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_TemporaryEquitySharesOutstandingThresholdSatisfiedNumberOfElectedBoardMembersPermitted', window );">Temporary equity, shares outstanding threshold met, number of board of director members entitled to elect | board_of_director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_CommonStockHoldingMajorityNumberOfElectedBoardMembersPermitted', window );">Common stock, holding majority, number of board of director members entitled to elect | board_of_director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_TemporaryEquityConvertibleStockPriceTrigger', window );">Conversion price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_TemporaryEquityConvertibleAggregateOfferingPriceTrigger', window );">Aggregate offering price conversion trigger | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Common stock warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">766,000<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=docs_RedeemableConvertiblePreferredStockWarrantsMember', window );">Redeemable convertible preferred stock warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Common stock warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,322<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price called by warrants (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.65<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants and rights outstanding | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=docs_RedeemableConvertiblePreferredStockWarrantsMember', window );">Redeemable convertible preferred stock warrants | Measurement Input, Expected Dividend Rate | Valuation Technique, Option Pricing Model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrant, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=docs_RedeemableConvertiblePreferredStockWarrantsMember', window );">Redeemable convertible preferred stock warrants | Measurement Input, Price Volatility | Valuation Technique, Option Pricing Model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrant, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.55<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=docs_RedeemableConvertiblePreferredStockWarrantsMember', window );">Redeemable convertible preferred stock warrants | Measurement Input, Risk Free Interest Rate | Valuation Technique, Option Pricing Model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrant, measurement input</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0113<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=docs_RedeemableConvertiblePreferredStockWarrantsMember', window );">Redeemable convertible preferred stock warrants | Measurement Input, Expected Term | Valuation Technique, Option Pricing Model</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants and rights outstanding, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConversionOfStockSharesIssued1', window );">Conversion of stock, shares issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,286,618<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_ConversionOfStockConversionRatio', window );">Conversion of stock conversion ratio</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_CommonStockVotingRightsNumberOfVotes', window );">Common stock, number of votes per share | vote</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Redeemable convertible preferred stock issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,636,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Redeemable convertible preferred stock outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,636,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreferencePerShare', window );">Temporary equity, liquidation preference per share (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.3892<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_TemporaryEquityDividendRate', window );">Temporary equity, dividend rate (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.03115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Redeemable convertible preferred stock issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,314,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Redeemable convertible preferred stock outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,314,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreferencePerShare', window );">Temporary equity, liquidation preference per share (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.6488925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_TemporaryEquityDividendRate', window );">Temporary equity, dividend rate (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0519<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember', window );">Series C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Redeemable convertible preferred stock issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,337,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Redeemable convertible preferred stock outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,337,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreferencePerShare', window );">Temporary equity, liquidation preference per share (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.4104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_TemporaryEquityDividendRate', window );">Temporary equity, dividend rate (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.19285<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_CommonStockHoldingMajorityNumberOfElectedBoardMembersPermitted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Holding Majority, Number of Elected Board Members Permitted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_CommonStockHoldingMajorityNumberOfElectedBoardMembersPermitted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_CommonStockVotingRightsNumberOfVotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Voting Rights, Number Of Votes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_CommonStockVotingRightsNumberOfVotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_ConversionOfStockConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Conversion Of Stock, Conversion Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_ConversionOfStockConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_TemporaryEquityConvertibleAggregateOfferingPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Convertible, Aggregate Offering Price Trigger</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_TemporaryEquityConvertibleAggregateOfferingPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_TemporaryEquityConvertibleStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Convertible, Stock Price Trigger</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_TemporaryEquityConvertibleStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_TemporaryEquityDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Dividend Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_TemporaryEquityDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_TemporaryEquityElectionOfBoardMembersSharesOutstandingThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Election Of Board Members, Shares Outstanding Threshold</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_TemporaryEquityElectionOfBoardMembersSharesOutstandingThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_TemporaryEquityPreferredStockOutstandingSeries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity Preferred Stock Outstanding Series</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_TemporaryEquityPreferredStockOutstandingSeries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_TemporaryEquitySharesOutstandingThresholdSatisfiedNumberOfElectedBoardMembersPermitted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Shares Outstanding Threshold Satisfied, Number of Elected Board Members Permitted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_TemporaryEquitySharesOutstandingThresholdSatisfiedNumberOfElectedBoardMembersPermitted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationsOfTemporaryToPermanentEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying amount of a financial instrument subject to a registration payment arrangement recorded as temporary equity prior to adoption of FSP EITF 00-19-2 and the carrying amount reclassified to permanent equity upon the adoption of FSP EITF 00-19-2. Recorded as a cumulative effect adjustment to the beginning balance of retained earnings. Does not apply to registration payment arrangements that are no longer outstanding upon adoption of FSP EITF 00-19-2.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123477628&amp;loc=d3e90193-114008<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationsOfTemporaryToPermanentEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLiquidationPreferencePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The per share liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLiquidationPreferencePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=docs_RedeemableConvertiblePreferredStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=docs_RedeemableConvertiblePreferredStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationTechniqueAxis=us-gaap_ValuationTechniqueOptionPricingModelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497060881688">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Redeemable Convertible Preferred Stock - Summary of Redeemable Convertible Preferred Stock Outstanding (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Redeemable convertible preferred stock, authorized (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">76,350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Redeemable convertible preferred stock issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">76,287,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Carrying Value</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 81,458<span></span>
</td>
<td class="nump">$ 81,458<span></span>
</td>
<td class="nump">$ 81,433<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Liquidation Preference</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 81,672<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember', window );">Series A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Redeemable convertible preferred stock, authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,636,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Redeemable convertible preferred stock issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,636,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Liquidation Preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,756<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember', window );">Series B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Redeemable convertible preferred stock, authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,314,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Redeemable convertible preferred stock issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,314,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Liquidation Preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember', window );">Series C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Redeemable convertible preferred stock, authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Redeemable convertible preferred stock issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,337,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 53,767<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Liquidation Preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 53,841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesCPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497063687656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Equity - Preferred Stock (Details) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized (in shares)</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497064752456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity - Common Stock and Creation of Dual-Class Structure (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 08, 2021 </div>
<div>vote </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>vote </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000,000<span></span>
</td>
<td class="nump">198,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_CommonStockVotingRightsNumberOfVotes', window );">Common stock, number of votes per share | vote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_ConversionOfStockConversionRatio', window );">Conversion of stock conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">192,398,000<span></span>
</td>
<td class="nump">82,910,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_CommonStockVotingRightsNumberOfVotes', window );">Common stock, number of votes per share | vote</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109,322,383<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="nump">500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_CommonStockVotingRightsNumberOfVotes', window );">Common stock, number of votes per share | vote</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_ConversionOfStockConversionRatio', window );">Conversion of stock conversion ratio</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83,076,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits', window );">Conversion of stock (in shares)</a></td>
<td class="nump">85,523,836<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_CommonStockVotingRightsNumberOfVotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Voting Rights, Number Of Votes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_CommonStockVotingRightsNumberOfVotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_ConversionOfStockConversionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Conversion Of Stock, Conversion Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_ConversionOfStockConversionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497059716536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity - Common Stock Warrants (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Oct. 08, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 14, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2017 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Common stock warrants (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">766,000<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,442<span></span>
</td>
<td class="nump">$ 7,252<span></span>
</td>
<td class="nump">$ 2,353<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unamortized compensation expense, weighted average period of recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 14 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=docs_ContractWithUSNewsWorldReportLPMember', window );">Contract With U S News World Report L P</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Common stock warrants (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price called by warrants (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_WarrantsAndRightsOutstandingVestingPeriod', window );">Warrants and rights outstanding, vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants and rights outstanding, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=docs_USNewsWarrantMember', window );">U S News Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Common stock warrants (in shares) | shares</a></td>
<td class="nump">516,000<span></span>
</td>
<td class="nump">1,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price called by warrants (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_WarrantsAndRightsOutstandingVestingPeriod', window );">Warrants and rights outstanding, vesting period</a></td>
<td class="text">6 years 5 months 23 days<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants and rights outstanding, term</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants and rights outstanding</a></td>
<td class="nump">$ 34,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unamortized compensation expense excluding option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unamortized compensation expense, weighted average period of recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=docs_USNewsWarrantMember', window );">U S News Warrant | Measurement Input, Share Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrant, measurement input</a></td>
<td class="nump">76.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=docs_USNewsWarrantMember', window );">U S News Warrant | Measurement Input, Price Volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrant, measurement input</a></td>
<td class="nump">0.469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=docs_USNewsWarrantMember', window );">U S News Warrant | Measurement Input, Risk Free Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrant, measurement input</a></td>
<td class="nump">0.0161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=docs_USNewsWarrantMember', window );">U S News Warrant | Measurement Input, Expected Term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingTerm', window );">Warrants and rights outstanding, term</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=docs_USNewsWarrantMember', window );">U S News Warrant | Measurement Input, Expected Dividend Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput', window );">Warrant, measurement input</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_WarrantsAndRightsOutstandingVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Warrants and Rights Outstanding, Vesting Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_WarrantsAndRightsOutstandingVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstandingTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstandingTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=docs_ContractWithUSNewsWorldReportLPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=docs_ContractWithUSNewsWorldReportLPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=docs_USNewsWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=docs_USNewsWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497061528264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity - Equity Incentive Plans (Details) - shares<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2010</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of shares reserved for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,232,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">114,663,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,966,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,983,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,576,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=docs_EquityIncentivePlan2010Member', window );">2010 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,312,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,856,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=docs_EquityIncentivePlan2010Member', window );">2010 Plan | Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period from the date of grant</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=docs_EquityIncentivePlan2010Member', window );">2010 Plan | Individuals With Voting Interest Less Than Threshold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock', window );">Grant exercise price, percentage of estimated fair value of common stock on date of grant (not less than)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=docs_EquityIncentivePlan2010Member', window );">2010 Plan | Individuals With Voting Interest At Threshold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock', window );">Grant exercise price, percentage of estimated fair value of common stock on date of grant (not less than)</a></td>
<td class="nump">110.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold', window );">Voting interests threshold</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=docs_StockOptionAndIncentivePlan2021Member', window );">2021 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of shares reserved for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding', window );">Maximum annual increase of shares reserved for future issuance as a percentage of common stock outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=docs_EmployeeStockPurchasePlan2021Member', window );">2021 ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Number of shares reserved for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding', window );">Maximum annual increase of shares reserved for future issuance as a percentage of common stock outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease', window );">Maximum annual increase of shares reserved for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member', window );">Options outstanding outside the Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,682,582<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised', window );">Options exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,011,252<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,671,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,720,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Capital Shares Reserved For Future Issuance, Maximum Annual Increase</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Capital Shares Reserved For Future Issuance, Maximum Annual Increase As A Percentage Of Common Stock Outstanding</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercise Price, Percentage Of Fair Value Of Common Stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercised</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Percentage Of Voting Interests Threshold</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=docs_EquityIncentivePlan2010Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=docs_EquityIncentivePlan2010Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GranteeStatusAxis=docs_IndividualsWithVotingInterestLessThanThresholdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GranteeStatusAxis=docs_IndividualsWithVotingInterestLessThanThresholdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GranteeStatusAxis=docs_IndividualsWithVotingInterestAtThresholdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GranteeStatusAxis=docs_IndividualsWithVotingInterestAtThresholdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=docs_StockOptionAndIncentivePlan2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=docs_StockOptionAndIncentivePlan2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=docs_EmployeeStockPurchasePlan2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=docs_EmployeeStockPurchasePlan2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497058864840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Equity - Common Stock Reserved for Issuance (Details) - shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Redeemable convertible preferred stock outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76,287,000<span></span>
</td>
<td class="nump">76,287,000<span></span>
</td>
<td class="nump">76,249,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Common stock warrants (in shares)</a></td>
<td class="nump">766,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding (in shares)</a></td>
<td class="nump">26,983,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,576,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total</a></td>
<td class="nump">55,232,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">114,663,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=docs_PerformanceBasedRestrictedStockUnitsMember', window );">Performance-Based Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Units outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Units outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=docs_EquityIncentivePlan2010Member', window );">2010 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding (in shares)</a></td>
<td class="nump">24,312,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,856,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for future grant (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,550,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=docs_StockOptionAndIncentivePlan2021Member', window );">2021 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for future grant (in shares)</a></td>
<td class="nump">22,466,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=docs_StockOptionAndIncentivePlan2021Member', window );">2021 Plan | Performance-Based Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Units outstanding (in shares)</a></td>
<td class="nump">12,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=docs_StockOptionAndIncentivePlan2021Member', window );">2021 Plan | Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Units outstanding (in shares)</a></td>
<td class="nump">534,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=docs_EmployeeStockPurchasePlan2021Member', window );">2021 ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares available for future grant (in shares)</a></td>
<td class="nump">4,471,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total</a></td>
<td class="nump">4,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member', window );">Options outstanding outside the Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems', window );"><strong>Subsidiary or Equity Method Investee [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding (in shares)</a></td>
<td class="nump">2,671,330<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,720,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=docs_PerformanceBasedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=docs_PerformanceBasedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=docs_EquityIncentivePlan2010Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=docs_EquityIncentivePlan2010Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=docs_StockOptionAndIncentivePlan2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=docs_StockOptionAndIncentivePlan2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=docs_EmployeeStockPurchasePlan2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=docs_EmployeeStockPurchasePlan2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497066933096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity - Stock Option Activity (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance (in shares)</a></td>
<td class="nump">36,576<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="nump">1,966<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised (in shares)</a></td>
<td class="num">(10,823)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Options forfeited and expired (in shares)</a></td>
<td class="num">(736)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance (in shares)</a></td>
<td class="nump">26,983<span></span>
</td>
<td class="nump">36,576<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Vested and exercisable, at end of period (in shares)</a></td>
<td class="nump">8,113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested and expected to vest, at end of period (in shares)</a></td>
<td class="nump">25,021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted-Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning balance (in dollars per share)</a></td>
<td class="nump">$ 2.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="nump">12.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="nump">1.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Forfeited or expired (in dollars per share)</a></td>
<td class="nump">3.16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Ending balance (in dollars per share)</a></td>
<td class="nump">4.15<span></span>
</td>
<td class="nump">$ 2.80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted average exercise price, vested and exercisable at period end (in dollars per share)</a></td>
<td class="nump">1.77<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price, vested and expected to vest at period end (in dollars per share)</a></td>
<td class="nump">$ 4.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Average remaining contractual term, outstanding</a></td>
<td class="text">7 years 7 months 17 days<span></span>
</td>
<td class="text">7 years 10 months 9 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Average remaining contractual term, vested and exercisable at period end</a></td>
<td class="text">6 years 1 month 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Average remaining contractual term, vested and expected to vest at period end</a></td>
<td class="text">7 years 6 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value, outstanding</a></td>
<td class="nump">$ 1,293,545<span></span>
</td>
<td class="nump">$ 357,366<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate intrinsic value, vested and exercisable at period end</a></td>
<td class="nump">408,238<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue', window );">Aggregate intrinsic value, vested and expected to vest at period end</a></td>
<td class="nump">$ 1,202,634<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497069716552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity - Stock Options (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Unamortized compensation expense, option</a></td>
<td class="nump">$ 521.6<span></span>
</td>
<td class="nump">$ 52.6<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant-date fair value of options granted (in dollars per share)</a></td>
<td class="nump">$ 10.73<span></span>
</td>
<td class="nump">$ 3.18<span></span>
</td>
<td class="nump">$ 0.77<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unamortized compensation expense, option</a></td>
<td class="nump">$ 55.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unamortized compensation expense, weighted average period of recognition</a></td>
<td class="text">3 years 14 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497065064744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity - Stock Options Valuation Assumptions (Details) - Stock options - $ / shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, minimum</a></td>
<td class="nump">46.50%<span></span>
</td>
<td class="nump">38.10%<span></span>
</td>
<td class="nump">39.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, maximum</a></td>
<td class="nump">47.00%<span></span>
</td>
<td class="nump">58.30%<span></span>
</td>
<td class="nump">46.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk free interest rate, minimum</a></td>
<td class="nump">0.77%<span></span>
</td>
<td class="nump">0.26%<span></span>
</td>
<td class="nump">0.68%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk free interest rate, maximum</a></td>
<td class="nump">1.02%<span></span>
</td>
<td class="nump">1.02%<span></span>
</td>
<td class="nump">2.36%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield (in percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice', window );">Fair value of common stock (in dollars per share)</a></td>
<td class="nump">$ 18.41<span></span>
</td>
<td class="nump">$ 2.06<span></span>
</td>
<td class="nump">$ 1.58<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years 11 months 8 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice', window );">Fair value of common stock (in dollars per share)</a></td>
<td class="nump">$ 21.41<span></span>
</td>
<td class="nump">$ 10.51<span></span>
</td>
<td class="nump">$ 1.91<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">6 years 1 month 2 days<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Share Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497058835832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity - Performance-Based Options (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2018</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,966,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,442<span></span>
</td>
<td class="nump">$ 7,252<span></span>
</td>
<td class="nump">$ 2,353<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unamortized compensation expense, option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unamortized compensation expense, weighted average period of recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 14 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,983,000<span></span>
</td>
<td class="nump">36,576,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unamortized compensation expense, option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">480,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember', window );">Chief Executive Officer | Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="nump">1,792,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="nump">$ 0.97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unamortized compensation expense, option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unamortized compensation expense, weighted average period of recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 months 1 day<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497066211512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity - Restricted Stock Units (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 24, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unamortized compensation expense, weighted average period of recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 14 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">572,904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Total fair value of vested equity instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unamortized compensation expense excluding option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 26.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unamortized compensation expense, weighted average period of recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 6 months 3 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Units outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Share Based Payment Arrangement Tranche One And Tranche Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">28,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Share-based Payment Arrangement, Tranche One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Share-based Payment Arrangement, Tranche Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Share-based Payment Arrangement, Tranche Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=docs_ShareBasedPaymentArrangementTrancheOneAndTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=docs_ShareBasedPaymentArrangementTrancheOneAndTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497059449352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity - Restricted Stock Unit Activity (Details) - Restricted Stock Units (RSUs)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning balance (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">572,904<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(38,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(1,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Ending balance (in shares) | shares</a></td>
<td class="nump">534,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted- Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">67.60<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="nump">59.04<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">54.59<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Ending balance (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 68.23<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497064855992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity - Performance-Based Restricted Stock Units (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation expense</a></td>
<td class="nump">$ 31,442<span></span>
</td>
<td class="nump">$ 7,252<span></span>
</td>
<td class="nump">$ 2,353<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unamortized compensation expense, weighted average period of recognition</a></td>
<td class="text">3 years 14 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=docs_PerformanceBasedRestrictedStockUnitsMember', window );">Performance-Based Restricted Stock Units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">15,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="nump">$ 80.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="nump">3,170<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested (in shares)</a></td>
<td class="nump">12,069<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation expense</a></td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unamortized compensation expense excluding option</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unamortized compensation expense, weighted average period of recognition</a></td>
<td class="text">4 months 17 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber', window );">Units outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of equity instruments other than options outstanding, including both vested and non-vested instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=docs_PerformanceBasedRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=docs_PerformanceBasedRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497070862408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity - Employee Stock Purchase Plan (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unamortized compensation expense, weighted average period of recognition</a></td>
<td class="text">3 years 14 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee Stock</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent', window );">Purchase price of common stock under an employee stock purchase plan as a percentage of market price</a></td>
<td class="nump">85.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="nump">$ 23.84<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unamortized compensation expense excluding option | $</a></td>
<td class="nump">$ 0.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unamortized compensation expense, weighted average period of recognition</a></td>
<td class="text">4 months 17 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod', window );">Employee stock purchase plan (in shares) | shares</a></td>
<td class="nump">28,812<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPricesPerShareIssued', window );">Employee stock purchase plan price per share (in dollars per share)</a></td>
<td class="nump">$ 48.40<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPricesPerShareIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Prices Per Share Issued</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPricesPerShareIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase price of common stock expressed as a percentage of its fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497061509176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity - Employee Stock Purchase Plan Valuation Assumptions (Details) - Employee Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>$ / shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, minimum</a></td>
<td class="nump">86.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, maximum</a></td>
<td class="nump">103.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk free interest rate, minimum</a></td>
<td class="nump">0.05%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk free interest rate, maximum</a></td>
<td class="nump">0.67%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield (in percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice', window );">Fair value of common stock (in dollars per share)</a></td>
<td class="nump">$ 57.44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">3 months 14 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice', window );">Fair value of common stock (in dollars per share)</a></td>
<td class="nump">$ 73.73<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">5 months 26 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Share Price</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497070725672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity - Stock-Based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation expense</a></td>
<td class="nump">$ 31,442<span></span>
</td>
<td class="nump">$ 7,252<span></span>
</td>
<td class="nump">$ 2,353<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation expense</a></td>
<td class="nump">4,979<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="nump">173<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation expense</a></td>
<td class="nump">7,065<span></span>
</td>
<td class="nump">1,975<span></span>
</td>
<td class="nump">710<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Sales and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation expense</a></td>
<td class="nump">8,108<span></span>
</td>
<td class="nump">1,998<span></span>
</td>
<td class="nump">847<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation expense</a></td>
<td class="nump">$ 11,290<span></span>
</td>
<td class="nump">$ 2,679<span></span>
</td>
<td class="nump">$ 623<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497064841336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share Attributable to Common Stockholders- Schedule of Earnings Per Share, Basic and Diluted (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareReconciliationAbstract', window );"><strong>Numerator</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 154,783<span></span>
</td>
<td class="nump">$ 50,210<span></span>
</td>
<td class="nump">$ 29,737<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic', window );">Undistributed earnings attributable to participating securities, basic</a></td>
<td class="num">(21,526)<span></span>
</td>
<td class="num">(28,654)<span></span>
</td>
<td class="num">(18,908)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted', window );">Undistributed earnings attributable to participating securities, diluted</a></td>
<td class="num">(21,526)<span></span>
</td>
<td class="num">(28,654)<span></span>
</td>
<td class="num">(18,908)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net income attributable to Class A and Class B common stockholders, basic</a></td>
<td class="nump">133,257<span></span>
</td>
<td class="nump">21,556<span></span>
</td>
<td class="nump">10,829<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net income attributable to Class A and Class B common stockholders, diluted</a></td>
<td class="nump">$ 133,257<span></span>
</td>
<td class="nump">$ 21,556<span></span>
</td>
<td class="nump">$ 10,829<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Denominator</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, basic (in shares)</a></td>
<td class="nump">163,484<span></span>
</td>
<td class="nump">74,342<span></span>
</td>
<td class="nump">66,758<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants', window );">Dilutive effect of assumed exercise of common stock warrants (in shares)</a></td>
<td class="nump">234<span></span>
</td>
<td class="nump">180<span></span>
</td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, diluted (in shares)</a></td>
<td class="nump">191,017<span></span>
</td>
<td class="nump">95,134<span></span>
</td>
<td class="nump">81,710<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net income per share attributable to Class A and Class B common stockholders, basic (in dollars per share)</a></td>
<td class="nump">$ 0.82<span></span>
</td>
<td class="nump">$ 0.29<span></span>
</td>
<td class="nump">$ 0.16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net income per share attributable to Class A and Class B common stockholders, diluted (in dollars per share)</a></td>
<td class="nump">$ 0.70<span></span>
</td>
<td class="nump">$ 0.23<span></span>
</td>
<td class="nump">$ 0.13<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Denominator</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of share-based payment (in shares)</a></td>
<td class="nump">27,290<span></span>
</td>
<td class="nump">20,612<span></span>
</td>
<td class="nump">14,892<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=docs_OtherShareBasedAwardsMember', window );">Other share-based awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Denominator</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of share-based payment (in shares)</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1828-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 65<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2793-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 66<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2814-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2740-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 65<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2793-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 66<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e2814-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=docs_OtherShareBasedAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=docs_OtherShareBasedAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497060960440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income Per Share Attributable to Common Stockholders -Antidilutive Securities Excluded from Computation of Net Income Per Share (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share, amount (in shares)</a></td>
<td class="nump">464<span></span>
</td>
<td class="nump">76,287<span></span>
</td>
<td class="nump">76,865<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RedeemableConvertiblePreferredStockMember', window );">Redeemable convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share, amount (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">76,287<span></span>
</td>
<td class="nump">76,287<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share, amount (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">578<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=docs_OtherShareBasedAwardsMember', window );">Other share-based awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share, amount (in shares)</a></td>
<td class="nump">217<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Common stock warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share, amount (in shares)</a></td>
<td class="nump">247<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=docs_OtherShareBasedAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=docs_OtherShareBasedAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497061030408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Income Tax Expense Benefit (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current provision:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 160<span></span>
</td>
<td class="nump">$ 1,302<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">309<span></span>
</td>
<td class="nump">1,270<span></span>
</td>
<td class="nump">876<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit', window );">Total</a></td>
<td class="nump">469<span></span>
</td>
<td class="nump">2,572<span></span>
</td>
<td class="nump">876<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred provision (benefit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(34,852)<span></span>
</td>
<td class="nump">4,862<span></span>
</td>
<td class="num">(6,458)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="num">(6,395)<span></span>
</td>
<td class="nump">125<span></span>
</td>
<td class="num">(641)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit', window );">Total</a></td>
<td class="num">(41,247)<span></span>
</td>
<td class="nump">4,987<span></span>
</td>
<td class="num">(7,099)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for (benefit from) income taxes</a></td>
<td class="num">$ (40,778)<span></span>
</td>
<td class="nump">$ 7,559<span></span>
</td>
<td class="num">$ (6,223)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state, local, and federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state, local, and federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497064751816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Income taxes at statutory rate</a></td>
<td class="nump">$ 23,941<span></span>
</td>
<td class="nump">$ 12,131<span></span>
</td>
<td class="nump">$ 4,938<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State income taxes, net of federal benefit</a></td>
<td class="nump">5,503<span></span>
</td>
<td class="nump">2,532<span></span>
</td>
<td class="nump">1,561<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">Research and development credits</a></td>
<td class="num">(8,332)<span></span>
</td>
<td class="num">(1,845)<span></span>
</td>
<td class="num">(1,842)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount', window );">Stock-based compensation</a></td>
<td class="num">(71,780)<span></span>
</td>
<td class="num">(5,796)<span></span>
</td>
<td class="nump">310<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="nump">1,878<span></span>
</td>
<td class="nump">171<span></span>
</td>
<td class="num">(11,995)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense', window );">Section 162(m) limitation</a></td>
<td class="nump">7,260<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other</a></td>
<td class="nump">752<span></span>
</td>
<td class="nump">366<span></span>
</td>
<td class="nump">805<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for (benefit from) income taxes</a></td>
<td class="num">$ (40,778)<span></span>
</td>
<td class="nump">$ 7,559<span></span>
</td>
<td class="num">$ (6,223)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 740<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120384911&amp;loc=d3e23163-113944<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497070729032">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue', window );">Accruals and deferred revenue</a></td>
<td class="nump">$ 1,760<span></span>
</td>
<td class="nump">$ 1,257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">32,215<span></span>
</td>
<td class="nump">486<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment', window );">Research &amp; development credit carryforwards</a></td>
<td class="nump">12,310<span></span>
</td>
<td class="nump">4,516<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_DeferredTaxAssetsLeasingArrangements', window );">Operating lease liabilities</a></td>
<td class="nump">276<span></span>
</td>
<td class="nump">315<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense', window );">Acquisition and other related expense</a></td>
<td class="nump">255<span></span>
</td>
<td class="nump">271<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock-based compensation expense</a></td>
<td class="nump">3,847<span></span>
</td>
<td class="nump">431<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross', window );">Unrealized loss</a></td>
<td class="nump">5,199<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Gross deferred tax assets</a></td>
<td class="nump">55,862<span></span>
</td>
<td class="nump">7,276<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowance</a></td>
<td class="num">(4,731)<span></span>
</td>
<td class="num">(2,896)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Deferred tax assets, net of valuation allowance</a></td>
<td class="nump">51,131<span></span>
</td>
<td class="nump">4,380<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesNetAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="num">(1,899)<span></span>
</td>
<td class="num">(1,701)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">Operating lease right-of-use assets</a></td>
<td class="num">(276)<span></span>
</td>
<td class="num">(336)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets', window );">Intangible assets</a></td>
<td class="num">(398)<span></span>
</td>
<td class="num">(231)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="num">(2,573)<span></span>
</td>
<td class="num">(2,268)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets</a></td>
<td class="nump">$ 48,558<span></span>
</td>
<td class="nump">$ 2,112<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Acquisition and Other Related Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_DeferredTaxAssetsLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Leasing Arrangements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_DeferredTaxAssetsLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Revenue</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497067053528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="nump">$ 4,731<span></span>
</td>
<td class="nump">$ 2,896<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Increase in valuation allowance</a></td>
<td class="nump">1,800<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal', window );">Net operating loss carryforwards, state</a></td>
<td class="nump">97,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic', window );">Net operating loss carryforwards, federal</a></td>
<td class="nump">124,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_OperatingLossCarryforwardsSubjectToExpiration', window );">State net operating loss carryforwards subject to expiration</a></td>
<td class="nump">83,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_TaxCreditCarryforwardsSubjectToExpiration', window );">State research and development tax credit carryforwards subject to expiration</a></td>
<td class="nump">200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">6,188<span></span>
</td>
<td class="nump">$ 3,162<span></span>
</td>
<td class="nump">$ 2,475<span></span>
</td>
<td class="nump">$ 2,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Effective tax rate</a></td>
<td class="nump">4,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Tax credit carryforwards, research</a></td>
<td class="nump">11,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardLineItems', window );"><strong>Tax Credit Carryforward [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Tax credit carryforwards, research</a></td>
<td class="nump">$ 8,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_OperatingLossCarryforwardsSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Loss Carryforwards, Subject To Expiration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_OperatingLossCarryforwardsSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_TaxCreditCarryforwardsSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax Credit Carryforwards, Subject to Expiration</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_TaxCreditCarryforwardsSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497065013384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Summary of Unrecognized Tax Benefits (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Beginning balance</a></td>
<td class="nump">$ 3,162<span></span>
</td>
<td class="nump">$ 2,475<span></span>
</td>
<td class="nump">$ 2,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Additions for tax positions related to the current year</a></td>
<td class="nump">2,995<span></span>
</td>
<td class="nump">687<span></span>
</td>
<td class="nump">670<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Additions for tax positions related to prior years</a></td>
<td class="nump">36<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Reductions for tax positions related to prior years</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,095)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations', window );">Reductions related to a lapse of statute</a></td>
<td class="num">(5)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Ending balance</a></td>
<td class="nump">$ 6,188<span></span>
</td>
<td class="nump">$ 3,162<span></span>
</td>
<td class="nump">$ 2,475<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497061148568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>May 15, 2022</div></th>
<th class="th"><div>Apr. 01, 2022</div></th>
<th class="th"><div>Oct. 08, 2021</div></th>
<th class="th"><div>May 27, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1', window );">Lease term for lease not yet commenced</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount', window );">Total undiscounted lease payments for lease not yet commenced</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_PartnershipAgreementExtensionPeriod', window );">Partnership agreement, extension period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted', window );">Partnerships agreement, period before termination is permitted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_PartnershipAgreementNoncancelablePeriod', window );">Partnership agreement, noncancelable period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod', window );">Partnership agreement, revenue guarantee during noncancelable period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_HostingArrangementPeriod', window );">Hosting arrangement period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_HostingArrangementAnnualCommitment', window );">Hosting arrangement annual commitment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAccrualProvision', window );">Loss contingency</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">572,904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">563,689<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 32.99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=docs_AMiONMember', window );">AMiON | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Payments to acquire businesses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 53,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Business combination, contingent consideration, liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 24,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod', window );">Business combination contingent consideration liability payable period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany', window );">Partnership agreement, annual revenue guarantee to partnering company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCommitmentsLineItems', window );"><strong>Other Commitments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany', window );">Partnership agreement, annual revenue guarantee to partnering company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Liability Payable Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_HostingArrangementAnnualCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Hosting Arrangement, Annual Commitment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_HostingArrangementAnnualCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_HostingArrangementPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Hosting Arrangement, Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_HostingArrangementPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Lease Not Yet Commenced, Undiscounted Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Partnership Agreement, Annual Revenue Guarantee To Partnering Company</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_PartnershipAgreementExtensionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Partnership Agreement Extension Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_PartnershipAgreementExtensionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_PartnershipAgreementNoncancelablePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Partnership Agreement Noncancelable Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_PartnershipAgreementNoncancelablePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Partnership Agreement, Revenue Guarantee To Partnering Company During Noncancelable Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Partnerships Agreement Period Before Termination Is Permitted</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease not yet commenced, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAccrualProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAccrualProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCommitmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCommitmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=docs_AMiONMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=docs_AMiONMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497161199976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Components of Lease Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 1,159<span></span>
</td>
<td class="nump">$ 2,372<span></span>
</td>
<td class="nump">$ 2,010<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease cost</a></td>
<td class="nump">114<span></span>
</td>
<td class="nump">143<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost</a></td>
<td class="nump">$ 1,273<span></span>
</td>
<td class="nump">$ 2,515<span></span>
</td>
<td class="nump">$ 2,010<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497071020504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Supplemental Cash Flow Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Cash paid for amounts included in measurement of lease liabilities&#8212;Operating cash flows</a></td>
<td class="nump">$ 1,107<span></span>
</td>
<td class="nump">$ 2,569<span></span>
</td>
<td class="nump">$ 2,069<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497071149208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Supplemental Balance Sheet Information (Details)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term (in years)</a></td>
<td class="text">1 year 7 months 20 days<span></span>
</td>
<td class="text">1 year 4 months 13 days<span></span>
</td>
<td class="text">1 year 1 month 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate</a></td>
<td class="nump">3.95%<span></span>
</td>
<td class="nump">3.95%<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497071159848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Maturities of Lease Liabilities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2023</a></td>
<td class="nump">$ 673<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2024</a></td>
<td class="nump">455<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future lease payments</a></td>
<td class="nump">1,128<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(39)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 1,089<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497070846920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plan (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PostemploymentBenefitsAbstract', window );"><strong>Postemployment Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Employer discretionary contribution amount</a></td>
<td class="nump">$ 2.1<span></span>
</td>
<td class="nump">$ 1.3<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PostemploymentBenefitsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PostemploymentBenefitsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497069457672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment and Geographic Information (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2022 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of Reportable Segments</a></td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140497064712728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 15, 2022</div></th>
<th class="th"><div>May 12, 2022</div></th>
<th class="th"><div>May 27, 2022</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramPeriodInForce1', window );">Stock repurchase program, period in force</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">572,904<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">563,689<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue', window );">Fair value of granted equity instruments</a></td>
<td class="nump">$ 18.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Granted in Period, Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>docs_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramPeriodInForce1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period which shares may be purchased under a stock repurchase plan authorized by an entity's Board of Directors, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramPeriodInForce1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>docs-20220331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:docs="http://www.doximity.com/20220331"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="docs-20220331.xsd" xlink:type="simple"/>
    <context id="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ifada4ef299464095aeb979c9bc3805d7_I20210930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
        </entity>
        <period>
            <instant>2021-09-30</instant>
        </period>
    </context>
    <context id="i74d0f3bb04994da080b1e644b3d7dc0a_I20220520">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-20</instant>
        </period>
    </context>
    <context id="ia4b07bfbd2c7447999b3dc774b9c116e_I20220520">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-20</instant>
        </period>
    </context>
    <context id="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5fbc45340fb149a4a4218570cd8171e7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i019f844806c4429ca710774cab1f0f66_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i861e24d19d314064a8c1591848e5a762_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i27e150c7cdf34baa99d770cedfcc88a0_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i1d3a91d95f5840f4be4445b0e6c7ad9f_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="id85d3aef9cef4f97829dac4fc1a6b84f_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ifb57040c2a0e4f15b5f7abbbebc4adf5_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="ic86efb5739b64e849f20b652dd30ebcd_I20190331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-31</instant>
        </period>
    </context>
    <context id="i30af202026344ba188b8654a2c38183c_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ibc604bd726fc487cb11cf5132d59f830_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ibf878bf045d24512bd9e3292775e7161_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i7a15f5b31d42419aa50ffb53e76f3705_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i414b68a2b4f24b3baf2fb76d57cbbea0_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i061b791ef37044a8a87103ab1684fc04_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ibcefd2d03bd84fb9ae242a16f4ac44ee_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="idb3c1cc4265d4d458fbb645f03094085_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i03b18f19eda34333b76bc6814b9d6346_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ibd16228ea691414ea7027a3ca0ceb2b0_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ifc4d8e5790824c048cce3a6bf007c91d_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i489aff50eced4b4e8409601ad948730d_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic1553167afc64f24beca75d407d45583_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i07067e700dd84b60a562fa298de61bc9_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4f5b7e290962451dbcf06e35be299e6a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iebb484f77246492db54ce7ef015c7dad_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i39670721aeba48af82262e3df7572d7b_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i200ee5197c714141a7a48e99357f4b5e_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia0bfa42b46ea49d485aa30692392a354_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icd3cf31e65de4bbca6609f7743bb7da5_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i708549cf187748d19458fd6a1acc45a2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i07f4d237a7d949c6a32f7dc1d04bf88e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i00ffd06e9957435f8a032e13e5872afd_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id9e2edf8663840efbaeced0815c8461f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2e82783b746e45e0a6c7e59883f52e81_D20210601-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">docs:InitialPublicOfferingIncludingOverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2bcd5d3197f043779574e3205ce6051a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">docs:InitialPublicOfferingIncludingOverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id77b48d8ffc446c1a18a4951dd7e173a_D20210601-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6d33d27d6278430c9585fcf4dd6fdf08_D20210601-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i62c961053180495bb8eed126ddb4d43b_D20210601-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iaca56ad88a7f461f9aa0ca6977c6c5a1_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic768fc083be84a7890c4145464deef64_D20210608-20210608">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
        </entity>
        <period>
            <startDate>2021-06-08</startDate>
            <endDate>2021-06-08</endDate>
        </period>
    </context>
    <context id="i3c255afc92154f4c84be5e86a09930da_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">docs:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i232cd9dacebb4bacabe5814953368da3_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">docs:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i05799a8437a248f4a953626f22ebc51e_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">docs:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="idce67be988654a3aba87d58e5fcbbae7_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">docs:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0c8278abf3274417845449b2b9d0ee93_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">docs:MarketingAgencyOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="if63822cdcbe54d9aa0abc1f888beaab3_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">docs:MarketingAgencyOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i448a0e1cd7da4509b2f34555307a9792_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">docs:SubscriptionMarketingSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7859c8cbc9bd4e129a62d90e12bfc46d_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">docs:SubscriptionHiringSolutionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2e71bd453e6a4a5c937ee4449f768fe2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">docs:DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i90363c012ca343ec80c6f828e4cfa8ee_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">docs:DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i64c2cfc1b0024d94aff990227a41ebbc_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CapitalizedContractCostAxis">docs:SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8a0e1d9ff3f146f5a3c9a2720e716d4c_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">docs:FurnitureAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i2deaa931c19f4b76a6b8cb6254e5036f_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">docs:FurnitureAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie20bbb49de3342faa35330af5ddaeedf_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">docs:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3585b880f7f444f1ae19972e18a16a3c_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i75a13b9faa46498d802095eeb320936a_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">docs:SubscriptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i00234c4f9e354fa79830f0c96b12428c_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">docs:SubscriptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id23527ddeed84383823da9485781ac68_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">docs:SubscriptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ifb9d4adeb75140e2a68cf494d5775877_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="idaeaebe3ab244209926951f374b9e9c8_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i51b462bd95564432b7a7495c9dff1958_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="if9ae84d280eb4f318ba2a0260ea07425_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if9fdd40c78d445c3a42dd89ccb0a4447_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib54faec0bdf04bf2afd9946218f0ac8a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iee115df4cfb64f938f087bc0a942628e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i72ae2b0209f24d0a8a959903f8cc0c7a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4492e8b1979a4c7ba9393c924e346c63_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2e676ae804004183a75c60a053663a51_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iae88e8a7906f4f01a07b94eb7dc2e2bf_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i18044c22d5b544cdbb5fdd7bb2fe76d4_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i604823b3602e46ca831f8718dbb39615_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4a05c1279cdf4518bd3081538e0be6be_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id244d9fec7044321a9fb14e83f5984f8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0ccabfb89c594e59b08be568c57aa776_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i48c4441bdd464dc0bb658f1e52a50fae_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i87abe2fab1ba4ef68a9cb17800dc430a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4e9550589bbf443f8841000a6dfbb584_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ide076cccc18c49e3a68b3143aa7c33e6_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iec88dd752efb47fab5bb0033f85e57f0_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib527f78664c7491ea47de8f8270b318c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iacfd3978047743d09395e66d7259d2ff_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i38b0eb18f6f9433eb026f897885f67f9_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ibcd72d89f10e46c5b83365968fb5b465_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i44d67e5169294894b512b0b90c0c74af_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4f0c5fbad8e940fd82c45fb0835f9376_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i26380d7634b346848bd64d717640dbd3_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2990b50678e04606a12ac8e532c0f906_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i98b116561d274486a93f0e9b833bbc09_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i13a7068cde934ebfaf0a93dc825b200e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i103e1316eb1546e9a33a93b9ee8e5d23_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i659c295d408e40e8921b445dd9705cba_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="if2b46ddbd30649f9964d6b0aef51743e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i2a78b23143e94b05b7011088f1bde0b1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3f12428258e7416aa2c26ccc9570922a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i721efafc234b48ab8ea99bb7a86b14aa_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6f8b0fb1f6524927bd336e7e7061c237_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id38c2d8b49424805aa289162c32d7b9e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i474320908a7b41cc92efce9528819f7b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i532a3e060f834264ba3c527d40875cdc_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i9f7356c1933c44718bcba9bf1f352ba2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i626d1eeffa1343138b59969cf31cd762_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4d81508e21044c96b9ecd160987e38c8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i932aa3c5dd54406697aee512b3d1806e_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3721da26311a44e19ada2d73129c607c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib6c70759748f44a39409b9430d98472c_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4a3cd669c0874efaa60ccd3fd01baaa5_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i982c335e998347a28b119b85613cdb3a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib38daf1082dc430a9b64f0b7677f6c83_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i38bda6505b4f4adf916f0a3922a00d63_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia91151d0fa9747bb8b8c5d38d7072ad2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i18e4692c47ad48329cebc83bc3799e68_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ifb043afb1f564202b46d46afa0477aaf_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i3bcc674299c845768df66da1b2f5bdb2_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iafc2fd89312947f7a003de3d37d11718_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ice4e787e809040d7940ae9963883e5f6_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="iac3932efeb454191b80019d9cc3d5da8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ib9b4c1c4fcf94d5695baa53fb6a9f916_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i86cda120cc8c4375b1f2178ee70c45d1_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i578db33c6a934072bbe067902c563ae8_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4c4f245f500f4927ad1eb8d7f12714bc_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i8476dc0fc3544b828b4aacf4934129b5_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie03e89c5126d41ec830e87d4165cf777_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i56c340497cf441e683bdc17f8fc2ff7e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i99d6758926cc4835972af44c8abfea6e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ifa762a9d99d64e26b88344760669498d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ibb407695229442378be2cc5e6794b4dc_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8c3a8d602839469aa9abd46d6b23c3b7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i45d51c39fc29442b936469cf96558a7a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i674cc6fab0fb438a93e5000f47d071fd_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6c14c0c571b24e4a8f722913926177f6_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i838d198056aa4046821706ffe91ac209_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8285a266d2b84f64a873ce73025e5feb_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i022beaddadf04d3e99f5082fadd56106_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6b1782e4152f4dd3a6b1f5b27d8f1bac_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib9b9e40170a94d1597c47f1a840054a0_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5ed0533ee5e34be3943e9fbebc78267c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9843e9aa5aa34d629a04be568ee0770f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i55a153d9fcf6462a90947a8c0cc01fad_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i92d19978f3d74e8393d55173e3261600_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i58b67667851745b0921de5486a701250_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iabb825f6081140068a661c6fce29a765_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9e5dd024a0ab400e9341bcfe83899418_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:CashAndCashEquivalentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i149cf0ff47ea404db23f4e4a1bc5fcdc_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6866262bbd66464e9d4917805ca3ad7e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2b6266c5703b4348bebf658eb91fde7f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia44e2eb3c48e4364866cc26deb91d1a3_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:AssetBackedSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5432548d20a44dd691468cebc30236b7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iea566254ac80466eb792b98fee4468fc_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if27d9ddc7c024d20a99d07f62ff1a2e1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib3515ce776444aa4be7ca30f76d95991_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie5c40b8b60cd40c8b22509a920df6d06_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i611917e8f7cf4a16937ba03415273dcd_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i41a927ca494a4351bd716a0e60b21d1e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i82b9f2d9387b45499ebeca44b8440fae_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i34e4bf763fea49b5bdcf75dc219e7e92_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i349cf5c5812341ab8fa0686e31856780_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1cb90c50d62d4afbb1940f34e2a856de_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2f039878467d46c288ef097207b6975b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3b01aa2ae05c4047a50651aab2e681d7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i719069eb844247a9b2bd30c54120b216_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie3163cbc1f2442c08773e69ca6f51425_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5d93e12f702349bd99bf9d5330c3fb1b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:SovereignDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i92a4a2d0006947a8927335cfa305416f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id1df4b610f3946d98ae080e642659498_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5373de11d949417cbb36d85c87552143_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia35ead93812940d69566b0152cbba00b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i309ea865186047c0a5538f09e3c70ca9_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib27f206c94d44a2ea0ddaed560a54ac0_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8e0ec08cc952440a92e76047bc39557f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5de02ef242964b299f7003623da7eef4_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AvailableforsaleSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8fd4715dabf14628bd22641238042d34_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia9f7e9e66c5b4bb09aa27555e1ad1902_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i83568bca22424ed2b2bcc387ae3fc3a2_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib1b26c7fd27543afab7eb6101e431209_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i973ce033b5444e8184b98b45f2f762bf_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">docs:FurnitureAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i408a5f0dc11f4858abf1563a67979081_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">docs:FurnitureAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1da69909cef146178323e0df47516982_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">docs:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ief36ad090dfc4a189faf599f7900747f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">docs:ComputerEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2c6dd1041fd64455ab9d78b3daad3f68_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5edcc49f367e4d8c82a0bbeef2050a74_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib5b202e466ea48b083f080fed8852b3f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i28a7eabc1a4d486b92834db5677e9a27_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1f64c4a29d62477a8fad14379556ccb8_D20200401-20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:THMEDLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="i79a66d68c93b4bd0b2886189e06be17c_I20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:THMEDLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-01</instant>
        </period>
    </context>
    <context id="iee7d28ec87cf452fb10c202c80f90fbe_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:THMEDLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i57a0104cac79435c8a441386b54274b2_D20200401-20200401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:THMEDLLCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-04-01</endDate>
        </period>
    </context>
    <context id="if7cf2424c4f2444491451d34b70a6297_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">docs:PortionOfCurativeTalentLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i700d59f0237c426e9f45e85c7868ccb3_D20201001-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">docs:PortionOfCurativeTalentLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="ie3c81df0162042a5b0dc0d0c8592051a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i96d0d9721f3845cf819e54f13b25b749_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2954aeea8a14482992a39c86bd074154_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InternetDomainNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i41a71c7b00044b929b014c5f2a720f8c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InternetDomainNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i90f5cd4e2e554cc583d589c82b6980d1_D20210601-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0d10847a28e64727936c5a6f5e2e80a5_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesAPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i123f862c0d9447efbbc8bdae111fa9a1_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesBPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1d83f10d2f3d4f9f8308f66e84ed7f02_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesCPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i183a0b8f69a94170b9913a445fe4ab57_I20120831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:RedeemableConvertiblePreferredStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2012-08-31</instant>
        </period>
    </context>
    <context id="i7bb2ecd4e0c946abb1d503513127046f_I20120831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:RedeemableConvertiblePreferredStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2012-08-31</instant>
        </period>
    </context>
    <context id="i903f14931847407cbb172b0f7bd884c6_I20120831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:RedeemableConvertiblePreferredStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2012-08-31</instant>
        </period>
    </context>
    <context id="i402085a78ad14a0f992a4f8b0ecdcd58_I20120831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:RedeemableConvertiblePreferredStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2012-08-31</instant>
        </period>
    </context>
    <context id="if157170dd5944a499d7ec585e0434c4d_I20120831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:RedeemableConvertiblePreferredStockWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ValuationTechniqueAxis">us-gaap:ValuationTechniqueOptionPricingModelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2012-08-31</instant>
        </period>
    </context>
    <context id="ib043fb4bcadb409c9fa4b0e1104a5b1d_I20210608">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-08</instant>
        </period>
    </context>
    <context id="i7606a71ce4a84be3a6dde5784b7d32ae_I20210608">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-08</instant>
        </period>
    </context>
    <context id="ib6f78b8e938a40e189a348c098b679d6_D20210608-20210608">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-08</startDate>
            <endDate>2021-06-08</endDate>
        </period>
    </context>
    <context id="iffeb565b4545435983a69c61108b5344_D20210608-20210608">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-08</startDate>
            <endDate>2021-06-08</endDate>
        </period>
    </context>
    <context id="i3ee03b9d354947dba14b2c512b9bc336_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4c6316b62a6d48928288e886e45e4dc6_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ie2075365cb96485192385bf947ef595a_I20170331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:ContractWithUSNewsWorldReportLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-03-31</instant>
        </period>
    </context>
    <context id="i3f99466cf9f5440d9a1deb4533b63a0e_D20170301-20170331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:ContractWithUSNewsWorldReportLPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-03-01</startDate>
            <endDate>2017-03-31</endDate>
        </period>
    </context>
    <context id="i07bcfcbefba64208b4423f3a902e75e2_I20210614">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-14</instant>
        </period>
    </context>
    <context id="i17b428b935264ffe87dec690a2b09118_D20210614-20210614">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-14</startDate>
            <endDate>2021-06-14</endDate>
        </period>
    </context>
    <context id="i8bd91cc36430472099a03473544779d1_I20211008">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-08</instant>
        </period>
    </context>
    <context id="i7358dd40974c4c15993593aef2ed49d4_I20211008">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-08</instant>
        </period>
    </context>
    <context id="ie76d6e6102ef406399e4e136b24eca26_I20211008">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-08</instant>
        </period>
    </context>
    <context id="i61bf36f882e84585b81cb908da335c25_I20211008">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-08</instant>
        </period>
    </context>
    <context id="i39eec364f5b04f648b48c3dcc6d77519_I20211008">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-08</instant>
        </period>
    </context>
    <context id="id8607743731e4071beb43262fa44f7cf_I20211008">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-08</instant>
        </period>
    </context>
    <context id="iefca250a775b47afb7490aca201d7488_D20211008-20211008">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-08</startDate>
            <endDate>2021-10-08</endDate>
        </period>
    </context>
    <context id="i16b887faed4f499cae154df41656fb5f_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id07380e73439483897907b5d88d89be6_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">docs:USNewsWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i6d4fd5c7f8d8423bb39a6ed8568b3356_D20100401-20100430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">docs:IndividualsWithVotingInterestLessThanThresholdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:EquityIncentivePlan2010Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2010-04-01</startDate>
            <endDate>2010-04-30</endDate>
        </period>
    </context>
    <context id="id1341fe12e41432d9a0dd420afc78a66_D20100401-20100430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">docs:IndividualsWithVotingInterestAtThresholdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:EquityIncentivePlan2010Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2010-04-01</startDate>
            <endDate>2010-04-30</endDate>
        </period>
    </context>
    <context id="i22d3b66c56b94252a2946d3a502fdae3_D20100401-20100430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:EquityIncentivePlan2010Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2010-04-01</startDate>
            <endDate>2010-04-30</endDate>
        </period>
    </context>
    <context id="i8ec1658b926c4ef39dfd202582dd44a8_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:StockOptionAndIncentivePlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iab2ea80b2cbf4380ba57669907c19c02_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:EmployeeStockPurchasePlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i5eaddeac25184da0affc7274c9201b26_D20170401-20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-04-01</startDate>
            <endDate>2018-03-31</endDate>
        </period>
    </context>
    <context id="if4e53989ad534fe89ef01474dae63d8f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i725f9096e258495b86d6aa50c855aaa9_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:EquityIncentivePlan2010Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i56d735fe4eb34fe1922c7e4400822779_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:EquityIncentivePlan2010Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3541a109248a45dc94084818f280ac54_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">docs:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:StockOptionAndIncentivePlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i67450ca940dd40f0a2d462baa0500656_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">docs:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:StockOptionAndIncentivePlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i062a7bd4fea64eff8312ec950069505b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:StockOptionAndIncentivePlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i474cc2747676411382999c3f91d30019_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:StockOptionAndIncentivePlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic7e987e8af04409dbdccaa86e531b3a0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:StockOptionAndIncentivePlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id01f8e0be0ee4f27ae203fcef745b3aa_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:StockOptionAndIncentivePlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ie51ad27fff7e4a428edc6ea000fd35d2_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:EmployeeStockPurchasePlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i434b921a71c247e49c95cbfb98931fc2_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">docs:ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i846bae41a5fe4dd4a8ee4faa714617c2_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i18e2b6fd4b074d7db710c23afcd10f34_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i20ae6e1b9ad04e07b4597114eca5d5ee_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i7493bbee46f24e8484095a81b057167c_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i226d0d1119d141748de5f3ec182d0ba9_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i6e6975dac5d14fdeb07a8ecc86e9912d_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i31208a9ec3934804b4c4c3c9e4b9ae56_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i63de954bcdf44beabda4a4cb41517cd6_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5570e6c29d854f898d1e5e342437be88_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i298cf9213fd94bf999a48f99a9e0d27c_D20180301-20180331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-03-01</startDate>
            <endDate>2018-03-31</endDate>
        </period>
    </context>
    <context id="i7c137a25b9864647b3377c74eb5c9329_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="icd3eb1cf82ec45919e291170d616104d_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i24ebf27ab6024144a01cc18be9301b97_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4d1acfbd8dc54fa9b2bcb6aafeb4d7f5_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ife196e39e85444efa18e6408b5528324_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i069e58edeaa64c12a8363d9a79919c2f_D20210624-20210624">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">docs:ShareBasedPaymentArrangementTrancheOneAndTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-24</startDate>
            <endDate>2021-06-24</endDate>
        </period>
    </context>
    <context id="i8d9b036a65e94e84b94ff795383a9281_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ieda01ec82c8347f79e1ed7baa2764e9c_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8d96c621dbad4b0893a45915a1e3eb41_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i22cded30244a4dc4b48d2cc92c10c4be_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i610bf1430732450cbbf831aa9fbaf023_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic960f45dc6ee4214a384c76564f6f1a3_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i117af75205314c998fad1407c682e2d0_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">docs:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8075f5e61a6f4e0fa23f0b2d73e6bc0b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">docs:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i54f0e6464d3d42999d152987a80350fc_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">docs:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i1e70174a995c49c9916aacfc83acfc7e_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">docs:PerformanceBasedRestrictedStockUnitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="id49a07de8105430d9e5b763fa04c9419_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i14587970434d4e5d831e458e0cf34e59_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i392e807a56904918a6a9e4076a92504d_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7d4c019a802944bb81efba9687e2e06a_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ifc62a205668f49b9bf71eefe850ffc3f_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9164774a82a1435bb9edf034bfb5610d_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i381d7bd945a246b38630bd42ca02f556_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i643419a5871c4616afc52904e8243daa_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i9c63553114c049e0b99db51fd02c3a5a_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i847059421e7947a984ad34ce247eb9e4_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i22d0ef822c3a4843b76143dba7a23603_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iec4edfed98534025a3c42e669b77c905_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="icce45add1e4a4c4ab8d74a95293ddd73_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ieee0bbd772344ba3aa609a2395100a50_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0872333d3b584eeebd4ed5658baa1b13_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4f8c647b40c747dba1ef8dc24e552b7a_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ifbdabf5291a64e328bdbbfff61aa8d5c_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">docs:OtherShareBasedAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ia9e97d96aecb4d1d904052c4e11402f0_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">docs:OtherShareBasedAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9e38c40919b2480382413b360d2df583_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">docs:OtherShareBasedAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i80014f589fa24025aba4a9a6e7337c21_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i37353189bac04c0c8499282980a6fbb4_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i47d1b632be7e4cc090898a23568e0174_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="if2c5b92d76cd41efbbbb13447fd077b8_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i433b7b224b754032ae79af210bdf56c0_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i19af305064d34ab0a9c791bd4989487e_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i7166b08eefb94201a936dda4ab4a1b6f_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">docs:OtherShareBasedAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3d0cf67197d64b82a0f9be653ff65148_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">docs:OtherShareBasedAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3a29bfa4143c42cb8c0f174e1b701e1f_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">docs:OtherShareBasedAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i366343ec548042d1a0b920b7da7cd459_D20210401-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie0f97ef761814d6fa5b6219079762edc_D20200401-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i1f1b807dde644927a5cecfcdc7ea90b4_D20190401-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-04-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i3e814b9bfb97496daff7da69a24ec5cd_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ic83e784502b44138b8906b62606b6cc0_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="ia779ca3233c64c28abdfc4d63196098d_D20211008-20211008">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
        </entity>
        <period>
            <startDate>2021-10-08</startDate>
            <endDate>2021-10-08</endDate>
        </period>
    </context>
    <context id="i5427186226c84ccfa0800cadaa7de7c6_D20211008-20211008">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-08</startDate>
            <endDate>2021-10-08</endDate>
        </period>
    </context>
    <context id="i810401f3e11544ccb12389b06a087e25_D20211008-20211008">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-08</startDate>
            <endDate>2021-10-08</endDate>
        </period>
    </context>
    <context id="i481113436cc1402f934510336edc992b_D20220401-20220401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:AMiONMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-01</endDate>
        </period>
    </context>
    <context id="i1761c372f61844c2b98a7f045fe36118_I20220401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">docs:AMiONMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-01</instant>
        </period>
    </context>
    <context id="ief085275d125487ab483dab51f92a13d_D20220501-20220527">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-01</startDate>
            <endDate>2022-05-27</endDate>
        </period>
    </context>
    <context id="ib1d009a88cef49af96f5da8fc0da7d35_D20211201-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
        </entity>
        <period>
            <startDate>2021-12-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9a3e9f0d2edd438b8e1b2bd756b26c00_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i16625e145bd74701a4ae78f95675b6e5_D20220515-20220515">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-15</startDate>
            <endDate>2022-05-15</endDate>
        </period>
    </context>
    <context id="id8a49fae532d49d9b87337bacae0b894_I20220512">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-12</instant>
        </period>
    </context>
    <context id="i809ae921d1e74261bd64ae9e74b5455c_D20220512-20220512">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001516513</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-12</startDate>
            <endDate>2022-05-12</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="reporting_unit">
        <measure>docs:reporting_unit</measure>
    </unit>
    <unit id="series">
        <measure>docs:series</measure>
    </unit>
    <unit id="vote">
        <measure>docs:vote</measure>
    </unit>
    <unit id="board_of_director">
        <measure>docs:board_of_director</measure>
    </unit>
    <unit id="segment">
        <measure>docs:segment</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODAzL2ZyYWc6MDM5NWU3OWJlZTRkNGY5ZmE3NzZhZTg2ZTlkZmJiOGMvdGFibGU6Y2M0ZjU3ZWNiYmNiNDAyNmJjMjZkMTdkNWRlNmRjNDgvdGFibGVyYW5nZTpjYzRmNTdlY2JiY2I0MDI2YmMyNmQxN2Q1ZGU2ZGM0OF8yLTEtMS0xLTEwNDY4Nw_068ef9e3-8ee8-4cc7-bedd-65399215c2b6">0001516513</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalYearFocus
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODAzL2ZyYWc6MDM5NWU3OWJlZTRkNGY5ZmE3NzZhZTg2ZTlkZmJiOGMvdGFibGU6Y2M0ZjU3ZWNiYmNiNDAyNmJjMjZkMTdkNWRlNmRjNDgvdGFibGVyYW5nZTpjYzRmNTdlY2JiY2I0MDI2YmMyNmQxN2Q1ZGU2ZGM0OF8zLTEtMS0xLTEwNDY4Nw_73e6d250-646b-431c-b9ed-6d12e81f86e9">2022</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODAzL2ZyYWc6MDM5NWU3OWJlZTRkNGY5ZmE3NzZhZTg2ZTlkZmJiOGMvdGFibGU6Y2M0ZjU3ZWNiYmNiNDAyNmJjMjZkMTdkNWRlNmRjNDgvdGFibGVyYW5nZTpjYzRmNTdlY2JiY2I0MDI2YmMyNmQxN2Q1ZGU2ZGM0OF80LTEtMS0xLTEwNDY4Nw_bad8dffc-696e-4d5c-85e9-43c5359eb11c">FY</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODAzL2ZyYWc6MDM5NWU3OWJlZTRkNGY5ZmE3NzZhZTg2ZTlkZmJiOGMvdGFibGU6Y2M0ZjU3ZWNiYmNiNDAyNmJjMjZkMTdkNWRlNmRjNDgvdGFibGVyYW5nZTpjYzRmNTdlY2JiY2I0MDI2YmMyNmQxN2Q1ZGU2ZGM0OF81LTEtMS0xLTEwNDY4Nw_a169f3f6-5d11-48e7-85b6-6baf38ded094">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6MTc5OTIxNDk0NmQwNGRlMGI1YjFjNjFmNjdlOWJlNjMvdGFibGVyYW5nZToxNzk5MjE0OTQ2ZDA0ZGUwYjViMWM2MWY2N2U5YmU2M18wLTAtMS0xLTEwNDUxNy90ZXh0cmVnaW9uOjQ3ZTM0ZDIyNmNjNTQ1N2VhOTQ3MDg2NzNjYTJlZTU2XzI5MTM3MDU4MTM2MDkz_fb3931c9-08ec-46f9-84b6-f32f5f1267e5">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6NmI5ZDAwMGUxODJhNDY3YjkxZGEyYmNhNjZjYWQ5YzAvdGFibGVyYW5nZTo2YjlkMDAwZTE4MmE0NjdiOTFkYTJiY2E2NmNhZDljMF8wLTAtMS0xLTEwNDUxMw_1b63be17-7929-4e45-9170-a4c2396c6d60">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6NmI5ZDAwMGUxODJhNDY3YjkxZGEyYmNhNjZjYWQ5YzAvdGFibGVyYW5nZTo2YjlkMDAwZTE4MmE0NjdiOTFkYTJiY2E2NmNhZDljMF8xLTEtMS0xLTEwMDYyMi90ZXh0cmVnaW9uOjQzOWEyMzllZTlkYjQ5MjE4NmIxOGQ0Mjg5NGNhYzhjXzI5MTM3MDU4MTM2MTI0_0672e854-1bc5-4604-8a25-e56a3a5ea6b6">2022-03-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6NmI5ZDAwMGUxODJhNDY3YjkxZGEyYmNhNjZjYWQ5YzAvdGFibGVyYW5nZTo2YjlkMDAwZTE4MmE0NjdiOTFkYTJiY2E2NmNhZDljMF8xLTEtMS0xLTEwMDYyMi90ZXh0cmVnaW9uOjQzOWEyMzllZTlkYjQ5MjE4NmIxOGQ0Mjg5NGNhYzhjXzI5MTM3MDU4MTM2MTI0_fa3edf9b-816a-4495-a8ae-63831fd3f942">--03-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6NmI5ZDAwMGUxODJhNDY3YjkxZGEyYmNhNjZjYWQ5YzAvdGFibGVyYW5nZTo2YjlkMDAwZTE4MmE0NjdiOTFkYTJiY2E2NmNhZDljMF8zLTAtMS0xLTEwNDUxNQ_b2322d51-2836-4990-b2bb-17dd18bd47a1">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGV4dHJlZ2lvbjo3NDc0N2YwMzE5ZjY0OGI1OTFmZTZkYjJmMjJmYTkwM180NDUzMDIyMDk1MjczOQ_b78c31c8-8c66-41fc-a29d-7e55dd102477">001-40508</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6NzdkNjI0YTY3YzNhNGUzMDk4YmEwNWZhMTk2ZDc3ZDYvdGFibGVyYW5nZTo3N2Q2MjRhNjdjM2E0ZTMwOThiYTA1ZmExOTZkNzdkNl8wLTAtMS0xLTEwNDUyNQ_f21dd48b-8d96-4152-aca9-1fbd5b0cd94e">Doximity, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6MzU4MmYxOTBiMjhlNGU0OGFiMWRhMDBjYTQ2MmE5MDkvdGFibGVyYW5nZTozNTgyZjE5MGIyOGU0ZTQ4YWIxZGEwMGNhNDYyYTkwOV8wLTAtMS0xLTEwNDUyNw_4a5fa676-ba9c-4d2f-8d44-b3cda87f0708">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6MzU4MmYxOTBiMjhlNGU0OGFiMWRhMDBjYTQ2MmE5MDkvdGFibGVyYW5nZTozNTgyZjE5MGIyOGU0ZTQ4YWIxZGEwMGNhNDYyYTkwOV8wLTItMS0xLTEwNDUyOQ_5341a5d4-60d3-42a7-aa39-e4c4844d5fd3">27-2485512</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6MzU4MmYxOTBiMjhlNGU0OGFiMWRhMDBjYTQ2MmE5MDkvdGFibGVyYW5nZTozNTgyZjE5MGIyOGU0ZTQ4YWIxZGEwMGNhNDYyYTkwOV8zLTAtMS0xLTEwMDcyMC90ZXh0cmVnaW9uOjRkMTlkZjYzYzZkNTRlNmI5OWY5NWRiMDZkNzljNTQ2XzMwNzg2MzI1NTc3ODc2_99e96b7c-f77e-447e-aceb-45b0ae88fe64">500 3rd St.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6MzU4MmYxOTBiMjhlNGU0OGFiMWRhMDBjYTQ2MmE5MDkvdGFibGVyYW5nZTozNTgyZjE5MGIyOGU0ZTQ4YWIxZGEwMGNhNDYyYTkwOV8zLTAtMS0xLTEwMDcyMC90ZXh0cmVnaW9uOjRkMTlkZjYzYzZkNTRlNmI5OWY5NWRiMDZkNzljNTQ2XzMwNzg2MzI1NTc3ODgw_ceceff67-6f6c-4345-9654-8d5d4e63747c">Suite 510</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6MzU4MmYxOTBiMjhlNGU0OGFiMWRhMDBjYTQ2MmE5MDkvdGFibGVyYW5nZTozNTgyZjE5MGIyOGU0ZTQ4YWIxZGEwMGNhNDYyYTkwOV8zLTAtMS0xLTEwMDcyMC90ZXh0cmVnaW9uOjRkMTlkZjYzYzZkNTRlNmI5OWY5NWRiMDZkNzljNTQ2XzMwNzg2MzI1NTc3ODg0_202a0b49-f50c-4475-9fc1-5a660b7db88d">San Francisco</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6MzU4MmYxOTBiMjhlNGU0OGFiMWRhMDBjYTQ2MmE5MDkvdGFibGVyYW5nZTozNTgyZjE5MGIyOGU0ZTQ4YWIxZGEwMGNhNDYyYTkwOV8zLTAtMS0xLTEwMDcyMC90ZXh0cmVnaW9uOjRkMTlkZjYzYzZkNTRlNmI5OWY5NWRiMDZkNzljNTQ2XzMwNzg2MzI1NTc3ODg4_394fdb21-e035-4885-bb38-b0ae0e15a7e3">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6MzU4MmYxOTBiMjhlNGU0OGFiMWRhMDBjYTQ2MmE5MDkvdGFibGVyYW5nZTozNTgyZjE5MGIyOGU0ZTQ4YWIxZGEwMGNhNDYyYTkwOV8zLTAtMS0xLTEwMDcyMC90ZXh0cmVnaW9uOjRkMTlkZjYzYzZkNTRlNmI5OWY5NWRiMDZkNzljNTQ2XzMwNzg2MzI1NTc3ODky_ad39dd10-7a40-4158-9e84-38d4bce6ad5b">94107</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6MzU4MmYxOTBiMjhlNGU0OGFiMWRhMDBjYTQ2MmE5MDkvdGFibGVyYW5nZTozNTgyZjE5MGIyOGU0ZTQ4YWIxZGEwMGNhNDYyYTkwOV80LTAtMS0xLTEwMDcyMC90ZXh0cmVnaW9uOjEyYjQxZTkyM2MzNDRmZTliNjU5OGZjYzZiODhmNzBiXzI5MTM3MDU4MTM2MTgy_bad0d714-103b-4d57-a31e-e8e5564fb30c">(650)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6MzU4MmYxOTBiMjhlNGU0OGFiMWRhMDBjYTQ2MmE5MDkvdGFibGVyYW5nZTozNTgyZjE5MGIyOGU0ZTQ4YWIxZGEwMGNhNDYyYTkwOV80LTAtMS0xLTEwMDcyMC90ZXh0cmVnaW9uOjEyYjQxZTkyM2MzNDRmZTliNjU5OGZjYzZiODhmNzBiXzI5MTM3MDU4MTM2MTc4_6300c65d-2b41-4e7d-810b-eec277f5e862">549-4330</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6ZWQ2NDc5ZmNkYzA3NGNkZjg5YjU1YTU2YTZhYzgxODQvdGFibGVyYW5nZTplZDY0NzlmY2RjMDc0Y2RmODliNTVhNTZhNmFjODE4NF8xLTAtMS0xLTEwMDc2Mg_e2cebb32-b22e-46d2-b2f2-cc21642d3cac">Class A common stock, $0.001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6ZWQ2NDc5ZmNkYzA3NGNkZjg5YjU1YTU2YTZhYzgxODQvdGFibGVyYW5nZTplZDY0NzlmY2RjMDc0Y2RmODliNTVhNTZhNmFjODE4NF8xLTItMS0xLTEwNDUzMQ_15caae5e-56c5-43e7-9c2a-a32a5d2d1647">DOCS</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6ZWQ2NDc5ZmNkYzA3NGNkZjg5YjU1YTU2YTZhYzgxODQvdGFibGVyYW5nZTplZDY0NzlmY2RjMDc0Y2RmODliNTVhNTZhNmFjODE4NF8xLTQtMS0xLTEwNDUzNA_5c941bc5-54b9-4b80-99ca-f6ed4c96db0c">NYSE</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGV4dHJlZ2lvbjo3NDc0N2YwMzE5ZjY0OGI1OTFmZTZkYjJmMjJmYTkwM180NDUzMDIyMDk1Mjc0Mw_021688a2-7942-48d5-87d7-473f0c12fa9f">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGV4dHJlZ2lvbjo3NDc0N2YwMzE5ZjY0OGI1OTFmZTZkYjJmMjJmYTkwM180NDUzMDIyMDk1Mjc0Mg_cf8caaa0-e627-4c23-999a-287de5ca6731">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGV4dHJlZ2lvbjo3NDc0N2YwMzE5ZjY0OGI1OTFmZTZkYjJmMjJmYTkwM180NDUzMDIyMDk1Mjc0NA_7a807dd2-011d-4c60-8813-67f6cad1fa8f">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGV4dHJlZ2lvbjo3NDc0N2YwMzE5ZjY0OGI1OTFmZTZkYjJmMjJmYTkwM180NDUzMDIyMDk1Mjc0NQ_f61797cf-0253-4ec9-bd17-437900b881f6">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6N2IxMTQwNmVlMzBiNDFiY2JjMzFlMTZjMjhkMDVkMmIvdGFibGVyYW5nZTo3YjExNDA2ZWUzMGI0MWJjYmMzMWUxNmMyOGQwNWQyYl8xLTAtMS0xLTEwNDYzNg_8a1b54ea-8dec-434a-90af-20b8541ef9ac">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6N2IxMTQwNmVlMzBiNDFiY2JjMzFlMTZjMjhkMDVkMmIvdGFibGVyYW5nZTo3YjExNDA2ZWUzMGI0MWJjYmMzMWUxNmMyOGQwNWQyYl8xLTQtMS0xLTEwNDYzOA_c66d5482-df71-42af-a26d-9316e4c8b7f4">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGFibGU6N2IxMTQwNmVlMzBiNDFiY2JjMzFlMTZjMjhkMDVkMmIvdGFibGVyYW5nZTo3YjExNDA2ZWUzMGI0MWJjYmMzMWUxNmMyOGQwNWQyYl8yLTQtMS0xLTEwNDY0MA_4ea16bb0-bff1-40db-8757-96747a4d41d5">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGV4dHJlZ2lvbjo3NDc0N2YwMzE5ZjY0OGI1OTFmZTZkYjJmMjJmYTkwM182ODcxOTQ3Njc2MzgyMQ_0fc07673-5672-4d85-9908-4a4ca47ef1ff">false</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGV4dHJlZ2lvbjo3NDc0N2YwMzE5ZjY0OGI1OTFmZTZkYjJmMjJmYTkwM180NDUzMDIyMDk1Mjc0Ng_ff4a504a-e01c-421e-9b4d-5bc263c76924">false</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGV4dHJlZ2lvbjo3NDc0N2YwMzE5ZjY0OGI1OTFmZTZkYjJmMjJmYTkwM180NDUzMDIyMDk1Mjc0Nw_422aea21-98f4-4d52-9a19-f6555aa5a9d2">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="ifada4ef299464095aeb979c9bc3805d7_I20210930"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGV4dHJlZ2lvbjo3NDc0N2YwMzE5ZjY0OGI1OTFmZTZkYjJmMjJmYTkwM18zMDIzNjU2OTc4NjQ5Nw_33ae53be-5ff7-4ae4-be93-2f04ccccd45b"
      unitRef="usd">9000000000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i74d0f3bb04994da080b1e644b3d7dc0a_I20220520"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGV4dHJlZ2lvbjo3NDc0N2YwMzE5ZjY0OGI1OTFmZTZkYjJmMjJmYTkwM180NDUzMDIyMDk1Mjc0MA_ffe6963e-33ae-4d79-a3bf-9f6a76aca2dd"
      unitRef="shares">110086201</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ia4b07bfbd2c7447999b3dc774b9c116e_I20220520"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGV4dHJlZ2lvbjo3NDc0N2YwMzE5ZjY0OGI1OTFmZTZkYjJmMjJmYTkwM18zMDc4NjMyNTU5OTY1Mw_b0fbc006-c075-4e9c-a771-bb0cd534364a"
      unitRef="shares">83022658</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xL2ZyYWc6NzQ3NDdmMDMxOWY2NDhiNTkxZmU2ZGIyZjIyZmE5MDMvdGV4dHJlZ2lvbjo3NDc0N2YwMzE5ZjY0OGI1OTFmZTZkYjJmMjJmYTkwM180NDUzMDIyMDk1Mjc0MQ_7482ebcf-fe51-4eb0-9e24-7f13d078bc5e">Portions of the registrant&#x2019;s Definitive Proxy Statement relating to the 2022 Annual Meeting of Stockholders are incorporated by reference into Part III of this Annual Report on Form 10-K where indicated. Such Definitive Proxy Statement will be filed with the Securities and Exchange Commission within 120 days after the end of the registrant&#x2019;s fiscal year ended March&#160;31, 2022.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorFirmId
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjMvZnJhZzo1ZmQ4M2U3NjNkNjM0OWM4YWE1ODlkODE4MmNiNjM1Yi90YWJsZTphZGEwZDc3ZDQwNTg0NmYzODdkZDI2ZWVkZmUxYjVhOC90YWJsZXJhbmdlOmFkYTBkNzdkNDA1ODQ2ZjM4N2RkMjZlZWRmZTFiNWE4XzEtMC0xLTEtMTI2OTExL3RleHRyZWdpb246ZTFkODljMzNkMzg3NDE1Y2I1NTY0MTlmMTFlNDQ1M2NfMjg1ODczMDIzMjI4OTU_29b52960-848d-4423-8a7b-c5bdd192711d">34</dei:AuditorFirmId>
    <dei:AuditorName
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjYvZnJhZzo3NDI1ZWYwYmIyYjE0ZTMyYTc0MWRiOTliZDQxOTlkMy90YWJsZTozYjZjMDE1MDZhZjc0OThmYWRiYjVlM2I0MWQ1YTA3NS90YWJsZXJhbmdlOjNiNmMwMTUwNmFmNzQ5OGZhZGJiNWUzYjQxZDVhMDc1XzAtMC0xLTEtNTIzMDEvdGV4dHJlZ2lvbjowNzEwNTA4YmNmOGU0Y2JlODA3MGU5NWRmZDIyYzBjNV8zMTMzNjA4MTM5MTY2Ng_fc133adb-8b2f-4e24-afbf-490c7ec40bf6">Deloitte &amp; Touche LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjYvZnJhZzo3NDI1ZWYwYmIyYjE0ZTMyYTc0MWRiOTliZDQxOTlkMy90YWJsZTozYjZjMDE1MDZhZjc0OThmYWRiYjVlM2I0MWQ1YTA3NS90YWJsZXJhbmdlOjNiNmMwMTUwNmFmNzQ5OGZhZGJiNWUzYjQxZDVhMDc1XzEtMC0xLTEtMTI3MDc3_186b0077-d14a-4182-bb77-3339549b6e7b">San Francisco, California</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzQtMy0xLTEtNDc5OTI_81fc70db-f37b-423b-995c-0106708b8fa1"
      unitRef="usd">112809000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzQtNS0xLTEtNDc5OTI_13f6cc5c-8c57-4a67-9523-e80fcb5f7648"
      unitRef="usd">66393000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzUtMy0xLTEtNDc5OTI_a357864d-5245-4aa0-99cb-aab9ca429087"
      unitRef="usd">685304000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzUtNS0xLTEtNDc5OTI_82d4fc09-a53e-4862-8b7d-22bff58d3081"
      unitRef="usd">76141000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzYtMC0xLTEtOTI4NjUvdGV4dHJlZ2lvbjo5NzE4ZjBkYTUxNjQ0YWRhODNhZjkwNDE2ZjQzYTBkM18yOTEzNzA1ODEzNjE5Ng_289e6c0c-b261-4aa3-982e-c2d02b3edad9"
      unitRef="usd">359000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzYtMC0xLTEtOTI4NjUvdGV4dHJlZ2lvbjo5NzE4ZjBkYTUxNjQ0YWRhODNhZjkwNDE2ZjQzYTBkM18yOTEzNzA1ODEzNjIwNA_68ef3fd1-e6cf-4ea9-a4e6-7f5b7a6389d6"
      unitRef="usd">955000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzYtMy0xLTEtNDc5OTI_cc885409-6883-4a21-a4bc-f37e199dfac3"
      unitRef="usd">81073000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzYtNS0xLTEtNDc5OTI_edaa7b8a-c9a3-40fe-b3e7-ee85ed215d09"
      unitRef="usd">50319000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzctMy0xLTEtNDc5OTI_4e5529d1-5a9a-4141-af76-c2f9d3d9cbc1"
      unitRef="usd">19439000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzctNS0xLTEtNDc5OTI_3f842234-aab2-4d13-a665-56794c313166"
      unitRef="usd">10692000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:CapitalizedContractCostNetCurrent
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzgtMy0xLTEtNDc5OTI_edef45a4-ff8b-4d2c-92ed-228b68ff3ced"
      unitRef="usd">5512000</us-gaap:CapitalizedContractCostNetCurrent>
    <us-gaap:CapitalizedContractCostNetCurrent
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzgtNS0xLTEtNDc5OTI_8a32a10e-e577-4d87-b4c5-b88584107822"
      unitRef="usd">5856000</us-gaap:CapitalizedContractCostNetCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzktMy0xLTEtNDc5OTI_cbdb4940-9674-4bc4-a4d8-9100e9048283"
      unitRef="usd">904137000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzktNS0xLTEtNDc5OTI_cd52303c-cea7-4569-88fc-0d3c7af8df60"
      unitRef="usd">209401000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzEwLTMtMS0xLTQ3OTky_c6c5f901-00c3-42b6-bd6d-5580db4862a7"
      unitRef="usd">8488000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzEwLTUtMS0xLTQ3OTky_97ae8cb4-717e-4836-8e80-50a5c90d4d54"
      unitRef="usd">7598000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzExLTMtMS0xLTQ3OTky_b4669728-42f3-41c8-9106-5c81eeecaa8f"
      unitRef="usd">48558000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzExLTUtMS0xLTQ3OTky_cc1ecdd2-6a75-404a-9bd4-f0a15bfb7e09"
      unitRef="usd">2112000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzEyLTMtMS0xLTQ3OTky_2260587c-2670-4b80-a1fc-282598c58cdc"
      unitRef="usd">1087000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzEyLTUtMS0xLTQ3OTky_e2911c6b-9cfd-44b4-8def-d3cdf8e588c4"
      unitRef="usd">1339000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzEzLTMtMS0xLTQ3OTky_4b9f64f0-f778-47b5-9c28-a4e936627e74"
      unitRef="usd">7909000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzEzLTUtMS0xLTQ3OTky_61d5e101-185f-40b2-a07b-0cc6db865f5d"
      unitRef="usd">9596000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:Goodwill
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzE0LTMtMS0xLTQ3OTky_a231f0d9-9cc1-41fa-b0a8-634fa4b351c6"
      unitRef="usd">18915000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzE0LTUtMS0xLTQ3OTky_59d3f758-138d-4aa4-9226-f13770f545cb"
      unitRef="usd">18915000</us-gaap:Goodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzE1LTMtMS0xLTQ3OTky_ef9953b6-b912-4e2f-a578-5d6ae3b0a845"
      unitRef="usd">2263000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzE1LTUtMS0xLTQ3OTky_3b4b1ec3-56c6-474c-a015-3dbe7a694e4a"
      unitRef="usd">2758000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzE2LTMtMS0xLTQ3OTky_a388062f-09c8-4358-8335-7c3e52f66bfc"
      unitRef="usd">991357000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzE2LTUtMS0xLTQ3OTky_cbb83793-fd4e-4229-8647-1d3bc9429e7a"
      unitRef="usd">251719000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzE5LTMtMS0xLTQ3OTky_f72e2be9-6878-4859-ac1a-a68df7122b3e"
      unitRef="usd">463000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzE5LTUtMS0xLTQ3OTky_70fa0c70-5886-44b2-8b49-99412d83a9c3"
      unitRef="usd">1515000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzIwLTMtMS0xLTQ3OTky_f1f1825b-74ee-43b8-82dd-8821210f3d13"
      unitRef="usd">25270000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzIwLTUtMS0xLTQ3OTky_e564c948-1351-4ccc-b8cf-1033ad594e07"
      unitRef="usd">16285000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzIxLTMtMS0xLTQ3OTky_9729c10c-b746-470f-9e9a-b0e384d828a1"
      unitRef="usd">84907000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzIxLTUtMS0xLTQ3OTky_60160432-470c-4ce6-872a-3f76a122424c"
      unitRef="usd">83272000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzIyLTMtMS0xLTQ3OTky_e1503a00-2077-4801-8420-1fe058e6247e"
      unitRef="usd">642000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzIyLTUtMS0xLTQ3OTky_4af03566-1ff4-4225-b4a6-5c318493dcb1"
      unitRef="usd">970000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzI0LTMtMS0xLTQ3OTky_de18afa6-6164-4e53-b2e3-e67e2c0352fd"
      unitRef="usd">111282000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzI0LTUtMS0xLTQ3OTky_03dfec13-bd23-48e2-80cc-93ea2db94895"
      unitRef="usd">102042000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzI1LTMtMS0xLTQ3OTky_d2d1b216-55b2-4d21-933c-1da2ddade1a7"
      unitRef="usd">78000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzI1LTUtMS0xLTQ3OTky_15a68d2b-82a3-409c-ac1d-acecb4944f85"
      unitRef="usd">220000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzI2LTMtMS0xLTQ3OTky_44d271df-1eae-4a6d-ab84-b213be49d985"
      unitRef="usd">447000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzI2LTUtMS0xLTQ3OTky_14882aad-77bf-4de0-b355-55f457670346"
      unitRef="usd">284000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzI3LTMtMS0xLTQ3OTky_4d119cf7-af2c-4b4d-925e-16a8ec3437ae"
      unitRef="usd">956000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzI3LTUtMS0xLTQ3OTky_9d0cb383-ef9f-4ac7-aa38-941af8f4fddd"
      unitRef="usd">972000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzI4LTMtMS0xLTQ3OTky_32dbdd1d-d994-4250-8429-f2dd7c2fa0d3"
      unitRef="usd">112763000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzI4LTUtMS0xLTQ3OTky_6d0fd023-53fc-4038-96e8-b110b241ae21"
      unitRef="usd">103518000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzI4LTEtMS0xLTEwMTY4NA_7ebeac49-ddb6-45ec-b048-d87231a900db"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzI4LTMtMS0xLTEwMTY4Ng_1f5ab4c1-1cc1-4bd4-a7ba-58a4606cd1d3"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM0LTAtMS0xLTQ4ODk5L3RleHRyZWdpb246YzZmNTRmMmVlMjk4NDBlNDljZDA4NmQxZjg3YmYwMmVfMjkxMzcwNTgxMzY5NzA_27f47052-3462-47da-befc-865f539ca4b0"
      unitRef="usdPerShare">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM0LTAtMS0xLTQ4ODk5L3RleHRyZWdpb246YzZmNTRmMmVlMjk4NDBlNDljZDA4NmQxZjg3YmYwMmVfMjkxMzcwNTgxMzY5NzA_7c36d684-7bdb-4ba1-96e6-5e0ff1837ca0"
      unitRef="usdPerShare">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM0LTAtMS0xLTQ4ODk5L3RleHRyZWdpb246YzZmNTRmMmVlMjk4NDBlNDljZDA4NmQxZjg3YmYwMmVfMjkxMzcwNTgxMzY5Nzk_1220a4f7-d6ff-44d3-b650-045d30154876"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM0LTAtMS0xLTQ4ODk5L3RleHRyZWdpb246YzZmNTRmMmVlMjk4NDBlNDljZDA4NmQxZjg3YmYwMmVfMjkxMzcwNTgxMzY5ODQ_5926d6d4-203b-4c57-99b8-b4984d0197cf"
      unitRef="shares">76350000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM0LTAtMS0xLTQ4ODk5L3RleHRyZWdpb246YzZmNTRmMmVlMjk4NDBlNDljZDA4NmQxZjg3YmYwMmVfMjkxMzcwNTgxMzY5ODk_2fa88795-1a60-4180-a1d7-6a8bf12c44e2"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM0LTAtMS0xLTQ4ODk5L3RleHRyZWdpb246YzZmNTRmMmVlMjk4NDBlNDljZDA4NmQxZjg3YmYwMmVfMjkxMzcwNTgxMzY5ODk_83b72113-b890-4c4a-b70e-51692e7dcd2a"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM0LTAtMS0xLTQ4ODk5L3RleHRyZWdpb246YzZmNTRmMmVlMjk4NDBlNDljZDA4NmQxZjg3YmYwMmVfMjkxMzcwNTgxMzY5OTQ_7f83bad9-0587-488b-9ac0-8b3c7a2eb5df"
      unitRef="shares">76287000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM0LTAtMS0xLTQ4ODk5L3RleHRyZWdpb246YzZmNTRmMmVlMjk4NDBlNDljZDA4NmQxZjg3YmYwMmVfMjkxMzcwNTgxMzY5OTQ_b4092f78-50d1-4156-89e1-5674d99b184c"
      unitRef="shares">76287000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM0LTAtMS0xLTQ4ODk5L3RleHRyZWdpb246YzZmNTRmMmVlMjk4NDBlNDljZDA4NmQxZjg3YmYwMmVfMjkxMzcwNTgxMzY5OTk_5d7b541b-a68f-41eb-9f4c-cd40ee7bb4bd"
      unitRef="usd">0</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM0LTAtMS0xLTQ4ODk5L3RleHRyZWdpb246YzZmNTRmMmVlMjk4NDBlNDljZDA4NmQxZjg3YmYwMmVfMjkxMzcwNTgxMzcwMDQ_acadada5-1962-47a4-8a4f-f23d0c34db18"
      unitRef="usd">81672000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM0LTMtMS0xLTQ3OTky_f8ab565e-66b3-4d8a-96d5-efc5a63b46e1"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM0LTUtMS0xLTQ3OTky_3de414e3-ec94-4717-807b-778a2d142407"
      unitRef="usd">81458000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzMyLTAtMS0xLTk3NjgyL3RleHRyZWdpb246NWZiODJhYWExMjAyNDJjMWFmM2I0MGE2NDA1ZmFmYjZfMjkxMzcwNTgxMzYyMjE_5b8a5791-e389-4667-937d-3509c479441a"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzMyLTAtMS0xLTk3NjgyL3RleHRyZWdpb246NWZiODJhYWExMjAyNDJjMWFmM2I0MGE2NDA1ZmFmYjZfMjkxMzcwNTgxMzYyMjE_728c2842-373a-4d52-a54f-0b49bb6d2d2c"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzMyLTAtMS0xLTk3NjgyL3RleHRyZWdpb246NWZiODJhYWExMjAyNDJjMWFmM2I0MGE2NDA1ZmFmYjZfMjkxMzcwNTgxMzYyNTU_46544d1c-d0f2-4fb4-87cc-12a16097748e"
      unitRef="shares">100000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzMyLTAtMS0xLTk3NjgyL3RleHRyZWdpb246NWZiODJhYWExMjAyNDJjMWFmM2I0MGE2NDA1ZmFmYjZfMjkxMzcwNTgxMzYyNTk_849bc39e-b5e1-4848-b7b2-d7674b789b61"
      unitRef="shares">0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzMyLTAtMS0xLTk3NjgyL3RleHRyZWdpb246NWZiODJhYWExMjAyNDJjMWFmM2I0MGE2NDA1ZmFmYjZfOTQ_086edaab-6544-4e8e-a0ae-8ba5f60f1e90"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzMyLTAtMS0xLTk3NjgyL3RleHRyZWdpb246NWZiODJhYWExMjAyNDJjMWFmM2I0MGE2NDA1ZmFmYjZfOTQ_1c451f10-6570-44bf-a8a0-04e821fd8c68"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzMyLTAtMS0xLTk3NjgyL3RleHRyZWdpb246NWZiODJhYWExMjAyNDJjMWFmM2I0MGE2NDA1ZmFmYjZfOTQ_3346a00c-502b-4a0e-93f2-83cf299467e3"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzMyLTAtMS0xLTk3NjgyL3RleHRyZWdpb246NWZiODJhYWExMjAyNDJjMWFmM2I0MGE2NDA1ZmFmYjZfOTQ_b5ed4614-20d9-4d08-b5fb-a70b47d986ae"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzMyLTEtMS0xLTEwMTY3Mg_222efae1-bdeb-4a3e-a978-a8d6b218d47c"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzMyLTMtMS0xLTEwMTY4MA_776deadb-8ca3-482f-acdc-1c35c39307aa"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM2LTAtMS0xLTQ5MDk0L3RleHRyZWdpb246YzkzMGM2OWNmYjIyNDM0ODlkMWU1MTU3MWYzODI4MzdfMjkxMzcwNTgxMzY1ODQ_07d4f461-b1d6-462d-9399-e12775f6d47f"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM2LTAtMS0xLTQ5MDk0L3RleHRyZWdpb246YzkzMGM2OWNmYjIyNDM0ODlkMWU1MTU3MWYzODI4MzdfMjkxMzcwNTgxMzY1ODQ_2e483ca5-e445-48b7-9a84-0fef83e965ef"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM2LTAtMS0xLTQ5MDk0L3RleHRyZWdpb246YzkzMGM2OWNmYjIyNDM0ODlkMWU1MTU3MWYzODI4MzdfMjkxMzcwNTgxMzY2ODE_2ac44ee8-ab6e-4cc1-86f3-04ba751aa2c1"
      unitRef="shares">1500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM2LTAtMS0xLTQ5MDk0L3RleHRyZWdpb246YzkzMGM2OWNmYjIyNDM0ODlkMWU1MTU3MWYzODI4MzdfMjkxMzcwNTgxMzY2Njk_3ad369e3-3408-44dc-9e91-a0a1549e9eac"
      unitRef="shares">198000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM2LTAtMS0xLTQ5MDk0L3RleHRyZWdpb246YzkzMGM2OWNmYjIyNDM0ODlkMWU1MTU3MWYzODI4MzdfMjkxMzcwNTgxMzY1OTc_276ea81b-c88b-49c4-9791-0f950a83d120"
      unitRef="shares">192398000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM2LTAtMS0xLTQ5MDk0L3RleHRyZWdpb246YzkzMGM2OWNmYjIyNDM0ODlkMWU1MTU3MWYzODI4MzdfMjkxMzcwNTgxMzY1OTc_83bda431-8992-4a67-babd-6054061240e3"
      unitRef="shares">192398000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM2LTAtMS0xLTQ5MDk0L3RleHRyZWdpb246YzkzMGM2OWNmYjIyNDM0ODlkMWU1MTU3MWYzODI4MzdfMjkxMzcwNTgxMzY2MDE_91988f95-96d5-4bee-813b-09a8c9d46d34"
      unitRef="shares">82910000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM2LTAtMS0xLTQ5MDk0L3RleHRyZWdpb246YzkzMGM2OWNmYjIyNDM0ODlkMWU1MTU3MWYzODI4MzdfMjkxMzcwNTgxMzY2MDE_e201dc84-c88e-4a10-8c18-2324b17a30e3"
      unitRef="shares">82910000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM2LTMtMS0xLTQ3OTky_ecc4674b-033f-4abb-96b4-6d989adbb7ff"
      unitRef="usd">192000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM2LTUtMS0xLTQ3OTky_f2064d55-d03b-4bdf-b02b-764e9fef5db0"
      unitRef="usd">83000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM3LTMtMS0xLTQ3OTky_4372c10b-780a-4cbe-a24a-27c087b0c509"
      unitRef="usd">702589000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM3LTUtMS0xLTQ3OTky_cfa20e71-327d-4ce4-82c4-64e5b1379338"
      unitRef="usd">30357000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM4LTMtMS0xLTQ3OTky_f24322b9-f04c-468b-bdca-20a34e286511"
      unitRef="usd">-15294000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM4LTUtMS0xLTQ3OTky_0fcf8dc9-a96f-453e-abd1-7dc202542843"
      unitRef="usd">-21000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM5LTMtMS0xLTQ3OTky_2b3cf571-426b-4349-8e6f-04e77ea8955e"
      unitRef="usd">191107000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzM5LTUtMS0xLTQ3OTky_31ff8a74-179b-4852-b516-6fc67d7a6fe3"
      unitRef="usd">36324000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzQwLTMtMS0xLTQ3OTky_64888a21-600c-43a2-8bba-f6f7cda6eede"
      unitRef="usd">878594000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzQwLTUtMS0xLTQ3OTky_dbcaf141-8db9-4bb7-bdf7-b06f800674d9"
      unitRef="usd">66743000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzQxLTMtMS0xLTQ3OTky_814d660d-c1b2-4c19-b3c4-3a0061332fad"
      unitRef="usd">991357000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNjkvZnJhZzo5MjcxMDBkZGE3Mzg0NWMyOWViMjllY2E0ZmY3MWI0OS90YWJsZTo2MDkxMTM1ODU3ZmE0YWJjOTgxZjcyYjdiNTMwOTQ3ZC90YWJsZXJhbmdlOjYwOTExMzU4NTdmYTRhYmM5ODFmNzJiN2I1MzA5NDdkXzQxLTUtMS0xLTQ3OTky_f61ebbdd-6a7f-492c-bd51-0a1fe2c8ee2e"
      unitRef="usd">251719000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzItMS0xLTEtNDgyODY_8e3cf32b-e178-46ed-ba6c-eefe3816f9eb"
      unitRef="usd">343548000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzItMy0xLTEtNDgyODY_95b08759-6d95-4aa2-b889-482375077d14"
      unitRef="usd">206897000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzItNS0xLTEtNDgyODY_504c6895-30ae-4a62-a70e-d2d267b2c1c2"
      unitRef="usd">116388000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzMtMS0xLTEtNDgyODY_8039636a-5e9e-48f1-be55-9a844eb0ae07"
      unitRef="usd">39787000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzMtMy0xLTEtNDgyODY_2569672a-5004-43b1-87b0-fd096b3a5c56"
      unitRef="usd">31196000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzMtNS0xLTEtNDgyODY_808dbd05-e7e2-4d9a-933a-5417df554bb9"
      unitRef="usd">14900000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzQtMS0xLTEtNDgyODY_4ca14627-bd8f-48bf-919a-00e11b22ae7e"
      unitRef="usd">303761000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzQtMy0xLTEtNDgyODY_2a68ee33-74f0-4cdf-8885-48923ae017da"
      unitRef="usd">175701000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzQtNS0xLTEtNDgyODY_b9503188-71e3-4fba-91b7-2667271d1403"
      unitRef="usd">101488000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzYtMS0xLTEtNDgyODY_c27abbaf-63d6-440d-958d-5472d5aabd7a"
      unitRef="usd">62350000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzYtMy0xLTEtNDgyODY_478cb838-ee2a-4338-a14e-9429ab763bc8"
      unitRef="usd">43873000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzYtNS0xLTEtNDgyODY_748aa391-896b-4c2b-825a-998baf333b01"
      unitRef="usd">32435000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzctMS0xLTEtNDgyODY_9f10e49c-c1b6-4517-a0d0-642f1a313a6a"
      unitRef="usd">92129000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzctMy0xLTEtNDgyODY_c7879bc9-3263-459c-8ad3-44a88f1cef84"
      unitRef="usd">62033000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzctNS0xLTEtNDgyODY_537c78b3-000d-4cde-8419-032dd00d564e"
      unitRef="usd">39448000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzgtMS0xLTEtNDgyODY_58787f3f-7779-4248-b33c-03faf482fbe5"
      unitRef="usd">35746000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzgtMy0xLTEtNDgyODY_8b5a6359-d0da-4318-b59d-052a047049fb"
      unitRef="usd">16492000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzgtNS0xLTEtNDgyODY_117308db-fb76-4cc9-b87e-e4960cec90e4"
      unitRef="usd">7442000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzktMS0xLTEtNDgyODY_54099246-d091-4d2e-a1c3-728ae3014f3f"
      unitRef="usd">190225000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzktMy0xLTEtNDgyODY_6ca0c1e3-8b2b-4938-a80a-b64d4de80cd5"
      unitRef="usd">122398000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzktNS0xLTEtNDgyODY_779e1a83-9521-4c36-bd38-222a19736df3"
      unitRef="usd">79325000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzEwLTEtMS0xLTQ4Mjg2_32e11b79-ea8a-49d3-bd24-c1828e0bf969"
      unitRef="usd">113536000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzEwLTMtMS0xLTQ4Mjg2_3c835c4b-7db3-4da8-bc8a-4ff6a4103027"
      unitRef="usd">53303000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzEwLTUtMS0xLTQ4Mjg2_701d61b1-5995-4669-8d8f-14dcf6ed0aa2"
      unitRef="usd">22163000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzEzLTEtMS0xLTQ4Mjg2_ed7de6ea-7643-47cd-994c-80e2a4fcdd28"
      unitRef="usd">469000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzEzLTMtMS0xLTQ4Mjg2_338c33e4-08c1-4bfa-9259-9d79253d8973"
      unitRef="usd">4466000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzEzLTUtMS0xLTQ4Mjg2_1bee2fb9-1723-4de4-8272-73ba4e57fc36"
      unitRef="usd">1351000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE0LTEtMS0xLTQ4Mjg2_3bfd87d6-5706-4f05-8bb1-53fb70f73bad"
      unitRef="usd">114005000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE0LTMtMS0xLTQ4Mjg2_1b5c71b5-98af-4fbe-a301-a77aa959b8ea"
      unitRef="usd">57769000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE0LTUtMS0xLTQ4Mjg2_b992c643-17e1-40dd-997c-b4b60fbb9c42"
      unitRef="usd">23514000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE1LTEtMS0xLTQ4Mjg2_0228cb6d-44f7-48dc-a817-97d128df7669"
      unitRef="usd">-40778000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE1LTMtMS0xLTQ4Mjg2_7b5dff80-1d93-46fd-b531-21b81dae1914"
      unitRef="usd">7559000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE1LTUtMS0xLTQ4Mjg2_009c0a36-65d3-4b51-9923-043d549cdf3c"
      unitRef="usd">-6223000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE2LTEtMS0xLTQ4Mjg2_d7eef550-8f30-4270-bede-5c19a5083b78"
      unitRef="usd">154783000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE2LTMtMS0xLTQ4Mjg2_29c56e15-c251-46b8-bf8e-b65d93b3f006"
      unitRef="usd">50210000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE2LTUtMS0xLTQ4Mjg2_956cd6a2-9587-43d9-a2bf-b493aba6bac3"
      unitRef="usd">29737000</us-gaap:NetIncomeLoss>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE3LTEtMS0xLTQ4Mjg2_10f48a89-c761-4381-9abc-dcb85e898922"
      unitRef="usd">21526000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE3LTEtMS0xLTQ4Mjg2_224d14cc-7a6a-4b4c-926c-fe6ad2e7b41f"
      unitRef="usd">21526000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE3LTMtMS0xLTQ4Mjg2_6e7a9abf-ab46-4fd0-950d-62a76b27e2b4"
      unitRef="usd">28654000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE3LTMtMS0xLTQ4Mjg2_7a1926a8-bab0-43a5-8f36-9fb774fdd97c"
      unitRef="usd">28654000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE3LTUtMS0xLTQ4Mjg2_52db5df5-79ed-4885-9f99-8a9f30006ac3"
      unitRef="usd">18908000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE3LTUtMS0xLTQ4Mjg2_9542465f-fbe0-4d0c-a491-32601fa8b388"
      unitRef="usd">18908000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE4LTEtMS0xLTQ4Mjg2_44f13d7b-4828-4724-b340-a14a5646d234"
      unitRef="usd">133257000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE4LTEtMS0xLTQ4Mjg2_bcdf6ff6-5829-4f04-bf6e-5f135379249e"
      unitRef="usd">133257000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE4LTMtMS0xLTQ4Mjg2_5bc43ea1-6d54-48a4-b8db-72d05b5c0ff8"
      unitRef="usd">21556000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE4LTMtMS0xLTQ4Mjg2_c8979cf3-788f-436c-a102-d54aa214be7a"
      unitRef="usd">21556000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE4LTUtMS0xLTQ4Mjg2_10b75117-d04e-441f-9d95-120b7f12e634"
      unitRef="usd">10829000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzE4LTUtMS0xLTQ4Mjg2_3f254eab-99b3-4502-977f-584d8b887b78"
      unitRef="usd">10829000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzIwLTEtMS0xLTQ4Mjg2_5597cb29-92b2-45a0-92b1-66731405a28d"
      unitRef="usdPerShare">0.82</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzIwLTMtMS0xLTQ4Mjg2_50c146fe-45b0-4aaa-8440-07c855147422"
      unitRef="usdPerShare">0.29</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzIwLTUtMS0xLTQ4Mjg2_9fe0bcb9-0696-48dd-a5a0-ff0bb4ca015c"
      unitRef="usdPerShare">0.16</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzIxLTEtMS0xLTQ4Mjg2_8ba40586-8a86-4906-bfaf-7e6a0a3f31a8"
      unitRef="usdPerShare">0.70</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzIxLTMtMS0xLTQ4Mjg2_b6baba44-dad2-48e7-a401-2801da8115bf"
      unitRef="usdPerShare">0.23</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzIxLTUtMS0xLTQ4Mjg2_ce6d1aa3-7d70-422c-8557-f99b01ad3100"
      unitRef="usdPerShare">0.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzIzLTEtMS0xLTQ4Mjg2_3a29832c-c9c5-4b0d-b3cb-1ebac6813e2d"
      unitRef="shares">163484000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzIzLTMtMS0xLTQ4Mjg2_70aaee8d-b4b1-4db2-824a-efc055b88cec"
      unitRef="shares">74342000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzIzLTUtMS0xLTQ4Mjg2_2ba89be2-4064-4624-92d5-59f8c07363a2"
      unitRef="shares">66758000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzI0LTEtMS0xLTQ4Mjg2_2358bdac-4f9b-4237-af70-ecb01a9f749d"
      unitRef="shares">191017000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzI0LTMtMS0xLTQ4Mjg2_1dcff520-28d6-422f-8ab0-e5cf63d00e87"
      unitRef="shares">95134000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzIvZnJhZzo2ZjNhZWQ2ZmNkOTI0MzYwOWY4YTVmNmMxZTJkYWI2NC90YWJsZTo2OWM5YmZjOTZlNjU0ODk1OGQwZjJhYzJmZDdiMDdmOS90YWJsZXJhbmdlOjY5YzliZmM5NmU2NTQ4OTU4ZDBmMmFjMmZkN2IwN2Y5XzI0LTUtMS0xLTQ4Mjg2_5f3b3888-90c5-4736-a335-e370e36bb62d"
      unitRef="shares">81710000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzUvZnJhZzo1MGU5NTkwMTNlNGU0N2Q5ODNjODlhYWQ5ZjVhMDllNC90YWJsZTpkNmI3M2M1NzE4NDE0Mjk3OTg2ZjVlNjFmZWU5OGQyOC90YWJsZXJhbmdlOmQ2YjczYzU3MTg0MTQyOTc5ODZmNWU2MWZlZTk4ZDI4XzItMS0xLTEtNDgzMzM_5806dc1c-cef6-4f53-a919-9c1023393f20"
      unitRef="usd">154783000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzUvZnJhZzo1MGU5NTkwMTNlNGU0N2Q5ODNjODlhYWQ5ZjVhMDllNC90YWJsZTpkNmI3M2M1NzE4NDE0Mjk3OTg2ZjVlNjFmZWU5OGQyOC90YWJsZXJhbmdlOmQ2YjczYzU3MTg0MTQyOTc5ODZmNWU2MWZlZTk4ZDI4XzItMy0xLTEtNDgzMzM_ea6e6a3e-86f7-4f00-b26e-5ebfda502a16"
      unitRef="usd">50210000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzUvZnJhZzo1MGU5NTkwMTNlNGU0N2Q5ODNjODlhYWQ5ZjVhMDllNC90YWJsZTpkNmI3M2M1NzE4NDE0Mjk3OTg2ZjVlNjFmZWU5OGQyOC90YWJsZXJhbmdlOmQ2YjczYzU3MTg0MTQyOTc5ODZmNWU2MWZlZTk4ZDI4XzItNS0xLTEtNDgzMzM_f8d26a16-6285-478d-a194-22287fdfafdc"
      unitRef="usd">29737000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzUvZnJhZzo1MGU5NTkwMTNlNGU0N2Q5ODNjODlhYWQ5ZjVhMDllNC90YWJsZTpkNmI3M2M1NzE4NDE0Mjk3OTg2ZjVlNjFmZWU5OGQyOC90YWJsZXJhbmdlOmQ2YjczYzU3MTg0MTQyOTc5ODZmNWU2MWZlZTk4ZDI4XzQtMC0xLTEtNDkyNzYvdGV4dHJlZ2lvbjowOWZiODEzMGZhNzc0M2ViYmQ1MWVkMjgyMGRjOGY2M18yOTEzNzA1ODEzNjI4Ng_b8341f6e-9610-4801-9176-598753e3ebe3"
      unitRef="usd">5199000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzUvZnJhZzo1MGU5NTkwMTNlNGU0N2Q5ODNjODlhYWQ5ZjVhMDllNC90YWJsZTpkNmI3M2M1NzE4NDE0Mjk3OTg2ZjVlNjFmZWU5OGQyOC90YWJsZXJhbmdlOmQ2YjczYzU3MTg0MTQyOTc5ODZmNWU2MWZlZTk4ZDI4XzQtMC0xLTEtNDkyNzYvdGV4dHJlZ2lvbjowOWZiODEzMGZhNzc0M2ViYmQ1MWVkMjgyMGRjOGY2M18yOTEzNzA1ODEzNjI5MQ_88939e1c-f170-42c1-9eb8-d31d16f2d862"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzUvZnJhZzo1MGU5NTkwMTNlNGU0N2Q5ODNjODlhYWQ5ZjVhMDllNC90YWJsZTpkNmI3M2M1NzE4NDE0Mjk3OTg2ZjVlNjFmZWU5OGQyOC90YWJsZXJhbmdlOmQ2YjczYzU3MTg0MTQyOTc5ODZmNWU2MWZlZTk4ZDI4XzQtMC0xLTEtNDkyNzYvdGV4dHJlZ2lvbjowOWZiODEzMGZhNzc0M2ViYmQ1MWVkMjgyMGRjOGY2M18yOTEzNzA1ODEzNjI5Ng_abea02f4-9655-41c5-880c-022d5102ea0f"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzUvZnJhZzo1MGU5NTkwMTNlNGU0N2Q5ODNjODlhYWQ5ZjVhMDllNC90YWJsZTpkNmI3M2M1NzE4NDE0Mjk3OTg2ZjVlNjFmZWU5OGQyOC90YWJsZXJhbmdlOmQ2YjczYzU3MTg0MTQyOTc5ODZmNWU2MWZlZTk4ZDI4XzQtMS0xLTEtNDgzMzM_6f0ebebc-5c34-4d25-926f-5cc7503feb06"
      unitRef="usd">-15273000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzUvZnJhZzo1MGU5NTkwMTNlNGU0N2Q5ODNjODlhYWQ5ZjVhMDllNC90YWJsZTpkNmI3M2M1NzE4NDE0Mjk3OTg2ZjVlNjFmZWU5OGQyOC90YWJsZXJhbmdlOmQ2YjczYzU3MTg0MTQyOTc5ODZmNWU2MWZlZTk4ZDI4XzQtMy0xLTEtNDgzMzM_991548c8-d502-4a9d-b56c-915d539bcdb8"
      unitRef="usd">-21000</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzUvZnJhZzo1MGU5NTkwMTNlNGU0N2Q5ODNjODlhYWQ5ZjVhMDllNC90YWJsZTpkNmI3M2M1NzE4NDE0Mjk3OTg2ZjVlNjFmZWU5OGQyOC90YWJsZXJhbmdlOmQ2YjczYzU3MTg0MTQyOTc5ODZmNWU2MWZlZTk4ZDI4XzQtNS0xLTEtNDgzMzM_e3234d14-a922-4842-a7ed-1681510c7ca2"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzUvZnJhZzo1MGU5NTkwMTNlNGU0N2Q5ODNjODlhYWQ5ZjVhMDllNC90YWJsZTpkNmI3M2M1NzE4NDE0Mjk3OTg2ZjVlNjFmZWU5OGQyOC90YWJsZXJhbmdlOmQ2YjczYzU3MTg0MTQyOTc5ODZmNWU2MWZlZTk4ZDI4XzUtMS0xLTEtNDgzMzM_2b87aaa9-b57b-44dd-8077-5df285d3d855"
      unitRef="usd">-15273000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzUvZnJhZzo1MGU5NTkwMTNlNGU0N2Q5ODNjODlhYWQ5ZjVhMDllNC90YWJsZTpkNmI3M2M1NzE4NDE0Mjk3OTg2ZjVlNjFmZWU5OGQyOC90YWJsZXJhbmdlOmQ2YjczYzU3MTg0MTQyOTc5ODZmNWU2MWZlZTk4ZDI4XzUtMy0xLTEtNDgzMzM_35e9ff67-9a21-40de-bf50-a1b184bf8dca"
      unitRef="usd">-21000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzUvZnJhZzo1MGU5NTkwMTNlNGU0N2Q5ODNjODlhYWQ5ZjVhMDllNC90YWJsZTpkNmI3M2M1NzE4NDE0Mjk3OTg2ZjVlNjFmZWU5OGQyOC90YWJsZXJhbmdlOmQ2YjczYzU3MTg0MTQyOTc5ODZmNWU2MWZlZTk4ZDI4XzUtNS0xLTEtNDgzMzM_1b059926-7a84-42fe-b966-c27c333e60a1"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzUvZnJhZzo1MGU5NTkwMTNlNGU0N2Q5ODNjODlhYWQ5ZjVhMDllNC90YWJsZTpkNmI3M2M1NzE4NDE0Mjk3OTg2ZjVlNjFmZWU5OGQyOC90YWJsZXJhbmdlOmQ2YjczYzU3MTg0MTQyOTc5ODZmNWU2MWZlZTk4ZDI4XzYtMS0xLTEtNDgzMzM_5f30165c-ebea-457c-a95e-3400f77e9b09"
      unitRef="usd">139510000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzUvZnJhZzo1MGU5NTkwMTNlNGU0N2Q5ODNjODlhYWQ5ZjVhMDllNC90YWJsZTpkNmI3M2M1NzE4NDE0Mjk3OTg2ZjVlNjFmZWU5OGQyOC90YWJsZXJhbmdlOmQ2YjczYzU3MTg0MTQyOTc5ODZmNWU2MWZlZTk4ZDI4XzYtMy0xLTEtNDgzMzM_4c043c6b-c18f-4ff2-8ca0-b4f99c7c0a85"
      unitRef="usd">50189000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzUvZnJhZzo1MGU5NTkwMTNlNGU0N2Q5ODNjODlhYWQ5ZjVhMDllNC90YWJsZTpkNmI3M2M1NzE4NDE0Mjk3OTg2ZjVlNjFmZWU5OGQyOC90YWJsZXJhbmdlOmQ2YjczYzU3MTg0MTQyOTc5ODZmNWU2MWZlZTk4ZDI4XzYtNS0xLTEtNDgzMzM_32a5bfe6-b065-431e-af0b-b012bdba3a2e"
      unitRef="usd">29737000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i27e150c7cdf34baa99d770cedfcc88a0_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzItMS0xLTEtNDg3NzU_a9758eff-16d8-4eb1-919f-9a0e5f4fe11f"
      unitRef="shares">76249000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i27e150c7cdf34baa99d770cedfcc88a0_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzItMy0xLTEtNDg3NzU_996ef013-d17a-476b-9d55-4431ef16629b"
      unitRef="usd">81433000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="i1d3a91d95f5840f4be4445b0e6c7ad9f_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzItNi0xLTEtNDg3NzU_26c078c1-3bbc-4583-9f8c-2c700b81a394"
      unitRef="shares">65526000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i1d3a91d95f5840f4be4445b0e6c7ad9f_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzItOC0xLTEtNDg3NzU_2475dc2b-69bc-4290-adf7-3e185f271780"
      unitRef="usd">65000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id85d3aef9cef4f97829dac4fc1a6b84f_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzItMTAtMS0xLTQ4Nzc1_4de5537c-5064-4fdb-a239-f7ded02b04f2"
      unitRef="usd">10623000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifb57040c2a0e4f15b5f7abbbebc4adf5_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzItMTItMS0xLTQ4Nzc1_71fca18e-38ed-4c84-a59f-3da3b2a92c84"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ic86efb5739b64e849f20b652dd30ebcd_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzItMTQtMS0xLTQ4Nzc1_c2b16bb1-6a00-4120-929e-0a272ec43ad2"
      unitRef="usd">-43623000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i27e150c7cdf34baa99d770cedfcc88a0_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzItMTYtMS0xLTQ4Nzc1_8737cf2a-900e-426a-82d5-d7b0724eda10"
      unitRef="usd">-32935000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i30af202026344ba188b8654a2c38183c_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzMtMTAtMS0xLTQ4Nzc1_c8222f8b-b6b6-4c08-a54a-a51d27fb7eda"
      unitRef="usd">2537000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzMtMTYtMS0xLTQ4Nzc1_88577753-4eb4-42c8-a6f6-2a5da86f4e18"
      unitRef="usd">2537000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ibc604bd726fc487cb11cf5132d59f830_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzQtNi0xLTEtNDg3NzU_d1d41fde-09d1-439d-84ed-b73981f5f477"
      unitRef="shares">3040000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ibc604bd726fc487cb11cf5132d59f830_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzQtOC0xLTEtNDg3NzU_7662380f-d4ee-4d4a-b4f6-289a1bcb01d1"
      unitRef="usd">3000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i30af202026344ba188b8654a2c38183c_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzQtMTAtMS0xLTQ4Nzc1_3494cc77-db1b-4a2f-8910-92bf31c0b587"
      unitRef="usd">1691000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzQtMTYtMS0xLTQ4Nzc1_8a2e3d16-0789-42e3-9100-fd317fc20e95"
      unitRef="usd">1694000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <docs:APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition
      contextRef="i30af202026344ba188b8654a2c38183c_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzYtMTAtMS0xLTQ4Nzc1_3523638a-996f-4ae2-b4bb-41d747b62819"
      unitRef="usd">57000</docs:APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition>
    <docs:APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzYtMTYtMS0xLTQ4Nzc1_acbf062f-d2d2-4dfc-8436-2160e0da4e45"
      unitRef="usd">57000</docs:APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition>
    <docs:TemporaryEquityExercisesOfWarrantsShares
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzktMS0xLTEtODgyMDQ_95452703-0466-4d95-95eb-23ac171a86c0"
      unitRef="shares">38000</docs:TemporaryEquityExercisesOfWarrantsShares>
    <docs:TemporaryEquityExercisesOfWarrantsAmount
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzktMy0xLTEtODgyMDQ_fb5884f9-a33a-4055-be6f-acf6e81cd6f4"
      unitRef="usd">25000</docs:TemporaryEquityExercisesOfWarrantsAmount>
    <docs:AdjustmentsToAdditionalPaidInCapitalExerciseOfWarrants
      contextRef="i30af202026344ba188b8654a2c38183c_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzktMTAtMS0xLTg4MjA0_517c5703-589f-4b39-ae6a-7332ad398e3f"
      unitRef="usd">46000</docs:AdjustmentsToAdditionalPaidInCapitalExerciseOfWarrants>
    <docs:AdjustmentsToAdditionalPaidInCapitalExerciseOfWarrants
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzktMTYtMS0xLTg4MjA0_4921521b-b6db-44a5-b92f-29cb3d3f82fd"
      unitRef="usd">46000</docs:AdjustmentsToAdditionalPaidInCapitalExerciseOfWarrants>
    <us-gaap:NetIncomeLoss
      contextRef="ibf878bf045d24512bd9e3292775e7161_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzgtMTQtMS0xLTQ4Nzc1_eb2592d2-ba0f-45b0-aa9a-100c4508373b"
      unitRef="usd">29737000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzgtMTYtMS0xLTQ4Nzc1_f0ce5488-6dc6-4aad-bc3f-07f99b07190f"
      unitRef="usd">29737000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i7a15f5b31d42419aa50ffb53e76f3705_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzktMS0xLTEtNDg3NzU_6e1ba95d-851a-4280-b01b-a4ea93c1a824"
      unitRef="shares">76287000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i7a15f5b31d42419aa50ffb53e76f3705_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzktMy0xLTEtNDg3NzU_7e8f830f-a75c-40a2-8401-ba6c75a8e3ac"
      unitRef="usd">81458000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="i414b68a2b4f24b3baf2fb76d57cbbea0_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzktNi0xLTEtNDg3NzU_6a7daadc-ed53-4d79-a442-3d9be3e5dad5"
      unitRef="shares">68566000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i414b68a2b4f24b3baf2fb76d57cbbea0_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzktOC0xLTEtNDg3NzU_97876703-b240-4855-a63c-aad0f4bd1547"
      unitRef="usd">68000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i061b791ef37044a8a87103ab1684fc04_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzktMTAtMS0xLTQ4Nzc1_e98d37cc-2d16-44f5-85c9-badafdc27ed9"
      unitRef="usd">14954000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibcefd2d03bd84fb9ae242a16f4ac44ee_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzktMTItMS0xLTQ4Nzc1_9386b74a-61b0-4be0-8c02-dee1d6047ac5"
      unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="idb3c1cc4265d4d458fbb645f03094085_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzktMTQtMS0xLTQ4Nzc1_6b07cde9-1034-48fd-92fc-14e890d9530e"
      unitRef="usd">-13886000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7a15f5b31d42419aa50ffb53e76f3705_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzktMTYtMS0xLTQ4Nzc1_1b004bf8-347d-42b9-8ee2-27bf7d070af0"
      unitRef="usd">1136000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i03b18f19eda34333b76bc6814b9d6346_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzEwLTEwLTEtMS00ODc3NQ_e34035cb-6e9c-4611-b179-eeda590adcee"
      unitRef="usd">7398000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzEwLTE2LTEtMS00ODc3NQ_d232af38-d149-44cf-a8c0-e7bfda0742c9"
      unitRef="usd">7398000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ibd16228ea691414ea7027a3ca0ceb2b0_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzExLTYtMS0xLTQ4Nzc1_dfc3848d-c6cc-4b57-8a1e-c85d4122c3e9"
      unitRef="shares">13890000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ibd16228ea691414ea7027a3ca0ceb2b0_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzExLTgtMS0xLTQ4Nzc1_6ce0ac4c-12f7-4607-ba70-3757d237e6cd"
      unitRef="usd">14000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i03b18f19eda34333b76bc6814b9d6346_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzExLTEwLTEtMS00ODc3NQ_dc9fb32a-f319-4390-943d-6ef5e0ee8acf"
      unitRef="usd">8883000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzExLTE2LTEtMS00ODc3NQ_f9f7f0ca-95b1-43a2-9a39-b332cbd0b984"
      unitRef="usd">8897000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="ibd16228ea691414ea7027a3ca0ceb2b0_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzEyLTYtMS0xLTQ4Nzc1_7692e7f9-b1a9-48e2-8095-44790e2eab42"
      unitRef="shares">22000</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="i03b18f19eda34333b76bc6814b9d6346_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzEyLTEwLTEtMS00ODc3NQ_2a279a94-11fc-4255-97e3-a34e31000276"
      unitRef="usd">34000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockIssuedDuringPeriodValueIssuedForServices
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzEyLTE2LTEtMS00ODc3NQ_9c741c3e-ff91-443f-b040-3371e41a87eb"
      unitRef="usd">34000</us-gaap:StockIssuedDuringPeriodValueIssuedForServices>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="ibd16228ea691414ea7027a3ca0ceb2b0_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzEzLTYtMS0xLTQ4Nzc1_61525ee3-4bd4-4693-b696-8749237d34cd"
      unitRef="shares">258000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i03b18f19eda34333b76bc6814b9d6346_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzEzLTEwLTEtMS00ODc3NQ_e5a8b7d6-dc91-41dd-8b09-67c0b49e2264"
      unitRef="usd">2022000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzEzLTE2LTEtMS00ODc3NQ_31da205d-89a0-432e-a0f9-7785c7bfa666"
      unitRef="usd">2022000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <docs:APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition
      contextRef="i03b18f19eda34333b76bc6814b9d6346_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzE2LTEwLTEtMS04ODI2OA_2466005f-566d-4c72-8be5-6aa549e61fc3"
      unitRef="usd">49000</docs:APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition>
    <docs:APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzE2LTE2LTEtMS04ODI2OA_df6bcfcc-f479-4494-b8f7-ba9c1b1d1e68"
      unitRef="usd">49000</docs:APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ifc4d8e5790824c048cce3a6bf007c91d_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzE3LTEyLTEtMS04ODI2OA_ffc3ea6c-da79-4afa-bfd1-49f83c2ae399"
      unitRef="usd">-21000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzE3LTE2LTEtMS04ODI2OA_7c3ea7b6-8d1e-4617-8013-2d2884295cc3"
      unitRef="usd">-21000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:StockIssuedDuringPeriodSharesAcquisitions
      contextRef="ibd16228ea691414ea7027a3ca0ceb2b0_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzE4LTYtMS0xLTg4MjY4_cd01c7e8-cb1f-436c-b5d3-573df6cf129e"
      unitRef="shares">690000</us-gaap:StockIssuedDuringPeriodSharesAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="ibd16228ea691414ea7027a3ca0ceb2b0_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzE4LTgtMS0xLTg4MjY4_615f1dec-18d5-4cc8-857e-6b7dbb5436c5"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i03b18f19eda34333b76bc6814b9d6346_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzE4LTEwLTEtMS04ODI2OA_73919cb5-c616-410e-b355-bb7ac2e6a214"
      unitRef="usd">1061000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:StockIssuedDuringPeriodValueAcquisitions
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzE4LTE2LTEtMS04ODI2OA_cfb66182-5231-42e2-a63a-962152c31136"
      unitRef="usd">1062000</us-gaap:StockIssuedDuringPeriodValueAcquisitions>
    <us-gaap:NetIncomeLoss
      contextRef="i489aff50eced4b4e8409601ad948730d_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzE0LTE0LTEtMS00ODc3NQ_3e25cff4-0df7-41c5-945b-141d7a3ef6b1"
      unitRef="usd">50210000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzE0LTE2LTEtMS00ODc3NQ_1d95e4a0-bec1-43f6-a4df-a7b6bd599716"
      unitRef="usd">50210000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzE1LTEtMS0xLTQ4Nzc1_26f781d9-1ff0-49fe-a344-7087f54f3697"
      unitRef="shares">76287000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzE1LTMtMS0xLTQ4Nzc1_fcb931ca-a9cc-4936-a77c-fc3a46b2b469"
      unitRef="usd">81458000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="ic1553167afc64f24beca75d407d45583_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzE1LTYtMS0xLTQ4Nzc1_aa2339ec-4db9-4706-a46e-05c4ba90b6bf"
      unitRef="shares">82910000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ic1553167afc64f24beca75d407d45583_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzE1LTgtMS0xLTQ4Nzc1_6f4c7b3d-4b16-4a05-8563-f23ea5f5ad41"
      unitRef="usd">83000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i07067e700dd84b60a562fa298de61bc9_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzE1LTEwLTEtMS00ODc3NQ_72f2a18f-59d8-4810-9d4e-5fe1ff402347"
      unitRef="usd">30357000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4f5b7e290962451dbcf06e35be299e6a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzE1LTEyLTEtMS00ODc3NQ_6e21ac6c-a348-4c1b-9366-42fd4aeedb4b"
      unitRef="usd">-21000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iebb484f77246492db54ce7ef015c7dad_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzE1LTE0LTEtMS00ODc3NQ_c99bf096-a040-490b-b867-6fe0d3af3bb2"
      unitRef="usd">36324000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZTpjNTQ1YzcyMzg5NTc0N2Y4ODE3ZmZhMTkzNzlhNWQ5NS90YWJsZXJhbmdlOmM1NDVjNzIzODk1NzQ3Zjg4MTdmZmExOTM3OWE1ZDk1XzE1LTE2LTEtMS00ODc3NQ_c21c0599-78be-4dc4-a5e9-9f8fcd106c3c"
      unitRef="usd">66743000</us-gaap:StockholdersEquity>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzAtMS0xLTEtOTc5MzY_26f781d9-1ff0-49fe-a344-7087f54f3697"
      unitRef="shares">76287000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzAtMy0xLTEtOTc5MzY_fcb931ca-a9cc-4936-a77c-fc3a46b2b469"
      unitRef="usd">81458000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="ic1553167afc64f24beca75d407d45583_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzAtNi0xLTEtOTc5MzY_aa2339ec-4db9-4706-a46e-05c4ba90b6bf"
      unitRef="shares">82910000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ic1553167afc64f24beca75d407d45583_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzAtOC0xLTEtOTc5MzY_6f4c7b3d-4b16-4a05-8563-f23ea5f5ad41"
      unitRef="usd">83000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i07067e700dd84b60a562fa298de61bc9_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzAtMTAtMS0xLTk3OTM2_72f2a18f-59d8-4810-9d4e-5fe1ff402347"
      unitRef="usd">30357000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4f5b7e290962451dbcf06e35be299e6a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzAtMTItMS0xLTk3OTM2_6e21ac6c-a348-4c1b-9366-42fd4aeedb4b"
      unitRef="usd">-21000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iebb484f77246492db54ce7ef015c7dad_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzAtMTQtMS0xLTk3OTM2_c99bf096-a040-490b-b867-6fe0d3af3bb2"
      unitRef="usd">36324000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzAtMTYtMS0xLTk3OTM2_c21c0599-78be-4dc4-a5e9-9f8fcd106c3c"
      unitRef="usd">66743000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i39670721aeba48af82262e3df7572d7b_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzAtMTAtMS0xLTk3OTA2_8cee6d1c-7235-4617-9b94-97cc609d540b"
      unitRef="usd">29341000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzAtMTYtMS0xLTk3OTA2_8b29bc19-dbcd-49ee-82ca-7fc50dcbe6b3"
      unitRef="usd">29341000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i200ee5197c714141a7a48e99357f4b5e_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzEtNi0xLTEtOTc5MDY_9a5f1f4e-9f66-45fe-ba72-862fcaafe811"
      unitRef="shares">10823000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i200ee5197c714141a7a48e99357f4b5e_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzEtOC0xLTEtOTc5MDY_56215e71-7db6-4c0e-b381-2ca46893c9b2"
      unitRef="usd">11000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i39670721aeba48af82262e3df7572d7b_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzEtMTAtMS0xLTk3OTA2_ccc80d54-1409-40fc-a0ff-33ab1f60ffd8"
      unitRef="usd">12601000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzEtMTYtMS0xLTk3OTA2_c6951aba-71f7-4cb7-9a56-aef2444807d7"
      unitRef="usd">12612000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i200ee5197c714141a7a48e99357f4b5e_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzUtNi0xLTEtOTgwNzg_e1a95fba-1a5d-45e2-9e99-901525f9aaef"
      unitRef="shares">24000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i39670721aeba48af82262e3df7572d7b_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzYtMTAtMS0xLTk4MDc4_6487503b-e3b0-48df-9c0b-b9d773ca747f"
      unitRef="usd">817000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzYtMTYtMS0xLTk4MDc4_c4b1c476-826a-4183-b2cc-d693664d7768"
      unitRef="usd">817000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodShares
      contextRef="i200ee5197c714141a7a48e99357f4b5e_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzQtNi0xLTEtOTc5MDY_ad9b62f2-48b5-483c-993b-bf4f29cfb39a"
      unitRef="shares">181000</us-gaap:StockRepurchasedAndRetiredDuringPeriodShares>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i39670721aeba48af82262e3df7572d7b_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzQtMTAtMS0xLTk3OTA2_69f5f364-b536-4653-8e97-c88b8738126c"
      unitRef="usd">2698000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzQtMTYtMS0xLTk3OTA2_486c1463-9798-4108-9137-717ad021622d"
      unitRef="usd">2698000</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <docs:APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition
      contextRef="i39670721aeba48af82262e3df7572d7b_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzUtMTAtMS0xLTk3OTA2_f3142c48-4731-4dc1-ad7f-48a3912d910f"
      unitRef="usd">2598000</docs:APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition>
    <docs:APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzUtMTYtMS0xLTk3OTA2_ddb14139-fdaf-41cf-acaf-b8bca99036d8"
      unitRef="usd">2598000</docs:APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ia0bfa42b46ea49d485aa30692392a354_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzYtMTItMS0xLTk3OTA2_721467db-07f4-413e-8c16-60b604b70670"
      unitRef="usd">-15273000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzYtMTYtMS0xLTk3OTA2_fa901e1c-f21c-41c0-a248-b62924ada149"
      unitRef="usd">-15273000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <docs:TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzctMS0xLTEtOTc5MDY_25e73c6d-f9f8-4a51-b0fb-32610a1f681d"
      unitRef="shares">76287000</docs:TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <docs:TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzctMy0xLTEtOTc5MDY_b45db22e-9316-483d-a9d5-f66a08cdf3cc"
      unitRef="usd">-81458000</docs:TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="i200ee5197c714141a7a48e99357f4b5e_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzctNi0xLTEtOTc5MDY_b987e271-c7db-4247-aea8-66b64acd9e2b"
      unitRef="shares">76287000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i200ee5197c714141a7a48e99357f4b5e_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzctOC0xLTEtOTc5MDY_f5aba060-36e1-4f0f-b518-9fa6eaa79b77"
      unitRef="usd">76000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i39670721aeba48af82262e3df7572d7b_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzctMTAtMS0xLTk3OTA2_e95106ea-d69d-4371-8d36-a378a063ed88"
      unitRef="usd">81382000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzctMTYtMS0xLTk3OTA2_6dda6f36-7200-4078-8031-c16abdf16eaf"
      unitRef="usd">81458000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i200ee5197c714141a7a48e99357f4b5e_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzgtNi0xLTEtOTc5MDY_79673fea-9506-433d-b56d-d5febcfde4c5"
      unitRef="shares">22506000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i200ee5197c714141a7a48e99357f4b5e_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzgtOC0xLTEtOTc5MDY_b720f398-6f49-4c36-bc3a-1c7f0c3845ca"
      unitRef="usd">22000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i39670721aeba48af82262e3df7572d7b_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzgtMTAtMS0xLTk3OTA2_f231fae7-9dc2-492b-ae71-9adc9b3925ae"
      unitRef="usd">548430000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzgtMTYtMS0xLTk3OTA2_36cb60c6-540d-41aa-bd2d-8f8cd78a3492"
      unitRef="usd">548452000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i200ee5197c714141a7a48e99357f4b5e_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzEyLTYtMS0xLTEwMTMyOA_a15662b1-61b8-4a68-bd40-de0c3fbae7bc"
      unitRef="shares">29000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i39670721aeba48af82262e3df7572d7b_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzEyLTEwLTEtMS0xMDEzMjg_6afc00c9-7932-4558-a4c9-b7af4d606e0c"
      unitRef="usd">1395000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzEyLTE2LTEtMS0xMDEzMjg_d85ab406-5242-4a07-993b-7e1deede1b7a"
      unitRef="usd">1395000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:NetIncomeLoss
      contextRef="icd3cf31e65de4bbca6609f7743bb7da5_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzktMTQtMS0xLTk3OTA2_1796e283-91b2-42fa-91aa-1b17e2612fb4"
      unitRef="usd">154783000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzktMTYtMS0xLTk3OTA2_3bbe3029-f4ff-44ff-b0bf-72f6151e67f7"
      unitRef="usd">154783000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzEwLTEtMS0xLTk3OTA2_d38fe96b-ce0b-4a2a-906f-74844eb31597"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzEwLTMtMS0xLTk3OTA2_88c5356c-c08e-46cc-8d6b-f727b327b973"
      unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:SharesOutstanding
      contextRef="i708549cf187748d19458fd6a1acc45a2_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzEwLTYtMS0xLTk3OTA2_f3593615-c36d-4966-958b-331426c46ecb"
      unitRef="shares">192398000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i708549cf187748d19458fd6a1acc45a2_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzEwLTgtMS0xLTk3OTA2_70b09ec3-02d5-4215-839a-c49d34cdee0d"
      unitRef="usd">192000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i07f4d237a7d949c6a32f7dc1d04bf88e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzEwLTEwLTEtMS05NzkwNg_d04b31e6-8d3b-4dde-85f0-0391636d3440"
      unitRef="usd">702589000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i00ffd06e9957435f8a032e13e5872afd_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzEwLTEyLTEtMS05NzkwNg_078ee5b2-10d5-46cf-b596-dad0cad2166e"
      unitRef="usd">-15294000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id9e2edf8663840efbaeced0815c8461f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzEwLTE0LTEtMS05NzkwNg_0916142d-b139-44db-a726-83159aaeb5b7"
      unitRef="usd">191107000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xNzgvZnJhZzo0MzJmNjRjMjJmZDE0ODkwOGM0MDg1YTFlM2RjYTdmMi90YWJsZToyNjA1YjNlZmEzYzk0NmJhYmVhZjgzZmM0ODY2YjIzZS90YWJsZXJhbmdlOjI2MDViM2VmYTNjOTQ2YmFiZWFmODNmYzQ4NjZiMjNlXzEwLTE2LTEtMS05NzkwNg_cfb88b5f-e4c2-419a-adff-54a4caa0c8eb"
      unitRef="usd">878594000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzMtOS0xLTEtNDg4NDc_658009bb-7424-481b-a2a0-13669c6d1888"
      unitRef="usd">154783000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzMtMTMtMS0xLTQ4ODU0_dff753f2-0114-447d-ab06-9c606bea9fad"
      unitRef="usd">50210000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzMtMTUtMS0xLTQ4ODYx_695b77f3-481a-4a21-bcf7-893c3622c8ac"
      unitRef="usd">29737000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzUtOS0xLTEtNDg4NDc_cf2c6fd7-4374-4c95-b499-4a71002602b7"
      unitRef="usd">5040000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzUtMTMtMS0xLTQ4ODU0_3f69c350-681a-4556-bfe3-1f7b093ed2f5"
      unitRef="usd">3702000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzUtMTUtMS0xLTQ4ODYx_4e652404-d96c-4b92-8f01-a09144c6bcce"
      unitRef="usd">900000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzYtOS0xLTEtNDg4NDc_7345076e-35f0-40b0-a4ee-f9fbf79323bf"
      unitRef="usd">-41247000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzYtMTMtMS0xLTQ4ODU0_146b058a-62b8-4f95-bfb2-a5d3d6396426"
      unitRef="usd">4987000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzYtMTUtMS0xLTQ4ODYx_2068cbbe-438a-4cf5-939e-85095330f9d5"
      unitRef="usd">-7099000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:ShareBasedCompensation
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzctOS0xLTEtNDg4NDc_e540e839-956f-493c-ae2b-063068df5fc0"
      unitRef="usd">31442000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzctMTMtMS0xLTQ4ODU0_82643bb9-d665-40bb-a27c-e7101ddcb30b"
      unitRef="usd">7252000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzctMTUtMS0xLTQ4ODYx_7b676013-2254-43b8-9aac-c8917f14826d"
      unitRef="usd">2353000</us-gaap:ShareBasedCompensation>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzktOS0xLTEtNDg4NDc_6d00ce50-850e-4f35-b68e-8585b217d0a7"
      unitRef="usd">1159000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzktMTMtMS0xLTQ4ODU0_09bd38e7-45e8-4c87-acbe-2802d5fd192c"
      unitRef="usd">2433000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzktMTUtMS0xLTQ4ODYx_31f567b9-4ee8-483a-ad51-f6d3482a1ef5"
      unitRef="usd">2000000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzExLTktMS0xLTQ4ODQ3_f861445e-3296-4d34-8bb3-175cd29c149f"
      unitRef="usd">-4332000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzExLTEzLTEtMS00ODg1NA_d24b4c57-185a-456a-a67e-4e4538f71f3f"
      unitRef="usd">-197000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzExLTE1LTEtMS00ODg2MQ_52288e6b-30e3-4d84-9847-4d30909ab336"
      unitRef="usd">441000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzExLTEtMS0xLTExNzA4OQ_914f2b60-d099-4baf-8fe0-c9c9686a5c48"
      unitRef="usd">-1231000</us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzExLTMtMS0xLTExNzA4OQ_8e18b169-0153-4c7c-8f44-c1183ba1fbd5"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzExLTUtMS0xLTExNzA4OQ_e0744f52-2424-48dc-bffa-d3c04a05b7e2"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleRealizedGainLoss>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzE0LTktMS0xLTQ4ODQ3_e2d81584-ea43-40d6-a544-330d7a8e435c"
      unitRef="usd">9755000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzE0LTEzLTEtMS00ODg1NA_b8016bbc-977a-498a-bf16-df82a1004db3"
      unitRef="usd">6883000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzE0LTE1LTEtMS00ODg2MQ_e0c0e279-a556-46b2-99e6-84bba300f19f"
      unitRef="usd">5070000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzE0LTEtMS0xLTExNzIzMQ_38a89b4d-a467-4f79-9a33-bc6e7414457e"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzE0LTMtMS0xLTExNzIzMQ_e91f8c06-687b-44ae-8289-48d72c0860e4"
      unitRef="usd">4698000</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:GainLossOnSaleOfBusiness
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzE0LTUtMS0xLTExNzIzMQ_c85aafdd-8147-4b48-b558-66b67ab07fc2"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfBusiness>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzE1LTEtMS0xLTk4MTI1_fa5fa3de-3d4a-4f25-83a0-9d5cf4a3e8ad"
      unitRef="usd">-410000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzE1LTMtMS0xLTk4MTI1_b1cc3baf-2161-4308-b7e2-abd36c47f434"
      unitRef="usd">-403000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzE1LTUtMS0xLTk4MTI1_4b892ce0-d15c-4ece-b649-45d513181b21"
      unitRef="usd">52000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzE2LTktMS0xLTQ4ODQ3_86a84beb-52ee-4dc5-88fe-54f1799040e4"
      unitRef="usd">31017000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzE2LTEzLTEtMS00ODg1NA_a064db5f-10bd-4730-b38d-da8fcd7d7a69"
      unitRef="usd">20452000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzE2LTE1LTEtMS00ODg2MQ_dd90d47d-9c54-45a9-8dbc-641a51d3d5f2"
      unitRef="usd">12036000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzE3LTktMS0xLTQ4ODQ3_eaae7092-f665-4b32-8f63-3f695a314225"
      unitRef="usd">9089000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzE3LTEzLTEtMS00ODg1NA_d56dd921-224f-42fe-ba18-21f1b8040262"
      unitRef="usd">1833000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzE3LTE1LTEtMS00ODg2MQ_ffcde728-d5b2-4b8c-87a1-9163b9c2a1f7"
      unitRef="usd">3040000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <docs:IncreaseDecreaseInCapitalizedContractCost
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzE5LTktMS0xLTQ4ODQ3_db8937b5-cea5-4a69-b9f3-612daf6f572e"
      unitRef="usd">9609000</docs:IncreaseDecreaseInCapitalizedContractCost>
    <docs:IncreaseDecreaseInCapitalizedContractCost
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzE5LTEzLTEtMS00ODg1NA_fe938286-3a19-48a9-a800-5a685622573f"
      unitRef="usd">9384000</docs:IncreaseDecreaseInCapitalizedContractCost>
    <docs:IncreaseDecreaseInCapitalizedContractCost
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzE5LTE1LTEtMS00ODg2MQ_fa4c1687-0ebe-4cd6-b217-cb58896f9cf2"
      unitRef="usd">5674000</docs:IncreaseDecreaseInCapitalizedContractCost>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzIxLTktMS0xLTQ4ODQ3_78b14593-0c8d-4e59-ac6f-d1829d9ccdf0"
      unitRef="usd">8664000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzIxLTEzLTEtMS00ODg1NA_ad0a5b8e-3f1c-42c3-8f8b-d66bd2341d2f"
      unitRef="usd">7285000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzIxLTE1LTEtMS00ODg2MQ_396485a2-5630-4a16-b198-664b4654337d"
      unitRef="usd">5056000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzIyLTktMS0xLTQ4ODQ3_a74148a0-0e53-4126-8453-c07b768bc650"
      unitRef="usd">1828000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzIyLTEzLTEtMS00ODg1NA_99605252-9351-4a45-a06a-94b0c8ba95f5"
      unitRef="usd">38571000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzIyLTE1LTEtMS00ODg2MQ_1541168a-1e35-411e-a98a-39bcf1bdfa25"
      unitRef="usd">13318000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzIzLTktMS0xLTQ4ODQ3_b5ee5c78-46ec-406e-8aa7-e21da8c481eb"
      unitRef="usd">-1107000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzIzLTEzLTEtMS00ODg1NA_9162142a-7812-4289-99f2-6bd1260f3255"
      unitRef="usd">-2583000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzIzLTE1LTEtMS00ODg2MQ_66ab4522-b709-4e46-9ab6-0d9681f0a412"
      unitRef="usd">-3893000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzI1LTktMS0xLTQ4ODQ3_616601a9-d14b-484b-8e50-3600bc284efb"
      unitRef="usd">126575000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzI1LTEzLTEtMS00ODg1NA_b789b658-6eeb-458f-9270-5791dcc3e70a"
      unitRef="usd">82973000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzI1LTE1LTEtMS00ODg2MQ_8aab8ff2-3420-453c-a4d3-837457bc3373"
      unitRef="usd">26199000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzI3LTktMS0xLTQ4ODQ3_4c73d306-fd2b-47c8-88a5-aa13e0a1c765"
      unitRef="usd">1912000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzI3LTEzLTEtMS00ODg1NA_f5b6e5e4-871a-4740-8cc4-afc2c463bed7"
      unitRef="usd">245000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzI3LTE1LTEtMS00ODg2MQ_2dcbcdde-54a1-4633-afa4-ce4420225bd8"
      unitRef="usd">285000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToDevelopSoftware
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzI4LTktMS0xLTQ4ODQ3_df0a9982-d5bb-4f24-8cd9-4413f992b3a9"
      unitRef="usd">3785000</us-gaap:PaymentsToDevelopSoftware>
    <us-gaap:PaymentsToDevelopSoftware
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzI4LTEzLTEtMS00ODg1NA_20bdcb17-e1b7-4a38-b402-dda2a2b30f70"
      unitRef="usd">4365000</us-gaap:PaymentsToDevelopSoftware>
    <us-gaap:PaymentsToDevelopSoftware
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzI4LTE1LTEtMS00ODg2MQ_4b87357b-627d-4b6b-911f-71c5647bc713"
      unitRef="usd">3959000</us-gaap:PaymentsToDevelopSoftware>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzI5LTktMS0xLTQ4ODQ3_23227689-c7a2-4776-bae5-c4d0043cbcda"
      unitRef="usd">1317193000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzI5LTEzLTEtMS00ODg1NA_ea4250af-d0ce-4cb7-8a60-3371fb6558cd"
      unitRef="usd">78880000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzI5LTE1LTEtMS00ODg2MQ_68eef138-983e-404b-8ef3-092e611e8bc3"
      unitRef="usd">79107000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzMwLTktMS0xLTQ4ODQ3_7a2c34e2-46fd-493a-a092-2cf9b34b1980"
      unitRef="usd">47919000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzMwLTEzLTEtMS00ODg1NA_0eeb0d2a-aa4b-47f2-a6f0-31a538f7a1d0"
      unitRef="usd">40537000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzMwLTE1LTEtMS00ODg2MQ_8f07ecfd-408c-4f93-9dff-c2d0c1b269bf"
      unitRef="usd">70256000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzMwLTktMS0xLTg4NjMz_47114145-0ddc-4d62-9f75-8e9c7b8b505a"
      unitRef="usd">633802000</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzMwLTEzLTEtMS04ODY0Mw_94523a88-2c13-4b88-92c8-975ec2820489"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzMwLTE1LTEtMS04ODY1Mw_60d942ca-aa05-47b1-b9a1-39f8af6899e4"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzMxLTktMS0xLTQ4ODQ3_01883374-8b15-4c1e-bbd4-50ca595505eb"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzMxLTEzLTEtMS00ODg1NA_88b2d431-33db-4682-aa03-e1b8b3f59596"
      unitRef="usd">31682000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzMxLTE1LTEtMS00ODg2MQ_dda8865d-8bc9-45cb-8d58-44f2bb29b831"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzMyLTktMS0xLTQ4ODQ3_35cabac8-eed2-4ac3-be3c-5613880ebcad"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzMyLTEzLTEtMS00ODg1NA_d389382f-4c68-4771-abdc-5f1503228ad8"
      unitRef="usd">4230000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzMyLTE1LTEtMS00ODg2MQ_bed84642-1d3e-46d0-8b82-ff7036c0f640"
      unitRef="usd">0</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzMzLTktMS0xLTQ4ODQ3_15be6637-661b-41c4-a825-63bc87334b6d"
      unitRef="usd">-595000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzMzLTEzLTEtMS00ODg1NA_d2781204-809f-41d2-933b-214e524f4c5c"
      unitRef="usd">12000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzMzLTE1LTEtMS00ODg2MQ_78a63021-1ee5-4742-a9e9-f64b3bc06295"
      unitRef="usd">0</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM0LTktMS0xLTQ4ODQ3_9d34b737-814f-46bf-9919-4d465a780dce"
      unitRef="usd">-640574000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM0LTEzLTEtMS00ODg1NA_d64e39d4-62c7-43ef-ba33-d7c8f67477db"
      unitRef="usd">-70417000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM0LTE1LTEtMS00ODg2MQ_30b0d2a7-6f94-4942-b0c1-ead4390bc16e"
      unitRef="usd">-13095000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM1LTEtMS0xLTk4MjE2_0c9bdf42-4bc7-4e9d-ab02-856d36c71f48"
      unitRef="usd">553905000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM1LTMtMS0xLTk4MjE2_0c791f66-15c0-4b34-92f6-c4045cbe6464"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM1LTUtMS0xLTk4MjE2_750c305e-9e46-4d83-98bb-072ca134ca63"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM3LTktMS0xLTQ4ODQ3_b909f485-8073-40b9-bda5-9b50531bb66b"
      unitRef="usd">12612000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM3LTEzLTEtMS00ODg1NA_942d14a8-b83f-42c8-aac7-faad906d7b24"
      unitRef="usd">8897000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM3LTE1LTEtMS00ODg2MQ_59026083-0753-4f85-9530-2345f8547d92"
      unitRef="usd">1694000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockPlans
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM2LTEtMS0xLTEwMDEwMQ_c452deaa-d902-4167-9e4c-5fac6cc81b82"
      unitRef="usd">1395000</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromStockPlans
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM2LTMtMS0xLTEwMDEwMQ_31d97cf1-a99b-4996-8ac1-08816d6374a1"
      unitRef="usd">0</us-gaap:ProceedsFromStockPlans>
    <us-gaap:ProceedsFromStockPlans
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM2LTUtMS0xLTEwMDEwMQ_a6127a8a-3899-454b-a2c1-55ff7d508694"
      unitRef="usd">0</us-gaap:ProceedsFromStockPlans>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM2LTEtMS0xLTk4MjA4_783512bb-d41a-4539-ac24-92f034454139"
      unitRef="usd">817000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM2LTMtMS0xLTk4MjA4_47d853c0-d42d-4c7b-8686-37ff57d00a64"
      unitRef="usd">0</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM2LTUtMS0xLTk4MjA4_a6c9dfaf-63c2-4e00-ba62-97f2f5dbf144"
      unitRef="usd">0</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM4LTktMS0xLTQ4ODQ3_5354d93b-2954-4f8f-9b43-cebab229253c"
      unitRef="usd">2698000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM4LTEzLTEtMS00ODg1NA_9e1803fa-8c53-4acb-8249-7850beeab714"
      unitRef="usd">2022000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM4LTE1LTEtMS00ODg2MQ_7a80d0e1-c6fd-468c-b34f-cde096b9887a"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM5LTktMS0xLTQ4ODQ3_12b67684-4235-4870-9597-40e5ebf25a74"
      unitRef="usd">3982000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM5LTEzLTEtMS00ODg1NA_7acf3867-c15a-48dc-884d-af5cfbc7fb23"
      unitRef="usd">1468000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzM5LTE1LTEtMS00ODg2MQ_f980626c-8ff4-42fd-9bdf-0e845d3fed59"
      unitRef="usd">0</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzQwLTEtMS0xLTk4MTg0_2681a6c8-209b-4669-a366-81450015ec0b"
      unitRef="usd">0</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzQwLTMtMS0xLTk4MTg0_fa9b218c-b5d7-4763-81c4-964ad2ecf51a"
      unitRef="usd">0</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzQwLTUtMS0xLTk4MTg0_7b563e53-c288-402a-be8e-b160b9a703d0"
      unitRef="usd">25000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzQwLTktMS0xLTQ4ODQ3_a2c3033c-704b-4232-ace6-8737d7e45c49"
      unitRef="usd">560415000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzQwLTEzLTEtMS00ODg1NA_3ed293bd-9076-40d8-8f11-a6d846aab05f"
      unitRef="usd">5407000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzQwLTE1LTEtMS00ODg2MQ_c7832808-f88d-4f3d-af75-1ee3a6ec329a"
      unitRef="usd">1719000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzQxLTktMS0xLTQ4ODQ3_a3bf5d5c-6f53-4b2e-a1f7-f62fe69c6b48"
      unitRef="usd">46416000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzQxLTEzLTEtMS00ODg1NA_3c1d1ff4-cff5-4cb6-a254-51757504fc71"
      unitRef="usd">17963000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzQxLTE1LTEtMS00ODg2MQ_a3456da2-2cd7-480b-9b84-478ed787a172"
      unitRef="usd">14823000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzQyLTktMS0xLTQ4ODQ3_02a1082a-6c33-4536-b961-56c8da43b0eb"
      unitRef="usd">66393000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7a15f5b31d42419aa50ffb53e76f3705_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzQyLTEzLTEtMS00ODg1NA_c8a50f6a-db1b-4894-8e7e-39143707be77"
      unitRef="usd">48430000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i27e150c7cdf34baa99d770cedfcc88a0_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzQyLTE1LTEtMS00ODg2MQ_b67c0af6-25b0-45b7-9eb9-c75138ff7db7"
      unitRef="usd">33607000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzQzLTktMS0xLTQ4ODQ3_7d0ccba8-8d7e-499c-8f28-d78b539e662a"
      unitRef="usd">112809000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzQzLTEzLTEtMS00ODg1NA_8326cf88-cc75-4530-ad49-699e780a9fb1"
      unitRef="usd">66393000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7a15f5b31d42419aa50ffb53e76f3705_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZTphNjljNzI1ZTdjMDA0MWI5YmYyMmZlNjJhZjExNWZhMi90YWJsZXJhbmdlOmE2OWM3MjVlN2MwMDQxYjliZjIyZmU2MmFmMTE1ZmEyXzQzLTE1LTEtMS00ODg2MQ_0e919040-e46c-4827-a6db-e317e4e834cd"
      unitRef="usd">48430000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxesPaid
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzEtMS0xLTEtOTgyMzU_8b628631-f6b2-441b-ad84-e0969c957468"
      unitRef="usd">206000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzEtMy0xLTEtOTgyMzU_72e8af14-b125-446d-91ce-b07f7ed32a6e"
      unitRef="usd">5972000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzEtNS0xLTEtOTgyMzU_7334fd2a-803f-4997-af0c-bc6303f2acae"
      unitRef="usd">1237000</us-gaap:IncomeTaxesPaid>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzMtMS0xLTEtOTgyNjc_db58cd1d-5eaf-4325-8d19-98fae36cbb83"
      unitRef="usd">81458000</us-gaap:ConversionOfStockAmountConverted1>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzMtMy0xLTEtOTgyNjc_aba49d1b-56f6-463b-ae9f-2fc4a5ce886a"
      unitRef="usd">0</us-gaap:ConversionOfStockAmountConverted1>
    <us-gaap:ConversionOfStockAmountConverted1
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzMtNS0xLTEtOTgyNjc_bb1e08af-269a-48ac-8928-9722dd917103"
      unitRef="usd">0</us-gaap:ConversionOfStockAmountConverted1>
    <docs:StockIssuancesCostsIncurredButNotYetPaid
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzMtMS0xLTEtOTgyMzU_151780e3-db18-4c60-ba9a-6053dabc3877"
      unitRef="usd">0</docs:StockIssuancesCostsIncurredButNotYetPaid>
    <docs:StockIssuancesCostsIncurredButNotYetPaid
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzMtMy0xLTEtOTgyMzU_29972f0a-cd37-40f9-bdf4-f2f2b5e4b6a9"
      unitRef="usd">782000</docs:StockIssuancesCostsIncurredButNotYetPaid>
    <docs:StockIssuancesCostsIncurredButNotYetPaid
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzMtNS0xLTEtOTgyMzU_571f4d19-f6bb-4441-b1e8-3bca22e5d30f"
      unitRef="usd">0</docs:StockIssuancesCostsIncurredButNotYetPaid>
    <docs:StockIssuedAcquisitions
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzQtMS0xLTEtOTgyMzU_523351b6-96a6-48a7-9e2a-1ffeec5348f7"
      unitRef="usd">0</docs:StockIssuedAcquisitions>
    <docs:StockIssuedAcquisitions
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzQtMy0xLTEtOTgyMzU_7a626fc4-083f-4932-9615-b861e0c611d7"
      unitRef="usd">1062000</docs:StockIssuedAcquisitions>
    <docs:StockIssuedAcquisitions
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzQtNS0xLTEtOTgyMzU_4d277c0a-b689-4e4a-98a1-fe26395cb8c6"
      unitRef="usd">0</docs:StockIssuedAcquisitions>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzUtMS0xLTEtOTgyMzU_077016de-0608-4f0d-8f8d-01030a321dbf"
      unitRef="usd">497000</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzUtMy0xLTEtOTgyMzU_b58d2538-f196-41c1-97d6-b0d02670af9b"
      unitRef="usd">195000</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzUtNS0xLTEtOTgyMzU_856e83cd-815f-4458-a0eb-68b5a23e7954"
      unitRef="usd">184000</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <docs:EscrowDepositsRelatedToSaleOfBusiness
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzYtMS0xLTEtOTgyMzU_9fc859fc-31ce-4b1f-91a2-4d1a85051deb"
      unitRef="usd">0</docs:EscrowDepositsRelatedToSaleOfBusiness>
    <docs:EscrowDepositsRelatedToSaleOfBusiness
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzYtMy0xLTEtOTgyMzU_c3d93bf9-07c5-475e-8b16-661201532de1"
      unitRef="usd">470000</docs:EscrowDepositsRelatedToSaleOfBusiness>
    <docs:EscrowDepositsRelatedToSaleOfBusiness
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzYtNS0xLTEtOTgyMzU_693756ff-411c-4adc-a632-1886c44931c3"
      unitRef="usd">0</docs:EscrowDepositsRelatedToSaleOfBusiness>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzgtMS0xLTEtOTgyMzU_176087e4-4543-4f69-8eb8-ce16bc7e8a48"
      unitRef="usd">1151000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzgtMy0xLTEtOTgyMzU_a747c52c-e400-46df-aabc-a7a4f46ccbcf"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODEvZnJhZzpkMTUwOTQwNzZmNTE0MGIwYTNiODE2NmUyZDE5ZWJiOS90YWJsZToyMWNjMTg3N2ViMTY0ZWVkOWFiYTA2ODc2Yzk4MWE4Ny90YWJsZXJhbmdlOjIxY2MxODc3ZWIxNjRlZWQ5YWJhMDY4NzZjOTgxYTg3XzgtNS0xLTEtOTgyMzU_99c38986-ee94-4483-810f-89019f2fdae0"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODcvZnJhZzoxMDA0YTgzMWIzMGM0YjU5YmYwMzVhYzY4ZjIzNzViMi90ZXh0cmVnaW9uOjEwMDRhODMxYjMwYzRiNTliZjAzNWFjNjhmMjM3NWIyXzY0MzIxNDMwMjQwNjY1_248194da-9f4e-496f-9dd4-9ae36d6227a3">DESCRIPTION OF BUSINESS&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Description of Business&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Doximity,&#160;Inc. (the &#x201c;Company&#x201d;) was incorporated in the state of Delaware in April 2010 as 3MD Communications, Inc. and is headquartered in San Francisco, California. The Company subsequently changed its name to Doximity, Inc. in June 2010. The Company provides an online platform, which enables physicians and other healthcare professionals to collaborate with their colleagues, securely coordinate patient care, stay up to date with the latest medical news and research, and manage their careers. The Company&#x2019;s customers primarily include pharmaceutical companies and health systems that connect with healthcare professionals through the Company&#x2019;s digital Marketing and Hiring Solutions. Marketing Solutions provide customers with the ability to share tailored content on the network. Hiring Solutions enable customers to identify, connect with, and hire from the network of both active and passive potential physician candidates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Initial Public Offering&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2021, the Company completed its initial public offering, or IPO, in which the Company issued and sold 22,505,750 shares of its Class A common stock at $26.00 per share, including 3,495,000 shares issued upon the exercise of the underwriters&#x2019; option to purchase additional shares. The Company received proceeds of $548.5 million after deducting underwriting discounts and commissions as well as deferred offering costs. In connection with the IPO, all 76,286,618 shares of the Company&#x2019;s outstanding redeemable convertible preferred stock automatically converted into an equivalent number of shares of Class B common stock on a one-to-one basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred offering costs, which consist of direct incremental legal, consulting, banking, and accounting fees relating to the Company&#x2019;s planned initial public offering, were capitalized. Upon the consummation of the IPO, the $5.5 million of deferred offering costs were offset against proceeds. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Split&lt;/span&gt;&lt;/div&gt;On June&#160;8, 2021, the Company&#x2019;s board of directors and stockholders approved an amendment to the Company&#x2019;s amended and restated certificate of incorporation effecting a 2-for-1 forward split of the Company&#x2019;s issued and outstanding stock, including outstanding stock-based instruments and redeemable convertible preferred stock. The par value of the common and redeemable convertible preferred stock was not adjusted as a result of the stock split. As such, the Company has reclassified amounts from additional paid-in capital to common stock. All issued and outstanding shares of common stock, stock-based instruments, redeemable convertible preferred stock, and per-share amounts included in the accompanying consolidated financial statements have been adjusted to reflect this stock split for all periods presented.</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i2e82783b746e45e0a6c7e59883f52e81_D20210601-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODcvZnJhZzoxMDA0YTgzMWIzMGM0YjU5YmYwMzVhYzY4ZjIzNzViMi90ZXh0cmVnaW9uOjEwMDRhODMxYjMwYzRiNTliZjAzNWFjNjhmMjM3NWIyXzI5MTM3MDU4MTQ0NDQ4_eb8a6870-cd7f-423e-b3ff-5d7c600f18db"
      unitRef="shares">22505750</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="i2bcd5d3197f043779574e3205ce6051a_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODcvZnJhZzoxMDA0YTgzMWIzMGM0YjU5YmYwMzVhYzY4ZjIzNzViMi90ZXh0cmVnaW9uOjEwMDRhODMxYjMwYzRiNTliZjAzNWFjNjhmMjM3NWIyXzI5MTM3MDU4MTQ0NDU3_de7ff991-0509-4eca-b9b6-9a4a9b553d9d"
      unitRef="usdPerShare">26.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="id77b48d8ffc446c1a18a4951dd7e173a_D20210601-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODcvZnJhZzoxMDA0YTgzMWIzMGM0YjU5YmYwMzVhYzY4ZjIzNzViMi90ZXh0cmVnaW9uOjEwMDRhODMxYjMwYzRiNTliZjAzNWFjNjhmMjM3NWIyXzI5MTM3MDU4MTQ0NDcw_e80b1fd6-b3b6-4db6-8d10-3cebc1fc5846"
      unitRef="shares">3495000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="i2e82783b746e45e0a6c7e59883f52e81_D20210601-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODcvZnJhZzoxMDA0YTgzMWIzMGM0YjU5YmYwMzVhYzY4ZjIzNzViMi90ZXh0cmVnaW9uOjEwMDRhODMxYjMwYzRiNTliZjAzNWFjNjhmMjM3NWIyXzI5MTM3MDU4MTQ0NDg3_a84f8937-c533-451c-bae8-6ec285f6104d"
      unitRef="usd">548500000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:ConversionOfStockSharesConverted1
      contextRef="i6d33d27d6278430c9585fcf4dd6fdf08_D20210601-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODcvZnJhZzoxMDA0YTgzMWIzMGM0YjU5YmYwMzVhYzY4ZjIzNzViMi90ZXh0cmVnaW9uOjEwMDRhODMxYjMwYzRiNTliZjAzNWFjNjhmMjM3NWIyXzI5MTM3MDU4MTQ0NTEx_c100b206-dc6d-4276-9e90-601ecada71fa"
      unitRef="shares">76286618</us-gaap:ConversionOfStockSharesConverted1>
    <docs:ConversionOfStockConversionRatio
      contextRef="i62c961053180495bb8eed126ddb4d43b_D20210601-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODcvZnJhZzoxMDA0YTgzMWIzMGM0YjU5YmYwMzVhYzY4ZjIzNzViMi90ZXh0cmVnaW9uOjEwMDRhODMxYjMwYzRiNTliZjAzNWFjNjhmMjM3NWIyXzI5MTM3MDU4MTQ0NTE3_7627e522-fa3d-4104-9503-be27b4d8ac55"
      unitRef="number">1</docs:ConversionOfStockConversionRatio>
    <us-gaap:DeferredOfferingCosts
      contextRef="iaca56ad88a7f461f9aa0ca6977c6c5a1_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODcvZnJhZzoxMDA0YTgzMWIzMGM0YjU5YmYwMzVhYzY4ZjIzNzViMi90ZXh0cmVnaW9uOjEwMDRhODMxYjMwYzRiNTliZjAzNWFjNjhmMjM3NWIyXzMwMjM2NTY5Nzc5NDI1_f813fd2e-9d1c-423c-ac9b-6d8298b8083d"
      unitRef="usd">5500000</us-gaap:DeferredOfferingCosts>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="ic768fc083be84a7890c4145464deef64_D20210608-20210608"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xODcvZnJhZzoxMDA0YTgzMWIzMGM0YjU5YmYwMzVhYzY4ZjIzNzViMi90ZXh0cmVnaW9uOjEwMDRhODMxYjMwYzRiNTliZjAzNWFjNjhmMjM3NWIyXzI5MTM3MDU4MTQ0NjM3_9b318ab8-808c-4f2e-a8ba-f37953e9f53a"
      unitRef="number">2</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0MzUx_941c7762-dc44-4417-be29-ae6a8738e34d">Summary of Significant Accounting Policies&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America, or U.S. GAAP.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements include the accounts of the Company and its consolidated subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. Certain prior year amounts were reclassified, as applicable, to conform to the current year presentation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fiscal Year &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s fiscal year ends on March 31&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;st&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Unless otherwise noted, all references to a particular year shall mean the Company&#x2019;s fiscal year. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of the Company&#x2019;s consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts stated in the consolidated financial statements and accompanying notes. These judgments, estimates, and assumptions are used for, but not limited to, revenue recognition, the fair values of acquired intangible assets and goodwill, the useful lives of long-lived assets, the valuation of the Company&#x2019;s common stock and stock-based awards, and deferred income taxes. The Company bases its estimates on historical experience and also on assumptions that management considers reasonable. The Company assesses these estimates on a regular basis; however, actual &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;results could differ from these estimates due to risks and uncertainties, including uncertainty in the current economic environment due to the potential long-term impact and duration of the ongoing COVID-19 pandemic.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentrations of Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities, and accounts receivable. The primary focus of the Company&#x2019;s investment strategy is to preserve capital and meet liquidity requirements. The Company&#x2019;s investment policy addresses the level of credit exposure by limiting the concentration in any one corporate issuer or sector and establishing a minimum allowable credit rating. To manage risk exposure, the Company invests cash equivalents and marketable securities in a variety of fixed income securities, including government and investment-grade debt securities and money market funds. The Company places its cash primarily in checking and money market accounts with reputable financial institutions. Deposits held with these financial institutions may exceed the amount of insurance provided on such deposits, if any.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Concentrations of credit risk with respect to accounts receivable are primarily limited to certain customers to which the Company makes substantial sales. The Company&#x2019;s significant customers that represented 10% or more of revenue or accounts receivable, net for the periods presented were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Accounts Receivable, Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;As of March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Customer A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;_______________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;* Less than 10%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the purpose of assessing concentration of credit risk for significant customers, the Company defines a customer as an entity that purchases the Company&#x2019;s services directly or indirectly through marketing agencies. The majority of marketing agencies have a pass-through arrangement for collection purposes, except one marketing agency which accounted for 17% and 18% of accounts receivable, net as of March&#160;31, 2022 and 2021, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s revenue is primarily derived from the sale of subscriptions for the following solutions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:63pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt"&gt;Marketing Solutions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Hosting of customer-sponsored content on the Doximity platform and providing access to the Company&#x2019;s professional database of healthcare professionals for referral or marketing purposes during the subscription period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:63pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt"&gt;Hiring Solutions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Providing customers access to the Company&#x2019;s professional tools where recruiters can access the Company&#x2019;s database of healthcare professionals, allowing customers to send messages for talent sourcing and to share job postings during the subscription period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines revenue recognition in accordance with ASC 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, through the following five steps:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt"&gt;Identify the contract with a customer&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers the terms and conditions of its contracts and the Company&#x2019;s customary business practices in identifying its contracts under ASC 606. The Company determines it has a contract with a customer when the contract has been approved by both parties, it can identify each party&#x2019;s rights regarding the services to be transferred and the payment terms for the services, it has determined the customer to have the ability and intent to pay, and the contract has commercial substance. At contract inception, the Company evaluates whether two or more contracts should be combined and accounted for as a single contract. The Company applies judgment in determining the customer&#x2019;s ability and intent to pay, which is based on a variety of factors, including the customer&#x2019;s payment history or, in the case of a new customer, credit and financial information pertaining to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contractual terms for Marketing Solutions contracts are generally 12 months or less. The contractual term for Hiring Solutions contracts is typically 12 months. Customers are generally billed for a portion of the contract upon contract execution and then billed throughout the remainder of the contract based on various time-based milestones. Certain Marketing Solutions &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;contracts are cancellable with a 30-day notice period. The Company is not required to refund any prepayment fees invoiced and customers are responsible for prorated amounts to cover services that were provided but payment was not made. Contracts related to Hiring Solutions are noncancellable and customers are billed in annual, quarterly, or monthly installments in advance of the service period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt"&gt;Identify the performance obligations in the contract&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Performance obligations promised in a contract are identified based on the services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the service either on its own or together with other resources that are readily available, and are distinct in the context of the contract, whereby the transfer of the services is separately identifiable from other promises in the contract.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Marketing Solutions customers may purchase a subscription for a specific module to be used over a defined period of time. These customers may purchase more than one module with either the same or different subscription periods. Modules are the core building blocks of the Company&#x2019;s customers&#x2019; marketing plan and can be broadly categorized as Awareness, Interactivity, and Peer. As an example, the Company&#x2019;s Awareness modules may include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;A sponsored article, including a headline that appears in the targeted member&#x2019;s newsfeed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Short, animated videos that are presented in targeted members&#x2019; newsfeeds.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Short-form content that is presented within the targeted members&#x2019; newsfeeds.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each module targets a consistent number of Doximity members per month for the duration of the subscription period. The Company treats each subscription to a specific module as a distinct performance obligation because each module is capable of being distinct as the customer can benefit from the subscription to each module on their own and each subscription can be sold standalone. Furthermore, the subscriptions to individual modules are distinct in the context of the contract as (1) the Company is not integrating the services with other services promised in the contract into a bundle of services that represent a combined output, (2) the subscriptions to specific modules do not significantly modify or customize the subscription to another module, and (3) the specific modules are not highly interdependent or highly interrelated. The subscription to each module is treated as a series of distinct performance obligations because it is distinct and substantially the same, satisfied over time, and has the same measure of progress.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Marketing Solutions customers may also purchase integrated subscriptions for a fixed subscription fee that are not tied to a single module but allow customers to utilize any combination of modules during the subscription period subject to limits on the total number of modules launched in a given period of time, active at any given time, and members targeted. These represent stand-ready obligations in that the delivery of the underlying sponsored content is within the control of the customer and the extent of use in any given period does not diminish the remaining services. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some customers have negotiated to receive credits to purchase additional services at no extra cost if certain metrics have not been achieved. These credits are accounted for as material rights.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subscriptions to Hiring Solutions provide customers access to the platform to place targeted job postings and send a fixed number of monthly messages. Each subscription is treated as a series of distinct performance obligations that are satisfied over time. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt"&gt;Determine the transaction price &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The transaction price is determined based on the consideration the Company expects to be entitled to in exchange for transferring services to the customer. Variable consideration is included in the transaction price if, in the Company&#x2019;s judgment, it is probable that a significant future reversal of cumulative revenue recognized under the contract will not occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may generate sales through the use of third-party media agencies that are authorized to enter into contracts on behalf of an end customer. The Company acts as the principal in these transactions since it maintains control prior to transferring the service to the customer and is primarily responsible for the fulfillment that occurs through the Company&#x2019;s platform. The Company records revenue for the amount to which it is entitled from the third-party media agencies as the Company does not know and expects not to know the price charged by the third-party media agencies to its customers. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized net of any taxes collected from customers, which are subsequently remitted to governmental entities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt"&gt;Allocate the transaction price to performance obligations in the contract&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative stand-alone selling price, or SSP. The determination of a SSP for each distinct performance obligation requires judgment. The Company determines SSP for performance obligations based on overall pricing objectives, which take into consideration market conditions and customer-specific factors, including a review of internal discounting tables, the type of services being sold, and other factors. The estimate of standalone selling price is based on historical sales of standalone services. The Company estimates standalone selling price for arrangements where standalone sales do not provide sufficient evidence of standalone selling price. The Company believes the use of its estimation approach and allocation of the transaction price on a relative SSP basis to each performance obligation results in revenue recognition in a manner consistent with the underlying economics of the transaction and the allocation principle included in ASC 606.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt"&gt;Recognize revenue when or as the Company satisfies a performance obligation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized when or as control of the promised goods or service is transferred to the customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. Subscriptions represent a series of distinct goods or services because the performance obligations are satisfied over time as customers simultaneously receive and consume the benefits related to the services as the Company performs. In the case of module specific subscriptions, a consistent level of service is provided during each monthly period the sponsored content is available on the Company&#x2019;s platform. The Company commences revenue recognition when the first content is launched on the platform for the initial monthly period and revenue is recognized over time as each subsequent content period is delivered. The Company&#x2019;s obligation for its integrated subscriptions is to stand-ready throughout the subscription period; therefore, the Company considers an output method of time to measure progress towards satisfaction of its obligations with revenue commencing upon the beginning of the subscription period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company treats Hiring Solutions subscriptions as a single performance obligation that represents a series of distinct performance obligations that is satisfied over time. Revenue recognition commences when the customer receives access to the services. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other revenue consists of fees earned from the temporary staffing and permanent placement of healthcare professionals. Revenue is recognized when control of these services is transferred to the Company&#x2019;s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract Balances &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Timing of revenue recognition may differ from the timing of invoicing to customers. A majority of customers are invoiced throughout the contract while others are billed upfront. Marketing Solutions customers are generally billed for a portion of the contract upon contract execution and then billed throughout the remainder of the contract based on various time-based milestones, starting when the tailored content is first shared on the Doximity platform. The Company&#x2019;s contracts do not contain significant financing components. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records unbilled revenue when revenue is recognized in amounts for which it is contractually entitled but exceeds the amounts the Company has a right to bill as of the end of the period. The Company records unbilled revenue on the consolidated balance sheets within prepaid expenses and other current assets. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Deferred revenue consists of noncancelable customer billings or payments received in advance of revenue recognition. Deferred revenue balances are generally expected to be recognized within 12 months. Since the majority of the Company&#x2019;s contracts have a duration of one year or less, the Company has elected not to disclose remaining performance obligations in accordance with the optional exemption in ASC 606. Remaining performance obligations for contracts with an original duration greater than one year are not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Contract Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalizes sales commissions that are considered to be incremental and recoverable costs of obtaining a contract with a customer. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sales compensation earned for the renewal of Marketing Solutions contracts are commensurate with commissions earned for a new or expansion Marketing Solutions contract, whereas commissions for the renewal of Hiring Solutions subscription contracts are earned at a lower rate than for new and expansion Hiring Solutions subscription contracts. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred compensation for Marketing Solutions contracts and Hiring Solutions renewal contracts is amortized over the weighted-average contractual term, ranging from 7 months to 13 months. Deferred compensation tied to new and expansion contracts for Hiring Solutions is amortized on a straight-line basis over the expected period of benefit of 4 years, which is determined by the nature of the Company&#x2019;s technology and services, the rate at which the Company continually enhances and updates its technology, and its historical customer retention. Deferred compensation is recorded as deferred contract costs on the consolidated balance sheets. Amortized costs are included in cost of revenues and sales and marketing expense in the consolidated statements of operations. Amounts expected to be recognized within one year of the balance sheet date are recorded as deferred contract costs, current, and the remaining portion is recorded as other assets on the consolidated balance sheets. Certain sales commissions that are not considered incremental costs are expensed in the same period as they are earned. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available-for-sale debt securities are recorded at fair value on the consolidated balance sheets. The carrying value of cash equivalents, accounts receivable, accounts payable, and accrued expenses and other current liabilities approximate their respective fair values due to their short maturities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a three-tier hierarchy, which prioritizes the inputs used in measuring fair value as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level&#160;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Inputs that are unadjusted quoted prices in active markets for identical assets or liabilities at the measurement date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level&#160;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Inputs (other than quoted prices included in Level&#160;1)&#160;that are either directly or indirectly observable for the asset or liability through correlation with market data at the measurement date and for the duration of the instrument&#x2019;s anticipated life.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level&#160;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities and which reflect management&#x2019;s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents and Marketable Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers all highly liquid investments with maturities of three months or less at the time of acquisition to be cash equivalents. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s marketable securities portfolio includes only debt securities. Marketable debt securities that the Company may sell prior to maturity in response to changes in the Company's investment strategy, liquidity needs, or for other reasons are classified as available-for-sale. The Company's portfolio as of March&#160;31, 2022 and 2021 includes only available-for-sale securities. Available-for-sale securities are stated at fair value as of each balance sheet date. Unrealized gains and losses for available-for-sale securities are included in accumulated other comprehensive income, a component of stockholders&#x2019; equity on the consolidated balance sheets. The Company&#x2019;s marketable securities are available for use in current operations, even if the security matures beyond 12 months. The Company classifies its marketable securities as current assets on the consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Periodically, the Company assesses the available-for-sale securities for impairment. An investment is impaired if the fair value of the investment is less than its amortized cost basis. The amortized cost of an investment will be written down to the fair value when the Company determines (i) it is more likely than not that management will be required to sell the impaired security before recovery of its amortized basis or (ii) management has the intention to sell the security. If neither of these conditions are met, the Company must determine whether the impairment is due to credit losses. A credit loss exists if the amortized cost basis of the security exceeds the present value of cash flows expected to be collected. All credit losses are recorded to other income, net and any remaining unrealized losses are recorded to other comprehensive loss. If the Company has the intent to sell an available-for-sale security in an unrealized loss position or it is more likely than not that it will be required to sell the security prior to recovery of its amortized cost basis, any previously recorded allowance is reversed and the entire difference between the amortized cost basis of the security and its fair value is recognized in other income, net in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines any realized gains or losses on the sale of marketable securities on a specific identification method and records them to other income, net. Amortization of premiums and accretion of discounts are recorded to other income, net. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable and Allowance for Doubtful Accounts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable are recorded and carried at the original invoiced amount less an allowance for any potential uncollectible amounts. The Company estimates its allowance for doubtful accounts by evaluating the Company&#x2019;s ability to collect outstanding receivable balances. The Company considers various factors, including the age of the balance, the creditworthiness of the customer, which is assessed based on ongoing credit evaluations and payment history, and the customer&#x2019;s current financial condition. The Company had no material bad debt write offs for the years ending March&#160;31, 2022, 2021, and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment are stated at cost less accumulated depreciation. Depreciation and amortization expense is recorded on a straight-line basis over the estimated useful lives of the assets. The estimated useful life of each asset category is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:9pt;text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3-5 years &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Computers and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Internal-use software development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shorter of useful life or remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When assets are retired or otherwise disposed of, the cost and accumulated depreciation and amortization are written off, and any resulting gain or loss is recorded in the consolidated statement of operations in the period realized. Maintenance and repairs are expensed as incurred. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Internal-Use Software Development Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalizes certain costs to develop its website, mobile applications and internal-use software when preliminary planning efforts are successfully completed, management has committed project resourcing, and it is probable that the project will be completed. Costs incurred prior to meeting these criteria, as well as costs incurred for training, maintenance, and minor modifications or enhancements, are expensed as incurred. Capitalized costs include personnel and related expenses for employees and costs of third-party contractors who are directly associated with and who devote time to internal-use software projects. Capitalization of these costs ceases once the project is substantially complete and the software is ready for its intended use. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Capitalized costs are included in property and equipment, net on the consolidated balance sheets and are amortized to cost of revenue over their estimated useful life. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;To determine whether a transaction is accounted for as an asset acquisition or business combination, the Company applies a screen test to evaluate if substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets. When the Company acquires a business, the purchase consideration is allocated to the tangible and intangible assets acquired and liabilities assumed at their estimated fair values on the acquisition date. The excess of the fair value of purchase consideration over the values of these identifiable assets and liabilities is recorded as goodwill. When determining the fair value of assets acquired and liabilities assumed, management makes significant estimates and assumptions, particularly with respect to the valuation of intangible assets. Acquisition costs, such as legal and consulting fees, are expensed as incurred. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill, Intangible Assets, and Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill represents the excess of the purchase price over the fair value of the net tangible and intangible assets acquired in a business combination. Goodwill is not amortized, but is tested for impairment at least annually or more frequently if events or changes in circumstances indicate that the asset may be impaired. The Company has one reporting unit and evaluates goodwill for impairment at the entity level. If the carrying value of the reporting unit exceeds its fair value, an impairment charge is &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;recognized for the excess of the carrying value of the reporting unit over its fair value, limited to the amount of goodwill allocated to the reporting unit. The Company performs its annual impairment test of goodwill in its fourth fiscal quarter and whenever events or circumstances indicate that the asset might be impaired. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The intangible assets are stated at cost less accumulated amortization and are amortized on a straight-line basis over their estimated remaining economic lives. Amortization expense related to intangible assets is included in sales and marketing expense. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Management evaluates the recoverability of the Company&#x2019;s property and equipment and intangible assets when events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets held and used is measured by comparison of the carrying amount of an asset or an asset group to the estimated undiscounted future net cash flows expected to be generated by the asset or asset group. If the carrying value exceeds the estimated undiscounted future cash flows, an impairment loss is recognized for the amount by which the carrying amount exceeds the fair value for the asset or asset group. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures compensation expense for all stock-based awards based on the estimated fair value of the awards on the date of grant. Stock-based awards include stock options with service-based, performance-based and market-based vesting conditions, restricted stock units, or RSUs, performance-based restricted stock units, or PSUs, and warrants granted to employees, directors, and non-employees, as well as stock purchase rights granted to employees under the 2021 Employee Stock Purchase Plan, or ESPP. For awards that vest based on continued service, stock-based compensation, net of estimated forfeitures, is recognized on a straight-line basis over the requisite service period. For awards with performance-based vesting conditions, stock-based compensation expense, net of estimated forfeitures, is recognized using an accelerated attribution method from the time it is deemed probable that the vesting condition will be met through the time the service-based vesting condition has been achieved. The Company reassesses the probability of achieving the performance condition at each reporting date. For awards with market-based vesting conditions, stock-based compensation expense, net of estimated forfeitures, is recognized on an accelerated attribution basis over the requisite service period, even if the market condition is not satisfied. Forfeitures are estimated based upon the Company&#x2019;s historical experience and the Company revises its estimates, if necessary, in subsequent periods if actual forfeitures differ from initial estimates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of each RSU and PSU is based on the fair value of the Company&#x2019;s common stock on the date of grant. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The grant-date fair value of warrants, stock purchase rights granted to employees under the ESPP, and stock options with service-based or performance-based vesting conditions is estimated using the Black-Scholes pricing model. The grant-date fair value of stock options with market-based vesting conditions is estimated using the Monte Carlo simulation model. The determination of the grant-date fair value using an option-pricing model is affected by the fair value of the Company&#x2019;s common stock and assumptions regarding a number of other complex and subjective variables. These assumptions include the expected term of the award, the expected stock price volatility over the expected term of the award, the risk-free interest rate for the expected term of the award, and expected dividends. The assumptions used in the Black-Scholes models are determined as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk-Free Interest Rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;The risk-free interest rate is based on the implied yield available on U.S. Treasury zero-coupon issues with an equivalent expected term of the options for each option group. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected Volatility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Prior to the IPO when there was no public market for the Company&#x2019;s common stock, the expected volatility was determined using the historical volatilities of several publicly listed peer companies over a period equivalent to the expected term of the awards. The Company has not issued any stock options subsequent to the IPO. After the IPO, for the Company&#x2019;s ESPP, the expected volatility was determined using the historical stock volatilities of the common stock of the Company over a period equivalent to the duration of the offering period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected Term&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;The expected term represents the period that the Company&#x2019;s stock-based awards are expected to be outstanding. For stock options granted to employees prior to the completion of the IPO, the Company estimated the expected term using the simplified method as the Company&#x2019;s historical share option exercise experience did not provide a reasonable basis upon which to estimate the expected term. The simplified method uses the average of the vesting period and contractual term. For stock options granted to non-employees prior to the completion of the IPO, the Company used the contractual term as the expected term. The Company has not issued any stock options subsequent to the IPO. For stock purchase rights granted to employees under the ESPP, the expected term is equivalent to the offering period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected Dividend Yield&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;The Company has not historically issued dividends and does not currently expect to issue a dividend in the future. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Per Share of the Company&#x2019;s Common Stock&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Because the Company&#x2019;s common stock was not publicly traded until the completion of the IPO, the Company&#x2019;s board of directors considered numerous objective and subjective factors to determine the fair value of the Company&#x2019;s common stock at each meeting during which awards were approved. These factors included, but were not limited to (i) contemporaneous third-party valuations of common stock; (ii) the rights and preferences of the Company&#x2019;s preferred stock relative to common stock; (iii) the lack of marketability of common stock; (iv) developments in the business; and (v) the likelihood of achieving a liquidity event, such as an IPO or sale of the Company, given prevailing market conditions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines if a contract is or contains a lease at inception. All of the Company&#x2019;s leases are operating leases. Operating lease right-of-use assets and lease liabilities are recognized at the lease commencement date based on the present value of the lease payments over the lease term, discounted using the Company&#x2019;s incremental borrowing rate. As none of the Company&#x2019;s leases provide an implicit rate, the incremental borrowing rate used is estimated based on what the Company would be required to pay for a collateralized loan over a similar term as the lease. The Company amortizes the present value of each right-of-use asset on a straight-line basis over its remaining lease term. Leases are included in operating lease right-of-use assets, operating lease liabilities, current, and operating lease liabilities, non-current on the consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options to extend or terminate a lease are included in the lease term when it is reasonably certain that such options will be exercised. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our lease agreements may contain variable costs such as common area maintenance, insurance, property tax, and other operating costs. Variable lease costs are expensed as incurred in the consolidated statements of operations. The Company does not separate non-lease components from lease components for its facility asset portfolio. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not recognize right-of-use assets and lease liabilities for short-term leases, which have a lease term of 12 months or less. Lease cost for short-term leases is recognized on a straight-line basis over the lease term. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Income Per Share Attributable to Common Stockholders&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted net income per share attributable to common stockholders is presented in conformity with the two-class method required for participating securities. Holders of redeemable convertible preferred stock are each entitled to receive noncumulative dividends out of any funds legally available, when and if declared by the Company&#x2019;s board of directors, payable prior and in preference to any dividends on any shares of common stock based on the proportion of common stock that would be held if all shares of redeemable convertible preferred stock were converted at the then-effective conversion rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Redeemable convertible preferred stock is therefore considered a participating security and is included in the computation of earnings per share under the two-class method. Holders of redeemable convertible preferred stock do not have a contractual obligation to share in the Company&#x2019;s losses. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the two-class method, net income attributable to common stockholders is determined by allocating undistributed earnings, calculated as net income, less (i) current period redeemable convertible preferred stock noncumulative dividends and (ii) earnings attributable to participating securities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income per share attributable to common stockholders is computed by dividing the net income attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diluted net income per share attributable to common stockholders is computed by dividing net income attributable to common stockholders by the weighted-average number of common shares outstanding and the effect of potentially dilutive securities outstanding during the period. Potentially dilutive securities include stock options, RSUs, PSUs, ESPP, redeemable convertible preferred stock, redeemable convertible preferred stock warrants, and common stock warrants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The rights, including the liquidation and dividend rights, of the holders of Class A and Class B common stock are identical, except with respect to voting, converting, and transfer rights. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis to each class of common stock and the resulting basic and diluted &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;net loss per share attributable to common stockholders are, therefore, the same for both Class A and Class B common stock on both an individual and combined basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. Deferred income tax assets and liabilities are measured using enacted tax rates for the year in which those temporary differences are expected to be recovered or settled. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the consolidated statements of operations in the period that includes the enactment date. A valuation allowance is recorded when it is more likely than not that some of the deferred tax assets will not be realized. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized. The Company&#x2019;s policy is to classify interest and penalties associated with uncertain tax positions, if any, as a component of its provision for (benefit from) income taxes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Legal Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may be subject to claims and other legal matters from time to time. The Company records a liability when it believes that it is both probable that a loss has been incurred and the amount can be reasonably estimated. When the Company believes that a loss is reasonably possible, it will disclose an estimate of the possible loss or range of loss. The Company expects to periodically evaluate developments in the legal matters that could affect the amount of liability that the Company accrues, if any, and adjust as appropriate. Until the final resolution of any such matter for which the Company may record a liability, there may be a loss exposure in excess of the liability recorded and such amount could be significant. Legal fees are expensed as incurred, other than amounts capitalized as deferred offering costs, as discussed above. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cost of Revenue &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of revenue consists primarily of expenses &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;related to cloud hosting, personnel-related expenses for the Company&#x2019;s customer success team, costs for third-party platform access, software services and contractors, and other services used in connection with &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;delivery and support of the Company&#x2019;s platform. Cost of revenue also includes the amortization of  internal-use software development costs, editorial and other content-related expenses, and allocated overhead. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and Development &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development expense is primarily comprised of personnel-related&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; associated with the Company&#x2019;s engineering and product teams who are responsible for building new products and improving existing products. Research and development expense also includes costs for third-party services and contractors, information technology and software-related costs, and allocated overhead. Other than internal-use software development costs that qualify for capitalization, research and development costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Advertising Expenses &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Advertising costs are expensed as incurred and are included in sales and marketing expense in the consolidated statements of operations. Advertising expense was $2.8 million, $2.6 million, and $2.0 million for the years ended March&#160;31, 2022, 2021, and 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting Pronouncements Recently Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2017, the FASB issued ASU 2017-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles&#x2014;Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, to simplify how entities assess goodwill for impairment by eliminating Step 2 from the goodwill impairment test. As amended, the goodwill impairment test consists of one step comparing the fair value of a reporting unit with its carrying amount. An entity should recognize a goodwill impairment charge for the amount by which the carrying amount exceeds the reporting unit&#x2019;s fair value. This guidance is effective for the Company for its interim and annual period beginning April 1, 2023, and early adoption is permitted. The Company early adopted this new guidance effective April 1, 2021, using a prospective approach. The Company performed its annual impairment assessment in the fourth quarter of fiscal &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2022 under this new guidance. The adoption of this guidance did not have a material impact on the consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, that simplifies the accounting for income taxes by removing certain exceptions to the general principles in such areas as intraperiod tax allocation, year-to-date losses in interim periods, and deferred tax liabilities related to outside basis differences. Amendments also include simplifications in other areas such as franchise taxes, step-up in tax basis goodwill, separate entity financial statements, and interim recognition of enactment of tax laws or rate changes. This guidance is effective for the Company for its fiscal year beginning April 1, 2022 and interim periods within its fiscal year beginning April 1, 2023. The Company expects the impact on the consolidated financial statements from the adoption of this standard to be immaterial. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, the FASB issued ASU 2021-08, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customer&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with Topic 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers,&lt;/span&gt; as if it had originated the contracts. Under the current business combinations guidance, such assets and liabilities are recognized by the acquirer at fair value on the acquisition date, which has historically resulted in a reduction to unearned revenue on the balance sheet on acquisition date, and therefore, a reduction to revenues subsequently recognized than otherwise would have been recorded as an independent entity. Adoption of this guidance will result in higher unearned revenue on the balance sheet on acquisition date and higher revenues subsequently recognized. This guidance is effective for the Company for its fiscal year beginning April 1, 2023 and interim periods within that fiscal year, and early adoption is permitted. The Company expects to adopt this guidance in the first quarter of fiscal 2023 and expects the adoption to impact the accounting of business combinations subsequent to the adoption date.</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0MzUy_e5646834-2636-4d7d-a509-a3ad6fe8ca98">&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America, or U.S. GAAP.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0Mzc4_f02e34e7-43d9-40b5-b78c-622eacc1194f">The accompanying consolidated financial statements include the accounts of the Company and its consolidated subsidiaries. All intercompany transactions and balances have been eliminated in consolidation. Certain prior year amounts were reclassified, as applicable, to conform to the current year presentation.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:FiscalPeriod
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0MzUz_d3a8ae64-0c70-4502-81b6-b3fb9d3e9964">Fiscal Year &lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s fiscal year ends on March 31&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;st&lt;/span&gt;. Unless otherwise noted, all references to a particular year shall mean the Company&#x2019;s fiscal year.</us-gaap:FiscalPeriod>
    <us-gaap:UseOfEstimates
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0MzU0_b157fe02-de0c-4119-82fd-0f59601e7bd2">&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of the Company&#x2019;s consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts stated in the consolidated financial statements and accompanying notes. These judgments, estimates, and assumptions are used for, but not limited to, revenue recognition, the fair values of acquired intangible assets and goodwill, the useful lives of long-lived assets, the valuation of the Company&#x2019;s common stock and stock-based awards, and deferred income taxes. The Company bases its estimates on historical experience and also on assumptions that management considers reasonable. The Company assesses these estimates on a regular basis; however, actual &lt;/span&gt;&lt;/div&gt;results could differ from these estimates due to risks and uncertainties, including uncertainty in the current economic environment due to the potential long-term impact and duration of the ongoing COVID-19 pandemic.</us-gaap:UseOfEstimates>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0MzU1_ed88eb55-2d3e-49ca-be94-f0d245bd659b">&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentrations of Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, marketable securities, and accounts receivable. The primary focus of the Company&#x2019;s investment strategy is to preserve capital and meet liquidity requirements. The Company&#x2019;s investment policy addresses the level of credit exposure by limiting the concentration in any one corporate issuer or sector and establishing a minimum allowable credit rating. To manage risk exposure, the Company invests cash equivalents and marketable securities in a variety of fixed income securities, including government and investment-grade debt securities and money market funds. The Company places its cash primarily in checking and money market accounts with reputable financial institutions. Deposits held with these financial institutions may exceed the amount of insurance provided on such deposits, if any.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0Mzc1_03bee1b0-92ec-421c-9c45-40af15d9029d">The Company&#x2019;s significant customers that represented 10% or more of revenue or accounts receivable, net for the periods presented were as follows:&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.162%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Accounts Receivable, Net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;As of March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Customer A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;_______________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"&gt;* Less than 10%&lt;/span&gt;&lt;/div&gt;</us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i3c255afc92154f4c84be5e86a09930da_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90YWJsZTpmZTA5N2ZjM2IyZmI0OTU5YmE1MjRlODE0NTY4YWU5MC90YWJsZXJhbmdlOmZlMDk3ZmMzYjJmYjQ5NTliYTUyNGU4MTQ1NjhhZTkwXzMtMy0xLTEtNTAyOTk_d90ef71c-9d12-417c-851e-462967abb567"
      unitRef="number">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i232cd9dacebb4bacabe5814953368da3_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90YWJsZTpmZTA5N2ZjM2IyZmI0OTU5YmE1MjRlODE0NTY4YWU5MC90YWJsZXJhbmdlOmZlMDk3ZmMzYjJmYjQ5NTliYTUyNGU4MTQ1NjhhZTkwXzMtNS0xLTEtNTAyOTk_582e3098-696e-48df-a643-605255a8fa55"
      unitRef="number">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i05799a8437a248f4a953626f22ebc51e_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90YWJsZTpmZTA5N2ZjM2IyZmI0OTU5YmE1MjRlODE0NTY4YWU5MC90YWJsZXJhbmdlOmZlMDk3ZmMzYjJmYjQ5NTliYTUyNGU4MTQ1NjhhZTkwXzMtNy0xLTEtNTAyOTk_8536bbff-ec93-4df3-914c-339bf8d882b2"
      unitRef="number">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="idce67be988654a3aba87d58e5fcbbae7_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90YWJsZTpmZTA5N2ZjM2IyZmI0OTU5YmE1MjRlODE0NTY4YWU5MC90YWJsZXJhbmdlOmZlMDk3ZmMzYjJmYjQ5NTliYTUyNGU4MTQ1NjhhZTkwXzMtOS0xLTEtNTAyOTk_0ebe1e94-4d93-4fcd-8a7d-bddd7b1c92e4"
      unitRef="number">0.25</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i0c8278abf3274417845449b2b9d0ee93_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzMwMjM2NTY5OTk5NzUy_a7eed2b4-d123-4a7d-aaf9-d3ee97cb17a0"
      unitRef="number">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="if63822cdcbe54d9aa0abc1f888beaab3_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzI4NTg3MzAyNTU4MTk1_dbd6b19b-5cac-4986-a19b-a2133ed15c4f"
      unitRef="number">0.18</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueRecognitionPolicyTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0MzU2_4e346800-0a67-48d5-a9cf-8082ba67940e">&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s revenue is primarily derived from the sale of subscriptions for the following solutions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:63pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt"&gt;Marketing Solutions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Hosting of customer-sponsored content on the Doximity platform and providing access to the Company&#x2019;s professional database of healthcare professionals for referral or marketing purposes during the subscription period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:63pt;text-align:justify;text-indent:-13.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:10pt"&gt;Hiring Solutions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: Providing customers access to the Company&#x2019;s professional tools where recruiters can access the Company&#x2019;s database of healthcare professionals, allowing customers to send messages for talent sourcing and to share job postings during the subscription period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines revenue recognition in accordance with ASC 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, through the following five steps:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt"&gt;Identify the contract with a customer&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers the terms and conditions of its contracts and the Company&#x2019;s customary business practices in identifying its contracts under ASC 606. The Company determines it has a contract with a customer when the contract has been approved by both parties, it can identify each party&#x2019;s rights regarding the services to be transferred and the payment terms for the services, it has determined the customer to have the ability and intent to pay, and the contract has commercial substance. At contract inception, the Company evaluates whether two or more contracts should be combined and accounted for as a single contract. The Company applies judgment in determining the customer&#x2019;s ability and intent to pay, which is based on a variety of factors, including the customer&#x2019;s payment history or, in the case of a new customer, credit and financial information pertaining to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contractual terms for Marketing Solutions contracts are generally 12 months or less. The contractual term for Hiring Solutions contracts is typically 12 months. Customers are generally billed for a portion of the contract upon contract execution and then billed throughout the remainder of the contract based on various time-based milestones. Certain Marketing Solutions &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;contracts are cancellable with a 30-day notice period. The Company is not required to refund any prepayment fees invoiced and customers are responsible for prorated amounts to cover services that were provided but payment was not made. Contracts related to Hiring Solutions are noncancellable and customers are billed in annual, quarterly, or monthly installments in advance of the service period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt"&gt;Identify the performance obligations in the contract&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Performance obligations promised in a contract are identified based on the services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the service either on its own or together with other resources that are readily available, and are distinct in the context of the contract, whereby the transfer of the services is separately identifiable from other promises in the contract.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Marketing Solutions customers may purchase a subscription for a specific module to be used over a defined period of time. These customers may purchase more than one module with either the same or different subscription periods. Modules are the core building blocks of the Company&#x2019;s customers&#x2019; marketing plan and can be broadly categorized as Awareness, Interactivity, and Peer. As an example, the Company&#x2019;s Awareness modules may include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;A sponsored article, including a headline that appears in the targeted member&#x2019;s newsfeed.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Short, animated videos that are presented in targeted members&#x2019; newsfeeds.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Short-form content that is presented within the targeted members&#x2019; newsfeeds.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each module targets a consistent number of Doximity members per month for the duration of the subscription period. The Company treats each subscription to a specific module as a distinct performance obligation because each module is capable of being distinct as the customer can benefit from the subscription to each module on their own and each subscription can be sold standalone. Furthermore, the subscriptions to individual modules are distinct in the context of the contract as (1) the Company is not integrating the services with other services promised in the contract into a bundle of services that represent a combined output, (2) the subscriptions to specific modules do not significantly modify or customize the subscription to another module, and (3) the specific modules are not highly interdependent or highly interrelated. The subscription to each module is treated as a series of distinct performance obligations because it is distinct and substantially the same, satisfied over time, and has the same measure of progress.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Marketing Solutions customers may also purchase integrated subscriptions for a fixed subscription fee that are not tied to a single module but allow customers to utilize any combination of modules during the subscription period subject to limits on the total number of modules launched in a given period of time, active at any given time, and members targeted. These represent stand-ready obligations in that the delivery of the underlying sponsored content is within the control of the customer and the extent of use in any given period does not diminish the remaining services. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some customers have negotiated to receive credits to purchase additional services at no extra cost if certain metrics have not been achieved. These credits are accounted for as material rights.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Subscriptions to Hiring Solutions provide customers access to the platform to place targeted job postings and send a fixed number of monthly messages. Each subscription is treated as a series of distinct performance obligations that are satisfied over time. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;3)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt"&gt;Determine the transaction price &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The transaction price is determined based on the consideration the Company expects to be entitled to in exchange for transferring services to the customer. Variable consideration is included in the transaction price if, in the Company&#x2019;s judgment, it is probable that a significant future reversal of cumulative revenue recognized under the contract will not occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may generate sales through the use of third-party media agencies that are authorized to enter into contracts on behalf of an end customer. The Company acts as the principal in these transactions since it maintains control prior to transferring the service to the customer and is primarily responsible for the fulfillment that occurs through the Company&#x2019;s platform. The Company records revenue for the amount to which it is entitled from the third-party media agencies as the Company does not know and expects not to know the price charged by the third-party media agencies to its customers. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized net of any taxes collected from customers, which are subsequently remitted to governmental entities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;4)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt"&gt;Allocate the transaction price to performance obligations in the contract&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative stand-alone selling price, or SSP. The determination of a SSP for each distinct performance obligation requires judgment. The Company determines SSP for performance obligations based on overall pricing objectives, which take into consideration market conditions and customer-specific factors, including a review of internal discounting tables, the type of services being sold, and other factors. The estimate of standalone selling price is based on historical sales of standalone services. The Company estimates standalone selling price for arrangements where standalone sales do not provide sufficient evidence of standalone selling price. The Company believes the use of its estimation approach and allocation of the transaction price on a relative SSP basis to each performance obligation results in revenue recognition in a manner consistent with the underlying economics of the transaction and the allocation principle included in ASC 606.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:4pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;5)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:9.67pt"&gt;Recognize revenue when or as the Company satisfies a performance obligation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized when or as control of the promised goods or service is transferred to the customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. Subscriptions represent a series of distinct goods or services because the performance obligations are satisfied over time as customers simultaneously receive and consume the benefits related to the services as the Company performs. In the case of module specific subscriptions, a consistent level of service is provided during each monthly period the sponsored content is available on the Company&#x2019;s platform. The Company commences revenue recognition when the first content is launched on the platform for the initial monthly period and revenue is recognized over time as each subsequent content period is delivered. The Company&#x2019;s obligation for its integrated subscriptions is to stand-ready throughout the subscription period; therefore, the Company considers an output method of time to measure progress towards satisfaction of its obligations with revenue commencing upon the beginning of the subscription period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company treats Hiring Solutions subscriptions as a single performance obligation that represents a series of distinct performance obligations that is satisfied over time. Revenue recognition commences when the customer receives access to the services. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other revenue consists of fees earned from the temporary staffing and permanent placement of healthcare professionals. Revenue is recognized when control of these services is transferred to the Company&#x2019;s customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract Balances &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Timing of revenue recognition may differ from the timing of invoicing to customers. A majority of customers are invoiced throughout the contract while others are billed upfront. Marketing Solutions customers are generally billed for a portion of the contract upon contract execution and then billed throughout the remainder of the contract based on various time-based milestones, starting when the tailored content is first shared on the Doximity platform. The Company&#x2019;s contracts do not contain significant financing components. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records unbilled revenue when revenue is recognized in amounts for which it is contractually entitled but exceeds the amounts the Company has a right to bill as of the end of the period. The Company records unbilled revenue on the consolidated balance sheets within prepaid expenses and other current assets. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Deferred revenue consists of noncancelable customer billings or payments received in advance of revenue recognition. Deferred revenue balances are generally expected to be recognized within 12 months. Since the majority of the Company&#x2019;s contracts have a duration of one year or less, the Company has elected not to disclose remaining performance obligations in accordance with the optional exemption in ASC 606. Remaining performance obligations for contracts with an original duration greater than one year are not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Contract Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalizes sales commissions that are considered to be incremental and recoverable costs of obtaining a contract with a customer. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sales compensation earned for the renewal of Marketing Solutions contracts are commensurate with commissions earned for a new or expansion Marketing Solutions contract, whereas commissions for the renewal of Hiring Solutions subscription contracts are earned at a lower rate than for new and expansion Hiring Solutions subscription contracts. &lt;/span&gt;&lt;/div&gt;Deferred compensation for Marketing Solutions contracts and Hiring Solutions renewal contracts is amortized over the weighted-average contractual term, ranging from 7 months to 13 months. Deferred compensation tied to new and expansion contracts for Hiring Solutions is amortized on a straight-line basis over the expected period of benefit of 4 years, which is determined by the nature of the Company&#x2019;s technology and services, the rate at which the Company continually enhances and updates its technology, and its historical customer retention. Deferred compensation is recorded as deferred contract costs on the consolidated balance sheets. Amortized costs are included in cost of revenues and sales and marketing expense in the consolidated statements of operations. Amounts expected to be recognized within one year of the balance sheet date are recorded as deferred contract costs, current, and the remaining portion is recorded as other assets on the consolidated balance sheets. Certain sales commissions that are not considered incremental costs are expensed in the same period as they are earned.</us-gaap:RevenueRecognitionPolicyTextBlock>
    <docs:ContractWithCustomerTerm
      contextRef="i448a0e1cd7da4509b2f34555307a9792_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzI5MTM3MDU4MTk4MzAw_f72f352d-74f9-4246-8885-7f8872009a58">P12M</docs:ContractWithCustomerTerm>
    <docs:ContractWithCustomerTerm
      contextRef="i7859c8cbc9bd4e129a62d90e12bfc46d_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzI5MTM3MDU4MTk4MzE1_f046b8ef-1eca-4433-9b94-39a6cd79414f">P12M</docs:ContractWithCustomerTerm>
    <docs:ContractWithCustomerCancellationNoticePeriod
      contextRef="i448a0e1cd7da4509b2f34555307a9792_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0Mzc2_fddaa341-27d7-49d3-9ca2-4975645a71d9">P30D</docs:ContractWithCustomerCancellationNoticePeriod>
    <us-gaap:CapitalizedContractCostAmortizationPeriod
      contextRef="i2e71bd453e6a4a5c937ee4449f768fe2_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzI4NTg3MzAyMzkzMjkx_3d40a24d-eed5-4bdc-afbe-7986fa45e616">P7M</us-gaap:CapitalizedContractCostAmortizationPeriod>
    <us-gaap:CapitalizedContractCostAmortizationPeriod
      contextRef="i90363c012ca343ec80c6f828e4cfa8ee_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzI4NTg3MzAyMzkzMjk4_1d163828-8d01-4c87-abdd-2e8b992e7c83">P13M</us-gaap:CapitalizedContractCostAmortizationPeriod>
    <us-gaap:CapitalizedContractCostAmortizationPeriod
      contextRef="i64c2cfc1b0024d94aff990227a41ebbc_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzMxMzM2MDgxNDY1ODU0_05f1f8f4-9f13-4e07-b2fe-3d9df485e4e7">P4Y</us-gaap:CapitalizedContractCostAmortizationPeriod>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0MzU4_5d4c7a11-a37e-40bc-b5b7-c7bdf4ed6b0f">&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available-for-sale debt securities are recorded at fair value on the consolidated balance sheets. The carrying value of cash equivalents, accounts receivable, accounts payable, and accrued expenses and other current liabilities approximate their respective fair values due to their short maturities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a three-tier hierarchy, which prioritizes the inputs used in measuring fair value as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level&#160;1&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Inputs that are unadjusted quoted prices in active markets for identical assets or liabilities at the measurement date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level&#160;2&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Inputs (other than quoted prices included in Level&#160;1)&#160;that are either directly or indirectly observable for the asset or liability through correlation with market data at the measurement date and for the duration of the instrument&#x2019;s anticipated life.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Level&#160;3&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities and which reflect management&#x2019;s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <docs:CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0MzU5_6bd4e3e9-1737-4947-8caf-055f72bcd7de">&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents and Marketable Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers all highly liquid investments with maturities of three months or less at the time of acquisition to be cash equivalents. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s marketable securities portfolio includes only debt securities. Marketable debt securities that the Company may sell prior to maturity in response to changes in the Company's investment strategy, liquidity needs, or for other reasons are classified as available-for-sale. The Company's portfolio as of March&#160;31, 2022 and 2021 includes only available-for-sale securities. Available-for-sale securities are stated at fair value as of each balance sheet date. Unrealized gains and losses for available-for-sale securities are included in accumulated other comprehensive income, a component of stockholders&#x2019; equity on the consolidated balance sheets. The Company&#x2019;s marketable securities are available for use in current operations, even if the security matures beyond 12 months. The Company classifies its marketable securities as current assets on the consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Periodically, the Company assesses the available-for-sale securities for impairment. An investment is impaired if the fair value of the investment is less than its amortized cost basis. The amortized cost of an investment will be written down to the fair value when the Company determines (i) it is more likely than not that management will be required to sell the impaired security before recovery of its amortized basis or (ii) management has the intention to sell the security. If neither of these conditions are met, the Company must determine whether the impairment is due to credit losses. A credit loss exists if the amortized cost basis of the security exceeds the present value of cash flows expected to be collected. All credit losses are recorded to other income, net and any remaining unrealized losses are recorded to other comprehensive loss. If the Company has the intent to sell an available-for-sale security in an unrealized loss position or it is more likely than not that it will be required to sell the security prior to recovery of its amortized cost basis, any previously recorded allowance is reversed and the entire difference between the amortized cost basis of the security and its fair value is recognized in other income, net in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;The Company determines any realized gains or losses on the sale of marketable securities on a specific identification method and records them to other income, net. Amortization of premiums and accretion of discounts are recorded to other income, net.</docs:CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock>
    <us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0MzYw_2921dce7-3678-479a-8d4d-10e900637008">Accounts Receivable and Allowance for Doubtful AccountsAccounts receivable are recorded and carried at the original invoiced amount less an allowance for any potential uncollectible amounts. The Company estimates its allowance for doubtful accounts by evaluating the Company&#x2019;s ability to collect outstanding receivable balances. The Company considers various factors, including the age of the balance, the creditworthiness of the customer, which is assessed based on ongoing credit evaluations and payment history, and the customer&#x2019;s current financial condition.</us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0MzYx_5097fecf-4f59-4a21-a637-871256094808">&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment are stated at cost less accumulated depreciation. Depreciation and amortization expense is recorded on a straight-line basis over the estimated useful lives of the assets. The estimated useful life of each asset category is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:9pt;text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3-5 years &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Computers and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Internal-use software development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shorter of useful life or remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;When assets are retired or otherwise disposed of, the cost and accumulated depreciation and amortization are written off, and any resulting gain or loss is recorded in the consolidated statement of operations in the period realized. Maintenance and repairs are expensed as incurred.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0Mzc0_86747943-1e3f-4495-973b-5c1f22129c36">The estimated useful life of each asset category is as follows:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:36.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:9pt;text-align:right"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3-5 years &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Computers and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Internal-use software development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shorter of useful life or remaining lease term&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net consisted of the following (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;As of March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Computers and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Internal-use software development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;15,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;10,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;16,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;12,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Less: accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(8,470)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4,862)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;8,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i8a0e1d9ff3f146f5a3c9a2720e716d4c_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90YWJsZTplOWZmY2I3MzQ4NWE0MmNiODY5OWNmMzQ3NTY4NjI5MC90YWJsZXJhbmdlOmU5ZmZjYjczNDg1YTQyY2I4Njk5Y2YzNDc1Njg2MjkwXzAtMS0xLTEtNTAzMjAvdGV4dHJlZ2lvbjpkNTExODc1OGFkMmE0YTUwYTE2YmNiYzRkMTE0Y2MyNl8zMDIzNjU2OTc2Mzg2NQ_830c731e-27aa-4e03-848a-b72937002c2f">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i2deaa931c19f4b76a6b8cb6254e5036f_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90YWJsZTplOWZmY2I3MzQ4NWE0MmNiODY5OWNmMzQ3NTY4NjI5MC90YWJsZXJhbmdlOmU5ZmZjYjczNDg1YTQyY2I4Njk5Y2YzNDc1Njg2MjkwXzAtMS0xLTEtNTAzMjAvdGV4dHJlZ2lvbjpkNTExODc1OGFkMmE0YTUwYTE2YmNiYzRkMTE0Y2MyNl8zMDIzNjU2OTc2Mzg3Nw_b5160a1c-82eb-4b72-8900-4f28196d6141">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ie20bbb49de3342faa35330af5ddaeedf_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90YWJsZTplOWZmY2I3MzQ4NWE0MmNiODY5OWNmMzQ3NTY4NjI5MC90YWJsZXJhbmdlOmU5ZmZjYjczNDg1YTQyY2I4Njk5Y2YzNDc1Njg2MjkwXzEtMS0xLTEtNTAzMjA_df2a67b1-1b5f-4d84-a94b-353872a992c5">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i3585b880f7f444f1ae19972e18a16a3c_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90YWJsZTplOWZmY2I3MzQ4NWE0MmNiODY5OWNmMzQ3NTY4NjI5MC90YWJsZXJhbmdlOmU5ZmZjYjczNDg1YTQyY2I4Njk5Y2YzNDc1Njg2MjkwXzMtMS0xLTEtNTAzMjA_4d7c19b1-990b-4565-b89b-985573e0e0ca">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:InternalUseSoftwarePolicy
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0MzYy_283aac72-aebd-479d-a999-d24710c8e24b">&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Internal-Use Software Development Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalizes certain costs to develop its website, mobile applications and internal-use software when preliminary planning efforts are successfully completed, management has committed project resourcing, and it is probable that the project will be completed. Costs incurred prior to meeting these criteria, as well as costs incurred for training, maintenance, and minor modifications or enhancements, are expensed as incurred. Capitalized costs include personnel and related expenses for employees and costs of third-party contractors who are directly associated with and who devote time to internal-use software projects. Capitalization of these costs ceases once the project is substantially complete and the software is ready for its intended use. &lt;/span&gt;&lt;/div&gt;Capitalized costs are included in property and equipment, net on the consolidated balance sheets and are amortized to cost of revenue over their estimated useful life.</us-gaap:InternalUseSoftwarePolicy>
    <us-gaap:BusinessCombinationsPolicy
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0MzYz_62c14031-ef2d-403b-8679-4c3693e1ce29">Business CombinationsTo determine whether a transaction is accounted for as an asset acquisition or business combination, the Company applies a screen test to evaluate if substantially all of the fair value of the gross assets acquired is concentrated in a single identifiable asset or group of similar identifiable assets. When the Company acquires a business, the purchase consideration is allocated to the tangible and intangible assets acquired and liabilities assumed at their estimated fair values on the acquisition date. The excess of the fair value of purchase consideration over the values of these identifiable assets and liabilities is recorded as goodwill. When determining the fair value of assets acquired and liabilities assumed, management makes significant estimates and assumptions, particularly with respect to the valuation of intangible assets. Acquisition costs, such as legal and consulting fees, are expensed as incurred.</us-gaap:BusinessCombinationsPolicy>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0MzY0_c2b64f42-dcc1-46ca-9104-cefc7304db3a">&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill, Intangible Assets, and Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill represents the excess of the purchase price over the fair value of the net tangible and intangible assets acquired in a business combination. Goodwill is not amortized, but is tested for impairment at least annually or more frequently if events or changes in circumstances indicate that the asset may be impaired. The Company has one reporting unit and evaluates goodwill for impairment at the entity level. If the carrying value of the reporting unit exceeds its fair value, an impairment charge is &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;recognized for the excess of the carrying value of the reporting unit over its fair value, limited to the amount of goodwill allocated to the reporting unit. The Company performs its annual impairment test of goodwill in its fourth fiscal quarter and whenever events or circumstances indicate that the asset might be impaired. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The intangible assets are stated at cost less accumulated amortization and are amortized on a straight-line basis over their estimated remaining economic lives. Amortization expense related to intangible assets is included in sales and marketing expense. &lt;/span&gt;&lt;/div&gt;Management evaluates the recoverability of the Company&#x2019;s property and equipment and intangible assets when events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets held and used is measured by comparison of the carrying amount of an asset or an asset group to the estimated undiscounted future net cash flows expected to be generated by the asset or asset group. If the carrying value exceeds the estimated undiscounted future cash flows, an impairment loss is recognized for the amount by which the carrying amount exceeds the fair value for the asset or asset group.</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:NumberOfReportingUnits
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzM0NjM0NjE2NDk4NzE3_65ee2026-07bb-4968-aded-e3238524b5c8"
      unitRef="reporting_unit">1</us-gaap:NumberOfReportingUnits>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0MzY1_27dad849-dc78-4395-b028-d4615bd0ad80">&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures compensation expense for all stock-based awards based on the estimated fair value of the awards on the date of grant. Stock-based awards include stock options with service-based, performance-based and market-based vesting conditions, restricted stock units, or RSUs, performance-based restricted stock units, or PSUs, and warrants granted to employees, directors, and non-employees, as well as stock purchase rights granted to employees under the 2021 Employee Stock Purchase Plan, or ESPP. For awards that vest based on continued service, stock-based compensation, net of estimated forfeitures, is recognized on a straight-line basis over the requisite service period. For awards with performance-based vesting conditions, stock-based compensation expense, net of estimated forfeitures, is recognized using an accelerated attribution method from the time it is deemed probable that the vesting condition will be met through the time the service-based vesting condition has been achieved. The Company reassesses the probability of achieving the performance condition at each reporting date. For awards with market-based vesting conditions, stock-based compensation expense, net of estimated forfeitures, is recognized on an accelerated attribution basis over the requisite service period, even if the market condition is not satisfied. Forfeitures are estimated based upon the Company&#x2019;s historical experience and the Company revises its estimates, if necessary, in subsequent periods if actual forfeitures differ from initial estimates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of each RSU and PSU is based on the fair value of the Company&#x2019;s common stock on the date of grant. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The grant-date fair value of warrants, stock purchase rights granted to employees under the ESPP, and stock options with service-based or performance-based vesting conditions is estimated using the Black-Scholes pricing model. The grant-date fair value of stock options with market-based vesting conditions is estimated using the Monte Carlo simulation model. The determination of the grant-date fair value using an option-pricing model is affected by the fair value of the Company&#x2019;s common stock and assumptions regarding a number of other complex and subjective variables. These assumptions include the expected term of the award, the expected stock price volatility over the expected term of the award, the risk-free interest rate for the expected term of the award, and expected dividends. The assumptions used in the Black-Scholes models are determined as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Risk-Free Interest Rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;The risk-free interest rate is based on the implied yield available on U.S. Treasury zero-coupon issues with an equivalent expected term of the options for each option group. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected Volatility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Prior to the IPO when there was no public market for the Company&#x2019;s common stock, the expected volatility was determined using the historical volatilities of several publicly listed peer companies over a period equivalent to the expected term of the awards. The Company has not issued any stock options subsequent to the IPO. After the IPO, for the Company&#x2019;s ESPP, the expected volatility was determined using the historical stock volatilities of the common stock of the Company over a period equivalent to the duration of the offering period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected Term&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;The expected term represents the period that the Company&#x2019;s stock-based awards are expected to be outstanding. For stock options granted to employees prior to the completion of the IPO, the Company estimated the expected term using the simplified method as the Company&#x2019;s historical share option exercise experience did not provide a reasonable basis upon which to estimate the expected term. The simplified method uses the average of the vesting period and contractual term. For stock options granted to non-employees prior to the completion of the IPO, the Company used the contractual term as the expected term. The Company has not issued any stock options subsequent to the IPO. For stock purchase rights granted to employees under the ESPP, the expected term is equivalent to the offering period. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Expected Dividend Yield&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;The Company has not historically issued dividends and does not currently expect to issue a dividend in the future. &lt;/span&gt;Fair Value Per Share of the Company&#x2019;s Common Stock&#x2014;Because the Company&#x2019;s common stock was not publicly traded until the completion of the IPO, the Company&#x2019;s board of directors considered numerous objective and subjective factors to determine the fair value of the Company&#x2019;s common stock at each meeting during which awards were approved. These factors included, but were not limited to (i) contemporaneous third-party valuations of common stock; (ii) the rights and preferences of the Company&#x2019;s preferred stock relative to common stock; (iii) the lack of marketability of common stock; (iv) developments in the business; and (v) the likelihood of achieving a liquidity event, such as an IPO or sale of the Company, given prevailing market conditions.</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0MzY2_3a5c4d1e-018b-4ff4-a56e-648da650909a">&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines if a contract is or contains a lease at inception. All of the Company&#x2019;s leases are operating leases. Operating lease right-of-use assets and lease liabilities are recognized at the lease commencement date based on the present value of the lease payments over the lease term, discounted using the Company&#x2019;s incremental borrowing rate. As none of the Company&#x2019;s leases provide an implicit rate, the incremental borrowing rate used is estimated based on what the Company would be required to pay for a collateralized loan over a similar term as the lease. The Company amortizes the present value of each right-of-use asset on a straight-line basis over its remaining lease term. Leases are included in operating lease right-of-use assets, operating lease liabilities, current, and operating lease liabilities, non-current on the consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Options to extend or terminate a lease are included in the lease term when it is reasonably certain that such options will be exercised. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our lease agreements may contain variable costs such as common area maintenance, insurance, property tax, and other operating costs. Variable lease costs are expensed as incurred in the consolidated statements of operations. The Company does not separate non-lease components from lease components for its facility asset portfolio. &lt;/span&gt;&lt;/div&gt;The Company does not recognize right-of-use assets and lease liabilities for short-term leases, which have a lease term of 12 months or less. Lease cost for short-term leases is recognized on a straight-line basis over the lease term.</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0MzY3_b0791923-cbdd-453e-91f2-fd2d1736d1d6">&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Income Per Share Attributable to Common Stockholders&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted net income per share attributable to common stockholders is presented in conformity with the two-class method required for participating securities. Holders of redeemable convertible preferred stock are each entitled to receive noncumulative dividends out of any funds legally available, when and if declared by the Company&#x2019;s board of directors, payable prior and in preference to any dividends on any shares of common stock based on the proportion of common stock that would be held if all shares of redeemable convertible preferred stock were converted at the then-effective conversion rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Redeemable convertible preferred stock is therefore considered a participating security and is included in the computation of earnings per share under the two-class method. Holders of redeemable convertible preferred stock do not have a contractual obligation to share in the Company&#x2019;s losses. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the two-class method, net income attributable to common stockholders is determined by allocating undistributed earnings, calculated as net income, less (i) current period redeemable convertible preferred stock noncumulative dividends and (ii) earnings attributable to participating securities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income per share attributable to common stockholders is computed by dividing the net income attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diluted net income per share attributable to common stockholders is computed by dividing net income attributable to common stockholders by the weighted-average number of common shares outstanding and the effect of potentially dilutive securities outstanding during the period. Potentially dilutive securities include stock options, RSUs, PSUs, ESPP, redeemable convertible preferred stock, redeemable convertible preferred stock warrants, and common stock warrants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The rights, including the liquidation and dividend rights, of the holders of Class A and Class B common stock are identical, except with respect to voting, converting, and transfer rights. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis to each class of common stock and the resulting basic and diluted &lt;/span&gt;&lt;/div&gt;net loss per share attributable to common stockholders are, therefore, the same for both Class A and Class B common stock on both an individual and combined basis.</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0MzY4_7c40aff8-7aaf-4854-b646-75c8c18c7984">&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. Deferred income tax assets and liabilities are measured using enacted tax rates for the year in which those temporary differences are expected to be recovered or settled. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in the consolidated statements of operations in the period that includes the enactment date. A valuation allowance is recorded when it is more likely than not that some of the deferred tax assets will not be realized. &lt;/span&gt;&lt;/div&gt;The Company recognizes the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such positions are then measured based on the largest benefit that has a greater than 50% likelihood of being realized. The Company&#x2019;s policy is to classify interest and penalties associated with uncertain tax positions, if any, as a component of its provision for (benefit from) income taxes.</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:LegalCostsPolicyTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0Mzgw_5bba7478-105d-445b-955e-1fc491249f86">Legal ContingenciesThe Company may be subject to claims and other legal matters from time to time. The Company records a liability when it believes that it is both probable that a loss has been incurred and the amount can be reasonably estimated. When the Company believes that a loss is reasonably possible, it will disclose an estimate of the possible loss or range of loss. The Company expects to periodically evaluate developments in the legal matters that could affect the amount of liability that the Company accrues, if any, and adjust as appropriate. Until the final resolution of any such matter for which the Company may record a liability, there may be a loss exposure in excess of the liability recorded and such amount could be significant. Legal fees are expensed as incurred, other than amounts capitalized as deferred offering costs, as discussed above.</us-gaap:LegalCostsPolicyTextBlock>
    <us-gaap:CostOfSalesPolicyTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0Mzcw_fce8101b-8067-4fc9-9591-84a9f2435749">Cost of Revenue &lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of revenue consists primarily of expenses &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;related to cloud hosting, personnel-related expenses for the Company&#x2019;s customer success team, costs for third-party platform access, software services and contractors, and other services used in connection with &lt;/span&gt;delivery and support of the Company&#x2019;s platform. Cost of revenue also includes the amortization of  internal-use software development costs, editorial and other content-related expenses, and allocated overhead.</us-gaap:CostOfSalesPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0Mzcx_c10791c6-de36-4442-88cc-f5e4ec888d47">&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and Development &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development expense is primarily comprised of personnel-related&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; associated with the Company&#x2019;s engineering and product teams who are responsible for building new products and improving existing products. Research and development expense also includes costs for third-party services and contractors, information technology and software-related costs, and allocated overhead. Other than internal-use software development costs that qualify for capitalization, research and development costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:AdvertisingCostsPolicyTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0Mzcy_a337e19b-ea6b-49fe-98a0-44b0afb33bab">Advertising Expenses Advertising costs are expensed as incurred and are included in sales and marketing expense in the consolidated statements of operations.</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzI5Njg2ODE0MDY2NjM0_652a6bb9-6923-464f-bac6-754e173c167b"
      unitRef="usd">2800000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzI5Njg2ODE0MDY2NjM5_c0483f0c-dd13-4998-8f16-eef27e724386"
      unitRef="usd">2600000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzI5Njg2ODE0MDY2NjQ4_8456a9c9-84b3-4efe-bc99-a82a5d502b60"
      unitRef="usd">2000000</us-gaap:AdvertisingExpense>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTAvZnJhZzo3M2Y1ZWZjNmNlNWI0ZDlmOWZjNWVlNmQ4NGQ1NmJjYy90ZXh0cmVnaW9uOjczZjVlZmM2Y2U1YjRkOWY5ZmM1ZWU2ZDg0ZDU2YmNjXzUxMTI3MjkwOTE0Mzcz_d7538eba-58e0-481e-a77d-54a96f1af52a">&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting Pronouncements Recently Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2017, the FASB issued ASU 2017-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles&#x2014;Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, to simplify how entities assess goodwill for impairment by eliminating Step 2 from the goodwill impairment test. As amended, the goodwill impairment test consists of one step comparing the fair value of a reporting unit with its carrying amount. An entity should recognize a goodwill impairment charge for the amount by which the carrying amount exceeds the reporting unit&#x2019;s fair value. This guidance is effective for the Company for its interim and annual period beginning April 1, 2023, and early adoption is permitted. The Company early adopted this new guidance effective April 1, 2021, using a prospective approach. The Company performed its annual impairment assessment in the fourth quarter of fiscal &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2022 under this new guidance. The adoption of this guidance did not have a material impact on the consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, that simplifies the accounting for income taxes by removing certain exceptions to the general principles in such areas as intraperiod tax allocation, year-to-date losses in interim periods, and deferred tax liabilities related to outside basis differences. Amendments also include simplifications in other areas such as franchise taxes, step-up in tax basis goodwill, separate entity financial statements, and interim recognition of enactment of tax laws or rate changes. This guidance is effective for the Company for its fiscal year beginning April 1, 2022 and interim periods within its fiscal year beginning April 1, 2023. The Company expects the impact on the consolidated financial statements from the adoption of this standard to be immaterial. &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2021, the FASB issued ASU 2021-08, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customer&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with Topic 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers,&lt;/span&gt; as if it had originated the contracts. Under the current business combinations guidance, such assets and liabilities are recognized by the acquirer at fair value on the acquisition date, which has historically resulted in a reduction to unearned revenue on the balance sheet on acquisition date, and therefore, a reduction to revenues subsequently recognized than otherwise would have been recorded as an independent entity. Adoption of this guidance will result in higher unearned revenue on the balance sheet on acquisition date and higher revenues subsequently recognized. This guidance is effective for the Company for its fiscal year beginning April 1, 2023 and interim periods within that fiscal year, and early adoption is permitted. The Company expects to adopt this guidance in the first quarter of fiscal 2023 and expects the adoption to impact the accounting of business combinations subsequent to the adoption date.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGV4dHJlZ2lvbjo0ZmQ4ODdmNzEzMWI0YTMwYjVhMGU0MjAxMDM5ZjZkM181ODI3NDExNjMwMTgxNQ_4f403247-8d0a-4ca2-bb7f-06c8d8d7a709">Revenue Recognition &lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Disaggregation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue consisted of the following (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Subscription&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;319,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;192,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;116,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;24,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;14,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;343,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;206,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;116,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract Balances &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the Company&#x2019;s deferred revenue balances were as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;As of March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;83,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;44,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Additions, net, during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;345,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;245,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Revenue recognized from the beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(82,534)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(43,054)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Revenue recognized from contracts invoiced during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(261,014)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(163,843)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;84,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;83,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s unbilled revenue balances were $1.4 million, $0.7 million, and $0.2 million as of March&#160;31, 2022, 2021 and 2020, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Contract Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company capitalized $9.6 million, $9.4 million, and $5.7 million of contract acquisition costs for the fiscal years ended March&#160;31, 2022, 2021, and 2020, respectively. Amortization of deferred contract costs was $9.8 million, $6.9 million, and $5.1 million for the fiscal years ended March&#160;31, 2022, 2021, and 2020, respectively. Deferred contract costs are &lt;/span&gt;&lt;/div&gt;periodically analyzed for impairment. There were no impairment losses relating to deferred contract costs during the fiscal years ended March&#160;31, 2022, 2021, and 2020.</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGV4dHJlZ2lvbjo0ZmQ4ODdmNzEzMWI0YTMwYjVhMGU0MjAxMDM5ZjZkM181ODI3NDExNjMwMTgxNg_ae202ce2-8971-4908-9d49-243a10381fa4">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue consisted of the following (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.084%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Subscription&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;319,298&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;192,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;116,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;24,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;14,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;343,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;206,897&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;116,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i75a13b9faa46498d802095eeb320936a_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGFibGU6YmI3OWI2NGU3ZTg3NGI3YWE3ZDBmYzA4MGIzZjAzYjcvdGFibGVyYW5nZTpiYjc5YjY0ZTdlODc0YjdhYTdkMGZjMDgwYjNmMDNiN18yLTUtMS0xLTgzNDE4_0b769e1f-4843-4cd1-88a5-01ddb86b14d0"
      unitRef="usd">319298000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i00234c4f9e354fa79830f0c96b12428c_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGFibGU6YmI3OWI2NGU3ZTg3NGI3YWE3ZDBmYzA4MGIzZjAzYjcvdGFibGVyYW5nZTpiYjc5YjY0ZTdlODc0YjdhYTdkMGZjMDgwYjNmMDNiN18yLTctMS0xLTgzNDE4_df3ab4bd-7fb9-4e94-b82f-33e12137a6a5"
      unitRef="usd">192256000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id23527ddeed84383823da9485781ac68_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGFibGU6YmI3OWI2NGU3ZTg3NGI3YWE3ZDBmYzA4MGIzZjAzYjcvdGFibGVyYW5nZTpiYjc5YjY0ZTdlODc0YjdhYTdkMGZjMDgwYjNmMDNiN18yLTUtMS0xLTg5NzE2_b2d8142a-cf2f-448c-8455-d48ed0094bbc"
      unitRef="usd">116388000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifb9d4adeb75140e2a68cf494d5775877_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGFibGU6YmI3OWI2NGU3ZTg3NGI3YWE3ZDBmYzA4MGIzZjAzYjcvdGFibGVyYW5nZTpiYjc5YjY0ZTdlODc0YjdhYTdkMGZjMDgwYjNmMDNiN18zLTUtMS0xLTgzNDE4_5bebce8b-0304-4484-a780-7e2837d93d4e"
      unitRef="usd">24250000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idaeaebe3ab244209926951f374b9e9c8_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGFibGU6YmI3OWI2NGU3ZTg3NGI3YWE3ZDBmYzA4MGIzZjAzYjcvdGFibGVyYW5nZTpiYjc5YjY0ZTdlODc0YjdhYTdkMGZjMDgwYjNmMDNiN18zLTctMS0xLTgzNDE4_b7092c6e-4ef7-4c74-a05d-68bf06f6b739"
      unitRef="usd">14641000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i51b462bd95564432b7a7495c9dff1958_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGFibGU6YmI3OWI2NGU3ZTg3NGI3YWE3ZDBmYzA4MGIzZjAzYjcvdGFibGVyYW5nZTpiYjc5YjY0ZTdlODc0YjdhYTdkMGZjMDgwYjNmMDNiN18zLTUtMS0xLTg5NzE2_1a2738ba-7b17-43bc-bdb2-0717eb2586a3"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGFibGU6YmI3OWI2NGU3ZTg3NGI3YWE3ZDBmYzA4MGIzZjAzYjcvdGFibGVyYW5nZTpiYjc5YjY0ZTdlODc0YjdhYTdkMGZjMDgwYjNmMDNiN180LTUtMS0xLTgzNDE4_dbf3b104-42fe-4797-8a64-695b145e4530"
      unitRef="usd">343548000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGFibGU6YmI3OWI2NGU3ZTg3NGI3YWE3ZDBmYzA4MGIzZjAzYjcvdGFibGVyYW5nZTpiYjc5YjY0ZTdlODc0YjdhYTdkMGZjMDgwYjNmMDNiN180LTctMS0xLTgzNDE4_67c85d3c-7b67-41da-8f96-4cba0c8afff9"
      unitRef="usd">206897000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGFibGU6YmI3OWI2NGU3ZTg3NGI3YWE3ZDBmYzA4MGIzZjAzYjcvdGFibGVyYW5nZTpiYjc5YjY0ZTdlODc0YjdhYTdkMGZjMDgwYjNmMDNiN180LTUtMS0xLTg5NzE2_30fbc5e9-cbf8-44a3-b2dd-4b18995511e7"
      unitRef="usd">116388000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGV4dHJlZ2lvbjo0ZmQ4ODdmNzEzMWI0YTMwYjVhMGU0MjAxMDM5ZjZkM181ODI3NDExNjMwMTgxNw_a51d28bd-02b4-4aac-ac61-1c8bfb555dc3">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the Company&#x2019;s deferred revenue balances were as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;As of March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;83,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;44,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Additions, net, during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;345,041&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;245,803&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Revenue recognized from the beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(82,534)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(43,054)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Revenue recognized from contracts invoiced during the period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(261,014)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(163,843)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;84,985&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;83,492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGFibGU6YmMxNWE0MDZjMGM0NDkzODkyYTc5MGY0ZDRhMTA2ZmMvdGFibGVyYW5nZTpiYzE1YTQwNmMwYzQ0OTM4OTJhNzkwZjRkNGExMDZmY18yLTEtMS0xLTk1ODAy_536e7af4-b59d-4a83-afbb-a092bd748aae"
      unitRef="usd">83492000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i7a15f5b31d42419aa50ffb53e76f3705_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGFibGU6YmMxNWE0MDZjMGM0NDkzODkyYTc5MGY0ZDRhMTA2ZmMvdGFibGVyYW5nZTpiYzE1YTQwNmMwYzQ0OTM4OTJhNzkwZjRkNGExMDZmY18yLTMtMS0xLTk1ODAy_07ac68cf-cc18-425d-a3e7-42ae10d5e7db"
      unitRef="usd">44586000</us-gaap:ContractWithCustomerLiability>
    <docs:ContractWithCustomerLiabilityAdditionsNet
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGFibGU6YmMxNWE0MDZjMGM0NDkzODkyYTc5MGY0ZDRhMTA2ZmMvdGFibGVyYW5nZTpiYzE1YTQwNmMwYzQ0OTM4OTJhNzkwZjRkNGExMDZmY18zLTEtMS0xLTk1ODAy_46afe89b-ac36-4104-95b7-107078cf445b"
      unitRef="usd">345041000</docs:ContractWithCustomerLiabilityAdditionsNet>
    <docs:ContractWithCustomerLiabilityAdditionsNet
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGFibGU6YmMxNWE0MDZjMGM0NDkzODkyYTc5MGY0ZDRhMTA2ZmMvdGFibGVyYW5nZTpiYzE1YTQwNmMwYzQ0OTM4OTJhNzkwZjRkNGExMDZmY18zLTMtMS0xLTk1ODAy_8b74f3b4-f30e-4715-bcfc-225cb61dd31a"
      unitRef="usd">245803000</docs:ContractWithCustomerLiabilityAdditionsNet>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGFibGU6YmMxNWE0MDZjMGM0NDkzODkyYTc5MGY0ZDRhMTA2ZmMvdGFibGVyYW5nZTpiYzE1YTQwNmMwYzQ0OTM4OTJhNzkwZjRkNGExMDZmY180LTEtMS0xLTk1ODAy_d6ecf298-4aa7-44f8-bc45-20e139cd0ec7"
      unitRef="usd">82534000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGFibGU6YmMxNWE0MDZjMGM0NDkzODkyYTc5MGY0ZDRhMTA2ZmMvdGFibGVyYW5nZTpiYzE1YTQwNmMwYzQ0OTM4OTJhNzkwZjRkNGExMDZmY180LTMtMS0xLTk1ODAy_4490210e-2d3d-4c96-982d-fab8fc55cf89"
      unitRef="usd">43054000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <docs:ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGFibGU6YmMxNWE0MDZjMGM0NDkzODkyYTc5MGY0ZDRhMTA2ZmMvdGFibGVyYW5nZTpiYzE1YTQwNmMwYzQ0OTM4OTJhNzkwZjRkNGExMDZmY181LTEtMS0xLTk1ODAy_dab73e75-808f-4ad4-bf2d-289e979f577c"
      unitRef="usd">261014000</docs:ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance>
    <docs:ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGFibGU6YmMxNWE0MDZjMGM0NDkzODkyYTc5MGY0ZDRhMTA2ZmMvdGFibGVyYW5nZTpiYzE1YTQwNmMwYzQ0OTM4OTJhNzkwZjRkNGExMDZmY181LTMtMS0xLTk1ODAy_98ec0559-95f2-47f8-88dc-66f5bb15f56d"
      unitRef="usd">163843000</docs:ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance>
    <us-gaap:ContractWithCustomerLiability
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGFibGU6YmMxNWE0MDZjMGM0NDkzODkyYTc5MGY0ZDRhMTA2ZmMvdGFibGVyYW5nZTpiYzE1YTQwNmMwYzQ0OTM4OTJhNzkwZjRkNGExMDZmY182LTEtMS0xLTk1ODAy_c0c3a88c-66aa-422d-8358-451a2d88fe04"
      unitRef="usd">84985000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGFibGU6YmMxNWE0MDZjMGM0NDkzODkyYTc5MGY0ZDRhMTA2ZmMvdGFibGVyYW5nZTpiYzE1YTQwNmMwYzQ0OTM4OTJhNzkwZjRkNGExMDZmY182LTMtMS0xLTk1ODAy_f1580ff5-193c-4205-8404-3b44bea82480"
      unitRef="usd">83492000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:UnbilledReceivablesCurrent
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGV4dHJlZ2lvbjo0ZmQ4ODdmNzEzMWI0YTMwYjVhMGU0MjAxMDM5ZjZkM18zMTMzNjA4MTQyMDY4Mg_07164fb3-f234-49df-aca3-be3ade40418a"
      unitRef="usd">1400000</us-gaap:UnbilledReceivablesCurrent>
    <us-gaap:UnbilledReceivablesCurrent
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGV4dHJlZ2lvbjo0ZmQ4ODdmNzEzMWI0YTMwYjVhMGU0MjAxMDM5ZjZkM18zMTMzNjA4MTQyMDY4Nw_5fe11d5b-c5e5-4c79-8964-4921abaf1558"
      unitRef="usd">700000</us-gaap:UnbilledReceivablesCurrent>
    <us-gaap:UnbilledReceivablesCurrent
      contextRef="i7a15f5b31d42419aa50ffb53e76f3705_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGV4dHJlZ2lvbjo0ZmQ4ODdmNzEzMWI0YTMwYjVhMGU0MjAxMDM5ZjZkM18zMTMzNjA4MTQyMDY5Ng_d368fcb9-012d-48be-81f4-97ea89d0cf22"
      unitRef="usd">200000</us-gaap:UnbilledReceivablesCurrent>
    <docs:CapitalizedContractCostAdditions
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGV4dHJlZ2lvbjo0ZmQ4ODdmNzEzMWI0YTMwYjVhMGU0MjAxMDM5ZjZkM18yOTEzNzA1ODE2MDg4MQ_79d20d92-ed49-4ffe-9e27-8d78b871353f"
      unitRef="usd">9600000</docs:CapitalizedContractCostAdditions>
    <docs:CapitalizedContractCostAdditions
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGV4dHJlZ2lvbjo0ZmQ4ODdmNzEzMWI0YTMwYjVhMGU0MjAxMDM5ZjZkM18yOTEzNzA1ODE2MDg5MA_5cc9d17c-eb21-4463-ab06-78682758f47d"
      unitRef="usd">9400000</docs:CapitalizedContractCostAdditions>
    <docs:CapitalizedContractCostAdditions
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGV4dHJlZ2lvbjo0ZmQ4ODdmNzEzMWI0YTMwYjVhMGU0MjAxMDM5ZjZkM18yOTEzNzA1ODE2MDg5OA_3d00b814-1e46-4926-a40a-5bb0e072953f"
      unitRef="usd">5700000</docs:CapitalizedContractCostAdditions>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGV4dHJlZ2lvbjo0ZmQ4ODdmNzEzMWI0YTMwYjVhMGU0MjAxMDM5ZjZkM18yOTEzNzA1ODE2MDkxNw_f9e55e05-66c5-4ee0-81e0-982a862f2de1"
      unitRef="usd">9800000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGV4dHJlZ2lvbjo0ZmQ4ODdmNzEzMWI0YTMwYjVhMGU0MjAxMDM5ZjZkM18yOTEzNzA1ODE2MDkzOA_90c65624-a718-4871-bc97-b54720a491ea"
      unitRef="usd">6900000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CapitalizedContractCostAmortization
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGV4dHJlZ2lvbjo0ZmQ4ODdmNzEzMWI0YTMwYjVhMGU0MjAxMDM5ZjZkM18yOTEzNzA1ODE2MDk1OA_e6def14e-c019-4d54-8763-b0e023d3165b"
      unitRef="usd">5100000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CapitalizedContractCostImpairmentLoss
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGV4dHJlZ2lvbjo0ZmQ4ODdmNzEzMWI0YTMwYjVhMGU0MjAxMDM5ZjZkM18yOTEzNzA1ODE2MTIwMA_13efe3cb-343a-4960-af59-b725a7f5258e"
      unitRef="usd">0</us-gaap:CapitalizedContractCostImpairmentLoss>
    <us-gaap:CapitalizedContractCostImpairmentLoss
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGV4dHJlZ2lvbjo0ZmQ4ODdmNzEzMWI0YTMwYjVhMGU0MjAxMDM5ZjZkM18yOTEzNzA1ODE2MTIwMA_31e67ff3-cc99-4afe-bca2-d42fc2c02fca"
      unitRef="usd">0</us-gaap:CapitalizedContractCostImpairmentLoss>
    <us-gaap:CapitalizedContractCostImpairmentLoss
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDM4L2ZyYWc6NGZkODg3ZjcxMzFiNGEzMGI1YTBlNDIwMTAzOWY2ZDMvdGV4dHJlZ2lvbjo0ZmQ4ODdmNzEzMWI0YTMwYjVhMGU0MjAxMDM5ZjZkM18yOTEzNzA1ODE2MTIwMA_f8f06aa8-0a59-4ec9-bbc8-2a24c6ac1835"
      unitRef="usd">0</us-gaap:CapitalizedContractCostImpairmentLoss>
    <us-gaap:InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90ZXh0cmVnaW9uOjBkZjE1MmE3YzBiNzRlNTBiNTQxYTNkZjMwNDM3OTczXzU2NjI0ODQ4ODQxMDM2_eda59157-447e-44a3-843e-f1bb9c5e6e06">Investments&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cost, gross unrealized gains and losses, and fair value of investments are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;As of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Cost or&lt;br/&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;22,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;22,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Corporate notes and bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,796)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;128,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Sovereign bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(334)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;549,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,260)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;531,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;705,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(20,494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;685,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;728,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(20,494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;708,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, the contractual maturities of the Company&#x2019;s available-for-sale debt securities were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Due within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;157,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Due in one year to three years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;530,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;687,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cost, gross unrealized gains and losses, and fair value of investments were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Cost or&lt;br/&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Corporate notes and bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;16,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;16,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;16,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;16,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Corporate notes and bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;46,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;46,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Sovereign bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;76,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;76,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;93,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;93,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022 and 2021, the Company has recognized accrued interest of $2.1 million and $0.3 million, respectively, which is included in prepaid expenses and other current assets in the consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unrealized losses associated with the Company&#x2019;s debt securities were $20.5 million as of March&#160;31, 2022. As the Company does not intend to sell these securities and it is more likely than not that the Company will hold these securities until maturity or until the cost basis is recovered, the Company did not recognize any impairment on these securities as of March&#160;31, 2022. The Company did not recognize any credit losses related to the Company&#x2019;s debt securities during the fiscal year ended March&#160;31, 2022. The fair value related to the debt securities with unrealized loss for which no credit losses were recognized was $684.7 million as of March&#160;31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unrealized losses associated with the Company&#x2019;s debt securities were not material as of March&#160;31, 2021. The Company did not recognize any credit losses related to the Company&#x2019;s debt securities during the fiscal year ended March&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90ZXh0cmVnaW9uOjBkZjE1MmE3YzBiNzRlNTBiNTQxYTNkZjMwNDM3OTczXzU2NjI0ODQ4ODQxMDM3_40b01fef-872b-4a72-8d9a-438ed5705688">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cost, gross unrealized gains and losses, and fair value of investments are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;As of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Cost or&lt;br/&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;22,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;22,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,791&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(51)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(53)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Corporate notes and bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(1,796)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;128,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Sovereign bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(334)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;8,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;549,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(18,260)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;531,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;705,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(20,494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;685,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;728,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(20,494)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;708,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The cost, gross unrealized gains and losses, and fair value of investments were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Cost or&lt;br/&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Corporate notes and bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;16,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;16,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,264&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;16,411&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;16,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Corporate notes and bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;46,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;46,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Sovereign bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,857&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;76,161&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;76,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;93,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(27)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;93,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="if9ae84d280eb4f318ba2a0260ea07425_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzMtMS0xLTEtODM1NTg_6f9d07cc-2363-44ef-8953-4c93abe28950"
      unitRef="usd">2686000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="if9ae84d280eb4f318ba2a0260ea07425_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzMtMy0xLTEtODM1NTg_3060ea69-6195-4949-884e-df229fcf041b"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="if9ae84d280eb4f318ba2a0260ea07425_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzMtNS0xLTEtODM1NTg_c79666c0-9c00-4661-af0b-2974dba3cc70"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="if9ae84d280eb4f318ba2a0260ea07425_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzMtOS0xLTEtODM1NTg_b8da9ba8-20f7-4eda-a1c3-47d472000290"
      unitRef="usd">2686000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="if9fdd40c78d445c3a42dd89ccb0a4447_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzUtMS0xLTEtODM1NTg_f0d62736-a649-426b-8591-9302f9c42d9d"
      unitRef="usd">20072000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="if9fdd40c78d445c3a42dd89ccb0a4447_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzUtOS0xLTEtODM1NTg_2bfcef17-29d0-4b89-9e3f-49f9913c8f16"
      unitRef="usd">20072000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <docs:CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost
      contextRef="ib54faec0bdf04bf2afd9946218f0ac8a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzctMS0xLTEtODM1NTg_50f6702a-949e-48c5-9379-d06cfd0e3205"
      unitRef="usd">22758000</docs:CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="ib54faec0bdf04bf2afd9946218f0ac8a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzctOS0xLTEtODM1NTg_af9625c8-1301-4488-ac80-5d2b3340045a"
      unitRef="usd">22758000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="iee115df4cfb64f938f087bc0a942628e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzktMS0xLTEtODM1NTg_668f5fbf-3729-4c35-91ee-9d29a5445af7"
      unitRef="usd">7791000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iee115df4cfb64f938f087bc0a942628e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzktMy0xLTEtODM1NTg_6443ac5e-fee5-4047-b992-07331b0846bf"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iee115df4cfb64f938f087bc0a942628e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzktNS0xLTEtODM1NTg_9157ddf9-a9e4-439e-b748-48bc2317c790"
      unitRef="usd">51000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="iee115df4cfb64f938f087bc0a942628e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzktOS0xLTEtODM1NTg_117af989-c3ff-4d09-bb9e-af816bcba136"
      unitRef="usd">7740000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i72ae2b0209f24d0a8a959903f8cc0c7a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzExLTEtMS0xLTgzNTU4_973efaea-43b8-4cff-8640-3b7df7762241"
      unitRef="usd">9436000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i72ae2b0209f24d0a8a959903f8cc0c7a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzExLTMtMS0xLTgzNTU4_9532a9ac-da5e-431b-8454-dc6be514cba5"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i72ae2b0209f24d0a8a959903f8cc0c7a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzExLTUtMS0xLTgzNTU4_efd1de31-6888-4490-b49f-ab0881779305"
      unitRef="usd">53000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i72ae2b0209f24d0a8a959903f8cc0c7a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzExLTktMS0xLTgzNTU4_278bdb55-45fb-4747-8ff0-11e78ead8389"
      unitRef="usd">9383000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i4492e8b1979a4c7ba9393c924e346c63_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzEyLTEtMS0xLTgzNTU4_7b453b3b-e34f-4e0e-84a6-b073324370c4"
      unitRef="usd">129900000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i4492e8b1979a4c7ba9393c924e346c63_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzEyLTMtMS0xLTgzNTU4_b67f945c-9c57-494e-a9d8-9dd7f8079d54"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i4492e8b1979a4c7ba9393c924e346c63_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzEyLTUtMS0xLTgzNTU4_a18555b0-b7f3-44a1-9a98-5e23b86d36be"
      unitRef="usd">1796000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i4492e8b1979a4c7ba9393c924e346c63_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzEyLTktMS0xLTgzNTU4_73ac729f-8902-4ec9-9e94-0415068d9523"
      unitRef="usd">128104000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i2e676ae804004183a75c60a053663a51_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzEzLTEtMS0xLTgzNTU4_b1e217e1-9d8e-4fdd-9231-91a1b1dd2fe3"
      unitRef="usd">8770000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i2e676ae804004183a75c60a053663a51_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzEzLTMtMS0xLTgzNTU4_f0fd8e13-f6f4-4a05-96d3-1af08c1dd57a"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i2e676ae804004183a75c60a053663a51_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzEzLTUtMS0xLTgzNTU4_d02d4179-979e-4214-a11e-e80b627ca1b7"
      unitRef="usd">334000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i2e676ae804004183a75c60a053663a51_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzEzLTktMS0xLTgzNTU4_f4d45dfd-fd77-45ed-96d3-346a0f39a56e"
      unitRef="usd">8436000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="iae88e8a7906f4f01a07b94eb7dc2e2bf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzE0LTEtMS0xLTgzNTU4_e36db7e1-9b5e-4f2b-970e-f8e9fb8863f4"
      unitRef="usd">549901000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iae88e8a7906f4f01a07b94eb7dc2e2bf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzE0LTMtMS0xLTgzNTU4_24020ef0-4e30-4123-8b19-d907173673f9"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iae88e8a7906f4f01a07b94eb7dc2e2bf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzE0LTUtMS0xLTgzNTU4_7c852c09-900b-4373-a20a-05ff08c7cf0d"
      unitRef="usd">18260000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="iae88e8a7906f4f01a07b94eb7dc2e2bf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzE0LTktMS0xLTgzNTU4_d9b727ee-e10e-435e-926c-d65525825a4d"
      unitRef="usd">531641000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i18044c22d5b544cdbb5fdd7bb2fe76d4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzE2LTEtMS0xLTgzNTU4_5999fad2-65df-4efe-aa02-6adbcd08c09f"
      unitRef="usd">705798000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i18044c22d5b544cdbb5fdd7bb2fe76d4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzE2LTMtMS0xLTgzNTU4_51337161-9156-48f2-b806-7be8037485bc"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i18044c22d5b544cdbb5fdd7bb2fe76d4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzE2LTUtMS0xLTgzNTU4_0916249a-b639-400e-a79e-f7f7f2b4a694"
      unitRef="usd">20494000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i18044c22d5b544cdbb5fdd7bb2fe76d4_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzE2LTktMS0xLTgzNTU4_48dec902-2a9f-4751-8910-8d92f80c8a5a"
      unitRef="usd">685304000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <docs:CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzE3LTEtMS0xLTgzNTU4_5ca0fd68-7ed7-4e41-84cd-df75472157f9"
      unitRef="usd">728556000</docs:CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzE3LTMtMS0xLTgzNTU4_c2506196-3178-4986-b6ed-973f7e263fd6"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzE3LTUtMS0xLTgzNTU4_7fe55c1f-e5dd-4cf2-aab8-4bfca4f9db4e"
      unitRef="usd">20494000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:CashCashEquivalentsAndShortTermInvestments
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MTg5MmJlODM0YzI0YTVhYjk5MTRjNTFmNWRlZWFhMS90YWJsZXJhbmdlOjYxODkyYmU4MzRjMjRhNWFiOTkxNGM1MWY1ZGVlYWExXzE3LTktMS0xLTgzNTU4_ed15f827-86fb-47c3-87fa-c7b50e6d5059"
      unitRef="usd">708062000</us-gaap:CashCashEquivalentsAndShortTermInvestments>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90ZXh0cmVnaW9uOjBkZjE1MmE3YzBiNzRlNTBiNTQxYTNkZjMwNDM3OTczXzU2NjI0ODQ4ODQxMDM5_028058d3-4cac-45ae-b380-d111f38e4f00">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, the contractual maturities of the Company&#x2019;s available-for-sale debt securities were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:87.204%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.596%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Due within one year&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;157,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Due in one year to three years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;530,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;687,990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo4MzUwYjk4YWI3Zjk0YWEzYTlhMjY1MzE2MGRlNzhmZS90YWJsZXJhbmdlOjgzNTBiOThhYjdmOTRhYTNhOWEyNjUzMTYwZGU3OGZlXzEtMS0xLTEtODM1NTg_818b406d-01cb-4f5b-894b-c57dbc6c646a"
      unitRef="usd">157948000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <docs:DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughThree
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo4MzUwYjk4YWI3Zjk0YWEzYTlhMjY1MzE2MGRlNzhmZS90YWJsZXJhbmdlOjgzNTBiOThhYjdmOTRhYTNhOWEyNjUzMTYwZGU3OGZlXzItMS0xLTEtODM1NTg_dcab6b27-4ee4-417e-be35-a5fcaa77a9d7"
      unitRef="usd">530042000</docs:DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughThree>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo4MzUwYjk4YWI3Zjk0YWEzYTlhMjY1MzE2MGRlNzhmZS90YWJsZXJhbmdlOjgzNTBiOThhYjdmOTRhYTNhOWEyNjUzMTYwZGU3OGZlXzMtMS0xLTEtODM1NTg_65e8ae7a-bc35-41eb-88fe-f6b559019619"
      unitRef="usd">687990000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i604823b3602e46ca831f8718dbb39615_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzMtMS0xLTEtODM1NTg_cd5a4ed5-2db0-422b-bebc-36955d557ac0"
      unitRef="usd">2290000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i604823b3602e46ca831f8718dbb39615_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzMtMy0xLTEtODM1NTg_9f3b445d-24cc-4562-810b-ed4c2cb53d84"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i604823b3602e46ca831f8718dbb39615_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzMtNS0xLTEtODM1NTg_98430932-e5fe-43c6-82e4-f4693730cae4"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i604823b3602e46ca831f8718dbb39615_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzMtOS0xLTEtODM1NTg_cdb975ff-3226-462f-a433-69d812f9c1a2"
      unitRef="usd">2290000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i4a05c1279cdf4518bd3081538e0be6be_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzQtMS0xLTEtODM1NTg_8a4761fa-5823-4224-a8fc-9d13476283d8"
      unitRef="usd">3517000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i4a05c1279cdf4518bd3081538e0be6be_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzQtMy0xLTEtODM1NTg_5461cd46-5179-40e0-a1c9-853408e5f52f"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i4a05c1279cdf4518bd3081538e0be6be_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzQtNS0xLTEtODM1NTg_9c4004b8-5a11-4e2f-9990-86d0bfed4f0d"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i4a05c1279cdf4518bd3081538e0be6be_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzQtOS0xLTEtODM1NTg_ad87014b-4719-4a97-a3b6-6363a93df1f0"
      unitRef="usd">3516000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="id244d9fec7044321a9fb14e83f5984f8_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzUtMS0xLTEtODM1NTg_e9ad4223-7994-4b21-9e70-d54afcf3db1b"
      unitRef="usd">9838000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="id244d9fec7044321a9fb14e83f5984f8_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzUtMy0xLTEtODM1NTg_8124bca1-e06a-4ba2-b67c-88390192dd51"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="id244d9fec7044321a9fb14e83f5984f8_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzUtNS0xLTEtODM1NTg_b7b79048-56c5-4ca1-9716-42616b1e0733"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="id244d9fec7044321a9fb14e83f5984f8_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzUtOS0xLTEtODM1NTg_a8cb212a-3396-4971-8e18-49e41caad058"
      unitRef="usd">9838000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i0ccabfb89c594e59b08be568c57aa776_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzYtMS0xLTEtODM1NTg_7f6340bb-b08a-46be-b6e2-7b464d2948f9"
      unitRef="usd">1301000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i0ccabfb89c594e59b08be568c57aa776_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzYtMy0xLTEtODM1NTg_d34120c1-eb53-4c53-8d5a-867b3dbef657"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i0ccabfb89c594e59b08be568c57aa776_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzYtNS0xLTEtODM1NTg_18fe21b0-623e-4be4-a97f-d464d15d4080"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i0ccabfb89c594e59b08be568c57aa776_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzYtOS0xLTEtODM1NTg_749bfcf3-5e94-47fc-9207-a7f78aa8dbb9"
      unitRef="usd">1301000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i48c4441bdd464dc0bb658f1e52a50fae_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzctMS0xLTEtODM1NTg_1537c87c-d22c-41c4-aa91-eadf853db432"
      unitRef="usd">16946000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i48c4441bdd464dc0bb658f1e52a50fae_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzctMy0xLTEtODM1NTg_86616619-c87e-4bc5-b151-eecb569f5a1c"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i48c4441bdd464dc0bb658f1e52a50fae_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzctNS0xLTEtODM1NTg_36ef0a39-2bb2-4b43-bc9f-0ad899c45934"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i48c4441bdd464dc0bb658f1e52a50fae_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzctOS0xLTEtODM1NTg_b9a49d33-1d5f-4fb6-9154-dee8ce51144d"
      unitRef="usd">16945000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i87abe2fab1ba4ef68a9cb17800dc430a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzktMS0xLTEtODM1NTg_7948821d-35a3-4014-98cb-8f9c5b7ef4f1"
      unitRef="usd">3264000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i87abe2fab1ba4ef68a9cb17800dc430a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzktMy0xLTEtODM1NTg_aaa1414d-6a4a-49ca-83d5-ec330fe08a52"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i87abe2fab1ba4ef68a9cb17800dc430a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzktNS0xLTEtODM1NTg_d5e6181f-f323-4b04-8c13-8b11c41fcf6c"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i87abe2fab1ba4ef68a9cb17800dc430a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzktOS0xLTEtODM1NTg_897d16e6-a1df-4bb6-8b3e-8ab0590e9178"
      unitRef="usd">3263000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i4e9550589bbf443f8841000a6dfbb584_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzEwLTEtMS0xLTgzNTU4_51faed7b-75d7-457e-b735-53ad989829be"
      unitRef="usd">4867000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i4e9550589bbf443f8841000a6dfbb584_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzEwLTMtMS0xLTgzNTU4_10275072-a3bd-4766-babd-6155a75a8b63"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i4e9550589bbf443f8841000a6dfbb584_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzEwLTUtMS0xLTgzNTU4_836f0a7e-16fc-4e52-b8e4-970f7f7ad8a1"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i4e9550589bbf443f8841000a6dfbb584_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzEwLTktMS0xLTgzNTU4_6aa3efea-269f-4dd2-a674-b59732fee8bb"
      unitRef="usd">4868000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="ide076cccc18c49e3a68b3143aa7c33e6_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzExLTEtMS0xLTgzNTU4_f4d604a7-6f1e-4574-8953-e01deee3012d"
      unitRef="usd">16411000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ide076cccc18c49e3a68b3143aa7c33e6_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzExLTMtMS0xLTgzNTU4_883d5430-39fd-4778-9a7b-fc50d1adb02b"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ide076cccc18c49e3a68b3143aa7c33e6_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzExLTUtMS0xLTgzNTU4_92a63452-7139-4e36-b102-c4e2fd26d8ce"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ide076cccc18c49e3a68b3143aa7c33e6_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzExLTktMS0xLTgzNTU4_359b88b0-60e7-4a0b-a524-2d46951a7e03"
      unitRef="usd">16412000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="iec88dd752efb47fab5bb0033f85e57f0_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzEyLTEtMS0xLTgzNTU4_0c9c1535-0575-4461-bb73-dce09184b0f3"
      unitRef="usd">46662000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iec88dd752efb47fab5bb0033f85e57f0_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzEyLTMtMS0xLTgzNTU4_c9ff9f1f-41d1-4b8d-a05e-c49f8ff6be49"
      unitRef="usd">3000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iec88dd752efb47fab5bb0033f85e57f0_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzEyLTUtMS0xLTgzNTU4_2ad78a11-4651-4d63-a5ad-9ba49300e84a"
      unitRef="usd">24000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="iec88dd752efb47fab5bb0033f85e57f0_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzEyLTktMS0xLTgzNTU4_50ea9d7d-f5eb-40c6-bd5e-3c6fa3de92db"
      unitRef="usd">46641000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="ib527f78664c7491ea47de8f8270b318c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzEzLTEtMS0xLTgzNTU4_2ee1b482-c20c-4253-b298-09a36244dd50"
      unitRef="usd">1100000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="ib527f78664c7491ea47de8f8270b318c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzEzLTMtMS0xLTgzNTU4_4bea9656-145b-4ff7-a1ce-ebcebcaec99c"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ib527f78664c7491ea47de8f8270b318c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzEzLTUtMS0xLTgzNTU4_1078e545-f88f-4e62-9305-410d7fc0ce29"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ib527f78664c7491ea47de8f8270b318c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzEzLTktMS0xLTgzNTU4_ef890b6a-0b0a-4891-9a13-374d822abe39"
      unitRef="usd">1099000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="iacfd3978047743d09395e66d7259d2ff_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzE0LTEtMS0xLTgzNTU4_9efdd27f-8b12-4558-bd55-2094dc2b00f0"
      unitRef="usd">3857000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="iacfd3978047743d09395e66d7259d2ff_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzE0LTMtMS0xLTgzNTU4_c4e86d40-57c9-4252-a2b5-6453f9cec5f6"
      unitRef="usd">1000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="iacfd3978047743d09395e66d7259d2ff_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzE0LTUtMS0xLTgzNTU4_b66f241c-1cce-42d7-acd1-b7e4bcacea84"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="iacfd3978047743d09395e66d7259d2ff_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzE0LTktMS0xLTgzNTU4_433d6a04-3ff4-49cf-a4b5-aba4ea0fa24f"
      unitRef="usd">3858000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i38b0eb18f6f9433eb026f897885f67f9_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzE1LTEtMS0xLTgzNTU4_3915518e-3f69-4d7b-9a42-fdfd6f51fc33"
      unitRef="usd">76161000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i38b0eb18f6f9433eb026f897885f67f9_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzE1LTMtMS0xLTgzNTU4_286de396-d03a-4bf3-b801-f8216f918e87"
      unitRef="usd">6000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i38b0eb18f6f9433eb026f897885f67f9_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzE1LTUtMS0xLTgzNTU4_2825410b-a5ef-4f66-9475-31137aafade6"
      unitRef="usd">26000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i38b0eb18f6f9433eb026f897885f67f9_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzE1LTktMS0xLTgzNTU4_1c25d3cc-5fe9-4270-a9e8-b292a3fdf34e"
      unitRef="usd">76141000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzE2LTEtMS0xLTgzNTU4_557aee50-1973-4cf2-8072-e4912d2896fa"
      unitRef="usd">93107000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzE2LTMtMS0xLTgzNTU4_c61bffd2-4d9f-48a6-ac8d-d69e579314b6"
      unitRef="usd">6000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzE2LTUtMS0xLTgzNTU4_45c20189-3b5d-4f1b-8221-dac78d0a270a"
      unitRef="usd">27000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90YWJsZTo2MzU5MDdhMTZmODI0ZmUyODQ3ZmJmMDhmMjdmNmVlYS90YWJsZXJhbmdlOjYzNTkwN2ExNmY4MjRmZTI4NDdmYmYwOGYyN2Y2ZWVhXzE2LTktMS0xLTgzNTU4_63217822-da30-4fd1-a707-4835f7159101"
      unitRef="usd">93086000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90ZXh0cmVnaW9uOjBkZjE1MmE3YzBiNzRlNTBiNTQxYTNkZjMwNDM3OTczXzI5MTM3MDU4MTQ2MDc2_2cfeb562-56e7-4902-901a-ac37d5af7fff"
      unitRef="usd">2100000</us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90ZXh0cmVnaW9uOjBkZjE1MmE3YzBiNzRlNTBiNTQxYTNkZjMwNDM3OTczXzI5MTM3MDU4MTQ2MDk0_d6283ace-55c4-436c-867d-80bbffcaec70"
      unitRef="usd">300000</us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90ZXh0cmVnaW9uOjBkZjE1MmE3YzBiNzRlNTBiNTQxYTNkZjMwNDM3OTczXzI5MTM3MDU4MTQ2MTM5_5bed2778-ebe9-498b-ad72-32c4d987d0c3"
      unitRef="usd">20500000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <docs:DebtSecuritiesAvailableForSaleImpairmentsLoss
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90ZXh0cmVnaW9uOjBkZjE1MmE3YzBiNzRlNTBiNTQxYTNkZjMwNDM3OTczXzI5MTM3MDU4MTUyODkz_43e04676-17f4-44ec-87ca-24f822b07714"
      unitRef="usd">0</docs:DebtSecuritiesAvailableForSaleImpairmentsLoss>
    <us-gaap:DebtSecuritiesAvailableForSaleChangeInPresentValueExpenseReversal
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90ZXh0cmVnaW9uOjBkZjE1MmE3YzBiNzRlNTBiNTQxYTNkZjMwNDM3OTczXzI5MTM3MDU4MTQ2MTUw_2782a44d-dbdd-46d2-9110-544c09f3ff7d"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleChangeInPresentValueExpenseReversal>
    <docs:DebtSecuritiesAvailableForSaleWithNoCreditAllowance
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90ZXh0cmVnaW9uOjBkZjE1MmE3YzBiNzRlNTBiNTQxYTNkZjMwNDM3OTczXzI5MTM3MDU4MTQ2MjI4_eda81a9d-14e0-46c2-9125-c1b72d409ad9"
      unitRef="usd">684700000</docs:DebtSecuritiesAvailableForSaleWithNoCreditAllowance>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90ZXh0cmVnaW9uOjBkZjE1MmE3YzBiNzRlNTBiNTQxYTNkZjMwNDM3OTczXzI5MTM3MDU4MTQ2MjY2_07131054-3bc0-4ddf-af25-44adb4f0af39"
      unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:DebtSecuritiesAvailableForSaleChangeInPresentValueExpenseReversal
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTMvZnJhZzowZGYxNTJhN2MwYjc0ZTUwYjU0MWEzZGYzMDQzNzk3My90ZXh0cmVnaW9uOjBkZjE1MmE3YzBiNzRlNTBiNTQxYTNkZjMwNDM3OTczXzI5MTM3MDU4MTQ2Mjg5_2e1c941e-bb24-4f90-b48b-435f366aa8ef"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleChangeInPresentValueExpenseReversal>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGV4dHJlZ2lvbjo0Njc1NGE1MTJmOGE0YWJlOTU2YTUzZDkyMzU3MjE2Nl81NjYyNDg0ODgzMzY4NA_f0d35a2e-1174-43c8-bf0e-fd01d405e200">Fair Value Measurements &lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the fair value hierarchy for the Company&#x2019;s assets measured at fair value on a recurring basis (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;20,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;20,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;20,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;22,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Corporate notes and bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;128,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;128,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Sovereign bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;8,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;8,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;530,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;531,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;530,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;155,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;685,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;550,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;157,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;708,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Corporate notes and bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;16,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;16,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;16,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Corporate notes and bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;46,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;46,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Sovereign bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;72,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;76,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;13,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;79,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;93,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fiscal years ended March&#160;31, 2022 and 2021, the Company had no transfers between levels of the fair value hierarchy.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGV4dHJlZ2lvbjo0Njc1NGE1MTJmOGE0YWJlOTU2YTUzZDkyMzU3MjE2Nl81NjYyNDg0ODgzMzY4NQ_8f81ab72-629f-49e9-8cfb-03a189adaf5c">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present the fair value hierarchy for the Company&#x2019;s assets measured at fair value on a recurring basis (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;20,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;20,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;20,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,686&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;22,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Corporate notes and bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;128,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;128,104&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Sovereign bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;8,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;8,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;530,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;531,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;530,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;155,130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;685,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;550,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;157,816&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;708,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.361%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash equivalents:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Corporate notes and bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Money market funds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;16,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Marketable securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Asset-backed securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Certificates of deposit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;16,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;16,412&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Corporate notes and bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;46,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;46,641&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Sovereign bonds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,099&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;U.S. government and agency securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;72,283&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;76,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total cash equivalents and marketable securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;13,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;79,390&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;93,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ibcd72d89f10e46c5b83365968fb5b465_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8zLTEtMS0xLTgzNjAx_9eb461c3-c2d8-4066-a3eb-43460cf79388"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i44d67e5169294894b512b0b90c0c74af_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8zLTMtMS0xLTgzNjAx_59472335-70db-4874-9639-4eca4f889fbd"
      unitRef="usd">2686000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i4f0c5fbad8e940fd82c45fb0835f9376_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8zLTUtMS0xLTgzNjAx_df6d72b3-bb6c-4ecc-b60e-7f7c43d62dd8"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i26380d7634b346848bd64d717640dbd3_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8zLTctMS0xLTgzNjAx_bc37f566-8688-430b-9732-42a3bedb0eaa"
      unitRef="usd">2686000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i2990b50678e04606a12ac8e532c0f906_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF81LTEtMS0xLTgzNjAx_daaa0bc7-b2c3-4cab-bdf2-a39aa0bf4076"
      unitRef="usd">20072000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i98b116561d274486a93f0e9b833bbc09_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF81LTMtMS0xLTgzNjAx_9af537f8-69ca-461b-b2d4-ff43a1c72df2"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i13a7068cde934ebfaf0a93dc825b200e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF81LTUtMS0xLTgzNjAx_c5c187e9-3f39-4960-9ede-cb3329ece324"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i103e1316eb1546e9a33a93b9ee8e5d23_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF81LTctMS0xLTgzNjAx_4f006121-b156-40a0-812b-39ec92b82f55"
      unitRef="usd">20072000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i659c295d408e40e8921b445dd9705cba_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF83LTEtMS0xLTgzNjAx_e7fb3a8a-43e3-4f4a-9cc7-b98021b1f4ab"
      unitRef="usd">20072000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="if2b46ddbd30649f9964d6b0aef51743e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF83LTMtMS0xLTgzNjAx_77c8eac7-a40f-494b-8f44-0ffcc59f5854"
      unitRef="usd">2686000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i2a78b23143e94b05b7011088f1bde0b1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF83LTUtMS0xLTgzNjAx_182ee517-41ad-43e3-a804-bee2b598bca8"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i3f12428258e7416aa2c26ccc9570922a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF83LTctMS0xLTgzNjAx_536f3cee-6aed-4177-bcf1-9ca480a59504"
      unitRef="usd">22758000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i721efafc234b48ab8ea99bb7a86b14aa_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF85LTEtMS0xLTgzNjAx_0fa94706-610c-44fc-888a-41f569489095"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i6f8b0fb1f6524927bd336e7e7061c237_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF85LTMtMS0xLTgzNjAx_011ed065-9ac0-40b1-aa6d-29030958f695"
      unitRef="usd">7740000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="id38c2d8b49424805aa289162c32d7b9e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF85LTUtMS0xLTgzNjAx_042f288e-cb2b-498a-b149-3c0090c1a24c"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i474320908a7b41cc92efce9528819f7b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF85LTctMS0xLTgzNjAx_fe967102-cb82-4982-a5d7-fd14b37fd958"
      unitRef="usd">7740000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i532a3e060f834264ba3c527d40875cdc_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xMS0xLTEtMS04MzYwMQ_8b47f5f4-8081-44ae-a552-6cf3ac4f4890"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i9f7356c1933c44718bcba9bf1f352ba2_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xMS0zLTEtMS04MzYwMQ_fc1bfc00-10ed-4a6d-b803-c6ab42973120"
      unitRef="usd">9383000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i626d1eeffa1343138b59969cf31cd762_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xMS01LTEtMS04MzYwMQ_d501fcfb-449a-4ef4-88db-5f18651c435a"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i4d81508e21044c96b9ecd160987e38c8_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xMS03LTEtMS04MzYwMQ_52f1f475-07b5-489f-b604-fc474bfc9d00"
      unitRef="usd">9383000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i932aa3c5dd54406697aee512b3d1806e_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xMi0xLTEtMS04MzYwMQ_74414aa9-b794-41e4-839a-2167d2284954"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i3721da26311a44e19ada2d73129c607c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xMi0zLTEtMS04MzYwMQ_47db5b24-67c0-4fcf-be65-03c82b84d510"
      unitRef="usd">128104000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ib6c70759748f44a39409b9430d98472c_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xMi01LTEtMS04MzYwMQ_1613e848-471f-4a2e-8d06-44e5702d7d23"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i4a3cd669c0874efaa60ccd3fd01baaa5_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xMi03LTEtMS04MzYwMQ_e1d4970d-1b22-4a01-917a-03d0f546dd62"
      unitRef="usd">128104000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i982c335e998347a28b119b85613cdb3a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xMy0xLTEtMS04MzYwMQ_6d55ebea-215a-4178-9300-f8a2bd77b9ed"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ib38daf1082dc430a9b64f0b7677f6c83_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xMy0zLTEtMS04MzYwMQ_8470ff90-6977-45af-ada3-e1998aaaefe9"
      unitRef="usd">8436000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i38bda6505b4f4adf916f0a3922a00d63_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xMy01LTEtMS04MzYwMQ_dc3e23ab-e294-4fe7-9390-733ea78ac935"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ia91151d0fa9747bb8b8c5d38d7072ad2_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xMy03LTEtMS04MzYwMQ_e2c7abb8-c56c-4629-b729-6a06c0b8f963"
      unitRef="usd">8436000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i18e4692c47ad48329cebc83bc3799e68_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xNC0xLTEtMS04MzYwMQ_cc6c6137-acad-4ed3-8e91-4314f3ab8fd1"
      unitRef="usd">530174000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ifb043afb1f564202b46d46afa0477aaf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xNC0zLTEtMS04MzYwMQ_af13798a-e81e-44c2-80c5-ab18845f4c33"
      unitRef="usd">1467000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i3bcc674299c845768df66da1b2f5bdb2_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xNC01LTEtMS04MzYwMQ_2f7ab420-c754-4366-8617-9166f1dddcc7"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="iafc2fd89312947f7a003de3d37d11718_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xNC03LTEtMS04MzYwMQ_b50748ed-ba65-4e57-a488-279d7c76f91c"
      unitRef="usd">531641000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ice4e787e809040d7940ae9963883e5f6_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xNi0xLTEtMS04MzYwMQ_1ea924d1-42b7-42b5-b8f3-36d3058740ac"
      unitRef="usd">530174000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="iac3932efeb454191b80019d9cc3d5da8_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xNi0zLTEtMS04MzYwMQ_b59f8efb-2886-4da4-9af4-aeca5b8f9f5d"
      unitRef="usd">155130000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ib9b4c1c4fcf94d5695baa53fb6a9f916_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xNi01LTEtMS04MzYwMQ_43d73544-79f5-454d-b7a5-55cb9fec5993"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i86cda120cc8c4375b1f2178ee70c45d1_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xNi03LTEtMS04MzYwMQ_e2995454-046e-49f2-825b-f73420a5d14e"
      unitRef="usd">685304000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i578db33c6a934072bbe067902c563ae8_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xNy0xLTEtMS04MzYwMQ_e1fbab55-2f0c-4d8b-a0fa-98db1b2bb007"
      unitRef="usd">550246000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i4c4f245f500f4927ad1eb8d7f12714bc_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xNy0zLTEtMS04MzYwMQ_106a7e50-9438-4ceb-b892-9ac7003de66a"
      unitRef="usd">157816000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i8476dc0fc3544b828b4aacf4934129b5_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xNy01LTEtMS04MzYwMQ_6f86cc2d-e81b-4f07-b726-bc7060bb17d4"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ie03e89c5126d41ec830e87d4165cf777_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6YmI1MTg2ZDQ5NzhlNGRmYWFjYTI2ODJiMjEyNGVlYzQvdGFibGVyYW5nZTpiYjUxODZkNDk3OGU0ZGZhYWNhMjY4MmIyMTI0ZWVjNF8xNy03LTEtMS04MzYwMQ_f9eec43f-0cd1-4eb1-9db6-78607ccbe286"
      unitRef="usd">708062000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i56c340497cf441e683bdc17f8fc2ff7e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8zLTEtMS0xLTgzNjAx_e5fe7e1d-71d4-4d6c-a05e-8465e5d922a1"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i99d6758926cc4835972af44c8abfea6e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8zLTMtMS0xLTgzNjAx_25acc87d-3267-413c-a7ad-59e1ce5d6ba9"
      unitRef="usd">2290000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ifa762a9d99d64e26b88344760669498d_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8zLTUtMS0xLTgzNjAx_92e10903-5b07-41a8-8b5a-055db6057bc1"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ibb407695229442378be2cc5e6794b4dc_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8zLTctMS0xLTgzNjAx_f77c7ba5-d51f-49d9-a4dd-65299158eab1"
      unitRef="usd">2290000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i8c3a8d602839469aa9abd46d6b23c3b7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl80LTEtMS0xLTgzNjAx_8aac5308-af74-4e2d-859a-3804cbb19f77"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i45d51c39fc29442b936469cf96558a7a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl80LTMtMS0xLTgzNjAx_b2152b2e-5ef1-4f68-a906-293df0f1a023"
      unitRef="usd">3516000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i674cc6fab0fb438a93e5000f47d071fd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl80LTUtMS0xLTgzNjAx_92189bd3-63e0-4b12-b7f5-aec98cfbfca5"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i6c14c0c571b24e4a8f722913926177f6_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl80LTctMS0xLTgzNjAx_53210c01-a0d6-4a21-8869-284dda44c403"
      unitRef="usd">3516000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i838d198056aa4046821706ffe91ac209_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl81LTEtMS0xLTgzNjAx_89fda72d-bd46-4bd5-83b8-ee797d951c86"
      unitRef="usd">9838000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i8285a266d2b84f64a873ce73025e5feb_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl81LTMtMS0xLTgzNjAx_dba43dc8-ee5f-449a-b08a-a52236e8a623"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i022beaddadf04d3e99f5082fadd56106_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl81LTUtMS0xLTgzNjAx_bb80ca8f-4848-485c-89c4-1ab11fbfeb5d"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i6b1782e4152f4dd3a6b1f5b27d8f1bac_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl81LTctMS0xLTgzNjAx_37b6fab9-c1d5-47af-ac8a-3023bb7a8b49"
      unitRef="usd">9838000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ib9b9e40170a94d1597c47f1a840054a0_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl82LTEtMS0xLTgzNjAx_9463da1f-72ab-4ded-a5c7-b62721344f35"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i5ed0533ee5e34be3943e9fbebc78267c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl82LTMtMS0xLTgzNjAx_212192a0-3a54-40ec-9b92-1c2c29cf8d03"
      unitRef="usd">1301000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i9843e9aa5aa34d629a04be568ee0770f_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl82LTUtMS0xLTgzNjAx_93686d43-6c9e-440e-90ba-df2d3c7f8314"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i55a153d9fcf6462a90947a8c0cc01fad_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl82LTctMS0xLTgzNjAx_a51f4ce7-b723-481c-94f6-3dbabc3bb4a0"
      unitRef="usd">1301000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i92d19978f3d74e8393d55173e3261600_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl83LTEtMS0xLTgzNjAx_03e7c12e-5f52-4e45-bcc8-a40e92ae42d0"
      unitRef="usd">9838000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i58b67667851745b0921de5486a701250_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl83LTMtMS0xLTgzNjAx_640e484f-4495-4aee-98ba-327db7fdcba1"
      unitRef="usd">7107000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="iabb825f6081140068a661c6fce29a765_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl83LTUtMS0xLTgzNjAx_414544f2-74f3-4a3e-89e8-12b3d4d84e77"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i9e5dd024a0ab400e9341bcfe83899418_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl83LTctMS0xLTgzNjAx_a14ac914-fbe6-437d-8ba7-30c09638f704"
      unitRef="usd">16945000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i149cf0ff47ea404db23f4e4a1bc5fcdc_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl85LTEtMS0xLTgzNjAx_a37e33e6-d25a-4410-be9c-3a8039fb61f3"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i6866262bbd66464e9d4917805ca3ad7e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl85LTMtMS0xLTgzNjAx_ec7e0ca7-7073-4e1d-a524-e680ccc5086f"
      unitRef="usd">3263000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i2b6266c5703b4348bebf658eb91fde7f_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl85LTUtMS0xLTgzNjAx_fd062f38-5441-4c2e-9ab2-5b3b1e6ecbcb"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ia44e2eb3c48e4364866cc26deb91d1a3_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl85LTctMS0xLTgzNjAx_1d78d526-8746-47c2-bddd-47c645f765d3"
      unitRef="usd">3263000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i5432548d20a44dd691468cebc30236b7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xMC0xLTEtMS04MzYwMQ_5b1b620e-ea6f-4d79-82e3-0c2cf7956f05"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="iea566254ac80466eb792b98fee4468fc_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xMC0zLTEtMS04MzYwMQ_707b854d-9542-4d21-af20-bffe1e87a67a"
      unitRef="usd">4868000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="if27d9ddc7c024d20a99d07f62ff1a2e1_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xMC01LTEtMS04MzYwMQ_4fcea5b3-dcc6-4c8b-99b4-eb2f50f91823"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ib3515ce776444aa4be7ca30f76d95991_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xMC03LTEtMS04MzYwMQ_cafa3260-33cd-425d-a665-14cda7da7bf7"
      unitRef="usd">4868000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ie5c40b8b60cd40c8b22509a920df6d06_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xMS0xLTEtMS04MzYwMQ_6bbeb87f-5979-4a33-9655-dfe3dc75403c"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i611917e8f7cf4a16937ba03415273dcd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xMS0zLTEtMS04MzYwMQ_1c2375b5-16ba-45fd-a756-9649638ae380"
      unitRef="usd">16412000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i41a927ca494a4351bd716a0e60b21d1e_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xMS01LTEtMS04MzYwMQ_6de2cd03-75c7-4cb2-83c7-052c3468ffa7"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i82b9f2d9387b45499ebeca44b8440fae_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xMS03LTEtMS04MzYwMQ_46fe798d-48c6-455c-a918-07d1f91cc65f"
      unitRef="usd">16412000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i34e4bf763fea49b5bdcf75dc219e7e92_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xMi0xLTEtMS04MzYwMQ_d8ec070a-31a7-4052-8d69-1a0bba62fc81"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i349cf5c5812341ab8fa0686e31856780_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xMi0zLTEtMS04MzYwMQ_8a4eb224-5844-4e55-9c0a-ec3da2b02b77"
      unitRef="usd">46641000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i1cb90c50d62d4afbb1940f34e2a856de_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xMi01LTEtMS04MzYwMQ_47c025f0-a9d7-4752-aabf-8a0eb633e1e5"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i2f039878467d46c288ef097207b6975b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xMi03LTEtMS04MzYwMQ_e33f8aa9-becc-449d-b254-99780fbbe512"
      unitRef="usd">46641000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i3b01aa2ae05c4047a50651aab2e681d7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xMy0xLTEtMS04MzYwMQ_6c53ef29-e0f7-4784-8d7f-56ec71c99a7b"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i719069eb844247a9b2bd30c54120b216_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xMy0zLTEtMS04MzYwMQ_2103d516-c65a-445b-b60b-133ba0cd5b95"
      unitRef="usd">1099000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ie3163cbc1f2442c08773e69ca6f51425_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xMy01LTEtMS04MzYwMQ_542c5abd-7805-42df-9b89-2270eea40bfc"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i5d93e12f702349bd99bf9d5330c3fb1b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xMy03LTEtMS04MzYwMQ_2cd58e1d-e6de-49cf-905c-ac17ede58cf2"
      unitRef="usd">1099000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i92a4a2d0006947a8927335cfa305416f_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xNC0xLTEtMS04MzYwMQ_c7135df2-8c32-484f-9fb5-69dbf81077a3"
      unitRef="usd">3858000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="id1df4b610f3946d98ae080e642659498_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xNC0zLTEtMS04MzYwMQ_21553759-166a-4e4d-89da-bc414d7c6eee"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i5373de11d949417cbb36d85c87552143_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xNC01LTEtMS04MzYwMQ_ee3d23bc-e5f6-4a67-8d21-817c1517ef79"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ia35ead93812940d69566b0152cbba00b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xNC03LTEtMS04MzYwMQ_a6c9fde7-1d51-43af-afcd-9a2dca77bcf8"
      unitRef="usd">3858000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i309ea865186047c0a5538f09e3c70ca9_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xNS0xLTEtMS04MzYwMQ_e55f8b7f-698c-409b-a785-f1e9036b9db9"
      unitRef="usd">3858000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ib27f206c94d44a2ea0ddaed560a54ac0_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xNS0zLTEtMS04MzYwMQ_743b5865-d242-4eca-af47-7728a2b663ac"
      unitRef="usd">72283000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i8e0ec08cc952440a92e76047bc39557f_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xNS01LTEtMS04MzYwMQ_1a4ec0a1-2db8-437b-a99d-069da0e4d634"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i5de02ef242964b299f7003623da7eef4_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xNS03LTEtMS04MzYwMQ_9450e859-f8d4-4cd1-b263-fb85807d02f3"
      unitRef="usd">76141000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i8fd4715dabf14628bd22641238042d34_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xNi0xLTEtMS04MzYwMQ_58ad6ef8-2018-418b-8920-0d7f5af9e4fe"
      unitRef="usd">13696000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ia9f7e9e66c5b4bb09aa27555e1ad1902_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xNi0zLTEtMS04MzYwMQ_13190f31-8bd5-41e3-b4f1-4a639868a802"
      unitRef="usd">79390000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="i83568bca22424ed2b2bcc387ae3fc3a2_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xNi01LTEtMS04MzYwMQ_e2386a5b-3b3e-41f6-8070-44cd517ff143"
      unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest
      contextRef="ib1b26c7fd27543afab7eb6101e431209_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yNDYxL2ZyYWc6NDY3NTRhNTEyZjhhNGFiZTk1NmE1M2Q5MjM1NzIxNjYvdGFibGU6OTExZjRlZjVhZjY5NGRmNWE0NDViNDg1YzYxMzYxN2YvdGFibGVyYW5nZTo5MTFmNGVmNWFmNjk0ZGY1YTQ0NWI0ODVjNjEzNjE3Zl8xNi03LTEtMS04MzYwMQ_14c40437-5a9a-4de3-88f5-0971fe16886a"
      unitRef="usd">93086000</us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90ZXh0cmVnaW9uOjRkYWRhMDgyMTgwMTQyZTE4NTc2MjkyNDBiNjUyZWQ0XzU2NjI0ODQ4ODM1OTg4_5a474adf-ce82-4cd8-911d-6e816eeb9a3a">Property and Equipment, Net&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net consisted of the following (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.075%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;As of March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;299&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Computers and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;704&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;549&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Internal-use software development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;15,057&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;10,908&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;16,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;12,460&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Less: accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(8,470)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4,862)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;8,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation and amortization expense on property and equipment for the fiscal years ended March&#160;31, 2022, 2021, and 2020 was $4.0 million, $2.6 million and $0.9 million, respectively. Included in these amounts was amortization expense for internal-use software development costs of $3.5 million, $2.2 million and $0.7 million for the fiscal years ended March&#160;31, 2022, 2021, and 2020, respectively. The amortization of the internal-use software development costs is included in cost of revenue in the consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended March&#160;31, 2022, 2021, and 2020, the Company capitalized $4.3 million, $4.6 million, and $4.1 million, respectively, of internal-use software development costs, which are included in property and equipment, net on the consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No impairment was recognized on property and equipment during the years ended March&#160;31, 2022, 2021, and 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i973ce033b5444e8184b98b45f2f762bf_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90YWJsZTo5NjVmNTk0MTczYmI0MWUyYTk2ZjZiYmZiYWM5NzgwZC90YWJsZXJhbmdlOjk2NWY1OTQxNzNiYjQxZTJhOTZmNmJiZmJhYzk3ODBkXzEtMS0xLTEtODM2ODU_5c621b18-bd89-40ce-9166-556fc2344e66"
      unitRef="usd">336000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i408a5f0dc11f4858abf1563a67979081_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90YWJsZTo5NjVmNTk0MTczYmI0MWUyYTk2ZjZiYmZiYWM5NzgwZC90YWJsZXJhbmdlOjk2NWY1OTQxNzNiYjQxZTJhOTZmNmJiZmJhYzk3ODBkXzEtMy0xLTEtODM2ODU_2b5f9c2b-ee50-4411-a242-8dc5993f9ba8"
      unitRef="usd">299000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i1da69909cef146178323e0df47516982_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90YWJsZTo5NjVmNTk0MTczYmI0MWUyYTk2ZjZiYmZiYWM5NzgwZC90YWJsZXJhbmdlOjk2NWY1OTQxNzNiYjQxZTJhOTZmNmJiZmJhYzk3ODBkXzItMS0xLTEtODM2ODU_00dbb913-dc82-46e5-a7e7-8d3cfd73dd5d"
      unitRef="usd">769000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ief36ad090dfc4a189faf599f7900747f_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90YWJsZTo5NjVmNTk0MTczYmI0MWUyYTk2ZjZiYmZiYWM5NzgwZC90YWJsZXJhbmdlOjk2NWY1OTQxNzNiYjQxZTJhOTZmNmJiZmJhYzk3ODBkXzItMy0xLTEtODM2ODU_af2eaead-4531-4b3b-9eb5-df7247894694"
      unitRef="usd">704000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i2c6dd1041fd64455ab9d78b3daad3f68_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90YWJsZTo5NjVmNTk0MTczYmI0MWUyYTk2ZjZiYmZiYWM5NzgwZC90YWJsZXJhbmdlOjk2NWY1OTQxNzNiYjQxZTJhOTZmNmJiZmJhYzk3ODBkXzMtMS0xLTEtODM2ODU_f4e512b2-bab1-4e39-a099-c09e12de861a"
      unitRef="usd">796000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i5edcc49f367e4d8c82a0bbeef2050a74_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90YWJsZTo5NjVmNTk0MTczYmI0MWUyYTk2ZjZiYmZiYWM5NzgwZC90YWJsZXJhbmdlOjk2NWY1OTQxNzNiYjQxZTJhOTZmNmJiZmJhYzk3ODBkXzMtMy0xLTEtODM2ODU_57f0db7b-19b6-4cd6-8574-951504400220"
      unitRef="usd">549000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ib5b202e466ea48b083f080fed8852b3f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90YWJsZTo5NjVmNTk0MTczYmI0MWUyYTk2ZjZiYmZiYWM5NzgwZC90YWJsZXJhbmdlOjk2NWY1OTQxNzNiYjQxZTJhOTZmNmJiZmJhYzk3ODBkXzQtMS0xLTEtODM2ODU_7c345235-e909-4c84-a458-a4e041128e1f"
      unitRef="usd">15057000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i28a7eabc1a4d486b92834db5677e9a27_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90YWJsZTo5NjVmNTk0MTczYmI0MWUyYTk2ZjZiYmZiYWM5NzgwZC90YWJsZXJhbmdlOjk2NWY1OTQxNzNiYjQxZTJhOTZmNmJiZmJhYzk3ODBkXzQtMy0xLTEtODM2ODU_a0c0549b-ba37-4fec-acf6-9c7491b79f1d"
      unitRef="usd">10908000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90YWJsZTo5NjVmNTk0MTczYmI0MWUyYTk2ZjZiYmZiYWM5NzgwZC90YWJsZXJhbmdlOjk2NWY1OTQxNzNiYjQxZTJhOTZmNmJiZmJhYzk3ODBkXzUtMS0xLTEtODM2ODU_8baf2f6c-69f6-4760-995d-62564a36383f"
      unitRef="usd">16958000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90YWJsZTo5NjVmNTk0MTczYmI0MWUyYTk2ZjZiYmZiYWM5NzgwZC90YWJsZXJhbmdlOjk2NWY1OTQxNzNiYjQxZTJhOTZmNmJiZmJhYzk3ODBkXzUtMy0xLTEtODM2ODU_e7edaab6-3e82-41be-aad2-27b5ff93fef1"
      unitRef="usd">12460000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90YWJsZTo5NjVmNTk0MTczYmI0MWUyYTk2ZjZiYmZiYWM5NzgwZC90YWJsZXJhbmdlOjk2NWY1OTQxNzNiYjQxZTJhOTZmNmJiZmJhYzk3ODBkXzYtMS0xLTEtODM2ODU_f26dd5ef-2231-491d-933f-5e2261919499"
      unitRef="usd">8470000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90YWJsZTo5NjVmNTk0MTczYmI0MWUyYTk2ZjZiYmZiYWM5NzgwZC90YWJsZXJhbmdlOjk2NWY1OTQxNzNiYjQxZTJhOTZmNmJiZmJhYzk3ODBkXzYtMy0xLTEtODM2ODU_8184729d-adfe-4941-99fa-c516dd92287d"
      unitRef="usd">4862000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90YWJsZTo5NjVmNTk0MTczYmI0MWUyYTk2ZjZiYmZiYWM5NzgwZC90YWJsZXJhbmdlOjk2NWY1OTQxNzNiYjQxZTJhOTZmNmJiZmJhYzk3ODBkXzctMS0xLTEtODM2ODU_00802c34-ca56-45d6-b5e7-ec07209766d5"
      unitRef="usd">8488000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90YWJsZTo5NjVmNTk0MTczYmI0MWUyYTk2ZjZiYmZiYWM5NzgwZC90YWJsZXJhbmdlOjk2NWY1OTQxNzNiYjQxZTJhOTZmNmJiZmJhYzk3ODBkXzctMy0xLTEtODM2ODU_ddf1c5af-e84e-4baf-8ce6-f74681b2d030"
      unitRef="usd">7598000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90ZXh0cmVnaW9uOjRkYWRhMDgyMTgwMTQyZTE4NTc2MjkyNDBiNjUyZWQ0XzI5MTM3MDU4MTM5NDQ2_26672ad9-ce70-401a-b80a-917edb52c9ea"
      unitRef="usd">4000000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90ZXh0cmVnaW9uOjRkYWRhMDgyMTgwMTQyZTE4NTc2MjkyNDBiNjUyZWQ0XzI5MTM3MDU4MTM5NDU1_8b4358f2-683f-496c-aa64-dcd41eafc68b"
      unitRef="usd">2600000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90ZXh0cmVnaW9uOjRkYWRhMDgyMTgwMTQyZTE4NTc2MjkyNDBiNjUyZWQ0XzI5MTM3MDU4MTM5NDc2_0292dddb-e8c9-4e9f-ac44-b5a830c3d161"
      unitRef="usd">900000</us-gaap:Depreciation>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90ZXh0cmVnaW9uOjRkYWRhMDgyMTgwMTQyZTE4NTc2MjkyNDBiNjUyZWQ0XzI5MTM3MDU4MTQxMTc3_eedee0cd-7bd2-4d94-aa0c-6c541356f336"
      unitRef="usd">3500000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90ZXh0cmVnaW9uOjRkYWRhMDgyMTgwMTQyZTE4NTc2MjkyNDBiNjUyZWQ0XzI5MTM3MDU4MTQxMTg1_61141241-358f-48c6-9170-eff42f142e0a"
      unitRef="usd">2200000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:CapitalizedComputerSoftwareAmortization1
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90ZXh0cmVnaW9uOjRkYWRhMDgyMTgwMTQyZTE4NTc2MjkyNDBiNjUyZWQ0XzI5MTM3MDU4MTQxMTky_849dd294-d417-4b0c-abc6-505570b8adcf"
      unitRef="usd">700000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:CapitalizedComputerSoftwareAdditions
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90ZXh0cmVnaW9uOjRkYWRhMDgyMTgwMTQyZTE4NTc2MjkyNDBiNjUyZWQ0XzI5MTM3MDU4MTQxMjEx_ed13d0ca-2098-4dea-a170-974db90707d7"
      unitRef="usd">4300000</us-gaap:CapitalizedComputerSoftwareAdditions>
    <us-gaap:CapitalizedComputerSoftwareAdditions
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90ZXh0cmVnaW9uOjRkYWRhMDgyMTgwMTQyZTE4NTc2MjkyNDBiNjUyZWQ0XzI5MTM3MDU4MTQxMjI5_bba0734e-808c-4e9e-bff6-eeda10d32505"
      unitRef="usd">4600000</us-gaap:CapitalizedComputerSoftwareAdditions>
    <us-gaap:CapitalizedComputerSoftwareAdditions
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90ZXh0cmVnaW9uOjRkYWRhMDgyMTgwMTQyZTE4NTc2MjkyNDBiNjUyZWQ0XzI5MTM3MDU4MTQxMjQ3_e0f8cd31-46b8-4e1e-87b2-a646d736ded6"
      unitRef="usd">4100000</us-gaap:CapitalizedComputerSoftwareAdditions>
    <us-gaap:TangibleAssetImpairmentCharges
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90ZXh0cmVnaW9uOjRkYWRhMDgyMTgwMTQyZTE4NTc2MjkyNDBiNjUyZWQ0XzMwNzg2MzI1NTgzMDQw_089f7229-a5b3-48eb-ae09-417ae9418f57"
      unitRef="usd">0</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:TangibleAssetImpairmentCharges
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90ZXh0cmVnaW9uOjRkYWRhMDgyMTgwMTQyZTE4NTc2MjkyNDBiNjUyZWQ0XzMwNzg2MzI1NTgzMDQw_30c2d3e8-c2c4-4421-8824-5440cae76738"
      unitRef="usd">0</us-gaap:TangibleAssetImpairmentCharges>
    <us-gaap:TangibleAssetImpairmentCharges
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTYvZnJhZzo0ZGFkYTA4MjE4MDE0MmUxODU3NjI5MjQwYjY1MmVkNC90ZXh0cmVnaW9uOjRkYWRhMDgyMTgwMTQyZTE4NTc2MjkyNDBiNjUyZWQ0XzMwNzg2MzI1NTgzMDQw_d2ddab0c-6b52-4eb0-b3f3-d4035f43c7c8"
      unitRef="usd">0</us-gaap:TangibleAssetImpairmentCharges>
    <docs:AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTkvZnJhZzo1YmNhZmVjYzFlNmE0N2IzOGExODc1YzljMzA0ZmRjMy90ZXh0cmVnaW9uOjViY2FmZWNjMWU2YTQ3YjM4YTE4NzVjOWMzMDRmZGMzXzU2NjI0ODQ4ODMwODg1_809ac93b-74e1-4ae7-8d73-d9b7112a030d">Accrued Expenses and Other Current Liabilities&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses and other current liabilities consisted of the following (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;As of March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accrued commissions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;6,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;5,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accrued payroll, bonus, and related expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;8,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;5,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Employee contributions under employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Rebate liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Sales and other tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;25,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;16,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</docs:AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock>
    <docs:ScheduleOfAccruedLiabilitiesCurrentTableTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTkvZnJhZzo1YmNhZmVjYzFlNmE0N2IzOGExODc1YzljMzA0ZmRjMy90ZXh0cmVnaW9uOjViY2FmZWNjMWU2YTQ3YjM4YTE4NzVjOWMzMDRmZGMzXzU2NjI0ODQ4ODMwODg2_c9327774-819b-42ad-9936-c9b865ff176f">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses and other current liabilities consisted of the following (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;As of March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accrued commissions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;6,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;5,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accrued payroll, bonus, and related expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;8,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;5,006&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Employee contributions under employee stock purchase plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Rebate liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Sales and other tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;25,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;16,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</docs:ScheduleOfAccruedLiabilitiesCurrentTableTextBlock>
    <us-gaap:AccruedSalesCommissionCurrent
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTkvZnJhZzo1YmNhZmVjYzFlNmE0N2IzOGExODc1YzljMzA0ZmRjMy90YWJsZTo0NzcxOGI4OGQxZDQ0YWM1YmFkZWYxZjM3M2M3MTBlNi90YWJsZXJhbmdlOjQ3NzE4Yjg4ZDFkNDRhYzViYWRlZjFmMzczYzcxMGU2XzItMS0xLTEtOTA0Nzg_7754a74d-9f33-41fa-a443-68f4a044e51f"
      unitRef="usd">6653000</us-gaap:AccruedSalesCommissionCurrent>
    <us-gaap:AccruedSalesCommissionCurrent
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTkvZnJhZzo1YmNhZmVjYzFlNmE0N2IzOGExODc1YzljMzA0ZmRjMy90YWJsZTo0NzcxOGI4OGQxZDQ0YWM1YmFkZWYxZjM3M2M3MTBlNi90YWJsZXJhbmdlOjQ3NzE4Yjg4ZDFkNDRhYzViYWRlZjFmMzczYzcxMGU2XzItMy0xLTEtOTA0Nzg_b8d8ec22-d38b-4cfa-a879-c1cc251a7dc5"
      unitRef="usd">5864000</us-gaap:AccruedSalesCommissionCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTkvZnJhZzo1YmNhZmVjYzFlNmE0N2IzOGExODc1YzljMzA0ZmRjMy90YWJsZTo0NzcxOGI4OGQxZDQ0YWM1YmFkZWYxZjM3M2M3MTBlNi90YWJsZXJhbmdlOjQ3NzE4Yjg4ZDFkNDRhYzViYWRlZjFmMzczYzcxMGU2XzMtMS0xLTEtNTA0ODc_1c0517a5-e811-4e2c-9600-fe95c4a2ff8f"
      unitRef="usd">8015000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTkvZnJhZzo1YmNhZmVjYzFlNmE0N2IzOGExODc1YzljMzA0ZmRjMy90YWJsZTo0NzcxOGI4OGQxZDQ0YWM1YmFkZWYxZjM3M2M3MTBlNi90YWJsZXJhbmdlOjQ3NzE4Yjg4ZDFkNDRhYzViYWRlZjFmMzczYzcxMGU2XzMtMy0xLTEtNTA0ODc_21b9e01d-878f-4914-8e05-aaa635a9b0e7"
      unitRef="usd">5006000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <docs:AccruedEmployeeStockPurchasePlanCurrent
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTkvZnJhZzo1YmNhZmVjYzFlNmE0N2IzOGExODc1YzljMzA0ZmRjMy90YWJsZTo0NzcxOGI4OGQxZDQ0YWM1YmFkZWYxZjM3M2M3MTBlNi90YWJsZXJhbmdlOjQ3NzE4Yjg4ZDFkNDRhYzViYWRlZjFmMzczYzcxMGU2XzQtMS0xLTEtOTA0Nzg_67526023-349b-4eeb-a5d7-562ee3ddd72c"
      unitRef="usd">621000</docs:AccruedEmployeeStockPurchasePlanCurrent>
    <docs:AccruedEmployeeStockPurchasePlanCurrent
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTkvZnJhZzo1YmNhZmVjYzFlNmE0N2IzOGExODc1YzljMzA0ZmRjMy90YWJsZTo0NzcxOGI4OGQxZDQ0YWM1YmFkZWYxZjM3M2M3MTBlNi90YWJsZXJhbmdlOjQ3NzE4Yjg4ZDFkNDRhYzViYWRlZjFmMzczYzcxMGU2XzQtMy0xLTEtOTA0Nzg_d8214fee-4e2e-4505-92ea-842f0e609fc5"
      unitRef="usd">0</docs:AccruedEmployeeStockPurchasePlanCurrent>
    <docs:RebateLiabilitiesCurrent
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTkvZnJhZzo1YmNhZmVjYzFlNmE0N2IzOGExODc1YzljMzA0ZmRjMy90YWJsZTo0NzcxOGI4OGQxZDQ0YWM1YmFkZWYxZjM3M2M3MTBlNi90YWJsZXJhbmdlOjQ3NzE4Yjg4ZDFkNDRhYzViYWRlZjFmMzczYzcxMGU2XzUtMS0xLTEtOTA0Nzg_0039bf7d-17eb-483a-b1b2-aa44f25c7e6b"
      unitRef="usd">4933000</docs:RebateLiabilitiesCurrent>
    <docs:RebateLiabilitiesCurrent
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTkvZnJhZzo1YmNhZmVjYzFlNmE0N2IzOGExODc1YzljMzA0ZmRjMy90YWJsZTo0NzcxOGI4OGQxZDQ0YWM1YmFkZWYxZjM3M2M3MTBlNi90YWJsZXJhbmdlOjQ3NzE4Yjg4ZDFkNDRhYzViYWRlZjFmMzczYzcxMGU2XzUtMy0xLTEtOTA0Nzg_3d6d1606-96be-4aa4-a157-4bb99956de27"
      unitRef="usd">1458000</docs:RebateLiabilitiesCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTkvZnJhZzo1YmNhZmVjYzFlNmE0N2IzOGExODc1YzljMzA0ZmRjMy90YWJsZTo0NzcxOGI4OGQxZDQ0YWM1YmFkZWYxZjM3M2M3MTBlNi90YWJsZXJhbmdlOjQ3NzE4Yjg4ZDFkNDRhYzViYWRlZjFmMzczYzcxMGU2XzQtMS0xLTEtNTA0ODc_5c04f397-a0e0-40ed-a495-76c1e89035be"
      unitRef="usd">785000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTkvZnJhZzo1YmNhZmVjYzFlNmE0N2IzOGExODc1YzljMzA0ZmRjMy90YWJsZTo0NzcxOGI4OGQxZDQ0YWM1YmFkZWYxZjM3M2M3MTBlNi90YWJsZXJhbmdlOjQ3NzE4Yjg4ZDFkNDRhYzViYWRlZjFmMzczYzcxMGU2XzQtMy0xLTEtNTA0ODc_1f7af170-b2c6-4b53-b1ef-077a24e8afdc"
      unitRef="usd">410000</us-gaap:TaxesPayableCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTkvZnJhZzo1YmNhZmVjYzFlNmE0N2IzOGExODc1YzljMzA0ZmRjMy90YWJsZTo0NzcxOGI4OGQxZDQ0YWM1YmFkZWYxZjM3M2M3MTBlNi90YWJsZXJhbmdlOjQ3NzE4Yjg4ZDFkNDRhYzViYWRlZjFmMzczYzcxMGU2XzUtMS0xLTEtNTA0ODc_b56d5cfb-69a3-4edd-84b3-0c6a4f0b1b30"
      unitRef="usd">4263000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTkvZnJhZzo1YmNhZmVjYzFlNmE0N2IzOGExODc1YzljMzA0ZmRjMy90YWJsZTo0NzcxOGI4OGQxZDQ0YWM1YmFkZWYxZjM3M2M3MTBlNi90YWJsZXJhbmdlOjQ3NzE4Yjg4ZDFkNDRhYzViYWRlZjFmMzczYzcxMGU2XzUtMy0xLTEtNTA0ODc_5a86b071-db44-4c08-a7b2-be250dbf0b9e"
      unitRef="usd">3547000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTkvZnJhZzo1YmNhZmVjYzFlNmE0N2IzOGExODc1YzljMzA0ZmRjMy90YWJsZTo0NzcxOGI4OGQxZDQ0YWM1YmFkZWYxZjM3M2M3MTBlNi90YWJsZXJhbmdlOjQ3NzE4Yjg4ZDFkNDRhYzViYWRlZjFmMzczYzcxMGU2XzYtMS0xLTEtNTA0ODc_197a177c-27ce-4bca-9df7-9f4392e75d23"
      unitRef="usd">25270000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8xOTkvZnJhZzo1YmNhZmVjYzFlNmE0N2IzOGExODc1YzljMzA0ZmRjMy90YWJsZTo0NzcxOGI4OGQxZDQ0YWM1YmFkZWYxZjM3M2M3MTBlNi90YWJsZXJhbmdlOjQ3NzE4Yjg4ZDFkNDRhYzViYWRlZjFmMzczYzcxMGU2XzYtMy0xLTEtNTA0ODc_60c95756-a6fb-4783-87dd-48d7764785d0"
      unitRef="usd">16285000</us-gaap:AccruedLiabilitiesCurrent>
    <docs:BusinessCombinationGoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90ZXh0cmVnaW9uOjVmZmEwNzUyZGExODQ2ZjFhMTMwZDU5ZGY4YmY3ODA1XzQ0NTMwMjIwOTM0MzI3_44204574-ef28-4285-8d33-8b6a2092ae0a">Business Combinations, Intangible Assets, and Goodwill&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Curative Talent Acquisition &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 1, 2020, the Company completed the acquisition of THMED, LLC (subsequently renamed Curative Talent, LLC, &#x201c;Curative&#x201d;), which was accounted for as a business combination. Curative provides temporary and permanent healthcare staffing services to hospitals, medical groups, and other healthcare facilities across the United States. The acquisition-date fair value of the consideration transferred was $34.7 million, consisting of $33.6 million in cash and 689,656 shares of common stock valued at $1.1 million. The purchase consideration was allocated to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair values as of the acquisition date, with the excess recorded to goodwill as shown below. The purchase consideration allocation was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Assets acquired: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;10,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;17,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Liabilities assumed:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net assets acquired, excluding goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;15,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;18,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total purchase consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;34,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill represents the future benefits as a result of the acquisition that will enhance the Company&#x2019;s product available to both new and existing customers and increase the Company&#x2019;s competitive position. Goodwill is deductible for income tax purposes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s acquisition-related costs were $1.2 million and were recorded as general and administrative expense in the Company&#x2019;s consolidated statements of operations during the fiscal year ended March&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets acquired are comprised of customer relationships with an estimated useful life of 10 years. The fair value assigned to the customer relationship was determined primarily using the multiple period excess earnings method cost approach, which estimates the direct cash flows expected to be generated from the existing customers acquired. The results of operations of this business combination have been included in the Company&#x2019;s consolidated financial statements from the acquisition date. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2020, the Company sold a portion of Curative Talent&#x2019;s business for total consideration of $4.7 million, of which $4.2 million has been received in cash and the remaining $0.5 million was held in escrow, subject to standard representations and warranties. The net assets of this business were not material. The Company recognized a gain on sale for the total consideration during the fiscal year ended March&#160;31, 2021 as a result of this sale. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets, net consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;As of March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;10,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Domain names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;10,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1,971)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1,120)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense for intangible assets was $1.0 million, $1.1 million and not material for the fiscal years ended March&#160;31, 2022, 2021, and 2020 respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, future amortization expense is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Years Ending March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total future amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill &lt;/span&gt;&lt;/div&gt;As of March&#160;31, 2022 and March&#160;31, 2021, goodwill was $18.9 million. No goodwill impairment charges were recorded for each of the fiscal years ended March&#160;31, 2022 and 2021.</docs:BusinessCombinationGoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i1f64c4a29d62477a8fad14379556ccb8_D20200401-20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90ZXh0cmVnaW9uOjVmZmEwNzUyZGExODQ2ZjFhMTMwZDU5ZGY4YmY3ODA1XzI5MTM3MDU4MTQyMTQ2_cd67e320-348f-49e4-bcdd-873d493181d8"
      unitRef="usd">34700000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i1f64c4a29d62477a8fad14379556ccb8_D20200401-20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90ZXh0cmVnaW9uOjVmZmEwNzUyZGExODQ2ZjFhMTMwZDU5ZGY4YmY3ODA1XzI5MTM3MDU4MTQyMTY1_ec1811ed-d0c3-4769-9b31-5f0d344a2633"
      unitRef="usd">33600000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
      contextRef="i1f64c4a29d62477a8fad14379556ccb8_D20200401-20200401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90ZXh0cmVnaW9uOjVmZmEwNzUyZGExODQ2ZjFhMTMwZDU5ZGY4YmY3ODA1XzI5MTM3MDU4MTQyMTc4_36f29736-066f-4b6a-ac73-b10b58aedb28"
      unitRef="shares">689656</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
    <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
      contextRef="i1f64c4a29d62477a8fad14379556ccb8_D20200401-20200401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90ZXh0cmVnaW9uOjVmZmEwNzUyZGExODQ2ZjFhMTMwZDU5ZGY4YmY3ODA1XzI5MTM3MDU4MTQyMTkz_e8be0fa4-e53d-4864-83e5-6526397cc940"
      unitRef="usd">1100000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90ZXh0cmVnaW9uOjVmZmEwNzUyZGExODQ2ZjFhMTMwZDU5ZGY4YmY3ODA1XzQ0NTMwMjIwOTM0MzI4_b9017b92-c5fa-4341-ab2d-8c3feffc222e">The purchase consideration allocation was as follows (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Assets acquired: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;10,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total assets acquired&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;17,830&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Liabilities assumed:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net assets acquired, excluding goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;15,800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;18,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total purchase consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;34,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i79a66d68c93b4bd0b2886189e06be17c_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTo2ZTI3YzA5MzgzNmU0YzJjYmM3ZmMzMWMwMjI0MmE2OS90YWJsZXJhbmdlOjZlMjdjMDkzODM2ZTRjMmNiYzdmYzMxYzAyMjQyYTY5XzEtMS0xLTEtNTA1MDA_41fc7f7e-0dbf-428a-b35c-75226a9e1299"
      unitRef="usd">1972000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i79a66d68c93b4bd0b2886189e06be17c_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTo2ZTI3YzA5MzgzNmU0YzJjYmM3ZmMzMWMwMjI0MmE2OS90YWJsZXJhbmdlOjZlMjdjMDkzODM2ZTRjMmNiYzdmYzMxYzAyMjQyYTY5XzItMS0xLTEtNTA1MDA_79eaa4a0-422d-4dad-b7bd-70abb48ee8c4"
      unitRef="usd">4075000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <docs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther
      contextRef="i79a66d68c93b4bd0b2886189e06be17c_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTo2ZTI3YzA5MzgzNmU0YzJjYmM3ZmMzMWMwMjI0MmE2OS90YWJsZXJhbmdlOjZlMjdjMDkzODM2ZTRjMmNiYzdmYzMxYzAyMjQyYTY5XzMtMS0xLTEtNTA1MDA_d01b84f9-4de0-4f8b-8ebe-63882e82fd6a"
      unitRef="usd">1503000</docs:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
      contextRef="i79a66d68c93b4bd0b2886189e06be17c_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTo2ZTI3YzA5MzgzNmU0YzJjYmM3ZmMzMWMwMjI0MmE2OS90YWJsZXJhbmdlOjZlMjdjMDkzODM2ZTRjMmNiYzdmYzMxYzAyMjQyYTY5XzQtMS0xLTEtNTA1MDA_b72c4972-e9f2-453d-9a03-75bd3e4a0357"
      unitRef="usd">10280000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
      contextRef="i79a66d68c93b4bd0b2886189e06be17c_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTo2ZTI3YzA5MzgzNmU0YzJjYmM3ZmMzMWMwMjI0MmE2OS90YWJsZXJhbmdlOjZlMjdjMDkzODM2ZTRjMmNiYzdmYzMxYzAyMjQyYTY5XzUtMS0xLTEtNTA1MDA_74256f53-0749-48a9-a9b0-24fb78ba56a6"
      unitRef="usd">17830000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i79a66d68c93b4bd0b2886189e06be17c_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTo2ZTI3YzA5MzgzNmU0YzJjYmM3ZmMzMWMwMjI0MmE2OS90YWJsZXJhbmdlOjZlMjdjMDkzODM2ZTRjMmNiYzdmYzMxYzAyMjQyYTY5XzgtMS0xLTEtNTA1MDA_2a5dc538-6eb1-478f-b851-05d8667dca1b"
      unitRef="usd">2030000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
      contextRef="i79a66d68c93b4bd0b2886189e06be17c_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTo2ZTI3YzA5MzgzNmU0YzJjYmM3ZmMzMWMwMjI0MmE2OS90YWJsZXJhbmdlOjZlMjdjMDkzODM2ZTRjMmNiYzdmYzMxYzAyMjQyYTY5XzktMS0xLTEtNTA1MDA_639ea852-837f-418c-9602-d1cd24aa39b8"
      unitRef="usd">15800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet>
    <us-gaap:Goodwill
      contextRef="i79a66d68c93b4bd0b2886189e06be17c_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTo2ZTI3YzA5MzgzNmU0YzJjYmM3ZmMzMWMwMjI0MmE2OS90YWJsZXJhbmdlOjZlMjdjMDkzODM2ZTRjMmNiYzdmYzMxYzAyMjQyYTY5XzEwLTEtMS0xLTUwNTAw_e4259cca-c2ab-4614-9eb1-a867e917c329"
      unitRef="usd">18915000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i79a66d68c93b4bd0b2886189e06be17c_I20200401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTo2ZTI3YzA5MzgzNmU0YzJjYmM3ZmMzMWMwMjI0MmE2OS90YWJsZXJhbmdlOjZlMjdjMDkzODM2ZTRjMmNiYzdmYzMxYzAyMjQyYTY5XzExLTEtMS0xLTUwNTAw_b29c85d7-f207-43bd-ae80-842fe9335fa9"
      unitRef="usd">34715000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="iee7d28ec87cf452fb10c202c80f90fbe_D20190401-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90ZXh0cmVnaW9uOjVmZmEwNzUyZGExODQ2ZjFhMTMwZDU5ZGY4YmY3ODA1XzI5MTM3MDU4MTQyMjEx_a3ac7e54-42d5-4666-9cae-1a1fa33d1f9e"
      unitRef="usd">1200000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i57a0104cac79435c8a441386b54274b2_D20200401-20200401"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90ZXh0cmVnaW9uOjVmZmEwNzUyZGExODQ2ZjFhMTMwZDU5ZGY4YmY3ODA1XzI5MTM3MDU4MTQyMjQx_7caacd51-a7da-4fba-a04b-1d8d4202edb9">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="if7cf2424c4f2444491451d34b70a6297_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90ZXh0cmVnaW9uOjVmZmEwNzUyZGExODQ2ZjFhMTMwZDU5ZGY4YmY3ODA1XzQ3Mjc5MDAwMDAzNjg0_e6f296cc-9e51-4105-a5cf-c5d523e0d5c9"
      unitRef="usd">4700000</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i700d59f0237c426e9f45e85c7868ccb3_D20201001-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90ZXh0cmVnaW9uOjVmZmEwNzUyZGExODQ2ZjFhMTMwZDU5ZGY4YmY3ODA1XzQ3Mjc5MDAwMDAzNzAy_b8c313b8-b04f-45a7-b4f8-c982565de360"
      unitRef="usd">4200000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <docs:DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow
      contextRef="if7cf2424c4f2444491451d34b70a6297_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90ZXh0cmVnaW9uOjVmZmEwNzUyZGExODQ2ZjFhMTMwZDU5ZGY4YmY3ODA1XzQ3Mjc5MDAwMDAzNzE5_c80b7c0b-fad4-4c84-83f9-103fffa26667"
      unitRef="usd">500000</docs:DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90ZXh0cmVnaW9uOjVmZmEwNzUyZGExODQ2ZjFhMTMwZDU5ZGY4YmY3ODA1XzQ0NTMwMjIwOTM0MzI5_a31fbbbc-bb8e-4ee3-a2b9-80bbacd19111">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets, net consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;As of March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,869&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;10,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Domain names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;10,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1,971)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1,120)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie3c81df0162042a5b0dc0d0c8592051a_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTpjNDgyOGMyMGMyOWE0ZmM2OWJkNDYyY2I4OGE2OTI2OC90YWJsZXJhbmdlOmM0ODI4YzIwYzI5YTRmYzY5YmQ0NjJjYjg4YTY5MjY4XzItMS0xLTEtNTA2MDE_ddf469bc-a22b-473a-b776-96289143cc3f"
      unitRef="usd">9869000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i96d0d9721f3845cf819e54f13b25b749_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTpjNDgyOGMyMGMyOWE0ZmM2OWJkNDYyY2I4OGE2OTI2OC90YWJsZXJhbmdlOmM0ODI4YzIwYzI5YTRmYzY5YmQ0NjJjYjg4YTY5MjY4XzItMy0xLTEtNTA2MDE_2530cd39-a14d-4433-96c8-48ab7c45ee4e"
      unitRef="usd">10280000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i2954aeea8a14482992a39c86bd074154_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTpjNDgyOGMyMGMyOWE0ZmM2OWJkNDYyY2I4OGE2OTI2OC90YWJsZXJhbmdlOmM0ODI4YzIwYzI5YTRmYzY5YmQ0NjJjYjg4YTY5MjY4XzMtMS0xLTEtNTA2MDE_f1952db4-fd28-4861-b4e1-35b147bd58d7"
      unitRef="usd">11000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i41a71c7b00044b929b014c5f2a720f8c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTpjNDgyOGMyMGMyOWE0ZmM2OWJkNDYyY2I4OGE2OTI2OC90YWJsZXJhbmdlOmM0ODI4YzIwYzI5YTRmYzY5YmQ0NjJjYjg4YTY5MjY4XzMtMy0xLTEtNTA2MDE_26257802-d721-4f4e-ab13-e0083511f641"
      unitRef="usd">436000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTpjNDgyOGMyMGMyOWE0ZmM2OWJkNDYyY2I4OGE2OTI2OC90YWJsZXJhbmdlOmM0ODI4YzIwYzI5YTRmYzY5YmQ0NjJjYjg4YTY5MjY4XzQtMS0xLTEtNTA2MDE_81728e4d-bea0-4a5d-adec-5af059bb7170"
      unitRef="usd">9880000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTpjNDgyOGMyMGMyOWE0ZmM2OWJkNDYyY2I4OGE2OTI2OC90YWJsZXJhbmdlOmM0ODI4YzIwYzI5YTRmYzY5YmQ0NjJjYjg4YTY5MjY4XzQtMy0xLTEtNTA2MDE_8241b9ff-65c5-45e6-b8df-0d150a5cc39d"
      unitRef="usd">10716000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTpjNDgyOGMyMGMyOWE0ZmM2OWJkNDYyY2I4OGE2OTI2OC90YWJsZXJhbmdlOmM0ODI4YzIwYzI5YTRmYzY5YmQ0NjJjYjg4YTY5MjY4XzUtMS0xLTEtNTA2MDE_e6f1b8ac-1e95-478c-904d-6744999fefaf"
      unitRef="usd">1971000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTpjNDgyOGMyMGMyOWE0ZmM2OWJkNDYyY2I4OGE2OTI2OC90YWJsZXJhbmdlOmM0ODI4YzIwYzI5YTRmYzY5YmQ0NjJjYjg4YTY5MjY4XzUtMy0xLTEtNTA2MDE_7a2bd33d-026d-401d-a2a9-2ca7fbdf535b"
      unitRef="usd">1120000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTpjNDgyOGMyMGMyOWE0ZmM2OWJkNDYyY2I4OGE2OTI2OC90YWJsZXJhbmdlOmM0ODI4YzIwYzI5YTRmYzY5YmQ0NjJjYjg4YTY5MjY4XzYtMS0xLTEtNTA2MDE_2c0b96b0-e9b3-4922-b8cf-325289f4d2a3"
      unitRef="usd">7909000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTpjNDgyOGMyMGMyOWE0ZmM2OWJkNDYyY2I4OGE2OTI2OC90YWJsZXJhbmdlOmM0ODI4YzIwYzI5YTRmYzY5YmQ0NjJjYjg4YTY5MjY4XzYtMy0xLTEtNTA2MDE_b4c3981c-2a5b-4dff-a8e3-6d97e29d7074"
      unitRef="usd">9596000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90ZXh0cmVnaW9uOjVmZmEwNzUyZGExODQ2ZjFhMTMwZDU5ZGY4YmY3ODA1XzMwNzg2MzI1NTg0OTUx_7e427445-62d5-4f4b-b2d7-245931c39e06"
      unitRef="usd">1000000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90ZXh0cmVnaW9uOjVmZmEwNzUyZGExODQ2ZjFhMTMwZDU5ZGY4YmY3ODA1XzMwNzg2MzI1NTg0OTYw_1291017e-989d-47ae-8464-8178bcae861a"
      unitRef="usd">1100000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90ZXh0cmVnaW9uOjVmZmEwNzUyZGExODQ2ZjFhMTMwZDU5ZGY4YmY3ODA1XzMwNzg2MzI1NTg0OTgw_85bf1272-cfac-47ae-a08c-296731a62a10"
      unitRef="usd">0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90ZXh0cmVnaW9uOjVmZmEwNzUyZGExODQ2ZjFhMTMwZDU5ZGY4YmY3ODA1XzQ0NTMwMjIwOTM0MzMw_522af5b3-1288-4758-8804-c12cae78b575">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, future amortization expense is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Years Ending March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;990&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total future amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,909&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTpmNzM2YzU5ZmM2YTE0MzkwYTUzODRkM2U0NGViOWQxNi90YWJsZXJhbmdlOmY3MzZjNTlmYzZhMTQzOTBhNTM4NGQzZTQ0ZWI5ZDE2XzEtMi0xLTEtNTA2MDg_c141c3f6-7fd7-44a1-a4e9-b8d1c34d7483"
      unitRef="usd">990000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTpmNzM2YzU5ZmM2YTE0MzkwYTUzODRkM2U0NGViOWQxNi90YWJsZXJhbmdlOmY3MzZjNTlmYzZhMTQzOTBhNTM4NGQzZTQ0ZWI5ZDE2XzItMi0xLTEtNTA2MDg_673a7a87-fa2a-4e59-895a-f1e311d60f6b"
      unitRef="usd">990000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTpmNzM2YzU5ZmM2YTE0MzkwYTUzODRkM2U0NGViOWQxNi90YWJsZXJhbmdlOmY3MzZjNTlmYzZhMTQzOTBhNTM4NGQzZTQ0ZWI5ZDE2XzMtMi0xLTEtNTA2MDg_bff233b8-ba8b-4ae8-9b51-c9528f5fbc7c"
      unitRef="usd">990000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTpmNzM2YzU5ZmM2YTE0MzkwYTUzODRkM2U0NGViOWQxNi90YWJsZXJhbmdlOmY3MzZjNTlmYzZhMTQzOTBhNTM4NGQzZTQ0ZWI5ZDE2XzQtMi0xLTEtNTA2MDg_3ffdb1e6-1287-4333-837b-61a38c159acb"
      unitRef="usd">990000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTpmNzM2YzU5ZmM2YTE0MzkwYTUzODRkM2U0NGViOWQxNi90YWJsZXJhbmdlOmY3MzZjNTlmYzZhMTQzOTBhNTM4NGQzZTQ0ZWI5ZDE2XzUtMi0xLTEtNTA2MDg_77187afc-aab6-4400-b56c-c1f67fba65ec"
      unitRef="usd">988000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTpmNzM2YzU5ZmM2YTE0MzkwYTUzODRkM2U0NGViOWQxNi90YWJsZXJhbmdlOmY3MzZjNTlmYzZhMTQzOTBhNTM4NGQzZTQ0ZWI5ZDE2XzYtMi0xLTEtNTA2MDg_e2b85161-2094-4526-b2bf-be204f722895"
      unitRef="usd">2961000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90YWJsZTpmNzM2YzU5ZmM2YTE0MzkwYTUzODRkM2U0NGViOWQxNi90YWJsZXJhbmdlOmY3MzZjNTlmYzZhMTQzOTBhNTM4NGQzZTQ0ZWI5ZDE2XzctMi0xLTEtNTA2MDg_5aa80fb8-86cf-47d4-9a6c-757b6a2aac67"
      unitRef="usd">7909000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:Goodwill
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90ZXh0cmVnaW9uOjVmZmEwNzUyZGExODQ2ZjFhMTMwZDU5ZGY4YmY3ODA1XzMwNzg2MzI1NTg1Mjcy_025ba9b7-5891-4f3f-9bb2-9f9f0aa9661e"
      unitRef="usd">18900000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90ZXh0cmVnaW9uOjVmZmEwNzUyZGExODQ2ZjFhMTMwZDU5ZGY4YmY3ODA1XzMwNzg2MzI1NTg1Mjcy_fc675553-6675-4a7c-ba2c-327c186933dd"
      unitRef="usd">18900000</us-gaap:Goodwill>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90ZXh0cmVnaW9uOjVmZmEwNzUyZGExODQ2ZjFhMTMwZDU5ZGY4YmY3ODA1XzMwNzg2MzI1NTg1Mjgw_3d565ca6-8110-40c9-94db-39d3bbe3ca1f"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDIvZnJhZzo1ZmZhMDc1MmRhMTg0NmYxYTEzMGQ1OWRmOGJmNzgwNS90ZXh0cmVnaW9uOjVmZmEwNzUyZGExODQ2ZjFhMTMwZDU5ZGY4YmY3ODA1XzMwNzg2MzI1NTg1Mjgw_b5996931-62a0-4617-bd0d-f9194aa22821"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <docs:TemporaryEquityTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzQ4Mzc4NTExNjQzMzYy_98e64fc6-0046-4ba7-b1c8-18c69c9d1075">Redeemable Convertible Preferred Stock&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2021, there were three outstanding series of redeemable convertible preferred stock, each with a par value of $0.001 per share. Upon completion of the IPO in June 2021, all shares of the Company&#x2019;s redeemable convertible preferred stock outstanding, totaling 76,286,618, were automatically converted into an equivalent number of shares of Class B common stock on a one-to-one basis. The carrying value of redeemable convertible preferred stock of $81.5 million was reclassified into stockholders&#x2019; equity. As of March&#160;31, 2022, there were no shares of redeemable convertible preferred stock issued or outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the redeemable convertible preferred stock outstanding as of March&#160;31, 2021 and other related information is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Series&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Shares&lt;br/&gt;Authorized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Shares&lt;br/&gt;Issued and&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Liquidation&lt;br/&gt;Preference&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;27,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;27,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;10,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;10,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;26,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;26,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;17,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;17,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;C&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;22,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;22,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;53,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;53,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;76,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;76,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;81,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;81,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The rights, preferences, privileges, restrictions, and other matters relating to the redeemable convertible preferred stock are summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Liquidation Preference&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;In the event of any liquidation event, either voluntary or involuntary, the holders of Series&#160;A, Series&#160;B, and Series&#160;C redeemable convertible preferred stock were entitled to receive, in priority and preference to common stockholders&#x2019; liquidation preference, $0.3892, $0.6488925 and $2.4104 per share, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;After paying the holders of the redeemable convertible preferred stock of their full respective preferential amounts, all of the remaining assets of the Company would be distributed on a pro rata basis among the holders of common stock. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Redemption&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;The redeemable convertible preferred stock was classified as mezzanine equity on the consolidated balance sheets. The redeemable convertible preferred stock was not mandatorily redeemable; however, upon the event of a voluntary or involuntary liquidation, dissolution, change in control, or winding up of the Company, holders of the redeemable convertible preferred stock may have had the right to receive their liquidation preference under the terms of the preferred stockholder agreements. Accordingly, the preferred stockholders were entitled to redemption features that were not solely within the control of the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Dividends&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;The holders of Series&#160;A, Series&#160;B, and Series&#160;C redeemable convertible preferred stock were entitled to receive noncumulative dividends at the per annum rate of $0.03115, $0.0519, and $0.19285 per share, respectively, in preference and priority to any common stockholder, when and if declared by the board of directors. If, after such dividends above were paid or set apart for payment in any fiscal year, the board of directors declared additional dividends out of funds legally available, then such additional dividends would be set aside or paid among the holders of the redeemable convertible preferred stock and common stock on a pro-rata basis. No dividends on redeemable convertible preferred stock or common &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;stock were declared by the board of directors from inception through the date the redeemable convertible preferred stock was converted into Class B common stock in June 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Voting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;The holders of redeemable convertible preferred stock had the same voting rights as the holders of common stock. The holders of common stock and redeemable convertible preferred stock voted together as a single class. Each holder of common stock was entitled to one vote for each share of common stock held and each holder of redeemable convertible preferred stock was entitled to the number of votes equal to the number of shares of common stock into which such shares of redeemable convertible preferred stock could then be converted. So long as at least 2,000,000&#160;shares of redeemable convertible preferred stock remained outstanding, the holders of redeemable convertible preferred stock were entitled to elect two members of the board of directors. The holders of a majority of the common stock were entitled to elect two members of the board of directors. Any additional member of the board of directors was elected by the holders of a majority of the then outstanding redeemable convertible preferred stock and common stock, each voting as separate classes (and, with respected to redeemable convertible preferred stock, on an as-converted basis).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Conversion&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;Each share of redeemable convertible preferred stock was convertible to common stock at the option of the holder. Such conversion was determined by dividing the original issue price by the then effective conversion price (adjusted for any stock dividends, combinations, or splits with respect to such shares).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each share of redeemable convertible preferred stock would be automatically converted into shares of common stock at the conversion rate at the time in effect for such series of redeemable convertible preferred stock immediately upon the earlier of (i)&#160;the Company&#x2019;s sale of its common stock in a firm commitment underwritten public offering pursuant to a registration statement under the Securities Act of 1933, as amended, with a price per share of at least $2.41 (adjusted for any stock dividends, combinations, or splits with respect to such shares) and an aggregate offering price of at least $50 million or (ii)&#160;the date specified by written consent or agreement of the majority of the holders of redeemable convertible preferred stock, voting together as a single class on an as-converted basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Redeemable Convertible Preferred Stock Warrants&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;In August 2012, the Company issued warrants to purchase 38,322&#160;shares of Series B redeemable convertible preferred stock at an exercise price of $0.65 per share. The warrants were issued to investors in connection with the Series&#160;B redeemable convertible preferred stock warrants financing. The fair value of the warrants at issuance was $14,000 based on the Black-Scholes option-pricing model using the assumptions of dividend yield of 0%, volatility of 55%, risk-free interest rate of 1.13%, and contractual life of seven years. The warrants were exercised during the fiscal year ended March&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;</docs:TemporaryEquityTextBlock>
    <docs:TemporaryEquityPreferredStockOutstandingSeries
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI5MTM3MDU4MTU3MDY4_47f45af2-b9f0-49df-9c88-168ef653990e"
      unitRef="series">3</docs:TemporaryEquityPreferredStockOutstandingSeries>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI5MTM3MDU4MTU3MDc4_4db56928-285f-4cdc-ab1e-a44566f6dfd3"
      unitRef="usdPerShare">0.001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:ConversionOfStockSharesIssued1
      contextRef="i90f5cd4e2e554cc583d589c82b6980d1_D20210601-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI4NTg3MzAyMzQyNjU3_7f63eec4-fb3c-4a02-8f53-85c69e99edf9"
      unitRef="shares">76286618</us-gaap:ConversionOfStockSharesIssued1>
    <docs:ConversionOfStockConversionRatio
      contextRef="i62c961053180495bb8eed126ddb4d43b_D20210601-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI4NTg3MzAyMzQyNzU2_e8840d34-e3b7-4bad-b7ce-6757cc2e5e60"
      unitRef="number">1</docs:ConversionOfStockConversionRatio>
    <us-gaap:ReclassificationsOfTemporaryToPermanentEquity
      contextRef="i62c961053180495bb8eed126ddb4d43b_D20210601-20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI4NTg3MzAyMzQyODM4_8979a1ab-3d28-484d-8136-6bd07ef58cf3"
      unitRef="usd">81500000</us-gaap:ReclassificationsOfTemporaryToPermanentEquity>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI4NTg3MzAyMzQyOTA4_262814f0-d8e4-41dc-bf07-bcc3835dfe28"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI4NTg3MzAyMzQyOTA4_dc4e4079-cb5d-4134-bc1a-8dd7c8a62dbe"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityTableTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzQ4Mzc4NTExNjQzMzY0_9b7b84f9-ad03-42a6-ae25-bfaae2fe854a">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of the redeemable convertible preferred stock outstanding as of March&#160;31, 2021 and other related information is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Series&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Shares&lt;br/&gt;Authorized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Shares&lt;br/&gt;Issued and&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Liquidation&lt;br/&gt;Preference&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;27,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;27,636&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;10,677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;10,756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;26,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;26,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;17,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;17,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;C&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;22,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;22,337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;53,767&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;53,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;76,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;76,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;81,458&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;81,672&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:TemporaryEquityTableTextBlock>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="i0d10847a28e64727936c5a6f5e2e80a5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90YWJsZTpiODQ1YTk3YmVlNTM0ODA4OGUxNDMzOWY2OGYxNWUyZS90YWJsZXJhbmdlOmI4NDVhOTdiZWU1MzQ4MDg4ZTE0MzM5ZjY4ZjE1ZTJlXzItMS0xLTEtNTAxMTg_a5aad7bb-fa54-44de-9fd0-d0b12eca8383"
      unitRef="shares">27636000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i0d10847a28e64727936c5a6f5e2e80a5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90YWJsZTpiODQ1YTk3YmVlNTM0ODA4OGUxNDMzOWY2OGYxNWUyZS90YWJsZXJhbmdlOmI4NDVhOTdiZWU1MzQ4MDg4ZTE0MzM5ZjY4ZjE1ZTJlXzItMy0xLTEtNTAxMTg_b80c7954-e284-4801-94e6-115296451507"
      unitRef="shares">27636000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i0d10847a28e64727936c5a6f5e2e80a5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90YWJsZTpiODQ1YTk3YmVlNTM0ODA4OGUxNDMzOWY2OGYxNWUyZS90YWJsZXJhbmdlOmI4NDVhOTdiZWU1MzQ4MDg4ZTE0MzM5ZjY4ZjE1ZTJlXzItMy0xLTEtNTAxMTg_c4574f83-2d53-4a48-8e85-97b1c3515128"
      unitRef="shares">27636000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i0d10847a28e64727936c5a6f5e2e80a5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90YWJsZTpiODQ1YTk3YmVlNTM0ODA4OGUxNDMzOWY2OGYxNWUyZS90YWJsZXJhbmdlOmI4NDVhOTdiZWU1MzQ4MDg4ZTE0MzM5ZjY4ZjE1ZTJlXzItNS0xLTEtNTAxMTg_977bf3d2-44e4-4b3e-a5b0-ea6414117c3a"
      unitRef="usd">10677000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="i0d10847a28e64727936c5a6f5e2e80a5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90YWJsZTpiODQ1YTk3YmVlNTM0ODA4OGUxNDMzOWY2OGYxNWUyZS90YWJsZXJhbmdlOmI4NDVhOTdiZWU1MzQ4MDg4ZTE0MzM5ZjY4ZjE1ZTJlXzItNy0xLTEtNTAxMTg_d0f55ef0-1217-4d75-bc8a-64fb3b96e1fe"
      unitRef="usd">10756000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="i123f862c0d9447efbbc8bdae111fa9a1_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90YWJsZTpiODQ1YTk3YmVlNTM0ODA4OGUxNDMzOWY2OGYxNWUyZS90YWJsZXJhbmdlOmI4NDVhOTdiZWU1MzQ4MDg4ZTE0MzM5ZjY4ZjE1ZTJlXzMtMS0xLTEtNTAxMTg_eabab2bc-a6d8-400a-89e4-f6ab569fd22e"
      unitRef="shares">26314000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i123f862c0d9447efbbc8bdae111fa9a1_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90YWJsZTpiODQ1YTk3YmVlNTM0ODA4OGUxNDMzOWY2OGYxNWUyZS90YWJsZXJhbmdlOmI4NDVhOTdiZWU1MzQ4MDg4ZTE0MzM5ZjY4ZjE1ZTJlXzMtMy0xLTEtNTAxMTg_1fc83bad-0761-48a0-9a39-4c00c4e3620f"
      unitRef="shares">26314000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i123f862c0d9447efbbc8bdae111fa9a1_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90YWJsZTpiODQ1YTk3YmVlNTM0ODA4OGUxNDMzOWY2OGYxNWUyZS90YWJsZXJhbmdlOmI4NDVhOTdiZWU1MzQ4MDg4ZTE0MzM5ZjY4ZjE1ZTJlXzMtMy0xLTEtNTAxMTg_5f2e21e9-cc56-4a09-92c2-115339624a34"
      unitRef="shares">26314000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i123f862c0d9447efbbc8bdae111fa9a1_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90YWJsZTpiODQ1YTk3YmVlNTM0ODA4OGUxNDMzOWY2OGYxNWUyZS90YWJsZXJhbmdlOmI4NDVhOTdiZWU1MzQ4MDg4ZTE0MzM5ZjY4ZjE1ZTJlXzMtNS0xLTEtNTAxMTg_3d74d53f-2ca9-45a7-beb1-f86921891fa8"
      unitRef="usd">17014000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="i123f862c0d9447efbbc8bdae111fa9a1_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90YWJsZTpiODQ1YTk3YmVlNTM0ODA4OGUxNDMzOWY2OGYxNWUyZS90YWJsZXJhbmdlOmI4NDVhOTdiZWU1MzQ4MDg4ZTE0MzM5ZjY4ZjE1ZTJlXzMtNy0xLTEtNTAxMTg_b351c112-a60b-480d-8528-db8f7da0c166"
      unitRef="usd">17075000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="i1d83f10d2f3d4f9f8308f66e84ed7f02_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90YWJsZTpiODQ1YTk3YmVlNTM0ODA4OGUxNDMzOWY2OGYxNWUyZS90YWJsZXJhbmdlOmI4NDVhOTdiZWU1MzQ4MDg4ZTE0MzM5ZjY4ZjE1ZTJlXzQtMS0xLTEtNTAxMTg_7cfd72e4-9d85-459a-85e7-8954917b82bf"
      unitRef="shares">22400000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i1d83f10d2f3d4f9f8308f66e84ed7f02_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90YWJsZTpiODQ1YTk3YmVlNTM0ODA4OGUxNDMzOWY2OGYxNWUyZS90YWJsZXJhbmdlOmI4NDVhOTdiZWU1MzQ4MDg4ZTE0MzM5ZjY4ZjE1ZTJlXzQtMy0xLTEtNTAxMTg_3190ed73-e6c9-49d4-bc3f-5d1efc32f6d8"
      unitRef="shares">22337000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i1d83f10d2f3d4f9f8308f66e84ed7f02_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90YWJsZTpiODQ1YTk3YmVlNTM0ODA4OGUxNDMzOWY2OGYxNWUyZS90YWJsZXJhbmdlOmI4NDVhOTdiZWU1MzQ4MDg4ZTE0MzM5ZjY4ZjE1ZTJlXzQtMy0xLTEtNTAxMTg_d2305e5b-a03c-4e17-b392-1e933cc3d0b9"
      unitRef="shares">22337000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i1d83f10d2f3d4f9f8308f66e84ed7f02_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90YWJsZTpiODQ1YTk3YmVlNTM0ODA4OGUxNDMzOWY2OGYxNWUyZS90YWJsZXJhbmdlOmI4NDVhOTdiZWU1MzQ4MDg4ZTE0MzM5ZjY4ZjE1ZTJlXzQtNS0xLTEtNTAxMTg_12efc4c0-23df-4879-8b9e-c981c397d786"
      unitRef="usd">53767000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="i1d83f10d2f3d4f9f8308f66e84ed7f02_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90YWJsZTpiODQ1YTk3YmVlNTM0ODA4OGUxNDMzOWY2OGYxNWUyZS90YWJsZXJhbmdlOmI4NDVhOTdiZWU1MzQ4MDg4ZTE0MzM5ZjY4ZjE1ZTJlXzQtNy0xLTEtNTAxMTg_0f6fa211-8270-4b93-8f75-777747f73025"
      unitRef="usd">53841000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90YWJsZTpiODQ1YTk3YmVlNTM0ODA4OGUxNDMzOWY2OGYxNWUyZS90YWJsZXJhbmdlOmI4NDVhOTdiZWU1MzQ4MDg4ZTE0MzM5ZjY4ZjE1ZTJlXzUtMS0xLTEtNTAxMTg_a247a13b-8688-4fbb-b3e9-a9f7dd703740"
      unitRef="shares">76350000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90YWJsZTpiODQ1YTk3YmVlNTM0ODA4OGUxNDMzOWY2OGYxNWUyZS90YWJsZXJhbmdlOmI4NDVhOTdiZWU1MzQ4MDg4ZTE0MzM5ZjY4ZjE1ZTJlXzUtMy0xLTEtNTAxMTg_c19245e3-68e3-4c5a-98ef-5ba2e48a1eff"
      unitRef="shares">76287000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90YWJsZTpiODQ1YTk3YmVlNTM0ODA4OGUxNDMzOWY2OGYxNWUyZS90YWJsZXJhbmdlOmI4NDVhOTdiZWU1MzQ4MDg4ZTE0MzM5ZjY4ZjE1ZTJlXzUtMy0xLTEtNTAxMTg_e288e7eb-67d4-4cb9-9700-e99a473a2766"
      unitRef="shares">76287000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90YWJsZTpiODQ1YTk3YmVlNTM0ODA4OGUxNDMzOWY2OGYxNWUyZS90YWJsZXJhbmdlOmI4NDVhOTdiZWU1MzQ4MDg4ZTE0MzM5ZjY4ZjE1ZTJlXzUtNS0xLTEtNTAxMTg_6e8948a0-3105-476a-ace4-7ab2941a2084"
      unitRef="usd">81458000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90YWJsZTpiODQ1YTk3YmVlNTM0ODA4OGUxNDMzOWY2OGYxNWUyZS90YWJsZXJhbmdlOmI4NDVhOTdiZWU1MzQ4MDg4ZTE0MzM5ZjY4ZjE1ZTJlXzUtNy0xLTEtNTAxMTg_a65d224d-101b-4686-b57f-1f109c49d262"
      unitRef="usd">81672000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityLiquidationPreferencePerShare
      contextRef="i0d10847a28e64727936c5a6f5e2e80a5_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI5MTM3MDU4MTU3MDg4_477d9a90-0b18-4cce-9ac3-103ff1a61b14"
      unitRef="usdPerShare">0.3892</us-gaap:TemporaryEquityLiquidationPreferencePerShare>
    <us-gaap:TemporaryEquityLiquidationPreferencePerShare
      contextRef="i123f862c0d9447efbbc8bdae111fa9a1_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI5MTM3MDU4MTU3MTAx_2cd53224-eb05-4ad1-8a63-f0dd94b942db"
      unitRef="usdPerShare">0.6488925</us-gaap:TemporaryEquityLiquidationPreferencePerShare>
    <us-gaap:TemporaryEquityLiquidationPreferencePerShare
      contextRef="i1d83f10d2f3d4f9f8308f66e84ed7f02_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI5MTM3MDU4MTU3MTEx_22906d8a-786c-4482-adef-87bdb26e4d77"
      unitRef="usdPerShare">2.4104</us-gaap:TemporaryEquityLiquidationPreferencePerShare>
    <docs:TemporaryEquityDividendRate
      contextRef="i0d10847a28e64727936c5a6f5e2e80a5_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI5MTM3MDU4MTU3MTIy_91931db0-d2d4-4638-b74f-1df2cfaa2b97"
      unitRef="usdPerShare">0.03115</docs:TemporaryEquityDividendRate>
    <docs:TemporaryEquityDividendRate
      contextRef="i123f862c0d9447efbbc8bdae111fa9a1_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI5MTM3MDU4MTU3MTMy_e03d997c-0c61-4cb7-9040-2d39b0ea101f"
      unitRef="usdPerShare">0.0519</docs:TemporaryEquityDividendRate>
    <docs:TemporaryEquityDividendRate
      contextRef="i1d83f10d2f3d4f9f8308f66e84ed7f02_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI5MTM3MDU4MTU3MTQz_be695c82-f1b8-4f94-aacd-b3bba7524fc6"
      unitRef="usdPerShare">0.19285</docs:TemporaryEquityDividendRate>
    <docs:CommonStockVotingRightsNumberOfVotes
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzM0NjM0NjE2Mjk3NTQ1_bf6c7530-bb1a-41fd-a347-ed296b37bc19"
      unitRef="vote">1</docs:CommonStockVotingRightsNumberOfVotes>
    <docs:TemporaryEquityElectionOfBoardMembersSharesOutstandingThreshold
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI5MTM3MDU4MTU3MTU2_15e96391-ba38-4a94-8f5e-2ce79a21ecb7"
      unitRef="shares">2000000</docs:TemporaryEquityElectionOfBoardMembersSharesOutstandingThreshold>
    <docs:TemporaryEquitySharesOutstandingThresholdSatisfiedNumberOfElectedBoardMembersPermitted
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzM0NjM0NjE2Mjk3NTU0_e1332e66-76c1-4ede-b377-2de8bb3be9a2"
      unitRef="board_of_director">2</docs:TemporaryEquitySharesOutstandingThresholdSatisfiedNumberOfElectedBoardMembersPermitted>
    <docs:CommonStockHoldingMajorityNumberOfElectedBoardMembersPermitted
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzM0NjM0NjE2Mjk3NTYz_5949d5a6-36c4-473b-8a06-88c8fac72c3e"
      unitRef="board_of_director">2</docs:CommonStockHoldingMajorityNumberOfElectedBoardMembersPermitted>
    <docs:TemporaryEquityConvertibleStockPriceTrigger
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI5MTM3MDU4MTU3MTY0_8787f9f6-7de1-4504-b695-e0076f304a79"
      unitRef="usdPerShare">2.41</docs:TemporaryEquityConvertibleStockPriceTrigger>
    <docs:TemporaryEquityConvertibleAggregateOfferingPriceTrigger
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI5MTM3MDU4MTU3MTc4_a10615b5-2751-4e0e-a0b6-55a8cc2c9bf1"
      unitRef="usd">50000000</docs:TemporaryEquityConvertibleAggregateOfferingPriceTrigger>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i183a0b8f69a94170b9913a445fe4ab57_I20120831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI5MTM3MDU4MTU3MTg5_85bf36be-00bb-4c0e-aa54-9015fdb47284"
      unitRef="shares">38322</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i183a0b8f69a94170b9913a445fe4ab57_I20120831"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI5MTM3MDU4MTU3MTk5_ef6439e6-ae76-4c2e-8e97-80df234e9600"
      unitRef="usdPerShare">0.65</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="i183a0b8f69a94170b9913a445fe4ab57_I20120831"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI5MTM3MDU4MTU3MjEx_6511f140-561b-49e2-a86f-0fc4a17a8819"
      unitRef="usd">14000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i7bb2ecd4e0c946abb1d503513127046f_I20120831"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI5MTM3MDU4MTU3MjE3_6e630b40-64fe-40be-bd1a-dd630816e4a0"
      unitRef="number">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i903f14931847407cbb172b0f7bd884c6_I20120831"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI5MTM3MDU4MTU3MjIz_d6c0f79d-e685-4d07-a1e2-7fb1a596f1e9"
      unitRef="number">0.55</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i402085a78ad14a0f992a4f8b0ecdcd58_I20120831"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI5MTM3MDU4MTU3MjM5_4a480d95-ce17-4d27-b9b0-f19728aaaac7"
      unitRef="number">0.0113</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="if157170dd5944a499d7ec585e0434c4d_I20120831"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMDgvZnJhZzo2NWRkOTBiZTM3MDI0OTE0OTEzMTcxZDBiMjlhY2FhNy90ZXh0cmVnaW9uOjY1ZGQ5MGJlMzcwMjQ5MTQ5MTMxNzFkMGIyOWFjYWE3XzI5MTM3MDU4MTU3MjUz_babdc801-4b6b-446d-92c3-5226185f2586">P7Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzU3NzI0MzYwNDgyNTQ0_85dd479f-826b-4f95-a68f-51b47de43171">Equity&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Preferred Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the IPO, the Company&#x2019;s amended and restated certificate of incorporation became effective, which authorized the issuance of 100,000,000 shares of undesignated preferred stock with a par value of $0.001 per share with rights and preferences, including voting rights, designated from time to time by the board of directors. As of March&#160;31, 2022, there were no shares of preferred stock issued and outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Common Stock and Creation of Dual-Class Structure &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has two classes of common stock authorized: Class A common stock and Class B common stock, and are collectively referred to as common stock throughout the notes to the consolidated financial statements, unless otherwise noted. On June 8, 2021, the Company&#x2019;s board of directors and stockholders approved an amendment to the Company&#x2019;s amended and restated certificate of incorporation which authorized 1,000,000,000 shares of Class A common stock with par value of $0.001 and one vote per share, and 500,000,000 shares of Class B common stock with par value of $0.001 and ten votes per share. The holders of common stock are entitled to receive dividends, as may be declared by the board of directors. Each of the Company&#x2019;s 85,523,836 shares of existing common stock outstanding was reclassified into Class B common stock. Each outstanding share of Class B common stock may be converted at any time at the option of the holder into one share of Class A common stock. As of March&#160;31, 2022, there were 109,322,383 shares of Class A common stock, and 83,076,040 shares of Class B common stock outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Common Stock Warrants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2017, the Company issued a warrant to purchase 250,000 shares of common stock at an exercise price of $0.72 per share in connection with a contract signed between the Company and U.S. News &amp;amp; World Report, L.P., or U.S. News. The warrant vested on a monthly basis over a 5-year term starting on March 1, 2017 and expires 10 years from the date of grant. The Company recognizes the fair value of the warrants as stock-based compensation expense and additional paid-in capital over the vesting term of the warrant. As of March&#160;31, 2022, the warrant was fully vested. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 14, 2021, the Company issued a warrant (the &#x201c;U.S. News Warrant&#x201d;) to U.S. News to purchase 1,200,000 shares of Class A common stock with an exercise price of $12.56 per share, contingent on the execution of a commercial agreement with the U.S. News (the &#x201c;Commercial Agreement&#x201d;) prior to September 10, 2021, which was then extended to October 10, 2021. The first tranche of the U.S. News Warrant will vest on May 1, 2022 and the remainder will vest on a monthly basis over approximately 6 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 8, 2021, the Company signed an amended agreement to revise and extend the existing partnership with the U.S. News. The U.S. News Warrant was concurrently amended to remove the contingency related to the execution of the Commercial Agreement and the number of shares of Class A common stock issuable upon exercise of the U.S. News Warrant was revised from 1,200,000 shares to 516,000 shares. Other terms of the U.S. News Warrant remained the same. The grant-date fair value of the U.S. News Warrant was $34.7 million, which was determined using the Black-Scholes option-pricing model on the date of grant using the following assumptions: fair value of common stock of $76.50, volatility of 46.9%, risk-free interest rate of 1.61%, contractual term of 10 years, and an expected dividend of 0%. The fair value of the warrant will be recognized as expense in cost of revenue in the consolidated statements of operations on a straight-line basis over its vesting term of 6.48 years. The warrant expires 10 years from the date of grant. During the fiscal year ended March&#160;31, 2022, $2.6 million was recognized as stock-based compensation expense relating to the U.S. News Warrant. As of March&#160;31, 2022, unamortized compensation expense, net of estimated forfeitures, related to the unvested warrants was $32.1 million, which is expected to be recognized over the remaining vesting period of 6 years.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity Incentive Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In April 2010, the Company&#x2019;s board of directors and stockholders approved the adoption of the 2010 Equity Incentive Plan (the &#x201c;2010 Plan&#x201d;). The 2010 Plan provides for the granting of incentive stock options, nonstatutory stock options, restricted stock units, and restricted stock awards to employees, non-employee directors, and consultants of the Company. Options may be granted at a price per share not less than 100% of the fair market value at date of grant. If the incentive stock option is granted to a 10% stockholder, then the purchase or exercise price per share shall not be less than 110% of the fair market value per share of common stock on the grant date. Options granted under the 2010 Plan continue to vest until the last day of employment and generally vest over four years and expire 10 years from the date of grant. Stock awards may also be granted for services performed by external consultants and vest according to an award-specific schedule as approved by the board of directors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2021, the Company&#x2019;s board of directors approved the adoption of the 2021 Stock Option and Incentive Plan (the &#x201c;2021 Plan&#x201d;), which became effective upon the Company&#x2019;s initial public offering. The 2021 Plan provides for the granting of incentive stock options, nonstatutory stock options, restricted stock units, and restricted stock awards to employees, non-employee directors, and consultants of the Company. A total of 22,500,000 shares of Class A common stock was initially reserved for the 2021 Plan. The number of shares reserved and available for issuance for the 2021 Plan will automatically increase each April 1, beginning on April 1, 2022, by the lesser of 5% of the outstanding number of shares of the Class A and Class B common stock on the immediately preceding March 31, or such lesser number of shares as determined by the Company&#x2019;s compensation committee. Any shares of Class B common stock that would have otherwise been returned to the Company&#x2019;s 2010 Plan as a result of forfeiture, expiration, cancellation, termination or net issuances of awards thereunder shall be returned to the share reserve under the 2021 Plan after being automatically converted from shares of Class B common stock to Class A common stock. The 2010 Plan and the 2021 Plan are collectively referred to as the &#x201c;Plans&#x201d; in the notes to the consolidated financial statements, unless otherwise noted.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s board of directors approved the adoption of the ESPP, which became effective upon the Company&#x2019;s initial public offering. A total of 4,500,000 shares of Class A common stock was initially reserved for the ESPP. The number of shares reserved and available for issuance for the ESPP will automatically increase each April 1, beginning on April 1, 2022 and continuing through April 1, 2031, by the lesser of 6,750,000 shares of Class A common stock, 1% of the outstanding number of shares of the Class A and Class B common stock on the immediately preceding March 31, or such lesser number of shares as determined by the Company&#x2019;s compensation committee.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company grants stock options under the terms of the Plans and outside of the Plans, as approved by the board of directors. The Company granted 4,682,582 options during the fiscal year ended March 31, 2018 outside of the Plans, of which 2,011,252 options were exercised as of March&#160;31, 2022. As of March&#160;31, 2022, 2,671,330 options issued outside of the Plans were outstanding. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has shares of common stock reserved for issuance as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.229%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Redeemable convertible preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;76,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Common stock warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2010 Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Options outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;33,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Shares available for future grant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2021 Plan&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Performance-based restricted stock units outstanding&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Restricted stock units outstanding&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Shares available for future grant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2021 ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Options outstanding outside the Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;114,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock option activities within the Plans as well as outside of the Plans were as follows for both service-based and performance-based options (in&#160;thousands, except per share information): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted-Average &lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Average Remaining Contractual Term &lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Balance, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;36,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.86&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;357,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;12.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(10,823)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Options forfeited or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(736)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;26,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.63&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,293,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Vested and exercisable as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;8,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;408,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Vested and expected to vest as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;25,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.55&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,202,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate intrinsic value of options exercised during the fiscal years ended March&#160;31, 2022, 2021, and 2020 was $521.6 million, $52.6 million, and $3.0 million respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average grant-date fair value of options granted for the fiscal years ended March&#160;31, 2022, 2021, and 2020 was $10.73, $3.18, and $0.77 respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, unamortized compensation expense, net of estimated forfeitures, related to unvested stock options was $55.2 million, which is expected to be recognized over a weighted-average period of 3.04 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of each option on the date of grant is determined using the Black-Scholes option-pricing model with the assumptions set forth in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Fair value of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$18.41 - $21.41&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$2.06 - $10.51&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$1.58 - $1.91&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;46.5% - 47.0%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;38.1% - 58.3%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;39.2% - 46.5%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;0.77% - 1.02%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;0.26% - 1.02%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;0.68% - 2.36%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;5.00 - 6.09&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;5.00 - 8.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;5.94 - 10.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Expected dividend&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Performance-Based Options &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2018, the board of directors of the Company granted 1,792,000 options to the Chief Executive Officer with an exercise price of $0.97 per share under the 2010 Plan (the &#x201c;2018 CEO Grant&#x201d;) with a liquidity-event performance-based vesting condition based on the occurrence of a qualifying liquidity event, including an IPO, as well as stock price target after the consummation of the IPO. In September 2020, the 2018 CEO Grant was modified to extend the stock price target achievement cutoff date. The fair value of the 2018 CEO Grant was determined using a Monte Carlo simulation approach on the modification date. The achievement of the qualifying event was not considered to be probable prior to the Company&#x2019;s IPO. Upon the Company's IPO, the liquidity-event performance-based condition was met. During the fiscal year ended March&#160;31, 2022, $1.7 million was recognized as stock-based compensation expense relating to the 2018 CEO Grant. As the grant consists of a single tranche, the Company will amortize the remaining unrecognized compensation expense of $0.2 million on a straight-line basis over the remaining term of 0.17 years.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, the Company has 480,000 outstanding options with performance-based and service-based vesting conditions. The performance conditions are satisfied upon meeting certain financial performance and sales targets. During the fiscal year ended March&#160;31, 2022, $1.7 million was recognized as stock-based compensation expense related to performance-based options whose performance condition have either been met or achievement of which is considered probable. For the options for which the achievement of the performance vesting conditions is met or is considered probable, the remaining unrecognized compensation expense is $1.4 million, which will be amortized using accelerated attribution method over the remainder of the vesting periods. The amount to be recognized may change based upon actual performance achieved and updates to estimates of future performance. During the fiscal year ended March&#160;31, 2021 and 2020, the stock-based compensation expense related to performance options was immaterial. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fiscal year ended March&#160;31, 2022, the Company granted 572,904 RSUs under the 2021 Plan. The Company granted 28,250 on June 24, 2021, 50% of which vested on November&#160;15, 2021, with the remaining 50% vested on February&#160;15, 2022. The remaining RSUs granted during the fiscal year ended March&#160;31, 2022 will generally vest over four years based on continued service.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The RSUs are valued using the closing stock price of the Company&#x2019;s common stock, which is traded on the NYSE, on the day of grant. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes RSU activity during the fiscal year ended March&#160;31, 2022 (in&#160;thousands, except per share information):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Unvested Balance, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;67.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;59.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;54.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Unvested Balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;68.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total fair value of RSUs vested during the fiscal year ended March&#160;31, 2022 was $2.5 million.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, total unrecognized stock-based compensation cost, net of estimated forfeitures, related to non-vested RSUs was $26.3 million, and is expected to be recognized over a weighted-average period of approximately 3.51 years. As of March&#160;31, 2021 and 2020, no RSUs were outstanding. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Performance-Based Restricted Stock Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fiscal year ended March&#160;31, 2022, the Company granted 15,239 PSUs under the 2021 Plan, which had a weighted-average grant date fair value of $80.00. The PSUs have performance-based vesting conditions that are satisfied upon meeting certain financial performance targets. During the fiscal year ended March&#160;31, 2022, 3,170 PSUs were forfeited. As of March&#160;31, 2022, 12,069 PSUs were unvested. The performance conditions of these PSUs were met as of March&#160;31, 2022.  During the fiscal year ended March&#160;31, 2022, $0.6 million  was recognized as stock-based compensation expense related to these PSUs. As of March&#160;31, 2022, the remaining unrecognized compensation expense was $0.3 million, which will be recognized on a straight-line basis over the remaining term of 0.38 years, as the PSUs consist of a single tranche. As of March&#160;31, 2021 and 2020, no PSUs were outstanding. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The PSUs are valued using the closing stock price of its common stock, which is traded on the NYSE, on the day of grant. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;ESPP&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s first offering period under the ESPP began on November&#160;1, 2021 and ended on February&#160;15, 2022. Subsequent offering periods will begin on the first business day occurring on or after each February 16th and August 16th, and will end on the last business day occurring on or before the following August 15th and February 15th, respectively, unless and until otherwise determined by the administrator of the ESPP. The price at which Class A common stock is purchased under the ESPP is equal to 85% of the fair market value of a share of the Company&#x2019;s Class A common stock on the first or last day of the offering period, whichever is lower. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted-average grant-date fair value of ESPP stock purchase rights granted during the fiscal year ended March&#160;31, 2022 was $23.84. The fair value of the ESPP stock purchase rights on the date of grant is determined using the Black-Scholes pricing model with the assumptions set forth in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.854%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Fair value of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$57.44 - $73.73&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;86.3% - 103.6%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;0.05% - 0.67%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;0.29 - 0.49&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Expected dividend&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, unamortized compensation expense, net of estimated forfeitures, related to the ESPP was $0.9 million, which will be recognized on a straight-line basis over a weighted-average period of 0.38 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the  fiscal year ended March&#160;31, 2022, 28,812 shares of Class A common stock were purchased under the ESPP at a weighted average price of $48.40 per share. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation Expense&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total stock-based compensation expense recognized in the consolidated statement of operations for the fiscal years ended March&#160;31, 2022, 2021, and 2020 was as follows (in&#160;thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.991%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Sales and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;8,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;11,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;31,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="iaca56ad88a7f461f9aa0ca6977c6c5a1_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwNzg2MzI1NTk0NjEw_0b5dacab-72c8-422c-bee1-76e1da0e55d4"
      unitRef="shares">100000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="iaca56ad88a7f461f9aa0ca6977c6c5a1_I20210630"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwNzg2MzI1NTk0NjIw_d0eb45ff-d280-4e67-a220-7ed3d7f186bf"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwNzg2MzI1NTk0NjI1_02724223-6385-43f4-a6d5-8799beed1b5a"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwNzg2MzI1NTk0NjI1_564fb8f5-f09c-4edd-a16f-877e0b5ca041"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ib043fb4bcadb409c9fa4b0e1104a5b1d_I20210608"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMDA4_5145abc2-da17-4993-91b8-631ee5dfb58e"
      unitRef="shares">1000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ib043fb4bcadb409c9fa4b0e1104a5b1d_I20210608"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMDE3_5490dcde-99fe-495e-b90a-9b806e6d4fdd"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <docs:CommonStockVotingRightsNumberOfVotes
      contextRef="ib043fb4bcadb409c9fa4b0e1104a5b1d_I20210608"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMDI0_1aa9a324-54be-43d2-94fb-763c20a1280d"
      unitRef="vote">1</docs:CommonStockVotingRightsNumberOfVotes>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i7606a71ce4a84be3a6dde5784b7d32ae_I20210608"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMDQw_79c85797-5214-457d-ada3-c3a7ed72baa3"
      unitRef="shares">500000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i7606a71ce4a84be3a6dde5784b7d32ae_I20210608"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMDQ5_80943b9b-566f-4806-a5c4-65fcc3aaadbc"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <docs:CommonStockVotingRightsNumberOfVotes
      contextRef="i7606a71ce4a84be3a6dde5784b7d32ae_I20210608"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMDU2_ac65d519-ff62-4af2-97b7-0e0edeca53ba"
      unitRef="vote">10</docs:CommonStockVotingRightsNumberOfVotes>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits
      contextRef="ib6f78b8e938a40e189a348c098b679d6_D20210608-20210608"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMDcx_9e5c867d-0a43-42c0-ac9e-f9255d0cf71b"
      unitRef="shares">85523836</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <docs:ConversionOfStockConversionRatio
      contextRef="iffeb565b4545435983a69c61108b5344_D20210608-20210608"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTc0Mzk0_8c299f27-4dc2-4183-a904-d5b18c9f7239"
      unitRef="number">1</docs:ConversionOfStockConversionRatio>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i3ee03b9d354947dba14b2c512b9bc336_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMTA1_ff03c226-bdb2-4e8a-a84a-0a738f786db5"
      unitRef="shares">109322383</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i4c6316b62a6d48928288e886e45e4dc6_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMTE5_1fb29184-af94-4c46-a9d5-0a8769b14b1e"
      unitRef="shares">83076040</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="ie2075365cb96485192385bf947ef595a_I20170331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMTMw_035e596f-e190-4986-8f3f-8e9eff05cdee"
      unitRef="shares">250000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="ie2075365cb96485192385bf947ef595a_I20170331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMTM4_da0777f1-c1b6-457a-ae35-a246becf3967"
      unitRef="usdPerShare">0.72</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <docs:WarrantsAndRightsOutstandingVestingPeriod
      contextRef="i3f99466cf9f5440d9a1deb4533b63a0e_D20170301-20170331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMTQy_91a84e20-0e09-4d9e-832a-05a56a62239e">P5Y</docs:WarrantsAndRightsOutstandingVestingPeriod>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="ie2075365cb96485192385bf947ef595a_I20170331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzQ3Mjc5MDAwMDE3MDQ0_6b66e4c0-e2f4-4b37-9a19-faf8c596753a">P10Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i07bcfcbefba64208b4423f3a902e75e2_I20210614"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMTU1_7f435ccf-06b3-4636-826b-9f3a82dc54f2"
      unitRef="shares">1200000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i07bcfcbefba64208b4423f3a902e75e2_I20210614"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMTY0_f4ee4f5a-1284-4d9e-bee3-22aa89a9816f"
      unitRef="usdPerShare">12.56</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <docs:WarrantsAndRightsOutstandingVestingPeriod
      contextRef="i17b428b935264ffe87dec690a2b09118_D20210614-20210614"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5Njg2ODEzOTkxNTU1_c43af69c-e3d5-4aae-9977-61d3108eb875">P6Y</docs:WarrantsAndRightsOutstandingVestingPeriod>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i07bcfcbefba64208b4423f3a902e75e2_I20210614"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMTgw_7f435ccf-06b3-4636-826b-9f3a82dc54f2"
      unitRef="shares">1200000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i8bd91cc36430472099a03473544779d1_I20211008"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMTkw_1c84336b-92a5-42cb-8f27-cad49c16d8f2"
      unitRef="shares">516000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:WarrantsAndRightsOutstanding
      contextRef="i8bd91cc36430472099a03473544779d1_I20211008"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMjA2_38c43269-6bb8-4590-b174-a4c808cc7322"
      unitRef="usd">34700000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i7358dd40974c4c15993593aef2ed49d4_I20211008"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMjE5_20075c4a-3a49-43ff-8333-bcc97025bc86"
      unitRef="number">76.50</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="ie76d6e6102ef406399e4e136b24eca26_I20211008"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMjI3_c684bac4-170c-4ec2-9354-cbadff0c847f"
      unitRef="number">0.469</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="i61bf36f882e84585b81cb908da335c25_I20211008"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMjM1_b0237d52-4e60-41cc-817c-ca1c98ebfffe"
      unitRef="number">0.0161</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="i39eec364f5b04f648b48c3dcc6d77519_I20211008"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMjQ2_647d02ee-9ee0-4d1e-b53e-15973fb5275a">P10Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="id8607743731e4071beb43262fa44f7cf_I20211008"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTUzMjU0_2152e8b7-2157-46ae-9136-17ad5579df2a"
      unitRef="number">0</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <docs:WarrantsAndRightsOutstandingVestingPeriod
      contextRef="iefca250a775b47afb7490aca201d7488_D20211008-20211008"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxMDU5_5a6b36a2-2a92-4394-87cc-5e7ecc5fcb85">P6Y5M23D</docs:WarrantsAndRightsOutstandingVestingPeriod>
    <us-gaap:WarrantsAndRightsOutstandingTerm
      contextRef="i8bd91cc36430472099a03473544779d1_I20211008"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzQ3Mjc5MDAwMDE3MDU2_15fcface-3503-4c11-8a0f-736afb928fd1">P10Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i16b887faed4f499cae154df41656fb5f_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxMTQ3_ef3592f4-e084-4b5c-8e86-3c5db85a17ad"
      unitRef="usd">2600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="id07380e73439483897907b5d88d89be6_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxMTg4_eb804a93-1499-42bf-ac0f-6d7b1edc0e42"
      unitRef="usd">32100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i16b887faed4f499cae154df41656fb5f_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxMjA0_ca957746-5c49-4fed-add3-935b0961a8bf">P6Y</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock
      contextRef="i6d4fd5c7f8d8423bb39a6ed8568b3356_D20100401-20100430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxMjEz_e2fb6d3e-4424-455b-b7db-10cc0b60cbe7"
      unitRef="number">1</docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock>
    <docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold
      contextRef="id1341fe12e41432d9a0dd420afc78a66_D20100401-20100430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxMjE5_d531f919-f59e-4db4-8fdc-cf4ab2cb7de2"
      unitRef="number">0.10</docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold>
    <docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock
      contextRef="id1341fe12e41432d9a0dd420afc78a66_D20100401-20100430"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxMjI2_9dcc7b43-fb3c-4853-9894-4090a905692d"
      unitRef="number">1.10</docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i22d3b66c56b94252a2946d3a502fdae3_D20100401-20100430"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxMjM5_39daaad1-0de4-4d68-af88-c96ddc8befe3">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i22d3b66c56b94252a2946d3a502fdae3_D20100401-20100430"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxMjUw_f8cab3db-2aa5-466c-a288-5f8524018942">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i8ec1658b926c4ef39dfd202582dd44a8_I20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5ODA0NTI5_1c0f0b23-bfae-4e53-afb8-d1601a88d184"
      unitRef="shares">22500000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <docs:CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding
      contextRef="i8ec1658b926c4ef39dfd202582dd44a8_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5ODA0NTM0_eb39c16d-acc4-45a2-8a34-f3f54ec28f91"
      unitRef="number">0.05</docs:CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="iab2ea80b2cbf4380ba57669907c19c02_I20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxMjgz_0ac3a8a4-c939-4f92-8b6a-84f2b018fafb"
      unitRef="shares">4500000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <docs:CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease
      contextRef="iab2ea80b2cbf4380ba57669907c19c02_I20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxMjg3_5a5f15c9-097b-4b07-b1ad-2e4474f7d618"
      unitRef="shares">6750000</docs:CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease>
    <docs:CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding
      contextRef="iab2ea80b2cbf4380ba57669907c19c02_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxMjkx_200c57fb-bd8d-4246-a0e8-ad57a30fb909"
      unitRef="number">0.01</docs:CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i5eaddeac25184da0affc7274c9201b26_D20170401-20180331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxMzAz_e6a64ee3-cf80-4a06-94b7-5e73b83c1d30"
      unitRef="shares">4682582</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised
      contextRef="if4e53989ad534fe89ef01474dae63d8f_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxMzE1_0533fade-66b6-4ff9-ab92-239037d02f1b"
      unitRef="shares">2011252</docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="if4e53989ad534fe89ef01474dae63d8f_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxMzI4_71ff9eb0-b65e-4bf2-9980-1646d4fa5a2d"
      unitRef="shares">2671330</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzU3NzI0MzYwNDgyNTQ1_7918c98a-a59e-4310-b0d4-6a479a76c4e1">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has shares of common stock reserved for issuance as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.514%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.229%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Redeemable convertible preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;76,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Common stock warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2010 Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Options outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;33,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Shares available for future grant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2021 Plan&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Performance-based restricted stock units outstanding&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Restricted stock units outstanding&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Shares available for future grant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2021 ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Options outstanding outside the Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;55,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;114,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTo0MmVkNTFjNzYzMzg0ZTcxYjZhMjViZWFlODViZmU5OS90YWJsZXJhbmdlOjQyZWQ1MWM3NjMzODRlNzFiNmEyNWJlYWU4NWJmZTk5XzEtMS0xLTEtODQ2MzM_93c5b53b-03b6-4190-ae18-eae9a410fecd"
      unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTo0MmVkNTFjNzYzMzg0ZTcxYjZhMjViZWFlODViZmU5OS90YWJsZXJhbmdlOjQyZWQ1MWM3NjMzODRlNzFiNmEyNWJlYWU4NWJmZTk5XzEtMy0xLTEtODQ2MzM_c6e57eb7-950c-4236-80ab-5e32abca3064"
      unitRef="shares">76287000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTo0MmVkNTFjNzYzMzg0ZTcxYjZhMjViZWFlODViZmU5OS90YWJsZXJhbmdlOjQyZWQ1MWM3NjMzODRlNzFiNmEyNWJlYWU4NWJmZTk5XzItMS0xLTEtODQ2MzM_b214e24a-b20f-4ea1-86bb-dbc2162f3400"
      unitRef="shares">766000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTo0MmVkNTFjNzYzMzg0ZTcxYjZhMjViZWFlODViZmU5OS90YWJsZXJhbmdlOjQyZWQ1MWM3NjMzODRlNzFiNmEyNWJlYWU4NWJmZTk5XzItMy0xLTEtODQ2MzM_b444b999-1e67-4393-ae0f-ddeed00fe0bb"
      unitRef="shares">250000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i725f9096e258495b86d6aa50c855aaa9_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTo0MmVkNTFjNzYzMzg0ZTcxYjZhMjViZWFlODViZmU5OS90YWJsZXJhbmdlOjQyZWQ1MWM3NjMzODRlNzFiNmEyNWJlYWU4NWJmZTk5XzQtMS0xLTEtODQ2MzM_d4b6b95c-2497-4e41-bcd2-ca81f57ffb6f"
      unitRef="shares">24312000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i56d735fe4eb34fe1922c7e4400822779_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTo0MmVkNTFjNzYzMzg0ZTcxYjZhMjViZWFlODViZmU5OS90YWJsZXJhbmdlOjQyZWQ1MWM3NjMzODRlNzFiNmEyNWJlYWU4NWJmZTk5XzQtMy0xLTEtODQ2MzM_49930b28-a476-4635-801d-c47df5144b5e"
      unitRef="shares">33856000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i725f9096e258495b86d6aa50c855aaa9_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTo0MmVkNTFjNzYzMzg0ZTcxYjZhMjViZWFlODViZmU5OS90YWJsZXJhbmdlOjQyZWQ1MWM3NjMzODRlNzFiNmEyNWJlYWU4NWJmZTk5XzUtMS0xLTEtODQ2MzM_f7d34332-509d-4c3c-875b-3486d2abb4a4"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="i56d735fe4eb34fe1922c7e4400822779_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTo0MmVkNTFjNzYzMzg0ZTcxYjZhMjViZWFlODViZmU5OS90YWJsZXJhbmdlOjQyZWQ1MWM3NjMzODRlNzFiNmEyNWJlYWU4NWJmZTk5XzUtMy0xLTEtODQ2MzM_9f319393-344b-4087-a50b-767b43f4e6fa"
      unitRef="shares">1550000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="i3541a109248a45dc94084818f280ac54_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTo0MmVkNTFjNzYzMzg0ZTcxYjZhMjViZWFlODViZmU5OS90YWJsZXJhbmdlOjQyZWQ1MWM3NjMzODRlNzFiNmEyNWJlYWU4NWJmZTk5XzctMS0xLTEtODQ2MzM_2da84ff3-1a03-418b-8571-bbef262fd59d"
      unitRef="shares">12000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="i67450ca940dd40f0a2d462baa0500656_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTo0MmVkNTFjNzYzMzg0ZTcxYjZhMjViZWFlODViZmU5OS90YWJsZXJhbmdlOjQyZWQ1MWM3NjMzODRlNzFiNmEyNWJlYWU4NWJmZTk5XzctMy0xLTEtODQ2MzM_208e7149-7373-4fe6-8c19-d6b96854d4bf"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="i062a7bd4fea64eff8312ec950069505b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTo0MmVkNTFjNzYzMzg0ZTcxYjZhMjViZWFlODViZmU5OS90YWJsZXJhbmdlOjQyZWQ1MWM3NjMzODRlNzFiNmEyNWJlYWU4NWJmZTk5XzgtMS0xLTEtODQ2MzM_5626fd98-c53f-4ada-99ad-1a95b914f410"
      unitRef="shares">534000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="i474cc2747676411382999c3f91d30019_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTo0MmVkNTFjNzYzMzg0ZTcxYjZhMjViZWFlODViZmU5OS90YWJsZXJhbmdlOjQyZWQ1MWM3NjMzODRlNzFiNmEyNWJlYWU4NWJmZTk5XzgtMy0xLTEtODQ2MzM_626cf978-d9bf-44fd-8b64-b0bac5b3eda3"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="ic7e987e8af04409dbdccaa86e531b3a0_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTo0MmVkNTFjNzYzMzg0ZTcxYjZhMjViZWFlODViZmU5OS90YWJsZXJhbmdlOjQyZWQ1MWM3NjMzODRlNzFiNmEyNWJlYWU4NWJmZTk5XzktMS0xLTEtODQ2MzM_1e2b056d-4bcf-4553-b4e4-27df3a4195c5"
      unitRef="shares">22466000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="id01f8e0be0ee4f27ae203fcef745b3aa_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTo0MmVkNTFjNzYzMzg0ZTcxYjZhMjViZWFlODViZmU5OS90YWJsZXJhbmdlOjQyZWQ1MWM3NjMzODRlNzFiNmEyNWJlYWU4NWJmZTk5XzktMy0xLTEtODQ2MzM_15210048-aa1f-44da-8ffe-8a7ada5c6c42"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="iab2ea80b2cbf4380ba57669907c19c02_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTo0MmVkNTFjNzYzMzg0ZTcxYjZhMjViZWFlODViZmU5OS90YWJsZXJhbmdlOjQyZWQ1MWM3NjMzODRlNzFiNmEyNWJlYWU4NWJmZTk5XzEwLTEtMS0xLTg0NjMz_1cb9ba78-7879-45c8-9ab6-66d0a416391f"
      unitRef="shares">4471000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="ie51ad27fff7e4a428edc6ea000fd35d2_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTo0MmVkNTFjNzYzMzg0ZTcxYjZhMjViZWFlODViZmU5OS90YWJsZXJhbmdlOjQyZWQ1MWM3NjMzODRlNzFiNmEyNWJlYWU4NWJmZTk5XzEwLTMtMS0xLTg0NjMz_4cfd80c2-c8f8-42a1-aafa-9c6e4af1cdec"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="if4e53989ad534fe89ef01474dae63d8f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTo0MmVkNTFjNzYzMzg0ZTcxYjZhMjViZWFlODViZmU5OS90YWJsZXJhbmdlOjQyZWQ1MWM3NjMzODRlNzFiNmEyNWJlYWU4NWJmZTk5XzExLTEtMS0xLTg0NjMz_f2a91660-435a-4b27-82db-fff14722cbfa"
      unitRef="shares">2671000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i434b921a71c247e49c95cbfb98931fc2_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTo0MmVkNTFjNzYzMzg0ZTcxYjZhMjViZWFlODViZmU5OS90YWJsZXJhbmdlOjQyZWQ1MWM3NjMzODRlNzFiNmEyNWJlYWU4NWJmZTk5XzExLTMtMS0xLTg0NjMz_8c8a548a-3655-4d20-9fbd-57ed9577c1e8"
      unitRef="shares">2720000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTo0MmVkNTFjNzYzMzg0ZTcxYjZhMjViZWFlODViZmU5OS90YWJsZXJhbmdlOjQyZWQ1MWM3NjMzODRlNzFiNmEyNWJlYWU4NWJmZTk5XzEyLTEtMS0xLTg0NjMz_99f0ccc3-dd23-473b-9aae-ad9b2837f0dc"
      unitRef="shares">55232000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTo0MmVkNTFjNzYzMzg0ZTcxYjZhMjViZWFlODViZmU5OS90YWJsZXJhbmdlOjQyZWQ1MWM3NjMzODRlNzFiNmEyNWJlYWU4NWJmZTk5XzEyLTMtMS0xLTg0NjMz_2e5714ad-7eea-40f1-8d1f-4a1ffe25a10f"
      unitRef="shares">114663000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzU3NzI0MzYwNDgyNTQ2_823551e2-42c4-4d34-957e-979c67c60fde">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock option activities within the Plans as well as outside of the Plans were as follows for both service-based and performance-based options (in&#160;thousands, except per share information): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.268%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.623%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted-Average &lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Average Remaining Contractual Term &lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Balance, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;36,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.86&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;357,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Options granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;12.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(10,823)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Options forfeited or expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(736)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;26,983&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.63&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,293,545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Vested and exercisable as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;8,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1.77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6.15&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;408,238&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Vested and expected to vest as of March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;25,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7.55&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,202,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzEtMS0xLTEtODQ2MzM_737606e5-320f-4c4a-a196-15023ff36b30"
      unitRef="shares">36576000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzEtMy0xLTEtODQ2MzM_290eb551-2513-4b3d-ab3d-71debbb52d60"
      unitRef="usdPerShare">2.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzEtNS0xLTEtODQ2MzM_d60f42ac-c95f-423f-a7d6-d98336ae1da2">P7Y10M9D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzEtNy0xLTEtODQ2MzM_02cdd31b-747c-4aca-89df-0a968e27b099"
      unitRef="usd">357366000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzItMS0xLTEtODQ2MzM_57b10008-44db-4dbc-8f5e-4d7cd4d73230"
      unitRef="shares">1966000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzItMy0xLTEtODQ2MzM_98b97460-8ade-412a-9de3-0ef6eee14828"
      unitRef="usdPerShare">12.56</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzMtMS0xLTEtODQ2MzM_bca8ea60-5e89-46c5-90f1-4d8b8eb8e29c"
      unitRef="shares">10823000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzMtMy0xLTEtODQ2MzM_90a19274-d09d-4fed-a0e4-8d8795518585"
      unitRef="usdPerShare">1.17</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzQtMS0xLTEtODQ2MzM_367905f3-2342-42b9-9ffa-1414276590ce"
      unitRef="shares">736000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzQtMy0xLTEtODQ2MzM_0cedb858-db39-4a60-92ed-9cae5e313a63"
      unitRef="usdPerShare">3.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzUtMS0xLTEtODQ2MzM_92b5f96f-7471-4905-a977-15e8154fd5b9"
      unitRef="shares">26983000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzUtMy0xLTEtODQ2MzM_7f4c5d7a-e2d7-448b-b41c-ce442ad72f59"
      unitRef="usdPerShare">4.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzUtNS0xLTEtODQ2MzM_bf3a328a-a539-4391-91cf-9c7b79b28802">P7Y7M17D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzUtNy0xLTEtODQ2MzM_3881563e-738a-45f7-86d9-15abd88d97e5"
      unitRef="usd">1293545000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzYtMS0xLTEtODQ2MzM_382b5032-c4a3-4b30-9036-6ed61868ab95"
      unitRef="shares">8113000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzYtMy0xLTEtODQ2MzM_a780835d-8c00-4c2f-82e9-48355857c4d9"
      unitRef="usdPerShare">1.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzYtNS0xLTEtODQ2MzM_2fa1be5e-20eb-4491-9d0c-a40adb0c8b93">P6Y1M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzYtNy0xLTEtODQ2MzM_e2753e39-89ef-49c4-9171-aaf37aeb875a"
      unitRef="usd">408238000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzctMS0xLTEtODQ2MzM_fb9d0df7-5885-447e-a47a-d66f10cee721"
      unitRef="shares">25021000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzctMy0xLTEtODQ2MzM_a9d9f45f-8ea1-42bb-b4a4-0cf37dad7dfb"
      unitRef="usdPerShare">4.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzctNS0xLTEtODQ2MzM_47e13394-464c-4e11-8481-59d1d0f8ad2b">P7Y6M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozMjU2NGRjZTlmZjY0N2IwOTQ0YmM5ZTUwMGVhYWJhYy90YWJsZXJhbmdlOjMyNTY0ZGNlOWZmNjQ3YjA5NDRiYzllNTAwZWFhYmFjXzctNy0xLTEtODQ2MzM_95d9fe6c-c542-4ebf-b63d-6f1d476bb0cb"
      unitRef="usd">1202634000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxNDU2_cabaf4c6-f160-45ea-a9aa-e443602f797f"
      unitRef="usd">521600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxNDc1_d358281d-2d9c-45e8-9fb2-ba7a783f086e"
      unitRef="usd">52600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTU1MTky_2795acb5-f1a8-4869-a834-ff6e7e87b69b"
      unitRef="usd">3000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxNTYx_d970b343-5d9e-42a1-8cc1-c9327189a7ca"
      unitRef="usdPerShare">10.73</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxNTcw_3624bf37-2858-4d92-801e-580ef78e5f7e"
      unitRef="usdPerShare">3.18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTU1MjEz_6580dbed-65a1-4cb1-b513-bbc4afd87698"
      unitRef="usdPerShare">0.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxNjA4_e3087973-35ea-4022-b2ae-1628aabf6e75"
      unitRef="usd">55200000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxNjMx_7dc4c30f-e947-4f9d-8d42-e6e9f058e699">P3Y14D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzU3NzI0MzYwNDgyNTQ3_fed109ce-7282-40c6-8d7f-c1ba23372d11">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of each option on the date of grant is determined using the Black-Scholes option-pricing model with the assumptions set forth in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.940%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Fair value of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$18.41 - $21.41&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$2.06 - $10.51&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$1.58 - $1.91&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;46.5% - 47.0%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;38.1% - 58.3%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;39.2% - 46.5%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;0.77% - 1.02%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;0.26% - 1.02%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;0.68% - 2.36%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;5.00 - 6.09&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;5.00 - 8.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;5.94 - 10.00&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Expected dividend&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice
      contextRef="i846bae41a5fe4dd4a8ee4faa714617c2_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzItMS0xLTEtMTAwOTcxL3RleHRyZWdpb246YTQzNzc5YzEwMDZkNGE4OWJlNWU4N2NiNGZmMjk2MThfMjk2ODY4MTM5NDk5NTY_0ec3d123-45a9-494a-9262-eebd0a63db30"
      unitRef="usdPerShare">18.41</docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice>
    <docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice
      contextRef="i18e2b6fd4b074d7db710c23afcd10f34_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzItMS0xLTEtMTAwOTcxL3RleHRyZWdpb246YTQzNzc5YzEwMDZkNGE4OWJlNWU4N2NiNGZmMjk2MThfMjk2ODY4MTM5NDk5NjI_bcb77023-a581-496e-9da3-4d5c93c4e578"
      unitRef="usdPerShare">21.41</docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice>
    <docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice
      contextRef="i20ae6e1b9ad04e07b4597114eca5d5ee_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzItNC0xLTEtMTAxMDA0L3RleHRyZWdpb246NjgwMDViZDkxMWE0NDAyOWJiNjczYTY1MTE3MWJmMjNfNDcyNzg5OTk5OTQzNzI_a9fe708d-b023-46ef-9d6a-3b49dd28172d"
      unitRef="usdPerShare">2.06</docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice>
    <docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice
      contextRef="i7493bbee46f24e8484095a81b057167c_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzItNC0xLTEtMTAxMDA0L3RleHRyZWdpb246NjgwMDViZDkxMWE0NDAyOWJiNjczYTY1MTE3MWJmMjNfNDcyNzg5OTk5OTQzNzg_74c4de36-feac-43e2-b9bf-a46b5838ed06"
      unitRef="usdPerShare">10.51</docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice>
    <docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice
      contextRef="i226d0d1119d141748de5f3ec182d0ba9_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzItOC0xLTEtMTAxMDI4L3RleHRyZWdpb246Nzk5YjQ0NDgyZDA0NDIzNDk2ZGZjZmUxNGUzZDk3OTRfNDcyNzg5OTk5OTQzNzI_19ce6c6d-aee6-49e1-bc54-33049e18b0fd"
      unitRef="usdPerShare">1.58</docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice>
    <docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice
      contextRef="i6e6975dac5d14fdeb07a8ecc86e9912d_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzItOC0xLTEtMTAxMDI4L3RleHRyZWdpb246Nzk5YjQ0NDgyZDA0NDIzNDk2ZGZjZmUxNGUzZDk3OTRfNDcyNzg5OTk5OTQzNzg_a38a2aeb-c5b5-4efd-ae54-72a99e64fbbb"
      unitRef="usdPerShare">1.91</docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="i31208a9ec3934804b4c4c3c9e4b9ae56_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzMtMS0xLTEtMTAxMDQwL3RleHRyZWdpb246OTAzMGViZTliYTFmNDczYzhiYTk0N2RmMjNiMTFkNWRfNDcyNzg5OTk5OTQzNzI_68d3051e-6a0f-47d3-9050-7bf76224286e"
      unitRef="number">0.465</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="i31208a9ec3934804b4c4c3c9e4b9ae56_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzMtMS0xLTEtMTAxMDQwL3RleHRyZWdpb246OTAzMGViZTliYTFmNDczYzhiYTk0N2RmMjNiMTFkNWRfNDcyNzg5OTk5OTQzNzg_10f06a04-565e-460b-b300-fc98a1d6853a"
      unitRef="number">0.470</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="i63de954bcdf44beabda4a4cb41517cd6_D20200401-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzMtNC0xLTEtMTAxMDQ0L3RleHRyZWdpb246MTc2ZTYwMjYyNTkxNGM3OTk0MzZmNGExNDJmYTRiODVfNDcyNzg5OTk5OTQzNzI_3835b649-5880-4ff9-8149-775a9dc15789"
      unitRef="number">0.381</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="i63de954bcdf44beabda4a4cb41517cd6_D20200401-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzMtNC0xLTEtMTAxMDQ0L3RleHRyZWdpb246MTc2ZTYwMjYyNTkxNGM3OTk0MzZmNGExNDJmYTRiODVfNDcyNzg5OTk5OTQzNzg_fbdc64e4-c06a-4739-a312-02c155a6d418"
      unitRef="number">0.583</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="i5570e6c29d854f898d1e5e342437be88_D20190401-20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzMtOC0xLTEtMTAxMDQ4L3RleHRyZWdpb246Njc2ZTUxYWMxZDc3NGJmNWE4YjYxZjVlMThhZWU3MWRfNDcyNzg5OTk5OTQzNzI_bbe982e8-f52e-4df7-b721-d69074bd0cd8"
      unitRef="number">0.392</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="i5570e6c29d854f898d1e5e342437be88_D20190401-20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzMtOC0xLTEtMTAxMDQ4L3RleHRyZWdpb246Njc2ZTUxYWMxZDc3NGJmNWE4YjYxZjVlMThhZWU3MWRfNDcyNzg5OTk5OTQzNzg_e36564ac-64fd-4007-906e-364813ed8d6e"
      unitRef="number">0.465</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="i31208a9ec3934804b4c4c3c9e4b9ae56_D20210401-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzQtMS0xLTEtMTAxMDU5L3RleHRyZWdpb246YzM5OTQ2ZWFiZTZkNDM5ODg4M2E4NmQxNDU3ZGE5ZDlfNDcyNzg5OTk5OTQzNzI_78e22093-c4ad-4f3e-959c-a6e940a62c0b"
      unitRef="number">0.0077</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="i31208a9ec3934804b4c4c3c9e4b9ae56_D20210401-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzQtMS0xLTEtMTAxMDU5L3RleHRyZWdpb246YzM5OTQ2ZWFiZTZkNDM5ODg4M2E4NmQxNDU3ZGE5ZDlfNDcyNzg5OTk5OTQzNzg_fe666055-7891-4071-ac56-51d6d8456c95"
      unitRef="number">0.0102</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="i63de954bcdf44beabda4a4cb41517cd6_D20200401-20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzQtNC0xLTEtMTAxMDY0L3RleHRyZWdpb246NzZmOGViZTdmNDU2NDA0ZDlhOWU3YjU5NzNkNjE3Y2JfNDcyNzg5OTk5OTQzODQ_e80800da-efa9-4a04-9a4b-e20d1e0d8f6e"
      unitRef="number">0.0026</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="i63de954bcdf44beabda4a4cb41517cd6_D20200401-20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzQtNC0xLTEtMTAxMDY0L3RleHRyZWdpb246NzZmOGViZTdmNDU2NDA0ZDlhOWU3YjU5NzNkNjE3Y2JfNDcyNzg5OTk5OTQzOTA_11ceba5e-dcdb-4f54-a202-5161db848884"
      unitRef="number">0.0102</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="i5570e6c29d854f898d1e5e342437be88_D20190401-20200331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzQtNy0xLTEtMTAxMDY4L3RleHRyZWdpb246MDg0OTNlM2E5MWE3NDBhZDk3ODE3OTM3MmVjMWZlYzlfNDcyNzg5OTk5OTQzNzI_ec222a0f-1592-4f9c-bbbc-4b2e1a030fe3"
      unitRef="number">0.0068</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="i5570e6c29d854f898d1e5e342437be88_D20190401-20200331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzQtNy0xLTEtMTAxMDY4L3RleHRyZWdpb246MDg0OTNlM2E5MWE3NDBhZDk3ODE3OTM3MmVjMWZlYzlfNDcyNzg5OTk5OTQzNzg_a9a9ab08-a79d-4cdc-a9f8-0987037eb9a7"
      unitRef="number">0.0236</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i846bae41a5fe4dd4a8ee4faa714617c2_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzUtMS0xLTEtMTAxMDc2L3RleHRyZWdpb246MmZmY2E0N2IzMDQzNGU3Mzg2M2QxOGE5ZDdmZDA4MWNfNDcyNzg5OTk5OTQzNzI_97a275e9-9024-41ad-8df2-00b518a14c5c">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i18e2b6fd4b074d7db710c23afcd10f34_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzUtMS0xLTEtMTAxMDc2L3RleHRyZWdpb246MmZmY2E0N2IzMDQzNGU3Mzg2M2QxOGE5ZDdmZDA4MWNfNDcyNzg5OTk5OTQzNzg_007b7ce0-22af-4162-98fb-5f21b4e07bf8">P6Y1M2D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i20ae6e1b9ad04e07b4597114eca5d5ee_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzUtNC0xLTEtMTAxMDgwL3RleHRyZWdpb246YmZhZTRiZTY2M2JjNDE3OWI3NzhhOTY3ZGMyYmE0YjZfNDcyNzg5OTk5OTQzNzI_f7f6e228-0179-4533-8e15-81cfabef4dad">P5Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i7493bbee46f24e8484095a81b057167c_D20200401-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzUtNC0xLTEtMTAxMDgwL3RleHRyZWdpb246YmZhZTRiZTY2M2JjNDE3OWI3NzhhOTY3ZGMyYmE0YjZfNDcyNzg5OTk5OTQzNzg_2c8b57fd-d891-4ec9-bf42-fe2141b5d705">P8Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i226d0d1119d141748de5f3ec182d0ba9_D20190401-20200331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzUtNy0xLTEtMTAxMDg0L3RleHRyZWdpb246Y2U3MGRhZTFlMjBhNDgwMzlhMWNkMjJhY2NmY2QwYTVfNDcyNzg5OTk5OTQzNzI_5e471bc7-d0db-494c-a82a-a8f7882d67f0">P5Y11M8D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i6e6975dac5d14fdeb07a8ecc86e9912d_D20190401-20200331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzUtNy0xLTEtMTAxMDg0L3RleHRyZWdpb246Y2U3MGRhZTFlMjBhNDgwMzlhMWNkMjJhY2NmY2QwYTVfNDcyNzg5OTk5OTQzNzg_96da3002-79b3-4240-88bb-c98c211b0338">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i31208a9ec3934804b4c4c3c9e4b9ae56_D20210401-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzYtOS0xLTEtODQ2MzM_eea4abae-4397-489d-81b4-950a80fb8c79"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i63de954bcdf44beabda4a4cb41517cd6_D20200401-20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzYtMTMtMS0xLTg0NjMz_a9023646-24eb-4e0a-ba37-eb83ce8844ab"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i5570e6c29d854f898d1e5e342437be88_D20190401-20200331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjOWZmZTA1ZWFiZmI0MzdjOWQxOTNiN2E2NDU4MzI1OS90YWJsZXJhbmdlOmM5ZmZlMDVlYWJmYjQzN2M5ZDE5M2I3YTY0NTgzMjU5XzYtOS0xLTEtMTAwNTc0_c4bafdd6-e9ff-40a4-8468-585bf1d56952"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i298cf9213fd94bf999a48f99a9e0d27c_D20180301-20180331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxNjUw_feebcff1-3031-46bf-9729-9d816c1b962b"
      unitRef="shares">1792000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i298cf9213fd94bf999a48f99a9e0d27c_D20180301-20180331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxNjU4_c09bea09-b67b-43ab-992e-c3570b400161"
      unitRef="usdPerShare">0.97</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7c137a25b9864647b3377c74eb5c9329_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxNzQ0_2fa5eae7-6702-44fb-a1c4-fd03766ba4d1"
      unitRef="usd">1700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="icd3eb1cf82ec45919e291170d616104d_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxNzgw_e1776ec2-685e-4930-8cfc-af89c84e8de5"
      unitRef="usd">200000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i7c137a25b9864647b3377c74eb5c9329_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTc0MzUx_9a6d1f8d-bb6f-42c5-ab7f-cd073a35e261">P0Y2M1D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i24ebf27ab6024144a01cc18be9301b97_I20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxODI5_fa5f7621-a55c-4d50-b35f-35bb2d818fdf"
      unitRef="shares">480000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4d1acfbd8dc54fa9b2bcb6aafeb4d7f5_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxODQ2_621e627c-d28c-472a-8552-a164b30fef17"
      unitRef="usd">1700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i24ebf27ab6024144a01cc18be9301b97_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgxOTUz_08215846-bdae-4a75-8d1d-e36c1802f446"
      unitRef="usd">1400000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ife196e39e85444efa18e6408b5528324_D20210401-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgyMDE1_25c25a38-6cb8-4310-b6f6-1c930b2de46f"
      unitRef="shares">572904</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i069e58edeaa64c12a8363d9a79919c2f_D20210624-20210624"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgyMDI0_dae1164d-0840-4015-a175-f858534deaeb"
      unitRef="shares">28250</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i8d9b036a65e94e84b94ff795383a9281_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgyMDMw_ab97c267-d7c1-4e4e-8230-f4c325352d4c"
      unitRef="number">0.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="ieda01ec82c8347f79e1ed7baa2764e9c_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgyMDM2_8dda4857-f401-497b-9d34-44800f3d9f67"
      unitRef="number">0.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i8d96c621dbad4b0893a45915a1e3eb41_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgyMTQ3_d0559a88-8394-424a-82cd-35b6e8a6ac9c">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzU3NzI0MzYwNDgyNTQ4_98f3dddd-549c-48de-9658-5813730f8cca">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes RSU activity during the fiscal year ended March&#160;31, 2022 (in&#160;thousands, except per share information):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Unvested Balance, March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;67.60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(38)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;59.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;54.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Unvested Balance, March 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;68.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i22cded30244a4dc4b48d2cc92c10c4be_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozZmY1N2ZmMzg3YTk0MmM4YTkzMzI4YWE4ZTIwYmI4NC90YWJsZXJhbmdlOjNmZjU3ZmYzODdhOTQyYzhhOTMzMjhhYThlMjBiYjg0XzEtMS0xLTEtODQ2MzM_98417c9c-f816-421b-ada6-61dc50661bbb"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i22cded30244a4dc4b48d2cc92c10c4be_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozZmY1N2ZmMzg3YTk0MmM4YTkzMzI4YWE4ZTIwYmI4NC90YWJsZXJhbmdlOjNmZjU3ZmYzODdhOTQyYzhhOTMzMjhhYThlMjBiYjg0XzEtMy0xLTEtODQ2MzM_594a98d3-a3ef-445b-876f-2ad426dfff4b"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ife196e39e85444efa18e6408b5528324_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozZmY1N2ZmMzg3YTk0MmM4YTkzMzI4YWE4ZTIwYmI4NC90YWJsZXJhbmdlOjNmZjU3ZmYzODdhOTQyYzhhOTMzMjhhYThlMjBiYjg0XzItMS0xLTEtODQ2MzM_705adc43-78b1-4139-8114-d226bb665d78"
      unitRef="shares">573000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ife196e39e85444efa18e6408b5528324_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozZmY1N2ZmMzg3YTk0MmM4YTkzMzI4YWE4ZTIwYmI4NC90YWJsZXJhbmdlOjNmZjU3ZmYzODdhOTQyYzhhOTMzMjhhYThlMjBiYjg0XzItMy0xLTEtODQ2MzM_3f0e29f1-5fb4-42d2-8d6c-7529f54fb047"
      unitRef="usdPerShare">67.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ife196e39e85444efa18e6408b5528324_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozZmY1N2ZmMzg3YTk0MmM4YTkzMzI4YWE4ZTIwYmI4NC90YWJsZXJhbmdlOjNmZjU3ZmYzODdhOTQyYzhhOTMzMjhhYThlMjBiYjg0XzMtMS0xLTEtODQ2MzM_047447b3-3181-4a12-afd0-ef45db1a17e0"
      unitRef="shares">38000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="ife196e39e85444efa18e6408b5528324_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozZmY1N2ZmMzg3YTk0MmM4YTkzMzI4YWE4ZTIwYmI4NC90YWJsZXJhbmdlOjNmZjU3ZmYzODdhOTQyYzhhOTMzMjhhYThlMjBiYjg0XzMtMy0xLTEtODQ2MzM_43c7de69-a9fe-405c-aedf-6e777baf97d1"
      unitRef="usdPerShare">59.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="ife196e39e85444efa18e6408b5528324_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozZmY1N2ZmMzg3YTk0MmM4YTkzMzI4YWE4ZTIwYmI4NC90YWJsZXJhbmdlOjNmZjU3ZmYzODdhOTQyYzhhOTMzMjhhYThlMjBiYjg0XzQtMS0xLTEtODQ2MzM_3ed3d677-4e2e-4055-9343-b4330d531646"
      unitRef="shares">1000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="ife196e39e85444efa18e6408b5528324_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozZmY1N2ZmMzg3YTk0MmM4YTkzMzI4YWE4ZTIwYmI4NC90YWJsZXJhbmdlOjNmZjU3ZmYzODdhOTQyYzhhOTMzMjhhYThlMjBiYjg0XzQtMy0xLTEtODQ2MzM_4a874d69-e5ce-4e96-a4d6-10e4883a36a8"
      unitRef="usdPerShare">54.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i610bf1430732450cbbf831aa9fbaf023_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozZmY1N2ZmMzg3YTk0MmM4YTkzMzI4YWE4ZTIwYmI4NC90YWJsZXJhbmdlOjNmZjU3ZmYzODdhOTQyYzhhOTMzMjhhYThlMjBiYjg0XzUtMS0xLTEtODQ2MzM_566bac8c-2951-4625-ba3f-77b2caed9a73"
      unitRef="shares">534000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i610bf1430732450cbbf831aa9fbaf023_I20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTozZmY1N2ZmMzg3YTk0MmM4YTkzMzI4YWE4ZTIwYmI4NC90YWJsZXJhbmdlOjNmZjU3ZmYzODdhOTQyYzhhOTMzMjhhYThlMjBiYjg0XzUtMy0xLTEtODQ2MzM_deef3dcb-8140-4f68-a311-24e1cba64405"
      unitRef="usdPerShare">68.23</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="ife196e39e85444efa18e6408b5528324_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzQ3Mjc5MDAwMDE4Mzky_87761866-e9bb-4903-93dd-444f328f802e"
      unitRef="usd">2500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="i610bf1430732450cbbf831aa9fbaf023_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgyMjY1_092aea50-180d-4259-9aed-0e259d451d3d"
      unitRef="usd">26300000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ife196e39e85444efa18e6408b5528324_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgyMjgy_87f63750-6820-4153-b6c3-965d6d10f9fc">P3Y6M3D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="i22cded30244a4dc4b48d2cc92c10c4be_I20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTc4MDU1_27a87c36-3e2f-4c7a-8535-881b0fbc40b3"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="ic960f45dc6ee4214a384c76564f6f1a3_I20200331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTc4MDU1_c7f2ec8f-7b38-4554-beda-de3d40682922"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i117af75205314c998fad1407c682e2d0_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgyMzUx_1a9f4d52-abc9-4b70-8b00-9cb4b78c82db"
      unitRef="shares">15239</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i117af75205314c998fad1407c682e2d0_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgyMzYw_c5d2f6d5-e0f9-4b3c-b8e3-63e200c0b59e"
      unitRef="usdPerShare">80.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i117af75205314c998fad1407c682e2d0_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzM0MDg0ODYwNDg0ODYy_79fb438a-4e54-4b60-8ee2-3132352075df"
      unitRef="shares">3170</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i8075f5e61a6f4e0fa23f0b2d73e6bc0b_I20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgyNDU2_5cf3ba3c-59f9-4bda-81db-4ec45ec7aead"
      unitRef="shares">12069</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i117af75205314c998fad1407c682e2d0_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgyNTM4_7a9b0a47-07db-44fc-9b84-323a764655ba"
      unitRef="usd">600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="i8075f5e61a6f4e0fa23f0b2d73e6bc0b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgyNTU3_8e7d4f20-9108-489a-931d-c001aa7977dd"
      unitRef="usd">300000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i117af75205314c998fad1407c682e2d0_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgyNTcy_fd41a36c-baf6-4c12-bf12-f13871c71e7a">P0Y4M17D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="i54f0e6464d3d42999d152987a80350fc_I20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTc4MDY0_a8680b50-f54c-4867-885f-4e25050d9c29"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
      contextRef="i1e70174a995c49c9916aacfc83acfc7e_I20200331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzI5MTM3MDU4MTc4MDY0_cbfe228d-2a34-425b-9654-53aed8cd62d7"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
      contextRef="id49a07de8105430d9e5b763fa04c9419_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgyNjMw_d9635b4e-dca4-47da-8175-4ccf7638fe22"
      unitRef="number">0.85</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="id49a07de8105430d9e5b763fa04c9419_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgyNjk2_786b0939-fa96-4bf6-a32f-811f2ace15ef"
      unitRef="usdPerShare">23.84</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzU3NzI0MzYwNDgyNTQ5_40cdb81b-7e92-4816-82b1-e271785eb908">The fair value of the ESPP stock purchase rights on the date of grant is determined using the Black-Scholes pricing model with the assumptions set forth in the following table:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:75.946%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.854%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Fair value of common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$57.44 - $73.73&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;86.3% - 103.6%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;0.05% - 0.67%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Expected term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;0.29 - 0.49&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Expected dividend&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock>
    <docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice
      contextRef="i14587970434d4e5d831e458e0cf34e59_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjNjgxYTIxZjhjNjA0MWYwOGU3ZDM5Y2IxMTBhY2ExMy90YWJsZXJhbmdlOmM2ODFhMjFmOGM2MDQxZjA4ZTdkMzljYjExMGFjYTEzXzItMS0xLTEtODQ2MzMvdGV4dHJlZ2lvbjpiNWVhNWVkZGY1ZjY0N2NhYmMyYWI5N2RjZmEwMWU4Y18yOTEzNzA1ODEzNjA5NQ_f982021d-2f46-4bca-80ae-52de0fc5c7a0"
      unitRef="usdPerShare">57.44</docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice>
    <docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice
      contextRef="i392e807a56904918a6a9e4076a92504d_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjNjgxYTIxZjhjNjA0MWYwOGU3ZDM5Y2IxMTBhY2ExMy90YWJsZXJhbmdlOmM2ODFhMjFmOGM2MDQxZjA4ZTdkMzljYjExMGFjYTEzXzItMS0xLTEtODQ2MzMvdGV4dHJlZ2lvbjpiNWVhNWVkZGY1ZjY0N2NhYmMyYWI5N2RjZmEwMWU4Y18yOTEzNzA1ODEzNjA5OQ_63acef34-f66a-4e01-bb4f-baa8bf79715e"
      unitRef="usdPerShare">73.73</docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="id49a07de8105430d9e5b763fa04c9419_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjNjgxYTIxZjhjNjA0MWYwOGU3ZDM5Y2IxMTBhY2ExMy90YWJsZXJhbmdlOmM2ODFhMjFmOGM2MDQxZjA4ZTdkMzljYjExMGFjYTEzXzMtMS0xLTEtODQ2MzMvdGV4dHJlZ2lvbjozNDVhM2U0YWY0ODE0NWQ4YTdkMWI1MTk2MmYxNTYzY18yOTEzNzA1ODEzNjA5MQ_2e5cfa1b-03d4-4d3e-b346-3fc1a562c899"
      unitRef="number">0.863</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="id49a07de8105430d9e5b763fa04c9419_D20210401-20220331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjNjgxYTIxZjhjNjA0MWYwOGU3ZDM5Y2IxMTBhY2ExMy90YWJsZXJhbmdlOmM2ODFhMjFmOGM2MDQxZjA4ZTdkMzljYjExMGFjYTEzXzMtMS0xLTEtODQ2MzMvdGV4dHJlZ2lvbjozNDVhM2U0YWY0ODE0NWQ4YTdkMWI1MTk2MmYxNTYzY18yOTEzNzA1ODEzNjA5NQ_dd2c58a3-01b1-4653-be80-60de1ffde424"
      unitRef="number">1.036</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="id49a07de8105430d9e5b763fa04c9419_D20210401-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjNjgxYTIxZjhjNjA0MWYwOGU3ZDM5Y2IxMTBhY2ExMy90YWJsZXJhbmdlOmM2ODFhMjFmOGM2MDQxZjA4ZTdkMzljYjExMGFjYTEzXzQtMS0xLTEtODQ2MzMvdGV4dHJlZ2lvbjpkMWJjOGM5ODQ0MjQ0YjE5ODAwNzk2Y2RlMjM2NGMyM18yOTEzNzA1ODEzNjA5MQ_e65fcfe6-5b59-46c4-a946-d054d9f4f65d"
      unitRef="number">0.0005</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="id49a07de8105430d9e5b763fa04c9419_D20210401-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjNjgxYTIxZjhjNjA0MWYwOGU3ZDM5Y2IxMTBhY2ExMy90YWJsZXJhbmdlOmM2ODFhMjFmOGM2MDQxZjA4ZTdkMzljYjExMGFjYTEzXzQtMS0xLTEtODQ2MzMvdGV4dHJlZ2lvbjpkMWJjOGM5ODQ0MjQ0YjE5ODAwNzk2Y2RlMjM2NGMyM18yOTEzNzA1ODEzNjA5NQ_3d85bc26-b65a-486b-8566-dbb7b54bd802"
      unitRef="number">0.0067</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i14587970434d4e5d831e458e0cf34e59_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjNjgxYTIxZjhjNjA0MWYwOGU3ZDM5Y2IxMTBhY2ExMy90YWJsZXJhbmdlOmM2ODFhMjFmOGM2MDQxZjA4ZTdkMzljYjExMGFjYTEzXzUtMS0xLTEtODQ2MzMvdGV4dHJlZ2lvbjoyMjcxM2NhY2U0MmU0YTQ0YTUyN2MwZTdiNzk4OGVkOF8yOTEzNzA1ODEzNjA4NQ_50865424-2577-4a3a-bccd-93a79d048fe9">P0Y3M14D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i392e807a56904918a6a9e4076a92504d_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjNjgxYTIxZjhjNjA0MWYwOGU3ZDM5Y2IxMTBhY2ExMy90YWJsZXJhbmdlOmM2ODFhMjFmOGM2MDQxZjA4ZTdkMzljYjExMGFjYTEzXzUtMS0xLTEtODQ2MzMvdGV4dHJlZ2lvbjoyMjcxM2NhY2U0MmU0YTQ0YTUyN2MwZTdiNzk4OGVkOF8yOTEzNzA1ODEzNjA4OQ_15fd8a3f-f07f-4a88-9876-ea035a50cccc">P0Y5M26D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="id49a07de8105430d9e5b763fa04c9419_D20210401-20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjNjgxYTIxZjhjNjA0MWYwOGU3ZDM5Y2IxMTBhY2ExMy90YWJsZXJhbmdlOmM2ODFhMjFmOGM2MDQxZjA4ZTdkMzljYjExMGFjYTEzXzYtMS0xLTEtODQ2MzM_97164f88-7efa-4f01-9f0b-425e33e69c91"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="i7d4c019a802944bb81efba9687e2e06a_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgyODIx_d885a67b-2e58-49e2-b2ac-40117df45ffc"
      unitRef="usd">900000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="id49a07de8105430d9e5b763fa04c9419_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwMjM2NTY5NzgyODMz_ca3f1e61-7754-4e2e-9089-bc1035d745e5">P0Y4M17D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
      contextRef="id49a07de8105430d9e5b763fa04c9419_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwNzg2MzI1NjAxODAy_f2d1cf83-8c76-4f25-a353-1a5e0246d05e"
      unitRef="shares">28812</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod>
    <docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardPricesPerShareIssued
      contextRef="id49a07de8105430d9e5b763fa04c9419_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzMwNzg2MzI1NjAxODI0_acfb7e5e-667f-40f1-b61d-1130f1198a3b"
      unitRef="usdPerShare">48.40</docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardPricesPerShareIssued>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90ZXh0cmVnaW9uOmQ5MzNmOTAwMTg4MTQ0MzQ5ZTFiNDc0NmY4MzU1MzdmXzU3NzI0MzYwNDgyNTUw_bb9fd056-feef-4f63-a75a-fadbf58c5867">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total stock-based compensation expense recognized in the consolidated statement of operations for the fiscal years ended March&#160;31, 2022, 2021, and 2020 was as follows (in&#160;thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.991%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;600&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Sales and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;8,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;11,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;31,442&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,353&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ifc62a205668f49b9bf71eefe850ffc3f_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjYzFhNzg4YTk5NzM0OTEyOGRhMWZhODg3NTExODBkYy90YWJsZXJhbmdlOmNjMWE3ODhhOTk3MzQ5MTI4ZGExZmE4ODc1MTE4MGRjXzItNS0xLTEtODQ2MzM_59fef0a9-6a4b-4cb1-a718-c4eae7201382"
      unitRef="usd">4979000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i9164774a82a1435bb9edf034bfb5610d_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjYzFhNzg4YTk5NzM0OTEyOGRhMWZhODg3NTExODBkYy90YWJsZXJhbmdlOmNjMWE3ODhhOTk3MzQ5MTI4ZGExZmE4ODc1MTE4MGRjXzItNy0xLTEtODQ2MzM_0552e010-b7ce-4ce9-bf0b-349e8b8ada60"
      unitRef="usd">600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i381d7bd945a246b38630bd42ca02f556_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjYzFhNzg4YTk5NzM0OTEyOGRhMWZhODg3NTExODBkYy90YWJsZXJhbmdlOmNjMWE3ODhhOTk3MzQ5MTI4ZGExZmE4ODc1MTE4MGRjXzItNS0xLTEtOTE3Mjg_3b123746-c29b-4aea-a357-0495c99ac4fc"
      unitRef="usd">173000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i643419a5871c4616afc52904e8243daa_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjYzFhNzg4YTk5NzM0OTEyOGRhMWZhODg3NTExODBkYy90YWJsZXJhbmdlOmNjMWE3ODhhOTk3MzQ5MTI4ZGExZmE4ODc1MTE4MGRjXzMtNS0xLTEtODQ2MzM_e9757dfd-b600-47e5-a331-ec600a882f52"
      unitRef="usd">7065000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i9c63553114c049e0b99db51fd02c3a5a_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjYzFhNzg4YTk5NzM0OTEyOGRhMWZhODg3NTExODBkYy90YWJsZXJhbmdlOmNjMWE3ODhhOTk3MzQ5MTI4ZGExZmE4ODc1MTE4MGRjXzMtNy0xLTEtODQ2MzM_51f64dec-5c6d-45b3-84e4-f54ec35e022f"
      unitRef="usd">1975000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i847059421e7947a984ad34ce247eb9e4_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjYzFhNzg4YTk5NzM0OTEyOGRhMWZhODg3NTExODBkYy90YWJsZXJhbmdlOmNjMWE3ODhhOTk3MzQ5MTI4ZGExZmE4ODc1MTE4MGRjXzMtNS0xLTEtOTE3Mjg_a9d21585-814e-4774-a8a7-808a036efe4d"
      unitRef="usd">710000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i22d0ef822c3a4843b76143dba7a23603_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjYzFhNzg4YTk5NzM0OTEyOGRhMWZhODg3NTExODBkYy90YWJsZXJhbmdlOmNjMWE3ODhhOTk3MzQ5MTI4ZGExZmE4ODc1MTE4MGRjXzQtNS0xLTEtODQ2MzM_b7ecd65f-8244-48ad-b509-5b8c8a76bed0"
      unitRef="usd">8108000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iec4edfed98534025a3c42e669b77c905_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjYzFhNzg4YTk5NzM0OTEyOGRhMWZhODg3NTExODBkYy90YWJsZXJhbmdlOmNjMWE3ODhhOTk3MzQ5MTI4ZGExZmE4ODc1MTE4MGRjXzQtNy0xLTEtODQ2MzM_8a6a4fb9-d758-4fb8-9960-ca4df95d7682"
      unitRef="usd">1998000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="icce45add1e4a4c4ab8d74a95293ddd73_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjYzFhNzg4YTk5NzM0OTEyOGRhMWZhODg3NTExODBkYy90YWJsZXJhbmdlOmNjMWE3ODhhOTk3MzQ5MTI4ZGExZmE4ODc1MTE4MGRjXzQtNS0xLTEtOTE3Mjg_4144cdf7-2000-4d46-bfbb-f910e7c660df"
      unitRef="usd">847000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ieee0bbd772344ba3aa609a2395100a50_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjYzFhNzg4YTk5NzM0OTEyOGRhMWZhODg3NTExODBkYy90YWJsZXJhbmdlOmNjMWE3ODhhOTk3MzQ5MTI4ZGExZmE4ODc1MTE4MGRjXzUtNS0xLTEtODQ2MzM_b61bb82a-c52a-4e5d-9998-b75238dbf0c8"
      unitRef="usd">11290000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0872333d3b584eeebd4ed5658baa1b13_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjYzFhNzg4YTk5NzM0OTEyOGRhMWZhODg3NTExODBkYy90YWJsZXJhbmdlOmNjMWE3ODhhOTk3MzQ5MTI4ZGExZmE4ODc1MTE4MGRjXzUtNy0xLTEtODQ2MzM_bfeb3a11-bfaf-4214-9537-99f9c58df194"
      unitRef="usd">2679000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4f8c647b40c747dba1ef8dc24e552b7a_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjYzFhNzg4YTk5NzM0OTEyOGRhMWZhODg3NTExODBkYy90YWJsZXJhbmdlOmNjMWE3ODhhOTk3MzQ5MTI4ZGExZmE4ODc1MTE4MGRjXzUtNS0xLTEtOTE3Mjg_8ed8d5ce-2a7b-4cfa-a8d4-641ace16d7be"
      unitRef="usd">623000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjYzFhNzg4YTk5NzM0OTEyOGRhMWZhODg3NTExODBkYy90YWJsZXJhbmdlOmNjMWE3ODhhOTk3MzQ5MTI4ZGExZmE4ODc1MTE4MGRjXzYtNS0xLTEtODQ2MzM_7a2db03c-a9f9-4d03-9a5e-ec77926ae69b"
      unitRef="usd">31442000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjYzFhNzg4YTk5NzM0OTEyOGRhMWZhODg3NTExODBkYy90YWJsZXJhbmdlOmNjMWE3ODhhOTk3MzQ5MTI4ZGExZmE4ODc1MTE4MGRjXzYtNy0xLTEtODQ2MzM_20b784af-4159-4c50-a1f4-d45dd92d757a"
      unitRef="usd">7252000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTEvZnJhZzpkOTMzZjkwMDE4ODE0NDM0OWUxYjQ3NDZmODM1NTM3Zi90YWJsZTpjYzFhNzg4YTk5NzM0OTEyOGRhMWZhODg3NTExODBkYy90YWJsZXJhbmdlOmNjMWE3ODhhOTk3MzQ5MTI4ZGExZmE4ODc1MTE4MGRjXzYtNS0xLTEtOTE3Mjg_da848416-96c4-4fad-9c12-f810fe5d7658"
      unitRef="usd">2353000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90ZXh0cmVnaW9uOmZmZWVkMjY1NTQxNzRiOGM5ODVjYzE0YTdhMDdkYzY5XzQ4Mzc4NTExNjIzNDgz_f5217449-2e41-4b57-bfd0-426d4e190963">Net Income Per Share Attributable to Common Stockholders&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the reconciliation of the numerator and denominator for calculating basic and diluted net income per share (in thousands, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.991%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Numerator&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;154,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;50,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;29,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Less: undistributed earnings attributable to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(21,526)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(28,654)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(18,908)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net income attributable to Class A and Class B common stockholders, basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;133,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;21,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;10,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Denominator&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;163,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;74,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;66,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Dilutive effect of assumed exercise of options to purchase common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;27,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;20,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;14,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Dilutive effect of assumed exercise of common stock warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Dilutive effect of other share-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;191,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;95,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;81,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net income per share attributable to Class A and Class B common stockholders, basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;0.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;0.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;0.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net income per share attributable to Class A and Class B common stockholders, diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;0.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;0.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;0.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain potentially dilutive securities have been excluded from the calculation of diluted net income per share during the applicable periods because their inclusion would have been anti-dilutive (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.991%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Redeemable convertible preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;76,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;76,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Other share-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Common stock warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;76,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;76,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90ZXh0cmVnaW9uOmZmZWVkMjY1NTQxNzRiOGM5ODVjYzE0YTdhMDdkYzY5XzQ4Mzc4NTExNjIzNDg0_a26b578e-a34c-4a81-b5c0-74e4b0620573">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the reconciliation of the numerator and denominator for calculating basic and diluted net income per share (in thousands, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.991%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Numerator&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;154,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;50,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;29,737&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Less: undistributed earnings attributable to participating securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(21,526)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(28,654)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(18,908)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net income attributable to Class A and Class B common stockholders, basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;133,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;21,556&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;10,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Denominator&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;163,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;74,342&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;66,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Dilutive effect of assumed exercise of options to purchase common stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;27,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;20,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;14,892&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Dilutive effect of assumed exercise of common stock warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Dilutive effect of other share-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;191,017&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;95,134&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;81,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net income per share attributable to Class A and Class B common stockholders, basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;0.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;0.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;0.16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net income per share attributable to Class A and Class B common stockholders, diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;0.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;0.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;0.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzMtNS0xLTEtODUwNDM_c7be9d79-ca7a-499b-9ac6-2bf915714e10"
      unitRef="usd">154783000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzMtNy0xLTEtODUwNDM_159de6ff-557a-4a76-93a1-07e4276809a3"
      unitRef="usd">50210000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzMtNS0xLTEtOTE4MDM_7432b139-af08-4443-8319-4c23cd41cdd1"
      unitRef="usd">29737000</us-gaap:NetIncomeLoss>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzQtNS0xLTEtODUwNDM_18fa0c5f-81a0-4d04-aa93-64f1efe23a06"
      unitRef="usd">21526000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzQtNS0xLTEtODUwNDM_f0624606-6225-4e1c-bf71-a1f8b9daeb31"
      unitRef="usd">21526000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzQtNy0xLTEtODUwNDM_301ccc17-c8c0-47c6-a96c-8b3a42ede777"
      unitRef="usd">28654000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzQtNy0xLTEtODUwNDM_661050f1-9352-495e-a856-0dfef1009dee"
      unitRef="usd">28654000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzQtNS0xLTEtOTE4MDM_9e52501f-dba5-42bb-81d0-57b5ce3564be"
      unitRef="usd">18908000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic>
    <us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzQtNS0xLTEtOTE4MDM_aeb1cecb-6469-4f60-981a-ef96e233e75e"
      unitRef="usd">18908000</us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzUtNS0xLTEtODUwNDM_42020a58-5ea4-4ee9-b545-026955fe6d11"
      unitRef="usd">133257000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzUtNS0xLTEtODUwNDM_566017f4-0ef4-4c84-8881-91cd9135081d"
      unitRef="usd">133257000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzUtNy0xLTEtODUwNDM_3a26ab3b-488d-41c1-a9d0-3f554c7d9f7a"
      unitRef="usd">21556000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzUtNy0xLTEtODUwNDM_d0e5ded6-2d6c-4020-ba0c-1140bfc1531a"
      unitRef="usd">21556000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzUtNS0xLTEtOTE4MDM_463a75ca-1a03-45f6-a910-3b664a44d951"
      unitRef="usd">10829000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzUtNS0xLTEtOTE4MDM_6442bd45-608f-4b75-b175-92aed2d5491d"
      unitRef="usd">10829000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzctNS0xLTEtODUwNDM_ddd33b39-c089-4743-b10e-c21b0b9f4e98"
      unitRef="shares">163484000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzctNy0xLTEtODUwNDM_4e876a0b-971c-4444-9d4f-027aef06bb41"
      unitRef="shares">74342000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzctNS0xLTEtOTE4MDM_cb9f40c7-52f4-4537-821f-3ea6a7655f6d"
      unitRef="shares">66758000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i31208a9ec3934804b4c4c3c9e4b9ae56_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzgtNS0xLTEtODUwNDM_40e48f9c-50bc-453e-a160-7684f6a62110"
      unitRef="shares">27290000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i63de954bcdf44beabda4a4cb41517cd6_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzgtNy0xLTEtODUwNDM_93bb21af-ce04-495f-9115-4f391c4ae467"
      unitRef="shares">20612000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i5570e6c29d854f898d1e5e342437be88_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzgtNS0xLTEtOTE4MDM_48903a5d-42c2-4853-a65f-6b02b18b7721"
      unitRef="shares">14892000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzEwLTUtMS0xLTg1MDQz_3e82eeb0-90e6-4b06-8ddb-36bfb44efb16"
      unitRef="shares">234000</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzEwLTctMS0xLTg1MDQz_31ad2edd-fcda-47da-b9ce-95a11cab855d"
      unitRef="shares">180000</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzEwLTUtMS0xLTkxODAz_1a15157e-13d4-4198-b9a6-465ecb486e69"
      unitRef="shares">60000</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ifbdabf5291a64e328bdbbfff61aa8d5c_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzExLTUtMS0xLTg1MDQz_04817225-f905-4495-b881-319b661be175"
      unitRef="shares">9000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ia9e97d96aecb4d1d904052c4e11402f0_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzExLTctMS0xLTg1MDQz_7e13a450-e76c-4a5f-a54a-c39a00d80bdd"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i9e38c40919b2480382413b360d2df583_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzExLTUtMS0xLTkxODAz_16e04652-b465-4633-9754-c10b3699167d"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzEzLTUtMS0xLTg1MDQz_0422ff7d-bce9-4bdc-857e-73c0efa5a4d9"
      unitRef="shares">191017000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzEzLTctMS0xLTg1MDQz_fe9b75ac-06f7-44d8-b679-bd6fde2ac7ba"
      unitRef="shares">95134000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzEzLTUtMS0xLTkxODAz_3e4dd8f0-0c7f-44b6-b55d-5f3bd7d7a234"
      unitRef="shares">81710000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzE0LTUtMS0xLTg1MDQz_33aba4d7-0f78-46fa-809f-396e9767cf9b"
      unitRef="usdPerShare">0.82</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzE0LTctMS0xLTg1MDQz_c80a3c9c-b2c8-4b51-b559-e00629be40ba"
      unitRef="usdPerShare">0.29</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzE0LTUtMS0xLTkxODAz_1d504e65-6998-40ed-b8a1-f8525884210f"
      unitRef="usdPerShare">0.16</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzE1LTUtMS0xLTg1MDQz_ff862ed4-5a25-4f6d-ba32-6a2035035b03"
      unitRef="usdPerShare">0.70</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzE1LTctMS0xLTg1MDQz_33a15d60-c1f5-4a9a-ba8a-4c9df82a8538"
      unitRef="usdPerShare">0.23</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2YmI1ZmEwYjEyNWY0OTI3YTcyZmRiZThlODY2YmMxNy90YWJsZXJhbmdlOjZiYjVmYTBiMTI1ZjQ5MjdhNzJmZGJlOGU4NjZiYzE3XzE1LTUtMS0xLTkxODAz_ad76e1bc-b079-4ef1-a1f2-0317d9248a73"
      unitRef="usdPerShare">0.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90ZXh0cmVnaW9uOmZmZWVkMjY1NTQxNzRiOGM5ODVjYzE0YTdhMDdkYzY5XzQ4Mzc4NTExNjIzNDg1_e8e83558-720f-4045-bf0f-09cf5b542c40">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain potentially dilutive securities have been excluded from the calculation of diluted net income per share during the applicable periods because their inclusion would have been anti-dilutive (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.467%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.991%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:0.5pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Redeemable convertible preferred stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;76,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;76,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:0.5pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;578&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Other share-based awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Common stock warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;464&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;76,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;76,865&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i80014f589fa24025aba4a9a6e7337c21_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2Zjk5YzhjMjkxYzM0ZGZiYTEwMzkzMjZhYTdjZTBlMC90YWJsZXJhbmdlOjZmOTljOGMyOTFjMzRkZmJhMTAzOTMyNmFhN2NlMGUwXzItNS0xLTEtODUwNDM_ebcccff4-af57-4e21-8bd4-a5e849ad03b4"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i37353189bac04c0c8499282980a6fbb4_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2Zjk5YzhjMjkxYzM0ZGZiYTEwMzkzMjZhYTdjZTBlMC90YWJsZXJhbmdlOjZmOTljOGMyOTFjMzRkZmJhMTAzOTMyNmFhN2NlMGUwXzItNy0xLTEtODUwNDM_64a2ea38-a17f-4624-9e2c-7bbdad3e40d1"
      unitRef="shares">76287000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i47d1b632be7e4cc090898a23568e0174_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2Zjk5YzhjMjkxYzM0ZGZiYTEwMzkzMjZhYTdjZTBlMC90YWJsZXJhbmdlOjZmOTljOGMyOTFjMzRkZmJhMTAzOTMyNmFhN2NlMGUwXzItNS0xLTEtOTE4Mjg_b6bcb232-0a80-4cfe-8e7a-1aa6e1e76c02"
      unitRef="shares">76287000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if2c5b92d76cd41efbbbb13447fd077b8_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2Zjk5YzhjMjkxYzM0ZGZiYTEwMzkzMjZhYTdjZTBlMC90YWJsZXJhbmdlOjZmOTljOGMyOTFjMzRkZmJhMTAzOTMyNmFhN2NlMGUwXzQtNS0xLTEtODUwNDM_ddde8c34-4922-416d-bade-db7c97015194"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i433b7b224b754032ae79af210bdf56c0_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2Zjk5YzhjMjkxYzM0ZGZiYTEwMzkzMjZhYTdjZTBlMC90YWJsZXJhbmdlOjZmOTljOGMyOTFjMzRkZmJhMTAzOTMyNmFhN2NlMGUwXzQtNy0xLTEtODUwNDM_40a86d68-6b8e-409b-8465-69a546e18723"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i19af305064d34ab0a9c791bd4989487e_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2Zjk5YzhjMjkxYzM0ZGZiYTEwMzkzMjZhYTdjZTBlMC90YWJsZXJhbmdlOjZmOTljOGMyOTFjMzRkZmJhMTAzOTMyNmFhN2NlMGUwXzQtNS0xLTEtOTE4Mjg_523b5c9a-beb2-4e39-a3e3-5c1cc776a906"
      unitRef="shares">578000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i7166b08eefb94201a936dda4ab4a1b6f_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2Zjk5YzhjMjkxYzM0ZGZiYTEwMzkzMjZhYTdjZTBlMC90YWJsZXJhbmdlOjZmOTljOGMyOTFjMzRkZmJhMTAzOTMyNmFhN2NlMGUwXzUtNS0xLTEtODUwNDM_2c8858a8-2213-481e-a649-23279e5de363"
      unitRef="shares">217000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3d0cf67197d64b82a0f9be653ff65148_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2Zjk5YzhjMjkxYzM0ZGZiYTEwMzkzMjZhYTdjZTBlMC90YWJsZXJhbmdlOjZmOTljOGMyOTFjMzRkZmJhMTAzOTMyNmFhN2NlMGUwXzUtNy0xLTEtODUwNDM_baae685e-e824-4823-b921-139cffc56b59"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i3a29bfa4143c42cb8c0f174e1b701e1f_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2Zjk5YzhjMjkxYzM0ZGZiYTEwMzkzMjZhYTdjZTBlMC90YWJsZXJhbmdlOjZmOTljOGMyOTFjMzRkZmJhMTAzOTMyNmFhN2NlMGUwXzUtNS0xLTEtOTE4Mjg_f6e2fed8-e9a0-42e5-afec-ff2839ce6423"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i366343ec548042d1a0b920b7da7cd459_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2Zjk5YzhjMjkxYzM0ZGZiYTEwMzkzMjZhYTdjZTBlMC90YWJsZXJhbmdlOjZmOTljOGMyOTFjMzRkZmJhMTAzOTMyNmFhN2NlMGUwXzctNS0xLTEtODUwNDM_063c0647-92a5-4fdc-85e3-fb0e949f102b"
      unitRef="shares">247000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie0f97ef761814d6fa5b6219079762edc_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2Zjk5YzhjMjkxYzM0ZGZiYTEwMzkzMjZhYTdjZTBlMC90YWJsZXJhbmdlOjZmOTljOGMyOTFjMzRkZmJhMTAzOTMyNmFhN2NlMGUwXzctNy0xLTEtODUwNDM_d51639c1-fc2f-4006-bb2c-f937fec0e74a"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i1f1b807dde644927a5cecfcdc7ea90b4_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2Zjk5YzhjMjkxYzM0ZGZiYTEwMzkzMjZhYTdjZTBlMC90YWJsZXJhbmdlOjZmOTljOGMyOTFjMzRkZmJhMTAzOTMyNmFhN2NlMGUwXzctNS0xLTEtOTE4Mjg_e680f90b-7963-471a-b498-f8c07ddd2ce8"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2Zjk5YzhjMjkxYzM0ZGZiYTEwMzkzMjZhYTdjZTBlMC90YWJsZXJhbmdlOjZmOTljOGMyOTFjMzRkZmJhMTAzOTMyNmFhN2NlMGUwXzgtNS0xLTEtODUwNDM_4ed072a8-4605-416e-88c4-bab6163d0316"
      unitRef="shares">464000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2Zjk5YzhjMjkxYzM0ZGZiYTEwMzkzMjZhYTdjZTBlMC90YWJsZXJhbmdlOjZmOTljOGMyOTFjMzRkZmJhMTAzOTMyNmFhN2NlMGUwXzgtNy0xLTEtODUwNDM_5c09038e-d00c-4862-944e-737ff048f277"
      unitRef="shares">76287000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjMvZnJhZzpmZmVlZDI2NTU0MTc0YjhjOTg1Y2MxNGE3YTA3ZGM2OS90YWJsZTo2Zjk5YzhjMjkxYzM0ZGZiYTEwMzkzMjZhYTdjZTBlMC90YWJsZXJhbmdlOjZmOTljOGMyOTFjMzRkZmJhMTAzOTMyNmFhN2NlMGUwXzgtNS0xLTEtOTE4Mjg_042b6921-c446-4cbc-8e8f-a0de9cdad4a8"
      unitRef="shares">76865000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90ZXh0cmVnaW9uOmU1MzdjYzA0NGE2YjQxMzRiMTM5ZTQwNmVkYzg5NGM0XzUxNjc3MDQ2NTEwOTgz_9e9e1a5a-2194-4602-90fb-ec7ae3e2f57f">Income Taxes&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All of the Company&#x2019;s income before income taxes was generated in the United States for the fiscal year ended March 31, 2022, 2021, and 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s provision for (benefit from) income taxes consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Current provision:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Deferred provision (benefit):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(34,852)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6,458)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6,395)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(641)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(41,247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(7,099)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total provision for (benefit from) income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(40,778)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6,223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of the income tax expense at the federal statutory tax rate to the Company&#x2019;s provision for (benefit from) income taxes (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Income taxes at statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;23,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;12,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;State income taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;5,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Research and development credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(8,332)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1,845)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1,842)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(71,780)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5,796)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(11,995)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Section 162(m) limitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total provision for (benefit from) income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(40,778)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6,223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Components of deferred tax assets and liabilities were as follows (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;As of March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accruals and deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;32,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Research &amp;amp; development credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;12,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Acquisition and other related expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Unrealized loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;5,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Gross deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;55,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Less: valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4,731)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2,896)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Deferred tax assets, net of valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;51,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1,899)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1,701)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(336)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(398)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(231)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2,573)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2,268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;48,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act, or CARES Act, was enacted and signed into law. The CARES Act did not have a material impact to the Company's consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company maintains a valuation allowance related to specific net deferred tax assets where it is not more likely than not that the deferred tax assets will be realized, which include California research and development credits and capital loss carryforwards. The Company concluded, based upon the preponderance of positive evidence (i.e., a strong earnings history exclusive of the loss that created the future deductible amount, a history of taxable income in recent periods, the taxable loss is a result of excess tax benefit on stock exercises as a result of a non-recurring event (IPO), and the current forecast of income before taxes for the United States going forward) over negative evidence and the anticipated ability to use the deferred tax assets, that it was more likely than not that the deferred tax assets could be realized. If there are unfavorable changes to actual operating results or to projections of future income, the Company may determine that it is more likely than not such deferred tax assets may not be realizable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The valuation allowance was $4.7 million and $2.9 million as of March&#160;31, 2022 and 2021, respectively, relating to the California research and development tax credits and capital loss carryforwards. The valuation allowance increased by $1.8 million during the fiscal year ended March&#160;31, 2022, primarily due to the increase in California research and development credits generated during the year. The change in valuation allowance during the fiscal year ended March 31, 2021 was not material. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022, the Company had net operating loss, or NOL, carryforwards for state tax purposes of $97.1 million and $124.1 million for federal tax purposes. If not utilized, $83.6 million of the state NOL carryforwards will expire at various dates beginning in the year 2027. The federal NOL carryforwards can be carried forward indefinitely. As of March&#160;31, 2022, the Company had research and development tax credit carryforwards for federal and state tax purposes of $11.4 million and $8.4 million, respectively. The federal research and development tax credit carryforwards will expire at various dates beginning in the year 2040. If not utilized, $0.2 million of the state research and development tax credit carryforwards will expire at various dates beginning in the year 2032. Based on an assessment of the Company&#x2019;s historical ownership changes through March&#160;31, 2022, the Company does not anticipate a current limitation on the tax attributes. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2022 and 2021, the Company had unrecognized tax benefits, or UTBs, of $6.2 million and $3.2 million, respectively. If realized, $4.2 million would impact the effective tax rate while the remainder would reduce deferred tax assets subject to a full valuation allowance. The Company does not expect any material changes to its UTBs within the next 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending balances for gross UTBs is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Additions for tax positions related to the current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Additions for tax positions related to prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Reductions for tax positions related to prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1,095)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Reductions related to a lapse of statute&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest and penalties were not material during the years ended March&#160;31, 2022, 2021, and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company files income tax returns in the U.S. federal and various state jurisdictions. With limited exceptions, all tax years for which the Company has filed a tax return remain subject to examination.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90ZXh0cmVnaW9uOmU1MzdjYzA0NGE2YjQxMzRiMTM5ZTQwNmVkYzg5NGM0XzUxNjc3MDQ2NTEwOTg1_67ecb188-49e7-47e9-b5b8-a49560e01ded">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s provision for (benefit from) income taxes consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Current provision:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,270&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Deferred provision (benefit):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(34,852)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6,458)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6,395)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(641)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(41,247)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,987&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(7,099)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total provision for (benefit from) income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(40,778)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6,223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzMtMS0xLTEtNDkzNTY_ab1078d5-df8f-4ea5-a1ab-9c382c2efa0d"
      unitRef="usd">160000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzMtMy0xLTEtNDkzNTY_3b5f5da2-b18b-49ff-b7c4-ba6871fdfd1b"
      unitRef="usd">1302000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzMtNS0xLTEtNDkzNTY_aaa76110-b451-497d-bb35-aef1ca72b873"
      unitRef="usd">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzQtMS0xLTEtNDkzNTY_a99b1694-45ec-443e-a503-9254728e66b1"
      unitRef="usd">309000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzQtMy0xLTEtNDkzNTY_dbaf4578-589e-4353-890a-0406121686ca"
      unitRef="usd">1270000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzQtNS0xLTEtNDkzNTY_e585777f-a2b6-4255-9e1d-11925c457cde"
      unitRef="usd">876000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzUtMS0xLTEtNDkzNTY_8ff4b103-ca30-4320-b10a-1c77b8118996"
      unitRef="usd">469000</us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzUtMy0xLTEtNDkzNTY_1a4d9376-8dc9-4313-adbd-cd570b2e0057"
      unitRef="usd">2572000</us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzUtNS0xLTEtNDkzNTY_ab6a326d-c1fb-4261-ae69-6d55fdbccb5e"
      unitRef="usd">876000</us-gaap:CurrentFederalStateAndLocalTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzctMS0xLTEtNDkzNTY_d9cd6bb2-edb3-40f5-a76d-68e5f864b5e3"
      unitRef="usd">-34852000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzctMy0xLTEtNDkzNTY_3e385d08-e110-43d6-994b-a35ef3625c58"
      unitRef="usd">4862000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzctNS0xLTEtNDkzNTY_2fb62aef-efe1-4e6b-85f8-c6d6f8287aad"
      unitRef="usd">-6458000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzgtMS0xLTEtNDkzNTY_51c25217-dd35-437f-9736-d6f2b667807c"
      unitRef="usd">-6395000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzgtMy0xLTEtNDkzNTY_61821e2f-3b0c-4df2-bfe0-07f6fc86bcf9"
      unitRef="usd">125000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzgtNS0xLTEtNDkzNTY_1c597677-1912-408e-9a79-e144197282dc"
      unitRef="usd">-641000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzktMS0xLTEtNDkzNTY_f179d5b4-b1f1-46c6-ae61-62abb349aa61"
      unitRef="usd">-41247000</us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit>
    <us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzktMy0xLTEtNDkzNTY_c6cc8f5d-42be-44ce-bb84-8d18de762e89"
      unitRef="usd">4987000</us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit>
    <us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzktNS0xLTEtNDkzNTY_f7fa65ac-4b2b-42b0-8e1f-a01c86c9da1e"
      unitRef="usd">-7099000</us-gaap:DeferredFederalStateAndLocalTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzEwLTEtMS0xLTQ5MzU2_de952962-d1dd-4d09-99cc-090140872326"
      unitRef="usd">-40778000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzEwLTMtMS0xLTQ5MzU2_6014d481-ac44-43d2-b8a8-1beabf7aa4d6"
      unitRef="usd">7559000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTozNTI5M2Y2MmFiZTY0NWNlYWQ5ZjMyZWYxNzRkYzhhYy90YWJsZXJhbmdlOjM1MjkzZjYyYWJlNjQ1Y2VhZDlmMzJlZjE3NGRjOGFjXzEwLTUtMS0xLTQ5MzU2_500d366f-69b2-4b07-ade1-00141845d8db"
      unitRef="usd">-6223000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90ZXh0cmVnaW9uOmU1MzdjYzA0NGE2YjQxMzRiMTM5ZTQwNmVkYzg5NGM0XzUxNjc3MDQ2NTEwOTg2_9ed7b676-4df4-4101-a6b5-1a6c857f6ffb">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a reconciliation of the income tax expense at the federal statutory tax rate to the Company&#x2019;s provision for (benefit from) income taxes (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Income taxes at statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;23,941&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;12,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,938&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;State income taxes, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;5,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Research and development credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(8,332)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1,845)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1,842)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(71,780)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(5,796)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;171&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(11,995)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Section 162(m) limitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,260&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total provision for (benefit from) income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(40,778)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(6,223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzItMS0xLTEtNDkzNjI_aae9074f-c5fb-4d38-9510-0e1ff57db2ac"
      unitRef="usd">23941000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzItMy0xLTEtNDkzNjI_45f7b09a-80bf-494e-8031-253e68f07dd5"
      unitRef="usd">12131000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzItNS0xLTEtNDkzNjI_18ad6dff-8217-42e8-8726-df861ed82f84"
      unitRef="usd">4938000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzMtMS0xLTEtNDkzNjI_671d9dbb-c4aa-4600-bbeb-35cc905cc217"
      unitRef="usd">5503000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzMtMy0xLTEtNDkzNjI_7feb32de-1e91-4da4-8595-817fee13903b"
      unitRef="usd">2532000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzMtNS0xLTEtNDkzNjI_df48182e-2351-4ce2-8d18-191975851f8d"
      unitRef="usd">1561000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzQtMS0xLTEtNDkzNjI_6b39665b-5992-483d-bc64-124f66559ec3"
      unitRef="usd">8332000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzQtMy0xLTEtNDkzNjI_143b478c-971b-4249-a944-655b933e058d"
      unitRef="usd">1845000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzQtNS0xLTEtNDkzNjI_ee1a49b1-711d-4d48-b2ea-5dc552a3b092"
      unitRef="usd">1842000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzUtMS0xLTEtNDkzNjI_f9a76bcb-be16-4912-b8c2-a9254089371f"
      unitRef="usd">-71780000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzUtMy0xLTEtNDkzNjI_9e6c5be1-23cd-4516-a690-923c533c15ec"
      unitRef="usd">-5796000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzUtNS0xLTEtNDkzNjI_ad8593c5-228d-4160-b7cc-a435f2eec40f"
      unitRef="usd">310000</us-gaap:EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzYtMS0xLTEtNDkzNjI_103e5a5b-db07-46d6-b8ce-4e0bb245811b"
      unitRef="usd">1878000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzYtMy0xLTEtNDkzNjI_43a76c9b-2dc0-46e3-80c1-2bcef0f9d1b1"
      unitRef="usd">171000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzYtNS0xLTEtNDkzNjI_f5c8a3b4-bbe9-4d97-b268-7f96f3e5fb03"
      unitRef="usd">-11995000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzctMS0xLTEtMTI3Njky_69e1e96e-ca7c-4daf-a4fa-a214a469344b"
      unitRef="usd">7260000</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzctMy0xLTEtMTI3Njky_799e4414-5003-47aa-9f93-7a5a420f024f"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpense
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzctNS0xLTEtMTI3Njky_b224bee0-a514-4c4b-a9e5-32cf710b685b"
      unitRef="usd">0</us-gaap:IncomeTaxReconciliationNondeductibleExpense>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzctMS0xLTEtNDkzNjI_63f849c8-bcbb-4904-aedc-e92bb3a0191e"
      unitRef="usd">752000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzctMy0xLTEtNDkzNjI_10624aff-ef37-48bd-8dd3-74f43a2517f4"
      unitRef="usd">366000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzctNS0xLTEtNDkzNjI_3c0f185f-8721-41f9-8550-ff2049b766c1"
      unitRef="usd">805000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzgtMS0xLTEtNDkzNjI_d16f6338-394a-4489-9458-603eb229071a"
      unitRef="usd">-40778000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzgtMy0xLTEtNDkzNjI_23bb35ad-41a7-46f8-9a33-239642d7b17c"
      unitRef="usd">7559000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZToyODUzNjk2MDIyNzY0NDRjOTEzNjUxOTgxNWY5ODcxMC90YWJsZXJhbmdlOjI4NTM2OTYwMjI3NjQ0NGM5MTM2NTE5ODE1Zjk4NzEwXzgtNS0xLTEtNDkzNjI_5d38e0ce-038b-435e-a2a8-c6ec18d2986a"
      unitRef="usd">-6223000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90ZXh0cmVnaW9uOmU1MzdjYzA0NGE2YjQxMzRiMTM5ZTQwNmVkYzg5NGM0XzUxNjc3MDQ2NTEwOTg3_7401ef29-3dd9-4542-a22b-3d02dfc8e16e">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Components of deferred tax assets and liabilities were as follows (in&#160;thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.621%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;As of March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Accruals and deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;32,215&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;486&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Research &amp;amp; development credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;12,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,516&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Acquisition and other related expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,847&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Unrealized loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;5,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Gross deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;55,862&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;7,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Less: valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(4,731)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2,896)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Deferred tax assets, net of valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;51,131&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;4,380&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1,899)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1,701)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(276)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(336)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(398)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(231)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2,573)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(2,268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;48,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <docs:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzMtMy0xLTEtNDkzNzA_3df8baa5-e9c1-4a8b-9f8d-2058e883bf2d"
      unitRef="usd">1760000</docs:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue>
    <docs:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzMtNS0xLTEtNDkzNzA_00929814-1933-4488-9ff8-7db5afaa1e48"
      unitRef="usd">1257000</docs:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzQtMy0xLTEtNDkzNzA_46b86b1a-2a63-46b2-9833-e42e6c1a9e02"
      unitRef="usd">32215000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzQtNS0xLTEtNDkzNzA_5bf7bdff-0500-40c7-b0f4-0d89385da8de"
      unitRef="usd">486000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzUtMy0xLTEtNDkzNzA_2d90aa57-8361-45bf-ba39-d52bfa20d5d4"
      unitRef="usd">12310000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzUtNS0xLTEtNDkzNzA_e97b5bd9-0690-4145-81eb-9494126558ca"
      unitRef="usd">4516000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <docs:DeferredTaxAssetsLeasingArrangements
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzYtMy0xLTEtNDkzNzA_6b38a4db-9975-4b51-8319-a6e50c13d9f4"
      unitRef="usd">276000</docs:DeferredTaxAssetsLeasingArrangements>
    <docs:DeferredTaxAssetsLeasingArrangements
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzYtNS0xLTEtNDkzNzA_122c5c7f-148d-4658-a90b-b8cac6b1c6c3"
      unitRef="usd">315000</docs:DeferredTaxAssetsLeasingArrangements>
    <docs:DeferredTaxAssetsAcquisitionAndOtherRelatedExpense
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzctMy0xLTEtNDkzNzA_9778f05b-940f-4906-b793-f7284cde4df1"
      unitRef="usd">255000</docs:DeferredTaxAssetsAcquisitionAndOtherRelatedExpense>
    <docs:DeferredTaxAssetsAcquisitionAndOtherRelatedExpense
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzctNS0xLTEtNDkzNzA_afa0250e-4c61-44df-aab0-32ef05d96f0c"
      unitRef="usd">271000</docs:DeferredTaxAssetsAcquisitionAndOtherRelatedExpense>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzgtMy0xLTEtNDkzNzA_1289b3f4-7739-4105-9e83-544e186b5164"
      unitRef="usd">3847000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzgtNS0xLTEtNDkzNzA_a3a492c1-12da-4cab-9cd5-30c50d8891b7"
      unitRef="usd">431000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzktMS0xLTEtMTI3NzQ4_b051b17f-8639-42f2-85a4-7667d9aea153"
      unitRef="usd">5199000</us-gaap:DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross>
    <us-gaap:DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzktMy0xLTEtMTI3NzQ4_af9ed5e5-b865-454b-b256-ec9ce7cbe5d0"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzktMy0xLTEtNDkzNzA_8332deec-2996-4820-9812-427eda379f82"
      unitRef="usd">55862000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzktNS0xLTEtNDkzNzA_1e956cc7-0869-4a7f-a567-d91f12c3d62d"
      unitRef="usd">7276000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzEwLTMtMS0xLTQ5Mzcw_6bfb5021-085f-459d-a8d8-53bd9ace264c"
      unitRef="usd">4731000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzEwLTUtMS0xLTQ5Mzcw_b113b9a5-56c8-4622-b70c-9c1e52528188"
      unitRef="usd">2896000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzExLTMtMS0xLTQ5Mzcw_28d37429-46a4-4f3f-834a-8c49d8b17021"
      unitRef="usd">51131000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzExLTUtMS0xLTQ5Mzcw_65b25590-2a9f-407b-a704-33ec5e589e30"
      unitRef="usd">4380000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzEzLTMtMS0xLTQ5Mzcw_ea041e78-ac7e-40b2-8414-269422ff270a"
      unitRef="usd">1899000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzEzLTUtMS0xLTQ5Mzcw_230b611a-ac48-4f36-b372-eeee5ec114b9"
      unitRef="usd">1701000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzE0LTMtMS0xLTQ5Mzcw_1cb26665-cd0c-428d-82ed-23b2e62e4594"
      unitRef="usd">276000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzE0LTUtMS0xLTQ5Mzcw_cce7607b-1954-412c-9414-5f865c73b89c"
      unitRef="usd">336000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzE1LTMtMS0xLTQ5Mzcw_daf2bba5-b30c-46fa-8d52-436b4745ba1f"
      unitRef="usd">398000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzE1LTUtMS0xLTQ5Mzcw_20e8d94b-8b9b-441e-a39a-5bd6edd81270"
      unitRef="usd">231000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzE2LTMtMS0xLTQ5Mzcw_b7d31fd9-c1b5-44c7-9381-3cb3cda6f1bc"
      unitRef="usd">2573000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzE2LTUtMS0xLTQ5Mzcw_05fc328f-6739-4772-bd6e-15789b7e5b69"
      unitRef="usd">2268000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzE3LTMtMS0xLTQ5Mzcw_75ccd24a-f746-4f8a-b2eb-f142611c0ca9"
      unitRef="usd">48558000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTo1NmZiZTdlM2NjZGU0YmRiYjAxOGFiZDU4YmU5NGYyNy90YWJsZXJhbmdlOjU2ZmJlN2UzY2NkZTRiZGJiMDE4YWJkNThiZTk0ZjI3XzE3LTUtMS0xLTQ5Mzcw_9db1f9fb-8524-425c-a81d-4a7ea4cb5274"
      unitRef="usd">2112000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90ZXh0cmVnaW9uOmU1MzdjYzA0NGE2YjQxMzRiMTM5ZTQwNmVkYzg5NGM0XzI5MTM3MDU4MTQwNjY1_a8c3717f-8210-4376-9b07-dcf085d0911e"
      unitRef="usd">4700000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90ZXh0cmVnaW9uOmU1MzdjYzA0NGE2YjQxMzRiMTM5ZTQwNmVkYzg5NGM0XzI5MTM3MDU4MTQwNjg0_7ba7c158-828e-4246-a415-9d143e2c7678"
      unitRef="usd">2900000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90ZXh0cmVnaW9uOmU1MzdjYzA0NGE2YjQxMzRiMTM5ZTQwNmVkYzg5NGM0XzI5MTM3MDU4MTQ3NDAz_e93810b5-cc4d-4c5f-8fd7-5256d6d6d112"
      unitRef="usd">1800000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90ZXh0cmVnaW9uOmU1MzdjYzA0NGE2YjQxMzRiMTM5ZTQwNmVkYzg5NGM0XzMwMjM2NTY5Nzc4Nzgz_28e666be-9c73-430a-9514-adabc739c5e3"
      unitRef="usd">0</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90ZXh0cmVnaW9uOmU1MzdjYzA0NGE2YjQxMzRiMTM5ZTQwNmVkYzg5NGM0XzI5MTM3MDU4MTQwNzQ2_55a0cc20-ce32-4f71-a57b-69d019f5bacf"
      unitRef="usd">97100000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90ZXh0cmVnaW9uOmU1MzdjYzA0NGE2YjQxMzRiMTM5ZTQwNmVkYzg5NGM0XzI5MTM3MDU4MTQwNzU3_26074e14-53cb-4478-a96f-99f345d8a45a"
      unitRef="usd">124100000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <docs:OperatingLossCarryforwardsSubjectToExpiration
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90ZXh0cmVnaW9uOmU1MzdjYzA0NGE2YjQxMzRiMTM5ZTQwNmVkYzg5NGM0XzI5MTM3MDU4MTUwOTI2_25927fbb-4b89-4397-98b2-99a86a41a3cd"
      unitRef="usd">83600000</docs:OperatingLossCarryforwardsSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="i3e814b9bfb97496daff7da69a24ec5cd_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90ZXh0cmVnaW9uOmU1MzdjYzA0NGE2YjQxMzRiMTM5ZTQwNmVkYzg5NGM0XzI5MTM3MDU4MTQwNzk4_aec53a2f-7e77-492e-98c7-698e2f9a7394"
      unitRef="usd">11400000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="ic83e784502b44138b8906b62606b6cc0_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90ZXh0cmVnaW9uOmU1MzdjYzA0NGE2YjQxMzRiMTM5ZTQwNmVkYzg5NGM0XzI5MTM3MDU4MTQwODE2_ad303f30-d087-4a72-a302-6382943c16a7"
      unitRef="usd">8400000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <docs:TaxCreditCarryforwardsSubjectToExpiration
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90ZXh0cmVnaW9uOmU1MzdjYzA0NGE2YjQxMzRiMTM5ZTQwNmVkYzg5NGM0XzI5MTM3MDU4MTUwOTQ3_5e86558f-61b9-496c-80d5-935e4e3b4b95"
      unitRef="usd">200000</docs:TaxCreditCarryforwardsSubjectToExpiration>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90ZXh0cmVnaW9uOmU1MzdjYzA0NGE2YjQxMzRiMTM5ZTQwNmVkYzg5NGM0XzI5MTM3MDU4MTQwODg1_9a2277ce-2724-48f5-a69d-eee883618714"
      unitRef="usd">6200000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90ZXh0cmVnaW9uOmU1MzdjYzA0NGE2YjQxMzRiMTM5ZTQwNmVkYzg5NGM0XzI5MTM3MDU4MTQwOTAy_5271eabd-a962-4160-a40d-cff0a0974ec6"
      unitRef="usd">3200000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90ZXh0cmVnaW9uOmU1MzdjYzA0NGE2YjQxMzRiMTM5ZTQwNmVkYzg5NGM0XzI5MTM3MDU4MTQwOTIw_66904f23-c77c-42c7-b526-4a1970ed19a6"
      unitRef="usd">4200000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90ZXh0cmVnaW9uOmU1MzdjYzA0NGE2YjQxMzRiMTM5ZTQwNmVkYzg5NGM0XzUxNjc3MDQ2NTEwOTg4_54d4dc9d-b993-45b4-b9e4-b95ec06852e3">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending balances for gross UTBs is as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,900&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Additions for tax positions related to the current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,995&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;687&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Additions for tax positions related to prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Reductions for tax positions related to prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(1,095)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Reductions related to a lapse of statute&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTpkMzcwMzU2MDQwZjg0MDNjOWUxYjY4NGY2NmM4YjllOC90YWJsZXJhbmdlOmQzNzAzNTYwNDBmODQwM2M5ZTFiNjg0ZjY2YzhiOWU4XzItMS0xLTEtNDk0NzY_7fcac7a6-3f69-4deb-b3af-bc92a4348be2"
      unitRef="usd">3162000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i7a15f5b31d42419aa50ffb53e76f3705_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTpkMzcwMzU2MDQwZjg0MDNjOWUxYjY4NGY2NmM4YjllOC90YWJsZXJhbmdlOmQzNzAzNTYwNDBmODQwM2M5ZTFiNjg0ZjY2YzhiOWU4XzItMy0xLTEtNDk0NzY_72d133fc-6428-46fb-8993-9eeee5c89171"
      unitRef="usd">2475000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i27e150c7cdf34baa99d770cedfcc88a0_I20190331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTpkMzcwMzU2MDQwZjg0MDNjOWUxYjY4NGY2NmM4YjllOC90YWJsZXJhbmdlOmQzNzAzNTYwNDBmODQwM2M5ZTFiNjg0ZjY2YzhiOWU4XzItNS0xLTEtNDk0NzY_d00cf2c6-12f1-42fb-b0de-b868f28af8b4"
      unitRef="usd">2900000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTpkMzcwMzU2MDQwZjg0MDNjOWUxYjY4NGY2NmM4YjllOC90YWJsZXJhbmdlOmQzNzAzNTYwNDBmODQwM2M5ZTFiNjg0ZjY2YzhiOWU4XzMtMS0xLTEtNDk0NzY_240c9181-ab99-422f-aabc-34e197ec5bee"
      unitRef="usd">2995000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTpkMzcwMzU2MDQwZjg0MDNjOWUxYjY4NGY2NmM4YjllOC90YWJsZXJhbmdlOmQzNzAzNTYwNDBmODQwM2M5ZTFiNjg0ZjY2YzhiOWU4XzMtMy0xLTEtNDk0NzY_1e8d96e6-6f4f-4e5d-aa4c-a2f90d4754b9"
      unitRef="usd">687000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTpkMzcwMzU2MDQwZjg0MDNjOWUxYjY4NGY2NmM4YjllOC90YWJsZXJhbmdlOmQzNzAzNTYwNDBmODQwM2M5ZTFiNjg0ZjY2YzhiOWU4XzMtNS0xLTEtNDk0NzY_e59bf255-e0af-49f4-a6ef-e7d443e877eb"
      unitRef="usd">670000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTpkMzcwMzU2MDQwZjg0MDNjOWUxYjY4NGY2NmM4YjllOC90YWJsZXJhbmdlOmQzNzAzNTYwNDBmODQwM2M5ZTFiNjg0ZjY2YzhiOWU4XzQtMS0xLTEtMTI3ODQ2_781338b1-bd4e-4753-9e9e-cb722161d7c6"
      unitRef="usd">36000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTpkMzcwMzU2MDQwZjg0MDNjOWUxYjY4NGY2NmM4YjllOC90YWJsZXJhbmdlOmQzNzAzNTYwNDBmODQwM2M5ZTFiNjg0ZjY2YzhiOWU4XzQtMy0xLTEtMTI3ODQ2_ae40fcb7-31fe-4de5-99a3-8f2c1abbb8a5"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTpkMzcwMzU2MDQwZjg0MDNjOWUxYjY4NGY2NmM4YjllOC90YWJsZXJhbmdlOmQzNzAzNTYwNDBmODQwM2M5ZTFiNjg0ZjY2YzhiOWU4XzQtNS0xLTEtMTI3ODQ2_36bbf676-b67b-4c41-b3a3-9dc80a7ca408"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTpkMzcwMzU2MDQwZjg0MDNjOWUxYjY4NGY2NmM4YjllOC90YWJsZXJhbmdlOmQzNzAzNTYwNDBmODQwM2M5ZTFiNjg0ZjY2YzhiOWU4XzQtMS0xLTEtNDk0NzY_1b6138c4-dba1-4cc6-9056-31e063a74c78"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTpkMzcwMzU2MDQwZjg0MDNjOWUxYjY4NGY2NmM4YjllOC90YWJsZXJhbmdlOmQzNzAzNTYwNDBmODQwM2M5ZTFiNjg0ZjY2YzhiOWU4XzQtMy0xLTEtNDk0NzY_e49b4635-e176-4d48-990f-500e02bf712c"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTpkMzcwMzU2MDQwZjg0MDNjOWUxYjY4NGY2NmM4YjllOC90YWJsZXJhbmdlOmQzNzAzNTYwNDBmODQwM2M5ZTFiNjg0ZjY2YzhiOWU4XzQtNS0xLTEtNDk0NzY_7cf6837d-391e-442b-89d7-70b1ca5b18f0"
      unitRef="usd">1095000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTpkMzcwMzU2MDQwZjg0MDNjOWUxYjY4NGY2NmM4YjllOC90YWJsZXJhbmdlOmQzNzAzNTYwNDBmODQwM2M5ZTFiNjg0ZjY2YzhiOWU4XzYtMS0xLTEtMTI4MDM1_0c55cae3-4c26-4c69-a66a-cc81c81818fd"
      unitRef="usd">5000</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTpkMzcwMzU2MDQwZjg0MDNjOWUxYjY4NGY2NmM4YjllOC90YWJsZXJhbmdlOmQzNzAzNTYwNDBmODQwM2M5ZTFiNjg0ZjY2YzhiOWU4XzYtMy0xLTEtMTI4MDM1_abcf7031-0dbd-4a4d-a434-638e8c7013a5"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTpkMzcwMzU2MDQwZjg0MDNjOWUxYjY4NGY2NmM4YjllOC90YWJsZXJhbmdlOmQzNzAzNTYwNDBmODQwM2M5ZTFiNjg0ZjY2YzhiOWU4XzYtNS0xLTEtMTI4MDM1_9a26c6fe-614f-429a-ada5-b1edc2429354"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTpkMzcwMzU2MDQwZjg0MDNjOWUxYjY4NGY2NmM4YjllOC90YWJsZXJhbmdlOmQzNzAzNTYwNDBmODQwM2M5ZTFiNjg0ZjY2YzhiOWU4XzUtMS0xLTEtNDk0NzY_58cfcde2-0f7e-48a4-bbb8-ff01f8f8cf4a"
      unitRef="usd">6188000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTpkMzcwMzU2MDQwZjg0MDNjOWUxYjY4NGY2NmM4YjllOC90YWJsZXJhbmdlOmQzNzAzNTYwNDBmODQwM2M5ZTFiNjg0ZjY2YzhiOWU4XzUtMy0xLTEtNDk0NzY_2cb6d205-e05f-4c80-baae-bb3661f0ca95"
      unitRef="usd">3162000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i7a15f5b31d42419aa50ffb53e76f3705_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjAvZnJhZzplNTM3Y2MwNDRhNmI0MTM0YjEzOWU0MDZlZGM4OTRjNC90YWJsZTpkMzcwMzU2MDQwZjg0MDNjOWUxYjY4NGY2NmM4YjllOC90YWJsZXJhbmdlOmQzNzAzNTYwNDBmODQwM2M5ZTFiNjg0ZjY2YzhiOWU4XzUtNS0xLTEtNDk0NzY_13fe155f-c431-47fe-82b0-c2388551d83a"
      unitRef="usd">2475000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTcvZnJhZzoyN2QxMGE5MDFmODY0OWMzOWU0MTRmYTlkMDNlYzZmYy90ZXh0cmVnaW9uOjI3ZDEwYTkwMWY4NjQ5YzM5ZTQxNGZhOWQwM2VjNmZjXzUxNjc3MDQ2NTE2MjEz_41573d22-c041-43a9-af0d-821e296dda5c">Commitments and Contingencies&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2021, the Company entered into an 8-year lease for office space in Irving, Texas. This lease will commence on or around June&#160;1, 2022, with total undiscounted lease payments of $17.9 million. In accordance with ASC 842, Leases, the classification of the lease will be determined and the lease right-of-use assets and lease liabilities will be recognized on the lease commencement date based on the present value of lease payments over the lease term, discounted using the Company&#x2019;s incremental borrowing rate. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Minimum Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October&#160;8, 2021, the Company signed an amended agreement to revise and extend the existing partnership with the U.S. News for six years. This agreement can be terminated after three years by either party. Under this amended agreement, the Company pays the U.S. News a portion of the revenue generated with the end customers, with an annual minimum guarantee amount ranging from $2.5 million to $6.2 million. The total minimum guarantee amount for the initial noncancelable period of three years is $9.1 million. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;AMiON Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February&#160;4, 2022, the Company entered into a definitive agreement to acquire the assets of the AMiON on-call scheduling and messaging application used by scheduling staff and physicians for cash consideration of $53.5 million paid at closing and earnout consideration of up to $24.0 million, payable over the next four years, subject to certain performance milestones. Under the definitive agreement, certain employees joining the Company as part of the acquisition are eligible for restricted stock unit awards, subject to future service-based vesting conditions. The acquisition closed and the cash consideration was paid on April 1, 2022. In May 2022, 93,458 restricted stock units with grant date fair value of $32.99 per share were granted to the eligible employees joining the Company as part of the acquisition. The acquisition will be accounted for as a business combination in fiscal 2023.   &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Contractual Commitments &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2021, the Company entered into a 3-year web hosting arrangement with an annual commitment of $5.2 million, starting January&#160;1, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Indemnification&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company enters into indemnification provisions under agreements with other companies in the ordinary course of business, including, but not limited to, clients, business partners, landlords, and other parties involved in the performance of the Company&#x2019;s services. Pursuant to these arrangements, the Company has agreed to indemnify, hold harmless, and reimburse the indemnified party for certain losses suffered or incurred by the indemnified party as a result of the Company&#x2019;s activities. The terms of these indemnification agreements are generally perpetual. The maximum potential amount of future payments the Company could be required to make under these agreements is not determinable. The Company has never incurred costs to defend lawsuits or settle claims related to these indemnification agreements. The Company maintains commercial general liability insurance and product liability insurance that may offset certain of its potential liabilities under these indemnification provisions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, the Company has agreed to indemnify its officers and directors and certain key employees while they are serving in good faith in their respective capacities. To date, there have been no claims under these indemnification provisions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Legal Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company has become involved in claims and other legal matters arising in the ordinary course of business. The Company investigates these claims as they arise. Although claims are inherently unpredictable, the Company is currently not aware of any matters that, if determined adversely to the Company, would individually or taken together have a material effect on its results of operations, financial position, or cash flows. No loss contingencies were recorded for the fiscal years ended March&#160;31, 2022, 2021, and 2020.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1
      contextRef="iaca56ad88a7f461f9aa0ca6977c6c5a1_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTcvZnJhZzoyN2QxMGE5MDFmODY0OWMzOWU0MTRmYTlkMDNlYzZmYy90ZXh0cmVnaW9uOjI3ZDEwYTkwMWY4NjQ5YzM5ZTQxNGZhOWQwM2VjNmZjXzI5MTM3MDU4MTQ1NTYx_fd754633-8833-4923-b990-a55bd143f830">P8Y</us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1>
    <docs:LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount
      contextRef="iaca56ad88a7f461f9aa0ca6977c6c5a1_I20210630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTcvZnJhZzoyN2QxMGE5MDFmODY0OWMzOWU0MTRmYTlkMDNlYzZmYy90ZXh0cmVnaW9uOjI3ZDEwYTkwMWY4NjQ5YzM5ZTQxNGZhOWQwM2VjNmZjXzI5MTM3MDU4MTQ1NTk1_9a9d47ef-ee61-49d9-9ee2-acbabcc95599"
      unitRef="usd">17900000</docs:LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount>
    <docs:PartnershipAgreementExtensionPeriod
      contextRef="ia779ca3233c64c28abdfc4d63196098d_D20211008-20211008"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTcvZnJhZzoyN2QxMGE5MDFmODY0OWMzOWU0MTRmYTlkMDNlYzZmYy90ZXh0cmVnaW9uOjI3ZDEwYTkwMWY4NjQ5YzM5ZTQxNGZhOWQwM2VjNmZjXzI5MTM3MDU4MTQ1NjI5_95d06f67-cda5-4fb3-96ee-51e7df366634">P6Y</docs:PartnershipAgreementExtensionPeriod>
    <docs:PartnershipsAgreementPeriodBeforeTerminationIsPermitted
      contextRef="ia779ca3233c64c28abdfc4d63196098d_D20211008-20211008"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTcvZnJhZzoyN2QxMGE5MDFmODY0OWMzOWU0MTRmYTlkMDNlYzZmYy90ZXh0cmVnaW9uOjI3ZDEwYTkwMWY4NjQ5YzM5ZTQxNGZhOWQwM2VjNmZjXzI5MTM3MDU4MTQ1NjQ0_741bf983-45e7-4fbb-8ae6-8e0d69dc46a2">P3Y</docs:PartnershipsAgreementPeriodBeforeTerminationIsPermitted>
    <docs:PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany
      contextRef="i5427186226c84ccfa0800cadaa7de7c6_D20211008-20211008"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTcvZnJhZzoyN2QxMGE5MDFmODY0OWMzOWU0MTRmYTlkMDNlYzZmYy90ZXh0cmVnaW9uOjI3ZDEwYTkwMWY4NjQ5YzM5ZTQxNGZhOWQwM2VjNmZjXzI5MTM3MDU4MTQ1Njc1_8eede031-91e7-4a44-8173-7f75433b99b2"
      unitRef="usd">2500000</docs:PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany>
    <docs:PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany
      contextRef="i810401f3e11544ccb12389b06a087e25_D20211008-20211008"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTcvZnJhZzoyN2QxMGE5MDFmODY0OWMzOWU0MTRmYTlkMDNlYzZmYy90ZXh0cmVnaW9uOjI3ZDEwYTkwMWY4NjQ5YzM5ZTQxNGZhOWQwM2VjNmZjXzI5MTM3MDU4MTQ1Njkz_93c09169-4739-4254-b9fc-731835676fba"
      unitRef="usd">6200000</docs:PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany>
    <docs:PartnershipAgreementNoncancelablePeriod
      contextRef="ia779ca3233c64c28abdfc4d63196098d_D20211008-20211008"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTcvZnJhZzoyN2QxMGE5MDFmODY0OWMzOWU0MTRmYTlkMDNlYzZmYy90ZXh0cmVnaW9uOjI3ZDEwYTkwMWY4NjQ5YzM5ZTQxNGZhOWQwM2VjNmZjXzI5MTM3MDU4MTQ1NjU5_079d69cd-036b-4259-9edd-6cf82dcd9f4c">P3Y</docs:PartnershipAgreementNoncancelablePeriod>
    <docs:PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod
      contextRef="ia779ca3233c64c28abdfc4d63196098d_D20211008-20211008"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTcvZnJhZzoyN2QxMGE5MDFmODY0OWMzOWU0MTRmYTlkMDNlYzZmYy90ZXh0cmVnaW9uOjI3ZDEwYTkwMWY4NjQ5YzM5ZTQxNGZhOWQwM2VjNmZjXzI5MTM3MDU4MTQ1NzEx_54a9740d-56d2-4d23-880b-de10288893cf"
      unitRef="usd">9100000</docs:PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i481113436cc1402f934510336edc992b_D20220401-20220401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTcvZnJhZzoyN2QxMGE5MDFmODY0OWMzOWU0MTRmYTlkMDNlYzZmYy90ZXh0cmVnaW9uOjI3ZDEwYTkwMWY4NjQ5YzM5ZTQxNGZhOWQwM2VjNmZjXzI5MTM3MDU4MTQ1ODgz_6b68292e-b51e-4b4f-a83f-cac7c5f285fe"
      unitRef="usd">53500000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i1761c372f61844c2b98a7f045fe36118_I20220401"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTcvZnJhZzoyN2QxMGE5MDFmODY0OWMzOWU0MTRmYTlkMDNlYzZmYy90ZXh0cmVnaW9uOjI3ZDEwYTkwMWY4NjQ5YzM5ZTQxNGZhOWQwM2VjNmZjXzI5MTM3MDU4MTQ1OTAy_abfd6b90-d54f-437f-a354-e9bf18618b12"
      unitRef="usd">24000000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <docs:BusinessCombinationContingentConsiderationLiabilityPayablePeriod
      contextRef="i481113436cc1402f934510336edc992b_D20220401-20220401"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTcvZnJhZzoyN2QxMGE5MDFmODY0OWMzOWU0MTRmYTlkMDNlYzZmYy90ZXh0cmVnaW9uOjI3ZDEwYTkwMWY4NjQ5YzM5ZTQxNGZhOWQwM2VjNmZjXzI5MTM3MDU4MTQ1OTE0_e42c2aa9-32d0-4d2d-9fd6-319c2eaca353">P4Y</docs:BusinessCombinationContingentConsiderationLiabilityPayablePeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ief085275d125487ab483dab51f92a13d_D20220501-20220527"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTcvZnJhZzoyN2QxMGE5MDFmODY0OWMzOWU0MTRmYTlkMDNlYzZmYy90ZXh0cmVnaW9uOjI3ZDEwYTkwMWY4NjQ5YzM5ZTQxNGZhOWQwM2VjNmZjXzM0MDg0ODYwNDgwMjEw_877c9552-fd28-48a8-85b8-ce4980f2d10b"
      unitRef="shares">93458</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ief085275d125487ab483dab51f92a13d_D20220501-20220527"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTcvZnJhZzoyN2QxMGE5MDFmODY0OWMzOWU0MTRmYTlkMDNlYzZmYy90ZXh0cmVnaW9uOjI3ZDEwYTkwMWY4NjQ5YzM5ZTQxNGZhOWQwM2VjNmZjXzM0MDg0ODYwNDgwMjE5_b15947cd-1beb-47bc-a93d-4bddb8df7d03"
      unitRef="usdPerShare">32.99</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <docs:HostingArrangementPeriod
      contextRef="ib1d009a88cef49af96f5da8fc0da7d35_D20211201-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTcvZnJhZzoyN2QxMGE5MDFmODY0OWMzOWU0MTRmYTlkMDNlYzZmYy90ZXh0cmVnaW9uOjI3ZDEwYTkwMWY4NjQ5YzM5ZTQxNGZhOWQwM2VjNmZjXzI4NTg3MzAyMzMyMzYw_7147a8d9-e603-4aa8-a6d1-1d2942402fac">P3Y</docs:HostingArrangementPeriod>
    <docs:HostingArrangementAnnualCommitment
      contextRef="i9a3e9f0d2edd438b8e1b2bd756b26c00_I20211231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTcvZnJhZzoyN2QxMGE5MDFmODY0OWMzOWU0MTRmYTlkMDNlYzZmYy90ZXh0cmVnaW9uOjI3ZDEwYTkwMWY4NjQ5YzM5ZTQxNGZhOWQwM2VjNmZjXzI4NTg3MzAyMzMyNDIy_226badd9-73a8-4680-bde9-32b990c992c0"
      unitRef="usd">5200000</docs:HostingArrangementAnnualCommitment>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTcvZnJhZzoyN2QxMGE5MDFmODY0OWMzOWU0MTRmYTlkMDNlYzZmYy90ZXh0cmVnaW9uOjI3ZDEwYTkwMWY4NjQ5YzM5ZTQxNGZhOWQwM2VjNmZjXzI5MTM3MDU4MTQ1NzYx_31e32331-92ca-4837-bbec-5a35248cf9bf"
      unitRef="usd">0</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTcvZnJhZzoyN2QxMGE5MDFmODY0OWMzOWU0MTRmYTlkMDNlYzZmYy90ZXh0cmVnaW9uOjI3ZDEwYTkwMWY4NjQ5YzM5ZTQxNGZhOWQwM2VjNmZjXzI5MTM3MDU4MTQ1NzYx_4d47253a-8479-4acb-ba74-6ca1450f9a96"
      unitRef="usd">0</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LossContingencyAccrualProvision
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMTcvZnJhZzoyN2QxMGE5MDFmODY0OWMzOWU0MTRmYTlkMDNlYzZmYy90ZXh0cmVnaW9uOjI3ZDEwYTkwMWY4NjQ5YzM5ZTQxNGZhOWQwM2VjNmZjXzI5MTM3MDU4MTQ1NzYx_594253c4-f456-47df-a3f0-e3bb0f8fa01b"
      unitRef="usd">0</us-gaap:LossContingencyAccrualProvision>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RleHRyZWdpb246MWI1ZTNmY2Y0MWU1NGRlZWIzN2Q0YjdiMTI4ZjI2NDJfMjgwMzc1NDY1MTUyNzQ_8010cbe5-4671-40b4-9690-c10c7ac56fda">Leases&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has non-cancelable operating leases for the rental of office space, corporate housing, and laptops with various expiration dates through 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash paid for amounts included in measurement of lease liabilities&#x2014;Operating cash flows&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Weighted-average remaining lease term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.64&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.37&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.15&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities as of March 31, 2022 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total future lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RleHRyZWdpb246MWI1ZTNmY2Y0MWU1NGRlZWIzN2Q0YjdiMTI4ZjI2NDJfMjgwMzc1NDY1MTUyNzU_8efc0917-ae47-4929-809d-4aa82e4df328">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental cash flow information related to leases was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash paid for amounts included in measurement of lease liabilities&#x2014;Operating cash flows&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supplemental balance sheet information related to leases was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.572%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Year Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Weighted-average remaining lease term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.64&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.37&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.15&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;3.95&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1.75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjVhYWU5MTQ2YWQyMDQ0ODE5NWNlMmM3Yjc5YjAwNGM3L3RhYmxlcmFuZ2U6NWFhZTkxNDZhZDIwNDQ4MTk1Y2UyYzdiNzliMDA0YzdfMi0xLTEtMS0xMzUwMzE_85c7d4b4-9b7c-4755-a03c-b269d1896a7a"
      unitRef="usd">1159000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjVhYWU5MTQ2YWQyMDQ0ODE5NWNlMmM3Yjc5YjAwNGM3L3RhYmxlcmFuZ2U6NWFhZTkxNDZhZDIwNDQ4MTk1Y2UyYzdiNzliMDA0YzdfMi0zLTEtMS0xMzUwMzE_0392b829-a32d-4229-8d8b-3a7f2a30866b"
      unitRef="usd">2372000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjVhYWU5MTQ2YWQyMDQ0ODE5NWNlMmM3Yjc5YjAwNGM3L3RhYmxlcmFuZ2U6NWFhZTkxNDZhZDIwNDQ4MTk1Y2UyYzdiNzliMDA0YzdfMi01LTEtMS0xMzUwMzE_2570ce6e-4a5d-4d20-8e48-a820c558fa85"
      unitRef="usd">2010000</us-gaap:OperatingLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjVhYWU5MTQ2YWQyMDQ0ODE5NWNlMmM3Yjc5YjAwNGM3L3RhYmxlcmFuZ2U6NWFhZTkxNDZhZDIwNDQ4MTk1Y2UyYzdiNzliMDA0YzdfMy0xLTEtMS0xMzUwMzE_aa94bbd7-90f1-4d99-be11-58012fd2c77f"
      unitRef="usd">114000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjVhYWU5MTQ2YWQyMDQ0ODE5NWNlMmM3Yjc5YjAwNGM3L3RhYmxlcmFuZ2U6NWFhZTkxNDZhZDIwNDQ4MTk1Y2UyYzdiNzliMDA0YzdfMy0zLTEtMS0xMzUwMzE_4b45ffe3-fbae-4a05-88e2-854bc9665239"
      unitRef="usd">143000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjVhYWU5MTQ2YWQyMDQ0ODE5NWNlMmM3Yjc5YjAwNGM3L3RhYmxlcmFuZ2U6NWFhZTkxNDZhZDIwNDQ4MTk1Y2UyYzdiNzliMDA0YzdfMy01LTEtMS0xMzUwMzE_da7c018f-53fc-425e-8961-e1b76bb3b602"
      unitRef="usd">0</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjVhYWU5MTQ2YWQyMDQ0ODE5NWNlMmM3Yjc5YjAwNGM3L3RhYmxlcmFuZ2U6NWFhZTkxNDZhZDIwNDQ4MTk1Y2UyYzdiNzliMDA0YzdfNC0xLTEtMS0xMzUwMzE_6e810386-409b-49ae-95fe-61943ef6ce8d"
      unitRef="usd">1273000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjVhYWU5MTQ2YWQyMDQ0ODE5NWNlMmM3Yjc5YjAwNGM3L3RhYmxlcmFuZ2U6NWFhZTkxNDZhZDIwNDQ4MTk1Y2UyYzdiNzliMDA0YzdfNC0zLTEtMS0xMzUwMzE_a35f8433-6447-438b-ade9-5ce9e18370b8"
      unitRef="usd">2515000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjVhYWU5MTQ2YWQyMDQ0ODE5NWNlMmM3Yjc5YjAwNGM3L3RhYmxlcmFuZ2U6NWFhZTkxNDZhZDIwNDQ4MTk1Y2UyYzdiNzliMDA0YzdfNC01LTEtMS0xMzUwMzE_814bcd16-51b0-477e-8d18-87911a1ff100"
      unitRef="usd">2010000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjU5OGE4Mjg3YmQwNTRhMmY5ZTg4YjM0MTI1NTY4OGY3L3RhYmxlcmFuZ2U6NTk4YTgyODdiZDA1NGEyZjllODhiMzQxMjU1Njg4ZjdfMi0xLTEtMS0xMzUwNDE_cf76f379-a907-4c3e-9d2d-2b0bde11ce8b"
      unitRef="usd">1107000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjU5OGE4Mjg3YmQwNTRhMmY5ZTg4YjM0MTI1NTY4OGY3L3RhYmxlcmFuZ2U6NTk4YTgyODdiZDA1NGEyZjllODhiMzQxMjU1Njg4ZjdfMi0zLTEtMS0xMzUwNDE_cd320aa8-e18f-4cbc-81ee-c4603f8167b7"
      unitRef="usd">2569000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjU5OGE4Mjg3YmQwNTRhMmY5ZTg4YjM0MTI1NTY4OGY3L3RhYmxlcmFuZ2U6NTk4YTgyODdiZDA1NGEyZjllODhiMzQxMjU1Njg4ZjdfMi01LTEtMS0xMzUwNDE_c5de2991-eb62-4577-ac25-4244088d0bf7"
      unitRef="usd">2069000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjMyMjdjMjJmNTY4OTQ3NWRhMzEzY2RhZDM0MDBkYWUwL3RhYmxlcmFuZ2U6MzIyN2MyMmY1Njg5NDc1ZGEzMTNjZGFkMzQwMGRhZTBfMi0xLTEtMS0xMzUwNjk_e172b130-5145-4042-be1d-19d9bf786bcd">P1Y7M20D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjMyMjdjMjJmNTY4OTQ3NWRhMzEzY2RhZDM0MDBkYWUwL3RhYmxlcmFuZ2U6MzIyN2MyMmY1Njg5NDc1ZGEzMTNjZGFkMzQwMGRhZTBfMi0zLTEtMS0xMzUwNjk_7196a8d1-fd47-44e6-828b-9c3308ec143f">P1Y4M13D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i7a15f5b31d42419aa50ffb53e76f3705_I20200331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjMyMjdjMjJmNTY4OTQ3NWRhMzEzY2RhZDM0MDBkYWUwL3RhYmxlcmFuZ2U6MzIyN2MyMmY1Njg5NDc1ZGEzMTNjZGFkMzQwMGRhZTBfMi01LTEtMS0xMzUwNjk_1ae22653-7848-4817-8665-b9cc7b433243">P1Y1M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjMyMjdjMjJmNTY4OTQ3NWRhMzEzY2RhZDM0MDBkYWUwL3RhYmxlcmFuZ2U6MzIyN2MyMmY1Njg5NDc1ZGEzMTNjZGFkMzQwMGRhZTBfMy0xLTEtMS0xMzUwNjk_d9ad173f-313d-48d5-8a74-3d82580460ec"
      unitRef="number">0.0395</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i5fbc45340fb149a4a4218570cd8171e7_I20210331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjMyMjdjMjJmNTY4OTQ3NWRhMzEzY2RhZDM0MDBkYWUwL3RhYmxlcmFuZ2U6MzIyN2MyMmY1Njg5NDc1ZGEzMTNjZGFkMzQwMGRhZTBfMy0zLTEtMS0xMzUwNjk_c8b542d3-e97f-4812-88b9-11fcc9340930"
      unitRef="number">0.0395</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i7a15f5b31d42419aa50ffb53e76f3705_I20200331"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjMyMjdjMjJmNTY4OTQ3NWRhMzEzY2RhZDM0MDBkYWUwL3RhYmxlcmFuZ2U6MzIyN2MyMmY1Njg5NDc1ZGEzMTNjZGFkMzQwMGRhZTBfMy01LTEtMS0xMzUwNjk_31350735-751d-4559-b7a1-5853ff911a7a"
      unitRef="number">0.0175</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RleHRyZWdpb246MWI1ZTNmY2Y0MWU1NGRlZWIzN2Q0YjdiMTI4ZjI2NDJfMjgwMzc1NDY1MTUyNzk_23fa48cc-2192-4859-9e74-d94a061bedb4">&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities as of March 31, 2022 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.620%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Total future lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,128&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(39)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;1,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjNkNTBhNzcwNjMwNTRhODM5ZTg3Y2FjZTU3YzRhNjViL3RhYmxlcmFuZ2U6M2Q1MGE3NzA2MzA1NGE4MzllODdjYWNlNTdjNGE2NWJfMS0xLTEtMS0xMzUxMjE_23aa36e0-0597-4629-a228-ed0bb1d1da36"
      unitRef="usd">673000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjNkNTBhNzcwNjMwNTRhODM5ZTg3Y2FjZTU3YzRhNjViL3RhYmxlcmFuZ2U6M2Q1MGE3NzA2MzA1NGE4MzllODdjYWNlNTdjNGE2NWJfMi0xLTEtMS0xMzUxMjE_8c989d97-6d4e-4540-8566-964e308dab73"
      unitRef="usd">455000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjNkNTBhNzcwNjMwNTRhODM5ZTg3Y2FjZTU3YzRhNjViL3RhYmxlcmFuZ2U6M2Q1MGE3NzA2MzA1NGE4MzllODdjYWNlNTdjNGE2NWJfNC0xLTEtMS0xMzUxMjE_602a3c13-7f54-4cdf-b77b-d80dd1f75b36"
      unitRef="usd">1128000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjNkNTBhNzcwNjMwNTRhODM5ZTg3Y2FjZTU3YzRhNjViL3RhYmxlcmFuZ2U6M2Q1MGE3NzA2MzA1NGE4MzllODdjYWNlNTdjNGE2NWJfNS0xLTEtMS0xMzUxMjE_6de31513-a1a3-43bd-ab1a-e521b190d8da"
      unitRef="usd">39000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yODU4NzMwMjMyNTA4NC9mcmFnOjFiNWUzZmNmNDFlNTRkZWViMzdkNGI3YjEyOGYyNjQyL3RhYmxlOjNkNTBhNzcwNjMwNTRhODM5ZTg3Y2FjZTU3YzRhNjViL3RhYmxlcmFuZ2U6M2Q1MGE3NzA2MzA1NGE4MzllODdjYWNlNTdjNGE2NWJfNi0xLTEtMS0xMzUxMjE_55c653ae-445f-4e81-8c73-65d2b5cc4686"
      unitRef="usd">1089000</us-gaap:OperatingLeaseLiability>
    <us-gaap:CompensationAndEmployeeBenefitPlansTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjkvZnJhZzpiYzRkYzhhMmExMWU0NDBjOTEyOGMyOTAwMDJlMTYwYS90ZXh0cmVnaW9uOmJjNGRjOGEyYTExZTQ0MGM5MTI4YzI5MDAwMmUxNjBhXzUxNjc3MDQ2NTA2Nzgz_0299e4fb-48bc-4d39-b5eb-7007415f4aea">Employee Benefit PlanThe Company sponsors a 401(k)&#160;savings plan. All U.S. employees are eligible to participate in the 401(k)&#160;plan after meeting certain eligibility requirements. Participants may elect to have a portion of their salary deferred and contributed to the 401(k)&#160;plan up to the limit allowed by applicable income tax regulations. The Company matched a portion of employee contributions to the 401(k) plan totaling $2.1 million, $1.3 million, and $0.7 million for the fiscal years ended March&#160;31, 2022, 2021 and 2020, respectively. Both employee contributions and the Company&#x2019;s matching contributions are fully vested upon contribution.</us-gaap:CompensationAndEmployeeBenefitPlansTextBlock>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjkvZnJhZzpiYzRkYzhhMmExMWU0NDBjOTEyOGMyOTAwMDJlMTYwYS90ZXh0cmVnaW9uOmJjNGRjOGEyYTExZTQ0MGM5MTI4YzI5MDAwMmUxNjBhXzI5MTM3MDU4MTM3MzA2_55852e91-4a5b-42bc-8a72-ea2e3595c7d9"
      unitRef="usd">2100000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="i019f844806c4429ca710774cab1f0f66_D20200401-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjkvZnJhZzpiYzRkYzhhMmExMWU0NDBjOTEyOGMyOTAwMDJlMTYwYS90ZXh0cmVnaW9uOmJjNGRjOGEyYTExZTQ0MGM5MTI4YzI5MDAwMmUxNjBhXzI5MTM3MDU4MTM3MzEx_540b8e9e-aae4-48fa-9143-d5bfff2b14e0"
      unitRef="usd">1300000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="i861e24d19d314064a8c1591848e5a762_D20190401-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjkvZnJhZzpiYzRkYzhhMmExMWU0NDBjOTEyOGMyOTAwMDJlMTYwYS90ZXh0cmVnaW9uOmJjNGRjOGEyYTExZTQ0MGM5MTI4YzI5MDAwMmUxNjBhXzI5MTM3MDU4MTM3MzM1_c032ecbb-54b7-4198-aa05-9ef951469e93"
      unitRef="usd">700000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjYvZnJhZzo4OTAxZmUyZjMyOGU0NzJlYWU2YzNkODY1MTFhYzExMC90ZXh0cmVnaW9uOjg5MDFmZTJmMzI4ZTQ3MmVhZTZjM2Q4NjUxMWFjMTEwXzUxNjc3MDQ2NTEwODcy_585a1729-e451-4b15-9bad-b3c871bc110f">Segment and Geographic InformationThe Company considers operating segments to be components of the Company in which separate financial information is available and is evaluated regularly by the Company&#x2019;s chief operating decision maker in deciding how to allocate resources and in assessing performance. The chief operating decision maker for the Company is the Chief Executive Officer. The chief operating decision maker reviews financial information on a consolidated basis to make decisions about how to allocate resources and how to measure the Company&#x2019;s performance. As such, the Company has determined that it has one operating and reportable segment. Substantially all of the Company&#x2019;s long-lived assets were based in the United States as of March&#160;31, 2022 and 2021. No country outside of the United States accounted for more than 10% of total revenue for the fiscal years ended March&#160;31, 2022, 2021, and 2020. Substantially all of the Company&#x2019;s revenue was derived in the United States for the fiscal years ended March&#160;31, 2022, 2021, and 2020.</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjYvZnJhZzo4OTAxZmUyZjMyOGU0NzJlYWU2YzNkODY1MTFhYzExMC90ZXh0cmVnaW9uOjg5MDFmZTJmMzI4ZTQ3MmVhZTZjM2Q4NjUxMWFjMTEwXzI5MTM3MDU4MTQxMzQx_68f9b619-c362-4c3b-ba73-52dd583911e7"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMjYvZnJhZzo4OTAxZmUyZjMyOGU0NzJlYWU2YzNkODY1MTFhYzExMC90ZXh0cmVnaW9uOjg5MDFmZTJmMzI4ZTQ3MmVhZTZjM2Q4NjUxMWFjMTEwXzI5MTM3MDU4MTQxMzQx_d812f442-db8a-45f6-a71c-bb3101d4fbb2"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMzIvZnJhZzo0MzQzYjgxYWVkMzE0MmRjYWNiMWNhN2RhNTczNzEyOC90ZXh0cmVnaW9uOjQzNDNiODFhZWQzMTQyZGNhY2IxY2E3ZGE1NzM3MTI4XzUxNjc3MDQ2NTE2OTEy_2238a37d-2353-41ae-9efb-e5536914bff0">Subsequent Events&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity Grants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2022, the Company&#x2019;s compensation committee granted 563,689 RSUs with an effective date of May 15, 2022 and an estimated fair value of $18.6 million, including the RSUs granted to employees joining the Company as part of the AMiON acquisition. These RSUs will generally vest over four years based on continued service. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Repurchase Program&lt;/span&gt;&lt;/div&gt;On May 12 2022, the Company&#x2019;s board of directors authorized a program to repurchase up to $70 million of the Company&#x2019;s Class A common stock. The repurchases may be executed from time to time over the next 12 months, subject to general business and market conditions and other investment opportunities, through open market purchases or privately negotiated transactions, including through Rule 10b5-1 plans. Immediately upon the repurchase of any shares of Class A common stock, such shares shall be retired by the Company and shall automatically return to the status of authorized but unissued shares of Class A common stock.</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i16625e145bd74701a4ae78f95675b6e5_D20220515-20220515"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMzIvZnJhZzo0MzQzYjgxYWVkMzE0MmRjYWNiMWNhN2RhNTczNzEyOC90ZXh0cmVnaW9uOjQzNDNiODFhZWQzMTQyZGNhY2IxY2E3ZGE1NzM3MTI4XzI5MTM3MDU4MTU1NDkw_655ec91c-f569-43f9-b107-caa14f90503d"
      unitRef="shares">563689</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue
      contextRef="i16625e145bd74701a4ae78f95675b6e5_D20220515-20220515"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMzIvZnJhZzo0MzQzYjgxYWVkMzE0MmRjYWNiMWNhN2RhNTczNzEyOC90ZXh0cmVnaW9uOjQzNDNiODFhZWQzMTQyZGNhY2IxY2E3ZGE1NzM3MTI4XzI5MTM3MDU4MTU1NTA4_dfa7cd1d-2cf1-42a0-8010-7b0d9064f19f"
      unitRef="usd">18600000</docs:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i16625e145bd74701a4ae78f95675b6e5_D20220515-20220515"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMzIvZnJhZzo0MzQzYjgxYWVkMzE0MmRjYWNiMWNhN2RhNTczNzEyOC90ZXh0cmVnaW9uOjQzNDNiODFhZWQzMTQyZGNhY2IxY2E3ZGE1NzM3MTI4XzI5MTM3MDU4MTU1NTI4_e08c3a3f-bca1-4ffc-b723-ab6374d4d795">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="id8a49fae532d49d9b87337bacae0b894_I20220512"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMzIvZnJhZzo0MzQzYjgxYWVkMzE0MmRjYWNiMWNhN2RhNTczNzEyOC90ZXh0cmVnaW9uOjQzNDNiODFhZWQzMTQyZGNhY2IxY2E3ZGE1NzM3MTI4XzI5MTM3MDU4MTU3Nzg4_2f0921da-617e-4833-b608-8d5413a5cf7d"
      unitRef="usd">70000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramPeriodInForce1
      contextRef="i809ae921d1e74261bd64ae9e74b5455c_D20220512-20220512"
      id="id3VybDovL2RvY3MudjEvZG9jOjZjNDQwNDE0MGVkYjQ4OTM4YmE0ZTMwYjI5MGM5ZWY5L3NlYzo2YzQ0MDQxNDBlZGI0ODkzOGJhNGUzMGIyOTBjOWVmOV8yMzIvZnJhZzo0MzQzYjgxYWVkMzE0MmRjYWNiMWNhN2RhNTczNzEyOC90ZXh0cmVnaW9uOjQzNDNiODFhZWQzMTQyZGNhY2IxY2E3ZGE1NzM3MTI4XzI5MTM3MDU4MTU5Njk2_32607070-21b6-4b1d-92a3-f23a095ce318">P12M</us-gaap:StockRepurchaseProgramPeriodInForce1>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>106
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MFM/3",8YT/Y!:SP;[H#VL4W^ E!+ P04    " #R@[M4N[YX7Q '  !''0
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MA=!FAMTV,[*,TCJ8^Z40>F_8 +70=_X"4$L#!!0    ( /*#NU37]T4.MP@
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M@+=95($CC/(@W90OKI0QH^PLRO,*Y^7G\-F5^\D/TKP;*E0%.$+4:G].0P7
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M#,X&HJ"U;'3X:+=OJ8MGPGBYU3[^%=MN;SH0>>.#K;K#\*!2IOV5#QT/_^9
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M5>';XN?US;KXZ^7E]?KW'!BVJH?*TC9R!MH!_WW%"Q&<''R<K=8-F\Y5SK0
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MU&2)@Z34CN7_^$4UR%)XQQ*WQ3W(*HKI>$V)IL^;Q"E34Z@;MENLDL;"-_Q
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MX:VBNW5BU[L%OW'8ZZ,QL9ELI?QL)S\7"R^TA*"&W%@$AJ]GV$!=6R"D\>6
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M+%WM?EC06PJU$Z#]E5)V/W$*VM?9_%]02P,$%     @ \H.[5$@B[8?9 @
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MCK/TQ)\>= ]6;=SWD[FR5JW=[4IPF(LFX/U"*=L]T +[#VIO_P-02P,$%
M  @ \H.[5*,!^^Q("   *Q0  !D   !X;"]W;W)K<VAE971S+W-H965T,C(N
M>&ULI5C?<]NX$?Y7,*JG3XIDR_;%OCJ><9*FEYMSDKDD[4.G#Q"Y$G$! 1X
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M5>5#K5F#B+GY^$I=G$%H]C0[5UD=HX'=6NH>@OCMR,HEH6[A.,H)>AG _8;
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M<VAE971S+W-H965T,C0N>&ULI55-;]LX$/TK S4HND"@+[MMT-H&XK3%]E#
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MO7$>!,SSXM7=7R]?%&_R]U[<2[WS8-D]A6NEX%MZFP(>X-C=(:"2.[E5"&3
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M2+1C7^4Z1ILO1L6L; )%2T'R]:0&(.MG3^:OLK?[-L!D:#&?P9^6$MJ9X'9
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M_D!/=;BS%UJ.\08!*V+"*<6"<33?D45$]D_PG;BD1$2!TC4\]RLX7YRUD=Y
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MVQQ[T]G&6R*#%@]N&9W=.FP7H/V2I:^->#:F1@0HYH3SCI\2S48,,,'F9P2
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M&35GTT*TCCMPABJ7O\L<5+B/F*@VX 0=PWFHQT:+PP4@:*1+=]S?0WLC8?^
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M>22L""*Q<%LIB8VI$O52/$8EZ"%=/BI,:@,8$M-=>I=C9,*7PC$I<-*H#<P
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M:&5E=#,P+GAM;*U76V_B.!3^*T?L:%6DM.2>T &DMG/9D;92-;2S#ZM],.%
MHB9QQG9@V%^_QPZ$T +=D>:AC7U\+M^YVHS67#S+%%'!CR(OY;B7*E5=#P8R
M2;%@\HI76-+)@HN"*=J*Y4!6 MG<"!7YP+7M<%"PK.Q-1H;V("8C7JL\*_%!
M@*R+@HG-+>9\/>XYO1WA:[9,E28,)J.*+7&*ZJEZ$+0;M%KF68&ES'@) A?C
MWHUS?1MH?L/P+<.U[*Q!>S+C_%EOOLS'/5L#PAP3I34P^JSP#O-<*R(8W[<Z
M>ZU)+=A=[[1_,KZ3+S,F\8[G?V5SE8Y[<0_FN&!UKK[R]1^X]<< 3'@NS7]8
M-[P164QJJ7BQ%:9]D97-E_W8QJ$C$-LG!-RM@&MP-X8,R@],L<E(\#4(S4W:
M],*X:J0)7%;JI$R5H-.,Y-3D2[E"J2C*2L+%(YOE*/NC@2+-^GR0;+7<-EK<
M$UH<%^YYJ5()'\LYS@\5# A2B\O=X;IUSVJ\9^(*/,<"UW;=,_J\UD_/Z//>
M]M."#SA3P,HY?/Q>9VH#4TQJD:D,)?Q],Y-*4*W\<\:HWQKUC5'_A-$[+I4%
MGP67$IY*ZID\^Q?G\)EZ11K[?]()$B"]_L0R =]87B/P!73P'DO'6;NZD:]E
MQ1(<]ZA3)8H5]B:/*4)B "T-H'H/:-D"RCN %AK0:@<HZQ0*$PA,PH+GU--4
M-UD)*N6U)"G9OX8;J04H@TG:IA!T+("+;32:_QV7[YA, 2D=9%#;N":!HD"1
M9"R'BE4HX!VX5AB']/W]M]AUW/<'J^:,JA WU!_BF>;9HB8\9-VR([?EW'VW
MY$>NR$#RPCJXKA4%\6NAAGQO].MF =F6CO9;HKJ<L>298KH_@,B*ADZKXR)P
M^IKDVZ]='%J^%W8XO3Z1O-@C3E%QP11"R14VN9IQ[9[C#JVA;>^%'+(6]HD>
M6X[MPY2O4-!L*K?\L15%'6[/\_M$TV:?KJ97L-3LI4ZSL4%SN4PV76<"7]OK
MN./$EAO:?0@HU:'O;"-:' L11'9 Z/9QO: L^$-"$,:!Y1':$^G04(YK? <1
M.1H$AV71ZJ5C.[;LD!+]Z\I_C3]=_\XOJG]W:)^L?WUVNDX\*W"B3M;ZAG*T
M8X96[+VN_89ZAT)EBRQA6CMY.<>*RTR!0^ES7LDTU!-)=4)KZ(<'D PI^-G^
M\J@ _1>NN:%W$JMOQ6$$>[1Z'[^.-X'Q':?#9PCNF1C[H152J7E4?U1[>D?]
M\+(!'6I+^]!KRQX._V?[>58<=+'K?7R^YT++"1T("12-!;WS3Z;D7)\-/0(>
MT2(T#1;U&YI-4_?,51FT5V7PQE59FFNW)ECW3.W,4M9N5BS+-9Q+>H9=3@EI
M<W_O+^UC%^19:\<OR&/7ED6-K>?&'EQQ $Z?4N%4K-R8C$3O*8@M8'HS7TH-
M>*X!=Z+YU@3I#(8/]+?.5$H<U*FP0:8G@1-$U"FQ.>V>*$YZ!#8[&M8>W7+^
M[I:CU,4D1F/B6,(&G4<D-<+2/)4E^5Z7JGE/MM3V-7[3/$+W[,U3GF*XU",U
MQP6)VE<194,TS^-FHWAEGJ0SKNB!:Y8I_:) H1GH?,&IL[8;;:#]C3+Y#U!+
M P04    " #R@[M4;$Q=I ,$  #3"@  &0   'AL+W=O<FMS:&5E=',O<VAE
M970S,2YX;6RM5FUOVS80_BN$5@PMP$6BWNW:!A)WQ08L0)"DW8=A'VCY;!&1
M1)6DXN;?[RC)LJO8SC#LB\7CW3WW3M]L)]63S@$,^5X6E9X[N3'UU'5UED/)
M]96LH4+.1JJ2&R35UM6U KYNE<K"]3TO=DLN*F<Q:^_NU&(F&U.("NX4T4U9
M<O5R X7<S1WF["_NQ38W]L)=S&J^A0<P7^H[A90[H*Q%"946LB(*-G/GFDUO
M0BO?"GP5L--'9V(C64GY9(G?UW/'LPY! 9FQ"!P_S["$HK! Z,:W'M,93%K%
MX_,>_7,;.\:RXAJ6LOA3K$T^=U*'K&'#F\+<R]UOT,<36;Q,%KK]);M.-DP<
MDC7:R+)71@]*475?_KW/PY%"ZIU1\'L%O_6[,]1Z^8D;OI@IN2/*2B.:/;2A
MMMKHG*AL41Z,0JY /;/XS(4B7WG1 +D%KAL%F'&CR?M'OBI ?YBY!JU863?K
M$6\Z1/\,(O/)K:Q,KLFOU1K6/P*XZ-[@H[_W\<:_B'C+U14)&"6^Y_L7\((A
MYJ#%"]Z.^9/062%MV)K\=;W21F&;_'W!1CC8"%L;X9LV*+G6&C"E?7[7!)OQ
M'K)&*5%MR0W70I_*\D5\.ZM37?,,Y@X.HP;U#,[B,0>RD04.FD4V;05)RZX,
M,99IO7IN(\\%**ZR_ 4U5,M<RK+FU<O//Z4^2SYJPCNWR[W;W!SKVXG"J=R'
ML;)AD/>B0BC9:%ZM]8<I1D[DAMQ:.T,!R1_P# 5A_7=/!^11&EZ0)=<Y@6^-
M0#.V$Z?6KQ)4)I!9\QH4>4=:'_V/>/)IG,8G;K %X04'13WAP[9IT!TT3KW$
M'R3WW_ZZLYZ-K.^Y'>B@XM,D2FU<B&ZS3+1-A# "]+0K]R\KGCUAT@Z,03NA
M2>B-J%<Q[MD3&J3!B%I*54O%#9!*&@3&9).5M"'NY9B?4N:%K^@'^0P*'ZIJ
M))_2,(A'U)>KARNRM0J5?1):*_A,5]G+<5!1X%&6A(31,$X&A B+'8>L3VIY
M*D\'S2BB+#@D)$XC&J"O9PIBW3@-^(Y$D4?]T+8#BQ*:LA\;(_%2ZL7^J:9D
M_W=3^A/OQ,W;A0MHQ.(1=:*5)S0-TE>=W-TN01FQ$1FW%C#0-=12"W/H!<PN
M&U%G<MT!)M@ZA]*RF$["Z+_V?D#].!A1;SD<TC1.1]39>4'W0N:/R;<3'\9M
MPX[(<_/"J#>9C*A_-R\!3:/7E>MN+TU+)Y%@'QT]!TE,67BV>I<FA04TGMCQ
M2/!)&?7J)* >/G:G_@3=HT4#\[]MURE-,ME4IMLYAMMA8[ON%I6#>+?N80-M
M1:5) 1M4]:Z2R"&J6Z$ZPLBZ75M6TN 2U!YSW#I!60'D;R26LB>L@6&/7?P#
M4$L#!!0    ( /*#NU2 _E4K,0,  !('   9    >&PO=V]R:W-H965T<R]S
M:&5E=#,R+GAM;(U5WV_3,!#^5TX1#YL4EA]-V[1J*VT#!!*@B@UX0#RXR:6Q
M<.Q@.^O&7\_9:;--6@LOB7V^^^Z^\]UYL5/ZEZD1+=PW0IIE4%O;SJ/(%#4V
MS%RH%B6=5$HWS-)6;R/3:F2E-VI$E,;Q)&H8E\%JX65KO5JHS@HN<:W!=$W#
M],,5"K5;!DEP$'SAV]HZ0;1:M&R+-VB_MFM-NVA *7F#TG E06.U#"Z3^57F
M]+W"-XX[\V0-CLE&J5]N\Z%<!K$+" 46UB$P^MWA-0KA@"B,WWO,8'#I#)^N
M#^CO/'?BLF$&KY7XSDM;+X,\@!(KU@G[1>W>XY[/V.$52AC_A5VOFY''HC-6
M-7MCVC=<]G]VO\_#$X,\/F*0[@U2'W?OR$?YAEFV6FBU ^VT"<TM/%5O3<%Q
MZ2[EQFHZY61G5VM-]ZOM S!9PMO?'6\IXS:$SU0/9[=L(]"<+R)+GIQ^5.Q1
MKWK4] AJDL(G)6UMX*TLL7P.$%&(0YSI(<ZK]"3B)Z8O8)2$D,9I>@)O-/ >
M>;S1/WB'L!9,VN?TX<?EQEA-%?/SA*ML<)5Y5]D15S?42&4G$%0%+Z?[I02?
MQ'2M.C<M*W 94"\:U'<8K&YK!#264ZUB"9W!JA,@>.4](RMJ8,;0O19TOE7Z
M ;@A"51*4&N:.;SKM.2VT^BCPR$;H]=C>$"F#5RKINTLTLII&%79'2/UT?[X
M@Z0SR<1K\OUX6N(=]7X/52ACS:#_$:F?:B5*X$VKU1TZ'0,WM=($Y*)^1D+3
M%'!SALLM"&<*I-4\SRD^EK!T5!6-#^/206"6\M.3=0AG7))$=8;,S/D<+HW3
MH3JC/!T*S7V2HWEY!:/1A+[I;'8L,]/)#*9Q=HSI=#:!<3;[[\0EXS >3R&)
MPUF<PZVR3$#[(GU()N%LG$.2AMDD)O^&+I@51==TPI='B50X!6?];"13UE#6
M^9]><):'V30^A[,LS"?I^4E7?:9? 9GD.?VGX7B6PTN-$SV94PWJK9_&AKAU
MTO8C:Y . _^RGW./ZOUK0?>TY=)0'51D&E],QP'H?@+W&ZM:/_4VRM(,]<N:
M'BW43H'.*Z7L8>,<#,_@ZB]02P,$%     @ \H.[5)11E(GS @  8 8  !D
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M+P"U,Z#[E5)VMW$$XY_*XC]02P,$%     @ \H.[5-Y1A0C> P  A@D  !D
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MO4=1)F='J1YUB6C@I:Z$GCNE,<W4\W1>8LWTC6Q0T,E>JIH96JJ#IQN%K.A
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M   9    >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;+U86V_CNA'^*P/76R2
M(DO4/4T")&GV=!].&R2[>U 4?6 DVB8BB3HD%2?]]9VA;,79=;1;M.B+38K#
MN?&;CR.=;91^-&LA+#PW=6O.9VMKN]/%PI1KT7#CJTZTN+)4NN$6IWJU,)T6
MO'*;FGK!@B!=-%RVLXLS]^Q67YRIWM:R%;<:3-\T7+]<B5IMSF?A;/?@3J[6
MEAXL+LXZOA+WPG[I;C7.%J.62C:B-5*UH,7R?'89GEX5).\$ODJQ,7MCH$@>
ME'JDR:?J?!:00Z(6I24-'/^>Q+6H:U*$;OR^U3D;3=+&_?%.^T<7.\;RP(VX
M5O5OLK+K\UD^@THL>5_;.[7YB]C&DY"^4M7&_<)FD$W08MD;JYKM9IPWLAW^
M^?,V#WL;\N"=#6R[@3F_!T/.RS]SRR_.M-J )FG41@,7JMN-SLF6#N7>:ER5
MN,]>W/S>2_L"1Y_Y0RW,\=G"HE):6I1;!5># O:.@I#!KZJU:P,W;26JMPH6
MZ,WH$MNY=,4F-?[*M0]1Z $+&)O0%XTA1DY?-!WB/RX?C-6(@G].Z(Q'G;'3
M&;^C\UHU#6+JWJKR$>Z$$?I)5( U I^,Z7E;BD.9G-1)Y7=J.EZ*\QG6EU,Y
MN_B\%H#&.MZ^P)H;,&N.:Z"64 XN&.>"WG=!;ET E%^J&NO.P)%LP:Y5;WA;
MF>-3P"27ZS'+;Z<A1E0)+'Z$!)IIGX2VDL;HUE)HC68&JW_\0\Y"]B?(4H_E
M&5SO>[3A6O/6&EQ,@24!*@X#N*UY"W_KJ" QB-X:B_[(=@4L]B*$4A1Y>9+"
M_1 E?^*R=EY06,O>]EK BM2.ID,O<;K1::?[5FC'5!C^"55K1:FQ6I9V]+IO
MI7UK' WO]-W]6#J)XE'\QXXRYL68@=T&Y^G-_>TMQ%Z<A>/S0SFAL:P$GIMP
MP1E@7HI[F)>Q #XKRVM($H]%#,(P]M(T@@EH)R.TDTEH#Y@>_(%+(DVLGD-H
MGE1S&,V#;M6]$K*T$O.WD7;M +H+%)&[0::F_UT6$/*OZQNAW\";TOZ@[!K(
MD!S/'A,)W7>(4-M<OZD)#\1S*3I+\D.5@6R'2P^%L6+^VC</N(1N; _]-\?X
MHCJYQ +!"PQV_W>";D,ZP6MD1J*<'D_JL] -7*Y66JRX%? )5R3>;25\Y74O
MX(K7Y*+W;2E&J9=D*<R!^7D F9_3.$HR+T)4[5#CH(:1A5Z!3T/F)Z]KXEGH
M4E+<1V'@Y2PZAM /LW$=8UP*2;LQA^*YDU3?1UF4'D/DA^D[CC%@J5?D$<1^
MF*!;B+W08T7D)7$"7[&(MMG?6G>UP1UO?:,F]\(0]_I9!BFIBH,<$9V_U=$)
M5Y%6P1,^/JR()1[E*_8#AOXD"?D38,%@M4Y413I61?K356'<D?&A0)!KF^'I
MH1J95DKDON12PY.# ,8D.(:TK0\U%$1%:,&E@4ZDP9[#(I10506](921U%7-
MR\>3^W*M:KH>G(:3#IF,!!I5B=H5F9/EKSYCO5A" *YLZV^H**>6#NT4/DI3
M(GS_+K@>KOCO$D]IQY\ /KZ)Y<T%-0]S/P[A!.8LI,&<^4%*TS#P$YR&?I*[
MJ5^$\%75F-V:;NTX]9,/N!!G?O !HMP/:9;D?H2SPF=NS<G<2?-XLM2"ZA83
M1#C1E+H H452(0+C \Y8NC]+<YHQ/\*G-R/.J%2)'5XP:',,B1\$*)7Z0;$;
MY_27^$5,N@*:C+LK9+5*(&ZWW/[A^\$$(+,1D-DD=O8NJ@&;7_"BFN3K27WO
M=Q_? &+;OLM_(<SN[K_L6/P%JE[OP+@<($/9 W$(,O\KYL6@GP:>>(\^=_?K
M?!S]LN7*)(L@1>(*=E1S%.5XU(4?Q/!QY,2C$)_%?E+\R!1S?4&:^VSR%L['
MX\TGC_>FZ6KU@F >#O>V1U-X>0U-SD_3S[2-[^F'#L\U)T/1=CNKFO)M_AM&
M^O]0T10!)9D?4[7.L\C'H]_CF#PE-J$ZCOQTBD@"1T5(&MD$62##%$XJ+B8X
M80(BQ0B1XL=7TLF5:VGH%0'?E =0D-76''P#F=3X#@>X/M,E<=L_E?O&Q& ,
MV^Q2K5JDA6IW?/CF8%0M"2W43.,?OLQ;.AB%E<['[N-;RC '.6.H9\\U!.ZR
MV7 S]8+S'UQ;U\HXM[1X$BU"9XZ]>9$5^)\BK\\A1+C0.Y[;3_8K%*Q5Y\+)
MO""E7J/(L W"-YQ[3G G*63)1V$)OMCC!#G)%#GD<0:_B!834#LI7F'A2'HS
MI<\3V,AC%Q6X1K^ %+GD)],_I\#BF.$@\UA"_\R+DL-<M-C[7M (O7)?10PJ
M[EL[?#H8GXX?7BZ'[PVOXL-7&TSJ"MM8J,42M^)=BV\%>O@2,DRLZMS7!^S.
MK6K<<"UX)30)X/I2*;N;D('Q<]3%OP%02P,$%     @ \H.[5,E'6GRG!
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M0/R ^)&'5S?P*-RMS_0]N3'<"!)X4_A#8X\D<41NI0&),)H2ZK*8VF_G8B%
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M"]1-D9A1$D0123SV?]$C&N@1O9H>0Z] 6LRT%I!GS/^GG,\!QR87>A<S]AK
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M5'MF;%^,K.TY;2X-G/KLXPJ.V4+A OB_D-+T+VA@.+B?_ U02P,$%     @
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M6Y4;1 J*9IRF-"9<PSR.Q9YKRC-8"T9CBNH*MB<.2[<UE HV:,Z;PLHY#"Y
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M140B79*VDSY]AY2L.MX:]&)QF?GGF^'FWD;(9U4 :/)2E5SUG4+KY9WKJJR
MBJH;L02.,W,A*ZJQ*Q>N6DJ@N76J2C?PO,2M*./.H&?''N2@)U:Z9!P>)%&K
MJJ+R=02EV/0=W]D.3-FBT&; '?26= &/H)^6#Q)[;JN2LPJX8H(3"?.^,_3O
MQJFQMP;?&&S43IN83&9"/)O.Y[SO> 8(2LBT4:#X6<,8RM(((<:O1M-I0QK'
MW?96_:/-'7.9405C47YGN2[Z3NJ0'.9T5>JIV'R")I_8Z&6B5/:7;!I;SR'9
M2FE1-<Y(4#%>?^E+4X<=!S\YX1 T#L&^0W3"(6P<0IMH36;3FE!-!STI-D0:
M:U0S#5L;ZXW9,&Y6\5%+G&7HIP=36 -? 9E")A:<V=)>DPG,04K(R79Z++B6
M6'(RHB7E&9#+"6C*2G6%UD^/$W)Y<44N"./D:R%6BO)<]5R-?":*FS4LHYHE
M.,'B!^0>XQ2*?. YY&\%7$RLS2[89C<*SBK>4WE#0K]# B\(C@"-W^_NG\$)
MVV*'5B\\H3<N*%^ J5);SPW3!1G;=0;9(5\8G;&2Z5?R8SA3UN3GF<!1&SBR
M@:,3@4>P8)PSOL M;]?OV.+4$K&5,(=_/4C#Z!;+MMZMV*%5%,5ITEJ]X8M;
MOO@LWS#/[=93'<)!=TB^D@96%T"6()G(C_'6DLD.21C%7N3O 1^:!0CLA<>)
MDY8X.4N\/1BR/C>_\:S,I:@L\NP]U4X.L*[3( ZC/?HC9E'HQ=%Q^FY+W_TO
M^JS9E@KWZ%JP#,??M13=0\H@\3U_/YLC=GX2IM&)Q4C;=-*SZ>!U\8]JIX=[
M.[I-XSV\(U9O3D -Y^[<MGAH%_814EB[%=?UU=2.MN_<T%[O>^,C?/_JY^JO
M3/UXXL6#6TB1$N8HZ=UTD4G6#U+=T6)I[_29T'ASV&:!;SA(8X#S<R'TMF,"
MM/\*!G\ 4$L#!!0    ( /*#NU2=NKF$T@(  $4(   9    >&PO=V]R:W-H
M965T<R]S:&5E=#0V+GAM;(U676_:,!3]*U:TAU;JFI#/K@(D()NVATX55;>'
M:0\FN1"KCIW:!MK^^ME.R&@3TO( MG/.N?=<.[Z,]UP\R ) H:>2,CEQ"J6J
M:]>560$EEI>\ J:?K+DHL=)3L7%E)0#GEE12U_>\V"TQ8<YT;-=NQ73,MXH2
M!K<"R6U98O$\!\KW$V?D'!:69%,HL^!.QQ7>P!VH^^I6Z)G;JN2D!"8)9TC
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M(B_8FN%K<Z6!$,=N3SJ,NYDG4=1UV,7%5U=!UV$7%WG):8=)ZS 9=)CV.[I
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M/;$/NSFVML])6TVG8RC^$_MBF_E8.."4)02)<^ LE>D#=(ZMK9I::SH=0PN
M(X[IUO1'<W' ,4X(DOL 3GN"#_DYMG:B'U/A,/L!G/9TQ#WWBI,)?!QP<!."
MQ#F ,Y[@ W2.K<_@-Y<*NI#<5"@3.G1N W#(TY'R=$@U.4R.+!^"1#> @J%
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M;]HP$/XK5M2'5FJ;D 38*D "TFE]:(7:=7N8]F#(0:PF=FH[T/;7[QR'+"5
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MEFR4S[@I^X.6^)8A3X]F$F^0U*^$\IA</Q<LQYKJ<W*'-^Z"W%$IJ2D,.8U
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MV835DI(2%AR)NB@PW]T!99NIY5K[%X]DG4O]PIY-*KR&)<BG:L'5S.ZB9*2
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MJ\\&X-I K:\8D_N)OIFZ#Y'9/U!+ P04    " #R@[M4Z/JBYSX$   1$
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MN_OGKJ%%5MR75D)COHO'#=[901H#?!\)H?<-<P6K_@68_ M02P,$%     @
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MB@2JO@+5$R-+=RG82H.'T TSO#:"LAOP^4Y*<YS8>T9[$5W]"U!+ P04
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MCU&OFF;>3(S<NGZXE :[JQL6^/T#90_@_EI*\S*Q+;;[HF:_ 5!+ P04
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MJ/L;QN3+B=ZK-O]^+/X#4$L#!!0    ( /*#NU3@D3,@:@(  #\'   9
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M)2'EVD ]7S'5'_9&GU:+_S\F/P!02P,$%     @ \H.[5!X<6A)=!0  >AH
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M3>E<&1-$_UG3"4U38TGS^%$9[=1K&N#N\];Z1^N\=N:!2#KAZ7<6J^2J,^B
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M=3L1Y4UZ^:+XRM[\/G"E>&8?$TIB*LP$_?N"<[5],0O4_Y\Q^AM02P,$%
M  @ \H.[5#"EP0=S!   .A8  !D   !X;"]W;W)K<VAE971S+W-H965T-C0N
M>&ULO9C?;^(X$,?_%8NGKG3;Q'828 5(UU^ZGK9:5+9W#Z=[<(F!J$G,V@9V
MI?OCSS9I#!O'37L]7L"!^7K&,\YG+(]VC#^)%:42?"_R4HQ[*RG7GX) S%>T
M(.*<K6FI_EDP7A"I'ODR$&M.26I$11Z@,$R"@F1E;S(ROTWY9,0V,L]*.N5
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MUP;J_P5C\OE!W]75U\63?P%02P,$%     @ \H.[5#/[#^C=!   %!,  !D
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M\;$#1S$MZ:(]W0=D]?@5\Q[P8!<@%Z$:0-/VYM "QRNC[QE_7H._O]?IC'#
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M\ VY9(G]N#I^7!X?'CD^".%>YB;5<)<GF+PE\$E++2C<"1J')QGOF6I!%%Q
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M3C*_!.<3+9;9+>]1:+PS9L,%HQ&39@%^GPFA=Q-S<2S_BAC^ %!+ P04
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M,T&_7W"NMAVS0%47COX"4$L#!!0    ( /*#NU1F5949H@,  '4,   9
M>&PO=V]R:W-H965T<R]S:&5E=#<Q+GAM;,U7WV_B.!#^5ZQH'UJI;>(D0+L"
MI )[=ROM2JA<[QY.]V"2@5A-;-8V4.ZOO[&3AK0E*=+=2?=";&?FFV]^>#(,
M]U(]Z0S D.<B%WKD9<9L/ON^3C(HF+Z1&Q#X9B55P0QNU=K7&P4L=4I%[H=!
MT/<+QH4W'KJSN1H/Y=;D7,!<$;TM"J8.$\CE?N11[^7@@:\S8P_\\7##UK
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M0KIM[-J)58UOIIZ4I=;,#]?4#*-V&^C]4BE[F+@#^O9Z_B]02P,$%     @
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MA 'H]UO.U?/$;%!_YLS^ %!+ P04    " #R@[M4WN7W&+L$   V$P  &0
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M;IACQPC*&N#[C91F/[$?:'O0Q0]02P,$%     @ \H.[5 0EL" S P  A H
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MI7,=*4V\;GGJ@60;TP0LF%0MA7E=JS81N Y0ZSEC\F.@-V@;S\E_4$L#!!0
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M]DU=(*6);B4<-+B,0^QV\ DK/N'_Y+.F";S.VAB%S11Z?B>EJ*(4]5*Z-PE
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M1Y3%\IYMK["YH:&.%[)8Y'_!ME@[4HQA)B1+#%B=)X06_]&K240-X/DM &@
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M\.(E9'$B69J_;EHQ*5F2'VXP4D^>7J"N/S(F=R?Z#5;Y*GCV/U!+ P04
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MN&"-L'=J]1F[?$X<7ZZ$\5]8=;91 'ECK*HZ,$50<=G^V5-7APU ?+H#D'2
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M'\"X"?1]HS4>.NY&Z?XXT[]02P,$%     @ \H.[5/+03#I3 @  N04  !D
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M&PX2PNOVHF@+5+4[G$N%=-3=L*"[%;1MH.^Y4OA1V//>W=;I.U!+ P04
M" #R@[M4W?#Q4%4"  "W!0  &0   'AL+W=O<FMS:&5E=',O<VAE970X-RYX
M;6R-5$MOVD 0_BLC*X=$:C&V(6TCL!1"JO: A(+2'JH>%GO J^S#W5T@^?>9
M71N7/$"Y>'=FY_OFY9G13IL'6R$Z>)1"V7%4.5=?Q;$M*I3,]G2-BEY6VDCF
M2#3KV-8&61E 4L1IOW\92\95E(^";F[RD=XXP17.#=B-E,P\35#HW3A*HKWB
MCJ\KYQ5Q/JK9&A?H[NNY(2GN6$HN45FN%1A<C:/KY&HZ\/;!X!?'G3VX@\]D
MJ?6#%WZ6XZCO T*!A?,,C(XMWJ 0GHC"^-=R1IU+#SR\[]F_A]PIER6S>*/%
M;UZZ:AQ]C:#$%=L(=Z=W/[#-9^CY"BUL^,*NL1U>1E!LK-.R!5,$DJOF9(]M
M'0X R3% V@+2UX#!$4#6 K*/ @8M()0Z;E()=9@RQ_*1T3LPWIK8_"44,Z I
M?:Y\VQ?.T"LGG,MO92WT$R),4.&*.Y@+IN!\BHYQ82_@,]POIG!^=@%GP!7,
MN!#4+CN*'3GW%''1.IHTCM(CCI(49EJYRL*M*K%\21!3U%WHZ3[T27J2<<9,
M#[+D$Z3]-'TGH)N/PY-WX-./P_LGLLFZ1F2!+SO"-]?686@&#97;M\/"G^NE
M=8;&X^\))X/.R2 X&9SNMH&2V\*@GSR:=2BH,88O-\TD2KU1[KT&-]S? K=?
M)]L\[5'EMH<U?VN3]+*7-M.W-OW>E\ZF22P^^*4EFG58#98BI=B:7Z33=MOG
M.@S=*_V$ME*S1/[3-"N-.KCFRH+ %5%2",,(3+,F&L'I.@S.4CL:PW"M:+.B
M\0;TOM+:[07OH-O5^3-02P,$%     @ \H.[5#K.)BD= @  WP0  !D   !X
M;"]W;W)K<VAE971S+W-H965T.#@N>&ULC53;;MLP#/T5P4\;,,2QDW1#X1A(
MVEWZT"%(L.UAV(-LT[9073R)KKN_KRZ.EP%-NA=;E'@.#RE2V:#T@VD!D#P)
M+LTZ:A&[ZS@V90N"FIGJ0-J36FE!T9JZB4VG@58>)'B<SN=7L:!,1GGF]W8Z
MSU2/G$G8:6)Z(:C^LP6NAG641,>-/6M:=!MQGG6T@0/@MVZGK15/+!43( U3
MDFBHU]$FN=ZNG+]W^,Y@,"=KXC(IE'IPQEVUCN9.$' HT3%0^WN$&^#<$5D9
MOT?.: KI@*?K(_LGG[O-I: &;A3_P2ILU]&'B%10TY[C7@U?8,S'"RP5-_Y+
MAN"[7$6D[ TJ,8*M L%D^-.GL0XG@#0Y TA'0.IUAT!>Y2U%FF=:#40[;\OF
M%CY5C[;BF'27<D!M3YG%87Z QI88"945^0RJT;1K64GN9+AO5[@WMX"4<?,V
MB]%&=+BX'-FW@3T]PYZDY%Y); WY*"NH_B6(K=1);WK4NTTO,MY3/2.+Y!U)
MYVEJ@O@+M(NI# M/NWBE#'OHE$8F&_)S4QC4MFE^7:!?3O1+3[\\0_^U%P5H
MHFIBITE3'V 4;UZJ:F"[\FQNK![S)(L?7Q"PF@2L_E- R) 6',CA@H+5JPKB
MDZ83H!L_6H:4JI<8^F_:G:9W$YKVKWL8?7NI#9.&<*@M=#Y[;Z/K,$[!0-7Y
M%BX4VH'PR]:^0*"=@SVOE<*CX0),;UK^#%!+ P04    " #R@[M4\M,^3 P#
M   ("@  &0   'AL+W=O<FMS:&5E=',O<VAE970X.2YX;6RU5EU/VS 4_2M7
MT1Y 8N2['ZBMQ.>&-"1$Q?8P[<&DMXU%$@?;:>FT'[_K)(2.I:%#XR6Q'9_C
M<X]SKSU:"7FO8D0-CVF2J;$5:YT?V;:*8DR9.A0Y9O1E+F3*-'7EPE:Y1#8K
M06EB>X[3LU/&,VLR*L>NY60D"IWP#*\EJ")-F5R?8")68\NUG@9N^"+69L">
MC'*VP"GJV_Q:4L]N6&8\Q4QQD8'$^=@Z=H_.7=\ RAE?.:[41AM,*'="W)O.
MY6QL.481)AAI0\'HM<133!+#1#H>:E*K6=, -]M/[!=E\!3,'5-X*I)O?*;C
ML36P8(9S5B3Z1JP^8QU0:/@BD:CR":MJ;NA9$!5*B[0&DX*49]6;/=9&;  H
MT': 5P.\70%^#?!W!00U('@)"+8 PAI0AFY7L9?&G3'-)B,I5B#-;&(SC=+]
M$DU^\<S\*%,MZ2LGG)Y,BSN%#P5F&LZ7]%2P=X::\43MPT>XG9[!WH=]^  \
M@RN>)+2W:F1K6MC [:A>Y*1:Q-NRR!5;@QL>@.=X7@OZ= >TMQ5]]CK:ZV]%
MG[^&EH?@NVUPFYQN[/8:N[V2+]C1[@Y*OZ'T2TI_1TKX_H5FP*7&5/WHX \:
M_J!;LA;1/=6$O)!13"D)N10+R=(#8(6.A>0_<08L%<7+:*J]K<C#DMQ4K>6D
M[XSL98N@L!$4OE%0CI*+F?E7J8)&V":GF]KU(!69CE6';[U&9J^3ZP:5ECS2
MY$ZE^#;C)KUNIK=JOX._W_#WWV7?!PW_H%/_)\DR(WZ/[%0QD_A2=94_%4EO
M8W_#OC=T@O8]'C:+#]]N'OR"?\@CUWDNA<Z[..IN%%OW/WAZ4K/\86K/[PV&
MC:EUY?M[WM /PD&[]^YSD7*[J]0%XQ*6+"D0Q!P6M6BRANLU91=M39&:LZ)5
M>T4]W-#D#@Y[6R0]%SG7[Y1TO&)R!DOZ+7BVJ!.]=?ENF@#6R&1K>ML;AZBY
M(U'I7U"LD."<J)S#/I4.65T[JHX6>7FNW@E-IW39C.FJAM),H.]S(?13QQS5
MS>5O\AM02P,$%     @ \H.[5/'-.5I? P  "!<   T   !X;"]S='EL97,N
M>&ULW5A1;]HP$/XKD3M-G30UA*R!K("T(56:M$V5VH>]588X8,EQ,L=TT%\_
M7QP2H#Y*^[#"@B#V?;GO/I_/B<.@U"O!;N>,:6^9"5D.R5SKXK/OE],YRVAY
MD1=,&B3-54:UZ:J97Q:*T:0$ITSXW4XG\C/*)1D-Y"*[SG3I3?.%U$,2-R;/
MGKXE0Q)$GXAGZ<9YPH;D_OS][T6NK]YY]GSV\>RL<__A:M=^7@$?B.\DO3R
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M:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " #R@[M4F*-*_M$&  "=.@
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M_;8VTRD+];ESH::-C,>,#:^G]RD+];GWNE%;&FN!7)_\@PVSA5YM:6SN2<I
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M8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " #R@[M4B<+36N\    K @  $0
M            @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " #R
M@[M4F5R<(Q &  "<)P  $P              @ '- 0  >&PO=&AE;64O=&AE
M;64Q+GAM;%!+ 0(4 Q0    ( /*#NU1/""V$" <  ) =   8
M  " @0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " #R
M@[M41PE$2"4"  !X!0  &               @(%,#P  >&PO=V]R:W-H965T
M<R]S:&5E=#(N>&UL4$L! A0#%     @ \H.[5+N^>%\0!P  1QT  !@
M         ("!IQ$  'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0
M   ( /*#NU2=1V'#M ,  $H.   8              " @>T8  !X;"]W;W)K
M<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " #R@[M4I2"6%=X%  "#%P
M&               @('7'   >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L!
M A0#%     @ \H.[5'RYKSHD P  Q@@  !@              ("!ZR(  'AL
M+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( /*#NU3EX\)!D@(
M /0%   8              " @44F  !X;"]W;W)K<VAE971S+W-H965T-RYX
M;6Q02P$"% ,4    " #R@[M4U_=%#K<(  "M+P  &               @($-
M*0  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ \H.[5,S2
MB 8P"@  ,2X  !@              ("!^C$  'AL+W=O<FMS:&5E=',O<VAE
M970Y+GAM;%!+ 0(4 Q0    ( /*#NU2)FR"YJ04  %(,   9
M  " @6 \  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @
M\H.[5/$3.D/C)P  %(8  !D              ("!0$(  'AL+W=O<FMS:&5E
M=',O<VAE970Q,2YX;6Q02P$"% ,4    " #R@[M4J*!TH<X#   )"0  &0
M            @(%::@  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4
M Q0    ( /*#NU349@SFM 4  !P0   9              " @5]N  !X;"]W
M;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ \H.[5#$,/)46!
M-0L  !D              ("!2G0  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX
M;6Q02P$"% ,4    " #R@[M4^>F1!KT#  "I"0  &0              @(&7
M>   >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( /*#NU1(
M(NV'V0(  'D&   9              " @8M\  !X;"]W;W)K<VAE971S+W-H
M965T,38N>&UL4$L! A0#%     @ \H.[5(FJI29.!P  "1(  !D
M     ("!FW\  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4
M" #R@[M45?XH<J,)  #F'   &0              @($@AP  >&PO=V]R:W-H
M965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( /*#NU21;"QQDA,  ,1$   9
M              " @?J0  !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L!
M A0#%     @ \H.[5,@3G1AG!   =0L  !D              ("!PZ0  'AL
M+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    " #R@[M4DF>;J@<*
M  !<&P  &0              @(%AJ0  >&PO=V]R:W-H965T<R]S:&5E=#(Q
M+GAM;%!+ 0(4 Q0    ( /*#NU2C ?OL2 @  "L4   9              "
M@9^S  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @ \H.[
M5#K[:KJG P  B @  !D              ("!'KP  'AL+W=O<FMS:&5E=',O
M<VAE970R,RYX;6Q02P$"% ,4    " #R@[M4K33?^B$#  #O!@  &0
M        @('\OP  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0
M   ( /*#NU0H6$F@=P,  *0(   9              " @53#  !X;"]W;W)K
M<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ \H.[5)W@EV*S @  PP4
M !D              ("! L<  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q0
M2P$"% ,4    " #R@[M4AMB&1;PK  ")F@  &0              @('LR0
M>&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( /*#NU223S7?
MWP,  !T)   9              " @=_U  !X;"]W;W)K<VAE971S+W-H965T
M,C@N>&UL4$L! A0#%     @ \H.[5![@J5I. P  <P<  !D
M ("!]?D  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4    " #R
M@[M4H+=U#;,$  "O#   &0              @(%Z_0  >&PO=V]R:W-H965T
M<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( /*#NU1L3%VD P0  -,*   9
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M970S-2YX;6Q02P$"% ,4    " #R@[M4"*M"@@ '  ":$@  &0
M    @($\% $ >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    (
M /*#NU3)1UI\IP0  !L,   9              " @7,; 0!X;"]W;W)K<VAE
M971S+W-H965T,S<N>&UL4$L! A0#%     @ \H.[5+^-KS\*!@  Q \  !D
M             ("!42 ! 'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q02P$"
M% ,4    " #R@[M4 E&*!I(#  #>"   &0              @(&2)@$ >&PO
M=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( /*#NU0E!C+SF0,
M #D+   9              " @5LJ 0!X;"]W;W)K<VAE971S+W-H965T-# N
M>&UL4$L! A0#%     @ \H.[5'\*&_)#!   F1$  !D              ("!
M*RX! 'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"% ,4    " #R@[M4
M<0G/'*("  #^!P  &0              @(&E,@$ >&PO=V]R:W-H965T<R]S
M:&5E=#0R+GAM;%!+ 0(4 Q0    ( /*#NU0%P#]QL@(  &$)   9
M      " @7XU 0!X;"]W;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%
M  @ \H.[5"O- =V] @  JP@  !D              ("!9S@! 'AL+W=O<FMS
M:&5E=',O<VAE970T-"YX;6Q02P$"% ,4    " #R@[M4*<&L._@"   A"
M&0              @(%;.P$ >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+
M 0(4 Q0    ( /*#NU2=NKF$T@(  $4(   9              " @8H^ 0!X
M;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @ \H.[5$U"4XZY
M!P  0S(  !D              ("!DT$! 'AL+W=O<FMS:&5E=',O<VAE970T
M-RYX;6Q02P$"% ,4    " #R@[M4\AD&J64"  "N!0  &0
M@(&#20$ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    ( /*#
MNU3DO9(LT0(  *P'   9              " @1], 0!X;"]W;W)K<VAE971S
M+W-H965T-#DN>&UL4$L! A0#%     @ \H.[5-FZ[(Q,"P  ['(  !D
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M=#4T+GAM;%!+ 0(4 Q0    ( /*#NU1,!ME,3P,  )0*   9
M  " @==H 0!X;"]W;W)K<VAE971S+W-H965T-34N>&UL4$L! A0#%     @
M\H.[5'_,]#C* @  N @  !D              ("!76P! 'AL+W=O<FMS:&5E
M=',O<VAE970U-BYX;6Q02P$"% ,4    " #R@[M4O(8G794"  !=!P  &0
M            @(%>;P$ >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+ 0(4
M Q0    ( /*#NU2L]JD-5P<  )<F   9              " @2IR 0!X;"]W
M;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @ \H.[5']!B(F_ P
M"1$  !D              ("!N'D! 'AL+W=O<FMS:&5E=',O<VAE970U.2YX
M;6Q02P$"% ,4    " #R@[M4X)$S(&H"   _!P  &0              @(&N
M?0$ >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0    ( /*#NU2J
M=M4JVP,   L1   9              " @4^  0!X;"]W;W)K<VAE971S+W-H
M965T-C$N>&UL4$L! A0#%     @ \H.[5!X<6A)=!0  >AH  !D
M     ("!880! 'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( /*#NU25RU]$[P,   X0   9              "
M@3F< 0!X;"]W;W)K<VAE971S+W-H965T-C<N>&UL4$L! A0#%     @ \H.[
M5!R,2&,:!   9!   !D              ("!7Z ! 'AL+W=O<FMS:&5E=',O
M<VAE970V."YX;6Q02P$"% ,4    " #R@[M43\V*1>X#  "6$   &0
M        @(&PI $ >&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;%!+ 0(4 Q0
M   ( /*#NU2 \:5R"@,  ",*   9              " @=6H 0!X;"]W;W)K
M<VAE971S+W-H965T-S N>&UL4$L! A0#%     @ \H.[5&95E1FB P  =0P
M !D              ("!%JP! 'AL+W=O<FMS:&5E=',O<VAE970W,2YX;6Q0
M2P$"% ,4    " #R@[M4=EOES&$#   0"@  &0              @('OKP$
M>&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;%!+ 0(4 Q0    ( /*#NU3K-Y%:
M4@,  &H+   9              " @8>S 0!X;"]W;W)K<VAE971S+W-H965T
M-S,N>&UL4$L! A0#%     @ \H.[5#.1.RAG P  \@P  !D
M ("!$+<! 'AL+W=O<FMS:&5E=',O<VAE970W-"YX;6Q02P$"% ,4    " #R
M@[M4WN7W&+L$   V$P  &0              @(&NN@$ >&PO=V]R:W-H965T
M<R]S:&5E=#<U+GAM;%!+ 0(4 Q0    ( /*#NU2]-9K8> ,  (\.   9
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M970X,"YX;6Q02P$"% ,4    " #R@[M4],<6.4D#  !#"@  &0
M    @('MT@$ >&PO=V]R:W-H965T<R]S:&5E=#@Q+GAM;%!+ 0(4 Q0    (
M /*#NU0V! ]O_@0  !86   9              " @6W6 0!X;"]W;W)K<VAE
M971S+W-H965T.#(N>&UL4$L! A0#%     @ \H.[5*6B,&6/ @  )0<  !D
M             ("!HML! 'AL+W=O<FMS:&5E=',O<VAE970X,RYX;6Q02P$"
M% ,4    " #R@[M4;X]>A8 "  #S!0  &0              @(%HW@$ >&PO
M=V]R:W-H965T<R]S:&5E=#@T+GAM;%!+ 0(4 Q0    ( /*#NU2J/FEE3@(
M 'T&   9              " @1_A 0!X;"]W;W)K<VAE971S+W-H965T.#4N
M>&UL4$L! A0#%     @ \H.[5/+03#I3 @  N04  !D              ("!
MI.,! 'AL+W=O<FMS:&5E=',O<VAE970X-BYX;6Q02P$"% ,4    " #R@[M4
MW?#Q4%4"  "W!0  &0              @($NY@$ >&PO=V]R:W-H965T<R]S
M:&5E=#@W+GAM;%!+ 0(4 Q0    ( /*#NU0ZSB8I'0(  -\$   9
M      " @;KH 0!X;"]W;W)K<VAE971S+W-H965T.#@N>&UL4$L! A0#%
M  @ \H.[5/+3/DP, P  " H  !D              ("!#NL! 'AL+W=O<FMS
M:&5E=',O<VAE970X.2YX;6Q02P$"% ,4    " #R@[M4\<TY6E\#   (%P
M#0              @ %1[@$ >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( /*#
MNU27BKL<P    !,"   +              "  =OQ 0!?<F5L<R\N<F5L<U!+
M 0(4 Q0    ( /*#NU28HTK^T08  )TZ   /              "  <3R 0!X
M;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #R@[M4.&5KYYH"  !R-   &@
M            @ '"^0$ >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"
M% ,4    " #R@[M4IY'J63<"  #?,@  $P              @ &4_ $ 6T-O
F;G1E;G1?5'EP97-=+GAM;%!+!08     80!A )X:  #\_@$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>311</ContextCount>
  <ElementCount>454</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>88</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>9</UnitCount>
  <MyReports>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0002002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1001003 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1002004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1003005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1004006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1005007 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1006008 - Statement - CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>1007009 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - DESCRIPTION OF BUSINESS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/DESCRIPTIONOFBUSINESS</Role>
      <ShortName>DESCRIPTION OF BUSINESS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - Summary Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/SummarySignificantAccountingPolicies</Role>
      <ShortName>Summary Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2109103 - Disclosure - Revenue Recognition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/RevenueRecognition</Role>
      <ShortName>Revenue Recognition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2114104 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/Investments</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2119105 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2122106 - Disclosure - Property and Equipment, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/PropertyandEquipmentNet</Role>
      <ShortName>Property and Equipment, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2126107 - Disclosure - Accrued Expenses and Other Current Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilities</Role>
      <ShortName>Accrued Expenses and Other Current Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2129108 - Disclosure - Business Combinations, Intangible Assets, and Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwill</Role>
      <ShortName>Business Combinations, Intangible Assets, and Goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2135109 - Disclosure - Redeemable Convertible Preferred Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/RedeemableConvertiblePreferredStock</Role>
      <ShortName>Redeemable Convertible Preferred Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2139110 - Disclosure - Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/Equity</Role>
      <ShortName>Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2156111 - Disclosure - Net Income Per Share Attributable to Common Stockholders</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholders</Role>
      <ShortName>Net Income Per Share Attributable to Common Stockholders</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2160112 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2167113 - Disclosure - Commitment and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/CommitmentandContingencies</Role>
      <ShortName>Commitment and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2169114 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2175115 - Disclosure - Employee Benefit Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/EmployeeBenefitPlan</Role>
      <ShortName>Employee Benefit Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2177116 - Disclosure - Segment and Geographic Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/SegmentandGeographicInformation</Role>
      <ShortName>Segment and Geographic Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2179117 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2204201 - Disclosure - Summary Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.doximity.com/role/SummarySignificantAccountingPolicies</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Summary Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/SummarySignificantAccountingPoliciesTables</Role>
      <ShortName>Summary Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.doximity.com/role/SummarySignificantAccountingPolicies</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2310302 - Disclosure - Revenue Recognition (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/RevenueRecognitionTables</Role>
      <ShortName>Revenue Recognition (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.doximity.com/role/RevenueRecognition</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2315303 - Disclosure - Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/InvestmentsTables</Role>
      <ShortName>Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.doximity.com/role/Investments</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2320304 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.doximity.com/role/FairValueMeasurements</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2323305 - Disclosure - Property and Equipment, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/PropertyandEquipmentNetTables</Role>
      <ShortName>Property and Equipment, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.doximity.com/role/PropertyandEquipmentNet</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2327306 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables</Role>
      <ShortName>Accrued Expenses and Other Current Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilities</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2330307 - Disclosure - Business Combinations, Intangible Assets, and Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillTables</Role>
      <ShortName>Business Combinations, Intangible Assets, and Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwill</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2336308 - Disclosure - Redeemable Convertible Preferred Stock (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/RedeemableConvertiblePreferredStockTables</Role>
      <ShortName>Redeemable Convertible Preferred Stock (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.doximity.com/role/RedeemableConvertiblePreferredStock</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2340309 - Disclosure - Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/EquityTables</Role>
      <ShortName>Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.doximity.com/role/Equity</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2357310 - Disclosure - Net Income Per Share Attributable to Common Stockholders (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersTables</Role>
      <ShortName>Net Income Per Share Attributable to Common Stockholders (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholders</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2361311 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.doximity.com/role/IncomeTaxes</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2370312 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.doximity.com/role/Leases</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2402401 - Disclosure - DESCRIPTION OF BUSINESS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/DESCRIPTIONOFBUSINESSDetails</Role>
      <ShortName>DESCRIPTION OF BUSINESS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.doximity.com/role/DESCRIPTIONOFBUSINESS</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - Summary of Significant Accounting Policies- Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies- Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - Summary of significant Accounting Policies- Significant Customers Representing 10% or more of Revenue or Accounts Receivable, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails</Role>
      <ShortName>Summary of significant Accounting Policies- Significant Customers Representing 10% or more of Revenue or Accounts Receivable, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2408404 - Disclosure - Summary of Significant Accounting Policies- Property, plant and equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesPropertyplantandequipmentDetails</Role>
      <ShortName>Summary of Significant Accounting Policies- Property, plant and equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2411405 - Disclosure - Revenue Recognition - Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/RevenueRecognitionDisaggregationofRevenueDetails</Role>
      <ShortName>Revenue Recognition - Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2412406 - Disclosure - Revenue Recognition - Deferred Revenue Contract Balance (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/RevenueRecognitionDeferredRevenueContractBalanceDetails</Role>
      <ShortName>Revenue Recognition - Deferred Revenue Contract Balance (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2413407 - Disclosure - Revenue Recognition - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/RevenueRecognitionNarrativeDetails</Role>
      <ShortName>Revenue Recognition - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2416408 - Disclosure - Investments - Cost, Gross Unrealized Gains and Losses, and Fair Value of Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails</Role>
      <ShortName>Investments - Cost, Gross Unrealized Gains and Losses, and Fair Value of Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2417409 - Disclosure - Investments - Contractual Maturities of Available-For-Sale Debt Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/InvestmentsContractualMaturitiesofAvailableForSaleDebtSecuritiesDetails</Role>
      <ShortName>Investments - Contractual Maturities of Available-For-Sale Debt Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2418410 - Disclosure - Investments - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/InvestmentsNarrativeDetails</Role>
      <ShortName>Investments - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2421411 - Disclosure - Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/FairValueMeasurementsDetails</Role>
      <ShortName>Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.doximity.com/role/FairValueMeasurementsTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2424412 - Disclosure - Property and Equipment, Net - Total Property and Equipment, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails</Role>
      <ShortName>Property and Equipment, Net - Total Property and Equipment, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2425413 - Disclosure - Property and Equipment, Net - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/PropertyandEquipmentNetNarrativeDetails</Role>
      <ShortName>Property and Equipment, Net - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2428414 - Disclosure - Accrued Expenses and Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails</Role>
      <ShortName>Accrued Expenses and Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2431415 - Disclosure - Business Combinations, Intangible Assets, and Goodwill - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillNarrativeDetails</Role>
      <ShortName>Business Combinations, Intangible Assets, and Goodwill - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillTables</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2432416 - Disclosure - Business Combinations, Intangible Assets, and Goodwill - Purchase Consideration Allocation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillPurchaseConsiderationAllocationDetails</Role>
      <ShortName>Business Combinations, Intangible Assets, and Goodwill - Purchase Consideration Allocation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2433417 - Disclosure - Business Combinations, Intangible Assets, and Goodwill - Intangible Assets, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillIntangibleAssetsNetDetails</Role>
      <ShortName>Business Combinations, Intangible Assets, and Goodwill - Intangible Assets, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2434418 - Disclosure - Business Combinations, Intangible Assets, and Goodwill - Future Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillFutureAmortizationExpenseDetails</Role>
      <ShortName>Business Combinations, Intangible Assets, and Goodwill - Future Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2437419 - Disclosure - Redeemable Convertible Preferred Stock - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails</Role>
      <ShortName>Redeemable Convertible Preferred Stock - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2438420 - Disclosure - Redeemable Convertible Preferred Stock - Summary of Redeemable Convertible Preferred Stock Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockOutstandingDetails</Role>
      <ShortName>Redeemable Convertible Preferred Stock - Summary of Redeemable Convertible Preferred Stock Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2441421 - Disclosure - Equity - Preferred Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/EquityPreferredStockDetails</Role>
      <ShortName>Equity - Preferred Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2442422 - Disclosure - Equity - Common Stock and Creation of Dual-Class Structure (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/EquityCommonStockandCreationofDualClassStructureDetails</Role>
      <ShortName>Equity - Common Stock and Creation of Dual-Class Structure (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2443423 - Disclosure - Equity - Common Stock Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/EquityCommonStockWarrantsDetails</Role>
      <ShortName>Equity - Common Stock Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2444424 - Disclosure - Equity - Equity Incentive Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/EquityEquityIncentivePlansDetails</Role>
      <ShortName>Equity - Equity Incentive Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2445425 - Disclosure - Equity - Common Stock Reserved for Issuance (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails</Role>
      <ShortName>Equity - Common Stock Reserved for Issuance (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2446426 - Disclosure - Equity - Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/EquityStockOptionActivityDetails</Role>
      <ShortName>Equity - Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2447427 - Disclosure - Equity - Stock Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/EquityStockOptionsDetails</Role>
      <ShortName>Equity - Stock Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2448428 - Disclosure - Equity - Stock Options Valuation Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails</Role>
      <ShortName>Equity - Stock Options Valuation Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2449429 - Disclosure - Equity - Performance-Based Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/EquityPerformanceBasedOptionsDetails</Role>
      <ShortName>Equity - Performance-Based Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2450430 - Disclosure - Equity - Restricted Stock Units (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/EquityRestrictedStockUnitsDetails</Role>
      <ShortName>Equity - Restricted Stock Units (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2451431 - Disclosure - Equity - Restricted Stock Unit Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails</Role>
      <ShortName>Equity - Restricted Stock Unit Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2452432 - Disclosure - Equity - Performance-Based Restricted Stock Units (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsDetails</Role>
      <ShortName>Equity - Performance-Based Restricted Stock Units (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2453433 - Disclosure - Equity - Employee Stock Purchase Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/EquityEmployeeStockPurchasePlanDetails</Role>
      <ShortName>Equity - Employee Stock Purchase Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2454434 - Disclosure - Equity - Employee Stock Purchase Plan Valuation Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/EquityEmployeeStockPurchasePlanValuationAssumptionsDetails</Role>
      <ShortName>Equity - Employee Stock Purchase Plan Valuation Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2455435 - Disclosure - Equity - Stock-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/EquityStockBasedCompensationExpenseDetails</Role>
      <ShortName>Equity - Stock-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2458436 - Disclosure - Net Income Per Share Attributable to Common Stockholders- Schedule of Earnings Per Share, Basic and Diluted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails</Role>
      <ShortName>Net Income Per Share Attributable to Common Stockholders- Schedule of Earnings Per Share, Basic and Diluted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2459437 - Disclosure - Net Income Per Share Attributable to Common Stockholders -Antidilutive Securities Excluded from Computation of Net Income Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersAntidilutiveSecuritiesExcludedfromComputationofNetIncomePerShareDetails</Role>
      <ShortName>Net Income Per Share Attributable to Common Stockholders -Antidilutive Securities Excluded from Computation of Net Income Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>2462438 - Disclosure - Income Taxes - Schedule of Income Tax Expense Benefit (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails</Role>
      <ShortName>Income Taxes - Schedule of Income Tax Expense Benefit (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>2463439 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails</Role>
      <ShortName>Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>2464440 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>2465441 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>2466442 - Disclosure - Income Taxes - Summary of Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/IncomeTaxesSummaryofUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes - Summary of Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>2468443 - Disclosure - Commitment and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/CommitmentandContingenciesDetails</Role>
      <ShortName>Commitment and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.doximity.com/role/CommitmentandContingencies</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>2471444 - Disclosure - Leases - Components of Lease Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/LeasesComponentsofLeaseExpenseDetails</Role>
      <ShortName>Leases - Components of Lease Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>2472445 - Disclosure - Leases - Supplemental Cash Flow Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/LeasesSupplementalCashFlowInformationDetails</Role>
      <ShortName>Leases - Supplemental Cash Flow Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>2473446 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/LeasesSupplementalBalanceSheetInformationDetails</Role>
      <ShortName>Leases - Supplemental Balance Sheet Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>2474447 - Disclosure - Leases - Maturities of Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails</Role>
      <ShortName>Leases - Maturities of Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>2476448 - Disclosure - Employee Benefit Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/EmployeeBenefitPlanDetails</Role>
      <ShortName>Employee Benefit Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.doximity.com/role/EmployeeBenefitPlan</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>2478449 - Disclosure - Segment and Geographic Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/SegmentandGeographicInformationDetails</Role>
      <ShortName>Segment and Geographic Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.doximity.com/role/SegmentandGeographicInformation</ParentRole>
      <Position>88</Position>
    </Report>
    <Report instance="docs-20220331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>2480450 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.doximity.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.doximity.com/role/SubsequentEvents</ParentRole>
      <Position>89</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="docs-20220331.htm">docs-20220331.htm</File>
    <File>docs-20220331.xsd</File>
    <File>docs-20220331_cal.xml</File>
    <File>docs-20220331_def.xml</File>
    <File>docs-20220331_lab.xml</File>
    <File>docs-20220331_pre.xml</File>
    <File>exhibit103-2021stockoption.htm</File>
    <File>exhibit211-listofsubsidiar.htm</File>
    <File>exhibit231-consentfy22.htm</File>
    <File>exhibit31133122.htm</File>
    <File>exhibit31233122.htm</File>
    <File>exhibit32133122.htm</File>
    <File>exhibit32233122.htm</File>
    <File>exhibit43-descriptionofsec.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>docs-20220331_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1143">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="40">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>112
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "docs-20220331.htm": {
   "axisCustom": 0,
   "axisStandard": 31,
   "contextCount": 311,
   "dts": {
    "calculationLink": {
     "local": [
      "docs-20220331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "docs-20220331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "docs-20220331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "docs-20220331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "docs-20220331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "docs-20220331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 694,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 4,
    "total": 4
   },
   "keyCustom": 60,
   "keyStandard": 394,
   "memberCustom": 25,
   "memberStandard": 59,
   "nsprefix": "docs",
   "nsuri": "http://www.doximity.com/20220331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.doximity.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - DESCRIPTION OF BUSINESS",
     "role": "http://www.doximity.com/role/DESCRIPTIONOFBUSINESS",
     "shortName": "DESCRIPTION OF BUSINESS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - Summary Significant Accounting Policies",
     "role": "http://www.doximity.com/role/SummarySignificantAccountingPolicies",
     "shortName": "Summary Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2109103 - Disclosure - Revenue Recognition",
     "role": "http://www.doximity.com/role/RevenueRecognition",
     "shortName": "Revenue Recognition",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2114104 - Disclosure - Investments",
     "role": "http://www.doximity.com/role/Investments",
     "shortName": "Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2119105 - Disclosure - Fair Value Measurements",
     "role": "http://www.doximity.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2122106 - Disclosure - Property and Equipment, Net",
     "role": "http://www.doximity.com/role/PropertyandEquipmentNet",
     "shortName": "Property and Equipment, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "docs:AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2126107 - Disclosure - Accrued Expenses and Other Current Liabilities",
     "role": "http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilities",
     "shortName": "Accrued Expenses and Other Current Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "docs:AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "docs:BusinessCombinationGoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2129108 - Disclosure - Business Combinations, Intangible Assets, and Goodwill",
     "role": "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwill",
     "shortName": "Business Combinations, Intangible Assets, and Goodwill",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "docs:BusinessCombinationGoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "docs:TemporaryEquityTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2135109 - Disclosure - Redeemable Convertible Preferred Stock",
     "role": "http://www.doximity.com/role/RedeemableConvertiblePreferredStock",
     "shortName": "Redeemable Convertible Preferred Stock",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "docs:TemporaryEquityTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2139110 - Disclosure - Equity",
     "role": "http://www.doximity.com/role/Equity",
     "shortName": "Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0002002 - Document - Audit Information",
     "role": "http://www.doximity.com/role/AuditInformation",
     "shortName": "Audit Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2156111 - Disclosure - Net Income Per Share Attributable to Common Stockholders",
     "role": "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholders",
     "shortName": "Net Income Per Share Attributable to Common Stockholders",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2160112 - Disclosure - Income Taxes",
     "role": "http://www.doximity.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2167113 - Disclosure - Commitment and Contingencies",
     "role": "http://www.doximity.com/role/CommitmentandContingencies",
     "shortName": "Commitment and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2169114 - Disclosure - Leases",
     "role": "http://www.doximity.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2175115 - Disclosure - Employee Benefit Plan",
     "role": "http://www.doximity.com/role/EmployeeBenefitPlan",
     "shortName": "Employee Benefit Plan",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2177116 - Disclosure - Segment and Geographic Information",
     "role": "http://www.doximity.com/role/SegmentandGeographicInformation",
     "shortName": "Segment and Geographic Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2179117 - Disclosure - Subsequent Events",
     "role": "http://www.doximity.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2204201 - Disclosure - Summary Significant Accounting Policies (Policies)",
     "role": "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies",
     "shortName": "Summary Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - Summary Significant Accounting Policies (Tables)",
     "role": "http://www.doximity.com/role/SummarySignificantAccountingPoliciesTables",
     "shortName": "Summary Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2310302 - Disclosure - Revenue Recognition (Tables)",
     "role": "http://www.doximity.com/role/RevenueRecognitionTables",
     "shortName": "Revenue Recognition (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001003 - Statement - CONSOLIDATED BALANCE SHEETS",
     "role": "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2315303 - Disclosure - Investments (Tables)",
     "role": "http://www.doximity.com/role/InvestmentsTables",
     "shortName": "Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2320304 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.doximity.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2323305 - Disclosure - Property and Equipment, Net (Tables)",
     "role": "http://www.doximity.com/role/PropertyandEquipmentNetTables",
     "shortName": "Property and Equipment, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": null
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "docs:ScheduleOfAccruedLiabilitiesCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2327306 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)",
     "role": "http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables",
     "shortName": "Accrued Expenses and Other Current Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "docs:ScheduleOfAccruedLiabilitiesCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2330307 - Disclosure - Business Combinations, Intangible Assets, and Goodwill (Tables)",
     "role": "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillTables",
     "shortName": "Business Combinations, Intangible Assets, and Goodwill (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2336308 - Disclosure - Redeemable Convertible Preferred Stock (Tables)",
     "role": "http://www.doximity.com/role/RedeemableConvertiblePreferredStockTables",
     "shortName": "Redeemable Convertible Preferred Stock (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2340309 - Disclosure - Equity (Tables)",
     "role": "http://www.doximity.com/role/EquityTables",
     "shortName": "Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2357310 - Disclosure - Net Income Per Share Attributable to Common Stockholders (Tables)",
     "role": "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersTables",
     "shortName": "Net Income Per Share Attributable to Common Stockholders (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2361311 - Disclosure - Income Taxes (Tables)",
     "role": "http://www.doximity.com/role/IncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2370312 - Disclosure - Leases (Tables)",
     "role": "http://www.doximity.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i62c961053180495bb8eed126ddb4d43b_D20210601-20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "docs:ConversionOfStockConversionRatio",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402401 - Disclosure - DESCRIPTION OF BUSINESS (Details)",
     "role": "http://www.doximity.com/role/DESCRIPTIONOFBUSINESSDetails",
     "shortName": "DESCRIPTION OF BUSINESS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "iaca56ad88a7f461f9aa0ca6977c6c5a1_I20210630",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DeferredOfferingCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdvertisingExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - Summary of Significant Accounting Policies- Narrative (Details)",
     "role": "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Summary of Significant Accounting Policies- Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdvertisingExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i3c255afc92154f4c84be5e86a09930da_D20200401-20210331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - Summary of significant Accounting Policies- Significant Customers Representing 10% or more of Revenue or Accounts Receivable, Net (Details)",
     "role": "http://www.doximity.com/role/SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails",
     "shortName": "Summary of significant Accounting Policies- Significant Customers Representing 10% or more of Revenue or Accounts Receivable, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i3c255afc92154f4c84be5e86a09930da_D20200401-20210331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i8a0e1d9ff3f146f5a3c9a2720e716d4c_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408404 - Disclosure - Summary of Significant Accounting Policies- Property, plant and equipment (Details)",
     "role": "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesPropertyplantandequipmentDetails",
     "shortName": "Summary of Significant Accounting Policies- Property, plant and equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i8a0e1d9ff3f146f5a3c9a2720e716d4c_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411405 - Disclosure - Revenue Recognition - Disaggregation of Revenue (Details)",
     "role": "http://www.doximity.com/role/RevenueRecognitionDisaggregationofRevenueDetails",
     "shortName": "Revenue Recognition - Disaggregation of Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i75a13b9faa46498d802095eeb320936a_D20210401-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i5fbc45340fb149a4a4218570cd8171e7_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412406 - Disclosure - Revenue Recognition - Deferred Revenue Contract Balance (Details)",
     "role": "http://www.doximity.com/role/RevenueRecognitionDeferredRevenueContractBalanceDetails",
     "shortName": "Revenue Recognition - Deferred Revenue Contract Balance (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i7a15f5b31d42419aa50ffb53e76f3705_I20200331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnbilledReceivablesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413407 - Disclosure - Revenue Recognition - Narrative (Details)",
     "role": "http://www.doximity.com/role/RevenueRecognitionNarrativeDetails",
     "shortName": "Revenue Recognition - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnbilledReceivablesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i5fbc45340fb149a4a4218570cd8171e7_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416408 - Disclosure - Investments - Cost, Gross Unrealized Gains and Losses, and Fair Value of Investments (Details)",
     "role": "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails",
     "shortName": "Investments - Cost, Gross Unrealized Gains and Losses, and Fair Value of Investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i5fbc45340fb149a4a4218570cd8171e7_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417409 - Disclosure - Investments - Contractual Maturities of Available-For-Sale Debt Securities (Details)",
     "role": "http://www.doximity.com/role/InvestmentsContractualMaturitiesofAvailableForSaleDebtSecuritiesDetails",
     "shortName": "Investments - Contractual Maturities of Available-For-Sale Debt Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418410 - Disclosure - Investments - Narrative (Details)",
     "role": "http://www.doximity.com/role/InvestmentsNarrativeDetails",
     "shortName": "Investments - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421411 - Disclosure - Fair Value Measurements (Details)",
     "role": "http://www.doximity.com/role/FairValueMeasurementsDetails",
     "shortName": "Fair Value Measurements (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "ie03e89c5126d41ec830e87d4165cf777_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleExcludingAccruedInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424412 - Disclosure - Property and Equipment, Net - Total Property and Equipment, Net (Details)",
     "role": "http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails",
     "shortName": "Property and Equipment, Net - Total Property and Equipment, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425413 - Disclosure - Property and Equipment, Net - Narrative (Details)",
     "role": "http://www.doximity.com/role/PropertyandEquipmentNetNarrativeDetails",
     "shortName": "Property and Equipment, Net - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "docs:ScheduleOfAccruedLiabilitiesCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedSalesCommissionCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428414 - Disclosure - Accrued Expenses and Other Current Liabilities (Details)",
     "role": "http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails",
     "shortName": "Accrued Expenses and Other Current Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "docs:ScheduleOfAccruedLiabilitiesCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedSalesCommissionCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDivestitureOfBusinesses",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431415 - Disclosure - Business Combinations, Intangible Assets, and Goodwill - Narrative (Details)",
     "role": "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillNarrativeDetails",
     "shortName": "Business Combinations, Intangible Assets, and Goodwill - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432416 - Disclosure - Business Combinations, Intangible Assets, and Goodwill - Purchase Consideration Allocation (Details)",
     "role": "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillPurchaseConsiderationAllocationDetails",
     "shortName": "Business Combinations, Intangible Assets, and Goodwill - Purchase Consideration Allocation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i79a66d68c93b4bd0b2886189e06be17c_I20200401",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433417 - Disclosure - Business Combinations, Intangible Assets, and Goodwill - Intangible Assets, Net (Details)",
     "role": "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillIntangibleAssetsNetDetails",
     "shortName": "Business Combinations, Intangible Assets, and Goodwill - Intangible Assets, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434418 - Disclosure - Business Combinations, Intangible Assets, and Goodwill - Future Amortization Expense (Details)",
     "role": "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillFutureAmortizationExpenseDetails",
     "shortName": "Business Combinations, Intangible Assets, and Goodwill - Future Amortization Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i5fbc45340fb149a4a4218570cd8171e7_I20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "docs:TemporaryEquityPreferredStockOutstandingSeries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "series",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437419 - Disclosure - Redeemable Convertible Preferred Stock - Narrative (Details)",
     "role": "http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails",
     "shortName": "Redeemable Convertible Preferred Stock - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i5fbc45340fb149a4a4218570cd8171e7_I20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "docs:TemporaryEquityPreferredStockOutstandingSeries",
      "reportCount": 1,
      "unique": true,
      "unitRef": "series",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquitySharesAuthorized",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438420 - Disclosure - Redeemable Convertible Preferred Stock - Summary of Redeemable Convertible Preferred Stock Outstanding (Details)",
     "role": "http://www.doximity.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockOutstandingDetails",
     "shortName": "Redeemable Convertible Preferred Stock - Summary of Redeemable Convertible Preferred Stock Outstanding (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:TemporaryEquityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i0d10847a28e64727936c5a6f5e2e80a5_I20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquitySharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "role": "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441421 - Disclosure - Equity - Preferred Stock (Details)",
     "role": "http://www.doximity.com/role/EquityPreferredStockDetails",
     "shortName": "Equity - Preferred Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "iaca56ad88a7f461f9aa0ca6977c6c5a1_I20210630",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442422 - Disclosure - Equity - Common Stock and Creation of Dual-Class Structure (Details)",
     "role": "http://www.doximity.com/role/EquityCommonStockandCreationofDualClassStructureDetails",
     "shortName": "Equity - Common Stock and Creation of Dual-Class Structure (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "ib043fb4bcadb409c9fa4b0e1104a5b1d_I20210608",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443423 - Disclosure - Equity - Common Stock Warrants (Details)",
     "role": "http://www.doximity.com/role/EquityCommonStockWarrantsDetails",
     "shortName": "Equity - Common Stock Warrants (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "ie2075365cb96485192385bf947ef595a_I20170331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444424 - Disclosure - Equity - Equity Incentive Plans (Details)",
     "role": "http://www.doximity.com/role/EquityEquityIncentivePlansDetails",
     "shortName": "Equity - Equity Incentive Plans (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i22d3b66c56b94252a2946d3a502fdae3_D20100401-20100430",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:TemporaryEquitySharesIssued",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquitySharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445425 - Disclosure - Equity - Common Stock Reserved for Issuance (Details)",
     "role": "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails",
     "shortName": "Equity - Common Stock Reserved for Issuance (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i725f9096e258495b86d6aa50c855aaa9_I20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i5fbc45340fb149a4a4218570cd8171e7_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446426 - Disclosure - Equity - Stock Option Activity (Details)",
     "role": "http://www.doximity.com/role/EquityStockOptionActivityDetails",
     "shortName": "Equity - Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447427 - Disclosure - Equity - Stock Options (Details)",
     "role": "http://www.doximity.com/role/EquityStockOptionsDetails",
     "shortName": "Equity - Stock Options (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i31208a9ec3934804b4c4c3c9e4b9ae56_D20210401-20220331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448428 - Disclosure - Equity - Stock Options Valuation Assumptions (Details)",
     "role": "http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails",
     "shortName": "Equity - Stock Options Valuation Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i31208a9ec3934804b4c4c3c9e4b9ae56_D20210401-20220331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449429 - Disclosure - Equity - Performance-Based Options (Details)",
     "role": "http://www.doximity.com/role/EquityPerformanceBasedOptionsDetails",
     "shortName": "Equity - Performance-Based Options (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4d1acfbd8dc54fa9b2bcb6aafeb4d7f5_D20210401-20220331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450430 - Disclosure - Equity - Restricted Stock Units (Details)",
     "role": "http://www.doximity.com/role/EquityRestrictedStockUnitsDetails",
     "shortName": "Equity - Restricted Stock Units (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "ife196e39e85444efa18e6408b5528324_D20210401-20220331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005007 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical)",
     "role": "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i22cded30244a4dc4b48d2cc92c10c4be_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451431 - Disclosure - Equity - Restricted Stock Unit Activity (Details)",
     "role": "http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails",
     "shortName": "Equity - Restricted Stock Unit Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i22cded30244a4dc4b48d2cc92c10c4be_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2452432 - Disclosure - Equity - Performance-Based Restricted Stock Units (Details)",
     "role": "http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsDetails",
     "shortName": "Equity - Performance-Based Restricted Stock Units (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i117af75205314c998fad1407c682e2d0_D20210401-20220331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2453433 - Disclosure - Equity - Employee Stock Purchase Plan (Details)",
     "role": "http://www.doximity.com/role/EquityEmployeeStockPurchasePlanDetails",
     "shortName": "Equity - Employee Stock Purchase Plan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "id49a07de8105430d9e5b763fa04c9419_D20210401-20220331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "id49a07de8105430d9e5b763fa04c9419_D20210401-20220331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454434 - Disclosure - Equity - Employee Stock Purchase Plan Valuation Assumptions (Details)",
     "role": "http://www.doximity.com/role/EquityEmployeeStockPurchasePlanValuationAssumptionsDetails",
     "shortName": "Equity - Employee Stock Purchase Plan Valuation Assumptions (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "id49a07de8105430d9e5b763fa04c9419_D20210401-20220331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455435 - Disclosure - Equity - Stock-Based Compensation Expense (Details)",
     "role": "http://www.doximity.com/role/EquityStockBasedCompensationExpenseDetails",
     "shortName": "Equity - Stock-Based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "ifc62a205668f49b9bf71eefe850ffc3f_D20210401-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2458436 - Disclosure - Net Income Per Share Attributable to Common Stockholders- Schedule of Earnings Per Share, Basic and Diluted (Details)",
     "role": "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails",
     "shortName": "Net Income Per Share Attributable to Common Stockholders- Schedule of Earnings Per Share, Basic and Diluted (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2459437 - Disclosure - Net Income Per Share Attributable to Common Stockholders -Antidilutive Securities Excluded from Computation of Net Income Per Share (Details)",
     "role": "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersAntidilutiveSecuritiesExcludedfromComputationofNetIncomePerShareDetails",
     "shortName": "Net Income Per Share Attributable to Common Stockholders -Antidilutive Securities Excluded from Computation of Net Income Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2462438 - Disclosure - Income Taxes - Schedule of Income Tax Expense Benefit (Details)",
     "role": "http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails",
     "shortName": "Income Taxes - Schedule of Income Tax Expense Benefit (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2463439 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)",
     "role": "http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails",
     "shortName": "Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "docs:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2464440 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)",
     "role": "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails",
     "shortName": "Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "docs:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i27e150c7cdf34baa99d770cedfcc88a0_I20190331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:TemporaryEquitySharesOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006008 - Statement - CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)",
     "role": "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT",
     "shortName": "CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i861e24d19d314064a8c1591848e5a762_D20190401-20200331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "docs:TemporaryEquityExercisesOfWarrantsShares",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2465441 - Disclosure - Income Taxes - Narrative (Details)",
     "role": "http://www.doximity.com/role/IncomeTaxesNarrativeDetails",
     "shortName": "Income Taxes - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i5fbc45340fb149a4a4218570cd8171e7_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2466442 - Disclosure - Income Taxes - Summary of Unrecognized Tax Benefits (Details)",
     "role": "http://www.doximity.com/role/IncomeTaxesSummaryofUnrecognizedTaxBenefitsDetails",
     "shortName": "Income Taxes - Summary of Unrecognized Tax Benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "iaca56ad88a7f461f9aa0ca6977c6c5a1_I20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2468443 - Disclosure - Commitment and Contingencies (Details)",
     "role": "http://www.doximity.com/role/CommitmentandContingenciesDetails",
     "shortName": "Commitment and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "iaca56ad88a7f461f9aa0ca6977c6c5a1_I20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2471444 - Disclosure - Leases - Components of Lease Expense (Details)",
     "role": "http://www.doximity.com/role/LeasesComponentsofLeaseExpenseDetails",
     "shortName": "Leases - Components of Lease Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2472445 - Disclosure - Leases - Supplemental Cash Flow Information (Details)",
     "role": "http://www.doximity.com/role/LeasesSupplementalCashFlowInformationDetails",
     "shortName": "Leases - Supplemental Cash Flow Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2473446 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)",
     "role": "http://www.doximity.com/role/LeasesSupplementalBalanceSheetInformationDetails",
     "shortName": "Leases - Supplemental Balance Sheet Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2474447 - Disclosure - Leases - Maturities of Lease Liabilities (Details)",
     "role": "http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails",
     "shortName": "Leases - Maturities of Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "ie3e9a674f7db4089b1639e59d3b4fd6b_I20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2476448 - Disclosure - Employee Benefit Plan (Details)",
     "role": "http://www.doximity.com/role/EmployeeBenefitPlanDetails",
     "shortName": "Employee Benefit Plan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2478449 - Disclosure - Segment and Geographic Information (Details)",
     "role": "http://www.doximity.com/role/SegmentandGeographicInformationDetails",
     "shortName": "Segment and Geographic Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "id8a49fae532d49d9b87337bacae0b894_I20220512",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2480450 - Disclosure - Subsequent Events (Details)",
     "role": "http://www.doximity.com/role/SubsequentEventsDetails",
     "shortName": "Subsequent Events (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "id8a49fae532d49d9b87337bacae0b894_I20220512",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007009 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "docs-20220331.htm",
      "contextRef": "i4bf94ca799ee4cf5953acb5d49eb1a61_D20210401-20220331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 88,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r659",
      "r660",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.doximity.com/role/AuditInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r659",
      "r660",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.doximity.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r659",
      "r660",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.doximity.com/role/AuditInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r659",
      "r660",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]",
        "terseLabel": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]",
        "terseLabel": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r662"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r657"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r672"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r670"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r656"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r671"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r659",
      "r660",
      "r661"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r658"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://www.doximity.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "docs_AMiONMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "AMiON",
        "label": "AMiON [Member]",
        "terseLabel": "AMiON"
       }
      }
     },
     "localname": "AMiONMember",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "APIC, Share-based Payment Arrangement, Stock Warrant Issued for Services, Increase for Cost Recognition",
        "label": "APIC, Share-based Payment Arrangement, Stock Warrant Issued for Services, Increase for Cost Recognition",
        "terseLabel": "Common stock warrant expense"
       }
      }
     },
     "localname": "APICShareBasedPaymentArrangementStockWarrantIssuedForServicesIncreaseForCostRecognition",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Payable And Accrued Liabilities, Current Disclosure",
        "label": "Accounts Payable And Accrued Liabilities, Current Disclosure [Text Block]",
        "terseLabel": "Accrued Expenses and Other Current Liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesCurrentDisclosureTextBlock",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "docs_AccruedEmployeeStockPurchasePlanCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Employee Stock Purchase Plan, Current",
        "label": "Accrued Employee Stock Purchase Plan, Current",
        "terseLabel": "Employee contributions under employee stock purchase plan"
       }
      }
     },
     "localname": "AccruedEmployeeStockPurchasePlanCurrent",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_AdjustmentsToAdditionalPaidInCapitalExerciseOfWarrants": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments To Additional Paid In Capital, Exercise Of Warrants",
        "label": "Adjustments To Additional Paid In Capital, Exercise Of Warrants",
        "terseLabel": "Exercise of Series B redeemable convertible preferred stock warrants"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalExerciseOfWarrants",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Approved By Board Of Directors, Excluding Equity Incentive Plan 2010 And Stock Option And Incentive Plan 2021",
        "label": "Approved By Board Of Directors, Excluding Equity Incentive Plan 2010 And Stock Option And Incentive Plan 2021 [Member]",
        "terseLabel": "Options outstanding outside the Plans"
       }
      }
     },
     "localname": "ApprovedByBoardOfDirectorsExcludingEquityIncentivePlan2010AndStockOptionAndIncentivePlan2021Member",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails",
      "http://www.doximity.com/role/EquityEquityIncentivePlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_AuditInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Audit Information [Abstract]",
        "label": "Audit Information [Abstract]"
       }
      }
     },
     "localname": "AuditInformationAbstract",
     "nsuri": "http://www.doximity.com/20220331",
     "xbrltype": "stringItemType"
    },
    "docs_BusinessCombinationContingentConsiderationLiabilityPayablePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Liability Payable Period",
        "label": "Business Combination, Contingent Consideration, Liability Payable Period",
        "terseLabel": "Business combination contingent consideration liability payable period"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiabilityPayablePeriod",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Goodwill And Intangible Assets Disclosure",
        "label": "Business Combination, Goodwill And Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationGoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://www.doximity.com/20220331",
     "xbrltype": "stringItemType"
    },
    "docs_BusinessCombinationGoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Goodwill And Intangible Assets Disclosure",
        "label": "Business Combination, Goodwill And Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Business Combinations, Intangible Assets, and Goodwill"
       }
      }
     },
     "localname": "BusinessCombinationGoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwill"
     ],
     "xbrltype": "textBlockItemType"
    },
    "docs_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther": {
     "auth_ref": [],
     "calculation": {
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillPurchaseConsiderationAllocationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Assets, Other",
        "label": "Business Combination, Recognized Identifiable Assets Acquired And Liabilities Assumed, Assets, Other",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsOther",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillPurchaseConsiderationAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_CapitalizedContractCostAdditions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capitalized Contract Cost, Additions",
        "label": "Capitalized Contract Cost, Additions",
        "terseLabel": "Capitalized contract acquisition costs"
       }
      }
     },
     "localname": "CapitalizedContractCostAdditions",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash and Cash Equivalents and Short Term Investments, Amortized Cost",
        "label": "Cash and Cash Equivalents and Short Term Investments, Amortized Cost",
        "totalLabel": "Cost or Amortized Cost, cash equivalents and marketable securities"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash, Cash Equivalent And Marketable Securities",
        "label": "Cash, Cash Equivalent And Marketable Securities [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalent and Marketable Securities"
       }
      }
     },
     "localname": "CashCashEquivalentAndMarketableSecuritiesPolicyTextBlock",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Capital Shares Reserved For Future Issuance, Maximum Annual Increase",
        "label": "Common Stock, Capital Shares Reserved For Future Issuance, Maximum Annual Increase",
        "terseLabel": "Maximum annual increase of shares reserved for future issuance (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncrease",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/EquityEquityIncentivePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "docs_CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Capital Shares Reserved For Future Issuance, Maximum Annual Increase As A Percentage Of Common Stock Outstanding",
        "label": "Common Stock, Capital Shares Reserved For Future Issuance, Maximum Annual Increase As A Percentage Of Common Stock Outstanding",
        "terseLabel": "Maximum annual increase of shares reserved for future issuance as a percentage of common stock outstanding"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuanceMaximumAnnualIncreaseAsAPercentageOfCommonStockOutstanding",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/EquityEquityIncentivePlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "docs_CommonStockHoldingMajorityNumberOfElectedBoardMembersPermitted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Holding Majority, Number of Elected Board Members Permitted",
        "label": "Common Stock, Holding Majority, Number of Elected Board Members Permitted",
        "terseLabel": "Common stock, holding majority, number of board of director members entitled to elect"
       }
      }
     },
     "localname": "CommonStockHoldingMajorityNumberOfElectedBoardMembersPermitted",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "docs_CommonStockVotingRightsNumberOfVotes": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Voting Rights, Number Of Votes",
        "label": "Common Stock, Voting Rights, Number Of Votes",
        "terseLabel": "Common stock, number of votes per share"
       }
      }
     },
     "localname": "CommonStockVotingRightsNumberOfVotes",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockandCreationofDualClassStructureDetails",
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "docs_ComputerEquipmentAndSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Computer Equipment and Software",
        "label": "Computer Equipment and Software [Member]",
        "terseLabel": "Computers and software"
       }
      }
     },
     "localname": "ComputerEquipmentAndSoftwareMember",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails",
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesPropertyplantandequipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_ContractWithCustomerCancellationNoticePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Cancellation, Notice Period",
        "label": "Contract With Customer, Cancellation, Notice Period",
        "terseLabel": "Contract with customer, cancellation period"
       }
      }
     },
     "localname": "ContractWithCustomerCancellationNoticePeriod",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "docs_ContractWithCustomerLiabilityAdditionsNet": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Liability, Additions, Net",
        "label": "Contract With Customer, Liability, Additions, Net",
        "terseLabel": "Additions, net, during the period"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityAdditionsNet",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/RevenueRecognitionDeferredRevenueContractBalanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with Customer, Liability, Revenue Recognized, Excluding Opening Balance",
        "label": "Contract with Customer, Liability, Revenue Recognized, Excluding Opening Balance",
        "negatedTerseLabel": "Revenue recognized from contracts invoiced during the period"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognizedExcludingOpeningBalance",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/RevenueRecognitionDeferredRevenueContractBalanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_ContractWithCustomerTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With Customer, Term",
        "label": "Contract With Customer, Term",
        "terseLabel": "Contractual terms"
       }
      }
     },
     "localname": "ContractWithCustomerTerm",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "docs_ContractWithUSNewsWorldReportLPMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract With U S News World Report L P",
        "label": "Contract With U S News World Report L P [Member]",
        "terseLabel": "Contract With U S News World Report L P"
       }
      }
     },
     "localname": "ContractWithUSNewsWorldReportLPMember",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockWarrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_ConversionOfStockConversionRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Conversion Of Stock, Conversion Ratio",
        "label": "Conversion Of Stock, Conversion Ratio",
        "terseLabel": "Conversion of stock conversion ratio"
       }
      }
     },
     "localname": "ConversionOfStockConversionRatio",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.doximity.com/role/EquityCommonStockandCreationofDualClassStructureDetails",
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "docs_CustomerAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer A",
        "label": "Customer A [Member]",
        "terseLabel": "Customer A"
       }
      }
     },
     "localname": "CustomerAMember",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughThree": {
     "auth_ref": [],
     "calculation": {
      "http://www.doximity.com/role/InvestmentsContractualMaturitiesofAvailableForSaleDebtSecuritiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-For-Sale, Fair Value, Maturity, Allocated And Single Maturity Date, After Year One Through Three",
        "label": "Debt Securities, Available-For-Sale, Fair Value, Maturity, Allocated And Single Maturity Date, After Year One Through Three",
        "terseLabel": "Due in one year to three years"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleFairValueMaturityAllocatedAndSingleMaturityDateAfterYearOneThroughThree",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/InvestmentsContractualMaturitiesofAvailableForSaleDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_DebtSecuritiesAvailableForSaleImpairmentsLoss": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available-for-sale, Impairments Loss",
        "label": "Debt Securities, Available-for-sale, Impairments Loss",
        "terseLabel": "Debt securities impairments loss"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleImpairmentsLoss",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_DebtSecuritiesAvailableForSaleWithNoCreditAllowance": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Securities, Available For Sale, With No Credit Allowance",
        "label": "Debt Securities, Available For Sale, With No Credit Allowance",
        "terseLabel": "Fair value of debt securities which no credit losses were recognized"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleWithNoCreditAllowance",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Commissions For Marketing Solutions Contracts And For Hiring Solutions Renewal Contracts",
        "label": "Deferred Commissions For Marketing Solutions Contracts And For Hiring Solutions Renewal Contracts [Member]",
        "terseLabel": "Deferred Commissions For Marketing Solutions Contracts And For Hiring Solutions Renewal Contracts"
       }
      }
     },
     "localname": "DeferredCommissionsForMarketingSolutionsContractsAndForHiringSolutionsRenewalContractsMember",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_DeferredTaxAssetsAcquisitionAndOtherRelatedExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Acquisition and Other Related Expense",
        "label": "Deferred Tax Assets, Acquisition and Other Related Expense",
        "terseLabel": "Acquisition and other related expense"
       }
      }
     },
     "localname": "DeferredTaxAssetsAcquisitionAndOtherRelatedExpense",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_DeferredTaxAssetsLeasingArrangements": {
     "auth_ref": [],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Leasing Arrangements",
        "label": "Deferred Tax Assets, Leasing Arrangements",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetsLeasingArrangements",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue": {
     "auth_ref": [],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Revenue",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Deferred Revenue",
        "terseLabel": "Accruals and deferred revenue"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRevenue",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal Group, Including Discontinued Operation, Consideration, Held In Escrow",
        "label": "Disposal Group, Including Discontinued Operation, Consideration, Held In Escrow",
        "terseLabel": "Sale of business consideration, held in escrow"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsiderationHeldInEscrow",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_EmployeeStockPurchasePlan2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee Stock Purchase Plan 2021",
        "label": "Employee Stock Purchase Plan 2021 [Member]",
        "terseLabel": "2021 ESPP"
       }
      }
     },
     "localname": "EmployeeStockPurchasePlan2021Member",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails",
      "http://www.doximity.com/role/EquityEquityIncentivePlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_EquityIncentivePlan2010Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Incentive Plan 2010",
        "label": "Equity Incentive Plan 2010 [Member]",
        "terseLabel": "2010 Plan"
       }
      }
     },
     "localname": "EquityIncentivePlan2010Member",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails",
      "http://www.doximity.com/role/EquityEquityIncentivePlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_EscrowDepositsRelatedToSaleOfBusiness": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Escrow Deposits Related To Sale Of Business",
        "label": "Escrow Deposits Related To Sale Of Business",
        "terseLabel": "Amounts held in escrow related to sale of business"
       }
      }
     },
     "localname": "EscrowDepositsRelatedToSaleOfBusiness",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_FurnitureAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Furniture and Equipment",
        "label": "Furniture and Equipment [Member]",
        "terseLabel": "Furniture and equipment"
       }
      }
     },
     "localname": "FurnitureAndEquipmentMember",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails",
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesPropertyplantandequipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_HostingArrangementAnnualCommitment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hosting Arrangement, Annual Commitment",
        "label": "Hosting Arrangement, Annual Commitment",
        "terseLabel": "Hosting arrangement annual commitment"
       }
      }
     },
     "localname": "HostingArrangementAnnualCommitment",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_HostingArrangementPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hosting Arrangement, Period",
        "label": "Hosting Arrangement, Period",
        "terseLabel": "Hosting arrangement period"
       }
      }
     },
     "localname": "HostingArrangementPeriod",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "docs_IncreaseDecreaseInCapitalizedContractCost": {
     "auth_ref": [],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Capitalized Contract Cost",
        "label": "Increase (Decrease) In Capitalized Contract Cost",
        "negatedTerseLabel": "Deferred contract costs"
       }
      }
     },
     "localname": "IncreaseDecreaseInCapitalizedContractCost",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_IndividualsWithVotingInterestAtThresholdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Individuals With Voting Interest At Threshold",
        "label": "Individuals With Voting Interest At Threshold [Member]",
        "terseLabel": "Individuals With Voting Interest At Threshold"
       }
      }
     },
     "localname": "IndividualsWithVotingInterestAtThresholdMember",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/EquityEquityIncentivePlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_IndividualsWithVotingInterestLessThanThresholdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Individuals With Voting Interest Less Than Threshold",
        "label": "Individuals With Voting Interest Less Than Threshold [Member]",
        "terseLabel": "Individuals With Voting Interest Less Than Threshold"
       }
      }
     },
     "localname": "IndividualsWithVotingInterestLessThanThresholdMember",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/EquityEquityIncentivePlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_InitialPublicOfferingIncludingOverAllotmentOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Initial Public Offering Including Over Allotment Option",
        "label": "Initial Public Offering Including Over Allotment Option [Member]",
        "terseLabel": "Initial Public Offering Including Over Allotment Option"
       }
      }
     },
     "localname": "InitialPublicOfferingIncludingOverAllotmentOptionMember",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/DESCRIPTIONOFBUSINESSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Lease Not Yet Commenced, Undiscounted Amount",
        "label": "Lessee, Operating Lease, Lease Not Yet Commenced, Undiscounted Amount",
        "terseLabel": "Total undiscounted lease payments for lease not yet commenced"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_MarketingAgencyOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Marketing Agency One",
        "label": "Marketing Agency One [Member]",
        "terseLabel": "Marketing Agency One"
       }
      }
     },
     "localname": "MarketingAgencyOneMember",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_OperatingLossCarryforwardsSubjectToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Loss Carryforwards, Subject To Expiration",
        "label": "Operating Loss Carryforwards, Subject To Expiration",
        "terseLabel": "State net operating loss carryforwards subject to expiration"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsSubjectToExpiration",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_OtherShareBasedAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Share-Based Awards",
        "label": "Other Share-Based Awards [Member]",
        "terseLabel": "Other share-based awards"
       }
      }
     },
     "localname": "OtherShareBasedAwardsMember",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersAntidilutiveSecuritiesExcludedfromComputationofNetIncomePerShareDetails",
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Partnership Agreement, Annual Revenue Guarantee To Partnering Company",
        "label": "Partnership Agreement, Annual Revenue Guarantee To Partnering Company",
        "terseLabel": "Partnership agreement, annual revenue guarantee to partnering company"
       }
      }
     },
     "localname": "PartnershipAgreementAnnualRevenueGuaranteeToPartneringCompany",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_PartnershipAgreementExtensionPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Partnership Agreement Extension Period",
        "label": "Partnership Agreement Extension Period",
        "terseLabel": "Partnership agreement, extension period"
       }
      }
     },
     "localname": "PartnershipAgreementExtensionPeriod",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "docs_PartnershipAgreementNoncancelablePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Partnership Agreement Noncancelable Period",
        "label": "Partnership Agreement Noncancelable Period",
        "terseLabel": "Partnership agreement, noncancelable period"
       }
      }
     },
     "localname": "PartnershipAgreementNoncancelablePeriod",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "docs_PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Partnership Agreement, Revenue Guarantee To Partnering Company During Noncancelable Period",
        "label": "Partnership Agreement, Revenue Guarantee To Partnering Company During Noncancelable Period",
        "terseLabel": "Partnership agreement, revenue guarantee during noncancelable period"
       }
      }
     },
     "localname": "PartnershipAgreementRevenueGuaranteeToPartneringCompanyDuringNoncancelablePeriod",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_PartnershipsAgreementPeriodBeforeTerminationIsPermitted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Partnerships Agreement Period Before Termination Is Permitted",
        "label": "Partnerships Agreement Period Before Termination Is Permitted",
        "terseLabel": "Partnerships agreement, period before termination is permitted"
       }
      }
     },
     "localname": "PartnershipsAgreementPeriodBeforeTerminationIsPermitted",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "docs_PerformanceBasedRestrictedStockUnitsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Performance-Based Restricted Stock Units",
        "label": "Performance-Based Restricted Stock Units [Member]",
        "terseLabel": "Performance-Based Restricted Stock Units"
       }
      }
     },
     "localname": "PerformanceBasedRestrictedStockUnitsMember",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails",
      "http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_PortionOfCurativeTalentLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion Of Curative Talent, LLC",
        "label": "Portion Of Curative Talent, LLC [Member]",
        "terseLabel": "Portion Of Curative Talent, LLC"
       }
      }
     },
     "localname": "PortionOfCurativeTalentLLCMember",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_RebateLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rebate Liabilities, Current",
        "label": "Rebate Liabilities, Current",
        "terseLabel": "Rebate liabilities"
       }
      }
     },
     "localname": "RebateLiabilitiesCurrent",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_RedeemableConvertiblePreferredStockWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Convertible Preferred Stock Warrants",
        "label": "Redeemable Convertible Preferred Stock Warrants [Member]",
        "terseLabel": "Redeemable convertible preferred stock warrants"
       }
      }
     },
     "localname": "RedeemableConvertiblePreferredStockWarrantsMember",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales Commissions For Subscriptions Of New And Expansion Hiring Solutions Contracts",
        "label": "Sales Commissions For Subscriptions Of New And Expansion Hiring Solutions Contracts [Member]",
        "terseLabel": "Sales Commissions For Subscriptions Of New And Expansion Hiring Solutions Contracts"
       }
      }
     },
     "localname": "SalesCommissionsForSubscriptionsOfNewAndExpansionHiringSolutionsContractsMember",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_ScheduleOfAccruedLiabilitiesCurrentTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Accrued Liabilities, Current",
        "label": "Schedule Of Accrued Liabilities, Current [Table Text Block]",
        "terseLabel": "Schedule of accrued expenses and other liabilities, current"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesCurrentTableTextBlock",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Granted in Period, Fair Value",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Granted in Period, Fair Value",
        "terseLabel": "Fair value of granted equity instruments"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantedInPeriodFairValue",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Share Price",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Fair Value Assumptions, Share Price",
        "terseLabel": "Fair value of common stock (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSharePrice",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/EquityEmployeeStockPurchasePlanValuationAssumptionsDetails",
      "http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercise Price, Percentage Of Fair Value Of Common Stock",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercise Price, Percentage Of Fair Value Of Common Stock",
        "terseLabel": "Grant exercise price, percentage of estimated fair value of common stock on date of grant (not less than)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePricePercentageOfFairValueOfCommonStock",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/EquityEquityIncentivePlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercised",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercised",
        "terseLabel": "Options exercised (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercised",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/EquityEquityIncentivePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Percentage Of Voting Interests Threshold",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Percentage Of Voting Interests Threshold",
        "terseLabel": "Voting interests threshold"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfVotingInterestsThreshold",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/EquityEquityIncentivePlansDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "docs_ShareBasedCompensationArrangementByShareBasedPaymentAwardPricesPerShareIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Prices Per Share Issued",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Prices Per Share Issued",
        "terseLabel": "Employee stock purchase plan price per share (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPricesPerShareIssued",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/EquityEmployeeStockPurchasePlanDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "docs_ShareBasedPaymentArrangementTrancheOneAndTrancheTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Payment Arrangement Tranche One And Tranche Two",
        "label": "Share Based Payment Arrangement Tranche One And Tranche Two [Member]",
        "terseLabel": "Share Based Payment Arrangement Tranche One And Tranche Two"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementTrancheOneAndTrancheTwoMember",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/EquityRestrictedStockUnitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_StockIssuancesCostsIncurredButNotYetPaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issuances Costs Incurred But Not Yet Paid",
        "label": "Stock Issuances Costs Incurred But Not Yet Paid",
        "terseLabel": "Unpaid deferred offering costs"
       }
      }
     },
     "localname": "StockIssuancesCostsIncurredButNotYetPaid",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_StockIssuedAcquisitions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued, Acquisitions",
        "label": "Stock Issued, Acquisitions",
        "terseLabel": "Common stock issued in acquisition"
       }
      }
     },
     "localname": "StockIssuedAcquisitions",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_StockOptionAndIncentivePlan2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Option and Incentive Plan 2021",
        "label": "Stock Option and Incentive Plan 2021 [Member]",
        "terseLabel": "2021 Plan"
       }
      }
     },
     "localname": "StockOptionAndIncentivePlan2021Member",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails",
      "http://www.doximity.com/role/EquityEquityIncentivePlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_SubscriptionHiringSolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subscription, Hiring Solutions",
        "label": "Subscription, Hiring Solutions [Member]",
        "terseLabel": "Subscription, Hiring Solutions"
       }
      }
     },
     "localname": "SubscriptionHiringSolutionsMember",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_SubscriptionMarketingSolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subscription, Marketing Solutions",
        "label": "Subscription, Marketing Solutions [Member]",
        "terseLabel": "Subscription, Marketing Solutions"
       }
      }
     },
     "localname": "SubscriptionMarketingSolutionsMember",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_SubscriptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subscription",
        "label": "Subscription [Member]",
        "terseLabel": "Subscription"
       }
      }
     },
     "localname": "SubscriptionMember",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/RevenueRecognitionDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_THMEDLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "THMED, LLC",
        "label": "THMED, LLC [Member]",
        "terseLabel": "THMED, LLC"
       }
      }
     },
     "localname": "THMEDLLCMember",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillNarrativeDetails",
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillPurchaseConsiderationAllocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_TaxCreditCarryforwardsSubjectToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Credit Carryforwards, Subject to Expiration",
        "label": "Tax Credit Carryforwards, Subject to Expiration",
        "terseLabel": "State research and development tax credit carryforwards subject to expiration"
       }
      }
     },
     "localname": "TaxCreditCarryforwardsSubjectToExpiration",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_TemporaryEquityConvertibleAggregateOfferingPriceTrigger": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Convertible, Aggregate Offering Price Trigger",
        "label": "Temporary Equity, Convertible, Aggregate Offering Price Trigger",
        "terseLabel": "Aggregate offering price conversion trigger"
       }
      }
     },
     "localname": "TemporaryEquityConvertibleAggregateOfferingPriceTrigger",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_TemporaryEquityConvertibleStockPriceTrigger": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Convertible, Stock Price Trigger",
        "label": "Temporary Equity, Convertible, Stock Price Trigger",
        "terseLabel": "Conversion price (in dollars per share)"
       }
      }
     },
     "localname": "TemporaryEquityConvertibleStockPriceTrigger",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "docs_TemporaryEquityDividendRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Dividend Rate",
        "label": "Temporary Equity, Dividend Rate",
        "terseLabel": "Temporary equity, dividend rate (in dollars per share)"
       }
      }
     },
     "localname": "TemporaryEquityDividendRate",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "docs_TemporaryEquityElectionOfBoardMembersSharesOutstandingThreshold": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Election Of Board Members, Shares Outstanding Threshold",
        "label": "Temporary Equity, Election Of Board Members, Shares Outstanding Threshold",
        "terseLabel": "Temporary equity, election of board members, shares outstanding threshold (in shares)"
       }
      }
     },
     "localname": "TemporaryEquityElectionOfBoardMembersSharesOutstandingThreshold",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "docs_TemporaryEquityExercisesOfWarrantsAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Exercises of Warrants, Amount",
        "label": "Temporary Equity, Exercises of Warrants, Amount",
        "terseLabel": "Exercise of Series B redeemable convertible preferred stock warrants"
       }
      }
     },
     "localname": "TemporaryEquityExercisesOfWarrantsAmount",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_TemporaryEquityExercisesOfWarrantsShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Exercises of Warrants, Shares",
        "label": "Temporary Equity, Exercises of Warrants, Shares",
        "verboseLabel": "Exercise of Series B redeemable convertible preferred stock warrants (in shares)"
       }
      }
     },
     "localname": "TemporaryEquityExercisesOfWarrantsShares",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "docs_TemporaryEquityPreferredStockOutstandingSeries": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity Preferred Stock Outstanding Series",
        "label": "Temporary Equity Preferred Stock Outstanding Series",
        "terseLabel": "Number of outstanding series of redeemable convertible preferred stock"
       }
      }
     },
     "localname": "TemporaryEquityPreferredStockOutstandingSeries",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "docs_TemporaryEquitySharesOutstandingThresholdSatisfiedNumberOfElectedBoardMembersPermitted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Shares Outstanding Threshold Satisfied, Number of Elected Board Members Permitted",
        "label": "Temporary Equity, Shares Outstanding Threshold Satisfied, Number of Elected Board Members Permitted",
        "terseLabel": "Temporary equity, shares outstanding threshold met, number of board of director members entitled to elect"
       }
      }
     },
     "localname": "TemporaryEquitySharesOutstandingThresholdSatisfiedNumberOfElectedBoardMembersPermitted",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "docs_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Stock Issued During Period, Shares, Conversion Of Convertible Securities",
        "label": "Temporary Equity, Stock Issued During Period, Shares, Conversion Of Convertible Securities",
        "negatedTerseLabel": "Conversion of redeemable convertible preferred stock upon initial public offering (in shares)"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "docs_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity, Stock Issued During Period, Value, Conversion Of Convertible Securities",
        "label": "Temporary Equity, Stock Issued During Period, Value, Conversion Of Convertible Securities",
        "terseLabel": "Conversion of redeemable convertible preferred stock upon initial public offering"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "docs_TemporaryEquityTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity",
        "label": "Temporary Equity [Text Block]",
        "terseLabel": "Redeemable Convertible Preferred Stock"
       }
      }
     },
     "localname": "TemporaryEquityTextBlock",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "docs_USNewsWarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U S News Warrant",
        "label": "U S News Warrant [Member]",
        "terseLabel": "U S News Warrant"
       }
      }
     },
     "localname": "USNewsWarrantMember",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockWarrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "docs_WarrantsAndRightsOutstandingVestingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants and Rights Outstanding, Vesting Period",
        "label": "Warrants and Rights Outstanding, Vesting Period",
        "terseLabel": "Warrants and rights outstanding, vesting period"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstandingVestingPeriod",
     "nsuri": "http://www.doximity.com/20220331",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockWarrantsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "srt_ChiefExecutiveOfficerMember": {
     "auth_ref": [
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Chief Executive Officer [Member]",
        "terseLabel": "Chief Executive Officer"
       }
      }
     },
     "localname": "ChiefExecutiveOfficerMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityPerformanceBasedOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r53",
      "r55",
      "r110",
      "r111",
      "r300",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r202",
      "r332",
      "r338",
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r299",
      "r310",
      "r357",
      "r359",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r589",
      "r627",
      "r630",
      "r650",
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails",
      "http://www.doximity.com/role/EquityEmployeeStockPurchasePlanValuationAssumptionsDetails",
      "http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails",
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesPropertyplantandequipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r299",
      "r310",
      "r357",
      "r359",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r589",
      "r627",
      "r630",
      "r650",
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails",
      "http://www.doximity.com/role/EquityEmployeeStockPurchasePlanValuationAssumptionsDetails",
      "http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails",
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesPropertyplantandequipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r202",
      "r332",
      "r338",
      "r629"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r199",
      "r332",
      "r336",
      "r592",
      "r626",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/RevenueRecognitionDisaggregationofRevenueDetails",
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r199",
      "r332",
      "r336",
      "r592",
      "r626",
      "r628"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/RevenueRecognitionDisaggregationofRevenueDetails",
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r299",
      "r310",
      "r347",
      "r357",
      "r359",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r589",
      "r627",
      "r630",
      "r650",
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails",
      "http://www.doximity.com/role/EquityEmployeeStockPurchasePlanValuationAssumptionsDetails",
      "http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails",
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesPropertyplantandequipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r299",
      "r310",
      "r347",
      "r357",
      "r359",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r589",
      "r627",
      "r630",
      "r650",
      "r651"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails",
      "http://www.doximity.com/role/EquityEmployeeStockPurchasePlanValuationAssumptionsDetails",
      "http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails",
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesPropertyplantandequipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r54",
      "r55",
      "r110",
      "r111",
      "r300",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r204",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityPerformanceBasedOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityPerformanceBasedOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r41",
      "r555"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.doximity.com/role/SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r10",
      "r25",
      "r205",
      "r206"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net of allowance for doubtful accounts of $359 and $955 as of March\u00a031, 2022 and 2021, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Accretion (Amortization) of Discounts and Premiums, Investments",
        "negatedTerseLabel": "Amortization of premium (accretion of discount) on marketable securities, net"
       }
      }
     },
     "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses and other current liabilities",
        "totalLabel": "Accrued expenses and other current liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails",
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalesCommissionCurrent": {
     "auth_ref": [
      "r13",
      "r14",
      "r44"
     ],
     "calculation": {
      "http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Sales Commission, Current",
        "terseLabel": "Accrued commissions"
       }
      }
     },
     "localname": "AccruedSalesCommissionCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r39",
      "r273"
     ],
     "calculation": {
      "http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Less: accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r28",
      "r57",
      "r58",
      "r59",
      "r616",
      "r638",
      "r642"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r56",
      "r59",
      "r67",
      "r68",
      "r69",
      "r113",
      "r114",
      "r115",
      "r485",
      "r633",
      "r634",
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Intangible assets acquired, useful life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r26",
      "r406",
      "r555"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r113",
      "r114",
      "r115",
      "r403",
      "r404",
      "r405",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "negatedTerseLabel": "Tax withholding on shares under stock-based compensation awards"
       }
      }
     },
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r362",
      "r365",
      "r409",
      "r410"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "auth_ref": [
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for advertising cost.",
        "label": "Advertising Cost [Policy Text Block]",
        "terseLabel": "Advertising Expenses"
       }
      }
     },
     "localname": "AdvertisingCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdvertisingExpense": {
     "auth_ref": [
      "r414"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.",
        "label": "Advertising Expense",
        "terseLabel": "Advertising expense"
       }
      }
     },
     "localname": "AdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r365",
      "r394",
      "r408"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Stock based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockWarrantsDetails",
      "http://www.doximity.com/role/EquityPerformanceBasedOptionsDetails",
      "http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsDetails",
      "http://www.doximity.com/role/EquityStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r32",
      "r207",
      "r233"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r94",
      "r258",
      "r265"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities excluded from computation of earnings per share, amount (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersAntidilutiveSecuritiesExcludedfromComputationofNetIncomePerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersAntidilutiveSecuritiesExcludedfromComputationofNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersAntidilutiveSecuritiesExcludedfromComputationofNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersAntidilutiveSecuritiesExcludedfromComputationofNetIncomePerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetBackedSecuritiesMember": {
     "auth_ref": [
      "r218",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans.",
        "label": "Asset-backed Securities [Member]",
        "terseLabel": "Asset-backed securities"
       }
      }
     },
     "localname": "AssetBackedSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsDetails",
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r106",
      "r185",
      "r189",
      "r195",
      "r226",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r481",
      "r487",
      "r519",
      "r553",
      "r555",
      "r600",
      "r615"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r11",
      "r12",
      "r52",
      "r106",
      "r226",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r481",
      "r487",
      "r519",
      "r553",
      "r555"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r213"
     ],
     "calculation": {
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss",
       "weight": -1.0
      },
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails_1": {
       "order": 2.0,
       "parentTag": "docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross Unrealized Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r214"
     ],
     "calculation": {
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss",
       "weight": 1.0
      },
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails_1": {
       "order": 3.0,
       "parentTag": "docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedTerseLabel": "Gross Unrealized Losses",
        "terseLabel": "Unrealized losses related to debt securities"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails",
      "http://www.doximity.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "auth_ref": [
      "r215",
      "r217",
      "r610"
     ],
     "calculation": {
      "http://www.doximity.com/role/InvestmentsContractualMaturitiesofAvailableForSaleDebtSecuritiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "terseLabel": "Due within one year"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/InvestmentsContractualMaturitiesofAvailableForSaleDebtSecuritiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableforsaleSecuritiesMember": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Available-for-sale Securities [Member]",
        "terseLabel": "Available-for-sale securities"
       }
      }
     },
     "localname": "AvailableforsaleSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsDetails",
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r366",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails",
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails",
      "http://www.doximity.com/role/EquityEmployeeStockPurchasePlanDetails",
      "http://www.doximity.com/role/EquityEmployeeStockPurchasePlanValuationAssumptionsDetails",
      "http://www.doximity.com/role/EquityEquityIncentivePlansDetails",
      "http://www.doximity.com/role/EquityPerformanceBasedOptionsDetails",
      "http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsDetails",
      "http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails",
      "http://www.doximity.com/role/EquityRestrictedStockUnitsDetails",
      "http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails",
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails",
      "http://www.doximity.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsDetails",
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r490",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsDetails",
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary Significant Accounting Policies"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r356",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillNarrativeDetails",
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillPurchaseConsiderationAllocationDetails",
      "http://www.doximity.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r356",
      "r358",
      "r463",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillNarrativeDetails",
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillPurchaseConsiderationAllocationDetails",
      "http://www.doximity.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": {
     "auth_ref": [
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of equity interests issued or issuable to acquire entity.",
        "label": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares",
        "terseLabel": "Number of shares issued"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillIntangibleAssetsNetDetails",
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillNarrativeDetails",
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillPurchaseConsiderationAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r462"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "terseLabel": "Acquisition related costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r471",
      "r472",
      "r474"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Consideration transferred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": {
     "auth_ref": [
      "r471",
      "r472"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.",
        "label": "Business Combination, Consideration Transferred, Equity Interests Issued and Issuable",
        "terseLabel": "Value of shares issued"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r470",
      "r473",
      "r477"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Business combination, contingent consideration, liability"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": {
     "auth_ref": [
      "r466"
     ],
     "calculation": {
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillPurchaseConsiderationAllocationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets",
        "totalLabel": "Total assets acquired"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillPurchaseConsiderationAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets [Abstract]",
        "terseLabel": "Assets acquired:"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillPurchaseConsiderationAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r466"
     ],
     "calculation": {
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillPurchaseConsiderationAllocationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillPurchaseConsiderationAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r466"
     ],
     "calculation": {
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillPurchaseConsiderationAllocationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillPurchaseConsiderationAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": {
     "auth_ref": [
      "r465",
      "r466"
     ],
     "calculation": {
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillPurchaseConsiderationAllocationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillPurchaseConsiderationAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r466"
     ],
     "calculation": {
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillPurchaseConsiderationAllocationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "terseLabel": "Accounts payable and accrued liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillPurchaseConsiderationAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities [Abstract]",
        "terseLabel": "Liabilities assumed:"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillPurchaseConsiderationAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r465",
      "r466"
     ],
     "calculation": {
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillPurchaseConsiderationAllocationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net",
        "totalLabel": "Net assets acquired, excluding goodwill"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillPurchaseConsiderationAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r466"
     ],
     "calculation": {
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillPurchaseConsiderationAllocationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Total purchase consideration"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillPurchaseConsiderationAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsPolicy": {
     "auth_ref": [
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.",
        "label": "Business Combinations Policy [Policy Text Block]",
        "terseLabel": "Business Combinations"
       }
      }
     },
     "localname": "BusinessCombinationsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareAdditions": {
     "auth_ref": [
      "r259"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions made to capitalized computer software costs during the period.",
        "label": "Capitalized Computer Software, Additions",
        "terseLabel": "Capitalized internal-use software development costs"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareAdditions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/PropertyandEquipmentNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedComputerSoftwareAmortization1": {
     "auth_ref": [
      "r652",
      "r654"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for amortization of capitalized computer software costs.",
        "label": "Capitalized Computer Software, Amortization",
        "terseLabel": "Amortization of internal-use software development costs"
       }
      }
     },
     "localname": "CapitalizedComputerSoftwareAmortization1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/PropertyandEquipmentNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedContractCostAmortization": {
     "auth_ref": [
      "r251"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.",
        "label": "Capitalized Contract Cost, Amortization",
        "terseLabel": "Amortization of deferred contract costs"
       }
      }
     },
     "localname": "CapitalizedContractCostAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.doximity.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedContractCostAmortizationPeriod": {
     "auth_ref": [
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization period of cost capitalized in obtaining or fulfilling contract with customer, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Capitalized Contract Cost, Amortization Period",
        "terseLabel": "Amortization period"
       }
      }
     },
     "localname": "CapitalizedContractCostAmortizationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_CapitalizedContractCostAxis": {
     "auth_ref": [
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by cost capitalized in obtaining or fulfilling contract with customer.",
        "label": "Capitalized Contract Cost [Axis]",
        "terseLabel": "Capitalized Contract Cost [Axis]"
       }
      }
     },
     "localname": "CapitalizedContractCostAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalizedContractCostDomain": {
     "auth_ref": [
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost capitalized in obtaining and fulfilling contract with customer.",
        "label": "Capitalized Contract Cost [Domain]",
        "terseLabel": "Capitalized Contract Cost [Domain]"
       }
      }
     },
     "localname": "CapitalizedContractCostDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CapitalizedContractCostImpairmentLoss": {
     "auth_ref": [
      "r251"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss for asset recognized from cost incurred to obtain or fulfill contract with customer.",
        "label": "Capitalized Contract Cost, Impairment Loss",
        "terseLabel": "Deferred contract costs, impairment losses"
       }
      }
     },
     "localname": "CapitalizedContractCostImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalizedContractCostNetCurrent": {
     "auth_ref": [
      "r250"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer; classified as current.",
        "label": "Capitalized Contract Cost, Net, Current",
        "terseLabel": "Deferred contract costs, current"
       }
      }
     },
     "localname": "CapitalizedContractCostNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r9",
      "r36",
      "r96"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails": {
       "order": 1.0,
       "parentTag": "docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and Cash Equivalents, at Carrying Value",
        "verboseLabel": "Cost or Amortized Cost, money market funds"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "calculation": {
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsAndShortTermInvestments",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Fair Value, money market funds"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Member]",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsDetails",
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CashCashEquivalentsAndShortTermInvestments": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails_1": {
       "order": 1.0,
       "parentTag": "docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.",
        "label": "Cash, Cash Equivalents, and Short-term Investments",
        "totalLabel": "Fair Value, cash equivalents and marketable securities"
       }
      }
     },
     "localname": "CashCashEquivalentsAndShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r90",
      "r96",
      "r101"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents, end of period",
        "periodStartLabel": "Cash and cash equivalents, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r90",
      "r528"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CertificatesOfDepositMember": {
     "auth_ref": [
      "r612"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured.",
        "label": "Certificates of Deposit [Member]",
        "terseLabel": "Certificates of deposit"
       }
      }
     },
     "localname": "CertificatesOfDepositMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsDetails",
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ChangeInContractWithCustomerLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Contract with Customer, Liability [Abstract]",
        "terseLabel": "Change in Contract with Customer, Liability [Abstract]"
       }
      }
     },
     "localname": "ChangeInContractWithCustomerLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/RevenueRecognitionDeferredRevenueContractBalanceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r105",
      "r106",
      "r134",
      "r139",
      "r144",
      "r149",
      "r153",
      "r161",
      "r162",
      "r163",
      "r226",
      "r288",
      "r292",
      "r293",
      "r294",
      "r297",
      "r298",
      "r308",
      "r309",
      "r312",
      "r313",
      "r519",
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CoverPage",
      "http://www.doximity.com/role/EquityCommonStockandCreationofDualClassStructureDetails",
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails",
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "auth_ref": [
      "r319",
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of warrant or right issued.",
        "label": "Class of Warrant or Right [Axis]",
        "terseLabel": "Class of Warrant or Right [Axis]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockWarrantsDetails",
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.",
        "label": "Class of Warrant or Right [Domain]",
        "terseLabel": "Class Of Warrant Or Right [Domain]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockWarrantsDetails",
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Exercise price called by warrants (in dollars per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockWarrantsDetails",
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [
      "r316"
     ],
     "calculation": {
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "terseLabel": "Common stock warrants (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails",
      "http://www.doximity.com/role/EquityCommonStockWarrantsDetails",
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommercialPaperMember": {
     "auth_ref": [
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.",
        "label": "Commercial Paper [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsDetails",
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommercialPaperNotIncludedWithCashAndCashEquivalentsMember": {
     "auth_ref": [
      "r348",
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds that is excluded from cash and cash equivalents.",
        "label": "Commercial Paper, Not Included with Cash and Cash Equivalents [Member]",
        "terseLabel": "Commercial paper"
       }
      }
     },
     "localname": "CommercialPaperNotIncludedWithCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r47",
      "r283",
      "r603",
      "r620"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 13)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r280",
      "r281",
      "r282",
      "r285",
      "r646"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonClassAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock representing ownership interest in a corporation.",
        "label": "Common Class A [Member]",
        "terseLabel": "Common Class A"
       }
      }
     },
     "localname": "CommonClassAMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CoverPage",
      "http://www.doximity.com/role/EquityCommonStockandCreationofDualClassStructureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonClassBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.",
        "label": "Common Class B [Member]",
        "terseLabel": "Common Class B"
       }
      }
     },
     "localname": "CommonClassBMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CoverPage",
      "http://www.doximity.com/role/EquityCommonStockandCreationofDualClassStructureDetails",
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "totalLabel": "Total",
        "verboseLabel": "Number of shares reserved for future issuance (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails",
      "http://www.doximity.com/role/EquityEquityIncentivePlansDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r113",
      "r114",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.doximity.com/role/EquityCommonStockandCreationofDualClassStructureDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.doximity.com/role/EquityCommonStockandCreationofDualClassStructureDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.doximity.com/role/EquityCommonStockandCreationofDualClassStructureDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r24",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.doximity.com/role/EquityCommonStockandCreationofDualClassStructureDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r24",
      "r555"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Class A and Class B common stock, $0.001 par value; 1,500,000 and 198,000 shares authorized as of March\u00a031, 2022 and 2021, respectively; 192,398 and 82,910 shares issued and outstanding as of March\u00a031, 2022 and 2021, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": {
     "auth_ref": [
      "r345",
      "r346",
      "r360",
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.",
        "label": "Compensation and Employee Benefit Plans [Text Block]",
        "terseLabel": "Employee Benefit Plan"
       }
      }
     },
     "localname": "CompensationAndEmployeeBenefitPlansTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EmployeeBenefitPlan"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r62",
      "r64",
      "r65",
      "r72",
      "r606",
      "r622"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r171",
      "r172",
      "r202",
      "r516",
      "r517",
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.doximity.com/role/SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r171",
      "r172",
      "r202",
      "r516",
      "r517",
      "r644",
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.doximity.com/role/SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r171",
      "r172",
      "r202",
      "r516",
      "r517",
      "r644",
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.doximity.com/role/SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r166",
      "r613"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration Risk [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r171",
      "r172",
      "r202",
      "r516",
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk, percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.doximity.com/role/SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r169",
      "r171",
      "r172",
      "r173",
      "r516",
      "r518",
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r171",
      "r172",
      "r202",
      "r516",
      "r517",
      "r645"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://www.doximity.com/role/SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r102",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": {
     "auth_ref": [
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.",
        "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]",
        "terseLabel": "Changes in Deferred Revenue Balance"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r321",
      "r322",
      "r333"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/RevenueRecognitionDeferredRevenueContractBalanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r321",
      "r322",
      "r333"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue, current"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r321",
      "r322",
      "r333"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract with Customer, Liability, Noncurrent",
        "terseLabel": "Deferred revenue, non-current"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r334"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "negatedTerseLabel": "Revenue recognized from the beginning balance"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/RevenueRecognitionDeferredRevenueContractBalanceDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConversionOfStockAmountConverted1": {
     "auth_ref": [
      "r98",
      "r99",
      "r100"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of Stock, Amount Converted",
        "terseLabel": "Conversion of redeemable convertible preferred stock to common stock"
       }
      }
     },
     "localname": "ConversionOfStockAmountConverted1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConversionOfStockSharesConverted1": {
     "auth_ref": [
      "r98",
      "r99",
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of Stock, Shares Converted",
        "terseLabel": "Conversion of stock, shares converted (in shares)"
       }
      }
     },
     "localname": "ConversionOfStockSharesConverted1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/DESCRIPTIONOFBUSINESSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ConversionOfStockSharesIssued1": {
     "auth_ref": [
      "r98",
      "r99",
      "r100"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Conversion of Stock, Shares Issued",
        "terseLabel": "Conversion of stock, shares issued (in shares)"
       }
      }
     },
     "localname": "ConversionOfStockSharesIssued1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r348",
      "r355",
      "r643"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate notes and bonds"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsDetails",
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r76",
      "r106",
      "r226",
      "r288",
      "r289",
      "r290",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r519"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "terseLabel": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfSalesPolicyTextBlock": {
     "auth_ref": [
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cost of product sold and service rendered.",
        "label": "Cost of Goods and Service [Policy Text Block]",
        "terseLabel": "Cost of Revenue"
       }
      }
     },
     "localname": "CostOfSalesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CreditConcentrationRiskMember": {
     "auth_ref": [
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that a specified receivable or amount at risk from a counterparty under a contractual arrangement is to a specified benchmark, such as total receivables, net revenues, pretax results. Risk is the materially adverse effects of loss attributable to (a) the failure to collect a significant receivable from a major customer or group of homogeneous accounts, or (b) a failure by a counterparty to perform under terms of a contractual arrangement.",
        "label": "Credit Concentration Risk [Member]",
        "terseLabel": "Credit Concentration Risk"
       }
      }
     },
     "localname": "CreditConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state, local, and federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal, State and Local, Tax Expense (Benefit)",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "CurrentFederalStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r107",
      "r443",
      "r453"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current provision:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r107",
      "r443",
      "r453"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r170",
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r469"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillIntangibleAssetsNetDetails",
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss": {
     "auth_ref": [
      "r216",
      "r239",
      "r241",
      "r242"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of accrued interest on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss": {
     "auth_ref": [
      "r239"
     ],
     "calculation": {
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails": {
       "order": 2.0,
       "parentTag": "docs_CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost excluding accrued interest, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, after Allowance for Credit Loss",
        "totalLabel": "Cost or Amortized Cost"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleChangeInPresentValueExpenseReversal": {
     "auth_ref": [
      "r240",
      "r245"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), from change in present value of expected cash flows.",
        "label": "Debt Securities, Available-for-sale, Change in Present Value, Expense (Reversal)",
        "terseLabel": "Debt securities credit losses"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleChangeInPresentValueExpenseReversal",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterest": {
     "auth_ref": [
      "r239"
     ],
     "calculation": {
      "http://www.doximity.com/role/InvestmentsContractualMaturitiesofAvailableForSaleDebtSecuritiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-Sale, Excluding Accrued Interest",
        "terseLabel": "Fair Value",
        "totalLabel": "Fair Value"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleExcludingAccruedInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsDetails",
      "http://www.doximity.com/role/InvestmentsContractualMaturitiesofAvailableForSaleDebtSecuritiesDetails",
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent": {
     "auth_ref": [
      "r239"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount excluding accrued interest, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.",
        "label": "Debt Securities, Available-for-Sale, Excluding Accrued Interest, Current",
        "terseLabel": "Marketable securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleRealizedGainLoss": {
     "auth_ref": [
      "r221"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Realized Gain (Loss)",
        "negatedTerseLabel": "Loss on sale of marketable securities"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleRealizedGainLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table]",
        "terseLabel": "Debt Securities, Available-for-sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "auth_ref": [
      "r222"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table Text Block]",
        "terseLabel": "Cost, Gross Unrealized Gains and Losses, and Fair Value of Investments"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r107",
      "r444",
      "r453"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state, local, and federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal, State and Local, Tax Expense (Benefit)",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "DeferredFederalStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r419",
      "r420"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "terseLabel": "Deferred income tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r94",
      "r107",
      "r444",
      "r453",
      "r454",
      "r455"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred provision (benefit):"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r19",
      "r20",
      "r433",
      "r601",
      "r614"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredOfferingCosts": {
     "auth_ref": [
      "r51",
      "r248"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.",
        "label": "Deferred Offering Costs",
        "terseLabel": "Capitalized deferred offering costs"
       }
      }
     },
     "localname": "DeferredOfferingCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/DESCRIPTIONOFBUSINESSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r107",
      "r444",
      "r453"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r434"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Gross deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": {
     "auth_ref": [
      "r441",
      "r442"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from in-process research and development costs expensed in connection with a business combination.",
        "label": "Deferred Tax Assets, in Process Research and Development",
        "terseLabel": "Research &amp; development credit carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r436"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r436"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Deferred tax assets, net of valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net [Abstract]",
        "terseLabel": "Deferred tax assets:"
       }
      }
     },
     "localname": "DeferredTaxAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r441",
      "r442"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": {
     "auth_ref": [
      "r441",
      "r442"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Domestic",
        "terseLabel": "Net operating loss carryforwards, federal"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": {
     "auth_ref": [
      "r441",
      "r442"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, State and Local",
        "terseLabel": "Net operating loss carryforwards, state"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "auth_ref": [
      "r439",
      "r441",
      "r442"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research",
        "terseLabel": "Tax credit carryforwards, research"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r441",
      "r442"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross": {
     "auth_ref": [
      "r441"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Deferred Tax Asset, Debt Securities, Available-for-Sale, Unrealized Loss",
        "terseLabel": "Unrealized loss"
       }
      }
     },
     "localname": "DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r435"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedTerseLabel": "Less: valuation allowance",
        "terseLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesNarrativeDetails",
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": {
     "auth_ref": [
      "r441",
      "r442"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.",
        "label": "Deferred Tax Liabilities, Intangible Assets",
        "negatedTerseLabel": "Intangible assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
     "auth_ref": [
      "r441",
      "r442"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.",
        "label": "Deferred Tax Liabilities, Leasing Arrangements",
        "negatedTerseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesLeasingArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Net [Abstract]",
        "terseLabel": "Deferred tax liabilities:"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r441",
      "r442"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedTerseLabel": "Property and equipment"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount",
        "terseLabel": "Employer discretionary contribution amount"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EmployeeBenefitPlanDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r94",
      "r271"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation and amortization expense"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/PropertyandEquipmentNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r94",
      "r183"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/RevenueRecognitionDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r332",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/RevenueRecognitionDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/RevenueRecognitionTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": {
     "auth_ref": [
      "r366",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of share-based payment arrangement.",
        "label": "Disclosure of Share-based Compensation Arrangements by Share-based Payment Award [Table Text Block]",
        "terseLabel": "Common Stock Reserved for Issuance"
       }
      }
     },
     "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r270",
      "r277"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposal Group, Disposed of by Sale, Not Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "terseLabel": "Sale of business consideration"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r356",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Domestic Tax Authority"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net income per share attributable to Class A and Class B common stockholders:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r73",
      "r122",
      "r123",
      "r124",
      "r125",
      "r126",
      "r131",
      "r134",
      "r149",
      "r152",
      "r153",
      "r157",
      "r158",
      "r503",
      "r504",
      "r607",
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in dollars per share)",
        "verboseLabel": "Net income per share attributable to Class A and Class B common stockholders, basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]",
        "terseLabel": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]"
       }
      }
     },
     "localname": "EarningsPerShareBasicLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r73",
      "r122",
      "r123",
      "r124",
      "r125",
      "r126",
      "r134",
      "r149",
      "r152",
      "r153",
      "r157",
      "r158",
      "r503",
      "r504",
      "r607",
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in dollars per share)",
        "verboseLabel": "Net income per share attributable to Class A and Class B common stockholders, diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r154",
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Income Per Share Attributable to Common Stockholders"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share Reconciliation [Abstract]",
        "terseLabel": "Numerator"
       }
      }
     },
     "localname": "EarningsPerShareReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r154",
      "r155",
      "r156",
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Income Per Share Attributable to Common Stockholders"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholders"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount": {
     "auth_ref": [
      "r411",
      "r422"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued payroll, bonus, and related expenses"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount": {
     "auth_ref": [
      "r395"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost capitalized for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Amount Capitalized",
        "terseLabel": "Capitalized stock-based compensation for internal-use software development costs"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Unamortized compensation expense, weighted average period of recognition"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockWarrantsDetails",
      "http://www.doximity.com/role/EquityEmployeeStockPurchasePlanDetails",
      "http://www.doximity.com/role/EquityPerformanceBasedOptionsDetails",
      "http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsDetails",
      "http://www.doximity.com/role/EquityRestrictedStockUnitsDetails",
      "http://www.doximity.com/role/EquityStockOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r396"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unamortized compensation expense excluding option"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockWarrantsDetails",
      "http://www.doximity.com/role/EquityEmployeeStockPurchasePlanDetails",
      "http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsDetails",
      "http://www.doximity.com/role/EquityRestrictedStockUnitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r396"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unamortized compensation expense, option"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityPerformanceBasedOptionsDetails",
      "http://www.doximity.com/role/EquityStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "Employee Stock"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityEmployeeStockPurchasePlanDetails",
      "http://www.doximity.com/role/EquityEmployeeStockPurchasePlanValuationAssumptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityEquityIncentivePlansDetails",
      "http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails",
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersAntidilutiveSecuritiesExcludedfromComputationofNetIncomePerShareDetails",
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r67",
      "r68",
      "r69",
      "r113",
      "r114",
      "r115",
      "r118",
      "r127",
      "r129",
      "r160",
      "r230",
      "r315",
      "r317",
      "r403",
      "r404",
      "r405",
      "r449",
      "r450",
      "r502",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r633",
      "r634",
      "r635",
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r505",
      "r506",
      "r507",
      "r512"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r505",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Fair Value, Assets Measured on Recurring Basis"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r301",
      "r304",
      "r305",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r506",
      "r562",
      "r563",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r505",
      "r506",
      "r509",
      "r510",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r301",
      "r348",
      "r349",
      "r354",
      "r355",
      "r506",
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r301",
      "r304",
      "r305",
      "r348",
      "r349",
      "r354",
      "r355",
      "r506",
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r301",
      "r304",
      "r305",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r506",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r301",
      "r304",
      "r305",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r562",
      "r563",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r511",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r514",
      "r515"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r218",
      "r219",
      "r223",
      "r224",
      "r225",
      "r234",
      "r235",
      "r236",
      "r237",
      "r238",
      "r243",
      "r244",
      "r246",
      "r247",
      "r303",
      "r314",
      "r493",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsDetails",
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r264"
     ],
     "calculation": {
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillIntangibleAssetsNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Less: accumulated amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "auth_ref": [],
     "calculation": {
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillFutureAmortizationExpenseDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r266"
     ],
     "calculation": {
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillFutureAmortizationExpenseDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "auth_ref": [
      "r266"
     ],
     "calculation": {
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillFutureAmortizationExpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r266"
     ],
     "calculation": {
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillFutureAmortizationExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r266"
     ],
     "calculation": {
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillFutureAmortizationExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r266"
     ],
     "calculation": {
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillFutureAmortizationExpenseDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillFutureAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r259",
      "r261",
      "r264",
      "r267",
      "r593",
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillIntangibleAssetsNetDetails",
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r264",
      "r597"
     ],
     "calculation": {
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillIntangibleAssetsNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Intangible assets, gross"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillIntangibleAssetsNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r259",
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillIntangibleAssetsNetDetails",
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r264",
      "r593"
     ],
     "calculation": {
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillFutureAmortizationExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillIntangibleAssetsNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Intangible assets, net",
        "totalLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillFutureAmortizationExpenseDetails",
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillIntangibleAssetsNetDetails",
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiscalPeriod": {
     "auth_ref": [
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining an entity's fiscal year or other fiscal period. This disclosure may include identification of the fiscal period end-date, the length of the fiscal period, any reporting period lag between the entity and its subsidiaries, or equity investees. If a reporting lag exists, the closing date of the entity having a different period end is generally noted, along with an explanation of the necessity for using different closing dates. Any intervening events that materially affect the entity's financial position or results of operations are generally also disclosed.",
        "label": "Fiscal Period, Policy [Policy Text Block]",
        "terseLabel": "Fiscal Year"
       }
      }
     },
     "localname": "FiscalPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GainLossOnSaleOfBusiness": {
     "auth_ref": [
      "r94",
      "r486"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant.",
        "label": "Gain (Loss) on Disposition of Business",
        "negatedTerseLabel": "Gain on sale of business"
       }
      }
     },
     "localname": "GainLossOnSaleOfBusiness",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r252",
      "r254",
      "r555",
      "r599"
     ],
     "calculation": {
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillPurchaseConsiderationAllocationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillNarrativeDetails",
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillPurchaseConsiderationAllocationDetails",
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r256",
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Goodwill Intangible Assets and Long-Lived Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r94",
      "r253",
      "r255",
      "r257"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill, impairment"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GranteeStatusAxis": {
     "auth_ref": [
      "r361",
      "r363",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of recipient to whom award is granted.",
        "label": "Grantee Status [Axis]",
        "terseLabel": "Grantee Status [Axis]"
       }
      }
     },
     "localname": "GranteeStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityEquityIncentivePlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GranteeStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of recipient to whom award is granted.",
        "label": "Grantee Status [Domain]",
        "terseLabel": "Grantee Status [Domain]"
       }
      }
     },
     "localname": "GranteeStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityEquityIncentivePlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r75",
      "r106",
      "r185",
      "r188",
      "r191",
      "r194",
      "r197",
      "r226",
      "r288",
      "r289",
      "r290",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r519"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r70",
      "r185",
      "r188",
      "r191",
      "r194",
      "r197",
      "r598",
      "r604",
      "r608",
      "r624"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r356",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r276",
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority, Name [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r108",
      "r423",
      "r431",
      "r438",
      "r451",
      "r456",
      "r458",
      "r459",
      "r460"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r109",
      "r128",
      "r129",
      "r184",
      "r421",
      "r452",
      "r457",
      "r625"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for (benefit from) income taxes",
        "totalLabel": "Provision for (benefit from) income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails",
      "http://www.doximity.com/role/IncomeTaxesScheduleofIncomeTaxExpenseBenefitDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r66",
      "r417",
      "r418",
      "r431",
      "r432",
      "r437",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r422"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Change in valuation allowance"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r422"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Income taxes at statutory rate"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpense": {
     "auth_ref": [
      "r422"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount",
        "terseLabel": "Section 162(m) limitation"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "auth_ref": [
      "r422"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r422"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "State income taxes, net of federal benefit"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r422"
     ],
     "calculation": {
      "http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount",
        "negatedTerseLabel": "Research and development credits"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesScheduleofEffectiveIncomeTaxRateReconciliationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r91",
      "r97"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Cash paid for taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable, accrued expenses and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r93",
      "r590"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities, net of effect of acquisition:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [
      "r93",
      "r543"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for operating lease.",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedTerseLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Temporary Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants": {
     "auth_ref": [
      "r135",
      "r136",
      "r137",
      "r153"
     ],
     "calculation": {
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants",
        "terseLabel": "Dilutive effect of assumed exercise of common stock warrants (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToCallOptionsAndWarrants",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r135",
      "r136",
      "r138",
      "r153"
     ],
     "calculation": {
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Dilutive effect of share-based payment (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_InternalUseSoftwarePolicy": {
     "auth_ref": [
      "r268",
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally.",
        "label": "Internal Use Software, Policy [Policy Text Block]",
        "terseLabel": "Internal-Use Software Development Costs"
       }
      }
     },
     "localname": "InternalUseSoftwarePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InternetDomainNamesMember": {
     "auth_ref": [
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "String of typographic characters used to describe the location of a specific individual, business, computer, or piece of information online. Formally known as the Uniform Resource Locator or URL, it is often considered to be the address of a certain World Wide Web site.",
        "label": "Internet Domain Names [Member]",
        "terseLabel": "Domain names"
       }
      }
     },
     "localname": "InternetDomainNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillIntangibleAssetsNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "terseLabel": "Contractual Maturities of Available-For-Sale Debt Securities"
       }
      }
     },
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for cash, cash equivalents, investments in debt and equity instruments (including cost and equity investees and related income statement amounts), equity and cost method investments, investments in joint ventures and any other investment.",
        "label": "Investments in Debt and Equity Instruments, Cash and Cash Equivalents, Unrealized and Realized Gains (Losses) [Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentsInDebtAndEquityInstrumentsCashAndCashEquivalentsUnrealizedAndRealizedGainsLossesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/Investments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r547",
      "r549"
     ],
     "calculation": {
      "http://www.doximity.com/role/LeasesComponentsofLeaseExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/LeasesComponentsofLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Components of Lease Expense and Supplemental Cash Flow/Balance Sheet Information Related to Leases"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LegalCostsPolicyTextBlock": {
     "auth_ref": [
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for legal costs incurred to protect or defend the entity's assets and rights, or to obtain assets, including monetary damages, or to obtain rights.",
        "label": "Legal Costs, Policy [Policy Text Block]",
        "terseLabel": "Legal Contingencies"
       }
      }
     },
     "localname": "LegalCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1": {
     "auth_ref": [
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease not yet commenced, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract",
        "terseLabel": "Lease term for lease not yet commenced"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLeaseNotYetCommencedTermOfContract1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Maturities of Lease Liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r548"
     ],
     "calculation": {
      "http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total future lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r548"
     ],
     "calculation": {
      "http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r548"
     ],
     "calculation": {
      "http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r548"
     ],
     "calculation": {
      "http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r43",
      "r106",
      "r190",
      "r226",
      "r288",
      "r289",
      "r290",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r482",
      "r487",
      "r488",
      "r519",
      "r553",
      "r554"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r31",
      "r106",
      "r226",
      "r519",
      "r555",
      "r602",
      "r618"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities, redeemable convertible preferred stock, and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities, Redeemable Convertible Preferred Stock, and Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r45",
      "r106",
      "r226",
      "r288",
      "r289",
      "r290",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r482",
      "r487",
      "r488",
      "r519",
      "r553",
      "r554",
      "r555"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAccrualProvision": {
     "auth_ref": [
      "r283"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged against operating income increasing loss contingency liability, after adjustments to reduce previously estimated charges.",
        "label": "Loss Contingency Accrual, Provision",
        "terseLabel": "Loss contingency"
       }
      }
     },
     "localname": "LossContingencyAccrualProvision",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MeasurementInputExpectedDividendRateMember": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year.",
        "label": "Measurement Input, Expected Dividend Rate [Member]",
        "terseLabel": "Measurement Input, Expected Dividend Rate"
       }
      }
     },
     "localname": "MeasurementInputExpectedDividendRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockWarrantsDetails",
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputExpectedTermMember": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.",
        "label": "Measurement Input, Expected Term [Member]",
        "terseLabel": "Measurement Input, Expected Term"
       }
      }
     },
     "localname": "MeasurementInputExpectedTermMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockWarrantsDetails",
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.",
        "label": "Measurement Input, Price Volatility [Member]",
        "terseLabel": "Measurement Input, Price Volatility"
       }
      }
     },
     "localname": "MeasurementInputPriceVolatilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockWarrantsDetails",
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.",
        "label": "Measurement Input, Risk Free Interest Rate [Member]",
        "terseLabel": "Measurement Input, Risk Free Interest Rate"
       }
      }
     },
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockWarrantsDetails",
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputSharePriceMember": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using share price of saleable stock.",
        "label": "Measurement Input, Share Price [Member]",
        "terseLabel": "Measurement Input, Share Price"
       }
      }
     },
     "localname": "MeasurementInputSharePriceMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockWarrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockWarrantsDetails",
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockWarrantsDetails",
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money market funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsDetails",
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r90",
      "r92",
      "r95"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r7",
      "r60",
      "r63",
      "r69",
      "r71",
      "r95",
      "r106",
      "r117",
      "r122",
      "r123",
      "r124",
      "r125",
      "r128",
      "r129",
      "r146",
      "r185",
      "r188",
      "r191",
      "r194",
      "r197",
      "r226",
      "r288",
      "r289",
      "r290",
      "r292",
      "r293",
      "r294",
      "r295",
      "r296",
      "r297",
      "r298",
      "r504",
      "r519",
      "r605",
      "r621"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income",
        "totalLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r122",
      "r123",
      "r124",
      "r125",
      "r131",
      "r132",
      "r148",
      "r153",
      "r185",
      "r188",
      "r191",
      "r194",
      "r197"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "totalLabel": "Net income attributable to Class A and Class B common stockholders, basic"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "auth_ref": [
      "r133",
      "r140",
      "r141",
      "r142",
      "r143",
      "r148",
      "r153"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "totalLabel": "Net income attributable to Class A and Class B common stockholders, diluted"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r116",
      "r117",
      "r118",
      "r119",
      "r120",
      "r121",
      "r124",
      "r130",
      "r157",
      "r210",
      "r211",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r287",
      "r399",
      "r400",
      "r401",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r447",
      "r448",
      "r449",
      "r450",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r551",
      "r594",
      "r595",
      "r596",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r639",
      "r640",
      "r641",
      "r642",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "Accounting Standards Update and Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Accounting Pronouncements Recently Adopted/ Accounting Pronouncements Not Yet Adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Non-cash financing and investing activities"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r178"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of Reportable Segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SegmentandGeographicInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportingUnits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.",
        "label": "Number of Reporting Units",
        "terseLabel": "Number of reporting units"
       }
      }
     },
     "localname": "NumberOfReportingUnits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r185",
      "r188",
      "r191",
      "r194",
      "r197"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Income from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r541",
      "r549"
     ],
     "calculation": {
      "http://www.doximity.com/role/LeasesComponentsofLeaseExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/LeasesComponentsofLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r537"
     ],
     "calculation": {
      "http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Present value of lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/LeasesMaturitiesofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r537"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liabilities, current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r537"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities, non-current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r538",
      "r543"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Cash paid for amounts included in measurement of lease liabilities\u2014Operating cash flows"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/LeasesSupplementalCashFlowInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r536"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Operating Lease, Right-of-Use Asset, Amortization Expense",
        "terseLabel": "Non-cash lease expense"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r546",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted-average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r545",
      "r549"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted-average remaining lease term (in years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r8",
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "DESCRIPTION OF BUSINESS"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/DESCRIPTIONOFBUSINESS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r13",
      "r14",
      "r15",
      "r44"
     ],
     "calculation": {
      "http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCommitmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Other Commitments [Line Items]",
        "terseLabel": "Other Commitments [Line Items]"
       }
      }
     },
     "localname": "OtherCommitmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherCommitmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about obligations resulting from other commitments.",
        "label": "Other Commitments [Table]",
        "terseLabel": "Other Commitments [Table]"
       }
      }
     },
     "localname": "OtherCommitmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r479",
      "r480",
      "r484"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.",
        "label": "Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Change in unrealized loss on available-for-sale-securities, net of tax of $5,199, $0, and $0, respectively"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent": {
     "auth_ref": [
      "r479",
      "r480",
      "r484"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit), after reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.",
        "label": "Other Comprehensive Income (Loss), Available-for-sale Securities, Tax, Portion Attributable to Parent",
        "terseLabel": "Change in unrealized loss on available-for-sale-securities, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMEParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r61",
      "r64",
      "r479",
      "r480",
      "r484"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "totalLabel": "Total other comprehensive loss",
        "verboseLabel": "Other comprehensive loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME",
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]",
        "terseLabel": "Other comprehensive loss"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r46"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities, non-current"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r95"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OverAllotmentOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.",
        "label": "Over-Allotment Option [Member]",
        "terseLabel": "Over-Allotment Option"
       }
      }
     },
     "localname": "OverAllotmentOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/DESCRIPTIONOFBUSINESSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r82",
      "r86"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Other"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "negatedTerseLabel": "Payments for deferred offering costs"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedTerseLabel": "Taxes paid related to net share settlement of equity awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r79",
      "r83",
      "r212"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Payments to Acquire Debt Securities, Available-for-sale",
        "negatedTerseLabel": "Purchases of marketable securities"
       }
      }
     },
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r84",
      "r475"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "terseLabel": "Payments to acquire businesses"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillNarrativeDetails",
      "http://www.doximity.com/role/CommitmentandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r84"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Cash paid for acquisition, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToDevelopSoftware": {
     "auth_ref": [
      "r85"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the development or modification of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.",
        "label": "Payments to Develop Software",
        "negatedTerseLabel": "Internal-use software development costs"
       }
      }
     },
     "localname": "PaymentsToDevelopSoftware",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Shares"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityPerformanceBasedOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r366",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails",
      "http://www.doximity.com/role/EquityEquityIncentivePlansDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails",
      "http://www.doximity.com/role/EquityEquityIncentivePlansDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PostemploymentBenefitsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Postemployment Benefits [Abstract]"
       }
      }
     },
     "localname": "PostemploymentBenefitsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r23",
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.doximity.com/role/EquityPreferredStockDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.doximity.com/role/EquityPreferredStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r23",
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.doximity.com/role/EquityPreferredStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.doximity.com/role/EquityPreferredStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r23",
      "r555"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.001 par value; 100,000 and zero shares authorized as of March\u00a031, 2022 and 2021, respectively; zero shares issued and outstanding as of March\u00a031, 2022 and 2021, respectively"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r11",
      "r34",
      "r35"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r81"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Proceeds from sale of business"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillNarrativeDetails",
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.",
        "label": "Proceeds from Issuance Initial Public Offering",
        "terseLabel": "Proceeds from issuance of common stock upon initial public offering after deducting underwriting discounts and commissions"
       }
      }
     },
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities": {
     "auth_ref": [
      "r79",
      "r80",
      "r212"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale",
        "terseLabel": "Maturities of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": {
     "auth_ref": [
      "r79",
      "r80",
      "r212"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Proceeds from Sale of Debt Securities, Available-for-sale",
        "terseLabel": "Sales of marketable securities"
       }
      }
     },
     "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r87",
      "r398"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from issuance of common stock upon exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockPlans": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the stock plan during the period.",
        "label": "Proceeds from Stock Plans",
        "terseLabel": "Proceeds from issuance of common stock in connection with the employee stock purchase plan"
       }
      }
     },
     "localname": "ProceedsFromStockPlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromWarrantExercises": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.",
        "label": "Proceeds from Warrant Exercises",
        "terseLabel": "Proceeds from exercise of redeemable convertible preferred stock warrants"
       }
      }
     },
     "localname": "ProceedsFromWarrantExercises",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r39",
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails",
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesPropertyplantandequipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r278",
      "r647",
      "r648",
      "r649"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/PropertyandEquipmentNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r38",
      "r272"
     ],
     "calculation": {
      "http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails",
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesPropertyplantandequipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r17",
      "r18",
      "r274",
      "r555",
      "r611",
      "r619"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r37",
      "r274",
      "r647",
      "r648"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r17",
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/PropertyandEquipmentNetTables",
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r17",
      "r272"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails",
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesPropertyplantandequipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property and equipment useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesPropertyplantandequipmentDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy": {
     "auth_ref": [
      "r33",
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.",
        "label": "Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]",
        "terseLabel": "Accounts Receivable and Allowance for Doubtful Accounts"
       }
      }
     },
     "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReclassificationsOfTemporaryToPermanentEquity": {
     "auth_ref": [
      "r307",
      "r492"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the carrying amount of a financial instrument subject to a registration payment arrangement recorded as temporary equity prior to adoption of FSP EITF 00-19-2 and the carrying amount reclassified to permanent equity upon the adoption of FSP EITF 00-19-2. Recorded as a cumulative effect adjustment to the beginning balance of retained earnings. Does not apply to registration payment arrangements that are no longer outstanding upon adoption of FSP EITF 00-19-2.",
        "label": "Reclassifications of Temporary to Permanent Equity",
        "terseLabel": "Reclassifications of temporary to permanent equity"
       }
      }
     },
     "localname": "ReclassificationsOfTemporaryToPermanentEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesSummaryofUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RedeemableConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of type or class of redeemable convertible preferred stock. Convertible redeemable preferred stock possess conversion and redemption features. The stock has redemption features that are outside the control of the issuer.",
        "label": "Redeemable Convertible Preferred Stock [Member]",
        "terseLabel": "Redeemable convertible preferred stock"
       }
      }
     },
     "localname": "RedeemableConvertiblePreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/DESCRIPTIONOFBUSINESSDetails",
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersAntidilutiveSecuritiesExcludedfromComputationofNetIncomePerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r415",
      "r591",
      "r653"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs)"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails",
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails",
      "http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails",
      "http://www.doximity.com/role/EquityRestrictedStockUnitsDetails",
      "http://www.doximity.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r27",
      "r317",
      "r406",
      "r555",
      "r617",
      "r637",
      "r642"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r113",
      "r114",
      "r115",
      "r118",
      "r127",
      "r129",
      "r230",
      "r403",
      "r404",
      "r405",
      "r449",
      "r450",
      "r502",
      "r633",
      "r635"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings (Accumulated Deficit)"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r181",
      "r182",
      "r187",
      "r192",
      "r193",
      "r199",
      "r200",
      "r202",
      "r331",
      "r332",
      "r592"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.doximity.com/role/RevenueRecognitionDisaggregationofRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerMember": {
     "auth_ref": [
      "r171",
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue from Contract with Customer Benchmark [Member]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummaryofsignificantAccountingPoliciesSignificantCustomersRepresenting10ormoreofRevenueorAccountsReceivableNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r335",
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/RevenueRecognition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRecognitionPolicyTextBlock": {
     "auth_ref": [
      "r103",
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.",
        "label": "Revenue [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueRecognitionPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r544",
      "r549"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Operating lease right-of-use assets obtained in exchange for modified operating lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received on stock transaction after deduction of issuance costs.",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "terseLabel": "Aggregate net proceeds from initial public offering"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/DESCRIPTIONOFBUSINESSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/DESCRIPTIONOFBUSINESSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Number of shares issued and sold in initial public offering"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/DESCRIPTIONOFBUSINESSDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Initial public offering price (in dollars per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/DESCRIPTIONOFBUSINESSDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersAntidilutiveSecuritiesExcludedfromComputationofNetIncomePerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Debt Securities, Available-for-sale [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r463",
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillNarrativeDetails",
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillPurchaseConsiderationAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Schedule of Components of Income Tax Expense (Benefit)"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable": {
     "auth_ref": [
      "r134",
      "r139",
      "r149",
      "r153",
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The table contains disclosure pertaining to an entity's basic earnings per share.",
        "label": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]",
        "terseLabel": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r365",
      "r393",
      "r408"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Stock-Based Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r259",
      "r263",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillIntangibleAssetsNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r259",
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Intangible Assets, Net"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": {
     "auth_ref": [
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units.",
        "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]",
        "terseLabel": "Restricted Stock Unit Activity"
       }
      }
     },
     "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r39",
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails",
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesPropertyplantandequipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Purchase Consideration Allocation"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r366",
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails",
      "http://www.doximity.com/role/EquityCommonStockWarrantsDetails",
      "http://www.doximity.com/role/EquityCommonStockandCreationofDualClassStructureDetails",
      "http://www.doximity.com/role/EquityEmployeeStockPurchasePlanDetails",
      "http://www.doximity.com/role/EquityEmployeeStockPurchasePlanValuationAssumptionsDetails",
      "http://www.doximity.com/role/EquityEquityIncentivePlansDetails",
      "http://www.doximity.com/role/EquityPerformanceBasedOptionsDetails",
      "http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsDetails",
      "http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails",
      "http://www.doximity.com/role/EquityStockBasedCompensationExpenseDetails",
      "http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r371",
      "r384",
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Employee Stock Purchase Plan Valuation Assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Stock Options Valuation Assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "auth_ref": [
      "r430",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits.",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Schedule of Unrecognized Tax Benefits Roll Forward"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Future Amortization Expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/BusinessCombinationsIntangibleAssetsandGoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": {
     "auth_ref": [
      "r169",
      "r171",
      "r172",
      "r173",
      "r516",
      "r518"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Schedules of Concentration of Risk, by Risk Factor [Table Text Block]",
        "terseLabel": "Significant Customers Representing 10% or more of Revenue or Accounts Receivable, Net"
       }
      }
     },
     "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r177",
      "r179",
      "r180",
      "r185",
      "r186",
      "r191",
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r201",
      "r202",
      "r203"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment and Geographic Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SegmentandGeographicInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Selling and Marketing Expense",
        "terseLabel": "Sales and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingAndMarketingExpenseMember": {
     "auth_ref": [
      "r74"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling and marketing expense.",
        "label": "Selling and Marketing Expense [Member]",
        "terseLabel": "Sales and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesAPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series A preferred stock or outstanding series A preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series A Preferred Stock [Member]",
        "terseLabel": "Series A"
       }
      }
     },
     "localname": "SeriesAPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails",
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesBPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series B preferred stock or outstanding series B preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series B Preferred Stock [Member]",
        "terseLabel": "Series B"
       }
      }
     },
     "localname": "SeriesBPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails",
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeriesCPreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Outstanding nonredeemable series C preferred stock or outstanding series C preferred stock. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Series C Preferred Stock [Member]",
        "terseLabel": "Series C"
       }
      }
     },
     "localname": "SeriesCPreferredStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails",
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ServiceOtherMember": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, financial service, and other financial service, classified as other.",
        "label": "Service, Other [Member]",
        "terseLabel": "Service, Other"
       }
      }
     },
     "localname": "ServiceOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/RevenueRecognitionDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r93"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation, net of amounts capitalized"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityEquityIncentivePlansDetails",
      "http://www.doximity.com/role/EquityRestrictedStockUnitsDetails",
      "http://www.doximity.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Forfeited (in shares)",
        "terseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsDetails",
      "http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails",
      "http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsDetails",
      "http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails",
      "http://www.doximity.com/role/EquityRestrictedStockUnitsDetails",
      "http://www.doximity.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r381"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails",
      "http://www.doximity.com/role/EquityEmployeeStockPurchasePlanDetails",
      "http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsDetails",
      "http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "terseLabel": "Unvested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsDetails",
      "http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Number of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Ending balance (in dollars per share)",
        "periodStartLabel": "Beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted- Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r386"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Total fair value of vested equity instruments"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityRestrictedStockUnitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield (in percent)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityEmployeeStockPurchasePlanValuationAssumptionsDetails",
      "http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum",
        "terseLabel": "Expected volatility, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityEmployeeStockPurchasePlanValuationAssumptionsDetails",
      "http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum",
        "terseLabel": "Expected volatility, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityEmployeeStockPurchasePlanValuationAssumptionsDetails",
      "http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum",
        "terseLabel": "Risk free interest rate, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityEmployeeStockPurchasePlanValuationAssumptionsDetails",
      "http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum",
        "terseLabel": "Risk free interest rate, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityEmployeeStockPurchasePlanValuationAssumptionsDetails",
      "http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockWarrantsDetails",
      "http://www.doximity.com/role/EquityCommonStockandCreationofDualClassStructureDetails",
      "http://www.doximity.com/role/EquityEmployeeStockPurchasePlanDetails",
      "http://www.doximity.com/role/EquityEmployeeStockPurchasePlanValuationAssumptionsDetails",
      "http://www.doximity.com/role/EquityEquityIncentivePlansDetails",
      "http://www.doximity.com/role/EquityPerformanceBasedOptionsDetails",
      "http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsDetails",
      "http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails",
      "http://www.doximity.com/role/EquityRestrictedStockUnitsDetails",
      "http://www.doximity.com/role/EquityStockBasedCompensationExpenseDetails",
      "http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": {
     "auth_ref": [
      "r372",
      "r374"
     ],
     "calculation": {
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number",
        "terseLabel": "Units outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails",
      "http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsDetails",
      "http://www.doximity.com/role/EquityRestrictedStockUnitsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r397"
     ],
     "calculation": {
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Shares available for future grant (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Vested and exercisable, at end of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, vested and exercisable at period end (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r386"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Unamortized compensation expense, option"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedTerseLabel": "Options forfeited and expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited or expired (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Options granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityEquityIncentivePlansDetails",
      "http://www.doximity.com/role/EquityPerformanceBasedOptionsDetails",
      "http://www.doximity.com/role/EquityStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r385"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted-average grant-date fair value of options granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r397"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value, outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r373",
      "r397"
     ],
     "calculation": {
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "terseLabel": "Options outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails",
      "http://www.doximity.com/role/EquityEquityIncentivePlansDetails",
      "http://www.doximity.com/role/EquityPerformanceBasedOptionsDetails",
      "http://www.doximity.com/role/EquityStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Ending balance (in dollars per share)",
        "periodStartLabel": "Beginning balance (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted-Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [
      "r387"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value, vested and expected to vest at period end"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Vested and expected to vest, at end of period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price, vested and expected to vest at period end (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period",
        "terseLabel": "Employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityEmployeeStockPurchasePlanDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r364",
      "r369"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails",
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails",
      "http://www.doximity.com/role/EquityEmployeeStockPurchasePlanDetails",
      "http://www.doximity.com/role/EquityEmployeeStockPurchasePlanValuationAssumptionsDetails",
      "http://www.doximity.com/role/EquityEquityIncentivePlansDetails",
      "http://www.doximity.com/role/EquityPerformanceBasedOptionsDetails",
      "http://www.doximity.com/role/EquityPerformanceBasedRestrictedStockUnitsDetails",
      "http://www.doximity.com/role/EquityRestrictedStockUnitActivityDetails",
      "http://www.doximity.com/role/EquityRestrictedStockUnitsDetails",
      "http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails",
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails",
      "http://www.doximity.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityPerformanceBasedOptionsDetails",
      "http://www.doximity.com/role/EquityStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche One [Member]",
        "terseLabel": "Share-based Payment Arrangement, Tranche One"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityRestrictedStockUnitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Third portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche Three [Member]",
        "terseLabel": "Share-based Payment Arrangement, Tranche Three"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheThreeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityRestrictedStockUnitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche Two [Member]",
        "terseLabel": "Share-based Payment Arrangement, Tranche Two"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityRestrictedStockUnitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r366",
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage",
        "terseLabel": "Vesting percentage"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityRestrictedStockUnitsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Expiration period from the date of grant"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityEquityIncentivePlansDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r390",
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityEmployeeStockPurchasePlanValuationAssumptionsDetails",
      "http://www.doximity.com/role/EquityStockOptionsValuationAssumptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r397"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value, vested and exercisable at period end"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Average remaining contractual term, vested and exercisable at period end"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Average remaining contractual term, outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Average remaining contractual term, vested and expected to vest at period end"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase price of common stock expressed as a percentage of its fair value.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent",
        "terseLabel": "Purchase price of common stock under an employee stock purchase plan as a percentage of market price"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityEmployeeStockPurchasePlanDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r320",
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).",
        "label": "Shareholders' Equity and Share-based Payments [Text Block]",
        "terseLabel": "Equity"
       }
      }
     },
     "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/Equity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SoftwareDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Internally developed software for sale, licensing or long-term internal use.",
        "label": "Software Development [Member]",
        "terseLabel": "Internal-use software development costs"
       }
      }
     },
     "localname": "SoftwareDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/PropertyandEquipmentNetTotalPropertyandEquipmentNetDetails",
      "http://www.doximity.com/role/SummaryofSignificantAccountingPoliciesPropertyplantandequipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SovereignDebtSecuritiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt security issued by foreign government (not within the country of domicile of the entity).",
        "label": "Sovereign Debt Securities [Member]",
        "terseLabel": "Sovereign bonds"
       }
      }
     },
     "localname": "SovereignDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsDetails",
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State and Local Jurisdiction"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r22",
      "r23",
      "r24",
      "r105",
      "r106",
      "r134",
      "r139",
      "r144",
      "r149",
      "r153",
      "r161",
      "r162",
      "r163",
      "r226",
      "r288",
      "r292",
      "r293",
      "r294",
      "r297",
      "r298",
      "r308",
      "r309",
      "r312",
      "r313",
      "r315",
      "r519",
      "r663"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CoverPage",
      "http://www.doximity.com/role/EquityCommonStockandCreationofDualClassStructureDetails",
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails",
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r50",
      "r67",
      "r68",
      "r69",
      "r113",
      "r114",
      "r115",
      "r118",
      "r127",
      "r129",
      "r160",
      "r230",
      "r315",
      "r317",
      "r403",
      "r404",
      "r405",
      "r449",
      "r450",
      "r502",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533",
      "r534",
      "r633",
      "r634",
      "r635",
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r113",
      "r114",
      "r115",
      "r160",
      "r592"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": {
     "auth_ref": [
      "r23",
      "r24",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.",
        "label": "Stock Issued During Period, Shares, Acquisitions",
        "terseLabel": "Issuance of common stock in connection with an acquisition (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r49",
      "r302",
      "r315",
      "r316",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "terseLabel": "Conversion of redeemable convertible preferred stock upon initial public offering (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": {
     "auth_ref": [
      "r23",
      "r24",
      "r315",
      "r316",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).",
        "label": "Stock Issued During Period, Shares, Conversion of Units",
        "terseLabel": "Conversion of stock (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfUnits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockandCreationofDualClassStructureDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r23",
      "r24",
      "r315",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Issuance of common stock in connection with the employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.",
        "label": "Stock Issued During Period, Shares, Issued for Services",
        "terseLabel": "Issuance of common stock in exchange for services (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r23",
      "r24",
      "r315",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of common stock upon initial public offering, net of underwriting discounts and commissions and deferred offering costs (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r23",
      "r24",
      "r315",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Vesting of restricted stock units (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r23",
      "r24",
      "r315",
      "r317",
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Options exercised (in shares)",
        "terseLabel": "Exercise of stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.doximity.com/role/EquityStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueAcquisitions": {
     "auth_ref": [
      "r50",
      "r315",
      "r317"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued pursuant to acquisitions during the period.",
        "label": "Stock Issued During Period, Value, Acquisitions",
        "terseLabel": "Issuance of common stock in connection with an acquisition"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueAcquisitions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r50",
      "r315",
      "r317"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "terseLabel": "Conversion of redeemable convertible preferred stock upon initial public offering"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r23",
      "r24",
      "r315",
      "r317"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Issuance of common stock in connection with the employee stock purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.",
        "label": "Stock Issued During Period, Value, Issued for Services",
        "terseLabel": "Issuance of common stock in exchange for services"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueIssuedForServices",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r23",
      "r24",
      "r315",
      "r317"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of common stock upon initial public offering, net of underwriting discounts and commissions and deferred offering costs"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r50",
      "r315",
      "r317"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock repurchase program, authorized amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramPeriodInForce1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period which shares may be purchased under a stock repurchase plan authorized by an entity's Board of Directors, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Stock Repurchase Program, Period in Force",
        "terseLabel": "Stock repurchase program, period in force"
       }
      }
     },
     "localname": "StockRepurchaseProgramPeriodInForce1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": {
     "auth_ref": [
      "r23",
      "r24",
      "r315",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased and retired during the period.",
        "label": "Stock Repurchased and Retired During Period, Shares",
        "negatedTerseLabel": "Repurchase and retirement of common stock (in shares)"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": {
     "auth_ref": [
      "r23",
      "r24",
      "r315",
      "r317"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).",
        "label": "Stock Repurchased and Retired During Period, Value",
        "negatedTerseLabel": "Repurchase and retirement of common stock"
       }
      }
     },
     "localname": "StockRepurchasedAndRetiredDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r24",
      "r29",
      "r30",
      "r106",
      "r209",
      "r226",
      "r519",
      "r555"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Stockholders\u2019 Equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": {
     "auth_ref": [
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.",
        "label": "Stockholders' Equity Note, Stock Split, Conversion Ratio",
        "terseLabel": "Forward split ratio"
       }
      }
     },
     "localname": "StockholdersEquityNoteStockSplitConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/DESCRIPTIONOFBUSINESSDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r535",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails",
      "http://www.doximity.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r535",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r535",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails",
      "http://www.doximity.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r535",
      "r557"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CommitmentandContingenciesDetails",
      "http://www.doximity.com/role/SubsequentEventsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r556",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Subsidiary or Equity Method Investee [Line Items]",
        "terseLabel": "Subsidiary or Equity Method Investee [Line Items]"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Different names of stock transactions and the different attributes of each transaction.",
        "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]",
        "terseLabel": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/DESCRIPTIONOFBUSINESSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/DESCRIPTIONOFBUSINESSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "terseLabel": "Subsidiary, Sale of Stock [Line Items]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/DESCRIPTIONOFBUSINESSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosures of cash flow information"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TangibleAssetImpairmentCharges": {
     "auth_ref": [
      "r5",
      "r275"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The charge against earnings resulting from the aggregate write down of tangible assets from their carrying value to their fair value.",
        "label": "Tangible Asset Impairment Charges",
        "terseLabel": "Impairment charges"
       }
      }
     },
     "localname": "TangibleAssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/PropertyandEquipmentNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TaxCreditCarryforwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Tax Credit Carryforward [Line Items]",
        "terseLabel": "Tax Credit Carryforward [Line Items]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardTable": {
     "auth_ref": [
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A listing of tax credit carryforwards available to reduce future taxable income including descriptions, amounts, expiration dates, limitations on use and the related deferred tax assets and valuation allowances.",
        "label": "Tax Credit Carryforward [Table]",
        "terseLabel": "Tax Credit Carryforward [Table]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxesPayableCurrent": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Taxes Payable, Current",
        "terseLabel": "Sales and other tax liabilities"
       }
      }
     },
     "localname": "TaxesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/AccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity [Abstract]",
        "terseLabel": "Redeemable Convertible Preferred Stock"
       }
      }
     },
     "localname": "TemporaryEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityByClassOfStockTable": {
     "auth_ref": [
      "r16",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table of capital stock that is classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. This table may include a description by series, value, shares authorized, shares issued and outstanding, redemption price per share and subscription receivable.",
        "label": "Temporary Equity, by Class of Stock [Table]",
        "terseLabel": "Temporary Equity, by Class of Stock [Table]"
       }
      }
     },
     "localname": "TemporaryEquityByClassOfStockTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails",
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "auth_ref": [
      "r288",
      "r292",
      "r293",
      "r294",
      "r297",
      "r298"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Redeemable convertible preferred stock, $0.001 par value; zero and 76,350 shares authorized as of March\u00a031, 2022 and 2021, respectively; zero and 76,287 shares issued and outstanding as of March\u00a031, 2022 and 2021, respectively; liquidation preference of zero and $81,672 as of March\u00a031, 2022 and 2021, respectively",
        "verboseLabel": "Carrying Value"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity Disclosure [Abstract]"
       }
      }
     },
     "localname": "TemporaryEquityDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Temporary Equity [Line Items]",
        "terseLabel": "Temporary Equity [Line Items]"
       }
      }
     },
     "localname": "TemporaryEquityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails",
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TemporaryEquityLiquidationPreference": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Liquidation Preference",
        "terseLabel": "Liquidation Preference"
       }
      }
     },
     "localname": "TemporaryEquityLiquidationPreference",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockOutstandingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityLiquidationPreferencePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The per share liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Liquidation Preference Per Share",
        "terseLabel": "Temporary equity, liquidation preference per share (in dollars per share)"
       }
      }
     },
     "localname": "TemporaryEquityLiquidationPreferencePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TemporaryEquityParOrStatedValuePerShare": {
     "auth_ref": [
      "r16",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.",
        "label": "Temporary Equity, Par or Stated Value Per Share",
        "terseLabel": "Redeemable convertible preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "TemporaryEquityParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TemporaryEquitySharesAuthorized": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Authorized",
        "terseLabel": "Redeemable convertible preferred stock, authorized (in shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesIssued": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Issued",
        "terseLabel": "Redeemable convertible preferred stock issued (in shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails",
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "terseLabel": "Redeemable convertible preferred stock outstanding (in shares)"
       }
      }
     },
     "localname": "TemporaryEquitySharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFREDEEMABLECONVERTIBLEPREFERREDSTOCKANDSTOCKHOLDERSEQUITYDEFICIT",
      "http://www.doximity.com/role/EquityCommonStockReservedforIssuanceDetails",
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails",
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockSummaryofRedeemableConvertiblePreferredStockOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquityTableTextBlock": {
     "auth_ref": [
      "r16",
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity [Table Text Block]",
        "terseLabel": "Summary of Redeemable Convertible Preferred Stock"
       }
      }
     },
     "localname": "TemporaryEquityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r218",
      "r219",
      "r223",
      "r224",
      "r225",
      "r303",
      "r314",
      "r493",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsDetails",
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember": {
     "auth_ref": [
      "r609"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt issued by US Government Corporations and Agencies. Investments in such US Government Corporations may include debt securities issued by the Government National Mortgage Association (Ginnie Mae) and by the Federal National Mortgage Association (Fannie Mae) and the Federal Home Loan Mortgage Corporation (Freddie Mac).",
        "label": "US Government Corporations and Agencies Securities [Member]",
        "terseLabel": "U.S. government and agency securities"
       }
      }
     },
     "localname": "USGovernmentCorporationsAndAgenciesSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/FairValueMeasurementsDetails",
      "http://www.doximity.com/role/InvestmentsCostGrossUnrealizedGainsandLossesandFairValueofInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnbilledReceivablesCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount received for services rendered and products shipped, but not yet billed, for non-contractual agreements due within one year or the normal operating cycle, if longer.",
        "label": "Unbilled Receivables, Current",
        "terseLabel": "Unbilled revenue"
       }
      }
     },
     "localname": "UnbilledReceivablesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/RevenueRecognitionNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic": {
     "auth_ref": [
      "r147",
      "r150",
      "r151"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.",
        "label": "Undistributed Earnings (Loss) Allocated to Participating Securities, Basic",
        "negatedTerseLabel": "Undistributed earnings attributable to participating securities, basic"
       }
      }
     },
     "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted": {
     "auth_ref": [
      "r145",
      "r147",
      "r150",
      "r151"
     ],
     "calculation": {
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of undistributed earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.",
        "label": "Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted",
        "negatedTerseLabel": "Undistributed earnings attributable to participating securities, diluted"
       }
      }
     },
     "localname": "UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r416",
      "r425"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesNarrativeDetails",
      "http://www.doximity.com/role/IncomeTaxesSummaryofUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r426"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "negatedTerseLabel": "Reductions for tax positions related to prior years"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesSummaryofUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r427"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Additions for tax positions related to the current year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesSummaryofUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r426"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Additions for tax positions related to prior years"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesSummaryofUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations": {
     "auth_ref": [
      "r428"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from lapses of applicable statutes of limitations.",
        "label": "Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations",
        "negatedTerseLabel": "Reductions related to a lapse of statute"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesSummaryofUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "auth_ref": [
      "r429"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "terseLabel": "Effective tax rate"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r164",
      "r165",
      "r167",
      "r168",
      "r174",
      "r175",
      "r176"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/SummarySignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r436"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "terseLabel": "Increase in valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/IncomeTaxesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ValuationTechniqueAxis": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by valuation approach and technique.",
        "label": "Valuation Approach and Technique [Axis]",
        "terseLabel": "Valuation Approach and Technique [Axis]"
       }
      }
     },
     "localname": "ValuationTechniqueAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ValuationTechniqueDomain": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation approach and technique.",
        "label": "Valuation Approach and Technique [Domain]",
        "terseLabel": "Valuation Approach and Technique [Domain]"
       }
      }
     },
     "localname": "ValuationTechniqueDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ValuationTechniqueOptionPricingModelMember": {
     "auth_ref": [
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Valuation technique calculating price of option.",
        "label": "Valuation Technique, Option Pricing Model [Member]",
        "terseLabel": "Valuation Technique, Option Pricing Model"
       }
      }
     },
     "localname": "ValuationTechniqueOptionPricingModelMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r542",
      "r549"
     ],
     "calculation": {
      "http://www.doximity.com/role/LeasesComponentsofLeaseExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease cost"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/LeasesComponentsofLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]",
        "terseLabel": "Vesting [Axis]"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityRestrictedStockUnitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r397"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]",
        "terseLabel": "Vesting [Domain]"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityRestrictedStockUnitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Common stock warrants"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersAntidilutiveSecuritiesExcludedfromComputationofNetIncomePerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.",
        "label": "Warrants and Rights Outstanding",
        "terseLabel": "Warrants and rights outstanding"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockWarrantsDetails",
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": {
     "auth_ref": [
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.",
        "label": "Warrants and Rights Outstanding, Measurement Input",
        "terseLabel": "Warrant, measurement input"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstandingMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockWarrantsDetails",
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_WarrantsAndRightsOutstandingTerm": {
     "auth_ref": [
      "r510"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Warrants and Rights Outstanding, Term",
        "terseLabel": "Warrants and rights outstanding, term"
       }
      }
     },
     "localname": "WarrantsAndRightsOutstandingTerm",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/EquityCommonStockWarrantsDetails",
      "http://www.doximity.com/role/RedeemableConvertiblePreferredStockNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r133",
      "r153"
     ],
     "calculation": {
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r131",
      "r153"
     ],
     "calculation": {
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted-average shares used in computing net income per share attributable to Class A and Class B common stockholders, basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "terseLabel": "Denominator"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://www.doximity.com/role/NetIncomePerShareAttributabletoCommonStockholdersScheduleofEarningsPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 9
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1828-109256"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2740-109256"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "65",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2793-109256"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "66",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2814-109256"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(27)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5144-111524"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL121698322-111563"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27198-111563"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL6284393-111563"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27357-111563"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82922868-210454"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL120267853-210455"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL120267856-210455"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922897-210455"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.A)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=122040515&loc=d3e105025-122735"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123353750&loc=SL49131251-203054"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123353750&loc=SL49131252-203054"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123353750&loc=SL49131252-203054"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "40",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=118172244&loc=d3e17916-109280"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=16397303&loc=d3e19379-109286"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2443-110228"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=27011672&loc=d3e149975-122751"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=SL6540498-122764"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 4.C)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "50",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130556-203045"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130558-203045"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130550-203045"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "705",
   "URI": "http://asc.fasb.org/topic&trid=2122478"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "710",
   "URI": "http://asc.fasb.org/topic&trid=2127225"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "712",
   "URI": "http://asc.fasb.org/topic&trid=2197446"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=SL116886442-113899"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4549-113899"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)-(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "740",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120384911&loc=d3e23163-113944"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(b)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=124434304&loc=d3e36027-109320"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Subparagraph": "(a)-(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=d3e5291-111683"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90193-114008"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=123371682&loc=d3e55415-109406"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(a)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=SL120269850-112803"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=116652737&loc=d3e64164-112818"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128487-111756"
  },
  "r655": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r656": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r657": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r658": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r659": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r660": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r661": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r662": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r663": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r664": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r665": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r666": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r667": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r668": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r669": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r670": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r671": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r672": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3151-108585"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>113
<FILENAME>0001516513-22-000037-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001516513-22-000037-xbrl.zip
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MAB1+ICIID074 1<"&#.FD)4&2!( R66,Y:A *;AW.7# DBS/6<AV 0#R@V.
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M3O"$"JSVAG&AE@3 *\)?60#[$*Q063/+.3"FK=>:1YTC$OLV6BT'@%>4N[(
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M57<)E$=S[KA!FTLJ8<^UDR9X)LON+B-3K, :RSG ZRK@64[E 4Y>AB@2./!
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M.\:QS%(O#AX_/^EW6T.2U-52=RHG,;W\ \QZE5F*G&>PRA::J+3TVCCCF*U
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M^MJK/F;L]S&-BLRO]EX?61<R6RV(>3H @SF$:$/RR#G/WOD*K(.YM8">5E-
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MT:< S$67/9!!YIR!5\2;)_&R9G9>4?QCPX9K=QTF:Q+--$(8S709V:<@TT)
MZ75*J Q]-DF*RS,K%T8N=S"<>R=R"3H;&RPZ:3V0GECG)=C(G W:N*0OQ]MM
M?6$$=$?#2S<,MU]*Z+O#[9^+_LJZK8Q!:54.A54@E;.D9BYJ,GXV* FPB,*\
MQ\F3>Y:F1&0RN"05.# I> Y!1,5%<"%*J>=_[GJ>7-D4IZBCEEP'+<B'@77"
MEA/0K-4("B'%A9/+W;JR*6X^%<PHJ54,3H-5W EI5<BNS&LIIT8KJBC F6.Y
M?(^N$TD?]GT<OFL-#]_L-/'3X%V/JM[&XUY_^/+5G5)T,[T,H=DYT#IFEQ4
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M$0+8)&)T(G)&WW#^5SO.F@S?R6)%S5G('"0S%)DH%D,H&V^\=SGXS(2L["#
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M@SMZ#W0M-O_LZ4'5[LFSW,5(GINNO3@HV_NU;?\#'MV\Y;9Y5I_TB\+^'=5
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M?FZ4I.92^VY\8X^ND9)%3]KPP<7\;0:8V@SI TQM_/%Y:>%)Y4.]6E%(//B
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M#AB*I,NNBR?+7M(G CGW^:1[)LK8T@*AF[(K^$_I)U[5SD79E<"& 9-C9"B
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MW#@JX?X.=YKE_9:=IL6Z0O),MJ@A5Z25MG_VSA5"PK3++6>@%=:^Z"8C#_D
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M6+O,QBK*,_[?-[L+3K=B%0.8,[F4-7V(BC="AFTT?@C/]D:T&JJK2&Q;*2I
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M#\!A5 H/2C)T0HQ\XL2O)IX-'5F"AXZ.*'0%*E8W^1],!H\,=W:5-U6]YD0
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M*ET!H#!JVV-ZNHCA - T1#I:"^)\U=U2H?<.LK)=)#]P@OBF=8<H^6G<D_6
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M]L"P3($N,-!??;WK/G:34[:$PHT11=]!W'1*.R?#.(1VWNY'<R7$K,<]=A)
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MZ0P],EKT<CGLGD^>P5HJ,08K(8I+0U-L*9.3!>RJ%RG3)1O?:E[FOO-W0T*
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M/XQ]\>R0J%W-*PZ'3'UJY5V ?_P+3$,0GT@@4PQN7G5UTZF2]D4#^:3R&LA
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M"]YQ7=VJWQ0GU(X,A #'83S6Q3OTJW_PIR\E!9IU'WN-/+DA0C?O99P;[NA
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M"L6$8!QSWB7;=HPEG4X.*P!&PY-9FRX:'$E*VL/2ZR2K:K=@D"L'TVL\93K
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M_",^NW2>Q#7Y$W?US [@/!IPO]4#((A9'0PNZ@6NHCA$F'R>S:"A"/!4*!.
MNRPL7*[891(42O<N)T@\#Y)CMF]$AX<MW6A%&,G+Y5J[3%9J :>D*O@Q3)QK
M^2 B1PAT_[4K(M+@S4_:V2G3URKONZBD+'MWT[<PC?2*R7SU1X[Z"RY8X-'3
MK+/0'$G> GQY[ A>CU'9-6,TC;<&^1'#%"I$61QEL:S"&F9!5F4,+:"MV ;E
M18C5?0"F;6[[-;WY]= ?]Y[BR!QN!K$?1Q_+"=KI,B)8*<H7D&J, </RQ;6(
M:YJ5KPU2_AX'1^8((N\MO05NTA_<./"!;">(L:BSLX]AC=EV=-^(XBU3'BH
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M#_KGZV!\TZ6-3+S-5-_Z3&#H-+%0U.QR1;[MXL51P):ON414<='H>3H-VH7
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M5@FDH*V[1MF5FD\/KC_ N6C4RY"2BE42 5/>-W6[$?$QT/6D;Y"K>3<K:WU
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MGU@PLT.":%](W^SCQ6O-K:NI^I"$K?//6)1U[VH_OR-M')W&:6FJH$ER61H
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M[P6[0N;(,9]31YW\N\5GGU[][X!HX\=S]O:!&OS1;:V3%L*F;9,N<"KXXL2
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M<]13?3RD%Y&3H)-.NGU= :^]SY-(&B%V&^T3T$&+I=HQ11MWPHEI9_ZN/MQ
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M1?%7GEGI,]42$[U02?Y!8T"(T.2L$)KX/4XFM]"9"[0#MS<YCH<!!AKOCB,
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M0N74\17F=#MG_%_M<"?Y0SQ)8:7KA$N"UG/]V>:KA6Z(@GW\8P2OD$$YT42
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MI1@3!1CU*8AHN&RN%(@E5,-#TM))951?EBI&_1^'%9U,5#[$N,(7YJ06\@=
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MMEVMYJCS"+6:3U62^= BS..]8#5MKS/@H#G>-U% 2^4_J=T)&R7UX+= \I>
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M*\]'JO>\A)OQJ2]@=829XN:*8?;/ HYD=H?Q._3J2UA*(XB&L,FS)(J26WR
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MN( %'"$A;]$.40'_F-QLB&51FL4?Q?1:F$+LP5;E24IDAY['-%2X#0'C*]R
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MF;C5+S%SHW9P=I+LCC+B@"!,_NQD!O4[O<M=Y^9NH319"G(M5>N);WC:\;9
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MA,,.&8RBF<0,3J/,480E8@%R$9J<COI*&N,EEFGT3W9P+*=>D7GVH7AV3I]
M+"6>8P,DUE&?@,JF='07__ VC0NF0:8^,/@9>CJ666/X943DOLK#2PC@/G!4
M)$/072%HL:4"C9J"0"X Y+4'5/.(/D92$%4)8CQ53B4(HC3G6SQ?=GW@P$AF
MUWNPZ[S&0&74%;0#0I@0M7P/@2&,1:4_4":X@(3RJ#%(ND3L^@)\#&7'RDKU
MA)=@L%3:PW+&&YH1YZZ(0Q85!(>0LD$ '; %U% '%&8>(*ZEMX02H?W:NF+W
M[J&?'0M+RZ>5=JK,?%H-G\Y/_W;0&B()\$%%S4#;R+&:2* HTD&&B*<N3;NX
M?YKE\OD25BAK(F=++(.^, -!.6):(2K1!>V!8&><0PXXI5(N%X,I[U*!@)T3
M%@<-7:IP1[@N*FNZD=,DG@>W/T":1.;V:KE]OMK#P> @)H"1$&T%F-0/[B4P
M"$&#HR+B,4KY$:3.4%5]L7-^Q'U[T/6/CSNC8Y^ZE:7N%HD'X])]ST:&J?W1
M[(]\#9$_[].6[O=W-(''A]$%?@X[?_4ZW?^[-AJ<^L5HYW3_&SVW.;O[*2+
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M: &#V "JH8\F;%3M)+$!*T6Y\&29("J3TU*34U3+'.4HY6@[%4U7&/6SB"Y
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MW=JZ4JC"V'UUW/3$CJ\,JQE6EU07S[#ZN+ ZGU[-D3?&.<"U"( J;*-FSA"
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M1D'H$3(8ZPA;J9,DJ0N^V-*I8N_%DKEQ,^\_B7V1>?^A>'_>NM!<>D\($#1
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M4EFY^H5RA1S1"CG% I,4!FH\I909Z+D5VJEP4\S)VM2#8DJS<QE3,+=02(L
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M;3K56<E] C>B#*=>4A4P-)QAYPB,X.:N![9K&M1E[>VA8>[#99B+!BGBQB#
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M#J2@"A/A"$T)A/B**2*W[DZVC #Q+#GXV<'XL[REVS2"?!@_YF]!-I=\/@
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M^*?T&,%BK<-:O9TLU>]G'X8Q7&+WM?/5*LR^0&8G<SJ:)%)B8@T*A#O$-?R
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M?83E%%K@*?1]3KM4 7OOK$8Z@)C)C<EIIU2CH#0H%R9*27-\!*%MC>\=(;%
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M7\]T$1Z8 :_LVL)[5WG/\_V$*1R[42'.@D$<.X&< D5(4AIASQ)B>)KEO5_
MS33V;BHD5]+S56VI#J.$EZ]<+0='=D+'#CK9RUI)_CEZ?G+SUNC";5FK1LYV
MJ[Z5EY :NYWC*ABQPJJ_O"%>M=9!XK>=#.<.8.TL@K8T%>XKV]1EC:5=*3XG
M((O[K#"T:\VDETV)4\M"U2<3Y(WJ0B>7"/75+%[O8MQZ4O3>\3AY8#R_Z63C
M15VQ]L7C]\/W_<"L!OF9(^P51EQ@BG3N:.=8<B:P:(SDLV(I5]0[S27CH TZ
MAVV@B@B6!/<8X"YG\5[/>>M3WM,_EIH7L(NO%;Q_/N*K3XBSK*T]MS0P[K"Q
MEANB6$Q>@E#GZ!,*'+.VH51/;D48L9=C17HY#-@?MAB93NY"QRI?B5L,]IJ,
MOBS)(E9]>S9_T@YCOL#*ZO#"JCUGSVZ.,?KGV^,5R&0@H WKP/C3'"*4LRE#
M'391&8=B=<QD1W:54MGQXZZ=G"##P_RIXVA[UYH#+RWYSRTW#TNG'X9Q-VT"
M&(^SZ%D(%>\[(E2*0*,A8I\+H1FD:0H(P_SF4 KE IVE&^JC5A%4_2@5EPJV
MD].8QQ@5@]W$V'(JCA_JN+GSW?-<!)J?4G2MVEUQ8<_EE]Q"XIW*ACE#HU(+
MSS4Y()#_C#O94%UGM$Q]4\?V2X2M,IG/VG<_'(Z/3VKYMDI&L97GJ1:D)X+J
MQ&'5N?# _WAHTYB JXGBE;L EO1H' XFQO'SH;3GQI*MX.-L38<G;+?<>%1Y
M"+*D75NQLV7]:P2$9 DZ]QG(7ZL= LEV)BZ)2@6HFF;7BO3(]@XJ\_NDAEN^
MZ4&_'TX[W6[]7;AE&G?A/E_K+W?[O0/4K8(MZ^_4'\M7_\GZ70X5GSH/)PZ"
MG/\5)L]\[KC._K^<CF6_S89[YB\-*\WE8NG@VH<=N.:@2C&*W[+)/A\8]3QV
MA_TJCFEV;2_M!C\)T\P^$SOL5UDZ5V^;GS?__R21_\J]LW?FH#J/J@"9WUJ'
M_5-8#E@IT)7&,*(?FQ)^Z(LN:?^K4MV<]E\2^!LUW/LE\%\K/?[4JC\C'3!J
MC04US 1#N7;1"24X98YD=48;?8==/SDL&Q79\5/A9[7V%&?2'7>!43LY!.@\
MA_ *=85QE? ZZ R_U.P_[OG:0).K<EYVE5^\<79^\$UL+W#>]/K'("S'WM?.
MH-^K^'1RY?RYBXS$ZO2 O7G<Z@"GPJE:,?[XZM$/G^GG.Z[O_K6U@8@!:1^D
M%+C^-;+[8XKNZ_U>1M8DD!]F;!V.J<XH_U;D>+(?@]8 -8% Q\NE"W)N4:Y#
M5/GJA M2&+><<OF5C5&[;JJ=T<I;8RF$]/,"'E<B8RH1ZAS<W2JQ_F@J*T^E
MIMID.S,_OIZ?3#OGH;87>>/Y W9X6"=@Y%\NPM:!DHZKE.TJ@*3*?^_43'4I
M[G8X20BZ$.'J:Y^![.S'-\;;=WH@XXXJ\AKFP<:#G"!;Y2%EN_+@ZWD(;IT;
M'V.6OV%H(2L<$PVC+N%T;8K\I>N?5'Z1'(,S.!<I6]W<#_C2[( 06Q5(:;FS
M6LZO(HAKA>-B/BMW&,QS#LX^K[)01^L,LC=K6 7L52/.@7:NVQD>UF%T( AU
MCL?'V<#2/ZT#<B;+4@4KPT/TIP4 JH6:CN=JE%']5,.YA9K4#[AFK:H1@\8
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MR3YF+D;B,#(TYE!ZXI'Q7"".;2(B&$S-G/*@DR+2>!PB: N64F,==0ZT#.-
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M>*7N O$'GQ>TJ2ZUWZ9KRYU*>T3:'JZ6 R,T[8#S!+XU)<[=<;.'0QHXE'H
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M\DZ/'_O/PWK;A;$GWHI:EWB^YD7 (V8U2V-+E,AW55UNC45 *;XCWDO?;;X
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MI"0Z]\8:TARL(<GR5:5<7TV+U8[UB\YI7P=E#75PT(/#T[')P30 *YJJ<7B
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M*,>%K0-(,@Z@!KY2FWE1&-L&]2E\L449_!)4/J>)GYA6!J$W$+U)=6&9_^G
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MY('L%4KQ3'Q;!3W?RK=8*,L-V%?P!' KN6J+(AG.)]E-+@.B@;\@S>S"A'X
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M,B(1SXGE.H()GG >Q3E3*E+9C>-8G;/IJ<B>UT[N>(?3R=7!X0=ZS+/8Y,(
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MEX4S35'%75;4@XNHZACG=XS/22#F1UURISY1.F\W?._DU)-,,4D5!%"P.F0
MEI01/@:FLREG:+,>]N5A-8'_P.S2YM:K+SL'?Q[N'/RUOW.P+4MVJ?/A%>VL
M_]7MK.^Q[8OM+VW\T^';8]FEOFQOO3[JO/D+?Q__/?A(=]YLL^VMM[3SH8SY
MKX/.P:L+_"-V#LWEUNBW?N])YJ03BT2S" 2B"L11F8@!)9.,15J1/>&S\)6M
MGB1;61N5EL9R%0(8(:WF#GDK&.=S<NI1V>JI)L0?C[+:URF+2Q>"T9$(KC0!
M)I"RM(M$VL0"<I;RSBZM\F5NISZ*50FK$M;C*(HYK;BSL1 7)*Z\,0) J](!
M$:R)U;U:$*YZ?YVK+$^,6BJ(]+1PE3/$>.D(E3)Z1:7VH;I7E:WFX=;N<YS5
M ]7*2LXM !?:^,1#D$EI"QYBJ.[5(E%6N$Y96>N@O9,DRM+>#6T2<1 C49);
MRZ1)SK/Y<Z^>4]>GV7:5?@ZR\B8(9Z*BW @+RCIGG8^@,%3@(@BOJWNU"%Q%
M)[)7QKD@!37$90T$'>=(C+2."$,A>,\LDEEM&_'T\0T2C540-H?&(_%6*(1Y
MR%9):9QVU2%9))"/Y7L\9Y)[GHA,F1'("N%NJ2+<BIAI9HZ6?K-B64Y_>J="
M?&XAKC2$H++S-'L0QEF1)"T']G2DFN6:(5D4=$]D2)BQ/@JB1*($/./$ZRR+
MM)8U(?L<7.W\]!SP'1@$&J1FGD,"9[+FW#)AN6*EAV,UX8L$\K&<@A0X=8$R
MXFA4I64\(\8H2[B!&!U  #J')OPYE?6T^[UT/A*W:>6SAR83[IK7762F,L)$
M9@V5RCF@H- R::IR3I:YP*FM3+4P3,4F,PHV1Z=Y)"4_A.Y(E,0(;TA*VNIH
M,<HL9ZWL,BZ".<I^ULX0,X8X-])QI2+W!@-.]$:T"$D+RF4IF/(UV%@0=(^E
M$J)W(&(H<):9 %A'/#6..,FY4,DXQ6>GUEGQ/;?XIIS[A#?H8J801;(V2VIX
MQI>D8O11@XV*[RGP/99,\-[0@*$C 0,&_Y*!&!N ,.<9RQZ9N^AT5WP_=7PK
MS[3A"9CD&2-,X53IU>BYCB8S?"3515\DD(\E$X3V)0]L26#HG8-VF;B 1AR]
M,^&]=L:#G3\7_9D4*#0'JE^6H60<3*E.Z&>$V'%_T#U]-N4)]/[M 6P"RC1U
M%B*35@?0F3F#5Y;@:'5'%H&I^$0RP8(2T;%,-'>>0,0'ZV30Q"NN.1, 6=2]
MC07$][T/SZ5(I1 8="8!/@D+&')DGWQ +T7IZHXL%,C'CZ,PSBQWE A7NLG2
M% C2.2<L\,!MR";2IENTH%,WF:P0GUN(6U,P[9QT3D!4W#J*2)?*I$2UIKF:
M\ 5!]WAY@E!&11!$!5MZP=-$+/6.Q,RC"#H;P68G;UGQ/;?XEM(Q*:+-(2LH
M1[6HQ<C3!!H"9=D]:OE1->'3@GPLH^ DRQ!2HUPK"!B&)ARR(B)ZYX/P'F.P
M^3/ALRQ/6(QVQN,->:8I47BV'<<LC\Q:;;*(&I(15D0IF19)<(5+^5&3#97)
MIF(R,9%QH"+IP$JM=):<0 ))? B&.'1<,$A)P".=;6YT0=2V*S7<Q<DQ7FFE
MM$$^ .FIY2PF"48Y31F7E1H6BAK&\A0**0 ,-&4/DH!+&,D8C&0$U]'K'(,O
M2C]ZF5%=J:%2PWB#<^\-EUE1PQA>3!FG% LJA\2MTTK6_,:"L,)8?@,82(#,
MB8:,H8\3B1B;#&'<BPC10)KA"<K*"T^.%VR2,5*. ;+S>+%4&OKXD#&N,-8"
M,]5E6"1R&,^+,'#!,B#9)T5 Z$C08]!$T$"M$B9K"DNK3"U;D O"#<] ][A]
M4X?B*GY<QUC%CZ>%UMI@D$Y)N:44O]/^N]9ACKP#!C9DFC/H5(Y*1<]%+H<[
MT460.3RN4%2-&A[J&,B)-*,3.@F!/D'DTA$ 1HE/-A#A#!4V>\5R/4?Q#/"M
MC%)<<>^C4J @V0B6:4-E<,+%QU4%K][_M" ?2QBFH!,-Z.YKJ@6!(A+N) >2
ME*$A!$F-RN70-E>B0OS)0IQ[1+@*4E/A08#QR6<E3?*6Y9AT+6Q:%'2/)?YR
MI(IG88A$\TT@\$2L\YQ(+SQ+*@4??#7A3Q_?#B#QY$4 DT H0(L> E>Q #PR
M)ZH)7R20CR7P6-0F2JZ(T47-0 =.?(RQ_*1 9JUD%/-GPI_)42E>CTH]H$0!
M!)=@(J=(7#$JRT"9D'PHI_]457)=#*;ZTGY96.I:EVOI&;J:-)'D5"80M26&
M)T%HX"%K*U6F];#4,T!X<E(IQ+@+AH)2R6O+O34Y)4"HYWI8:K%@?C$&<TVU
M-Q(BL1(XPIPSXC*GQ.><6#+:*>V65F'9J*DK%"O(YQ;DF>MH8PPZ4 [%F%L;
MJ<X8D6;F>&+5C"\*OMD8OB$'9' O2 P!0XY@/+'6 TF>9TFS96:&$DL5X7.+
M<"\DDR%IK0# .?!)!R<HQIS12FL?%>'5C$\-<S$&\^"R$UQ1(D2(!+B,Q"DE
M"8,0G<;_?-;S9\:?4ZW"CQHUUPSH9< A U!OO*(A D6#Q;FDUEE.8U:QBL$M
M"DF]FT@I*.^3-SH3:;4MQ<V"E(X@).8DT/>40$6H>QQ/'^&*,<MT,KET+W=,
M6:&]HZ+(PVE<"/7P]F+!?#REP (76GIT/I1W!&1&7T1+A5B'4J7LDC"T*5,&
MQBO*GRS*@:'-QB #+#C Z,-'S92C25'/662/6HQ4[?@T !_/*:B8>(A4$%W4
MTR!X3HS GZCD092D<'8S/Z14$3Y_"#?<V\RC%49[D&!M\@GQ#MX T.QJN>%B
MP7P\IP J)VU-)&!*ZE#*0)QEAE =6;8L!"7S'-KQ9U6N4%O/WI.S!"3P62N1
M$WHF7OH8LI8Q<&:33I97KV0QZ*H[D5V()@6JJ2.".?1*T!DA)BI+F*/>.\5S
M,*SN=#P'A-N099"&<8$QB#?94654$LQ(I4U535DLF(]G%XR#Y#D'(M'+))"D
M)#8@ZE,0T7%/N2\*":"6%<R3.EQ%^8R/,@9O:9 T*A[!Y=)<'&,.M.[<(<QC
MS2XL#, G*A9*$8K,%(.-B'9<HQUWSF=B'$U>"9%8JH6'SP#A/%-AC3:@= 05
MN#$I4ZLYU5Y9+1^UZ5NUXU/#?#R[D(3(QCE+? JAB*!%XKD$4K0P*?)YDHS/
MH1U_3B4+[_HX&'RA-T5.X3GD086GS#GN$BVE"Z"=I$KB*YXG95BLAR 6A*3.
M)RL6@A0I<TL2S<47,4!,+ 4,*@7-@K5.UU.9SP#AFEFJ;"H;&QSQ;3WW46#X
M 7@ES]FCUB157V1JF(_G%,K41<D4":K13Y&>>$4]84)X1T.4WLHB.$^MK2!_
MLB!/@BD1?&"9(\P#-5J+I&QP*DL&O&JJ+@R^QU,*$J=3.A])T<(AP&,FUAM+
M.-<T%2DLGVOAX3- N(Q6),:SIER ]=%:GVV4 DVYR)[5E,)BP7P\I<#14INB
MBY143*1L Q%+2]5"8#K%)$W(?/[,^'.J5WB_\FZEM5?2"KVCU#MMZA7<7NJ%
M\VGE&Y]#1M1R!XY''(YJNEU9KH60(3M!,1)1CZK]5.EK.OKJ3"HN!,V$C)D3
M$P0G36\(F[TDRD:?#:-:NT8=QLAY.L-5MSUF"_+(8@:O&,W"@HK6N$0-30JX
MDA;LHRJXURAD&GQ/9AFD%%I:PI1RI1E4),9&1WP !E$'E5*J&YM/'^&X"$1,
MC$6$,S =O!<J&AF,EI(S>%2)MXKP:1 ^GF=(240N?"!)9D7 *4U,450Q.,M,
M8A"2M:T(?_H(=T(F5\Y%,&Z!1F6E4IXRR1'KCM*:9U@LF(_G&9P*MHCM$A8E
M(R!<)BZ'2"P&9\%I[4,V\^>H/[_^M$<W=5ZI36H?4N% ;7)&2684+?5Y#CU9
MD_%%$30-SE9"6R!"FQ1F2%)FXW4FRII @%I/G#:29)8L%<K;Z.V,".V>2%J@
MG9-G2PZ>Z\PIVD2( (XG1V-T*4J%- $NU ,7BT4.$PJ1(+Q$[B>1%X7(%!QZ
M.Z")UMPX[I42+BRM:K[,S:Q4JRL[/!UV,(FF0$T(5G( ZBQ/NC@1/@@K96U8
ML3C$,)[M8 [)@#I&>/2FM*-$K\':2*BRT=$$40FHO6HK,]Q>C9$H3QFMBE7@
MN;594_0VN8A.8]0+U6]8*'H8SY)8D#09:4DV$0B$R(CG2I#L,8R@.E)>FM)I
MM<RF/^#Q2.SP#+K5#C,GP0WV6^D_9]U/B(+>Z5!8XD[IE#OV,QW>X@N!$Q'[
M9^62S21-Q87S]BC_\8N>S5.Q#R9'T$Q&YS,#Q8V/G"M@7!@*/(IJ'Q;)/DSJ
M=4CCHDK9$$X9NH_,>&(LIX1&G:7+-D%.2ZM,+"NK9I1&GPW ?O$N6V78RK"S
MVJ=$ESO95/I)>O">6N>XEE(FYB*S]%'%D"K#3LVP$T*L B<Q"T;0=$IDV"2(
MA\Q*88*P1AEG*$</W"X+2RO#5H:M##M['U9(97QPG .'%+GG/@1AM$LB!^&J
MW-S"D.M$K1?&(<I)3X07"<DU*V*HI@0@1,ETQIAEYHUU*KM6=JWL>F7GF7FN
M@LX1O=92AN6\3J5TGB40>+%:EK)8%#N>0690Y%2$)M)91R"B_VI,EH1:S7)B
MRB !+ZU:L4S-T\@0-/GE?S8I5OPW=C^M7MY6Y^P(P116_P=?O+R)(W>RU^U=
MCM5>I[J#L\%I-Y\/7^KV8NHAODQ#Q#/%-*-W O4Z8JNWUSK=3ZW<+<AHG2=W
M,F@E'%ELM=U)V!].F&#++00M;S+.!;W+S8=>]H]PU.>M?1=;O7[K] 3'DA->
MP*?3SRGU6H?I4SIL6C8WW^&Z)ZU/[O LM?:[Z:1<_GSEZUKX^F +F71[9ZY9
M,%<?[6CL4,H<FP;0^ LO3M(A_N:G]-OG;CS=QSMOV.K*IT8S0;]]Q'E<(6>G
MMW_DNW,84F&:7S1CVHP]KRM_EQMH2$T%0(0RH"EZ,%88[R )ZKFEP:9L=YE5
M2Y>?VC^YO(=CMY>(/TGN(W$9;_&%._SLS@=+_[S^;/#!C(:D.8[YMF?X^$],
MW[S&-__>:&]L;2^W-CHOQU;;' ZW@\S^KK6UV7JYV7FW^<?&^MK6J_76ZXW.
M6N?EQMH?K7=;^$+[56?KW4T+X;MK>/1*X4GU")1S\_VIE2&CC S!-1X=ZU3B
MLX7@M+4I0<C22N&"EQ%L\LPIMKO>N!% &2G4-/0GKGL0_S[I'R.SG__[T/5.
MUWKQU7_.NL?EB/,ZLMUA?W!VDK;P^_YUV \??ZU#\&5S:_O33N_W_9V+/AKD
MUQ^WM]:@?? *VN7[CMY_V5Q_+SKE.P[>XG=ML_;17Q\[+RW=^7N?AJ._>NZ#
M/=L\^//C]H<_]]OK>^?MK;W/[:VWYSM;KZ"S%7C[X",Z'?_J=@[>G^]\>$O_
MOGC/\7HX)KR/]3;;W-J#7>E @XN9A&1XV1PVQ#(6B4J&J92\=<(-G3WDYQ37
MBI-5",4(-+,B&4#C;T1D(D,"S9-S)BVU$EJ6XP(Q=-.65B_GI#$E7R=D&=?7
MZ819O;;"QRS#<+I^^.VW?$Z@QR(%+AZN''AF\9/:V*BM!\FSH_>P!W-FTZ\]
MW_3M^?;2:9FY07=PBK;]TB+W#P_[GXL/\%_=WA"2I_O],_S^./CO%[>2Y=WL
MXVA3^M(*-TX:/H5#=SQ(+RY_^"UV!\>'[OQ%M]?<2_.AWZY_0;'W8QY:\WW#
MM[]9H!4ZM$*C6H#1-X_>7FG>&O,XA^\INT*UO/5MNL)N?>][EV5B13+[H,M^
M_SUAX*<,EO,[7?8']18_K+ZR$[]Z0U)@N(I^301\L^5::_S8QBENH3]\+8:9
M]I%<2=Q\"V;8=T.9^7Y8Q2+?>J;G/G?[K!X9N\^B>@IU3:_/3GK=4W3#KENK
M!^8'?K "GG3R\4?W_E22BU:+D-#7]Q( T"TUX*U!IRWSK!7WP\)U_N/DXJVA
MP9N3_F P+WG"!X<%VQ]^'Y1<7^?@KZ/.UD?:W@H7VT<;M/WA_?GVUD>^<[#3
MW3["/Q_:LG.Q]WGG\C-__[[OC^+AYL%'WOFPC6$!CO.BT\7[^K*S]?O^YM;.
M4>?H]^[.T>_[VQ<?Q>;ZOS[^?='D!YM*(@PE.(YI5P;%F6>&^&@L 1H21A)*
M$2E5#ES@U"FUM"K$C#.$/[8!"[#'4FGLZ=,84.-DIC$PEL%(4ZHII1).::LM
M->RN>R25QF9+8^?7:8Q[F6W@GJ0DRR8R8\25\W8F!FFMR-8[@Y[;],J%CT)C
M,](:F&?>*3L29Z=E"Z(XE(-^/OWL3E+MD7!;OZ;HE+74AE2*N9DV@HM$8P8M
MF;*&5V_J%]#0QH0W16GTWC)!8BAY694D<3H5&2,1<M0B1AG+H9UY$E"M*LDS
MUD'/0KE(+:(S@&/&9I=E.9UG*=5P]Q.[%:JSA>J8Q^ R3RZY2$ *1L +3VSR
MDL2L.6AC05E J%*8(Z@^@T33'\D-TG[_,+:Z1\<G_4^IK/BJ:7QKE[>@8F04
M6(X*0$KG;=3&B^A<%%F9ZA?\ K)I3_@%&4H_-L^)=Q[))@E+'+66!&H3XS$9
MQ5PY2C"K+,L<Y5(J5"_/ZZ<8 ECT#G2":-!!+)VU\;XYE=3I.Y_'K%"=+53'
M_ *I,SKQVA-FO2JE%8H8J8%8R20%7 5(ITNK$F:52:CY@CL!K:D:[N%0S@;I
M:[H <?(I'?:;U8\W/GB@H_ <HA(O/=)+ J62 ^.I$9D:FE,T1G(O9K8=LP U
MW0M"36\GO @=!$@N)$F66J0F \2!-/A70@^0<9-87EIE<IE*/4=12TTPS-CG
M-TXGYP-S$,$H;[D1$+U46B?K^)W[I58H/R*4Q[,/-%#T(3P&!$(3R*FT6<J*
MV*#!,J]M9A&A3)<MG95F:$U W$/!Y_C&XLQITA#/5J<L"60EI2'KZ($:ZYD2
M-DD;A8<<E:^>Q[S1U?L)S\-XEWE6@2A;.C-H18FU,A+%I0(GE$!W$NE*+=N9
M:;8OR''<2@%W27UD'T *H-DSL X<<(9!-0W1,,U2]5CFD0+&/):D4W3.*R*:
M(R?,)^)<Y(1K+W.V(J?,D +X,J@9JZ',CQ[AXJ5-_DB#P8N6"^'LZ.S0E0,E
M,1V?("2&1VR:!I)'?1SN1?/"\TJ?_-<O\&+6ODW%^I69P)\/4_D!66WMRH3<
MRGB5[&9'=MN3^S5<Q2A3)IR7S6'+(K%"9"(3YXI99L':I56S#'J2Z_Z[YEB>
M -YGY;)4O,\EWL><FW(\07,;B8NYM+X&AO%-=B1(AD1@.3<Z+JW"LE%\/O#^
MS!,QS2G9JIU<E9$6-6?529719\CHX89*7$-Y$$""DXJ C(IXF31)@6I.K58J
MRL:#,S-.6%5UN<JAE4,?(^E7.736'#KF%<>869 NDV0 O6*//YF0%,D:E&&>
M1RKHTJI>EO9I<.@M^G&WRIPMDMK,^O?2?JWTY3CU!JF%/][L<!><W4-^;GFD
M/3=2H:.MSV[0^L=]CET^1%/J"HO(28W*;_=_-]90"\H:#Q>:PFMMM45[_3W@
MOQ+OC>]RI31WT9*0BC@O98YX0QVQ3*?H)0\V.0R,5R;38"U<Q(?XP_*]YITR
MFPV H44:CUM< 8QJC2O!LTRS4LV\T\MYG[0>==YG,._OV:[Q(*3)G"@C,@&K
M G%. 8DA DLN!V7\TBI?F2Q8OYSW!OOWF7JC6.(0&099#*@"9P*3EADP23JM
M>)EZ9B^GGM:I_QE3'_@NY9;'&#U:_6 )))N)0S!B^.2,H$%$IMC2*EV9+(#^
M!OF3-#A.H:A]'IZOM#9Z10$8+46W5VP(VADT/F>E+U8Q"S<:HF)NNG<K^2UB
M3[_4M+QTQ]U3-/H7*5Z>:GXW&NW5U"ZK:_#':_#M%W1RQ6Y*,26,%(CVD1.(
M%I!^:" J2&!"JBQ$4259D?-J=NJ:F.V:V&.[BC%@'!@IAHF ":IX(91@W  \
M,^")NF*2)C/T\V.2ZK*8[;+X>+YKP,;(D2#0,=$8I")+.(]K0U(I-?7&Q9"+
MN9JLB/^Z+*:+;<:MW=9^NF[31A*>=S5G7?SOBL$L+Y9+G. O]L[2R(8V"J$E
M^FUJ.@:G^$]S4+;\9HG?FF\>K+0>I@PZ;['K-_7S>\_-5?7S\ U]\^LQQ-AH
MG]^QFNW94\#!JR^[*3(1:7#X]*TIC0X<<<4R6 W16ZJICKH$J6(1O86Z'NZW
M'C;DKO>.:@&)&&I"B6 2\3DK@EZE8S0*CK:AK(?;@]?E^785ZIJXWYIXBQ$%
MS2;$4LRE/')$8K@ZM.?$*5!1"X4&194U,=E+^^:H=KE8VCN:].76Y_UNV&^5
M-Z^:]N_4-I1,[(29]^[0]0)^TWY*IT_%N#\B[TYL+6VYWE[7'Z:UP2"=;J"3
MT#TI,_!R'Y]?&ORP_1M]=L!J?^Y<[/'VQ0;K;.U=X#@_[U)CL^;<$B>]P+ L
M>>)2.9[*M$L6F,E2WZ_GWY1,6F?Y)\RRH(&7U@TD\  $T<>(,1R(!$#'*VFE
MA;F?KN:4/G6=Y9\PRY''Z$H$K;SD:"0])5YD@:$U%3*#"#K@+'?Z$S;RQR\4
M.:?1E#19WY,4^GN])A2[?=,Q/CCPNT^WJBDZ"JV==-WA;?;O3N;O!B-^U]90
M=NE.IG\NN@GIQ^@F%/MA4 JNF[V%?[OSLI%?ZJN'?0?_Z#K?/6Q:%+X\.SF9
MT^9"'R]9@&T?=?9WCOXZV+YX?=C!ZW?X!G[N%3)!8-L7AP?MBS6Z<_3G0?M\
MG 7^ZF[SUT<['SH'[0_O^?;66[%]@&,L3'#Q%WY7&]'^Y]'.F_;%6'.ASYOK
M>VS74.N"%9YH=),)N$:_4B,+6*\9XXX*&L>;"V49H@W>Z&0<!' ^4@<^9)!)
M0G1BO+G0:$Y:KX;[/4,5V$T$^DEK-#FM*_/U@'Y#/QS0ZL]<A._"?HIGAVDS
MW[KXMLKJK.ONZ[KCN[CFN$9_GAAF/0'N(K%6*!*L-TKFS+3*X^MH4:.>R_6?
MKJ[_?K/^PVC]'WY;,C^O']0B=7_2?,5H-?N&2FQ%+4[W)QPLO]N 9M?]Z2$'
M81^S;8^I;:%F_;!J6ZB'/+*?WA;JTHK-447XI24+_:.C[F!0TM*U*U1MI_+S
MC]&755?ZRP]>?EUY(]=Z44X%/,SG'IT*H)V+\&7SS09LOGG[96?]+;[>QNN\
M_HCC^;)ST!9MCG^V_G78Z8Z?"G@K.A>O8/M@#W;67W_LK/^YOWV!OON'TJ7^
M]5'[(EQLX[7;;][S:ST.MM;P._=VM9;@-*!SGH4@P+(C#D 093(X"D7I."^M
MJF4E)_=;Y['92NT954EN/D\^59)[/)([OTYRWD23 N<D"N,)A$)R1EL26 A<
M,J=CD$NK<MFHJ?M#+&I'J3GV18_=^4G_\'"YY?N]L\%P5^ D#?6/+C,NSTOJ
MZ!>X:*^.C@_[YRG].7SPDQG0RF"S8[!O+2<ZR& XGET6J&3:29(,*RTG>"!6
M44IRLC* XSF;7 [ 4S991%^UHI\*F&?EBE0P/RZ8SZ^#F3-O$V61&%W./E@&
MQ"0JB7-.">FLITD7=X32J3O(S+=(T1PZ'9?0:(!WTO5G36DF@A+=N5:Z?'-P
MV@\?6\=G)V'?#5+K^- ]3&SQ.73*F=8#N:P#*+[@Y>R\*\__WZ/'7Z0DOO)6
MI:9[4-/;B720TI(KR@411<X>4JG_DU$3J7A*(L:H>5A:57RRL+:VMGHJ@)W6
MR[@?8']0R5>!?$<@CZ4\HN$,<DHE5L"_)+H7EB='#/!,DZ(VEY3'__L_^&O\
MMSD"\_-(;?R9/#K>5XM":@+C9[H/P^==XYR?R4'O)YP)2H7U.&^$:?0CP A'
M/"NG=!Q YC+HI'S18;5BZKVEFK286P#/Q)VH 'X4 (\Y$2*JB#!4Q"J/3@3B
MEC@FR[E\;ZV5*B:NEU;9,DS?)Z8F*NZ)P&8?\4JAZ:G[,K4_\1RBFUEMB&RY
M+^GR6$+-/DR7?;A,C,I (0NKB:.IZ--A,.C 2J)58,E8*J1/2ZO:3+W'4;,/
M<XO/6>UQ5'S.+JGP=1<R:Y>+%H?G0:$7( 4Z]"D3JK7CD(S+,:!#SV;5,JHF
M%.X*L.:P5<TA_&2;WSSE6\^ U5CD9R03+KG'8[@A0_9$62<(I!B) 2\(#<I!
MII[Y(E\-RUS59,+31?*LO(.*Y,?/*GSU\IU1GFI&D(R!0*"&N"+>XQ.7-'K$
MLD4O7RQ+F*>^]\\CJS!LT^3N=9[UI[4%>*Z5]=,]F:="]3,^7%19_F>R_/9D
MQ:K5CFD="->AM!L)CMB8-;$9A.5)R\C%TBJ7R_R&KIL_N=_(PI\[JMQ9N?,1
MSRQ5[OS)W#GF(2L:K-12$:<PX 5M!#$: UXP46N%_U]&C'696N8S2X7_2NZ\
MI5/3-8F@19+\JL.:O4 :\M4"":291Q-(^]?9 +]]4$Z4^FZOP<:;?C]^[AX>
MKO7B1N_TJI#B8.XTTL[;ZQM?*7KG:&>_C73</OISO[VU1SM'VU^VMU[A9]ZR
MS0]_'N$UCDIGO,Z[":VJHYVC5Y\[%^_/=QI*?\N19O$:[<\[Z^_ESIMM'.^V
MV%Q?8W_CV#KX>OM@XS/>!VU?;(A= $Y!:B I<T, 6968*)!TO7*<6NY*,XHQ
MC3065*)9,J68!$!.YM(F*'IJB:MH[+BVU>5$M:[,U&"Y]6V&6L,I&IYOO)S#
M!VBE_7A@UV\$O'<N:>U%0 2:8#(/,5%/G6<BF_ C6:[K@'M$2:[FBB\:6>UP
M!TRBY^**VG-K"WV3WFEK+?SGK#MHI+>?AO;R9J^U=GS2/6P-533'VR7@OX>I
MG)DMK[HK-]_/K:W_;;]:7V[]\<?+UG\-SOP@_><,;^;PO(6^'G)-;(T]O.97
MEUNE?)C3WR[?;/XO^^V_+Q6RFWY00P%'O$3IRU%>:/E+)(1O2%CY]@W')_U/
MW8B/Y30='?=/W,E01_0XH;_9*Q.WG]SAZ7XH^MN#4Y=ST4W#1_:I&\J'^JW]
M_J 16T<HX="+U]$J+L_Q"%K#/-:5BV07+I797#CIX\#*$WJ/WC6.^EUIQC$8
M]0'Y]M!(T?#&3W9/6I_<X5FZ5')KI-WBJ&-'Z_0$IS,G])CCO7LFLJR*TB&W
M47'0VIGL(@.AK90J!&^NRV,W/WQ?@OX&2_'RZFBWO@UV,3K6_ +;<4V*_AS_
M\-T0E4Z"4R*@.<R7@/A0-J>T0",NF&'1+*T*^$[+FN5+1<"RDN_9_VSFR^3?
M[KSI/;/5;PCR)%VNFS1X4\!1E\;=EL8VVTT!9Y^E2"(- L,X98GU@A&9:12
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M/+9<RG /S\H=?*V^G29G/D6\5OENMGR'LUUY;G8\]W&"YXH$DC.2$R-T)J4
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M9*V3B(,X(">D1YXDJ9*S4L3,<K2N6,ZS5NT<Q5XLTA JKK-6P+.5U^0&?=Y
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M'']E+94DB]%SE!SSX+=CBG0"-UX+8"41>&!(YMU[)3>HEAN2S"8T;)0&SUZ
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M>I:)J9^&.6/!P;-"-Y[59JW1';^9TX6=PM[PV).T+4M*UNOVZ84MLY'&B-R
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M#@Z5ZUFL6/G0BZWO):ZQ?7(20QN.#!=VDV-B>YUVB:?_:/^S)+IC*0Z#I&,
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M7 5G"7?4"T*!/'C&Y,+Q^AE>__HRYE\:"9M;I)42!F^.2I1GCR >M45 JBP
MHV(:[)D,3N1]99.+AS:8GLUVO"<*]!#GCWO)B'22 K/CVE"=ATMK+2,7$:2\
M$I+G%)(=T2+)44,T1S9W7>:> [LW08"0:"6- Q4F$<PEV\!*;F"^O//WUC9S
MIJM*JT[$"W4BIE4GXK?;B?C>M,BI-,KDHJ4ZP;O><LZI)BX)AA5/+C'CW%JG
M4=Z78%B0LEP'KN;6@=MA+OHC"L$CQ4HP*;PSDFMP[2G+A<8F#[001MBB'$$M
M8H3?1"'XB]OI^F4+,Q%SA1**Q&#$C99()Y9RZ6X$HB=\B&"GJ;@W0CO=GFAE
M%=X/$ZI?K<+[Y66%MX+%2JE$D"=.YH@^$/_(!+*42Q<]0*0LYN+,&8$]EB(X
MIW3;C@J?:CD1,$??XOEEC*<30)6=@J^;7S8S)O9K_\>>G/U>^];M=4+M<SSK
M]LXW:O_9_&NS:,PS^MA$E4TM5X\/A^^!L)X?=:X&L_>Z/W(_DSMKK5@RADOI
MDTF"<QR,)2'G3#+F)+,XYEA&EL.B3F,HD&/AB[LJKOZ.13RHC-7-+;W*Y3]O
M7@8_Y=E,X&L").0HL4$\F(@TH^!\BIPZ+"EE!O!*3-=<H*)\*G?&RPDVO2+X
MUAW:Q")$0539R_KG63LCVEV2L PBK:#J[DTN_2=6/_:BOKV5SP,B\ FWP+L'
M=]YC%&D"E](QA4 '#1"FI#W8,%@3F^,.TVM?UM\-,HN'_9/ &!WFI2@!8@@Q
MO>B[AZ? J\IF_7=U@.B7I@Z5'0# ^IW%T_Y@GOC/_',Y&&BL#6F>=X,R^MFS
M[ *6F),/^J/4_E(\)T]T7T1M!&TY8)Q'EUX-0.[5S0J=SUN'F6Z$STEUFZ6N
M_\COYKT8BG^_,14#K2M>)[__,Q/<FS<?SG:Q<CYY%Y.SDE.L'7@,+#%K,(U*
MQ.$P+TGXW)AVQ76?U79\)2V5.!/>)X2E8WFNGRR+_PPLFJ;!"YYH3F"CCTE>
M6QGO?9AX5;QWQ7*SCUN)Q\B3L(A0S4O.X6)DB%)KM;%&$YE ;NBFF+/K-Y;2
M5 8;#HNF?(-6JC]!OX=;;;:0IKPP>=+TJ'_?J!KP!K/&8>[#S7>VAM\9(5TQ
MEBY#W)=X=EYVP29XB*1E=NYE.9@F2^UYF=\+']_SY]WQ#P\:(K5[_?,:\/13
M?S2RB#,P"Q?<Z116J&185[6!P2KLX<W$[+RE./'1^9P\9RC_!.$N>M#>Q<J(
M<IQJ9YB@DJ<4M0*MD 9;ZK A1 _W&@E'-XI3\?/'Z4KC^)#"\:_WFM]_-C+&
M>LYLDL:CR() W-J<#*H4DB0P@G5T6HEW[^5\CO;KD):A LW+T!_ZN,.<^_SC
M2-N+_)0?[0%[+'5R !6#G($\Y?$T]OI'[;,YV%!JZARE+/N, YO(L^SS],:3
MD;:#/G;+H=LW$.4S&>[8\YO9/!-8-;B=&>09Z?B\83USC691<9S;LA7]I4>F
M\W9T*3(C?A1=,@I*7Y&V7PE0)HWOX>7*2-M=N2MS)46[8(CW3'*&N:+8&(L9
M5TQPKI0)@V)D@F])6:DDY5DEY?MEBWC-&<NB0:W(&5H.Z9SDXFW@QA,9=)84
M0>1=<K)9VRMZ&V=?O'\["HWF- VG_96X6X044!%@F(T=S,>R95I'/DPDD5A]
MZ\@7[^W]T@)WO$5;3 /;H=(@Z?)X:6$P<D1Q9+G76'NO& 6!8WQ3W=K=>YR%
MCTWNN&D3N4!/R8$O,1'6&CM"ZG8ZW<MRP,RHY>1O4_(YF5IQE\,ZO_LD$SH$
MCHWBGGLB#+!PPVQ,-(+N!3Y?,%?3@O#-8]_QCFB!]5/"<XN8Y2;7R2>D&6/(
M>6\4IL+YW(Y,R<TYG>8?UWTR*AEDE 3X4^)8,F,BCP1@F/+H+97SEWZI;K9K
MW';PQ==^E[6\U-Q9SQ%1.)?1>XI _3CRSH:4,%A%E=Z]YW+3/&G_24ER2_&D
M-8V:"RV<)MX9K(-E0."HF"\(OTK_R1<7A#II.4R9"B+G9$J,.# %I(GR0("(
M-^!ZIY1R@>ZFG"VH^9^-B=Z3PYV(._=#38R9BB3A,$^2@RNE/0O>RZ"4(&9\
MO:M=L-4L\B?:DEP%P-J(X/'#(@<2D1,L(C"ZBB4GJ!)W[()M#.?1Y#VJ8IC<
MJ/'TT@H?M,1*<:88B1PKXJ++=(@FRWE2/BWH(%4*_S!9^(I;E @ 6Z<0_*#
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M?1()GP.-*>:N+H'EB)/#1A*K<Y_86_?W7\T&_Y*E>F6G]]KN:2ZARLTE_NK
M\5_+S=Y7.K1UUFMW<HXT7D&KP6+X59CL,) /79O[#"=RG8J/Y5>'"4ZEUS!Z
MN99/T0YP[WF&[_EP0ZY(]BYZ$PX./-CF.!M,\@4YS;[J!5SXU?1[.2 * GP^
MZB>:S>\@C#+SGBV0)V-H'"!6>70T_/7F 8WFO?0O.N=VX".//=O-VL D#OLU
M%'<RZ-8P,[7ZM)M'"/=S)A<\A27CMKDMF_ J 4G@E#G'C)4Q:"&U8TP4/4C
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MOE D[/RP[4Y1)9._/AK2-W.L,G'#@AJ!$+1]<6;0N5[,/E3,?4++4![ D(N
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M$!Z]%4'$N&CV104(:P0(C0\C0/A9W]["TX#0.#Z$Z_Z[?;#]_6?]6[[VK2L
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MQ,F$./4"69>;#@>LF&4BTJ%92=342?NHR_OK< QL%X@^T\:X#>HGL*',Z08
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MED;.HT#LXY21PV)@02J%>*0%B ED&&?(<<9P$(S((EEQ 1NG=.&4-LZR 6
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M_6VO%NQ[=2.Q/\34>3M&S7MT\C@4+H].7IS0'[!C'57@B0)-(U@CKHU%AI&
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M1TZ60DEM?Z22[V#\O<KV'77->GH^  -KV,3U[A+FN*K_YH:N0'+GZ^@5N+'
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M,9.%_25+U-TW<%+WV>8N!)DR#)OHP+ ?11AF//FK@QY* XY)TVQ#<,V94Y(
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MADH;I7$;6XQ4.9^N[K-0K.J":O4RXO1+7"UQ]:<4F)BD.==8>E R PA+L%*
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M<E(9Y(),(5+KE;,;6T94R=(.:$MP>#7@\%2)4"4X/*WI,")=+/(0=,((>Y4
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M@\PVM!#+JK-30F@)H:\80M?#2U&"Z9. Z<%=,!48!R9E0M(XBKC#"MD0"<(
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M8\+F) ";8VF31L8RAB@SDM.@'%%^2>V92P0M$?3U(^B:13J66+HZ+)UT.XC
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M\]%$IF%C>I9W1C7D:&-YG+ZLAUW<Q>+%9CX;&[Y>R7M]:F8??NMRLS+'OOL
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MZ K\-\T3X>1?;K>OU-I\P9N_=FOS#3!:*^I/X)6"I(=#TG#>+*4TL,,P\O3
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M_*I80C7X'Q7K@UY*0:F0%HE8%?SZ:#!XMS ;].]X]_)JV;5F(9VG*+)3:,6
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M<$@'UGCI1N<E-H44MY?7:R,+"#Z 7<?&9$ .2BI2L$E2C)$JKT@!2CB\QTB
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M;JLTV-O_HJ3!(FFPQ^,D390P4,) "0-UZ]L0!M]V/BMAL$@8?*,A[R@YH.2
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M-"X%#\R$'!_X;Q!%X[* "[.A.O4VCSOC^*O^'MKSJW[4GXKHC_ 0 ]-],/V
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MG1-^_6^\0)#CWQ^L.73ET+8-([7&M1W:Z..%G,\17MY'R:_G\"OE\QWJ!.6
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MCS"?AWJP ^=I7,L9I=)%2TZ,9O5H1TXT=,D<<..MK>59TO<IB;X/U9 :7CR
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MGW"^_/9F$J;+]>5@G^J.SX@5%[CU9#V,)$]7FD1!5%#@& 7HP<3@;)\$S)9
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M2%E0J5A.X?_U[8^O/1\5/1P/R]KQ"G^\^H3RK/V0P)]S&"=(/_\T3'_[>>A
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MT%MT D+R/%&=0C-]\Q/6]VZB77.ZTNG\[ :JI_CMF^F'R1_C 41F)#6,I%"
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M--E]L=:=TEHF9J7FC8[:=X%YJL2IK* &5O'U0/,%Y.OY$&C3LP%3:-Y$X8A
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M+7_[^8<Z5ZBAT$DUP59V_98%9&]@6IFW6X"J?CRP$4[_QP%=]31I)>3>&&
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MQEE8]:[U*ECQ'<3)Q^6G/1O._,>/4_BXN"C^FA?>X59UYV=4N#_M-JY;-Z6
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M'G)$AO&^&IDT$&=%OWZ!Z^GD_.)R#M.OF$IHPR3/__!36 7V,F4DY<AM+]#
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MSH&S8(&W,=.V '="%*JMBKML,9WN"?>E^-]AA(OO\QE*^8\!*!'*K07)PN
MI!3$41R ,]D8 )EMOA5'ON$FL0::$R#/831SEUJVL[EU+;CX3;Z]60^R"<[R
M9(@PRA+)G"1>6DM2PB62^B08-.I;?R^N$V!0 P7<I8?K2H_5)<9 I:@4I$2L
MM:4Q;V+$HS- 2BZ1R5)(U^AF887@A%2^EU#7''5V/A!? 7EY?N&'TT5P<3F!
M-4%RS]$B8H%%M(U\(L[I3$+(VHI(>:OTW/5X3E#S'02^A@>=S[R_Q?VN&?GL
MR9=K/RWC?RUS'C+/) I;ZJXF36RTCF2OC3 \>=WH='M7I'U%ZS=C3%/5'$N\
M_IJA+:(\E:"">F0!,R5I!:UTXD.)PK&24LTX>!F;T&P#H,/'Y;<@P</W)3LK
MHY][N:O3IE7(SS8 VQ:C>0CB@6K2U%#H%B3IKHV#T(9EET Z38R1FDA7CATM
MSLN,'KY56=E$V]Z&]4R7A^K4'(0MNRBA=KS]A[__^OS9JU=/5W5PLY":F4B"
M0LM<!L^)=4")2SF7&I4LWBY\O>&HY.;G'H45VT7JDSHB:].99M-MPY,OO_K_
MFDR?CCS*H=#8:).2$3AD*C.1.:H2P2F(TB%:QJAEJ8U)L0/(1V%FM%):BY9]
MFZ%^ _K:GZ^FU39PV[;OVPWPP5K0M"' ]D2KIKT6;=IVA"THEUQ#:< L\$LY
M,@PB2%S:$_,R*!ES&S/F*,CV</^8H^3:+DIK4:3O<C:?G,-T$?]1UOA/PXM5
M!HR,"0V]4B/.E8-G*PRQ'M=VER@-U$(6ILW)_SV@#M#XKZ5";]?MJZ2-!A;6
MC9NNQ9B77216SD'*3$>>@/@HT1"@)8]2<4&< <V4M%KH-H'3#P![%)943>4T
MB F\!][5I-D&8%-[Z4&(A[&0JBIV>])TT$J#/>IAH$9'Y@R71*A2[%^I1!PP
M1U)@U'MEP9@>XJ_ZH\T#MLYA6;.+,EJS9?D#)%R%O[SW(W@]F:\-SOA:IQ^$
M8<)28H4K=^TTHU $RL@'RS-UG#>JCM<%=?\V4642W$>QEAIL8":]'$<TX-[/
M_7QQ/W:]@&^IXY?20C-^5,8PFI2N F@+W!CP[/XPHJ6'$FFF)N= J/)RV63
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MI:E=1':48=2W?X4V>7^AT_<\O/]PZ6TE<2M$6HHHHO5&:Q$E4]0S"891J[A
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M)$"@1!MC2^:V];;_;O"W4?Z@5RT5-H@5.!LMW@-IO<Q*0=OQ# 8V4)% 9.)
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M*[5?M'RAC/-,)EJFS&90!@4$7B)X'I3#.BP@-6Q1-Y(6KQ/7IX# G+KX/GM
M_6O'D+HYH'8<J:_=R!:V=IM$9R Y1?D.6@N1NPBHK,&B7$++Y@7\0?J^+9'Y
MP>J<.*C?/FG_EPZ-LB@%37$N ,M*@<I.0G!>@@Y:&*VS"JG-=>#)5'YU2^H\
MP-6 I#HQ)5<77RAETL"CISU$U['1A3,P3HE,&PB%EWA>2^GE,+MGN7Z&PVA.
M[87) OMU?_\DOL?O90&E#B5!"+XV_6(6*&BMU\Q%9<NUBFYF'89[:/?J%LCL
M(#/K/L/&^*2=CQ Q&UK?EGYEBP8R,BO%\<A-H]3]%5+"!\'Z)"X_-27\X5=N
MHXS(HK+';*@U1S: *X)^R[V0M6VGC&]=]<9&PI,,JSX>.1=N2A>=WAA61S"L
M>H%E"I+*,9X^%Q2[$I.JPQ!X(K54\!QHT2.DG&*]3<J(;PRK'@RKV8&WCX,;
M@/;I$=^).VEEXF!TR:!22N!2;:I<,@\\),U,FZ?/5S&9O8_G>TUF[^.V!L_P
MUV]+N_6691*V:B5-[<<@?(&8LP#ME&2N:"9D&S+)+2%>=Z1WK#<://-=BW*-
M_R["- W0[HASFLCJ:.<\[.0!EFUPMMP5JMXU6ET(N;0)T?&K([CH?"T*83%Y
MIV6C&^T)W/Q,"-+&RWT,.J)W#^;3WVQ6W_:RC_0KVOE^O:QGWO5O/O[WZOIL
MXI&)J J#["K'V%@!SD8%Z+)*/AA1RD'R?Y]L.TR$Z<.' 7Y;36[TZ1HW[LZW
MKW)?BZJ9#\GK!#%% 8I6! 1I+$BT3*'.)IM)>[@^).1T")K2[]VRG<%.FR[S
MOB7J-Y-$6622R4".D4SB1(%0%.XFE^LHA(URTM>BAX1\P]< ITU'3[LM*D'E
M9C$P)QASWH(WN!M'R" HRAB$\2:%&(*PD_+G'Q;S'$_!]OYX='.:I@+I7=HN
MO]1:^P:%2(>?W;(>Z4D]#LJ2R#FJ8.3)"Z&8]2[)DE043GM3/!>/ER4=?LL,
MJI,D"LL2(1D+;5-:@V-2@^ <DS:4IJ.?%Q/AY_E7)WTEPWQ875S\N%K7O[2P
M@8D<K0$GZE,LDI&]T1:2LUP7R[-+)QHV,ZJ>,[SI''<53,?8'0RC4S2T'Z[M
M->&%!^]Y+H3H:!,H:1"<SAY$3B%S$="XF=5-]E7QC);*!%B=?ED= ;0YU47U
MK72TIE"B8QE(1T&K4KF 3UF"IAC6!*5\5C.KF7JY1;(O:3T-@-D9UV4MK+7)
M12/!Y3I9QJL,(>U*B+DVZ(2)W;KSS6@YW=7P;3F=9#D-@%F#RJQV>I(7"BYO
MJYJ"B%R@!6VC)G]X1O[(!K3)-@EFN9GVGK.%DF^+ZB2+:AC8YC1 H'=XZ[C7
M:)2E>#;4#DD4XWK.': LQ1E3''-M'K%/E$?-TA<'<[=V(=/W88M?*W!O+Z&2
MG=#U32+)6.?)>P>.A0!6&R.3S9;+<XLLCC+$&>V59W.5U R(9Y49=S?'HH1@
MI2P!I SUG' 28M8%HBM"11T2\C:3FN>@_1FMP#DL@1DNYU[X/:LU_.1@RP<,
MX;60+%((Q+CQH$2A@,\+,H0*.2HN=- SF[0\M@G>5O,\5W-+))_Q#=OSAJ"D
MS07%$W"G:&\K69 A"D+DBD654>/9!<H]3?"VI.>YI%LB^1QO^:[6N'G>"E(G
M+(DK")6@IRANJ;0G =(+EF3875><V7KNH__;8I[G8FZ&X?.\5WS>!C&;I+PU
M=1KKCENMP)<8 "EH$<9:QOFYA=K'YLRG[+02-?-2> \N*4-QHM/@-2VIDH+T
M.2>56G'[7F6GE0'W?B=Q^3P[K5A'_V3/0 912XQE@!#JRV?!&#6WWC:JOGUA
MG59Z(>')3BM]/'(N/2JZZ/36::53/?  L$S1K.(83Y\+BEGTPBKNP-(I PJ3
M@9AK1VRE4T&;9?(GBK-F@]Y>G59F!]X^#IZ\TTHF<]B<*,YQZ;JWG(^5]^=C
MLBD;SG*;\/(U=%KIY?E>G5;ZN&W*Z5:WIG'M#-5DVE6?+QFMVNQHS0[*SI1Q
MW$M,GC.I&'>A,!<-#T(%KK*\*3OK\W4GKS^3Z+1RL8!1PH,R3$!DA4'R,2CM
MDS%E9E51/\^__NR D:T5"M2< :UL#8H5"\'X I2MRHC!9Z7.K9+F;(G_QR'_
M9&3^/M YJVJSOF^NP6KD107(VF$-#<E;C@N0=+[4 92!CIJS7D,OZ77BO!;9
MN. [*P[/?5JV-"ATR1R\,1G(=?7I $-]$D5;@M&"GUN1VCG7 ,Q])0T#T%F1
M8PYY_8:EHKQ!2(XI4L\6"$(JT(HRQA2%E_'<HKKSK8^>^SH9 IX&?)-W%[L_
M<WN$TFV-?_BS_A(72:!'JV@9"^9 >:;!^2+ ,U:9JX',V:CK?B?Y7AT^&[CM
MG,9>??ND_5^Z-^_+!Y'I],D@5%U5*B%$BP*X-4%GAB:4,YN ]9S*KVX)G >X
M&LS%FG@*F)#1B5S''6$M6TBTAW@1&!3:21(&%)FU>5QX&R9WGNMG.(Q:3,TZ
MUMA])H.A\L+96F<=Z^Q6X6/]51UC'P5Y(@ONU;P2@9<^3.XD.4 KR-Q?%G8^
M%$<E1/&UILVQP$D1A> ,SR"ML\X';Y)HQ!A_A13'0; ^B<OG27%TS@2!11*V
M[*XA,$)0.4%AGF.@!-S'-G><+XSBV L)3U(<^WCD7,AA771ZHS@>07'L!99)
MYG$=X>ES0;$)+G#$.D;(2CISD$,H+@.JRF%R+I*BKQR]O2B.LP-O'P>//1*F
M"U/JAC6GLBY)9& V53I]9! RK\")/*/1/*MN,V"Z?^<,4Y_F#EZU]\Z4G,:O
MMQU5X-^NUND3*5+M,YC(^.PGC\9>[*?# 661V<"223)&KU3.*G+-BJ0]2!L6
MA2^+CM]Q<IXB0ZX+]PB6:ZS-%WG%LP9C%>IB,U(Z-*]+EI]'Y2G&YR6(AQ)\
M=22M6@KWZ6]_7EWN74SI OVIA5(R55X]"&42635J\!(5Y!T5.?J@6,-1L4UT
MFN&N/2ZZ'XP*3@^/E\T^](DV3F$@::0SE(L +M-OC7(F:N.%R.?6Z.0UL \'
M+ZLY6+X7^!JDE2=\<?5&1Y8XV$ ^5"HH"$X(X-D*%D+2$MM<+K\]YT^URLX#
M7 UXBE._PUJ&)A4'E(K5DUQE\,(5R,&2KK5#B'U[SG];/V/":$YMLG;_=O-^
ML[FZQ53F*:G@,D)"D6D'\ I\]@YX-"&SZ"53,^N2\Y :KP[RIP/!B%S)@R&J
M/37996P;TF#WG_<:+;1DS->1+R:Y $H; ]&E1" TM&:="-GR3C>DHXKU:N!Y
M8H\V8!R.]U L=6&IU%45<M[W0 Z6]D4LZ))67BK1J*CH%;)$!NVM)W'Y/%DB
M(<C@4J0\F]8@**,%. P,Z-_YI&R,AK>IC']A+)%>2'B2)=+'(^?ROMY%IS>6
MR!$LD5Y@F>*A_1A/GPN*"R_2&$-K7,HZF=U&\"$JR"4R+TN,RI]H<MALT-N+
M)3([\/9Q<,L[Z/HZ=<TY2-K&Y+B%H!.=*RE6#G7VX'U&K[G47+<)*A\09H99
M3G,O/W83=:2+9D$+J0\N>T-2!O9Y?U/<CBKRU+>UIX]TUO6 4F(H*\TE)!E4
M;7Q%J:F/43(O8K0Z6?\<I>2I[STYS<1GEH5.AOQ8-UY/86O010)WWBD4B>#;
MIOOMZ6@FPRXNOCY3WO+F[D_N;C06C$XLE[4"QA@EHR))<#$IH%]848QP2LBV
MEU)/"SC#C7M<D(YS/36BE^?$$WE(K5I$7SF._UI=T,=<T$[V(6SQ[X2+SU>?
M%[35.:9$ 9VCH!.M]N-BA4Y(CX[YHFVP,YM&UUO'5[,D9@Z?.362ZJ%I^'.G
MJ7#6V%HHGT.]NTZ"DI=<=I$@=\*%4N;6\["WCF\+91[PF5,7J8<T_;#<_.>/
M:\3WEUM<XV9[>T-PZ!RSLK8 <AX4\YKT=()PG:-*27'K9D9K[JGAVR*9 W3F
MQ,7HK.?U5F!]QH@Q0XJF#E"MP24Y IQBM2V\4B7-K+U"3PW?EL@<H--J%M@Q
MS/RGSLN/N/[,%RXY9URI2[X&DM%9\"('BBN-BY('[^/,"C>>U>EU+H/3PZ,%
M<Z1%H/C]\LLRXV6N"WRAM(F<JP321JSQH8=023+)<A&"+"+8$STX#57M=2Z#
MV8"E11.J\1IN!.<#:0.!L]I-RT1PD7ZKK1-:>!M4:(3Z5\BC&H3ID[A\ICPJ
MGKAQPH*-N@YU\@PH\M* 4F3-/<I8VER9OC >52\D/,VCZN&1<V&@=-'IC4=U
M#(^J#U@FX5$=X>ES0;%2TLI:E(:UA89*UD-D40)F9ETTT9161.FS06\_'M7<
MP-O'P1/QJ++@G"?)06DZ392U",Y&"YE)PXNPR>$;CZJAESOPJ/JX:,3W]<UZ
MN_A0[;!;2R9PJU16P)6AM<1X@" T@K':2DWJ2M.)#T^?>@LC]+M#?-SYVM<9
MMQUO^1$?P[X*<8W"+F+T";&Z V'\S>'Y:&B "PZ=.,!^(YX!A^)HKX.R+().
M6"_'A2*$JD))KLVN]I:PHE-WA7FX\9&P8'PO]C';R-Z[?OF[%H19XW(51.RZ
M 7LE(9;,Z+?H<\B.\]#IW.[DOSM?/=TI/<CXJS$L-_)Q>OTR=2T(5SXERU(=
M!2SI< ^U-$I:H./>V6QC$&R\(_7.5Y^A"X^VW*.KL &S?!>UW0L6K@?S#&:2
M=_KTT9CC_74Y;#Y('B[>*):$5B+:R V7RG-4M/ZTE(L>WW-R9CAJ-'5K %%,
MW32,@&@HH,N,IZ"3CMSS+FOUC)CA7W/J;F.G9$1?+&.@N28+D9O!2;*5UZP8
MLEY$*9M8Z 5/"^N#NB.GA?5Q6POR]GB)5BS1TOY/BM1C/>L(P>D,(21A;.'<
ML$;<[%?X.C8$F*=Q^5Q>Q]Y?TCF+_]C2RJP?]W/]"U7IFJ!DQTQ1TD"T=5P2
M+YDB4YZ!2^==,#);T88U_810+^ &I@]*5FV\U> R]Q'1KN\@NPC7]$'L2?%.
M\[(UFC.[@62 )R:'2S+:2L<1G+ ,E$D1/'<&9)(B)(.9^39$]!/ Y)DGI-.@
MI(\#&J"C]@"DG39<X$U/?Z,4D[6H3Z(A@>@?"!X]"!-R-!EK*ZHFB+@GRO21
M^XBN6HUIYP;Q]P?<('W@IW>7^7O\@A>K/ZK&U\G!M8A"H'0Q29".!5 "$T0Z
M02&0Y*&$(%QL4Q7=0;B7!(ZQ?=&"]H 7])]^)PG_'M;_B5OZ]5WY0@PD" \@
MZ?]!!<<HDT0.+EAN):O,N4;,]&<D>TE &=4+#>KG?L)+7(<+DN]=_DQVWFS7
MI/H7O"LDD[%8S02I;$C()#/X)!((LDKF%J6U;2I[.HGWDO ROC\>K2@;]5+]
M%]SNC7+3&?/==KM>QJMMS>NVJULC*SZM+DB*S4W2N"H_A/4E+8NO/34I-URF
M0!OK\N*J$L2/OXMO+]0(5_@36^[@YM\9::1V)O$2E61T7@E>M!,R&T%GEURT
M%V\@4>JA+_EV^Y7KW*R8 G!4"53.&J+0%IC5AH[D+)1MTSKZ:;D&T\,./KWV
M_KY,RXOE/@&*==M(VX5DG)(>X8"+4&B?(.V]L1JLX%:+^IKGVCR%=)-O^HU[
M1+3<HX.-[Y(&2<37Y?SS:K-9<!6UH4P81*[G"%.%].461,F4V41CN&Z3.=X1
MX_0P&,-7J[$,W2 7^.=EKI%$W;8QWRA?!?OZ\O1Q]5M8;Y=I^4>H,>H_,%VM
MR0FXV:V0!0HZ&ARIGI/FE/H63R&--6"X*RE8X5ELTV)WJ.0O$EN3NK-!TC%
M_NO889&*4X4[!3;$JD'B$$QP4!QBT5IPWZC7P'#9WR YW*4-VF3<V;#??:'0
MM$:X'Q^(</=KR I*P;RA+"]G 8IG$E<9 XY+9Y$647+8_NQ\7M 7";>6SFK0
M7Z*[N#>+(03&>0D,5"$0**DE^)(=."N<R5PYS]O,,>PMZBO'US$.:]#(X6 X
MX2]7U837#_*;7Z^VFRTEWF2TF]Q[N:E,BJOU/O'Y:C/4-C!E1&T(&4!%6< Y
MI4!$%K7E)>72)F$<1_[38W'$A/($+FV0>G358K]/,XY.,]2@-1EM;Z\8:N<L
M7UPP5OE&US6]Q)P>9J? PI%P[._(-A2*]>YJ?C<_KV[9.S%OWUU^7-UG(MTB
M*BT<YUHDEJ"P3,='L!*<U(YB4BP6$T],MDEYA\O^*O$YL<L;I,6=-/@N7%Q<
M3T9]=YG_'=:[&<6+6JC*.6-5:OHA5*10-RE(%)-D[E).C2C= X1^@VE#)S?(
MD!^QWK6Q[AEQ@5;FXD.":$NL,F>(*0; 4EAMYL25;G-'TU/05XG#ELYLD$$_
M&&<O)*;,#0^07""AK,@0.$$"I?/>F1*D;M-FZT%Q7E3V,=S@+69Q'PAUDWR+
MZ*RJ10TE%-H8H[(0.08(T2I4106';6Y+'A'H12/A&*.W:&O\M>K@0=W_]M?^
M>/WN(FPV^^H"DXOVGL3D5I# Z!T9@7X((WS0,F3=:F1,7U&G*B]JB)JV[IE+
MB=#=)D8Y<.-,9N"%<J!8+.#)><"B]S(D5#&WV89FUD"OB<>?;)37Q_+GTF*L
MBTYOC?*.:)37"RQ3]!H[QM/G@F)IBV8B)S 1!2AE;&UU+0$-+7V+*NANS:A>
M,'I[-<J;'7C[.+AUH[S]G<E-+S9+,:E4&ABZ>ILG/<6G]*LBDTE1&&.PS?7#
MHR+-L+%!<X\_U33O:'>-2(S<C=O[=?OI6ZB">]UOJKY(/9W1>\@\>%!">%IP
MP=7G#.E]S-D<EE0],ACQB2]YQ< 8U?[3-!#J38E_=[E=YIHU+[_@-][3#W^F
MBZN,N3JG.H'^?I5L5>Y]_I0E$&/)>HK*B"9V/BB8$ DEYX8719E+BBYRI$2%
M,PP$3\E8_X*)L:0>F,D^*<6/=Z6XG^)]NS0P.121<@;-9*)-@$?PBA>PUO+D
MA=/)MN'%C:7!X#N!87*\^[RZNMPNBI4\14Q0<JZ36JV ((H!*S&+PGD4O T3
M8A3QIS_03H+?>Y<2D[N^:9^G@>KL+WDX1JF8-'4B9&TCJ"/$A Y"BED;;QPK
MK4>AC*''5%>RL\#Q"2$PFYO=88K_[:^'/V"7P]MD0X[90E):@G(\@>=H ,E!
MRFE78ICEWOZ44J>_=9X>JN/N_J-!IL$MR\.2W4K]NLC7]++Z.0E/=/$\%TAT
M@NI ?YX"=SQ)U H5"*XI5LH,(6H25F(1QF9E>:/QFJ?!VW-7Q><*MSYN; "S
M#Y@1/]<#X+O5Y1=<;Y?TR]\(+KA>8[X]X,,KD82V!:2WBJ(JY\ GHR!:K9DV
MA@G6!F^=19Q+ZG6L=^]U6FKAF@9IT^,WVTGJ&)+(8%.D2-QS22LG1PB9K,*D
M,!G;=.R;T4-$4XR,8_H1]Y5G+[6+\R8P$4$$"BX5<@8Q4XJ/9(;  B7^X:!]
M[#D\*C1Q\JBV;,!)O&9GWW1F2IB23AF48;0),<W 9^<A,Q=+L5)13MZ&\WQ;
MC!?B^N$FGJ;YU?X^_F/XLVJ\WC?L&O!F\]3'C?"LTEG:@Y</*9+UVD9O"U.!
M>Y>RCLDB1^N83WSQU </6V/TF=_1:;_<?D>?^U=9K>^V.#?1:R\=@DBUQ;ES
M]=!'#]))F1GS1M@V').GY1JZLWQ_'>30M[S;;'"[J3.T]^^T%Q>K_PZ7"1?*
M&1.Y2,"2I0,N10->)@^E""5#HK!<M[E*ZB#<]+O0B#@YW(/&=D:#"/2^1(="
M?_>I/N^_O[Q^:-!"1F%](0&= *45!4:192C,2$NKV]G2)IGI*^F+0E)3-S5(
MCN\A_]<_<+WKX5*;(]RVSV;7$?/=9?Z9/O1BD4W(@14'1?$Z^JDVXW:9 8G+
M@U9"8Z/ZKV,E?E$PF\1M#>+I'G)3:(F;;6WO8H6.%/Y1<!EU;;7,P:4Z3!A1
M)UNX=8T>RX\0]K6"["AGC5@WM,\C'U\#5_'_8=I^7/WPYQ_+]6Y_7OA:;5MG
MP;+ "ZAH"GA.-M)1*\UB%"B?#>;[?^V+ $AC:S>H,+T'Y0>MLKGI_+Z(E&]R
M+!JR#I30\I# B>)IFRQ2BFPY:S0!OJ>@+P).4SAIQ*Y,._0_+-I#R _&JV(S
M@D=/.Z*1 F+<32'7WI0<G3P,E![99SI_Y8L 14,KW\>"&=[T<HUI]?OE\G]V
M\/T;7I+5MQLZ#E%'%2BFU\&"DBI#U"6"%%87Y4N*H<WKP","O0AHC&GT^UBP
MC;#P\5/8_GMU=9'??_XCI.T/I1"&EU_JE=H'BM 7MAAE:CQ>1*3=S,0Z2[=V
MFXL:L9+OLVU37WJ<O*\!26.Z[#[0W%"@/6B0/=.)>3H)K6(D66UV5*0"Q[T@
M&34Z&7U0K$TU_.,R3<6Q; B3D0P^%Q;DURO]=U?;3ZOU<OO7C@M"((_H$4&C
MK!TO/:?MTT?P3-4)$ADY;_/*]; \I^(>CN7L!\?/#3)ZLZF$MZ6Z?MGK(M<$
M\ROO2W;*T97#O/<L( :8?E)H.,EL"?4M!'5]JJ6=E.)L<,IR]"F%5J/8IX5$
MIS&5$R&BA\5;O!5<7_)]5Q\NUG_=S#@+**(F):/W!I3RCK)P;0&%B8(QY0UO
M]!#PD#BG&A<VU%N'5R&#3=VB=NCV2\+_O5HO-WF9;O&QI,Z$;!= ^MJ'W9H
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MR3=OE/Y8[]P?:-/=_O7^<K-=7^V,N3/NQT_A\GK:UT^[05_O;VXH<LP1M37
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MRW'>+N:ZYOJ=YW4NOVN6FSY-7P3X+YB8FP!,S$S #<8/0-\$#AAY!+IY IX
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MD$L2N60X()</L+0!!@D[*/ 6>H:#EE*%;:2)G4'1 >DBFN1QDA$=*"H#_>E
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M4(NU$B:YGL1 D@\1G_<BR)>$$?7W?SDN:W-40!S_:N9]L*$'ZX'N%R$:>YE
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MQBU-%_!R;'+IT &"M;4$F-@#)QBG)NU+-T7L\2.\3(D1V:]:T@T;: -.+T[
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M=+-N]-8O>.R#]CRL-?\<&#-F6^9BO1)7,5C^4>B(>_R!B=\1;J_;UQG!&\%
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MLTTII\$S=OC-E:$YN_&E ?_?E4T.>?-9#_2?KWA=4?UH=2FNY-FK']H6L_
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M*0Y=B^YX3^I:%=9XTG8BM+X9_1Q$/W>;M+.0_=#B%K1#.DW;@!*]U@YZD^_
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M)%D<-A]3#00T FFVP+8GQ0L?[M-D=' ?Z7E,S_P:5$[69"R?N1EN_<QO=&N
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M,@I69'-M'OEK[U"65.5T'PP9,5;UP\))[";X*SA^U!:,U>68SBW'#+N/J-G
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M"_U=+[9VO0B!YFD+B0SVG D<V1Z%7R;R1(C=@HMY0AQ<OE5':0=FKX8JQK'
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MG;[*!KJJR\S>TCS[^NJ[A73M8(&=J-<W6\S^\-+<I$9!--+D;B07R=IY'I&
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M<!]_!O'%J3I<<30E(C!R\ZD>42)0U99TWN#"^L@17D/LTF'>T69*-'FO[0R
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MFQ_0_< AFN$W6^^#-NE'\72R;C_R9"<3%!W=]@1&5\\S2D,#5S>F(NG8T^:
M>U]$(7Q+P[2=0'H1L&[\9?/-#&L:,)&C.X499;8C(U:WF" =E1-,T*<G!&ZD
M 7;57I8L^F4VPV5AL:X?ZUQ3FZ8CF9VB*_];;U5/8FA7;[I[V)3"#]SFF@ @
M%&/ />NZG4)$Z-/0YK5K;;8,.1AK8"0S)FB8MQ4E"4S-HD<-*,]()A,L)5JH
MN9$_$WMQ/+#*I/Q4;S.+!(MTJ;\+4T[\OC6*@@UKB,Q-<6\AMTI@J3-+8905
M%*727-Y=&_](,^OH?KH1!6ZX#\V<O5*HWO(XR[IHP,B&6AI;E+E9.[:PAV&S
M&&J& WJ$F2?+8%+8/F$,,F9!&-'2":#G_8')>JO^H?]H5RV8(D4BRJF.#+Y-
M0'L73.2A:C53+FL01]IN./K[CO'OP6BGTBG'R7EO\!H(4TH&_7.=Q"@J?:;X
MR=3#GCKU?.WHZ/R>@41W1XV64DS&W<?1!8F'X],/P#% WX69X^$E*N<M(-SS
M84/*>C;W6[TW]H(E"\MT?RY4^\LJMNHD7ZK?#3FUT;UL$G4)NS5/K_N??'.3
M28VDZ<UL<BP'V$N3[:O=<U<&'WZ$*VR6"%QRN#WP<?AEUOC06]00@?20"6+Q
M7IGR^QHC7#[:&_C66C/6-&K[R\5$QSP/93&A%K)>RB$3"P.[0;C0WAA 5CK2
MB^9*MK1&'Z5=UZ.-<=Z33RG*B*VLOE"2W2Z*C'#K]/*^83E%8H(./2D_+DC)
M]31_K&C L(<&[IN$;\-S*HC^1:C %GNQF:OK 10+4[TYI6Z&W5VWP %,\Y&:
M*3NLTT8 H0)+X\]JG>)#0O]S,OE14O)&9>'4?:^^EF8C=[MN7W?OYL^KSN\=
M0$:_'Z\R0>N5K%44A3$9:F\CC,6W)"$P+2IET1^1:GM$C2=W_W@O_7%]W&9L
M]$?1JK$U1)>JC/HYQ49P!A]'-T%(Z4UO^7_WA/7[U?XV"$'J!DHVS&F$/OS&
M>^&V5/W5>I'F>,5 G5-6\&.]B""HWF#04.&:)$F^)VY"SC]>17[ZN+=O3+AK
MZT"*5,'@&<=<T=1L6+O\5@H]L.@C3*_W13''@S?:?W<Z@V75'Z7(VAC<M[CY
M1?LL9\%G]H<W0<>Y2K5](/P$=^C(W+09CP\Y;RXO%'F)7\6+S!M97'P^PJM0
M-OQ),.B89N%VT'6E1Z.T]X\O=^WH53'TB9A\%:,8Y3*#^;C1* ##DH8BPJPI
M: %,%\=6,(*5T+,3S1F4S).D]6T6:I0K-X0+'+SEQ'Y$B:$;>\H1Z>8L669#
ML:5'57JY4)YK?YH4&SR6' _?,;B?+0<\D-TLPQ[3T.F:Z]:5S^?<R_?0GV""
M$'-Y.=TR>'32S$2.E<I(\%1R]Y ,&0I<&B(*%3(Z,*4<+?'Q#!$993N.YM\U
MUQ/%G.,HL_<JJ]Z]:69/<QN.F_&9)-P@S!01_FTC7EL H%3-3M(VM(9:UCZC
M'B)YSQ4(K>FKS52= $L#(;+O );//N+/0K5JI!$ P=*@="SDZ<]*I^_?500F
M3]>2_1@Y2]T_ I\%.IN,'O]IYGVG0=2G-<3"="8<FKCX7M9'U"<TC_./_(LL
MXX%T?;T?'=K6&IT&$SG5S3#UEB=N1C<U-'5&_9-L"[T&]DKWX45K:H3(W6C"
M2>"-V0\\@5 ='#TV5IVFYRWE?V5+O53RXX=$O?E$0XO\2AXM)DB/@-$?N))3
M55/U\6LU+O-J_)FH^\[.&J\YQ=[\C0HG_'5[_ES>L,;&,Q"<I#YEN@8').-I
M_*ZS.-II7WORC?29;I!*[ L%?FLQ5A2LO>R()N>UA>X%N%E<1L$5D$^C/O]0
M6B#X?\7_88(BNM&-3[74GBC\^P0\*2<GS019HC(/#2I4N>8=W/WYCA<X-=0%
M(\'WPHKK5*C.[51#!$$?[\76:*V]_M#6^L[9#K2?]^#:N0TQD;L21<,0>5,(
MPI(HFD]%(^1%F* G (?9CQVJ><NS)<;^%*P=I42&'9G7\#%)ZUB>+=5XYR=C
MY%N67!&=6S_8?\8FH+8^LWW95OWE;[+5$_2C]Q<"G!+'ZO<FEY;B*2JT\W+4
M6YB=+A,H^TH?;^K>P8F/"TN,ZJ,UX%@P:0X*R"ZUBW10]5F\H@/"8>C.64"G
MU4 46W^@4>D]K:AA+!X]4X620KR)/XH\>\J;BKD^!#N0$[R.;IJB5_U# ;'X
M<*D&E0G(<*P A'0A%F7%!/&E:S0Q03_+#[UIHKSX3H9N)B5/9<0'T&V;NH%=
M#Q;!G)E:<9SC!;':+(!Q$L^[ N54>R#=TD4]SXZM.85R)*G_:)K!)_K]I=[Z
M]AF6NPICI5P[R2H&B&B<E"<_-B*0WB&JW/;HJ!8Y)NB!)1;=)$L-0F 8=^PO
MJ@7AZ%K6S:^8H*>'((/Q@#-T]&Z++4"8<Y.9,%O%^<Z1'+[6(='1DY(NEI3J
M#&W&T7PF:*7R]-=4WOE^U#F^_;7]<=ST%" E2#NM/MTK,0I=CR4MLH&5NF=Y
MI&3W; -X@YP<0K;3=C*$VS#E"DV%IW, 4VN2_UOOK*-]VE0-?:4Q)[8#R[1'
MJ 8!;P:*0-:?]7=,%3AP,&6"0J['8G[5G+]&.0U 7,,) WZ=;1L2M;%G&-QG
M(<5("W75KFU=I,O%'$OZ_B_8@:EKC@%/Q!?:S4O_=E 'F-&QJ$/NU6;D](F;
M#&X[+7^Z/CO=,Z.?"8*#PP2J#:\UCR[TG0AM/..!/BV%UE_9(8PH3)](#8<=
M*MJ Q*T>!%X#!,<.+'5SD<* 89;#"H'GQ<WA%TG4JQ>G]GI,T-;;AO'\=73\
M8FWJ^J0P8"SQ![62;M+!!.%/7:.M=:'=,%&LP.*5W%)NX#4!Y/4NF<N2CY+7
M<_C&4Q]RE28MH-^+@I;;\'WEWTO[9K>N7/GZ"E)]_+'NO.Q'H)O$\OG-TP88
MSJE?%]*?I;6M>2/?]I\OCIM^;1:OH[F2VU?#1E:?TZ6=8IL.:#GOC^9#WB [
ML\15=O6[NJJ3UL43::7S^S[EXCI74<LA69]!/KJ-:$""HV$S8G1=]"*0-,O2
M3V<[O,001=*5-@8W'O_<%K?P?^<4TDN%WN&<Q4^0]YH4(M$\?D+7_]U4X;+(
MKW-!?BZF[E2\^;OC8-MGNL\ND7C_/7&J\NP.B]80+HO._H<VYF.R^7@MWL7P
MVCZ'.GCNP(#H3 FT"]J5"7(WH_CC1I9P=.0"!;.O-,<$%>ZKX"CX5M@2O(9"
M.X&AO !VT20.O?K2,M)]0F^)4]@]GP<.!D^BS-@O".G^LHSAK9$=TX!0_9&7
M^ZO:2Y9'J]*6-I7"I&)0,F,$\N@.[QLTU_7X4-2A-XU5,;A3IYS[Y;E\?*X=
M^C'7![HD&J6^F$WF:(2$9EX>'YUJKI>RA-=?M2IZ#@;./298TU:J)D;6GSI,
M(!_1/S 4E[MG"*?6&,(#Z]XWDPS)/&6!)L%G-\R.T@I;4 KHQC,LBY\Z57'\
ME$<BX\^Y&[$^6@^"4E_!)?H.GYYX4O78&SUMG+8+/8EJ@;#[L=RY5%Y.*?5K
M[UY0?-/#^?BV:N[N8<=6:_9&/!! ]II.!8[\K3L.(68_^'=MA.?@KQ]O-'\6
M^"X,%[R'[4E?HE,\F*!KF?C3W%$6Q>P*9A_)KJWQ@#*V8; F@B:!+MLCPF<5
M>.UM"!^=X;,A-]1S+8G1Z1:OLMJQ*>W[0^>9H.,8EOV29+02((U,4+PO4K=7
M3LWF[BS"SWDK@A2I'&HE&'>C.5%=='=OCW81AK-L9H+VV1$)E1],-Y]09#_%
M4Q&'NF>Z%&C*,"+?-#QI5J611):>_%CD6B6W25B\NWN8<._+'/3LG\2LM+8X
MM33JS2C%S,Q\'=B-D7EH^-:"O,<),PQ"#[NMVS ()CW3I9TQH#C41]^CUZ =
MO"+CQ%4P(S@&. U&:39*:KZ\<8/==.R\YS+L-8;T'$L[W3FKF^1*OJQA-\V=
MVY"\6WQ\TCH<,I'8D?-<<U294;ECGT'UI2F0>=)74"JD\S3%<:F.66[^\2MY
MWQS&],"DT_;.9%G*#1;OWD3UBSKAE0'AZ4+AM9B/"B_&A%X(QRX!HS9P"?7@
M4H?@Q2HFR%I#^D_%[RV/#^Z:2V&%Z)H,J \R77I5E2(,G$U6'O6A6^3AD0+T
M"H(39O3R$^AK2$7 &Z2>CZ+P"[HZ+*RDG3JX$%K(!!TVML^ );, FY4FPY@1
M\*R(R1JD7)>H/ L]\7-*P\?C\)AUQ=UAA12'!-W:^TL$3=ENR,SP% D&'1[:
M8XE7+!$YJ= G5UW>0ZRS'P8%C7AT4LRU&L>NH_-%S[NJS>_3W#N(Q\U537#%
MYHB0GY"*[1@5:AM?Y22/ 1,D.4Y/RDZ\]_:<E:W,-\F/<2#17()P*H/[&A/$
M_I$>3^@A/&5Y%335]0%+9<;'>BPUJU@_3CWO$^RU:(4!CB,MWZ(;#5D=Q]NK
MT7]H<;MCCN"/(V0M@(#LJ;?"[<89=JZI)O9'_-]>]XA8!\9M^4TOC')R<7J/
MES<8*?\N5S/[(F/2W#4RE&?"?X&_UM]0#]^9;%>1;F">@9+I=.MYGY:81I6[
M/K4"8(JF3K.:*669IP>$4%'IU,9)97I)G88?IZ025#3:,Z! PN@$5T7*PU]1
MMX^<M'FMVAJTU  9C:8@Z-]H*M+1$%="C#5O]-//,CC#;%AAAT>+TY4>$3UN
MOI\G"@S1DLE3J-],4$5[F\*(\)Q $KEY&ATMU5M9+.-PWQ(N13G?4%_9=/C(
M]Q]GG;1:'K\4IQP?6ZY/8H*<#:@JPJ9KE]V)JG:J6H,Q9E\Q*'>;<JV@".%9
MS1I*_Y!T\@9^SW5/_*"W((@)BGS!R^6V)WJ!K%/MFKM"*=VLP1.J[S\.0]=M
MS,O$/_<D_YIC<+."PNY/K\V#GV T0,HX*#SO\SJ]_#OU0\RG41AE8F^[,Z_J
MS-S/W=F\7LAT*)ID3!AC,XEFN5=C)FC,;H?J#%>MR%?6\RN,-I[@5VEW]^S?
M/JT6DX0;(BO/*(LD^)(MW.^R>ZWD$0O1TS5HS#6M)&K0HPS%ZY*FW3/QDRQ)
M0053XEE+@(72C2H$U_@*]T&"X#QYLOBH+L7UI9SV0=(8_5*9C:.FSV7Q7KP&
M&4P3;&=P7: ^]K04Y?A79L!H36K(H>4.3!FEV]2\T91P,8\;'*I"]ER,W[3\
M"^9 3R=#2+H*(]*_\$,T+<(IOTXDN!)1L$DUMXHPIKB9>REE_@F-^ZBQ-"E.
M+]V1XX"^:6""0 RN=B_/PX%!(6DV14HMA D#3Y^7FF^XT&L<H>/*N98I_>WF
ML*UM?OE'L)H<'DGPY9&(@6OKKN0U&6,B>P 3]$H3K[NTFTKCPS*X#U&#)EJQ
MK-&QC+TGCK21?.VMQ-^27=/\CF-K[[^7NZT_T5H3$Z/,XM. "RQ-=(PU)D?4
M;X%!Q@6@&>X[%Z(C!B9FJ@]:R!K.E70^0OX800^G=AVD4;PP.-[6[KI>A/\?
MJ%_I,<P?])*UJ"@]%#7E2\\C7YLU')C_XWO=_]@V*Y'MG,>A]"W9CJXZ^[F8
M;MY=:_Y!@0A]!*) R5ZO?0J7E*2K X[8^G5MZ7W@PB3\(T,-=30CE7B>*DOC
M)JTB9*<W0XN(%53CZ!#9IC01?XN$3XXO!:ZSO?KUQG9GJA+7#H[L4TYM H=)
MGLS (W")Q*3Q[UQO64ASQ+((T*6X -+3$V6/$ *#JRP%D!IKH'(<6@*6X?W+
MM?'YM;!;RN0H?]SUL_>T09=V0"^P71YF^=;>OEZX0K@%W6H]^VM1E1:+8\).
M4ZUHEOL,"=IM-:\BS)J<,_XGBS%R6>A9"WG+WX_092DPYVRO]-:TP2]%][5V
M/)HF!5ANNP3&!(&Q\*^?72$ST# 8#^W$9X1IH[5?TJMX-74'9_%)G4YPRU $
MTI4>N8G=#:3IDA)71RYF='9D34!2Q!T[MM+/CC$Z'45_3(>(:X.0[E]0K1B1
M2H/=JH'KZ7)7ST]I=OWY(OQ2\U9D*<0(PG7@.)W7".5!GB'UN1UHA"]NS$?T
M*Q\[*6O4\ S$X!>Z:?O):4M/JE;MOY;ILK$@P0,=JC(E@#H?&'3\PJZ=O*.O
M,S@P7)',MJK#N2O#$024K XN_EHT4.\,"'?[E%VJ'V9U5N3D[?F3P98K[,\9
MUP$%4OGL^>XQY./I0O7:UR 5L>O/OY\_A/A52C,$(7D]/7V#?<]G9-1V72\Y
M=>GKG=_K1B#0<SW-0B)TQ'&&?Z\)'J%E47_2T-+L@^UD^R1?C,2]@U>)(=Q\
MHS50=IH@8$7:6B+B>4GF&3D-1[@3S^F9B7[6"/N .EKS_W\? A@PN%*I D!<
MLWD\99J>/A@":6& $Q0T=$^D*4E$"W!-M7'0*F(.+9Z(>>-#+:YE.5X'^)AN
M,Z9*I>GZH+2;G(9E5L'MV5BI:R_+^+;&==3V31P2Z+U">NJWM5:7$R_$W3M>
MI/BK62Q>G_:77H+GH+&6UFM71J\ F,4:ZV-/=-]4&O2)YF=+W1,HOO"[RN10
M[Z2M=RSAU?M#KR-M=B?!+3, $R01?V(N.ROF*V;  U)1\S=IG=&\@C,P(/^Y
MT#2KH=GMW/*#4]5A37FWQH>JD(.07V4<V&SLU:$?7"I1F0:W0P^A>J:X=@C1
ML!-^8'5H_]?]F><:8WH1!S\EV39J1#F7=3A_BF7^(EQN?5QZ]LH#TN[LW,T;
MV9FQREG0OW1?[JCFN6=_6QXOYAS+N=3AD>:Q@I5Z'76IB.>_W1QTQ-G2).[S
M:\7;(GSV-M3[2"&2?S4):SOP G+$O:-PS#KD*W>MIX0>7L?2)QE4>JE(T7>P
MWN@UV^&BJ[P/W=BVO:,.H'.0==T0=&'W+"0TU:+CS(:]H>@*K518%/I^N&V*
M8G-VMYTM["_A27><=<[!F$>:8<K'$YN9BTL/8QM$/]][A,D#AX&>3QUYP1MU
MT![3RH*RX72J#107&/KEZ\-(W93GSOLG[LYQ3/761S $I(E],_'[W B15746
M!;64J):S5N%OB#Z%]S6&74.99-ILF+6\)9Q>FPA^V"]QJUC]4 ,;8.8T\]PG
MJ4,B;7V9;;$;> J-G11E@A+ZIC_$PZ>8(.UJ5EQ[7I5:5A" 2[P1S@V#>.')
MQC6*S4XJ$W3'#/O%(RY_!GU\+9 Q2B+&3@;1"WHDNND[/*! ^U2J#_(,H:'.
M\$FG)JK/H8B#3O4OB3>@?V,<7@58 ,'GY2A=V7^J.;[U+U=] :H;<V072<?.
MQ+VK7O4J/@(Y4/#R3<M;=R4)/NRH(A$G$C2)?I>AC!BY6^?;4LGJ,WC<JVS$
MOPY*?VTLN->^Q9,V:C6#0/U-NAPO-'G64;0:RS4 <8!'7)M?9B@->KU=EM[*
M8=O29EG#-^3R6=T(+5'4WP3&;S#[1B4$O+KWG![Q,%KO[>-8>9L+Q2CJE1Q+
MK<?JYJI':,6XH8ZR*T,0K,RC<T;>?,^3B]X_P7EU?,M9[9ESM6(8-P\C!MH'
M'IHFAL+]%Z0K3**>PWNNZ5+&Z/E:%U&3!"$YPA.%D8LZM7]C%R<"'KV^<Z'_
MW WV^8#S5V8T-I9^.W#R4.NGW!F=D+* 9L@(;'H=PJ4AF]<:U)?W<9;':'7"
M8#65_5FWF.H^),ST76&[1"(2UH IA;3SOA'T1;R9>8 7Z57 ?KZ']SH%NZAW
M:\DQB2L"M)0O7O]B"D['URDQ\+]7^12@$R.&&.H<+TRW1</.0.C]WXZR J/P
M4\F?DMQ_Y1B5?TI.8JR.H*=E("K-G\ V[)\L_VQ[%."OEB2X*Y\S.[CSR6Z4
ML3U!FU^H)@<SCOU[?; /K"UVDJ4IVB3#UI;];6S%Q(47:_G'-OI&/N1(CU>B
M;J,;@_YYH7^G"*V?=B3MM:/+=2-V:WG46U5&,W)Q7M\\N@/@< D];\K:Z?O<
M^0Y[0N/$A+-MBKX'+)O!(TLU1\#CSR %ML7MRS).K6HP00W-_'19ECZ8SK:D
M8'";ZP-^5"V@L^'OLG6H=8QU2D)17;&XU41+HHRBSJU;C\7%G^OI.*B*Q0<W
MPTYMQPG.QD@^\+]:V)AOG2VR<.EYQ\WMYS>&?HRF1#$V(@B?YG\@_8]^S3'2
MZAU5E]C((*(U\:[;=.V J7,0%W <!%0YL@-["^'=)#I&W2GU>':K=V1<P27.
M6?B^^"<1Q6XQT4N  E61Y@-02QJ_TFX :+2?2!E[JFGFT:@_$\$528JC()%I
MY[B;1\BP9=V#Y@26[74/\< ,$-'NW:(& 8OU\1VH_"@*HSUAFU).& _Y=_$4
MB@6K=Y:G2"9TA3:4/!G;6@QM2H.&;C[U$F-T]?3.5!YST<O4/J7^2BC61&'F
MZ7YSKBK]+$F0)@S^5\E)PG?4V<UB(_%2[]!%<508#A>&CX9[QW'0CM,]X(#4
MYA@3])AWI&R,$@QX3=]4IM_>/:8LYVIU/WLB,%#F8OG9OT[?^ H45(>C>,62
M-C$D',0+<Q;]DV.FNL\</\=SMK6]Q/M1?!LA%+'=AI?K0B2=V4+ZZ3_2\C0U
MKH#)Z/G:24("\^3L!H@Y1:BLY&>3A\-/@!]EYYB,3MD%^_<Y2C? 2/<P@&1[
M<WU\-JKCG-SZVY@.K(=*3=SVJL5B +3ADN@ $764G@)Q)H3^+$?>I&<@V6<:
M.7]U9B&,?OTM4=^(4U;=P\JRM(DSU0=H9MS-A*@]0M=!*E-$6%F<]H@UNDU1
M1/AM2!Q#*;#X4]6P<[4T@UT<NQ1%RP.WC.NEP=9^C%;":;O2"EWE$SFO&_\R
MSM]L[Y$(CBLE>\X$1+PZU]XB)S"16@3/UR4P]CD@.<@>JAM"G'*2GK\3 !=<
M@\-GW2Z,/)[U8GOP;D+[U591:$%."WI=Z:?0Z$\CSYX*^+#"3&SNT&"=<=&D
MXFIIG<\%V@TENF=!#Q/D1'B9IG4>>4+>%GU^8;[7E7'8!KYB:^7B_F%^>'B6
MI&RGEC!J[(_*=-\U6MG54<TU3UE"7)XF[V29O,?%) ]AD^S.E=OD(I6HYP$J
M)9.>L)M"^@R$Y2*R&MX^:Y([0<\]D3 _,_TD>[1T]:%@O 0)V@4S4"!VDSE:
M ["Y2$T >F3O4FW:H2NXN,\[DD_,;F)](>R,DQDR(3QXP64>=U^^N$6.W@NR
M,J)?R@@J<["3C%X"21\;B>;4L$:[*0RSM0:%I^>/W!_BF7F/E]4(&;;^U;X7
MI?M(4OK9S_&18S#GB.)7<^.S?M=B;!4K%^M'9/1,/Q%6YK,D?TUMWR2H?(7.
MDL_X,,!.?_.2'):BOW!L:@]Z9XLS049SE_!.*3TF]@860S^8H*9 JA\KL+<8
M/&J/O*=&OC?&T[@DHJ" ";K*-7J?+-@J[A"[-Z?6_Q;PPIGDUO51[OU[A[X\
M>6$@:7J)^#:'EQ.1.P@OJ\)IUMJ,&EY2UQ]O:Q#6N]:/F5A2W0+X*0OU+8+/
M) >*5JZ8?$;,Q[Z1S1<ZPM=X) ";.2M_]O^IJTN5#6HS>&08$%/E2;8S<>UY
M-L7OA+1\??#'SO*CG*1@]C352,&,">+HJ4 NN5,Y/-6*FC;;8 *3[I!(;:=>
M)987J</TUBG,YC5WF<X$Q&%IP@7BF')]PZ+U'Z>; O4X^OW:[W 289_]?B'-
M *5I:(S:DT>(6B.XVDE49\C31NDWFOY5G.+T1$Y*%W)_1[=AH)=VD70BBZPP
M*_IQ1E-K(L.EVK+VV<TH=K&?2WW<??WOU(=JF:!FPG48+A!#*O?&=]72H90G
M^Q]VIA8=M:B>0RA^VEF2="-1:5U#/$\E0Q'L@:]VV.Z.2T\''6+\! 6[O%2K
M^3_<Z"OCF4:)F(F].-<B*CGH=7V-^V8,+F!HB/NXHMCJGXT[WT2S9XL:-504
M<[HJ.B6>7W*;UV&WNO]3+.[ST)(N34"=I3%36WA?POAHC^=X@O5(Z"8,A]T(
MCW#S@=-B,!,DH)$Z.+BF.98_=IS+^:J$7<#%#9,[-71#J@G-8Q#MB@:D]R+Q
M2@@/8]'\+."4PGK^Q]M\=@8BS^Y*\7(\311WV&V[Q#;H#"20-J9:#::M:,%?
M<ZN D2Q\/F?-TY@8[=K N<SD2A@?4IV5*!:H/_9*]/ 73!"@AQ3 H4\I,T''
M=$OL:+<R9W4&DFPR#SV7%F3'>>E]X/G8+$-K2-3;CA=B#('Y&1!TXQ4&%\)C
MK$TP!24#-,ZE\X+61L=/$:L5H_.+ES (AJK%6=S!V_& S[Q_L;RT^T# [(3%
MW!T2-OZ%G=%!-\2SO&_WODO*<9'SRS'ZV^WBQ5Z631!<]_IMDC3%D)X23[Q,
ME49P#36B5 !3'\=ORP>#[S?*)EOD+X8CO,?\O?GG_.4($L0V_W(V"JZY6W"4
M=H=T-&)N[>R#9YYIFB5?CCO-?S4\]?-H\+0RZ.G_+@5QA437*0M_F!^\<#SO
M^+%E-S:=J*[_?I'#R^O?BJ;^^RT,W]B66)-U&4X[@YL!TT[[SIPGQ-0YYVE5
MSWKYS$<T99ZI_,&G%W(19&\E\F;A5GJJ[TR<G=EEZ?BV^$@"R<>2QL_69B^-
ML2%A6@VYFRRNZGUXX278)'"M^13%;B\!*AN<R 0]>/&-,#VS&:6VUP(&+A.B
M-"#H@OJV]!D[[OM]%?>WMW2/IQC;:_5L*O^NAD0\AIT8VL.$HOA(X<*ABM5Q
MCF'A%_$7^;Y-W,]O4TI;C'$4LI?I\=@8\CX8[4!98I;VPQXTO<@W;%+T<B,&
MNXUYVG4/80!I+$VD<,X3(^S.!!V'P.L5##'Z_=*/G@"OOCX*R;01='PYY$^F
M)6HG7B7+G&%3!^/^0D18"B27P%+('E@A2 ,8D-Y\K6PF:!4'YRL2ACO'JS]X
M6SM?%HW9+;F[I1I#0A_RW(2,\,Y8T@0<YU(;BN4A(WVS%EDSO(<]W#I<"]UK
MLM74844F&E>VNEU>KSX7.A^@_VC: ?DC?P[,7:<Q\QM*6;]P]\3$URQK[^MG
M=CWTTZ"9%M ]]V\5)8D!KF]B6GPL3QJ'VT6T&IV9F- U4BF:RZL5PFW(;Y4'
M%0_&[_11$/\Y,(J-GBZ7!4Q1GR/U_OK9^<VKR&=>&'",T*]XG_&[5[-9872^
M6Q)S+!%E<LMC R^';O2"3'^ L%\,/G^7\J5G-SU2\*F%UHD*C!EOW(VBJI]_
MX]MNR6XG-3%!)#B$R$:6M60E4Q8EBI[-,[ S/O[3N[6E>RK];8X_),9O$\/-
MFJ])\(AK$\IV4FYH??>MZ1&] D_!:^]">L^\OG%P4ALEV'(6P^,#3!6[5@^*
M@Y4KGNV87]*EEE)*?FGY3(5TE\V,AQ-.3.,+WT]_N:,0:&3;F\1P5RY$U3XM
MBF3(HQO[6!)S,6;+BL9%_ZAA-VOUW.0R33O?9L6G=/DL)[YW73/2)*2PW8^5
MO/\*G>]2WBIX4C4974&ZH44Y3%!\B [X>.?U-UHXM3?T#,+F\!ZVCG&69;,4
MF2!G;-BO-\UJF6]SK\;![I+Z!<K 19AK2GO**S66ZQCJ#7= I68Q"ZEK[/N-
MG8-!_SH4QJ@%_-ZOO"?1_A=[[QW55-?NBP91.H)*1XE*DRX=*8FH@(@0$"G2
MHH+2!$0% H8$Z3T("E(C3:0KO4>Z@HAT 2$D2)5((A "*=SX[3ON_O:][W?/
MN>>6<_:Y[\B88^2?9ZUG/NMIO[GFFC]W:3))\YXMHVXB?U<=R_C\1178WUO7
M>DD>G+SRP[>:&,'@/D.UK,ZE7F9\S]@_DM1GOIPF'*<L>5@">V_,U=%N7YCU
MZ\0!( 9+-!J>1EGD>"%%$3H4:J]U:W!:=X$G.>OB_77#U/MM]T779V^BO>AQ
MHQU<B,]B6KS5D4^:.3:#%--6& QU.[.B:;C$5W]Z7,%JX-,0<4>.Q7[Z[X)W
M/4S  OHT,KADQFY.SQ+(/_+;YYK9TMG\[F!W;4T;>53;#^R>R@?:',6(RHKH
MRF-1=8+KT\,JVLQ@KWI7$G;$Z8\_;\]Q*K#0) 6WA[LI8$\5CC7D-^01I+LS
M>Z?0=8 CF(]R"6L>R_+U00I+?U-U27^BOC(;6SW[BMD_T6-!6;)(0'[WU [7
MA%)'VN,7'3]FS7Z$C)^'79>O%_-'%5S=HS($IP@C^.H];LJ/M=86)J0=U?%G
M0MH!Y+7*"D3? 4!LIUU^>:4'*W3"LNFJ*+[^:>;*B:ML-MI7[41/\RPFUV_;
M_34]%3Y7=A%%@# [Y>\4:>H56/1*STQQ^V:TOE53\:_B-\:%PP&+]+/"(H&G
MN'FK'K*XAK&G4/08'*7$3?/)&YO]8/$ 'X=/0/_:L>U7&]-]B+7G11G)_0#@
M)05R!'[S SH<*N2'=LEP$'-YN[C;V"!UU_7;Q\@[J*9.@T]5LI?HB1TB#M *
MQEE*HR:AI>&ZT*0WRYU5^UI&&$)P7\@.WQ@;K&5?0Y.XHS-Z[9.FJ$[5R(N"
M)8&6<_6^,<^A9P94->F5U^0&EZO7TVJI*&;="H<A!H%\&J*+(_IZQ/V^J2Z0
M1+U;<F_E;J]F=R(O=6NY0UM/_?CCNK2/U35/,*PPV<O]9)6(NG+])U1E]$EF
MANBX:</'94J<ZA03D! G5C2DV]K^C,7%YK5_DDUW_9Z3Y@#]=\L188E&<)M@
MVTIMN4\-/V9]&LM]VAU#'0WL+VG@"P7=&HPS+%[8^OVUU>.,7PIF_PM^-("G
MU2W,7])]6;+]#R]U!,(/5Z'XX]O[>UR.C/J)M@QJAC.1F'C,BI-V+-A5Y5G(
M_'+MB)]&OV_U'00=D>K'2A1<1?_UM=@CUK'O[+ZM4(/"0>><'*^BUR=_C2T#
MR:-:3$4ZO$IH\JA9Z(>3%"B>9<(5TBRV7G '9=YXD65;<!OXEV:_R;*%H^>#
MO8&'>/,N4*S)'ZWI][K7;E0A"44F@W0%(I;![>BC7$Q]"HO!7Y?@B;G\GN22
M63)_:]KA[>^7!?7)DT[\\=JBI]WO)"Y?SUF1W3?[I]:A>AA#4=3>L")ND:LQ
M"983*HAA@QZ6;12_PQ4),^YZ0W%)N3[*W'$UR^>MOH9'#(&E%' ?Q8)U4631
M/X,L>'9MJ-+I9I:7[4]/(Y>9W_-3(6"^V$<#F6^<UL8H:2U;C9 L9#"%VRA4
M91%(D<(2GN'F[FWH&^ J9:'UV-C-;;H7QXLJF+2OF!;[J8OLW[+(X&D5!B=O
MU1I#Z3TI@R 9?._QJ;HUZ9+([7YU^AM+XXFF-/%K*Q6>K4&BM]7XR%^\%]EC
M@EUL%(/(4;HMSI=R7I29;CLEV#?2F=%6A_"^'%,;LC.AXK:X/)&ZM[/G1*4R
M.*&/J;=AC@Q.9NT;PX'#:-*:=4(M5W8YWVJ&V2H$!!E\M4U_O!1>\+ )(-BG
M&[]_'$N^0IDB'0_HH+23[,O26C]N_6A]0@:\9(*5L%2%20379=QF#)BK#LSF
M["WT4_-E"O62Y,.:9N5UU6_JQRAVUO^<+E>4'V>.?ZE-M+ACY6!39E%HYK8B
M*]-A![[=;94LSL>EX%'4L>0Z1).D"M,$B?/3]6;<0_?OK03F/[KD/BTYH[HQ
M76WV55\!A^::H2=T@R1JQG#]JM,.11?I@<^RW/\Z8I>SQ6[^BVB^R5)L=/]?
ML2->_%OL_PLQ^P, O_X1G$H\B'N<(4'9,HJQ&M5\:MR J<WQ/ZN=OUYQE./.
M0 K'Z3 OOW]!K;9F4VI<Y&7M<TU)8S))L\QSV^-+I7S VK7<JZ7&IF_R2DL*
MS0,@I7OY"^AC<&-FJ3% 3*;!^/KLA+/07<-"0\LF >_>I6(#)YHOZ@B?=U.,
M!>V3]PHEM[&7IC20)U8;\B2)Y)(CA"AZC=,M%\>K$A?P 3Q5%3JGPSE .TO(
M^HQ.O@AL?4DG=3.*H391B<N) "64R_NF6;0"(E^&FNC=>J0M)QD1#@(S[QR
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M>I::P!MMHZF]"R[;)6WZ:V8PS=$9/V_MQUOS4@L\RNY)C(F!LC89 Q];<<A
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M!;7(O^8ZK1Z$3 S)*VC_-5<I8/0_"/X?2$8MCY3][Q9)04[,O#**'%!G2!\
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M,(TMFS.0* YEMVG]6C^HY =I/C_L'G22>+UH6=N81SP9=EJ,OD@!4V\PAL'
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M/HH#EANS6K0*I.A$' #B*\6A)V"^NR9(_FE*>)\/2/-^ZKY"G<=-E7GISAG
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MC&&,D"MEBZC=!16[\S7;#"H(0TS==+Y0!5]\(!/G]GN0X$SYHE[G_M4N%9;
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M?.K#=XG22Q(G6Y+<HQ@G8.D,[E %O#2CW%TV3; [LJ&EM2;I<T/#;R&GJZ8
MM;P@Y5#612PA*(#8CV](HQK0I"G:Y?#+)$9E$:AJYFCV6\-[1]%O*O*L6II;
M<B+C'*X7)*K>Y5A@SFICVP[%&,+4%P%/PJ%X:*2+#L6Y'':BOX/?7GH*KO!G
M5MG!_V%6W0]-)'4D_AP[$P8#XMK QW>JC\,4+)M&VSCQ[>"N??TL?:QG*TFY
M\;&/P)"K'XL-!ZENI$1Y>F]XL/$P*W:U.I>)X1[!-KL/ "?@"L05<A[]93TV
M^CUEF>+)$)A<)AU)+_4TV+OQR5W/4<MGZ>'YL'"1'ZR=9[$]*";X)V/%Z@\
M8=C:C(VI"MJUR3:@NY__HGB"<^#8];HQ,3Q8C=M?Z5//6 WOK,!MUJDSS":8
M(+B"K=4FG%I SZ!P-\$"<.$[R)*H]KQNVY$=V&&[$.=MOAIOSQ?'6<M#3O(;
M;CY;XF3VE\"Q';[HCJ,DE2@0I]<,$RXRI+U;*DNZ,6P>,SGF6J7W[OE+N5ME
M!=OJ$.YXC-R3;O0Y7JW(>AZP?S>>! R'-LB4+J(2I\"UJ+[-9S.8;M1)Y<2
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M%*K%DJ\L,S=0#7RG/KIN/WY]MT.$0%^J:'*&-$[&Z:J2P4[T&H9$5*VYE=%
MU^@(_=[L07]AKO:G]B]I[\>N'I\P>'@BNF$&S[?YF)QC"BS@;3+!S9%$0?\5
M5[2D80#JXK1&%N>96J_04&[X[<@OYW(O<>/U3\+&3JTFFL2P;[91M8!0RFW
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MFS0Z;#./<*+7,LYZ8^<[4!R)E,51%[U&[7C;5H-)(<.)4)FH5"7)^+-7K;G
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M%K(L#CL<'UZUKI.46I*\X7(&R:E4*E;FL'NO(*::+<BB3X(CB*_)&YD%<R:
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M76=9YZN1O-\@*Q70QH ,0CL06 /_6B24Y6"9==J0,CU+'GLC[/>L\J@,*83
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M>1([$8RKMQD2M+[;UI2X'MN50WWV\:/LZZR[$A?U6MPZ1FRRP,<.05Y(3L1
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MT$V:P<G%&!<+Z'IXE2,"?]NNBRLN75QZ]%@3]E[6EL/+OXI5JK;LGZO84$X
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M*89M<6KQ+G1Y<UI$Z\QN%QG8LQ?OD^OBYB7N !C>-MPECFP?<@<.)Z@G!,<
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M89F7,1N035>!N<@[I^5%*0RITACT40$]6 #]#OK7M=  C<W-D9X8S>$.J"5
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MS6":>IGB!Y((E'B$9L:1:F>'FALQ*,F $M$BMND\EN>9P"U"(Y/!QH9K!=5
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M=Z0LOV=-MX3J92%?\#IG"Q_%$1<H@Q%.)?N&<0A3%'C0]WQ)O"GC8695ZW2
M#',C7=V_J)-:=PX$K"_W#<B$G!2RO+(+E,'LF!'KR)B/S*='>TAM- !*!7"W
MBW^GQ8C]I,PA'+?=E($<S]N-RARHB\VJ+!XUMWK2NW6Q%SZ11)HA:<2*Q(<H
M90*F- U@&-*(1/*?N#>3"M*[@L^-BONM(Z8]WK6=\9$]X"/.X_Q]W0.[/<S
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M]7;3RY;Q).,XXC D))"T+&)(*$LA\TB$?$H2W[=R,UP><FZD?+:3T15]A@W
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MQ"+)(/*\#*8BC& 6LC2-PI"G'A]@VUJ*,5.+MY-71WF(3EC+U"K+"3$SC,?
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M!XXL"N-0(.CA,()(2"XAF$MJ"8,8!RR1_VRU);8<?VXDH^54[0S41U,K"6_
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M;I'7RS6WU;7IFLCZ>H&E5&E ITD'DV9XT#3]5(Q]OJ1G84>E+OGL)Z75GV^
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MD%S Q$S1/,)IAA7V"W^[*F]J^QZMNN!(7V 5]@V)NXZSXW%0./2&/AVZ#-P
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M"ICE.4Y()#/IMTUVNTI3FR;>M LSL]!7HDID+@]VVA^;G79;-;]N(.E9]BK
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MB1N20AS5</JRQT\*J=3ME_?ABK_;J<00<(Z<]V%C9WYIE0?VF_P+J,\P=@:
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M=]_5FMVKMS_56A2EJM*/YRQ&$=8QARS!.32>0 I)AA74,C<OD<Q($CF=0;^
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MO8>ID>>+5MC2>,[2QZV(YPO*22$\[P?T/-,4WY3<+HR3]OMRK<3J?EG\;]6
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M /-#N?&L6.""O9N_'AC1H?=T]MJ"5EU@]9V!0XT#)JFYPQ,V6<U![KA):^Y
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M+9_F.>6Y2M,,DE2;]51"<T@S',,\%HBF+%4QYWW"9/Q5F1J5'1AS&"O#*GO
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M.@.I-BJ]AH7S.04'?GI//_!\'^I]D_%73_M+FFWQJDMUG7;Y?FFTJ"(+RZH
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M&[%;%2',\ *2P.RG=-KN\;LNVV%G5\=$?5#@ZM2T4LH6I2Q[?OT"O$C4'8
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M0:M$5&LQV;:1^3G1+DTJE"$U4R;6?PFRBCXO/!+5K2!ZI3%G808EN5LA.Z3
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M@[:1>O\>L;L&^!(.6HO=, C$ ^UOOJ"VVZBL$;NX]9B/-MQF8JWAWO9@__3
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M/REH=2&8Y5S-]+TKX3@M14Q@S""(>9JI?4-@@%&9 TGCDC.9%9DNRW*]BN(
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M=++/U@71*C:)N$L%*/NU,^/]H"L2F-CU8NP1^8['ZP7I>3&VX%\KOV5-U\X
M>N5C>RD&)5QGD X9U7T@/TVM:\_+E]6,=>V3,:4(E30&1::+XN6" YP)!B A
M$DM8E@6RJEQ^;<*QV<8G>BS7(D>US+=UK3X"VXS2?$(8F,$NHS= 6^ISV 1M
M1GTTZ:NVH#X'P;7&TV>?L^]B4@=)?)8?%EPWL=Z0>1V!G$B&9:;.Y5*F2-?;
MC %&,@.(4U+(6)E@S.CJYNP,8^.2;0C.3DSKMB:GH;Q,'%X "LP4#MA8]3FY
MJ/_-K4Y.CSY8MY.+RO4;GES^8.A35UV=<IKEM$1%#H&,)=4WMKJ2 H0@R7(I
M12QCD:$P9ZYZ_O^-)RZJ%0MUWFI6S?=IRWHM1GC6>G,1]H GK3WP7NF<U<@P
MTE/6'D#N9ZS]8=R+?#VH1Z>DC&&.4@[* JJ35)%(@+D0((4B9ABGE'.S3I\'
M X_-RMF6K]+"V=?RJK&ZS#:W(!"81LR4=RK9U=?TYE)=]6"#E^CJJW"J--?>
MO]]:8>23[CA6K07_JOY7'6/43_6[_??%;%W=L;6R@-8_#^K)9P4C>09+D):Y
M!! G!)"T8-HVB3F/&2LRJYO#FZ09VXN]D[S9!R,M>]3)[EHGQ&69S(R1P< /
MS"G]&J1;3:*3JU%MEV.@&A\W(!NHCH>+1*]4J^,&\,[7X[AE4)?PNGYFFS*K
MYAL^6WP_F<]VOUQ4,][^\I]BSC\LWE4*NC^G L&BS-(,H$+91S I,T 1IT"2
MG/*"(LCT-9QI^)T'B<9&O3I-L,XF[4H0L[[DD^A1R:[C-T0MO4V8F8_ENV*M
MO<:BA#;S#C)^MQJ=2?&=1/?["Z;U4D]%[UYEP6SB!@=>N*'B"@=:0,OH0X]@
M7XY.]#'1@-&+'G'9CV[T.;#]O<B7U9)OF-J6%[PMGU6U^56,QY*3N  9XKK)
M.^* 0GT+&R<I2RC'"<I-[T;.SC*V7:X5M/9WMI):9JM=!O7Z+8D7J +O/4XH
M6=V57$7AYON2\S,,=F=R5<G^O<GU#[MY*Y2-+M1#C[IEEW@1\^5STPFQKM\X
MY33C0L04T%2GINCJII0R 3B$*"<E+ 2S\D9<G&UL9- )6W_/^4Y<.S_#98#-
M_ C>8 M,#'N(]22]6LG5^OQOA(C7\_WE&0<]OQLI?W@^-WO(,3UVL]+!L^^%
MMD[FWY3I+-0T']4JSA_(CW:.-V(AY&P]Q3$O.2]R4,88 DAI"6@F"I"6HDCB
M' F<")O;5YO)QW;U6I>BL,R0M<':C%Y"(1B8;5JQHU;N251+7G-/+7N=5=!1
M3_1+J\#YA&3[W%H'W/PFV]H(,&SVK0,T1^FX+F,$Z=7\YF=S,UN'0#1]QT0*
M8TY1KJL$2@!3 0'&) ,,)I00FB0TL\KZMY9@;-:248/@NE=9&\E0J]+W>SS\
MV06<_";6CTM^:P<YTZ6TO<L)L$ #WM\,M#:^6SJ?QW?(9LXGI!A3&^?S(%DV
M<+XPD!O!=MWLU+!TMNC<63K=7S'\GF/K8YOW_W-:0I3F,2M *?(40%G& )64
M UE*3&"1,P&M*-9!AK&1[)O=[<M6ATG$MEH<WLIT110L[\9=5LN,10.O06 >
MW<)_WX=_I\"AB_[C5?BM:?(& +T2I8L<@U+E#4 =DN4M0PW<Z?ZC$O3#6CQ5
M4TSS4@I)05*D.8!YP@&6- <)PDC&4,A4&/GO_8DT-C*]N4UZ](?6+:J5L[52
M;U]@0[-UT&4+;<<.LV+#]; _ GD<+>MW8OTU.M0?P>BM(?WQR&Z$_I[,5K^3
M^4:\^=G+<GN_$O_:B 7[6:=093G"$DL&2(P)@ 6A@+!"K6HN(!,92B1C-HQM
M,.?8*+F?K;D5U*G1B G@9@SJ&<; %.F$H#7A66#BE=%,YAV4LBR ..0DFT>=
M\^+N2?7X9;5\418J?_/S[XK=/BRVE?;:6,R9J*8IDNK_: &*$N:Z#$D.*!42
M)&F2<F4[TES8IL093CVV*QF=AL64Z-%S*[LV*);;XH1D*[AUMIOI6IC14AB$
M [.3!E=+'7WI@?N+ECR:+7Z-=C4@[Z[#[)+=9HF8[\0VT^F'SFFSA.5$.IOM
M"#=:44TA0'T;M*L2VI(H_[SXJHL]K?3$"_YIN5AUOVK79NOS)Y3F)"YC4,H$
M AAG"2!IRD!!9*G,K+A .'.RM6Z5;&P6F58LJC6;1%OIZSO6OOQN5S7^EM/2
MDAMRD0(SJJ?U<;< ?6$9QDZ\6;K7L29]@7K6YO0V@6O4(1?B20]TKY.%5NN9
M^O'+JJWT6F<+M06)6%X6)8>Z*08L ,SC#&"84$#S+,Y)$D/)K;KQ&<\\-B+>
M":XO>3K)E97:U2>N"S+8QB::+H,9P08!-S"!]G#M"1UMI6YS&_T7BK(&RW,X
MH^GL X<V6H)R'.9H.X ;@^DBU$(W#C](#*:93"G.8I#E9:(.TA0!7"8E2(H8
M%2*.)4NL#,LS\XR-G;1;=;G0I;AUC$DM]#;RKDX3V#P_SVL'!YDW)\#W\^6?
M__Z&J%&8B+X]BKKZB5RNGAJ/_E<Q)SJS>+UL1K,\;I];'C,>\P!Z8-:J)=17
MS]4Z:)[U%22\4M*YN08EH"L*']+-M8\[7O]N:%6[ =?O7M3_[.[\4H%%BCD"
M"8RIKBN? !IS#$H:"]UOJ""6E[IG)AH;O>SDC&I!;[EY/8>MX7VJ!\1"WY(Z
M@65_Z7D%";]7F><F&_:"\HK*1]>.US[O4.[@W=/S?/E3B-J4^:*^,X^*@72S
M,XU<=VA*99+AD@*69SF %"8 Y5*Q!A4Q+%'&E3%B7,W 8,*QT866+'KW[<L7
MB[1V$UPO4T0(M )312=M>\CIY(WJ[H0UBE?//6Y(6N3_>T9TH/3^J\AZ2MBW
M0.=B/K[).,.EVUMHM9=-;_.<8ZH;>9ZMFP8U.@9P1=A:FW]U/$&)!(P3GH-<
M%D)99R4!5*889'$)$>:YD+F5K^K"7&-CW)ZH42=K>SIQ"-ZX!+*9F>8)NL#T
MZXR:?:K:=3S\9J9=F&_81+3KBA_EG1D\XMY&5JS8C,R_D&>Q^K1<-QDV@O]C
MMG[4;I&[!=?_>?>OS>R%S+4_I=TP,U1P"&D.LI+IK%G) 44%!@6"HH@A@1D3
MMEUFW409'?5L-8F>M2KV#6<=E\20B08!.C11[3"NM9A$2H^H4R3Z4VG2>/7J
M0M'ZAYXV 7SGMX/JO>FMHSB#]\2]#;93+7-O'-&-2O\A9M\?UX+?O8@5^2X^
M;?28GV73M_?S9EVMU5>QO;)DTT1 *4J6@2+7V;HED@"5A3H59U*P&"'$&;=A
M3ZO9QT:8M5#N+;KMD"=%2@G!%(A$:)L8%0!CKMZ@LH"<2IAEJ9RJD>CRU;'O
M2Q$._4Y\0!KYVT6(-DT0G,[L>][4,7"+75U^]6HUG[NQ0O]0JVZV-09;R<"[
M82=WU H>-9+KFZ^VDWM/>.]%^IU0\[K=V4DPZ [G!,[AIN8VB-L^=IA^W?46
M3,J4LDP9^ G**(!,WR,34@#"89DAR6!!L<V.=6:>L>U-K5@U3_'E?$Y6U8[\
M+"GK'+1EQK)<%^P0,6$ XE@9 S3) "E$)GA""..%W9;D =QA-I]/7K<4/L!B
MF>TD'A8@M*?]1-D-[YTRK\#@=1,X-]>@=']%X4-BO_9QQ]OZ?F6B_[-9S2H^
M8_IV81O"F- L5]:O*'3!,Y(4@*:P!!#%>984)$YB:75I?WF^L5'Z056NJ"^Q
MY=7]%: -;_#]P1?Z(O\"<@&<*H; ^+W7OS+GL-?[9@ <W?(;/N;(+D17Z6DN
MM'0KS(Z[IC!+2\D(!G&6*#+!3 "*(0>(\122LJ!QD5C1RIF)QL8G'Q:S=>WL
MW="Y.M$NI11UBL-SW=#5ARUR%G)#@O$ 9&AF:;LYU$).VEZX6\O$(Z5<@<(O
MEYR;;%@2N:+R$7M<^[P;;6R3[^H(Q:_Z0/M9_KUJ$C_NGI:K]>Q_ZA"(KA(Q
MPW'!.2> P*P $"((*.$(Y''.,L[C3$"K Z>M &.CF4_+!:CS@.=U,+.X4L'8
MSR*8$4Q(: ,3SR[#MXU@KJ4'2PF4_%&MP"3JJ^"_=+0K>EZYREJ(03G,%:)#
M;G,>QXWS?A>5GJSMM2!C5F0)D8#A#*MC%R\ R2D#25+R+),IR[!5^<"]T<?&
M5JUPELTJ3@-G1D+.< 1F&&,DK(GCI,9>66%_AD%?^9/*';[/IS_D]K(V#7 ?
MR(^O0HLXF\]J)E#;+A>ZTX7.V^JVQ2(12%"J($LE!)"I\PZ&2 *<P)@4G"(J
MK6P3B[G']J)_$\WQ/RG27YY^C>:SIUD3RFKWQMN@;\8'@3 -[995IT==G4)T
MK;=UR?BOVNVRKX8.>.DITEDEM:VRN= 2Q)ID'&#T2D$V\P]*4 [ '-*7RQ#>
MRAWK.;\O=%#A!RX6ZYF<Z?N6-@^?_6LS6PF^GX^O_FWSI/Y8?V2:,UVRA&>*
M PMMSB18G<_R%!1(D SFE%-B5:')OXA65#E4<XV(U+)%I)7_YD+(MZZC&9N^
M[NH$)MW3991W^D5]!9M#H6XKW*C8^,-W2D:MEI/V@T%++7M:@]"5F&\5\[4+
M-7N"V:".LZ^9O.3Y5KL\=8D4ITO$%+U3"2#,,^V7HX 6(LTS;?QR*XOW[$RC
MLV\/DE<M\_[/(VKHN_>!4VCG_2%$T1]A>JQ?PR)DAF_U6KW1KRE])<?WQ /.
MN2+/*_&HC%%U.FDLUT]B_5DJ\W7*4F7^)20'.>.Z,P9E@,@R Y+EVF</<R%B
MJQ9JY^<:FU&W)VH;RV2=\7$66#.2\ 178)K81ZH]WO[R<5E5OZK3K%CK^S\E
ML;*;#N*_OI#5I2Z7+LD:U^#RG8UQ=KZATRVN*7XBG^+J(VY\\B">GI<KLOJI
M,S'63;GSZFZS?ERNM/DS)4(P7F8<L$Q 97%@"#"4.: ED@@7F!<YM;$XKLPW
M-KO#K+S:)");#=QCZ:\MA1D+>00X,!-M)8T:42==F/Q.6G]L8PB+5\:Y-N>@
MK&,(P"'SF#[F:LU4BL6^"F4B;<24QAP64A:@(*C0]@M27%.H(TZ&N61"<D:L
M(B+W1A\;L]3YW&JO737BV1HK?=Q,S1-'-((;) T07Z\ X6!@G%#8LTG1GV%@
M(^*$<L=FPZD/N;ZJ3<Y[G<"Y4=O>DUCMVKS1')$B3B$0.,D Y&FNK^*4F9 B
M0A BRH2 TV>QFBWYMS59K4U?X MSVGR%#V<.Z,04WV<+'4T>T::(H>V+?0GE
M)(EQ"=,2Y"16!%ED!&":Y("7RA;+F:2<I"W*[Q;\53#NY@UX-U<G686 UY1'
M/0$6G%?;RB%-&GXK:9#N@T:0>&;>2S,.S,0&RA\SL\E#7ON[O)\MU NSWU,D
MR8N\T T.$HHI@"1. 8XA CSC98F+3'W)"@_]74Y,/38'TLG^+K*3VW=_EU-K
M8<8^81 .3$57^KMLA1^RO\L%Q(;H[W)J^C'T=[D BV%_ETLCA"WJ<4>KFE2G
M,.,ICBD'G.$<0)05 ,$, ICCHF HYQFT<EK9"C"VL^;K%)?XCS"E)+:K;$:8
M(=<N,&U:%I3HDN3_Z%3Q>.GGBN*K%)C8"C'*&A.'$+F6F3@:9^">TO7_M*&_
M7^JS7S*5#+&TC#E '"8ZDYD!+ H"$L[3#.:,P=2JS8%/X<9&RDWGX9<V+KTY
M/0_4+?K4TIFQZ6LM2&"FO;F#]*1M)-VE&7RYO)S#M9*^@/LXFDJ?$O"OT5[Z
M K3>&DU?FL.A2OQ];:756:7_J8PT->AOY+^7J]GZ9[?-O)L+IC:?-TLU;Y.H
MKLMB/,W6=?6A)$8BD13$C#*=.U4"G&8"Q!GF:2H8B;'1!8T'6<;&YO<]^W<2
M/38*14^M1I-HL37=J%9'_\!G*Z7?<A4]-;I%.M)P/6^ZVPBMNT5U]1M7]C+[
M#[Q>P1VC]5*U2>ZM+M%OVZ7:6=FM0E&M4=2J%&UU&FYY+.KB#[=, Y7,#[]<
M=J7U_0!\L>K^C5,,5Y#?#Q9[M?H]#>G20J52BO_Y5CPOJ]FZ:CN-/2R;2@Q=
MD/B4)UA?:": %9 "F%,)*"4(R#A7RT@@S8B1;\E\RK%M=4UN6Q4]BGGM/1*U
M$M%JUYJM:NN(T%8#FRXA1HM@L%UYAS;PKM3(&W4";SO=/2RCNBS+9QF]"06G
M3=L5W[ .U7C% [R6+5ALD+K<A,5HI ';L-AHMM^(Q>I)U[I[:NOX4%4;P=]N
M5MMS4^,_:[I_5NJK]EGV.H%^TZV,VRM1GE&$> I(6G( &4, 2<)  3%,80[3
M'-NEV-PDSMBX?R=P$[MF$AT;;9[5QV=GZG,YA\O>N,Z&_J[!5B^TAZM>B4:3
MJ%&E=5)U8;>3:']Q^VV/=RKYK"OH UK/90=O$FG@JH0^X#LN6NAEU-O2X^L,
M2[5!:!=9DVPIVAHT<4QC1 H"XK+4&4XP 3@O=*QA5I2$,EI J^*&5V<<&_]N
M<Z1[$D^Z)&CA6.?G.NYF9.D5S<!\>"N0SFGC5\$)D@5^?M972>J^"L*Y'.WK
M#SH<_)V]\Y^?]0>K=S]TKYM*=(4:F3[.?%<6[7LR6_U.YANA^7+KUICR),\Y
M1#% C)7*Q(0E0$GM3)!,$ X3*8Q8[#6$'QLA_DWIN8Y$JT13[76B;U-;/;0E
MHZ]/GNK3GE0Z12]:*?WW?LQ*I'[@NL"/^OOW>LQ?%LMU--<4L7XD"T/C]%6^
M3P;>D!%_2P:YVGUS^6KW37>U^^;4U6Z+P23J4&@JXTZB'1#:?Z"AB&HL]&]]
MM_6(OSL6KI\1?X<&<B*-^KMDYYUZI<6\Z.<:6J;A/&:OA/:>[^VU9' QR#:T
M8JO9<Z^)@RQPDC*2 2YT;FB"2T $E" C)4Y(S/)$FE^['(\_-K.F+Z'-[G$,
MG(EQ<!,<H??OGG N;>=/0&*SY]T$S5#;DLF7Q7)[.*OW908_?FQ DCTK\SX/
MGO^8:V;L2J?(K\5;0=<[9UC[92,\+SF4%!2E%.J(EV- H4Q!P27&<2QHAJQ"
M8B_.-C8:VPH;J<.4J.J, ;I<<,LLJLL(FSFGO.$6/#JI@TP+VO.\!^F7;(")
MY[S-2S,.G+=IH/QQWJ;)0PXFST&=C<[8JC[+?Q!MHJVKQ@<_C3FF0C$($!PJ
M0XA ""CG,4@$YG%&*)<L,6M3:#6OS1LR3-/"[0%*I\.(E7Y#WIC>2/[9ZF9_
M^VBW6 ;&5X@%"$Q1QX5[ME+KQ>CD[BX60P!K8<*% '@@P\X7T':VGRU@%RU"
MX\&&LQ-M]=NS'JT?=@QB88^";W14S+84_:Y,N=I^]DN5/VC"V]4TY3$KDI*J
MS1<+M45DF6Z)0 1(LU*(C.642:NV]K<(,S:+M-.ECA<VK/)O&9=RR](91J4,
MM""AC_8.:Q']4:L3A2EMZP%7OP$IMP@T;#B*!^B.@E%\C.G&OUN?YMM9Q>;+
M:J.^][NWE'($22Q*W2 \!Y"C#% 90X 8@9BS-)/0JE#=Q=G&QJ"]JXG?!-&R
M/MD7Y+Z,KQD+>D,M,,WU .M)&J@ZMQ$H7CGJ\HR#DI"1\H<L8_;0D&$E_<N5
MWY<Z]?/#0KW9HEI7#VKI*IU=.,U3=>*G. <B3Q" *<T!+K,2<)EG4* 2"83"
M!Y&8B#HV FODC&:=H-&ZDW2(>WJCQ0T9T>%[R<8?O[%_M=XN_U;IZ&%TRS]$
M4(;OK\%?)P3CYJ_#0)$6-BL4)J["2(*_0!2%#9)^8B:L9G0[HMPQ5N=AJFGU
MR>=^L]+]&:8E033#% $N4G4VH2@%F-,4T#R6C)188"ALSB:GIQG;GMY)&3TW
M8MJ=1LY :78,N1V@P#OH%IM6PDG4RNCOU'$9 Z_'C3-3#7K.N*SNX0'CRJ>=
MRW%K@EDU[<IFU3_?_'Q0(]W]F%533K#@'*< (D[4T0!3@$11 (1I6K R)7%I
M64?_[%QCXX$]42,M:Z1%C?[0PEJFQ5R"V#3FP MPP2,.G#!SJ1)]#0W?-:+/
MSC=TA>AKBI^H#WWU$3?B>"N>5X(U+E/U\US4%LV"WSTM5^O9_S1'#D(D3'!!
M0)XP76@>2X!RSG69:%%FDF286"5!FTPZ-BKIRUP'+I&>L'9,8H2Y&:7X1C(P
MM_3%G41;@6L\[TSPM&89&X"\THW1Q(/RC@T4AP1D]:SC'8LN"2 ^SEYTU>BU
M^M;,=CU6>[.TK;?_2Y"5/CJ)*<P10Q@E((4)!)"II:")9(#'!<>,D92QV.KV
MQ4V.L?&5^EKFEI<PC@M@>#T3'M;0%S>U!J!6(=KIT'24UK$XSTV]L;XZDTAK
M4CN1/+8RNA%+O_<]CK(,>Q-T&V!'=T0W#G?C)70S4WO;RC_K]M3J$#E;?']#
MJEGOWC2+"<$E@B#5#B"8ZA1C@6,0%S##*$LA)*73O;2A &.CQ-W-:]<&OKNR
MYCK?=ZM%5*OA>(-MNCB6E]H!(!_LGML$[:"!/*XHAKD8-Q7B=>[*+2$Z>WUN
M.\Z->8'_.=-C?UO.-W5V8I=M UF2LB(&0NK('(&(OA5G("](BC$119(QIS3!
MD].-C>_Z D^B1N1H*[-CTMQIH$UNJ'W"%_J6^2)RM^8=GH;0,0WQ9BA?(2O1
MXLOHGJ=X$1CCM,73H[Q.%N-%C<XF-5Y^RO&R\87,YGJ_ELN5KNYZE(17)@P3
M67*0TI3J!J E($@9H2G/,YJQHE2@6UT[7IEP;-2[E1<H@4%= +>Z7C3/#6O#
M>TF/"(:^H3P&+VC>HRDT?B\NKTTZ[!6F(01'EYFFS]U6 O!^^41GBWJ'JKXL
MYS/V<ZH["$&$,Y#F60%@#"F@@@M THRGDL70L/G$]:G&QBW;6G5]4=U*_)W
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M5B\SIL;\+-^K\^^"S<C\PZ):K^HKF4H'^5:G_ZEMQ8 I25F:9R".8]UB&Q.
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M_=;WA 4@95+JPN,QS8JB8*G1/:'EO&-CN9[DH!8]VLG>E-2^DBUWTR)<YKB
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MV\QHMA,W4D=1FP(K=DMPF6'" AN8<0SBZB>]&KA5]#$DT!;55H(!/E#!%;_
MVU5?<<+N8@$6NQ&'J\'BI.E>&1:W$;R$Z7V<J?_P^GOXI0Y)$TKAJ<*=%U!
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M&CFSM=$=?JKL?4.=ZJ[NMYPC3K!3AYY?#J=1?:$RT@S\>N51>5N):HM^FZY
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M#;;27[5BE^\>']=F2^?S<J,FWF7!*DVY-$4H3<,42A8G$)$40QRA$&9(A%G
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MB*AZY2BD*0\@2@F#1.0Y3(7,(HEHR .GH,CNYJ;V@NY-!,38.-/%%-Q>URL
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MH E>C+@-* I+"7IVBDAI,#X4 4A"7X\*P!?H4Y#9V]^]H6 8H/3NO_0JZ$8
M\PG?.[)4*G3X$P'M7-F1#:X;CZ&R R<C54!9?P I3VS*H=U3?X^ 8F=A-@*"
ML^GTRD\^P-?9?#GB'AAH!L2H#$3:@/93!TFTL,+;0"733WFPNX'A]I.;LA+]
M@6)OX38"CO<P'\_2JVEZB0[]B H:HD+?B>*.BG;366*5R<1EED Z+YCJ#QUW
M'KT5/,3)P6-_\0Z,C_.K>1'<Z_$B^LE_@9]?\V!DR!*B0L\Z6"+1YR).9T>
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M/[F"D8C1*P>&@"GG0U9)=+U13"KB>O)<*IDJC279AKP6$'40#.[/$NA=)PT
M[26$Y?KFV1@69]_\>%(ZZ;^>S3\B?Z^^Q\E5.8H\BW%^!:FK[X;%\KJPFTE)
M%4,;GD6IA<%(D#CJ,11D46=GLI/YJ2.8_0%X$-G#3KCH'YC'TV$#@$4N2C_"
MQ0>(@&L0^7P'-[Q E!X\!V*-+_U:< 5:T(9DKEBB+O-LG\K2'K"E/D'5,*%>
M/;CUIH$&T/1^#E_].+WZ_A6F"T#K?K'\ O,[,ALYKTKDRDG2&BUZSHIXAU^X
MCCED&QP-=6;S;$'<,(W1ZV&K;WTT +%S_W6\])/Q/R"=SZ:=B,YGB^7M-<,X
M. >..,-*1:D&XB+ZO3FD8($SRNU397B'N''/D#9,._6:+ER?NF@ 7'=7!HU*
M.R$9X:S<Z:5.D^"2(XP!S929;-53^>R>(LIA6JU7W._VEO'^ )DA2GO:X&9?
M8;[\\7[BR]":5"*7KR53@Y@?>8[A="SCI'7I+I$1[!8W:J)=Y#'[%($_=7W@
MD)UM,U4M>.>])")Z$WT#=N;E^K&EJO 2/OGO*SD53E09QA>M*4/6].IR;T /
M$(,(3@U/#,#62?9NIJD%C[L7"/4D]@8 =(%+P9=& F_!+^##^/.7Y47^'5V\
MPM!(*.T#I4!$.3B2WI="9Q29\(91%]&KXW7R"$^2U8)SW0N,^A-^ TAZ/9Z.
ME_!V_*U+9?CIYS%&H#_7A6'9@0V6\%C*FK6AQ+DBI\2EY=9+RNIDU9^FJP5/
MNA<L]2C^!L#TE]DL_3&>3$8R1V.#](0)Q+_TJ.*0DR 43!:4"X=Q9A787%/0
M@M?<"T#V$FD#4+B5:7@WF\:UNU\Z9R67@7C.'>(9!+'>(KR5YA(B=5S5.=Y]
ME)QAAA75V)$.%G8#B%G1/](4+ \<8TN9R_1Q&4E0F1/#NGE]GDOSU(6F0Z/N
M8:8053NXW4F<#038;\<^C">KDY=IZB[R?9E-4.B+$N\M?]R(1B3TLE)*) M?
MAH J7095,,(-1"<L*_]5@<FV% X;>%<O(:FBJ :LT"V^[F>]>'11,1,(LV4'
M=FA/0YF!02.+.CAI+*L.N:;*3.I@8#/0#E%( ]"Z/NE[[W^48[Z;$^-LDH54
M.E;[5%(/F02M&?$>F.$N6)GJ9'P>IZ<92!VD[0V'K >(O@T E9*#AS(:41J%
M$1(("&G*_9]$O'&>:,\@8^B(C#XU<>(@##U.TK#;7ST8]:" !I!T?5SWM_'R
MR_G58CF[A/DU5]?-2D=2:$4S>HU:E*;'EF7D*6@"W%"3HZ+*53I(W8*Z89/2
ME?#5NUH:@-K=;.D#;A*&HD$ZBE&II^5:O"YM"35)DG-FL_1,U@GWGJ9KV&1U
M)7CUJ(H&@/6(%9;,X_M*9US)7)G^P(G#()?@3RZR(%F,Q_+0A\U05P+0@2)O
M(+_PI(6]G3M#R LJ&;$ZH&?(T=PZ1QV)0J;(K1*YTC'LE@0VXU[5"_QJJ*H!
ML[7!"-]BB'F [#DGC-- 9#*<A$@CB<%%#BY*7,#'W!)W1-TQG*YZJ.M7/2W@
MK9P-W!+=+4Y$Z28#H?,?39%3)-XY2XS(P;!DI+O?7*#/TYA':6K&[ZJ(L'X4
MT@"T;C$Q8DY297,B*9:N9\)2$CP@$\QR9[D03P\.Z<7U:L;G.DHV=">1-^%Z
M75Z.EUTWO7+O"W=WM+(PC865Z$5&:YI)+D->I90)G=+H202G,T]):E''<7^"
MJ&%+"([D8O6CD@9LT2>X+.T9YS_NB<?0&$*YSP"*H7>(OB NDB2)\3:K)$3P
MO@ZR-A T;,W!45#5ARK:0]3UO=2SRW*2<+9<SL?A:EE.$S[-WG?"'V5<&M0J
M3@ 7#Y%!4^*I] @.:AEUU&A;I[IE9U*'/>3I!2!/@ZYG;34 QX>+]<UT?17U
M?1DJAJJ[PV5Q*TL$/9O@)WZ^OJ;Z\PJ'T!HEK,NP7(QB@@W$*9!$9ZW!9!7I
MD^U>#VDJTB<?PY;K',6<#JCX!F#__OJYG1A630$H<X$GM!/1:E7F?T<2LM,H
M36D\Y)Q]YE6P^P@Q0W>*&0X;#^^:'J2H!K!VJWO\BGZFHW2EEM\):4O]72*.
M8F2>*-,I&YT9K;.AWZ=DZ&*R9E!VD(H:@-A92ET-GI^\]^/T9KJ^0CL*%I+.
M49(4RD5_GAP)I>VSI2X($75B[JF6>0<4<#Q.T+"9WH8 UX?"6L!=C%>75Y,R
MOJ#+/Y:!.W/X M/%^!NL[L.]G2W*G9.+_,E_'VDCK/3.$\ER7#4O##%SHB/7
MCNO,N:Y4A;T;H</FBUO":44%-X#?#[#TXRFD5WX^1=$M;K'[$O(XCI<C=#%\
M+B5\*95ARCXQ8JVAY>)#Q-T@65;IV.QYVH9-3#>$TI[5V  P'PIW%)EU!EPF
MRF@4D$0. N>* #,9?P7.R#IU<P]I&3:'W1#P#E13 \<GS^4:1L;+3',,)/@R
M R#+,D6/>\*"E!XB%:92WYOG*-L*A+V/+1SJ6.YPY?0&MF.U<5XE5+_ <APQ
M<KC#Q8$]G>]^<MT&ST]P<<QNSY1K[U)2),ER[B8L(L530QA34H$W(>LZ762.
MTNUY,IG]@1]=NBF^G%V%9;Z:/&R =UU;&)B7OHQ%R52C Y"](D'@RDE9J>P<
MQ>V@3HYZ)S*'S@#VC*D'@44UE37@O=T[-4(3<#'O))JZ[-)[F'=C)$>2>MP>
M9'$X/!!IRW<9@!B+_U%KM4]U,LY;$CAT?K R!FNHJ3WTK2:6GETMO\SFI:?>
M"-V$Y+UWQ&<N2>GU@1Z)%L3*F%,"K@*KX]$]0]C0R<'CHNT@M;2*LC>+Q16R
M IPY*1DG@&8;0VP,KCR5BG &@4GEJ')'J8ZY3=30*;TAT+6'.EI%UNV)RV65
MY" %$5PDE%/&1:)2)M%R%@(XY7*=HM#G*!LZ(3<$QO953'M >SO&OU*GKM6I
M<QG%/,HIYLR5(YJG4I>?,'[/)A.N P>P#*WS47;+1ZD;.A%W7, =KJ &0'>W
MH&&CSXD.IK..,9(9"DNBATF\*A=#.(J,96> U>KZN@U]P]:;5@=>!24U![T'
M#JC(V5@?&;$NH0-J7=?8BY+HT64 =$&=JU.6\C1=P];B'1EJ!RFE48BMO5#D
M0U')(F&9V]7<R>""("H%#UFCY&2U"0T;:!KV"&$0:.VAC$9A==OQ9!C92 X.
M5<^AE!UP$G)01*D,VAJ(/-6)")XA;+LD+OVG0MB^>FD 9K?* )_8\P,NCVB(
M]E$3&60D-L1$F!(J*Y82C]6+-P_RRMCI'AKTK9^V(/<P(RC!=?,PO'8H*JLM
ML3('#'2" Y62B*G.1>HGB-H.8J=[)M"7/EJ$UGKOEUFB?*+"O5]1(DT$XKS.
MQ)C *:/">G<D6.W@A;'33?SWH8<6X71[H[<J9 A"D2S1]$J)DG*^'&- 2%'P
M8('6<<">HFH[8)UNSK\WC9S"A/>/G_#K;Z_>??IX\?KB_:L/9Y_>X&\/+0O:
M\*F]EP1M0WU/Y4"KJNP;\/WL^IV=T50#(BTG(C6U"(@8B5?<)PU&!%['<=U
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MRT>/M434C ?O""W+5G+\@C]IY-H92KUUR/DQ</@\J8//0!D$F#VK<'"DEI/
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MC.QP&1V1G!F,$(U!#"7+LY 21)TRYZU);&ULRY'PV(?"&D#B]F6W(\ND=0J
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M=]H:$2J!\%G:6D'C02"X#ZU^-3)TPO/1%@DW-<87WV!>,K[=),W5=?;?X#+
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MHY)$)/P-"S[@3U4@=)N*85/WE2"SMY@;@,COI:/_J\5R?.F792ZXXE* \B2
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M1,H+_C.PD6?":Q8$R3:7D[HDB=-E!HEC0#6E-D&ED\TGJ#K-LZ>>3%Q?VFH
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MD_S/A6!]Q-@3I4 SHR7AB1%)\)H ,V "RPQXG7*.K<@[#8NU"Y+N6ZS^M=2
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M.;M \6ICX.ZDKQ-4GA<\ST%X.$WVA,_[Q]N/_&U'Y A17/'"U&*X"(J;1"Y
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M>PMZ@K$^\IRN[]A.A<,K.U+N_<VD,%94"!&2B!X4)D996ZDC_412G&6&C5=
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M,R *&NYR--JWN6G?G\9Q [4SX6X@%74(OALG_A$77[8<"1>Y#=*!=U[5]"F
M]ZZ^686 NA090IL!PB_3-NZMZIG/U2-5T@'(_AZNKM=:^8CI\VSZ/]>;2%<H
MKQG/"7QFCFA/Q(\4DH3$=$:FG"UM@/4T/>."J7&*.8 *N@32UMY$5$%HI<'8
M3 ;!G:,CG](GIA4KTG)#_W\F*/607 ZA[1<!=(3HNX30'U_K'VLH.9U]^NL\
MX]7-49XB=\D($,Y)4,I(\ 4I'?>.9QZ5UNI<H'J.QMY@=@PF7@3:( KJ 'J/
M7/QOMZ/R7*I/KM(#2Y8<NW1TG&M&Z7'F6J .K#2ZP7B.HG%W-#4^"@=1P]@O
M0X^8>/@H\<?U:KD*LTSFLGFJG^B4;*BEC4K5,!%-A!"E@6)9RE)&&<JCTO7]
M&@)?^-ZNBH>/5/2.[L AI=Z??_HS+/Y8K(MG<_7)^"<N/GPFP4_,NCC$9BA>
MUY:BE,#EX-9=W9XS%W-H4Z2^)X%=U4F<AKJ6JND <9MGU25I9NO=UUPL?UTN
MKS'S"3EW4[37X$(]WYVV%*_* B7[)#5#CKS-T-W=='7U%CD,O@94Q-@GXP^L
MW/W%^ZJD"7>Y7L*0+T;+09G:R9U5@)Q+I*C5.QO#7F?A2]_4U87" *??H)+M
MP/N\QU0#RVF9ILV<X3_*K= ^SLFG?@DS$O1&?A/+6:SR 1XRV0 %F. 9%\"C
M$=SDS(MJ\X)]$)E=1>[#^*9V:NH @X\D=M_M3GB110A?P#!&0F/HP"4DH<EH
MO!+2LMSF^-M!U#ASL<X96QVM@E[1="\OF3AM0G*5BT#.62E)![G.$4KBFA+J
MX&RCQ7LO43;.6*OSX^I89?0'KM^F]#\Y;*[F*D4X2W>)2(B"4@XKP)DBZ@U@
M ><VXW*D"86E@&UZ>0ZA<B_0N4L&W7!*&CNL_V'&P%V1T<1:KJ0B0\J\3D_1
MFLY\FR((2;FO"EE$/&K<U?TOV0LK_B*P,J@\Q\;%IK5VG8[\?;XBM[JN_%[^
M?EU?"/XH]'>XG$A*8EF,#"26NNT/,X1ZJC.2G3&JA"#C7@#9Y]OVN_1DEP.5
MP44\-F8>B>CG*TRK=5;[=AX6>?.XM/SAO*[STY>?YU<4%2;#F6,&I#&1),E(
MDDG2'P.WZ&.PS/-C_,VAA.R'M,N]7V^JF,Y ^#Q7'TBCRS+%?&-P:[%@OB^3
MF@5/5_27$V8ML<T*A"!4W;.22/;*40(C,,EL0Y+[-0"UH6\_R%[&Y7PO:AP;
MR??.A_\B1NLC?5WD2]+8BU6T@D?F-11=)QCPNKI<UH8'Z9,61>N8V:&'\Q%T
M[(?,R[C6/[=:QD;@(^'=Z]9;L[\N$_^XF'[Z5#<_!Q\D&1$46^IZ2F/ 9ZF!
M3@>5N4^>/WZ]W,]![OK2_;!U04\!K03>+Y#>?/JT6.\<_:,0661,#WA4J#DZ
MDEP0CJ)?6[?5BY3!<YMS]E8Z(T\$U4X"]@/89=S[GTT1'=RI/=FV?..>/V"Z
M)G==1VV$JRORT]]ONHVW/[B<6*.M,>2:2Q#$+OEE"-'7=P_,J!F/LM%(RA,)
MWP^OE_6.<$Y=]@K=G_^-BS1=XMHF;__QED<^<5J(:).'6&M3E(\9G(P49)24
MI'5T3I@VXZ&/(G<_F%[6LT1[O74 SAL&WLSRAH,'[RX,+:]KR4VNN14G$7I4
M!5*,3,C(H\4V?2>[J-H/:I?U&#&8%CI'U...K4E1PLO"/!15&RV,4> \"BB<
M*Q8T"Q;;S-$\A,K]$'<93QK-M=0Y FMOX 0E5SER =K4]4I8;S\-%L"@%?<B
M,<J_SHZZ2ME^!;F7\2+21!L7O'CAP_67+R3:>=GC9^^)J.V:AA.).M=2AR%E
M=[X5$,QP)B*E*5$AJ&!E+8G29$.2SFT;N(YM1D/UL +"2!-B]AX"R[6^WM<5
MAP(!32G6"53&GZ53ZQ)70!R FR-60!RBF0X.\^>'TAMI31%U85F=(Z=(,!!T
M;1IB.2DO'&<\-X'8Y:Z .$CW>Z^ .$01'2#JB1F_+F?O$C,@>"(.>$W:8]*
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M]7FS%&#(<G"<S@G9Z&[D.9(Z;_5JCI;G+E5/4ET'&#SZ]?&WVU6DP4=R!"R
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MJ>993MJ,1"\).0^4[C-91SLP(\"K@!!3HK0_>9=4HV;Q3D>B1\V\%-X#<6Y
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MC.S#?/VOGU:(/R^(0%R?WW8^#IUC5M9IFHY2>>8UR<4)LHD<54J*6]=9"^-
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MQ)4GPP(KN-6B#J9TQWE0?)R^OI+=0Q#Q MA&4$\'H+N^%_MEN5[/N(K:9"M
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M)H6.X+-#LAKIC%2!)=W&1^U)<%_O\GO"97E\W4U]=;HKCW\L\GR=:O4RYNU
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MK!V@E/:E+]O_4'^)1/+_^5__'U!+ P04    " #R@[M4H6\=V^E&  ! RP$
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M1R7T_?C1R49RQU8IN/ &PKH:[6>IZ2H1P:.CYG#TT,$AU^DZ0_ 8;RD:=ON
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M+FUK]+%6E<G=2=+68W)[-?3D*B6.ZI+$>4#IOZ>-?.+V*#YV<DV,= 4]/+1
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MU>^,2Q,\SS/<KN]Y;OO7N]<&Q'"S[_M^#[3B*1<Y+(T^\ 3X5F@7VJ$"7/6
M0W+_[%U_/!T7:']\Y/3L@>NWJV[S6#"O3EI;)RS3%.A6V9"64(983%&F8VPX
MD65R)_R&YE3MVS!EL0FH* @2I9ZF4J54PD?&MEIK41-PH,:QC2^0<%'9WFL5
M( R_.C4B3FMR/.<?)L=\9G/X!YO!\5'''\AJA0G).%6*P/&1UQ] Q+>QO@OG
MY_/_%]X2Z>LMRCJ1,6_#6/^9]!UG%+T8TJNWI0<1WQY4"EZ/:4'=+:[)DZ/+
MX;?]2P6M)<^VZFF5ETP[S5I/9=5\./H)4$L#!!0    ( /*#NU1/\$]!YP<
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M3\3UA(T3.==+F"JZ$MJ@[C:,VX?>;EA97D.;7AJS8>V+ 5QKZP WO!.=U[H
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M3.7>F9 I4F*A'IO\Q]G8^EH>TYD#P\Z_4$L#!!0    ( /*#NU1M#0X:BQH
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ME68G)]EW_W]\#*/<A^?Y)5NM<O6W!W-=C&<*!W#Z^&11/5WJM)J='AX<?/.
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M: L)-\V&VGNQN;U*%=2>;4&"@O #^, 5MF?K"?BX%;\@N7OH(Q)8BPZ@&A[
MEAB3FZW,5($0E^1P">2EP/L@(+OEH+#?>& C4"*YPM>QV:6VJG>2R)F!U>S
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MW,T;,%S>8;"@\PE9RZJL,?H QQ,QH#>$$U6H3%=^B6->BY\ R]AMB<(^LJP
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M!S>V("-J'%1(.96%_H^S;Y[7)TK%!25X[H[M>3S,]A OWC>6J-M;GV%Y(M:
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MD04,R2<R>QU(YWRN.$8XU'.HBD"J;& >%,7B"[TI3SI*SN';Q( (MUD)AP'
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M,C R,C S,S$N:'1M4$L! A0#%     @ \H.[5+>,HQ/D%P  J@@! !$
M         ( !>=H# &1O8W,M,C R,C S,S$N>'-D4$L! A0#%     @ \H.[
M5*-P7=GC*P  ^L0! !4              ( !C/(# &1O8W,M,C R,C S,S%?
M8V%L+GAM;%!+ 0(4 Q0    ( /*#NU0-";/KJ((  $45!@ 5
M  "  :(>! !D;V-S+3(P,C(P,S,Q7V1E9BYX;6Q02P$"% ,4    " #R@[M4
M[@.,GMU@ 0"ERP$ %               @ %]H00 9&]C<RTR,#(R,#,S,5]G
M,2YJ<&=02P$"% ,4    " #R@[M4P9MU=9Y( 0!JT@T %0
M@ &, @8 9&]C<RTR,#(R,#,S,5]L86(N>&UL4$L! A0#%     @ \H.[5,@D
MV".+T0  >@P* !4              ( !74L' &1O8W,M,C R,C S,S%?<')E
M+GAM;%!+ 0(4 Q0    ( /*#NU2A;QW;Z48  $#+ 0 >              "
M 1L=" !E>&AI8FET,3 S+3(P,C%S=&]C:V]P=&EO;BYH=&U02P$"% ,4
M" #R@[M4P,G92>X"  #1"P  '@              @ % 9 @ 97AH:6)I=#(Q
M,2UL:7-T;V9S=6)S:61I87(N:'1M4$L! A0#%     @ \H.[5-E.X <# P
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M>&AI8FET,S(Q,S,Q,C(N:'1M4$L! A0#%     @ \H.[5$%*_U+J!   BQ0
M !,              ( !Z'\( &5X:&EB:70S,C(S,S$R,BYH=&U02P$"% ,4
M    " #R@[M4;0T.&HL:  "O?@  '@              @ $#A0@ 97AH:6)I
M=#0S+61E<V-R:7!T:6]N;V9S96,N:'1M4$L%!@     /  \ _ ,  ,J?"
!  $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
